PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Murray, PJ; Allen, JE; Biswas, SK; Fisher, EA; Gilroy, DW; Goerdt, S; Gordon, S; Hamilton, JA; Ivashkiv, LB; Lawrence, T; Locati, M; Mantovani, A; Martinez, FO; Mege, JL; Mosser, DM; Natoli, G; Saeij, JP; Schultze, JL; Shirey, KA; Sica, A; Suttles, J; Udalova, I; van Ginderachter, JA; Vogel, SN; Wynn, TA				Murray, Peter J.; Allen, Judith E.; Biswas, Subhra K.; Fisher, Edward A.; Gilroy, Derek W.; Goerdt, Sergij; Gordon, Siamon; Hamilton, John A.; Ivashkiv, Lionel B.; Lawrence, Toby; Locati, Massimo; Mantovani, Alberto; Martinez, Fernando O.; Mege, Jean-Louis; Mosser, David M.; Natoli, Gioacchino; Saeij, Jeroen P.; Schultze, Joachim L.; Shirey, Kari Ann; Sica, Antonio; Suttles, Jill; Udalova, Irina; van Ginderachter, Jo A.; Vogel, Stefanie N.; Wynn, Thomas A.			Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines	IMMUNITY			English	Review							NITRIC-OXIDE PRODUCTION; GENE-EXPRESSION; ALTERNATIVE ACTIVATION; MOUSE MACROPHAGES; ATHEROSCLEROSIS; DIFFERENTIATION; INFLAMMATION; PLASTICITY; DIVERSITY; MECHANISM	Description of macrophage activation is currently contentious and confusing. Like the biblical Tower of Babel, macrophage activation encompasses a panoply of descriptors used in different ways. The lack of consensus on how to define macrophage activation in experiments in vitro and in vivo impedes progress in multiple ways, including the fact that many researchers still consider there to be only two types of activated macrophages, often termed M1 and M2. Here, we describe a set of standards encompassing three principles-the source of macrophages, definition of the activators, and a consensus collection of markers to describe macrophage activation-with the goal of unifying experimental standards for diverse experimental scenarios. Collectively, we propose a common framework for macrophage-activation nomenclature.	[Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JR, Midlothian, Scotland; [Biswas, Subhra K.] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Fisher, Edward A.] NYU, Sch Med, Ctr Prevent Cardiovasc Dis, New York, NY USA; [Gilroy, Derek W.] UCL, Rayne Inst, Div Med, London WC1 6JJ, England; [Goerdt, Sergij] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, D-68167 Mannheim, Germany; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Hamilton, John A.] Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia; [Hamilton, John A.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Ivashkiv, Lionel B.] Cornell Univ, Hosp Special Surg, New York, NY 10021 USA; [Ivashkiv, Lionel B.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Lawrence, Toby] Ctr Immunol Marseille Luminy, F-13009 Marseille, France; [Locati, Massimo; Mantovani, Alberto] Univ Milan, Sch Med, Ist Clin Humanitas, I-20089 Milan, Italy; [Martinez, Fernando O.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Mege, Jean-Louis] Aix Marseille Univ, F-13285 Marseille, France; [Mosser, David M.] Univ Maryland, Dept Cell Biol, College Pk, MD 20742 USA; [Natoli, Gioacchino] European Inst Oncol, Dept Expt Oncol, I-20146 Milan, Italy; [Saeij, Jeroen P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Schultze, Joachim L.] Univ Bonn, LIMES Inst, D-32115 Bonn, Germany; [Shirey, Kari Ann; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Sica, Antonio] Ist Clin Humanitas, I-20089 Milan, Italy; [Sica, Antonio] Univ Piemonte Orientale Amedeo Avogadro, Dept Pharmaceut Sci, I-28100 Novara, Italy; [Suttles, Jill] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Udalova, Irina] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [van Ginderachter, Jo A.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium; [van Ginderachter, Jo A.] VIB, Lab Myeloid Cell Immunol, B-1050 Brussels, Belgium; [Wynn, Thomas A.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Edinburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); New York University; University of London; King's College London; University College London; Ruprecht Karls University Heidelberg; University of Oxford; University of Melbourne; Royal Melbourne Hospital; Cornell University; Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; IRCCS Humanitas Research Hospital; University of Milan; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; University System of Maryland; University of Maryland College Park; IRCCS European Institute of Oncology (IEO); Massachusetts Institute of Technology (MIT); University of Bonn; University System of Maryland; University of Maryland Baltimore; IRCCS Humanitas Research Hospital; University of Eastern Piedmont Amedeo Avogadro; University of Louisville; University of Oxford; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018; Gilroy, Derek/AAP-7227-2020; Mosser, David M/I-6697-2016; MEGE, JEAN-LOUIS/O-6063-2016; Fisher, Edward/ABE-7469-2020; Wynn, Thomas A/AAO-3523-2021; Martinez Estrada, Fernando O/AAW-9409-2021; Van Ginderachter, Jo A/H-5473-2013; Sica, Antonio/AAB-9546-2020; Schultze, Joachim L/D-7794-2011; Natoli, gioacchino/J-2100-2018; Locati, Massimo/ABF-6807-2021; Schultze, Joachim L./ABA-8176-2020; Lawrence, Toby/GLU-3895-2022; Mantovani, Alberto/HCI-7449-2022; Gilroy, Derek W/C-2588-2009; Natoli, gioacchino/ABB-8679-2020; Allen, Judith E/C-9198-2011; Locati, Massimo/H-8404-2015	Murray, Peter J/0000-0001-6329-9802; Gilroy, Derek/0000-0003-3476-0844; Mosser, David M/0000-0002-9503-4187; Wynn, Thomas A/0000-0002-7244-8731; Martinez Estrada, Fernando O/0000-0003-0908-9366; Van Ginderachter, Jo A/0000-0002-4442-7474; Schultze, Joachim L/0000-0003-2812-9853; Schultze, Joachim L./0000-0003-2812-9853; Lawrence, Toby/0000-0003-0967-6122; Mantovani, Alberto/0000-0001-5578-236X; Allen, Judith E/0000-0002-3829-066X; Fisher, Edward/0000-0001-9802-143X; Hamilton, John A/0000-0002-9493-9224; Saeij, Jeroen/0000-0003-0289-7109; Udalova, Irina/0000-0002-6716-2528; Locati, Massimo/0000-0003-3077-590X; Natoli, Gioacchino/0000-0003-0711-2411	NIH [AI062921, AI080621, HL084312, AI18797]; Alex's Lemonade Stand Foundation; Hartwell Foundation; Cancer Center Core grant [P30 CA21765]; American Lebanese Syrian Associated Charities; NIH Intramural Program; MRC [MR/J001899/1, MR/K01207X/1] Funding Source: UKRI; Medical Research Council [MR/K01207X/1, MR/J001899/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062921, R01AI046712, R01AI044938, R56AI018797, R01AI080621, R01AI018797, R37AI018797, ZIAAI000829, R21AI097485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102589] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Hartwell Foundation; Cancer Center Core grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NIH Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants AI062921 (P.J.M.), AI080621 (J.P.S.), HL084312 (E.A.F.), and AI18797 (K.A.S. and S.N.V.), Alex's Lemonade Stand Foundation (P.J.M.), the Hartwell Foundation (P.J.M.), Cancer Center Core grant P30 CA21765 (P.J.M.), the American Lebanese Syrian Associated Charities (P.J.M.), and the NIH Intramural Program (T.A.W.).	Ai D, 2014, CIRC RES, V114, P1576, DOI 10.1161/CIRCRESAHA.114.302313; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Festuccia WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095432; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Sans-Fons MG, 2013, J INFECT DIS, V207, P1684, DOI 10.1093/infdis/jit084; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Joshi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095893; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Shirey KA, 2014, MUCOSAL IMMUNOL, V7, P549, DOI 10.1038/mi.2013.71; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; TAUB DD, 1995, J LEUKOCYTE BIOL, V58, P80, DOI 10.1002/jlb.58.1.80; WARREN MK, 1985, J IMMUNOL, V134, P982; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yue S, 2014, J IMMUNOL, V192, P5343, DOI 10.4049/jimmunol.1400280	45	3371	3476	52	613	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					14	20		10.1016/j.immuni.2014.06.008	http://dx.doi.org/10.1016/j.immuni.2014.06.008			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035950	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000341444200007
J	Chen, DS; Mellman, I				Chen, Daniel S.; Mellman, Ira			Oncology Meets Immunology: The Cancer-Immunity Cycle	IMMUNITY			English	Review							T-CELLS; PROGRAMMED DEATH-1; LOCAL RADIATION; PD-1 PATHWAY; PHASE-II; IMMUNOTHERAPY; BLOCKADE; MELANOMA; ANTIGEN; INHIBITION	The genetic and cellular alterations that define cancer provide the immune system with the means to generate T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of nonself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, including PD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hinders immune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune responses. The presence of suppressive factors in the tumor microenvironment may explain the limited activity observed with previous immune-based therapies and why these therapies may be more effective in combination with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immunotherapy is likely to become a key part of the clinical management of cancer.	[Chen, Daniel S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Mellman, Ira] Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Chen, Daniel S.; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Stanford University; University of California System; University of California San Francisco; Roche Holding; Genentech	Mellman, I (corresponding author), Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	mellman.ira@gene.com	Chen, Daniel Shin-Yu/AGD-8923-2022; Mellman, Ira/ABG-5896-2020	Chen, Daniel Shin-Yu/0000-0001-5085-3579; 				BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bulgaru Anca M, 2003, Expert Rev Anticancer Ther, V3, P269, DOI 10.1586/14737140.3.3.269; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Cho D.C, 2013, ASCO M, V31, P4505, DOI DOI 10.1200/JC0.2013.31.15_; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Davis M.M., 2012, SCI TRANSL MED, V4; Demaria S, 2005, CLIN CANCER RES, V11, P728; Drake CG, 2013, J CLIN ONCOL S, V31, P4514; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Ferguson TA, 2011, IMMUNOL REV, V241, P77, DOI 10.1111/j.1600-065X.2011.01006.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Franciszkiewicz K, 2013, CANCER RES, V73, P617, DOI 10.1158/0008-5472.CAN-12-2569; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Gajewski TF, 2012, MOL ONCOL, V6, P242, DOI 10.1016/j.molonc.2012.01.002; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gandhi L., 2013, J CLIN ONCOL, V31, P8030; Ge Y, 2013, CANCER LETT, V336, P253, DOI 10.1016/j.canlet.2013.03.010; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Greaves P, 2013, BLOOD, V121, P734, DOI 10.1182/blood-2012-10-385591; Grosso J, 2013, J CLIN ONCOL, V31; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hainsworth JD, 2013, J CLIN ONCOL, V31; Hamid O, 2013, N ENGL J MED; Hamid O, 2013, J CLIN ONCOL, V31; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Herbst RS, 2013, J CLIN ONCOL, V31; Hiniker SM, 2012, TRANSL ONCOL, V5, P404, DOI 10.1593/tlo.12280; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang TG, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-30; Isaacs JD, 1996, CLIN EXP IMMUNOL, V106, P427, DOI 10.1046/j.1365-2249.1996.d01-876.x; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; James BR, 2012, J IMMUNOL, V189, P1311, DOI 10.4049/jimmunol.1100587; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Karan D, 2012, IMMUNOTHERAPY-UK, V4, P577, DOI [10.2217/IMT.12.53, 10.2217/imt.12.53]; Kasuga Kie, 2013, Methods Mol Biol, V1023, P203, DOI 10.1007/978-1-4614-7209-4_14; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kruit WHJ, 2013, J CLIN ONCOL, V31, P2413, DOI 10.1200/JCO.2012.43.7111; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Madan RA, 2012, LANCET ONCOL, V13, P501, DOI 10.1016/S1470-2045(12)70006-2; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P489, DOI 10.1038/nrd4066; Ott PA, 2013, CANCER IMMUNOL IMMUN, V62, P811, DOI 10.1007/s00262-012-1389-z; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patnaik A, 2012, J CLIN ONCOL, V30; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Powderly JD, 2013, J CLIN ONCOL, V31; Predina J, 2013, P NATL ACAD SCI USA, V110, pE415, DOI 10.1073/pnas.1211850110; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rammensee HG, 2002, IMMUNOL REV, V188, P164, DOI 10.1034/j.1600-065X.2002.18815.x; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Rotem-Yehudar R., 2009, P AM ASS CANC RES; Rothman J, 2013, EXPERT REV VACCINES, V12, P493, DOI [10.1586/ERV.13.34, 10.1586/erv.13.34]; Rothschild S.I., 2013, CLIN LUNG CANC; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Smothers F, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt042.6; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Stewart R.A., 2011, CANCER RES, V71; Sznol M, 2013, J CLIN ONCOL, V31; Tabernero J, 2013, J CLIN ONCOL, V31, P3622; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Topalian SL, 2013, J CLIN ONCOL, V31; van den Boorn JG, 2013, IMMUNITY, V39, P27, DOI 10.1016/j.immuni.2013.07.011; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; Wang L., 2013, HAEMATOLOGICA; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Westin JR, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.793.793; Wolchok JD, 2013, N ENGL J MED; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	84	3276	3438	92	845	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					1	10		10.1016/j.immuni.2013.07.012	http://dx.doi.org/10.1016/j.immuni.2013.07.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890059	Bronze			2022-12-18	WOS:000330948300001
J	Zlotnik, A; Yoshie, O				Zlotnik, A; Yoshie, O			Chemokines: A new classification system and their role in immunity	IMMUNITY			English	Review							NAIVE T-CELLS; CC-CHEMOKINE; DENDRITIC CELLS; MOLECULAR-CLONING; LYMPHOID-TISSUES; RECEPTOR CXCR4; B-CELLS; EXPRESSION; CHEMOATTRACTANT; LYMPHOPOIESIS		DNAX Res Inst Mol & Cellular Biol Inc, Res Inst, Palo Alto, CA 94304 USA; Kinki Univ, Sch Med, Dept Bacteriol, Osaka 5898511, Japan	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Kindai University (Kinki University)	Zlotnik, A (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Res Inst, Palo Alto, CA 94304 USA.		Li, Chia Cheng/D-9906-2015; Zlotnik, Albert/C-3791-2011	Yoshie, Osamu/0000-0003-4353-5809				Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bradley LM, 1999, J IMMUNOL, V162, P2511; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Cao XT, 1998, J IMMUNOL, V161, P6238; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hedrick JA, 1998, BLOOD, V91, P4242, DOI 10.1182/blood.V91.11.4242; Hieshima K, 1997, J IMMUNOL, V159, P1140; HORNEY B, 2000, IN PRESS J IMMUNOL; Imai T, 1996, J BIOL CHEM, V271, P21514, DOI 10.1074/jbc.271.35.21514; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Karpus WJ, 1997, J LEUKOCYTE BIOL, V62, P681, DOI 10.1002/jlb.62.5.681; Kellermann SA, 1999, J IMMUNOL, V162, P3859; KELNER GS, 1995, J LEUKOCYTE BIOL, V57, P778, DOI 10.1002/jlb.57.5.778; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagira M, 1998, EUR J IMMUNOL, V28, P1516, DOI 10.1002/(SICI)1521-4141(199805)28:05<1516::AID-IMMU1516>3.0.CO;2-J; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; ORLOFSKY A, 1994, J IMMUNOL, V152, P5084; Rossi DL, 1999, J IMMUNOL, V162, P5490; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wang JM, 1998, J IMMUNOL METHODS, V220, P1, DOI 10.1016/S0022-1759(98)00128-8; Wilkinson B, 1999, J IMMUNOL, V162, P3873; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zaitseva MB, 1998, J IMMUNOL, V161, P3103; Zingoni A, 1998, J IMMUNOL, V161, P547; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	47	3021	3245	13	223	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					121	127		10.1016/S1074-7613(00)80165-X	http://dx.doi.org/10.1016/S1074-7613(00)80165-X			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714678	Bronze			2022-12-18	WOS:000085621400002
J	Veldhoen, M; Hocking, RJ; Atkins, CJ; Locksley, RM; Stockinger, B				Veldhoen, M; Hocking, RJ; Atkins, CJ; Locksley, RM; Stockinger, B			TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR; SYNOVIAL INFLAMMATION; IL-6-DEFICIENT MICE; GENE-EXPRESSION; HELPER TYPE-1; DISTINCT; INHIBITION; LINEAGE; INTERLEUKIN-6	We describe de novo generation of IL-17-producing T cells from naive CD4 T cells, induced in cocultures of naive CD4 T cells and naturally occurring CD4(+) CD25(+) T cells (Treg) in the presence of TLR3, TLR4, or TLR9 stimuli. Treg can be substituted by TGF beta 1, which, together with the proinflammatory cytokine IL-6, supports the differentiation of IL-17-producing T cells, a process that is amplified by IL-1 beta and TNF alpha. We could not detect a role for IL-23 in the differentiation of IL-17-producing T cells but confirmed its importance for their survival and expansion. Transcription factors GATA-3 and T-bet, as well as its target Hlx, are absent in IL-17-producing T cells, and they do not express the negative regulator for TGF beta signaling, Smad7. Our data indicate that, in the presence of IL-6, TGF beta 1 subverts Th1 and Th2 differentiation for the generation of IL-17-producing T cells.	Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; Univ Calif San Francisco, Natl Inst Med Res, Div Immunoregulat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA	MRC National Institute for Medical Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Veldhoen, M (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk	Veldhoen, Marc/AAM-5357-2021; Veldhoen, Marc/AAJ-2759-2020	Veldhoen, Marc/0000-0002-1478-9562; Stockinger, Brigitta/0000-0001-8781-336X	NIAID NIH HHS [AI30663] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; ALLEN JB, 1990, J EXP MED, V171, P231, DOI 10.1084/jem.171.1.231; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; EIJNDEN VS, 2005, EUR J IMMUNOL, V35, P469; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; FAVA RA, 1991, J EXP MED, V173, P1121, DOI 10.1084/jem.173.5.1121; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Letterio JJ, 2005, ONCOGENE, V24, P5701, DOI 10.1038/sj.onc.1208922; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McKarns SC, 2000, IMMUNOPHARMACOLOGY, V48, P101, DOI 10.1016/S0162-3109(00)00183-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Rochman I, 2005, J IMMUNOL, V174, P4761, DOI 10.4049/jimmunol.174.8.4761; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; STOCKINGER B, 1994, INT IMMUNOL, V6, P247, DOI 10.1093/intimm/6.2.247; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; WAHL SM, 1993, J EXP MED, V177, P225, DOI 10.1084/jem.177.1.225; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	70	2851	3076	4	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					179	189		10.1016/j.immuni.2006.01.001	http://dx.doi.org/10.1016/j.immuni.2006.01.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473830	Bronze			2022-12-18	WOS:000235479000009
J	Takeuchi, O; Hoshino, K; Kawai, T; Sanjo, H; Takada, H; Ogawa, T; Takeda, K; Akira, S				Takeuchi, O; Hoshino, K; Kawai, T; Sanjo, H; Takada, H; Ogawa, T; Takeda, K; Akira, S			Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components	IMMUNITY			English	Article							DROSOPHILA HOST-DEFENSE; RECEPTOR FAMILY; SIGNALING PATHWAY; LIPOTEICHOIC ACID; IL-1 RECEPTOR; KAPPA-B; TOLL; GENE; LIPOPOLYSACCHARIDE; PROTEIN	Toll-like receptor (TLR) 2 and TLR4 are implicated in the recognition of various bacterial cell wall components, such as lipopolysaccharide (LPS). To investigate in vivo roles of TLR2, we generated TLR2-deficient mice. In contrast to LPS unresponsiveness in TLR4-deficient mice, TLR2-deficient mice responded to LPS to the same extent as wild-type mice. TLR2-deficient macrophages were hyporesponsive to several Gram-positive bacterial cell walls as well as Staphylococcus aureus peptidoglycan. TLR4-deficient macrophages lacked the response to Gram-positive lipoteichoic acids. These results demonstrate that TLR2 and TLR4 recognize different bacterial cell wall components in vivo and TLR2 plays a major role in Gram-positive bacterial recognition.	Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Core Res Evolutional Sci & Technol Japan Sci, Suita, Osaka 5650871, Japan; Technol Corp, Suita, Osaka 5650871, Japan; Tohoku Univ, Sch Dent, Dept Microbiol & Immunol, Aoba Ku, Sendai, Miyagi 9800872, Japan; Asahi Univ, Sch Dent, Dept Oral Microbiol, Gifu 5010296, Japan	Osaka University; Japan Science & Technology Agency (JST); Tohoku University; Asahi University	Akira, S (corresponding author), Osaka Univ, Dept Host Def, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Hoshino, Katsuaki/AAE-2830-2022; Takeuchi, Osamu/D-6007-2011; Takeda, Kiyoshi/C-9331-2009; Takeuchi, Osamu/AAG-9359-2019; Hoshino, Katsuaki/L-9162-2014; Akira, Shizuo/C-3134-2009	Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Hoshino, Katsuaki/0000-0003-0493-4815; Kawai, Taro/0000-0001-7510-4662				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cleveland MG, 1996, INFECT IMMUN, V64, P1906, DOI 10.1128/IAI.64.6.1906-1912.1996; Denlinger LC, 1998, INFECT IMMUN, V66, P1638, DOI 10.1128/IAI.66.4.1638-1647.1998; Fischer W., 1990, HDB LIPID RES, P123; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Heine H, 1999, J IMMUNOL, V162, P6971; HEUMANN D, 1994, INFECT IMMUN, V62, P2715, DOI 10.1128/IAI.62.7.2715-2721.1994; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KELLER R, 1992, INFECT IMMUN, V60, P3664, DOI 10.1128/IAI.60.9.3664-3672.1992; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; KOTANI S, 1975, BIKEN J, V18, P77; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Morrison D C, 1979, Adv Immunol, V28, P293; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; OGAWA T, 1982, INFECT IMMUN, V38, P817, DOI 10.1128/IAI.38.3.817-824.1982; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sugiyama A, 1996, INFECT IMMUN, V64, P1426, DOI 10.1128/IAI.64.4.1426-1431.1996; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1999, J IMMUNOL, V163, P639; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1	46	2672	2786	2	222	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1999	11	4					443	451		10.1016/S1074-7613(00)80119-3	http://dx.doi.org/10.1016/S1074-7613(00)80119-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549626	Bronze			2022-12-18	WOS:000083343100006
J	Gordon, S; Martinez, FO				Gordon, Siamon; Martinez, Fernando O.			Alternative Activation of Macrophages: Mechanism and Functions	IMMUNITY			English	Review							ANTIGEN-PRESENTING CELLS; RECEPTOR-ACTIVITY; SUPPRESSOR-CELLS; VIRAL-INFECTION; SHIP REPRESSES; IN-VITRO; IL-13; INFLAMMATION; EXPRESSION; POLARIZATION	The concept of an alternative pathway of macrophage activation has stimulated interest in its definition, mechanism, and functional significance in homeostasis and disease. We assess recent research in this field, argue for a restricted definition, and explore pathways by which the T helper 2 (Th2) cell cytokines interleukin-4 (IL-4) and IL-13 mediate their effects on macrophage cell biology, their biosynthesis, and responses to a normal and pathological microenvironment. The stage is now set to gain deeper insights into the role of alternatively activated macrophages in immunobiology.	[Gordon, Siamon; Martinez, Fernando O.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Gordon, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	siamon.gordon@path.ox.ac.uk; fernando.martinezestrada@path.ox.ac.uk	Martinez Estrada, Fernando O/AAW-9409-2021	Martinez Estrada, Fernando O/0000-0003-0908-9366	British Heart Foundation; Medical Research Council [G0600727] Funding Source: researchfish; MRC [G0600727] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank colleagues for sharing unpublished results, Stefanie Vogel and Keri Ann Shirey for Figure 3, and Thiru Ramalingam for Figure 2. This review was prepared while S.G. was a visiting NCI/NIAID scholar and he thanks Giorgio Trinchieri and Alan Sher for their hospitality. F.O.M. was supported by the British Heart Foundation.	Agapov E, 2009, AM J RESP CELL MOL, V41, P379, DOI [10.1165/2009-0122R, 10.1165/2009-0122RC]; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Blease K, 2008, CURR OPIN INVEST DR, V9, P1180; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; DEBROSKI RH, 2010, J IMMUNOL IN PRESS, DOI DOI 10.4049/JIMMUNOL.0902009; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; DOYLE AG, 1994, EUR J IMMUNOL, V24, P1441, DOI 10.1002/eji.1830240630; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, CANCER RES, V68, P3467, DOI 10.1158/0008-5472.CAN-07-5301; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gangadharan B, 2008, J LEUKOCYTE BIOL, V84, P50, DOI 10.1189/jlb.0507270; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gordan S., 2008, FUNDAMENTAL IMMUNOLO, P547; Gratchev A, 2001, SKIN PHARMACOL APPL, V14, P272, DOI 10.1159/000056357; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Heinsbroek SEM, 2009, J INNATE IMMUN, V1, P244, DOI 10.1159/000173694; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Holtzman MJ, 2009, ADV IMMUNOL, V102, P245, DOI 10.1016/S0065-2776(09)01205-X; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kawashima R, 2006, GASTROENTEROLOGY, V131, P130, DOI 10.1053/j.gastro.2006.04.022; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Kzhyshkowska J, 2009, IMMUNOBIOLOGY, V214, P576, DOI 10.1016/j.imbio.2009.03.007; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Linehan SA, 2003, LAB INVEST, V83, P1223, DOI 10.1097/01.LAB.0000081392.93701.6F; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4&lt;1127::AID-IMMU1127&gt;3.0.CO;2-#; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lupardus PJ, 2010, STRUCTURE, V18, P332, DOI 10.1016/j.str.2010.01.003; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mitchell J, 2010, CURR OPIN INVEST DR, V11, P527; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; MOKOENA T, 1985, J CLIN INVEST, V75, P624, DOI 10.1172/JCI111740; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; O'Toole M, 2008, CLIN EXP ALLERGY, V38, P594, DOI 10.1111/j.1365-2222.2007.02921.x; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356; Rodriguez-Sosa M, 2002, INFECT IMMUN, V70, P3656, DOI 10.1128/IAI.70.7.3656-3664.2002; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Ruschmann J, 2010, EXP HEMATOL, V38, P392, DOI 10.1016/j.exphem.2010.03.010; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2010, J LEUKOCYTE BIOL, V87, P19, DOI 10.1189/jlb.0509311; Syed F, 2007, BIOMARKERS, V12, P414, DOI 10.1080/13547500701192652; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	112	2642	2804	16	433	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					593	604		10.1016/j.immuni.2010.05.007	http://dx.doi.org/10.1016/j.immuni.2010.05.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20510870	Bronze			2022-12-18	WOS:000278280500006
J	Schmitz, J; Owyang, A; Oldham, E; Song, YL; Murphy, E; McClanahan, TK; Zurawski, G; Moshrefi, M; Qin, JZ; Li, XX; Gorman, DM; Bazan, JF; Kastelein, RA				Schmitz, J; Owyang, A; Oldham, E; Song, YL; Murphy, E; McClanahan, TK; Zurawski, G; Moshrefi, M; Qin, JZ; Li, XX; Gorman, DM; Bazan, JF; Kastelein, RA			IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines	IMMUNITY			English	Article							NF-KAPPA-B; T1/ST2; CELLS; FAMILY; IDENTIFICATION; SEQUENCE; GENE; EXPRESSION; MOLECULE; CLONING	Cytokines of the interleukin-1 (IL-1) family, such as IL-1 alpha/beta and IL-18, have important functions in host defense, immune regulation, and inflammation. Insight into their biological functions has led to novel therapeutic approaches to treat human inflammatory diseases. Within the IL-1 family, IL-1 alpha/beta, IL-1Ra, and IL-18 have been matched to their respective receptor complexes and have been shown to have distinct biological functions. The most prominent orphan IL-1 receptor is ST2. This receptor has been described as a negative regulator of Toll-like receptor-IL-1 receptor signaling, but it also functions as an important effector molecule of T helper type 2 responses. We report a member of the IL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST2, activates NFKB and MAP kinases, and drives production of T(H)2-assoclated cytokines from in vitro polarized T(H)2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.	Schering Plough Biopharma, Palo Alto, CA 94304 USA; Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA	Merck & Company; Cleveland Clinic Foundation	Bazan, JF (corresponding author), Schering Plough Biopharma, 901 Calif Ave, Palo Alto, CA 94304 USA.	jfbazan@gene.com; rob.kastelein@dnax.org	Bazan, J. Fernando/B-4562-2010					BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bost KL, 1996, IMMUNOLOGY, V87, P633, DOI 10.1046/j.1365-2567.1996.502574.x; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Corrigall W A, 1999, Nicotine Tob Res, V1, P11, DOI 10.1080/14622299050011121; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello CA, 2000, EUR CYTOKINE NETW, V11, P483; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gayle MA, 1996, J BIOL CHEM, V271, P5784, DOI 10.1074/jbc.271.10.5784; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Karlen S, 1998, Int Rev Immunol, V16, P227, DOI 10.3109/08830189809042996; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; KUMAR S, 1995, J BIOL CHEM, V270, P27905, DOI 10.1074/jbc.270.46.27905; Leung BP, 2004, J IMMUNOL, V173, P145, DOI 10.4049/jimmunol.173.1.145; Lohning M, 1999, J IMMUNOL, V162, P3882; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Moritz DR, 1998, J IMMUNOL, V161, P4866; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; PENE J, 1988, J IMMUNOL, V141, P1218; PRIESTLE JP, 1988, EMBO J, V7, P339, DOI 10.1002/j.1460-2075.1988.tb02818.x; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Roboz G J, 1999, Curr Opin Hematol, V6, P164, DOI 10.1097/00062752-199905000-00007; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Sims JE, 2001, TRENDS IMMUNOL, V22, P536, DOI 10.1016/S1471-4906(01)02040-3; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Tajima S, 2003, CHEST, V124, P1206, DOI 10.1378/chest.124.4.1206; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787	49	2632	2872	7	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					479	490		10.1016/j.immuni.2005.09.015	http://dx.doi.org/10.1016/j.immuni.2005.09.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286016	Bronze			2022-12-18	WOS:000233660700005
J	Geissmann, F; Jung, S; Littman, DR				Geissmann, F; Jung, S; Littman, DR			Blood monocytes consist of two principal subsets with distinct migratory properties	IMMUNITY			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; INTERFERON-PRODUCING CELLS; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; INFLAMED LYMPH-NODES; ENDOTHELIAL-CELLS; KUPFFER CELLS; CHEMOKINE; DIFFERENTIATION; MACROPHAGE	Peripheral blood monocytes are a heterogeneous population of circulating leukocytes. Using a murine adoptive transfer system to probe monocyte homing and differentiation in vivo, we identified two functional subsets among murine blood monocytes: a short-lived CX(3)CR1(lo)CCR2(+)Gr1(+) subset that is actively recruited to inflamed tissues and a CX(3)CR1(hi)CCR2(-)Gr1(-) subset characterized by CX(3)CR1-dependent recruitment to noninflamed tissues. Both subsets have the potential to differentiate into dendritic cells in vivo. The level of CX(3)CR1 expression also defines the two major human monocyte subsets, the CD14(+)CD16(-) and CD14(lo)CD16(+) monocytes, which share phenotype and homing potential with the mouse subsets. These findings raise the potential for novel therapeutic strategies in inflammatory diseases.	NYU, Sch Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, 540 1st Ave, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; geissmann, frederic/0000-0001-5029-2468				Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Akagawa KS, 1996, BLOOD, V88, P4029, DOI 10.1182/blood.V88.10.4029.bloodjournal88104029; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kennedy DW, 1998, P NATL ACAD SCI USA, V95, P14944, DOI 10.1073/pnas.95.25.14944; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Liu J, 1999, J BIOL CHEM, V274, P15781, DOI 10.1074/jbc.274.22.15781; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Muller WA, 2001, J EXP MED, V194, pF47, DOI 10.1084/jem.194.9.f47; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571; Schreurs MWJ, 1999, EUR J IMMUNOL, V29, P2835, DOI 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; THOMAS ED, 1976, SCIENCE, V192, P1016, DOI 10.1126/science.775638; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; VANFURTH R, 1988, INFLAMMATION BASIC P, P281; WiktorJedrzejczak W, 1996, PHYSIOL REV, V76, P927, DOI 10.1152/physrev.1996.76.4.927; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603	50	2476	2540	1	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2003	19	1					71	82		10.1016/S1074-7613(03)00174-2	http://dx.doi.org/10.1016/S1074-7613(03)00174-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871640	Bronze			2022-12-18	WOS:000184260400009
J	Wiley, SR; Schooley, K; Smolak, PJ; Din, WS; Huang, CP; Nicholl, JK; Sutherland, GR; Smith, TD; Rauch, C; Smith, CA; Goodwin, RG				Wiley, SR; Schooley, K; Smolak, PJ; Din, WS; Huang, CP; Nicholl, JK; Sutherland, GR; Smith, TD; Rauch, C; Smith, CA; Goodwin, RG			Identification and characterization of a new member of the TNF family that induces apoptosis	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; MOLECULAR-CLONING; INTERLEUKIN-4 RECEPTOR; HODGKINS LYMPHOMA; ENDOTOXIC-SHOCK; EMERGING FAMILY; CELL-SURFACE; CYTOKINES; LIGAND; HOMOLOGY	A novel tumor necrosis factor (TNF) family member has been cloned and characterized. This protein, designated TNF-related apoptosis-inducing ligand (TRAIL), consists of 281 and 291 aa in the human and murine forms, respectively, which share 65% aa identity. TRAIL is a type II membrane protein, whose C-terminal extracellular domain shows clear homology to other TNF family members. TRAIL transcripts are detected in a variety of human tissues, most predominantly in spleen, lung, and prostate. The TRAIL gene is located on chromosome 3 at position 3q26, which is not close to any other known TNF ligand family members. Both full-length cell surface expressed TRAIL and picomolar concentrations of soluble TRAIL rapidly induce apoptosis in a wide variety of transformed cell lines of diverse origin.	WOMENS & CHILDRENS HOSP,DEPT CYTOGENET & MOLEC GENET,CTR MED GENET,ADELAIDE,SA 5006,AUSTRALIA	Womens & Childrens Hospital Australia	Wiley, SR (corresponding author), IMMUNEX RES & DEV CORP,51 UNIV ST,SEATTLE,WA 98101, USA.		Serei, Virian D/B-4616-2015; Sutherland, Grant Robert/D-2606-2012					ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1758; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; CERAMI A, 1988, IMMUNOL TODAY, V9, P28, DOI 10.1016/0167-5699(88)91353-9; COHEN J, 1988, BONE MARROW TRANSPL, V3, P193; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; CREASEY AA, 1987, CANCER RES, V47, P145; DANIEL PT, 1994, J IMMUNOL, V152, P5624; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; ECK MJ, 1992, J BIOL CHEM, V267, P2119; FISCHER P, 1988, BLOOD, V72, P234; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; HERNANDEZCASELLES T, 1993, J IMMUNOL, V151, P3999; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; RAMSDELL F, 1994, EUR J IMMUNOL, V24, P928, DOI 10.1002/eji.1830240422; RAWLINSON WD, 1993, J VIROL, V67, P5502, DOI 10.1128/JVI.67.9.5502-5513.1993; REVEL M, 1987, CIBA F SYMP, V129, P223; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sambrook J., 1989, MOL CLONING LAB MANU; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wyllie A H, 1992, Semin Immunol, V4, P389; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	46	2468	2998	2	106	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					673	682		10.1016/1074-7613(95)90057-8	http://dx.doi.org/10.1016/1074-7613(95)90057-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777713	Bronze			2022-12-18	WOS:A1995TM02300002
J	Kawai, T; Akira, S				Kawai, Taro; Akira, Shizuo			Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity	IMMUNITY			English	Review							PLASMACYTOID DENDRITIC CELLS; HEPATITIS-C VIRUS; REGULATORY T-CELLS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; STAPHYLOCOCCUS-AUREUS INFECTION; PYOGENIC BACTERIAL-INFECTIONS; HERPES-SIMPLEX ENCEPHALITIS; NUCLEIC-ACID RECOGNITION; HOST-DEFENSE; NLRP3 INFLAMMASOME	Toll-like receptors (TLRs) are germline-encoded pattern recognition receptors (PRRs) that play a central role in host cell recognition and responses to microbial pathogens. TLR-mediated recognition of components derived from a wide range of pathogens and their role in the subsequent initiation of innate immune responses is widely accepted; however, the recent discovery of non-TLR PRRs, such as C-type lectin receptors, NOD-like receptors, and RIG-I-like receptors, suggests that many aspects of innate immunity are more sophisticated and complex. In this review, we will focus on the role played by TLRs in mounting protective immune responses against infection and their crosstalk with other PRRs with respect to pathogen recognition.	[Kawai, Taro; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka 5650871, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan	Osaka University; Osaka University	Akira, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009	Kawai, Taro/0000-0001-7510-4662				Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; BIONDO C, 2011, EUR J IMMUN IN PRESS; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bourgeois C, 2011, J IMMUNOL, V186, P3104, DOI 10.4049/jimmunol.1002599; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gerold G, 2007, SEMIN IMMUNOL, V19, P41, DOI 10.1016/j.smim.2006.12.003; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge Helen S., 2008, V183, P87; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marakalala MJ, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/567571; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Ropert C, 2004, J ENDOTOXIN RES, V10, P425, DOI 10.1179/096805104225006507; Saiga H, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/347594; Saitoh SI, 2009, IMMUNOL REV, V227, P32, DOI 10.1111/j.1600-065X.2008.00729.x; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Verdrengh M, 2004, MICROBES INFECT, V6, P1268, DOI 10.1016/j.micinf.2004.08.009; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	127	2414	2556	15	516	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					637	650		10.1016/j.immuni.2011.05.006	http://dx.doi.org/10.1016/j.immuni.2011.05.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616434	Bronze			2022-12-18	WOS:000291456500002
J	Noy, R; Pollard, JW				Noy, Roy; Pollard, Jeffrey W.			Tumor-Associated Macrophages: From Mechanisms to Therapy	IMMUNITY			English	Review							REGULATORY T-CELLS; MYELOID CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; MICROENVIRONMENTAL REGULATION; COSTIMULATORY MOLECULES; ALTERNATIVE ACTIVATION; CLINICAL-SIGNIFICANCE; PULMONARY METASTASIS; MAMMARY CARCINOMAS	The tumor microenvironment is a complex ecology of cells that evolves with and provides support to tumor cells during the transition to malignancy. Among the innate and adaptive immune cells recruited to the tumor site, macrophages are particularly abundant and are present at all stages of tumor progression. Clinical studies and experimental mouse models indicate that these macrophages generally play a protumoral role. In the primary tumor, macrophages can stimulate angiogenesis and enhance tumor cell invasion, motility, and intravasation. During monocytes and/or metastasis, macrophages prime the premetastatic site and promote tumor cell extravasation, survival, and persistent growth. Macrophages are also immunosuppressive, preventing tumor cell attack by natural killer and T cells during tumor progression and after recovery from chemo-or immunotherapy. Therapeutic success in targeting these protumoral roles in preclinical models and in early clinical trials suggests that macrophages are attractive targets as part of combination therapy in cancer treatment.	[Noy, Roy; Pollard, Jeffrey W.] Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, New York, NY 10461 USA; [Pollard, Jeffrey W.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh EH16 4TJ, Midlothian, Scotland	Yeshiva University; University of Edinburgh	Pollard, JW (corresponding author), Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, New York, NY 10461 USA.	jeff.pollard@ed.ac.uk			NIH [RO1 CA172451, PO1 CA100324]; Rowley Breast Cancer Scientific Research Project [1003251030]; Wellcome Trust, UK; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; Wellcome Trust [101067/Z/13/Z] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA100324, R01CA172451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rowley Breast Cancer Scientific Research Project; Wellcome Trust, UK(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The author's work has been supported by NIH grants RO1 CA172451 and PO1 CA100324, The Rowley Breast Cancer Scientific Research Project #1003251030, NY, and the Wellcome Trust, UK. J.W.P. has patents pending on some aspects of macrophage inhibition in tumor therapy.	Abraham D, 2010, INT J CANCER, V126, P1339, DOI 10.1002/ijc.24859; Adeegbe DO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00190; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Belai EB, 2014, CARCINOGENESIS, V35, P424, DOI 10.1093/carcin/bgt305; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bloch O, 2013, CLIN CANCER RES, V19, P3165, DOI 10.1158/1078-0432.CCR-12-3314; Boissonnas A, 2013, NEOPLASIA, V15, P85, DOI 10.1593/neo.121572; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brown ER, 2008, ANN ONCOL, V19, P1340, DOI 10.1093/annonc/mdn054; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Camacho D.F., 2014, CANC METASTASIS REV; Chen C, 2012, J IMMUNOTHER, V35, P354, DOI 10.1097/CJI.0b013e31824212c4; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Daurkin I, 2011, CANCER RES, V71, P6400, DOI 10.1158/0008-5472.CAN-11-1261; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Ferjancic S, 2013, BLOOD, V121, P3289, DOI 10.1182/blood-2012-08-449819; FIDLER IJ, 1988, CIBA F SYMP, V141, P211; Forget MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098623; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greaves P, 2013, BLOOD, V121, P734, DOI 10.1182/blood-2012-10-385591; Greenwald RJ, 2002, CURR OPIN IMMUNOL, V14, P391, DOI 10.1016/S0952-7915(02)00341-2; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Jobin C, 2013, CANCER DISCOV, V3, P384, DOI 10.1158/2159-8290.CD-13-0042; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Kennedy BC, 2013, J ONCOL, V2013, DOI 10.1155/2013/486912; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kren L, 2010, J NEUROIMMUNOL, V220, P131, DOI 10.1016/j.jneuroim.2010.01.014; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Matsunaga T, 2011, YONAGO ACTA MED, V54, P1; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McIntire RH, 2004, J LEUKOCYTE BIOL, V76, P1220, DOI 10.1189/jlb.0604337; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Morandi F, 2007, CANCER RES, V67, P6433, DOI 10.1158/0008-5472.CAN-06-4588; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Oh SA, 2013, J IMMUNOL, V191, P3973, DOI 10.4049/jimmunol.1301843; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Redente EF, 2010, AM J PATHOL, V176, P2972, DOI 10.2353/ajpath.2010.090879; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rohan TE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju136; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith HO, 2013, MOL ONCOL, V7, P41, DOI 10.1016/j.molonc.2012.07.002; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Tamura H, 2005, CLIN CANCER RES, V11, P5708, DOI 10.1158/1078-0432.CCR-04-2672; Tirapu I, 2006, CANCER RES, V66, P2442, DOI 10.1158/0008-5472.CAN-05-1681; VILLANUEVA POF, 1994, J IMMUNOL, V153, P5190; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yeo EJ, 2014, CANCER RES, V74, P2962, DOI 10.1158/0008-5472.CAN-13-2421	128	2277	2380	43	533	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					49	61		10.1016/j.immuni.2014.06.010	http://dx.doi.org/10.1016/j.immuni.2014.06.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035953	Bronze, Green Accepted			2022-12-18	WOS:000341444200010
J	TIVOL, EA; BORRIELLO, F; SCHWEITZER, AN; LYNCH, WP; BLUESTONE, JA; SHARPE, AH				TIVOL, EA; BORRIELLO, F; SCHWEITZER, AN; LYNCH, WP; BLUESTONE, JA; SHARPE, AH			LOSS OF CTLA-4 LEADS TO MASSIVE LYMPHOPROLIFERATION AND FATAL MULTIORGAN TISSUE DESTRUCTION, REVEALING A CRITICAL NEGATIVE REGULATORY ROLE OF CTLA-4	IMMUNITY			English	Article							T-CELL PROLIFERATION; COUNTER-RECEPTOR; STEM-CELLS; CD28; MOUSE; EXPRESSION; LIGAND; ACTIVATION; SEQUENCE; B7-2	The B7-CD28/CTLA-4 costimulatory pathway can provide a signal pivotal for T cell activation, Signaling through this pathway is complex due to the presence of two B7 family members, B7-1 and B7-2, and two counterreceptors, CD28 and CTLA-4. Studies with anti-CTLA-4 monoclonal antibodies have suggested both positive and negative roles for CTLA-4 in T cell activation, To elucidate the in vivo function of CTLA-4, we generated CTLA-4-deficient mice. These mice rapidly develop lymphoproliferative disease with multiorgan lymphocytic infiltration and tissue destruction, with particularly severe myocarditis and pancreatitis, and die by 3-4 weeks of age. The phenotype of the CTLA-4-deficient mouse strain is supported by studies that have suggested a negative role for CTLA-4 in T cell activation. The severe phenotype of mice lacking CTLA-4 implies a critical role for CTLA-4 in downregulating T cell activation and maintaining immunologic homeostasis. In the absence of CTLA-4, peripheral T cells are activated, can spontaneously proliferate, and may mediate lethal tissue injury.	UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637	University of Chicago	TIVOL, EA (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,DIV IMMUNOL RES,BOSTON,MA 02115, USA.			Borriello, Frank/0000-0003-3957-3685; Sharpe, Arlene/0000-0002-9736-2109	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HLO7627] Funding Source: Medline; NIAID NIH HHS [P01 AI35225] Funding Source: Medline; NIAMS NIH HHS [1P30AR42689] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BOUSSIOTIS VA, 1994, CURR OPIN IMMUNOL, V6, P797, DOI 10.1016/0952-7915(94)90087-6; CROSS AH, 1995, J CLIN INVEST, V95, P2783, DOI 10.1172/JCI117982; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; GREENFIELD CL, 1994, P NATL ACAD SCI USA, V92, P811; HARPER K, 1991, J IMMUNOL, V147, P1037; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; LYNCH WP, 1995, J VIROL, V69, P1408, DOI 10.1128/JVI.69.3.1408-1419.1995; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; NELSON AJ, 1993, J IMMUNOL, V151, P2453; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; SETHNA MP, 1994, IMMUNITY, V1, P415, DOI 10.1016/1074-7613(94)90072-8; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	30	2209	2316	2	79	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					541	547		10.1016/1074-7613(95)90125-6	http://dx.doi.org/10.1016/1074-7613(95)90125-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584144	Bronze			2022-12-18	WOS:A1995TG28100002
J	Oppmann, B; Lesley, R; Blom, B; Timans, JC; Xu, YM; Hunte, B; Vega, F; Yu, N; Wang, J; Singh, K; Zonin, F; Vaisberg, E; Churakova, T; Liu, MR; Gorman, D; Wagner, J; Zurawski, S; Liu, YJ; Abrams, JS; Moore, KW; Rennick, D; de Waal-Malefyt, R; Hannum, C; Bazan, JF; Kastelein, RA				Oppmann, B; Lesley, R; Blom, B; Timans, JC; Xu, YM; Hunte, B; Vega, F; Yu, N; Wang, J; Singh, K; Zonin, F; Vaisberg, E; Churakova, T; Liu, MR; Gorman, D; Wagner, J; Zurawski, S; Liu, YJ; Abrams, JS; Moore, KW; Rennick, D; de Waal-Malefyt, R; Hannum, C; Bazan, JF; Kastelein, RA			Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12	IMMUNITY			English	Article							CELL STIMULATORY FACTOR; MULTIPLE SEQUENCE ALIGNMENT; TYROSINE PHOSPHORYLATION; FACTOR INTERLEUKIN-12; PROTECTIVE IMMUNITY; T-CELLS; RECEPTOR; MICE; EXPRESSION; CHAIN	A novel sequence discovered in a computational screen appears distantly related to the p35 subunit of IL-12. This factor, which we term p19, shows no biological activity by itself; instead, it combines with the p40 subunit of IL-12 to form a novel, biologically active, composite cytokine, which we term IL-23. Activated dendritic cells secrete detectable levels of this complex. IL-23 binds to IL-12R beta1 but fails to engage IL-12R beta2; nonetheless, IL-23 activates Stat4 in PHA blast T cells. IL-23 induces strong proliferation of mouse memory (CD4(+)CD45Rb(low))T cells, a unique activity of IL-23 as IL-12 has no effect on this cell population. Similar to IL-12, human IL-23 stimulates IFN-gamma production and proliferation in PHA blast T cells, as well as in CD45RO (memory)T cells.	DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Kastelein, RA (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.	kastelein@dnax.org	Bazan, J. Fernando/B-4562-2010	de Waal Malefyt, Rene/0000-0002-2663-383X				Adorini L, 1997, CHEM IMMUNOL, V68, P175; Anderson R, 1997, HUM GENE THER, V8, P1125, DOI 10.1089/hum.1997.8.9-1125; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Bolin LM, 1997, J NEUROSCI, V17, P5493; Brombacher F, 1999, INT IMMUNOL, V11, P325, DOI 10.1093/intimm/11.3.325; Carra G, 2000, J IMMUNOL, V164, P4752, DOI 10.4049/jimmunol.164.9.4752; CHUA AO, 1995, J IMMUNOL, V155, P4286; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; David ZV, 1998, E EUR POLIT SOC, V12, P1; Davidson N J, 2000, Int Rev Immunol, V19, P91, DOI 10.3109/08830180009048392; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Gately MK, 1996, ANN NY ACAD SCI, V795, P1, DOI 10.1111/j.1749-6632.1996.tb52650.x; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Greenberger MJ, 1996, J IMMUNOL, V157, P3006; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Gubler U, 1996, ANN NY ACAD SCI, V795, P36, DOI 10.1111/j.1749-6632.1996.tb52653.x; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Heath VL, 2000, J IMMUNOL, V164, P2861, DOI 10.4049/jimmunol.164.6.2861; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kitamura T, 1998, INT J HEMATOL, V67, P351; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Leonard JP, 1997, BLOOD, V90, P2541; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mattner F, 1997, INFECT IMMUN, V65, P4378, DOI 10.1128/IAI.65.11.4378-4383.1997; Naeger LK, 1999, J BIOL CHEM, V274, P1875, DOI 10.1074/jbc.274.4.1875; Presky DH, 1996, ANN NY ACAD SCI, V795, P390, DOI 10.1111/j.1749-6632.1996.tb52702.x; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Showe LC, 1996, ANN NY ACAD SCI, V795, P413, DOI 10.1111/j.1749-6632.1996.tb52708.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; TRIPP CS, 1994, J IMMUNOL, V152, P1883; WOLF SF, 1991, J IMMUNOL, V146, P3074; Wu CY, 2000, FASEB J, V14, pA1182; Wu CY, 1996, EUR J IMMUNOL, V26, P345, DOI 10.1002/eji.1830260212; Wu CY, 1997, J IMMUNOL, V159, P1658	49	2096	2343	3	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					715	725		10.1016/S1074-7613(00)00070-4	http://dx.doi.org/10.1016/S1074-7613(00)00070-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114383	Bronze			2022-12-18	WOS:000165598500013
J	Thorsson, V; Gibbs, DL; Brown, SD; Wolf, D; Bortone, DS; Yang, THO; Porta-Pardo, E; Gao, GF; Plaisier, CL; Eddy, JA; Ziv, E; Culhane, AC; Paull, EO; Sivakumar, IKA; Gentles, AJ; Malhotra, R; Farshidfar, F; Colaprico, A; Parker, JS; Mose, LE; Vo, NS; Liu, JF; Liu, YX; Rader, J; Dhankani, V; Reynolds, SM; Bowlby, R; Califano, A; Cherniack, AD; Anastassiou, D; Bedognetti, D; Rao, A; Chen, K; Krasnitz, A; Hu, H; Malta, TM; Noushmehr, H; Pedamallu, CS; Bullman, S; Ojesina, AI; Lamb, A; Zhou, WD; Shen, H; Choueiri, TK; Weinstein, JN; Guinney, J; Saltz, J; Holt, RA; Rabkin, CE; Lazar, AJ; Serody, JS; Demicco, EG; Disis, ML; Vincent, BG; Shmulevich, L				Thorsson, Vesteinn; Gibbs, David L.; Brown, Scott D.; Wolf, Denise; Bortone, Dante S.; Yang, Tai-Hsien Ou; Porta-Pardo, Eduard; Gao, Galen F.; Plaisier, Christopher L.; Eddy, James A.; Ziv, Elad; Culhane, Aedin C.; Paull, Evan O.; Sivakumar, I. K. Ashok; Gentles, Andrew J.; Malhotra, Raunaq; Farshidfar, Farshad; Colaprico, Antonio; Parker, Joel S.; Mose, Lisle E.; Nam Sy Vo; Liu, Jianfang; Liu, Yuexin; Rader, Janet; Dhankani, Varsha; Reynolds, Sheila M.; Bowlby, Reanne; Califano, Andrea; Cherniack, Andrew D.; Anastassiou, Dimitris; Bedognetti, Davide; Rao, Arvind; Chen, Ken; Krasnitz, Alexander; Hu, Hai; Malta, Tathiane M.; Noushmehr, Houtan; Pedamallu, Chandra Sekhar; Bullman, Susan; Ojesina, Akinyemi I.; Lamb, Andrew; Zhou, Wanding; Shen, Hui; Choueiri, Toni K.; Weinstein, John N.; Guinney, Justin; Saltz, Joel; Holt, Robert A.; Rabkin, Charles E.; Lazar, Alexander J.; Serody, Jonathan S.; Demicco, Elizabeth G.; Disis, Mary L.; Vincent, Benjamin G.; Shmulevich, Llya		Canc Genome Atlas Res Network	The Immune Landscape of Cancer	IMMUNITY			English	Article							T-CELL-RECEPTOR; COMPREHENSIVE ANALYSIS; REGULATORY NETWORK; SOMATIC MUTATIONS; GENOMIC ANALYSES; SEQUENCING DATA; PREDICTION; REVEALS; CLASSIFICATION; INFORMATION	We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we identified six immune subtypes-wound healing, IFN-gamma dominant, inflammatory, lymphocyte depleted, immunologically quiet, and TGF-beta dominant-characterized by differences in macrophage or lymphocyte signatures, Th1:Th2 cell ratio, extent of intratumoral heterogeneity, aneuploidy, extent of neoantigen load, overall cell proliferation, expression of immunomodulatory genes, and prognosis. Specific driver mutations correlated with lower (CTNNB1, NRAS, or IDH1) or higher (BRAF, TP53, or CASP8) leukocyte levels across all cancers. Multiple control modalities of the intracellular and extracellular networks (transcription, microRNAs, copy number, and epigenetic processes) were involved in tumor-immune cell interactions, both across and within immune subtypes. Our immunogenomics pipeline to characterize these heterogeneous tumors and the resulting data are intended to serve as a resource for future targeted studies to further advance the field.	[Thorsson, Vesteinn; Gibbs, David L.; Plaisier, Christopher L.; Dhankani, Varsha; Reynolds, Sheila M.; Shmulevich, Llya] Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA; [Brown, Scott D.; Bowlby, Reanne; Holt, Robert A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Wolf, Denise] Univ Calif San Francisco, Box 0808,2340 Sutter St,S433, San Francisco, CA 94115 USA; [Bortone, Dante S.; Parker, Joel S.; Mose, Lisle E.; Vincent, Benjamin G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Bioinformat & Computat Biol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Yang, Tai-Hsien Ou; Anastassiou, Dimitris] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Yang, Tai-Hsien Ou; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Porta-Pardo, Eduard] Barcelona Supercomp Ctr, C Jordi Girona 29, Barcelona 08034, Spain; [Porta-Pardo, Eduard] SBP Med Discovery Inst, La Jolla, CA 92037 USA; [Gao, Galen F.; Cherniack, Andrew D.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Gao, Galen F.; Cherniack, Andrew D.] Harvard Univ, Cambridge, MA 02142 USA; [Plaisier, Christopher L.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Eddy, James A.; Lamb, Andrew; Guinney, Justin] Sage Bionetworks, 2901 Third Ave,Suite 330, Seattle, WA 98121 USA; [Ziv, Elad] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Inst Human Genet, Dept Med, 1450 3rd St, San Francisco, CA 94143 USA; [Culhane, Aedin C.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Paull, Evan O.; Califano, Andrea] Irving Canc Res Ctr, Room 913,1130 St Nicholas Ave, New York, NY 10032 USA; [Sivakumar, I. K. Ashok] Johns Hopkins Univ, Inst Computat Med, Dept Comp Sci, Baltimore, MD 21218 USA; [Gentles, Andrew J.] Stanford Univ, Dept Med & Biomed Data Sci, Stanford, CA 94305 USA; [Malhotra, Raunaq] Seven Bridges Genom, Cambridge, MA 02142 USA; [Farshidfar, Farshad] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Colaprico, Antonio] ULB, Fac Sci, Comp Sci Dept, Blvd Triomphe CP212, B-1050 Brussels, Belgium; [Nam Sy Vo; Liu, Yuexin; Rao, Arvind; Chen, Ken; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Liu, Jianfang; Hu, Hai] Chan Soon Shiong Inst Mol Med Windber, Windber, PA 15963 USA; [Rader, Janet] Med Coll Wisconsin, 9200 Wisconsin Ave, Milwaukee, WI 53226 USA; [Bedognetti, Davide] Sidra Med & Res Ctr, Div Translat Med, Res Branch, POB 26999, Doha, Qatar; [Krasnitz, Alexander] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Malta, Tathiane M.; Noushmehr, Houtan] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Malta, Tathiane M.; Noushmehr, Houtan] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Sao Paulo, Brazil; [Pedamallu, Chandra Sekhar; Bullman, Susan; Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ojesina, Akinyemi I.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Zhou, Wanding; Shen, Hui] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Saltz, Joel] Stony Brook Med, Dept Biomed Informat, 100 Nicolls Rd, Stony Brook, NY 11794 USA; [Rabkin, Charles E.] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Bethesda, MD 20892 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd Unit 85, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd Unit 85, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 1515 Holcombe Blvd Unit 85, Houston, TX 77030 USA; [Serody, Jonathan S.] Dept Med & Microbiol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Serody, Jonathan S.] Lineberger Comprehens Canc Ctr, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Demicco, Elizabeth G.] Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Disis, Mary L.] Univ Washington, UW Med Canc Vaccine Inst, 850 Republican St,Brotman Bldg,2nd Floor,Room 221, Seattle, WA 98109 USA	Institute for Systems Biology (ISB); British Columbia Cancer Agency; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Arizona State University; Arizona State University-Tempe; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Stanford University; University of Calgary; Universite Libre de Bruxelles; University of Texas System; UTMD Anderson Cancer Center; Windber Research Institute; Medical College of Wisconsin; Sidra Medical & Research Center; Cold Spring Harbor Laboratory; Henry Ford Health System; Henry Ford Hospital; Universidade de Sao Paulo; Harvard University; Dana-Farber Cancer Institute; University of Alabama System; University of Alabama Birmingham; Van Andel Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Washington; University of Washington Seattle	Thorsson, V; Shmulevich, L (corresponding author), Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA.; Vincent, BG (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Bioinformat & Computat Biol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	vesteinn.thorsson@systemsbiology.org; benjamin.vincent@unchealth.unc.edu; ilya.shmulevich@systemsbiology.org	Carvalho, Andre Lopes/S-7053-2016; dhanasekaran, renumathy/B-3300-2014; Lazar, Alexander J/A-3416-2008; Laird, Peter W/G-8683-2012; Silveira, Henrique C S/J-1730-2014; Marra, Marco A/B-5987-2008; Bedognetti, Davide/GLQ-9410-2022; Parker, Joel/AAG-1108-2019; Tavobilov, Mikhail/AAE-9175-2022; Barnholtz-Sloan, Jill/A-4817-2011; Shen, Hui/AAO-4387-2020; De Rose, Agostino Maria/V-4910-2019; N, Houtan/C-9692-2013; Stern, Marc-Henri/A-2728-2011; Holt, Robert A/C-3303-2009; Lyadov, Vladimir/AAA-3897-2019; Wilson, Richard K./AAF-4139-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Culhane, Aedin/AAG-8490-2019; Chen, Ken/AAU-1432-2021; Calatozzolo, Chiara/AAM-1153-2021; Scolyer, Richard/AAE-8511-2019; Carlotti, Carlos G/C-1608-2012; mattei, luca/K-7709-2016; Perou, Charles M/H-9934-2014; Khuri, Fadlo R./AAU-4942-2020; von Deimling, Andreas/F-7774-2013; Grazi, Gian Luca/J-7215-2018; Shabunin, Alexey/AFE-8506-2022; Plaisier, Christopher/HGD-5631-2022; Perin, Alessandro/AAC-1316-2019; Fan, Huihui/AGB-0221-2022; Longatto-Filho, Adhemar/N-3397-2019; Choueiri, Toni/K-5238-2019; Pedamallu, Chandra Sekhar/AAV-6723-2020; Cherniack, Andrew D./AAY-8132-2020; ALVARO, Domenico/J-8600-2018; Cherniack, Andrew/AAC-5310-2019; Jones, Steven J/C-3621-2009; Porta-Pardo, Eduard/AAS-7638-2020; longatto-filho, adhemar/D-7039-2013; Reis, Rui Manuel/B-1744-2018; Moiseenko, Fedor/E-1775-2014; Vidal, Daniel O./C-7203-2012; Pollo, Bianca/K-5347-2018; de Carvalho, Ana Carolina/Q-4055-2019; Bryce, Alan/W-1765-2019; Adebamowo, Clement/C-8778-2011; Shinbrot, Eve/V-2784-2019; Porta-Pardo, Eduard/K-9162-2016; Van Den Berg, David J/G-8598-2017; Reis, Rui Manuel/AAD-6470-2020; Santos, José Sebastião/A-2179-2008; Dubina, Michael/E-1888-2014; Plaisier, Christohper L/H-3238-2019; Ganesh, Dunna Sai/AGX-5170-2022; Malta, Tathiane/N-1686-2013; Mungall, Andrew J./U-7067-2018; Yang, Ian A/B-9609-2008; Marino, Mirella/A-7548-2018; Becker, Karl-Friedrich/D-3636-2015; Mann, Graham/G-4758-2014; Long, Georgina/C-1771-2013; DiMeco, Francesco/Q-3785-2016; hayward, nicholas/C-1367-2015	Carvalho, Andre Lopes/0000-0001-7214-6402; dhanasekaran, renumathy/0000-0001-8819-7511; Lazar, Alexander J/0000-0002-6395-4499; Laird, Peter W/0000-0001-9117-3641; Silveira, Henrique C S/0000-0001-8607-6206; Marra, Marco A/0000-0001-7146-7175; Tavobilov, Mikhail/0000-0003-0335-1204; Barnholtz-Sloan, Jill/0000-0001-6190-9304; De Rose, Agostino Maria/0000-0003-3310-8088; N, Houtan/0000-0003-4051-8114; Stern, Marc-Henri/0000-0002-8100-2272; Holt, Robert A/0000-0002-7259-1247; Lyadov, Vladimir/0000-0002-7281-3591; Wilson, Richard K./0000-0002-1992-1358; Culhane, Aedin/0000-0002-1395-9734; Chen, Ken/0000-0003-4013-5279; Calatozzolo, Chiara/0000-0003-0165-3495; Scolyer, Richard/0000-0002-8991-0013; Carlotti, Carlos G/0000-0002-7055-0564; mattei, luca/0000-0002-7330-502X; Perou, Charles M/0000-0001-9827-2247; Khuri, Fadlo R./0000-0002-8638-7618; von Deimling, Andreas/0000-0002-5863-540X; Grazi, Gian Luca/0000-0002-3279-0313; Shabunin, Alexey/0000-0002-4230-8033; Perin, Alessandro/0000-0002-6697-9835; Fan, Huihui/0000-0003-4233-5389; Longatto-Filho, Adhemar/0000-0002-5779-9752; Choueiri, Toni/0000-0002-9201-3217; Cherniack, Andrew D./0000-0003-0470-0111; ALVARO, Domenico/0000-0003-3771-9644; Jones, Steven J/0000-0003-3394-2208; Porta-Pardo, Eduard/0000-0001-7900-4239; longatto-filho, adhemar/0000-0002-5779-9752; Reis, Rui Manuel/0000-0002-9639-7940; Moiseenko, Fedor/0000-0003-2544-9042; Pollo, Bianca/0000-0002-5523-4256; de Carvalho, Ana Carolina/0000-0002-0114-7659; Bryce, Alan/0000-0002-0206-3895; Adebamowo, Clement/0000-0002-6571-2880; Shinbrot, Eve/0000-0002-8879-3150; Porta-Pardo, Eduard/0000-0001-7900-4239; Van Den Berg, David J/0000-0002-5404-5218; Reis, Rui Manuel/0000-0002-9639-7940; Santos, José Sebastião/0000-0001-5118-0361; Dubina, Michael/0000-0002-6606-3309; Plaisier, Christohper L/0000-0003-3273-5717; Malta, Tathiane/0000-0003-1129-5791; Mungall, Andrew J./0000-0002-0905-2742; Yang, Ian A/0000-0001-8338-1993; Marino, Mirella/0000-0002-0045-0234; deCarvalho, Ana C/0000-0003-1183-4548; Milhem, Mohammed/0000-0003-4663-6824; Boussioutas, Alex/0000-0002-8109-6897; Kovatich, Albert/0000-0002-5169-4087; Shannon, Kerwin/0000-0001-8538-3132; Cardinale, Vincenzo/0000-0003-0234-3341; Colaprico, Antonio/0000-0003-1044-4361; Ha, Gavin/0000-0001-7578-7272; Ajani, Jaffer A/0000-0001-9946-0629; McCall, Shannon/0000-0003-3957-061X; catto, james/0000-0003-2787-8828; Kakavand, Hojabr/0000-0002-3458-7853; Roberts, Lewis/0000-0001-7885-8574; Mills, Gordon/0000-0002-0144-9614; Cuzzubbo, Stefania/0000-0003-0288-4607; doddapaneni, harshavardhan/0000-0002-2433-633X; Bowen, Jay/0000-0001-6861-9043; Hovens, Christopher/0000-0002-0610-1289; Lipp, Eric/0000-0002-4372-5533; Omberg, Larsson/0000-0002-4719-9120; Bergeron, Alain/0000-0002-2875-0773; Moncrieff, Marc/0000-0003-4492-235X; Giordano, Thomas/0000-0003-0641-8873; Schlomm, Thorsten/0000-0001-9557-4653; Bootwalla, Moiz/0000-0001-6158-7114; Gabra, Hani/0000-0002-3322-4399; Lacombe, Louis/0000-0003-4811-0308; Asa, Sylvia/0000-0001-8418-5054; Pennell, Nathan/0000-0002-1458-0064; Bullman, Susan/0000-0002-7713-0810; Heiman, David/0000-0001-7895-4259; MCLELLAN, MICHAEL/0000-0002-2703-8784; Gao, Galen/0000-0003-3143-9270; Tarnuzzer, Roy/0000-0002-3725-4173; de Bruijn, Ino/0000-0001-5427-4750; Weinstein, John/0000-0001-9401-6908; Gibbs, David/0000-0003-1121-5114; Setdikova, Galiya/0000-0002-5262-4953; Sanchez-Vega, Francisco/0000-0002-2990-4893; Stuart, Joshua/0000-0002-2171-565X; Fong, Kwun/0000-0002-6507-1403; Califano, Andrea/0000-0003-4742-3679; Thomas, George V/0000-0001-7416-8840; Wang, Linghua/0000-0001-9380-0266; Vo, Nam/0000-0002-5454-9176; Jakrot, Valerie/0000-0002-8578-5964; Giuliante, Felice/0000-0003-2087-2589; Facciolo, Francesco/0000-0002-7137-8946; Becker, Karl-Friedrich/0000-0002-6801-4498; Rai, Karan/0000-0001-6260-6268; Aredes, Natalia Del Angelo/0000-0002-1661-8601; Mann, Graham/0000-0003-1301-405X; Hoadley, Katherine/0000-0002-1216-477X; ma, deqin/0000-0002-8581-6345; Schadendorf, Dirk/0000-0003-3524-7858; Ou Yang, Tai-Hsien/0000-0001-9650-1253; Auman, James/0000-0002-9328-8829; Brown, Scott/0000-0003-4000-4148; He, Jing/0000-0003-0816-3843; Mieczkowski, Piotr/0000-0003-2418-0096; Long, Georgina/0000-0001-8894-3545; Fassnacht, Martin/0000-0001-6170-6398; Finocchiaro, Gaetano/0000-0003-3583-4040; DiMeco, Francesco/0000-0001-6213-5793; Feltmate, Colleen/0000-0002-7700-8575; Creaney, Jenette/0000-0002-9391-9395; Ho, Thai/0000-0003-0023-2939; hayward, nicholas/0000-0003-4760-1033; Rubin, Mark/0000-0002-8321-9950; Bailey, Matthew H./0000-0003-4526-9727; wilmott, james/0000-0002-6750-5244; Shen, Hui/0000-0001-9767-4084	Institute for Systems Biology-Cancer Genomics Cloud (ISB-CGC) [HHSN261201400007C]; National Cancer Institute, NIH, Department of Health and Human Services; Cancer Research Institute; NCI [U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P30 CA016672]; US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-12-2-0050, HU0001-16-2-0004]; Seven Bridges Cancer Genomics Cloud [HHSN261201400008C]; NATIONAL CANCER INSTITUTE [P30CA016672, U24CA143840, P30CA016086, R37CA214955, P30CA045508, ZIACP010212, U24CA180924, P50CA058223, R50CA221675, U24CA210950, U24CA210949, U24CA143883, U24CA210990, R35CA197745, U24CA210957, U24CA143843, P30CA124435, U24CA143799, U24CA143867, U24CA144025, U24CA143848, R01CA163722, K24CA169004, U24CA143866, U24CA143858, U24CA143882, U24CA143845, U54CA209997, U24CA143835] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003273, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009239] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764, S10OD012351] Funding Source: NIH RePORTER	Institute for Systems Biology-Cancer Genomics Cloud (ISB-CGC); National Cancer Institute, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Seven Bridges Cancer Genomics Cloud; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to all the patients and families who contributed to this study. We also thank the Office of Cancer Genomics at the NCI for organizational and logistical support of this study. The high-throughput analyses in this study were performed on the Institute for Systems Biology-Cancer Genomics Cloud (ISB-CGC) under contract number HHSN261201400007C and on the Seven Bridges Cancer Genomics Cloud under contract HHSN261201400008C, with federal funds from the National Cancer Institute, NIH, Department of Health and Human Services. Funding from the Cancer Research Institute is gratefully acknowledged, as is support from NCI through U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, and P30 CA016672. The study was supported by W81XWH-12-2-0050, HU0001-16-2-0004 from the US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine. We thank Peter Hammerman and Yasin Sxenbabaoglu for contributions in early phases of this work.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Amankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116; Aten JE, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-34; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Bedognetti D, 2016, CURR OPIN IMMUNOL, V39, P150, DOI 10.1016/j.coi.2016.02.001; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benyamine A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1146843; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brown SD, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0248-x; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Calabro A, 2009, BREAST CANCER RES TR, V116, P69, DOI 10.1007/s10549-008-0105-3; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Cubillos-Ruiz JR, 2010, ONCOTARGET, V1, P329, DOI 10.18632/oncotarget.165; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drake JM, 2016, CELL, V166, P1041, DOI 10.1016/j.cell.2016.07.007; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Gusenleitner D, 2012, BIOINFORMATICS, V28, P2484, DOI 10.1093/bioinformatics/bts438; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hendrickx W, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1253654; Hornik K, 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I12; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Iglesia MD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw144; Ilieva KM, 2014, MOL CANCER THER, V13, P2769, DOI 10.1158/1535-7163.MCT-14-0290; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Knijnenburg TA, 2018, CELL REP, V23, P239, DOI 10.1016/j.celrep.2018.03.076; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Legut M, 2015, CELL MOL IMMUNOL, V12, P656, DOI 10.1038/cmi.2015.28; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Liang Y, 2015, J LEUKOCYTE BIOL, V97, P487, DOI 10.1189/jlb.1RU0814-369R; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Mose LE, 2016, BIOINFORMATICS, V32, P3729, DOI 10.1093/bioinformatics/btw526; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Paull EO, 2013, BIOINFORMATICS, V29, P2757, DOI 10.1093/bioinformatics/btt471; Pavesi Giulio, 2006, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0211s15; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Plaisier CL, 2016, CELL SYST, V3, P172, DOI 10.1016/j.cels.2016.06.006; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Porta-Pardo E, 2016, CANCER IMMUNOL RES, V4, P789, DOI 10.1158/2326-6066.CIR-15-0233; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Punt S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984547; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Reiss DJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv300; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Scrucca L, 2016, R J, V8, P289; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Silva Tiago C, 2016, F1000Res, V5, P1542, DOI 10.12688/f1000research.8923.2; Siragusa E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Tang J, 2018, ANN ONCOL, V29, P84, DOI 10.1093/annonc/mdx755; Tatlow PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39259; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Teschendorff AE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-604; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Wolf DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088309; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	102	2088	2109	44	273	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					812	+		10.1016/j.immuni.2018.03.023	http://dx.doi.org/10.1016/j.immuni.2018.03.023			33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29628290	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000430198900025
J	Dunn, GP; Old, LJ; Schreiber, RD				Dunn, GP; Old, LJ; Schreiber, RD			The immunobiology of cancer immunosurveillance and immunoediting	IMMUNITY			English	Review							MHC CLASS-I; APOPTOSIS-INDUCING LIGAND; TOLL-LIKE RECEPTOR-4; DELTA-T-CELLS; TUMOR-IMMUNITY; INTERFERON-GAMMA; NKG2D RECEPTOR; NK CELLS; HUMAN-MELANOMA; RETINOIC ACID	The last fifteen years have seen a reemergence of interest in cancer immunosurveillance and a broadening of this concept into one termed cancer immunoediting. The latter, supported by strong experimental data derived from murine tumor models and provocative correlative data obtained by studying human cancer, holds that the immune system not only protects the host against development of primary nonviral cancers but also sculpts tumor immunogenicity. Cancer immunoediting is a process consisting of three phases: elimination (i.e., cancer immunosurveillance), equilibrium, and escape. Herein, we summarize the data supporting the existence of each of the three cancer immunoediting phases. The full understanding of the immunobiology of cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective immunotherapeutic approaches to control and/or eliminate human cancers.	Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Washington University (WUSTL); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341				Algarra I, 2000, HUM IMMUNOL, V61, P65, DOI 10.1016/S0198-8859(99)00156-1; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bahram S, 2000, Adv Immunol, V76, P1; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Burnet F M, 1971, Transplant Rev, V7, P3; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; BURNET M, 1964, BRIT MED BULL, V20, P154, DOI 10.1093/oxfordjournals.bmb.a070310; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Conejo-Garcia JR, 2003, CANCER BIOL THER, V2, P446, DOI 10.4161/cbt.2.4.479; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Cui Z, 2003, P NATL ACAD SCI USA, V100, P6682, DOI 10.1073/pnas.1031601100; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Ehrrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Elder GJ, 1997, CLIN TRANSPLANT, V11, P565; Engel AM, 1996, APMIS, V104, P629, DOI 10.1111/j.1699-0463.1996.tb04923.x; Fallarino F, 1999, J IMMUNOL, V163, P4109; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hayakawa Y, 2003, P NATL ACAD SCI USA, V100, P9464, DOI 10.1073/pnas.1630663100; Jager E, 1997, INT J CANCER, V71, P142, DOI 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Khong HT, 2004, J IMMUNOTHER, V27, P184, DOI 10.1097/00002371-200405000-00002; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; LOEB LA, 1991, CANCER RES, V51, P3075; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Nishikawa H, 2003, P NATL ACAD SCI USA, V100, P10902, DOI 10.1073/pnas.1834479100; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; Old Lloyd J, 2003, Cancer Immun, V3 Suppl 2, P1; Onizuka S, 1999, CANCER RES, V59, P3128; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pende D, 2002, CANCER RES, V62, P6178; Penn I, 1996, TRANSPLANTATION, V61, P274, DOI 10.1097/00007890-199601270-00019; PENN I, 1991, TRANSPLANT P, V23, P2629; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schreiber RD, 2004, NAT IMMUNOL, V5, P4, DOI 10.1038/ni0104-4; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shimizu J, 1999, J IMMUNOL, V163, P5211; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; STUTMAN O, 1979, J NATL CANCER I, V62, P353; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; Suranyi MG, 1998, TRANSPLANTATION, V66, P655, DOI 10.1097/00007890-199809150-00020; Svane IM, 1996, EUR J IMMUNOL, V26, P1844, DOI 10.1002/eji.1830260827; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; THOMAS L, 1982, YALE J BIOL MED, V55, P329; Thomas L, 1959, CELLULAR HUMORAL ASP, P529; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; UHR JW, 1991, CANCER RES, V51, pS5045; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vetter CS, 2002, J INVEST DERMATOL, V118, P600, DOI 10.1046/j.1523-1747.2002.01700.x; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wheelock E F, 1981, Adv Cancer Res, V34, P107; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; Woo EY, 2001, CANCER RES, V61, P4766; Wu GS, 1999, CANCER RES, V59, P2770; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	117	1916	2037	6	240	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					137	148		10.1016/j.immuni.2004.07.017	http://dx.doi.org/10.1016/j.immuni.2004.07.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308095	Bronze			2022-12-18	WOS:000223441900003
J	Nishimura, H; Nose, M; Hiai, H; Minato, N; Honjo, T				Nishimura, H; Nose, M; Hiai, H; Minato, N; Honjo, T			Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; LYMPHOCYTE IMMUNE DEFECT; CELL ANTIGEN RECEPTOR; VERSUS-HOST DISEASE; LYN-DEFICIENT MICE; NEGATIVE SELECTION; TRANSGENIC MICE; B-CELLS; REGULATED EXPRESSION; CD22-DEFICIENT MICE	PD-1, a 55 kDa transmembrane protein containing an immunoreceptor tyrosine-based inhibitory motif, is induced in lymphocytes and monocytic cells following activation. Aged C57BL/6(B6)-PD-1(-/-) congenic mice spontaneously developed characteristic lupus-like proliferative arthritis and glomerulonephritis with predominant IgG3 deposition, which were markedly accelerated by introduction of a Fas mutation (lpr). Introduction of a PD-1 null mutation into the 2C-TCR (anti-H-2L(d)) transgenic mice of the H-2(b/d) background resulted in the chronic and systemic graft-versus-host-like disease. Furthermore, CD8(+)2C-TCR+PD-1(-/-) cells exhibited markedly augmented proliferation in vitro in response to H-2(d) allogenic cells. Collectively, it is suggested that PD-1 is involved in the maintenance of peripheral self-tolerance by serving as a negative regulator of immune responses.	Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Ehime Univ, Sch Med, Dept Pathol, Shigenobu, Ehime 7910295, Japan	Kyoto University; Kyoto University; Kyoto University; Ehime University	Honjo, T (corresponding author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.		Honjo, Tasuku/N-4470-2016					Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; ASANO T, 1988, CLIN EXP IMMUNOL, V74, P36; Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DRAKE CG, 1995, IMMUNOL REV, V144, P51, DOI 10.1111/j.1600-065X.1995.tb00065.x; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; IZUI S, 1995, IMMUNOL REV, V144, P137, DOI 10.1111/j.1600-065X.1995.tb00068.x; IZUI S, 1984, J IMMUNOL, V133, P227; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KARIYONE A, 1988, CELL IMMUNOL, V115, P112, DOI 10.1016/0008-8749(88)90166-9; KAWAI K, 1991, CLIN EXP IMMUNOL, V84, P359; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Ma J, 1996, J IMMUNOL, V157, P417; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MILLER JFAP, 1994, CURR OPIN IMMUNOL, V6, P892, DOI 10.1016/0952-7915(94)90010-8; MILLER JFAP, 1992, ANNU REV IMMUNOL, V10, P51, DOI 10.1146/annurev.iy.10.040192.000411; Mondino A, 1996, P NATL ACAD SCI USA, V93, P2245, DOI 10.1073/pnas.93.6.2245; MURPHY GF, 1991, AM J PATHOL, V138, P983; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; PERLMUTTER RM, 1979, J EXP MED, V149, P993, DOI 10.1084/jem.149.4.993; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1126; ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHER I, 1975, J EXP MED, V141, P788; SCHER I, 1975, J EXP MED, V142, P637, DOI 10.1084/jem.142.3.637; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; SLACK JH, 1984, J IMMUNOL, V132, P1271; STEINBERG EB, 1983, J IMMUNOL, V131, P2789; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TAKAHASHI S, 1993, MOL IMMUNOL, V30, P177; TAKAHASHI S, 1991, J IMMUNOL, V147, P515; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; VOLCPLATZER B, 1988, J INVEST DERMATOL, V91, P162, DOI 10.1111/1523-1747.ep12464407; VONBOEHMER H, 1991, CURR OPIN IMMUNOL, V3, P210, DOI 10.1016/0952-7915(91)90052-3; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961	58	1858	2106	14	137	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					141	151		10.1016/S1074-7613(00)80089-8	http://dx.doi.org/10.1016/S1074-7613(00)80089-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485649	Bronze			2022-12-18	WOS:000082383400003
J	Bindea, G; Mlecnik, B; Tosolini, M; Kirilovsky, A; Waldner, M; Obenauf, AC; Angell, H; Fredriksen, T; Lafontaine, L; Berger, A; Bruneval, P; Fridman, WH; Becker, C; Pages, F; Speicher, MR; Trajanoski, Z; Galon, J				Bindea, Gabriela; Mlecnik, Bernhard; Tosolini, Marie; Kirilovsky, Amos; Waldner, Maximilian; Obenauf, Anna C.; Angell, Helen; Fredriksen, Tessa; Lafontaine, Lucie; Berger, Anne; Bruneval, Patrick; Fridman, Wolf Herman; Becker, Christoph; Pages, Franck; Speicher, Michael R.; Trajanoski, Zlatko; Galon, Jerome			Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	IMMUNITY			English	Article							COLORECTAL-CANCER; T-CELLS; TUMOR IMMUNOGENICITY; EXPRESSION PROFILES; SYSTEMS BIOLOGY; GENE-EXPRESSION; CYTOSCAPE; SURVIVAL; MEMORY; IDENTIFICATION	The complex interactions between tumors and their microenvironment remain to be elucidated. Combining large-scale approaches, we examined the spatio-temporal dynamics of 28 different immune cell types (immunome) infiltrating tumors. We found that the immune infiltrate composition changed at each tumor stage and that particular cells had a major impact on survival. Densities of T follicular helper (Tfh) cells and innate cells increased, whereas most T cell densities decreased along with tumor progression. The number of B cells, which are key players in the core immune network and are associated with prolonged survival, increased at a late stage and showed a dual effect on recurrence and tumor progression. The immune control relevance was demonstrated in three endoscopic orthotopic colon-cancer mouse models. Genomic instability of the chemokine CXCL13 was a mechanism associated with Tfh and B cell infiltration. CXCL13 and IL21 were pivotal factors for the Tfh/B cell axis correlating with survival. This integrative study reveals the immune landscape in human colorectal cancer and the major hallmarks of the microenvironment associated with tumor progression and recurrence.	[Bindea, Gabriela; Mlecnik, Bernhard; Tosolini, Marie; Kirilovsky, Amos; Waldner, Maximilian; Angell, Helen; Fredriksen, Tessa; Lafontaine, Lucie; Pages, Franck; Galon, Jerome] INSERM U872, Lab Integrat Canc Immunol, F-75006 Paris, France; [Bindea, Gabriela; Mlecnik, Bernhard; Tosolini, Marie; Kirilovsky, Amos; Waldner, Maximilian; Angell, Helen; Fredriksen, Tessa; Lafontaine, Lucie; Fridman, Wolf Herman; Pages, Franck; Galon, Jerome] Univ Paris 05, F-75006 Paris, France; [Bindea, Gabriela; Mlecnik, Bernhard; Tosolini, Marie; Kirilovsky, Amos; Waldner, Maximilian; Angell, Helen; Fredriksen, Tessa; Lafontaine, Lucie; Fridman, Wolf Herman; Pages, Franck; Galon, Jerome] Univ Paris 06, Cordeliers Res Ctr, F-75006 Paris, France; [Waldner, Maximilian; Becker, Christoph] Univ Erlangen Nurnberg, D-91001 Erlangen, Germany; [Obenauf, Anna C.; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Berger, Anne; Galon, Jerome] AP HP, Dept Gen & Digest Surg, F-75015 Paris, France; [Bruneval, Patrick] Georges Pompidou European Hosp, Dept Pathol, F-75015 Paris, France; [Pages, Franck] Georges Pompidou European Hosp, Dept Immunol, F-75015 Paris, France; [Fridman, Wolf Herman] INSERM, U872, Team 13, F-75006 Paris, France; [Trajanoski, Zlatko] Med Univ Innsbruck, Sect Bioinformat, Bioctr, A-6020 Innsbruck, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Erlangen Nuremberg; Medical University of Graz; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck	Galon, J (corresponding author), INSERM U872, Lab Integrat Canc Immunol, F-75006 Paris, France.	jerome.galon@crc.jussieu.fr	Speicher, Michael R/B-5362-2013; Tosolini, Marie/AAL-5941-2020; Tosolini, Marie/A-6653-2009; Becker, Christoph/L-2996-2016; Trajanoski, Zlatko/AAT-6703-2021; mlecnik, bernhard/AAT-7467-2021; Galon, Jerome/G-9838-2019; Becker, Christoph/A-6694-2008	Speicher, Michael R/0000-0003-0105-955X; Tosolini, Marie/0000-0001-5278-5952; Tosolini, Marie/0000-0001-5278-5952; Galon, Jerome/0000-0001-9635-1339; Obenauf, Anna/0000-0002-9556-5914; fridman, wolf herman/0000-0002-1332-0973; Becker, Christoph/0000-0002-1388-1041	National Cancer Institute of France (INCa); Canceropole Ile de France; Ville de Paris; MedImmune; INSERM; Austrian Federal Ministry of Science and Research (GEN-AU project Bioinformatics Integration Network); Qatar National Research Fund under National Priorities Research Program [NPRP09-1174-3-291]; European Commission (7FP, Geninca Consortium) [202230]; LabEx Immuno-oncology	National Cancer Institute of France (INCa); Canceropole Ile de France(Region Ile-de-France); Ville de Paris; MedImmune(AstraZenecaMedimmune); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Austrian Federal Ministry of Science and Research (GEN-AU project Bioinformatics Integration Network); Qatar National Research Fund under National Priorities Research Program(Qatar National Research Fund (QNRF)); European Commission (7FP, Geninca Consortium); LabEx Immuno-oncology	We are grateful to Ion Gresser for providing helpful comments and critical review of the manuscript. This work was supported by grants from the National Cancer Institute of France (INCa), the Canceropole Ile de France, Ville de Paris, MedImmune, INSERM, the Austrian Federal Ministry of Science and Research (GEN-AU project Bioinformatics Integration Network), Qatar National Research Fund under its National Priorities Research Program award number NPRP09-1174-3-291, the European Commission (7FP, Geninca Consortium, grant 202230), and the LabEx Immuno-oncology.	Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Ancona N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-387; Angel H, 2013, CURR OPIN IMMUNOL, V25, P261, DOI 10.1016/j.coi.2013.03.004; Atreya I, 2008, EXPERT REV ANTICANC, V8, P561, DOI 10.1586/14737140.8.4.561; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2010, CURR OPIN IMMUNOL, V22, P215, DOI 10.1016/j.coi.2010.02.006; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Deola S, 2008, J IMMUNOL, V180, P1362, DOI 10.4049/jimmunol.180.3.1362; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2007, CANCER RES, V67, P1883, DOI 10.1158/0008-5472.CAN-06-4806; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hollander N, 2004, STAT MED, V23, P1701, DOI 10.1002/sim.1611; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jenh CH, 2001, CYTOKINE, V15, P113, DOI 10.1006/cyto.2001.0923; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kim PS, 2009, METHOD ENZYMOL, V467, P79, DOI 10.1016/S0076-6879(09)67004-X; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Mlecnik B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S7; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sutherland APR, 2013, J IMMUNOL, V190, P3977, DOI 10.4049/jimmunol.1201730; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tegner J, 2006, CELL IMMUNOL, V244, P105, DOI 10.1016/j.cellimm.2007.01.010; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Wang E, 2008, TRENDS IMMUNOL, V29, P256, DOI 10.1016/j.it.2008.03.002; Wang E, 2004, CELL MOL IMMUNOL, V1, P256; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wendt K, 2006, J LEUKOCYTE BIOL, V80, P1529, DOI 10.1189/jlb.0306191	52	1824	1861	21	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					782	795		10.1016/j.immuni.2013.10.003	http://dx.doi.org/10.1016/j.immuni.2013.10.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138885	Bronze			2022-12-18	WOS:000330950000018
J	Fontenot, JD; Rasmussen, JP; Williams, LM; Dooley, JL; Farr, AG; Rudensky, AY				Fontenot, JD; Rasmussen, JP; Williams, LM; Dooley, JL; Farr, AG; Rudensky, AY			Regulatory T cell lineage specification by the forkhead transcription factor FoxP3	IMMUNITY			English	Article							IN-VIVO; SCURFIN; SELF; DISEASE; INDUCTION; PROTEIN; THYMUS	Regulatory T cell-mediated dominant tolerance has been demonstrated to play an important role in the prevention of autoimmunity. Here, we present data arguing that the forkhead transcription factor Foxp3 acts as the regulatory T cell lineage specification factor and mediator of the genetic mechanism of dominant tolerance. We show that expression of Foxp3 is highly restricted to the subset up of T cells and, irrespective of CD25 expression, correlates with suppressor activity. Induction of Foxp3 expression in nonregulatory T cells does not occur during pathogen-driven immune responses, and Foxp3 deficiency does not impact the functional responses of nonregulatory T cells. Furthermore, T cell-specific ablation of Foxp3 is sufficient to induce the identical early onset lymphoproliferative syndrome observed in Foxp3-deficient mice. Analysis of Foxp3 expression during thymic development suggests that this mechanism is not hard-wired but is dependent on TCR/MHC ligand interactions.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fontenot, JD (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	fontenot@u.washington.edu; aruden@u.washington.edu		Dooley, James/0000-0003-3154-4708; Rasmussen, Jeffrey/0000-0001-6997-3773				Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Clark LB, 1999, J IMMUNOL, V162, P2546; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Mach N, 2000, CANCER RES, V60, P3239; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; TANDON P, 1979, IMMUNOLOGY, V38, P653; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Wolff U, 2001, IEEE SENS J, V1, P4, DOI 10.1109/JSEN.2001.923583; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; WU Z, 2004, 1 J HOPK U DEP BIOST; Zahorsky-Reeves JL, 2001, EUR J IMMUNOL, V31, P196, DOI 10.1002/1521-4141(200101)31:1<196::AID-IMMU196>3.0.CO;2-9	28	1804	1926	1	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					329	341		10.1016/j.immuni.2005.01.016	http://dx.doi.org/10.1016/j.immuni.2005.01.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780990	Bronze			2022-12-18	WOS:000228105700008
J	Yona, S; Kim, KW; Wolf, Y; Mildner, A; Varol, D; Breker, M; Strauss-Ayali, D; Viukov, S; Guilliams, M; Misharin, A; Hume, DA; Perlman, H; Malissen, B; Zelzer, E; Jung, S				Yona, Simon; Kim, Ki-Wook; Wolf, Yochai; Mildner, Alexander; Varol, Diana; Breker, Michal; Strauss-Ayali, Dalit; Viukov, Sergey; Guilliams, Martin; Misharin, Alexander; Hume, David A.; Perlman, Harris; Malissen, Bernard; Zelzer, Elazar; Jung, Steffen			Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis	IMMUNITY			English	Article							DENDRITIC CELL-DEVELOPMENT; BONE-MARROW; BLOOD MONOCYTES; FLUORESCENT PROTEIN; MICROGLIA DERIVE; GROWTH-FACTOR; YOLK-SAC; IDENTIFICATION; PROGENITORS; EXPRESSION	Mononuclear phagocytes, including monocytes, macrophages, and dendritic cells, contribute to tissue integrity as well as to innate and adaptive immune defense. Emerging evidence for labor division indicates that manipulation of these cells could bear therapeutic potential. However, specific ontogenies of individual populations and the overall functional organization of this cellular network are not well defined. Here we report a fate-mapping study of the murine monocyte and macrophage compartment taking advantage of constitutive and conditional CX(3)CR1 promoter-driven Cre recombinase expression. We have demonstrated that major tissue-resident macrophage populations, including liver Kupffer cells and lung alveolar, splenic, and peritoneal macrophages, are established prior to birth and maintain themselves subsequently during adulthood independent of replenishment by blood monocytes. Furthermore, we have established that short-lived Ly6C(+) monocytes constitute obligatory steady-state precursors of blood-resident Ly6C(-) cells and that the abundance of Ly6C(+) blood monocytes dynamically controls the circulation lifespan of their progeny.	[Yona, Simon; Kim, Ki-Wook; Wolf, Yochai; Mildner, Alexander; Varol, Diana; Breker, Michal; Strauss-Ayali, Dalit; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Viukov, Sergey; Zelzer, Elazar] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Guilliams, Martin; Malissen, Bernard] Aix Marseille Univ, INSERM, U1104, CNRS,UMR7280,Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; [Misharin, Alexander; Perlman, Harris] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Guilliams, Martin] VIB, Lab Immunoregulat & Mucosal Immunol, Dept Mol Biomed Res, Ghent, Belgium	Weizmann Institute of Science; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Northwestern University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Flanders Institute for Biotechnology (VIB)	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Hume, David A/C-7695-2013; Misharin, Alexander/AAD-6456-2019; Guilliams, Martin/N-7803-2013; mildner, alexander/GQA-3761-2022; mildner, alexander/AFK-2161-2022; Yona, Simon/ABE-6572-2020; Jung, Steffen/K-1409-2012; mildner, alexander/AAF-9451-2022; Mildner, Alexander/ABG-6122-2020; Breker-Dekel, Michal/ABS-5753-2022; Malissen, Bernard/AAK-4659-2020	Guilliams, Martin/0000-0003-3525-7570; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; Yona, Simon/0000-0002-3984-2008; Malissen, Bernard/0000-0003-1340-9342; Hume, David/0000-0002-2615-1478; Wolf, Yochai/0000-0003-0270-2025; Misharin, Alexander/0000-0003-2879-3789; /0000-0002-7207-4389	FEBS fellowship; Leir Charitable Foundation; Wolfson Family Charitable Trust; Israel Science Foundation (ISF); Deutsche Forschungsgemeinschaft (DFG) Research Unit (FOR) [1336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050250, R01AR054796] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BBS/E/D/20251969] Funding Source: researchfish; Medical Research Council [G0901193] Funding Source: researchfish; BBSRC [BBS/E/D/20221657, BBS/E/D/20251969] Funding Source: UKRI; MRC [G0901193] Funding Source: UKRI	FEBS fellowship; Leir Charitable Foundation; Wolfson Family Charitable Trust; Israel Science Foundation (ISF)(Israel Science Foundation); Deutsche Forschungsgemeinschaft (DFG) Research Unit (FOR)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank R. Haffner for guidance with the ES cell work and the staff of the Weizmann Animal facility for the excellent care. S.Y. was a recipient of a long-term FEBS fellowship; A.M. was a fellow of the Minerva foundation. This work was supported by the Leir Charitable Foundation, the Wolfson Family Charitable Trust, the Israel Science Foundation (ISF), and the Deutsche Forschungsgemeinschaft (DFG) Research Unit (FOR) 1336. S.J. is a Helmsley Scholar at the Crohn's & Colitis Foundation.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; HUME DA, 1984, EXP CELL RES, V150, P347, DOI 10.1016/0014-4827(84)90578-0; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V47, P651; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yona Simon, 2010, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1415s88; Yrlid U, 2006, EUR J IMMUNOL, V36, P2639, DOI 10.1002/eji.200636426; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	66	1789	1828	14	200	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					79	91		10.1016/j.immuni.2012.12.001	http://dx.doi.org/10.1016/j.immuni.2012.12.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23273845	Green Accepted, Bronze			2022-12-18	WOS:000314195500011
J	Kolls, JK; Linden, A				Kolls, JK; Linden, A			Interleukin-17 family members and inflammation	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; BRONCHIAL EPITHELIAL-CELLS; FACTOR-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; RECEPTOR-LIKE PROTEIN; AIRWAYS IN-VIVO; T-CELL; NEUTROPHIL RECRUITMENT; GENE-EXPRESSION; CUTTING EDGE	IL-17A was cloned more than 10 years ago and six IL-17 family members (IL-17A-F) have subsequently been described. IL-17A is largely produced by activated memory T lymphocytes but stimulates innate immunity and host defense. IL-17A and IL-17F both mobilize neutrophils partly through granulopoeisis and CXC chemokine induction, as well as increased survival locally. IL-17A and IL-17F production by T lymphocytes is regulated by IL-23 independent of T cell receptor activation. Increasing evidence shows that IL-1 7 family members play an active role in inflammatory diseases, autoimmune diseases, and cancer. This places IL-17 family members and their receptors as potential targets for future pharmacotherapy.	Childrens Hosp Pittsburgh, Dept Pediat, Div Pulm, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Sahlgrens Acad, Inst Internal Med, Dept Allergol & Resp Med, S-41345 Gothenburg, Sweden; Univ Gothenburg, S-41345 Gothenburg, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Gothenburg; University of Gothenburg	Kolls, JK (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, Div Pulm, Pittsburgh, PA 15213 USA.	jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Linden, Anders/0000-0003-1258-2928	NHLBI NIH HHS [R37 HL079142] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079142] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Awane M, 1999, J IMMUNOL, V162, P5337; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Cai XY, 1998, IMMUNOL LETT, V62, P51, DOI 10.1016/S0165-2478(98)00027-3; Casado B, 2004, ELECTROPHORESIS, V25, P1386, DOI 10.1002/elps.200305862; Chabaud M, 2000, CYTOKINE, V12, P1092, DOI 10.1006/cyto.2000.0681; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harper R, 2001, AM J RESP CELL MOL, V25, P178, DOI 10.1165/ajrcmb.25.2.4471; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hoshino H, 1999, AM J RESP CRIT CARE, V159, P1423, DOI 10.1164/ajrccm.159.5.9806008; Hoshino H, 2000, J ALLERGY CLIN IMMUN, V105, P143, DOI 10.1016/S0091-6749(00)90189-1; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Kawaguchi M, 2001, J IMMUNOL, V167, P4430, DOI 10.4049/jimmunol.167.8.4430; Kennedy T, 1998, AM J RESP CELL MOL, V19, P366, DOI 10.1165/ajrcmb.19.3.3042; Kim MR, 2002, BLOOD, V100, P2330, DOI 10.1182/blood-2002-01-0012; Kolls JK, 2003, AM J RESP CELL MOL, V28, P9, DOI 10.1165/rcmb.2002-0255PS; Laan M, 2002, EUR RESPIR J, V19, P534, DOI 10.1183/09031936.02.00280902; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; Laan M, 1999, J IMMUNOL, V162, P2347; Larsson R, 2000, INFECT IMMUN, V68, P6962, DOI 10.1128/IAI.68.12.6962-6969.2000; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Molet SM, 2003, LARYNGOSCOPE, V113, P1803, DOI 10.1097/00005537-200310000-00027; Moore EE, 2002, NEUROMUSCULAR DISORD, V12, P141, DOI 10.1016/S0960-8966(01)00250-4; Mori N, 1999, INFECT IMMUN, V67, P3872, DOI 10.1128/IAI.67.8.3872-3878.1999; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Numasaki M, 2004, IMMUNOL LETT, V93, P39, DOI 10.1016/j.imlet.2004.01.014; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Reynolds SJ, 1996, AM J IND MED, V29, P33, DOI 10.1002/(SICI)1097-0274(199601)29:1<33::AID-AJIM5>3.0.CO;2-#; Rifas L, 2003, ARTHRITIS RHEUM-US, V48, P993, DOI 10.1002/art.10872; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Shin HCK, 1999, CYTOKINE, V11, P257, DOI 10.1006/cyto.1998.0433; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Tartour E, 1999, CANCER RES, V59, P3698; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Vanaudenaerde BM, 2003, J HEART LUNG TRANSPL, V22, P1280, DOI 10.1016/S1053-2498(02)01234-2; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	78	1742	1992	0	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					467	476		10.1016/j.immuni.2004.08.018	http://dx.doi.org/10.1016/j.immuni.2004.08.018			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485625	Bronze			2022-12-18	WOS:000224744400004
J	Adachi, O; Kawai, T; Takeda, K; Matsumoto, M; Tsutsui, H; Sakagami, M; Nakanishi, K; Akira, S				Adachi, O; Kawai, T; Takeda, K; Matsumoto, M; Tsutsui, H; Sakagami, M; Nakanishi, K; Akira, S			Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DORSAL-VENTRAL PATTERN; INTERLEUKIN-1 RECEPTOR; DROSOPHILA EMBRYO; DORSOVENTRAL SIGNAL; PELLE KINASE; PROTEIN; CLONING; TUBE; EXPRESSION	MyD88, originally isolated as a myeloid differentiation primary response gene, is shown to act as an adaptor in interleukin-1 (IL-1) signaling by interacting with both the IL-1 receptor complex and IL-1 receptor-associated kinase (IRAK). Mice generated by gene targeting to lack MyD88 have defects in T cell proliferation as well as induction of acute phase proteins and cytokines in response to IL-1. Increases in interferon-gamma production and natural killer cell activity in response to IL-18 are abrogated. In vivo Th1 response is also impaired. Furthermore, IL-18-induced activation of NF-kappa B and c-Jun N-terminal kinase (JNK) is blocked in MyD88(-/-) Th1-developing cells. Taken together, these results demonstrate that MyD88 is a critical component in the signaling cascade that is mediated by IL-1 receptor as well as IL-18 receptor.	Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Otolaryngol, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine	Akira, S (corresponding author), Hyogo Coll Med, Dept Biochem, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	akira@hyo-med.ac.jp	Takeda, Kiyoshi/C-9331-2009; Akira, Shizuo/C-3134-2009	Kawai, Taro/0000-0001-7510-4662; Tsutsui, Hiroko/0000-0001-7928-4875				Barbulescu K, 1998, J IMMUNOL, V160, P3642; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]; GALINDO RL, 1995, DEVELOPMENT, V121, P2209; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; GROSSHANS J, 1994, NATURE, V372, P563, DOI 10.1038/372563a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hardiman G, 1996, ONCOGENE, V13, P2467; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; HUITMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LETSOU A, 1993, EMBO J, V12, P3449, DOI 10.1002/j.1460-2075.1993.tb06019.x; LORD KA, 1990, ONCOGENE, V5, P1095; Lovenberg TW, 1996, J NEUROIMMUNOL, V70, P113, DOI 10.1016/S0165-5728(96)00047-1; MANNEL DN, 1985, J IMMUNOL, V134, P3108; Matsui K, 1997, J IMMUNOL, V159, P97; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Norris JL, 1996, GENE DEV, V10, P862, DOI 10.1101/gad.10.7.862; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Parnet P, 1996, J BIOL CHEM, V271, P3967; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; SUDA T, 1989, J IMMUNOL METHODS, V120, P173, DOI 10.1016/0022-1759(89)90239-1; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Ushio S, 1996, J IMMUNOL, V156, P4274; WASSERMAN SA, 1993, MOL BIOL CELL, V4, P767, DOI 10.1091/mbc.4.8.767; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; YANAGISAWA K, 1993, FEBS LETT, V318, P83, DOI 10.1016/0014-5793(93)81333-U	49	1714	1782	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					143	150		10.1016/S1074-7613(00)80596-8	http://dx.doi.org/10.1016/S1074-7613(00)80596-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697844	Bronze			2022-12-18	WOS:000075066600014
J	Wynn, TA; Vannella, KM				Wynn, Thomas A.; Vannella, Kevin M.			Macrophages in Tissue Repair, Regeneration, and Fibrosis	IMMUNITY			English	Review							SKELETAL-MUSCLE REGENERATION; MESENCHYMAL STEM-CELLS; MURINE LIVER FIBROSIS; INJURED SPINAL-CORD; REGULATORY T-CELLS; GROWTH-FACTOR; RESIDENT MACROPHAGES; INNATE IMMUNITY; M2 MACROPHAGES; RENAL INJURY	Inflammatory monocytes and tissue-resident macrophages are key regulators of tissue repair, regeneration, and fibrosis. After tissue injury, monocytes and macrophages undergo marked phenotypic and functional changes to play critical roles during the initiation, maintenance, and resolution phases of tissue repair. Disturbances in macrophage function can lead to aberrant repair, such that uncontrolled production of inflammatory mediators and growth factors, deficient generation of anti-inflammatory macrophages, or failed communication between macrophages and epithelial cells, endothelial cells, fibroblasts, and stem or tissue progenitor cells all contribute to a state of persistent injury, and this could lead to the development of pathological fibrosis. In this review, we discuss the mechanisms that instruct macrophages to adopt pro-inflammatory, pro-wound-healing, pro-fibrotic, anti-inflammatory, anti-fibrotic, pro-resolving, and tissue-regenerating phenotypes after injury, and we highlight how some of these mechanisms and macrophage activation states could be exploited therapeutically.	[Wynn, Thomas A.; Vannella, Kevin M.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wynn, TA (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731	NIAID of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019, ZIAAI000829] Funding Source: NIH RePORTER	NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T.A.W. and K.M.V. are supported by the intramural research program at the NIAID of the NIH. We would like to sincerely thank Ethan Tyler and Alan Hoofring of the NIH Medical Arts for help with figures. Both authors would also like to acknowledge the following colleagues at the NIH and abroad for many fruitful discussions on this topic: Peter Murray, John Pesce, Mark Wilson, Satish Madala, Rafael Prado, Trey Gieseck, David Cantu, Kayla Knilans, Robert Thompson, Lee Borthwick, Luke Barron, Kevin Hart, and Thiru Ramalingam.	Alexander KA, 2014, J CLIN INVEST, V124, P4266, DOI 10.1172/JCI75935; [Anonymous], 2015, TRENDS ENDOCRIN MET; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175; Borthwick LA, 2016, MUCOSAL IMMUNOL, V9, P38, DOI 10.1038/mi.2015.34; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164; Cao Q, 2011, J AM SOC NEPHROL, V22, P1229, DOI 10.1681/ASN.2010070693; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chen CC, 2015, CELL, V161, P277, DOI 10.1016/j.cell.2015.02.016; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chen GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033626; Chen L, 2015, J CLIN INVEST, V125, P2399, DOI 10.1172/JCI80467; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Chujo S, 2009, J CELL PHYSIOL, V220, P189, DOI 10.1002/jcp.21750; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Dalmas E, 2015, NAT MED, V21, P610, DOI 10.1038/nm.3829; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Heymann F, 2012, HEPATOLOGY, V55, P898, DOI 10.1002/hep.24764; Hos D, 2016, AM J PATHOL, V186, P159, DOI 10.1016/j.ajpath.2015.09.012; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kluth DC, 2007, KIDNEY INT, V72, P234, DOI 10.1038/sj.ki.5002332; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Knuever J, 2015, J IMMUNOL, V195, P5296, DOI 10.4049/jimmunol.1501237; Korf-Klingebiel M, 2015, NAT MED, V21, P140, DOI 10.1038/nm.3778; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Lorchner H, 2015, NAT MED, V21, P353, DOI 10.1038/nm.3816; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray PJ, 2015, CELL METAB, V22, P190, DOI 10.1016/j.cmet.2015.06.014; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Ramachandran P, 2015, SEMIN LIVER DIS, V35, P119, DOI 10.1055/s-0035-1550057; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shaked I, 2015, NAT IMMUNOL, V16, P1228, DOI 10.1038/ni.3321; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Stutchfield BM, 2015, GASTROENTEROLOGY, V149, P1896, DOI 10.1053/j.gastro.2015.08.053; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wehr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112327; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Xu J, 2015, J CLIN INVEST, V125, P1579, DOI 10.1172/JCI76468; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003; Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zheng D, 2011, NEPHRON EXP NEPHROL, V118, pE87, DOI 10.1159/000321034; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	127	1690	1753	56	534	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					450	462		10.1016/j.immuni.2016.02.015	http://dx.doi.org/10.1016/j.immuni.2016.02.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982353	Bronze, Green Accepted			2022-12-18	WOS:000372784200002
J	WALUNAS, TL; LENSCHOW, DJ; BAKKER, CY; LINSLEY, PS; FREEMAN, GJ; GREEN, JM; THOMPSON, CB; BLUESTONE, JA				WALUNAS, TL; LENSCHOW, DJ; BAKKER, CY; LINSLEY, PS; FREEMAN, GJ; GREEN, JM; THOMPSON, CB; BLUESTONE, JA			CTLA-4 CAN FUNCTION AS A NEGATIVE REGULATOR OF T-CELL ACTIVATION	IMMUNITY			English	Article							LYMPHOCYTES-T; COUNTER-RECEPTOR; CD28; EXPRESSION; ANTIBODY; ANTIGEN; MOLECULE; LIGAND; MOUSE; PROLIFERATION	CD28 and CTLA-4 are related glycoproteins found on T cells. Ligation of CD28 following antigen receptor engagement provides a costimulatory signal required for T cell activation. Anti-CTLA-4 antibodies were generated to examine the role of the CTLA-4 receptor on murine T cells. Expression of CTLA-4 as a homodimer is up-regulated 2-3 days following T cell activation. Anti-CTLA-4 antibodies and Fab fragments augmented T cell proliferation in an allogeneic MLR. However, when optimal costimulation and Fc cross-linking were present, anti-CTLA-4 MAbs inhibited T cell proliferation. Together, these results suggest that the MAb may obstruct the interaction of CTLA-4 with its natural ligand and block a negative signal, or directly signal T cells to down-regulate immune function.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,SEATTLE,WA 98121; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,DIV HEMATOL MALIGNANCIES,BOSTON,MA 02115	University of Chicago; Howard Hughes Medical Institute; University of Chicago; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	WALUNAS, TL (corresponding author), UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637, USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Walunas, Theresa/0000-0002-7653-3650; Green, Jonathan/0000-0002-7449-4387	NATIONAL CANCER INSTITUTE [R01CA040216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035294] Funding Source: NIH RePORTER; NCI NIH HHS [CA40216] Funding Source: Medline; NIAID NIH HHS [P01 AI35294, AI35225] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BRUCE J, 1981, J IMMUNOL, V127, P2496; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; DAMLE NK, 1994, J IMMUNOL, V152, P2686; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARPER K, 1991, J IMMUNOL, V147, P1037; HOULDEN BA, 1989, COLD SH Q B, V54, P45; JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; LAFAGEPOCHITALO.M, 1990, IMMUNOGENETICS, V31, P19; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LESSLAUER W, 1986, EUR J IMMUNOL, V16, P1289, DOI 10.1002/eji.1830161017; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; OZATO K, 1981, J IMMUNOL, V126, P317; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SMITH JD, 1992, J EXP MED, V175, P191, DOI 10.1084/jem.175.1.191; STAUNTON DE, 1992, J IMMUNOL, V148, P3271; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WALLACE PW, 1994, IN RPESS TRANSPLANTA	36	1685	1803	0	63	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					405	413		10.1016/1074-7613(94)90071-X	http://dx.doi.org/10.1016/1074-7613(94)90071-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882171				2022-12-18	WOS:A1994PK16800009
J	Murali-Krishna, K; Altman, JD; Suresh, M; Sourdive, DJD; Zajac, AJ; Miller, JD; Slansky, J; Ahmed, R				Murali-Krishna, K; Altman, JD; Suresh, M; Sourdive, DJD; Zajac, AJ; Miller, JD; Slansky, J; Ahmed, R			Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ESCHERICHIA-COLI; IN-VIVO; IMMUNOLOGICAL MEMORY; IMMUNE-RESPONSES; DEFICIENT MICE; CTL RESPONSE; IFN-GAMMA; EXPANSION; TURNOVER	Viral infections induce extensive T cell proliferation in vivo, but the specificity of the majority of the responding T cells has not been defined. To address this issue we used tetramers of MHC class I molecules containing viral peptides to directly visualize antigen-specific CD8 T cells during acute LCMV infection of mice. Based on tetramer binding and two sensitive assays measuring interferon-gamma production at the single-cell level, we found that 50%-70% of the activated CD8 T cells were LCMV specific (2 x 10(7) virus-specific cells/spleen). Following viral clearance, antigen-specific CD8 T cell numbers dropped to 10(6) per spleen and were maintained at this level for the life of the mouse. Upon rechallenge with LCMV, there was rapid expansion of memory T cells, but after infection with the heterologous vaccinia virus there was no detectable change in the numbers of LCMV-specific memory CTL. Therefore, much of the CD8 T cell expansion seen during viral infection represents antigen-specific cells and warrants a revision of our current thinking on the size of the antiviral response.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Emory University; Emory University; Johns Hopkins University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ra@microbio.emory.edu		Suresh, Marulasiddappa/0000-0003-1794-3358	NIAID NIH HHS [AI30048] Funding Source: Medline; NINDS NIH HHS [NS 21496] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021496] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; ANDERSSON EC, 1995, SCAND J IMMUNOL, V42, P110, DOI 10.1111/j.1365-3083.1995.tb03633.x; Asano MS, 1996, J EXP MED, V183, P2165, DOI 10.1084/jem.183.5.2165; BEVERLEY PCL, 1990, IMMUNOL TODAY, V11, P203, DOI 10.1016/0167-5699(90)90083-L; BI ZB, 1995, J VIROL, V69, P6466, DOI 10.1128/JVI.69.10.6466-6472.1995; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Bruno L, 1996, EUR J IMMUNOL, V26, P3179, DOI 10.1002/eji.1830261251; BYRNE JA, 1984, J IMMUNOL, V133, P433; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; CAO WX, 1995, NATURE, V378, P295, DOI 10.1038/378295a0; Cose SC, 1997, EUR J IMMUNOL, V27, P2310, DOI 10.1002/eji.1830270927; COUSENS LP, 1995, J IMMUNOL, V155, P5690; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; Doherty PC, 1997, CURR OPIN IMMUNOL, V9, P477, DOI 10.1016/S0952-7915(97)80098-2; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; MATZINGER P, 1994, NATURE, V369, P605, DOI 10.1038/369605a0; MOSKOPHIDIS D, 1987, J VIROL, V61, P1867, DOI 10.1128/JVI.61.6.1867-1874.1987; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Murata K, 1996, CELL IMMUNOL, V173, P96, DOI 10.1006/cimm.1996.0255; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAHILL SR, 1993, J EXP MED, V177, P317, DOI 10.1084/jem.177.2.317; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Oldstone MBA, 1996, P NATL ACAD SCI USA, V93, P12756, DOI 10.1073/pnas.93.23.12756; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; RAZVI ES, 1995, J IMMUNOL, V154, P620; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Slifka MK, 1997, BLOOD, V90, P2103, DOI 10.1182/blood.V90.5.2103; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; SUNILCHANDRA NP, 1994, AM J PATHOL, V145, P818; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; Tough DF, 1996, IMMUNOL REV, V150, P129, DOI 10.1111/j.1600-065X.1996.tb00699.x; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; vanderMost RG, 1996, J IMMUNOL, V157, P5543; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	58	1670	1733	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1998	8	2					177	187		10.1016/S1074-7613(00)80470-7	http://dx.doi.org/10.1016/S1074-7613(00)80470-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9491999	hybrid			2022-12-18	WOS:000072201800005
J	Salomon, B; Lenschow, DJ; Rhee, L; Ashourian, N; Singh, B; Sharpe, A; Bluestone, JA				Salomon, B; Lenschow, DJ; Rhee, L; Ashourian, N; Singh, B; Sharpe, A; Bluestone, JA			B7/CD28 costimulation is essential for the homeostasis of the CD4(+)CD25(+) immunoregulatory T cells that control autoimmune diabetes	IMMUNITY			English	Article							CD28-DEFICIENT MICE; CD28 COSTIMULATION; NEGATIVE REGULATOR; IN-VIVO; CTLA-4; INDUCTION; DISEASE; TOLERANCE; EXPRESSION; ACTIVATION	CD28/B7 costimulation has been implicated in the induction and progression of autoimmune diseases. Experimentally induced models of autoimmunity have been shown to be prevented or reduced in intensity in mice rendered deficient for CD28 costimulation. In sharp contrast, spontaneous diabetes is exacerbated in both B7-1/B7-2-deficient and CD28-deficient NOD mice. These mice present a profound decrease of the immunoregulatory CD4(+)CD25(+) T cells, which control diabetes in prediabetic NOD mice. These cells are absent from both CD28KO and B7-1/B7-2KO mice, and the transfer of this regulatory T cell subset from control NOD animals into CD28-deficient animals can delay/prevent diabetes. The results suggest that the CD28/B7 costimulatory pathway is essential for the development and homeostasis of regulatory T cells that control spontaneous autoimmune diseases.	Univ Chicago, Comm Immunol, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Chicago; University of Chicago; Western University (University of Western Ontario); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bluestone, JA (corresponding author), Univ Chicago, Comm Immunol, Ben May Inst Canc Res, Chicago, IL 60637 USA.		Singh, Bhagirath/C-4010-2013; Salomon, Benoit L/M-2421-2017; Salomon, Benoit/AAP-5209-2021	Singh, Bhagirath/0000-0002-9792-8694; Salomon, Benoit L/0000-0001-9673-5578; Salomon, Benoit/0000-0001-9673-5578	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049799] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49799] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alegre ML, 1996, J IMMUNOL, V157, P4762; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bachmaier K, 1996, J IMMUNOL, V157, P1752; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Bluestone JA, 1999, FUNDAMENTAL IMMUNOLO, P449; BOITARD C, 1989, J EXP MED, V169, P1669, DOI 10.1084/jem.169.5.1669; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; Finn PW, 1997, J IMMUNOL, V158, P4074; Herbelin A, 1998, J IMMUNOL, V161, P2620; Itoh M, 1999, J IMMUNOL, V162, P5317; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; King C, 1998, IMMUNITY, V8, P601, DOI 10.1016/S1074-7613(00)80565-8; King C, 1997, CURR OPIN IMMUNOL, V9, P863, DOI 10.1016/S0952-7915(97)80191-4; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Lin H, 1998, J EXP MED, V188, P199, DOI 10.1084/jem.188.1.199; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; Peterson KE, 1999, J IMMUNOL, V162, P1859; Rulifson IC, 1997, J IMMUNOL, V158, P658; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shi FD, 1998, EUR J IMMUNOL, V28, P3587, DOI 10.1002/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.3.CO;2-P; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Szot GL, 2000, TRANSPLANTATION, V69, P904; Tada Y, 1999, J IMMUNOL, V162, P203; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Todd JA, 1997, PATHOL BIOL, V45, P219; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855	39	1663	1752	1	52	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2000	12	4					431	440		10.1016/S1074-7613(00)80195-8	http://dx.doi.org/10.1016/S1074-7613(00)80195-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795741	Bronze			2022-12-18	WOS:000086757300008
J	Kawai, T; Adachi, O; Ogawa, T; Takeda, K; Akira, S				Kawai, T; Adachi, O; Ogawa, T; Takeda, K; Akira, S			Unresponsiveness of MyD88-deficient mice to endotoxin	IMMUNITY			English	Article							NF-KAPPA-B; RECEPTOR ACCESSORY PROTEIN; GAMMA-INDUCING FACTOR; BACTERIAL LIPOPOLYSACCHARIDE; MURINE MACROPHAGES; DROSOPHILA TOLL; SIGNALING PATHWAYS; KINASE-INHIBITORS; ADAPTER PROTEIN; ACTIVATION	MyD88 is a general adaptor protein that plays an important role in the Toll/IL-1 receptor family signalings. Recently, Toll-like receptors 2 and 4 (TLR2 and TLR4) have been suggested to be the signaling receptors for lipopolysaccharide (LPS). In this study, we demonstrate that MyD88 knockout mice lack the ability to respond to LPS as measured by shock response, B cell proliferative response, and secretion of cytokines by macrophages and embryonic fibroblasts. However, activation of neither NF-kappa B nor the mitogen-activated protein (MAP) kinase family is abolished in MyD88 knockout mice. These findings demonstrate that signaling via MyD88 is essential for LPS response, but the inability of MyD88 knockout mice to induce LPS-dependent gene expression cannot simply be attributed to lack of the activation of MAP kinases and NF-kappa B.	Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Nishinomiya, Hyogo 6638501, Japan; Asahi Univ, Sch Dent, Dept Oral Microbiol, Gifu 5010296, Japan	Hyogo College of Medicine; Japan Science & Technology Agency (JST); Asahi University	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Takeda, Kiyoshi/C-9331-2009	Kawai, Taro/0000-0001-7510-4662				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; DING AH, 1995, J LEUKOCYTE BIOL, V57, P174, DOI 10.1002/jlb.57.1.174; DONG ZY, 1993, J IMMUNOL, V151, P2717; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Morrison D C, 1979, Adv Immunol, V28, P293; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; NAKANO M, 1993, IMMUNOBIOLOGY, V187, P272, DOI 10.1016/S0171-2985(11)80344-X; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Perera PY, 1997, J IMMUNOL, V158, P4422; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Sanghera JS, 1996, J IMMUNOL, V156, P4457; SHINJI H, 1994, J IMMUNOL, V153, P5760; TAKASUKA N, 1995, J IMMUNOL, V154, P4803; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13	46	1653	1718	0	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1999	11	1					115	122		10.1016/S1074-7613(00)80086-2	http://dx.doi.org/10.1016/S1074-7613(00)80086-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435584	Bronze			2022-12-18	WOS:000081671300011
J	Sugiyama, T; Kohara, H; Noda, M; Nagasawa, T				Sugiyama, Tatsuki; Kohara, Hiroshi; Noda, Mamiko; Nagasawa, Takashi			Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches	IMMUNITY			English	Article							PROGENITOR CELLS; IN-VIVO; RECEPTOR CXCR4; NOD/SCID MICE; MURINE; PROLIFERATION; ENGRAFTMENT; RECONSTITUTION; REPOPULATION; DEFICIENCY	In the bone marrow, the special microenvironment niches nurture a pool of hematopoietic stem cells (HSCs). Many HSCs reside near the vasculature, but the molecular regulatory mechanism of niches for HSC maintenance remains unclear. Here we showed that the induced deletion of CXCR4, a receptor for CXC chemokine ligand (CXCL) 12 in adult mice, resulted in severe reduction of HSC numbers and increased sensitivity to myelotoxic injury, although it did not impair expansion of the more mature progenitors. Most HSCs were found in contact with the cells expressing high amounts of CXCL12, which we have called CXCL12-abundant reticular (CAR) cells. CAR cells surrounded sinusoidal endothelial cells or were located near the endosteum. CXCL12-CXCR4 signaling plays an essential role in maintaining the quiescent HSC pool, and CAR cells appear to be a key component of HSC niches, including both vascular and endosteal niches in adult bone marrow.	Kyoto Univ, Dept Med Syst Control, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Nagasawa, T (corresponding author), Kyoto Univ, Dept Med Syst Control, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Sugiyama, Tatsuki/0000-0002-9349-0824; Nagasawa, Takashi/0000-0002-1085-0960				Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Cashman J, 2002, J EXP MED, V196, P1141, DOI 10.1084/jem.20010916; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; GERDES J, 1984, J IMMUNOL, V133, P1710; GIDALI J, 1981, CELL TISSUE KINET, V14, P1, DOI 10.1111/j.1365-2184.1981.tb00505.x; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P57, DOI 10.1111/j.1749-6632.1999.tb08453.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; PLOEMACHER RE, 1989, BLOOD, V74, P2755; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; ROULEAU MF, 1990, J BONE MINER RES, V5, P1043; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	51	1603	1658	8	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					977	988		10.1016/j.immuni.2006.10.016	http://dx.doi.org/10.1016/j.immuni.2006.10.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174120	Bronze			2022-12-18	WOS:000243087500016
J	Miyara, M; Yoshioka, Y; Kitoh, A; Shima, T; Wing, K; Niwa, A; Parizot, C; Taflin, C; Heike, T; Valeyre, D; Mathian, A; Nakahata, T; Yamaguchi, T; Nomura, T; Ono, M; Amoura, Z; Gorochov, G; Sakaguchi, S				Miyara, Makoto; Yoshioka, Yumiko; Kitoh, Akihiko; Shima, Tomoko; Wing, Kajsa; Niwa, Akira; Parizot, Christophe; Taflin, Cecile; Heike, Toshio; Valeyre, Dominique; Mathian, Alexis; Nakahata, Tatsutoshi; Yamaguchi, Tomoyuki; Nomura, Takashi; Ono, Masahiro; Amoura, Zahir; Gorochov, Guy; Sakaguchi, Shimon			Functional Delineation and Differentiation Dynamics of Human CD4(+) T Cells Expressing the FoxP3 Transcription Factor	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; PERIPHERAL-BLOOD; REGULATORY CELLS; IN-VITRO; HELPER-CELLS; NAIVE; POPULATION; IDENTIFICATION; PROLIFERATION; SUBPOPULATION	FoxP3 is a key transcription factor for the development and function of natural CD4(+) regulatory T cells (Treg cells). Here we show that human FoxP3(+)CD4(+) T cells were composed of three phenotypically and functionally distinct subpopulations: CD45RA(+)FoxP3(lo) resting Treg cells (rTreg cells) and CD45RA(-)FoxP3(hi) activated Treg cells (aTreg cells), both of which were suppressive in vitro, and cytokine-secreting CD45RA(-)FoxP3(lo) nonsuppressive T cells. The proportion of the three subpopulations differed between cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTreg cells rapidly died whereas rTreg cells proliferated and converted into aTreg cells in vitro and in vivo. This was shown by the transfer of rTreg cells into NOD-scid-common gamma-chain-deficient mice and by TCR sequence-based T cell clonotype tracing in peripheral blood in a normal individual. Taken together, the dissection of FoxP3(+) cells into subsets enables one to analyze Treg cell differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3(+) subpopulations.	[Miyara, Makoto; Yoshioka, Yumiko; Kitoh, Akihiko; Shima, Tomoko; Wing, Kajsa; Yamaguchi, Tomoyuki; Nomura, Takashi; Ono, Masahiro; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; [Niwa, Akira; Heike, Toshio; Nakahata, Tatsutoshi] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Parizot, Christophe; Taflin, Cecile; Mathian, Alexis; Gorochov, Guy] Hop La Pitie Salpetriere, Lab AP HP Immunol Cellulaire & Tissulaire, INSERM, UMR S 945, F-75013 Paris, France; [Valeyre, Dominique] Hop Avicenne, AP HP, Dept Pneumol, F-93000 Bobigny, France; [Amoura, Zahir] Hop La Pitie Salpetriere, AP HP, Dept Internal Med, F-75013 Paris, France; [Amoura, Zahir; Gorochov, Guy] Univ Paris 06, F-75005 Paris, France; [Sakaguchi, Shimon] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Sakaguchi, Shimon] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Japan Science & Technology Agency (JST); Osaka University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Gorochov, Guy/P-2911-2017; Sakaguchi, Shimon/C-9535-2009; Miyara, Makoto/P-4491-2017; Amoura, Zahir/P-5325-2017; Ono, Masahiro/H-2378-2011; Mathian, Alexis/P-5355-2017; AMOURA, Zahir/P-5324-2017	Miyara, Makoto/0000-0001-8743-8846; Ono, Masahiro/0000-0002-9284-7326; AMOURA, Zahir/0000-0003-0292-9043; Wing, Kajsa/0000-0001-7744-4847; Gorochov, Guy/0000-0003-2097-9677; Yamaguchi, Tomoyuki/0000-0002-4159-5448; Valeyre, dominique/0000-0003-4470-1776	Ministry of Education, Sports, and Culture of Japan; Fondation pour la Recherche Medicale; Japan Society for the Promotion of Science; European Union [LHS-CT-2005-018914]; Grants-in-Aid for Scientific Research [21791073] Funding Source: KAKEN	Ministry of Education, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Union(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant in aid from the Ministry of Education, Sports, and Culture of Japan. M.M. was successively supported by la Fondation pour la Recherche Medicale and by Japan Society for the Promotion of Science. The study was also in part supported by a grant from the European Union (ATTACK project LHS-CT-2005-018914). We thank the blood donors and the patients who participated in the study, R. Ishii for expertise in cell sorting, M. Kakino for assistance in molecular biology, M. Yoshida for maintaining mice, and S. Teradaira, A. Kishi, M. Hashimoto, S. Maeda, H. Uryu, K. Hirota, C. Badoual, and N. Sakaguchi for technical help and valuable discussion.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	49	1556	1641	4	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 19	2009	30	6					899	911		10.1016/j.immuni.2009.03.019	http://dx.doi.org/10.1016/j.immuni.2009.03.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19464196	Bronze			2022-12-18	WOS:000267270700016
J	Jung, S; Unutmaz, D; Wong, P; Sano, GI; De los Santos, K; Sparwasser, T; Wu, SJ; Vuthoori, S; Ko, K; Zavala, F; Pamer, EG; Littman, DR; Lang, RA				Jung, S; Unutmaz, D; Wong, P; Sano, GI; De los Santos, K; Sparwasser, T; Wu, SJ; Vuthoori, S; Ko, K; Zavala, F; Pamer, EG; Littman, DR; Lang, RA			In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens	IMMUNITY			English	Article							MHC CLASS-I; DIPHTHERIA-TOXIN RECEPTOR; LISTERIA-MONOCYTOGENES; POSITIVE SELECTION; RESPONSES; LYMPHOCYTES; EXPRESSION; INDUCTION; INFECTION; REQUIRES	Cytotoxic T lymphocytes (CTL) respond to antigenic peptides presented on MHC class I molecules. On most cells, these peptides are exclusively of endogenous, cytosolic origin. Bone marrow-derived antigen-presenting cells, however, harbor a unique pathway for MHC I presentation of exogenous antigens. This mechanism permits cross-presentation of pathogen-infected cells and the priming of CTL responses against intracellular microbial infections. Here, we report a novel diphtheria toxin-based system that allows the inducible, short-term ablation of dendritic cells (DC) in vivo. We show that in vivo DC are required to cross-prime CTL precursors. Our results thus define a unique in vivo role of DC, i.e., the sensitization of the immune system for cell-associated antigens. DC-depleted mice fall to mount CTL responses to infection with the intracellular bacterium Listeria monocytogenes and the rodent malaria parasite Plasmodium yoelii.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Program Immunol, New York, NY 10021 USA; NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; Memorial Sloan Kettering Cancer Center; New York University	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il; littman@saturn.med.nyu.edu; lann15@chmcc.org	Jung, Steffen/K-1409-2012; Sparwasser, Tim D/AAA-4306-2022; Lang, Richard/E-5578-2011; Sparwasser, Tim/AAF-7085-2019	Jung, Steffen/0000-0003-4290-5716; Sparwasser, Tim/0000-0001-5645-902X; Lang, Richard/0000-0002-5212-254X; Wong, Phillip/0000-0002-6360-849X	NATIONAL EYE INSTITUTE [R01EY010559] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010559, R01 EY010559-11] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bellone M, 1997, J IMMUNOL, V159, P5391; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; DEBRICK JE, 1991, J IMMUNOL, V147, P2846; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Hamilton SE, 2001, J IMMUNOL, V167, P5603, DOI 10.4049/jimmunol.167.10.5603; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lechler R, 2001, IMMUNITY, V14, P357, DOI 10.1016/S1074-7613(01)00116-9; Lenz LL, 2000, J EXP MED, V192, P1135, DOI 10.1084/jem.192.8.1135; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94, DOI 10.1093/infdis/145.1.94; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seaman MS, 1999, J IMMUNOL, V162, P5429; Sheehan B, 1994, Curr Top Microbiol Immunol, V192, P187; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Wang B, 2001, J IMMUNOL, V167, P1283, DOI 10.4049/jimmunol.167.3.1283; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	48	1391	1433	1	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2002	17	2					211	220		10.1016/S1074-7613(02)00365-5	http://dx.doi.org/10.1016/S1074-7613(02)00365-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196292	Bronze, Green Accepted			2022-12-18	WOS:000177669400009
J	Catlett-Falcone, R; Landowski, TH; Oshiro, MM; Turkson, J; Levitzki, A; Savino, R; Ciliberto, G; Moscinski, L; Fernandez-Luna, JL; Nunez, G; Dalton, WS; Jove, R				Catlett-Falcone, R; Landowski, TH; Oshiro, MM; Turkson, J; Levitzki, A; Savino, R; Ciliberto, G; Moscinski, L; Fernandez-Luna, JL; Nunez, G; Dalton, WS; Jove, R			Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells	IMMUNITY			English	Article							EPIDERMAL GROWTH-FACTOR; BCL-X GENE; MULTIPLE-MYELOMA; TRANSCRIPTION FACTORS; JAK/STAT PROTEINS; DNA-BINDING; INTERLEUKIN-6; RECEPTOR; PATHWAY; PROLIFERATION	Interleukin 6 (IL-6) is the major survival factor for myeloma tumor cells and induces signaling through the STAT proteins. We report that one STAT family member, Stat3 is constitutively activated in bone marrow mononuclear cells from patients with multiple myeloma and in the IL-6-dependent human myeloma cell line U266, Moreover, U266 cells are inherently resistant to Fas-mediated apoptosis and express high levels of the antiapoptotic protein Bcl-x(L). Blocking IL-6 receptor signaling from Janus kinases to the Stat3 protein inhibits Bcl-x(L) expression and induces apoptosis, demonstrating that Stat3 signaling is essential for the survival of myeloma tumor cells. These findings provide evidence that constitutively activated Stat3 signaling contributes to the pathogenesis of multiple myeloma by preventing apoptosis.	H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr & Res Inst, Clin Invest Program, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Internal Med, Tampa, FL 33612 USA; Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; Ist Rec Biol Mol P Angeletti, I-00040 Pomezia, Italy; Hosp Univ Marques Valdecilla, Santander 39008, Spain; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Hebrew University of Jerusalem; Hospital Universitario Marques de Valdecilla (HUMV); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dalton, WS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	dalton@moffit.usf.edu; richjove@moffitt.usf.edu	Nuñez, Gabriel/A-7160-2014; Ciliberto, Gennaro/J-4131-2017	Ciliberto, Gennaro/0000-0003-2851-8605; Savino, Rocco/0000-0002-4046-1472	NATIONAL CANCER INSTITUTE [R01CA055652, R01CA077859] Funding Source: NIH RePORTER; NCI NIH HHS [CA55652, CA77859] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Chai SK, 1997, J IMMUNOL, V159, P4720; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; Chauhan D, 1997, BLOOD, V89, P227, DOI 10.1182/blood.V89.1.227.227_227_234; DAMELL JE, 1994, SCIENCE, V264, P1415; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; KELLER ET, 1995, J IMMUNOL, V154, P4091; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Landowski TH, 1997, BLOOD, V90, P4266, DOI 10.1182/blood.V90.11.4266.4266_4266_4270; LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076; Lund TC, 1997, J VIROL, V71, P6677, DOI 10.1128/JVI.71.9.6677-6682.1997; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Ogata A, 1997, J IMMUNOL, V159, P2212; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Sartor CI, 1997, CANCER RES, V57, P978; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; Schneider TJ, 1997, J IMMUNOL, V159, P4834; SCHWARTZ M, 1995, IEEE PERS COMMUN, V2, P8, DOI 10.1109/98.388925; SCHWARTZ TJ, 1991, IEEE EXPERT, V6, P77; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Silva M, 1996, BLOOD, V88, P1576, DOI 10.1182/blood.V88.5.1576.1576; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; Sporeno E, 1996, BLOOD, V87, P4510, DOI 10.1182/blood.V87.11.4510.bloodjournal87114510; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tu YP, 1998, CANCER RES, V58, P256; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WeberNordt RM, 1996, BLOOD, V88, P809; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xu FH, 1998, BLOOD, V92, P241, DOI 10.1182/blood.V92.1.241.413k28_241_251; Yu CL, 1997, J IMMUNOL, V159, P5206; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	56	1379	1491	1	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					105	115		10.1016/S1074-7613(00)80011-4	http://dx.doi.org/10.1016/S1074-7613(00)80011-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023775	Bronze			2022-12-18	WOS:000078428700011
J	Hashimoto, D; Chow, A; Noizat, C; Teo, P; Beasley, MB; Leboeuf, M; Becker, CD; See, P; Price, J; Lucas, D; Greter, M; Mortha, A; Boyer, SW; Forsberg, EC; Tanaka, M; van Rooijen, N; Garcia-Sastre, A; Stanley, ER; Ginhoux, F; Frenette, PS; Merad, M				Hashimoto, Daigo; Chow, Andrew; Noizat, Clara; Teo, Pearline; Beasley, Mary Beth; Leboeuf, Marylene; Becker, Christian D.; See, Peter; Price, Jeremy; Lucas, Daniel; Greter, Melanie; Mortha, Arthur; Boyer, Scott W.; Forsberg, E. Camilla; Tanaka, Masato; van Rooijen, Nico; Garcia-Sastre, Adolfo; Stanley, E. Richard; Ginhoux, Florent; Frenette, Paul S.; Merad, Miriam			Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes	IMMUNITY			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; GM-CSF AUTOANTIBODIES; CHEMOKINE RECEPTOR 2; DENDRITIC CELLS; BONE-MARROW; MICE; ORIGIN; DIFFERENTIATION	Despite accumulating evidence suggesting local self-maintenance of tissue macrophages in the steady state, the dogma remains that tissue macrophages derive from monocytes. Using parabiosis and fate-mapping approaches, we confirmed that monocytes do not show significant contribution to tissue macrophages in the steady state. Similarly, we found that after depletion of lung macrophages, the majority of repopulation occurred by stochastic cellular proliferation in situ in a macrophage colony-stimulating factor (M-Csf)- and granulocyte macrophage (GM)-CSF-dependent manner but independently of interleukin-4. We also found that after bone marrow transplantation, host macrophages retained the capacity to expand when the development of donor macrophages was compromised. Expansion of host macrophages was functional and prevented the development of alveolar proteinosis in mice transplanted with GM-Csf-receptor-deficient progenitors. Collectively, these results indicate that tissue-resident macrophages and circulating monocytes should be classified as mononuclear phagocyte lineages that are independently maintained in the steady state.	[Hashimoto, Daigo; Chow, Andrew; Noizat, Clara; Leboeuf, Marylene; Becker, Christian D.; Price, Jeremy; Greter, Melanie; Mortha, Arthur; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Hashimoto, Daigo; Chow, Andrew; Noizat, Clara; Leboeuf, Marylene; Becker, Christian D.; Price, Jeremy; Greter, Melanie; Mortha, Arthur; Merad, Miriam] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Hashimoto, Daigo; Chow, Andrew; Leboeuf, Marylene; Becker, Christian D.; Price, Jeremy; Mortha, Arthur; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Beasley, Mary Beth] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Beasley, Mary Beth; Becker, Christian D.] Mt Sinai Sch Med, Dept Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Chow, Andrew; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Noizat, Clara] Univ Paris 06, F-75005 Paris, France; [Teo, Pearline; See, Peter; Ginhoux, Florent] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Greter, Melanie] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Boyer, Scott W.; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Program Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Forsberg, E. Camilla] Univ Calif Santa Cruz, Dept Biomol Engn, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA; [Tanaka, Masato] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Immune Regulat, Hachioji, Tokyo 1920392, Japan; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1081 Amsterdam, Netherlands; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Zurich; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Tokyo University of Pharmacy & Life Sciences; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu	Mortha, Arthur/ABE-6250-2020; Lucas, Daniel/ABB-6893-2021; Van Rooijen, Nico/Z-1578-2019; Stanley, Evan R/J-9154-2013; Frenette, Paul S/J-8272-2012; Hashimoto, Daigo/O-1013-2013; Price, Jeremy G/G-1612-2013	Lucas, Daniel/0000-0002-0147-5425; Stanley, Evan R/0000-0002-2910-2065; Frenette, Paul S/0000-0003-0862-9922; Hashimoto, Daigo/0000-0001-9489-9704; Price, Jeremy G/0000-0003-0491-3176; See, Peter/0000-0003-4428-7763; Greter, Melanie/0000-0002-7220-5369; Mortha, Arthur/0000-0003-2673-0485; Teo, Pearline/0000-0002-8283-6308; Chow, Andrew/0000-0003-1151-2450; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health (NIH) [CA154947A, AI10008, AI089987, HL116340, DK056638, HL097700, HL069438, 2T32GM008646]; National Heart, Lung, and Blood Institute [5F30HL099028]; California Institute for Regenerative Medicine New Faculty Award; NATIONAL CANCER INSTITUTE [R01CA154947, R01CA173861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097700, R01HL116340, R01HL086899, F30HL099028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390095] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine New Faculty Award(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M. M. is supported by National Institutes of Health (NIH) grants CA154947A, AI10008, and AI089987. P. S. F. is supported by NIH grants HL116340, DK056638, HL097700, and HL069438. A. C. is supported by a predoctoral fellowship from the National Heart, Lung, and Blood Institute (5F30HL099028). S. W. B. is supported by predoctoral NIH training grant 2T32GM008646 to the University of California-Santa Cruz; E. C. F. is supported by a California Institute for Regenerative Medicine New Faculty Award.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; Emile JF, 2000, BLOOD, V96, P58; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Hashimoto D, 2011, SEMIN IMMUNOL, V23, P50, DOI 10.1016/j.smim.2011.01.005; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; PARWARESCH MR, 1984, CELL TISSUE KINET, V17, P25, DOI 10.1111/j.1365-2184.1984.tb00565.x; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Sakagami T, 2009, NEW ENGL J MED, V361, P2679, DOI 10.1056/NEJMc0904077; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Takahashi K., 2001, J CLIN EXP HEMATOP, V41, P1, DOI DOI 10.3960/JSLRT.41.1; TARLING JD, 1987, J LEUKOCYTE BIOL, V42, P443, DOI 10.1002/jlb.42.5.443; THOMAS ED, 1976, SCIENCE, V192, P1016, DOI 10.1126/science.775638; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Uchida K, 2007, NEW ENGL J MED, V356, P567, DOI 10.1056/NEJMoa062505; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Vinh DC, 2010, BLOOD, V115, P1519, DOI 10.1182/blood-2009-03-208629; VIROLAINEN M, 1968, J EXP MED, V127, P943, DOI 10.1084/jem.127.5.943; WACKER HH, 1986, VIRCHOWS ARCH B, V51, P71, DOI 10.1007/BF02899017	47	1346	1381	6	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					792	804		10.1016/j.immuni.2013.04.004	http://dx.doi.org/10.1016/j.immuni.2013.04.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601688	Green Accepted, Bronze			2022-12-18	WOS:000330942100020
J	Wherry, EJ; Ha, SJ; Kaech, SM; Haining, WN; Sarkar, S; Kalia, V; Subramaniam, S; Blattman, JN; Barber, DL; Ahmed, R				Wherry, E. John; Ha, Sang-Jun; Kaech, Susan M.; Haining, W. Nicholas; Sarkar, Surojit; Kalia, Vandana; Subramaniam, Shruti; Blattman, Joseph N.; Barber, Daniel L.; Ahmed, Rafi			Molecular signature of CD8(+) T cell exhaustion during chronic viral infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TRANSCRIPTIONAL REPRESSOR BLIMP-1; INHIBITORY RECEPTOR; PD-1 EXPRESSION; MEMORY; ACTIVATION; PERSISTENCE; EFFECTOR; HOMEOSTASIS; DIFFERENTIATION	Chronic viral infections often result in T cell exhaustion. To determine the molecular signature of exhaustion, we compared the gene-expression profiles of dysfunctional lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells from chronic infection to functional LCMV-specific effector and memory CD8(+) T cells generated after acute infection. These data showed that exhausted CD8+ T cells: (1) overexpressed several inhibitory receptors, including PD-1, (2) had major changes in T cell receptor and cytokine signaling pathways, (3) displayed altered expression of genes involved in chemotaxis, adhesion, and migration, (4) expressed a distinct set of transcription factors, and (5) had profound metabolic and bioenergetic deficiencies. T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes. Thus, functional exhaustion is probably due to both active suppression and passive defects in signaling and metabolism. These results provide a framework for designing rational immunotherapies during chronic infections.	Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	The Wistar Institute; Emory University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Emory University	Wherry, EJ (corresponding author), Wistar Inst Anat & Biol, Program Immunol, 3601 Spruce St,Room 251, Philadelphia, PA 19104 USA.	jwherry@wistar.org; ra@microbio.emory.edu	Barber, Daniel L./V-1190-2019; Wherry, John/ABI-1280-2020	Ha, Sang-Jun/0000-0002-1192-6031	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309, R01AI030048, R37AI030048] Funding Source: NIH RePORTER; NIAID NIH HHS [AI071309, AI30048] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Assarsson E, 2005, J IMMUNOL, V175, P2045, DOI 10.4049/jimmunol.175.4.2045; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; EJMAES M, 2006, J EXP MED, V203, P2461; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Maeda M, 2005, J IMMUNOL, V175, P4426, DOI 10.4049/jimmunol.175.7.4426; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rojo S, 1997, J IMMUNOL, V158, P9; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sagerstrom CG, 2004, DEV CELL, V6, P737, DOI 10.1016/j.devcel.2004.05.015; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826	56	1336	1380	4	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					670	684		10.1016/j.immuni.2007.09.006	http://dx.doi.org/10.1016/j.immuni.2007.09.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17950003				2022-12-18	WOS:000250490700017
J	FLYNN, JL; GOLDSTEIN, MM; CHAN, J; TRIEBOLD, KJ; PFEFFER, K; LOWENSTEIN, CJ; SCHREIBER, R; MAK, TW; BLOOM, BR				FLYNN, JL; GOLDSTEIN, MM; CHAN, J; TRIEBOLD, KJ; PFEFFER, K; LOWENSTEIN, CJ; SCHREIBER, R; MAK, TW; BLOOM, BR			TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE	IMMUNITY			English	Article							INTERFERON-GAMMA; NITRIC-OXIDE; MACROPHAGE ACTIVATION; MURINE MACROPHAGES; INFECTION; RESISTANCE; MONOCYTOGENES; GENERATION; CYTOKINES; GROWTH	Understanding the immunological mechanisms of protection and pathogenesis in tuberculosis remains problematic. We have examined the extent to which tumor necrosis factor-alpha (TNF alpha) contributes to this disease using murine models in which the action of TNF alpha is inhibited. TNF alpha was neutralized in vivo by monoclonal antibody; in addition, a mouse strain with a disruption in the gene for the 55 kDa TNF receptor was used. The data from both models established that TNF alpha and the 55 kDa TNF receptor are essential for protection against tuberculosis in mice, and for reactive nitrogen production by macrophages early in infection. Granulomas were formed in equal numbers in control and experimental mice, but necrosis was observed only in mice deficient in TNF alpha or TNF receptor. TNF alpha and the 55 kDa TNF receptor are necessary conditions for protection against murine M. tuberculosis infection, but are not solely responsible for the tissue damage observed.	MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; ALBERT EINSTEIN COLL MED,MONTEFIORE HOSP,DEPT MED,DIV INFECT DIS,BRONX,NY 10467; YESHIVA UNIV ALBERT EINSTEIN COLL MED,HOWARD HUGHES MED INST,BRONX,NY 10461; UNIV TORONTO,ONTARIO CANC INST,AMGEN INST,DEPT MED BIOPHYS,TORONTO,ON M4X 1K9,CANADA; UNIV TORONTO,ONTARIO CANC INST,AMGEN INST,DEPT IMMUNOL,TORONTO,ON M4X 1K9,CANADA; JOHNS HOPKINS UNIV,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21205; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johns Hopkins University; Washington University (WUSTL)	FLYNN, JL (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15261, USA.		Schreiber, Robert/Q-7550-2019; Flynn, JoAnne/ABC-7371-2020	Lowenstein, Charles/0000-0003-0485-7514; Pfeffer, Klaus/0000-0002-5652-6330				BANCROFT GJ, 1989, J IMMUNOL, V143, P127; BERMUDEZ LEM, 1989, J IMMUNOL, V143, P2996; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DENIS M, 1991, J LEUKOCYTE BIOL, V50, P495, DOI 10.1002/jlb.50.5.495; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; FLESCH IEA, 1990, INFECT IMMUN, V58, P2675, DOI 10.1128/IAI.58.8.2675-2677.1990; FLORY CM, 1992, J LEUKOCYTE BIOL, V51, P225, DOI 10.1002/jlb.51.3.225; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; HARLOW E, 1988, ANTIBODIES LABORATOR; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; LIEW FY, 1990, J IMMUNOL, V145, P4306; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; ORME IM, 1984, CELL IMMUNOL, V84, P113, DOI 10.1016/0008-8749(84)90082-0; ORME IM, 1992, J IMMUNOL, V148, P189; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; ROACH TIA, 1993, J IMMUNOL, V150, P1886; ROOK GAW, 1987, IMMUNOLOGY, V62, P229; ROOK GAW, 1990, PATHOL BIOL, V38, P276; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884	28	1317	1343	0	41	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					561	572		10.1016/1074-7613(95)90001-2	http://dx.doi.org/10.1016/1074-7613(95)90001-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7540941	Bronze			2022-12-18	WOS:A1995RE53800002
J	Shevach, EM				Shevach, Ethan M.			Mechanisms of Foxp3(+) T Regulatory Cell-Mediated Suppression	IMMUNITY			English	Review							DENDRITIC CELLS; TGF-BETA; CUTTING EDGE; AUTOIMMUNE-DISEASE; IN-VITRO; GRANZYME-B; EFFECTOR; ACTIVATION; EXPRESSION; TOLERANCE	Foxp3(+) T regulatory (Treg) cells control all aspects of the immune response. Here, I will review the in vitro model systems that have been developed to define the mechanisms used by Treg cells to suppress a large number of distinct target cell types. These mechanisms can be broadly divided into those that target T cells (suppressor cytokines, IL-2 consumption, cytolysis) and those that primarily target antigen-presenting cells (decreased costimulation or decreased antigen presentation). Although multiple mechanisms for Treg cell suppression have been shown in vitro, it is unclear whether the same or different mechanisms are used by Treg cells in vivo. An increase in our understanding of Treg cell suppressor mechanisms will offer an insight into how Treg cell function can be manipulated either positively or negatively in vivo.	NIAID, Immunol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shevach, EM (corresponding author), NIAID, Immunol Lab, Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959, Z01AI000959] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; DiPaolo RJ, 2005, J IMMUNOL, V175, P7135, DOI 10.4049/jimmunol.175.11.7135; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mamura M, 2004, BLOOD, V103, P4594, DOI 10.1182/blood-2003-08-2897; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Qureshi OS, 2008, IMMUNOLOGY, V125, P99; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; TRAN DQ, 2009, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2009-01-199950; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	67	1298	1382	0	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					636	645		10.1016/j.immuni.2009.04.010	http://dx.doi.org/10.1016/j.immuni.2009.04.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464986	Bronze			2022-12-18	WOS:000266356900004
J	Kaplan, MH; Schindler, U; Smiley, ST; Grusby, MJ				Kaplan, MH; Schindler, U; Smiley, ST; Grusby, MJ			Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells	IMMUNITY			English	Article							STIMULATORY FACTOR-I; RECEPTOR EXPRESSION; GROWTH-FACTOR; GAMMA-CHAIN; B-CELLS; IDENTIFICATION; INTERLEUKIN-2; ACTIVATION; GENERATION; EPSILON	Interleukin-4 (IL-4) stimulation of cells leads to the activation of multiple signaling pathways, one of which involves State. We have generated State-deficient mice by gene targeting in embryonic stem cells to determine the role of this transcription factor in mediating the biologic functions of IL-4. IL-4-induced increases in the cell surface expression of both MHC class II antigens and IL-4 receptor are completely abrogated, and lymphocytes from State-deficient animals fail to proliferate in response to IL-4. Stat6-deficient B cells do not produce IgE following in vivo immunization with anti-IgD. In addition, State-deficient T lymphocytes fail to differentiate into Th2 cells in response to either IL-4 or IL-13. These results demonstrate that, despite the existence of multiple signaling pathways activated by IL-4, State is essential for mediating responses to IL-4 in lymphocytes.	HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115; TULARIK INC,S SAN FRANCISCO,CA 94080; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School				Kaplan, Mark/0000-0002-2923-8245				COFFMAN RL, 1986, J IMMUNOL, V136, P4538; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; CONRAD DH, 1987, J IMMUNOL, V139, P2290; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; ICHIKI T, 1993, J IMMUNOL, V150, P5408; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OHARA J, 1988, P NATL ACAD SCI USA, V85, P8221, DOI 10.1073/pnas.85.21.8221; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SWAIN SL, 1990, J IMMUNOL, V145, P3796; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	42	1293	1321	1	33	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					313	319		10.1016/S1074-7613(00)80439-2	http://dx.doi.org/10.1016/S1074-7613(00)80439-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624821	Bronze			2022-12-18	WOS:A1996UC01800012
J	Agostini, L; Martinon, F; Burns, K; McDermott, MF; Hawkins, PN; Tschopp, J				Agostini, L; Martinon, F; Burns, K; McDermott, MF; Hawkins, PN; Tschopp, J			NALP3 forms an IL-l beta-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder	IMMUNITY			English	Article							CASPASE RECRUITMENT DOMAIN; NF-KAPPA-B; CONTAINING APAF1-LIKE PROTEIN; REGULATES ACTIVATION; APOPTOSIS; FAMILY; ASC; MUTATIONS; DISEASES; SPECTRUM	Mutations within the NALP3/cryopyrin/CIAS1 gene are responsible for three autoinflammatory disorders: Muckle-Wells syndrome, familial cold autoinflammatory syndrome, and CINCA. The NALP3 protein is homologous to NALP1, which is a component of the inflammasome, a molecular platform that activates the proinflarnmatory caspases-1 and -5. NALP3 (and other members of the NALP family) lacks the C-terminal, CARD-containing sequence of NALP1, and its role in caspase activation is unclear. Here, we report that NALP2 and NALP3 associate with ASC, the CARD-containing protein Cardinal, and caspase-1 (but not caspase-5), thereby forming an inflammasome with high proIL-1beta-processing activity. Macrophages from Muckle-Wells patients spontaneously secrete active IL-1beta. Increased inflammasome activity is therefore likely to be the molecular basis of the symptoms associated with NALP3-dependent autoinflammatory disorders.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Queen Marys Sch Med & Dent, Mol Med Unit, London E1 1BG, England; Royal Free Hosp, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of Lausanne; University of London; Queen Mary University London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@ib.unil.ch	McDermott, Michael/S-8490-2019; Hawkins, Philip N/C-5573-2008; Martinon, Fabio/A-5575-2009; McDermott, Michael Francis/GZM-5330-2022	McDermott, Michael/0000-0002-1015-0745; Martinon, Fabio/0000-0002-6969-822X; 				Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; AHWKINS PN, 2003, NEW ENGL J MED, V348, P2583; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Arend WP, 2000, ANN RHEUM DIS, V59, P60, DOI 10.1136/ard.59.suppl_1.i60; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; GrazianiBowering GM, 1997, J IMMUNOL METHODS, V207, P157, DOI 10.1016/S0022-1759(97)00114-2; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MARTINON F, 1950, CURR BIOL, V10, pR118; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; McDermott MF, 2002, TRENDS MOL MED, V8, P550, DOI 10.1016/S1471-4914(02)02425-5; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200	28	1274	1329	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					319	325		10.1016/S1074-7613(04)00046-9	http://dx.doi.org/10.1016/S1074-7613(04)00046-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030775	Bronze			2022-12-18	WOS:000221442600009
J	O'Garra, A				O'Garra, A			Cytokines induce the development of functionally heterogeneous T helper cell subsets	IMMUNITY			English	Review							GROWTH-FACTOR-BETA; INTERFERON-GAMMA-PRODUCTION; MURINE IL-4 GENE; DENDRITIC CELLS; NATURAL-KILLER; DIFFERENTIAL REGULATION; PHENOTYPE DEVELOPMENT; IL-4-PRODUCING CELLS; LEISHMANIA-MAJOR; PROTEIN ANTIGEN		DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	O'Garra, A (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.	aog@dnax.org		O'Garra, Anne/0000-0001-9845-6134				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Bridoux F, 1997, J EXP MED, V185, P1769, DOI 10.1084/jem.185.10.1769; Brown DR, 1997, J EXP MED, V186, P101, DOI 10.1084/jem.186.1.101; BURSTEIN HJ, 1993, J EXP MED, V177, P457, DOI 10.1084/jem.177.2.457; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; DAVYDOV IV, 1995, J IMMUNOL, V155, P5273; DEWIT D, 1992, J EXP MED, V175, P9, DOI 10.1084/jem.175.1.9; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Karpus WJ, 1997, J IMMUNOL, V158, P4129; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; LICHTMAN AH, 1988, P NATL ACAD SCI USA, V85, P9699, DOI 10.1073/pnas.85.24.9699; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; MOORE K, 1993, ANNU REV IMMUNOL, V11, P1665; Morawetz RA, 1996, J EXP MED, V184, P1651, DOI 10.1084/jem.184.5.1651; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; OGARRA A, 1993, CURR OPIN IMMUNOL, V5, P880, DOI 10.1016/0952-7915(93)90100-7; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; PAUL WE, 1993, ADV IMMUNOL, V53, P1, DOI 10.1016/S0065-2776(08)60496-4; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; ROCKEN M, 1992, J IMMUNOL, V148, P47; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SCHEICHER C, 1995, EUR J IMMUNOL, V25, P1566, DOI 10.1002/eji.1830250615; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; SWAIN SL, 1991, J IMMUNOL, V147, P2991; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Ushio S, 1996, J IMMUNOL, V156, P4274; vonderWeid T, 1996, J IMMUNOL, V157, P4421; Weiner HL, 1997, ANNU REV MED, V48, P341; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; [No title captured]	95	1264	1319	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1998	8	3					275	283		10.1016/S1074-7613(00)80533-6	http://dx.doi.org/10.1016/S1074-7613(00)80533-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529145	Bronze			2022-12-18	WOS:000072705300001
J	Ouyang, WJ; Kolls, JK; Zheng, Y				Ouyang, Wenjun; Kolls, Jay K.; Zheng, Yan			The biological functions of T helper 17 cell effector cytokines in inflammation	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; BRONCHIAL EPITHELIAL-CELLS; PROINFLAMMATORY GENE-EXPRESSION; FOLLICULAR-HELPER-CELLS; COMMON GAMMA-CHAIN; T-CELL; CUTTING EDGE; INTERLEUKIN-17 RECEPTOR; NEUTROPHIL RECRUITMENT; INDUCIBLE FACTOR	T helper 17 (Th17) cells belong to a recently identified T helper subset, in addition to the traditional Th1 and Th2 subsets. These cells are characterized as preferential producers of interleukin-17A (IL-17A), IL-17F, IL-21, and IL-22. Th17 cells and their effector cytokines mediate host defensive mechanisms to various infections, especially extracellular bacteria infections, and are involved in the pathogenesis of many autoimmune diseases. The receptors for IL-17 and IL-22 are broadly expressed on various epithelial tissues. The effector cytokines of Th17 cells, therefore, mediate the crucial crosstalk between immune system and tissues, and play indispensable roles in tissue immunity.	[Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kolls, Jay K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Div Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USA; [Zheng, Yan] Pfizer Global Res & Dev, St Louis Labs, Inflammat Pathways Grp, Chesterfield, MO 63017 USA	Roche Holding; Genentech; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pfizer	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	ouyang.wenjun@gene.com; jay.kolls@chp.edu	Ouyang, Wenjun/ABA-8763-2020; Zheng, Yan/A-6993-2008; Kolls, Jay/AAH-1829-2019	Zheng, Yan/0000-0002-7002-277X; Kolls, Jay/0000-0001-5151-6304; Ouyang, Wenjun/0000-0002-1811-5864	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079142, R37HL079142] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R37 HL079142, R01 HL079142] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; BOURMA G, 2003, NAT REV IMMUNOL, V3, P521; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Brandt K, 2003, J INVEST DERMATOL, V121, P1379, DOI 10.1046/j.1523-1747.2003.12603.x; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Cai XY, 1998, IMMUNOL LETT, V62, P51, DOI 10.1016/S0165-2478(98)00027-3; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Caruso R, 2007, J IMMUNOL, V178, P5957, DOI 10.4049/jimmunol.178.9.5957; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; Distler JHW, 2005, ARTHRITIS RHEUM-US, V52, P856, DOI 10.1002/art.20883; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gays F, 2005, J IMMUNOL, V175, P2938, DOI 10.4049/jimmunol.175.5.2938; Glimcher LH, 2000, GENE DEV, V14, P1693; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; HWANG SY, 2004, ARTHRITIS RES THER, V13, P6; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; Laan M, 1999, J IMMUNOL, V162, P2347; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Locksley RM, 2008, IMMUNITY, V28, P437, DOI 10.1016/j.immuni.2008.03.009; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Monteleone G, 2006, GUT, V55, P1774, DOI 10.1136/gut.2006.093187; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; OZALKI K, 2000, P NATL ACAD SCI USA, V97, P11439; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SAWALHA AH, 2008, RHEUM DIS, V68, P458; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Suto A, 2002, BLOOD, V100, P4565, DOI 10.1182/blood-2002-04-1115; Tan WH, 2006, J IMMUNOL, V176, P6186, DOI 10.4049/jimmunol.176.10.6186; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Wang G, 2003, CANCER RES, V63, P9016; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weber GF, 2007, INFECT IMMUN, V75, P1690, DOI 10.1128/IAI.01564-06; Whittington HA, 2004, AM J RESP CELL MOL, V31, P220, DOI 10.1165/rcmb.2003-0285OC; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	164	1261	1351	3	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					454	467		10.1016/j.immuni.2008.03.004	http://dx.doi.org/10.1016/j.immuni.2008.03.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400188	Bronze, Green Accepted			2022-12-18	WOS:000254939400004
J	Wang, RN; Dillon, CP; Shi, LZ; Milasta, S; Carter, R; Finkelstein, D; McCormick, LL; Fitzgerald, P; Chi, HB; Munger, J; Green, DR				Wang, Ruoning; Dillon, Christopher P.; Shi, Lewis Zhichang; Milasta, Sandra; Carter, Robert; Finkelstein, David; McCormick, Laura L.; Fitzgerald, Patrick; Chi, Hongbo; Munger, Joshua; Green, Douglas R.			The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation	IMMUNITY			English	Article							C-MYC; GLUTAMINE-METABOLISM; GENE-EXPRESSION; ARGININE METABOLISM; ENERGY-METABOLISM; CELL-ACTIVATION; CANCER; PROLIFERATION; GROWTH; DIFFERENTIATION	To fulfill the bioenergetic and biosynthetic demand of proliferation, T cells reprogram their metabolic pathways from fatty acid beta-oxidation and pyruvate oxidation via the TCA cycle to the glycolytic, pentose-phosphate, and glutaminolytic pathways. Two of the top-ranked candidate transcription factors potentially responsible for the activation-induced T cell metabolic transcriptome, HIF1 alpha and Myc, were induced upon T cell activation, but only the acute deletion of Myc markedly inhibited activation-induced glycolysis and glutaminolysis in T cells. Glutamine deprivation compromised activation-induced T cell growth and proliferation, and this was partially replaced by nucleotides and polyamines, implicating glutamine as an important source for biosynthetic precursors in active T cells. Metabolic tracer analysis revealed a Myc-dependent metabolic pathway linking glutaminolysis to the biosynthesis of polyamines. Therefore, a Myc-dependent global metabolic transcriptome drives metabolic reprogramming in activated, primary T lymphocytes. This may represent a general mechanism for metabolic reprogramming under patho-physiological conditions.	[Wang, Ruoning; Dillon, Christopher P.; Shi, Lewis Zhichang; Milasta, Sandra; McCormick, Laura L.; Fitzgerald, Patrick; Chi, Hongbo; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Carter, Robert; Finkelstein, David] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Munger, Joshua] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Rochester	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Munger, Joshua/ABA-6395-2020; Dillon, Christopher/P-4457-2014; Chi, Hongbo/M-9397-2018; Wang, Ruoning/C-1683-2014; Green, Douglas R/N-8083-2018	Dillon, Christopher/0000-0002-9458-0266; Chi, Hongbo/0000-0002-9997-2496; Green, Douglas R/0000-0002-7332-1417; Shi, Lewis/0000-0002-5351-8730; Munger, Joshua/0000-0001-5379-9440	St Jude Children Hospital; Damon Runyon-Rachleff Innovator Award; NIH [AI081773, S064599, AR053573, AI40646, GM52735]; American Lebanese and Syrian Associated Charities; Sass Foundation for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R56AI081773, R01AI081773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM052735] Funding Source: NIH RePORTER	St Jude Children Hospital; Damon Runyon-Rachleff Innovator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Sass Foundation for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Feng for providing the Gls2 antibody and P. Murray for providing Arginase-I knockout mice. We thank H. Wang, D. Spierings, T. Moldoveanu, H. Beere, L. Bouchier-Hayes, D. Smithson, J. Qualls, C. Subramanian, and C. Rock for valuable discussions and technical assistance. We thank the members of the St. Jude Immunology FACS core facility as well as the St. Jude Hartwell Center. This work was supported by the George J. Mitchell fellowship from St Jude Children Hospital (R.W.), a Damon Runyon-Rachleff Innovator Award (J.M.), NIH grants AI081773 (J.M.), S064599 and AR053573 (H.C.), and AI40646 and GM52735 (D.R.G.), the American Lebanese and Syrian Associated Charities, and a fellowship grant from the Sass Foundation for Medical Research (C.P.D.).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badea TC, 2003, J NEUROSCI, V23, P2314; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BOWLIN TL, 1987, CELL IMMUNOL, V106, P420, DOI 10.1016/0008-8749(87)90184-5; BRAND K, 1984, BIOCHEM J, V221, P471, DOI 10.1042/bj2210471; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Green DR, 2003, SEMIN IMMUNOL, V15, P121, DOI 10.1016/S1044-5323(03)00028-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Iritani BM, 2002, EMBO J, V21, P4820, DOI 10.1093/emboj/cdf492; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; KOVACEVIC Z, 1983, PHYSIOL REV, V63, P547, DOI 10.1152/physrev.1983.63.2.547; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Morris SM, 2004, CURR OPIN CLIN NUTR, V7, P45, DOI 10.1097/00075197-200401000-00009; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Ryan HE, 2000, CANCER RES, V60, P4010; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Wu GY, 2000, COMP BIOCHEM PHYS A, V126, P115, DOI 10.1016/S1095-6433(00)00196-3	54	1259	1294	10	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					871	882		10.1016/j.immuni.2011.09.021	http://dx.doi.org/10.1016/j.immuni.2011.09.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195744	Green Accepted, Bronze			2022-12-18	WOS:000298777300007
J	Shimada, K; Crother, TR; Karlin, J; Dagvadorj, J; Chiba, N; Chen, S; Ramanujan, VK; Wolf, AJ; Vergnes, L; Ojcius, DM; Rentsendorj, A; Vargas, M; Guerrero, C; Wang, YS; Fitzgerald, KA; Underhill, DM; Town, T; Arditi, M				Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Dagvadorj, Jargalsaikhan; Chiba, Norika; Chen, Shuang; Ramanujan, V. Krishnan; Wolf, Andrea J.; Vergnes, Laurent; Ojcius, David M.; Rentsendorj, Altan; Vargas, Mario; Guerrero, Candace; Wang, Yinsheng; Fitzgerald, Katherine A.; Underhill, David M.; Town, Terrence; Arditi, Moshe			Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis	IMMUNITY			English	Article							NALP3 INFLAMMASOME; ATP BINDING; MECHANISM; DAMAGE; IL-1-BETA; INHIBIT; BRAIN; BCL-2	We report that in the presence of signal 1 (NF-kappa B), the NLRP3 inflammasome was activated by mitochondrial apoptotic signaling that licensed production of interleukin-1 beta (IL-1 beta). NLRP3 secondary signal activators such as ATP induced mitochondrial dysfunction and apoptosis, resulting in release of oxidized mitochondrial DNA (mtDNA) into the cytosol, where it bound to and activated the NLRP3 inflammasome. The antiapoptotic protein Bcl-2 inversely regulated mitochondrial dysfunction and NLRP3 inflammasome activation. Mitochondrial DNA directly induced NLRP3 inflammasome activation, because macrophages lacking mtDNA had severely attenuated IL-1 beta production, yet still underwent apoptosis. Both binding of oxidized mtDNA to the NLRP3 inflammasome and IL-1 beta secretion could be competitively inhibited by the oxidized nucleoside 8-OH-dG. Thus, our data reveal that oxidized mtDNA released during programmed cell death causes activation of the NLRP3 inflammasome. These results provide a missing link between apoptosis and inflammasome activation, via binding of cytosolic oxidized mtDNA to the NLRP3 inflammasome.	[Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Dagvadorj, Jargalsaikhan; Chiba, Norika; Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Rentsendorj, Altan; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Rentsendorj, Altan; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Wolf, Andrea J.; Underhill, David M.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Vergnes, Laurent] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Ojcius, David M.] UC Merced, Hlth Sci Res Inst, Merced, CA 95343 USA; [Ojcius, David M.] UC Merced, Sch Nat Sci, Merced, CA 95343 USA; [Vargas, Mario; Guerrero, Candace; Wang, Yinsheng] UC Riverside, Dept Chem, Riverside, CA 92521 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Riverside; University of Massachusetts System; University of Massachusetts Worcester	Arditi, M (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	moshe.arditi@cshs.org	Fitzgerald, Katherine/ABE-6317-2020; Ramanujan, V Krishnan/O-2831-2014; Crother, Timothy R/E-2879-2010; UNDERHILL, DAVID/ABE-2185-2021; Ojcius, David/ABE-6557-2020	Crother, Timothy R/0000-0001-8465-6127; Fitzgerald, Kate/0000-0003-3175-609X; vergnes, laurent/0000-0002-8804-589X; Ojcius, David/0000-0003-1461-4495; Underhill, David/0000-0002-2989-658X	National Institutes of Health (NIH) [HL-66436, AI-067995, AG-029726, NS-076794, GM-085796]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067995, R01AI067995, R01AI083713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG029726, R00AG029726] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Sun, W. Zhang, and G. Huang for expert technical assistance. We are grateful to G. Nunez (University of Michigan) for kindly providing the pSFFV-neo plasmid, to R.A. Flavell (Yale University) for supplying Casp1<SUP>-/-</SUP> mice, and to E. Latz (University of Bonn) for kindly providing the NLRP3 plasmid. This work was supported by National Institutes of Health (NIH) grants HL-66436 and AI-067995 (to M.A.). T.T. is supported by NIH grants AG-029726 and NS-076794 and is the inaugural holder of the Ben Winters Endowed Chair in Regenerative Medicine at CSMC. D.M. Underhill is supported by NIH grant GM-085796 and holds the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at CSMC.	Akahoshi T, 1997, RHEUMATOL INT, V16, P231, DOI 10.1007/BF01375654; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055; Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ghribi O, 2001, J ALZHEIMERS DIS, V3, P387, DOI 10.3233/JAD-2001-3404; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hinokio Y, 1999, DIABETOLOGIA, V42, P995, DOI 10.1007/s001250051258; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kage H, 2008, J BACTERIOL, V190, P2470, DOI 10.1128/JB.01385-07; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Park IS, 2002, J BIOCHEM MOL BIOL, V35, P41; Patrushev M, 2006, MITOCHONDRION, V6, P43, DOI 10.1016/j.mito.2005.12.001; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; RIESBECK K, 1990, ANTIMICROB AGENTS CH, V34, P167, DOI 10.1128/AAC.34.1.167; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Simone S, 2008, DIABETES, V57, P2626, DOI 10.2337/db07-1579; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yamagata M, 1996, BRIT J CANCER, V73, P1328, DOI 10.1038/bjc.1996.254; Yang L, 2008, CELL MOL BIOL LETT, V13, P119, DOI 10.2478/s11658-007-0042-x; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	51	1251	1298	10	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					401	414		10.1016/j.immuni.2012.01.009	http://dx.doi.org/10.1016/j.immuni.2012.01.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22342844	Bronze, Green Accepted			2022-12-18	WOS:000302048400012
J	Xue, J; Schmidt, SV; Sander, J; Draffehn, A; Krebs, W; Quester, I; De Nardo, D; Gohel, TD; Emde, M; Schmidleithner, L; Ganesan, H; Nino-Castro, A; Mallmann, MR; Labzin, L; Theis, H; Kraut, M; Beyer, M; Latz, E; Freeman, TC; Ulas, T; Schultze, JL				Xue, Jia; Schmidt, Susanne V.; Sander, Jil; Draffehn, Astrid; Krebs, Wolfgang; Quester, Inga; De Nardo, Dominic; Gohel, Trupti D.; Emde, Martina; Schmidleithner, Lisa; Ganesan, Hariharasudan; Nino-Castro, Andrea; Mallmann, Michael R.; Labzin, Larisa; Theis, Heidi; Kraut, Michael; Beyer, Marc; Latz, Eicke; Freeman, Tom C.; Ulas, Thomas; Schultze, Joachim L.			Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation	IMMUNITY			English	Article							GENE-EXPRESSION; REGULATORY NETWORK; DENDRITIC CELLS; MOUSE; POLARIZATION; INFECTION; PROGRAMS; DIFFERENTIATION; CONSERVATION; DIVERGENCE	Macrophage activation is associated with profound transcriptional reprogramming. Although much progress has been made in the understanding of macrophage activation, polarization, and function, the transcriptional programs regulating these processes remain poorly characterized. We stimulated human macrophages with diverse activation signals, acquiring a data set of 299 macrophage transcriptomes. Analysis of this data set revealed a spectrum of macrophage activation states extending the current M1 versus M2-polarization model. Network analyses identified central transcriptional regulators associated with all macrophage activation complemented by regulators related to stimulus-specific programs. Applying these transcriptional programs to human alveolar macrophages from smokers and patients with chronic obstructive pulmonary disease (COPD) revealed an unexpected loss of inflammatory signatures in COPD patients. Finally, by integrating murine data from the ImmGen project we propose a refined, activation-independent core signature for human and murine macrophages. This resource serves as a framework for future research into regulation of macrophage activation in health and disease.	[Xue, Jia; Schmidt, Susanne V.; Sander, Jil; Draffehn, Astrid; Krebs, Wolfgang; Quester, Inga; Gohel, Trupti D.; Emde, Martina; Schmidleithner, Lisa; Ganesan, Hariharasudan; Nino-Castro, Andrea; Mallmann, Michael R.; Theis, Heidi; Kraut, Michael; Beyer, Marc; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, LIMES Inst, D-53115 Bonn, Germany; [De Nardo, Dominic; Labzin, Larisa; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke] UMass Med Sch, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany; [Freeman, Tom C.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Freeman, Tom C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland	University of Bonn; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schultze, JL (corresponding author), Univ Bonn, LIMES Inst, D-53115 Bonn, Germany.	j.schultze@uni-bonn.de	Schmidt, Susanne/AAU-6827-2021; Schultze, Joachim L/D-7794-2011; Latz, Eicke/H-3951-2014; Schultze, Joachim L./ABA-8176-2020; Labzin, Larisa/AAC-8618-2020; Beyer, Marc/ABE-1408-2021	Schultze, Joachim L/0000-0003-2812-9853; Latz, Eicke/0000-0003-1488-5666; Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; De Nardo, Dominic/0000-0002-7045-4695; Nino-Castro, Andrea/0000-0002-0895-3637; Freeman, Thomas/0000-0001-5235-8483; Labzin, Larisa/0000-0001-9098-4493	German Research Foundation [Sonderforschungsbereich 645, SFB 704, SFB 832, INST 217/575-1, INST 217/576-1, INST 217/577-1]; European Union's Seventh Framework Programme under REA grant [317445]; UK BBSRC Institute Strategic Programme Grant; BBSRC [BBS/E/D/05191131, BB/F003722/1, BB/I001107/1, BBS/E/D/20211552] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191131, BBS/E/D/20211552, BB/I001107/1, BB/F003722/1] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); European Union's Seventh Framework Programme under REA grant; UK BBSRC Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Bohmann for her technical assistance and J. Oldenburg for providing us with blood samples from healthy individuals. This work was supported by the German Research Foundation (Sonderforschungsbereich 645, SFB 704, SFB 832, INST 217/575-1, INST 217/576-1, and INST 217/577-1 to J.L.S.). J.L.S. and E.L. are members of the Excellence Cluster ImmunoSensation, and the research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2077-2013 under REA grant agreement no. 317445. T.C.F. is supported by a UK BBSRC Institute Strategic Programme Grant to The Roslin Institute.	Aluru M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks904; Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Hume DA, 2010, GENOMICS, V95, P328, DOI 10.1016/j.ygeno.2010.03.002; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Poland GA, 2013, VACCINE, V31, P2911, DOI 10.1016/j.vaccine.2013.04.043; Popov A, 2008, J IMMUNOL, V181, P4976, DOI 10.4049/jimmunol.181.7.4976; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	53	1250	1268	12	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					274	288		10.1016/j.immuni.2014.01.006	http://dx.doi.org/10.1016/j.immuni.2014.01.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24530056	Green Published, hybrid			2022-12-18	WOS:000331637600014
J	Joshi, NS; Cui, W; Chandele, A; Lee, HK; Urso, DR; Hagman, J; Gapin, L; Kaech, SM				Joshi, Nikhil S.; Cui, Weiguo; Chandele, Anmol; Lee, Heung Kyu; Urso, David R.; Hagman, James; Gapin, Laurent; Kaech, Susan M.			Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor	IMMUNITY			English	Article							IL-7 RECEPTOR; CUTTING EDGE; SELECTIVE EXPRESSION; PROTECTIVE IMMUNITY; VIRAL-INFECTIONS; RESPONSES; DIFFERENTIATION; HOMEOSTASIS; GENERATION; LINEAGE	As acute infections resolve, effector CD8(+) T cells differentiate into interleukin-7 receptor(lo) (IL-7R(lo)) short-lived effector cells (SLECs) and IL-7R(hi) memory precursor effector cells (MPECs) capable of generating long-lived memory CD8(+) T cells. By using another SLEC marker, KLRG1, we found that KLRG1(hi) effector cells began appearing early during infection and were committed to downregulating IL-7R. Unlike IL-7R(hi) MPECs, KLRG1(hi) IL-7R(lo) SLECs relied on IL-15, but I L-15 could not sustain their long-term maintenance or homeostatic turnover. The decision between SLEC and MPEC fates was regulated by the amount of inflammatory cytokines (i.e., IL-12) present during T cell priming. According to the amount of inflammation, a gradient of T-bet was created in which high T-bet expression induced SLECs and low expression promoted MPECs. These results elucidate a mechanism by which the innate immune system sets the relative amounts of a lineage-determining transcription factor in activated CD8(+) T cells and, correspondingly, regulates their memory cell potential.	Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA	Yale University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunol, 333 Cedar St, New Haven, CT 06520 USA.	susan.kaech@yale.edu	Hagman, James/R-7013-2019; Lee, Heung Kyu/C-2073-2011	Hagman, James/0000-0002-5436-8455; Lee, Heung Kyu/0000-0002-3977-1510; Joshi, Nikhil/0000-0002-7045-7837	NIAID NIH HHS [R01 AI066232-01, T32 AI055403, R01 AI054661, R01 AI056322-01, R01 AI056322, P01 AI022295, R01 AI066232, R01 AI 066232-01, R01 AI057485, R01 AI057485-01, P01 AI22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054661, P01AI022295, R01AI056322, T32AI055403, R01AI057485, R01AI066232] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 2006, EUR J IMMUNOL, V36, P842, DOI 10.1002/eji.200535730; Bachmann MF, 2004, J IMMUNOL, V173, P2217, DOI 10.4049/jimmunol.173.4.2217; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Bree GJ, 2005, J INFECT DIS, V191, P1710, DOI 10.1086/429695; Doherty TM, 1996, J IMMUNOL, V156, P735; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; ORTEGA E, 1991, INT IMMUNOL, V3, P333, DOI 10.1093/intimm/3.4.333; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Robbins SH, 2005, EUR J IMMUNOL, V35, P757, DOI 10.1002/eji.200425797; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van Leeuwen EMM, 2006, IMMUNOL REV, V211, P225, DOI 10.1111/j.0105-2896.2006.00379.x; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507	50	1243	1265	5	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					281	295		10.1016/j.immuni.2007.07.010	http://dx.doi.org/10.1016/j.immuni.2007.07.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723218	Bronze, Green Accepted			2022-12-18	WOS:000249056300014
J	Garlanda, C; Dinarello, CA; Mantovani, A				Garlanda, Cecilia; Dinarello, Charles A.; Mantovani, Alberto			The Interleukin-1 Family: Back to the Future	IMMUNITY			English	Review							DELTA T-CELLS; INNATE LYMPHOID-CELLS; INVARIANT NKT CELLS; IL-1 FAMILY; STERILE INFLAMMATION; RECEPTOR ANTAGONIST; DENDRITIC CELLS; AUTOINFLAMMATORY DISEASE; INTESTINAL INFLAMMATION; ACTIVATED MACROPHAGES	Interleukin-1 (IL-1) is a central mediator of innate immunity and inflammation. The IL-1 family includes seven ligands with agonist activity (IL-1 alpha and IL-1 beta, IL-18, IL-33, IL-36 alpha, IL-36 beta, IL-36 gamma), three receptor antagonists (IL-1Ra, IL-36Ra, IL-38), and an anti-inflammatory cytokine (IL-37). Members of the IL-1 Receptor (IL-1R) family include six receptor chains forming four signaling receptor complexes, two decoy receptors (IL-1R2, IL-18BP), and two negative regulators (TIR8 or SIGIRR, IL-1RAcPb). A tight regulation via receptor antagonists, decoy receptors, and signaling inhibitors ensures a balance between amplification of innate immunity and uncontrolled inflammation. All cells of the innate immune system express and/or are affected by IL-1 family members. Moreover, IL-1 family members play a key role in the differentiation and function of polarized innate and adaptive lymphoid cells. Here we will review the key properties of IL-1 family members, with emphasis on pathways of negative regulation and orchestration of innate and adaptive immunity.	[Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, I-20089 Rozzano, Italy; [Dinarello, Charles A.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO 80045 USA; [Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HC Nijmegen, Netherlands; [Mantovani, Alberto] Univ Milan, BIOMETRA Dept, I-20133 Milan, Italy	IRCCS Humanitas Research Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Radboud University Nijmegen; University of Milan	Mantovani, A (corresponding author), Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Rozzano, Italy.	alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022; Dinarello, Charles/C-8524-2013; Garlanda, Cecilia/K-4601-2016	Mantovani, Alberto/0000-0001-5578-236X; Garlanda, Cecilia/0000-0002-1510-7703	European Research Council; European Commission [FP7-HEALTH-2011-ADITEC 280873]; Associazione Italiana per la Ricerca sul Cancro (AIRC); National Institutes of Health [A115614, AR-45584]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	A.M. and C. G. are supported by European Research Council (Project HIIIS), European Commission (FP7-HEALTH-2011-ADITEC 280873), and Associazione Italiana per la Ricerca sul Cancro (AIRC). C. A. D. is supported by the National Institutes of Health Grants A115614 and AR-45584. A. M. and C. G. are inventors in patents related to the IL-1 inducible gene PTX3, and Humanitas receives royalties to IL-1 family reagents.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Albacker LA, 2013, NAT MED, V19, P1297, DOI 10.1038/nm.3321; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bellora F, 2012, EUR J IMMUNOL, V42, P1618, DOI 10.1002/eji.201142173; Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Berda-Haddad Y, 2011, P NATL ACAD SCI USA, V108, P20684, DOI 10.1073/pnas.1116848108; Bersudsky M., 2013, GUT IN PRESS; Bertilaccio MTS, 2011, BLOOD, V118, P660, DOI 10.1182/blood-2011-01-329870; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Bozza S, 2008, J IMMUNOL, V180, P4022, DOI 10.4049/jimmunol.180.6.4022; Brydges S. D, 2013, J CLIN INVE IN PRESS; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Carmi Y, 2013, J IMMUNOL, V190, P3500, DOI 10.4049/jimmunol.1202769; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen XX, 2011, SHOCK, V35, P198, DOI 10.1097/SHK.0b013e3181f226f3; Chien YH, 2013, TRENDS IMMUNOL, V34, P151, DOI 10.1016/j.it.2012.11.004; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Drexler SK, 2010, ARTHRITIS RHEUM-US, V62, P2249, DOI 10.1002/art.27517; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Fock V, 2013, J IMMUNOL, V191, P3734, DOI 10.4049/jimmunol.1300490; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Garlanda C, 2007, CANCER RES, V67, P6017, DOI 10.1158/0008-5472.CAN-07-0560; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gresnigt MS, 2013, EUR J IMMUNOL, V43, P416, DOI 10.1002/eji.201242711; Grimsby S, 2004, FEBS LETT, V577, P93, DOI 10.1016/j.febslet.2004.09.069; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Ho JE, 2013, J CLIN INVEST, V123, P4208, DOI 10.1172/JCI67119; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hong DS, 2011, MOL CANCER THER, V10, DOI [10.1158/1535-7163.TARG-11-A211, DOI 10.1158/1535-7163.TARG-11-A211]; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Huang X, 2006, J IMMUNOL, V177, P548, DOI 10.4049/jimmunol.177.1.548; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Joeckel LT, 2012, J VIROL, V86, P8713, DOI 10.1128/JVI.00682-12; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kumar S, 2002, COMPUT SCI ENG, V4, P18, DOI 10.1109/MCISE.2002.976433; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Langley N. J., 1906, P ROY SOC LOND B BIO, V78, P170; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lech M, 2010, J PATHOL, V220, P596, DOI 10.1002/path.2678; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Lorenzen I, 2012, FEBS LETT, V586, P1093, DOI 10.1016/j.febslet.2012.03.012; Luo YC, 2013, CYTOKINE, V63, P283, DOI 10.1016/j.cyto.2013.06.174; Maggi L, 2012, EUR J IMMUNOL, V42, P3180, DOI 10.1002/eji.201242648; Mailliard RB, 2005, J EXP MED, V202, P941, DOI 10.1084/hem.20050128; Maksymowych WP, 2006, ARTHRITIS RHEUM-US, V54, P974, DOI 10.1002/art.21642; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin P, 2013, J LEUKOCYTE BIOL, V94, P791, DOI 10.1189/jlb.0113035; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monteiro M, 2013, J IMMUNOL, V190, P805, DOI 10.4049/jimmunol.1201010; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Nold MF, 2013, CYTOKINE, V63, P287, DOI 10.1016/j.cyto.2013.06.190; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; Noris M, 2009, J IMMUNOL, V183, P4249, DOI 10.4049/jimmunol.0803549; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2010, J AUTOIMMUN, V34, P121, DOI 10.1016/j.jaut.2009.08.002; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Paget C, 2012, J BIOL CHEM, V287, P8816, DOI 10.1074/jbc.M111.304758; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Russell SE, 2013, J IMMUNOL, V191, P3337, DOI 10.4049/jimmunol.1300828; Sakai N, 2012, J GASTROEN HEPATOL, V27, P1609, DOI 10.1111/j.1440-1746.2012.07187.x; Salcedo R, 2013, TRENDS IMMUNOL, V34, P379, DOI 10.1016/j.it.2013.03.008; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Santarlasci V, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00182; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Sica A., 2013, HEPATOLOGY IN PRESS; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Smith DE, 2009, IMMUNITY, V30, P817, DOI 10.1016/j.immuni.2009.03.020; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tack CJ, 2012, IMMUNOL REV, V249, P239, DOI 10.1111/j.1600-065X.2012.01145.x; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Xiao H, 2010, GASTROENTEROLOGY, V139, P574, DOI 10.1053/j.gastro.2010.04.043; Yousif NG, 2011, CIRCULATION, V124; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	150	1207	1272	10	230	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1003	1018		10.1016/j.immuni.2013.11.010	http://dx.doi.org/10.1016/j.immuni.2013.11.010			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332029	Bronze, Green Accepted			2022-12-18	WOS:000330951000008
J	Loo, YM; Gale, M				Loo, Yueh-Ming; Gale, Michael, Jr.			Immune Signaling by RIG-I-like Receptors	IMMUNITY			English	Review							WEST-NILE-VIRUS; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; ANTIVIRAL INNATE IMMUNITY; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; DIFFERENTIATION-ASSOCIATED GENE-5; INTERFERON REGULATORY FACTOR-3; INTERSTITIAL LUNG-DISEASE; TUMOR-SUPPRESSOR CYLD; TOLL-LIKE RECEPTOR-3	The RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2 play a major role in pathogen sensing of RNA virus infection to initiate and modulate antiviral immunity. The RLRs detect viral RNA ligands or processed self RNA in the cytoplasm to trigger innate immunity and inflammation and to impart gene expression that serves to control infection. Importantly, RLRs cooperate in signaling crosstalk networks with Toll-like receptors and other factors to impart innate immunity and to modulate the adaptive immune response. RLR regulation occurs at a variety of levels ranging from autoregulation to ligand and cofactor interactions and posttranslational modifications. Abberant RLR signaling or dysregulation of RLR expression is now implicated in the development of autoimmune diseases. Understanding the processes of RLR signaling and response will provide insights to guide RLR-targeted therapeutics for antiviral and immune-modifying applications.	[Loo, Yueh-Ming; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gale, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	mgale@uw.edu		Loo, Yueh-Ming/0000-0001-6294-7273; Gale, Michael/0000-0002-6332-7436	NIAID NIH HHS [U19 AI083019-01, U19 AI083019, R21 AI057568-02, R01 AI060389-08, U19 AI088778, R21 AI057568-01A2, R01 AI060389-11, U19 AI083019-04, U19 AI088778-01, R21 AI057568-03, R01 AI060389-09, U19 AI088778-02, U19 AI083019-02, U19 AI088778-03, U19 AI083019-03, R21 AI057568, U19 AI083019-02S1, R01 AI060389-10, R01 AI060389-07, R01 AI060389] Funding Source: Medline; NIDA NIH HHS [R01 DA024563, R01 DA024563-03, R01 DA024563-02, R01 DA024563-04, R01 DA024563-05, R01 DA024563-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI088778, R01AI060389, U19AI083019, R21AI057568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024563] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Betteridge ZE, 2009, CURR OPIN RHEUMATOL, V21, P604, DOI 10.1097/BOR.0b013e328331638a; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colli ML, 2010, HUM MOL GENET, V19, P135, DOI 10.1093/hmg/ddp474; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; FUNKE B, 2011, INFLAMM BOW IN PRESS; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gondai T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1043; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hiscott J, 2006, BIOCHEM PHARMACOL, V72, P1477, DOI 10.1016/j.bcp.2006.06.030; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jaidane H, 2010, REV MED VIROL, V20, P265, DOI 10.1002/rmv.647; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Johnsen IB, 2009, J BIOL CHEM, V284, P19122, DOI 10.1074/jbc.M808233200; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li XJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P23, DOI 10.1016/j.abb.2009.06.008; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luke JM, 2011, J VIROL, V85, P1370, DOI 10.1128/JVI.01250-10; Luthra P, 2011, P NATL ACAD SCI USA, V108, P2118, DOI 10.1073/pnas.1012409108; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Mashima R, 2005, J BIOL CHEM, V280, P41289, DOI 10.1074/jbc.M508221200; Mattei F, 2010, CYTOKINE GROWTH F R, V21, P227, DOI 10.1016/j.cytogfr.2010.05.002; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ohman T, 2009, J IMMUNOL, V182, P5682, DOI 10.4049/jimmunol.0803093; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; PAZ S, 2011, CELL RES IN PRESS; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Pothlichet J, 2011, EMBO MOL MED, V3, P142, DOI 10.1002/emmm.201000120; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Song T, 2010, FEBS LETT, V584, P33, DOI 10.1016/j.febslet.2009.11.025; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	144	1203	1263	5	181	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					680	692		10.1016/j.immuni.2011.05.003	http://dx.doi.org/10.1016/j.immuni.2011.05.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616437	Green Accepted, Bronze			2022-12-18	WOS:000291456500005
J	Munoz-Planillo, R; Kuffa, P; Martinez-Colon, G; Smith, BL; Rajendiran, TM; Nunez, G				Munoz-Planillo, Raul; Kuffa, Peter; Martinez-Colon, Giovanny; Smith, Brenna L.; Rajendiran, Thekkelnaycke M.; Nunez, Gabriel			K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter	IMMUNITY			English	Article							NALP3 INFLAMMASOME; ATP; RELEASE; MEMBRANE; RECEPTOR; MACROPHAGES; PANNEXIN-1; INHIBITORS; PATHWAYS; CRYSTALS	The NLRP3 inflammasome is an important component of the innate immune system. However, its mechanism of activation remains largely unknown. We show that NLRP3 activators including bacterial pore-forming toxins, nigericin, ATP, and particulate matter caused mitochondrial perturbation or the opening of a large membrane pore, but this was not required for NLRP3 activation. Furthermore, reactive oxygen species generation or a change in cell volume was not necessary for NLRP3 activation. Instead, the only common activity induced by all NLRP3 agonists was the permeation of the cell membrane to K+ and Na+. Notably, reduction of the intracellular K+ concentration was sufficient to activate NLRP3, whereas an increase in intracellular Na+ modulated but was not strictly required for inflammasome activation. These results provide a unifying model for the activation of the NLRP3 inflammasome in which a drop in cytosolic K+ is the common step that is necessary and sufficient for caspase-1 activation.	[Munoz-Planillo, Raul; Kuffa, Peter; Martinez-Colon, Giovanny; Smith, Brenna L.; Rajendiran, Thekkelnaycke M.; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Munoz-Planillo, Raul; Kuffa, Peter; Martinez-Colon, Giovanny; Smith, Brenna L.; Rajendiran, Thekkelnaycke M.; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Rajendiran, Thekkelnaycke M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014		National Institutes of Health (NIH) [AI06333, DK091191, AR059688]; Michigan Nutrition Obesity Research Center (NIH) [DK089503]; NIH [R25 GM086262]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R56AI063331, R01AI064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R01DK091191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Nutrition Obesity Research Center (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The studies were supported by National Institutes of Health (NIH) grants AI06333, DK091191, and AR059688 (to G.N.). Bioenergetics studies were done at the Molecular Phenotyping Core, supported by the Michigan Nutrition Obesity Research Center (NIH grant DK089503). G. M.-C. was supported by the postbaccalaureate Research Education Program grant 5 R25 GM086262 from the NIH. We thank Millenium Pharmaceuticals, George Dubyak, Eicke Latz, and Warren Strober for generously supplying mutant mice, Yuumi Nakamura for maintaining the Nlrp3<SUP>R258W</SUP> knockin colony, Stephen Fisher for help with [<SUP>3</SUP>H]-taurine experiments, Grace Chen and Luigi Franchi for critical review of this manuscript, Joel Whitfield for ELISA measurements, Sherry Koonse for animal husbandry, Sydney Bridges for performing Seahorse experiments, Ted Huston for ICP-MS measurements, Keith Matz for lactate measurements, and James Windak for ICP-OES technical support.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Andersen OS, 2005, IEEE T NANOBIOSCI, V4, P10, DOI 10.1109/TNB.2004.842470; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P589, DOI 10.1113/jphysiol.1975.sp010949; Chen YJ, 2012, J BIOL CHEM, V287, P18806, DOI 10.1074/jbc.M112.340935; Chifflet S, 2004, EXP EYE RES, V79, P769, DOI 10.1016/j.exer.2004.08.031; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Decleva E, 2006, J LEUKOCYTE BIOL, V79, P87, DOI 10.1189/jlb.0605338; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Langheinrich U, 1997, J PHYSIOL-LONDON, V502, P397, DOI 10.1111/j.1469-7793.1997.397bk.x; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Peppelenbosch MP, 1999, BLOOD, V93, P4011, DOI 10.1182/blood.V93.11.4011.411a29_4011_4018; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	40	1194	1239	13	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1142	1153		10.1016/j.immuni.2013.05.016	http://dx.doi.org/10.1016/j.immuni.2013.05.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809161	Bronze, Green Accepted			2022-12-18	WOS:000330947500010
J	Butte, MJ; Keir, ME; Phamduy, TB; Sharpe, AH; Freeman, GJ				Butte, Manish J.; Keir, Mary E.; Phamduy, Theresa B.; Sharpe, Arlene H.; Freeman, Gordon J.			Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses	IMMUNITY			English	Article							DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE-RESPONSES; PD-1 EXPRESSION; IN-VIVO; FAMILY; CTLA-4; ACTIVATION; LIGATION; ANTIGEN	Pathways in the B7:CD28 family of costimulatory molecules regulate T cell activation and tolerance. B7-dependent responses in Cd28(-/-) Ctla4(-/-) T cells together with reports of stimulatory and inhibitory functions for Programmed Death-1 Ligand 1 or 2 molecules (PD-L1 or PD-L2) have suggested additional receptors for these 137 family members. We show that B7-1 and PD-L1 interacted with affinity intermediate to that of B7-1:CD28 and B7-1:CTLA-4. The PD-L1:B7-1 interface overlapped with the B7-1:CTLA-4 and PD-L1:PD-1 (Programmed Death-1) interfaces. T cell activation and cytokine production were inhibited by the interaction of B7-1 with PD-L1. The responses of PD-1 -deficient versus PD-1,B7-1 double-deficient T cells to PD-L1 and of CD28,CTLA-4 double-deficient versus CD28,CTLA-4,PD-L1 triple-deficient T cells to B7-1 demonstrated that PD-L1 and B7-1 interact specifically to inhibit T cell activation. Our findings point to a substantial bidirectional inhibitory interaction between B7-1 and PD-L1 and add an additional dimension to immunoregulatory functions of the B7:CD28 family.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu	Butte, Manish/T-8860-2019; Freeman, Gordon/AAC-5380-2019; Butte, Manish/AAM-8604-2020	Butte, Manish/0000-0002-4490-5595; Freeman, Gordon/0000-0002-7210-5616; Butte, Manish/0000-0002-4490-5595	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038310, R01AI040614, P01AI056299, R01AI046414, R37AI038310] Funding Source: NIH RePORTER; NCRR NIH HHS [S10RR017948-01A1, S10 RR017948] Funding Source: Medline; NIAID NIH HHS [P01 AI056299-04, R01 AI040614, R01 AI038310-07, R01 AI38310, R01 AI038310, P01 AI56299, R01 AI038310-05, R01 AI46414, R01 AI040614-07, R01 AI040614-05, P01 AI056299-05, P01 AI056299, R01 AI040614-06, R37 AI038310, R01 AI038310-06] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baban B, 2005, INT IMMUNOL, V17, P909, DOI 10.1093/intimm/dxh271; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Broeren CPM, 2000, J IMMUNOL, V165, P6908, DOI 10.4049/jimmunol.165.12.6908; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chikuma S, 2003, IMMUNOL RES, V28, P241, DOI 10.1385/IR:28:3:241; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Davis SJ, 2001, ACTA CRYSTALLOGR D, V57, P605, DOI 10.1107/S0907444901001895; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 2006, CELL MOL IMMUNOL, V3, P179; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Ito T, 2005, J IMMUNOL, V174, P6648, DOI 10.4049/jimmunol.174.11.6648; Kanai T, 2003, J IMMUNOL, V171, P4156, DOI 10.4049/jimmunol.171.8.4156; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Liu XL, 2003, J EXP MED, V197, P1721, DOI 10.1084/jem.20022089; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Radhakrishnan S, 2005, J ALLERGY CLIN IMMUN, V116, P668, DOI 10.1016/j.jaci.2005.04.038; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Schweitzer AN, 1999, J IMMUNOL, V163, P4819; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Taylor PA, 2004, J IMMUNOL, V172, P34, DOI 10.4049/jimmunol.172.1.34; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Tsushima F, 2003, EUR J IMMUNOL, V33, P2773, DOI 10.1002/eji.200324084; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9	53	1192	1355	10	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					111	122		10.1016/j.immuni.2007.05.016	http://dx.doi.org/10.1016/j.immuni.2007.05.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17629517	Green Accepted, Bronze			2022-12-18	WOS:000248398100013
J	Yang, XXO; Pappu, BP; Nurieva, R; Akimzhanov, A; Kang, HS; Chung, Y; Ma, L; Shah, B; Panopoulos, AD; Schluns, KS; Watowich, SS; Tian, Q; Jetten, AM; Dong, C				Yang, Xuexian O.; Pappu, Bhanu P.; Nurieva, Roza; Akimzhanov, Askar; Kang, Hong Soon; Chung, Yeonseok; Ma, Li; Shah, Bhavin; Panopoulos, Athanasia D.; Schluns, Kimberly S.; Watowich, Stephanie S.; Tian, Qiang; Jetten, Anton M.; Dong, Chen			T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma	IMMUNITY			English	Article							HELPER T-CELLS; EXPRESSION; GENERATION; CYTOKINE; T(H)17; INFLAMMATION; IL-21; INTERLEUKIN-4; INDUCTION; PATHWAYS	T cell functional differentiation is mediated by lineage-specific transcription factors. T helper 17 (Th17) has been recently identified as a distinct Th lineage mediating tissue inflammation. Retinoic acid receptor-related orphan receptor gamma (ROR gamma) was shown to regulate Th17 differentiation; ROR gamma deficiency, however, did not completely abolish Th17 cytokine expression. Here, we report Th17 cells highly expressed another related nuclear receptor, ROR alpha, induced by transforming growth factor-beta and interleukin-6 (IL-6), which is dependent on signal transducer and activator of transcription 3. Overexpression of ROR alpha promoted Th17 differentiation, possibly through the conserved noncoding sequence 2 in II17-II17f locus. ROR alpha deficiency resulted in reduced IL-17 expression in vitro and in vivo. Furthermore, ROR alpha and ROR gamma coexpression synergistically led to greater Th17 differentiation. Double deficiencies in ROR alpha and ROR gamma globally impaired Th17 generation and completely protected mice against experimental autoimmune encephalomyelitis. Therefore, Th17 differentiation is directed by two lineage-specific nuclear receptors, ROR alpha and ROR gamma.	[Yang, Xuexian O.; Pappu, Bhanu P.; Nurieva, Roza; Akimzhanov, Askar; Chung, Yeonseok; Shah, Bhavin; Panopoulos, Athanasia D.; Schluns, Kimberly S.; Watowich, Stephanie S.; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, LRB, NIH, Res Triangle Pk, NC 27709 USA; [Ma, Li; Tian, Qiang] Inst Syst Biol, Seattle, WA 98103 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institute for Systems Biology (ISB)	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	cdong@mdanderson.org	Schluns, Kimberly/R-5635-2019; dong, chen/B-3181-2009; Yang, Xuexian/Y-2472-2019; Jetten, Anton/C-3736-2019	dong, chen/0000-0002-0084-9130; Yang, Xuexian/0000-0001-6816-7024; Jetten, Anton/0000-0003-0954-4445; Panopoulos, Athanasia/0000-0002-9610-2604; Akimzhanov, Askar/0000-0002-5592-8215; Watowich, Stephanie/0000-0003-1969-659X; Chung, Yeonseok/0000-0001-5780-4841	NIAID NIH HHS [U19 AI071130, U19 AI071130-020006] Funding Source: Medline; NIAMS NIH HHS [R01 AR050772-06, R01 AR050772, R01 AR050772-05, AR050772] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dzhagalov I, 2004, J IMMUNOL, V173, P2952, DOI 10.4049/jimmunol.173.5.2952; Glimcher LH, 2000, GENE DEV, V14, P1693; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JETTEN AM, 2004, ALLERGY, V3, P395; KANG HS, 2007, IN PRESS PHYSL GENOM; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KleinHessling S, 1996, P NATL ACAD SCI USA, V93, P15311, DOI 10.1073/pnas.93.26.15311; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Park SH, 2005, CHEM MATER, V17, P6, DOI 10.1021/cm048433e; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng WP, 2004, J IMMUNOL, V172, P114, DOI 10.4049/jimmunol.172.1.114; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	40	1191	1320	7	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					29	39		10.1016/j.immuni.2007.11.016	http://dx.doi.org/10.1016/j.immuni.2007.11.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18164222	Green Accepted, Bronze			2022-12-18	WOS:000252627300008
J	Zelante, T; Iannitti, RG; Cunha, C; De Luca, A; Giovannini, G; Pieraccini, G; Zecchi, R; D'Angelo, C; Massi-Benedetti, C; Fallarino, F; Carvalho, A; Puccetti, P; Romani, L				Zelante, Teresa; Iannitti, Rossana G.; Cunha, Cristina; De Luca, Antonella; Giovannini, Gloria; Pieraccini, Giuseppe; Zecchi, Riccardo; D'Angelo, Carmen; Massi-Benedetti, Cristina; Fallarino, Francesca; Carvalho, Agostinho; Puccetti, Paolo; Romani, Luigina			Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22	IMMUNITY			English	Article							JOHNSONII STRAIN NCC533; REGULATORY T-CELLS; CANDIDA-ALBICANS; LACTOBACILLUS-PLANTARUM; GASTROINTESTINAL-TRACT; MICE; COLONIZATION; PROBIOTICS; IL-22; INFLAMMATION	Endogenous tryptophan (Trp) metabolites have an important role in mammalian gut immune homeostasis, yet the potential contribution of Trp metabolites from resident microbiota has never been addressed experimentally. Here, we describe a metabolic pathway whereby Trp metabolites from the microbiota balance mucosal reactivity in mice. Switching from sugar to Trp as an energy source (e.g., under conditions of unrestricted Trp availability), highly adaptive lactobacilli are expanded and produce an aryl hydrocarbon receptor (AhR) ligand-indole-3-aldehyde-that contributes to AhR-dependent Il22 transcription. The resulting IL-22-dependent balanced mucosal response allows for survival of mixed microbial communities yet provides colonization resistance to the fungus Candida albicans and mucosal protection from inflammation. Thus, the microbiota-AhR axis might represent an important strategy pursued by coevolutive commensalism for fine tuning host mucosal reactivity contingent on Trp catabolism.	[Zelante, Teresa; Iannitti, Rossana G.; Cunha, Cristina; De Luca, Antonella; Giovannini, Gloria; D'Angelo, Carmen; Massi-Benedetti, Cristina; Fallarino, Francesca; Carvalho, Agostinho; Puccetti, Paolo; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06132 Perugia, Italy; [Pieraccini, Giuseppe; Zecchi, Riccardo] Univ Florence, Mass Spectrometry Ctr CISM, I-50139 Florence, Italy	University of Perugia; University of Florence	Romani, L (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06132 Perugia, Italy.	luigina.romani@unipg.it	Cunha, Cristina/AAH-9951-2021; Romani, Luigina/O-9987-2018; Cunha, Cristina/D-2687-2009; Benedetti, Cristina Massi/C-1811-2018; Fallarino, Francesca/O-3358-2013; Carvalho, Agostinho/D-2667-2009; zelante, teresa/F-7933-2017; Zecchi, Riccardo/AAG-7553-2021	Cunha, Cristina/0000-0002-6002-5782; Cunha, Cristina/0000-0002-6002-5782; Benedetti, Cristina Massi/0000-0003-0120-9992; Fallarino, Francesca/0000-0002-8501-2136; Carvalho, Agostinho/0000-0001-8935-8030; zelante, teresa/0000-0002-7071-0302; Zecchi, Riccardo/0000-0001-9338-9956; DE LUCA, ANTONELLA/0000-0002-6866-5530; Romani, Luigina/0000-0002-1356-525X; Pieraccini, Giuseppe/0000-0003-3103-3924; Puccetti, Paolo/0000-0001-6674-2128	Specific Targeted Research Project FUNMETA; AIRC (Italian Association for Cancer Research)	Specific Targeted Research Project FUNMETA; AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Specific Targeted Research Project FUNMETA to L.R. and by an AIRC (Italian Association for Cancer Research) grant to P.P. We thank G. Stockinger (Division of Molecular Immunology, MRC) for providing us with the Ahr<SUP>-/-</SUP> mice, E. Ciurnella (Microbiology, University of Perugia) for assistance with bacterial growth and identification, M.G. Ganzle and J. Teixeira (Department of Agricultural, Food and Nutritional Science, University of Alberta) for advice regarding gene deletion of L. reuteri, J. Scott (Microbiology Department, Emory University) for providing the pJRS233 plasmid, and E. Michelucci (CISM, University of Florence) for help in metabolomics.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BALISH E, 1993, J MED VET MYCOL, V31, P143; Boekhorst J, 2004, MICROBIOL-SGM, V150, P3601, DOI 10.1099/mic.0.27392-0; BROWN JF, 1978, APPL ENVIRON MICROB, V36, P144, DOI 10.1128/AEM.36.1.144-159.1978; Chung KT, 2011, ENVIRON MOL MUTAGEN, V52, P81, DOI 10.1002/em.20588; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Dai XC, 2010, J HISTOCHEM CYTOCHEM, V58, P17, DOI 10.1369/jhc.2009.953604; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Denou E, 2007, J BACTERIOL, V189, P8109, DOI 10.1128/JB.00991-07; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Fuentes S, 2008, FEMS MICROBIOL ECOL, V63, P65, DOI 10.1111/j.1574-6941.2007.00411.x; Gummalla S, 1999, J DAIRY SCI, V82, P2070, DOI 10.3168/jds.S0022-0302(99)75448-2; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Karczewska E, 2009, J PHYSIOL PHARMACOL, V60, P33; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lutgendorff F, 2008, CURR MOL MED, V8, P282, DOI 10.2174/156652408784533779; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Mason KL, 2012, INFECT IMMUN, V80, P150, DOI 10.1128/IAI.05162-11; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pena JA, 2004, APPL ENVIRON MICROB, V70, P558, DOI 10.1128/AEM.70.1.558-568.2004; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rijnen L, 1999, APPL ENVIRON MICROB, V65, P4873; ROACH S, 1977, APPL ENVIRON MICROB, V33, P1197, DOI 10.1128/AEM.33.5.1197-1203.1977; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; SAVAGE DC, 1969, J BACTERIOL, V98, P1278, DOI 10.1128/JB.98.3.1278-1283.1969; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tannock GW, 2012, ISME J, V6, P927, DOI 10.1038/ismej.2011.161; TANNOCK GW, 1984, CAN J MICROBIOL, V30, P849, DOI 10.1139/m84-131; TANNOCK GW, 1974, INFECT IMMUN, V9, P591, DOI 10.1128/IAI.9.3.591-598.1974; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; TANNOCK GW, 1982, CAN J MICROBIOL, V28, P1196, DOI 10.1139/m82-177; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yamaguchi N, 2005, J NUTR, V135, P109, DOI 10.1093/jn/135.1.109	56	1174	1239	23	246	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					372	385		10.1016/j.immuni.2013.08.003	http://dx.doi.org/10.1016/j.immuni.2013.08.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973224	Bronze			2022-12-18	WOS:000330948800018
J	Coffman, RL; Sher, A; Seder, RA				Coffman, Robert L.; Sher, Alan; Seder, Robert A.			Vaccine Adjuvants: Putting Innate Immunity to Work	IMMUNITY			English	Review							PATTERN-RECOGNITION RECEPTORS; DENDRITIC CELL ACTIVATION; MONOPHOSPHORYL-LIPID-A; SINGLE-STRANDED RNA; HEPATITIS-B-VACCINE; TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNITY; IMMUNOSTIMULATORY DNA; NALP3 INFLAMMASOME; ANTIBODY-RESPONSES	Adjuvants enhance immunity to vaccines and experimental antigens by a variety of mechanisms In the past decade, many receptors and signaling pathways in the innate immune system have been defined and these innate responses strongly influence the adaptive immune response The focus of this review is to delineate the innate mechanisms by which adjuvants mediate their effects We highlight how adjuvants can be used to influence the magnitude and alter the quality of the adaptive response in order to provide maximum protection against specific pathogens Despite the impressive success of currently approved adjuvants for generating immunity to viral and bacterial infections, there remains a need for improved adjuvants that enhance protective antibody responses, especially in populations that respond poorly to current vaccines However, the larger challenge is to develop vaccines that generate strong T cell immunity with purified or recombinant vaccine antigens	[Coffman, Robert L.] Dynavax Technol Corp, Berkeley, CA 94710 USA; [Sher, Alan] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; [Seder, Robert A.] NIAID, Cellular Immunol Sect, Vaccine Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Coffman, RL (corresponding author), Dynavax Technol Corp, Berkeley, CA 94710 USA.				Intramural NIH HHS [ZIA AI001044-04] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001044, ZIAAI005016] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Beran J, 2008, EXPERT OPIN BIOL TH, V8, P235, DOI 10.1517/14712598.8.2.235 ; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boyle J, 2007, VACCINE, V25, P2541, DOI 10.1016/j.vaccine.2006.12.018; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dupuis M, 1998, CELL IMMUNOL, V186, P18, DOI 10.1006/cimm.1998.1283; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gowen BB, 2007, J IMMUNOL, V178, P5200, DOI 10.4049/jimmunol.178.8.5200; Gram GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006950; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Halperin SA, 2006, VACCINE, V24, P20, DOI 10.1016/j.vaccine.2005.08.095; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenney R., 2010, NEW GENERATION VACCI, V4th ed., P250; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kobayashi H, 1999, CELL IMMUNOL, V198, P69, DOI 10.1006/cimm.1999.1572; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; LEVY HB, 1975, J INFECT DIS, V132, P434, DOI 10.1093/infdis/132.4.434; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; Maraskovsky E, 2009, IMMUNOL CELL BIOL, V87, P371, DOI 10.1038/icb.2009.21; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Mckee AS, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-37; Miao EA, 2010, J CLIN IMMUNOL, V30, P502, DOI 10.1007/s10875-010-9386-5; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Moreira LO, 2008, VACCINE, V26, P5808, DOI 10.1016/j.vaccine.2008.08.038; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Ott G, 1995, Pharm Biotechnol, V6, P277; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0; Pulendran B, 2010, NEW GENERATION VACCI, P183; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sanders CJ, 2008, J IMMUNOL, V180, P7184, DOI 10.4049/jimmunol.180.11.7184; Schnurr M, 2009, J IMMUNOL, V182, P1253, DOI 10.4049/jimmunol.182.3.1253; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Serre K, 2008, MOL IMMUNOL, V45, P3558, DOI 10.1016/j.molimm.2008.05.010; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Shenderov K, 2010, J IMMUNOL, V184; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; STAHL HC, 2009, PLOS PATHOG, V5; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Verstraeten T, 2008, VACCINE, V26, P6630, DOI 10.1016/j.vaccine.2008.09.049; Wang YM, 2010, J IMMUNOL, V184, P2751, DOI 10.4049/jimmunol.0903201; WILLE RU, 2005, P NATL ACAD SCI USA, V102, P15190; WILLE RU, 2006, J EXP MED, V203, P1249; Wu CCN, 2007, P NATL ACAD SCI USA, V104, P3990, DOI 10.1073/pnas.0611624104; Zandman-Goddard G, 2005, AUTOIMMUNITY, V38, P473, DOI 10.1080/08916930500285352	111	1170	1233	9	352	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					492	503		10.1016/j.immuni.2010.10.002	http://dx.doi.org/10.1016/j.immuni.2010.10.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029960	Green Accepted, Bronze			2022-12-18	WOS:000284300200006
J	Singh, N; Gurav, A; Sivaprakasam, S; Brady, E; Padia, R; Shi, HD; Thangaraju, M; Prasad, PD; Manicassamy, S; Munn, DH; Lee, JR; Offermanns, S; Ganapathy, V				Singh, Nagendra; Gurav, Ashish; Sivaprakasam, Sathish; Brady, Evan; Padia, Ravi; Shi, Huidong; Thangaraju, Muthusamy; Prasad, Puttur D.; Manicassamy, Santhakumar; Munn, David H.; Lee, Jeffrey R.; Offermanns, Stefan; Ganapathy, Vadivel			Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis	IMMUNITY			English	Article							REGULATORY T-CELLS; CHAIN FATTY-ACIDS; DENDRITIC CELLS; APC(MIN/+) MICE; INTERLEUKIN-10 RECEPTOR; INTESTINAL INFLAMMATION; GUT MICROBIOTA; NICOTINIC-ACID; RETINOIC-ACID; BOWEL-DISEASE	Commensal gut microflora and dietary fiber protect against colonic inflammation and colon cancer through unknown targets. Butyrate, a bacterial product from fermentation of dietary fiber in the colon, has been implicated in this process. GPR109A (encoded by Niacr1) is a receptor for butyrate in the colon. GPR109A is also a receptor for niacin, which is also produced by gut microbiota and suppresses intestinal inflammation. Here we showed that Gpr109a signaling promoted anti-inflammatory properties in colonic macrophages and dendritic cells and enabled them to induce differentiation of Treg cells and IL-10-producing T cells. Moreover, Gpr109a was essential for butyrate-mediated induction of IL-18 in colonic epithelium. Consequently, Niacr1(-/-) mice were susceptible to development of colonic inflammation and colon cancer. Niacin, a pharmacological Gpr109a agonist, suppressed colitis and colon cancer in a Gpr109a-dependent manner. Thus, Gpr10a has an essential role in mediating the beneficial effects of gut microbiota and dietary fiber in colon.	[Singh, Nagendra; Gurav, Ashish; Sivaprakasam, Sathish; Brady, Evan; Padia, Ravi; Shi, Huidong; Thangaraju, Muthusamy; Prasad, Puttur D.; Ganapathy, Vadivel] Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Singh, Nagendra; Shi, Huidong; Thangaraju, Muthusamy; Prasad, Puttur D.; Manicassamy, Santhakumar; Munn, David H.; Ganapathy, Vadivel] Georgia Regents Univ, Canc Res Ctr, Augusta, GA 30912 USA; [Munn, David H.] Georgia Regents Univ, Dept Pediat, Med Coll Georgia, Augusta, GA 30912 USA; [Lee, Jeffrey R.] Charlie Norwood Vet Adm Med Ctr, Dept Pathol, Augusta, GA 30904 USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Max Planck Society	Singh, N (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	nasingh@gru.edu; vganapat@gru.edu	Sivaprakasam, Sathish/E-9367-2018; Offermanns, Stefan/L-3313-2017	Sivaprakasam, Sathish/0000-0002-9230-0144; Offermanns, Stefan/0000-0001-8676-6805; Shi, Huidong/0000-0003-1137-3390; Munn, David/0000-0002-7711-2858	National Institutes of Health [AI085440, CA152396]; NATIONAL CANCER INSTITUTE [R01CA096651, R21CA152396, R01CA103320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097271, R01DK103576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants AI085440 (N.S.) and CA152396 (V.G.). We thank L. Ignatowicz for helpful discussions.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Ganapathy V, 2013, CURR OPIN PHARMACOL, V13, P869, DOI 10.1016/j.coph.2013.08.006; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jeon SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002714; Kalina U, 2002, EUR J IMMUNOL, V32, P2635, DOI 10.1002/1521-4141(200209)32:9<2635::AID-IMMU2635>3.0.CO;2-N; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Millard AL, 2002, CLIN EXP IMMUNOL, V130, P245; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Takagawa T, 2005, INFLAMM BOWEL DIS, V11, P1038, DOI 10.1097/01.MIB.0000182868.67025.b9; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; Urbanska AM, 2009, DIGEST DIS SCI, V54, P264, DOI 10.1007/s10620-008-0363-2; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Wang B, 2008, CELL IMMUNOL, V253, P54, DOI 10.1016/j.cellimm.2008.04.016; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046	48	1167	1246	16	211	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					128	139		10.1016/j.immuni.2013.12.007	http://dx.doi.org/10.1016/j.immuni.2013.12.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412617	Green Accepted, Bronze			2022-12-18	WOS:000331476900015
J	Iwata, M; Hirakiyama, A; Eshima, Y; Kagechika, H; Kato, C; Song, SY				Iwata, M; Hirakiyama, A; Eshima, Y; Kagechika, H; Kato, C; Song, SY			Retinoic acid imprints gut-homing specificity on T cells	IMMUNITY			English	Article							VITAMIN-A STATUS; RETINOBENZOIC ACIDS; INDUCED APOPTOSIS; DENDRITIC CELLS; CHEMOKINE TECK; EXPRESSION; LYMPHOCYTE; LOCALIZATION; ACTIVATION; EFFECTOR	For a preferential homing of T cells to the gut, expression of the integrin alpha4beta7 and the chemokine receptor CCR9 is essential and is induced by antigenic stimulation with dendritic cells from the gut-associated lymphoid organs. Here, we show that the vitamin A (retinol) metabolite, retinoic acid, enhances the expression of alpha4beta7 and CCR9 on T cells upon activation and imprints them with the gut tropism. Dendritic cells from the gut-associated lymphoid organs produced retinoic acid from retinol. The enhanced alpha4beta7 expression on T cells by antigenic stimulation with these dendritic cells was suppressed by the retinal dehydrogenase inhibitor citral and the retinoic acid receptor antagonist LE135. Accordingly, vitamin A deficiency caused a reduction in alpha4beta7(+) memory/activated T cells in lymphoid organs and a depletion of T cells from the intestinal lamina propria. These findings revealed a novel role for retinoic acid in the imprinting of gut-homing specificity on T cells.	Mitsubishi Kasei Inst Life Sci, Machida, Tokyo 1948511, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Iwata, M (corresponding author), Mitsubishi Kasei Inst Life Sci, 11 Minamiooya, Machida, Tokyo 1948511, Japan.	iwata@libra.ls.m-kagaku.co.jp	Eckhardt, Erik/G-1567-2010	Kagechika, Hiroyuki/0000-0002-6747-1013; Iwata, Makoto/0000-0001-9218-2662				Adachi S, 2000, J BIOL CHEM, V275, P14708, DOI 10.1074/jbc.275.19.14708; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; CARMAN JA, 1989, J IMMUNOL, V142, P388; Castellaneta A, 2004, HUM IMMUNOL, V65, P104, DOI 10.1016/j.humimm.2003.10.006; Chatellard-Gruaz D, 1998, J LIPID RES, V39, P1421; CONNOR MJ, 1987, BIOCHEM J, V244, P489, DOI 10.1042/bj2440489; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Driscoll HK, 1996, METABOLISM, V45, P248, DOI 10.1016/S0026-0495(96)90062-1; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Faveeuw C, 1995, INT IMMUNOL, V7, P1905, DOI 10.1093/intimm/7.12.1905; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hoag KA, 2002, J NUTR, V132, P3736, DOI 10.1093/jn/132.12.3736; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; IWATA M, 1992, J IMMUNOL, V149, P3302; Jaakkola I, 2003, EUR J IMMUNOL, V33, P3255, DOI 10.1002/eji.200324405; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Kantele A, 1999, J IMMUNOL, V162, P5173; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; LEFRANCOIS L, 1999, CURRENT PROTOCOLS IM; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Lim SP, 1998, IMMUNOGENETICS, V48, P184, DOI 10.1007/s002510050422; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MOLRINE DC, 1995, INFECT IMMUN, V63, P2867, DOI 10.1128/IAI.63.8.2867-2872.1995; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; RACKE MK, 1995, J IMMUNOL, V154, P450; Ross AC, 2003, J NUTR, V133, p291S; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SOMMER A, 1986, LANCET, V1, P1169; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; URBACH J, 1994, BIOCHEM J, V299, P459, DOI 10.1042/bj2990459; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; WANG XD, 1992, ARCH BIOCHEM BIOPHYS, V293, P298, DOI 10.1016/0003-9861(92)90399-H; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yang XD, 1997, DIABETES, V46, P1542, DOI 10.2337/diabetes.46.10.1542; YANG YL, 1993, P NATL ACAD SCI USA, V90, P6170, DOI 10.1073/pnas.90.13.6170; Zhai Y, 2001, J CELL PHYSIOL, V186, P220, DOI 10.1002/1097-4652(200102)186:2&lt;220::AID-JCP1018&gt;3.0.CO;2-N	52	1139	1189	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					527	538		10.1016/j.immuni.2004.08.011	http://dx.doi.org/10.1016/j.immuni.2004.08.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485630	Bronze			2022-12-18	WOS:000224744400009
J	McHugh, RS; Whitters, MJ; Piccirillo, CA; Young, DA; Shevach, EM; Collins, M; Byrne, MC				McHugh, RS; Whitters, MJ; Piccirillo, CA; Young, DA; Shevach, EM; Collins, M; Byrne, MC			CD4(+)CD25(+) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor	IMMUNITY			English	Article							LYMPHOCYTE-ASSOCIATED ANTIGEN-4; INTESTINAL INFLAMMATION; EFFECTOR FUNCTION; IDENTIFICATION; INDUCTION; INHIBIT; FAMILY; DIFFERENTIATION; COSTIMULATION; RESPONSES	CD4(+)CD25(+) immunoregulatory T cells represent a unique lineage of thymic-derived cells that potently suppress both in vitro and in vivo effector T cell function. We analyzed CD4(+)CD25(+) and CD4(+)CD25(-) T cells by DNA microarray, identifying 29 genes differentially expressed in the resting subpopulations, and 77 that were differentially expressed following activation. Most of these genes were elevated in the CD4(+)CD25(+) population, suggesting a previously activated phenotype. Among these were a number of genes that antagonize signaling, including members of the SOCS family, which may contribute to their anergic phenotype. Multiple cell surface receptors also had increased expression in CD4(+)CD25(+) cells, including GITR, a member of the TNF receptor superfamily. Importantly, antibodies to GITR abrogated suppression, demonstrating a functional role for this receptor in regulating the CD4(+)CD25(+) T cell subset.	NIAID, Cellular Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Wyeth Ayerst Res, Genet Inst, Cambridge, MA 02140 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pfizer	Shevach, EM (corresponding author), NIAID, Cellular Immunol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000224, ZIAAI000224] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Alizadeh AA, 2000, CURR OPIN IMMUNOL, V12, P219, DOI 10.1016/S0952-7915(99)00078-3; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; BYRNE MC, 2000, CURRENT PROTOCOLS MO; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; DeBenedette MA, 1997, J IMMUNOL, V158, P551; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; HARRIGAN MT, 1991, MOL ENDOCRINOL, V5, P1331, DOI 10.1210/mend-5-9-1331; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Jordan MS, 2000, EUR J IMMUNOL, V30, P136, DOI 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.3.CO;2-S; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KOBATA T, 1994, J IMMUNOL, V153, P5422; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; Lerner CG, 2000, J IMMUNOL, V164, P3996, DOI 10.4049/jimmunol.164.8.3996; Losman JA, 1999, J IMMUNOL, V162, P3770; Marrack P, 2000, CURR OPIN IMMUNOL, V12, P206, DOI 10.1016/S0952-7915(99)00075-8; MCHUGH R, 2001, IN PRESS MICROBES IN, V3; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2000, CELL DEATH DIFFER, V7, P408, DOI 10.1038/sj.cdd.4400670; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schon MP, 1999, J IMMUNOL, V162, P6641; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suri-Payer E, 1999, EUR J IMMUNOL, V29, P669, DOI 10.1002/(SICI)1521-4141(199902)29:02<669::AID-IMMU669>3.0.CO;2-J; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Wilson SB, 2000, P NATL ACAD SCI USA, V97, P7411, DOI 10.1073/pnas.120161297; Yahata T, 2000, J NEUROIMMUNOL, V105, P103, DOI 10.1016/S0165-5728(00)00188-0; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	52	1129	1229	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					311	323		10.1016/S1074-7613(02)00280-7	http://dx.doi.org/10.1016/S1074-7613(02)00280-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869690	Bronze			2022-12-18	WOS:000174039600013
J	Laurence, A; Tato, CM; Davidson, TS; Kanno, Y; Chen, Z; Yao, Z; Blank, RB; Meylan, F; Siegel, R; Hennighausen, L; Shevach, EM; O'Shea, JJ				Laurence, Arian; Tato, Cristina M.; Davidson, Todd S.; Kanno, Yuka; Chen, Zhi; Yao, Zhengju; Blank, Rebecca B.; Meylan, Francoise; Siegel, Richard; Hennighausen, Lothar; Shevach, Ethan M.; O'Shea, John J.			Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation	IMMUNITY			English	Article							REGULATORY T-CELLS; AUTOIMMUNE INFLAMMATION; ANTIGEN RECEPTOR; HELPER-CELLS; JAK KINASES; BETA; DIFFERENTIATION; ACTIVATION; TOLERANCE; LYMPHOCYTES	Recent work has identified a new subset of effector T cells that produces interleukin (IL)-17 known as T helper 17 (Th17) cells, which is involved in the pathophysiology of inflammatory diseases and is thought to be developmentally related to regulatory T (Treg) cells. Because of its importance for Treg cells, we examined the role of IL-2 in Th17 generation and demonstrate that a previously unrecognized aspect of IL-2 function is to constrain IL-17 production. Genetic deletion or antibody blockade of IL-2 promoted differentiation of the Th17 cell subset. Whereas STAT3 appeared to be a key positive regulator of ROR gamma t and IL-17 expression, absence of IL-2 or disruption of its signaling by deletion of the transcription factor STAT5 resulted in enhanced Th17 cell development. We conclude that in addition to the promotion of activation-induced cell death of lymphocytes and the generation of Treg cells, inhibition of Th17 polarization appears to be an important function of IL-2.	NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, Bethesda, MD 20892 USA; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Tato, CM (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	tatoc@mail.nih.gov	Kanno, Yuka/B-5802-2013; Siegel, Richard/C-7592-2009; Laurence, Arian/A-8770-2009	Kanno, Yuka/0000-0001-5668-9319; Siegel, Richard/0000-0001-5953-9893; Laurence, Arian/0000-0003-0942-8292; Tato, Cristina M./0000-0002-0614-756X; Hennighausen, Lothar/0000-0001-8319-9841	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041159, Z01AR041133, Z01AR041106, Z01AR041174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK061000, Z01DK061002] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AR999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abbas AK, 2003, AUTOIMMUN REV, V2, P115, DOI 10.1016/S1568-9972(03)00028-4; Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Astoul E, 2003, J BIOL CHEM, V278, P9267, DOI 10.1074/jbc.M211252200; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Flavell RA, 1999, IMMUNOL RES, V19, P159, DOI 10.1007/BF02786484; Glimcher LH, 2001, J CLIN INVEST, V108, ps25; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lee JY, 2005, BIOCHEM BIOPH RES CO, V334, P764, DOI 10.1016/j.bbrc.2005.06.162; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Refaeli Y, 1999, IMMUNOL REV, V169, P273, DOI 10.1111/j.1600-065X.1999.tb01322.x; Refaeli Y, 1998, EUR CYTOKINE NETW, V9, P81; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; Strober W, 1998, ANN INTERN MED, V128, P848, DOI 10.7326/0003-4819-128-10-199805150-00009; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; YAO Z, 2007, BLOOD PRESS; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	42	1127	1214	3	64	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2007	26	3					371	381		10.1016/j.immuni.2007.02.009	http://dx.doi.org/10.1016/j.immuni.2007.02.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17363300	Bronze			2022-12-18	WOS:000245228100013
J	Sutton, CE; Lalor, SJ; Sweeney, CM; Brereton, CF; Lavelle, EC; Mills, KHG				Sutton, Caroline E.; Lalor, Stephen J.; Sweeney, Cheryl M.; Brereton, Corinna F.; Lavelle, Ed C.; Mills, Kingston H. G.			Interleukin-1 and IL-23 Induce Innate IL-17 Production from gamma delta T Cells, Amplifying Th17 Responses and Autoimmunity	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; PROINFLAMMATORY IL-17(+); MULTIPLE-SCLEROSIS; CUTTING EDGE; T(H)17 CELLS; TGF-BETA; RECEPTOR; DIFFERENTIATION; INFLAMMATION; CYTOKINE	Th17 cells, CD4(+) T cells that secrete interleukin-17 (IL-17), are pathogenic in autoimmune diseases and their development and expansion is driven by the cytokines IL-6, TGF-beta, IL-21, IL-1, and IL-23. However, there are also innate sources of IL-17. Here, we show that gamma delta T cells express IL-23R and the transcription factor ROR gamma t and produce IL-17, IL-21, and IL-22 in response to IL-1 beta and IL-23, without T cell receptor engagement. IL-17-producing gamma delta T cells were found at high frequency in the brain of mice with experimental autoimmune encephalomyelitis (EAE). gamma delta T cells activated by IL-1 beta and IL-23 promoted IL-17 production by CD4(+) T cells and increased susceptibility to EAE, suggesting that gamma delta T cells act in an amplification loop for IL-1 7 production by Th17 cells. Our findings demonstrate that gamma delta T cells activated by IL-1 beta and IL-23 are an important source of innate IL-17 and IL-21 and provide an alternative mechanism whereby IL-1 and IL-23 may mediate autoimmune inflammation.	[Sutton, Caroline E.; Lalor, Stephen J.; Sweeney, Cheryl M.; Brereton, Corinna F.; Mills, Kingston H. G.] Trinity Coll Dublin, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin 2, Ireland; [Lavelle, Ed C.] Trinity Coll Dublin, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Mills, KHG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin 2, Ireland.	kingston.mills@tcd.ie	Mills, Kingston H/F-5684-2013; Lavelle, Ed/A-1716-2008	Mills, Kingston H/0000-0003-3646-8222; Lavelle, Ed/0000-0002-3167-1080; Lalor, Stephen/0000-0003-0882-7152	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank J. Fletcher for discussions and B. Moran for technical help with FACS. This work was supported by a Science Foundation Ireland PI Award to K.M. K.M. is cofounder and shareholder of Opsona Therapeutics Ltd, a university start-up company involved in the development of anti-inflammatory therapeutics.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P975, DOI 10.1002/art.20885; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; Nanno M, 2008, GASTROENTEROLOGY, V134, P481, DOI 10.1053/j.gastro.2007.11.056; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; SHIMONKEVITZ R, 1993, P NATL ACAD SCI USA, V90, P923, DOI 10.1073/pnas.90.3.923; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	41	1122	1176	1	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					331	341		10.1016/j.immuni.2009.08.001	http://dx.doi.org/10.1016/j.immuni.2009.08.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19682929	Green Submitted, Bronze			2022-12-18	WOS:000269338600018
J	Blair, PA; Norena, LY; Flores-Borja, F; Rawlings, DJ; Isenberg, DA; Ehrenstein, MR; Mauri, C				Blair, Paul A.; Norena, Lina Yassin; Flores-Borja, Fabian; Rawlings, David J.; Isenberg, David A.; Ehrenstein, Michael R.; Mauri, Claudia			CD19(+)CD24(hi)CD38(hi) B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients	IMMUNITY			English	Article							T-CELL; SUPPRESSIVE FUNCTION; MICE; ACTIVATION; RESPONSES; DISEASE; CD40; INTERLEUKIN-10; AUTOIMMUNITY; EXPRESSION	The immunosuppressive function of regulatory B cells has been shown in several murine models of chronic inflammation, including collagen-induced arthritis, inflammatory bowel disease, and experimental autoimmune encephalomyelitis. Despite interest in these cells, their relevance to the maintenance of peripheral tolerance in humans remains elusive. Here, we demonstrate that human CD19(+) CD24(hi)CD38(hi) B cells possessed regulatory capacity. After CD40 stimulation, CD19(+)CD24(hi)CD38(hi) B cells suppressed the differentiation of T helper 1 cells, partially via the provision of interleukin-10 (IL-10), but not transforming growth factor-beta (TGF-beta), and their suppressive capacity was reversed by the addition of CD80 and CD86 mAbs. In addition, CD19(+)CD24(hi)CD38(hi) SLE B cells isolated from the peripheral blood of systemic lupus erythematosus (SLE) patients were refractory to further CD40 stimulation, produced less IL-10, and lacked the suppressive capacity of their healthy counterparts. Altered cellular function within this compartment may impact effector immune responses in SLE and other autoimmune disorders.	[Blair, Paul A.; Norena, Lina Yassin; Flores-Borja, Fabian; Isenberg, David A.; Ehrenstein, Michael R.; Mauri, Claudia] UCL, Ctr Rheumatol Res, Dept Med, London W1T4 JF, England; [Rawlings, David J.] Seattle Childrens Res Inst, Dept Pediat, Seattle, WA 98101 USA; [Rawlings, David J.] Seattle Childrens Res Inst, Dept Immunol, Seattle, WA 98101 USA; [Rawlings, David J.] Univ Washington, Seattle, WA 98101 USA	University of London; University College London; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Mauri, C (corresponding author), UCL, Ctr Rheumatol Res, Dept Med, 46 Cleveland St, London W1T4 JF, England.	c.mauri@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022; Rawlings, David/CAI-4751-2022; Flores-Borja, Fabian/P-2477-2019	Flores-Borja, Fabian/0000-0002-0881-8822; Isenberg, David/0000-0001-9514-2455; Mauri, Claudia/0000-0001-9761-2625; Ehrenstein, Michael/0000-0003-1673-743X	Arthritis Research Campaign (ARC) Programme [MP/17707]; Oliver Bird Rheumatism Programme; Lupus UK [P7575]; Versus Arthritis [17707, 19314] Funding Source: researchfish	Arthritis Research Campaign (ARC) Programme(Versus Arthritis); Oliver Bird Rheumatism Programme; Lupus UK; Versus Arthritis(Versus Arthritis)	We thank J. Evans for providing technical assistance with flow cytometry sorting and M. Maini for helpful discussions and for critically reviewing this manuscript. This project and F.F.B. are funded by the Arthritis Research Campaign (ARC) Programme grant MP/17707. P.A.B is funded by the Oliver Bird Rheumatism Programme and by a Lupus UK grant (P7575).	Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Gantner F, 2003, EUR J IMMUNOL, V33, P1576, DOI 10.1002/eji.200323444; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Hajoui O, 2004, J ALLERGY CLIN IMMUN, V114, P657, DOI 10.1016/j.jaci.2004.05.034; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; HAY EM, 1993, Q J MED, V86, P447; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lenert P, 2005, J CLIN IMMUNOL, V25, P29, DOI 10.1007/s10875-005-0355-6; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; MASOOD R, 1995, BLOOD, V85, P3423, DOI 10.1182/blood.V85.12.3423.bloodjournal85123423; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Miyashita T, 1997, J IMMUNOL, V158, P4620; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Plebani A, 2007, IMMUNOLOGY, V121, P183, DOI 10.1111/j.1365-2567.2006.02556.x; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Silverman GJ, 2008, CLIN EXP IMMUNOL, V153, P102, DOI 10.1111/j.1365-2249.2008.03680.x; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Suen JL, 2009, IMMUNOLOGY, V127, P196, DOI 10.1111/j.1365-2567.2008.02937.x; Sugimoto K, 2007, GASTROENTEROLOGY, V133, P124, DOI 10.1053/j.gastro.2007.03.112; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Van Parijs L, 1998, SCIENCE, V280, P243; Vargas-Rojas MI, 2008, LUPUS, V17, P289, DOI 10.1177/0961203307088307; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	53	1107	1197	2	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					129	140		10.1016/j.immuni.2009.11.009	http://dx.doi.org/10.1016/j.immuni.2009.11.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20079667	Bronze			2022-12-18	WOS:000274119900017
J	Radtke, F; Wilson, A; Stark, G; Bauer, M; van Meerwijk, J; MacDonald, HR; Aguet, M				Radtke, F; Wilson, A; Stark, G; Bauer, M; van Meerwijk, J; MacDonald, HR; Aguet, M			Deficient T cell fate specification in mice with an induced inactivation of Notch1	IMMUNITY			English	Article							DROSOPHILA NOTCH; MAMMALIAN NOTCH; BONE-MARROW; MOUSE NOTCH; THYMOCYTE DEVELOPMENT; ALPHA-BETA; GENE; EXPRESSION; HOMOLOG; DELTA	Notch proteins are cell surface receptors that mediate developmental cell specification events. To explore the function of murine Notch1, an essential portion of the gene was flanked with loxP sites and inactivation induced via interferon-regulated Cre recombinase. Mice with a neonatally induced loss of Notch1 function were transiently growth retarded and had a severe deficiency in thymocyte development. Competitive repopulation of lethally irradiated wild-type hosts with wild-type- and Notch-1-deficient bone marrow revealed a cell autonomous blockage in T cell development at an early stage, before expression of T cell lineage markers. Notch1-deficient bone marrow did, however, contribute normally to all other hematopoietic lineages. These findings suggest that Notch1 plays an obligatory and selective role in T cell lineage induction.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Genentech Inc, San Francisco, CA 94080 USA	Swiss Institute Experimental Cancer Research; Ludwig Institute for Cancer Research; University of Lausanne; Roche Holding; Genentech	Aguet, M (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	michel.aguet@isrec.unil.ch	Radtke, Freddy/Q-3198-2017; van Meerwijk, Joost P.M./K-1345-2014; Wilson, Anne/A-7131-2011	Radtke, Freddy/0000-0003-4315-4045; van Meerwijk, Joost P.M./0000-0001-8231-1897; 				Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; CEREDIG R, 1982, J IMMUNOL, V128, P614; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CIVAS A, 1991, NUCLEIC ACIDS RES, V19, P4497, DOI 10.1093/nar/19.16.4497; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Ferrero I, 1999, EUR J IMMUNOL, V29, P1598, DOI 10.1002/(SICI)1521-4141(199905)29:05<1598::AID-IMMU1598>3.3.CO;2-F; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; GRESSER I, 1981, AM J PATHOL, V102, P396; GRESSER I, 1975, NATURE, V258, P76, DOI 10.1038/258076a0; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; INABA K, 1990, International Reviews of Immunology, V6, P117, DOI 10.3109/08830189009056623; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; KADISH JL, 1975, J IMMUNOL, V114, P452; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; KOPAN R, 1994, DEVELOPMENT, V120, P2385; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; MIYAMAINABA M, 1988, J EXP MED, V168, P811, DOI 10.1084/jem.168.2.811; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976; NYE JS, 1995, CURR BIOL, V5, P966, DOI 10.1016/S0960-9822(95)00189-8; NYE JS, 1994, DEVELOPMENT, V120, P2421; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SIMPSON P, 1995, NATURE, V375, P736, DOI 10.1038/375736a0; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931	54	1106	1133	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1999	10	5					547	558		10.1016/S1074-7613(00)80054-0	http://dx.doi.org/10.1016/S1074-7613(00)80054-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367900	Bronze			2022-12-18	WOS:000080709400006
J	Pflanz, S; Timans, JC; Cheung, J; Rosales, R; Kanzler, H; Gilbert, J; Hibbert, L; Churakova, T; Travis, M; Vaisberg, E; Blumenschein, WM; Mattson, JD; Wagner, JL; To, W; Zurawski, S; McClanahan, TK; Gorman, DM; Bazan, JF; Malefyt, RD; Rennick, D; Kastelein, RA				Pflanz, S; Timans, JC; Cheung, J; Rosales, R; Kanzler, H; Gilbert, J; Hibbert, L; Churakova, T; Travis, M; Vaisberg, E; Blumenschein, WM; Mattson, JD; Wagner, JL; To, W; Zurawski, S; McClanahan, TK; Gorman, DM; Bazan, JF; Malefyt, RD; Rennick, D; Kastelein, RA			IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4(+) T cells	IMMUNITY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HELICAL CYTOKINES; IMMUNE-RESPONSES; DENDRITIC CELLS; INDUCED GENE-3; INTERLEUKIN-12; RECEPTOR; VIRUS; IL-12; TH1	An efficient Th1-driven adaptive immune response requires activation of the T cell receptor and secretion of the T cell stimulatory cytokine IL-12 by activated antigen-presenting cells. IL-12 triggers Th1 polarization of naive CD4(+) T cells and secretion of IFN-gamma. We describe a new heterodimeric cytokine termed IL-27 that consists of EBI3, an IL-12p40-related protein, and p28, a newly discovered IL-12p35-related polypeptide. IL-27 is an early product of activated antigen-presenting cells and drives rapid clonal expansion of naive but not memory CD4+ T cells. It also strongly synergizes with IL-12 to trigger IFN-gamma production of naive CD4(+) T cells. IL-27 mediates its biologic effects through the orphan cytokine receptor WSX-1/TCCR.	DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Kastelein, RA (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.		Bazan, J. Fernando/B-4562-2010	de Waal Malefyt, Rene/0000-0002-2663-383X				Anderson R, 1997, HUM GENE THER, V8, P1125, DOI 10.1089/hum.1997.8.9-1125; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Bolin LM, 1997, J NEUROSCI, V17, P5493; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; David ZV, 1998, E EUR POLIT SOC, V12, P1; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; FISCHER M, 1997, NAT BIOTECHNOL, V69, P139; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; LING P, 1995, J IMMUNOL, V154, P116; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; WOLF SF, 1991, J IMMUNOL, V146, P3074; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	31	1093	1205	1	47	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					779	790		10.1016/S1074-7613(02)00324-2	http://dx.doi.org/10.1016/S1074-7613(02)00324-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121660	Bronze			2022-12-18	WOS:000176534000004
J	Crotty, S				Crotty, Shane			T Follicular Helper Cell Differentiation, Function, and Roles in Disease	IMMUNITY			English	Review							GERMINAL CENTER FORMATION; TRANSCRIPTION FACTOR; B-CELLS; BCL6 EXPRESSION; NEGATIVE REGULATOR; MESSENGER-RNAS; CENTER LIGHT; TFH CELLS; C-MAF; CD4(+)	Follicular helper T (Tfh) cells are specialized providers of T cell help to B cells, and are essential for germinal center formation, affinity maturation, and the development of most high-affinity antibodies and memory B cells. Tfh cell differentiation is a multistage, multifactorial process involving B cell lymphoma 6 (Bcl6) and other transcription factors. This article reviews understanding of Tfh cell biology, including their differentiation, migration, transcriptional regulation, and B cell help functions. Tfh cells are critical components of many protective immune responses against pathogens. As such, there is strong interest in harnessing Tfh cells to improve vaccination strategies. Tfh cells also have roles in a range of other diseases, particularly autoimmune diseases. Overall, there have been dramatic advances in this young field, but there is much to be learned about Tfh cell biology in the interest of applying that knowledge to biomedical needs.	La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@lji.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	NIAID NIH HHS [R01 AI072543, U19 AI090970, UM1 AI100663, U19 AI109976, R01 AI063107] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109976, R01AI063107, R01AI072543, U19AI090970, UM1AI100663] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Ballesteros-Tato A, 2014, IMMUNOL CELL BIOL, V92, P22, DOI 10.1038/icb.2013.62; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Duan ZJ, 2014, VACCINE, V32, P5316, DOI 10.1016/j.vaccine.2014.07.064; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Holland S.M., 2006, PRIMARY IMMUNODEFICI, P450; Hu J, 2013, CURR OPIN VIROL, V3, P363, DOI 10.1016/j.coviro.2013.05.015; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Ploquin MJY, 2011, J IMMUNOL, V187, P3321, DOI 10.4049/jimmunol.1101006; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2013, IMMUNITY, V39, P629, DOI 10.1016/j.immuni.2013.09.011; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stone E.L., 2013, J IMMUNOL, V190, P508; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Szabo K, 2013, CLIN IMMUNOL, V147, P95, DOI 10.1016/j.clim.2013.02.024; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weinstein JS, 2014, J IMMUNOL, V192, P3166, DOI 10.4049/jimmunol.1302617; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yarke CA, 2008, J IMMUNOL, V180, P156, DOI 10.4049/jimmunol.180.1.156; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	122	1083	1139	9	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					529	542		10.1016/j.immuni.2014.10.004	http://dx.doi.org/10.1016/j.immuni.2014.10.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367570	Green Accepted, Bronze			2022-12-18	WOS:000345504300008
J	Zhou, L; Chong, MMW; Littman, DR				Zhou, Liang; Chong, Mark M. W.; Littman, Dan R.			Plasticity of CD4(+) T Cell Lineage Differentiation	IMMUNITY			English	Review							TRANSCRIPTION FACTOR FOXP3; ROR-GAMMA-T; FOLLICULAR-HELPER-CELLS; TGF-BETA; RETINOIC-ACID; CUTTING EDGE; DNA METHYLATION; GENE-EXPRESSION; TH17 CELLS; AUTOIMMUNE ENCEPHALOMYELITIS	The differentiation of naive CD4(+) T cells into lineages with distinct effector functions has been considered to be an irreversible event. T helper type 1 (Th1) cells stably express IFN-gamma, whereas Th2 cells express IL-4. The discovery and investigation of two other CD4(+) T cell subsets, induced regulatory T (iTreg) cells and Th17 cells, has led to a rethinking of the notion that helper T cell subsets represent irreversibly differentiated endpoints. Accumulating evidence suggests that CD4(+) T cells, particularly iTreg and Th17 cells, are more plastic than previously appreciated. It appears that expression of Foxp3 by iTreg cells or IL-17 by Th17 cells may not be stable and that there is a great degree of flexibility in their differentiation options. Here, we will discuss recent findings that demonstrate the plasticity of CD4(+) T cell differentiation and the biological implications of this flexibility.	[Zhou, Liang; Chong, Mark M. W.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Zhou, Liang; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Chong, Mark/H-6684-2016	Chong, Mark/0000-0002-3701-7397	Howard Hughes Medical Institute; Sandler Program for Asthma Research; National Multiple Sclerosis Society; Irvington Institute; Cancer Research Institute Fellowship; Helen and Martin Kimmel Center for Stem Cell Biology Award	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Program for Asthma Research; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Irvington Institute; Cancer Research Institute Fellowship; Helen and Martin Kimmel Center for Stem Cell Biology Award	Work in the laboratory was supported by grants from the Howard Hughes Medical Institute, the Sandler Program for Asthma Research, and the National Multiple Sclerosis Society. L.Z. was supported by a Fellowship from the Irvington Institute and M.M.W.C. was supported sequentially by a Cancer Research Institute Fellowship and a Helen and Martin Kimmel Center for Stem Cell Biology Award.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boyton RJ, 2002, TRENDS IMMUNOL, V23, P526, DOI 10.1016/S1471-4906(02)02319-0; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Croxford AL, 2009, J IMMUNOL, V182, P1237, DOI 10.4049/jimmunol.182.3.1237; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; DuPont HL, 2008, CURR OPIN INFECT DIS, V21, P500, DOI 10.1097/QCO.0b013e32830f9397; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Krawczyk CM, 2007, J IMMUNOL, V178, P4080, DOI 10.4049/jimmunol.178.7.4080; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Merkenschlager M, 2008, CURR OPIN IMMUNOL, V20, P131, DOI 10.1016/j.coi.2008.03.013; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rowel E, 2008, CURR OPIN IMMUNOL, V20, P272, DOI 10.1016/j.coi.2008.03.012; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	100	1083	1131	2	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					646	655		10.1016/j.immuni.2009.05.001	http://dx.doi.org/10.1016/j.immuni.2009.05.001			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464987	Bronze			2022-12-18	WOS:000266356900005
J	Wolk, K; Kunz, S; Witte, E; Friedrich, M; Asadullah, K; Sabat, R				Wolk, K; Kunz, S; Witte, E; Friedrich, M; Asadullah, K; Sabat, R			IL-22 increases the innate immunity of tissues	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; II CYTOKINE RECEPTOR; INDUCIBLE FACTOR; ANTIMICROBIAL PEPTIDES; ATOPIC-DERMATITIS; BETA-DEFENSINS; IL-TIF; IL-10; CELLS; INTERLEUKIN-1	Interleukin 22 (IL-22) is mainly produced by activated Th1 cells. The data presented here indicate that neither resting nor activated immune cells express IL-22 receptor, and IL-22 did not have any effects on these cells in vitro and in vivo. In contrast, cells of the skin and the digestive and respiratory systems represent putative targets of this cytokine. The expression of IL-22 receptor in keratinocytes was upregulated by Interferon-gamma. In these cells, IL-22 activated STAT3 and directly and transcriptionally increased the expression of beta-Defensin 2 and beta-Defensin 3. High levels of IL-22 were associated with strongly upregulated beta-Defensin expression in skin from patients with T cell-mediated dermatoses. Taken together, IL-22 does not serve the communication between immune cells but is a T cell mediator that directly promotes the innate, nonspecific immunity of tissues.	Schering AG, Corp Res Business Area Dermatol, D-13342 Berlin, Germany; Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol Dermatol M, D-10117 Berlin, Germany; Univ Hosp Charite, Dept Dermatol Venerol & Allergol, D-10117 Berlin, Germany; Univ Hosp Charite, Inst Med Immunol, D-10117 Berlin, Germany	Schering AG; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sabat, R (corresponding author), Schering AG, Corp Res Business Area Dermatol, D-13342 Berlin, Germany.	robert.sabat@charite.de	Asadullah, Khusru/AAG-9810-2021; Wolk, Kerstin/O-1205-2013	Wolk, Kerstin/0000-0002-7689-4130				Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Gruenberg BH, 2001, GENES IMMUN, V2, P329, DOI 10.1038/sj.gene.6363786; HAMMERBERG C, 1992, J CLIN INVEST, V90, P571, DOI 10.1172/JCI115896; Jia HP, 2001, GENE, V263, P211; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; LARSEN CG, 1989, IMMUNOLOGY, V68, P31; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Niyonsaba F, 2001, EUR J IMMUNOL, V31, P1066, DOI 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2003, J BIOL CHEM, V278, P18030, DOI 10.1074/jbc.M207714200; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	33	1083	1161	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					241	254		10.1016/j.immuni.2004.07.007	http://dx.doi.org/10.1016/j.immuni.2004.07.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308104	Bronze			2022-12-18	WOS:000223441900012
J	Wu, HJ; Ivanov, II; Darce, J; Hattori, K; Shima, T; Umesaki, Y; Littman, DR; Benoist, C; Mathis, D				Wu, Hsin-Jung; Ivanov, Ivaylo I.; Darce, Jaime; Hattori, Kimie; Shima, Tatsuichiro; Umesaki, Yoshinori; Littman, Dan R.; Benoist, Christophe; Mathis, Diane			Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells	IMMUNITY			English	Article							TH17 CELLS; INTESTINAL BACTERIA; DENDRITIC CELLS; LAMINA PROPRIA; DISEASE; MICE; RECOGNITION; MICROBIOTA; INDUCTION; FLORA	Commensal microbes can have a substantial impact on autoimmune disorders, but the underlying molecular and cellular mechanisms remain largely unexplored. We report that autoimmune arthritis was strongly attenuated in the K/BxN mouse model under germ-free (GF) conditions, accompanied by reductions in serum autoantibody titers, splenic autoantibody-secreting cells, germinal centers, and the splenic T helper 17 (Th17) cell population. Neutralization of interleukin-17 prevented arthritis development in specific-pathogen-free K/BxN mice resulting from a direct effect of this cytokine on B cells to inhibit germinal center formation. The systemic deficiencies of the GF animals reflected a loss of Th17 cells from the small intestinal lamina propria. Introduction of a single gut-residing species, segmented filamentous bacteria, into GF animals reinstated the lamina propria Th17 cell compartment and production of autoantibodies, and arthritis rapidly ensued. Thus, a single commensal microbe, via its ability to promote a specific Th cell subset, can drive an autoimmune disease.	[Wu, Hsin-Jung; Darce, Jaime; Hattori, Kimie; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wu, Hsin-Jung; Darce, Jaime; Hattori, Kimie; Benoist, Christophe; Mathis, Diane] Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; [Ivanov, Ivaylo I.; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Shima, Tatsuichiro; Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Benoist, Christophe; Mathis, Diane] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; New York University; Howard Hughes Medical Institute; New York University; Yakult Honsha Company, Limited; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu			NIH [P01 AI065858, RC1AI 087266]; Joslin's NIDDK; National Research Service Award (DFCI/NCI) [T32 CA007386]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI087266, P01AI065858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK085329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin's NIDDK; National Research Service Award (DFCI/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Tocker (Amgen Inc, Seattle, WA) for providing IL-17R<SUP>-/-</SUP> mice; A. Ortiz-Lopez for RT-PCR primers and assistance with the mouse colonies; M. Kriegel for assistance with part of the SFB quantitative PCR analysis; K. Leatherbee for microarrays; J. Lavecchio and G. Buruzula for flow cytometry; and C. Laplace for assistance with figure preparation. This work was supported by grants from the NIH to D.M. and C.B. (P01 AI065858) and to D.R.L. (RC1AI 087266) and by Joslin's NIDDK-funded DERC cores. J.D. was funded by National Research Service Award (DFCI/NCI: T32 CA007386) and I.I.I. by a Pathway to Independence Award from the NIH (1K99DK085329-01).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; BJORK J, 1994, SCAND J IMMUNOL, V40, P648, DOI 10.1111/j.1365-3083.1994.tb03518.x; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DeVoss JJ, 2008, J IMMUNOL, V181, P4072, DOI 10.4049/jimmunol.181.6.4072; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Edwards CJ, 2008, J RHEUMATOL, V35, P1477; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GARLAND CD, 1982, MICROB ECOL, V8, P181, DOI 10.1007/BF02010451; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; KLAASEN HLBM, 1992, FEMS MICROBIOL LETT, V88, P165, DOI 10.1016/0378-1097(92)90801-T; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Stone M, 2003, J RHEUMATOL, V30, P2112; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Talham GL, 1999, INFECT IMMUN, V67, P1992; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vassallo MF, 2008, NESTLE NUTR WORKS SE, V61, P211, DOI 10.1159/0000113496; Voedisch S, 2009, INFECT IMMUN, V77, P3170, DOI 10.1128/IAI.00272-09; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wu HJ, 2007, J EXP MED, V204, P1911, DOI 10.1084/jem.20070285; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	59	1080	1140	3	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					815	827		10.1016/j.immuni.2010.06.001	http://dx.doi.org/10.1016/j.immuni.2010.06.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620945	Green Accepted, Bronze			2022-12-18	WOS:000279365800012
J	Morita, R; Schmitt, N; Bentebibel, SE; Ranganathan, R; Bourdery, L; Zurawski, G; Foucat, E; Dullaers, M; Oh, S; Sabzghabaei, N; Lavecchio, EM; Punaro, M; Pascual, V; Banchereau, J; Ueno, H				Morita, Rimpei; Schmitt, Nathalie; Bentebibel, Salah-Eddine; Ranganathan, Rajaram; Bourdery, Laure; Zurawski, Gerard; Foucat, Emile; Dullaers, Melissa; Oh, SangKon; Sabzghabaei, Natalie; Lavecchio, Elizabeth M.; Punaro, Marilynn; Pascual, Virginia; Banchereau, Jacques; Ueno, Hideki			Human Blood CXCR5(+)CD4(+) T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHEMOKINE RECEPTOR EXPRESSION; HELPER MEMORY CELLS; HUMAN TH17 CELLS; B-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; CUTTING EDGE; IL-21; RESPONSES	Although a fraction of human blood memory CD4(+) T cells expresses chemokine (C-X-C motif) receptor 5 (CXCR5), their relationship to T follicular helper (Tfh) cells is not well established. Here we show that human blood CXCR5(+)CD4(+) T cells share functional properties with Tfh cells and appear to represent their circulating memory compartment. Blood CXCR5(+)CD4(+) T cells comprised three subsets: T helper 1 (Th1), Th2, and Th17 cells. Th2 and Th17 cells within CXCR5(+), but not within CXCR5(-), compartment efficiently induced naive B cells to produce immunoglobulins via interleukin-21 (IL-21). In contrast, Th1 cells from both CXCR5(+) and CXCR5(-) compartments lacked the capacity to help B cells. Patients with juvenile dermatomyositis, a systemic autoimmune disease, displayed a profound skewing of blood CXCR5(+) Th cell subsets toward Th2 and Th17 cells. Importantly, the skewing of subsets correlated with disease activity and frequency of blood plasmablasts. Collectively, our study suggests that an altered balance of Tfh cell subsets contributes to human autoimmunity.	[Morita, Rimpei; Schmitt, Nathalie; Bentebibel, Salah-Eddine; Ranganathan, Rajaram; Bourdery, Laure; Zurawski, Gerard; Foucat, Emile; Dullaers, Melissa; Oh, SangKon; Sabzghabaei, Natalie; Lavecchio, Elizabeth M.; Pascual, Virginia; Banchereau, Jacques; Ueno, Hideki] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Zurawski, Gerard; Oh, SangKon; Banchereau, Jacques; Ueno, Hideki] INSERM, U899, Dallas, TX 75204 USA; [Punaro, Marilynn; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Punaro, Marilynn] Univ Texas SW Med Ctr Dallas, Dallas, TX 75235 USA; [Punaro, Marilynn] Childrens Med Ctr, Dallas, TX 75235 USA; [Banchereau, Jacques] Mt Sinai Sch Med, Inst Immunol, Dept Gene & Cell Med, New York, NY 10029 USA; [Banchereau, Jacques] Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA	Baylor Scott & White Health; Baylor University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Banchereau, J (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	jacquesb@baylorhealth.edu; hidekiu@baylorhealth.edu	Ueno, Hideki/L-1237-2016; Pascual, Virginia/ABD-3099-2020; Bentebibel, Salah-Eddine/AAS-9766-2021; sabzghabaei, natalie/GQQ-9897-2022	Ueno, Hideki/0000-0001-7747-0738; Schmitt, Nathalie/0000-0001-9993-2788; Dullaers, Melissa/0000-0003-0223-230X	Baylor Health Care System;  [U19-AI057234];  [R01-CA84512];  [R01-CA078846];  [AR054083-01];  [U19-AI082715-01]; NATIONAL CANCER INSTITUTE [R01CA078846, P01CA084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715, U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083] Funding Source: NIH RePORTER	Baylor Health Care System; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank E. Kowalski and S. Coquery for cell sorting; L. Walters for cell processing from apheresis blood; S. Zurawski for IL-21 Luminex analysis; and I. Munagala for real-time RT-PCR. We thank A. Karolina Palucka for critical reading and discussions. This study was supported by U19-AI057234, R01-CA84512, R01-CA078846, AR054083-01 (J.B.), U19-AI082715-01 (H.U., Program PI: V.P.), and Baylor Health Care System (H.U. and J.B.). J.B. holds the W.W. Caruth, Jr., Chair for Transplantation Immunology Research.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1; FORSTER R, 1994, BLOOD, V84, P830; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Lane PJL, 2005, NAT REV IMMUNOL, V5, P655, DOI 10.1038/nri1665; Lewkowicz Debra, 2004, Dermatol Ther, V17, P364, DOI 10.1111/j.1396-0296.2004.04039.x; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rabin RL, 2003, J IMMUNOL, V171, P2812, DOI 10.4049/jimmunol.171.6.2812; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Suber TL, 2008, NAT CLIN PRACT RHEUM, V4, P201, DOI 10.1038/ncprheum0760; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	58	1077	1143	2	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					108	121		10.1016/j.immuni.2010.12.012	http://dx.doi.org/10.1016/j.immuni.2010.12.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21215658	Green Accepted, Bronze			2022-12-18	WOS:000287336600014
J	Weaver, CT; Harrington, LE; Mangan, PR; Gavrieli, M; Murphy, KM				Weaver, Casey T.; Harrington, Laurie E.; Mangan, Paul R.; Gavrieli, Maya; Murphy, Kenneth M.			Th17: An effector CD4 T cell lineage with regulatory T cell ties	IMMUNITY			English	Review							COLLAGEN-INDUCED ARTHRITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INTERFERON-GAMMA PRODUCTION; GROWTH-FACTOR-BETA; TGF-BETA; TRANSCRIPTION FACTOR; IL-12 RESPONSIVENESS; JOINT INFLAMMATION; THYMIC SELECTION; DENDRITIC CELLS	The naive CD4 T cell is a multipotential precursor with defined antigen recognition specificity but substantial plasticity for development down distinct effector or regulatory lineages, contingent upon signals from cells of the innate immune system. The range of identified effector CD4 T cell lineages has recently expanded with description of an IL-17-producing subset, called Th17, which develops; via cytokine signals distinct from, and antagonized by, products of the Th1 and Th2 lineages. Remarkably, Th17 development depends on the pleiotropic cytokine TGF-beta, which is also linked to regulatory T cell development and function, providing a unique mechanism for matching CD4 T cell effector and regulatory lineage specification. Here, we review Th17 lineage development, emphasizing similarities and differences with established effector and regulatory T cell developmental programs that have important implications for immune regulation, immune pathogenesis, and host defense.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793	NIAID NIH HHS [AI35783, AI57956] Funding Source: Medline; NIDDK NIH HHS [DK64400] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057956, R01AI035783, R21AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Akbari O, 2003, CURR OPIN IMMUNOL, V15, P627, DOI 10.1016/j.coi.2003.09.012; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Constantinescu CS, 1998, J IMMUNOL, V161, P5097; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fedele G, 2005, INFECT IMMUN, V73, P1590, DOI 10.1128/IAI.73.3.1590-1597.2005; Ferber IA, 1996, J IMMUNOL, V156, P5; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HATTRI R, 2003, NAT IMMUNOL, V4, P337; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kageyama Y, 1998, J IMMUNOL, V161, P1542; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P975, DOI 10.1002/art.20885; Koenders MI, 2005, AM J PATHOL, V167, P141, DOI 10.1016/S0002-9440(10)62961-6; KOLLOCH RE, 2004, PERFUSION-GERMANY, V17, P467; Kubo T, 2004, J IMMUNOL, V173, P7249, DOI 10.4049/jimmunol.173.12.7249; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Matthys P, 1999, J IMMUNOL, V163, P3503; Matthys P, 1998, EUR J IMMUNOL, V28, P2143, DOI 10.1002/(SICI)1521-4141(199807)28:07<2143::AID-IMMU2143>3.0.CO;2-C; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Park SH, 2005, CHEM MATER, V17, P6, DOI 10.1021/cm048433e; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Way SS, 2004, J IMMUNOL, V173, P5918, DOI 10.4049/jimmunol.173.10.5918; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng WP, 2004, J IMMUNOL, V172, P114, DOI 10.4049/jimmunol.172.1.114	103	1076	1207	4	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					677	688		10.1016/j.immuni.2006.06.002	http://dx.doi.org/10.1016/j.immuni.2006.06.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782025	Bronze			2022-12-18	WOS:000238592200007
J	Sato, M; Suemori, H; Hata, N; Asagiri, M; Ogasawara, K; Nakao, K; Nakaya, T; Katsuki, M; Noguchi, S; Tanaka, N; Taniguchi, T				Sato, M; Suemori, H; Hata, N; Asagiri, M; Ogasawara, K; Nakao, K; Nakaya, T; Katsuki, M; Noguchi, S; Tanaka, N; Taniguchi, T			Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction	IMMUNITY			English	Article							BETA-INTERFERON GENE; NF-KAPPA-B; REGULATORY ELEMENTS; INDUCIBLE ENHANCER; POSITIVE FEEDBACK; VIRAL INDUCTION; FACTOR COMPLEX; A GENES; EXPRESSION; ACTIVATION	Induction of the interferon (IFN)-alpha/beta gene transcription in virus-infected cells is an event central to innate immunity. Mice lacking the transcription factor IRF-3 are more vulnerable to virus infection. In embryonic fibroblasts, virus-induced IFN-alpha/beta gene expression levels are reduced and the spectrum of the IFN-alpha mRNA subspecies altered. Furthermore, cells additionally defective in IRF-7 expression totally fail to induce these genes in response to infections by any of the virus types tested. In these cells, a normal profile of IFN-alpha/beta mRNA induction can be achieved by coexpressing both IRF-3 and IRF-7. These results demonstrate the essential and distinct roles of the two factors, which together ensure the transcriptional efficiency and diversity of IFN-alpha/beta genes for the antiviral response.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Kanagawa Acad Sci & Technol, Bio Signal Pathway Project, Odawara, Kanagawa 2500862, Japan; Meiji Milk Prod Co Ltd, Odawara, Kanagawa 2500862, Japan; Univ Tokyo, Inst Med Sci, Dept DNA Biol & Embryo Engn, Minato Ku, Tokyo 1068639, Japan	University of Tokyo; University of Tokyo; Kanagawa Academy Science & Technology; Meiji Holdings Co., Ltd.; University of Tokyo	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Ogasawara, Kouetsu/G-9892-2011	Tanaka, Nobuyuki/0000-0002-6373-2220				Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; CASTRILLO JL, 1986, MOL CELL BIOCHEM, V71, P53; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; CIVAS A, 1991, NUCLEIC ACIDS RES, V19, P4497, DOI 10.1093/nar/19.16.4497; Demaeyer E., 1988, INTERFERONS OTHER RE; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FUJITA T, 1989, NUCLEIC ACIDS RES, V17, P3335, DOI 10.1093/nar/17.9.3335; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; FUJITA T, 1981, VIROLOGY, V112, P62, DOI 10.1016/0042-6822(81)90612-7; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Genin P, 1995, NUCLEIC ACIDS RES, V23, P5055; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Harada H, 1996, GENES CELLS, V1, P995, DOI 10.1046/j.1365-2443.1996.870287.x; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; ICHII Y, 1986, NUCLEIC ACIDS RES, V14, P10117, DOI 10.1093/nar/14.24.10117; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; KAWAKAMI T, 1995, FEBS LETT, V358, P225, DOI 10.1016/0014-5793(94)01426-2; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; LEBLANC JF, 1990, MOL CELL BIOL, V10, P3987, DOI 10.1128/MCB.10.8.3987; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; MANIATIS T, 1992, TRANSCRIPTIONAL REGU, V2, P1193; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; NOURBAKHSH M, 1993, EMBO J, V12, P451, DOI 10.1002/j.1460-2075.1993.tb05677.x; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; RAJ NBK, 1989, J BIOL CHEM, V264, P11149; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROBERTSON EJ, 1991, BIOL REPROD, V44, P238, DOI 10.1095/biolreprod44.2.238; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; SHAW GD, 1983, NUCLEIC ACIDS RES, V11, P555, DOI 10.1093/nar/11.3.555; STEWART WE, 1971, J VIROL, V7, P792, DOI 10.1128/JVI.7.6.792-801.1971; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tanaka N, 1998, GENES CELLS, V3, P29, DOI 10.1046/j.1365-2443.1998.00164.x; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439, DOI 10.1146/annurev.iy.06.040188.002255; TANIGUCHI T, 2000, S QUANT BIOL, V64, P465; VILCEK J, 1996, FIELDS VIROLOGY, P375; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160	54	1073	1110	1	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					539	548		10.1016/S1074-7613(00)00053-4	http://dx.doi.org/10.1016/S1074-7613(00)00053-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070172	Bronze			2022-12-18	WOS:000090079100013
J	Krasemann, S; Madore, C; Cialic, R; Baufeld, C; Calcagno, N; El Fatimy, R; Beckers, L; O'Loughlin, E; Xu, Y; Fanek, Z; Greco, DJ; Smith, ST; Tweet, G; Humulock, Z; Zrzavy, T; Conde-Sanroman, P; Gacias, M; Weng, ZP; Chen, H; Tjon, E; Mazaheri, F; Hartmann, K; Madi, A; Ulrich, JD; Glatzel, M; Worthmann, A; Heeren, J; Budnik, B; Lemere, C; Ikezu, T; Heppner, FL; Litvak, V; Holtzman, DM; Lassmann, H; Weiner, HL; Ochando, J; Haass, C; Butovsky, O				Krasemann, Susanne; Madore, Charlotte; Cialic, Ron; Baufeld, Caroline; Calcagno, Narghes; El Fatimy, Rachid; Beckers, Lien; O'Loughlin, Elaine; Xu, Yang; Fanek, Zain; Greco, David J.; Smith, Scott T.; Tweet, George; Humulock, Zachary; Zrzavy, Tobias; Conde-Sanroman, Patricia; Gacias, Mar; Weng, Zhiping; Chen, Hao; Tjon, Emily; Mazaheri, Fargol; Hartmann, Kristin; Madi, Asaf; Ulrich, Jason D.; Glatzel, Markus; Worthmann, Anna; Heeren, Joerg; Budnik, Bogdan; Lemere, Cynthia; Ikezu, Tsuneya; Heppner, Frank L.; Litvak, Vladimir; Holtzman, David M.; Lassmann, Hans; Weiner, Howard L.; Ochando, Jordi; Haass, Christian; Butovsky, Oleg			The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases	IMMUNITY			English	Article							GENE-EXPRESSION SIGNATURE; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; MOUSE MODEL; CELLS; DEFICIENCY; MACROPHAGE; DEGENERATION; PROGRESSION; ACTIVATION	Microglia play a pivotal role in the maintenance of brain homeostasis but lose homeostatic function during neurodegenerative disorders. We identified a specific apolipoprotein E (APOE)-dependent molecular signature in microglia from models of amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Alzheimer's disease (AD) and in microglia surrounding neuritic b-amyloid (Ab)-plaques in the brains of people with AD. The APOE pathway mediated a switch from a homeostatic to a neurodegenerative microglia phenotype after phagocytosis of apoptotic neurons. TREM2 (triggering receptor expressed on myeloid cells 2) induced APOE signaling, and targeting the TREM2-APOE pathway restored the homeostatic signature of microglia in ALS and AD mouse models and prevented neuronal loss in an acute model of neurodegeneration. APOE-mediated neurodegenerative microglia had lost their tolerogenic function. Our work identifies the TREM2-APOE pathway as a major regulator of microglial functional phenotype in neurodegenerative diseases and serves as a novel target that could aid in the restoration of homeostatic microglia.	[Krasemann, Susanne; Madore, Charlotte; Cialic, Ron; Baufeld, Caroline; Calcagno, Narghes; El Fatimy, Rachid; Beckers, Lien; O'Loughlin, Elaine; Fanek, Zain; Greco, David J.; Smith, Scott T.; Tweet, George; Humulock, Zachary; Tjon, Emily; Madi, Asaf; Lemere, Cynthia; Weiner, Howard L.; Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Krasemann, Susanne; Hartmann, Kristin; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Xu, Yang; Litvak, Vladimir] Univ Massachusetts, Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Zrzavy, Tobias; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Conde-Sanroman, Patricia; Gacias, Mar; Ochando, Jordi] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Weng, Zhiping; Chen, Hao] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Mazaheri, Fargol; Haass, Christian] German Ctr Neurodegenerat Dis, Munich, Germany; [Ulrich, Jason D.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders,Dept Neurol, St Louis, MO 63108 USA; [Worthmann, Anna; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Budnik, Bogdan] Harvard Univ, Fac Arts & Sci, Div Sci, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02215 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Heppner, Frank L.] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany; [Heppner, Frank L.] NeuroCure, Cluster Excellence, CharitePl 1, D-10117 Berlin, Germany; [Weiner, Howard L.; Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Haass, Christian] Ludwig Maximilians Univ Munchen, Biomed Ctr, Biochem, Munich, Germany; [Haass, Christian] Munich Cluster Syst Neurol, Munich, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Massachusetts System; University of Massachusetts Worcester; Medical University of Vienna; Icahn School of Medicine at Mount Sinai; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Washington University (WUSTL); University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Boston University; Boston University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Munich	Butovsky, O (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Butovsky, O (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.	obutovsky@rics.bwh.harvard.edu	Ochando, Jordi/B-6219-2008; Madore, Charlotte/AAK-8735-2021; Chen, Hao/AAN-4948-2021; Fatimy, Rachid El/K-2822-2019; Budnik, Bogdan/AGG-8824-2022; Worthmann, Anna/AAF-9563-2020; Ochando, jordi/ABE-2358-2020; Budnik, Bogdan/AAH-9987-2019; Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019; Butovsky, Oleg/ABG-9086-2020; Cialic, Ron/ABB-8565-2020; Lassmann, Hans/Z-2269-2019; Heppner, Frank/ABH-8393-2020	Ochando, Jordi/0000-0001-7037-1681; Madore, Charlotte/0000-0002-0704-6496; Budnik, Bogdan/0000-0003-3622-2003; Ochando, jordi/0000-0001-7037-1681; Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Butovsky, Oleg/0000-0003-0186-8867; Lassmann, Hans/0000-0001-8617-5052; Heppner, Frank/0000-0001-9816-8917; Ikezu, Tsuneya/0000-0002-3979-8596; Calcagno, Narghes/0000-0003-0615-891X; Zrzavy, Tobias/0000-0001-8909-1591; Madi, Asaf/0000-0003-3441-3228; Beckers, Lien/0000-0003-4625-9811; EL FATIMY, Rachid/0000-0002-7652-5562; Cialic, Ron/0000-0002-1589-2262	NIH National Institute of Neurological Disorders and Stroke [1R01NS088137]; NIH National Institute on Aging (NIH-NIA) [R01AG051812, R01AG054672]; National Multiple Sclerosis Society [5092A1]; Amyotrophic Lateral Sclerosis Association [2087]; Nancy Davis Foundation Faculty Award; Cure Alzheimer's Fund (APOE: Butovsky); Department of Defense [AL120029]; Thome Foundation [2011D002865]; NIH-NIA [R01AG043975, R01AG040092, RF1AG054199-01]; European Research Council [321366-Amyloid]; Deutsche Forschungsgemeinschaft (DFG) [EXC 1010 SyNergy]; Cure Alzheimer's Fund; MetLife Foundation Award; DFG [SFB841, GRK1459, SFB877]; Austrian Science Foundation [P27744-B27]; National Multiple Sclerosis Society;  [P50AG05681];  [P01-AG0399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000399, RF1AG054199, R01AG054672, P01AG003991, P50AG005681, R01AG040092, R01AG051812, R01AG043975] Funding Source: NIH RePORTER	NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute on Aging (NIH-NIA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Amyotrophic Lateral Sclerosis Association; Nancy Davis Foundation Faculty Award; Cure Alzheimer's Fund (APOE: Butovsky); Department of Defense(United States Department of Defense); Thome Foundation; NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cure Alzheimer's Fund; MetLife Foundation Award; DFG(German Research Foundation (DFG)); Austrian Science Foundation(Austrian Science Fund (FWF)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the following organizations to the indicated authors. O.B.: NIH National Institute of Neurological Disorders and Stroke (1R01NS088137), NIH National Institute on Aging (NIH-NIA) (R01AG051812 and R01AG054672), National Multiple Sclerosis Society (5092A1), Amyotrophic Lateral Sclerosis Association (2087), Nancy Davis Foundation Faculty Award, Cure Alzheimer's Fund (2017APOE: Butovsky). H.L.W.: Department of Defense (AL120029), Thome Foundation (2011D002865), NIH-NIA (R01AG043975 and R01AG040092). C.H.: European Research Council (321366-Amyloid), Deutsche Forschungsgemeinschaft (DFG) (EXC 1010 SyNergy), Cure Alzheimer's Fund, MetLife Foundation Award. J.H.: DFG (SFB841). D.M.H.: P50AG05681, P01-AG0399. C.L.: NIH-NIA (R01AG040092). T.I.: NIH-NIA (RF1AG054199-01). M.G.: DFG (GRK1459, SFB877). H.L.: Austrian Science Foundation Project (P27744-B27). C.M.: National Multiple Sclerosis Society (postdoctoral fellowship). We thank Prize4Life, a nonprofit organization dedicated to the discovery of treatments and a cure for ALS; Marco Colonna for Trem2<SUP>-/-</SUP> mice; Microscopy Core Facility/Universitatsklinikum Hamburg-Eppendorf; Deneen Kozoriz for FACS sorting. C.H. is a Roche advisor and collaborator.	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bai B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007869; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; DICKSON DW, 1988, AM J PATHOL, V132, P86; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LARNER AJ, 1995, DEMENTIA, V6, P218, DOI 10.1159/000106950; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lu D, 2014, J EXP MED, V211, P2183, DOI 10.1084/jem.20140338; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Masliah E, 1998, J NEUROPATH EXP NEUR, V57, P1041, DOI 10.1097/00005072-199811000-00007; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Shin S, 2014, J NEUROIMMUNOL, V271, P8, DOI 10.1016/j.jneuroim.2014.03.010; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Toledo JB, 2014, ACTA NEUROPATHOL, V127, P621, DOI 10.1007/s00401-013-1236-0; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Verheijden S, 2013, NEUROBIOL DIS, V58, P258, DOI 10.1016/j.nbd.2013.06.006; Wagner T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145102; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yuan P, 2016, NEURON, V92, P252, DOI 10.1016/j.neuron.2016.09.016	58	1056	1069	24	263	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					566	+		10.1016/j.immuni.2017.08.008	http://dx.doi.org/10.1016/j.immuni.2017.08.008			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930663	Green Accepted, Bronze			2022-12-18	WOS:000411128200019
J	Rubtsov, YP; Rasmussen, JP; Chi, EY; Fontenot, J; Castelli, L; Ye, X; Treuting, P; Siewe, L; Roers, A; Henderson, WR; Muller, W; Rudensky, AY				Rubtsov, Yuri P.; Rasmussen, Jeffrey P.; Chi, Emil Y.; Fontenot, Jason; Castelli, Luca; Ye, Xin; Treuting, Piper; Siewe, Lisa; Roers, Axel; Henderson, William R., Jr.; Muller, Werner; Rudensky, Alexander Y.			Reaulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; MOUSE ASTHMA MODEL; INTESTINAL INFLAMMATION; MEDIATED SUPPRESSION; TGF-BETA; AIRWAY INFLAMMATION; REGULATORY CELLS; DENDRITIC CELLS; TARGET GENES; MICE	The regulatory T (Treg) cells restrain immune responses through suppressor-function elaboration that is dependent upon expression of the transcription factor Foxp3. Despite a critical role for Treg cells in maintaining lympho-myeloid homeostasis, it remains unclear whether a single mechanism or multiple mechanisms of Treg cell-mediated suppression are operating in vivo and how redundant such mechanisms might be. Here we addressed these questions by examining the role of the immunomodulatory cytokine IL-10 in Treg cell-mediated suppression. Analyses of mice in which the Treg cell-specific ablation of a conditional IL-10 allele was induced by Cre recombinase knocked into the Foxp3 gene locus showed that although IL-10 production by Treg cells was not required for the control of systemic autoimmunity, it was essential for keeping immune responses in check at environmental interfaces such as the colon and lungs. Our study suggests that Treg cells utilize multiple means to limit immune responses. Furthermore, these mechanisms are likely to be nonredundant, in that a distinct suppressor mechanism most likely plays a prominent and identifiable role at a particular tissue and inflammatory setting.	[Rubtsov, Yuri P.; Rasmussen, Jeffrey P.; Fontenot, Jason; Castelli, Luca; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Chi, Emil Y.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Ye, Xin; Henderson, William R., Jr.] Univ Washington, Sch Med, Dept Med, Ctr Allergy & Immunol, Seattle, WA 98109 USA; [Siewe, Lisa; Roers, Axel] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Muller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cologne; University of Manchester	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu	Muller, Werner/B-9044-2008; Rubtsov, Yury P/A-8227-2014; Treuting, Piper M./AAB-2721-2019	Muller, Werner/0000-0002-1297-9725; Rubtsov, Yury P/0000-0001-9175-3013; Treuting, Piper M./0000-0002-1812-1519	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Annacker O, 2003, J AUTOIMMUN, V20, P277, DOI 10.1016/S0896-8411(03)00045-3; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Drakes ML, 2005, J LEUKOCYTE BIOL, V78, P1291, DOI 10.1189/jlb.0605342; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Mahic M, 2006, J IMMUNOL, V177, P246, DOI 10.4049/jimmunol.177.1.246; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhang Y, 1997, AM J RESP CRIT CARE, V155, P661, DOI 10.1164/ajrccm.155.2.9032210; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	55	1053	1090	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					546	558		10.1016/j.immuni.2008.02.017	http://dx.doi.org/10.1016/j.immuni.2008.02.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18387831	Bronze			2022-12-18	WOS:000254939400015
J	BOISE, LH; MINN, AJ; NOEL, PJ; JUNE, CH; ACCAVITTI, MA; LINDSTEN, T; THOMPSON, CB				BOISE, LH; MINN, AJ; NOEL, PJ; JUNE, CH; ACCAVITTI, MA; LINDSTEN, T; THOMPSON, CB			CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)	IMMUNITY			English	Article							HUMAN PERIPHERAL-BLOOD; ACTIVATION PATHWAY; GENE-EXPRESSION; MESSENGER-RNA; FAS ANTIGEN; DEATH; BCL-2; APOPTOSIS; INTERLEUKIN-2; PROTEIN	T cell activation through the TCR can result in either cell proliferation or cell death. The role of costimulatory receptors in regulating T cell survival has not been defined. Here, we present data demonstrating that CD28 costimulation enhances the in vitro survival of activated T cells. One mechanism for this enhancement is the ability of CD28 costimulation to augment the production of IL-2, which acts as an extrinsic survival factor for T cells. In addition, CD28 costimulation augments the intrinsic ability of T cells to resist apoptosis. Although CD28 signal transduction had no effect on Bcl-2 expression, CD28 costimulation was found to augment the expression of Bcl-x(L) substantially. Transfection experiments demonstrated that this level of Bcl-x(L) could prevent T cell death in response to TCR cross-linking, Fas cross-linking, or IL-2 withdrawal. These data suggest that an important role of CD28 costimulation is to augment T cell survival during antigen activation.	UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA; UNIV CHICAGO, COMM IMMUNOL, CHICAGO, IL 60637 USA; UNIV CHICAGO, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA; USN, MED RES INST, IMMUNOL CELL BIOL PROGRAM, BETHESDA, MD 20889 USA; UNIV ALABAMA, DEPT MED, BIRMINGHAM, AL 35294 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy; University of Alabama System; University of Alabama Birmingham	BOISE, LH (corresponding author), UNIV CHICAGO, GWEN KNAPP CTR LUPUS & IMMUNOL RES, CHICAGO, IL 60637 USA.		Boise, Lawrence/AAD-2314-2019	Boise, Lawrence/0000-0001-9436-8815; June, Carl/0000-0003-0241-3557; Minn, Andy/0000-0003-1418-0906	NIAID NIH HHS [P01 AI35294] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035294] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIERER BE, 1991, ADV CANCER RES, V56, P49; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; GROUX H, 1993, EUR J IMMUNOL, V23, P1623, DOI 10.1002/eji.1830230734; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KABELITZ D, 1992, INT IMMUNOL, V4, P1381, DOI 10.1093/intimm/4.12.1381; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Kearney JF, 1984, FUNDAMENTAL IMMUNOLO, P751; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LOWENTHAL JW, 1985, J IMMUNOL, V135, P1119; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; REED JC, 1992, LAB INVEST, V67, P443; REED JC, 1987, SCIENCE, V236, P1295, DOI 10.1126/science.3495884; SCHREK R, 1964, J NATL CANCER I, V32, P507; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STEWART CC, 1988, INT J RADIAT BIOL, V53, P77, DOI 10.1080/09553008814550441; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; UCKER DS, 1989, J IMMUNOL, V143, P3461; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J	40	1048	1077	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1995	3	1					87	98		10.1016/1074-7613(95)90161-2	http://dx.doi.org/10.1016/1074-7613(95)90161-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621080	Bronze			2022-12-18	WOS:A1995RK86800010
J	Lodolce, JP; Boone, DL; Chai, S; Swain, RE; Dassopoulos, T; Trettin, S; Ma, A				Lodolce, JP; Boone, DL; Chai, S; Swain, RE; Dassopoulos, T; Trettin, S; Ma, A			IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation	IMMUNITY			English	Article							INTERLEUKIN-2 RECEPTOR; BETA-CHAIN; T-CELLS; DEFICIENT MICE; KILLER-CELLS; GAMMA-CHAIN; GENE; DIFFERENTIATION; RECOGNITION; INDUCTION	The IL-15 receptor alpha subunit (IL-15R alpha) mediates high-affinity binding of IL-15, a pleiotropic cytokine implicated in the development of innate immune cells. We have generated IL-15R alpha null (IL-15R alpha(-/-)) mice to understand the role of IL-15R alpha in immune development and function. IL-15R alpha(-/-) mice are markedly lymphopenic despite grossly normal T and B lymphocyte development. This lymphopenia is due to decreased proliferation and decreased homing of IL-15R alpha(-/-) lymphocytes to peripheral lymph nodes. These mice are also deficient in natural killer cells, natural killer T cells, CD8(+) T lymphocytes, and TCR gamma delta intraepithelial lymphocytes. In addition, memory phenotype CD8(+) T cells are selectively reduced in number. Thus, IL-15R alpha has pleiotropic roles in immune development and function, including the positive maintenance of lymphocyte homeostasis.	Univ Chicago, Dept Med, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ma, A (corresponding author), Univ Chicago, Dept Med, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ama@medicine.bsd.uchicago.edu			NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052751, P30DK042086] Funding Source: NIH RePORTER; NCI NIH HHS [CA-14599] Funding Source: Medline; NIDDK NIH HHS [DK-42086, DK52751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BulfonePaus S, 1997, NAT MED, V3, P1124, DOI 10.1038/nm1097-1124; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1997, J IMMUNOL, V159, P5931; Oppenheimer-Marks N, 1998, J CLIN INVEST, V101, P1261, DOI 10.1172/JCI1986; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; [No title captured]	33	1047	1076	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1998	9	5					669	676		10.1016/S1074-7613(00)80664-0	http://dx.doi.org/10.1016/S1074-7613(00)80664-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846488	Bronze			2022-12-18	WOS:000077298300009
J	Kariko, K; Buckstein, M; Ni, HP; Weissman, D				Kariko, K; Buckstein, M; Ni, HP; Weissman, D			Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; DENDRITIC CELLS; MESSENGER-RNA; IN-VITRO; INTERFERON-ALPHA; INNATE IMMUNITY; N-6-METHYLADENOSINE; TRANSFECTION; ACTIVATION; APOPTOSIS	DNA and RNA stimulate the mammalian innate immune system through activation of Toll-like receptors (TLRs). DNA containing methylated CpG motifs, however, is not stimulatory. Selected nucleosides in naturally occurring RNA are also methylated or otherwise modified, but the immunomodulatory effects of these alterations remain untested. We show that RNA signals through human TLR3, TLR7, and TLR8, but incorporation of modified nucleosides m5C, m6A, m5U, s2U, or pseudouridine ablates activity. Dendritic cells (DCs) exposed to such modified RNA express significantly less cytokines and activation markers than those treated with unmodified RNA. DCs and TLR-expressing cells are potently activated by bacterial and mitochondrial RNA, but not by mammalian total RNA, which is abundant in modified nucleosides. We conclude that nucleoside modifications suppress the potential of RNA to activate DCs. The innate immune system may therefore detect RNA lacking nucleoside modification as a means of selectively responding to bacteria or necrotic tissue.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kariko, K (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	kariko@mail.med.upenn.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050484, R01AI060505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014825] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060505, AI50484] Funding Source: Medline; NIDCR NIH HHS [DE14825] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bachellerie J. P., 1998, MODIFICATION EDITING, P255; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Charette M, 2000, IUBMB LIFE, V49, P341; Crawford DR, 1997, FREE RADICAL BIO MED, V22, P1295, DOI 10.1016/S0891-5849(96)00544-8; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Greenwood RC, 2002, FEMS MICROBIOL LETT, V208, P203; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffman RW, 2004, ARTHRITIS RHEUM-US, V50, P2891, DOI 10.1002/art.20428; HOUGE G, 1995, MOL CELL BIOL, V15, P2051; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; KANE SE, 1987, J BIOL CHEM, V262, P3422; Kariko K, 1998, BBA-BIOMEMBRANES, V1369, P320, DOI 10.1016/S0005-2736(97)00238-1; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Margulis L, 1998, TRENDS MICROBIOL, V6, P342, DOI 10.1016/S0966-842X(98)01325-0; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; NARAYAN P, 1987, MOL CELL BIOL, V7, P1572, DOI 10.1128/MCB.7.4.1572; Ronnblom L, 2003, AUTOIMMUNITY, V36, P463, DOI 10.1080/08916930310001602128; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710	31	1043	1188	16	197	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2005	23	2					165	175		10.1016/j.immuni.2005.06.008	http://dx.doi.org/10.1016/j.immuni.2005.06.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111635	Bronze			2022-12-18	WOS:000231721700007
J	Kato, H; Sato, S; Yoneyama, M; Yamamoto, M; Uematsu, S; Matsui, K; Tsujimura, T; Takeda, K; Fujita, T; Takeuchi, O; Akira, S				Kato, H; Sato, S; Yoneyama, M; Yamamoto, M; Uematsu, S; Matsui, K; Tsujimura, T; Takeda, K; Fujita, T; Takeuchi, O; Akira, S			Cell type-specific involvement of RIG-I in antiviral response	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-7; KAPPA-B KINASE; PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; DEPENDENT PROTEIN-KINASE; SIGNALING PATHWAY; VIRAL-INFECTIONS; TRANSCRIPTION FACTORS; LIVER DEGENERATION	Toll-like receptors (TLRs) play an important role in antiviral response by recognizing viral components. Recently, a RNA helicase, RIG-I, was also suggested to recognize viral double-stranded RNA. However, how these molecules contribute to viral recognition in vivo is poorly understood. We show by gene targeting that RIG-I is essential for induction of type I interferons (IFNs) after infection with RNA viruses in fibroblasts and conventional dendritic cells (DCs). RIG-I induces type I IFNs by activating IRF3 via I kappa B kinase-related kinases. In contrast, plasmacytoid DCs, which produce large amounts of IFN-alpha, use the TLR system rather than RIG-I for viral detection. Taken together, RIG-I and the TLR system exert antiviral responses in a cell type-specific manner.	Osaka Univ, Res Inst Microbial Dis, Dept Host Defense, Suita, Osaka 5650871, Japan; ERATO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Organ Med REs, Bunkyo Ku, Tokyo 1338613, Japan; Hyogo Med Univ, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 8128582, Japan	Osaka University; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science; Hyogo College of Medicine; University of Hyogo; Kyushu University	Akira, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Host Defense, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009; Yoneyama, Mitsutoshi/D-8244-2017; Takeda, Kiyoshi/C-9331-2009; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; Yoneyama, Mitsutoshi/0000-0001-9512-0408; Takeda, Kiyoshi/0000-0002-1778-6332; Sato, Shintaro/0000-0001-5156-3354				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Kaisho T, 2003, CURR MOL MED, V3, P759, DOI 10.2174/1566524033479366; KAWAI T, 2004, NAT IMMUNOL, V10, P1118; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Sun Y.W., 1997, THESIS SHANGHAI 2 ME; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; WILLIAMS BR, 2002, SCI STKE, V89, pRE2; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	47	1040	1122	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					19	28		10.1016/j.immuni.2005.04.010	http://dx.doi.org/10.1016/j.immuni.2005.04.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039576	Bronze			2022-12-18	WOS:000231024800005
J	Kontoyiannis, D; Pasparakis, M; Pizarro, TT; Cominelli, F; Kollias, G				Kontoyiannis, D; Pasparakis, M; Pizarro, TT; Cominelli, F; Kollias, G			Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA DEGRADATION; ACTIVATED PROTEIN-KINASE; FACTOR-ALPHA; 3'-UNTRANSLATED REGION; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; FACTOR RECEPTOR; CROHNS-DISEASE; T-CELLS	We addressed the impact of deleting TNF AU-rich elements (ARE) from the mouse genome on the regulation of TNF biosynthesis and the physiology of the host. Absence of the ARE affected mechanisms responsible for TNF mRNA destabilization and translational repression in hemopoietic and stromal cells. In stimulated conditions, TNF ARE were required both for the alleviation and reinforcement of message destabilization and translational silencing. Moreover, the mutant mRNA was no longer responsive to translational modulation by the p38 and JNK kinases, demonstrating that TNF ARE are targets for these signals. Development of two specific pathologies in mutant mice, i.e., chronic inflammatory arthritis and Crohn's-like inflammatory bowel disease, suggests that defective function of ARE may be etiopathogenic for the development of analogous human pathologies.	Hellenic Pasteur Inst, Mol Genet Lab, Athens 11521, Greece; Univ Virginia, Hlth Sci Ctr, Div Gastroenterol & Hepatol, Charlottesville, VA 22906 USA	University of Virginia	Kollias, G (corresponding author), Hellenic Pasteur Inst, Mol Genet Lab, Athens 11521, Greece.	giorgos_kollias@hol.gr	Kollias, George/A-7079-2012; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	Kollias, George/0000-0003-1867-3150; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Kontoyiannis, Dimitris/0000-0003-4682-9490	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK042191, R01DK042191, R37DK042191] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexopoulou L, 1997, EUR J IMMUNOL, V27, P2588, DOI 10.1002/eji.1830271018; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BRENNAN FM, 1989, LANCET, V2, P244; BROWN CR, 1995, J VIROL, V69, P7187, DOI 10.1128/JVI.69.11.7187-7195.1995; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Douni E, 1996, J INFLAMM, V47, P27; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; GOLDFELD AE, 1991, J EXP MED, V174, P73, DOI 10.1084/jem.174.1.73; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; HAN J, 1991, J IMMUNOL, V146, P1843; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; HAN JH, 1991, BIOCHIM BIOPHYS ACTA, V1090, P22, DOI 10.1016/0167-4781(91)90032-H; Jacob CO, 1996, J IMMUNOL, V156, P3043; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LIEBERMAN AP, 1990, J EXP MED, V172, P989, DOI 10.1084/jem.172.3.989; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasparakis Manolis, 1996, Cytokine and Growth Factor Reviews, V7, P223, DOI 10.1016/S1359-6101(96)00031-7; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; PRICHETT W, 1995, J INFLAMM, V45, P97; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Santee SM, 1996, J BIOL CHEM, V271, P21151, DOI 10.1074/jbc.271.35.21151; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Strober W, 1998, SCAND J IMMUNOL, V48, P453; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; WARREN MK, 1985, J IMMUNOL, V134, P982; Yang Y, 1998, J EXP MED, V188, P247, DOI 10.1084/jem.188.2.247	51	1031	1072	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1999	10	3					387	398		10.1016/S1074-7613(00)80038-2	http://dx.doi.org/10.1016/S1074-7613(00)80038-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204494	Bronze			2022-12-18	WOS:000079455700011
J	Anderson, AC; Joller, N; Kuchroo, VK				Anderson, Ana C.; Joller, Nicole; Kuchroo, Vijay K.			Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation	IMMUNITY			English	Review							T-CELL IMMUNOGLOBULIN; INTERFERON-GAMMA PRODUCTION; CENTRAL-NERVOUS-SYSTEM; NATURAL-KILLER-CELLS; EXPRESSION DEFINES; EFFECTOR FUNCTION; CRYSTAL-STRUCTURE; MICE DEFICIENT; TH1 CELLS; ACTIVATION	Co-inhibitory receptors, such as CTLA-4 and PD-1, have an important role in regulating T cell responses and have proven to be effective targets in the setting of chronic diseases where constitutive co-inhibitory receptor expression on T cells dampens effector T cell responses. Unfortunately, many patients still fail to respond to therapies that target CTLA-4 and PD-1. The next wave of co-inhibitory receptor targets that are being explored in clinical trials include Lag-3, Tim-3, and TIGIT. These receptors, although they belong to the same class of receptors as PD-1 and CTLA-4, exhibit unique functions, especially at tissue sites where they regulate distinct aspects of immunity. Increased understanding of the specialized functions of these receptors will inform the rational application of therapies that target these receptors to the clinic.	[Anderson, Ana C.; Kuchroo, Vijay K.] Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, 75 Francis St, Boston, MA 02115 USA; [Anderson, Ana C.; Kuchroo, Vijay K.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Anderson, Ana C.; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Joller, Nicole] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Zurich	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, 75 Francis St, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	vkuchroo@evergrande.hms.harvard.edu	Anderson, Ana C/ABD-6829-2021; Joller, Nicole/G-7897-2015	Anderson, Ana C/0000-0002-0877-2932; Joller, Nicole/0000-0003-1996-1672	NIH [P01 AI073748, P01 NS076410, P01 AI039671, R01 NS045937, R01 CA187975]; Melanoma Research Alliance; Melanoma Research Foundation; American Cancer Society [RSG-11-057-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA187975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, P01AI039671, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS076410, R01NS045937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Melanoma Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research in the authors' laboratories was supported by grants from the NIH (P01 AI073748, P01 NS076410, P01 AI039671, and R01 NS045937 to V.K.K. and R01 CA187975 to A.C.A.), from the Melanoma Research Alliance (to A.C.A.), from the Melanoma Research Foundation (to A.C.A.), and from the American Cancer Society (RSG-11-057-01-LIB to A.C.A.).	Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boivin N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124802; Boles KS, 2009, EUR J IMMUNOL, V39, P695, DOI 10.1002/eji.200839116; Brignone C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-71; Brignone C, 2009, CLIN CANCER RES, V15, P6225, DOI 10.1158/1078-0432.CCR-09-0068; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Casado JG, 2009, CANCER IMMUNOL IMMUN, V58, P1517, DOI 10.1007/s00262-009-0682-y; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Chen JX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0082-9; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; da Silva IP, 2014, CANCER IMMUNOL RES, V2, P410, DOI 10.1158/2326-6066.CIR-13-0171; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fuhrman CA, 2015, J IMMUNOL, V195, P145, DOI 10.4049/jimmunol.1402381; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Gautron AS, 2014, EUR J IMMUNOL, V44, P2703, DOI 10.1002/eji.201344392; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Hannier S, 1998, J IMMUNOL, V161, P4058; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jha V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104484; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; Kanai Y, 2012, ACTA DERM-VENEREOL, V92, P367, DOI 10.2340/00015555-1285; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Lee SY, 2013, J IMMUNOL, V190, P4991, DOI 10.4049/jimmunol.1300083; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Li M, 2014, J BIOL CHEM, V289, P17647, DOI 10.1074/jbc.M114.572420; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Liu Y, 2010, CLIN IMMUNOL, V137, P288, DOI 10.1016/j.clim.2010.07.012; Lozano E, 2013, J IMMUNOL, V191, P3673, DOI 10.4049/jimmunol.1300945; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Maiti AK, 2010, RHEUMATOLOGY, V49, P1239, DOI 10.1093/rheumatology/kep470; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Ottoboni L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004186; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Prigent P, 1999, EUR J IMMUNOL, V29, P3867, DOI 10.1002/(SICI)1521-4141(199912)29:12<3867::AID-IMMU3867>3.3.CO;2-5; Qu HQ, 2009, GENES IMMUN, V10, pS27, DOI 10.1038/gene.2009.88; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Richter K, 2010, INT IMMUNOL, V22, P13, DOI 10.1093/intimm/dxp107; Romano E, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-97; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Song YW, 2011, HUM IMMUNOL, V72, P652, DOI 10.1016/j.humimm.2011.04.007; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Wang MF, 2014, DNA CELL BIOL, V33, P723, DOI 10.1089/dna.2014.2456; Wang-Gillam A, 2013, INVEST NEW DRUG, V31, P707, DOI 10.1007/s10637-012-9866-y; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Welch MJ, 2012, VIROLOGY, V429, P163, DOI 10.1016/j.virol.2012.04.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Wu W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-113; Xu F, 2014, CANCER RES, V74, P3418, DOI 10.1158/0008-5472.CAN-13-2690; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058006; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yang XM, 2013, J IMMUNOL, V190, P2068, DOI 10.4049/jimmunol.1202661; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017; Zhang Y, 2012, J LEUKOCYTE BIOL, V91, P189, DOI 10.1189/jlb.1010591; Zhang YX, 2013, BLOOD, V122, P2823, DOI 10.1182/blood-2013-02-481788; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	127	1025	1112	10	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					989	1004		10.1016/j.immuni.2016.05.001	http://dx.doi.org/10.1016/j.immuni.2016.05.001			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192565	Bronze, Green Accepted			2022-12-18	WOS:000376478500003
J	Deng, LF; Liang, H; Xu, M; Yang, XM; Burnette, B; Arina, A; Li, XD; Mauceri, H; Beckett, M; Darga, T; Huang, XN; Gajewski, TF; Chen, ZJJ; Fu, YX; Weichselbaum, RR				Deng, Liufu; Liang, Hua; Xu, Meng; Yang, Xuanming; Burnette, Byron; Arina, Ainhoa; Li, Xiao-Dong; Mauceri, Helena; Beckett, Michael; Darga, Thomas; Huang, Xiaona; Gajewski, Thomas F.; Chen, Zhijian J.; Fu, Yang-Xin; Weichselbaum, Ralph R.			STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors	IMMUNITY			English	Article							CYCLIC GMP-AMP; INNATE; CELLS; 2ND-MESSENGER; RECOGNITION; ACTIVATION; RECEPTORS; THERAPY; ADAPTER; SYSTEM	Ionizing radiation-mediated tumor regression depends on type I interferon (IFN) and the adaptive immune response, but several pathways control I IFN induction. Here, we demonstrate that adaptor protein STING, but not MyD88, is required for type I IFN-dependent antitumor effects of radiation. In dendritic cells (DCs), STING was required for IFN-beta induction in response to irradiated-tumor cells. The cytosolic DNA sensor cyclic GMP-AMP (cGAMP) synthase (cGAS) mediated sensing of irradiated-tumor cells in DCs. Moreover, STING was essential for radiation-induced adaptive immune responses, which relied on type I IFN signaling on DCs. Exogenous IFN-beta treatment rescued the cross-priming by cGAS or STING-deficient DCs. Accordingly, activation of STING by a second messenger cGAMP administration enhanced antitumor immunity induced by radiation. Thus radiation-mediated antitumor immunity in immunogenic tumors requires a functional cytosolic DNA-sensing pathway and suggests that cGAMP treatment might provide a new strategy to improve radiotherapy.	[Deng, Liufu; Liang, Hua; Burnette, Byron; Arina, Ainhoa; Mauceri, Helena; Beckett, Michael; Darga, Thomas; Huang, Xiaona; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Xu, Meng; Yang, Xuanming; Gajewski, Thomas F.; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Deng, Liufu; Liang, Hua; Burnette, Byron; Arina, Ainhoa; Mauceri, Helena; Beckett, Michael; Darga, Thomas; Fu, Yang-Xin; Weichselbaum, Ralph R.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Li, Xiao-Dong; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Chicago; University of Chicago; University of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yfu@uchicago.edu; rrw@radonc.uchicago.edu	Ren, Zhenhua/R-3751-2018; Deng, Liufu/I-4443-2013; Chen, Zhijian/C-6039-2012; Deng, Liufu/AAG-7244-2021	Ren, Zhenhua/0000-0002-2560-5618; Chen, Zhijian/0000-0002-8475-8251; Deng, Liufu/0000-0002-1164-6777; Yang, Xuanming/0000-0002-3261-8206; Darga, Thomas/0000-0002-8968-6701; Li, Xiao-Dong/0000-0002-4349-6996; fu, yang-xin/0000-0001-8441-6617	US National Institutes of Health grants [CA141975, CA134563, CA111423, R01 CA181160]; Ludwig Foundation; NATIONAL CANCER INSTITUTE [R01CA111423, R01CA141975, R01CA181160, R01CA134563] Funding Source: NIH RePORTER	US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge J.A. Wroblewska, X. Guo, and Y. Zhang for helpful scientific discussion. We thank R. Torres for expert technical assistance. This work was in part supported by US National Institutes of Health grants CA141975 and CA134563 to Y.-X. F., CA111423 to R.R.W., R01 CA181160 to T.F.G., a grant from the Ludwig Foundation to R.R.W., and a generous gift from The Foglia Foundation (Y.-X.F. and R.R.W.).	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liang H, 2013, J IMMUNOL, V190, P5874, DOI 10.4049/jimmunol.1202612; Liauw SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005148; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	41	1024	1074	19	171	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					843	852		10.1016/j.immuni.2014.10.019	http://dx.doi.org/10.1016/j.immuni.2014.10.019			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517616	Green Accepted, Bronze			2022-12-18	WOS:000345504900019
J	Gaboriau-Routhiau, V; Rakotobe, S; Lecuyer, E; Mulder, I; Lan, A; Bridonneau, C; Rochet, V; Pisi, A; De Paepe, M; Brandi, G; Eberl, G; Snel, J; Kelly, D; Cerf-Bensussan, N				Gaboriau-Routhiau, Valerie; Rakotobe, Sabine; Lecuyer, Emelyne; Mulder, Imke; Lan, Annaig; Bridonneau, Chantal; Rochet, Violaine; Pisi, Annamaria; De Paepe, Marianne; Brandi, Giovanni; Eberl, Gerard; Snel, Johannes; Kelly, Denise; Cerf-Bensussan, Nadine			The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses	IMMUNITY			English	Article							MUCOSAL IMMUNE-SYSTEM; COMMENSAL BACTERIA; INTESTINAL BACTERIA; LAMINA PROPRIA; MICROBIOTA; MICE; HOMEOSTASIS; IGA; DIFFERENTIATION; DISEASE	Microbiota-induced cytokine responses participate in gut homeostasis, but the cytokine balance at steady-state and the role of individual bacterial species in setting the balance remain elusive. Herein, systematic analysis of gnotobiotic mice indicated that colonization by a whole mouse microbiota orchestrated a broad spectrum of proinflammatory T helper 1 (Th1), Th17, and regulatory T cell responses whereas most tested complex microbiota and individual bacteria failed to efficiently stimulate intestinal T cell responses. This function appeared the prerogative of a restricted number of bacteria, the prototype of which is the segmented filamentous bacterium, a nonculturable Clostridia-related species, which could largely recapitulate the coordinated maturation of T cell responses induced by the whole mouse microbiota. This bacterium, already known as a potent inducer of mucosal IgA, likely plays a unique role in the postnatal maturation of gut immune functions. Changes in the infant flora may thus influence the development of host immune responses.	[Gaboriau-Routhiau, Valerie; Rakotobe, Sabine; Lecuyer, Emelyne; Bridonneau, Chantal; Rochet, Violaine] INRA, U910, Unite Ecol & Physiol Syst Digestif, F-78350 Jouy En Josas, France; [Gaboriau-Routhiau, Valerie; Rakotobe, Sabine; Lecuyer, Emelyne; De Paepe, Marianne; Cerf-Bensussan, Nadine] Univ Paris 05, INSERM, U793, F-75730 Paris 15, France; [Mulder, Imke; Lan, Annaig; Kelly, Denise] Univ Aberdeen, Coll Life Sci & Med, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland; [Pisi, Annamaria] Univ Bologna, DISTA, I-40127 Bologna, Italy; [Brandi, Giovanni] Univ Bologna, Policlin St Orsola, Dept Hemathol & Oncol Sci Seragnoli, I-40127 Bologna, Italy; [Eberl, Gerard] Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA 1961, F-75724 Paris 15, France; [Snel, Johannes] NIZO Food Res, NL-6710 BA Ede, Netherlands	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Aberdeen; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; NIZO Food Research	Gaboriau-Routhiau, V (corresponding author), INRA, U910, Unite Ecol & Physiol Syst Digestif, F-78350 Jouy En Josas, France.	valerie.gaboriau-routhiau@inserm.fr	Eberl, Gerard/A-1160-2013; RAKOTOBE, Sabine/H-9535-2017; Brandi, Giovanni/AAD-6327-2021; Cerf-Bensussan, nadine/H-9505-2017; LAN, ANNAIG/AAM-1363-2020; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; LECUYER, Emelyne/ABG-2277-2020	RAKOTOBE, Sabine/0000-0001-7622-755X; Brandi, Giovanni/0000-0003-0013-2858; Cerf-Bensussan, nadine/0000-0003-0665-1245; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; LECUYER, Emelyne/0000-0002-4396-9511; Eberl, Gerard/0000-0002-1119-5638; Lan, Annaig/0000-0003-2044-9377	INSERM; Universite Paris Descartes; INRA; Fondation Princesse Grace; Institut Danone-Fondation pour la Recherche Medicale (INSERM U793); RERAD (Rowett Institute); La Region Ile de France; Marie-Curie network Cross-talk	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; INRA; Fondation Princesse Grace; Institut Danone-Fondation pour la Recherche Medicale (INSERM U793); RERAD (Rowett Institute); La Region Ile de France(Region Ile-de-France); Marie-Curie network Cross-talk(European Commission)	The authors acknowledge funding from INSERM, Universite Paris Descartes, INRA, Fondation Princesse Grace, Institut Danone-Fondation pour la Recherche Medicale (INSERM U793), and RERAD (Rowett Institute). M.D.P. has a fellowship from La Region Ile de France. E.L. is part of a PhD programme supported by the Marie-Curie network Cross-talk.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brandi G, 1996, ULTRASTRUCT PATHOL, V20, P203, DOI 10.3109/01913129609016316; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; GUYGRAND D, 1974, EUR J IMMUNOL, V4, P435, DOI 10.1002/eji.1830040610; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; KLAASEN HLBM, 1992, FEMS MICROBIOL LETT, V88, P165, DOI 10.1016/0378-1097(92)90801-T; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; KLAASEN HLBM, 1991, ARCH MICROBIOL, V156, P148, DOI 10.1007/BF00290989; Lan A, 2007, BRIT J NUTR, V97, P714, DOI 10.1017/S0007114507433001; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Snel J, 1998, CAN J MICROBIOL, V44, P1177, DOI 10.1139/cjm-44-12-1177; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	41	994	1087	8	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					677	689		10.1016/j.immuni.2009.08.020	http://dx.doi.org/10.1016/j.immuni.2009.08.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833089	Bronze			2022-12-18	WOS:000271403900018
J	Zhang, XH; Sun, SQ; Hwang, IK; Tough, DF; Sprent, J				Zhang, XH; Sun, SQ; Hwang, IK; Tough, DF; Sprent, J			Potent and selective stimulation of memory-phenotype CD8(+) T cells in vivo by IL-15	IMMUNITY			English	Article							LYMPHOID ORGANS; LIFE-SPANS; NAIVE; INTERLEUKIN-2; LYMPHOCYTES; RECEPTOR; EXPRESSION; RESPONSES; INDUCTION; CLONING	Proliferation of memory-phenotype (CD44(hi)) CD8(+) cells induced by infectious agents can be mimicked by injection of type I interferon (IFN I) and by IFN I-inducing agents such as lipopolysaccharide and Poly I:C; such proliferation does not affect naive T cells and appears to be TCR independent. Since IFN I inhibits proliferation in vitro, IFN I-induced proliferation of CD8(+) cells in vivo presumably occurs indirectly through production of secondary cytokines, e.g., interleukin-2 (IL-2) or IL-15. We show here that, unlike IL-2, IL-15 closely mimics the effects of IFN I in causing strong and selective stimulation of memory-phenotype CD44(hi) CD8(+) (but not CD4(+)) cells in vivo; similar specificity applies to purified T cells in vitro and correlates with much higher expression of IL-2R beta on CD8(+) cells than on CD4(+) cells.	Scripps Res Inst, Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sprent, J (corresponding author), Scripps Res Inst, Res Inst, Dept Immunol, IMM4, La Jolla, CA 92037 USA.			Hwang, Inkyu/0000-0001-8997-6090	NATIONAL CANCER INSTITUTE [R01CA038355, P01CA025803, R37CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487] Funding Source: NIH RePORTER; NCI NIH HHS [CA38355, CA25803] Funding Source: Medline; NIAID NIH HHS [AI21487] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHUR RP, 1986, J EXP MED, V163, P774, DOI 10.1084/jem.163.4.774; Atedzoe BN, 1997, J IMMUNOL, V159, P4966; BAMFORD RN, 1997, IMMUNOLOGIST, V5, P52; Benoist C, 1997, SCIENCE, V276, P2000, DOI 10.1126/science.276.5321.2000; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Doherty TM, 1996, J IMMUNOL, V156, P735; Everett N. B., 1967, International Review of Cytology, V22, P205, DOI 10.1016/S0074-7696(08)61836-7; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Kanegane H, 1996, BLOOD, V88, P230; KAPPLER JW, 1974, J IMMUNOL, V113, P27; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kennedy Mary K., 1998, P443; Kennedy MK, 1996, J CLIN IMMUNOL, V16, P134, DOI 10.1007/BF01540911; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Miller J F, 1969, Transplant Rev, V1, P3; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; ROCHA B, 1983, J IMMUNOL, V131, P2158; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; SPRENT J, 1985, J EXP MED, V162, P2068, DOI 10.1084/jem.162.6.2068; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891	30	986	1012	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					591	599		10.1016/S1074-7613(00)80564-6	http://dx.doi.org/10.1016/S1074-7613(00)80564-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620680	Bronze			2022-12-18	WOS:000073885400007
J	Jha, AK; Huang, SCC; Sergushichev, A; Lampropoulou, V; Ivanova, Y; Loginicheva, E; Chmielewski, K; Stewart, KM; Ashall, J; Everts, B; Pearce, EJ; Driggers, EM; Artyomov, MN				Jha, Abhishek K.; Huang, Stanley Ching-Cheng; Sergushichev, Alexey; Lampropoulou, Vicky; Ivanova, Yulia; Loginicheva, Ekaterina; Chmielewski, Karina; Stewart, Kelly M.; Ashall, Juliet; Everts, Bart; Pearce, Edward J.; Driggers, Edward M.; Artyomov, Maxim N.			Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization	IMMUNITY			English	Article							NITRIC-OXIDE; GLYCOSYLATION; IMMUNITY; INNATE	Macrophage polarization involves a coordinated metabolic and transcriptional rewiring that is only partially understood. By using an integrated high-throughput transcriptional-metabolic profiling and analysis pipeline, we characterized systemic changes during murine macrophage M1 and M2 polarization. M2 polarization was found to activate glutamine catabolism and UDP-GlcNAc-associated modules. Correspondingly, glutamine deprivation or inhibition of N-glycosylation decreased M2 polarization and production of chemokine CCL22. In M1 macrophages, we identified a metabolic break at Idh, the enzyme that converts isocitrate to alpha-ketoglutarate, providing mechanistic explanation for TCA cycle fragmentation. 13 C-tracer studies suggested the presence of an active variant of the aspartate-arginosuccinate shunt that compensated for this break. Consistently, inhibition of aspartate-aminotransferase, a key enzyme of the shunt, inhibited nitric oxide and interleukin-6 production in M1 macrophages, while promoting mitochondrial respiration. This systems approach provides a highly integrated picture of the physiological modules supporting macrophage polarization, identifying potential pharmacologic control points for both macrophage phenotypes.	[Jha, Abhishek K.; Chmielewski, Karina; Stewart, Kelly M.; Driggers, Edward M.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Huang, Stanley Ching-Cheng; Sergushichev, Alexey; Lampropoulou, Vicky; Ivanova, Yulia; Loginicheva, Ekaterina; Ashall, Juliet; Everts, Bart; Pearce, Edward J.; Artyomov, Maxim N.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Sergushichev, Alexey] ITMO Univ, St Petersburg 197101, Russia	Agios Pharmaceuticals; Washington University (WUSTL); ITMO University	Driggers, EM (corresponding author), Gen Metabol, 30 Arlington St, Winchester, MA 01890 USA.	edward.driggers@generalmetabolics.com; martyomov@pathology.wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019; Everts, Bart/H-6986-2016; Sergushichev, Alexey A/J-8756-2015	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Everts, Bart/0000-0002-3764-5131; Sergushichev, Alexey A/0000-0003-1159-7220; Jha, Abhishek/0000-0001-9161-0450				Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beisser D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-72; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bordbar A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.21; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Geisbrecht BV, 1999, J BIOL CHEM, V274, P30527, DOI 10.1074/jbc.274.43.30527; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; KOCH HU, 1979, EUR J BIOCHEM, V94, P515, DOI 10.1111/j.1432-1033.1979.tb12920.x; Lehninger A., 2008, LEHNINGER PRINCIPLES, P684; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Schmidlin A, 1998, GLIA, V24, P428, DOI 10.1002/(SICI)1098-1136(199812)24:4<428::AID-GLIA8>3.0.CO;2-1; Shanware NP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5900; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; STADLER J, 1991, AM J PHYSIOL, V260, pC910, DOI 10.1152/ajpcell.1991.260.5.C910; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vats D, 2006, CELL METAB, V4, P255, DOI 10.1016/j.cmet.2006.08.006; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zhu J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001301	38	985	1022	17	134	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					419	430		10.1016/j.immuni.2015.02.005	http://dx.doi.org/10.1016/j.immuni.2015.02.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786174	Green Submitted, Bronze			2022-12-18	WOS:000351301900008
J	Varfolomeev, EE; Schuchmann, M; Luria, V; Chiannilkulchai, N; Beckmann, JS; Mett, IL; Rebrikov, D; Brodianski, VM; Kemper, OC; Kollet, O; Lapidot, T; Soffer, D; Sobe, T; Avraham, KB; Goncharov, T; Holtmann, H; Lonai, P; Wallach, D				Varfolomeev, EE; Schuchmann, M; Luria, V; Chiannilkulchai, N; Beckmann, JS; Mett, IL; Rebrikov, D; Brodianski, VM; Kemper, OC; Kollet, O; Lapidot, T; Soffer, D; Sobe, T; Avraham, KB; Goncharov, T; Holtmann, H; Lonai, P; Wallach, D			Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally	IMMUNITY			English	Article							NF-KAPPA-B; APOPTOSIS-MEDIATING RECEPTOR; NECROSIS-FACTOR RECEPTOR-1; DOMAIN-CONTAINING RECEPTOR; ADAPTER MOLECULE; JUN KINASE; ACTIVATION; PROTEIN; PROLIFERATION; PROTEASES	Homozygous targeted disruption of the mouse Caspase 8 (Casp8) gene was found to be lethal in utero. The Caspase 8 null embryos exhibited impaired heart muscle development and congested accumulation of erythrocytes. Recovery of hematopoietic colony-forming cells from the embryos was very low. In fibroblast strains derived from these embryos, the TNF receptors, Fas/Apo1, and DR3 were able to activate the Jun N-terminal kinase and to trigger I kappa B alpha phosphorylation and degradation. They failed, however, to induce cell death, while doing so effectively in wild-type fibroblasts. These findings indicate that Caspase 8 plays a necessary and nonredundant role in death induction by several receptors of the TNF/NGF family and serves a vital role in embryonal development.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Genethon, URA CNRS 1922, F-91002 Evry, France; Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, IL-69978 Tel Aviv, Israel; Sch Med, Inst Mol Pharmacol, D-30623 Hannover, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Rebrikov, Denis/AAH-3811-2020; Kollet, Orit/A-6861-2008; Lapidot, Tsvee/A-1812-2010; Beckmann, Jacques S/A-9772-2008; Rebrikov, Denis/G-8672-2016	Beckmann, Jacques S/0000-0002-9741-1900; Rebrikov, Denis/0000-0002-1884-1807; Avraham, Karen B/0000-0002-4913-251X; Luria, Victor/0000-0003-0558-0983				Ahmad M, 1997, CANCER RES, V57, P615; ALMAZAN G, 1992, BRAIN RES, V579, P234, DOI 10.1016/0006-8993(92)90056-F; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CONLON RA, 1992, METHOD ENZYMOL, V225, P361; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FINTER NB, 1969, J GEN VIROL, V5, P419, DOI 10.1099/0022-1317-5-3-419; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; GRUSS HJ, 1995, CYTOKINES MOL THER, V1, P75; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Matsumoto M, 1997, IMMUNOL REV, V156, P137, DOI 10.1111/j.1600-065X.1997.tb00965.x; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGY A, 1993, GENE TARGETING PRACT, V147; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; WALLACH D, 1984, J IMMUNOL, V132, P2464; WALLACH D, 1997, NATURE, V388, P125; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	59	982	1002	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1998	9	2					267	276		10.1016/S1074-7613(00)80609-3	http://dx.doi.org/10.1016/S1074-7613(00)80609-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729047	Bronze			2022-12-18	WOS:000075610300013
J	Liddelow, SA; Barres, B				Liddelow, Shane A.; Barres, Ben A.			Reactive Astrocytes: Production, Function, and Therapeutic Potential	IMMUNITY			English	Review							NF-KAPPA-B; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD REGENERATION; PLURIPOTENT STEM-CELLS; INTERMEDIATE-FILAMENT; SIGNALING CONTROLS; SCAR FORMATION; MOTOR-NEURONS; UP-REGULATION; NITRIC-OXIDE	Astrocytes constitute approximately 30% of the cells in the mammalian central nervous system (CNS). They are integral to brain and spinal-cord physiology and perform many functions important for normal neuronal development, synapse formation, and proper propagation of action potentials. We still know very little, however, about how these functions change in response to immune attack, chronic neurodegenerative disease, or acute trauma. In this review, we summarize recent studies that demonstrate that different initiating CNS injuries can elicit at least two types of "reactive'' astrocytes with strikingly different properties, one type being helpful and the other harmful. We will also discuss new methods for purifying and investigating reactive-astrocyte functions and provide an overview of new markers for delineating these different states of reactive astrocytes. The discovery that astrocytes have different types of reactive states has important implications for the development of new therapies for CNS injury and diseases.	[Liddelow, Shane A.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Liddelow, SA; Barres, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	liddelow@stanford.edu; barres@stanford.edu	Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437				Ajtai BM, 1998, BRAIN RES, V802, P285, DOI 10.1016/S0006-8993(98)00622-2; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; ANDERSON MJ, 1984, J HISTOCHEM CYTOCHEM, V32, P1099, DOI 10.1177/32.10.6481149; [Anonymous], 1856, GESAMMELTE ABH; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; BERNSTEIN JJ, 1967, EXP NEUROL, V19, P25, DOI 10.1016/0014-4886(67)90004-0; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bloom O, 2014, EXP NEUROL, V258, P130, DOI 10.1016/j.expneurol.2013.12.023; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004; Boulay AC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.5; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; CANADY KS, 1992, J NEUROSCI, V12, P1001; Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cekanaviciute E, 2014, J IMMUNOL, V193, P139, DOI 10.4049/jimmunol.1303284; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; CHAO CC, 1992, J IMMUNOL, V149, P2736; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Crosio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017187; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dieters O., 1865, UNTERSUCHUNGEN GEHIR; Doherty J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001985; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; EGAR M, 1972, EXP NEUROL, V37, P422, DOI 10.1016/0014-4886(72)90085-4; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gu JH, 2008, J NEURO-ONCOL, V89, P9, DOI 10.1007/s11060-008-9590-9; Hayakawa K, 2014, STEM CELL RES, V12, P531, DOI 10.1016/j.scr.2013.12.008; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsiao HY, 2013, HUM MOL GENET, V22, P1826, DOI 10.1093/hmg/ddt036; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; HUNG YH, 1991, EXP NEUROL, V112, P273, DOI 10.1016/0014-4886(91)90127-X; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7; Kalman M, 2013, J EXP ZOOL PART B, V320, P351, DOI 10.1002/jez.b.22505; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kanski R, 2014, CELL MOL LIFE SCI, V71, P433, DOI 10.1007/s00018-013-1435-9; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Krencik R, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00025; Lang DM, 2008, DEV NEUROBIOL, V68, P899, DOI 10.1002/dneu.20624; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liedtke W, 1998, AM J PATHOL, V152, P251; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MARGOTTA V, 1991, J HIRNFORSCH, V32, P485; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Migheli A, 1997, J NEUROPATH EXP NEUR, V56, P1314, DOI 10.1097/00005072-199712000-00006; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; MURRAY M, 1976, J COMP NEUROL, V168, P175, DOI 10.1002/cne.901680202; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; OHARA CM, 1992, DEV DYNAM, V193, P103, DOI 10.1002/aja.1001930202; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Puschmann TB, 2014, J NEUROCHEM, V128, P878, DOI 10.1111/jnc.12519; REIER PJ, 1979, BRAIN RES, V164, P61, DOI 10.1016/0006-8993(79)90006-4; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; Sharif A, 2012, METHODS MOL BIOL, V814, P137, DOI 10.1007/978-1-61779-452-0_11; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; SOMJEN GG, 1988, GLIA, V1, P2, DOI 10.1002/glia.440010103; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Szekely A.D., 1991, ANAT ANZ S, V170, P689; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; Virchow R., 1855, VIRCH ARCH, V8, P537, DOI 10.1007/bf01936110; von Lenhossek M, 1895, FEINERE BAU NERVENSY; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	111	976	1009	13	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					957	967		10.1016/j.immuni.2017.06.006	http://dx.doi.org/10.1016/j.immuni.2017.06.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636962	Bronze			2022-12-18	WOS:000403665900005
J	Cosman, D; Mullberg, J; Sutherland, CL; Chin, W; Armitage, R; Fanslow, W; Kubin, M; Chalupny, NJ				Cosman, D; Mullberg, J; Sutherland, CL; Chin, W; Armitage, R; Fanslow, W; Kubin, M; Chalupny, NJ			ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; LEUCINE-ZIPPER; T-CELLS; B-CELLS; FAMILY; GENE; RECOGNITION; EXPRESSION; HOMOLOG	The human cytomegalovirus glycoprotein, UL16, binds to two members of a novel family of molecules, the ULBPs, and to the MHC class I homolog, MICE. The ULBPs are GPI-linked glycoproteins belonging to the extended MHC class I family but are only distantly related to MICE. The ULBP and MICE molecules are ligands for the activating receptor, NKG2D/DAP10, and this interaction is blocked by a soluble form of UL16. The ULBPs stimulate cytokine and chemokine production from NK cells, and expression of ULBPs in NK cell-resistant target cells confers susceptibility to NK cell cytotoxicity. Masking of NK cell recognition of ULBP or MIC antigens by UL16 provides a potential mechanism by which human cytomegalovirus-infected cells might evade attack by the immune system.	Immunex Corp, Dept Biol Mol, Seattle, WA 98101 USA; Immunex Corp, Dept Immunobiol, Seattle, WA 98101 USA	Immunex Corporation; Immunex Corporation	Cosman, D (corresponding author), Immunex Corp, Dept Biol Mol, 51 Univ St, Seattle, WA 98101 USA.							Ando H, 1997, IMMUNOGENETICS, V46, P499, DOI 10.1007/s002510050311; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Britt W. J., 1996, FIELDS VIROLOGY, P2493; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9; FANSLOW WC, 1992, J IMMUNOL, V149, P655; Farrell HE, 1999, IMMUNOL REV, V168, P187, DOI 10.1111/j.1600-065X.1999.tb01293.x; Fodil N, 1996, IMMUNOGENETICS, V44, P351, DOI 10.1007/s002510050136; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GODING JW, 1983, MONOCLONAL ANTIBODIE, P544; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HOUCHINS JP, 1990, J MOL CELL IMMUNOL, V4, P295; KAYE J, 1992, J VIROL, V66, P6609, DOI 10.1128/JVI.66.11.6609-6615.1992; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LEELAYUWAT C, 1994, IMMUNOGENETICS, V40, P339, DOI 10.1007/BF01246675; Leong CC, 1998, J EXP MED, V187, P1681, DOI 10.1084/jem.187.10.1681; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; Lopez-Botet M, 2000, HUM IMMUNOL, V61, P7, DOI 10.1016/S0198-8859(99)00161-5; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; YABE T, 1993, IMMUNOGENETICS, V37, P455; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579	44	972	1069	1	29	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2001	14	2					123	133		10.1016/S1074-7613(01)00095-4	http://dx.doi.org/10.1016/S1074-7613(01)00095-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239445	Bronze			2022-12-18	WOS:000167092500003
J	KAWABE, T; NAKA, T; YOSHIDA, K; TANAKA, T; FUJIWARA, H; SUEMATSU, S; YOSHIDA, N; KISHIMOTO, T; KIKUTANI, H				KAWABE, T; NAKA, T; YOSHIDA, K; TANAKA, T; FUJIWARA, H; SUEMATSU, S; YOSHIDA, N; KISHIMOTO, T; KIKUTANI, H			THE IMMUNE-RESPONSES IN CD40-DEFICIENT MICE - IMPAIRED IMMUNOGLOBULIN CLASS SWITCHING AND GERMINAL CENTER FORMATION	IMMUNITY			English	Article							HUMAN B-CELLS; HUMAN LYMPHOCYTES-B; PROTEIN-TYROSINE PHOSPHORYLATION; VIVO CD40-GP39 INTERACTIONS; DEPENDENT HUMORAL IMMUNITY; X-LINKED IMMUNODEFICIENCY; RECOMBINANT CD40 LIGAND; CTLA-4 COUNTER-RECEPTOR; HYPER-IGM SYNDROME; ACTIVATED T-CELLS	An engagement of CD40 with CD40 ligand (CD40L) expressed on activated T cells is known to provide an essential costimulatory signal to B cells in vitro. To investigate the role of CD40 in in vivo immune responses, CD40-deficient mice were generated by gene targeting. The significant reduction of CD23 expression on mature B cells and relatively decreased number of IgM bright and IgD dull B cells were observed in the mutant mice. The mutant mice mounted IgM responses but no IgG, IgA, and IgE responses to thymus-dependent (TD) antigens. However, IgG as well as IgM responses to thymus-independent (TI) antigens were normal. Furthermore, the germinal center formation was defective in the mutant mice. These results suggest that CD40 is essential for T cell-dependent immunoglobulin class switching and germinal center formation, but not for in vivo T cell-dependent IgM responses and T cell-independent antibody responses.	OSAKA UNIV, SCH MED, DEPT MED 3, SUITA, OSAKA 565, JAPAN; OSAKA MED CTR MATERNAL & CHILD HLTH, RES INST, IZUMI, OSAKA 59002, JAPAN	Osaka University	KAWABE, T (corresponding author), OSAKA UNIV, INST MOLEC & CELLULAR BIOL, 1-3 YAMADA OKA, SUITA, OSAKA 565, JAPAN.		Tanaka, Takashi/O-8254-2015; Kikutani, Hitoshi/C-9525-2009; Kishimoto, Tadamitsu/C-8470-2009; Kawabe, Tsutomu/I-6277-2014	Naka, Tetsuji/0000-0002-1269-3997; Kawabe, Tsutomu/0000-0002-9319-9930				ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; BARRETT TB, 1991, J IMMUNOL, V146, P1722; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; DEFRANCE T, 1987, J EXP MED, V165, P1459, DOI 10.1084/jem.165.6.1459; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; FARRAH T, 1992, NATURE, V358, P26, DOI 10.1038/358026b0; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; FULLER KA, 1993, J IMMUNOL, V151, P4505; GALY AHM, 1992, J IMMUNOL, V149, P775; GASCAN H, 1991, J IMMUNOL, V147, P8; GRABSTEIN KH, 1993, J IMMUNOL, V150, P3141; GRIMALDI JC, 1992, J IMMUNOL, V149, P3921; HART DNJ, 1988, J EXP MED, V168, P157, DOI 10.1084/jem.168.1.157; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; HOWARD MC, 1992, PROGR IMMUNOLOGY, V8, P327; INUI S, 1990, EUR J IMMUNOL, V20, P1747, DOI 10.1002/eji.1830200819; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; KANSAS GS, 1991, J IMMUNOL, V147, P4094; KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8; KNOX KA, 1993, EUR J IMMUNOL, V23, P2578, DOI 10.1002/eji.1830231030; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; LEDBETTER JA, 1987, J IMMUNOL, V138, P788; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; MALISZEWSKI CR, 1993, EUR J IMMUNOL, V23, P1044, DOI 10.1002/eji.1830230510; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MONGINI PKA, 1981, J EXP MED, V153, P1, DOI 10.1084/jem.153.1.1; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; NORTARANGELO LD, 1992, IMMUNODEF REV, V3, P101; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; SAELAND S, 1992, EXP HEMATOL, V20, P24; SAELAND S, 1993, J EXP MED, V178, P113, DOI 10.1084/jem.178.1.113; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHAPIRA SK, 1992, J EXP MED, V175, P289, DOI 10.1084/jem.175.1.289; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TORRES RM, 1992, J IMMUNOL, V148, P620; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; UCKUN FM, 1991, J BIOL CHEM, V266, P17478; VALLE A, 1989, EUR J IMMUNOL, V19, P1463, DOI 10.1002/eji.1830190818; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; YOUNG LS, 1989, INT J CANCER, V43, P786, DOI 10.1002/ijc.2910430508; ZHANG K, 1991, J IMMUNOL, V146, P1836	67	972	1002	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1994	1	3					167	178		10.1016/1074-7613(94)90095-7	http://dx.doi.org/10.1016/1074-7613(94)90095-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7534202				2022-12-18	WOS:A1994PK16500001
J	Takeda, K; Clausen, BE; Kaisho, T; Tsujimura, T; Terada, N; Forster, I; Akira, S				Takeda, K; Clausen, BE; Kaisho, T; Tsujimura, T; Terada, N; Forster, I; Akira, S			Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils	IMMUNITY			English	Article							INFLAMMATORY BOWEL-DISEASE; CD4(+) T-CELLS; TARGETED DISRUPTION; INTERLEUKIN-10-DEFICIENT MICE; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAY; GENE-REGULATION; RESPONSES; TRANSCRIPTION; MECHANISMS	We have generated mice with a cell type-specific disruption of the Stat3 gene in macrophages and neutrophils, The mutant mice are highly susceptible to endotoxin shock with increased production of inflammatory cytokines such as TNF alpha, IL-1, IFN gamma, and IL-6. Endotoxin-induced production of inflammatory cytokines is augmented because the suppressive effects of IL-10 on inflammatory cytokine production from macrophages and neutrophils are completely abolished. The mice show a polarized immune response toward the Th1 type and develop chronic enterocolitis with age. Taken together, Stat3 plays a critical role in deactivation of macrophages and neutrophils mainly exerted by IL-10.	Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1010062, Japan	Hyogo College of Medicine; Hyogo College of Medicine; University of Cologne; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Hyogo Coll Med, Dept Biochem, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	akira@hyo-med.ac.jp	Kaisho, Tsuneyasu/B-4130-2012; Akira, Shizuo/C-3134-2009; CLAUSEN, Björn Erik/A-8229-2010; Förster, Irmgard/P-8545-2016; Takeda, Kiyoshi/C-9331-2009	CLAUSEN, Björn Erik/0000-0002-2484-7842; Förster, Irmgard/0000-0002-7644-5642; 				ADAMS DO, 1987, IMMUNOL REV, V97, P5, DOI 10.1111/j.1600-065X.1987.tb00514.x; Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; BONIFER C, 1994, EUR J BIOCHEM, V226, P227, DOI 10.1111/j.1432-1033.1994.tb20045.x; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Davidson RJ, 1996, NEUROPSYCHOLOGY, V10, P241; DE WMR, 1991, J EXP MED, V174, P1209; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kuhn R, 1997, CURR OPIN IMMUNOL, V9, P183, DOI 10.1016/S0952-7915(97)80133-1; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lai CF, 1996, J BIOL CHEM, V271, P13968, DOI 10.1074/jbc.271.24.13968; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Wehinger J, 1996, FEBS LETT, V394, P365, DOI 10.1016/0014-5793(96)00990-8; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	39	970	1007	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					39	49		10.1016/S1074-7613(00)80005-9	http://dx.doi.org/10.1016/S1074-7613(00)80005-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023769	Bronze			2022-12-18	WOS:000078428700005
J	Honda, K; Takaoka, A; Taniguchi, T				Honda, Kenya; Takaoka, Akinori; Taniguchi, Tadatsugu			Type I inteferon gene induction by the interferon regulatory factor family of transcription factors	IMMUNITY			English	Review							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; RIG-I; CRYSTAL-STRUCTURE; ANTIVIRAL RESPONSE; ALPHA PRODUCTION; POSITIVE FEEDBACK; ADAPTER PROTEIN; CUTTING EDGE	Induction of type I interferons (IFNs) by viruses and other pathogens is crucial for innate immunity, and it is mediated by the activation of pattern-recognition receptors, such as Toll-like receptors and cytosolic receptors such as RIG-I and MDA5. The type I IFN induction is primarily controlled at the gene transcriptional level, wherein a family of transcription factors, interferon regulatory factors (IRFs), plays central roles. Here, we summarize the recent studies on IRFs, providing a paradigm of how genes are ingeniously regulated during immune responses. We also consider some evolutional aspects on the IFN-IRF system.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Honda, Kenya/N-5297-2015					Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Brunetti CR, 1998, J VIROL, V72, P3330, DOI 10.1128/JVI.72.4.3330-3339.1998; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Graff JW, 2002, J VIROL, V76, P9545, DOI 10.1128/JVI.76.18.9545-9550.2002; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim TK, 2000, CANCER RES, V60, P1153; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; NEGISHI H, 2006, IN PRESS P NATL ACAD; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; REIS LFL, 1989, J BIOL CHEM, V264, P16351; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seya T, 2005, INT J BIOCHEM CELL B, V37, P524, DOI 10.1016/j.biocel.2004.07.018; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takeshita F, 2005, EUR J IMMUNOL, V35, P2477, DOI 10.1002/eji.200526151; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; TANIGUCHI T, 1980, NATURE, V285, P547, DOI 10.1038/285547a0; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	107	965	1006	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					349	360		10.1016/j.immuni.2006.08.009	http://dx.doi.org/10.1016/j.immuni.2006.08.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979567	Bronze			2022-12-18	WOS:000240862200002
J	POWRIE, F; LEACH, MW; MAUZE, S; MENON, S; CADDLE, LB; COFFMAN, RL				POWRIE, F; LEACH, MW; MAUZE, S; MENON, S; CADDLE, LB; COFFMAN, RL			INHIBITION OF TH1 RESPONSES PREVENTS INFLAMMATORY BOWEL-DISEASE IN SCID MICE RECONSTITUTED WITH CD45RB(HI) CD4(+) T-CELLS	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; INTESTINAL EPITHELIAL MONOLAYERS; INTERLEUKIN-10 PROTECTS MICE; INTERFERON-GAMMA PRODUCTION; IFN-GAMMA; BOWEL-DISEASE; CYTOKINE PRODUCTION; MONOCLONAL-ANTIBODIES; ULCERATIVE-COLITIS; FACTOR CACHECTIN	We have described a murine model of IBD that was induced in C.B-17 scid mice by transfer of the CD45RB(hi) subpopulation of CD4(+) T cells from normal BALB/c mice and could be prevented by cotransfer of the CD45RB(lo) CD4(+) T cell subset. Here we have dissected the mechanism of pathogenesis of IBD in this model and used this information for rational immunotherapy of the disease. CD4(+) cells from diseased mice displayed a highly polarized Th1 pattern of cytokine synthesis upon polyclonal stimulation in vitro. The administration of anti-IFN gamma MAb to mice soon after T cell transfer prevented development of colitis for up to 12 weeks. Continual neutralization of TNF with anti-TNF MAbs reduced the incidence of severe disease; however, neutralization of TNF during only the first 3-4 weeks had no effect. Severe colitis was completely abrogated in mice treated systemically with rlL-10, but not with rlL-4.	SCHERING PLOUGH CORP,RES INST,LAFAYETTE,NJ 07848	Merck & Company; Schering Plough Corporation	POWRIE, F (corresponding author), DNAX RES INST MOLEC & CELLULAR BIOL INC,901 CALIF AVE,PALO ALTO,CA 94040, USA.							ABRAMS JS, 1988, J IMMUNOL, V140, P131; ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; BARKIN R, 1992, SEMIN VET MED SURG, V7, P117; BEAGLEY KW, 1992, GASTROENTEROL CLIN N, V21, P347; BEAN AGD, 1993, INFECT IMMUN, V61, P4937, DOI 10.1128/IAI.61.11.4937-4939.1993; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; BREESE E, 1993, IMMUNOLOGY, V78, P127; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; CAPPELLO M, 1992, GUT, V33, P1214, DOI 10.1136/gut.33.9.1214; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; CHOY MY, 1990, GUT, V31, P1365, DOI 10.1136/gut.31.12.1365; Coffman R L, 1982, Immunol Rev, V69, P5; COLGAN SP, 1993, J CELL BIOL, V120, P785, DOI 10.1083/jcb.120.3.785; DOUKAS J, 1990, J IMMUNOL, V145, P1727; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; HUNTER CA, 1993, INFECT IMMUN, V61, P4038, DOI 10.1128/IAI.61.10.4038-4044.1993; ISSEKUTZ TB, 1988, J IMMUNOL, V140, P2989; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LOWES JR, 1990, SPRINGER SEMIN IMMUN, V12, P251; MACDONALD TT, 1990, CLIN EXP IMMUNOL, V81, P301; MACDONALD TT, 1988, J EXP MED, V167, P1341, DOI 10.1084/jem.167.4.1341; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1993, RES IMMUNOL, V144, P629, DOI 10.1016/S0923-2494(05)80016-1; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MOWAT AM, 1989, IMMUNOLOGY, V68, P18; MURPHY E, 1993, J IMMUNOL METHODS, V162, P211, DOI 10.1016/0022-1759(93)90386-L; OLIFF A, 1988, CELL, V54, P141, DOI 10.1016/0092-8674(88)90543-0; PELEMAN R, 1989, J EXP MED, V170, P1751, DOI 10.1084/jem.170.5.1751; PENNLINE KJ, 1994, CLIN IMMUNOL IMMUNOP, V71, P169, DOI 10.1006/clin.1994.1068; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, EUR J IMMUNOL, V23, P2223, DOI 10.1002/eji.1830230926; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; POWRIE F, 1993, RES IMMUNOL, V144, P639, DOI 10.1016/S0923-2494(05)80019-7; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; SARTOR RB, 1992, INFLAMM BOWEL DIS, P175; SCOTT P, 1991, J IMMUNOL, V147, P3149; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P5914, DOI 10.1073/pnas.90.13.5914; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; VANDERHEIJDEN PJ, 1987, J IMMUNOL METHODS, V103, P161, DOI 10.1016/0022-1759(87)90285-7; VERCELLI D, 1990, J IMMUNOL, V144, P570; WOGENSEN L, 1994, J EXP MED, V179, P1379, DOI 10.1084/jem.179.4.1379; [No title captured]	54	959	1007	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					553	562		10.1016/1074-7613(94)90045-0	http://dx.doi.org/10.1016/1074-7613(94)90045-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600284				2022-12-18	WOS:A1994PN12700004
J	Zhong, B; Yang, Y; Li, S; Wang, YY; Li, Y; Diao, FC; Lei, CQ; He, X; Zhang, L; Tien, P; Shu, HB				Zhong, Bo; Yang, Yan; Li, Shu; Wang, Yan-Yi; Li, Ying; Diao, Feici; Lei, Caoqi; He, Xiao; Zhang, Lu; Tien, Po; Shu, Hong-Bing			The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation	IMMUNITY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; STIMULATED RESPONSE ELEMENT; INNATE ANTIVIRAL RESPONSE; TANK-BINDING KINASE-1; HEPATITIS-C VIRUS; IFN-BETA PROMOTER; RIG-I; NEGATIVE REGULATION; VIRAL-INFECTION	Viral infection triggers activation of transcription factors such as NF-kappa B and IRF3, which collaborate to induce type I interferons (IFNs) and elicit innate antiviral response. Here, we identified MITA as a critical mediator of virus-triggered type I IFN signaling by expression cloning. Overexpression of MITA activated IRF3, whereas knockdown of MITA inhibited virus-triggered activation of IRF3, expression of type I IFNs, and cellular antiviral response. MITA was found to localize to the outer membrane of mitochondria and to be associated with VISA, a mitochondrial protein that acts as an adaptor in virus-triggered signaling. MITA also interacted with IRF3 and recruited the kinase TBK1 to the VISA-associated complex. MITA was phosphorylated by TBK1, which is required for MITA-mediated activation of IRF3. Our results suggest that MITA is a critical mediator of virus-triggered IRF3 activation and IFN expression and further demonstrate the importance of certain mitochondrial proteins in innate antiviral immunity.	[Zhong, Bo; Yang, Yan; Li, Shu; Wang, Yan-Yi; Li, Ying; Diao, Feici; Lei, Caoqi; He, Xiao; Zhang, Lu; Tien, Po; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	Zhang, Lu/P-6929-2015		Chinese 973 program [2006CB504301, 2009CB522506]; National Natural Science Foundation of China [30630019, 30700431]; Chinese 863 program [2006AA02A306]	Chinese 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China)	We thank L.-G. Xu, L. Guo, F. Yang, P. Xue, and R.-P. Wang for technique help, W.-C. Yeh, D.-Y. Guo, and Y. Wu for reagents. This work was supported by grants from the Chinese 973 program (#2006CB504301 and #2009CB522506), the National Natural Science Foundation of China (#30630019 and #30700431), and the Chinese 863 program (#2006AA02A306).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; WATHELET MG, 1987, EUR J BIOCHEM, V169, P313, DOI 10.1111/j.1432-1033.1987.tb13614.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	47	956	1025	8	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					538	550		10.1016/j.immuni.2008.09.003	http://dx.doi.org/10.1016/j.immuni.2008.09.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18818105	Bronze			2022-12-18	WOS:000260316700008
J	Hsu, HL; Huang, JN; Shu, HB; Baichwal, V; Goeddel, DV				Hsu, HL; Huang, JN; Shu, HB; Baichwal, V; Goeddel, DV			TNF-Dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATION; EXPRESSION; CLONING	The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD. Here, we show that TRADD interacts strongly with RIP, another death domain protein that was shown previously to associate with Fas antigen. We also show that RIP is a serine-threonine kinase that is recruited by TRADD to TNFR1 in a TNF-dependent process. Overexpression of the intact RIP protein induces both NF-kappa B activation and apoptosis. However, expression of the death domain of RIP induces apoptosis, but potently inhibits NF-kappa B activation by TNF. These results suggest that distinct domains of RIP participate in the TNF signaling cascades leading to apoptosis and NF-kappa B activation.			Hsu, HL (corresponding author), TULARIK INC,270 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.							AUSUBEL FM, 1994, CURR PROT MOL BIOL, V1; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; COLIGAN JE, 1992, CURR PROT IMMUNOL, V2; DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; GOODWIN RG, 1991, MOL CELL BIOL, V11, P3020, DOI 10.1128/MCB.11.6.3020; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; LAEGREID A, 1994, J BIOL CHEM, V269, P7785; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; ROTHE J, 1992, IMMUNOL RES, V11, P81, DOI 10.1007/BF02918612; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Sambrook J, 1989, MOL CLONING LAB MANU; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; VANARSDALE TL, 1994, J IMMUNOL, V153, P3043; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; WONG GHW, 1994, J IMMUNOL, V152, P1751	39	944	1000	0	37	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					387	396		10.1016/S1074-7613(00)80252-6	http://dx.doi.org/10.1016/S1074-7613(00)80252-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612133	Bronze			2022-12-18	WOS:A1996UH52200007
J	Greten, FR; Grivennikov, SI				Greten, Florian R.; Grivennikov, Sergei, I			Inflammation and Cancer: Triggers, Mechanisms, and Consequences	IMMUNITY			English	Review							TUMOR-ASSOCIATED MACROPHAGES; DELTA T-CELLS; NF-KAPPA-B; COLORECTAL-CANCER; BREAST-CANCER; IKK-BETA; INTESTINAL TUMORIGENESIS; PANCREATIC ONCOGENESIS; MAMMARY CARCINOMAS; ADAPTIVE IMMUNITY	Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.	[Greten, Florian R.] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany; [Greten, Florian R.] Goethe Univ Frankfurt, Frankfurt Canc Inst, D-60596 Frankfurt, Germany; [Greten, Florian R.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Greten, Florian R.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Grivennikov, Sergei, I] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA	Octapharma; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Fox Chase Cancer Center	Greten, FR (corresponding author), Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany.; Greten, FR (corresponding author), Goethe Univ Frankfurt, Frankfurt Canc Inst, D-60596 Frankfurt, Germany.; Greten, FR (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.; Greten, FR (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.; Grivennikov, SI (corresponding author), Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA.	greten@gsh.uni-frankfurt.de; Sergey.Grivennikov@fccc.edu	Greten, Florian R/AAF-5196-2020; Grivennikov, Sergei/AAE-7365-2019	Greten, Florian R/0000-0002-3928-6080; Grivennikov, Sergei/0000-0003-2987-0555	National Institutes of Health (NIH) [R01CA227629, CA218133]; Pew Scholar in Biomedical Sciences; AACR-Landon Innovator; US-Israel BSF awards; NIH [P30 CA-006927]; Georg-Speyer-Haus; LOEWE Center Frankfurt Cancer Institute (FCI) - Hessen State Ministry for Higher Education; Research and the Arts [III L 5 - 519/03/03.001 - (0015)]; Deutsche Forschungsgemeinschaft [FOR2438: Gr1916/11-1, SFB 815, SFB 1177, SFB 1292]; German Federal Ministry of Health; Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK); NATIONAL CANCER INSTITUTE [R01CA227629, R01CA218133, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in Biomedical Sciences; AACR-Landon Innovator; US-Israel BSF awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georg-Speyer-Haus; LOEWE Center Frankfurt Cancer Institute (FCI) - Hessen State Ministry for Higher Education; Research and the Arts; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Health; Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to colleagues whose important work could not be cited due to the citation limits. This work was supported by National Institutes of Health (NIH) R01CA227629 and CA218133, Pew Scholar in Biomedical Sciences, AACR-Landon Innovator and US-Israel BSF awards to S.I.G. and NIH P30 CA-006927 to Fox Chase Cancer Center. F.R.G. is supported by institutional funds from the Georg-Speyer-Haus; by the LOEWE Center Frankfurt Cancer Institute (FCI), funded by the Hessen State Ministry for Higher Education; Research and the Arts [III L 5 - 519/03/03.001 - (0015)]; and Deutsche Forschungsgemeinschaft (FOR2438: Gr1916/11-1; SFB 815, 1177 and 1292). The Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health and the Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK).	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Akkari L, 2014, GENE DEV, V28, P2134, DOI 10.1101/gad.249599.114; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Alexander J, 2016, CURR OPIN CELL BIOL, V42, P80, DOI 10.1016/j.ceb.2016.05.002; Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Andon FT, 2017, SEMIN IMMUNOL, V34, P103, DOI 10.1016/j.smim.2017.09.004; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Andriani GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35218; Aran D, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0995-z; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Canli O, 2017, CANCER CELL, V32, P869, DOI 10.1016/j.ccell.2017.11.004; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Chang WCL, 2007, CARCINOGENESIS, V28, P2375, DOI 10.1093/carcin/bgm134; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Das S, 2019, ONCOGENE, V38, P3316, DOI 10.1038/s41388-018-0668-3; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; DeGregori J, 2017, CANCER RES, V77, P6065, DOI 10.1158/0008-5472.CAN-17-1207; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dmitrieva-Posocco O, 2019, IMMUNITY, V50, P166, DOI 10.1016/j.immuni.2018.11.015; Dominguez C, 2017, SEMIN CANCER BIOL, V47, P177, DOI 10.1016/j.semcancer.2017.08.002; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Francart ME, 2018, DEV DYNAM, V247, P432, DOI 10.1002/dvdy.24506; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gatenbee C., 2019, BIORXIV; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greathouse KL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1501-6; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011; Halbrook CJ, 2019, CELL METAB, V29, P1390, DOI 10.1016/j.cmet.2019.02.001; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henry CJ, 2015, J CLIN INVEST, V125, P4666, DOI 10.1172/JCI83024; Hou JJ, 2017, NAT REV IMMUNOL, V17, P401, DOI 10.1038/nri.2017.46; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Iannello A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27616; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jiang H, 2017, CANCER IMMUNOL IMMUN, V66, P1037, DOI 10.1007/s00262-017-2003-1; Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kadariya Y, 2016, CANCER PREV RES, V9, P406, DOI 10.1158/1940-6207.CAPR-15-0347; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kersten K, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1334744; Khambu B, 2018, J CLIN INVEST, V128, P2419, DOI 10.1172/JCI91814; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Koliaraki V, 2017, GASTROENTEROLOGY, V152, P964, DOI 10.1053/j.gastro.2016.11.049; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Krall JA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3464; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Liao WT, 2019, CANCER CELL, V35, P559, DOI 10.1016/j.ccell.2019.02.008; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Majumder S, 2019, NAT IMMUNOL, V20, P534, DOI 10.1038/s41590-019-0367-4; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Malesci A, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1342918; Mantovani A, 2019, J INTERN MED, V285, P524, DOI 10.1111/joim.12886; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Marusyk A, 2016, CANCER RES, V76, P6495, DOI 10.1158/0008-5472.CAN-16-1457; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Medler TR, 2018, CANCER CELL, V34, P561, DOI 10.1016/j.ccell.2018.09.003; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Meisel M, 2018, NATURE, V557, P580, DOI 10.1038/s41586-018-0125-z; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Nywening TM, 2018, GUT, V67, P1112, DOI 10.1136/gutjnl-2017-313738; Ozdemir BC, 2015, CANCER CELL, V28, P831, DOI 10.1016/j.ccell.2015.11.002; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Pallangyo CK, 2015, J EXP MED, V212, P2253, DOI 10.1084/jem.20150576; Panigrahy D., 2019, J CLIN INVEST, V130; Panni R. Z., 2019, SCI TRANSL MED, V11; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Patel S, 2018, NAT IMMUNOL, V19, P1236, DOI 10.1038/s41590-018-0229-5; Ponzetta A., 2019, CELL, V178, P1; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Pylayeva-Gupta Y, 2016, CANCER DISCOV, V6, P247, DOI 10.1158/2159-8290.CD-15-0843; Quail DF, 2019, NAT REV ENDOCRINOL, V15, P139, DOI 10.1038/s41574-018-0126-x; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Roberts E. W. R., 2019, BIORXIV, DOI [10.1101/691873, DOI 10.1101/691873]; Robles AI, 2016, GASTROENTEROLOGY, V150, P931, DOI 10.1053/j.gastro.2015.12.036; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rozhok A, 2019, ELIFE, V8, DOI 10.7554/eLife.39950; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sanchez-Danes A, 2018, NATURE, V562, P434, DOI 10.1038/s41586-018-0603-3; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Shalapour S, 2019, IMMUNITY, V51, P15, DOI 10.1016/j.immuni.2019.06.021; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi Y, 2019, NATURE, V569, P131, DOI 10.1038/s41586-019-1130-6; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Snyder ME, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav5581; Spranger S, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0089-6; Srivatsa S, 2017, GASTROENTEROLOGY, V153, P178, DOI 10.1053/j.gastro.2017.03.053; Suarez-Carmona M, 2017, MOL ONCOL, V11, P805, DOI 10.1002/1878-0261.12095; Sweis RF, 2016, CANCER IMMUNOL RES, V4, P563, DOI 10.1158/2326-6066.CIR-15-0274; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; Tomkovich S, 2019, J CLIN INVEST, V129, P1699, DOI 10.1172/JCI124196; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Varga J, 2017, NAT CELL BIOL, V19, P1133, DOI 10.1038/ncb3611; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yang M, 2018, CANCER RES, V78, P5492, DOI 10.1158/0008-5472.CAN-18-1367; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014; Ziegler PK, 2018, CELL, V174, P88, DOI 10.1016/j.cell.2018.05.028; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	175	942	967	76	350	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					27	41		10.1016/j.immuni.2019.06.025	http://dx.doi.org/10.1016/j.immuni.2019.06.025			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315034	Green Accepted, Bronze			2022-12-18	WOS:000475561000008
J	Pearce, EL; Pearce, EJ				Pearce, Erika L.; Pearce, Edward J.			Metabolic Pathways in Immune Cell Activation and Quiescence	IMMUNITY			English	Review							ALTERNATIVE MACROPHAGE ACTIVATION; NLRP3 INFLAMMASOME ACTIVATION; MULTIPLE SIGNALING PATHWAYS; NITRIC-OXIDE; DENDRITIC CELLS; RETINOIC-ACID; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; IDO EXPRESSION	Studies of immune system metabolism ("immunometabolism'') segregate along two paths. The first investigates the effects of immune cells on organs that regulate whole-body metabolism, such as adipose tissue and liver. The second explores the role of metabolic pathways within immune cells and how this regulates immune response outcome. Distinct metabolic pathways diverge and converge at many levels, and, therefore, cells face choices as to how to achieve their metabolic goals. There is interest in fully understanding how and why immune cells commit to particular metabolic fates and in elucidating the immunologic consequences of reaching a metabolic endpoint by one pathway versus another. This is particularly intriguing, given that metabolic commitment is influenced not only by substrate availability but also by signaling pathways elicited by metabolites. Thus, metabolic choices in cells enforce fate and function, and this area will be the subject of this review.	[Pearce, Erika L.; Pearce, Edward J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Pearce, EL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	erikapearce@path.wustl.edu; edwardpearce@path.wustl.edu			National Cancer Institute; National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [R21CA158823, R01CA164062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank C.-H. Chang, B. Everts, S. Huang, D. O'Sullivan, R. van der Windt, M. Artyomov, D. Bhattacharya and R. Jones for many stimulating discussions that have contributed to the ideas in this review. The authors' research is supported by grants from the National Cancer Institute and the National Institute of Allergy and Infectious Diseases.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Eberl M, 2009, TRENDS IMMUNOL, V30, P562, DOI 10.1016/j.it.2009.09.001; Endo T, 1998, AM J RESP CELL MOL, V19, P300, DOI 10.1165/ajrcmb.19.2.2915; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Norris BA, 2013, IMMUNITY, V38, P309, DOI 10.1016/j.immuni.2012.10.022; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rees DD, 1998, BRIT J PHARMACOL, V124, P540, DOI 10.1038/sj.bjp.0701815; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; SHER R, 1983, CLIN EXP IMMUNOL, V51, P525; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Sumbayev VV, 2009, EUR J IMMUNOL, V39, P3511, DOI 10.1002/eji.200939370; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Thomas GD, 2012, BLOOD, V120, pE93, DOI 10.1182/blood-2012-07-442640; Thompson CB, 2011, COLD SH Q B, V76, P23, DOI 10.1101/sqb.2012.76.010496; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; VALENTINE WN, 1951, J LAB CLIN MED, V38, P39; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Venge P, 2003, RESP MED, V97, P1109, DOI 10.1016/S0954-6111(03)00143-4; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Zemirli N, 2012, INT J BIOCHEM CELL B, V44, P1473, DOI 10.1016/j.biocel.2012.05.018; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	108	940	965	16	146	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					633	643		10.1016/j.immuni.2013.04.005	http://dx.doi.org/10.1016/j.immuni.2013.04.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601682	Bronze, Green Accepted			2022-12-18	WOS:000330942100007
J	Frauwirth, KA; Riley, JL; Harris, MH; Parry, RV; Rathmell, JC; Plas, DR; Elstrom, RL; June, CH; Thompson, CB				Frauwirth, KA; Riley, JL; Harris, MH; Parry, RV; Rathmell, JC; Plas, DR; Elstrom, RL; June, CH; Thompson, CB			The CD28 signaling pathway regulates glucose metabolism	IMMUNITY			English	Article							PROTEIN-KINASE-B; T-CELL PROLIFERATION; BCL-X-L; PHOSPHATIDYLINOSITOL 3-KINASE; CD28-MEDIATED COSTIMULATION; CUTTING EDGE; IN-VIVO; CTLA-4; STIMULATION; SURVIVAL	Lymphocyte activation initiates a program of cell growth, proliferation, and differentiation that increases metabolic demand. Although T cells increase glucose uptake and glycolysis during an immune response, the signaling pathways that regulate these increases remain largely unknown. Here we show that CD28 costimulation, acting through phosphatidylinositol X-kinase (PI3K) and Akt, is required for T cells to increase their glycolytic rate in response to activation. Furthermore, CD28 controls a primary response pathway, inducing a level of glucose uptake and glycolysis in excess of that needed to maintain cellular ATP/ ADP levels or macromolecular synthesis. These data suggest that CD28 costimulation functions to increase glycolytic flux, allowing T cells to anticipate energetic and biosynthetic needs associated with a sustained response.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Riley, James L/D-1255-2009	June, Carl/0000-0003-0241-3557; Riley, James/0000-0002-1057-576X				AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Blair PJ, 1998, J IMMUNOL, V160, P12; Brunner MC, 1999, J IMMUNOL, V162, P5813; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Chuang E, 1999, J IMMUNOL, V162, P1270; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; COOPER EH, 1963, BRIT J HAEMATOL, V9, P101, DOI 10.1111/j.1365-2141.1963.tb05446.x; CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820; CULVENOR JG, 1976, BIOCHIM BIOPHYS ACTA, V437, P354, DOI 10.1016/0304-4165(76)90005-2; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; HEDESKOV CJ, 1968, BIOCHEM J, V110, P373, DOI 10.1042/bj1100373; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lafont V, 2000, FEBS LETT, V486, P38, DOI 10.1016/S0014-5793(00)02235-3; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; RILEY JL, 2002, IN PRESS P NATL ACAD; ROOS D, 1970, BIOCHIM BIOPHYS ACTA, V222, P565, DOI 10.1016/0304-4165(70)90182-0; SAGONE AL, 1974, CELL IMMUNOL, V14, P443, DOI 10.1016/0008-8749(74)90195-6; Scheel-Toellner D, 2002, EUR J IMMUNOL, V32, P486, DOI 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO;2-U; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Summers SA, 1999, ANN NY ACAD SCI, V892, P169, DOI 10.1111/j.1749-6632.1999.tb07795.x; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; TRUITT KE, 1995, J IMMUNOL, V155, P4702; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Wang QH, 1999, MOL CELL BIOL, V19, P4008; WHETTON AD, 1984, EMBO J, V3, P409, DOI 10.1002/j.1460-2075.1984.tb01821.x; Williamson P, 1993, Semin Immunol, V5, P337, DOI 10.1006/smim.1993.1040	52	937	963	3	49	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					769	777		10.1016/S1074-7613(02)00323-0	http://dx.doi.org/10.1016/S1074-7613(02)00323-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121659	Bronze			2022-12-18	WOS:000176534000003
J	Yanaba, K; Bouaziz, JD; Haas, KM; Poe, JC; Fujimoto, M; Tedder, TF				Yanaba, Koichi; Bouaziz, Jean-David; Haas, Karen M.; Poe, Jonathan C.; Fujimoto, Manabu; Tedder, Thomas F.			A regulatory B cell subset with a unique CD1d(hi)CD5(+) phenotype controls T cell-dependent inflammatory responses	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; MARGINAL ZONE; AUTOIMMUNE ENCEPHALOMYELITIS; CONTACT HYPERSENSITIVITY; LYMPHOCYTE DEPLETION; CD19; MICE; EXPRESSION; IMMUNOTHERAPY; INTERLEUKIN-10	B cells mediate multiple functions that influence immune and inflammatory responses. In this study, T cell-mediated inflammation was exaggerated in CD19-deficient (Cd19(-/-)) mice and wild-type mice depleted of CD20(+) B cells, whereas inflammation was substantially reduced in mice with hyperactive B cells as a result of CD19 overexpression (hCD19Tg). These inflammatory responses were negatively regulated by a unique CD1d(hi)CD5(+) B cell subset that was absent in Cd19(-/-) mice, represented only 1%-2% of spleen B220(+) cells in wild-type mice, but was expanded to similar to 10% of spleen B220(+) cells in hCD19Tg mice. Adoptive transfer of these CD1d(hi)CD5(+) B cells normalized inflammation in wild-type mice depleted of CD20+ B cells and in Cd19(-/-) mice. Remarkably, IL-10 production was restricted to this CD1d(hi)CD5(+) B cell subset, with IL-10 production diminished in Cd19(-/-) mice, yet increased in hCD19Tg mice. Thereby, CD1d(hi)CD5(+) B cells represent a unique subset of potent regulatory B cells.	[Yanaba, Koichi; Bouaziz, Jean-David; Haas, Karen M.; Poe, Jonathan C.; Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Yanaba, Koichi; Bouaziz, Jean-David] Kanazawa Univ, Grad Sch Med, Dept Dermatol, Kanazawa, Ishikawa 9208614, Japan	Duke University; Kanazawa University	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	thomas.tedder@duke.edu		Poe, Jonathan/0000-0002-7789-1564; Fujimoto, Manabu/0000-0002-3062-4872	NATIONAL CANCER INSTITUTE [R01CA096547, R01CA105001, R01CA098492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105001, R01 CA096547, CA105001, CA098492, CA96547, R01 CA098492] Funding Source: Medline; NIAID NIH HHS [U19 AI056363, AI56363] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; CONSTANT S, 1995, J IMMUNOL, V155, P3734; Dass S, 2007, ARTHRITIS RHEUM, V56, P2715, DOI 10.1002/art.22811; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Duan BY, 2007, LAB INVEST, V87, P14, DOI 10.1038/labinvest.3700497; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; FERGUSON TA, 1994, J EXP MED, V179, P1597, DOI 10.1084/jem.179.5.1597; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hamaguchi Y, 2005, J IMMUNOL, V174, P4389, DOI 10.4049/jimmunol.174.7.4389; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hasegawa M, 2006, AM J PATHOL, V169, P954, DOI 10.2353/ajpath.2006.060205; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; Itakura A, 2005, J IMMUNOL, V175, P7170, DOI 10.4049/jimmunol.175.11.7170; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Matsushita T, 2006, AM J PATHOL, V168, P812, DOI 10.2353/ajpath.2006.050923; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; SCHWARZ A, 1994, J INVEST DERMATOL, V103, P211, DOI 10.1111/1523-1747.ep12393073; Spencer NFL, 1997, INT IMMUNOL, V9, P745, DOI 10.1093/intimm/9.5.745; Tedder TF, 1998, SEMIN IMMUNOL, V10, P259, DOI 10.1006/smim.1998.0118; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; TEDDER TF, 2007, J IMMUNOL, V179, P1369; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Watanabe R, 2007, AM J PATHOL, V171, P560, DOI 10.2353/ajpath.2007.061279; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yazawa N, 2005, P NATL ACAD SCI USA, V102, P15178, DOI 10.1073/pnas.0505539102	46	927	1006	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					639	650		10.1016/j.immuni.2008.03.017	http://dx.doi.org/10.1016/j.immuni.2008.03.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482568	Bronze			2022-12-18	WOS:000256003900011
J	van der Windt, GJW; Everts, B; Chang, CH; Curtis, JD; Freitas, TC; Amiel, E; Pearce, EJ; Pearce, EL				van der Windt, Gerritje J. W.; Everts, Bart; Chang, Chih-Hao; Curtis, Jonathan D.; Freitas, Tori C.; Amiel, Eyal; Pearce, Edward J.; Pearce, Erika L.			Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8(+) T Cell Memory Development	IMMUNITY			English	Article							OXIDATIVE-PHOSPHORYLATION; SIGNAL-TRANSDUCTION; AEROBIC GLYCOLYSIS; CUTTING EDGE; COMPLEX-I; IL-15; METABOLISM; PROLIFERATION; HOMEOSTASIS; EXPRESSION	CD8(+) T cells undergo major metabolic changes upon activation, but how metabolism influences the establishment of long-lived memory T cells after infection remains a key question. We have shown here that CD8(+) memory T cells, but not CD8(+) T effector (Teff) cells, possessed substantial mitochondrial spare respiratory capacity (SRC). SRC is the extra capacity available in cells to produce energy in response to increased stress or work and as such is associated with cellular survival. We found that interleukin-15 (IL-15), a cytokine critical for CD8(+) memory T cells, regulated SRC and oxidative metabolism by promoting mitochondrial biogenesis and expression of carnitine palmitoyl transferase (CPT1a), a metabolic enzyme that controls the rate-limiting step to mitochondria, fatty acid oxidation (FAO). These results show how cytokines control the bioenergetic stability of memory T cells after infection by regulating mitochondrial metabolism.	[van der Windt, Gerritje J. W.; Everts, Bart; Chang, Chih-Hao; Curtis, Jonathan D.; Freitas, Tori C.; Amiel, Eyal; Pearce, Edward J.; Pearce, Erika L.] Trudeau Inst, Saranac Lake, NY 12983 USA	Trudeau Institute	Pearce, EL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	erikapearce@path.wustl.edu	Everts, Bart/H-6986-2016	Everts, Bart/0000-0002-3764-5131; CHANG, CHIH-HAO/0000-0002-0139-7439	Trudeau Institute; NIH; NIAID; Netherlands Organisation for Scientific Research; Emerald Foundation; NATIONAL CANCER INSTITUTE [R21CA158823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER	Trudeau Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Emerald Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tighe, D. Duso, R. Lacourse, B. Sells, and G. Perona-Wright for technical assistance and D. Woodland and J. Kohlmeier for critical reading of the manuscript. This work was supported in part by the Trudeau Institute, grants from the NIH (E.L.P., E.J.P.), NIAID Institutional Training Grant (E.A.), Netherlands Organisation for Scientific Research (G.J.W.W.), and the Emerald Foundation (E.L.P.). G.J.W.W., BE., J.D.C., E.A., E.J.P., and E.L.P. designed the research and analyzed the data. G.J.W.W., B.E., C.-H.C., J.D.C., T.C.F., and E.L.P. performed experiments. G.J.W.W., B.E., E.J.P., and E.L.P. contributed to the preparation of the manuscript. G.J.W.W. wrote the manuscript with E.L.P.	Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hofmann SR, 2002, CURR OPIN ALLERGY CL, V2, P495, DOI 10.1097/00130832-200212000-00004; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; Sandau MM, 2010, J IMMUNOL, V184, P35, DOI 10.4049/jimmunol.0803355; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Stonier SW, 2008, BLOOD, V112, P4546, DOI 10.1182/blood-2008-05-156307; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Waldmann T, 1998, Int Rev Immunol, V16, P205, DOI 10.3109/08830189809042995; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V124, P269; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	48	921	939	5	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					68	78		10.1016/j.immuni.2011.12.007	http://dx.doi.org/10.1016/j.immuni.2011.12.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22206904	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000299766000011
J	Woo, SR; Fuertes, MB; Corrales, L; Spranger, S; Furdyna, MJ; Leung, MYK; Duggan, R; Wang, Y; Barber, GN; Fitzgerald, KA; Alegre, ML; Gajewski, TF				Woo, Seng-Ryong; Fuertes, Mercedes B.; Corrales, Leticia; Spranger, Stefani; Furdyna, Michael J.; Leung, Michael Y. K.; Duggan, Ryan; Wang, Ying; Barber, Glen N.; Fitzgerald, Katherine A.; Alegre, Maria-Luisa; Gajewski, Thomas F.			STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors	IMMUNITY			English	Article							CYCLIC GMP-AMP; I INTERFERON; CLINICAL ACTIVITY; DENDRITIC CELLS; UP-REGULATION; T-CELLS; REJECTION; CANCER; RECEPTOR; SENSOR	Spontaneous T cell responses against tumors occur frequently and have prognostic value in patients. The mechanism of innate immune sensing of immunogenic tumors leading to adaptive T cell responses remains undefined, although type I interferons (IFNs) are implicated in this process. We found that spontaneous CD8(+) T cell priming against tumors was defective in mice lacking stimulator of interferon genes complex (STING), but not other innate signaling pathways, suggesting involvement of a cytosolic DNA sensing pathway. In vitro, IFN-beta production and dendritic cell activation were triggered by tumor-cell-derived DNA, via cyclic-GMP-AMP synthase (cGAS), STING, and interferon regulatory factor 3 (IRF3). In the tumor microenvironment in vivo, tumor cell DNA was detected within host antigen-presenting cells, which correlated with STING pathway activation and IFN-beta production. Our results demonstrate that a major mechanism for innate immune sensing of cancer occurs via the host STING pathway, with major implications for cancer immunotherapy.	[Woo, Seng-Ryong; Fuertes, Mercedes B.; Corrales, Leticia; Spranger, Stefani; Furdyna, Michael J.; Leung, Michael Y. K.; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Wang, Ying; Alegre, Maria-Luisa; Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Duggan, Ryan] Univ Chicago, Flow Cytometry Core Facil, Chicago, IL 60637 USA; [Barber, Glen N.] Univ Miami, Dept Cell Biol, Miami, FL 33136 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Dept Infect Dis & Immunol, Worcester, MA 01605 USA	University of Chicago; University of Chicago; University of Chicago; University of Miami; University of Massachusetts System; University of Massachusetts Worcester	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, 929 E57th St GCIS W423H, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu	Fitzgerald, Katherine/ABE-6317-2020	Fuertes, Mercedes Beatriz/0000-0002-2734-1468; Fitzgerald, Kate/0000-0003-3175-609X	National Cancer Institute [P01 CA97296, R01 CA181160];  [AI067497]; NATIONAL CANCER INSTITUTE [R01CA197296, R01CA181160, P01CA097296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497, R01AI079336, R01AI067497, R01AI093752, R56AI067497] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.Kline for critical reading of the manuscript; C. Nagler and H. Huang for providing Tlr4<SUP>-/-</SUP> mice; R. Schreiber for the 1969 tumor cells; Y. Zheng for help with data analysis; and M. Gao for technical assistance. This work was supported by P01 CA97296 and R01 CA181160 from the National Cancer Institute and AI067497 to K.A.F.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Blank C, 2005, J IMMUNOL, V174, P3416, DOI 10.4049/jimmunol.174.6.3416; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gajewski TF, 2006, CLIN CANCER RES, V12, p2326S, DOI 10.1158/1078-0432.CCR-05-2517; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P259, DOI 10.1016/j.coi.2013.03.008; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jounai N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00168; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Molinero LL, 2008, AM J TRANSPLANT, V8, P21, DOI 10.1111/j.1600-6143.2007.02038.x; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Twitty CG, 2011, CLIN CANCER RES, V17, P6467, DOI 10.1158/1078-0432.CCR-11-0812; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Zhou SH, 2009, J VIROL, V83, P1625, DOI 10.1128/JVI.01770-08	49	919	961	19	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					830	842		10.1016/j.immuni.2014.10.017	http://dx.doi.org/10.1016/j.immuni.2014.10.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517615	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000345504900018
J	Nurieva, RI; Chung, Y; Hwang, D; Yang, XO; Kang, HS; Ma, L; Wang, YH; Watowich, SS; Jetten, AM; Tian, Q; Dong, C				Nurieva, Roza I.; Chung, Yeonseok; Hwang, Daehee; Yang, Xuexian O.; Kang, Hong Soon; Ma, Li; Wang, Yi-Hong; Watowich, Stephanie S.; Jetten, Anton M.; Tian, Qiang; Dong, Chen			Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; B-CELLS; GENE-EXPRESSION; ROR-GAMMA; DIFFERENTIATION; RESPONSES; AUTOIMMUNITY; IL-21; BETA; T(H)17	After activation, CD4(+) helper T (Th) cells differentiate into distinct effector subsets. Although chemokine (C-X-C motif]I receptor 5-expressing T follicular helper (Tfh) cells are important in humoral immunity, their developmental regulation is unclear. Here we show that Tfh cells had a distinct gene expression profile and developed in vivo independently of the Th1 or Th2 cell lineages. Tfh cell generation was regulated by ICOS ligand (ICOSL) expressed on B cells and was dependent on interleukin-21 (IL-21), IL-6, and signal transducer and activator of transcription 3 (STAT3). However, unlike Th17 cells, differentiation of Tfh cells did not require transforming growth factor 0 (TGF-beta) or Th17-specific orphan nuclear receptors ROR alpha and ROR gamma in vivo. Finally, naive T cells activated in vitro in the presence of IL-21 but not TGF-beta signaling preferentially acquired Tfh gene expression and promoted germinal-center reactions in vivo. This study thus demonstrates that Tfh is a distinct Th cell lineage.	[Nurieva, Roza I.; Chung, Yeonseok; Yang, Xuexian O.; Wang, Yi-Hong; Watowich, Stephanie S.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Nurieva, Roza I.; Chung, Yeonseok; Yang, Xuexian O.; Wang, Yi-Hong; Watowich, Stephanie S.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Kyungbuk 790784, South Korea; [Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Kyungbuk 790784, South Korea; [Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, LRB, NIH, Res Triangle Pk, NC 27709 USA; [Tian, Qiang] Inst Syst Biol, Seattle, WA 98103 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institute for Systems Biology (ISB)	Nurieva, RI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009; Jetten, Anton/C-3736-2019	Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130; Jetten, Anton/0000-0003-0954-4445; Watowich, Stephanie/0000-0003-1969-659X; Chung, Yeonseok/0000-0001-5780-4841	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050761, R01AI050761, R01AI054912, R01AI050746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES101586-05] Funding Source: Medline; NIAID NIH HHS [R01 AI050746, R01 AI050746-05, R56 AI050761, R56 AI050761-07A2, R01 AI050761-07A1, R01 AI054912, R01 AI050746-01, R01 AI050761-06, R01 AI054912-01A3, R01 AI050761, R01 AI050761-05] Funding Source: Medline; NIAMS NIH HHS [R01 AR050772, R01 AR050772-06, R01 AR050772-08, R01 AR050772-05, R01 AR050772-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2003, J AUTOIMMUN, V21, P255, DOI 10.1016/S0896-8411(03)00119-7; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ebert LM, 2004, EUR J IMMUNOL, V34, P3562, DOI 10.1002/eji.200425478; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Junt T, 2005, J IMMUNOL, V175, P7109, DOI 10.4049/jimmunol.175.11.7109; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Nurieva RI, 2003, P NATL ACAD SCI USA, V100, P14163, DOI 10.1073/pnas.2335041100; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Storey J.D., 2001, ESTIMATING POSITIVE; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	43	911	961	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					138	149		10.1016/j.immuni.2008.05.009	http://dx.doi.org/10.1016/j.immuni.2008.05.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18599325	Bronze, Green Accepted			2022-12-18	WOS:000257905400017
J	Vabret, N; Britton, GJ; Gruber, C; Hegde, S; Kim, J; Kuksin, M; Levantovsky, R; Malle, L; Moreira, A; Park, MD; Pia, L; Risson, E; Saffern, M; Salome, B; Selvan, ME; Spindler, MP; Tan, J; van der Heide, V; Gregory, JK; Alexandropoulos, K; Bhardwaj, N; Brown, BD; Greenbaum, B; Gumus, ZH; Homann, D; Horowitz, A; Kamphorst, AO; de Lafaille, MAC; Mehandru, S; Merad, M; Samstein, RM				Vabret, Nicolas; Britton, Graham J.; Gruber, Conor; Hegde, Samarth; Kim, Joel; Kuksin, Maria; Levantovsky, Rachel; Malle, Louise; Moreira, Alvaro; Park, Matthew D.; Pia, Luisanna; Risson, Emma; Saffern, Miriam; Salome, Berengere; Selvan, Myvizhi Esai; Spindler, Matthew P.; Tan, Jessica; van der Heide, Verena; Gregory, Jill K.; Alexandropoulos, Konstantina; Bhardwaj, Nina; Brown, Brian D.; Greenbaum, Benjamin; Gumus, Zeynep H.; Homann, Dirk; Horowitz, Amir; Kamphorst, Alice O.; de Lafaille, Maria A. Curotto; Mehandru, Saurabh; Merad, Miriam; Samstein, Robert M.		Sinai Immunology Review Project	Immunology of COVID-19: Current State of the Science	IMMUNITY			English	Review							ACUTE RESPIRATORY SYNDROME; INNATE LYMPHOID-CELLS; SARS CORONAVIRUS INFECTION; NATURAL-KILLER-CELLS; CELLULAR IMMUNE-RESPONSES; HUMAN MONOCLONAL-ANTIBODY; POTENT NEUTRALIZATION; I INTERFERON; INFLAMMATORY CYTOKINES; DENDRITIC CELLS	The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an unprecedented effort from the scientific community to understand the biological underpinning of COVID19 pathophysiology. In this Review, we summarize the current state of knowledge of innate and adaptive immune responses elicited by SARSCoV-2 infection and the immunological pathways that likely contribute to disease severity and death, We also discuss the rationale and clinical outcome of current therapeutic strategies as well as prospective clinical trials to prevent or treat SARS-CoV-2 infection.	[Vabret, Nicolas; Britton, Graham J.; Gruber, Conor; Hegde, Samarth; Kim, Joel; Kuksin, Maria; Levantovsky, Rachel; Malle, Louise; Moreira, Alvaro; Park, Matthew D.; Pia, Luisanna; Risson, Emma; Saffern, Miriam; Salome, Berengere; Selvan, Myvizhi Esai; Spindler, Matthew P.; Tan, Jessica; van der Heide, Verena; Gregory, Jill K.; Alexandropoulos, Konstantina; Bhardwaj, Nina; Brown, Brian D.; Greenbaum, Benjamin; Gumus, Zeynep H.; Homann, Dirk; Horowitz, Amir; Kamphorst, Alice O.; de Lafaille, Maria A. Curotto; Mehandru, Saurabh; Merad, Miriam; Samstein, Robert M.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Vabret, N; Merad, M; Samstein, RM (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.	nicolas.vabret@mssm.edu; miriam.merad@mssm.edu; robert.samstein@mountsinai.org	Mahmood, Zafar/D-2659-2018; Martinez-Delgado, Gustavo/X-7033-2019; Britton, Graham/CAI-2177-2022; Britton, Graham/V-1370-2019; Jha, Divya/AAE-9646-2021; Selvan, Myvizhi Esai/AAC-9982-2020; Lubitz, Gabrielle/U-7293-2018	Mahmood, Zafar/0000-0003-4496-2810; Martinez-Delgado, Gustavo/0000-0003-4655-3770; Britton, Graham/0000-0003-4630-1223; Jha, Divya/0000-0002-5038-241X; Selvan, Myvizhi Esai/0000-0003-4640-5727; Salome, Berengere/0000-0002-4768-4505; Lin, Matthew/0000-0003-4503-4653; Vaninov, Natalie/0000-0002-5133-6941; Risson, Emma/0000-0002-0371-9067; Belabed, Meriem/0000-0002-3210-1581; Tan, Jessica/0000-0001-8269-5560; Samstein, Robert/0000-0001-6860-2401; Wilk, Christian Matthias/0000-0001-5429-7143; Cimen Bozkus, Cansu/0000-0001-7834-4792; Bhardwaj, Nina/0000-0003-1865-4187; Noel, Justine/0000-0002-0692-1412; Levantovsky, Rachel/0000-0003-4756-5319; Kamphorst, Alice/0000-0002-9230-9501; Agrawal, Manasi/0000-0003-4729-1485; Hegde, Samarth/0000-0001-6319-0372; Lozano-Ojalvo, Daniel/0000-0002-3524-2929; Homann, Dirk/0000-0002-7622-5754; Lubitz, Gabrielle/0000-0002-1534-0169; van der Heide, Verena/0000-0002-3602-4405; Brown, Matthew/0000-0001-5832-4073; Moreira, Alvaro/0000-0002-5244-9286; Humblin, Etienne/0000-0002-4559-6106; Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777	Fastgrant; NCI Cancer Center Support Grant Supplement; Burroughs Wellcome Fund; NIH Director's Early Independence Award; NIH [R01AI081848]	Fastgrant; NCI Cancer Center Support Grant Supplement; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Director's Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We apologize to all authors whose work we could not cite due to space limitations. Trainee (PhD and MD/PhD or postdocs) and faculty contributing authors are listed in alphabetical order. Illustrations are by Jill K. Gregory and used with permission of Mount Sinai Health System. We would like to acknowledge funding sources including Fastgrant (M.M.), NCI Cancer Center Support Grant Supplement (M.M., R.M.S.) Burroughs Wellcome Fund (R.M.S.), NIH Director's Early Independence Award (R.M.S.) and NIH R01AI081848 (N.V., N.B., B.D.G.).	Adams E.R., 2020, EVALUATION ANTIBODY, DOI 10.1101/2020.04.15.20066407; Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Andre FE, 2003, VACCINE, V21, P593, DOI 10.1016/S0264-410X(02)00702-8; Andreakos E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01232; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], J IMMUNOL; [Anonymous], J VIROL; [Anonymous], 2020, J KOREAN MED SCI, DOI [10.3346/jkms.2020.35.e149, DOI 10.3346/JKMS.2020.35.E149]; [Anonymous], 2020, CANCER DISCOV, DOI [DOI 10.1038/S41379-019-0362-1, DOI 10.1038/S41421-020-0168-9]; [Anonymous], 2020, SARS COV 2 RECEPTOR, DOI [10.1101/2020.04.10.036418, DOI 10.1101/2020.04.10.036418]; [Anonymous], 2020, TRAVEL MED INFECT DI, DOI DOI 10.1016/j.tmaid.2020.101663; Antrobus RD, 2014, MOL THER, V22, P668, DOI 10.1038/mt.2013.284; Arabi YM, 2020, CLIN INFECT DIS, V70, P1837, DOI 10.1093/cid/ciz544; Arabi YM, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0198-x; Asselta R, 2020, ACE2 TMPRSS2 VARIANT, DOI [10.1101/2020.03.30.20047878., DOI 10.18632/AGING.103415, 10.1101/2020.03.30.20047878]; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Bao L., 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226, DOI 10.1101/2020.03.13.990226V1, https://doi.org/10.1101/2020.03.13.990226]; Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652; Baruah V, 2020, J MED VIROL, V92, P495, DOI 10.1002/jmv.25698; Benetti E, 2020, ACE2 VARIANTS UNDERL, DOI [10.1101/2020.04.03.20047977, DOI 10.1101/2020.04.03.20047977]; Bernardet L., 2020, EGU GEN ASSEMBLY C A, P22093, DOI [10.1101/2020.04.05.20046433, DOI 10.1101/2020.04.05.20046433]; Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Braun J., 2020, PRESENCE SARS COV 2, DOI [DOI 10.1101/2020.04.17.20061440, 10.1101/2020.04.17.20061440]; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Bukreyeva N., 2020, BIORXIV, DOI [10.1101/2020.04.07.028589, DOI 10.1101/2020.04.07.028589]; Cai XF, 2020, J INFECT DIS, V222, P189, DOI 10.1093/infdis/jiaa243; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cameron MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045842; Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550; Campbell Katie M, 2020, bioRxiv, DOI 10.1101/2020.03.30.016931; Canton J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006838; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Cao X., 2020, GGG, V20, P269; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Cao ZL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-299; Carlin LE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00781; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chan K. S., 2003, Hong Kong Medical Journal, V9, P399; Chan KYK, 2007, J INFECT DIS, V196, P271, DOI 10.1086/518892; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Charbonneau MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15508-1; Chen C., 2020, MEDRXIV, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03; Chen L, 2020, ZHONGHUA JIE HE HE H, V43, P203, DOI DOI 10.3760/CMA.J.ISSN.1001-0939.2020.0005; Chen X, 2020, RESTORATION LEUKOMON, DOI 10.1101/2020.03.03.20030437; Chen X., 2020, CLIN INFECT DIS, DOI [DOI 10.1093/CID/CIAA449, 10.1093/cid/ciaa449.;PMCID]; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Cheng YF, 2005, JAMA-J AM MED ASSOC, V293, P1450, DOI 10.1001/jama.293.12.1450-c; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Chien JY, 2006, RESPIROLOGY, V11, P715, DOI 10.1111/j.1440-1843.2006.00942.x; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380; Cifaldi L, 2015, ARTHRITIS RHEUMATOL, V67, P3037, DOI 10.1002/art.39295; Clay C, 2012, J VIROL, V86, P4234, DOI 10.1128/JVI.06791-11; Clementi N., 2020, BIORXIV, DOI [10.1101/2020.03.29.014407, DOI 10.1101/2020.03.29.014407]; Comar CE, 2019, MBIO, V10, DOI 10.1128/mBio.00319-19; Corley M.J., 2020, BIORXIV, DOI [10.1101/2020.04.13.039263, DOI 10.1101/2020.04.13.039263]; Cui P, 2020, JPN J APPL PHYS, V59; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; De Grove KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145961; de Marcken M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw1347; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Deng XF, 2017, P NATL ACAD SCI USA, V114, pE4251, DOI 10.1073/pnas.1618310114; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Diez JM, 2020, BIORXIV, DOI [10.1101/2020.04.07.029017, DOI 10.1101/2020.04.07.029017]; Dong P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02812; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Du ML, 2020, GASTROENTEROLOGY, V158, P2298, DOI 10.1053/j.gastro.2020.03.045; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Duev-Cohen A, 2016, ONCOTARGET, V7, P13093, DOI 10.18632/oncotarget.7597; Fang XW, 2020, J INFECTION, V81, P147, DOI 10.1016/j.jinf.2020.03.039; Fast E., 2020, POTENTIAL T CELL B C, DOI [10.1101/2020.03.03.962332(2020)606, DOI 10.1101/2020.03.03.962332(2020)606, 10.1101/2020.02.19.955484, DOI 10.1101/2020.02.19.955484]; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Fei J, 2020, REDUCTION LYMPHOCYTE; Feng Z., 2020, MEDRXIV, p2020.03.27.20045427, DOI 10.1101/2020.03.27.20045427; Feng ZC, 2020, EARLY PREDICTION DIS; Flores-Torres AS, 2019, VIRAL IMMUNOL, V32, P198, DOI 10.1089/vim.2018.0150; Fogarty H, 2020, BRIT J HAEMATOL, V189, P1044, DOI [10.1111/bjh.16749, 10.1111/bjh.16791]; Forni D, 2015, SCI REP-UK, V5, DOI 10.1038/srep14480; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gangopadhyay KK., 2020, ROLE CORTICOSTEROIDS, DOI [DOI 10.1101/2020.04.17.20069773, 10.1101/2020.04.17.20069773]; Gao K., 2020, BIORXIV, DOI [10.1101/2020.01.30, DOI 10.1101/2020.01.30]; Gao L, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01352-w; Gao Q, 2020, BIORXIV, DOI [10.1101/2020.04.17.046375, DOI 10.1101/2020.04.17.046375]; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Garulli B, 2008, CLIN VACCINE IMMUNOL, V15, P1497, DOI 10.1128/CVI.00166-08; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gautret P., 2020, INT J ANTIMICROB AG; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gioia C, 2005, INT J IMMUNOPATH PH, V18, P525, DOI 10.1177/039463200501800312; Giron CC, 2020, VIRUS RES, V285, DOI 10.1016/j.virusres.2020.198021; Glasner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036837; Gong J., 2020, PREPRINT, DOI [DOI 10.1101/2020.02.25.20025643, 10.1101/2020.02.25.20025643, 10.1186/s12879-020-05681-5]; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Guan Y., 2020, EXPLORATORY RANDOMIZ, V2020, DOI [10.1101/2020.03.19.20038984, DOI 10.1101/2020.03.19.20038984]; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Guo C., 2020, BIORXIV, DOI [10.1101/2020.04.08, DOI 10.1101/2020.04.08]; Hackbart M, 2020, P NATL ACAD SCI USA, V117, P8094, DOI 10.1073/pnas.1921485117; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Haja Mohideen S.M., 2020, CELL HOST MICROBE; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; Hayden FG, 2019, CURR OPIN INFECT DIS, V32, P176, DOI 10.1097/QCO.0000000000000532; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659; Hou P, 2020, INCIDENCE CLIN CHARA, DOI 10.1101/2020.03.17.20037572; Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang Angkana T, 2020, medRxiv, DOI [10.1038/s41467-020-18450-4, 10.1101/2020.04.14.20065771]; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Huang HH, 2019, CELL MOL IMMUNOL, V16, P602, DOI 10.1038/s41423-018-0164-2; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang L, 2020, BLOOD SINGLE CELL IM, DOI 10.1101/2020.03.15.20033472; Huang Y, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.27.20029009, DOI 10.1101/2020.02.27.20029009]; Hulme O.J., 2020, BAYESIAN REANALYSIS, DOI [10.1101/2020.03.31.20048777, DOI 10.1101/2020.03.31.20048777]; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Ivagnes A, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1386826; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Ji W., 2020, ANAL CLIN FEATURES C, DOI [10.1101/2020.03.10.20033613, DOI 10.1101/2020.03.10]; Jia WX, 2019, EMERG MICROBES INFEC, V8, P760, DOI 10.1080/22221751.2019.1620083; John S, 2018, VACCINE, V36, P1689, DOI 10.1016/j.vaccine.2018.01.029; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085; Kim J, 2019, J ALLERGY CLIN IMMUN, V143, P1769, DOI 10.1016/j.jaci.2018.10.040; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Konig MF., 2020, TARGETING CATECHOLAM, V130, P3345, DOI DOI 10.1101/2020.04.02.20051565; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Laouunan, 2020, BRIEF REV ANTIVIRAL; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Ledford H, 2020, NATURE, V580, P311, DOI 10.1038/d41586-020-01056-7; Lee HK, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/5617192; Lee J, 2009, BIOCHEM BIOPH RES CO, V386, P718, DOI 10.1016/j.bbrc.2009.06.120; Lee Kyung-Yil, 2020, Clin Exp Pediatr, V63, P117, DOI 10.3345/cep.2020.00290; Lei CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16048-4; Levine MM, 2019, NEW ENGL J MED, V381, P2365, DOI 10.1056/NEJMe1915350; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Li K., 2020, RADIOGRAPHIC FINDING, V236, P1067, DOI 10.1101/2020.03.23.20041673; Li Y, 2020, J ENERGY STORAGE; Liang Q., 2020, MED, DOI [10.1016/j.medj.2020.07.002, 10.1101/2020.03.31.019216]; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lin JT, 2007, ANTIVIR THER, V12, P1107; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu B., 2020, PERSISTENT SARS COV, DOI 10.1101/2020.03.26.20044768; Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Liu T, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012421; Liu W, 2006, J INFECT DIS, V193, P792, DOI 10.1086/500469; Liu Y, 2019, APPL MATH COMPUT, V349, P1, DOI 10.1016/j.amc.2018.12.021; Lokugamage Kumari G, 2020, bioRxiv, DOI 10.1101/2020.03.07.982264; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Lon JR, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01437-4; Lou B., 2020, SEROLOGY CHARACTERIS, DOI [10.1101/2020.03.23, DOI 10.1101/2020.03.23]; Lover A.A., 2020, QUANTIFYING TREATMEN, DOI [10.1101/2020.03.22.20040949, DOI 10.1101/2020.03.22.20040949]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lu XF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02964-w; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mantlo E.K., 2020, ANTIVIRAL RES, DOI [10.1016/j.antiviral.2020, DOI 10.1016/J.ANTIVIRAL.2020]; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Marquardt N, 2017, J ALLERGY CLIN IMMUN, V139, P1321, DOI 10.1016/j.jaci.2016.07.043; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17; Milewska A, 2020, BIORXIV, DOI DOI 10.1101/2020.03.29.014183; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Nailwal H, 2019, CELL DEATH DIFFER, V26, P4, DOI 10.1038/s41418-018-0172-x; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nie JH, 2020, EMERG MICROBES INFEC, V9, P680, DOI 10.1080/22221751.2020.1743767; Nie S., 2020, METABOLIC DISTURBANC, DOI [10.1101/ 2020.03.24.20042283, 10.1101/2020.03.24.20042283]; Niemeyer D, 2013, J VIROL, V87, P12489, DOI 10.1128/JVI.01845-13; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Okabayashi T, 2006, J MED VIROL, V78, P417, DOI 10.1002/jmv.20556; Okba NMA, 2020, EMERG INFECT DIS, V26, P1024, DOI 10.3201/eid2605.190921; Page C, 2012, J VIROL, V86, P13334, DOI 10.1128/JVI.01689-12; Pan X., 2020, BIORXIV, DOI [10.1101/2020.04.07, DOI 10.1101/2020.04.07]; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Park T., 2020, BIORXIV, DOI [10.1101/2020.02.22, DOI 10.1101/2020.02.22]; Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706; Pei S., 2020, CONVALESCENT PLASMA, DOI [10.1101/2020.04.07.20056440, DOI 10.1101/2020.04.07.20056440]; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]; Pinto Dora, 2020, bioRxiv, DOI 10.1101/2020.04.07.023903; Poor HD, 2020, CLIN TRANSL MED, V10, DOI [10.1002/ctm2.44, 10.1101/2020.04.17.20057125]; Prokunina-Olsson L, 2020, J EXP MED, V217, DOI 10.1084/jem.20200653; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Qiu MF, 2005, MICROBES INFECT, V7, P882, DOI 10.1016/j.micinf.2005.02.006; Qu R, 2020, J MED VIROL, V92, P1533, DOI 10.1002/jmv.25767; Rabouw HH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005982; Ramsuran V, 2018, SCIENCE, V359, P86, DOI 10.1126/science.aam8825; REED SE, 1984, J MED VIROL, V13, P179, DOI 10.1002/jmv.1890130208; Roumier M., 2020, INTERLEUKIN 6 BLOCKA, DOI 10.1101/2020.04.20.20061861; Sakai A., 2020, NATURE, V581, P53, DOI [10.1038/s41586-020-2230-z, DOI 10.1038/S41586-020-2979-0, DOI 10.1038/S41586-020-2312-Y]; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Schrezenmeier E, 2020, NAT REV RHEUMATOL, V16, P155, DOI 10.1038/s41584-020-0372-x; Shamshirian A., 2020, HYDROXYCHLOROQUINE V, DOI [10.1101/2020.04.14, DOI 10.1101/2020.04.14]; Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5; Shao Z., 2020, CLIN EFFICACY INTRAV, DOI 10.2139/ssrn.3576827; Shatizadeh Malekshahi S, 2016, INFECT DIS-NOR, V5, DOI [10.5812/pedinfect.36953., DOI 10.1093/CID/CIAA344, DOI 10.1093/cid/ciaa344]; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Siu KL, 2014, J VIROL, V88, P4866, DOI 10.1128/JVI.03649-13; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Sivori S, 2019, CELL MOL IMMUNOL, V16, P430, DOI 10.1038/s41423-019-0206-4; Song C.-Y., 2020, MEDRXIV, DOI [10.1101/2020.03.05.20031906, DOI 10.1101/2020.03.05.20031906, 10.1101/2020.03.05.20031906.]; Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059; Stanifer M.L., 2020, BIORXIV, DOI [10.1101/2020.04.24.059667, DOI 10.1101/2020.04.24.059667]; Stawiski E.W., 2020, BIORXIV, DOI [10.1101/2020.04.07.024752, DOI 10.1101/2020.04.07.024752]; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Sun C., 2020, BIORXIV, DOI [10.1101/2020.02.16, DOI 10.1101/2020.02.16]; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Tan W, 2020, VIRAL KINETICS ANTIB, DOI 10.1101/2020.03.24.20042382; Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tang T, 2020, MEDRXIV, DOI [10.1101/2020.04.03.20051763v1, DOI 10.1101/2020.04.03.20051763, 10.1101/2020.04.03.20051763]; Tang W., 2020, HYDROXYCHLOROQUINE P, DOI [10.1101/2020.04.10.20060558, DOI 10.1101/2020.04.10.20060558]; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829; Tetro JA, 2020, MICROBES INFECT, V22, P72, DOI 10.1016/j.micinf.2020.02.006; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; The World Health Organization, 2020, DRAFT LANDSC COVID 1; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Thornbrough JM, 2016, MBIO, V7, DOI 10.1128/mBio.00258-16; Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1; Vabret N, 2020, NAT REV IMMUNOL, V20, P338, DOI 10.1038/s41577-020-0319-0; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Von Holle TA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01457; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walter JM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123287; Wan S, CHARACTERISTICS LYMP, DOI [10.1101/2020.02.10.20021832, 10.1101]; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang, LANCET, V395, P497; Wang CH, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-42; Wang C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15001-9; Wang D., 2020, MEDRXIV, p2020.04.21.20066258, DOI [10.1101/2020.04.21.20066258, DOI 10.1101/2020.04.21.20066258]; Wang D., CLIN CHARACTERISTICS; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang SF, 2011, VIRAL IMMUNOL, V24, P421, DOI 10.1089/vim.2011.0024; Wang W, 2020, DEFINITION RISKS CYT, DOI [10.1101/2020.02.26.20026989, DOI 10.1101/2020.02.26.20026989, 10.1093/infdis/jiaa387]; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Watanabe K, 2022, SOC SCI COMPUT REV, V40, P346, DOI 10.1177/0894439320907027; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Williamson Brandi N, 2020, bioRxiv, DOI 10.1101/2020.04.15.043166; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Xia CQ, 2004, AM J CLIN PATHOL, V121, P507, DOI 10.1309/WPK7Y2XKNF4CBF3R; Xiang J., 2020, POTENTIAL BIOCH MARK, DOI 10.1101/2020.03.19.20034447; Xiang J., 2020, EVALUATION ENZYME LI, DOI [10.1101/2020.02.27.20028787, DOI 10.1101/2020.02.27.20028787]; Xiaofeng Yang TD, 2020, ANAL ADAPTIVE IMMUNE, DOI [10.1101/2020.03.23.20040675, DOI 10.1101/2020.03.23.20040675, 10.1101/2020.03.23.20040675.2020.03.23.20040675.]; Xiong R., 2020, BIORXIV, DOI [10.1101/2020.03.11.983056, DOI 10.1101/2020.03.11.983056]; Xu, 2020, MORTALITY COVID 19 I, DOI [10.1101/2020.03.08.20031229., DOI 10.1101/2020.03.08.20031229]; Xu H, 2020, ACUTE MYOCARDIAL INJ, DOI [10.1101/2020.03.05.20031591, DOI 10.1101/2020.03.05.20031591]; Xu X, 2020, CHINAXIV20200300026, DOI [10.1073/pnas.2005615117, DOI 10.1073/PNAS.2005615117]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yamamoto N., 2020, BIORXIV, DOI [10.1101/2020.04.06.026476, DOI 10.1101/2020.04.06.026476]; Yan D, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00799-2020; YAN L, 2020, PHOSPHORUS SULFUR SI; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17554; Yang ZW, 2020, J INFECTION, V81, pE13, DOI 10.1016/j.jinf.2020.03.062; Yao X, 2020, ZHONGHUA BING LI XUE, V49, pE009, DOI [DOI 10.3760/CMA.J.CN112151-20200312-00193, 10.3760/cma.j.cn112151-20200312-00193]; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237; Yin Wang WJ, 2020, EARLY LOW DOSE SHORT, DOI [10.1101/2020.03.06.20032342, DOI 10.1101/2020.03.06.20032342]; Ying TL, 2015, MICROBES INFECT, V17, P142, DOI 10.1016/j.micinf.2014.11.008; Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zha L, 2020, MED J AUSTRALIA, V212, P416, DOI 10.5694/mja2.50577; Zhang B, 2020, IMMUNE PHENOTYPING B, DOI 10.1101/2020.03.12.20035048; Zhang B, 2020, CHEST, V158, pE9, DOI 10.1016/j.chest.2020.03.039; Zhang D, 2020, COVID 19 INFECTION I, DOI [10.1101/2020.03.24.20042655., 10.1101/2020.03.24.20042655]; Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499; Zhang Z, 2020, EFFICACY HYDROXYCHLO, DOI [10.1101/2020.03.22.20040758, 10.1101/2020.03.22.20040758., DOI 10.1101/2020.03.22.20040758]; Zhang Z.G., 2020, MEDRXIV, P2020, DOI [10.1101/2020.03.03.20030650, DOI 10.1101/2020.03.03.20030650]; Zhao J., 2020, RELATIONSHIP ABO BLO, DOI [10.1101/2020.03.11, DOI 10.1101/2020.03.11]; Zhao K, 2011, VACCINE, V29, P6670, DOI 10.1016/j.vaccine.2011.06.100; Zhao X., 2020, BIORXIV, DOI [10.1101/2020.04.02.021469, DOI 10.1101/2020.04.02.021469]; Zhao XS, 2018, J VIROL, V92, DOI 10.1128/JVI.01535-17; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zheng M, 2020, CELL MOL IMMUNOL, V17, P536, DOI 10.1038/s41423-020-0385-z; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504; Zhou Y., 2020, BIORXIV, DOI [10.1101/2020.02.11.20021956, 10.1101/2020.03.24.20042119]; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zhou YS, 2018, EXPERT REV VACCINES, V17, P677, DOI 10.1080/14760584.2018.1506702; Zhu FC, 2017, LANCET, V389, P621, DOI [10.1016/S0140-6736(16)32617-4, 10.1016/s0140-6736(16)32617-4]; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zietz Michael, 2020, medRxiv, DOI 10.1101/2020.04.08.20058073	359	909	949	21	181	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					910	941		10.1016/j.immuni.2020.05.002	http://dx.doi.org/10.1016/j.immuni.2020.05.002			32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32505227	Green Published, Bronze			2022-12-18	WOS:000541890000009
J	Guidotti, LG; Ishikawa, T; Hobbs, MV; Matzke, B; Schreiber, R; Chisari, FV				Guidotti, LG; Ishikawa, T; Hobbs, MV; Matzke, B; Schreiber, R; Chisari, FV			Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes	IMMUNITY			English	Article							TRANSGENIC MICE; MONOCLONAL-ANTIBODIES; GENE-EXPRESSION; CHORIOMENINGITIS VIRUS; CELLS; MECHANISMS; CLEARANCE; BIOLOGY; DNA	It is widely believed that viral clearance is mediated principally by the destruction of infected cells by CTLs. In this report, we use a transgenic mouse model of HBV replication to demonstrate that this assumption may not be true for all viruses. We find that adoptively transferred virus-specific CTLs can abolish HBV gene expression and replication in the liver without killing the hepatocytes. This antiviral function is mediated by IFN gamma and TNF alpha secreted by the CTL or by the antigen-nonspecific macrophages and T cells that they activate following antigen recognition. These cytokines activate two independent virocidal pathways: the first pathway eliminates HBV nucleocapsid particles and their cargo of replicating viral genomes, while the second pathway destabilizes the viral RNA. Intracellular viral inactivation mechanisms such as these could greatly amplify the protective effects of the immune response, while failure of such mechanisms could lead to viral persistence or to the death of the host.	SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; UNIV PARMA, IST PATOL GEN, I-43100 PARMA, ITALY; WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA	Scripps Research Institute; University of Parma; Washington University (WUSTL)	Guidotti, LG (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Schreiber, Robert/Q-7550-2019; Guidotti, Luca G. G/I-8542-2018; Chisari, Francis V/A-3086-2008	Guidotti, Luca G. G/0000-0002-0205-2678; Schreiber, Robert/0000-0003-1590-2341; Chisari, Francis/0000-0002-4832-1044	NCI NIH HHS [R37CA40489] Funding Source: Medline; NIA NIH HHS [AG09822] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009822] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; ANDO K, 1994, J IMMUNOL, V152, P3245; BYRNE JA, 1984, J VIROL, V51, P682, DOI 10.1128/JVI.51.3.682-686.1984; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; FOUREL I, 1994, J VIROL, V68, P8321, DOI 10.1128/JVI.68.12.8321-8330.1994; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; Gegin Cem, 1992, Journal of Immunology, V149, P3331; GILLES PN, 1992, J VIROL, V66, P3955, DOI 10.1128/JVI.66.6.3955-3960.1992; GUIDOTTI LG, 1994, J VIROL, V68, P5469, DOI 10.1128/JVI.68.9.5469-5475.1994; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; GUIDOTTI LG, 1994, J VIROL, V68, P1265, DOI 10.1128/JVI.68.3.1265-1270.1994; GUILHOT S, 1993, J VIROL, V67, P7444, DOI 10.1128/JVI.67.12.7444-7449.1993; HOBBS MV, 1993, J IMMUNOL, V150, P3602; JILBERT AR, 1992, J VIROL, V66, P1377, DOI 10.1128/JVI.66.3.1377-1388.1992; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAJINO K, 1994, J VIROL, V68, P5792, DOI 10.1128/JVI.68.9.5792-5803.1994; KURKI P, 1988, J IMMUNOL METHODS, V109, P49, DOI 10.1016/0022-1759(88)90441-3; LAMARS WH, 1989, HEPATOLOGY, V1, P72; LEHMANNGRUBE F, 1985, J IMMUNOL, V134, P608; LEHMANNGRUBE F, 1988, CYTOTOXIC T CELLS BI, P238; MARTZ E, 1989, IMMUNOL TODAY, V10, P79, DOI 10.1016/0167-5699(89)90231-4; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; MOSKOPHIDIS D, 1994, J VIROL, V68, P1951, DOI 10.1128/JVI.68.3.1951-1955.1994; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Tsui LV, 1995, P NATL ACAD SCI USA, V92, P12398, DOI 10.1073/pnas.92.26.12398; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; YU MS, 1994, J VIROL, V68, P2965, DOI 10.1128/JVI.68.5.2965-2969.1994; ZHOU SL, 1992, J VIROL, V66, P5393, DOI 10.1128/JVI.66.9.5393-5398.1992	36	906	950	1	35	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					25	36		10.1016/S1074-7613(00)80295-2	http://dx.doi.org/10.1016/S1074-7613(00)80295-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574849	Bronze			2022-12-18	WOS:A1996TT31900003
J	Slifka, MK; Antia, R; Whitmire, JK; Ahmed, R				Slifka, MK; Antia, R; Whitmire, JK; Ahmed, R			Humoral immunity due to long-lived plasma cells	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY B-CELLS; LIMITING DILUTION ANALYSIS; BONE-MARROW; T-CELL; IMMUNOLOGICAL MEMORY; SERUM IMMUNOGLOBULINS; ANTIBODY-PRODUCTION; MICE; RESPONSES	Conventional models suggest that long-term antibody responses are maintained by the continuous differentiation of memory B cells into antibody-secreting plasma cells. This is based on the notion that plasma cells are short-lived and need to be continually replenished by memory B cells. We examined the issue of plasma cell longevity by following the persistence of LCMV-specific antibody and plasma cell numbers after in vivo depletion of memory B cells and by adoptive transfer of virus-specific plasma cells into naive mice. The results show that a substantial fraction of plasma cells can survive and continue to secrete antibody for extended periods of time (>1 year) in the absence of any detectable memory B cells. This study documents the existence of long-lived plasma cells and demonstrates a new mechanism by which humoral immunity is maintained.	Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.			Whitmire, Jason/0000-0003-2578-6073	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030048, R01AI030048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021496] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30048] Funding Source: Medline; NIGMS NIH HHS [R29-GM-54268] Funding Source: Medline; NINDS NIH HHS [NS-21496] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1978, J IMMUNOL, V120, P2041; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1988, J VIROL, V62, P2102, DOI 10.1128/JVI.62.6.2102-2106.1988; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; ANDERSON RE, 1980, EXP CELL BIOL, V48, P255; BACHMANN MF, 1994, J IMMUNOL, V152, P4235; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; COOPER EH, 1961, IMMUNOLOGY, V4, P219; DILOSA RM, 1991, J IMMUNOL, V146, P4071; FAHEY JL, 1965, J EXP MED, V122, P41, DOI 10.1084/jem.122.1.41; GOTTLIEB S, 1964, AM J PUBLIC HEALTH N, V54, P961, DOI 10.2105/AJPH.54.6.961; Gray D, 1996, IMMUNOL REV, V150, P45, DOI 10.1111/j.1600-065X.1996.tb00695.x; Gray D, 1993, Trends Microbiol, V1, P39, DOI 10.1016/0966-842X(93)90026-N; HALPER J, 1978, J IMMUNOL, V120, P1480; HELMREICH E, 1961, J BIOL CHEM, V236, P464; HIBI T, 1986, EUR J IMMUNOL, V16, P139, DOI 10.1002/eji.1830160206; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; HYLAND L, 1994, J VIROL, V68, P6083, DOI 10.1128/JVI.68.9.6083-6086.1994; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; KJELDSEN K, 1985, LANCET, V1, P900; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LEVY M, 1987, EUR J IMMUNOL, V17, P849, DOI 10.1002/eji.1830170618; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MAKELA O, 1962, J EXP MED, V115, P231, DOI 10.1084/jem.115.1.231; MAKINODAN T, 1962, J IMMUNOL, V88, P31; MAKINODAN T, 1967, J CELL PHYSIOL, V69, P355, DOI 10.1002/jcp.1040690312; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MILLER JJ, 1964, J IMMUNOL, V92, P673; MOSKOPHIDIS D, 1984, J IMMUNOL, V133, P3366; NOSSAL GJV, 1962, J EXP MED, V115, P209, DOI 10.1084/jem.115.1.209; OKUDAIRA H, 1981, CELL IMMUNOL, V58, P188, DOI 10.1016/0008-8749(81)90160-X; OLDSTONE MB, 1967, SCIENCE, V158, P1193, DOI 10.1126/science.158.3805.1193; OLDSTONE MBA, 1985, BRIT MED BULL, V41, P70, DOI 10.1093/oxfordjournals.bmb.a072029; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Plotkin SA, 1988, VACCINES-BASEL; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; SCHOOLEY JC, 1961, J IMMUNOL, V86, P331; SHEPHERD DM, 1991, TRANSPLANTATION, V52, P97, DOI 10.1097/00007890-199107000-00020; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stites D.P., 1994, BASIC CLIN IMMUNOLOG; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; TALBOT PJ, 1987, IMMUNOLOGY, V60, P485; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; TOMASZ M, 1974, BIOCHEMISTRY-US, V13, P4878, DOI 10.1021/bi00721a002; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	51	903	930	0	35	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					363	372		10.1016/S1074-7613(00)80541-5	http://dx.doi.org/10.1016/S1074-7613(00)80541-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529153	Bronze			2022-12-18	WOS:000072705300009
J	Stark, GR; Darnell, JE				Stark, George R.; Darnell, James E., Jr.			The JAK-STAT Pathway at Twenty	IMMUNITY			English	Review							PROTEIN-TYROSINE KINASES; DNA-BINDING PROTEINS; INTERFERON-INDUCED TRANSCRIPTION; SIGNAL-TRANSDUCTION PATHWAY; PHASE RESPONSE FACTOR; EPSILON IKK-EPSILON; 1ST 3 ENZYMES; NF-KAPPA-B; ALPHA-INTERFERON; IFN-GAMMA	We look back on the discoveries that the tyrosine kinases TYK2 and JAK1 and the transcription factors STAT1, STAT2, and IRF9 are required for the cellular response to type I interferons. This initial description of the JAK-STAT pathway led quickly to additional discoveries that type II interferons and many other cytokines signal through similar mechanisms. This well-understood pathway now serves as a paradigm showing how information from protein-protein contacts at the cell surface can be conveyed directly to genes in the nucleus. We also review recent work on the STAT proteins showing the importance of several different post-translational modifications, including serine phosphorylation, acetylation, methylation, and sumoylation. These remarkably proficient proteins also provide noncanonical functions in transcriptional regulation and they also function in mitochondrial respiration and chromatin organization in ways that may not involve transcription at all.	[Stark, George R.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Darnell, James E., Jr.] Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA	Cleveland Clinic Foundation; Rockefeller University	Stark, GR (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA.	starkg@ccf.org; darnell@mail.rockefeller.edu			NATIONAL CANCER INSTITUTE [R01CA095851] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095851-06, R01 CA095851-09, R01 CA095851, R01 CA095851-08, R01 CA095851-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.biochem.56.1.159; BLOMSTROM DC, 1986, J BIOL CHEM, V261, P8811; Bourne H.D., 1990, ONCOGENES MOL ORIGIN, P97; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; CAYLEY PJ, 1982, EUR J BIOCHEM, V122, P601; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Christova R, 2007, J CELL SCI, V120, P3262, DOI 10.1242/jcs.012328; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; COX RF, 1976, CELL, V7, P455, DOI 10.1016/0092-8674(76)90176-8; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DECKER T, 1989, EMBO J, V8, P2009, DOI 10.1002/j.1460-2075.1989.tb03608.x; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; Droescher M, 2011, J BIOL CHEM, V286, P18731, DOI 10.1074/jbc.M111.235978; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gill G., 1990, ONCOGENES MOL ORIGIN, P67; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gough D.J., 2011, JAK STAT SIGNALING B; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Hunter T., 1990, ONCOGENES MOL ORIGIN, P142; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Iwasaki H, 2010, CIRC RES, V107, P992, DOI 10.1161/CIRCRESAHA.110.225326; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KELLY JM, 1985, EUR J BIOCHEM, V153, P367, DOI 10.1111/j.1432-1033.1985.tb09312.x; KEMPE TD, 1976, CELL, V9, P541, DOI 10.1016/0092-8674(76)90036-2; KERR IM, 1977, NATURE, V268, P540, DOI 10.1038/268540a0; KNIGHT E, 1979, P NATL ACAD SCI USA, V76, P1824, DOI 10.1073/pnas.76.4.1824; KNIGHT E, 1967, J MOL BIOL, V28, P491, DOI 10.1016/S0022-2836(67)80099-8; Komyod W, 2005, J BIOL CHEM, V280, P21700, DOI 10.1074/jbc.C400606200; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; Lee JE, 2012, AM J PHYSIOL-CELL PH, V302, pC804, DOI 10.1152/ajpcell.00379.2011; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; LEVY D, 1990, New Biologist, V2, P923; LEVY D, 1986, P NATL ACAD SCI USA, V83, P8929, DOI 10.1073/pnas.83.23.8929; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; LEW DJ, 1989, MOL CELL BIOL, V9, P5404, DOI 10.1128/MCB.9.12.5404; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; LOCKART RZ, 1958, J INFECT DIS, V103, P163, DOI 10.1093/infdis/103.2.163; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; Meissner T, 2004, CELL, V119, P587, DOI 10.1016/S0092-8674(04)01090-6; Morrow AN, 2011, J IMMUNOL, V186, P1685, DOI 10.4049/jimmunol.1001359; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(01)00269-0; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NAGANO Y, 1954, CR SOC BIOL, V148, P1700; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; O'Shea JJ, 2005, SCIENCE, V307, P217, DOI 10.1126/science.1108164; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; PENE JJ, 1968, J MOL BIOL, V33, P609, DOI 10.1016/0022-2836(68)90309-4; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; POWELL DJ, 1984, J MOL BIOL, V179, P21, DOI 10.1016/0022-2836(84)90304-8; RANE SG, 1994, ONCOGENE, V9, P2415; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; REID TR, 1984, ANAL BIOCHEM, V136, P136, DOI 10.1016/0003-2697(84)90315-4; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Sehgal P.B., 2003, SIGNAL TRANSDUCERS A; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; Stark GR, 2011, CELL RES, V21, P375, DOI 10.1038/cr.2010.174; Stark GR, 2005, J BIOL CHEM, V280, P9753, DOI 10.1074/jbc.X400011200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Testoni B, 2011, J BIOL CHEM, V286, P20217, DOI 10.1074/jbc.M111.231068; Ungureanu D, 2005, BLOOD, V106, P224, DOI 10.1182/blood-2004-11-4514; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WAHL GM, 1979, J BIOL CHEM, V254, P8679; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Yan SJ, 2011, FASEB J, V25, P232, DOI 10.1096/fj.10-169367; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	118	902	950	13	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					503	514		10.1016/j.immuni.2012.03.013	http://dx.doi.org/10.1016/j.immuni.2012.03.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520844	Green Accepted, Bronze			2022-12-18	WOS:000303223900001
J	Wesche, H; Henzel, WJ; Shillinglaw, W; Li, S; Cao, ZD				Wesche, H; Henzel, WJ; Shillinglaw, W; Li, S; Cao, ZD			MyD88: An adapter that recruits IRAK to the IL-1 receptor complex	IMMUNITY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCTION PATHWAY; INTERLEUKIN-1 RECEPTOR; DROSOPHILA EMBRYO; DORSOVENTRAL SIGNAL; MOLECULAR-CLONING; DEATH DOMAIN; PELLE KINASE; CELL-DEATH	IL-1 is a proinflammatory cytokine that signals through a receptor complex of two different transmembrane chains to generate multiple cellular responses, including activation of the transcription factor NF-kappa B. Here we show that MyD88, a previously described protein of unknown function, is recruited to the IL-l receptor complex following IL-l stimulation. MyD88 binds to both IRAK (IL-l receptor-associated kinase) and the heterocomplex (the signaling complex) of the two receptor chains and thereby mediates the association of IRAK with the receptor. Ectopic expression of MyD88 or its death domain-containing N-terminus activates NF-kappa B. The C-terminus of MyD88 interacts with the IL-l receptor and blocks NF-kappa B activation induced by IL-l, but not by TNF. Thus, MyD88 plays the same role in IL-l signaling as TRADD and Tube do in TNF and Toll pathways, respectively: it couples a serine/threonine protein kinase to the receptor complex.	Tularik Inc, S San Francisco, CA 94080 USA; Genentech Inc, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Cao, ZD (corresponding author), Tularik Inc, 2 Corp Dr, S San Francisco, CA 94080 USA.			Henzel, William/0000-0003-2940-3797				Aizawa S, 1997, J BIOL CHEM, V272, P2042; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bauerle PA, 1996, CELL, V87, P13; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; ELDON E, 1994, DEVELOPMENT, V120, P885; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; GALINDO RL, 1995, DEVELOPMENT, V121, P2209; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; GROSSHANS J, 1994, NATURE, V372, P563, DOI 10.1038/372563a0; Hardiman G, 1996, ONCOGENE, V13, P2467; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HEGUY A, 1992, J BIOL CHEM, V267, P2605; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; KAUFMANN R, 1994, INT J MASS SPECTROM, V131, P355, DOI 10.1016/0168-1176(93)03876-N; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; KUNO K, 1993, J BIOL CHEM, V268, P13510; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LETSOU A, 1993, EMBO J, V12, P3449, DOI 10.1002/j.1460-2075.1993.tb06019.x; LEUNG KY, 1994, J BIOL CHEM, V269, P1579; LORD KA, 1990, ONCOGENE, V5, P1095; Lovenberg TW, 1996, J NEUROIMMUNOL, V70, P113, DOI 10.1016/S0165-5728(96)00047-1; Lui M, 1996, ANAL BIOCHEM, V241, P156, DOI 10.1006/abio.1996.0393; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Norris JL, 1996, GENE DEV, V10, P862, DOI 10.1101/gad.10.7.862; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Parnet P, 1996, J BIOL CHEM, V271, P3967; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WASSERMAN SA, 1993, MOL BIOL CELL, V4, P767, DOI 10.1091/mbc.4.8.767; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; YANAGISAWA K, 1993, FEBS LETT, V318, P83, DOI 10.1016/0014-5793(93)81333-U; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	74	902	939	1	32	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					837	847		10.1016/S1074-7613(00)80402-1	http://dx.doi.org/10.1016/S1074-7613(00)80402-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430229	Bronze			2022-12-18	WOS:000071351300011
J	Kelliher, MA; Grimm, S; Ishida, Y; Kuo, F; Stanger, BZ; Leder, P				Kelliher, MA; Grimm, S; Ishida, Y; Kuo, F; Stanger, BZ; Leder, P			The death domain kinase RIP mediates the TNF-induced NF-kappa B signal	IMMUNITY			English	Article							NECROSIS-FACTOR RECEPTOR-1; CELL-DEATH; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; MICE DEFICIENT; ACTIVATION; PROTEINS; ALPHA; FADD; CD95	The death domain serine/threonine kinase RIP interacts with the death receptors Pas and tumor necrosis receptor 1 (TNFR1). In vitro, RIP stimulates apoptosis, SAPK/JNK, and NF-kappa B activation. To define the physiologic role(s) that RIP plays in regulating apoptosis in vivo, we introduced a rip null mutation in mice through homologous recombination. RIP-deficient mice appear normal at birth but fail to thrive, displaying extensive apoptosis in both the lymphoid and adipose tissue and dying at 1-3 days of age. In contrast to a normal thymic anti-Fas response, rip(-/-) cells are highly sensitive to TNF alpha-induced cell death. Sensitivity to TNF alpha-mediated cell death in rip(-/-) cells is accompanied by a failure to activate the transcription factor NF-kappa B.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Kelliher, MA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kelliher@rascal.med.harvard.edu						BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	43	901	934	1	33	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					297	303		10.1016/S1074-7613(00)80535-X	http://dx.doi.org/10.1016/S1074-7613(00)80535-X			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529147	Bronze			2022-12-18	WOS:000072705300003
J	Lee, PP; Fitzpatrick, DR; Beard, C; Jessup, HK; Lehar, S; Makar, KW; Perez-Melgosa, M; Sweetser, MT; Schlissel, MS; Nguyen, S; Cherry, SR; Tsai, JH; Tucker, SM; Weaver, WM; Kelso, A; Jaenisch, R; Wilson, CB				Lee, PP; Fitzpatrick, DR; Beard, C; Jessup, HK; Lehar, S; Makar, KW; Perez-Melgosa, M; Sweetser, MT; Schlissel, MS; Nguyen, S; Cherry, SR; Tsai, JH; Tucker, SM; Weaver, WM; Kelso, A; Jaenisch, R; Wilson, CB			A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival	IMMUNITY			English	Article							GAMMA PROMOTER DEMETHYLATION; GENE-EXPRESSION; V(D)J RECOMBINATION; IFN-GAMMA; INTERLEUKIN-7 RECEPTOR; DISTINCT METHYLATION; HISTONE ACETYLATION; TRANSCRIPTION; ACCESSIBILITY; GATA-3	The role of DNA methylation and of the maintenance DNA methyltransferase Dnmt1 in the epigenetic regulation of developmental stage- and cell lineage-specific gene expression in vivo is uncertain. This is addressed here through the generation of mice in which Dnmt1 was inactivated by Cre/loxP-mediated deletion at sequential stages of T cell development. Deletion of Dnmt1 in early double-negative thymocytes led to impaired survival of TCR alpha beta (+) cells and the generation of atypical CD8(+)TCR gamma delta (+) cells. Deletion of Dnmt1 in double-positive thymocytes impaired activation-induced proliferation but differentially enhanced cytokine mRNA expression by naive peripheral T cells. We conclude that Dnmt1 and DNA methylation are required for the proper expression of certain genes that define fate and determine function in T cells.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Queensland, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Joint Transplantat Biol Program, Brisbane, Qld 4029, Australia; MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley	Wilson, CB (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	cbwilson@u.washington.edu		Tucker, Sean/0000-0002-6233-225X; cherry, sara/0000-0003-3956-6610; Kelso, Anne/0000-0002-3166-3267				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; CARBONE AM, 1988, SCIENCE, V242, P1174, DOI 10.1126/science.2460926; Cedar H, 1999, CURR OPIN IMMUNOL, V11, P64, DOI 10.1016/S0952-7915(99)80012-0; Chao DT, 1997, INT IMMUNOL, V9, P1375, DOI 10.1093/intimm/9.9.1375; Cherry SR, 2000, P NATL ACAD SCI USA, V97, P8467, DOI 10.1073/pnas.150218497; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Engler P, 1999, MOL IMMUNOL, V36, P1169, DOI 10.1016/S0161-5890(99)00124-8; FAN G, 1921, J NEUROSCI, V21, P788; Fitzpatrick DR, 1999, J IMMUNOL, V162, P5053; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hamerman JA, 1997, J IMMUNOL, V159, P1240; HU LJ, 2001, IMMUNITY, V14, P1; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; KAY MA, 1995, NAT GENET, V11, P191, DOI 10.1038/ng1095-191; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Krangel MS, 2001, J EXP MED, V193, pF27, DOI 10.1084/jem.193.7.F27; Leduc I, 2000, J IMMUNOL, V165, P1364, DOI 10.4049/jimmunol.165.3.1364; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lei H, 1996, DEVELOPMENT, V122, P3195; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; MELVIN AJ, 1995, EUR J IMMUNOL, V25, P426, DOI 10.1002/eji.1830250218; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PENIT C, 1995, J IMMUNOL, V154, P5103; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Ward SB, 1998, NUCLEIC ACIDS RES, V26, P2923, DOI 10.1093/nar/26.12.2923; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; YOUNG HA, 1994, J IMMUNOL, V153, P3603	56	900	912	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2001	15	5					763	774		10.1016/S1074-7613(01)00227-8	http://dx.doi.org/10.1016/S1074-7613(01)00227-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728338	Bronze			2022-12-18	WOS:000172528200009
J	Iwakura, Y; Ishigame, H; Saijo, S; Nakae, S				Iwakura, Yoichiro; Ishigame, Harumichi; Saijo, Shinobu; Nakae, Susumu			Functional Specialization of Interleukin-17 Family Members	IMMUNITY			English	Review							COLLAGEN-INDUCED ARTHRITIS; DELTA-T-CELLS; TH17 CELLS; HOST-DEFENSE; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; DIFFERENTIAL EXPRESSION; IL-17 CONTRIBUTES; INNATE PRODUCTION	Interleukin-17A (IL-17A) is the signature cytokine of the recently identified T helper 17 (Th17) cell subset. IL-17 has six family members (IL-17A to IL-17F). Although IL-17A and IL-17F share the highest amino acid sequence homology, they perform distinct functions; IL-17A is involved in the development of autoimmunity, inflammation, and tumors, and also plays important roles in the host defenses against bacterial and fungal infections, whereas IL-17F is mainly involved in mucosal host defense mechanisms. IL-17E (IL-25) is an amplifier of Th2 immune responses. The functions of IL-17B, IL-17C, and IL-17D remain largely elusive. In this review, we describe the identified functions of each IL-17 family member and discuss the potential of these molecules as therapeutic targets.	[Iwakura, Yoichiro] Univ Tokyo, Ctr Expt Med & Syst Biol, Inst Med Sci, Lab Mol Pathogenesis,Minato Ku, Tokyo 1088639, Japan; [Ishigame, Harumichi] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Saijo, Shinobu] Chiba Univ, Med Mycol Res Ctr, Dept Mol Immunol, Chuo Ku, Chiba 2608673, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Minato Ku, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Yale University; Chiba University; University of Tokyo; Japan Science & Technology Agency (JST)	Iwakura, Y (corresponding author), Univ Tokyo, Ctr Expt Med & Syst Biol, Inst Med Sci, Lab Mol Pathogenesis,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iwakura@ims.u-tokyo.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775	Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST; Promotion of Basic Research Activities for Innovative Biosciences program; Program for Improvement of Research Environment for Young Researchers	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST(Core Research for Evolutional Science and Technology (CREST)); Promotion of Basic Research Activities for Innovative Biosciences program; Program for Improvement of Research Environment for Young Researchers	We thank C. Cheng-Mayer for critical reading of the manuscript. This work is supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, CREST, and the Promotion of Basic Research Activities for Innovative Biosciences program (Y.I.) and the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S.N.).	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Benatar T, 2010, CANCER IMMUNOL IMMUN, V59, P805, DOI 10.1007/s00262-009-0802-8; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Broxmeyer HE, 2006, BLOOD, V108, P770, DOI 10.1182/blood-2006-01-0292; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caruso R, 2009, GASTROENTEROLOGY, V136, P2270, DOI 10.1053/j.gastro.2009.02.049; Chabaud M, 1998, J IMMUNOL, V161, P409; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cunnusamy K, 2010, J IMMUNOL, V185, P4651, DOI 10.4049/jimmunol.1001576; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Gerhardt S, 2009, J MOL BIOL, V394, P905, DOI 10.1016/j.jmb.2009.10.008; Geyer M, 2010, CURR OPIN RHEUMATOL, V22, P246, DOI 10.1097/BOR.0b013e3283373fa0; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gorbacheva V, 2010, AM J PATHOL, V177, P1265, DOI 10.2353/ajpath.2010.091106; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hwang SY, 2005, MOL CELLS, V19, P180; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kimball AB, 2011, J AM ACAD DERMATOL, V64, P263, DOI 10.1016/j.jaad.2010.01.030; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Li J, 2006, EUR J CARDIO-THORAC, V29, P779, DOI 10.1016/j.ejcts.2006.01.052; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Mchenga SSS, 2008, CELL MOL IMMUNOL, V5, P425, DOI 10.1038/cmi.2008.53; Milner JD, 2010, CURR OPIN HIV AIDS, V5, P179, DOI 10.1097/COH.0b013e328335ed3e; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakajima A, 2010, J IMMUNOL, V185, P1887, DOI 10.4049/jimmunol.1001227; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Patel AM, 2010, DRUG DES DEV THER, V4, P263, DOI 10.2147/DDDT.S14099; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Stamp LK, 2008, ARTHRITIS RHEUM-US, V58, P1601, DOI 10.1002/art.23455; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Tartour E, 1999, CANCER RES, V59, P3698; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Venken K, 2010, J NEUROIMMUNOL, V226, P185, DOI 10.1016/j.jneuroim.2010.05.025; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	139	899	979	7	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					149	162		10.1016/j.immuni.2011.02.012	http://dx.doi.org/10.1016/j.immuni.2011.02.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349428	Bronze			2022-12-18	WOS:000287989500006
J	Magram, J; Connaughton, SE; Warrier, RR; Carvajal, DM; Wu, CY; Ferrante, J; Stewart, C; Sarmiento, U; Faherty, DA; Gately, MK				Magram, J; Connaughton, SE; Warrier, RR; Carvajal, DM; Wu, CY; Ferrante, J; Stewart, C; Sarmiento, U; Faherty, DA; Gately, MK			IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses	IMMUNITY			English	Article							CELL STIMULATORY FACTOR; LYMPHOCYTE MATURATION FACTOR; CD4+ T-CELLS; FACTOR INTERLEUKIN-12; GENES; IL-12; PURIFICATION; CLONING	IL-12 is a cytokine that can exert regulatory effects on T and NK cells and promote Th1 responses. To delineate further the physiologic role of IL-12 in immunity, mice deficient for this cytokine were generated. IL-12-deficient mice were impaired but not completely lacking in the ability to produce IFN gamma following endotoxin administration and to mount a Th1 response in vivo, as measured by antigen-induced IFN gamma secretion by immune lymph node cells in vitro. In contrast, secretion of IL-4 was enhanced, while proliferation and secretion of IL-2 and IL-10 were normal following antigen stimulation. DTH responses were significantly reduced in IL-12-deficient mice, but no defect in allogeneic CTL responses was observed. These results indicate that IL-12 plays an essential role in regulating IFN gamma production and in facilitating normal DTH responses. However, other phenomena associated with Th1 responses and cell-mediated immunity, i.e., IL-2 secretion and CTL generation, were not compromised in the absence of IL-12.	HOFFMANN LA ROCHE INC, DEPT IMFLAMMAT AUTOIMMUNE DIS, NUTLEY, NJ 07110 USA; HOFFMANN LA ROCHE INC, ROCHE INST MOLEC BIOL, NUTLEY, NJ 07110 USA; HOFFMANN LA ROCHE INC, DEPT TOXICOL & PATHOL, NUTLEY, NJ 07110 USA	Roche Holding; Roche Holding; Roche Holding	Magram, J (corresponding author), HOFFMANN LA ROCHE INC, DEPT BIOTECHNOL, 340 KINGSLAND ST, NUTLEY, NJ 07110 USA.							ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; BELLONE G, 1994, J IMMUNOL, V153, P930; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; CHEHIMI J, 1996, IN PRESS RES IMMUNOL; CHIZZONITE R, 1996, IN PRESS CYTOKINES; CHOUAIB S, 1994, P NATL ACAD SCI USA, V91, P12659, DOI 10.1073/pnas.91.26.12659; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; GATELY MK, 1988, J IMMUNOL, V141, P189; GATELY MK, 1994, INT IMMUNOL, V6, P157, DOI 10.1093/intimm/6.1.157; GATELY MK, 1995, CURRENT PROTOCOLS IM, V1; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; GODFREY DI, 1994, J IMMUNOL, V152, P2729; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; HEINZEL FP, 1994, INFECT IMMUN, V62, P4244, DOI 10.1128/IAI.62.10.4244-4249.1994; HENDRZAK JA, 1995, LAB INVEST, V72, P619; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JACOBSEN SEW, 1993, J EXP MED, V178, P413, DOI 10.1084/jem.178.2.413; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; KENNEDY MK, 1994, EUR J IMMUNOL, V24, P2271, DOI 10.1002/eji.1830241002; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MORRIS SC, 1994, J IMMUNOL, V152, P1047; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; MULLER G, 1995, J IMMUNOL, V155, P4661; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SIEBURTH D, 1992, GENOMICS, V14, P59, DOI 10.1016/S0888-7543(05)80283-6; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; SZABO P, 1994, DEVELOPMENT, V120, P1651; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; TRIPP CS, 1994, J IMMUNOL, V152, P1883; WILKINSON V, 1996, IN PRESS J IMMUNOL M; WOLF SF, 1991, J IMMUNOL, V146, P3074; YANAGIDA T, 1994, J IMMUNOL, V152, P4919	48	896	914	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1996	4	5					471	481		10.1016/S1074-7613(00)80413-6	http://dx.doi.org/10.1016/S1074-7613(00)80413-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630732	Bronze			2022-12-18	WOS:A1996UM67800006
J	Sun, C; Mezzadra, R; Schumacher, TN				Sun, Chong; Mezzadra, Riccardo; Schumacher, Ton N.			Regulation and Function of the PD-L1 Checkpoint	IMMUNITY			English	Review							SQUAMOUS-CELL CARCINOMA; CISPLATIN-INELIGIBLE PATIENTS; TUMOR-ASSOCIATED MACROPHAGES; CLASSICAL HODGKIN LYMPHOMA; PROGRAMMED DEATH LIGAND-1; INDUCED UP-REGULATION; CD8(+) T-CELLS; IFN-GAMMA; B7-H1 EXPRESSION; DENDRITIC CELLS	Expression of programmed death-ligand 1 (PD-L1) is frequently observed in human cancers. Binding of PD-L1 to its receptor PD-1 on activated T cells inhibits anti-tumor immunity by counteracting T cell-activating signals. Antibody-based PD-1-PD-L1 inhibitors can induce durable tumor remissions in patients with diverse advanced cancers, and thus expression of PD-L1 on tumor cells and other cells in the tumor microenviroment is of major clinical relevance. Here we review the roles of the PD-1-PD-L1 axis in cancer, focusing on recent findings on the mechanisms that regulate PD-L1 expression at the transcriptional, posttranscriptional, and protein level. We place this knowledge in the context of observations in the clinic and discuss how it may inform the design of more precise and effective cancer immune checkpoint therapies.	[Sun, Chong; Mezzadra, Riccardo; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	Sun, Chong/AAB-4859-2021; Schumacher, Ton/Y-2432-2019	Sun, Chong/0000-0001-9008-2158; Schumacher, Ton/0000-0003-0517-8804; Mezzadra, Riccardo/0000-0002-7737-8461	ERC AdG SENSIT; Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship	ERC AdG SENSIT; Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship	We would like to thank Lisette Rozeman, Daniela Thommen, and Christian Blank for valuable discussions. This work was supported by ERC AdG SENSIT (to T.N.S.) and The Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship (to C.S.). We apologize to colleagues whose work was not cited in this review owing to space constraints.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Armand P, 2016, J CLIN ONCOL, V34, P3733, DOI 10.1200/JCO.2016.67.3467; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Atsaves V, 2017, LEUKEMIA, V31, P1633, DOI 10.1038/leu.2017.103; Audrito V, 2017, ONCOTARGET, V8, P15894, DOI 10.18632/oncotarget.15213; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellone S., 2018, CLIN CANC RES; Bi XW, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0341-7; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Boes M, 2015, CANCER LETT, V361, P49, DOI 10.1016/j.canlet.2015.02.027; Bouillez A, 2017, ONCOGENE, V36, P4037, DOI 10.1038/onc.2017.47; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bu LL, 2017, J DENT RES, V96, P1027, DOI 10.1177/0022034517712435; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Carbognin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130142; Carbotti G, 2015, ONCOTARGET, V6, P43267, DOI 10.18632/oncotarget.6530; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen N, 2017, CANCER IMMUNOL IMMUN, V66, P1175, DOI 10.1007/s00262-017-2005-z; Chen N, 2015, J THORAC ONCOL, V10, P910, DOI 10.1097/JTO.0000000000000500; Chen R, 2017, J CLIN ONCOL, V35, P2125, DOI 10.1200/JCO.2016.72.1316; Coelho MA, 2017, IMMUNITY, V47, P1083, DOI 10.1016/j.immuni.2017.11.016; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Concha-Benavente F, 2016, CANCER RES, V76, P1031, DOI 10.1158/0008-5472.CAN-15-2001; Cortez MA, 2015, JNCI-J NATL CANCER I, V108, P108; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; de Kleijn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072249; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dorand RD, 2016, SCIENCE, V353, P399, DOI 10.1126/science.aae0477; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Erkes DA, 2017, J IMMUNOL, V198, P2979, DOI 10.4049/jimmunol.1601064; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fuchs CS, 2017, J CLIN ONCOL, V35; Fujita Y, 2015, MOL THER, V23, P717, DOI 10.1038/mt.2015.10; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gato-Canas M, 2017, CELL REP, V20, P1818, DOI 10.1016/j.celrep.2017.07.075; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; George J, 2017, CLIN CANCER RES, V23, P1220, DOI 10.1158/1078-0432.CCR-16-1069; Gibbons DL, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8063; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Gowrishankar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123410; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Guo R., 2017, J CLIN ONCOL, V35; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirano F, 2005, CANCER RES, V65, P1089; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Ikeda S, 2016, J THORAC ONCOL, V11, P62, DOI 10.1016/j.jtho.2015.09.010; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jeyakumar G, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.7_suppl.37; Jia L, 2017, BIOCHEM BIOPH RES CO, V488, P425, DOI 10.1016/j.bbrc.2017.05.074; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kao SC, 2017, J THORAC ONCOL, V12, P1421, DOI 10.1016/j.jtho.2017.05.024; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Karakhanova S, 2010, EUR J IMMUNOL, V40, P254, DOI 10.1002/eji.200939289; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kil SH, 2017, BLOOD, V130; Kim EY, 2017, LUNG CANCER, V110, P63, DOI 10.1016/j.lungcan.2017.06.006; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Koh J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1108514; Kok Marleen, 2017, JCO Precis Oncol, V1, P1, DOI 10.1200/PO.17.00052; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Kryczek I, 2008, J IMMUNOL, V181, P5842, DOI 10.4049/jimmunol.181.9.5842; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lau J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14572; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Li CW, 2018, CANCER CELL, V33, P187, DOI 10.1016/j.ccell.2018.01.009; Li CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12632; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Lin KL, 2015, BIOCHEM BIOPH RES CO, V463, P95, DOI 10.1016/j.bbrc.2015.05.030; Liu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003856; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Loi S, 2016, CLIN CANCER RES, V22, P1499, DOI 10.1158/1078-0432.CCR-15-1125; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Matta BM, 2012, J IMMUNOL, V188, P5227, DOI 10.4049/jimmunol.1103382; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; Messai Y, 2016, EUR UROL, V70, P623, DOI 10.1016/j.eururo.2015.11.029; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Minchom A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186106; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Muthumani K, 2011, J IMMUNOL, V187, P2932, DOI 10.4049/jimmunol.1100594; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Ni XY, 2012, ONCOL REP, V28, P615, DOI 10.3892/or.2012.1822; Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Ou JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00295; Overman MJ, 2017, LANCET ONCOL, V18, P1182, DOI 10.1016/S1470-2045(17)30422-9; Park BV, 2016, CANCER DISCOV, V6, P1366, DOI 10.1158/2159-8290.CD-15-1347; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Patel MR, 2018, LANCET ONCOL, V19, P51, DOI 10.1016/S1470-2045(17)30900-2; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Powles T, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2411; Pulko V, 2009, J IMMUNOL, V183, P3634, DOI 10.4049/jimmunol.0900974; Qian YG, 2008, CANCER INVEST, V26, P816, DOI 10.1080/07357900801941852; Quandt D, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-151; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roemer MGM, 2016, J CLIN ONCOL, V34, P2690, DOI 10.1200/JCO.2016.66.4482; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Schoop R, 2004, NEPHROL DIAL TRANSPL, V19, P2713, DOI 10.1093/ndt/gfh423; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Seliger B, 2014, J IMMUNOTOXICOL, V11, P308, DOI 10.3109/1547691X.2013.875084; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Snyder A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002309; Song MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065821; Song SS, 2014, INT IMMUNOPHARMACOL, V20, P117, DOI 10.1016/j.intimp.2014.02.027; Straub M, 2016, ONCOTARGET, V7, P12024, DOI 10.18632/oncotarget.7593; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sumimoto H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166626; Sun C, 2014, TRENDS BIOCHEM SCI, V39, P465, DOI 10.1016/j.tibs.2014.08.010; Sun ZJ, 2015, CANCER RES, V75, P1635, DOI 10.1158/0008-5472.CAN-14-3016; Thommen D. S., 2018, CANC CELL, V33; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; UGI S, 1994, FEBS LETT, V340, P216, DOI 10.1016/0014-5793(94)80141-X; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang J, 2017, ONCOGENE, V36, P6235, DOI 10.1038/onc.2017.217; Wang WP, 2013, HUM GENET, V132, P641, DOI 10.1007/s00439-013-1275-6; Wang X, 2017, IMMUNOL LETT, V184, P7, DOI 10.1016/j.imlet.2017.02.006; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wintterle S, 2003, CANCER RES, V63, P7462; Xie GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168822; Xiong HY, 2014, ASIAN PAC J CANCER P, V15, P5767, DOI 10.7314/APJCP.2014.15.14.5767; Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033; Xue JL, 2017, ONCOTARGET, V8, P42414, DOI 10.18632/oncotarget.17123; Yamamoto H, 2001, GASTROENTEROLOGY, V120, P1565, DOI 10.1053/gast.2001.24497; Yamamoto R, 2009, CANCER SCI, V100, P2093, DOI 10.1111/j.1349-7006.2009.01302.x; Yang LY, 2017, INT J GYNECOL CANCER, V27, P196, DOI 10.1097/IGC.0000000000000875; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Yearley JH, 2017, CLIN CANCER RES, V23, P3158, DOI 10.1158/1078-0432.CCR-16-1761; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang J, 2017, NATURE, V551, P57, DOI 10.1038/nature24278; Zhang N, 2016, INT J ONCOL, V49, P1360, DOI 10.3892/ijo.2016.3632; Zhang XH, 2017, INT J CLIN ONCOL, V22, P1026, DOI 10.1007/s10147-017-1161-7; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2; Zhao L, 2016, ONCOTARGET, V7, P45370, DOI 10.18632/oncotarget.9659; Zhu JJ, 2014, HUM IMMUNOL, V75, P348, DOI 10.1016/j.humimm.2014.01.006	205	877	911	38	283	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					434	452		10.1016/j.immuni.2018.03.014	http://dx.doi.org/10.1016/j.immuni.2018.03.014			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562194	Bronze, Green Accepted			2022-12-18	WOS:000427916900003
J	Borregaard, N				Borregaard, Niels			Neutrophils, from Marrow to Microbes	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; BINDING-PROTEIN-EPSILON; JUNCTIONAL ADHESION MOLECULE; PEROXIDASE-NEGATIVE GRANULES; ACTIVATED ENDOTHELIAL-CELLS; HEMATOPOIETIC STEM-CELLS; LEUKOCYTE ADHESION; IN-VIVO; SUBCELLULAR-LOCALIZATION; BONE-MARROW	Neutrophils are produced in the bone marrow from stem cells that proliferate and differentiate to mature neutrophils fully equipped with an armory of granules. These contain proteins that enable the neutrophil to deliver lethal hits against microorganisms, but also to cause great tissue damage. Neutrophils circulate in the blood as dormant cells. At sites of infection, endothelial cells capture bypassing neutrophils and guide them through the endothelial cell lining whereby the neutrophils are activated and tuned for the subsequent interaction with microbes. Once in tissues, neutrophils kill microorganisms by microbicidal agents liberated from granules or generated by metabolic activation. As a final act, neutrophils can extrude stands of DNA with bactericidal proteins attached that act as extracellular traps for microorganisms.	Univ Copenhagen, Rigshosp, Natl Univ Hosp, Granulocyte Res Lab,Dept Hematol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Borregaard, N (corresponding author), Univ Copenhagen, Rigshosp, Natl Univ Hosp, Granulocyte Res Lab,Dept Hematol, DK-2100 Copenhagen, Denmark.	borregaard@rh.dk			Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was suppoted by the Danish Medical Research Council. N.B. is member of the board of the Novo Nordisk Foundation.	Abram CL, 2009, IMMUNOL CELL BIOL, V87, P440, DOI 10.1038/icb.2009.32; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Alcaide P, 2009, MICROCIRCULATION, V16, P43, DOI 10.1080/10739680802273892; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arnljots K, 1998, LEUKEMIA, V12, P1789, DOI 10.1038/sj.leu.2401202; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Barreiro O, 2009, REV ESP CARDIOL, V62, P552, DOI 10.1016/S0300-8932(09)71035-8; Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Bixel MG, 2010, BLOOD, V116, P1172, DOI 10.1182/blood-2009-12-256388; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; BORREGAARD N, 1993, EUR J HAEMATOL, V51, P318; BORREGAARD N, 1987, SCIENCE, V237, P1204, DOI 10.1126/science.3629236; BORREGAARD N, 1994, J LEUKOCYTE BIOL, V56, P80, DOI 10.1002/jlb.56.1.80; BORREGAARD N, 1992, J CLIN INVEST, V90, P86, DOI 10.1172/JCI115860; BORREGAARD N, 1995, BLOOD, V85, P812, DOI 10.1182/blood.V85.3.812.bloodjournal853812; BORREGAARD N, 1983, J CELL BIOL, V97, pA419; BORREGAARD N, 1984, J BIOL CHEM, V259, P47; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; Bunting M, 2002, CURR OPIN HEMATOL, V9, P30, DOI 10.1097/00062752-200201000-00006; Buscher K, 2010, J BIOL CHEM, V285, P13490, DOI 10.1074/jbc.M110.102640; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cash JL, 2010, J IMMUNOL, V184, P5315, DOI 10.4049/jimmunol.0903378; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; Cheng QA, 2010, J IMMUNOL, V185, P1238, DOI 10.4049/jimmunol.0904104; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Chumakov AM, 2007, BLOOD, V109, P4209, DOI 10.1182/blood-2005-09-031963; Corada M, 2005, P NATL ACAD SCI USA, V102, P10634, DOI 10.1073/pnas.0500147102; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Di Gennaro A, 2009, FASEB J, V23, P1750, DOI 10.1096/fj.08-121277; DUCKER TP, 1992, J LEUKOCYTE BIOL, V52, P11, DOI 10.1002/jlb.52.1.11; Dufour EM, 2008, CELL COMMUN ADHES, V15, P351, DOI 10.1080/15419060802442191; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fernandez-Borja M, 2010, CARDIOVASC RES, V86, P202, DOI 10.1093/cvr/cvq003; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gery S, 2004, BLOOD, V103, P828, DOI 10.1182/blood-2003-01-0159; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jacobsen LC, 2007, BLOOD, V109, P3084, DOI 10.1182/blood-2006-06-032599; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Johansson B, 2001, CLIN EXP ALLERGY, V31, P379, DOI 10.1046/j.1365-2222.2001.01017.x; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Khandoga A, 2009, J HEPATOL, V50, P755, DOI 10.1016/j.jhep.2008.11.027; Khanna-Gupta A, 2007, BLOOD, V109, P4181, DOI 10.1182/blood-2005-05-022004; KJELDSEN L, 1992, BIOCHEM J, V287, P603, DOI 10.1042/bj2870603; KJELDSEN L, 1993, BLOOD, V82, P3183; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Kolaczkowska E, 2009, J LEUKOCYTE BIOL, V85, P374, DOI 10.1189/jlb.0808460; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Lapinet JA, 2000, INFECT IMMUN, V68, P6917, DOI 10.1128/IAI.68.12.6917-6923.2000; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LeCabec V, 1996, P NATL ACAD SCI USA, V93, P6454, DOI 10.1073/pnas.93.13.6454; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LOLLIKE K, 1995, LEUKEMIA, V9, P159; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/88289; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Mambole A, 2010, J LEUKOCYTE BIOL, V88, P321, DOI 10.1189/jlb.1009704; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; McCormick A, 2010, MICROBES INFECT, V12, P928, DOI 10.1016/j.micinf.2010.06.009; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Morosetti R, 1997, BLOOD, V90, P2591, DOI 10.1182/blood.V90.7.2591.2591_2591_2600; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; MURTHY ARK, 1993, J IMMUNOL, V151, P6291; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Phillips ML, 1995, J CLIN INVEST, V96, P2898, DOI 10.1172/JCI118361; Phillipson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001649; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Pospieszalska MK, 2009, CELL MOL BIOENG, V2, P207, DOI 10.1007/s12195-009-0063-9; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Qian H, 2006, BLOOD, V107, P3503, DOI 10.1182/blood-2005-10-3932; Qian H, 2007, BLOOD, V110, P2399, DOI 10.1182/blood-2006-10-051276; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Rorvig S, 2009, J LEUKOCYTE BIOL, V86, P1439, DOI 10.1189/jlb.1008606; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Salipante SJ, 2009, MOL CELL BIOL, V29, P4394, DOI 10.1128/MCB.00596-09; Sasawatari S, 2010, IMMUNITY, V32, P200, DOI 10.1016/j.immuni.2010.01.012; SATO N, 1992, J CELL SCI, V103, P131; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009; Scheiermann C, 2010, CURR OPIN HEMATOL, V17, P25, DOI 10.1097/MOH.0b013e328333d2a3; Schreiber TD, 2009, HAEMATOL-HEMATOL J, V94, P1493, DOI 10.3324/haematol.2009.006072; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; SENGELOV H, 1995, J IMMUNOL, V154, P4157; SENGELOV H, 1994, J IMMUNOL, V153, P804; SENGELOV H, 1993, J IMMUNOL, V150, P1535; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skubitz KM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-78; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sorensen O, 1999, J BIOL CHEM, V274, P22445, DOI 10.1074/jbc.274.32.22445; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Steegmaier M, 1997, J CELL SCI, V110, P687; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Theilgaard-Monch K, 2006, CURR OPIN IMMUNOL, V18, P54, DOI 10.1016/j.coi.2005.11.010; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Theilgaard-Monch K, 2006, BLOOD, V108, P353, DOI 10.1182/blood-2005-09-3890; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van Buul JD, 2008, TRANSFUS CLIN BIOL, V15, P3, DOI 10.1016/j.tracli.2008.04.002; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; van Buul JD, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/120328; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Velu CS, 2009, BLOOD, V113, P4720, DOI 10.1182/blood-2008-11-190215; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; von Vietinghoff S, 2009, J IMMUNOL, V183, P865, DOI 10.4049/jimmunol.0804080; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wegmann F, 2006, J EXP MED, V203, P1671, DOI 10.1084/jem.20060565; Williams SL, 2010, J IMMUNOL, V185, P3057, DOI 10.4049/jimmunol.1000119; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Wojcikiewicz EP, 2009, BIOPHYS J, V96, P285, DOI 10.1529/biophysj.108.135491; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930; Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang L, 2006, CIRC RES, V98, P394, DOI 10.1161/01.RES.0000201958.59020.1a; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440; Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zarbock A, 2009, CURR TOP MICROBIOL, V334, P129, DOI 10.1007/978-3-540-93864-4_6; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	218	877	908	5	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					657	670		10.1016/j.immuni.2010.11.011	http://dx.doi.org/10.1016/j.immuni.2010.11.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21094463	Bronze			2022-12-18	WOS:000286082600006
J	Serbina, NV; Salazar-Mather, TP; Biron, CA; Kuziel, WA; Pamer, EG				Serbina, NV; Salazar-Mather, TP; Biron, CA; Kuziel, WA; Pamer, EG			TN/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES INFECTION; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; T-CELLS; IN-VIVO; CHEMOKINE RECEPTOR; IFN-GAMMA; PERITONEAL-MACROPHAGES; MICE DEFICIENT; FACTOR-ALPHA	Dendritic cells (DCs) present microbial antigens to T cells and provide inflammatory signals that modulate T cell differentiation. While the role of DCs in adaptive immunity is well established, their involvement in innate immune defenses is less well defined. We have identified a TNF/iNOS-producing (Tip)-DC subset in spleens of Listeria monocytogenes-infected mice that is absent from CCR2-deficient mice. The absence of Tip-DCs results in profound TNF and iNOS deficiencies and an inability to clear primary bacterial infection. CD8 and CD4 T cell responses to L. monocytogenes antigens are preserved in CCR2-deficient mice, indicating that Tip-DCs are not essential for T cell priming. Tip-DCs, as the predominant source of TNF and iNOS during L. monocytogenes infection, orchestrate and mediate innate immune defense against this intracellular bacterial pathogen.	Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Program Immunol, New York, NY 10021 USA; Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA; Univ Texas, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	Memorial Sloan Kettering Cancer Center; Brown University; University of Texas System; University of Texas Austin	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Program Immunol, 1275 York Ave, New York, NY 10021 USA.				NCI NIH HHS [CA 09149] Funding Source: Medline; NIAID NIH HHS [R01 AI 42135, R37 AI039031, AI 39031] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042135, R01AI039031, R37AI039031] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBINA JE, 1991, J IMMUNOL, V147, P144; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; COSSART P, 1989, MOL BIOL MED, V6, P463; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Everest P, 1998, INFECT IMMUN, V66, P3355, DOI 10.1128/IAI.66.7.3355-3364.1998; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; FLOTTE TJ, 1983, AM J PATHOL, V111, P112; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Harty JT, 1996, INFECT IMMUN, V64, P3632, DOI 10.1128/IAI.64.9.3632-3640.1996; HO MK, 1983, J BIOL CHEM, V258, P636; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kerksiek KM, 2003, J IMMUNOL, V170, P1862, DOI 10.4049/jimmunol.170.4.1862; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lu LN, 1996, J IMMUNOL, V157, P3577; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Merrick JC, 1997, AM J PATHOL, V151, P785; Nolte MA, 2000, EUR J IMMUNOL, V30, P626; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; ROSEN H, 1989, J EXP MED, V170, P27, DOI 10.1084/jem.170.1.27; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; SHEFFLER LA, 1995, J IMMUNOL, V155, P886; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sodhi A, 2002, J INTERF CYTOK RES, V22, P517, DOI 10.1089/10799900252981990; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491	50	877	902	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					59	70		10.1016/S1074-7613(03)00171-7	http://dx.doi.org/10.1016/S1074-7613(03)00171-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871639	Bronze			2022-12-18	WOS:000184260400008
J	Romano, M; Sironi, M; Toniatti, C; Polentarutti, N; Fruscella, P; Ghezzi, P; Faggioni, R; Luini, W; vanHinsbergh, V; Sozzani, S; Bussolino, F; Poli, V; Ciliberto, G; Mantovani, A				Romano, M; Sironi, M; Toniatti, C; Polentarutti, N; Fruscella, P; Ghezzi, P; Faggioni, R; Luini, W; vanHinsbergh, V; Sozzani, S; Bussolino, F; Poli, V; Ciliberto, G; Mantovani, A			Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment	IMMUNITY			English	Article							HUMAN-ENDOTHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; MONOCYTE-CHEMOTACTIC PROTEIN-1; INTERLEUKIN-6 IL-6; MOLECULAR-CLONING; CYTOKINE REGULATION; ACTIVATING FACTOR; INTERFERON-GAMMA; TRANSGENIC MICE; GROWTH-FACTOR	IL-6(-/-) mice showed impaired leukocyte accumulation in subcutaneous air pouches. Defective leukocyte accumulation was not due to a reduced migratory capacity of IL-6(-/-) leukocytes and was associated with a reduced in situ production of chemokines. These observations led to a reexamination of the interaction of IL-6 with endothelial cells (EC). Sc express only the gp130 signal transducing chain and not the subunit-specific IL-6R and are therefore unresponsive to IL-6. However, EC are responsive to a combination of IL-6 and soluble IL-6R as measured by the activation of STATE, chemokine expression, and augmentation of ICAM-1. Activation by IL-6-IL-6R complexes was inhibited by an IL-6 receptor antagonist and potentiated by a superagonist. Hence, in vivo and in vitro evidence supports the concept that the IL-6 system plays an unexpected positive role in local inflammatory reactions by amplifying leukocyte recruitment.	IST RIC FARMACOL MARIO NEGRI,MILAN,ITALY; UNIV BRESCIA,DEPT BIOTECHNOL,SECT PATHOL & IMMUNOL,I-25121 BRESCIA,ITALY; IST RIC BIOL MOL P ANGELETTI,ROME,ITALY; UNIV TURIN,DIPARTIMENTO GENET BIOL & CHIM MED,I-10124 TURIN,ITALY; TNO,PG,GAUBIUS LAB,LEIDEN,NETHERLANDS	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia; Merck & Company; University of Turin; Netherlands Organization Applied Science Research			Mantovani, Alberto/HCI-7449-2022; Sozzani, Silvano/C-1447-2009; Bussolino, Federico/AES-3951-2022; Ciliberto, Gennaro/J-4131-2017; Poli, Valeria/A-9215-2012; sironi, marina/AAB-5757-2020; Bussolino, Federico/K-2500-2016	Mantovani, Alberto/0000-0001-5578-236X; Sozzani, Silvano/0000-0002-3144-8743; Ciliberto, Gennaro/0000-0003-2851-8605; Poli, Valeria/0000-0002-3739-3966; sironi, marina/0000-0002-3342-1149; Bussolino, Federico/0000-0002-5348-1341; Ghezzi, Pietro/0000-0003-0911-8358				ADERKA D, 1989, J IMMUNOL, V143, P3517; AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ALLAVENA P, 1991, J EXP MED, V173, P439, DOI 10.1084/jem.173.2.439; ANDERT SE, 1992, CLIN EXP IMMUNOL, V88, P555; ARBO A, 1990, CHEMOTHERAPY, V36, P337, DOI 10.1159/000238786; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; BARUT B, 1993, J CLIN INVEST, V92, P2346, DOI 10.1172/JCI116839; BIONDI A, 1989, BLOOD, V73, P1279; BOETCHER DA, 1975, J NATL CANCER I, V54, P795; BROWN TJ, 1991, J IMMUNOL, V147, P2175; BUSSOLINO F, 1988, J BIOL CHEM, V263, P11856; CAMPBELL IL, 1994, AM J PATHOL, V145, P157; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLOTTA F, 1992, CYTOKINE, V4, P24, DOI 10.1016/1043-4666(92)90032-M; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; DEJANA E, 1987, BLOOD, V69, P695; DICOSMO BF, 1994, INT IMMUNOL, V6, P1829, DOI 10.1093/intimm/6.12.1829; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Fantuzzi G, 1996, J LEUKOCYTE BIOL, V59, P489, DOI 10.1002/jlb.59.4.489; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; FRIELING JTM, 1995, J INFECT DIS, V171, P469, DOI 10.1093/infdis/171.2.469; FURUTANI Y, 1989, BIOCHEM BIOPH RES CO, V159, P248; GAILLARD JP, 1993, EUR J IMMUNOL, V23, P820, DOI 10.1002/eji.1830230408; GHIGO D, 1995, J EXP MED, V181, P9, DOI 10.1084/jem.181.1.9; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; HONDA M, 1992, J IMMUNOL, V148, P2175; HOWELLS G, 1991, EUR J IMMUNOL, V21, P97, DOI 10.1002/eji.1830210115; INTRONA M, 1993, EUR HEART J, V14, P78; JIRIK FR, 1989, J IMMUNOL, V142, P144; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LUINI W, 1994, CYTOKINE, V6, P28, DOI 10.1016/1043-4666(94)90004-3; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; MARTICH GD, 1991, J EXP MED, V173, P1021, DOI 10.1084/jem.173.4.1021; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; MINTY A, 1993, EUR CYTOKINE NETW, V4, P99; MOTRO B, 1990, P NATL ACAD SCI USA, V87, P3092, DOI 10.1073/pnas.87.8.3092; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; PERI G, 1994, J IMMUNOL METHODS, V174, P249, DOI 10.1016/0022-1759(94)90029-9; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; PODOR TJ, 1989, ANN NY ACAD SCI, V557, P374; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; ROLLINS BJ, 1991, AM J PATHOL, V138, P1315; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; SALVATI AL, 1995, J BIOL CHEM, V270, P12242, DOI 10.1074/jbc.270.20.12242; SAVINO R, 1994, EMBO J, V13, P5883; SCHINDLER R, 1990, BLOOD, V75, P40; SCHWAB G, 1991, BLOOD, V77, P587; SHALABY MR, 1989, CELL IMMUNOL, V121, P372, DOI 10.1016/0008-8749(89)90036-1; SICA A, 1990, J IMMUNOL, V144, P3034; SIN YM, 1989, AGENTS ACTIONS, V28, P98, DOI 10.1007/BF02022988; Sporeno E, 1996, BLOOD, V87, P4510, DOI 10.1182/blood.V87.11.4510.bloodjournal87114510; SPORENO E, 1994, J BIOL CHEM, V269, P10991; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Toniatti C, 1996, EMBO J, V15, P2726, DOI 10.1002/j.1460-2075.1996.tb00633.x; VANHINSBERGH VWM, 1987, THROMB HAEMOSTASIS, V57, P148; VINK A, 1990, J EXP MED, V172, P997, DOI 10.1084/jem.172.3.997; YAN SF, 1995, J BIOL CHEM, V270, P11463, DOI 10.1074/jbc.270.19.11463; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	69	874	903	2	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					315	325		10.1016/S1074-7613(00)80334-9	http://dx.doi.org/10.1016/S1074-7613(00)80334-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075932	Bronze			2022-12-18	WOS:A1997XC61800011
J	Delgoffe, GM; Kole, TP; Zheng, Y; Zarek, PE; Matthews, KL; Xiao, B; Worley, PF; Kozma, SC; Powell, JD				Delgoffe, Greg M.; Kole, Thomas P.; Zheng, Yan; Zarek, Paul E.; Matthews, Krystal L.; Xiao, Bo; Worley, Paul F.; Kozma, Sara C.; Powell, Jonathan D.			The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment	IMMUNITY			English	Article							MAMMALIAN TARGET; FOXP3 EXPRESSION; RAPAMYCIN; ACTIVATION; AKT; TH17; INDUCTION; MAINTENANCE; INSIGHTS; PATHWAY	Effector T cell differentiation requires the simultaneous integration of multiple, and sometimes opposing, cytokine signals. We demonstrated mTOR's role in dictating the outcome of T cell fate. mTOR-deficient T cells displayed normal activation and IL-2 production upon initial stimulation. However, such cells failed to differentiate into T helper 1 (Th1), Th2, or Th17 effector cells. The inability to differentiate was associated with decreased STAT transcription factor activation and failure to upregulate lineagespecific transcription factors. Under normally activating conditions, T cells lacking mTOR differentiated into Foxp3(+) regulatory T cells. This was associated with hyperactive Smad3 activation in the absence of exogenous TGF-beta. Surprisingly, T cells selectively deficient in TORC1 do not divert to a regulatory T cell pathway, implicating both TORC1 and TORC2 in preventing the generation of regulatory T cells. Overall, our studies suggest that mTOR kinase signaling regulates decisions between effector and regulatory T cell lineage commitment.	[Delgoffe, Greg M.; Kole, Thomas P.; Zheng, Yan; Zarek, Paul E.; Matthews, Krystal L.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Xiao, Bo; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 20205 USA; [Kozma, Sara C.] Univ Cincinnati, Genome Res Inst, Cincinnati, OH 45237 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University System of Ohio; University of Cincinnati	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	poweljo@jhmi.edu	Zheng, Yan/N-8184-2018; Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135; Xiao, Bo/0000-0002-6161-9478	NIH [R01CA098109, R01CA14227]; NATIONAL CANCER INSTITUTE [R01CA098109, R01CA114227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the members of the Powell and Drake Labs and D. Pardoll, J. Liu, and G. Thomas for their helpful suggestions and reagent contributions. In addition, we would like to thank R. Schwartz with whom this line of inquiry was initiated. This work was supported by NIH grants R01CA098109 and R01CA14227.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Powell JD, 2005, TRANSPLANTATION, V80, P1541, DOI 10.1097/01.tp.0000185299.72295.90; Powell JD, 2006, CLIN IMMUNOL, V120, P239, DOI 10.1016/j.clim.2006.02.004; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wiederrecht G J, 1995, Prog Cell Cycle Res, V1, P53; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	36	873	917	6	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					832	844		10.1016/j.immuni.2009.04.014	http://dx.doi.org/10.1016/j.immuni.2009.04.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538929	Green Accepted, Bronze			2022-12-18	WOS:000267270700011
J	Chung, Y; Chang, SH; Martinez, GJ; Yang, XXO; Nurieva, R; Kang, HS; Ma, L; Watowich, SS; Jetten, AM; Tian, Q; Dong, C				Chung, Yeonseok; Chang, Seon Hee; Martinez, Gustavo J.; Yang, Xuexian O.; Nurieva, Roza; Kang, Hong Soon; Ma, Li; Watowich, Stephanie S.; Jetten, Anton M.; Tian, Qiang; Dong, Chen			Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling	IMMUNITY			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR-BETA; HYPER-IGE SYNDROME; TGF-BETA; AUTOIMMUNE MYOCARDITIS; HELPER-CELLS; T(H)17 CELLS; GENERATION; IL-21	T helper (Th) 17 cells have been recently discovered in both mouse and human. Here we show that interleukin-1 (IL-1) signaling on T cells is critically required for the early programming of Th17 cell lineage and Th17 cell-mediated autoimmunity. IL-1 receptor1 expression in T cells, which was induced by IL-6, was necessary for the induction of experimental autoimmune encephalomyelitis and for early Th17 cell differentiation in vivo. Moreover, IL-1 signaling in T cells was required in dendritic cell-mediated Th17 cell differentiation from naive or regulatory precursors and IL-1 synergized with IL-6 and IL-23 to regulate Th17 cell differentiation and maintain cytokine expression in effector Th17 cells. Importantly, IL-1 regulated the expression of the transcription factors IRF4 and ROR gamma t during Th17 cell differentiation; overexpression of these two factors resulted in IL-1-independent Th17 cell polarization. Our data thus indicate a critical role of IL-1 in Th17 cell differentiation and this pathway may serve as a unique target for Th17 cell-mediated immunopathology.	[Chung, Yeonseok; Chang, Seon Hee; Martinez, Gustavo J.; Yang, Xuexian O.; Nurieva, Roza; Watowich, Stephanie S.; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Kang, Hong Soon; Jetten, Anton M.] Natl Inst Environm Sci, Cell Biol Sect, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Ma, Li; Tian, Qiang] Inst Syst Biol, Seattle, WA 98103 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institute for Systems Biology (ISB)	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009; Yang, Xuexian/Y-2472-2019; Jetten, Anton/C-3736-2019; Chang, Seon Hee/AAQ-9521-2020	dong, chen/0000-0002-0084-9130; Yang, Xuexian/0000-0001-6816-7024; Jetten, Anton/0000-0003-0954-4445; Chang, Seon Hee/0000-0002-9389-508X; Chung, Yeonseok/0000-0001-5780-4841; Watowich, Stephanie/0000-0003-1969-659X; Martinez, Gustavo/0000-0003-0178-3329	NIH; NIEHS; Leukemia and Lymphoma Society; MD Anderson Cancer Center; Gillson Longenbaugh Foundation; Schissler Foundation; American Heart Association; Cancer Research Institute; American Lung Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MD Anderson Cancer Center; Gillson Longenbaugh Foundation; Schissler Foundation; American Heart Association(American Heart Association); Cancer Research Institute; American Lung Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank A. Rudensky for Foxp3-GFP reporter mice, Z. He and K. Ramirez for helping cell sorting, and the entire Dong lab for their help. The work is supported by research grants from NIH (to C.D.), an Intramural Research Program of the NIEHS, NIH (to A.M.J.), Leukemia and Lymphoma Society (to C.D.), MD Anderson Cancer Center (to C.D. and S.S.W.), and the Gillson Longenbaugh Foundation (to S.S.W.). G.J.M. is a Schissler Foundation MD Anderson Cancer Center Fellow in cancer research. R.N. is a recipient of a Scientist Development Grant from the American Heart Association. C.D. is a Trust Fellow of the MD Anderson Cancer Center, a Cancer Research Institute Investigator, a Leukemia and Lymphoma Society Scholar, and an American Lung Association Career Investigator.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	35	873	932	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					576	587		10.1016/j.immuni.2009.02.007	http://dx.doi.org/10.1016/j.immuni.2009.02.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19362022	Bronze, Green Accepted			2022-12-18	WOS:000265319000014
J	Yang, XO; Nurieva, R; Martinez, GJ; Kang, HS; Chung, Y; Pappu, BP; Shah, B; Chang, SH; Schluns, KS; Watowich, SS; Feng, XH; Jetten, AM; Dong, C				Yang, Xuexian O.; Nurieva, Roza; Martinez, Gustavo J.; Kang, Hong Soon; Chung, Yeonseok; Pappu, Bhanu P.; Shah, Bhavin; Chang, Seon Hee; Schluns, Kimberly S.; Watowich, Stephanie S.; Feng, Xin-Hua; Jetten, Anton M.; Dong, Chen			Molecular antagonism and plasticity of regulatory and inflammatory T cell programs	IMMUNITY			English	Article							RECEPTOR ROR-GAMMA; TGF-BETA; GENERATION; FOXP3; DIFFERENTIATION; RESPONSES; T(H)17; SELF	Regulatory T (Treg) and T helper 17 (Th17) cells were recently proposed to be reciprocally regulated during differentiation. To understand the underlying mechanisms, we utilized a Th17 reporter mouse with a red fluorescent protein (RFP) sequence inserted into the interleukin-17F (IL-17F) gene. Using IL-17F-RFP together with a Foxp3 reporter, we found that the development of Th17 and Foxp3(+) Treg cells was associated in immune responses. Although TGF-beta receptor I signaling was required for both Foxp3 and IL-17 induction, SMAD4 was only involved in Foxp3 upregulation. Foxp3 inhibited Th17 differentiation by antagonizing the function of the transcription factors ROR gamma t and ROR alpha. In contrast, IL-6 overcame this suppressive effect of Foxp3 and, together with IL-1, induced genetic reprogramming in Foxp3(+) Treg cells. STAT3 regulated Foxp3 downregulation whereas STAT3, ROR gamma, and ROR alpha were required for IL-17 expression in Treg cells. Our data demonstrate molecular antagonism and plasticity of Treg and Th17 cell programs.	[Yang, Xuexian O.; Nurieva, Roza; Martinez, Gustavo J.; Chung, Yeonseok; Pappu, Bhanu P.; Shah, Bhavin; Chang, Seon Hee; Schluns, Kimberly S.; Watowich, Stephanie S.; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, LRB, NIH, Res Triangle Pk, NC 27709 USA; [Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine; Baylor College of Medicine	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	Schluns, Kimberly/R-5635-2019; Chang, Seon Hee/AAQ-9521-2020; Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009; Jetten, Anton/C-3736-2019	Chang, Seon Hee/0000-0002-9389-508X; Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130; Jetten, Anton/0000-0003-0954-4445; Martinez, Gustavo/0000-0003-0178-3329; Chung, Yeonseok/0000-0001-5780-4841; Watowich, Stephanie/0000-0003-1969-659X	Intramural NIH HHS [Z01 ES101586-05] Funding Source: Medline; NCI NIH HHS [R01 CA108454, CA108454] Funding Source: Medline; NIAID NIH HHS [R01 AI050746-01, R01 AI050746] Funding Source: Medline; NIAMS NIH HHS [AR050772, R01 AR050772] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Kurebayashi S, 2004, BIOCHEM BIOPH RES CO, V315, P919, DOI 10.1016/j.bbrc.2004.01.131; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	28	872	907	1	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					44	56		10.1016/j.immuni.2008.05.007	http://dx.doi.org/10.1016/j.immuni.2008.05.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18585065	Green Accepted, Bronze			2022-12-18	WOS:000257905400009
J	Uhrberg, M; Valiante, NM; Shum, BP; Shilling, HG; Lienert-Weidenbach, K; Corliss, B; Tyan, D; Lanier, LL; Parham, P				Uhrberg, M; Valiante, NM; Shum, BP; Shilling, HG; Lienert-Weidenbach, K; Corliss, B; Tyan, D; Lanier, LL; Parham, P			Human diversity in killer cell inhibitory receptor genes	IMMUNITY			English	Article							CLASS-I RECEPTORS; HLA-C MOLECULES; NK CLONES; B MOLECULES; T-CELLS; RECOGNITION; ANTIGEN; DOMAINS; FAMILY; CD94	The presence and expression of killer inhibitory receptor (KIR) and CD94:NKG2 genes from 68 donors were analyzed using molecular typing techniques. The genes encoding CD94:NKG2 receptors were present in each person, but KIR gene possession varied. Most individuals expressed inhibitory KIR for the three well-defined HLA-B and -C ligands, but noninhibitory KIR genes were more variable. Twenty different KIR phenotypes were defined. Two groups of KIR haplotypes were distinguished and occurred at relatively even frequency. Group A KIR haplotypes consist of six genes: the main inhibitory KIR, one noninhibitory KIR, and a structurally divergent KIR. Allelic polymorphism within five KIR genes was detected. Group B comprises more noninhibitory KIR genes and contains at least one additional gene not represented in group A. The KIR locus therefore appears to be polygenic and polymorphic within the human population.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol & Microbiol, Stanford, CA 94305 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94306 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Dept Pediat, Los Angeles, CA 90048 USA	Stanford University; Stanford University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Parham, P (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.		Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017892, R37AI017892, T32AI007290, R01AI022039] Funding Source: NIH RePORTER; NIAID NIH HHS [5T32 AI-07290, AI-17892, AI-22039] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMKIEWICZ TV, 1994, IMMUNOGENETICS, V39, P218; BAKER E, 1995, CHROMOSOME RES, V3, P511; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; BIASSONI R, 1995, J EXP MED, V182, P605, DOI 10.1084/jem.182.2.605; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; CICCONE E, 1992, J EXP MED, V176, P963, DOI 10.1084/jem.176.4.963; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P7983, DOI 10.1073/pnas.89.17.7983; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; DANDREA A, 1995, J IMMUNOL, V155, P2306; Dohring C, 1996, IMMUNOGENETICS, V44, P227, DOI 10.1007/s002510050116; Dohring C, 1996, J IMMUNOL, V156, P3098; DOMENA JD, 1993, TISSUE ANTIGENS, V42, P509; Gumperz JE, 1996, J EXP MED, V183, P1817, DOI 10.1084/jem.183.4.1817; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; Lazetic S, 1996, J IMMUNOL, V157, P4741; LITWIN V, 1993, J EXP MED, V178, P1321, DOI 10.1084/jem.178.4.1321; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1996, IMMUNOL TODAY, V17, P100, DOI 10.1016/0167-5699(96)80590-1; MELERO I, 1994, J IMMUNOL, V152, P1662; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; Parham P, 1994, Semin Immunol, V6, P373, DOI 10.1006/smim.1994.1047; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Pende D, 1996, J EXP MED, V184, P505, DOI 10.1084/jem.184.2.505; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Plougastel B, 1996, IMMUNOGENETICS, V44, P286, DOI 10.1007/BF02602558; Selvakumar A, 1996, TISSUE ANTIGENS, V48, P285, DOI 10.1111/j.1399-0039.1996.tb02647.x; Selvakumar A, 1997, TISSUE ANTIGENS, V49, P564, DOI 10.1111/j.1399-0039.1997.tb02803.x; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; SUM BP, 1996, P NATL ACAD SCI USA, V93, P2779; VALLANTE NM, 1997, IMMUNITY, V7, P739; VALLANTE NM, 1997, IMMUNOL REV, V155, P155; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Wilson MJ, 1997, TISSUE ANTIGENS, V49, P574, DOI 10.1111/j.1399-0039.1997.tb02804.x; YABE T, 1993, IMMUNOGENETICS, V37, P455; YOKOYAMA WM, 1993, CURR OPIN IMMUNOL, V5, P67, DOI 10.1016/0952-7915(93)90083-5; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	50	872	922	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					753	763		10.1016/S1074-7613(00)80394-5	http://dx.doi.org/10.1016/S1074-7613(00)80394-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430221	Bronze			2022-12-18	WOS:000071351300003
J	Nakae, S; Komiyama, Y; Nambu, A; Sudo, K; Iwase, M; Homma, I; Sekikawa, K; Asano, M; Iwakura, Y				Nakae, S; Komiyama, Y; Nambu, A; Sudo, K; Iwase, M; Homma, I; Sekikawa, K; Asano, M; Iwakura, Y			Antigen-specific T cell Sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses	IMMUNITY			English	Article							DEPENDENT ANTIBODY-PRODUCTION; COLONY-STIMULATING FACTOR; CONTACT HYPERSENSITIVITY; DEFICIENT MICE; HUMAN KERATINOCYTES; DENDRITIC CELL; TNF-ALPHA; IL-17; EXPRESSION; INTERLEUKIN-17	Interleukin-17 (IL-17) is a proinflammatory cytokine produced by T cells. The involvement of IL-17 in human diseases has been suspected because of its detection in sera from asthmatic patients and synovial fluids from arthritic patients. In this study, we generated IL-17-deficient mice and investigated the role of IL-17 in various disease models. We found that contact, delayed-type, and airway hypersensitivity responses, as well as T-dependent antibody production, were significantly reduced in the mutant mice, while IL-17 deficiency of donor T cells did not affect acute graft-versus-host reaction. The results suggest that impaired responses were caused by the defects of allergen-specific T cell activation. Our findings indicate that IL-17 plays an important role in activating T cells in allergen-specific T cell-mediated immune responses.	Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan; Kanazawa Univ, Sch Med, Inst Expt Anim, Kanazawa, Ishikawa 9208640, Japan; Showa Univ, Sch Med, Shinagawa Ku, Tokyo 1428555, Japan; Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	University of Tokyo; Kanazawa University; Showa University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Iwakura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iwakura@ims.u-tokyo.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Nambu, Aya/0000-0002-2797-6420				Aarvak T, 1999, J IMMUNOL, V162, P1246; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x; Albanesi C, 1999, J IMMUNOL, V162, P494; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Attur MG, 1997, ARTHRITIS RHEUM, V40, P1050, DOI 10.1002/art.1780400609; Bouloc A, 1998, J INVEST DERMATOL, V111, P44, DOI 10.1046/j.1523-1747.1998.00236.x; Brewer JM, 1999, J IMMUNOL, V163, P6448; Buhlmann JE, 1999, J IMMUNOL, V162, P4373; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Higgins LM, 1999, J IMMUNOL, V162, P486; Hirahara N, 2000, ANTICANCER RES, V20, P3137; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lloyd CM, 2001, ADV IMMUNOL, V77, P263, DOI 10.1016/S0065-2776(01)77019-8; MARTIN TR, 1993, J CLIN INVEST, V91, P1176, DOI 10.1172/JCI116277; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Nakae S, 2001, INT IMMUNOL, V13, P1471, DOI 10.1093/intimm/13.12.1471; Nakae S, 2001, J IMMUNOL, V167, P90, DOI 10.4049/jimmunol.167.1.90; Nakae S, 2001, IMMUNOLOGY, V104, P402, DOI 10.1046/j.1365-2567.2001.01337.x; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Shin HCK, 1999, CYTOKINE, V11, P257, DOI 10.1006/cyto.1998.0433; Sulakvelidze I, 1998, EUR RESPIR J, V11, P821, DOI 10.1183/09031936.98.11040821; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; YOO ZB, 1995, J IMMUNOL, V155, P5483; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	42	867	927	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2002	17	3					375	387		10.1016/S1074-7613(02)00391-6	http://dx.doi.org/10.1016/S1074-7613(02)00391-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354389	Bronze			2022-12-18	WOS:000178163100013
J	Ginhoux, F; Guilliams, M				Ginhoux, Florent; Guilliams, Martin			Tissue-Resident Macrophage Ontogeny and Homeostasis	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; MONONUCLEAR PHAGOCYTE SYSTEM; ERYTHRO-MYELOID PROGENITORS; YOLK-SAC; BONE-MARROW; LANGERHANS CELLS; DENDRITIC CELLS; ADIPOSE-TISSUE; CIRCULATING MONOCYTES; ALVEOLAR MACROPHAGES	Defining the origins and developmental pathways of tissue-resident macrophages should help refine our understanding of the role of these cells in various disease settings and enable the design of novel macrophage-targeted therapies. In recent years the long-held belief that macrophage populations in the adult are continuously replenished by monocytes from the bone marrow (BM) has been overturned with the advent of new techniques to dissect cellular ontogeny. The new paradigm suggests that several tissue-resident macrophage populations are seeded during waves of embryonic hematopoiesis and self-maintain independently of BM contribution during adulthood. However, the exact nature of the embryonic progenitors that give rise to adult tissue-resident macrophages is still debated, and the mechanisms enabling macrophage population maintenance in the adult are undefined. Here, we review the emergence of these concepts and discuss current controversies and future directions in macrophage biology.	[Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 3, Singapore 138648, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Guilliams, Martin] VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University; Flanders Institute for Biotechnology (VIB); Ghent University	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 3, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.; Guilliams, M (corresponding author), VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	florent_ginhoux@immunol.a-star.edu.sg; martin.guilliams@irc.ugent.be	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570	Singapore Immunology Network; Shanghai Institute of Immunology; Marie Curie Reintegration grant; Odysseus grant; FWO grants of the Flemish Government	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Shanghai Institute of Immunology; Marie Curie Reintegration grant(European Commission); Odysseus grant; FWO grants of the Flemish Government(FWO)	This work was supported by core grants of the Singapore Immunology Network and the Shanghai Institute of Immunology to F.G. M.G. is supported by a Marie Curie Reintegration grant, an Odysseus grant, and FWO grants of the Flemish Government. We thank Lucy Robinson for editing the manuscript. We thank Alicia Wong for the design of the figures.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Calderon B, 2015, J EXP MED, V212, P1497, DOI 10.1084/jem.20150496; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Clarke D, 2000, ONCOGENE, V19, P3343, DOI 10.1038/sj.onc.1203661; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MIZOGUCHI S, 1992, J LEUKOCYTE BIOL, V52, P52, DOI 10.1002/jlb.52.1.52; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; NAITO M, 1990, J LEUKOCYTE BIOL, V48, P27, DOI 10.1002/jlb.48.1.27; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Scott CL, 2014, IMMUNOL REV, V262, P9, DOI 10.1111/imr.12220; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; SOROKIN SP, 1992, ANAT REC, V232, P527, DOI 10.1002/ar.1092320410; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tober J, 2007, BLOOD, V109, P1433, DOI 10.1182/blood-2006-06-031898; Tober J, 2013, DEVELOPMENT, V140, P3765, DOI 10.1242/dev.094961; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; VANFURTH R, 1970, J EXP MED, V132, P813, DOI 10.1084/jem.132.4.813; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yoder MC, 1997, BLOOD, V89, P2176, DOI 10.1182/blood.V89.6.2176; Yona S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00328; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	89	866	897	10	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					439	449		10.1016/j.immuni.2016.02.024	http://dx.doi.org/10.1016/j.immuni.2016.02.024			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982352	Bronze			2022-12-18	WOS:000372784200001
J	Fort, MM; Cheung, J; Yen, D; Li, J; Zurawski, SM; Lo, S; Menon, S; Clifford, T; Hunte, B; Lesley, R; Muchamuel, T; Hurst, SD; Zurawski, G; Leach, MW; Gorman, DM; Rennick, DM				Fort, MM; Cheung, J; Yen, D; Li, J; Zurawski, SM; Lo, S; Menon, S; Clifford, T; Hunte, B; Lesley, R; Muchamuel, T; Hurst, SD; Zurawski, G; Leach, MW; Gorman, DM; Rennick, DM			IL-25 induces IL-4 IL-5, and IL-13 and Th2-associated pathologies in vivo	IMMUNITY			English	Article							INTERLEUKIN-13 RECEPTOR; BINDING SUBUNIT; DEFICIENT MICE; CYTOKINES; CELLS; GRANULOPOIESIS; REQUIREMENT; EXPRESSION; COMPONENT; RESPONSES	We have characterized a cytokine produced by Th2 cells, designated as IL-25. Infusion of mice with IL-25 induced IL-4, IL-5, and IL-13 gene expression. The induction of these cytokines resulted in Th2-like responses marked by increased serum IgE, IgG(1), and IgA levels, blood eosinophilia, and pathological changes in the lungs and digestive tract that included eosinophilic infiltrates, increased mucus production, and epithelial cell hyperplasia/hypertrophy. In addition, our studies show that IL-25 induces Th2-type cytokine production by accessory cells that are MHC class IIhigh, CD11c(dull), and lineage(-).These results suggest that IL-25, derived from Th2 T cells, is capable of amplifying allergic type inflammatory responses by its actions on other cell types.	DNAX Res Inst Molec & Cellular Biol Inc, Palo Alto, CA 94304 USA; Schering Plough Res Inst, Lafayette, NJ 07848 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Schering-Plough Research Institute	Rennick, DM (corresponding author), DNAX Res Inst Molec & Cellular Biol Inc, Palo Alto, CA 94304 USA.	rennick@dnax.org		Muchamuel, Tony/0000-0002-4143-3086				Bost KL, 1996, IMMUNOLOGY, V87, P633, DOI 10.1046/j.1365-2567.1996.502574.x; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Corry DB, 1999, CURR OPIN IMMUNOL, V11, P610, DOI 10.1016/S0952-7915(99)00025-4; DeKruyff R H, 1993, Semin Immunol, V5, P421, DOI 10.1006/smim.1993.1048; ENNULAT D, 1998, VET PATHOL, V35, P456; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Furuta GT, 1998, J PEDIATR GASTR NUTR, V26, P468, DOI 10.1097/00005176-199804000-00021; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; Harding SM, 1999, J ALLERGY CLIN IMMUN, V104, P251, DOI 10.1016/S0091-6749(99)70360-X; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hoshino T, 1999, J IMMUNOL, V162, P5070; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Karlen S, 1998, Int Rev Immunol, V16, P227, DOI 10.3109/08830189809042996; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Li L, 1999, J IMMUNOL, V162, P2477; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; Roboz G J, 1999, Curr Opin Hematol, V6, P164, DOI 10.1097/00062752-199905000-00007; ROMAGNANI S, 1992, IMMUNOL TODAY, V13, P379, DOI 10.1016/0167-5699(92)90083-J; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Walsh SV, 1999, AM J SURG PATHOL, V23, P390, DOI 10.1097/00000478-199904000-00003; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Yamamoto M, 1996, ANN NY ACAD SCI, V778, P64, DOI 10.1111/j.1749-6632.1996.tb21115.x; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	36	866	957	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					985	995		10.1016/S1074-7613(01)00243-6	http://dx.doi.org/10.1016/S1074-7613(01)00243-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754819	Bronze			2022-12-18	WOS:000172961400012
J	KEARNEY, ER; PAPE, KA; LOH, DY; JENKINS, MK				KEARNEY, ER; PAPE, KA; LOH, DY; JENKINS, MK			VISUALIZATION OF PEPTIDE-SPECIFIC T-CELL IMMUNITY AND PERIPHERAL TOLERANCE INDUCTION IN-VIVO	IMMUNITY			English	Article							ALLERGIC ENCEPHALOMYELITIS; COSTIMULATORY SIGNAL; ANTIGEN RECEPTOR; PROTEIN ANTIGENS; TRANSGENIC MICE; B-CELLS; UNRESPONSIVENESS; INTERLEUKIN-2; LYMPHOCYTES; INVIVO	An adoptive transfer system was used to monitor physically the behavior of a trace population of TCR transgenic T cells in vivo. After subcutaneous injection of antigen in adjuvant, the antigen-specific cells accumulated first in the paracortical region of the draining lymph nodes, proliferated there for several days, and then moved into lymph node follicles, where they accounted for most of the T cells. They then disappeared slowly from the draining nodes, and the remaining cells were hypersensitive to antigenic stimulation in vitro. In contrast, when the antigen was introduced into the blood, the antigen-specific cells rapidly accumulated in the paracortical regions of all lymph nodes, proliferated there for a short time, but never entered follicles. Most of the cells then rapidly disappeared, leaving behind a population that was hyporesponsive to antigenic stimulation. These results provide a physical basis for the classical finding that antigen-specific memory and tolerance can be influenced by the form of antigen administration.	WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DETP GENET,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	KEARNEY, ER (corresponding author), UNIV MINNESOTA,SCH MED,DEPT MICROBIOL,MINNEAPOLIS,MN 55455, USA.		Jenkins, Marc/G-1063-2012	Jenkins, Marc/0000-0001-8009-7655	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027998, P01AI035296] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-35296, AI-27998] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AICHELE P, 1994, P NATL ACAD SCI USA, V91, P444, DOI 10.1073/pnas.91.2.444; BLACKMAN MA, 1991, P NATL ACAD SCI USA, V88, P6682, DOI 10.1073/pnas.88.15.6682; BRINER TJ, 1993, P NATL ACAD SCI USA, V90, P7608, DOI 10.1073/pnas.90.16.7608; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; BURSTEIN HJ, 1993, J EXP MED, V177, P457, DOI 10.1084/jem.177.2.457; CHILLER JM, 1971, SCIENCE, V171, P813, DOI 10.1126/science.171.3973.813; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; DEWIT D, 1992, J EXP MED, V175, P9, DOI 10.1084/jem.175.1.9; DRESSER DW, 1961, NATURE, V191, P1169, DOI 10.1038/1911169a0; DRESSER DW, 1962, IMMUNOLOGY, V5, P378; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; FREI PC, 1965, P NATL ACAD SCI USA, V53, P20, DOI 10.1073/pnas.53.1.20; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; HAMMERLING GJ, 1991, IMMUNOL REV, V122, P47, DOI 10.1111/j.1600-065X.1991.tb00596.x; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JENKINS MK, 1992, IMMUNOL TODAY, V13, P69, DOI 10.1016/0167-5699(92)90137-V; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KENNEDY MK, 1988, J IMMUNOL, V141, P2986; KREIGER JI, 1985, J IMMUNOL, V135, P2937; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; KYEWSKI BA, 1984, NATURE, V308, P196, DOI 10.1038/308196a0; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; MILLER SD, 1979, J EXP MED, V149, P758, DOI 10.1084/jem.149.3.758; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; MULLER KP, 1993, EUR J IMMUNOL, V23, P3203, DOI 10.1002/eji.1830231224; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PULENDRAN B, 1994, P NATL ACAD SCI USA, V91, P2639, DOI 10.1073/pnas.91.7.2639; RIA F, 1990, NATURE, V343, P381, DOI 10.1038/343381a0; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROMBALL CG, 1993, J EXP MED, V178, P1637, DOI 10.1084/jem.178.5.1637; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; SPRENT J, 1976, CELL IMMUNOL, V21, P278, DOI 10.1016/0008-8749(76)90057-5; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; WANG R, 1993, J IMMUNOL, V150, P3832; WARREN HS, 1986, ANNU REV IMMUNOL, V4, P369, DOI 10.1146/annurev.iy.04.040186.002101; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WEIGLE WO, 1980, ADV IMMUNOL, V30, P159; WILSON DB, 1971, J EXP MED, V131, P442; YOKOCHI T, 1982, J IMMUNOL, V128, P823	54	859	872	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1994	1	4					327	339		10.1016/1074-7613(94)90084-1	http://dx.doi.org/10.1016/1074-7613(94)90084-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889419				2022-12-18	WOS:A1994PK16600010
J	Anfossi, N; Andre, P; Guia, S; Falk, CS; Roetynck, S; Stewart, CA; Breso, V; Frassati, C; Reviron, D; Middleton, D; Romagne, F; Ugolini, S; Vivier, E				Anfossi, Nicolas; Andre, Pascale; Guia, Sophie; Falk, Christine S.; Roetynck, Sophie; Stewart, C. Andrew; Breso, Violette; Frassati, Coralie; Reviron, Denis; Middleton, Derek; Romagne, Francois; Ugolini, Sophie; Vivier, Eric			Human NK cell education by inhibitory receptors for MHC class I	IMMUNITY			English	Article							NATURAL-KILLER-CELL; IMMUNOGLOBULIN-LIKE RECEPTORS; BARE LYMPHOCYTE SYNDROME; SELF-TOLERANCE; T-CELLS; MOLECULES; COMPLEX; MICE; RECOGNITION; HLA	Natural killer (NK) cells recognize the absence of self MHC class I as a way to discriminate normal cells from cells in distress. In humans, this "missing self" recognition is ensured by inhibitory receptors such as KIR, which dampen NK cell activation upon interaction with their MHC class I ligands. We show here that NK cells lacking inhibitory KIR for self MHC class I molecules are present in human peripheral blood. These cells harbor a mature NK cell phenotype but are hyporesponsive to various stimuli, including MHC class I-deficient target cells. This response is in contrast to NK cells that express a single inhibitory KIR specific for self MHC class 1, which are functionally competent when exposed to the same stimuli. These results show the involvement of KIR-MHC class I interactions in the calibration of NK cell effector capacities, suggesting its role in the subsequent "missing self" recognition.	Univ Mediterranee, Dtr Immunol marseille Luminy, F-13009 Marseille, France; Innate Pharma, F-13009 Marseille, France; INSERM, U631, F-13009 Marseille, France; CNRS, UMR6102, F-13009 Marseille, France; Natl Res Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany; Etab Francais Sang Alpes Mediterranee, F-13392 Marseille, France; City Hosp, No Ireland Histocompatibil & Immunogenet Lab, Belfast BT9 7TS, Antrim, North Ireland; Hop Marseille, Hop Concept Assistance Publ, F-13385 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University of Munich	Ugolini, S (corresponding author), Univ Mediterranee, Dtr Immunol marseille Luminy, F-13009 Marseille, France.	ugolini@ciml.univ-mrs.fr; vivier@ciml.univ-mrs.fr	Falk, Christine/Q-4143-2016; Stewart, Charles/G-2470-2012; Vivier, Eric/F-8939-2010	Falk, Christine/0000-0003-1376-7318; Vivier, Eric/0000-0001-7022-8287; Ugolini, Sophie/0000-0003-4041-0103				Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Carrington M, 2006, CURR TOP MICROBIOL, V298, P225; Cooper GJS, 2001, AUST J DAIRY TECHNOL, V56, P97; Crum KA, 2000, TISSUE ANTIGENS, V56, P313, DOI 10.1034/j.1399-0039.2000.560403.x; Daeron M, 1999, CURR TOP MICROBIOL, V244, P1; Dorfman JR, 1996, EUR J IMMUNOL, V26, P151, DOI 10.1002/eji.1830260123; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Furukawa H, 1999, HUM IMMUNOL, V60, P32, DOI 10.1016/S0198-8859(98)00097-4; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; TAY CH, 1995, J IMMUNOL, V154, P780; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vitale M, 2002, BLOOD, V99, P1723, DOI 10.1182/blood.V99.5.1723; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Williams F, 2002, HUM IMMUNOL, V63, P602, DOI 10.1016/S0198-8859(02)00408-1; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	41	855	881	0	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					331	342		10.1016/j.immuni.2006.06.013	http://dx.doi.org/10.1016/j.immuni.2006.06.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16901727	Bronze			2022-12-18	WOS:000240047500018
J	Yu, D; Rao, S; Tsai, LM; Lee, SK; He, YQ; Sutcliffe, EL; Srivastava, M; Linterman, M; Zheng, L; Simpson, N; Ellyard, JI; Parish, IA; Ma, CS; Li, QJ; Parish, CR; Mackay, CR; Vinuesa, CG				Yu, Di; Rao, Sudha; Tsai, Louis M.; Lee, Sau K.; He, Yiqing; Sutcliffe, Elissa L.; Srivastava, Monika; Linterman, Michelle; Zheng, Lei; Simpson, Nicholas; Ellyard, Julia I.; Parish, Ian A.; Ma, Cindy S.; Li, Qi-Jing; Parish, Christopher R.; Mackay, Charles R.; Vinuesa, Carola G.			The Transcriptional Repressor Bcl-6 Directs T Follicular Helper Cell Lineage Commitment	IMMUNITY			English	Article							GERMINAL-CENTER FORMATION; CXC CHEMOKINE RECEPTOR-5; CENTER B-CELLS; IMMUNOGLOBULIN PRODUCTION; SYSTEMIC AUTOIMMUNITY; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; GENE-EXPRESSION; C-MAF; DIFFERENTIATION	Follicular helper T (Tfh) cells provide selection signals to germinal center B cells, which is essential for long-lived antibody responses. High CXCR5 and low CCR7 expression facilitates their homing to B cell follicles and distinguishes them from T helper 1 (Th1), Th2, and Th17 cells. Here, we showed that Bcl-6 directs Tfh cell differentiation: Bcl-6-deficient T cells failed to develop into Tfh cells and could not sustain germinal center responses, whereas forced expression of Bcl-6 in CD4(+) T cells promoted expression of the hallmark Tfh cell molecules CXCR5, CXCR4, and PD-1. Bcl-6 bound to the promoters of the Th1 and Th17 cell transcriptional regulators T-bet and ROR gamma t and repressed IFN-gamma and IL-17 production. Bcl-6 also repressed expression of many microRNAs (miRNAs) predicted to control the Tfh cell signature, including miR-17-92, which repressed CXCR5 expression. Thus, Bcl-6 positively directs Tfh cell differentiation, through combined repression of miRNAs and transcription factors.	[Yu, Di; Tsai, Louis M.; Zheng, Lei; Ma, Cindy S.; Mackay, Charles R.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Yu, Di; Rao, Sudha; Lee, Sau K.; He, Yiqing; Sutcliffe, Elissa L.; Srivastava, Monika; Linterman, Michelle; Simpson, Nicholas; Ellyard, Julia I.; Parish, Ian A.; Parish, Christopher R.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Mackay, Charles R.] UNSW, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW 2010, Australia; [Mackay, Charles R.] Monash Univ, Fac Med, Nursing Serv, Clayton, Vic 3800, Australia; [Mackay, Charles R.] Monash Univ, Hlth Serv, Clayton, Vic 3800, Australia	Garvan Institute of Medical Research; Australian National University; John Curtin School of Medical Research; Duke University; University of New South Wales Sydney; Monash University; Monash University	Mackay, CR (corresponding author), Garvan Inst Med Res, Sydney, NSW 2010, Australia.	charles.mackay@med.monash.edu.au; carola.vinuesa@anu.edu.au	Linterman, Michelle/AAN-4210-2021; Mackay, Charles R/A-9673-2008; Vinuesa, Carola G/B-1108-2010; Yu, Di/C-2163-2009; Rao, Sudha/AAW-5192-2020; S, Cindy/B-2340-2012	Linterman, Michelle/0000-0001-6047-1996; Mackay, Charles R/0000-0002-6338-7340; Vinuesa, Carola G/0000-0001-9799-0298; Yu, Di/0000-0003-1721-8922; Rao, Sudha/0000-0001-9547-947X; S, Cindy/0000-0001-5387-8413; Parish, Christopher/0000-0001-7740-0430; Parish, Ian/0000-0003-3528-478X	Viertel Senior Medical Research Fellowship; National Health and Medical Research Council (NHMRC); Cooperative Research Centre; Cancer Institute NSW Fellowship	Viertel Senior Medical Research Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cancer Institute NSW Fellowship	We thank X. Hu and J. Hogan (animal experiments), N. Chevalier and C. Wang (miRNA experiments), A. Wilson and M. Cook (obtaining tonsils), R. Brink and D. Gatto (OT-11 transfer experiments), F. Sierro (immunofluorescence), H. Speirs (RNA preparation), and H. Vora, C. Brownlee, and Y. Sontani (cell sorting) for their help. This work was funded by a Viertel Senior Medical Research Fellowship to C.G.V., National Health and Medical Research Council (NHMRC) Fellowships to D.Y., C.S.M., and C.R.M, Cooperative Research Centre Scholarship to L.M.T.,. a Cancer Institute NSW Fellowship to D.Y., a NHMRC project grant to S.R. and NHMRC program grants to C.G.V., C.R.M., and C. R P.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	55	851	893	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					457	468		10.1016/j.immuni.2009.07.002	http://dx.doi.org/10.1016/j.immuni.2009.07.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19631565	Bronze			2022-12-18	WOS:000270525900013
J	Munn, DH; Sharma, MD; Baban, B; Harding, HP; Zhang, YH; Ron, D; Mellor, AL				Munn, DH; Sharma, MD; Baban, B; Harding, HP; Zhang, YH; Ron, D; Mellor, AL			GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase	IMMUNITY			English	Article							EUKARYOTIC INITIATION FACTOR-2-ALPHA; ENDOPLASMIC-RETICULUM STRESS; DENDRITIC CELLS; GENE-EXPRESSION; TRYPTOPHAN CATABOLISM; TRANSLATIONAL CONTROL; MAMMALIAN-CELLS; IN-VIVO; PHOSPHORYLATION; REINITIATION	Indoleamine 2,3 dioxygenase (IDO) catabolizes the amino acid tryptophan. IDO-expressing immunoregulatory dendritic cells (DCs) have been implicated in settings including tumors, autoimmunity, and transplant tolerance. However, the downstream molecular mechanisms by which IDO functions to regulate T cell responses remain unknown. We now show that IDO-expressing plasmacytoid DCs activate the GCN2 kinase pathway in responding T cells. GCN2 is a stress-response kinase that is activated by elevations in uncharged tRNA. T cells with a targeted disruption of GCN2 were not susceptible to IDO-mediated suppression of proliferation in vitro. In vivo, proliferation of GCN2-knockout T cells was not inhibited by IDO-expressing DCs from tumor-draining lymph nodes. IDO induced profound anergy in responding wild-type T cells, but GCN2-knockout cells were refractory to IDO-induced anergy. We hypothesize that GCN2 acts as a molecular sensor in T cells, allowing them to detect and respond to conditions created by IDO.	Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; Med Coll Georgia, Dept Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; New York University; University System of Georgia; Augusta University	Munn, DH (corresponding author), Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA.	dmunn@mail.mcg.edu	Wilson, Matthew H/K-3193-2013	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636; Munn, David/0000-0002-7711-2858	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041187] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA096651, R01CA103320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119, R29DK047119, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NCI NIH HHS [CA 096651, CA 103320] Funding Source: Medline; NICHD NIH HHS [HD 41187] Funding Source: Medline; NIDDK NIH HHS [DK 47119] Funding Source: Medline; NIEHS NIH HHS [ES 08681] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Beretta L, 2004, INT REV IMMUNOL, V23, P347, DOI 10.1080/08830180490452549; Crosby JS, 2000, BLOOD, V96, P3241; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; HINNEBUSCH AG, 2000, TRANSLATIONAL CONTRO; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Li YY, 2004, HUM IMMUNOL, V65, P114, DOI 10.1016/j.humimm.2003.11.004; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marshall B, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-5; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Niwa M, 2000, P NATL ACAD SCI USA, V97, P12396, DOI 10.1073/pnas.250476097; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sood R, 2000, GENETICS, V154, P787; Tarazona R, 1996, INT IMMUNOL, V8, P351, DOI 10.1093/intimm/8.3.351; van Wissen M, 2002, J IMMUNOL, V169, P7039, DOI 10.4049/jimmunol.169.12.7039; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Zelenika D, 1998, J IMMUNOL, V161, P1868; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	42	851	913	6	53	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2005	22	5					633	642		10.1016/j.immuni.2005.03.013	http://dx.doi.org/10.1016/j.immuni.2005.03.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894280	Bronze			2022-12-18	WOS:000229447200012
J	Basu, S; Binder, RJ; Ramalingam, T; Srivastava, PK				Basu, S; Binder, RJ; Ramalingam, T; Srivastava, PK			CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin	IMMUNITY			English	Article							DENDRITIC CELLS; PEPTIDE COMPLEXES; TUMOR; ANTIGEN; BINDING; CHAPERONE; MATURATION; CANCER	Complexes of the heat shock protein gp96 and antigenic peptides are taken up by antigen-presenting cells and presented by MHC class I molecules. In order to explain the unusual efficiency of this process, the uptake of gp96 had been postulated to occur through a receptor, identified recently as CD91. We show here that complexes of peptides with heat shock proteins hsp90, calreticulin, and hsp70 are also taken up by macrophages and dendritic cells and re-presented by MHC class I molecules. All heat shock proteins utilize the CD91 receptor, even though some of the proteins have no homology with each other. Postuptake processing of gp96-chaperoned peptides requires proteasomes and the transporters associated with antigen processing, utilizing the classical endogenous antigen presentation pathway.	Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA	University of Connecticut	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, MC1601, Farmington, CT 06030 USA.	srivastava@nso2.uchc.edu			NCI NIH HHS [CA64394] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064394] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Binder RJ, 2000, J IMMUNOL, V165, P2582, DOI 10.4049/jimmunol.165.5.2582; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Breloer M, 1998, EUR J IMMUNOL, V28, P1016, DOI 10.1002/(SICI)1521-4141(199803)28:03<1016::AID-IMMU1016>3.0.CO;2-G; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Ishii T, 1999, J IMMUNOL, V162, P1303; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Panjwani NN, 2000, CELL STRESS CHAPERON, V5, P391; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1984, INT J CANCER, V33, P417, DOI 10.1002/ijc.2910330321; SRIVASTAVA PK, 1994, EXPERIENTIA, V50, P1054, DOI 10.1007/BF01923461; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Srivastava PK, 1997, METHODS, V12, P165, DOI 10.1006/meth.1997.0464; SRIVASTAVA PK, 1982, THESIS OSMANIA U HYD; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; UDONO H, 1994, J IMMUNOL, V152, P5398; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Wang XY, 2000, FEBS LETT, V465, P98, DOI 10.1016/S0014-5793(99)01733-0; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	34	850	940	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2001	14	3					303	313		10.1016/S1074-7613(01)00111-X	http://dx.doi.org/10.1016/S1074-7613(01)00111-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290339	Bronze			2022-12-18	WOS:000167959500009
J	Wei, G; Wei, L; Zhu, JF; Zang, CZ; Hu-Li, J; Yao, ZJ; Cui, KR; Kanno, Y; Roh, TY; Watford, WT; Schones, DE; Peng, WQ; Sun, HW; Paul, WE; O'Shea, JJ; Zhao, KJ				Wei, Gang; Wei, Lai; Zhu, Jinfang; Zang, Chongzhi; Hu-Li, Jane; Yao, Zhengju; Cui, Kairong; Kanno, Yuka; Roh, Tae-Young; Watford, Wendy T.; Schones, Dustin E.; Peng, Weiqun; Sun, Hong-wei; Paul, William E.; O'Shea, John J.; Zhao, Keji			Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4(+) T Cells	IMMUNITY			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; GENE-EXPRESSION; TGF-BETA; TRANSCRIPTION FACTORS; FOXP3 EXPRESSION; HELPER TYPE-1; T(H)17 CELLS; TH17 CELLS; TH2 CELLS	Multipotential naive CD4(+) T cells differentiate into distinct lineages including T helper 1 (Th1), Th2, Th17, and inducible T regulatory (iTreg) cells. The remarkable diversity of CD4(+) T cells begs the question whether the observed changes reflect terminal differentiation with heritable epigenetic modifications or plasticity in T cell responses. We generated genome-wide histone H3 lysine 4 (H3K4) and lysine 27 (H3K27) trimethylation maps in naive, Th1, Th2, Th17, iTreg, and natural Treg (nTreg) cells. We found that although modifications of signature-cytokine genes (Ifng, II4, and II17) partially conform to the expectation of lineage commitment, genes encoding transcription factors like Tbx21 exhibit a broad spectrum of epigenetic states, consistent with our demonstration of T-bet and interferon-gamma induction in nTreg cells. Our data suggest an epigenetic mechanism underlying the specificity and plasticity of effector and regulatory T cells and also provide a framework for understanding complexity of CD4(+) T helper cell differentiation.	[Wei, Lai; Yao, Zhengju; Kanno, Yuka; Watford, Wendy T.; O'Shea, John J.] NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Wei, Gang; Cui, Kairong; Roh, Tae-Young; Schones, Dustin E.; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Sun, Hong-wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); George Washington University	O'Shea, JJ (corresponding author), NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov; zhaok@nhlbi.nih.gov	Wei, Gang/A-3291-2011; Hu, Ruogu/B-2203-2008; Zhu, Jinfang/B-7574-2012; Kanno, Yuka/B-5802-2013; Wei, Lai/D-1088-2014; /AAI-2516-2019; Zang, Chongzhi/D-1445-2011	Zhu, Jinfang/0000-0002-0117-4745; Kanno, Yuka/0000-0001-5668-9319; Zang, Chongzhi/0000-0003-4812-3627; Peng, Weiqun/0000-0001-5521-9091; Watford, Wendy/0000-0003-4261-5399; Roh, Tae-Young/0000-0001-5833-0844	National Institute of Allergy and Infectious Diseases (NIAID); NHLBI; NIAMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZICHL005905, ZIAHL005801, ZICHL006018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041159] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank W. Leonard for critical reading of the manuscript and J. Simone for technical help with cell sorting. The gene-expression analysis with the Affymetrix microarrays was performed by the Gene Expression Gore Facilities of National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This research was supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases (NIAID), NHLBI, and NIAMS.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; He X, 2006, CURR OPIN IMMUNOL, V18, P135, DOI 10.1016/j.coi.2006.02.003; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	59	847	888	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					155	167		10.1016/j.immuni.2008.12.009	http://dx.doi.org/10.1016/j.immuni.2008.12.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144320	Bronze, Green Accepted			2022-12-18	WOS:000262769900018
J	Cros, J; Cagnard, N; Woollard, K; Patey, N; Zhang, SY; Senechal, B; Puel, A; Biswas, SK; Moshous, D; Picard, C; Jais, JP; D'Cruz, D; Casanova, JL; Trouillet, C; Geissmann, F				Cros, Jerome; Cagnard, Nicolas; Woollard, Kevin; Patey, Natacha; Zhang, Shen-Ying; Senechal, Brigitte; Puel, Anne; Biswas, Subhra K.; Moshous, Despina; Picard, Capucine; Jais, Jean-Philippe; D'Cruz, David; Casanova, Jean-Laurent; Trouillet, Celine; Geissmann, Frederic			Human CD14(dim) Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors	IMMUNITY			English	Article							PYOGENIC BACTERIAL-INFECTIONS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENDRITIC CELL PRECURSORS; NATURAL-KILLER-CELLS; BLOOD MONOCYTES; CD16(+) MONOCYTES; PROTECTIVE IMMUNITY; 6-SULFO LACNAC; IN-VIVO; SUBSETS	Monocytes are effectors of the inflammatory response to microbes. Human CD14(+) monocytes specialize in phagocytosis and production of reactive oxygen species and secrete inflammatory cytokines in response to a broad range of microbial cues. Here, we have characterized the functions of human monocytes that lack CD14 (CD14(dim)) and express CD16. CD14(dim) monocytes were genetically distinct from natural killer cells. Gene expression analyses indicated similarities with murine patrolling Gr1(dim) monocytes, and they patrolled the endothelium of blood vessels after adoptive transfer, in a lymphocyte function-associated antigen-1-dependent manner. CD14(dim) monocytes were weak phagocytes and did not produce ROS or cytokines in response to cell-surface Toll-like receptors. Instead, they selectively produced TNF-alpha, IL-1 beta, and CCL3 in response to viruses and immune complexes containing nucleic acids, via a proinflammatory TLR7-TLR 8-MyD88-MEK pathway. Thus, CD14(dim) cells are bona fide monocytes involved in the innate local surveillance of tissues and the pathogenesis of autoimmune diseases.	[Woollard, Kevin; Trouillet, Celine; Geissmann, Frederic] Kings Coll London, Div Immunol Infect & Inflammatory Dis, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Cros, Jerome; Patey, Natacha; Senechal, Brigitte; Geissmann, Frederic] Univ Paris 05, INSERM, U838, F-75015 Paris, France; [Cagnard, Nicolas; Jais, Jean-Philippe] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Biostat, F-75015 Paris, France; [Zhang, Shen-Ying; Puel, Anne; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, Lab Human Genet Infect Dis, New York, NY 10065 USA; [Biswas, Subhra K.] Singapore Immunol Network, SIgN BMSI A STAR, Immunos 138648, Singapore; [Moshous, Despina; Picard, Capucine; Casanova, Jean-Laurent] Univ Paris 05, Hop Necker Enfants Malad, Pediat Immunohematol Unit, F-75015 Paris, France; [D'Cruz, David] St Thomas Hosp, Kings Coll London, Louise Coote Lupus Unit, London SE1 7EH, England; [Casanova, Jean-Laurent] INSERM, Necker Branch, Lab Human Genet Infect Dis, U550, F-75015 Paris, France; [Casanova, Jean-Laurent] Univ Paris 05, Necker Med Sch, F-75015 Paris, France	University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Geissmann, F (corresponding author), Kings Coll London, Div Immunol Infect & Inflammatory Dis, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Moshous, Despina/B-7507-2017; Picard, Capucine/H-3914-2017; Zhang, Shen-Ying/I-2685-2017; Casanova, Jean-Laurent/I-3418-2017; Puel, Anne/H-7305-2017; Cros, Jerome/X-7677-2019; Cagnard, Nicolas/K-2754-2014	Moshous, Despina/0000-0001-6719-3693; Picard, Capucine/0000-0001-8788-5056; Zhang, Shen-Ying/0000-0002-9449-3672; Puel, Anne/0000-0003-2603-0323; Cros, Jerome/0000-0002-4935-3865; geissmann, frederic/0000-0001-5029-2468; Woollard, Kevin/0000-0002-9839-5463; Casanova, Jean-Laurent/0000-0002-7782-4169; Cagnard, Nicolas/0000-0002-9051-1896	Arthritis Research UK; EURYI; Medical Research Council [G0900867]; MRC [G0900867] Funding Source: UKRI; British Heart Foundation [FS/09/003/26551] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); EURYI(European Science Foundation (ESF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	Authors are indebted to members of the Geissmann Lab for support and critical discussions, to M. Bertolaccini for preparation of patient serums, C. Wirrig for help with preparation of arrays and Facs analysis, to F. Rosenberg for HSV-1 GFP, to M. Dionne, A. Fischer, M. Marber, E. Zorn, and R. Medzhitov for helpful discussions and critical reading of the manuscript. Work was supported by Arthritis Research UK, and EURYI and Medical Research Council (G0900867) Grants to FG. K.W. is a British Heart Foundation fellow. F.G., J.C., and K.W. designed the study and wrote the manuscript. N.C. and J.P.J. performed the bio-informatical analysis. J.C., K.W., C.T., N.P., S.Y.Z., A.P., C.P., D.M., S.B., and D.D.'C. performed experiments and contributed to the analysis of results.	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gupta M, 2001, VIROLOGY, V284, P20, DOI 10.1006/viro.2001.0836; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hill GS, 2005, KIDNEY INT, V68, P2288, DOI 10.1111/j.1523-1755.2005.00688.x; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rhodes B, 2008, RHEUMATOLOGY, V47, P1603, DOI 10.1093/rheumatology/ken247; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2009, J IMMUNOL, V183, P2678, DOI 10.4049/jimmunol.0803398; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Stroher U, 2001, J VIROL, V75, P11025, DOI 10.1128/JVI.75.22.11025-11033.2001; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vidovic D, 2003, HUM IMMUNOL, V64, P238, DOI 10.1016/S0198-8859(02)00780-2; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	53	841	895	2	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					375	386		10.1016/j.immuni.2010.08.012	http://dx.doi.org/10.1016/j.immuni.2010.08.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20832340	hybrid, Green Published			2022-12-18	WOS:000282798500012
J	Stetson, DB; Medzhitov, R				Stetson, Daniel B.; Medzhitov, Ruslan			Type I interferons in host defense	IMMUNITY			English	Review							DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTOR-9; IFN-BETA PROMOTER; VIRAL VIF PROTEIN; RIG-I	Type I interferons (IFNs) are a family of cytokines specialized to coordinate immunity to viruses and other intracellular infections. In the past several years, many of the receptors and signaling pathways that link pathogen detection to induction of type I IFNs have been identified and characterized. An integrated picture has emerged in which type I IFNs have essential functions in several seemingly disparate processes: they restrict viral spread by engaging machinery that ultimately cripples and kills infected cells, yet they are also positively linked to the activation and expansion of lymphocytes that are important for control of intracellular infections. These advances highlight the context-specific actions of type I IFNs and clarify the multiple points at which they are integrated into both innate and adaptive immunity.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Stetson, DB (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA.	daniel.stetson@yale.edu; ruslan.medzhitov@yale.edu	Bremner, James D/B-1632-2013					Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HESS CB, 1987, J IMMUNOL, V138, P3949; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; NAGANO Y, 1958, CR SOC BIOL, V152, P1627; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; PAVLOVIC J, 1993, CIBA F SYMP, V176, P233; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	83	841	873	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					373	381		10.1016/j.immuni.2006.08.007	http://dx.doi.org/10.1016/j.immuni.2006.08.007			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979569	Bronze			2022-12-18	WOS:000240862200004
J	Surh, CD; Sprent, J				Surh, Charles D.; Sprent, Jonathan			Homeostasis of Naive and Memory T Cells	IMMUNITY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; LYMPHOPENIA-INDUCED PROLIFERATION; NATURAL-KILLER-CELL; CLASS-II MOLECULES; CUTTING EDGE; RECEPTOR EXPRESSION; IN-VIVO; INTERLEUKIN (IL)-15R-ALPHA; SELECTIVE STIMULATION; HOST-DEFENSE	The peripheral mature T cell pool is regulated by complex homeostatic mechanisms. Naive T cells are maintained by interleukin-7 (IL-7) and T cell receptor (TCR) signaling from contact with major histocompatibility complex (MHC), which sustain expression of antiapoptotic molecules and allow the cells to survive in interphase. Competition for these ligands declines when T cell numbers are reduced and causes residual naive T cells to proliferate and differentiate into memory-like cells. This memory cell population is thus heterogeneous and comprised of cells derived from responses to both foreign and self-antigens. Typical memory cells are kept alive and induced to divide intermittently by a mixture of IL-7 and IL-15. This review highlights recent advances in how naive and memory T cell homeostasis is regulated.	[Surh, Charles D.] Scripps Res Inst, La Jolla, CA 92037 USA; [Sprent, Jonathan] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Scripps Research Institute; Garvan Institute of Medical Research	Surh, CD (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	csurh@scripps.edu						Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Buentke E, 2006, BLOOD, V108, P1949, DOI 10.1182/blood-2006-04-016857; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carrio R, 2007, EUR J IMMUNOL, V37, P3078, DOI 10.1002/eji.200737585; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Dai ZH, 2001, J IMMUNOL, V167, P6711, DOI 10.4049/jimmunol.167.12.6711; Davey GM, 2005, J EXP MED, V202, P1099, DOI 10.1084/jem.20050003; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Hagen KA, 2004, J IMMUNOL, V173, P3909, DOI 10.4049/jimmunol.173.6.3909; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kamimura D, 2004, J IMMUNOL, V173, P6041, DOI 10.4049/jimmunol.173.10.6041; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kennedy P, 2000, LAT TRADE, V8, P15; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Krogsgaard M, 2007, SEMIN IMMUNOL, V19, P236, DOI 10.1016/j.smim.2007.04.003; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Li O, 2006, J EXP MED, V203, P1713, DOI 10.1084/jem.20052293; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Martin B, 2004, J IMMUNOL, V172, P3391, DOI 10.4049/jimmunol.172.6.3391; Martin B, 2003, P NATL ACAD SCI USA, V100, P6021, DOI 10.1073/pnas.1037754100; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; PEREIRA P, 1986, EUR J IMMUNOL, V16, P685, DOI 10.1002/eji.1830160616; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Ramanathan S, 2006, J IMMUNOL, V176, P4029, DOI 10.4049/jimmunol.176.7.4029; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Robertson JM, 2006, IMMUNOL REV, V211, P49, DOI 10.1111/j.0105-2896.2006.00383.x; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Selin LK, 2004, IMMUNITY, V20, P5, DOI 10.1016/S1074-7613(03)00356-X; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEZYS V, 2008, NATURE IN PRESS; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; VOS Q, 1992, J IMMUNOL, V149, P1204; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	134	835	866	1	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					848	862		10.1016/j.immuni.2008.11.002	http://dx.doi.org/10.1016/j.immuni.2008.11.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100699	Bronze			2022-12-18	WOS:000262012400006
J	CAO, XQ; SHORES, EW; HULI, J; ANVER, MR; KELSALL, BL; RUSSELL, SM; DRAGO, J; NOGUCHI, M; GRINBERG, A; BLOOM, ET; PAUL, WE; KATZ, SI; LOVE, PE; LEONARD, WJ				CAO, XQ; SHORES, EW; HULI, J; ANVER, MR; KELSALL, BL; RUSSELL, SM; DRAGO, J; NOGUCHI, M; GRINBERG, A; BLOOM, ET; PAUL, WE; KATZ, SI; LOVE, PE; LEONARD, WJ			DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; EPIDERMAL T-CELLS; IL-2 RECEPTOR; BETA-CHAIN; FUNCTIONAL COMPONENT; MONOCLONAL-ANTIBODY; GENE; DISEASE; REQUIREMENT; ACTIVATION	The common gamma chain (gamma(c)) of the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors is defective in hu mans with XSCID. Mice lacking gamma(c) expression had hypoplastic thymuses; the thymocytes responded to gamma(c)-independent mitogens, but not gamma(c)-dependent stimuli. Splenic T cells were diminished at 3 weeks of age, but CD4+ T cells markedly increased by 4 weeks. B cells were greatly diminished, in contrast with the situation in XSCID. NK cells, gamma delta intestinal intraepithelial lymphocytes, dendritic epidermal T cells, peripheral lymph nodes, and gut-associated lymphoid tissue were absent. These findings underscore the importance of gamma(c) in lymphoid development. Moreover, differences in humans and mice lacking ye expression indicate species-specific differences in the roles of gamma(c)-dependent cytokines or in the existence of redundant pathways. These mice provide an important model for studying the pathophysiology of and gene therapy for human XSCID.	NIAID,IMMUNOL LAB,BETHESDA,MD 20892; NIAID,MUCOSAL IMMUN SECT,BETHESDA,MD 20892; NIAID,CLIN INVEST LAB,BETHESDA,MD 20892; NICHHD,MAMMALIAN GENES & DEV LAB,BETHESDA,MD 20892; US FDA,CTR BIOL EVALUAT & RES,DIV CELLULAR & GENE THERAPIES,DIV HEMATOL PROD,BETHESDA,MD 20892; US FDA,CTR BIOL EVALUAT & RES,DIV CELLULAR & GENE THERAPIES,CELLULAR IMMUNOL LAB,BETHESDA,MD 20892; NCI,FREDERICK CANC RES & DEV CTR,DYNCORP INC,PROGRAM RESOURCES,PATHOL HISTOTECHNOL LAB,FREDERICK,MD 21702; NCI,DERMATOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	CAO, XQ (corresponding author), NHLBI,MOLEC IMMUNOL LAB,BETHESDA,MD 20892, USA.		Russell, Sarah M/B-9341-2009; Leonard, Warren/AAA-1397-2022	Russell, Sarah M/0000-0001-5826-9641; 				ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; BAMFORD TN, 1994, P NATL ACAD SCI USA, V91, P4940; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BERGSTRESSER PR, 1993, J INVEST DERMATOL, V100, pS80, DOI 10.1111/1523-1747.ep12356076; BLOOM ET, 1994, J IMMUNOL, V152, P4242; BLOOM ET, 1983, J IMMUNOL METHODS, V58, P323, DOI 10.1016/0022-1759(83)90360-5; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; BROOKS EG, 1990, J CLIN INVEST, V86, P1623, DOI 10.1172/JCI114884; CAO XQ, 1993, P NATL ACAD SCI USA, V90, P8464, DOI 10.1073/pnas.90.18.8464; CASEY LS, 1992, J IMMUNOL, V148, P3418; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; CONLEY ME, 1992, ANNU REV IMMUNOL, V10, P215; DISANTO JP, 1994, P NATL ACAD SCI USA, V91, P9466, DOI 10.1073/pnas.91.20.9466; DISANTO JP, 1994, EUR J IMMUNOL, V24, P475, DOI 10.1002/eji.1830240232; Felsburg P J, 1992, Immunodefic Rev, V3, P277; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOSSEYE S, 1983, CLIN IMMUNOL IMMUNOP, V29, P58, DOI 10.1016/0090-1229(83)90007-7; GRABSTEIN KH, 1993, J EXP MED, V17, P257; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HENTHORN PS, 1994, GENOMICS, V23, P69, DOI 10.1006/geno.1994.1460; Ishida Y, 1989, Int Immunol, V1, P113, DOI 10.1093/intimm/1.2.113; ISHII N, 1994, J IMMUNOL, V153, P1310; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LEFRANCOIS L, 1994, HDB MUCOSAL IMMUNOLO, P287; LEONARD WJ, 1994, IMMUNOL REV, V138, P61, DOI 10.1111/j.1600-065X.1994.tb00847.x; LEONARD WJ, 1994, CURR OPIN IMMUNOL, V6, P631, DOI 10.1016/0952-7915(94)90152-X; LIN JX, 1995, IN PRESS IMMUNITY, V2; LOVE PE, 1994, J EXP MED, V179, P1485, DOI 10.1084/jem.179.5.1485; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MATSUE H, 1993, J IMMUNOL, V151, P6012; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Nezelof C, 1986, Curr Top Pathol, V75, P151; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, J BIOL CHEM, V268, P13601; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; PUCK JM, 1993, ADV HUM GENET, V21, P104; QAZIBASH MH, 1995, IN PRESS J HEMATOTHE; RUSSELL RJ, 1995, IN PRESS LAB ANIMAL; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHMALSTIEG FC, 1995, IN PRESS J CLIN INVE; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; SNYDER PW, 1993, CLIN IMMUNOL IMMUNOP, V67, P55, DOI 10.1006/clin.1993.1045; SOMBERG RL, 1994, J IMMUNOL, V153, P4006; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANAKA T, 1992, INT IMMUNOL, V4, P487, DOI 10.1093/intimm/4.4.487; TSCHACHLER E, 1989, J INVEST DERMATOL, V92, P763, DOI 10.1111/1523-1747.ep12722546; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222	62	833	863	0	12	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1995	2	3					223	238		10.1016/1074-7613(95)90047-0	http://dx.doi.org/10.1016/1074-7613(95)90047-0			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7697543	Bronze			2022-12-18	WOS:A1995QP27600002
J	Epelman, S; Lavine, KJ; Randolph, GJ				Epelman, Slava; Lavine, Kory J.; Randolph, Gwendalyn J.			Origin and Functions of Tissue Macrophages	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; COLONY-STIMULATING FACTOR-1; GENE-EXPRESSION PROFILES; CHEMOKINE RECEPTOR CCR2; TRANSCRIPTION FACTOR; ALZHEIMERS-DISEASE; DENDRITIC CELLS; BONE-MARROW; RESIDENT MACROPHAGES; ALVEOLAR MACROPHAGES	Macrophages are distributed in tissues throughout the body and contribute to both homeostasis and disease. Recently, it has become evident that most adult tissue macrophages originate during embryonic development and not from circulating monocytes. Each tissue has its own composition of embryonically derived and adult-derived macrophages, but it is unclear whether macrophages of distinct origins are functionally interchangeable or have unique roles at steady state. This new understanding also prompts reconsideration of the function of circulating monocytes. Classical Ly6c(hi) monocytes patrol the extravascular space in resting organs, and Ly6c(lo) nonclassical monocytes patrol the vasculature. Inflammation triggers monocytes to differentiate into macrophages, but whether resident and newly recruited macrophages possess similar functions during inflammation is unclear. Here, we define the tools used for identifying the complex origin of tissue macrophages and discuss the relative contributions of tissue niche versus ontological origin to the regulation of macrophage functions during steady state and inflammation.	[Epelman, Slava; Lavine, Kory J.; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA; [Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Epelman, S (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA.	sepelman@dom.wustl.edu; grandolph@path.wustl.edu	Epelman, Slava/AAO-1728-2020	Epelman, Slava/0000-0003-3400-4475	NIAID NIH HHS [R01 AI049653] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arnold T, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-4; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Gautier E.L., 2014, J EXP MED IN PRESS; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Huang WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066613; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; KODAMA H, 1991, J EXP MED, V173, P1291, DOI 10.1084/jem.173.5.1291; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Makhijani K, 2012, FLY, V6, P254, DOI 10.4161/fly.22267; Malur A, 2011, AM J PHYSIOL-LUNG C, V300, pL73, DOI 10.1152/ajplung.00128.2010; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Miyamoto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00070; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 2014, CIRC RES, V114, P1757, DOI 10.1161/CIRCRESAHA.114.301174; Randolph GJ, 2013, NAT MED, V19, P1094, DOI 10.1038/nm.3316; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Samokhvalov IM, 2014, CELL MOL LIFE SCI, V71, P957, DOI 10.1007/s00018-013-1364-7; SAWYER RT, 1982, LAB INVEST, V46, P165; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tremblay ME, 2012, GLIA, V60, P541, DOI 10.1002/glia.22287; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VOLKMAN A, 1983, LAB INVEST, V49, P291; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; WEATHERSTONE KB, 1989, PEDIATR RES, V25, P342, DOI 10.1203/00006450-198904000-00006; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; You Q, 2013, BIOCHEM PHARMACOL, V86, P836, DOI 10.1016/j.bcp.2013.07.006; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	114	831	871	22	190	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					21	35		10.1016/j.immuni.2014.06.013	http://dx.doi.org/10.1016/j.immuni.2014.06.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035951	Bronze, Green Accepted			2022-12-18	WOS:000341444200008
J	Kaczmarek, A; Vandenabeele, P; Krysko, DV				Kaczmarek, Agnieszka; Vandenabeele, Peter; Krysko, Dmitri V.			Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; RECEPTOR-INTERACTING PROTEIN; ISCHEMIA-REPERFUSION INJURY; T-CELL HOMEOSTASIS; DEATH DOMAIN FADD; GROUP BOX 1; NECROTIC CELLS; PROGRAMMED NECROSIS; INFLAMMATORY RESPONSE; APOPTOTIC CELLS	Regulated necrosis, termed necroptosis, is negatively regulated by caspase-8 and is dependent on the kinase activity of RIPK1 and RIPK3. Necroptosis leads to rapid plasma membrane permeabilization and to the release of cell contents and exposure of damage-associated molecular patterns (DAMPs). We are only beginning to identify the necroptotic DAMPs, their modifications, and their potential role in the regulation of inflammation. In this review, we discuss the physiological relevance of necroptosis and its role in the modulation of inflammation. For example, during viral infection, RIPK3-mediated necroptosis acts as a backup mechanism to clear pathogens. Necroptosis is also involved in apparently immunologically silent maintenance of T cell homeostasis. In contrast, the induction of necroptosis in skin, intestine, systemic inflammatory response syndrome, and ischemia reperfusion injury provoke a strong inflammatory response, which might be triggered by emission of DAMPs from necroptotic cells, showing the detrimental side of necroptosis.	[Kaczmarek, Agnieszka; Vandenabeele, Peter; Krysko, Dmitri V.] VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium; [Kaczmarek, Agnieszka; Vandenabeele, Peter; Krysko, Dmitri V.] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium.	peter.vandenabeele@dmbr.vib-ugent.be	Krysko, Dmitri V./AAE-9368-2019; Vandenabeele, Peter/AAD-5793-2022	Krysko, Dmitri V./0000-0002-9692-2047; Vandenabeele, Peter/0000-0002-6669-8822	Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0728.10, 3G067512, 3G060713, 3G0A5413]; FWO-Vlaanderen [31507110]; Emmanuel van der Schueren scholarship from the Flemish league against cancer; European grants (FP6 ApopTrain, FP7 EC RTD Integrated Project, Apo-Sys, Euregional PACT II) [MRTNCT-035624, FP7-200767]; Belgian grants (Interuniversity Attraction Poles) [IAP 6/18, IAP 7/32]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N]; Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Foundation against Cancer [F94]; Methusalem grant from the Flemish Government [BOF09/01M00709]	Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); FWO-Vlaanderen(FWO); Emmanuel van der Schueren scholarship from the Flemish league against cancer; European grants (FP6 ApopTrain, FP7 EC RTD Integrated Project, Apo-Sys, Euregional PACT II); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Foundation against Cancer; Methusalem grant from the Flemish Government	We thank A. Bredan for editing the manuscript. This work was supported by project grants from the Fund for Scientific Research Flanders (FWO-Vlaanderen, G.0728.10, 3G067512, 3G060713, and 3G0A5413 to D. V. K.) and by an individual research grant from FWO-Vlaanderen (31507110 to D. V. K.). D. V. K. is a postdoctoral fellow and A. K. is a doctoral fellow, both paid by fellowships from FWO-Vlaanderen. A. K. is also a recipient of an Emmanuel van der Schueren scholarship from the Flemish league against cancer. Research in the Vandenabeele group is supported by European grants (FP6 ApopTrain, MRTNCT-035624; FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18, IAP 7/32), Flemish grants (Research Foundation Flanders, FWO G.0875.11, FWO G.0973.11, and FWO G.0A45.12N), Ghent University grants (MRP, GROUP-ID consortium), grants from Flanders Institute for Biotechnology (VIB), and grants from the Foundation against Cancer (F94). P. V. holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. The figures in this review were produced using Servier Medical Art (www.servier.com).	Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Aravalli RN, 2008, J NEUROIMMUNE PHARM, V3, P5, DOI 10.1007/s11481-007-9097-8; Ayna G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040069; Bartholomae WC, 2004, J IMMUNOL, V173, P1012, DOI 10.4049/jimmunol.173.2.1012; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan J, 2012, BIOCHEMISTRY-US, V51, P433, DOI 10.1021/bi201019n; Chavez-Valdez R, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/257563; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; DOURMASHKIN RR, 1983, HUM PATHOL, V14, P643, DOI 10.1016/S0046-8177(83)80207-X; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Duttagupta PA, 2009, CRIT REV IMMUNOL, V29, P469, DOI 10.1615/CritRevImmunol.v29.i6.20; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Inzkirweli N, 2007, ANTICANCER RES, V27, P2121; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Krysko DV, 2003, J MORPHOL, V258, P336, DOI 10.1002/jmor.10161; Lalanne AI, 2010, J IMMUNOL, V184, P5678, DOI 10.4049/jimmunol.0903854; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Lohmann C, 2009, J IMMUNOL, V182, P4538, DOI 10.4049/jimmunol.0803989; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Lu JV, 2011, P NATL ACAD SCI USA, V108, P15312, DOI 10.1073/pnas.1102779108; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luheshi NM, 2009, EUR J IMMUNOL, V39, P2973, DOI 10.1002/eji.200939712; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Miles K, 2009, J IMMUNOL, V183, P2122, DOI 10.4049/jimmunol.0804187; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Morinaga Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-158; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Ong SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041932; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Peri P, 2011, J GEN VIROL, V92, P173, DOI 10.1099/vir.0.025080-0; Petit F, 2002, J BIOL CHEM, V277, P1477, DOI 10.1074/jbc.M102671200; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Saelens X, 2005, J CELL BIOL, V168, P545, DOI 10.1083/jcb.200407162; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Stridh L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-45; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vanden Berghe T, 2006, CELL SIGNAL, V18, P328, DOI 10.1016/j.cellsig.2005.05.003; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Wang F, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-30; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wheeler DS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-31; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Yoon TJ, 2008, EXP MOL MED, V40, P130, DOI 10.3858/emm.2008.40.1.130; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	126	831	871	13	228	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					209	223		10.1016/j.immuni.2013.02.003	http://dx.doi.org/10.1016/j.immuni.2013.02.003			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438821	Bronze			2022-12-18	WOS:000330940800005
J	Satoh-Takayama, N; Vosshenrich, CAJ; Lesjean-Pottier, S; Sawa, S; Lochner, M; Rattis, F; Mention, JJ; Thiam, K; Cerf-Bensussan, N; Mandelboim, O; Eberl, G; Di Santo, JP				Satoh-Takayama, Naoko; Vosshenrich, Christian A. J.; Lesjean-Pottier, Sarah; Sawa, Shinichiro; Lochner, Matthias; Rattis, Frederique; Mention, Jean-Jacques; Thiam, Kader; Cerf-Bensussan, Nadine; Mandelboim, Ofer; Eberl, Gerard; Di Santo, James P.			Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46(+) Cells that Provide Innate Mucosal Immune Defense	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; ROR-GAMMA-T; NK CELLS; IN-VIVO; LYMPHOID-TISSUES; PROINFLAMMATORY IL-17(+); DEVELOPMENTAL PATHWAYS; LAMINA PROPRIA; HOST-DEFENSE; DIFFERENTIATION	Natural killer (NK) cells are innate lymphocytes with spontaneous antitumor activity, and they produce interferon-gamma (IFN-gamma) that primes immune responses. Whereas T helper cell subsets differentiate from naive T cells via specific transcription factors, evidence for NK cell diversification is limited. In this report, we characterized intestinal lymphocytes expressing the NK cell natural cytotoxicity receptor NKp46. Gut NKp46(+) cells were distinguished from classical NK cells by limited IFN-gamma production and absence of perforin, whereas several subsets expressed the nuclear hormone receptor retinoic acid receptor-related orphan receptor t (ROR gamma t) and interleukin-22 (IL-22). Intestinal NKp46(+)IL-22(+) cells were generated via a local process that was conditioned by commensal bacteria and required ROR gamma t. Mice lacking IL-22-producing NKp46(+) cells showed heightened susceptibility to the pathogen Citrobacter rodentium, consistent with a role for intestinal NKp46(+) cells in immune protection. ROR gamma t-driven diversification of intestinal NKp46(+) cells thereby specifies an innate cellular defense mechanism that operates at mucosal surfaces.	[Satoh-Takayama, Naoko; Vosshenrich, Christian A. J.; Lesjean-Pottier, Sarah; Mention, Jean-Jacques; Di Santo, James P.] Inst Pasteur, Cytokines & Lymphoid Dev Unit, F-75724 Paris, France; [Satoh-Takayama, Naoko; Vosshenrich, Christian A. J.; Lesjean-Pottier, Sarah; Mention, Jean-Jacques; Di Santo, James P.] Inst Pasteur, INSERM, U668, F-75724 Paris, France; [Sawa, Shinichiro; Lochner, Matthias; Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Grp, F-75724 Paris, France; [Rattis, Frederique; Thiam, Kader] genOway, F-69362 Lyon, France; [Cerf-Bensussan, Nadine] Fac Med Necker Enfants Malad, INSERM, U793, F-75724 Paris, France; [Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hebrew University of Jerusalem	Di Santo, JP (corresponding author), Inst Pasteur, Cytokines & Lymphoid Dev Unit, F-75724 Paris, France.	disanto@pasteur.fr	Eberl, Gerard/A-1160-2013; Vosshenrich, Christian AJ/M-6523-2014; Cerf-Bensussan, nadine/H-9505-2017; Lochner, Matthias/L-6963-2015; Di Santo, James P/M-4298-2014	Vosshenrich, Christian AJ/0000-0002-4407-8649; Cerf-Bensussan, nadine/0000-0003-0665-1245; Lochner, Matthias/0000-0002-7979-5613; Di Santo, James P/0000-0002-7146-1862; Mandelboim, Ofer/0000-0002-9354-1855; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur and Inserm; Ligue Nationale Contra le Cancer	Institut Pasteur and Inserm; Ligue Nationale Contra le Cancer	The work was supported by grants from the Institut Pasteur and Inserm and as an "Equipe Labelise" by the Ligue Nationale Contra le Cancer. We would like to thank D. Guy-Grand, N. Huntington, H. Kiyono, P. Bousso, and A. Cumano for their critical comments and M. Berard and N. Winter for supplying C. rodentium and MyD88-deficient mice, respectively.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chen Z, 2008, CYTOKINE, V41, P71, DOI 10.1016/j.cyto.2007.09.009; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2007, TRENDS IMMUNOL, V28, P423, DOI 10.1016/j.it.2007.07.009; Eiras P, 2000, SCAND J IMMUNOL, V52, P1; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1986, J IMMUNOL, V136, P4480; Leon F, 2003, GASTROENTEROLOGY, V125, P345, DOI 10.1016/S0016-5085(03)00886-2; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; SCHAUER DB, 1993, INFECT IMMUN, V61, P2486, DOI 10.1128/IAI.61.6.2486-2492.1993; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; TAGLIABUE A, 1982, J EXP MED, V155, P1785, DOI 10.1084/jem.155.6.1785; Trinchieri G, 1995, Semin Immunol, V7, P83, DOI 10.1006/smim.1995.0012; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Veinotte LL, 2008, BLOOD, V111, P4201, DOI 10.1182/blood-2007-04-087577; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	54	827	852	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					958	970		10.1016/j.immuni.2008.11.001	http://dx.doi.org/10.1016/j.immuni.2008.11.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19084435	Bronze			2022-12-18	WOS:000262012400015
J	Mantovani, A; Sica, A; Locati, M				Mantovani, A; Sica, A; Locati, M			Macrophage polarization comes of age	IMMUNITY			English	Editorial Material							ACTIVATED MACROPHAGES; RESPONSES	Functional polarization of macrophages into M1 or M2 cells is an operationally useful, simplified conceptual framework describing the plasticity of mononuclear phagocytes. Genetic approaches have begun to shed new light on mechanisms underlying macrophage polarization and on the actual in vivo significance of polarized M2 cells (Rauh et al., 2005 [this issue of Immunity]).	Ist Clin Humanitas, Milan, Italy; Univ Milan, Inst Gen Pathol, Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan	Mantovani, A (corresponding author), Ist Clin Humanitas, Milan, Italy.		Locati, Massimo/H-8404-2015; Sica, Antonio/AAB-9546-2020; Locati, Massimo/ABF-6807-2021; Mantovani, Alberto/HCI-7449-2022	Locati, Massimo/0000-0003-3077-590X; Mantovani, Alberto/0000-0001-5578-236X				Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	13	827	871	4	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					344	346		10.1016/j.immuni.2005.10.001	http://dx.doi.org/10.1016/j.immuni.2005.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226499	Bronze			2022-12-18	WOS:000232995800002
J	Epelman, S; Lavine, KJ; Beaudin, AE; Sojka, DK; Carrero, JA; Calderon, B; Brija, T; Gautier, EL; Ivanov, S; Satpathy, AT; Schilling, JD; Schwendener, R; Sergin, I; Razani, B; Forsberg, EC; Yokoyama, WM; Unanue, ER; Colonna, M; Randolph, GJ; Mann, DL				Epelman, Slava; Lavine, Kory J.; Beaudin, Anna E.; Sojka, Dorothy K.; Carrero, Javier A.; Calderon, Boris; Brija, Thaddeus; Gautier, Emmanuel L.; Ivanov, Stoyan; Satpathy, Ansuman T.; Schilling, Joel D.; Schwendener, Reto; Sergin, Ismail; Razani, Babak; Forsberg, E. Camilla; Yokoyama, Wayne M.; Unanue, Emil R.; Colonna, Marco; Randolph, Gwendalyn J.; Mann, Douglas L.			Embryonic and Adult-Derived Resident Cardiac Macrophages Are Maintained through Distinct Mechanisms at Steady State and during Inflammation	IMMUNITY			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; MONOCYTE SUBSETS; DENDRITIC CELL; YOLK-SAC; BLOOD; HETEROGENEITY; PROGENITORS; DYNAMICS	Cardiac macrophages are crucial for tissue repair after cardiac injury but are not well characterized. Here we identify four populations of cardiac macrophages. At steady state, resident macrophages were primarily maintained through local proliferation. However, after macrophage depletion or during cardiac inflammation, Ly6c(hi) monocytes contributed to all four macrophage populations, whereas resident macrophages also expanded numerically through proliferation. Genetic fate mapping revealed that yolk-sac and fetal monocyte progenitors gave rise to the majority of cardiac macrophages, and the heart was among a minority of organs in which substantial numbers of yolk-sac macrophages persisted in adulthood. CCR2 expression and dependence distinguished cardiac macrophages of adult monocyte versus embryonic origin. Transcriptional and functional data revealed that monocyte-derived macrophages coordinate cardiac inflammation, while playing redundant but lesser roles in antigen sampling and efferocytosis. These data highlight the presence of multiple cardiac macrophage subsets, with different functions, origins, and strategies to regulate compartment size.	[Epelman, Slava; Lavine, Kory J.; Brija, Thaddeus; Sergin, Ismail; Razani, Babak; Randolph, Gwendalyn J.; Mann, Douglas L.] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA; [Beaudin, Anna E.; Forsberg, E. Camilla] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Sojka, Dorothy K.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; [Carrero, Javier A.; Calderon, Boris; Gautier, Emmanuel L.; Ivanov, Stoyan; Satpathy, Ansuman T.; Schilling, Joel D.; Unanue, Emil R.; Colonna, Marco; Mann, Douglas L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Schilling, Joel D.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Schwendener, Reto] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	Washington University (WUSTL); University of California System; University of California Santa Cruz; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of Zurich	Mann, DL (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA.	dmann@dom.wustl.edu	Gautier, Emmanuel L./E-2259-2017; Epelman, Slava/AAO-1728-2020; Schwendener, Reto A/F-6373-2011; Mann, Douglas Lowell/AAQ-3524-2021	Gautier, Emmanuel L./0000-0003-2976-7566; Epelman, Slava/0000-0003-3400-4475; Mann, Douglas/0000-0002-2516-0145; Ivanov, Stoyan/0000-0002-0527-2297; Calderon, Boris/0000-0003-1575-0739; Razani, Babak/0000-0002-7172-9240; Satpathy, Ansuman/0000-0002-5167-537X; Colonna, Marco/0000-0001-5222-4987	 [AHA-SDG-12SDG8030003];  [NIH K08HL112826-01];  [T32HL007081-37];  [T32CA009547];  [RO1 HL111094-02]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL112826, R01HL111094, T32HL007081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100917] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for these studies was provided by AHA-SDG-12SDG8030003 (S.E.), NIH K08HL112826-01 (S.E.) and T32HL007081-37 (S.E., K.J.L.), T32CA009547 (D. K. S.), and RO1 HL111094-02 (D. L. M.). We thank Liping Yang for experimental help and advice on parabiosis, Joan Avery and Kassandra Weber for their technical assistance, and Susan Gilfillan for generating the Ccr2<SUP>GFP/GFP</SUP>. This work benefitted from data assembled by the ImmGen consortium.	Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Carrero JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032310; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Francis Gary S, 2011, Cleve Clin J Med, V78 Suppl 1, pS75, DOI 10.3949/ccjm.78.s1.13; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sondergaard CS, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-24; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	34	826	841	7	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					91	104		10.1016/j.immuni.2013.11.019	http://dx.doi.org/10.1016/j.immuni.2013.11.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439267	Green Accepted, Bronze			2022-12-18	WOS:000331476900012
J	Schmitt, TM; Zuniga-Pflucker, JC				Schmitt, TM; Zuniga-Pflucker, JC			Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro	IMMUNITY			English	Article							BONE-MARROW; LINEAGE COMMITMENT; STROMAL CELLS; B-LYMPHOCYTES; ALPHA-BETA; THYMOCYTES; THYMUS; NOTCH1; MICE; EXPRESSION	The molecular interactions provided by the thymic microenvironment that predicate T cell development remain obscure. Here, we show that a bone marrow stromal cell line ectopically expressing the Notch ligand Delta-like-1 loses its ability to support B cell lymphopoiesis, but acquires the capacity to induce the differentiation of hematopoietic progenitors into CD4 CD8 double- and single-positive T cells. Both gammabeta-TCR+ and alphabeta-TCR+ T cells are generated, and CD8(+) TCRhi cells produce gamma-interferon following CD3/TCR stimulation. These results establish that expression of Delta-like-1 on stromal cells provides key signals for the induction of T cell lineage commitment, stage-specific progenitor expansion, TCR gene rearrangement, and T cell differentiation in the absence of a thymus. Thus, it is likely that Delta-like-1/Notch interactions by the thymus underpin its unique ability to promote lineage commitment and differentiation of T cells.	Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Immunol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Immunol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.		Schmitt, Tom/AAG-9941-2020; Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Schmitt, Thomas/0000-0002-0736-4195				Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bertrand FE, 2000, LEUKEMIA, V14, P2095, DOI 10.1038/sj.leu.2401942; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kawamoto H, 1999, J IMMUNOL, V162, P2725; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; KODAMA H, 1994, EXP HEMATOL, V22, P979; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; OSMOND DG, 1994, ADV EXP MED BIOL, V355, P15; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Taniguchi Y, 2002, P NATL ACAD SCI USA, V99, P4014, DOI 10.1073/pnas.052017699; tenBoekel E, 1997, IMMUNITY, V7, P357; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	33	819	860	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					749	756		10.1016/S1074-7613(02)00474-0	http://dx.doi.org/10.1016/S1074-7613(02)00474-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479821	Bronze			2022-12-18	WOS:000179985500007
J	Kischkel, FC; Lawrence, DA; Chuntharapai, A; Schow, P; Kim, KJ; Ashkenazi, A				Kischkel, FC; Lawrence, DA; Chuntharapai, A; Schow, P; Kim, KJ; Ashkenazi, A			Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5	IMMUNITY			English	Article							NF-KAPPA-B; APOPTOSIS-INDUCING LIGAND; TRAIL-INDUCED APOPTOSIS; SIGNALING COMPLEX DISC; T-CELL PROLIFERATION; TUMORICIDAL ACTIVITY; DEPENDENT APOPTOSIS; MEDIATED APOPTOSIS; DECOY RECEPTORS; FAMILY	Fas (APO-1/CD95) and tumor necrosis factor receptor 1 (TNFR1) trigger apoptosis by recruiting the apoptosis initiator caspase-8 through the adaptor FADD. Fas binds FADD directly, whereas TNFR1 binds FADD indirectly, through TRADD. TRADD alternatively recruits the NF-kappa B-inducing adaptor RIP. The TNF homolog Apo2L/TRAIL triggers apoptosis through two distinct death receptors, DR4 and DR5; however, receptor overexpression studies have yielded conflicting results on the ligand's signaling mechanism. Apo2L/TRAIL induced homomeric and heteromeric complexes of DR4 and DR5 and stimulated recruitment of FADD and caspase-8 and caspase-8 activation in nontransfected cells. TRADD and RIP, which bound TNFR1, did not bind DR4 and DR5. Thus, Apo2L/TRAIL and FasL initiate apoptosis through similar mechanisms, and FADD may be a universal adaptor for death receptors.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Antibody Technol, San Francisco, CA 94080 USA; Genentech Inc, Dept Cell Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Griffith TS, 1998, J IMMUNOL, V161, P2833; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Gronbaek K, 2000, BLOOD, V95, P2184; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Johnsen AC, 1999, CYTOKINE, V11, P664, DOI 10.1006/cyto.1999.0489; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Mongkolsapaya J, 1998, J IMMUNOL, V160, P3; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Ng PWP, 1999, J BIOL CHEM, V274, P10301, DOI 10.1074/jbc.274.15.10301; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wallach D, 1997, NATURE, V388, P123, DOI 10.1038/40516; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	51	819	870	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					611	620		10.1016/S1074-7613(00)80212-5	http://dx.doi.org/10.1016/S1074-7613(00)80212-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894161	Bronze			2022-12-18	WOS:000087937300003
J	Xavier, R; Brennan, T; Li, QQ; McCormack, C; Seed, B				Xavier, R; Brennan, T; Li, QQ; McCormack, C; Seed, B			Membrane compartmentation is required for efficient T cell activation	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; GPI-ANCHORED PROTEINS; RECEPTOR ZETA-CHAIN; BASOPHILIC LEUKEMIA-CELLS; PHOSPHOLIPASE C-GAMMA-1; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; CAVEOLAE MEMBRANE; SELECTIVE MODULATION; ACTIN CYTOSKELETON	The plasma membrane of mammalian cells contains detergent-resistant membrane rafts enriched in glycosphingolipids and cholesterol. Although several important signaling molecules have been found in such rafts, evidence documenting a functional role for their localization has been scarce. Using a fractionation scheme that preserves tyrosine phosphorylation, we show that T cell activation leads to a striking compartmentation in the rafts of activated T cell receptor and associated signal-transducing molecules. Conditions that reversibly disrupt raft structure either by dispersing their contents or by forcing their internalization reversibly disrupt the earliest steps of T cell activation. Thus, raft integrity is a prerequisite for efficient T cell receptor signal transduction.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Seed, B (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	seed@molbio.mgh.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027849, R37AI027849, K08AI001472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043031] Funding Source: NIH RePORTER; NIAID NIH HHS [AI01472, AI27849] Funding Source: Medline; NIDDK NIH HHS [DK43031] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; BOHUSLAV J, 1993, EUR J IMMUNOL, V23, P825, DOI 10.1002/eji.1830230409; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CAPLAN S, 1995, P NATL ACAD SCI USA, V92, P4768, DOI 10.1073/pnas.92.11.4768; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; CHUCK RS, 1990, P NATL ACAD SCI USA, V87, P5021, DOI 10.1073/pnas.87.13.5021; CINEK T, 1992, J IMMUNOL, V149, P2262; COLLINS TL, 1997, TODAY, V18, P221; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; FRA AM, 1994, J BIOL CHEM, V269, P30745; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GALLAGHER PF, 1989, P NATL ACAD SCI USA, V86, P10044, DOI 10.1073/pnas.86.24.10044; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; KAWAGUCHI T, 1989, BIOCHEM BIOPH RES CO, V158, P1050, DOI 10.1016/0006-291X(89)92828-3; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; LI W, 1992, MOL CELL BIOL, V12, P3176, DOI 10.1128/MCB.12.7.3176; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; MAHAUTSMITH MP, 1995, J PHYSIOL-LONDON, V484, P15, DOI 10.1113/jphysiol.1995.sp020644; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MITTLER RS, 1989, P NATL ACAD SCI USA, V86, P8531, DOI 10.1073/pnas.86.21.8531; Musci MA, 1997, J IMMUNOL, V159, P1639; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; OFFNER H, 1987, J IMMUNOL, V139, P3295; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PARK DJ, 1991, J BIOL CHEM, V266, P24237; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; REIF K, 1993, J BIOL CHEM, V268, P10780; REPKE H, 1992, J IMMUNOL, V149, P2585; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SHAKARJIAN MP, 1993, J BIOL CHEM, V268, P15252; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385, DOI 10.1128/MCB.13.10.6385; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SORICE M, 1995, SCAND J IMMUNOL, V41, P148, DOI 10.1111/j.1365-3083.1995.tb03547.x; STAHL A, 1995, J CELL BIOL, V129, P335, DOI 10.1083/jcb.129.2.335; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Stulnig TM, 1997, J BIOL CHEM, V272, P19242, DOI 10.1074/jbc.272.31.19242; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; THOMAS PM, 1992, J BIOL CHEM, V267, P12317; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9	88	814	827	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1998	8	6					723	732		10.1016/S1074-7613(00)80577-4	http://dx.doi.org/10.1016/S1074-7613(00)80577-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655486	Bronze			2022-12-18	WOS:000074396300008
J	Blasius, AL; Beutler, B				Blasius, Amanda L.; Beutler, Bruce			Intracellular Toll-like Receptors	IMMUNITY			English	Review							PLASMACYTOID DENDRITIC CELLS; INTERFERON-ALPHA INDUCTION; SINGLE-STRANDED RNA; ACTIVATE B-CELLS; I INTERFERON; ENDOSOMAL TRANSLOCATION; ESSENTIAL COMPONENTS; EXONUCLEASE TREX1; MAMMALIAN DNA; CUTTING EDGE	Foreign nucleic acids, the signature of invading viruses and certain bacteria, are sensed intracellularly. The nucleic acid-specific Toll-like receptors (TLRs) detect and signal within endolysosomal compartments, triggering the induction of cytokines essential for the innate immune response. These cytokines include proinflammatory molecules produced mainly by macrophages and conventional dendritic cells, as well as type I interferons, which are produced in great quantities by plasmacytoid dendritic cells. The cellular and molecular pathways by which nucleic acids and TLRs meet within the endosome assure host protection yet also place the host at risk for the development of autoimmunity. Here, we review the latest findings on the intracellular TLRs, with special emphasis on ligand uptake, receptor trafficking, signaling, and regulation.	[Blasius, Amanda L.; Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, 10550 N Torrey Pines Rd,SP 293, La Jolla, CA 92037 USA.	bruce@scripps.edu			NIH [P01 A1070167, HHSN272200700038C]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to E.M. Moresco for her critical reading of this paper and assistance in its preparation. This work was supported by NIH grant P01 A1070167 and NIH Contract HHSN272200700038C. ALB. is supported by The Irvington Institute Fellowship Program of the Cancer Research Institute.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Beutler B, 2008, CURR TOP MICROBIOL, V321, P3; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding CL, 2009, J IMMUNOL, V183, P7140, DOI 10.4049/jimmunol.0901175; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Eberle F, 2009, EUR J IMMUNOL, V39, P2537, DOI 10.1002/eji.200838978; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; MANCUSO G, 2009, NAT IMMUNOL IN PRESS; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Saha SK, 2006, CELL CYCLE, V5, P804, DOI 10.4161/cc.5.8.2637; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Siggs OM, 2010, P NATL ACAD SCI USA, V107, P3046, DOI 10.1073/pnas.0915098107; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Wagner H, 2008, CURR OPIN IMMUNOL, V20, P396, DOI 10.1016/j.coi.2008.06.013; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang JY, 2006, J BIOL CHEM, V281, P37427, DOI 10.1074/jbc.M605311200; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	113	812	876	5	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					305	315		10.1016/j.immuni.2010.03.012	http://dx.doi.org/10.1016/j.immuni.2010.03.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20346772	Bronze			2022-12-18	WOS:000276125400005
J	Allen, IC; Scull, MA; Moore, CB; Holl, EK; McElvania-TeKippe, E; Taxman, DJ; Guthrie, EH; Pickles, RJ; Ting, JPY				Allen, Irving C.; Scull, Margaret A.; Moore, Chris B.; Holl, Eda K.; McElvania-TeKippe, Erin; Taxman, Debra J.; Guthrie, Elizabeth H.; Pickles, Raymond J.; Ting, Jenny P. -Y.			The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA	IMMUNITY			English	Article							NALP3 INFLAMMASOME; CUTTING EDGE; ACTIVATION; INFECTION; CASPASE-1; CRYSTALS; ADAPTERS; ASC	The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) family of pattern-recognition molecules mediate host immunity to various pathogenic stimuli. However, in vivo evidence for the involvement of NLR proteins in viral sensing has not been widely investigated and remains controversial. As a test of the physiologic role of the NLR molecule NLRP3 during RNA viral infection, we explored the in vivo role of NLRP3 inflammasome components during influenza virus infection. Mice lacking NIrp3, Pycard, or caspase-1, but not NIrc4, exhibited dramatically increased mortality and a reduced immune response after exposure to the influenza virus. Utilizing analogs of dsRNA (poly(I:C)) and ssRNA (ssRNA40), we demonstrated that an NLRP3-mediated response could be activated by RNA species. Mechanistically, NLRP3 inflammasome activation by the influenza virus was dependent on lysosomal maturation and reactive oxygen species (ROS). Inhibition of ROS induction eliminated IL-1 beta production in animals during influenza infection. Together, these data place the NLRP3 inflammasome as an essential component in host defense against influenza infection through the sensing of viral RNA.	[Allen, Irving C.; Moore, Chris B.; Guthrie, Elizabeth H.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Scull, Margaret A.; Holl, Eda K.; McElvania-TeKippe, Erin; Taxman, Debra J.; Pickles, Raymond J.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Scull, Margaret A.; Pickles, Raymond J.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu	Scull, Margaret/K-9963-2019	Allen, Irving/0000-0001-9573-5250; Scull, Margaret/0000-0002-6860-2468	National Institutes of Health; Triangle Community Foundation;  [3-U54-AI057157-06S1];  [A1067798];  [05-0064];  [1U19A1077437-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, U19AI077437, U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Triangle Community Foundation; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Carolina Vaccine Institute for supplying aliquots of the mouse-adapted influenza A/PR/8/34 virus. We acknowledge Wendy Barclay for critical review and advice on viral propagation and Rob Tarran for providing the JME cell line. We thank Richard Flavell (Yale University), Vishva M. Dixit (Genentech, Inc), Fayyaz Sutterwala (the University of Iowa), and Millenium Pharmaceuticals for supplying the Nlrp3<SUP>-/-</SUP>, Pycard<SUP>-/-</SUP>, Nirc4<SUP>-/-</SUP> and Casp1<SUP>-/-</SUP> mice. We also thank Willie June Brickey and Sushmita Jha for maintaining mouse colonies and providing histology scoring assistance. This work is supported by 3-U54-AI057157-06S1, A1067798, 05-0064, and 1U19A1077437-01 (J.P.Y.T.). I.C.A. is supported by a National Institutes of Health training grant. M.A.S. is a recipient of the George H. Hitchings Fund for Health Research and Science Education of the Triangle Community Foundation.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Springer J, 2007, CLIN EXP ALLERGY, V37, P1788, DOI 10.1111/j.1365-2222.2007.02851.x; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	29	809	848	1	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					556	565		10.1016/j.immuni.2009.02.005	http://dx.doi.org/10.1016/j.immuni.2009.02.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19362020	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000265319000012
J	Batlle, E; Massague, J				Batlle, Eduard; Massague, Joan			Transforming Growth Factor-beta Signaling in Immunity and Cancer	IMMUNITY			English	Review							REGULATORY T-CELLS; LATENT TGF-BETA; CLASS-II TRANSACTIVATOR; MYELOID CELLS; DOWN-REGULATION; COLON-CANCER; IFN-GAMMA; NK CELLS; SURFACE EXPRESSION; TUMOR PROGRESSION	Transforming growth factor (TGF)-beta is a crucial enforcer of immune homeostas's -Ind tolerance, inhibiting the expansion and function of many components of the immune system. Perturbations in TGF-beta signaling under-lie inflammatory diseases and promote tumor emergence. TGF-beta is also central to immune suppression within the tumor microenvironment, and recent studies have revealed roles in tumor immune evasion and poor responses to cancer immunotherapy. Here, we present an overview of the complex biology of the TGF-beta family and its context-dependent nature. Then, focusing on cancer, we discuss the roles of TGF-beta signaling in distinct immune cell types and how this knowledge is being leveraged to unleash the immune system against the tumor.	[Batlle, Eduard] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; [Batlle, Eduard] Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain; [Batlle, Eduard] ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10065 USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; ICREA; Memorial Sloan Kettering Cancer Center	Batlle, E (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.; Batlle, E (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain.; Batlle, E (corresponding author), ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain.; Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10065 USA.	eduard.batlle@irbbarcelona.org; j-massague@ski.mskcc.org	Batlle, Eduard/K-8080-2014	Batlle, Eduard/0000-0003-2422-0326	European Research Council [340176]; MINECO I+D Retos 2017 [SAF2017-86782-R]; Fundacion BBVA; World Wide Cancer Research [WWCR 19-0005]; AGAUR [2017 SGR698]; Association Espanola de Investigation contra el Cancer (AECC); NIH [R01-CA34610, P01-CA94060, P01-CA129243, U54-CA209975, U2C-CA233284, P30-CA008748]; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center at MSKCC; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA034610, P01CA129243, P01CA094060, U54CA209975] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); MINECO I+D Retos 2017; Fundacion BBVA(BBVA Foundation); World Wide Cancer Research; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Association Espanola de Investigation contra el Cancer (AECC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center at MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to authors whose papers could not be cited due to space restrictions. We thank Elena Sancho for proofreading the manuscript. Work in the laboratory of E.B. is supported by the European Research Council advanced grant 340176, MINECO I+D Retos 2017 SAF2017-86782-R, Fundacion BBVA, World Wide Cancer Research (WWCR 19-0005), AGAUR 2017 SGR698, and Association Espanola de Investigation contra el Cancer (AECC). Work in the laboratory of J.M. is supported by NIH grants R01-CA34610, P01-CA94060, P01-CA129243, U54-CA209975, U2C-CA233284, and P30-CA008748 and The Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center at MSKCC.	Achyut BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003251; Ahmadzadeh M, 2005, J IMMUNOL, V174, P5215, DOI 10.4049/jimmunol.174.9.5215; ALLEN JB, 1990, J EXP MED, V171, P231, DOI 10.1084/jem.171.1.231; Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Arwert EN, 2018, CELL REP, V23, P1239, DOI 10.1016/j.celrep.2018.04.007; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Battaglia A, 2013, IMMUNOLOGY, V139, P109, DOI 10.1111/imm.12061; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194; Bendle GM, 2013, J IMMUNOL, V191, P3232, DOI 10.4049/jimmunol.1301270; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bollard CM, 2018, J CLIN ONCOL, V36, P1128, DOI 10.1200/JCO.2017.74.3179; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155, DOI 10.1128/MCB.13.2.1155; Budhu S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9702; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Charney RM, 2017, DEV CELL, V40, P595, DOI 10.1016/j.devcel.2017.02.017; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Courau T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85974; Crane CA, 2010, NEURO-ONCOLOGY, V12, P7, DOI 10.1093/neuonc/nop009; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dodagatta-Marri E, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-018-0493-9; Donatelli SS, 2014, P NATL ACAD SCI USA, V111, P4203, DOI 10.1073/pnas.1319269111; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; Downs-Canner S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14649; Dumitriu IE, 2009, J IMMUNOL, V182, P2795, DOI 10.4049/jimmunol.0712671; Edwards J, 2018, CLIN CANCER RES, V24, P3036, DOI 10.1158/1078-0432.CCR-17-2257; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Faivre SJ, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.3_suppl.lba173; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Formenti SC, 2018, CLIN CANCER RES, V24, P2493, DOI 10.1158/1078-0432.CCR-17-3322; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabriely G, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1738; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Giacomini MM, 2012, EXP CELL RES, V318, P716, DOI 10.1016/j.yexcr.2012.01.020; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hahn JN, 2011, J CLIN INVEST, V121, P4030, DOI 10.1172/JCI45114; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Holmgaard RB, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0356-4; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Ihara S, 2017, J GASTROENTEROL, V52, P777, DOI 10.1007/s00535-017-1350-1; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kalathil S, 2013, CANCER RES, V73, P2435, DOI 10.1158/0008-5472.CAN-12-3381; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kelly A, 2018, J EXP MED, V215, P2725, DOI 10.1084/jem.20171491; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Kobayashi S, 1999, J IMMUNOL, V163, P4013; Kovacs RJ, 2015, CARDIOVASC TOXICOL, V15, P309, DOI 10.1007/s12012-014-9297-4; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li ZY, 2012, INT J CANCER, V131, P2584, DOI 10.1002/ijc.27572; Lienart S, 2018, SCIENCE, V362, P952, DOI 10.1126/science.aau2909; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Mami-Chouaib F, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0399-6; Marcoe JP, 2012, NAT IMMUNOL, V13, P843, DOI 10.1038/ni.2388; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Melisi D, 2018, BRIT J CANCER, V119, P1208, DOI 10.1038/s41416-018-0246-z; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Metelli A, 2016, CANCER RES, V76, P7106, DOI 10.1158/0008-5472.CAN-16-1456; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mullen AC, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022186; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Nakanishi Y, 2018, IMMUNITY, V49, P1132, DOI 10.1016/j.immuni.2018.09.013; Nandan D, 1997, J IMMUNOL, V158, P1095; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Papaspyridonos M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7840; Park SR, 2005, EUR J IMMUNOL, V35, P946, DOI 10.1002/eji.200425848; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pickup MW, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022285; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; Piskurich JF, 1998, J IMMUNOL, V160, P233; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Rachidi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7911; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Rani R, 2011, EUR J IMMUNOL, V41, P2000, DOI 10.1002/eji.201041135; Ravi R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02696-6; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Robinson RT, 2007, J IMMUNOL, V179, P71, DOI 10.4049/jimmunol.179.1.71; Rodriguez-Ruiz ME, 2019, MOL CANCER THER, V18, P621, DOI 10.1158/1535-7163.MCT-18-0558; SAD S, 1994, J IMMUNOL, V153, P3514; Sanjabi S, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022236; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Spender LC, 2019, MOL PHARMACOL, V95, P222, DOI 10.1124/mol.118.112946; Stockis J., 2017, NATL ACAD SCI US, V114; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Takasaka N, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122591; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Vanpouille-Box C, 2015, CANCER RES, V75, P2232, DOI 10.1158/0008-5472.CAN-14-3511; Verstraeten A, 2016, HUM MUTAT, V37, P524, DOI 10.1002/humu.22977; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; WAHL SM, 1993, P NATL ACAD SCI USA, V90, P4577, DOI 10.1073/pnas.90.10.4577; Wang LX, 2010, CLIN CANCER RES, V16, P164, DOI 10.1158/1078-0432.CCR-09-1758; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wolfraim LA, 2004, J IMMUNOL, V173, P3093, DOI 10.4049/jimmunol.173.5.3093; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoon JH, 2013, EMBO MOL MED, V5, P1720, DOI 10.1002/emmm.201302524; Yu JH, 2006, IMMUNITY, V24, P575, DOI 10.1016/j.immuni.2006.03.016; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319; Zhang Q, 2005, CANCER RES, V65, P1761, DOI 10.1158/0008-5472.CAN-04-3169; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	183	797	816	26	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					924	940		10.1016/j.immuni.2019.03.024	http://dx.doi.org/10.1016/j.immuni.2019.03.024			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995507	Green Accepted, Bronze			2022-12-18	WOS:000464660800011
J	Huang, CT; Workman, CJ; Flies, D; Pan, XY; Marson, AL; Zhou, G; Hipkiss, EL; Ravi, S; Kowalski, J; Levitsky, HI; Powell, JD; Pardoll, DM; Drake, CG; Vignali, DAA				Huang, CT; Workman, CJ; Flies, D; Pan, XY; Marson, AL; Zhou, G; Hipkiss, EL; Ravi, S; Kowalski, J; Levitsky, HI; Powell, JD; Pardoll, DM; Drake, CG; Vignali, DAA			Role of LAG-3 in regulatory T cells	IMMUNITY			English	Article							IN-VIVO; CD4(+)CD25(+); TOLERANCE; CD25(+); MICE; CD223; POPULATION; EXPRESSION; INDUCTION; EXPANSION	Regulatory T cells (Tregs) limit auto-immunity but also attenuate the magnitude of antipathogen and antitumor immunity. Understanding the mechanism of Treg function and therapeutic manipulation of Tregs in vivo requires identification of Treg-selective receptors. A comparative analysis of gene expression arrays from antigen-specific CD4(+) T cells differentiating to either an effector/memory or a regulatory phenotype revealed Treg-selective expression of LAG-3, a CD4-related molecule that binds MHC class II. Antibodies to LAG-3 inhibit suppression by induced Tregs both in vitro and in vivo. Natural CD4(+)CD25(+) Tregs express LAG-3 upon activation, which is significantly enhanced in the presence of effector cells, whereas CD4(+)CD25(+) Tregs from LAG-3(-/-) mice exhibit reduced regulatory activity. Lastly, ectopic expression of LAG-3 on CD4(+) T cells significantly reduces their proliferative capacity and confers on them suppressor activity toward effector T cells. We propose that LAG-3 marks regulatory T cell populations and contributes to their suppressor activity.	Johns Hopkins Med Inst, Sidney Kimmell Comprehens Canc Ctr, Baltimore, MD 21231 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Johns Hopkins University; Johns Hopkins Medicine; St Jude Children's Research Hospital	Drake, CG (corresponding author), Johns Hopkins Med Inst, Sidney Kimmell Comprehens Canc Ctr, Baltimore, MD 21231 USA.	drakech@jhmi.edu; dario.vignali@stjude.org	Chuang, shengHao/C-8217-2012	Kowalski, Jeanne/0000-0003-3458-3024	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Adler AJ, 2000, J IMMUNOL, V164, P649, DOI 10.4049/jimmunol.164.2.649; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bruder D, 2004, EUR J IMMUNOL, V34, P1498, DOI 10.1002/eji.200490008; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Chen TC, 2004, J IMMUNOL, V172, P5900, DOI 10.4049/jimmunol.172.10.5900; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Hannier S, 1998, J IMMUNOL, V161, P4058; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Jooss K, 2001, P NATL ACAD SCI USA, V98, P8738, DOI 10.1073/pnas.151088898; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mastrangeli R, 1996, ANAL BIOCHEM, V241, P93, DOI 10.1006/abio.1996.0382; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2003, J IMMUNOL, V170, P1675, DOI 10.4049/jimmunol.170.4.1675; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Vignali DAA, 1999, J IMMUNOL, V162, P1431; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392	45	794	873	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					503	513		10.1016/j.immuni.2004.08.010	http://dx.doi.org/10.1016/j.immuni.2004.08.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485628	Bronze			2022-12-18	WOS:000224744400007
J	Nimmerjahn, F; Ravetch, JV				Nimmerjahn, F; Ravetch, JV			Fc gamma receptors: Old friends and new family members	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENDRITIC CELL MATURATION; IMMUNOGLOBULIN-G; DEFICIENT MICE; IN-VIVO; ANTIGEN PRESENTATION; INHIBITORY RECEPTOR; ARTHUS REACTION; FCGR2B GENE; T-CELLS	Although cellular receptors for immunoglobulins were first identified nearly 40 years ago, their central role in the immune response was discovered only in the last decade. They are key players in both the afferent and efferent phase of an immune response, setting thresholds for B cell activation, regulating the maturation of dendritic cells, and coupling the exquisite specificity of the antibody response to innate effector pathways, such as phagocytosis, anti body-dependent cellular cytotoxicity, and the recruitment and activation of inflammatory cells. Moreover, because of their general presence as receptor pairs consisting of activating and inhibitory molecules on the same cell, they have become a paradigm for studying the balance of positive and negative signals that ultimately determine the outcome of an immune response. This review will summarize recent results in Fc-receptor biology with an emphasis on data obtained in in vivo model systems.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA.	ravetch@rockefeller.edu	Nimmerjahn, Falk/J-4986-2013; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X				Barnes N, 2002, IMMUNITY, V16, P379, DOI 10.1016/S1074-7613(02)00287-X; Blank MC, 2005, HUM GENET, V117, P220, DOI 10.1007/s00439-005-1302-3; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Bona CA, 2004, MOL BIOL B CELLS, P381; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chu ZT, 2004, TISSUE ANTIGENS, V63, P21, DOI 10.1111/j.1399-0039.2004.00142.x; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Coffman R L, 1989, Semin Immunol, V1, P55; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Davis RS, 2005, EUR J IMMUNOL, V35, P674, DOI 10.1002/eji.200425886; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Fujii T, 2003, KIDNEY INT, V64, P1406, DOI 10.1046/j.1523-1755.2003.00203.x; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Grimaldi C, 2005, J IMMUNOL, V174, P1775, DOI 10.4049/jimmunol.174.4.1775; Groh V, 2005, P NATL ACAD SCI USA, V102, P6461, DOI 10.1073/pnas.0501953102; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Kyogoku C, 2004, ARTHRITIS RHEUM, V50, P671, DOI 10.1002/art.20029; Maddison PJ, 1999, ADV EXP MED BIOL, V455, P141; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Mechetina LV, 2002, IMMUNOGENETICS, V54, P463, DOI 10.1007/s00251-002-0486-0; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Meyer D, 1998, BLOOD, V92, P3997, DOI 10.1182/blood.V92.11.3997.423k52_3997_4002; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nguyen C, 2002, ARTHRITIS RES THER, V4, pS255, DOI 10.1186/ar583; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Okayama Y, 2000, J IMMUNOL, V164, P4332, DOI 10.4049/jimmunol.164.8.4332; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; PENNINGER JM, 1995, J IMMUNOL, V155, P3847; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Rudge EU, 2002, J EXP MED, V195, P1079, DOI 10.1084/jem.20011435; SCHLAGETER AM, 1990, INFECT IMMUN, V58, P1914, DOI 10.1128/IAI.58.6.1914-1918.1990; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Siriboonrit U, 2003, TISSUE ANTIGENS, V61, P374, DOI 10.1034/j.1399-0039.2003.00047.x; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tridandapani S, 2003, J IMMUNOL, V170, P4572, DOI 10.4049/jimmunol.170.9.4572; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Tzeng SJ, 2005, J BIOL CHEM, V280, P35247, DOI 10.1074/jbc.M505308200; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Weng WK, 2004, J CLIN ONCOL, V22, P4717, DOI 10.1200/JCO.2004.06.003; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Zhang ML, 2004, CANCER RES, V64, P5825, DOI 10.1158/0008-5472.CAN-04-1088	86	792	870	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					19	28		10.1016/j.immuni.2005.11.010	http://dx.doi.org/10.1016/j.immuni.2005.11.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413920	Bronze			2022-12-18	WOS:000234850200007
J	Gorelik, L; Flavell, RA				Gorelik, L; Flavell, RA			Abrogation of TGF beta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; MHC GENE-EXPRESSION; ANTIGEN EXPRESSION; II RECEPTOR; B-CELLS; MICE; MOUSE; DEFECTS; GAMMA; PHOSPHORYLATION	Targeted mutation of TGF beta 1 in mice demonstrated that TGF beta 1 is one of the key negative regulators of immune homeostasis, as its absence leads to activation of a self-targeted immune response. Nevertheless, because of the highly pleiotropic properties of TGF beta and the presence of TGF beta receptors on most cell types, its biologic role in the regulation of immune homeostasis is not yet understood. To limit the consequences of TGF beta effects to a single cell type, we developed a transgenic approach to abrogate the TGF beta response in key immune cells. Specifically, we expressed a dominant-negative TGF beta receptor type II under a T cell-specific promoter and created a mouse model where signaling by TGF beta is blocked specifically in T cells. Using this transgenic model, we show that T cell homeostasis requires TGF beta signaling in T cells.	Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA.							Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Akkaraju S, 1997, J EXP MED, V186, P2005, DOI 10.1084/jem.186.12.2005; Amendt C, 1998, ONCOGENE, V17, P25, DOI 10.1038/sj.onc.1202161; Arai K.-I., 1990, PEPTIDE GROWTH FACTO; Bottinger EP, 1997, CANCER RES, V57, P5564; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; CHRIST M, 1994, J IMMUNOL, V153, P1936; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; Dixon F J, 1978, Arthritis Rheum, V21, pS64, DOI 10.1002/art.1780210909; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; GEISER AG, 1993, P NATL ACAD SCI USA, V90, P9944, DOI 10.1073/pnas.90.21.9944; Gorelik L, 1995, CANCER IMMUNOL IMMUN, V41, P363, DOI 10.1007/BF01526556; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KIM PH, 1990, J IMMUNOL, V145, P3773; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Lee YJ, 1997, J IMMUNOL, V158, P2065; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MARTIN JS, 1995, ANN NY ACAD SCI, V752, P300, DOI 10.1111/j.1749-6632.1995.tb17439.x; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; PANEK RB, 1995, J IMMUNOL, V154, P610; PELTON RW, 1989, DEVELOPMENT, V106, P759; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Qian SW, 1996, J BIOL CHEM, V271, P30656, DOI 10.1074/jbc.271.48.30656; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHMID P, 1991, DEVELOPMENT, V111, P117; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; Williams AO, 1996, ULTRASTRUCT PATHOL, V20, P477, DOI 10.3109/01913129609016352; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439	41	791	845	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					171	181		10.1016/S1074-7613(00)80170-3	http://dx.doi.org/10.1016/S1074-7613(00)80170-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714683	Bronze			2022-12-18	WOS:000085621400007
J	Lee, YK; Turner, H; Maynard, CL; Oliver, JR; Chen, DQ; Elson, CO; Weaver, CT				Lee, Yun Kyung; Turner, Henrietta; Maynard, Craig L.; Oliver, James R.; Chen, Dongquan; Elson, Charles O.; Weaver, Casey T.			Late Developmental Plasticity in the T Helper 17 Lineage	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; TGF-BETA; CELL-DIFFERENTIATION; TH17 CELLS; HETERODIMERIC CYTOKINE; IL-12 RESPONSIVENESS; ROR-GAMMA; INFLAMMATION	Development of T helper (Th) 17 cells requires transforming growth factor (TGF)-beta and interleukin (IL)-6 and is independent of the Th1 pathway. Although T cells that produce interferon (IFN)-gamma are a recognized feature of Th17 cell responses, mice deficient for STAT4 and T-bet-two prototypical Th1 transcription factors-are protected from autoimmunity associated with Th17 pathogenesis. To examine the fate and pathogenic potential of Th17 cells and origin of IFN-gamma-producing T cells that emerge during Th17 immunity, we developed IL-17F reporter mice that identify cells committed to expression of IL-17F and IL-17A. Th17 cells required TGF-beta for sustained expression of IL-17F and IL-17A. In the absence of TGF-beta, both IL-23 and IL-12 acted to suppress IL-17 and enhance IFN-gamma production in a STAT4- and T-bet-dependent manner, albeit with distinct efficiencies. These results support a model of late Th17 developmental plasticity with implications for autoimmunity and host defense.	[Lee, Yun Kyung; Turner, Henrietta; Maynard, Craig L.; Oliver, James R.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Lee, Yun Kyung] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Chen, Dongquan; Elson, Charles O.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793	NIH; Daichi-Sankyo Co. Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783, R01AI077574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400, P01DK071176] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daichi-Sankyo Co. Ltd(Daiichi Sankyo Company Limited); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to D. Chaplin, T. Benveniste, and C. Klug, as well as members of the Weaver laboratory, for their helpful comments and suggestions. We gratefully acknowledge R. Kastelein for provision of anti-IL-23R. We also thank C. Song, M. Blake, and B.J. Parsons for expert technical assistance and G. Gaskins foreditorial assistance and acknowledge the UAB Transgenic Mouse Facility for blastocyst injections, the UAB Digestive Diseases Research Developmental Center (DDRDC) for generation and phenotyping of gene-targeted mice, the UAB Epitope Recognition and Immunoreagent Core Facility for antibody preparations, and the UAB Comprehensive Cancer Center Gene Expression Shared Facility for gene-expression studies. This work was supported by grants from the NIH (C.T.W.) and Daichi-Sankyo Co. Ltd. (C.T.W.).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Ferber IA, 1996, J IMMUNOL, V156, P5; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Gorham JD, 1998, J IMMUNOL, V161, P1664; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	60	780	812	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					92	107		10.1016/j.immuni.2008.11.005	http://dx.doi.org/10.1016/j.immuni.2008.11.005			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19119024	Green Accepted, Bronze			2022-12-18	WOS:000262769900013
J	MORRISON, SJ; WEISSMAN, IL				MORRISON, SJ; WEISSMAN, IL			THE LONG-TERM REPOPULATING SUBSET OF HEMATOPOIETIC STEM-CELLS IS DETERMINISTIC AND ISOLATABLE BY PHENOTYPE	IMMUNITY			English	Article							MURINE BONE-MARROW; FUNCTIONAL-CHARACTERIZATION; ANTIGEN EXPRESSION; C-KIT; CFU-S; MOUSE; INVIVO; HETEROGENEITY; PURIFICATION; PRECURSOR	The Thy-1.1(lo)Sca-1(hi)Lin(-/lo) population, representing 0.05% of C57BL/Ka-Thy-1.1 bone marrow, is highly enriched for hematopoietic stem cells and includes all multipotent progenitors in this mouse strain; however, the functional reconstituting activity of this fraction is heterogeneous. Only around 25% of clonal reconstitutions by cells from this population are long term; remaining clones yield transient multilineage reconstitutions. By fractionating based on lineage marker expression, the Thy-1.1(lo)Sca-1(hi)Lin(-/lo) population has been resolved into three subpopulations: Lin(-)Mac-1(-)CD4(-); Lin-Mac(-1lo)CD4(-); and Mac-1(lo)CD4(lo). Of these, only the Lin(-)Mac-1-CD4(-) population is highly enriched for long-term reconstituting hematopoietic stem cells. A comparison of transient and long-term multipotent progenitors indicates that long-term progenitors have less CFU-S activity, are equally radioprotective, and are less frequently in cell cycle. The ability to predict the longevity of reconstitution based on lineage marker expression indicates that reconstitution potential is deterministic, not stochastic.	STANFORD UNIV, SCH MED, DEPT DEV BIOL, STANFORD, CA 94305 USA	Stanford University	MORRISON, SJ (corresponding author), STANFORD UNIV, SCH MED, DEPT PATHOL, STANFORD, CA 94305 USA.		Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NCI NIH HHS [CA42551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BERTONCELLO I, 1989, IMMUNOL CELL BIOL, V67, P127, DOI 10.1038/icb.1989.18; CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DICK JE, 1991, BLOOD, V78, P624, DOI 10.1182/blood.V78.3.624.bloodjournal783624; DOHERTY DE, 1988, LAB INVEST, V59, P200; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; FREDRICKSON GG, 1989, J EXP MED, V169, P1473, DOI 10.1084/jem.169.4.1473; HARRISON DE, 1992, P NATL ACAD SCI USA, V89, P10134, DOI 10.1073/pnas.89.21.10134; HELLMAN S, 1978, P NATL ACAD SCI USA, V75, P490, DOI 10.1073/pnas.75.1.490; HENRY C, 1980, SELECTED METHODS CEL, P138; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JURECIC R, 1993, BLOOD, V82, P2673, DOI 10.1182/blood.V82.9.2673.bloodjournal8292673; KAY HEM, 1965, LANCET, V2, P418; LI CL, 1992, J EXP MED, V175, P1443, DOI 10.1084/jem.175.6.1443; Micklem H. S., 1976, STEM CELLS RENEWING, P331; MORRISON J, 1994, BLOOD, V83, P3480; OKADA S, 1992, BLOOD, V80, P3044; PARKS DR, 1984, METHOD ENZYMOL, V108, P197; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; PLOEMACHER RE, 1988, EXP HEMATOL, V16, P27; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; ROSENDAAL M, 1979, CELL TISSUE KINET, V12, P17, DOI 10.1111/j.1365-2184.1979.tb00110.x; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPAIN LM, 1992, P NATL ACAD SCI USA, V89, P3790, DOI 10.1073/pnas.89.9.3790; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SZILVASSY SJ, 1993, BLOOD, V81, P2310; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; UCHIDA N, 1993, CURR OPIN IMMUNOL, V5, P177, DOI 10.1016/0952-7915(93)90002-A; UCHIDA N, 1992, THESIS STANFORD U ST; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VANDERLOO JCM, 1994, BLOOD, V83, P1769; VARMUS HE, 1977, CELL, V11, P307, DOI 10.1016/0092-8674(77)90047-2; VISSER JWM, 1990, EXP HEMATOL, V18, P248; WINEMAN JP, 1992, BLOOD, V80, P1717; WOLF NS, 1993, EXP HEMATOL, V21, P614	43	778	830	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1994	1	8					661	673		10.1016/1074-7613(94)90037-X	http://dx.doi.org/10.1016/1074-7613(94)90037-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7541305				2022-12-18	WOS:A1994PT93000004
J	Jego, G; Palucka, AK; Blanck, JP; Chalouni, C; Pascual, V; Banchereau, J				Jego, G; Palucka, AK; Blanck, JP; Chalouni, C; Pascual, V; Banchereau, J			Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN B-CELLS; ANTIVIRAL DEFENSE; HUMORAL IMMUNITY; CD40 LIGAND; T-CELLS; ANTIBODY-RESPONSES; ENDOTHELIAL-CELLS; ADAPTIVE IMMUNITY; LYMPH-NODES	Dendritic cells (DCs) initiate and control immune responses. Plasmacytoid DCs (pDCs) represent a unique DC subset able to promptly release large amounts of type I interferon (IFN-alphabeta) upon viral encounter. Here we report that depletion of pDCs from human blood mononuclear cells abrogates the secretion of specific and polyclonal IgGs in response to influenza virus. Furthermore, purified pDCs triggered with virus induce CD40-activated B cells to differentiate into plasma cells. Two pDC cytokines act sequentially, with IFN-alphabeta generating non-Ig-secreting plasma blasts and IL-6 inducing their differentiation into Ig-secreting plasma cells. These plasma cells display the high levels of CD38 found on tissue plasma cells. Thus, pDCs are critical for the generation of plasma cells and antibody responses.	Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health	Banchereau, J (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak St, Dallas, TX 75204 USA.		Pascual, Virginia/ABD-3099-2020; jego, gaetan/N-7226-2018	jego, gaetan/0000-0003-0376-9299	NCI NIH HHS [R01 CA78846] Funding Source: Medline; NIAMS NIH HHS [R01 AR46589] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046589] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BANCHEREAU J, 1992, ADV IMMUNOL, V52, P125, DOI 10.1016/S0065-2776(08)60876-7; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; BOEHM U, 1997, ANNU REV IMMUNOL, V20, P15; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; DEMAEYER E, 1980, NATURE, V284, P173, DOI 10.1038/284173a0; DEMAEYER E, 1988, INTERFERONS OTHER RE, P91; Dubois B, 1998, J IMMUNOL, V161, P2223; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; FLUCKIGER AC, 1993, J EXP MED, V178, P1473, DOI 10.1084/jem.178.5.1473; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Galinski W, 1996, NATO ASI SER SER I, V40, P183; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; GRAMMER AC, 1995, J IMMUNOL, V154, P4996; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; INABA K, 1983, P NATL ACAD SCI-BIOL, V80, P6041, DOI 10.1073/pnas.80.19.6041; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kumanogoh A, 1997, P NATL ACAD SCI USA, V94, P2478, DOI 10.1073/pnas.94.6.2478; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MORIKAWA K, 1987, J IMMUNOL, V139, P761; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; NEUBAUER RH, 1985, J IMMUNOL, V134, P299; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; PETERS M, 1986, J IMMUNOL, V137, P3153; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; SOMASSE T, 1992, J EXP MED, V175, P15; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Wykes M, 1998, J IMMUNOL, V161, P1313	64	775	836	0	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					225	234		10.1016/S1074-7613(03)00208-5	http://dx.doi.org/10.1016/S1074-7613(03)00208-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932356	Bronze			2022-12-18	WOS:000184929000010
J	WILLERFORD, DM; CHEN, JZ; FERRY, JA; DAVIDSON, L; MA, A; ALT, FW				WILLERFORD, DM; CHEN, JZ; FERRY, JA; DAVIDSON, L; MA, A; ALT, FW			INTERLEUKIN-2 RECEPTOR-ALPHA CHAIN REGULATES THE SIZE AND CONTENT OF THE PERIPHERAL LYMPHOID COMPARTMENT	IMMUNITY			English	Article							T-CELLS; LYMPHOCYTES-T; IL-2 RECEPTOR; MICE; PATHWAY; GENE; BINDING; DEFICIENT; SUBUNIT; SYSTEM	Interleukin-2 receptor alpha chain (IL-2R alpha) expression occurs at specific stages of early T and B lymphocyte development and is induced upon activation of mature lymphocytes. Young mice that lack IL-2R alpha have phenotypically normal development of T and B cells. However, as adults, these mice develop massive enlargement of peripheral lymphoid organs associated with polyclonal T and B cell expansion, which, for T cells, is correlated with impaired activation-induced cell death in vivo. Older IL-2R alpha-deficient mice also develop autoimmune disorders, including hemolytic anemia and inflammatory bower disease. Thus, IL-2R alpha is essential for regulation of both the size and content of the peripheral lymphoid compartment, probably by influencing the balance between clonal expansion and cell death following lymphocyte activation.	HARVARD UNIV, SCH MED, DEPT GENET, CTR BLOOD RES, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	WILLERFORD, DM (corresponding author), CHILDRENS HOSP, HOWARD HUGHES MED INST, DEPT PEDIAT, BOSTON, MA 02115 USA.				NIAID NIH HHS [AI20047, AI01173] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CARDING SR, 1991, IMMUNOL TODAY, V12, P239, DOI 10.1016/0167-5699(91)90037-T; CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; Coligan JKA, 1991, CURRENT PROTOCOLS IM; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; GRANT AJ, 1992, P NATL ACAD SCI USA, V89, P2165, DOI 10.1073/pnas.89.6.2165; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KONDO M, 1994, EUR J IMMUNOL, V24, P2026, DOI 10.1002/eji.1830240914; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; KUO LM, 1986, J IMMUNOL, V137, P1544; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LEONARD WJ, 1994, IMMUNOL REV, V138, P61, DOI 10.1111/j.1600-065X.1994.tb00847.x; LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LORENZO F, 1991, J IMMUNOL, V147, P2970; MACDONALD HR, 1990, CURR TOP MICROBIOL, V159, P97; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MEUER SC, 1984, P NATL ACAD SCI-BIOL, V81, P1509, DOI 10.1073/pnas.81.5.1509; NAGATA S, 1994, ADV IMMUNOL, V57, P129, DOI 10.1016/S0065-2776(08)60672-0; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; TENTORI L, 1988, J EXP MED, V168, P1741, DOI 10.1084/jem.168.5.1741; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; TIGGES MA, 1989, SCIENCE, V243, P781, DOI 10.1126/science.2492678; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Zuniga-Pflucker J C, 1990, Dev Immunol, V1, P59; ZUNIGAPFLUCKER JC, 1990, J IMMUNOL, V144, P3736	52	772	805	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1995	3	4					521	530		10.1016/1074-7613(95)90180-9	http://dx.doi.org/10.1016/1074-7613(95)90180-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584142	Bronze			2022-12-18	WOS:A1995TB60800012
J	LINSLEY, PS; GREENE, JL; BRADY, W; BAJORATH, J; LEDBETTER, JA; PEACH, R				LINSLEY, PS; GREENE, JL; BRADY, W; BAJORATH, J; LEDBETTER, JA; PEACH, R			HUMAN B7-1 (CD80) AND B7-2 (CD86) BIND WITH SIMILAR AVIDITIES BUT DISTINCT KINETICS TO CD28 AND CTLA-4 RECEPTORS	IMMUNITY			English	Article							T-CELL PROLIFERATION; INTERLEUKIN-2 PRODUCTION; ACTIVATION ANTIGEN-B7; ADDITIONAL LIGAND; COUNTER-RECEPTOR; LYMPHOCYTES-T; B-CELLS; EXPRESSION; COSTIMULATION; MOLECULE	B7-0 or B7-2 (CD86) is a T cell costimulatory molecule that binds the same receptors (CD28 and CTLA-4) as B7-1 (CD80), but shares with it only similar to 25% sequence identity and is expressed earlier during an immune response. Here we show that human CD86 maintains similar (within similar to 2- to 3-fold) overall receptor binding and T cell costimulatory properties as CD80. However, CD80 and CD86 did not bind equivalently to CTLA-4: CD80 bound Y100A, a form of CTLA4lg with a mutation in the CDR3-like region, >200-fold better than did CD86; inhibition of CD80-mediated cellular responses required similar to 100-fold lower CTLA4lg concentrations; and CD80-CTLA4lg complexes dissociated 5- to 8-fold more slowly. Thus, CD80 and CD86 utilize different binding determinants and have different kinetics of binding to CD28 and CTLA-4.			LINSLEY, PS (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,3005 1ST AVE,SEATTLE,WA 98121, USA.		Bajorath, Jürgen/F-7493-2014					AKESON AL, 1993, J IMMUNOL METHODS, V163, P181, DOI 10.1016/0022-1759(93)90121-M; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HEMLER ME, 1988, IMMUNOL TODAY, V9, P109, DOI 10.1016/0167-5699(88)91280-7; JENKINS MK, 1993, CURR OPIN IMMUNOL, V5, P361, DOI 10.1016/0952-7915(93)90054-V; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; LARSEN CP, 1994, J IMMUNOL, V152, P5208; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; PEACH RJ, 1994, IN PRESS J EXP MED, V180; RAZIWOLF Z, 1993, P NATL ACAD SCI USA, V90, P11182, DOI 10.1073/pnas.90.23.11182; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STACK RM, 1994, J IMMUNOL, V152, P5723; SYMINGTON FW, 1993, J IMMUNOL, V150, P1286; TAN P, 1992, J EXP MED, V177, P165; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; WALLACE PM, 1994, TRANSPLANTATION, V58, P602, DOI 10.1097/00007890-199409150-00013; WU Y, 1993, J EXP MED, V178, P1789, DOI 10.1084/jem.178.5.1789; YOKOCHI T, 1981, J IMMUNOL, V128, P823	37	762	836	4	33	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					793	801		10.1016/S1074-7613(94)80021-9	http://dx.doi.org/10.1016/S1074-7613(94)80021-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7534620				2022-12-18	WOS:A1994PX64800009
J	Takeda, K; Tsutsui, H; Yoshimoto, T; Adachi, O; Yoshida, N; Kishimoto, T; Okamura, H; Nakanishi, K; Akira, S				Takeda, K; Tsutsui, H; Yoshimoto, T; Adachi, O; Yoshida, N; Kishimoto, T; Okamura, H; Nakanishi, K; Akira, S			Defective NK cell activity and Th1 response in IL-18-deficient mice	IMMUNITY			English	Article							GAMMA-INDUCING FACTOR; T-CELLS; INTERFERON-GAMMA; IMMUNOREGULATORY FUNCTIONS; INTERLEUKIN-12; CYTOKINE; TYPE-1; CLONING; INDUCTION	IL-18 is a cytokine that is secreted from activated macrophages and induces IFN gamma production. To investigate the in vivo role of IL-18, we generated IL-18-deficient mice. In Propionibacterium acnes (P. acnes)-primed IL-18-deficient mice, LPS-induced IFN gamma production was markedly reduced, despite normal IL-12 induction. Natural killer cell activity was significantly impaired. Th1 cell response after injection of P. acnes or Mycobacterium bovis (bacillus Calmette-Guerin [BCG]) was significantly reduced. Similar results were observed in IL-12-deficient mice. Interestingly, Th1 response was induced after BCG infection in IL-12-deficient mice. We therefore generated mice lacking both IL-18 and IL-12. In these mice, NK activity and Th1 response were further impaired. This demonstrates the important role of both IL-18 and IL-12 in NK activity, as well as in in vivo Th1 response.	Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 663, Japan; Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 663, Japan; Hyogo Coll Med, Inst Adv Med Sci, Nishinomiya, Hyogo 663, Japan; Osaka Maternal & Child Hlth Ctr, Res Inst, Osaka 59002, Japan; Osaka Univ, Suita, Osaka 565, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine; Osaka University	Akira, S (corresponding author), Hyogo Coll Med, Dept Biochem, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 663, Japan.		Akira, Shizuo/C-3134-2009; Yoshimoto, Tomohiro/E-2224-2014; Takeda, Kiyoshi/C-9331-2009; Kishimoto, Tadamitsu/C-8470-2009	Tsutsui, Hiroko/0000-0001-7928-4875				Ahn HJ, 1997, J IMMUNOL, V159, P2125; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Conti B, 1997, J BIOL CHEM, V272, P2035; Dao T, 1996, CELL IMMUNOL, V173, P230, DOI 10.1006/cimm.1996.0272; GATELY MK, 1994, INT IMMUNOL, V6, P157, DOI 10.1093/intimm/6.1.157; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; KAWAMURA I, 1992, J IMMUNOL, V148, P2887; Kohno K, 1997, J IMMUNOL, V158, P1541; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; Matsui K, 1997, J IMMUNOL, V159, P97; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; OKAMURA H, 1982, INFECT IMMUN, V38, P440, DOI 10.1128/IAI.38.2.440-443.1982; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Parnet P, 1996, J BIOL CHEM, V271, P3967; PAUL WE, 1991, BLOOD, V77, P1859; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Tsutsui H, 1997, J IMMUNOL, V159, P3961; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; Ushio S, 1996, J IMMUNOL, V156, P4274; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948	36	759	788	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					383	390		10.1016/S1074-7613(00)80543-9	http://dx.doi.org/10.1016/S1074-7613(00)80543-9			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529155	Bronze			2022-12-18	WOS:000072705300011
J	de Lafaille, MAC; Lafaille, JJ				de Lafaille, Maria A. Curotto; Lafaille, Juan J.			Natural and Adaptive Foxp3(+) Regulatory T Cells: More of the Same or a Division of Labor?	IMMUNITY			English	Review							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; RECEPTOR TRANSGENIC MICE; C VIRUS-INFECTION; GERM-FREE MICE; TGF-BETA; RETINOIC-ACID; IMMUNE-RESPONSES; DENDRITIC CELLS; ORAL TOLERANCE	Adaptive Foxp3(+)CD4(+) regulatory T (iTreg) cells develop outside the thymus under subimmunogenic antigen presentation, during chronic inflammation, and during normal homeostasis of the gut. iTreg cells are essential in mucosal immune tolerance and in the control of severe chronic allergic inflammation, and most likely are one of the main barriers to the eradication of tumors. The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus. The full extent of differences and similarities between iTreg and nTreg cells is yet to be defined. We speculate that iTreg cell development is driven by the need to maintain a noninflammatory environment in the gut, to suppress immune responses to environmental and food allergens, and to decrease chronic inflammation, whereas nTreg cells prevent autoimmunity and raise the activation threshold for all immune responses.	[de Lafaille, Maria A. Curotto] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University	de Lafaille, MAC (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	maria.lafaille@med.nyu.edu; juan.lafaille@med.nyu.edu		Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777				Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Aricha R, 2008, J IMMUNOL, V180, P2132, DOI 10.4049/jimmunol.180.4.2132; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Demengeot J, 2006, SPRINGER SEMIN IMMUN, V28, P41, DOI 10.1007/s00281-006-0024-5; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Dolganiuc A, 2008, J LEUKOCYTE BIOL, V84, P614, DOI 10.1189/jlb.1107770; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gad M, 2004, EUR J IMMUNOL, V34, P695, DOI 10.1002/eji.200324394; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2002, EUR J IMMUNOL, V32, P3729, DOI 10.1002/1521-4141(200212)32:12<3729::AID-IMMU3729>3.0.CO;2-2; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Ishikawa H, 2008, CLIN EXP IMMUNOL, V153, P127, DOI 10.1111/j.1365-2249.2008.03668.x; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kandulski A, 2008, HELICOBACTER, V13, P295, DOI 10.1111/j.1523-5378.2008.00612.x; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Larkin J, 2008, J IMMUNOL, V180, P2149, DOI 10.4049/jimmunol.180.4.2149; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lim SP, 1998, IMMUNOGENETICS, V48, P184, DOI 10.1007/s002510050422; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Maizels Rick, 2007, Novartis Found Symp, V281, P192; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Modigliani Y, 1996, IMMUNOL REV, V149, P155, DOI 10.1111/j.1600-065X.1996.tb00903.x; Moreau MC, 1996, RES IMMUNOL, V147, P49, DOI 10.1016/0923-2494(96)81548-3; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nishikawa H, 2003, P NATL ACAD SCI USA, V100, P10902, DOI 10.1073/pnas.1834479100; Onizuka S, 1999, CANCER RES, V59, P3128; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Rask C, 2005, SCAND J IMMUNOL, V61, P529, DOI 10.1111/j.1365-3083.2005.01598.x; Robertson SJ, 2006, SPRINGER SEMIN IMMUN, V28, P51, DOI 10.1007/s00281-006-0019-2; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shen SQ, 2005, J CLIN INVEST, V115, P3517, DOI 10.1172/JCI25463; Shimizu J, 1999, J IMMUNOL, V163, P5211; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Sudo N, 1997, J IMMUNOL, V159, P1739; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; van Maren WWC, 2008, IMMUNOLOGY, V124, P445, DOI 10.1111/j.1365-2567.2008.02871.x; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wilson MS, 2004, CLIN REV ALLERG IMMU, V26, P35, DOI 10.1385/CRIAI:26:1:35; Wohlfert E, 2008, J CLIN IMMUNOL, V28, P707, DOI 10.1007/s10875-008-9248-6; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	116	758	792	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					626	635		10.1016/j.immuni.2009.05.002	http://dx.doi.org/10.1016/j.immuni.2009.05.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464985	Bronze			2022-12-18	WOS:000266356900003
J	Stetson, DB; Medzhitov, R				Stetson, DB; Medzhitov, R			Recognition of cytosolic DNA activates an IRF3-dependent innate immune response	IMMUNITY			English	Article							NF-KAPPA-B; LISTERIA-MONOCYTOGENES INFECTION; RECEPTOR-INTERACTING PROTEIN-2; TOLL-LIKE RECEPTORS; HEPATITIS-C VIRUS; LEGIONELLA-PNEUMOPHILA; RIG-I; GENE-EXPRESSION; INTERFERON-PRODUCTION; MAMMALIAN-CELLS	Nucleic acid recognition upon viral infection triggers type I interferon production. Viral RNA is detected by both endosomal, TLR-dependent and cytosolic, RIG-I/MDA5-dependent pathways. TLR9 is the only known sensor of foreign DNA; it is unknown whether innate immune recognition of DNA exists in the cytosol. Here we present evidence that cytosolic DNA activates a potent type I interferon response to the invasive bacterium Listeria monocytogenes. The noninvasive Legionella pneumophila triggers an identical response through its type IV secretion system. Activation of type I interferons by cytosolic DNA is TLR independent and requires IRF3 but occurs without detectable activation of NF-kappa B and MAP kinases. Microarray analyses reveal a unique but overlapping gene-expression program activated by cytosolic DNA compared to TLR9- and RIG-I/MDA5-dependent responses. These findings define an innate immune response to DNA linked to type I interferon production.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu			PHS HHS [UO1A161360-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Charpentier E, 1999, J BACTERIOL, V181, P3368, DOI 10.1128/JB.181.11.3368-3374.1999; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hauf N, 1997, P NATL ACAD SCI USA, V94, P9394, DOI 10.1073/pnas.94.17.9394; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HESS CB, 1987, J IMMUNOL, V138, P3949; Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Malmgaard L, 2004, J IMMUNOL, V173, P6890, DOI 10.4049/jimmunol.173.11.6890; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Portnoy DA, 2005, CURR OPIN IMMUNOL, V17, P25, DOI 10.1016/j.coi.2004.11.002; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Roy CR, 1997, INFECT IMMUN, V65, P571, DOI 10.1128/IAI.65.2.571-578.1997; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Suzuki K, 1999, P NATL ACAD SCI USA, V96, P2285, DOI 10.1073/pnas.96.5.2285; Vogel JP, 1999, CURR OPIN MICROBIOL, V2, P30, DOI 10.1016/S1369-5274(99)80005-8; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	59	755	796	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					93	103		10.1016/j.immuni.2005.12.003	http://dx.doi.org/10.1016/j.immuni.2005.12.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413926	Bronze			2022-12-18	WOS:000234850200013
J	Pui, JC; Allman, D; Xu, LW; DeRocco, S; Karnell, FG; Bakkour, S; Lee, JY; Kadesch, T; Hardy, RR; Aster, JC; Pear, WS				Pui, JC; Allman, D; Xu, LW; DeRocco, S; Karnell, FG; Bakkour, S; Lee, JY; Kadesch, T; Hardy, RR; Aster, JC; Pear, WS			Notch1 expression in early lymphopoiesis influences B versus T lineage determination	IMMUNITY			English	Article							TRANSCRIPTION FACTOR BSAP; SPLIT COMPLEX GENES; MOUSE BONE-MARROW; MAMMALIAN NOTCH; ALPHA-BETA; INTRACELLULAR DOMAIN; SIGNALING PATHWAY; CELL DEVELOPMENT; ANKYRIN REPEATS; HUMAN HOMOLOG	Notch receptors regulate fate decisions in many cells. One outcome of Notch signaling is differentiation of bipotential precursors into one cell type versus another. To investigate consequences of Notch1 expression in hematolymphoid progenitors, mice were reconstituted with bone marrow (BM) transduced with retroviruses encoding a constitutively active form of Notch1. Although neither granulocyte or monocyte differentiation were appreciably affected, lymphopoiesis was dramatically altered. As early as 3 weeks following transplantation, mice receiving activated Notch1-transduced BM contained immature CD4(+)CD8(+) T cells in the BM and exhibited a simultaneous block in early B cell lymphopoiesis. These results suggest that Notch1 provides a key regulatory signal in determining T lymphoid versus B lymphoid lineage decisions, possibly by influencing lineage commitment from a common lymphoid progenitor cell.	Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Inst Med & Engn, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Genet, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Fox Chase Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pear, WS (corresponding author), Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu	Aster, Jon C/B-6857-2009					ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Aguila HL, 1997, IMMUNOL REV, V157, P13, DOI 10.1111/j.1600-065X.1997.tb00971.x; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Aster JC, 1997, J BIOL CHEM, V272, P11336; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Berry LW, 1997, DEVELOPMENT, V124, P925; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Carter RS, 1997, MOL CELL BIOL, V17, P18, DOI 10.1128/MCB.17.1.18; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Eastman DS, 1997, MOL CELL BIOL, V17, P5620, DOI 10.1128/MCB.17.9.5620; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; FENTON RG, 1988, SCIENCE, V241, P1089, DOI 10.1126/science.2970670; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jehn BM, 1999, J IMMUNOL, V162, P635; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; KOPAN R, 1994, DEVELOPMENT, V120, P2385; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; MILNER LA, 1994, BLOOD, V83, P2057; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; PEAR W, 1996, CURRENT PROTOCOLS MO; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Vamum-Finney B, 1998, BLOOD, V91, P4084; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	68	755	784	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1999	11	3					299	308		10.1016/S1074-7613(00)80105-3	http://dx.doi.org/10.1016/S1074-7613(00)80105-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514008	Bronze			2022-12-18	WOS:000082918500005
J	Fu, BQ; Zhou, YG; Ni, X; Tong, XH; Xu, XX; Dong, ZJ; Sun, R; Tian, ZG; Wei, HM				Fu, Binqing; Zhou, Yonggang; Ni, Xiang; Tong, Xianhong; Xu, Xiuxiu; Dong, Zhongjun; Sun, Rui; Tian, Zhigang; Wei, Haiming			Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; RESIDENT NK CELLS; HLA-G; IMMUNE TOLERANCE; PREGNANCY; INTERFACE; DIFFERENTIATION; SENESCENCE; EXPRESSION; INFLAMMATION	Natural killer (NK) cells are present in large populations at the maternal-fetal interface during early pregnancy. However, the role of NK cells in fetal growth is unclear. Here, we have identified a CD49a(+)Eomes(+) subset of NK cells that secreted growth-promoting factors (GPFs), including pleiotrophin and osteoglycin, in both humans and mice. The crosstalk between HLA-G and ILT2 served as a stimulus for GPF-secreting function of this NK cell subset. Decreases in this GPF-secreting NK cell subset impaired fetal development, resulting in fetal growth restriction. The transcription factor Nfil3, but not T-bet, affected the function and the number of this decidual NK cell subset. Adoptive transfer of induced CD49a(+)Eomes(+) NK cells reversed impaired fetal growth and rebuilt an appropriate local microenvironment. These findings reveal properties of NK cells in promoting fetal growth. In addition, this research proposes approaches for therapeutic administration of NK cells in order to reverse restricted nourishments within the uterine microenvironment during early pregnancy.	[Fu, Binqing; Zhou, Yonggang; Ni, Xiang; Xu, Xiuxiu; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230001, Anhui, Peoples R China; [Fu, Binqing; Zhou, Yonggang; Ni, Xiang; Xu, Xiuxiu; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Sch Life Sci, Hefei 230001, Anhui, Peoples R China; [Fu, Binqing; Zhou, Yonggang; Ni, Xiang; Xu, Xiuxiu; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Med Ctr, Hefei 230001, Anhui, Peoples R China; [Fu, Binqing; Zhou, Yonggang; Ni, Xiang; Xu, Xiuxiu; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230001, Anhui, Peoples R China; [Tong, Xianhong] Anhui Prov Hosp, Hefei 230001, Anhui, Peoples R China; [Dong, Zhongjun] Tsinghua Univ, Sch Med, Beijing 100086, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230001, Anhui, Peoples R China.; Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Sch Life Sci, Hefei 230001, Anhui, Peoples R China.; Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei 230001, Anhui, Peoples R China.; Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230001, Anhui, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Wei, Haiming/G-7703-2018; Zhou, Yonggang/G-7775-2018	Wei, Haiming/0000-0002-1675-6502; Zhou, Yonggang/0000-0003-2905-3213; Shaw, Kelly/0000-0003-2964-8946; xu, xiuxiu/0000-0002-2863-166X; Shenouda, Josephine/0000-0003-2279-9549	Natural Science Foundation of China [91442202, 81788104, 81330071, 81471527]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (91442202, 81788104, 81330071, and 81471527).	Ahokas R.A., 2008, DEV PHYSL PLACENTA M; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Boulenouar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00043; Camous X, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/195956; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Colucci F, 2015, TRENDS MOL MED, V21, P60, DOI 10.1016/j.molmed.2014.12.009; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Doisne JM, 2015, J IMMUNOL, V195, P3937, DOI 10.4049/jimmunol.1500689; Dreyfus J, 1998, INT J DEV BIOL, V42, P189; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Fu BQ, 2014, CELL MOL IMMUNOL, V11, P564, DOI 10.1038/cmi.2014.54; Fu BQ, 2014, IMMUNOLOGY, V141, P483, DOI 10.1111/imm.12224; Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hiby SE, 2014, J IMMUNOL, V192, P5069, DOI 10.4049/jimmunol.1400577; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Jurisicova A, 1996, P NATL ACAD SCI USA, V93, P161, DOI 10.1073/pnas.93.1.161; Kalkunte SS, 2009, J IMMUNOL, V182, P4085, DOI 10.4049/jimmunol.0803769; Kieckbusch J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4359; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Male V, 2011, EUR J IMMUNOL, V41, P3017, DOI 10.1002/eji.201141445; Mansell T, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.32; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Peng H, 2017, CELL MOL IMMUNOL, V14, P890, DOI 10.1038/cmi.2017.72; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53; Rajagopalan S, 2012, P NATL ACAD SCI USA, V109, P20596, DOI 10.1073/pnas.1208248109; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Roy AK, 2002, AGEING RES REV, V1, P367, DOI 10.1016/S1568-1637(02)00006-5; SANDERS SK, 1991, J EXP MED, V174, P737, DOI 10.1084/jem.174.3.737; Sarwar R, 2009, HEART, V95, pA4; Schulkey CE, 2015, NATURE, V520, P230, DOI 10.1038/nature14361; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Singh M, 2014, LIFE SCI, V118, P1, DOI 10.1016/j.lfs.2014.09.014; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Sun Li Li, 2011, J Reprod Infertil, V12, P215; Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P13312, DOI 10.1073/pnas.1517724112; Vacca P, 2013, J REPROD IMMUNOL, V97, P14, DOI 10.1016/j.jri.2012.10.008; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Williamson RE, 2008, HEARING RES, V237, P57, DOI 10.1016/j.heares.2007.12.006; Woods L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00308-x; Xiong S, 2013, J CLIN INVEST, V123, P4264, DOI 10.1172/JCI68991; Zhang JH, 2017, CELL MOL IMMUNOL, V14, P203, DOI 10.1038/cmi.2015.66; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38	64	754	823	13	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1100	+		10.1016/j.immuni.2017.11.018	http://dx.doi.org/10.1016/j.immuni.2017.11.018			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	32214087	Bronze			2022-12-18	WOS:000418486500014
J	Shaffer, AL; Lin, KI; Kuo, TC; Yu, X; Hurt, EM; Rosenwald, A; Giltnane, JM; Yang, LM; Zhao, H; Calame, K; Staudt, LM				Shaffer, AL; Lin, KI; Kuo, TC; Yu, X; Hurt, EM; Rosenwald, A; Giltnane, JM; Yang, LM; Zhao, H; Calame, K; Staudt, LM			Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program	IMMUNITY			English	Article							GERMINAL-CENTER FORMATION; TRANSCRIPTION FACTOR BSAP; C-MYC; SWITCH RECOMBINATION; ANTIGEN RECEPTOR; TARGET GENES; TERMINAL DIFFERENTIATION; TYROSINE KINASE; IN-VIVO; SPI-B	Blimp-1, a transcriptional repressor, drives the terminal differentiation of B cells to plasma cells. Using DNA microarrays, we found that introduction of Blimp-1 into B cells blocked expression of a remarkably large set of genes, while a much smaller number was induced. Blimp-1 initiated this cascade of gene expression changes by directly repressing genes encoding several transcription factors, including Spi-B and Id3, that regulate signaling by the B cell receptor. Blimp-1 also inhibited immunoglobulin class switching by blocking expression of AID, Ku70, Ku86, DNA-PKcs, and STAT6. These findings suggest that Blimp-1 promotes plasmacytic differentiation by extinguishing gene expression important for B cell receptor signaling, germinal center B cell function, and proliferation while allowing expression of important plasma cell genes such as XBP-1.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University	Calame, K (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.		Giltnane, Jennifer/D-2584-2013; Lin, KUO-I/C-6928-2009; Staudt, Louis/AAC-5324-2019		NIAID NIH HHS [AI43576] Funding Source: Medline; NIGMS NIH HHS [GM29361] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029361] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carey GB, 2000, IMMUNOL REV, V176, P105; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Chilosi M, 1999, MODERN PATHOL, V12, P1101; CHRISTOPH T, 1994, INT IMMUNOL, V6, P1203, DOI 10.1093/intimm/6.8.1203; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Cunningham K, 1998, INT IMMUNOL, V10, P1027, DOI 10.1093/intimm/10.8.1027; Dalla-Favera R, 1999, CURR TOP MICROBIOL, V246, P257; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eilers M, 1999, MOL CELLS, V9, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Garrett-Sinha LA, 2001, BLOOD, V97, P2908, DOI 10.1182/blood.V97.9.2908; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; GOLDSTEIN H, 1993, J IMMUNOL, V151, P6701; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Katsuta H, 1998, J IMMUNOL, V160, P1547; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; Knodel M, 2001, EUR J IMMUNOL, V31, P1972; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; LIAO F, 1994, J IMMUNOL, V152, P2904; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Linehan LA, 1998, J IMMUNOL, V161, P302; Ma C, 2001, PHILOS T ROY SOC B, V356, P83, DOI 10.1098/rstb.2000.0752; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Max E E, 1995, Curr Top Microbiol Immunol, V194, P449; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Moriyama M, 1997, ONCOGENE, V14, P2465, DOI 10.1038/sj.onc.1201084; Muller S, 1996, ONCOGENE, V13, P1955; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Nutt S L, 2001, Int Rev Immunol, V20, P65, DOI 10.3109/08830180109056723; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; Singh G, 1999, IEEE MULTIMEDIA, V6, P18; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Usui T, 1997, J IMMUNOL, V158, P3197; Waldburger JM, 2000, IMMUNOL REV, V178, P148, DOI 10.1034/j.1600-065X.2000.17813.x; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; Wen XY, 1999, INT J ONCOL, V15, P173; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zelazowski P, 1997, J IMMUNOL, V159, P2559	69	754	780	4	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					51	62		10.1016/S1074-7613(02)00335-7	http://dx.doi.org/10.1016/S1074-7613(02)00335-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150891	Bronze			2022-12-18	WOS:000177187500006
J	Kanneganti, TD; Lamkanfi, M; Nunez, G				Kanneganti, Thirumala-Devi; Lamkanfi, Mohamed; Nunez, Gabriel			Intracellular NOD-like receptors in host Defense and disease	IMMUNITY			English	Review							COLD AUTOINFLAMMATORY SYNDROME; LEGIONELLA-PNEUMOPHILA GROWTH; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; NUCLEOTIDE-BINDING; CROHNS-DISEASE; CASPASE-1 ACTIVATION; ADAPTIVE IMMUNITY; INFLAMMATORY CASPASES; CARD15 MUTATIONS	The innate immune system comprises several classes of pattern recognition receptors, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-1 -like receptors (RLRs). TLRs recognize microbes on the cell surface and in enclosomes, whereas NLRs and RLRs detect microbial components in the cytosol. Here we discuss the recent understanding in NLRs. Two NLRs, NOW and NOD2, sense the cytosolic presence of the pepticloglycan fragments meso-DAP and muramyl dipeptide, respectively, and drive the activation of mitogen-activated protein kinase (MAPK) and the transcription factor NF-B-K. A different set of NLRs induces caspase-1 activation through the assembly of large protein complexes named inflammasomes. Genetic variations in several NLR members are associated with the development of inflammatory disorders. Further understanding of NLRs should provide new insights into the mechanisms of host defense and the pathogenesis of inflammatory diseases.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Kanneganti, Thirumala-Devi/M-9435-2018; Nuñez, Gabriel/A-7160-2014; Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443				Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Elmaagacli AH, 2006, TRANSPLANTATION, V81, P247, DOI 10.1097/01.tp.0000188671.94646.16; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Granell M, 2006, HAEMATOLOGICA, V91, P1372; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Holt PG, 2002, EUR RESPIR J, V19, P538, DOI 10.1183/09031936.02.00229302; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; Leppla SH, 1999, J APPL MICROBIOL, V87, P284, DOI 10.1046/j.1365-2672.1999.00890.x; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Netea MG, 2005, NETH J MED, V63, P305; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Rosengren S, 2007, J ALLERGY CLIN IMMUN, V119, P991, DOI 10.1016/j.jaci.2006.12.649; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zilbauer M, 2007, CELL MICROBIOL, V9, P2541, DOI 10.1111/j.1462-5822.2007.01008.x	104	750	790	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					549	559		10.1016/j.immuni.2007.10.002	http://dx.doi.org/10.1016/j.immuni.2007.10.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17967410	Bronze			2022-12-18	WOS:000250490700007
J	Rosser, EC; Mauri, C				Rosser, Elizabeth C.; Mauri, Claudia			Regulatory B Cells: Origin, Phenotype, and Function	IMMUNITY			English	Review							B10 CELLS; T-CELLS; AUTOIMMUNE; INDUCTION; SUPPRESSION; RESPONSES; IMMUNITY; SUBSET; IL-10; INFLAMMATION	Regulatory B (Breg) cells are immunosuppressive cells that support immunological tolerance. Through the production of interleukin-10 (IL-10), IL-35, and transforming growth factor beta (TGF-beta), Breg cells suppress immunopathology by prohibiting the expansion of pathogenic T cells and other pro-inflammatory lymphocytes. Recent work has shown that different inflammatory environments induce distinct Breg cell populations. Although these findings highlight the relevance of inflammatory signals in the differentiation of Breg cells, they also raise other questions about Breg cell biology and phenotype. For example, what are the functional properties and phenotype of Breg cells? Can a Breg cell arise at every stage in B cell development? Is inflammation the primary requisite for Breg cell differentiation? Here, we use these questions to discuss the advances in understanding Breg cell biology, with a particular emphasis on their ontogeny; we propose that multiple Breg cell subsets can be induced in response to inflammation at different stages in development.	[Rosser, Elizabeth C.; Mauri, Claudia] UCL, Ctr Rheumatol Res, Div Med, London WC1E 6JF, England	University of London; University College London	Mauri, C (corresponding author), UCL, Ctr Rheumatol Res, Div Med, 5 Univ St, London WC1E 6JF, England.	c.mauri@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022	Rosser, Elizabeth/0000-0003-4800-4695; Mauri, Claudia/0000-0001-9761-2625	Arthritis Research UK [MP/17707, MP/19314]; Versus Arthritis [20959, 17707, 19314] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This work was funded by a program grant (MP/17707 to C.M.) and PhD studentship (MP/19314 to C.M.) from Arthritis Research UK. We would like to thank Dr. Kiran Nistala and Dr. Paul Blair for their constructive criticism of the manuscript.	Bankoti R, 2012, J IMMUNOL, V188, P3961, DOI 10.4049/jimmunol.1102880; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Bosma A, 2012, IMMUNITY, V36, P477, DOI 10.1016/j.immuni.2012.02.008; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Horikawa M, 2013, J IMMUNOL, V190, P1158, DOI 10.4049/jimmunol.1201427; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; KATZ SI, 1974, NATURE, V251, P550, DOI 10.1038/251550a0; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Rafei M, 2009, NAT MED, V15, P1038, DOI 10.1038/nm.2003; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun JB, 2008, J IMMUNOL, V181, P8278, DOI 10.4049/jimmunol.181.12.8278; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	45	746	780	10	148	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					607	612		10.1016/j.immuni.2015.04.005	http://dx.doi.org/10.1016/j.immuni.2015.04.005			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902480	Bronze			2022-12-18	WOS:000353347500008
J	Christensen, SR; Shupe, J; Nickerson, K; Kashgarian, M; Flavell, RA; Shlomchik, MJ				Christensen, Sean R.; Shupe, Jonathan; Nickerson, Kevin; Kashgarian, Michael; Flavell, Richard A.; Shlomchik, Mark J.			Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; ACTIVATE B-CELLS; I INTERFERON; ANTINUCLEAR ANTIBODIES; NEGATIVE REGULATION; IMMUNE-COMPLEXES; DNA ANTIBODIES; ANTI-SM; INDUCE; AUTOIMMUNITY	Antibodies (Abs) to RNA- and DNA-containing autoantigens are characteristic of systemic lupus erythematosus (SLE). We showed previously that Toll-like receptor (TLR) 9, recognizing DNA, is required for the spontaneous generation of DNA autoantibodies, but not for the development of lupus nephritis in susceptible mice. We report that lupus-prone mice deficient in TLR7, a receptor for ssRNA, failed to generate Abs to RNA-containing antigens (Ags) such as Smith (Sm) Ag. TLR9 and TLR7 also had dramatic effects on clinical disease in lupus-prone mice. In the absence of TLR9, autoimmune disease was exacerbated, lymphocytes and plasmacytoid DCs were more activated, and serum IgG and IFN-alpha were increased. In contrast, TLR7-deficient mice had ameliorated disease, decreased lymphocyte activation, and decreased serum IgG. These findings reveal opposing inflammatory and regulatory roles for TLR7 and TLR9, despite similar tissue expression and signaling pathways. These results have important implications for TLR-directed therapy of autoimmune disease.	Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Immunol Sect, 333 Cedar St, New Haven, CT 06510 USA.	mark.shlomchik@yale.edu	Shlomchik, Mark J./AAN-6189-2020; Nickerson, Kevin M/B-1351-2009	Shlomchik, Mark J./0000-0002-2152-0959; Nickerson, Kevin M/0000-0002-0114-2671	NIAID NIH HHS [P01-AI36529] Funding Source: Medline; NIAMS NIH HHS [P01-AR050256] Funding Source: Medline; NIGMS NIH HHS [GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050256] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Alba P, 2003, ANN RHEUM DIS, V62, P556, DOI 10.1136/ard.62.6.556; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Egner W, 2000, J CLIN PATHOL, V53, P424, DOI 10.1136/jcp.53.6.424; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Emlen W, 1997, ARTHRITIS RHEUM-US, V40, P1612, DOI 10.1002/art.1780400910; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; ISENBERG DA, 1987, ANN RHEUM DIS, V46, P448, DOI 10.1136/ard.46.6.448; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LOSMAN MJ, 1993, INT IMMUNOL, V5, P513, DOI 10.1093/intimm/5.5.513; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Migliorini P, 2005, AUTOIMMUNITY, V38, P47, DOI 10.1080/08916930400022715; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Muro Y, 2005, AUTOIMMUNITY, V38, P3, DOI 10.1080/08916930400024612; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Patole PS, 2005, J AM SOC NEPHROL, V16, P3273, DOI 10.1681/ASN.2005060658; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Takagi S., 1991, JPN WORLD ECON, V3, P147, DOI [10.1016/0922-1425(91)90002-T, DOI 10.1016/0922-1425(91)90002-T]; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vinuesa CG, 2002, NATURE, V416, P595, DOI 10.1038/416595a; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Werwitzke S, 2005, ARTHRITIS RHEUM-US, V52, P3629, DOI 10.1002/art.21379; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553	50	746	798	3	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					417	428		10.1016/j.immuni.2006.07.013	http://dx.doi.org/10.1016/j.immuni.2006.07.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16973389	Bronze			2022-12-18	WOS:000240862200011
J	Dejardin, E; Droin, NM; Delhase, M; Haas, E; Cao, YX; Makris, C; Li, ZW; Karin, M; Ware, CF; Green, DR				Dejardin, E; Droin, NM; Delhase, M; Haas, E; Cao, YX; Makris, C; Li, ZW; Karin, M; Ware, CF; Green, DR			The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappa B pathways	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; SECONDARY LYMPHOID-TISSUES; SEVERE LIVER DEGENERATION; ALPHA-DEFICIENT MICE; BREAST-CANCER CELLS; IKK-ALPHA; KINASE COMPLEX; SPLENIC MICROARCHITECTURE; ABNORMAL-DEVELOPMENT; TRANSCRIPTIONAL ACTIVITY	The lymphotoxin-beta receptor (LTbetaR) plays critical roles in inflammation and lymphoid organogenesis through activation of NF-kappaB. In addition to activation of the classical NF-kappaB, ligation of this receptor induces the processing of the cytosolic NF-kappaB2/p100 precursor to yield the mature p52 subunit, followed by translocation of p52 to the nucleus. This activation of NF-kappaB2 requires NIK and IKKalpha, while NEMO/IKKgamma is dispensable for p100 processing. IKKbeta-dependent activation of canonical NF-kappaB is required for the expression but not processing of p100 and for the expression of proinflammatory molecules including VCAM-1, MIP-1beta, and MIP-2 in response to LTbetaR ligation. In contrast, IKKalpha controls the induction by LTbetaR ligation of chemokines and cytokines involved in lymphoid organogenesis, including SLC, BLC, ELC, SDF1, and BAFF.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology; University of California System; University of California San Diego	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Green, Douglas R/N-8083-2018; Dejardin, Emmanuel/AAE-9076-2021; Delhase, Mireille/ABE-5256-2021; Droin, Nathalie M/Y-5506-2018	Green, Douglas R/0000-0002-7332-1417; Delhase, Mireille/0000-0003-2312-1051; Droin, Nathalie M/0000-0002-6099-5324	NCI NIH HHS [CA69381] Funding Source: Medline; NIAID NIH HHS [AI44828, AI03368, AI48073, AI43477] Funding Source: Medline; NIEHS NIH HHS [ES04151] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R01AI044828, R01AI043477, R37AI044828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; BANKS TA, 1995, J IMMUNOL, V155, P1685; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; BROWNING JL, 1995, J IMMUNOL, V154, P33; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Dejardin E, 1999, ONCOGENE, V18, P2567, DOI 10.1038/sj.onc.1202599; DEJARDIN E, 1995, ONCOGENE, V11, P1835; Dejardin E, 1998, ONCOGENE, V16, P3299, DOI 10.1038/sj.onc.1201879; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DOBRZANSKI P, 1995, ONCOGENE, V10, P1003; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; FORCE WR, 1995, J IMMUNOL, V155, P5280; Force WR, 2000, J BIOL CHEM, V275, P11121, DOI 10.1074/jbc.275.15.11121; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Matsumoto M, 1999, J IMMUNOL, V163, P1584; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; PEPIN N, 1994, VIROLOGY, V204, P706, DOI 10.1006/viro.1994.1586; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shakhov AN, 2001, CYTOKINE GROWTH F R, V12, P107, DOI 10.1016/S1359-6101(01)00004-1; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; VANARSDALE TL, 1994, J IMMUNOL, V153, P3043; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 1996, J IMMUNOL, V157, P3974; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	73	745	777	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					525	535		10.1016/S1074-7613(02)00423-5	http://dx.doi.org/10.1016/S1074-7613(02)00423-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387745	Bronze, Green Published			2022-12-18	WOS:000178667100012
J	Sutterwala, FS; Ogura, Y; Szczepanik, M; Lara-Tejero, M; Lichtenberger, GS; Grant, EP; Berlin, J; Coyle, AJ; Galan, JE; Askenase, PW; Flavell, RA				Sutterwala, FS; Ogura, Y; Szczepanik, M; Lara-Tejero, M; Lichtenberger, GS; Grant, EP; Berlin, J; Coyle, AJ; Galan, JE; Askenase, PW; Flavell, RA			Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1	IMMUNITY			English	Article							NF-KAPPA-B; INTERLEUKIN-1-BETA CONVERTING-ENZYME; COLD AUTOINFLAMMATORY SYNDROME; CONTAINING APAF1-LIKE PROTEIN; BACTERIAL MURAMYL DIPEPTIDE; MUCKLE-WELLS-SYNDROME; MICE DEFICIENT; IL-1-BETA-CONVERTING ENZYME; RECRUITMENT DOMAIN; MACROPHAGE DEATH	Mutations in the NALP3/CIAS1/cryopyrin gene are linked to three autoinflammatory disorders: Muckle-Wells syndrome, familial cold autoinflammatory syndrome, and chronic infantile neurologic cutaneous and articular syndrome. NALP3, with the adaptor molecule ASC, has been proposed to form a caspase-1-activating "inflammasome," a complex with pro-IL1 beta-processing activity. Here, we demonstrate the effect of NALP3 deficiency on caspase-1 function. NALP3 was essential for the ATP-driven activation of caspase-1 in lipopolysaccharide-stimulated macrophages and for the efficient secretion of the caspase-1-dependent cytokines IL-1 alpha, IL-1 beta, and IL-18. IL-1 beta has been shown to play a key role in contact hypersensitivity; we show that ASC- and NALP3-deficient mice also demonstrate an impaired contact hypersensitivity response to the hapten trinitrophenylchloride. NALP3, however, was not required for caspase-1 activation by Salmonella typhimurium, and NALP3 deficiency only partially protects mice from the lethal effects of endotoxin. These data suggest that NALP3 plays a specific role in the caspase-1 activation pathway.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Allergy & Clin Immunol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Jagiellonian Univ, Sch Med, Dept Human Dev Biol, Krakow, Poland; Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Jagiellonian University; Yale University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Grant, Ethan/GQP-2720-2022; Szczepanik, Marian/ABA-7001-2021; Cassel, Suzanne/AAI-3947-2021; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; 				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; Conway KE, 2000, CANCER RES, V60, P6236; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; ENK AH, 1993, J IMMUNOL, V150, P3698; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hueffer K, 2004, CELL MICROBIOL, V6, P1019, DOI 10.1111/j.1462-5822.2004.00451.x; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srinivasula SM, 2002, J BIOL CHEM, V19, P19; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x	40	742	769	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					317	327		10.1016/j.immuni.2006.02.004	http://dx.doi.org/10.1016/j.immuni.2006.02.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546100	Bronze			2022-12-18	WOS:000236504500012
J	Ohl, L; Mohaupt, M; Czeloth, N; Hintzen, G; Kiafard, Z; Zwirner, J; Blankenstein, T; Henning, G; Forster, R				Ohl, L; Mohaupt, M; Czeloth, N; Hintzen, G; Kiafard, Z; Zwirner, J; Blankenstein, T; Henning, G; Forster, R			CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions	IMMUNITY			English	Article							LYMPHOID-ORGAN CHEMOKINE; LANGERHANS CELLS; IMMUNE-RESPONSE; CUTTING EDGE; EXPRESSION; RECEPTOR; MATURE; MATURATION; TOLERANCE; DELETION	The CC chemokine receptor CCR7 has been identified as a key regulator of homeostatic B and T cell trafficking to secondary lymphoid organs. Data presented here demonstrate that CCR7 is also an essential mediator for entry of both dermal and epidermal dendritic cells (DC) into the lymphatic vessels within the dermis while this receptor is dispensable for the mobilization of Langerhans cells from the epidermis to the dermis. Moreover, a distinct population of CD11c(+)MHCII(high) DC showing low expression of the costimulatory molecules CD40, CD80, and CD86 in wild-type animals was virtually absent in skin-draining lymph nodes of CCR7-deficient mice under steady-state conditions. We provide evidence that these cells represent a semimature population of DC that is capable of initiating T cell proliferation under conditions known to induce tolerance. Thus, our data identify CCR7 as a key regulator that governs trafficking of skin DC under both inflammatory and steady-state conditions.	Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Univ Gottingen, Dept Immunol, D-37075 Gottingen, Germany	Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen	Forster, R (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	foerster.reinhold@mh-hannover.de	Förster, Reinhold/D-6770-2011	Forster, Reinhold/0000-0001-6190-7923				Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BARKER JNWN, 1991, J IMMUNOL, V146, P1192; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; FORSTER R, 1994, BLOOD, V84, P830; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HERNMI H, 2001, INT IMMUNOL, V13, P695; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Katou F, 2001, AM J PATHOL, V158, P1263, DOI 10.1016/S0002-9440(10)64077-1; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Price AA, 1997, J EXP MED, V186, P1725, DOI 10.1084/jem.186.10.1725; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Qin ZH, 1997, J IMMUNOL, V159, P770; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sozzani S, 1998, J IMMUNOL, V161, P1083; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STINGL G, 1980, IMMUNOL REV, V53, P149, DOI 10.1111/j.1600-065X.1980.tb01043.x; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Weinlich G, 1998, J INVEST DERMATOL, V110, P441, DOI 10.1046/j.1523-1747.1998.00161.x; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yoshino M, 2003, INT IMMUNOL, V15, P773, DOI 10.1093/intimm/dxg075	45	737	766	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					279	288		10.1016/j.immuni.2004.06.014	http://dx.doi.org/10.1016/j.immuni.2004.06.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308107	Bronze			2022-12-18	WOS:000223441900015
J	Yao, ZB; Fanslow, WC; Seldin, MF; Rousseau, AM; Painter, SL; Comeau, MR; Cohen, JI; Spriggs, MK				Yao, ZB; Fanslow, WC; Seldin, MF; Rousseau, AM; Painter, SL; Comeau, MR; Cohen, JI; Spriggs, MK			Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor	IMMUNITY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL; BIOLOGICAL CHARACTERIZATION; INTERSPECIFIC CROSS; CYTOPLASMIC REGION; MOLECULAR-CLONING; SIGNAL TRANSDUCER; LINKAGE MAP	Herpesvirus Saimiri gene 13 (HVS13) exhibits 57% identity with the predicted sequence of a T cell-derived molecule termed CTLA8. Recombinant HVS13 and CTLA8 stimulate transcriptional factor NF-kappa B activity and interleukin-6 (IL-6) secretion in fibroblasts, and costimulate T cell proliferation. An HVS13.Fc fusion protein was used to isolate a cDNA encoding a novel receptor that also binds CTLA8. This receptor is unrelated to previously identified cytokine receptor families. A recombinant soluble receptor inhibited T cell proliferation and IL-2 production induced by PHA, concanavalin A (conA), and anti-TCR MAb. These results define CTLA8 and HVS13 as novel cytokines that bind to a novel cytokine receptor. We propose to call these molecules IL-17, vlL-17, and IL-17R, respectively.	DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710; NIH,CLIN INVEST LAB,BETHESDA,MD 20892	Duke University; Duke University; National Institutes of Health (NIH) - USA	Yao, ZB (corresponding author), IMMUNEX RES & DEV CORP,51 UNIV ST,SEATTLE,WA 98101, USA.				NHGRI NIH HHS [HG00734] Funding Source: Medline; NIAMS NIH HHS [AR41053] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041053] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHUJA SK, 1993, J BIOL CHEM, V268, P20691; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; ALCOVER A, 1987, IMMUNOL REV, V95, P5, DOI 10.1111/j.1600-065X.1987.tb00498.x; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; BISHOP D T, 1985, Genetic Epidemiology, V2, P349, DOI 10.1002/gepi.1370020404; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; CROWE JS, 1992, CLIN EXP IMMUNOL, V87, P105; FANSLOW WC, 1992, J IMMUNOL, V149, P655; FANSLOW WC, 1991, J IMMUNOL, V147, P535; FANSLOW WC, 1994, J IMMUNOL, V152, P4262; Fleckenstein B., 1982, HERPESVIRUSES, V1, P253; FRENKEL N, 1990, J VIROL, V64, P4598, DOI 10.1128/JVI.64.9.4598-4602.1990; FUKUNAGA R, 1990, CELL, V61, P341, DOI 10.1016/0092-8674(90)90814-U; GAO JL, 1994, J BIOL CHEM, V269, P28539; GOODING LR, 1992, CELL, V71, P5; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; GREEN EL, 1981, LINKAGE RECOMBINATIO, P77; GREENE WC, 1989, IMMUNOL TODAY, V10, P272, DOI 10.1016/0167-5699(89)90141-2; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HENIKOFF S, 1991, NUCLEIC ACIDS RES, V19, P6565, DOI 10.1093/nar/19.23.6565; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRAI H, 1994, P NATL ACAD SCI USA, V91, P3584, DOI 10.1073/pnas.91.9.3584; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KOWALIK TF, 1993, P NATL ACAD SCI USA, V90, P1107, DOI 10.1073/pnas.90.3.1107; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MCGUIRE KL, 1993, J VIROL, V67, P1590, DOI 10.1128/JVI.67.3.1590-1599.1993; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MEIER T, 1992, ANAL BIOCHEM, V204, P220, DOI 10.1016/0003-2697(92)90165-4; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NICHOLAS J, 1992, NATURE, V355, P362, DOI 10.1038/355362a0; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; PATEL A, 1995, GENOMICS, V25, P314, DOI 10.1016/0888-7543(95)80146-D; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PICKUP DJ, 1994, INFECT AGENT DIS, V3, P116; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; ROIZMAN B, 1992, HUMAN HERPESVIRUSES, P1; ROUVIER E, 1993, J IMMUNOL, V150, P5445; SAMBUCETTI LC, 1989, EMBO J, V8, P4251, DOI 10.1002/j.1460-2075.1989.tb08610.x; SAUNDERS AM, 1990, GENOMICS, V8, P525, DOI 10.1016/0888-7543(90)90040-2; SCHALL TJ, 1995, VIROCEPTORS VIROKINE, P201; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; SELDIN MF, 1988, IMMUNOGENETICS, V27, P396, DOI 10.1007/BF00395138; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIMIZU S, 1988, BLOOD, V72, P1826; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SPRIGGS MK, 1994, CURR OPIN IMMUNOL, V6, P526, DOI 10.1016/0952-7915(94)90136-8; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; WALLACE JC, 1992, COMPUT APPL BIOSCI, V8, P249; WATSON ML, 1992, MAMM GENOME, V2, P158, DOI 10.1007/BF00302874; WATSON ML, 1994, METH MOL G, V5, P369; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	69	737	856	2	32	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					811	821		10.1016/1074-7613(95)90070-5	http://dx.doi.org/10.1016/1074-7613(95)90070-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777726	Bronze			2022-12-18	WOS:A1995TM02300015
J	ARBONES, ML; ORD, DC; LEY, K; RATECH, H; MAYNARDCURRY, C; OTTEN, G; CAPON, DJ; TEDDER, TF				ARBONES, ML; ORD, DC; LEY, K; RATECH, H; MAYNARDCURRY, C; OTTEN, G; CAPON, DJ; TEDDER, TF			LYMPHOCYTE HOMING AND LEUKOCYTE ROLLING AND MIGRATION ARE IMPAIRED IN L-SELECTIN-DEFICIENT MICE	IMMUNITY			English	Article							HIGH-ENDOTHELIAL VENULES; AFFERENT LYMPHATIC VESSELS; ADHESION MOLECULE-1 LAM-1; GRANULE MEMBRANE-PROTEIN; CELL-SURFACE MOLECULE; MEDIATED LUNG INJURY; RECEPTOR-IGG CHIMERA; MEMORY T-CELLS; P-SELECTIN; VASCULAR ADDRESSIN	L-selectin, a cell adhesion molecule expressed by leukocytes, mediates the attachment of lymphocytes to high endothelial venules (HEV) of peripheral lymph nodes and mediates the earliest interactions between leukocytes and activated vascular endothelium. Mice possessing a mutant L-selectin gene that results in the complete loss of cell surface receptor expression were generated by gene targeting. Lymphocytes from these mice did not bind to peripheral lymph node HEV and these mice had a severe reduction in the number of lymphocytes localized to peripheral lymph nodes. Short-term homing experiments demonstrated that L-selectin was also involved in lymphocyte migration to mucosal lymph nodes, Peyer's patches, and spleen. Furthermore, significant defects in leukocyte rolling and neutrophil migration into the peritoneum in response to an inflammatory stimulus were observed. Thus; L-selectin plays an essential role in leukocyte homing to lymphoid tissues and sites of inflammation.	DUKE UNIV,MED CTR,DEPT IMMUNOL,DURHAM,NC 27710; UNIV VIRGINIA,SCH MED,DEPT BIOMED ENGN,CHARLOTTESVILLE,VA 22908; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710	Duke University; University of Virginia; Duke University	ARBONES, ML (corresponding author), CELL GENESYS INC,322 LAKESIDE DR,FOSTER CITY,CA 94404, USA.		Arbones, Maria/D-4668-2016	Arbones, Maria/0000-0002-6035-0235	NATIONAL CANCER INSTITUTE [R55CA054464, P01CA034183, R01CA054464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026872] Funding Source: NIH RePORTER; NCI NIH HHS [CA54464, CA34183] Funding Source: Medline; NIAID NIH HHS [AI-26872] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARBONES ML, 1994, NAT GENET, V6, P90, DOI 10.1038/ng0194-90; ATHERTON A, 1972, J PHYSIOL-LONDON, V222, P447, DOI 10.1113/jphysiol.1972.sp009808; BARGATZE RF, 1987, J EXP MED, V166, P1125, DOI 10.1084/jem.166.4.1125; BARGATZE RF, 1990, J CELL BIOCHEM, V42, P219, DOI 10.1002/jcb.240420405; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BOWEN BR, 1990, J CELL BIOL, V110, P147, DOI 10.1083/jcb.110.1.147; BRADY HR, 1992, J IMMUNOL, V149, P2437; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; BUTCHER EC, 1980, J IMMUNOL METHODS, V37, P109, DOI 10.1016/0022-1759(80)90196-9; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; COLLINS T, 1991, J BIOL CHEM, V266, P2466; DOWBENKO DJ, 1991, GENOMICS, V9, P270, DOI 10.1016/0888-7543(91)90252-A; DRAYSON MT, 1984, IMMUNOBIOLOGY, V168, P362, DOI 10.1016/S0171-2985(84)80123-0; FIEBIG E, 1991, INT J MICROCIRC, V10, P127; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GEOFFROY JS, 1989, J CELL BIOL, V109, P2463, DOI 10.1083/jcb.109.5.2463; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; GUNDEL RH, 1991, J CLIN INVEST, V88, P1407, DOI 10.1172/JCI115447; HAMANN A, 1991, EUR J IMMUNOL, V21, P2925, DOI 10.1002/eji.1830211205; HAMANN A, 1988, J IMMUNOL, V140, P693; HENDRIKS HR, 1980, CELL TISSUE RES, V211, P375; HENDRIKS HR, 1987, EUR J IMMUNOL, V17, P1691, DOI 10.1002/eji.1830171203; HENDRIKS HR, 1983, EUR J IMMUNOL, V13, P663, DOI 10.1002/eji.1830130811; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HSULIN SC, 1984, J BIOL CHEM, V259, P9121; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; IMAI Y, 1990, J CELL BIOL, V111, P1225, DOI 10.1083/jcb.111.3.1225; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JUNG TM, 1988, J IMMUNOL, V141, P4110; JUTILA MA, 1989, J IMMUNOL, V143, P3318; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; KANSAS GS, 1991, J CELL BIOL, V114, P351, DOI 10.1083/jcb.114.2.351; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; LARSEN E, 1990, CELL, V63, P467, DOI 10.1016/0092-8674(90)90443-I; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1993, J IMMUNOL, V151, P6338; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; LEY K, 1993, BLOOD, V82, P1632; LEY K, 1987, INT J MICROCIRC, V6, P161; LEY K, 1991, BLOOD, V77, P2553; LUSCINSKAS FW, 1991, J IMMUNOL, V146, P1617; MARTIN DR, 1989, J EXP MED, V170, P679, DOI 10.1084/jem.170.3.679; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; MULLIGAN MS, 1991, J CLIN INVEST, V88, P1396, DOI 10.1172/JCI115446; MULLIGAN MS, 1993, J IMMUNOL, V151, P6410; MULLIGAN MS, 1993, NATURE, V364, P149, DOI 10.1038/364149a0; ORD DC, 1990, J BIOL CHEM, V265, P7760; PABST R, 1988, IMMUNOL TODAY, V9, P43, DOI 10.1016/0167-5699(88)91258-3; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PICKER LJ, 1990, J IMMUNOL, V145, P3247; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; ROSEN SD, 1989, J IMMUNOL, V142, P1895; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; SHIMIZU Y, 1991, NATURE, V349, P799, DOI 10.1038/349799a0; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SLEASMAN JW, 1990, EUR J IMMUNOL, V20, P1357, DOI 10.1002/eji.1830200623; SMITH CW, 1991, J CLIN INVEST, V87, P609, DOI 10.1172/JCI115037; SPERTINI O, 1992, J EXP MED, V175, P1789, DOI 10.1084/jem.175.6.1789; SPERTINI O, 1991, NATURE, V349, P691, DOI 10.1038/349691a0; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPERTINI O, 1991, LEUKEMIA, V5, P300; SPERTINI O, 1991, J IMMUNOL, V147, P942; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1990, J IMMUNOL, V144, P532; TEDDER TF, 1990, EUR J IMMUNOL, V20, P1351, DOI 10.1002/eji.1830200622; VONADRIAN UH, 1992, AM J PHYSL, V262; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; WATSON ML, 1990, J EXP MED, V172, P263, DOI 10.1084/jem.172.1.263; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221; WATSON SR, 1991, NATURE, V349, P164, DOI 10.1038/349164a0; WESTERMANN J, 1992, EUR J IMMUNOL, V22, P2219, DOI 10.1002/eji.1830220906	93	734	772	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1994	1	4					247	260		10.1016/1074-7613(94)90076-0	http://dx.doi.org/10.1016/1074-7613(94)90076-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7534203				2022-12-18	WOS:A1994PK16600002
J	Bajenoff, M; Egen, JG; Koo, LY; Laugier, JP; Brau, F; Glaichenhaus, N; Germain, RN				Bajenoff, Marc; Egen, Jackson G.; Koo, Lily Y.; Laugier, Jean Pierre; Brau, Frederic; Glaichenhaus, Nicolas; Germain, Ronald N.			Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; B-CELLS; T-CELLS; IN-VIVO; ANTIGEN; CHEMOKINES; IMMUNITY; TRAFFICKING; FOLLICLES; MOTILITY	After entry into lymph nodes (LNs), B cells migrate to follicles, whereas T cells remain in the paracortex, with each lymphocyte type showing apparently random migration within these distinct areas. Other than chemokines, the factors contributing to this spatial segregation and to the observed patterns of lymphocyte movement are poorly characterized. By combining confocal, electron, and intravital microscopy, we showed that the fibroblastic reticular cell network regulated naive T cell access to the paracortex and also supported and defined the limits of T cell movement within this domain, whereas a distinct follicular dendritic cell network similarly served as the substratum for movement of follicular B cells. These results highlight the central role of stromal microanatomy in orchestrating cell migration within the LN.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Nice, INSERM, F-06560 Valbonne, France; Univ Nice, Ctr Commun Microscopie Appl, F-06103 Nice, France; Univ Nice, CNRS, UMR 6097, F-06560 Valbonne, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Egen, Jackson/0000-0003-2053-0837	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000545] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000545-19] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Carroll M C, 2000, Adv Immunol, V74, P61; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215; Cyster JG, 2000, IMMUNOL REV, V176, P181; FORSTER R, 1994, BLOOD, V84, P830; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Germain RN, 2005, SEMIN IMMUNOL, V17, P431, DOI 10.1016/j.smim.2005.09.003; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747; HAYAKAWA M, 1988, ARCH HISTOL CYTOL, V51, P233, DOI 10.1679/aohc.51.233; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; JANSEN CR, 1962, BLOOD, V20, P443, DOI 10.1182/blood.V20.4.443.443; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; MATOUSMALBOHAN I, 1974, CELL IMMUNOL, V12, P345, DOI 10.1016/0008-8749(74)90090-2; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Ogata T, 1996, BLOOD, V88, P2995, DOI 10.1182/blood.V88.8.2995.bloodjournal8882995; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Ratner S, 2003, J LEUKOCYTE BIOL, V73, P830, DOI 10.1189/jlb.1001894; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; USHIKI T, 1995, ANAT REC, V241, P113, DOI 10.1002/ar.1092410115; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x	51	733	746	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					989	1001		10.1016/j.immuni.2006.10.011	http://dx.doi.org/10.1016/j.immuni.2006.10.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17112751	Bronze, Green Accepted			2022-12-18	WOS:000243087500017
J	Zhang, WG; Trible, RP; Samelson, LE				Zhang, WG; Trible, RP; Samelson, LE			LAT palmitoylation: Its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; G-PROTEINS; KINASE; LOCALIZATION; DOMAINS; CAVEOLAE; MYRISTYLATION; PALMITYLATION; ACYLATION	The linker molecule LAT is a critical substrate of the tyrosine kinases activated upon TCR engagement. Phosphorylated LAT binds Grb2, PLC-gamma 1, and other signaling molecules. We demonstrate that human LAT is palmitoylated and that palmitoylated LAT predominantly localizes into glycolipid-enriched microdomains (GEMs). Although the LAT transmembrane domain is sufficient for membrane localization, palmitoylation at C26 and C29 is essential for efficient partitioning into GEMs. LAT palmitoylation is necessary for its tyrosine phosphorylation. After T cell activation, most tyrosine-phosphorylated LAT molecules and a fraction of PLC-gamma 1 and other signaling molecules are present in GEMs. LAT is central to T cell activation and is a novel linker molecule shown to require targeting to membrane microdomains for signaling.	National Institute Child Health & Human Dev, Cell Biol & Metab Branch, Sect Lymphocyte Signaling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Samelson, LE (corresponding author), National Institute Child Health & Human Dev, Cell Biol & Metab Branch, Sect Lymphocyte Signaling, NIH, Bethesda, MD 20892 USA.	samelson@helix.nih.gov						ALLAND L, 1994, J BIOL CHEM, V269, P16701; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown RE, 1998, J CELL SCI, V111, P1; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Koretzky GA, 1997, IMMUNOL TODAY, V18, P401, DOI 10.1016/S0167-5699(97)01088-8; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; LUBLIN DM, 1992, CURR TOP MICROBIOL, V178, P141; MARTH JD, 1989, J IMMUNOL, V142, P2430; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SIEH M, 1994, MOL CELL BIOL, V14, P4435, DOI 10.1128/MCB.14.7.4435; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN A, 1996, CURRENT PROTOCOLS IM; Willumsen BM, 1996, ONCOGENE, V13, P1901; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	39	733	751	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					239	246		10.1016/S1074-7613(00)80606-8	http://dx.doi.org/10.1016/S1074-7613(00)80606-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729044	Bronze			2022-12-18	WOS:000075610300010
J	Ishigame, H; Kakuta, S; Nagai, T; Kadoki, M; Nambu, A; Komiyama, Y; Fujikado, N; Tanahashi, Y; Akitsu, A; Kotaki, H; Sudo, K; Nakae, S; Sasakawa, C; Iwakura, Y				Ishigame, Harumichi; Kakuta, Shigeru; Nagai, Takeshi; Kadoki, Motohiko; Nambu, Aya; Komiyama, Yutaka; Fujikado, Noriyuki; Tanahashi, Yuko; Akitsu, Aoi; Kotaki, Hayato; Sudo, Katsuko; Nakae, Susumu; Sasakawa, Chihiro; Iwakura, Yoichiro			Differential Roles of Interleukin-17A and-17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses	IMMUNITY			English	Article							IL-1 RECEPTOR ANTAGONIST; T-HELPER-CELLS; CITROBACTER-RODENTIUM; AUTOIMMUNE ENCEPHALOMYELITIS; IL-17-DEFICIENT MICE; FAMILY-MEMBERS; CUTTING EDGE; TNF-ALPHA; INFLAMMATION; CYTOKINE	Interleukin-17A (IL-17A) is a cytokine produced by T helper 17 (Th17) cells and plays important roles in the development of inflammatory diseases. Although IL-17F is highly homologous to IL-17A and binds the same receptor, the functional roles of this molecule remain largely unknown. Here, we demonstrated with II17a(-/-), II17f(-/-), and II17a(-/-)II17f(-/-) mice that IL-17F played only marginal roles, if at all, in the development of delayed-type and contact hypersensitivities, autoimmune encephalomyelitis, collagen-induced arthritis, and arthritis in II1rn(-/-) mice. In contrast, both IL-17F and IL-17A were involved in host defense against mucoepithelial infection by Staphylococcus aureus and Citrobacter rodentium. IL-17A was produced mainly in T cells, whereas IL-17F was produced in T cells, innate immune cells and epithelial cells. Although only IL-17A efficiently; induced cytokines in macrophages, both cytokines activated epithelial innate immune responses. These observations indicate that IL-17A and IL-17F have overlapping yet distinct roles in host immune and defense mechanisms.	[Ishigame, Harumichi; Kakuta, Shigeru; Kadoki, Motohiko; Nambu, Aya; Komiyama, Yutaka; Fujikado, Noriyuki; Tanahashi, Yuko; Akitsu, Aoi; Kotaki, Hayato; Sudo, Katsuko; Nakae, Susumu; Iwakura, Yoichiro] Univ Tokyo, Ctr Med Expt, Minato Ku, Inst Med Sci, Tokyo 1088639, Japan; [Nagai, Takeshi; Sasakawa, Chihiro] Univ Tokyo, Dept Microbiol & Immun, Minato Ku, Inst Med Sci, Tokyo 1088639, Japan; [Nakae, Susumu] Univ Tokyo, Frontier Res Initiat, Minato Ku, Inst Med Sci, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Iwakura, Y (corresponding author), Univ Tokyo, Ctr Med Expt, Minato Ku, Inst Med Sci, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iwakura@ims.u-tokyo.ac.jp	Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018	Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Fujikado, Noriyuki/0000-0002-0415-5929; Nambu, Aya/0000-0002-2797-6420; Kadoki, Motohiko/0000-0002-0124-7406; Fujikado, Noriyuki/0000-0002-3183-5866	Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation; Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Chemical Industry Association; Program for Improvement of Research Environment for Young Researchers; Special Coordination Funds for Promoting Science and Technology, MEXT; Japan Society for the Promotion of Science	Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation(Core Research for Evolutional Science and Technology (CREST)); Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Chemical Industry Association; Program for Improvement of Research Environment for Young Researchers; Special Coordination Funds for Promoting Science and Technology, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Saito and J. Abe, N.M. Tsuji, Y. Kobayashi, M. Kawaguchi, K. Matsushima and S. Ueha, and K. Aozasa, E. Morii, and H. Mimuro for their kind cooperation and discussions; C. Cheng-Mayer for critical reading of the manuscript; T. Yoshimoto for providing the IFN-gamma and IL-4 mAbs; A. Nakano and D.L. Hu for providing S. aureus 834 strain; N. Watanabe and Y. Ishii for cell sorting; N. Hashimoto, S. Azechi, A. Ikeda, and M. Kaneko for technical assistance; and all of the members of our laboratory for animal care. This work was supported by Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation (Y.I.); the Promotion of Basic Research Activities for Innovative Biosciences (Y.I.); Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labour and Welfare of Japan; the Japan Chemical Industry Association (the Long-Range Research Initiative) (Y.I. and S.K.); the Program for Improvement of Research Environment for Young Researchers; the Special Coordination Funds for Promoting Science and Technology, MEXT (S.N.); and the Japan Society for the Promotion of Science (H.I.).	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Horai R, 2004, J CLIN INVEST, V114, P1603, DOI 10.1172/JCI200420742; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Oda N, 2005, AM J RESP CRIT CARE, V171, P12, DOI 10.1164/rccm.200406-778OC; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Schwarzenberger P, 2002, J CELL BIOCHEM, P88, DOI 10.1002/jcb.10054; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Suzuki S, 2007, INT ARCH ALLERGY IMM, V143, P89, DOI 10.1159/000101413; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	50	732	772	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					108	119		10.1016/j.immuni.2008.11.009	http://dx.doi.org/10.1016/j.immuni.2008.11.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144317	Bronze			2022-12-18	WOS:000262769900014
J	Kissenpfennig, A; Henri, S; Dubois, B; Laplace-Builhe, C; Perrin, P; Romani, N; Tripp, CH; Douillard, P; Leserman, L; Kaiserlian, D; Saeland, S; Davoust, J; Malissen, B				Kissenpfennig, A; Henri, S; Dubois, B; Laplace-Builhe, C; Perrin, P; Romani, N; Tripp, CH; Douillard, P; Leserman, L; Kaiserlian, D; Saeland, S; Davoust, J; Malissen, B			Dynamics and function of langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating langerhans cells	IMMUNITY			English	Article							CD4 T-CELLS; CONTACT HYPERSENSITIVITY; STEADY-STATE; BIRBECK GRANULES; MURINE SKIN; LIFE-SPAN; MOUSE; ANTIGEN; CD8(+); IMMUNITY	Langerhans cells (LCs) are prominent dendritic cells (DCs) in epithelia, but their role in immunity is poorly defined. To track and discriminate LCs from dermal DCs in vivo, we developed knockin mice expressing enhanced green fluorescent protein (EGFP) under the control of the langerin (CD207) gene. By using vital imaging, we showed that most EGFP(+) LCs were sessile under steady-state conditions, whereas skin inflammation induced LC motility and emigration to lymph nodes (LNs). After skin immunization, dermal DCs arrived in LNs first and colonized areas distinct from slower migrating LCs. LCs reaching LNs under steady-state or inflammatory conditions expressed similar levels of costimulatory molecules. Langerin and EGFP were also expressed on thymic DCs and on blood-derived, CD8 alpha(+) DCs from all secondary lymphoid organs. By using a similar knockin strategy involving a diphtheria toxin receptor (DTR) fused to EGFP, we demonstrated that LCs were dispensable for triggering hapten-specific T cell effectors through skin immunization.	Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; INSERM, CERVI, U404, F-69365 Lyon, France; Ctr Rech & Appl Therapies Gen, UMR 8115, F-91002 Evry, France; Innsbruck Med Univ, Dept Dermatol, A-6020 Innsbruck, Austria; Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; Merck & Company; Schering Plough Corporation	Malissen, B (corresponding author), Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, Parc Sci & Technol Luminy,Case 906, F-13288 Marseille, France.	bernardm@ciml.univ-mrs.fr	KAISERLIAN, Dominique/G-3325-2013; LAPLACE-BUILHE, Corinne/ABD-4479-2020; Dubois, Bertrand/D-4446-2013; Davoust, Jean/ABB-6720-2020; Henri, Sandrine/O-3045-2016; Malissen, Bernard/AAK-4659-2020	KAISERLIAN, Dominique/0000-0001-6252-4916; Dubois, Bertrand/0000-0002-7859-4975; Romani, Nikolaus/0000-0003-1614-9128; HENRI, Sandrine/0000-0002-8980-9193; Malissen, Bernard/0000-0003-1340-9342; Davoust, Jean/0000-0002-3098-7665; Tripp, Christoph/0000-0001-5502-7241; LAPLACE-BUILHE, Corinne/0000-0003-2885-6073; Kissenpfennig, Adrien/0000-0002-9633-3111				Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Bacci S, 1997, EUR J IMMUNOL, V27, P442, DOI 10.1002/eji.1830270214; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; BREEL M, 1987, EUR J IMMUNOL, V17, P1555, DOI 10.1002/eji.1830171105; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Heath WR, 2005, NAT IMMUNOL, V6, P125, DOI 10.1038/ni0205-125; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; HOEFSMIT ECM, 1982, IMMUNOBIOLOGY, V161, P255, DOI 10.1016/S0171-2985(82)80081-8; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasaki A, 2003, J EXP MED, V198, P185, DOI 10.1084/jem.20030737; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; SULLIVAN S, 1986, J IMMUNOL, V137, P2460; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; TIGELAAR RE, 1982, J IMMUNOL, V129, P1898; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	43	729	747	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					643	654		10.1016/j.immuni.2005.04.004	http://dx.doi.org/10.1016/j.immuni.2005.04.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894281	Green Published, Bronze			2022-12-18	WOS:000229447200013
J	Le Bon, A; Schiavoni, G; D'Agostino, G; Gresser, I; Belardelli, F; Tough, DF				Le Bon, A; Schiavoni, G; D'Agostino, G; Gresser, I; Belardelli, F; Tough, DF			Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo	IMMUNITY			English	Article							PERITONEAL-MACROPHAGES; PLASMA-CELLS; MICE; ANTIBODY; EXPRESSION; ALPHA; INNATE; DNA; SUPPRESSION; CYTOKINES	Type I interferons (IFN-I) are rapidly induced following infection and play a key role in nonspecific inhibition of virus replication. Here we have investigated the effects of IFN-I on the generation of antigen-specific antibody responses. The data show that IFN-I potently enhance the primary antibody response to a soluble protein, stimulating the production of all subclasses of IgG, and induce long-lived antibody production and immunological memory. In addition, endogenous production of IFN-I was shown to be essential for the adjuvant activity of CFA. Finally, IFN-I enhanced the antibody response and induced isotype switching when dendritic cells were the only cell type responding to IFN-I. The data reveal the potent adjuvant activity of IFN-I and their important role in linking innate and adaptive immunity.	Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy; Inst Curie, INSERM, U255, F-75248 Paris, France	Istituto Superiore di Sanita (ISS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Tough, DF (corresponding author), Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England.		Le Bon, Agnes/L-3237-2017; Schiavoni, Giovanna/T-4418-2017; Schiavoni, Giovanna/K-2448-2019	Le Bon, Agnes/0000-0003-4204-8136; Schiavoni, Giovanna/0000-0001-9135-0556; Schiavoni, Giovanna/0000-0001-9135-0556; D'Agostino, Giuseppina/0000-0003-1852-4665; Belardelli, Filippo/0000-0002-3082-3169				BELARDELLI F, 1987, J GEN VIROL, V68, P2203, DOI 10.1099/0022-1317-68-8-2203; BELARDELLI F, 1984, P NATL ACAD SCI-BIOL, V81, P602, DOI 10.1073/pnas.81.2.602; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; BRAUN W, 1972, P SOC EXP BIOL MED, V141, P769; BRODEUR BR, 1974, J IMMUNOL, V113, P1319; BRODEUR BR, 1975, J IMMUNOL, V114, P1323; CHESTER TJ, 1973, NATURE, V246, P92, DOI 10.1038/246092a0; COUTELIER JP, 1991, J IMMUNOL, V147, P1383; DEMAEYER E, 1980, NATURE, V284, P173, DOI 10.1038/284173a0; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; GISLER RH, 1974, J IMMUNOL, V113, P438; GRESSER I, 1988, J EXP MED, V168, P1271, DOI 10.1084/jem.168.4.1271; GRESSER I, 1991, J EXP MED, V173, P1193, DOI 10.1084/jem.173.5.1193; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; KAWADE Y, 1987, P 3 INT TNO M BIOL I; KIRCHNER H, 1984, SPRINGER SEMIN IMMUN, V7, P347; LINDAHL P, 1976, P NATL ACAD SCI USA, V73, P1284, DOI 10.1073/pnas.73.4.1284; LINDAHLM.P, 1972, NATURE-NEW BIOL, V237, P120, DOI 10.1038/newbio237120a0; Luft T, 1998, J IMMUNOL, V161, P1947; MANDLER R, 1993, J IMMUNOL, V150, P497; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; Radvanyi LG, 1999, SCAND J IMMUNOL, V50, P499; Roman M, 1997, NAT MED, V3, P849, DOI 10.1038/nm0897-849; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; SIEBENKOTTEN G, 1992, EUR J IMMUNOL, V22, P1827, DOI 10.1002/eji.1830220723; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SNAPPER CM, 1991, INT IMMUNOL, V3, P845, DOI 10.1093/intimm/3.9.845; STRANNEGARD O, 1978, INFECT IMMUN, V20, P334; Sun SQ, 1998, J EXP MED, V187, P1145, DOI 10.1084/jem.187.7.1145; Sun SQ, 1998, J EXP MED, V188, P2335, DOI 10.1084/jem.188.12.2335; TOVEY MG, 1974, P SOC EXP BIOL MED, V146, P809; VIGNAUX F, 1980, EUR J IMMUNOL, V10, P767, DOI 10.1002/eji.1830101008; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Wenner CA, 1996, J IMMUNOL, V156, P1442; Wykes M, 1998, J IMMUNOL, V161, P1313; YOSHIDA K, 1990, P NATL ACAD SCI USA, V87, P7829, DOI 10.1073/pnas.87.20.7829	44	728	795	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					461	470		10.1016/S1074-7613(01)00126-1	http://dx.doi.org/10.1016/S1074-7613(01)00126-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336691	Bronze			2022-12-18	WOS:000168246700013
J	Bird, JJ; Brown, DR; Mullen, AC; Moskowitz, NH; Mahowald, MA; Sider, JR; Gajewski, TF; Wang, CR; Reiner, SL				Bird, JJ; Brown, DR; Mullen, AC; Moskowitz, NH; Mahowald, MA; Sider, JR; Gajewski, TF; Wang, CR; Reiner, SL			Helper T cell differentiation is controlled by the cell cycle	IMMUNITY			English	Article							INTERFERON-GAMMA PRODUCTION; LEISHMANIA-MAJOR; INTERLEUKIN-4 PROMOTER; PHENOTYPE DEVELOPMENT; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; CHROMATIN STRUCTURE; GENE-EXPRESSION; IFN-GAMMA; IL-4	Helper T (Th) cell differentiation is highly regulated by cytokines but initiated by mitogens. By examining gene expression in discrete generations of dividing cells, we have delineated the relationship between proliferation and differentiation. Initial expression of IL-2 is cell cycle-independent, whereas effector cytokine expression is cell cycle-dependent. IFN gamma expression increases in frequency with successive cell cycles, while IL-4 expression requires three cell divisions. Cell cycle progression and cytokine signaling act in concert Po relieve epigenetic repression and can be supplanted by agents that hyperacetylate histones and demethylate DNA. Terminally differentiated cells exhibit stable epigenetic modification and cell cycle-independent gene expression. These data reveal a novel mechanism governing Th cell fate that initially integrates proliferative and differentiative signals and subsequently maintains stability of the differentiated state.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Reiner, SL (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	sreiner@midway.uchicago.edu		Mullen, Alan/0000-0002-4096-3106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370, R29AI040310] Funding Source: NIH RePORTER; NIAID NIH HHS [R29 AI040310, R29 AI040310-04, AI-42370] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; BARTON MC, 1994, GENE DEV, V8, P2453, DOI 10.1101/gad.8.20.2453; BERTON MT, 1990, J EXP MED, V172, P375, DOI 10.1084/jem.172.1.375; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Brown DR, 1997, J EXP MED, V186, P101, DOI 10.1084/jem.186.1.101; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; BURGER C, 1990, EUR J IMMUNOL, V20, P2285, DOI 10.1002/eji.1830201018; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; CORRY DB, 1994, J IMMUNOL, V153, P4142; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Guery JC, 1997, J IMMUNOL, V159, P2147; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HEINZEL FP, 1993, J IMMUNOL, V150, P3924; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huang H, 1997, J IMMUNOL, V159, P3731; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kang CJ, 1998, IMMUNITY, V8, P285, DOI 10.1016/S1074-7613(00)80534-8; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; KleinHessling S, 1996, P NATL ACAD SCI USA, V93, P15311, DOI 10.1073/pnas.93.26.15311; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Launois P, 1997, J IMMUNOL, V158, P3317; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; Lee WT, 1996, J IMMUNOL, V157, P5300; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LU P, 1994, J EXP MED, V180, P693, DOI 10.1084/jem.180.2.693; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; MELVIN AJ, 1995, EUR J IMMUNOL, V25, P426, DOI 10.1002/eji.1830250218; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOORE EC, 1969, CANCER RES, V29, P291; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schmitz J, 1989, Int Immunol, V1, P570, DOI 10.1093/intimm/1.6.570; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; SWAIN SL, 1988, J IMMUNOL, V141, P3445; THOMAS MD, 1995, MYCOLOGIA, V87, P87, DOI 10.2307/3760951; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; WEINTRAUB H, 1977, COLD SPRING HARB SYM, V42, P401, DOI 10.1101/SQB.1978.042.01.042; Weiss A, 1997, INT IMMUNOL, V9, P1347, DOI 10.1093/intimm/9.9.1347; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; YOUNG HA, 1994, J IMMUNOL, V153, P3603; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	77	725	741	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					229	237		10.1016/S1074-7613(00)80605-6	http://dx.doi.org/10.1016/S1074-7613(00)80605-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729043	Bronze			2022-12-18	WOS:000075610300009
J	Hammond, TR; Dufort, C; Dissing-Olesen, L; Giera, S; Young, A; Wysoker, A; Walker, AJ; Gergits, F; Segel, M; Nemesh, J; Marsh, SE; Saunders, A; Macosko, E; Ginhoux, F; Chen, JM; Franklin, RJM; Piao, XH; McCarroll, SA; Stevens, B				Hammond, Timothy R.; Dufort, Connor; Dissing-Olesen, Lasse; Giera, Stefanie; Young, Adam; Wysoker, Alec; Walker, Alec J.; Gergits, Frederick; Segel, Michael; Nemesh, James; Marsh, Samuel E.; Saunders, Arpiar; Macosko, Evan; Ginhoux, Florent; Chen, Jinmiao; Franklin, Robin J. M.; Piao, Xianhua; McCarroll, Steven A.; Stevens, Beth			Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes	IMMUNITY			English	Article							CHEMOKINE RECEPTORS; COMMON VARIANTS; ADULT MICROGLIA; DENDRITIC CELL; M2 MICROGLIA; ACTIVATION; MYELINOGENESIS; NEUROTOXICITY; MACROPHAGES; REGULATOR	Microglia, the resident immune cells of the brain, rapidly change states in response to their environment, but we lack molecular and functional signatures of different microglial populations. Here, we analyzed the RNA expression patterns of more than 76,000 individual microglia in mice during development, in old age, and after brain injury. Our analysis uncovered at least nine transcriptionally distinct microglial states, which expressed unique sets of genes and were localized in the brain using specific markers. The greatest microglial heterogeneity was found at young ages; however, several states-including chemokine-enriched inflammatory microglia-persisted throughout the lifespan or increased in the aged brain. Multiple reactive microglial subtypes were also found following demyelinating injury in mice, at least one of which was also found in human multiple sclerosis lesions. These distinct microglia signatures can be used to better understand microglia function and to identify and manipulate specific subpopulations in health and disease.	[Hammond, Timothy R.; Dufort, Connor; Dissing-Olesen, Lasse; Giera, Stefanie; Walker, Alec J.; Gergits, Frederick; Marsh, Samuel E.; Piao, Xianhua; Stevens, Beth] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Hammond, Timothy R.; Dissing-Olesen, Lasse; Giera, Stefanie; Walker, Alec J.; Marsh, Samuel E.; Piao, Xianhua; Stevens, Beth] Harvard Med Sch, Boston, MA 02115 USA; [Hammond, Timothy R.; Dissing-Olesen, Lasse; Wysoker, Alec; Walker, Alec J.; Nemesh, James; Marsh, Samuel E.; Saunders, Arpiar; Macosko, Evan; McCarroll, Steven A.; Stevens, Beth] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Stevens, Beth] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Saunders, Arpiar; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Young, Adam; Segel, Michael; Franklin, Robin J. M.] Univ Cambridge, Wellcome Trust Med Res Council, Cambridge Stem Cell Inst, Cambridge, England; [Giera, Stefanie; Piao, Xianhua] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA USA; [Ginhoux, Florent; Chen, Jinmiao] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Cambridge; Harvard University; Boston Children's Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Stevens, B (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Stevens, B (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Stevens, B (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; McCarroll, SA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu; beth.stevens@childrens.harvard.edu	Chen, Jinmiao/ABE-5601-2021; Macosko, Evan/X-4664-2019	Marsh, Samuel/0000-0002-3012-6945; Segel, Michael/0000-0001-8986-7417; Dufort, Connor/0000-0002-7477-5023; Franklin, Robin/0000-0001-6522-2104	Simons Foundation/SFARI [346197]; Silvio O. Conte Center (NIH) [P50MH112491]; Stanley Center for Psychiatric Research at the Broad Institute; Helen Hay Whitney Fellowship; Lundbeck Foundation International Postdoc Fellowships;  [3214]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH112491] Funding Source: NIH RePORTER	Simons Foundation/SFARI; Silvio O. Conte Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Center for Psychiatric Research at the Broad Institute; Helen Hay Whitney Fellowship; Lundbeck Foundation International Postdoc Fellowships; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Dr. Richard Ransohoff, Dr. Christina Usher, and Dr. Daisy Robinton for their critical feedback and insight while preparing the manuscript. We would like to thank Jon Hammond for developing the website and searchable dataset (www.microgliasinglecell.com).This work was funded by grants from the Simons Foundation/SFARI (#346197 to S.A.M. and B.S.), Rettsyndrome. org mentored fellowship training award (#3214 to T.R.H.), Silvio O. Conte Center (NIH #P50MH112491 to B.S. and S.A.M.), Stanley Center for Psychiatric Research at the Broad Institute (B.S. and S.A.M.), Helen Hay Whitney Fellowship (A.S.), and Lundbeck Foundation International Postdoc Fellowships (L.D.-O.).	Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; EON KL, 2016, IMMUNOL CELL BIOL, V94, P11, DOI DOI 10.1038/ICB.2015.48; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fuger P, 2017, NAT NEUROSCI, V20, P1371, DOI 10.1038/nn.4631; Furuichi K, 2008, J IMMUNOL, V181, P8670, DOI 10.4049/jimmunol.181.12.8670; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; HALL SM, 1972, J CELL SCI, V10, P535; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; Hanamsagar R, 2017, GLIA, V65, P1504, DOI 10.1002/glia.23176; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Politis M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00096; Poon HF, 2004, CLIN GERIATR MED, V20, P329, DOI 10.1016/j.cger.2004.02.005; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Szczucinski A, 2007, ACTA NEUROL SCAND, V115, P137, DOI 10.1111/j.1600-0404.2006.00749.x; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Wong K, 2017, NAT IMMUNOL, V18, P633, DOI 10.1038/ni.3743; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	66	724	728	13	157	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					253	+		10.1016/j.immuni.2018.11.004	http://dx.doi.org/10.1016/j.immuni.2018.11.004			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30471926	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000455661600024
J	Martin, F; Oliver, AM; Kearney, JF				Martin, F; Oliver, AM; Kearney, JF			Marginal zone and B1B cells unite in the early response against T-independent blood-borne particulate antigens	IMMUNITY			English	Article							ANTI-PHOSPHOCHOLINE ANTIBODIES; FACTOR-KAPPA-B; IMMUNE-RESPONSE; TYPE-2 ANTIGENS; POSITIVE SELECTION; TRANSGENIC MICE; INFLUENZA-VIRUS; ACTIVATION; B-1; LYMPHOCYTES	The rate of pathogen elimination determines the extent and consequences of an infection. In this context, the spleen with its highly specialized lymphoid compartments plays a central role in clearing blood-borne pathogens. Splenic marginal zone B cells (MZ), by virtue of their preactivated state and topographical location, join B1 B cells to generate a massive wave of IgM producing plasmablasts in the initial 3 days of a primary response to particulate bacterial antigens. Because of the intensity and rapidity of this response, combined with the types of antibodies produced, splenic MZ and B1 B cells endowed with a "natural memory" provide a bridge between the very early innate and the later appearing adaptive immune response.	Univ Alabama Birmingham, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kearney, JF (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.	john.kearney@ccc.uab.edu	Kearney, John/GOV-3123-2022		NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014782, R21AI014782, T32AI007051] Funding Source: NIH RePORTER; NCI NIH HHS [CA13148] Funding Source: Medline; NIAID NIH HHS [T32 AI007051, R01 AI014782, AI07051, AI14782] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMLOT PL, 1985, LANCET, V1, P1008, DOI 10.1016/S0140-6736(85)91613-7; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Buiting AMJ, 1996, SCAND J IMMUNOL, V43, P398, DOI 10.1046/j.1365-3083.1996.d01-54.x; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; CLAFLIN JL, 1974, J EXP MED, V139, P58, DOI 10.1084/jem.139.1.58; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fagarasan S, 2000, IMMUNOL REV, V176, P205; FEENEY AJ, 1991, J IMMUNOL, V147, P4343; GEARHART PJ, 1977, J EXP MED, V145, P876, DOI 10.1084/jem.145.4.876; GRAY D, 1985, ADV EXP MED BIOL, V186, P437; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hayakawa K, 1997, ANN NY ACAD SCI, V815, P15, DOI 10.1111/j.1749-6632.1997.tb52041.x; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; HUMPHREY JH, 1981, EUR J IMMUNOL, V11, P221, DOI 10.1002/eji.1830110311; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kenny JJ, 2000, INT IMMUNOL, V12, P873, DOI 10.1093/intimm/12.6.873; Kouskoff V, 2000, SCIENCE, V287, P2501, DOI 10.1126/science.287.5462.2501; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Li XL, 2001, J IMMUNOL, V166, P3122, DOI 10.4049/jimmunol.166.5.3122; Linton P J, 1992, Semin Immunol, V4, P3; LINTON PJ, 1992, EUR J IMMUNOL, V22, P1293, DOI 10.1002/eji.1830220526; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 1997, INT IMMUNOL, V9, P493, DOI 10.1093/intimm/9.4.493; Martin F, 1998, J IMMUNOL, V160, P3748; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; MCDANIEL LS, 1984, J IMMUNOL, V133, P3308; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; Ochsenbein AF, 2000, J IMMUNOL, V164, P6296, DOI 10.4049/jimmunol.164.12.6296; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; SIGAL NH, 1975, J IMMUNOL, V114, P1354; Stall A M, 1996, Semin Immunol, V8, P45, DOI 10.1006/smim.1996.0007; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; Tanguay DA, 1999, J EXP MED, V189, P1685, DOI 10.1084/jem.189.11.1685; VANDENEERTWEGH AJM, 1992, EUR J IMMUNOL, V22, P719, DOI 10.1002/eji.1830220315; VANDENEERTWEGH AJM, 1993, ADV EXP MED BIOL, V329, P345; Vos Q, 2000, IMMUNOL REV, V176, P154; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	58	724	747	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					617	629		10.1016/S1074-7613(01)00129-7	http://dx.doi.org/10.1016/S1074-7613(01)00129-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371363	Bronze			2022-12-18	WOS:000168880900013
J	Degli-Esposti, MA; Dougall, WC; Smolak, PJ; Waugh, JY; Smith, CA; Goodwin, RG				Degli-Esposti, MA; Dougall, WC; Smolak, PJ; Waugh, JY; Smith, CA; Goodwin, RG			The novel receptor TRAIL-R4 induces NF-kappa B and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain	IMMUNITY			English	Article							SIGNALS CELL-DEATH; TNF RECEPTOR; ACTIVATION; ANTIGEN; FAMILY	A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has been cloned and characterized. TRAIL-R4 encodes a 386-amino acid protein with an extracellular domain showing 58%-70% identity to those of TRAIL-Ri, TRAIL-R2, and TRAIL-R3. The signaling capacity of TRAIL-R4 is similar to that of TRAIL-Ri and TRAIL-R2 with respect to NF-KB activation, but differs in its inability to induce apoptosis. Yet TRAIL-R4 retains a C-terminal element containing one third of a consensus death domain motif. Transient overexpression of TRAIL-R4 in cells normally sensitive to TRAIL-mediated killing confers complete protection, suggesting that one function of TRAIL-R4 may be inhibition of TRAIL cytotoxicity. Like TRAIL-Ri and TRAIL-RP, this receptor shows widespread tissue expression. The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.	Immunex Res & Dev Corp, Dept Biochem, Seattle, WA 98101 USA; Immunex Res & Dev Corp, Dept Mol Biol, Seattle, WA 98101 USA		Degli-Esposti, MA (corresponding author), Immunex Res & Dev Corp, Dept Biochem, 51 Univ St, Seattle, WA 98101 USA.		Degli-Esposti, Mariapia/H-9073-2014; Degli-Esposti, Mariapia/E-9529-2013	Dougall, William/0000-0001-9487-251X				Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1993, J BIOL CHEM, V268, P10932; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sambrook J, 1989, MOL CLONING LAB MANU; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5	22	722	767	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					813	820		10.1016/S1074-7613(00)80399-4	http://dx.doi.org/10.1016/S1074-7613(00)80399-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430226	Bronze			2022-12-18	WOS:000071351300008
J	Shaffer, AL; Shapiro-Shelef, M; Iwakoshi, NN; Lee, AH; Qian, SB; Zhao, H; Yu, X; Yang, LM; Tan, BK; Rosenwald, A; Hurt, EM; Petroulakis, E; Sonenberg, N; Yewdell, JW; Calame, K; Glimcher, LH; Staudt, LM				Shaffer, AL; Shapiro-Shelef, M; Iwakoshi, NN; Lee, AH; Qian, SB; Zhao, H; Yu, X; Yang, LM; Tan, BK; Rosenwald, A; Hurt, EM; Petroulakis, E; Sonenberg, N; Yewdell, JW; Calame, K; Glimcher, LH; Staudt, LM			XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation	IMMUNITY			English	Article							2 MESSENGER-RNAS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; GENE-EXPRESSION; B-CELLS; TRANSMEMBRANE PROTEIN; STRESS; REPRESSION; ATF6; INDUCTION	The differentiation of B cells into immunoglobulin-secreting plasma cells is controlled by two transcription factors, Blimp-1 and XBP1. By gene expression profiling, we defined a set of genes whose induction during mouse plasmacytic differentiation is dependent on Blimp-1 and/or XBP1. Blimp-1-deficient B cells failed to upregulate most plasma cell-specific genes, including xbp1. Differentiating xbp1-deficient B cells induced Blimp-1 normally but failed to upregulate genes encoding many secretory pathway components. Conversely, ectopic expression of XBP1 induced a wide spectrum of secretory pathway genes and physically expanded the endoplasmic reticulum. In addition, XBP1 increased cell size, lysosome content, mitochondrial mass and function, ribosome numbers, and total protein synthesis. Thus, XBP1 coordinates diverse changes in cellular structure and function resulting in the characteristic phenotype of professional secretory cells.	NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Biophys Cellular & Mol Studies, New York, NY 10032 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); McGill University	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Shelef, Miriam/0000-0002-8842-0303	NIAID NIH HHS [AI50659, AI43576, AI32412] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC004024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000653, R01AI050659, R01AI043576, R01AI032412] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Anderson P, 2000, NEW LEFT REV, P5; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; BENJAMIN D, 1984, P NATL ACAD SCI-BIOL, V81, P3547, DOI 10.1073/pnas.81.11.3547; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; DENG YP, 1995, J HISTOCHEM CYTOCHEM, V43, P907, DOI 10.1177/43.9.7543914; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; KLINTWORTH GK, 1979, ARCH PATHOL LAB MED, V103, P297; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LAFRENZ D, 1982, J IMMUNOL, V129, P1329; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Ma YJ, 2003, NAT IMMUNOL, V4, P310, DOI 10.1038/ni0403-310; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Mori K, 1998, J BIOL CHEM, V273, P9912, DOI 10.1074/jbc.273.16.9912; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Poot M, 1999, CYTOMETRY, V35, P311, DOI 10.1002/(SICI)1097-0320(19990401)35:4<311::AID-CYTO3>3.3.CO;2-5; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; RIGHT G, 2003, P NATL ACAD SCI USA, V100, P9991; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Singh M, 1996, P NATL ACAD SCI USA, V93, P4392, DOI 10.1073/pnas.93.9.4392; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; TERASAKI M, 1984, CELL, V38, P101, DOI 10.1016/0092-8674(84)90530-0; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	70	720	753	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					81	93		10.1016/j.immuni.2004.06.010	http://dx.doi.org/10.1016/j.immuni.2004.06.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345222	Bronze, Green Published			2022-12-18	WOS:000222975500010
J	Valladeau, J; Ravel, O; Dezutter-Dambuyant, C; Moore, K; Kleijmeer, M; Liu, Y; Duvert-Frances, V; Vincent, C; Schmitt, D; Davoust, J; Caux, C; Lebecque, S; Saeland, S				Valladeau, J; Ravel, O; Dezutter-Dambuyant, C; Moore, K; Kleijmeer, M; Liu, Y; Duvert-Frances, V; Vincent, C; Schmitt, D; Davoust, J; Caux, C; Lebecque, S; Saeland, S			Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules	IMMUNITY			English	Article							HUMAN ASIALOGLYCOPROTEIN RECEPTOR; DENDRITIC CELLS; B-CELLS; MOLECULAR-CLONING; MANNOSE RECEPTOR; ANTIGEN; EXPRESSION; CDNA; DOMAINS; ALPHA	We have identified a type II Ca2+-dependent lectin displaying mannose-binding specificity, exclusively expressed by Langerhans cells (LC), and named Langerin. LC are uniquely characterized by Birbeck granules (BG), which are organelles consisting of superimposed and zippered membranes. Here, we have shown that Langerin is constitutively associated with BG and that antibody to Langerin is internalized into these structures. Remarkably, transfection of Langerin cDNA into fibroblasts created a compact network of membrane structures with typical features of BG. Langerin is thus a potent inducer of membrane superimposition and zippering leading to BG formation. Our data suggest that induction of BG is a consequence of the antigen-capture function of Langerin, allowing routing into these organelles and providing access to a nonclassical antigen-processing pathway.	Schering Plough, Lab Immunol Res, F-69571 Dardilly, France; Ctr Hosp Edouard Herriot, INSERM, U346, F-69437 Lyon, France; DNAX Res Inst, Palo Alto, CA 94304 USA; Univ Utrecht, Sch Med, NL-3584 CX Utrecht, Netherlands; Biomembrane Inst, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Baylor Inst Immunol Res, Dallas, TX 75246 USA	Merck & Company; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Utrecht University; Baylor Scott & White Health	Saeland, S (corresponding author), Schering Plough, Lab Immunol Res, F-69571 Dardilly, France.		valladeau, jenny/G-4404-2013; dezutter-dambuyant, colette/F-5962-2013	dezutter-dambuyant, colette/0000-0002-3866-4537; Davoust, Jean/0000-0002-3098-7665; lebecque, serge/0000-0003-4006-8061; Caux, Christophe/0000-0003-2438-833X				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; ANDERSSON L, 1988, LANGERHANS CELL, P185; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARTOSIK J, 1992, J INVEST DERMATOL, V99, P53, DOI 10.1111/1523-1747.ep12611845; BARTOSIK J, 1985, ACTA DERM-VENEREOL, V65, P157; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; BEZOUSKA K, 1991, J BIOL CHEM, V266, P11604; BIEBER T, 1992, RES IMMUNOL, V143, P445, DOI 10.1016/S0923-2494(05)80082-3; BIRBECK MS, 1961, J INVEST DERMATOL, V37, P51, DOI 10.1038/jid.1961.80; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; de la Salle H, 1997, Int Rev Immunol, V16, P187, DOI 10.3109/08830189709045708; DESAINT VB, 1998, IMMUNITY, V9, P326; Hall A, 1993, CURR OPIN CELL BIOL, V5, P265, DOI 10.1016/0955-0674(93)90114-6; HANAU D, 1987, P NATL ACAD SCI USA, V84, P2901, DOI 10.1073/pnas.84.9.2901; HANAU D, 1989, J INVEST DERMATOL, V92, P689, DOI 10.1111/1523-1747.ep12696879; HASHIMOTO K, 1968, ARCH DERMATOL, V97, P450, DOI 10.1001/archderm.97.4.450; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; HOYLE GW, 1988, J BIOL CHEM, V263, P7487; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KANERVA L, 1989, ACTA DERM-VENEREOL, V69, P407; KASHIHARA M, 1986, J INVEST DERMATOL, V87, P602, DOI 10.1111/1523-1747.ep12455849; KOLDE G, 1987, J INVEST DERMATOL, V89, P19, DOI 10.1111/1523-1747.ep12580290; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; MIKULOWSKA A, 1988, ACTA DERM-VENEREOL, V68, P254; Mommaas AM, 1999, EUR J IMMUNOL, V29, P571, DOI 10.1002/(SICI)1521-4141(199902)29:02<571::AID-IMMU571>3.0.CO;2-E; NAIR S, 1992, J EXP MED, V175, P609, DOI 10.1084/jem.175.2.609; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Poggi A, 1997, EUR J IMMUNOL, V27, P2965, DOI 10.1002/eji.1830271132; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; ROMANI N, 1989, J INVEST DERMATOL, V93, P600, DOI 10.1111/1523-1747.ep12319727; Rovere P, 1998, P NATL ACAD SCI USA, V95, P1067, DOI 10.1073/pnas.95.3.1067; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; SPIESS M, 1985, J BIOL CHEM, V260, P1979; STAHL PD, 1992, CURR OPIN IMMUNOL, V4, P49, DOI 10.1016/0952-7915(92)90123-V; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Suzuki N, 1996, J IMMUNOL, V156, P128; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAKIGAWA M, 1985, J INVEST DERMATOL, V85, P12, DOI 10.1111/1523-1747.ep12274494; TYNDALL C, 1981, NUCL ACIDS, V9, P5231; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.3.CO;2-H; VANKOOTEN C, 1994, EUR J IMMUNOL, V24, P787, DOI 10.1002/eji.1830240402; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WOLFF K, 1967, J CELL BIOL, V35, P468, DOI 10.1083/jcb.35.2.468; ZELICKSO.AS, 1966, J INVEST DERMATOL, V47, P498, DOI 10.1038/jid.1966.176	54	718	757	1	33	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					71	81		10.1016/S1074-7613(00)80160-0	http://dx.doi.org/10.1016/S1074-7613(00)80160-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661407	Bronze			2022-12-18	WOS:000085011900008
J	Trinchieri, G; Pflanz, S; Kastelein, RA				Trinchieri, G; Pflanz, S; Kastelein, RA			The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses	IMMUNITY			English	Review							MICE; INTERLEUKIN-12; RECEPTOR; IL-23; P19; RESISTANCE; INFECTION; DISTINCT; IMMUNITY; FORM	Originally the only known heterodimeric cytokine, IL-12 is now part of a family of five cytokines and shares important functions in the regulation of both innate and adaptive immunity with two of them, IL-23 and IL-27. Although initially these three cytokines were considered to have largely overlapping immunological functions, more recent studies, including two articles in this issue of Immunity (Hamano et al., 2003; Villarino et al., 2003), indicate that they mediate complex and well-differentiated functions.	Schering Plough Corp, Res Inst, Lab Immunol Res, F-69571 Dardilly, France; DNAX Res Inst Mol & Cellular Biol Inc, Dept Discovery Biol, Palo Alto, CA 94304 USA	Merck & Company; Schering Plough Corporation; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Trinchieri, G (corresponding author), Schering Plough Corp, Res Inst, Lab Immunol Res, F-69571 Dardilly, France.		Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Broberg EK, 2002, J INTERF CYTOK RES, V22, P641, DOI 10.1089/10799900260100123; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Lelievre E, 2001, J BIOL CHEM, V276, P22476, DOI 10.1074/jbc.M101681200; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; PFLANZ S, 2003, IMMUNITY, V3, P133; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153	18	715	773	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					641	644		10.1016/S1074-7613(03)00296-6	http://dx.doi.org/10.1016/S1074-7613(03)00296-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614851	Bronze			2022-12-18	WOS:000186672200004
J	O'Shea, JJ; Plenge, R				O'Shea, John J.; Plenge, Robert			JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease	IMMUNITY			English	Review							GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; ACTIVE RHEUMATOID-ARTHRITIS; INHIBITOR TOFACITINIB CP-690,550; TRANSCRIPTION FACTOR; INADEQUATE RESPONSE; MITOCHONDRIAL STAT3; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; SH2 DOMAIN	The discovery of the Janus kinase (JAK)-signal transducer and activator of transcripton (STAT) signaling pathway, a landmark in cell biology, provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins. As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technology that permits genome-wide views. As we celebrate the 20th anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease. Not only have genome-wide association studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.	[O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Plenge, Robert] Brigham & Womens Hosp, Div Genet, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Plenge, Robert] Broad Inst & Harvard, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov			Pfizer; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041106] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	J.J.O'S. and National Institutes of Health (NIH) hold patents related to targeting JAKs as targets for immunomodulatory agents and have a Collaborative Research Agreement and Development Award with Pfizer.	Alloza I., 2011, GENES IMMUN IN PRESS; Bowes J, 2011, ANN RHEUM DIS, V70, P1641, DOI 10.1136/ard.2011.150102; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fridman JS, 2010, J IMMUNOL, V184, P5298, DOI 10.4049/jimmunol.0902819; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin TH, 2010, ARTHRITIS RHEUM-US, V62, P2283, DOI 10.1002/art.27536; Lu LD, 2011, J IMMUNOL, V187, P3840, DOI 10.4049/jimmunol.1101228; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mandal PK, 2011, J MED CHEM, V54, P3549, DOI 10.1021/jm2000882; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nelson EA, 2011, ONCOTARGET, V2, P518; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Plenge R, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-212; Potla R, 2006, MOL CELL BIOL, V26, P8562, DOI 10.1128/MCB.00497-06; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sewgobind VDKD, 2010, AM J TRANSPLANT, V10, P1785, DOI 10.1111/j.1600-6143.2010.03200.x; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Stump KL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3329; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tanaka Y, 2011, ARTHRIT CARE RES, V63, P1150, DOI 10.1002/acr.20494; Timofeeva OA, 2007, ACS CHEM BIOL, V2, P799, DOI 10.1021/cb700186x; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	109	714	776	8	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					542	550		10.1016/j.immuni.2012.03.014	http://dx.doi.org/10.1016/j.immuni.2012.03.014			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520847	Green Accepted, Bronze			2022-12-18	WOS:000303223900004
J	Murphy, JM; Czabotar, PE; Hildebrand, JM; Lucet, IS; Zhang, JG; Alvarez-Diaz, S; Lewis, R; Lalaoui, N; Metcalf, D; Webb, AI; Young, SN; Varghese, LN; Tannahill, GM; Hatchell, EC; Majewski, IJ; Okamoto, T; Dobson, RCJ; Hilton, DJ; Babon, JJ; Nicola, NA; Strasser, A; Silke, J; Alexander, WS				Murphy, James M.; Czabotar, Peter E.; Hildebrand, Joanne M.; Lucet, Isabelle S.; Zhang, Jian-Guo; Alvarez-Diaz, Silvia; Lewis, Rowena; Lalaoui, Najoua; Metcalf, Donald; Webb, Andrew I.; Young, Samuel N.; Varghese, Leila N.; Tannahill, Gillian M.; Hatchell, Esme C.; Majewski, Ian J.; Okamoto, Toru; Dobson, Renwick C. J.; Hilton, Douglas J.; Babon, Jeffrey J.; Nicola, Nicos A.; Strasser, Andreas; Silke, John; Alexander, Warren S.			The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism	IMMUNITY			English	Article							MIXED LINEAGE KINASE; PROTEIN-KINASE; DOMAIN-LIKE; NECROSIS; TNF; CELL; IDENTIFICATION; DOWNSTREAM; ACTIVATION; FEATURES	Mixed lineage kinase domain-like (MLKL) is a component of the "necrosome," the multiprotein complex that triggers tumor necrosis factor (TNF)-induced cell death by necroptosis. To define the specific role and molecular mechanism of MLKL action, we generated MLKL-deficient mice and solved the crystal structure of MLKL. Although MLKL-deficient mice were viable and displayed no hematopoietic anomalies or other obvious pathology, cells derived from these animals were resistant to TNF-induced necroptosis unless MLKL expression was restored. Structurally, MLKL comprises a four-helical bundle tethered to the pseudokinase domain, which contains an unusual pseudoactive site. Although the pseudokinase domain binds ATP, it is catalytically inactive and its essential nonenzymatic role in necroptotic signaling is induced by receptor-interacting serine-threonine kinase 3 (RIPK3)-mediated phosphorylation. Structure-guided mutation of the MLKL pseudoactive site resulted in constitutive, RIPK3-independent necroptosis, demonstrating that modification of MLKL is essential for propagation of the necroptosis pathway downstream of RIPK3.	[Murphy, James M.; Czabotar, Peter E.; Hildebrand, Joanne M.; Zhang, Jian-Guo; Alvarez-Diaz, Silvia; Lewis, Rowena; Lalaoui, Najoua; Metcalf, Donald; Webb, Andrew I.; Young, Samuel N.; Varghese, Leila N.; Tannahill, Gillian M.; Hatchell, Esme C.; Majewski, Ian J.; Okamoto, Toru; Hilton, Douglas J.; Babon, Jeffrey J.; Nicola, Nicos A.; Strasser, Andreas; Silke, John; Alexander, Warren S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Murphy, James M.; Czabotar, Peter E.; Hildebrand, Joanne M.; Zhang, Jian-Guo; Alvarez-Diaz, Silvia; Lewis, Rowena; Lalaoui, Najoua; Metcalf, Donald; Webb, Andrew I.; Young, Samuel N.; Varghese, Leila N.; Tannahill, Gillian M.; Hatchell, Esme C.; Majewski, Ian J.; Okamoto, Toru; Hilton, Douglas J.; Babon, Jeffrey J.; Nicola, Nicos A.; Strasser, Andreas; Silke, John; Alexander, Warren S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Lucet, Isabelle S.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Monash University; University of Canterbury; University of Melbourne	Murphy, JM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	jamesm@wehi.edu.au	Alvarez-Diaz, Silvia/P-4948-2018; Strasser, Andreas/C-7581-2013; babon, jeffrey j/B-9170-2013; Hilton, Douglas J/C-7250-2013; Dobson, Renwick/AAZ-7020-2021; Murphy, James/B-4863-2017; Silke, John/B-7622-2008; Lalaoui, Najoua/C-1410-2014; Nicola, Nicos/D-2989-2011	Alvarez-Diaz, Silvia/0000-0002-8897-1893; Strasser, Andreas/0000-0002-5020-4891; babon, jeffrey j/0000-0002-5408-6239; Hilton, Douglas J/0000-0002-7698-2392; Dobson, Renwick/0000-0002-5506-4939; Murphy, James/0000-0003-0195-3949; Silke, John/0000-0002-7611-5774; Lalaoui, Najoua/0000-0002-0165-3324; Varghese, Leila/0000-0003-2476-0306; Majewski, Ian/0000-0002-6087-635X; Nicola, Nicos/0000-0003-1054-7889; Czabotar, Peter/0000-0002-2594-496X; Hildebrand, Joanne/0000-0002-1456-2042	NHMRC [1016647, 461221, 1016701, 637342, 1025594, 1046984]; ARC; Cancer Council Victoria fellowship; Leukaemia Foundation; Australian Stem Cell Centre; Australian Cancer Research Fund; Victorian State Government Operational Infrastructure Support; NHMRC IRIISS [361646]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Cancer Council Victoria fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation; Australian Stem Cell Centre; Australian Cancer Research Fund; Victorian State Government Operational Infrastructure Support; NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	We thank staff in the WEHI Bioservices facility, V. Dixit for Ripk3<SUP>-/-</SUP> mice, J. Rickard for generating Ripk3<SUP>-/-</SUP> MDFs, P. Colman and D. Huang for discussions, MX and SAXS beamline staff at the Australian Synchrotron, the Monash University Protein Production Unit for access to the Corbett RT-PCR instrument, and J. Corbin, L. DiRago, C. Hyland, S. Mifsud, D. Stockwell, and T. Willson for technical assistance. This work was supported by NHMRC grants (1016647, 461221, 1016701, 637342, 1025594, 1046984) and fellowships to J. M. H., I. J. M., D. J. H., N.A.N., A. S., J. S., and W. S. A.; ARC fellowships to J. M. M., P. E. C., T.O., and J. J. B.; a Cancer Council Victoria fellowship to D. M.; Leukaemia Foundation and Australian Stem Cell Centre scholarships to L.N.V.; and additional support from the Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support, and NHMRC IRIISS grant (361646).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyers PA, 2013, BIOCHEM SOC T, V41, P969, DOI 10.1042/BST20130115; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jaleel M, 2006, BIOCHEMISTRY-US, V45, P1888, DOI 10.1021/bi052089x; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lucet IS, 2013, BIOCHEM SOC T, V41, P975, DOI 10.1042/BST20130075; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	41	709	732	2	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					443	453		10.1016/j.immuni.2013.06.018	http://dx.doi.org/10.1016/j.immuni.2013.06.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24012422	Bronze			2022-12-18	WOS:000330949600009
J	Lezzi, G; Karjalainen, K; Lanzavecchia, A				Lezzi, G; Karjalainen, K; Lanzavecchia, A			The duration of antigenic stimulation determines the fate of naive and effector T cells	IMMUNITY			English	Article							IMMUNOLOGICAL MEMORY; INTERLEUKIN-2 GENE; PROTEIN-KINASE; ACTIVATION; RECEPTOR; COSTIMULATION; EXPRESSION; SIGNALS; LIGAND; SYSTEM	It is known that T cells engage antigen-presenting cells (APCs) in a stable interaction that results in sustained TCR signaling. We show here that the duration of this process is critical in determining whether T cells will be activated or deleted. Whereas naive T cells require approximately 20 hr of sustained signaling to be committed to proliferation, effector T cells become committed after only 1 hr but die following activation if antigenic stimulation is prolonged. Costimulation by anti-CD28 facilitates T cell activation by decreasing the time of commitment and by protecting T cells from death. These findings explain in quantitative terms the essential requirement for professional APCs in T cell priming and show that the duration of antigenic stimulation is the major factor determining the fate of naive and effector T cells.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Lanzavecchia, A (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.		Karjalainen, Klaus/A-2206-2011	Iezzi, Giandomenica/0000-0001-5841-495X				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; CROFT M, 1994, J IMMUNOL, V152, P2675; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; Dubey C, 1996, J IMMUNOL, V157, P3280; Ericsson PO, 1996, J IMMUNOL, V156, P2045; GLIMCHER LH, 1982, J EXP MED, V155, P445, DOI 10.1084/jem.155.2.445; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HORGAN KJ, 1990, EUR J IMMUNOL, V20, P1111, DOI 10.1002/eji.1830200525; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MALISSEN B, 1986, P NATL ACAD SCI USA, V83, P3958, DOI 10.1073/pnas.83.11.3958; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; ROBINSON AT, 1993, EUR J IMMUNOL, V23, P61, DOI 10.1002/eji.1830230111; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; SOLDAINI E, 1995, J BIOL CHEM, V270, P10733, DOI 10.1074/jbc.270.18.10733; Sprent J, 1997, CURR OPIN IMMUNOL, V9, P371, DOI 10.1016/S0952-7915(97)80084-2; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WALLNY HJ, 1995, EUR J IMMUNOL, V25, P1262, DOI 10.1002/eji.1830250520; WEISS A, 1987, J IMMUNOL, V138, P2169; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	40	706	724	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					89	95		10.1016/S1074-7613(00)80461-6	http://dx.doi.org/10.1016/S1074-7613(00)80461-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462514	Bronze			2022-12-18	WOS:000071765700009
J	Randolph, GJ; Inaba, K; Robbiani, DF; Steinman, RM; Muller, WA				Randolph, GJ; Inaba, K; Robbiani, DF; Steinman, RM; Muller, WA			Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo	IMMUNITY			English	Article							MONOCLONAL-ANTIBODY; LANGERHANS CELLS; MACROPHAGE DIFFERENTIATION; DRAINING LYMPH; OP/OP MOUSE; HUMAN BLOOD; IN-VIVO; ANTIGEN; MODEL; RAT	We investigated the differentiation and trafficking of inflammatory monocytes that phagocytosed subcutaneously injected fluorescent microspheres. As expected, most of the monocytes became microsphere(+) macrophages, which remained in subcutaneous tissue. However, about 25% of latex(+) cells migrated to the T cell area of draining lymph nodes, where they expressed dendritic cell (DC)-restricted markers and high levels of costimulatory molecules. Microsphere-transporting cells were distinct from resident skin DCs, and this transport was reduced by more than 85% in monocyte-deficient osteopetrotic mice. Thus, a substantial minority of inflammatory monocytes carry phagocytosed particles to lymph nodes and differentiate into DCs.	Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; Kyoto Univ, Dept Anim Dev & Physiol, Immunobiol Lab, Kyoto 6068502, Japan	Cornell University; Rockefeller University; Kyoto University	Randolph, GJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA.		Steinman, Ralph/F-7729-2012; Robbiani, Davide F./AAF-7662-2019	Robbiani, Davide F./0000-0001-7379-3484	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046849, F32HL009722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013013, R37AI013013] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL09722, HL 46849] Funding Source: Medline; NIAID NIH HHS [AI 13013] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; BREEL M, 1987, EUR J IMMUNOL, V17, P1555, DOI 10.1002/eji.1830171105; CHANG MDY, 1995, CELL IMMUNOL, V162, P146, DOI 10.1006/cimm.1995.1062; COHEN S, 1966, LAB INVEST, V15, P1143; CORRY D, 1984, AM J PATHOL, V115, P321; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HARDONK MJ, 1986, VIRCHOWS ARCH B, V51, P429, DOI 10.1007/BF02899050; HARMSEN AG, 1985, SCIENCE, V230, P1277, DOI 10.1126/science.4071052; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Ortner U, 1996, J IMMUNOL METHODS, V193, P71, DOI 10.1016/0022-1759(96)00058-0; Randolph GJ, 1996, J EXP MED, V183, P451, DOI 10.1084/jem.183.2.451; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Raychaudhuri S, 1998, NAT BIOTECHNOL, V16, P1025, DOI 10.1038/3469; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; ROSEN H, 1990, EUR J IMMUNOL, V20, P1251, DOI 10.1002/eji.1830200609; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sato K, 1998, J IMMUNOL, V161, P6835; Shortman K, 1997, STEM CELLS, V15, P409, DOI 10.1002/stem.150409; SMITH JB, 1970, J ANAT, V107, P87; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; TILNEY NL, 1971, J ANAT, V109, P369; VANFURTH R, 1988, INFLAMMATION BASIC P, P281; Weinlich G, 1998, J INVEST DERMATOL, V110, P441, DOI 10.1046/j.1523-1747.1998.00161.x; WIKTORJEDRZEJCZAK W, 1992, EUR J IMMUNOL, V22, P1951, DOI 10.1002/eji.1830220743; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; YAMASHITA A, 1978, TRANSPLANTATION, V26, P56, DOI 10.1097/00007890-197807010-00013; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	41	705	726	0	35	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					753	761		10.1016/S1074-7613(00)80149-1	http://dx.doi.org/10.1016/S1074-7613(00)80149-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626897	Green Published, Bronze			2022-12-18	WOS:000084612900011
J	Dubois, S; Mariner, J; Waldmann, TA; Tagaya, Y				Dubois, S; Mariner, J; Waldmann, TA; Tagaya, Y			IL-15R alpha recycles and presents IL-15 in trans to neighboring cells	IMMUNITY			English	Article							RECEPTOR-ALPHA-CHAIN; NATURAL-KILLER; BETA-CHAIN; T-CELLS; BINDING; IDENTIFICATION; LOCALIZATION; TRAFFICKING; HOMEOSTASIS; ENDOCYTOSIS	We report intriguing aspects of the contribution of IL-15Ralpha to IL-15 functions. Consistent with high-affinity interactions between IL-15 and IL-1513, these two molecules form stable complexes on the cell surface of activated monocytes. The formation of IL-15/IL-15Ralpha complexes on cell surfaces induces a transendosomal recycling of IL-15 leading to the persistence of surface-bound IL-15 due to the constant reappearance of IL-15 on plasma membranes. This complex contributes to the long survival of T cells expressing IL-15Ra after IL-15 withdrawal. Finally, these complexes on activated monocytes present IL-15 in trans to target cells such as CD8+ T cells that express only IL-2/15Rbeta and gammac upon cell-cell interaction.	NCI, Metab Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tagaya, Y (corresponding author), NCI, Metab Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA.	ytagaya@helix.nih.gov	Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Dubois, Sigrid/0000-0002-4543-5222				ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Azimi N, 2001, P NATL ACAD SCI USA, V98, P14559, DOI 10.1073/pnas.251540598; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Fallon EM, 2000, J BIOL CHEM, V275, P6790, DOI 10.1074/jbc.275.10.6790; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRANT AJ, 1992, P NATL ACAD SCI USA, V89, P2165, DOI 10.1073/pnas.89.6.2165; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P519, DOI 10.1016/0955-0674(95)80008-5; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Johnson E W, 1996, J Back Musculoskelet Rehabil, V7, P3, DOI 10.3233/BMR-1996-7102; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Musso T, 1999, BLOOD, V93, P3531; Neely GG, 2001, J IMMUNOL, V167, P5011, DOI 10.4049/jimmunol.167.9.5011; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Pereno R, 1999, ANN NY ACAD SCI, V876, P236, DOI 10.1111/j.1749-6632.1999.tb07644.x; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; [No title captured]	34	703	742	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2002	17	5					537	547		10.1016/S1074-7613(02)00429-6	http://dx.doi.org/10.1016/S1074-7613(02)00429-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433361	Bronze			2022-12-18	WOS:000179335100001
J	Sena, LA; Li, S; Jairaman, A; Prakriya, M; Ezponda, T; Hildeman, DA; Wang, CR; Schumacker, PT; Licht, JD; Perlman, H; Bryce, PJ; Chandel, NS				Sena, Laura A.; Li, Sha; Jairaman, Amit; Prakriya, Murali; Ezponda, Teresa; Hildeman, David A.; Wang, Chyung-Ru; Schumacker, Paul T.; Licht, Jonathan D.; Perlman, Harris; Bryce, Paul J.; Chandel, Navdeep S.			Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling	IMMUNITY			English	Article							AEROBIC GLYCOLYSIS; COMPLEX-III; LYMPHOCYTE ACTIVATION; GLUCOSE-METABOLISM; IMMUNE-RESPONSES; GLUTAMINE UPTAKE; SUPEROXIDE; PROLIFERATION; TRANSDUCTION; PROTEIN	It is widely appreciated that T cells increase glycolytic flux during activation, but the role of mitochondrial flux is unclear. Here, we have shown that mitochondrial metabolism in the absence of glucose metabolism is sufficient to support interleukin-2 (IL-2) induction. Furthermore, we used mice with reduced mitochondrial reactive oxygen species (mROS) production in T cells (T-Uqcrfs(-/-) mice) to show that mitochondria are required for T cell activation to produce mROS for activation of nuclear factor of activated T cells (NFAT) and subsequent IL-2 induction. These mice could not induce antigen-specific expansion of T cells in vivo, but Uqcrfs1(-/-) T cells retained the ability to proliferate in vivo under lymphopenic conditions. This suggests that Uqcrfs1(-/-) T cells were not lacking bioenergetically but rather lacked specific ROS-dependent signaling events needed for antigen-specific expansion. Thus, mitochondrial metabolism is a critical component of T cell activation through the production of complex III ROS.	[Sena, Laura A.; Ezponda, Teresa; Licht, Jonathan D.; Perlman, Harris; Bryce, Paul J.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Li, Sha; Wang, Chyung-Ru] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Jairaman, Amit; Prakriya, Murali] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Hildeman, David A.] Univ Cincinnati, Coll Med, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA; [Hildeman, David A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	nav@northwestern.edu	Licht, Jonathan/L-4239-2019; Ezponda, Teresa/AAA-5040-2020; Hildeman, David/I-4884-2015; Licht, Jonathan/AAL-9184-2020; Hildeman, David/AAA-1757-2020	Ezponda, Teresa/0000-0003-3682-7125; Hildeman, David/0000-0002-0421-8483; Licht, Jonathan/0000-0002-3942-1369; Hildeman, David/0000-0002-0421-8483; Prakriya, Murali/0000-0003-0781-4480; Schumacker, Paul T/0000-0001-9591-2034	National Institute of Health [F30ES019815, T32-HL76139, 5P01HL071643, R01-AI076456, NS047599, R01-AI057753, R01-AI040310, RR025355, HL35440, AR050250, AR054796, AI092490, HL108795]; Northwestern University, Feinberg School of Medicine; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035440, T32HL076139, P01HL071643, P01HL108795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040310, R21AI092490, R01AI057753, R01AI076456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054796, R01AR050250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES019815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599, R56NS047599, R01NS057499] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University, Feinberg School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Balaraman Kalyanaraman and Joy Joseph for their kind contribution of mitovitamin E. This work was supported by National Institute of Health grants F30ES019815 (L. A. S.), T32-HL76139 (L. A. S.), 5P01HL071643 (N.S.C.), R01-AI076456 (P. B.), NS047599 (A.J.), R01-AI057753 (D. A. H.), R01-AI040310 (C. W.), RR025355 (P. T. S.), HL35440 (P. T. S.), AR050250 (H. P.), AR054796 (H. P.), AI092490 (H. P.), and HL108795 (H. P.) and funds provided by Northwestern University, Feinberg School of Medicine to Harris Perlman.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bryce PJ, 2006, J CLIN INVEST, V116, P1624, DOI 10.1172/JCI26150; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cho HS, 2011, J IMMUNOL, V186, P489, DOI 10.4049/jimmunol.1002639; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Laniewski NG, 2004, J VIROL, V78, P11246, DOI 10.1128/JVI.78.20.11246-11257.2004; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Piganelli JD, 2002, DIABETES, V51, P347, DOI 10.2337/diabetes.51.2.347; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snyder CH, 1999, J BIOENERG BIOMEMBR, V31, P235, DOI 10.1023/A:1005419712731; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; Wang YD, 1998, SCIENCE, V279, P537, DOI 10.1126/science.279.5350.537; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	45	701	720	7	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					225	236		10.1016/j.immuni.2012.10.020	http://dx.doi.org/10.1016/j.immuni.2012.10.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23415911	Bronze, Green Accepted			2022-12-18	WOS:000330940800006
J	Yeh, WC; Shahinian, A; Speiser, D; Kraunus, J; Billia, F; Wakeham, A; delaPompa, JL; Ferrick, D; Hum, B; Iscove, N; Ohashi, P; Rothe, M; Goeddel, DV; Mak, TW				Yeh, WC; Shahinian, A; Speiser, D; Kraunus, J; Billia, F; Wakeham, A; delaPompa, JL; Ferrick, D; Hum, B; Iscove, N; Ohashi, P; Rothe, M; Goeddel, DV; Mak, TW			Early lethality, functional NF-kappa B activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCING PROTEINS; FACTOR RECEPTOR; CYTOPLASMIC DOMAIN; INDUCED APOPTOSIS; IMMUNE-RESPONSES; FACTOR FAMILY; CONTAINS 2; CD40; ASSOCIATION	TRAF2 is an intracellular signal-transducing protein recruited to the TNFR1 and TNFR2 receptors following TNF stimulation. To investigate the physiological role of TRAF2, we generated TRAF2-deficient mice. traf2(-/-) mice appeared normal at birth but became progressively runted and died prematurely. Atrophy of the thymus and spleen and depletion of B cell precursors also were observed. Thymocytes and other hematopoietic progenitors were highly sensitive to TNF-induced cell death and serum TNF levels were elevated in these TRAF2-deficient animals. Examination of traf2(-/-) cells revealed a severe reduction in TNF-mediated JNK/SAPK activation but a mild effect on NF-kappa B activation. These results suggest that TRAF2-independent pathways of NF-kappa B activation exist and that TRAF2 is required for an NF-kappa B-independent signal that protects against TNF-induced apoptosis.	AMGEN INST,TORONTO,ON,CANADA; UNIV TORONTO,ONTARIO CANC INST,DEPT MED BIOPHYS,DEPT IMMUNOL,TORONTO,ON M5G 2C1,CANADA; TULARIK INC,S SAN FRANCISCO,CA 94080	University of Toronto; University Toronto Affiliates; University Health Network Toronto			Billia, Filio/B-3011-2014; Speiser, Daniel E./F-2173-2013; De La Pompa, José Luis/F-9719-2014	Billia, Filio/0000-0002-2824-1215; De La Pompa, José Luis/0000-0001-6761-7265; Ohashi, Pamela S./0000-0003-2915-9317				Aizawa S, 1997, J BIOL CHEM, V272, P2042; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Ansieau S, 1996, P NATL ACAD SCI USA, V93, P14053, DOI 10.1073/pnas.93.24.14053; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; MONTGOMERY RI, 1996, CELL, V87, P426; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PROBERT L, 1993, J IMMUNOL, V151, P1894; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; SHU HB, 1996, P NATL ACAD SCI USA, V93, P13978; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P1390, DOI 10.1073/pnas.94.4.1390; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5	52	700	731	2	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					715	725		10.1016/S1074-7613(00)80391-X	http://dx.doi.org/10.1016/S1074-7613(00)80391-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390694	Bronze			2022-12-18	WOS:A1997YH55400013
J	SINGER, GG; ABBAS, AK				SINGER, GG; ABBAS, AK			THE FAS ANTIGEN IS INVOLVED IN PERIPHERAL BUT NOT THYMIC DELETION OF T-LYMPHOCYTES IN T-CELL RECEPTOR TRANSGENIC MICE	IMMUNITY			English	Article							LPR/LPR MICE; LPR MICE; SYSTEMIC AUTOIMMUNITY; NEGATIVE SELECTION; CLONAL ELIMINATION; ENTEROTOXIN-B; APOPTOSIS; DEATH; GENE; THYMOCYTES	The role of a cell death-associated gene, fas, in T lymphocyte development and responses to antigen has been analyzed by breeding a transgenic T cell receptor specific for the 81-104 peptide of pigeon cytochrome c into fas-defective MRL-lpr/lpr and control MRL(+/+) mice. Transgene-expressing T cells mature normally in both strains and populate peripheral lymphoid tissues in normal numbers. Mature CD4(+) T cells from the lpr/lpr mice are resistant to suppression by high doses of antigen and to apoptotic cell death. In vivo administration of peptide antigen causes deletion of thymic T cells in both MRL-lpr/lpr and MRL(+/+) strains. By contrast, antigen-induced deletion of peripheral T cells occurs in the MRL(+/+) but not in the MRL-lpr/lpr strain. Therefore, the fas gene plays an essential role in activation-induced cell death in mature T lymphocytes, but not in the negative selection of immature cells in the thymus.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV RENAL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School	SINGER, GG (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,DIV IMMUNOL RES,BOSTON,MA 02115, USA.				NIAID NIH HHS [AI32531, P01 AI35297] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BOSSU P, 1993, J IMMUNOL, V151, P7233; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DAVIGNON JL, 1985, J IMMUNOL, V135, P2423; DRISCOLL M, 1992, J NEUROBIOL, V23, P1327, DOI 10.1002/neu.480230919; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663; HERRON LR, 1993, J IMMUNOL, V151, P3450; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KURTJONES EA, 1987, J EXP MED, V166, P1774, DOI 10.1084/jem.166.6.1774; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MOUNTZ JD, 1990, J EXP MED, V172, P1805, DOI 10.1084/jem.172.6.1805; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PERKINS DL, 1990, J IMMUNOL, V145, P549; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHI YF, 1991, J IMMUNOL, V146, P3340; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SOBEL ES, 1991, J EXP MED, V173, P1441, DOI 10.1084/jem.173.6.1441; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SUZUKI G, 1988, J IMMUNOL, V140, P1359; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WEBB SR, 1994, J IMMUNOL, V152, P586; WESTON KM, 1988, J IMMUNOL, V141, P1941; ZHOU T, 1991, J IMMUNOL, V147, P466	46	697	704	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					365	371		10.1016/1074-7613(94)90067-1	http://dx.doi.org/10.1016/1074-7613(94)90067-1			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7533645				2022-12-18	WOS:A1994PK16800005
J	Cai, YH; Shen, XY; Ding, CL; Qi, CJ; Li, KJ; Li, X; Jala, VR; Zhang, HG; Wang, T; Zheng, J; Yan, J				Cai, Yihua; Shen, Xiaoyan; Ding, Chuanlin; Qi, Chunjian; Li, Kejia; Li, Xia; Jala, Venkatakrishna R.; Zhang, Huang-ge; Wang, Tian; Zheng, Jie; Yan, Jun			Pivotal Role of Dermal IL-17-Producing gamma delta T Cells in Skin Inflammation	IMMUNITY			English	Article							PSORIATIC SKIN; EPIDERMAL HYPERPLASIA; INTERFERON-GAMMA; INNATE IMMUNITY; IN-VITRO; EXPRESSION; RECEPTOR; INTERLEUKIN-17; IL-23; PATHOGENESIS	Interleukin-23 (IL-23) and CD4(+) T helper 17 (Th17) cells are thought to be critical in psoriasis pathogenesis. Here, we report that IL-23 predominantly stimulated dermal gamma delta T cells to produce IL-17 that led to disease progression. Dermal gamma delta T cells constitutively expressed the IL-23 receptor (IL-23R) and transcriptional factor ROR gamma t. IL-17 production from dermal gamma delta T cells was independent of alpha beta T cells. The epidermal hyperplasia and inflammation induced by IL-23 were significantly decreased in T cell receptor delta-deficient (Tcrd(-/-)) and IL-17 receptor-deficient (Il17ra(-/-)) mice but occurred normally in Tcra(-/-) mice. Imiquimod-induced skin pathology was also significantly decreased in Tcrd(-/-) mice. Perhaps further promoting disease progression, IL-23 stimulated dermal gamma delta T cell expansion. In psoriasis patients, gamma delta T cells were greatly increased in affected skin and produced large amounts of IL-17. Thus, IL-23-responsive dermal gamma delta T cells are the major IL-17 producers in the skin and may represent a novel target for the treatment of psoriasis.	[Cai, Yihua; Shen, Xiaoyan; Li, Kejia; Li, Xia; Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai 20025, Peoples R China; [Cai, Yihua; Ding, Chuanlin; Qi, Chunjian; Jala, Venkatakrishna R.; Zhang, Huang-ge; Yan, Jun] Univ Louisville, Dept Microbiol & Immunol, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Cai, Yihua; Ding, Chuanlin; Qi, Chunjian; Jala, Venkatakrishna R.; Zhang, Huang-ge; Yan, Jun] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Shanghai Jiao Tong University; University of Louisville; University of Louisville; University of Texas System; University of Texas Medical Branch Galveston	Zheng, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai 20025, Peoples R China.	jie-zheng2001@126.com; jun.yan@louisville.edu	Yan, Jun/A-8988-2008; Jala, Venkatakrishna R/K-7255-2018; Cai, Yihua/N-2879-2015	Jala, Venkatakrishna R/0000-0002-4206-7305; 	National Institutes of Health; National Natural Science Foundation of China [30872278/H1103]; Science and Technology Commission of Shanghai Municipality [08JC1415700]; NATIONAL CANCER INSTITUTE [R01CA150947, R01CA086412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. O'Brien (National Jewish Health, Denver, CO) for providing TCR V gamma mAbs. We also thank J.W. Eaton for critical reading of this manuscript. This work was supported by the National Institutes of Health (J.Y.), National Natural Science Foundation of China (30872278/H1103), and Science and Technology Commission of Shanghai Municipality (08JC1415700, J.Z.).	Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Blauvelt A, 2008, J INVEST DERMATOL, V128, P1064, DOI 10.1038/jid.2008.85; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Born WK, 2010, J IMMUNOL, V184, P4055, DOI 10.4049/jimmunol.0903679; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cai YH, 2009, J INVEST DERMATOL, V129, P2653, DOI 10.1038/jid.2009.153; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Gudjonsson JE, 2003, BRIT J DERMATOL, V149, P530, DOI 10.1046/j.1365-2133.2003.05552.x; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Matsubara S, 2009, AM J RESP CELL MOL, V40, P454, DOI 10.1165/rcmb.2008-0346OC; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Rajan N, 2006, CLIN EXP DERMATOL, V31, P140, DOI 10.1111/j.1365-2230.2005.01938.x; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Seung NR, 2007, J CUTAN PATHOL, V34, P903, DOI 10.1111/j.1600-0560.2007.00756.x; Simonian PL, 2006, J IMMUNOL, V177, P4436, DOI 10.4049/jimmunol.177.7.4436; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; YOSHINAGA Y, 1995, ARCH DERMATOL RES, V287, P158, DOI 10.1007/BF01262325; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	57	692	745	5	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					596	610		10.1016/j.immuni.2011.08.001	http://dx.doi.org/10.1016/j.immuni.2011.08.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	21982596	Green Accepted, Bronze			2022-12-18	WOS:000296657700018
J	Moon, JJ; Chu, HH; Pepper, M; McSorley, SJ; Jameson, SC; Kedl, RM; Jenkins, MK				Moon, James J.; Chu, H. Hamlet; Pepper, Marion; McSorley, Stephen J.; Jameson, Stephen C.; Kedl, Ross M.; Jenkins, Marc K.			Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude	IMMUNITY			English	Article							PRECURSOR FREQUENCY; IN-VIVO; ANTIGENIC-STIMULATION; EXPANSION; PEPTIDE; PROLIFERATION; CD8(+); INFECTION; AFFINITY; MICE	Cell-mediated immunity stems from the proliferation of naive T lymphocytes expressing T cell antigen receptors (TCRs) specific for foreign peptides bound to host major histocompatibility complex (MHC) molecules. Because of the tremendous diversity of the T cell repertoire, naive T cells specific for any one peptide:MHC complex (pMHC) are extremely rare. Thus, it is not known how many naive T cells of any given pMlHC specificity exist in the body or how that number influences the immune response. By using soluble pMHC class II (pMHCII) tetramers and magnetic bead enrichment, we found that three different pMHCII-specific naive CD4(+) T cell populations vary in frequency from 20 to 200 cells per mouse. Moreover, naive population size predicted the size and TCR diversity of the primary CD4(+) T cell response after immunization with relevant peptide. Thus, variation in naive T cell frequencies can explain why some peptides are stronger immunogens than others.	Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Jenkins, Marc K/G-1063-2012; Jameson, Stephen C/D-9892-2013; moon, james/F-1031-2014	Jenkins, Marc K/0000-0001-8009-7655; Jameson, Stephen C/0000-0001-9137-1146; McSorley, Stephen/0000-0002-6363-3222; moon, james/0000-0001-8071-1491	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063793] Funding Source: NIH RePORTER; NIAID NIH HHS [F32 AI063793-02, F32 AI063793] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Badovinac VP, 2007, J IMMUNOL, V179, P53, DOI 10.4049/jimmunol.179.1.53; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Ford ML, 2007, J EXP MED, V204, P299, DOI 10.1084/jem.20062319; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; Jang MH, 2003, J IMMUNOL, V171, P4175, DOI 10.4049/jimmunol.171.8.4175; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kedzierska K, 2006, J IMMUNOL, V177, P6705, DOI 10.4049/jimmunol.177.10.6705; KLINMAN NR, 1972, J EXP MED, V136, P241, DOI 10.1084/jem.136.2.241; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Pearce EL, 2004, J IMMUNOL, V173, P2494, DOI 10.4049/jimmunol.173.4.2494; Prlic M, 2002, MICROBES INFECT, V4, P531, DOI 10.1016/S1286-4579(02)01569-1; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; RUPPERT J, 1993, P NATL ACAD SCI USA, V90, P2671, DOI 10.1073/pnas.90.7.2671; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; STEINMETZ M, 1989, GENOME, V31, P652, DOI 10.1139/g89-119; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	50	692	704	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					203	213		10.1016/j.immuni.2007.07.007	http://dx.doi.org/10.1016/j.immuni.2007.07.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17707129	Green Accepted, Bronze			2022-12-18	WOS:000249056300008
J	Mizoguchi, A; Mizoguchi, E; Takedatsu, H; Blumberg, RS; Bhan, AK				Mizoguchi, A; Mizoguchi, E; Takedatsu, H; Blumberg, RS; Bhan, AK			Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation	IMMUNITY			English	Article							KILLER T-CELLS; CYTOKINE PRODUCTION; AUTOIMMUNE-DISEASE; EPITHELIAL-CELLS; BOWEL-DISEASE; MURINE MODEL; IN-VIVO; RECEPTOR; ACTIVATION; COLITIS	B cells possess a variety of immune functions that are involved in normal and abnormal immune responses, including autoimmune disorders. Through murine models of intestinal inflammation, we here demonstrate a B cell subset that is induced in gut-associated lymphoid tissues and is characterized by CD1d upregulation. This B cell subset appears under a chronic inflammatory environment, produces IL-10, and suppresses progression of intestinal inflammation by downregulating inflammatory cascades associated with IL-1 upregulation and STAT3 activation rather than by altering polarized T helper responses. This study indicates that B cells, by producing cytokines such as IL-10, can act as regulatory cells in immunologically mediated inflammatory reactions.	Massachusetts Gen Hosp, Dept Pathol, Immunopathol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Stusy Inflammatory Bowel Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Mizoguchi, A (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Immunopathol Unit, Boston, MA 02114 USA.	amizoguchi@partners.org	Takedatsu, Hidetoshi/AAD-1037-2020	Takedatsu, Hidetoshi/0000-0002-0318-0129	NIDDK NIH HHS [DK44319, DK47677, DK34584, DK51362, DK53056, DK43351] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK044319, R01DK051362, P30DK043351, R01DK047677, R56DK053056, R01DK053056] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Amano M, 1998, J IMMUNOL, V161, P1710; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Behar SM, 1999, J EXP MED, V189, P1973, DOI 10.1084/jem.189.12.1973; Behar SM, 2000, SEMIN IMMUNOL, V12, P551, DOI 10.1006/smim.2000.0273; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Bhan AK, 1999, IMMUNOL REV, V169, P195, DOI 10.1111/j.1600-065X.1999.tb01316.x; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Brossay L, 1997, J IMMUNOL, V159, P1216; Burdin N, 1999, CURR OPIN IMMUNOL, V11, P326, DOI 10.1016/S0952-7915(99)80052-1; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; Dao T, 2001, J IMMUNOL, V166, P3090, DOI 10.4049/jimmunol.166.5.3090; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Dombrowicz D, 2001, J EXP MED, V193, P25, DOI 10.1084/jem.193.1.25; Fagarasan S, 2000, IMMUNOL REV, V176, P205; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Iijima H, 1999, J EXP MED, V190, P607, DOI 10.1084/jem.190.5.607; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MA A, 1995, J EXP MED, V182, P1567, DOI 10.1084/jem.182.5.1567; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ozaki ME, 1999, J IMMUNOL, V163, P5250; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Taniguchi M, 1996, P NATL ACAD SCI USA, V93, P11025, DOI 10.1073/pnas.93.20.11025; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Toh BH, 2000, IMMUNOL TODAY, V21, P348, DOI 10.1016/S0167-5699(00)01653-4; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Zeng D, 2000, J IMMUNOL, V164, P5000, DOI 10.4049/jimmunol.164.10.5000	58	692	738	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2002	16	2					219	230		10.1016/S1074-7613(02)00274-1	http://dx.doi.org/10.1016/S1074-7613(02)00274-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869683	Bronze			2022-12-18	WOS:000174039600006
J	Cohen, GB; Gandhi, RT; Davis, DM; Mandelboim, O; Chen, BK; Strominger, JL; Baltimore, D				Cohen, GB; Gandhi, RT; Davis, DM; Mandelboim, O; Chen, BK; Strominger, JL; Baltimore, D			The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MHC CLASS-I; LYMPHOCYTE-T CLONE; HLA-C; MEDIATED LYSIS; NEF PROTEIN; RECEPTORS; RECOGNITION; MOLECULES; BINDING	To avoid detection by CTL, HIV encodes mechanisms for removal of class I MHC proteins from the surface of infected cells. However, class I downregulation potentially exposes the virus-infected cell to attack by NK cells. Human lymphoid cells are protected from NK cell cytotoxicity primarily by HLA-C and HLA-E, We present evidence that HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E. We then identify the residues in HLA-C and HLA-E that protect them from HIV downregulation. This selective downregulation allows HIV-infected cells to avoid NK cell-mediated lysis and may represent for HIV a balance between escape from CTL and maintenance of protection from NK cells. These results suggest that subpopulations of CTL and NK cells may be uniquely suited for combating HIV.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	Baltimore, D (corresponding author), CALTECH, Off President, Pasadena, CA 91125 USA.			Davis, Daniel/0000-0002-9182-291X; Mandelboim, Ofer/0000-0002-9354-1855; Chen, Benjamin K/0000-0002-5404-1997	NCI NIH HHS [R35CA47554] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047554] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; BAKER BW, 1992, NUCLEIC ACIDS RES, V20, P5234, DOI 10.1093/nar/20.19.5234; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Bruunsgaard H, 1997, SCAND J IMMUNOL, V46, P91, DOI 10.1046/j.1365-3083.1997.d01-98.x; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davis DM, 1997, EUR J IMMUNOL, V27, P2714, DOI 10.1002/eji.1830271035; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; JOHNSON RP, 1993, J VIROL, V67, P438, DOI 10.1128/JVI.67.1.438-445.1993; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kerkau T, 1997, J EXP MED, V185, P1295, DOI 10.1084/jem.185.7.1295; Lanier LL, 1998, CELL, V92, P705, DOI 10.1016/S0092-8674(00)81398-7; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Leibson PJ, 1998, IMMUNITY, V9, P289, DOI 10.1016/S1074-7613(00)80611-1; LITTAUA RA, 1991, J VIROL, V65, P4051, DOI 10.1128/JVI.65.8.4051-4056.1991; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Nehete PN, 1998, VIRAL IMMUNOL, V11, P119, DOI 10.1089/vim.1998.11.119; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PerezVillar JJ, 1997, J IMMUNOL, V158, P5736; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; SCHMID I, 1994, J IMMUNOL METHODS, V170, P145, DOI 10.1016/0022-1759(94)90390-5; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SLEZAK SE, 1989, J IMMUNOL METHODS, V117, P205, DOI 10.1016/0022-1759(89)90142-7; TAY CH, 1998, IMMUNITY, V7, P739; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4; YONEDA N, 1992, LEUKEMIA, V6, P136; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; ZEMMOUR J, 1992, TISSUE ANTIGENS, V39, P249, DOI 10.1111/j.1399-0039.1992.tb01943.x	41	692	713	0	28	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					661	671		10.1016/S1074-7613(00)80065-5	http://dx.doi.org/10.1016/S1074-7613(00)80065-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403641	Bronze			2022-12-18	WOS:000081209600004
J	XU, JC; FOY, TM; LAMAN, JD; ELLIOTT, EA; DUNN, JJ; WALDSCHMIDT, TJ; ELSEMORE, J; NOELLE, RJ; FLAVELL, RA				XU, JC; FOY, TM; LAMAN, JD; ELLIOTT, EA; DUNN, JJ; WALDSCHMIDT, TJ; ELSEMORE, J; NOELLE, RJ; FLAVELL, RA			MICE DEFICIENT FOR THE CD40 LIGAND	IMMUNITY			English	Article							VIVO CD40-GP39 INTERACTIONS; DEPENDENT HUMORAL IMMUNITY; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; CELL INTERACTIONS; T-CELLS; EXPRESSION; GP39; ANTIBODY; ANTIGEN	To study the potential roles of CD40L in immune responses, we generated CD40L-deficient mice by gene targeting. Similar to the effects of CD40L mutations in humans (hyper-IgM syndrome), CD40L-deficient mice have a decreased IgM response to thymus-dependent antigens, fail altogether to produce an antigen-specific IgG1 response following immunization, yet respond normally to a T-independent antigen, TNP-Ficoll. Moreover, these mice do not develop germinal centers in response to thymus-dependent antigens, suggesting an inability to develop memory B cell responses. Although CD40L-deficient mice have low levels of most circulating immunoglobulin isotypes, they do not exhibit the spontaneous hyper-IgM syndrome seen in humans, at least up to 12 weeks of age. In summary, our study confirms the important role of CD40-CD40L interactions in thymus-dependent humoral immune responses and germinal center formation.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756; ALEX PHARMACEUT INC,NEW HAVEN,CT 06511; UNIV IOWA,SCH MED,DEPT PATHOL,IOWA CITY,IA 52242	Howard Hughes Medical Institute; Yale University; Dartmouth College; University of Iowa	XU, JC (corresponding author), YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.			Waldschmidt, Thomas/0000-0001-6147-6991				ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BANIYASH M, 1984, EUR J IMMUNOL, V14, P799, DOI 10.1002/eji.1830140907; Claman H N, 1969, Transplant Rev, V1, P92; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; JERNE NK, 1974, TRANSPLANT REV-DENMA, V18, P130; KATZ DH, 1973, P NATL ACAD SCI USA, V70, P2624, DOI 10.1073/pnas.70.9.2624; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KEEGAN AD, 1989, J IMMUNOL, V142, P3868; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; MITCHISON N A, 1971, European Journal of Immunology, V1, P68, DOI 10.1002/eji.1830010204; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Raff M C, 1970, Nature, V226, P1257, DOI 10.1038/2261257a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555	22	691	707	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					423	431		10.1016/1074-7613(94)90073-6	http://dx.doi.org/10.1016/1074-7613(94)90073-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882172				2022-12-18	WOS:A1994PK16800011
J	Rogers, NC; Slack, EC; Edwards, AD; Nolte, MA; Schulz, O; Schweighoffer, E; Williams, DL; Gordon, S; Tybulewicz, VL; Brown, GD; Sousa, CRE				Rogers, NC; Slack, EC; Edwards, AD; Nolte, MA; Schulz, O; Schweighoffer, E; Williams, DL; Gordon, S; Tybulewicz, VL; Brown, GD; Sousa, CRE			Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins	IMMUNITY			English	Article							BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTOR-2; REGULATORY T-CELLS; ACTIVATED PROTEIN-KINASE; DENDRITIC CELLS; TYROSINE KINASE; DC-SIGN; ANTIGEN PRESENTATION; CANDIDA-ALBICANS; IL-2 PRODUCTION	Pattern-recognition receptors (PRRs) detect molecular signatures of microbes and initiate immune responses to infection. Prototypical PRRs such as Toll-like receptors (TLRs) signal via a conserved pathway to induce innate response genes. In contrast, the signaling pathways engaged by other classes of putative PRRs remain ill defined. Here, we demonstrate that the p-glucan receptor Dectin-1, a yeast binding C type lectin known to synergize with TLR2 to induce TNF alpha and IL-12, can also promote synthesis of IL-2 and IL-10 through phosphorylation of the membrane proximal tyrosine in the cytoplasmic domain and recruitment of Syk kinase. syk(-/-) dendritic cells (DCs) do not make IL-10 or IL-2 upon yeast stimulation but produce IL-12, indicating that the Dectin-1/Syk and Dectin-1/TLR2 pathways can operate independently. These results identify a novel signaling pathway involved in pattern recognition by C type lectins and suggest a potential role for Syk kinase in regulation of innate immunity.	Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England; Natl Inst Med Res, London NW7 1AA, England; E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; Univ Oxford, Sir William Dunn Sch Psychol, Oxford OX1 3RE, England	Cancer Research UK; MRC National Institute for Medical Research; East Tennessee State University; University of Oxford	Sousa, CRE (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Edwards, Alexander D/F-7440-2010; Reis e Sousa, Caetano/O-1657-2014; Slack, Emma/B-1612-2016; Edwards, Alexander Daniel/AAX-8524-2021; Reis e Sousa, Caetano/ABD-7322-2021; brown, gordon/B-4249-2012; Nolte, Martijn A./AAC-8092-2022; Slack, Emma/AAD-5837-2019	Edwards, Alexander D/0000-0003-2369-989X; Reis e Sousa, Caetano/0000-0001-7392-2119; Slack, Emma/0000-0002-2473-1145; Edwards, Alexander Daniel/0000-0003-2369-989X; Reis e Sousa, Caetano/0000-0001-7392-2119; Nolte, Martijn A./0000-0002-5447-0839; Slack, Emma/0000-0002-2473-1145; brown, gordon/0000-0002-0287-5383; Tybulewicz, Victor/0000-0003-2439-0798; Rogers, Neil/0000-0001-8977-7585; Schulz, Oliver/0000-0002-1493-3341				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Feau S, 2005, BLOOD, V105, P697, DOI 10.1182/blood-2004-03-1059; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KAPPLER J, 1982, P NATL ACAD SCI-BIOL, V79, P3604, DOI 10.1073/pnas.79.11.3604; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Muller A, 1996, J IMMUNOL, V156, P3418; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qi H, 2003, INFECT IMMUN, V71, P3337, DOI 10.1128/IAI.71.6.3337-3342.2003; Reid DM, 2004, J LEUKOCYTE BIOL, V76, P86, DOI 10.1189/jlb.0104031; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Sedlik C, 2003, J IMMUNOL, V170, P846, DOI 10.4049/jimmunol.170.2.846; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 2003, EUR J IMMUNOL, V33, P1767, DOI 10.1002/eji.200324037	49	690	718	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					507	517		10.1016/j.immuni.2005.03.004	http://dx.doi.org/10.1016/j.immuni.2005.03.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845454	Bronze			2022-12-18	WOS:000228909600011
J	Zlotnik, A; Yoshie, O				Zlotnik, Albert; Yoshie, Osamu			The Chemokine Superfamily Revisited	IMMUNITY			English	Review							THYMUS-EXPRESSED CHEMOKINE; T-CELL DEVELOPMENT; SPECTRUM ANTIMICROBIAL ACTIVITY; HEMATOPOIETIC STEM; DENDRITIC CELLS; ADAPTIVE IMMUNITY; CXCR4 ANTAGONIST; POTENT INHIBITOR; PROGENITOR CELLS; SECRETING CELLS	The chemokine superfamily consists of a large number of ligands and receptors. At first glance, this family appears redundant and their ligand-receptor relationships promiscuous, making its study challenging. However, analyzing this family from the evolutionary perspective greatly simplifies understanding both the organization and function of this apparently complex system. In particular, the functions of a subgroup of chemokines (designated homeostatic chemokines) have played pivotal roles in advancing our understanding of the organization and function of the cellular networks that shape the immune system. Here, we update the full scope of the human and mouse chemokine superfamilies and their relationships and summarize several important roles that homeostatic chemokines play in the immune system.	[Zlotnik, Albert] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Yoshie, Osamu] Kinki Univ, Fac Med, Dept Microbiol, Osaka 5898511, Japan	University of California System; University of California Irvine; Kindai University (Kinki University)	Zlotnik, A (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	azlotnik@uci.edu; o.yoshie@med.kindai.ac.jp		Yoshie, Osamu/0000-0003-4353-5809	NIH NIAID [1R01AI093548-01A1]; Grants-in-Aid for Scientific Research [23501273] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083540, R01AI093548] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.Z. is supported by NIH NIAID grant 1R01AI093548-01A1.	Albert ML, 2011, HEPATOLOGY, V53, P1410, DOI 10.1002/hep.24055; Amanatidou V, 2011, CRIT REV IMMUNOL, V31, P341, DOI 10.1615/CritRevImmunol.v31.i4.40; Amersi FF, 2008, CLIN CANCER RES, V14, P638, DOI 10.1158/1078-0432.CCR-07-2025; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bourges D, 2008, MOL IMMUNOL, V45, P3354, DOI 10.1016/j.molimm.2008.04.017; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Eksteen B, 2010, IDRUGS, V13, P472; Eliasson Mette, 2008, V15, P101, DOI 10.1159/000136317; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Flad HD, 2010, CELL MOL LIFE SCI, V67, P2363, DOI 10.1007/s00018-010-0306-x; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gilliam BL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S9; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hevezi PA, 2011, AUTOIMMUNITY, V44, P532, DOI 10.3109/08916934.2011.592881; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Keating GM, 2011, DRUGS, V71, P1623, DOI 10.2165/11206040-000000000-00000; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kometani K, 2008, BLOOD, V112, P4565, DOI 10.1182/blood-2008-06-164517; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Leick M, 2010, IMMUNOLOGY, V129, P536, DOI 10.1111/j.1365-2567.2009.03209.x; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mariani M, 2004, EUR J IMMUNOL, V34, P231, DOI 10.1002/eji.200324429; Melve GK, 2011, EXPERT REV HEMATOL, V4, P563, DOI [10.1586/ehm.11.54, 10.1586/EHM.11.54]; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Misslitz A, 2006, IMMUNOL REV, V209, P115, DOI 10.1111/j.0105-2896.2006.00351.x; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Morteau O, 2008, J IMMUNOL, V181, P6309, DOI 10.4049/jimmunol.181.9.6309; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nandagopal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018183; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nomiyama H, 2011, DEV COMP IMMUNOL, V35, P705, DOI 10.1016/j.dci.2011.01.019; Nomiyama H, 2010, CYTOKINE GROWTH F R, V21, P253, DOI 10.1016/j.cytogfr.2010.03.004; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Norment AM, 2000, J IMMUNOL, V164, P639, DOI 10.4049/jimmunol.164.2.639; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Peled A, 2012, EXPERT OPIN INV DRUG, V21, P341, DOI 10.1517/13543784.2012.656197; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Proudfoot AEI, 2010, EXPERT OPIN INV DRUG, V19, P345, DOI 10.1517/13543780903535867; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Pusic I, 2010, CURR OPIN HEMATOL, V17, P319, DOI 10.1097/MOH.0b013e328338b7d5; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Svensson M, 2008, J LEUKOCYTE BIOL, V83, P156, DOI 10.1189/jlb.0607423; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tobinai K, 2012, CURR HEMATOL MALIG R, V7, P235, DOI 10.1007/s11899-012-0124-3; Toiyama Y, 2012, INT J ONCOL, V40, P560, DOI 10.3892/ijo.2011.1247; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Uy GL, 2008, EXPERT OPIN BIOL TH, V8, P1797, DOI 10.1517/14712598.8.11.1797 ; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Weinstein EJ, 2006, BIOCHEM BIOPH RES CO, V350, P74, DOI 10.1016/j.bbrc.2006.08.194; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Wilson E, 2004, J EXP MED, V200, P805, DOI 10.1084/jem.20041069; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9; Zingoni A, 1998, J IMMUNOL, V161, P547; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	104	689	716	4	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					705	716		10.1016/j.immuni.2012.05.008	http://dx.doi.org/10.1016/j.immuni.2012.05.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633458	Green Accepted, Bronze			2022-12-18	WOS:000304976000006
J	Zaki, MH; Boyd, KL; Vogel, P; Kastan, MB; Lamkanfi, M; Kanneganti, TD				Zaki, Md. Hasan; Boyd, Kelli L.; Vogel, Peter; Kastan, Michael B.; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis	IMMUNITY			English	Article							BOWEL-DISEASE; ULCERATIVE-COLITIS; IL-1-BETA-CONVERTING ENZYME; MICE DEFICIENT; DOUBLE-BLIND; CASPASE-1; RECOGNITION; INFECTION; INNATE; IL-18	Decreased expression of the Nlrp3 protein is associated with susceptibility to Crohn's disease. However, the role of Nlrp3 in colitis has not been characterized. Nlrp3 interacts with the adaptor protein ASC to activate caspase-1 in inflammasomes, which are protein complexes responsible for the maturation and secretion of interleukin-1 beta (IL-1 beta) and IL-18. Here, we showed that mice deficient for Nlrp3 or ASC and caspase-1 were highly susceptible to dextran sodium sulfate (DSS)-induced colitis. Defective inflammasome activation led to loss of epithelial integrity, resulting in systemic dispersion of commensal bacteria, massive leukocyte infiltration, and increased chemokine production in the colon. This process was a consequence of a decrease in IL-18 in mice lacking components of the Nlrp3 inflammasome, resulting in higher mortality rates. Thus, the NIrp3 inflammasome is critically involved in the maintenance of intestinal homeostasis and protection against colitis.	[Zaki, Md. Hasan; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Boyd, Kelli L.; Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Kastan, Michael B.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Ghent University; Flanders Institute for Biotechnology (VIB)	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Zaki, Hasan/0000-0001-9002-5399	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; National Institutes of Health [AR056296]; Cancer Center Support Grant (CCSG) [2 P30 CA 21765]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant (CCSG); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Coyle, E. Grant, J. Bertin (Millennium Pharmaceuticals), G. Nunez (University of Michigan), and R. Flavell (Yale) for generous supply of mutant mice. M.L. is supported by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. This work was supported by National Institutes of Health Grant AR056296, a Cancer Center Support Grant (CCSG 2 P30 CA 21765), and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Bauer C, 2007, DIGEST DIS SCI, V52, P1642, DOI 10.1007/s10620-007-9802-8; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goyette P, 2007, ANN MED, V39, P177, DOI 10.1080/07853890701197615; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KEITH JC, 1994, STEM CELLS, V12, P79; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Loher F, 2004, J PHARMACOL EXP THER, V308, P583, DOI 10.1124/jpet.103.057059; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olee T, 1999, J IMMUNOL, V162, P1096; PALMEN MJHJ, 1995, CLIN EXP IMMUNOL, V99, P226; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; PODOLSKY DK, 1984, GASTROENTEROLOGY, V87, P991; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Turunen UM, 1998, GASTROENTEROLOGY, V115, P1072, DOI 10.1016/S0016-5085(98)70076-9; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	57	689	729	5	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					379	391		10.1016/j.immuni.2010.03.003	http://dx.doi.org/10.1016/j.immuni.2010.03.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20303296	Green Accepted, Bronze			2022-12-18	WOS:000276125400011
J	Grossman, WJ; Verbsky, JW; Barchet, W; Colonna, M; Atkinson, JP; Ley, TJ				Grossman, WJ; Verbsky, JW; Barchet, W; Colonna, M; Atkinson, JP; Ley, TJ			Human T regulatory cells can use the perforin pathway to cause autologous target cell death	IMMUNITY			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; GRANZYME-B INHIBITOR; DENDRITIC CELLS; ANTIGEN; LYMPHOCYTES; EXPRESSION; IMMUNITY; CD46; FAS; PROTEINASE-INHIBITOR-9	Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4(+) T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4(+)CD25(+) natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg sub-types display perforin-dependent cytotoxicity against autologous target cells, including activated CD4(+) and CD8(+) T cells, CD14(+) monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.	Washington Univ, Sch Med, Siteman canc Ctr, Dept Genet,Dept Internal Med, St Louis, MO 63110 USA; St Louis Childrens Hosp, Dept Pediat, Div Hematol Oncol, St Louis, MO 63110 USA; St Louis Childrens Hosp, Dept Pediat, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Siteman canc Ctr, Dept Genet,Dept Internal Med, St Louis, MO 63110 USA.	tley@im.wustl.edu		Colonna, Marco/0000-0001-5222-4987; Atkinson, John/0000-0002-2514-3441; Barchet, Winfried/0000-0002-6745-6606	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049786] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 37618] Funding Source: Medline; NICHD NIH HHS [5T32 HD 43010] Funding Source: Medline; NIDDK NIH HHS [DK 49786] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen M, 2001, HAEMATOLOGICA, V86, P499; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Arico M, 2001, BLOOD, V97, P1131, DOI 10.1182/blood.V97.4.1131; ATKINSON JP, 1994, CLIN EXP IMMUNOL, V2, P1; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Bladergroen BA, 2001, J IMMUNOL, V166, P3218, DOI 10.4049/jimmunol.166.5.3218; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Buzza MS, 2001, CELL IMMUNOL, V210, P21, DOI 10.1006/cimm.2001.1806; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark W R, 1995, Int Rev Immunol, V13, P1, DOI 10.3109/08830189509061734; Day NE, 2003, LEUKEMIA RES, V27, P1027, DOI 10.1016/S0145-2126(03)00072-9; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Dumitriu IE, 2001, ANAL BIOCHEM, V299, P247, DOI 10.1006/abio.2001.5415; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; GEPPERT TD, 1988, J CLIN INVEST, V81, P1497, DOI 10.1172/JCI113481; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Grossman WJ, 1999, BLOOD, V94, P932, DOI 10.1182/blood.V94.3.932.415k30_932_939; HANSON RD, 1991, J BIOL CHEM, V266, P24433; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Hirst CE, 2001, MOL HUM REPROD, V7, P1133, DOI 10.1093/molehr/7.12.1133; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; LINDAHL G, 2000, HUMAN COMPLEMENT REG, P44; Malipiero U, 1997, EUR J IMMUNOL, V27, P3151, DOI 10.1002/eji.1830271211; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Pham CTN, 1998, J BIOL CHEM, V273, P1629, DOI 10.1074/jbc.273.3.1629; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Song WC, 2004, CURR DIRECT AUTOIMMU, V7, P181; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Susskind B, 1996, HUM IMMUNOL, V45, P64, DOI 10.1016/0198-8859(95)00151-4	61	689	746	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					589	601		10.1016/j.immuni.2004.09.002	http://dx.doi.org/10.1016/j.immuni.2004.09.002			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485635	Bronze			2022-12-18	WOS:000224744400014
J	Xu, Y; Jagannath, C; Liu, XD; Sharafkhaneh, A; Kolodziejska, KE; Eissa, NT				Xu, Yi; Jagannath, Chinnaswamy; Liu, Xian-De; Sharafkhaneh, Amir; Kolodziejska, Katarzyna E.; Eissa, N. Tony			Toll-like receptor 4 is a sensor for autophagy associated with innate immunity	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; CELL-DEATH; ACTIVATION; LIPOPOLYSACCHARIDE; TUBERCULOSIS; DEGRADATION; APOPTOSIS; ENDOTOXIN; SURVIVAL	Autophagy has recently been shown to be an important component of the innate immune response. The signaling pathways leading to activation of autophagy in innate immunity are not known. Here we showed that Toll-like receptor 4 (TLR4) served as a previously unrecognized environmental sensor for autophagy. Autophagy was induced by lipopolysaccharide (LIPS) in primary human macrophages and in the murine macrophage RAW264.7 cell line. We defined a new molecular pathway in which LPS-induced autophagy was regulated through a Toll-interleukin-1 receptor domain-containing adaptor-inducing interferon-beta (TRIF)-dependent, myeloid differentiation factor 88 (MyD88)-independent TLR4 signaling pathway. Receptor-interacting protein (RIP1) and p38 mitogen-activated protein kinase were downstream components of this pathway. This signaling pathway did not affect cell viability, indicating that it is distinct from the autophagic death signaling pathway. We further showed that LPS-induced autophagy could enhance mycobacterial colocalization with the autophagosomes. This study links two ancient processes, autophagy and innate immunity, together through a shared signaling pathway.	Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Eissa, NT (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	teissa@bcm.edu		Liu, xiande/0000-0002-9639-0458	NHLBI NIH HHS [1F32 HL078520-01, R01 HL069033, R01 HL069033-04, R01 HL080205, R01 HL075421, R01 HL075421-04, R01 HL080205-03, R01 HL084322-02, R01 HL084322, F32 HL078520] Funding Source: Medline; NIAID NIH HHS [U19 AI070973, U19 AI070973-010001] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069033, R01HL084322, R01HL075421, F32HL078520, R01HL080205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070973] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Holland GN, 2000, OCUL IMMUNOL INFLAMM, V8, P1, DOI 10.1076/0927-3948(200003)8:1;1-S;FT001; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lorenz E, 2002, INFECT IMMUN, V70, P4892, DOI 10.1128/IAI.70.9.4892-4896.2002; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	30	687	732	2	106	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					135	144		10.1016/j.immuni.2007.05.022	http://dx.doi.org/10.1016/j.immuni.2007.05.022			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17658277	Bronze, Green Accepted			2022-12-18	WOS:000248398100015
J	O'Connell, RM; Kahn, D; Gibson, WSJ; Round, JL; Scholz, RL; Chaudhuri, AA; Kahn, ME; Rao, DS; Baltimore, D				O'Connell, Ryan M.; Kahn, Daniel; Gibson, William S. J.; Round, June L.; Scholz, Rebecca L.; Chaudhuri, Aadel A.; Kahn, Melissa E.; Rao, Dinesh S.; Baltimore, David			MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development	IMMUNITY			English	Article							CUTTING EDGE; TGF-BETA; DIFFERENTIATION; ACTIVATION; EXPRESSION; TARGET; ROLES; MICE; GENERATION; PATHWAY	Mammalian noncoding microRNAs (miRNAs) are a class of gene regulators that have been linked to immune system function Here, we have investigated the role of miR-155 during an autoimmune inflammatory disease Consistent with a positive role for mir155(-/-) in mediating inflammatory responses, Mir155(-/-) mice were highly resistant to experimental autoimmune encephalomyelitis (EAE) miR-155 functions in the hematopoietic compartment to promote the development of inflammatory T cells including the T helper 17 (Th17) cell and Th1 cell subsets Furthermore, the major contribution of miR-155 to EAE was CD4(+) T cell intrinsic, whereas miR-155 was also required for optimum dendritic cell production of cytokines that promoted Th17 cell formation Our study shows that one aspect of miR-155 function is the promotion of T cell-dependent tissue inflammation, suggesting that miR-155 might be a promising therapeutic target for the treatment of autoimmune disorders	[O'Connell, Ryan M.; Kahn, Daniel; Gibson, William S. J.; Round, June L.; Scholz, Rebecca L.; Chaudhuri, Aadel A.; Rao, Dinesh S.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kahn, Daniel] Univ Calif Los Angeles, Div Maternal Fetal Med, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kahn, Melissa E.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Baltimore, D (corresponding author), CALTECH, Div Biol, 330 Braun,1200 E Calif Blvd, Pasadena, CA 91125 USA.		Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337	Cancer Research Institute; National Heart Lung and Blood Institute [K99HL102228]; National Institutes of Health Building Interdisciplinary Research Careers in Women s Health (BIRCWH) center at UCLA [K12 HD001400]; National Science Foundation; National Cancer Institute [1K08CA133521]; NIH [1R01A1079243 01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079243] Funding Source: NIH RePORTER	Cancer Research Institute; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Building Interdisciplinary Research Careers in Women s Health (BIRCWH) center at UCLA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	R M O was funded in part by the Irvington Institute Fellowship Program of the Cancer Research Institute and by award number K99HL102228 from the National Heart Lung and Blood Institute D K was supported by the National Institutes of Health Building Interdisciplinary Research Careers in Women s Health (BIRCWH) center at UCLA (K12 HD001400) A A C was funded by the Graduate Research Fellowship Program of the National Science Foundation D S R was funded by award number 1K08CA133521 from the National Cancer Institute J L R is a Merck Fellow of the Jane Coffin Child s Memorial Fund This work was also supported by NIH grant 1R01A1079243 01 We would like to thank A Bradley for providing us with Mir155<SUP>-/-</SUP> animals D B is a scientific advisor to Regulus Therapeutics a company devoted to micro RNA therapeutics	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	43	683	755	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					607	619		10.1016/j.immuni.2010.09.009	http://dx.doi.org/10.1016/j.immuni.2010.09.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	20888269	Green Accepted, Bronze			2022-12-18	WOS:000284300200017
J	Banchereau, J; Pascual, V				Banchereau, Jacques; Pascual, Virginia			Type I interferon in systemic lupus erythematosus and other autoimmune diseases	IMMUNITY			English	Review							PLASMACYTOID DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; PRIMARY SJOGRENS-SYNDROME; NAIVE B-LYMPHOCYTES; IFN-ALPHA; T-CELLS; MURINE LUPUS; DIRECT STIMULATION; GRANZYME-B	Different genetic alterations may lead to type I interferon (IFN) overproduction in human systemic lupus erythematosus (SLE). The increased bioavailability of type I IFN contributes to peripheral tolerance breakdown through the activation of immature myeloid dendritic cells (mDCs). IFN-matured mDCs activate autoreactive T cells. These cells, together with plasmacytoid DCs, help expand autoreactive B cells. IFN-matured DCs also activate cytotoxic CD8(+) T cells, possibly increasing apoptotic cell availability. The capture of apoptotic cells by mDCs and of nucleic acid-containing immune complexes by plasmacytoid DCs and B cells amplifies the autoimmune reaction leading to disease manifestations. Genetic alterations in lineages other than B cells might explain other autoimmune syndromes where type I IFNs appear to be involved.	Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health	Banchereau, J (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak, Dallas, TX 75204 USA.	virginip@baylorhealth.edu	Pascual, Virginia/ABD-3099-2020		NATIONAL CANCER INSTITUTE [R01CA078846, P01CA084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046589] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA084512, R01 CA078846] Funding Source: Medline; NIAID NIH HHS [U19 AI057234-02] Funding Source: Medline; NIAMS NIH HHS [R01 AR46589-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alarcon-Riquelme ME, 2005, J AUTOIMMUN, V25, P46, DOI 10.1016/j.jaut.2005.09.012; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Aringer M, 2004, ARTHRITIS RHEUM-US, V50, P3161, DOI 10.1002/art.20576; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bondanza A, 2003, J IMMUNOL, V170, P24, DOI 10.4049/jimmunol.170.1.24; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Di Pucchio T, 2006, CANCER RES, V66, P4943, DOI 10.1158/0008-5472.CAN-05-3396; Dubois B, 1998, J IMMUNOL, V161, P2223; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fukuda A, 2000, CYTOKINES CELL MOL T, V6, P149, DOI 10.1080/mccm.6.3.149.154; FUNK J, 1991, BRIT J DERMATOL, V125, P463, DOI 10.1111/j.1365-2133.1991.tb14774.x; Gill MA, 2002, HUM IMMUNOL, V63, P1172, DOI 10.1016/S0198-8859(02)00756-5; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hron JD, 2004, J IMMUNOL, V173, P2134, DOI 10.4049/jimmunol.173.3.2134; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Isenberg DA, 2006, J RHEUMATOL, V33, P24; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Kyttaris VC, 2004, CURR OPIN RHEUMATOL, V16, P548, DOI 10.1097/01.bor.0000132646.55056.e0; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Liu K, 2006, CLIN IMMUNOL, V119, P123, DOI 10.1016/j.clim.2006.01.014; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Martin DA, 2005, J EXP MED, V202, P1465, DOI 10.1084/jem.20052228; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Matsushita M, 2000, CLIN RHEUMATOL, V19, P270, DOI 10.1007/PL00011171; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pawar RD, 2006, J AM SOC NEPHROL, V17, P141, DOI 10.1681/ASN.2005070714; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; RONNBLOM LE, 1991, ACTA ONCOL, V30, P537; Rothuizen LE, 1999, J NEUROIMMUNOL, V99, P131, DOI 10.1016/S0165-5728(99)00029-6; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Shodell M, 2003, LUPUS, V12, P222, DOI 10.1191/0961203303lu362xx; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tezak Z, 2002, J IMMUNOL, V168, P4154, DOI 10.4049/jimmunol.168.8.4154; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; Viallard JF, 2001, CLIN EXP IMMUNOL, V125, P485, DOI 10.1046/j.1365-2249.2001.01623.x; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Wykes M, 1998, J IMMUNOL, V161, P1313; Yamada M, 2002, ARTHRITIS RHEUM, V46, P735, DOI 10.1002/art.10112; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang S, 2004, IMMUNOLOGY, V112, P274, DOI 10.1111/j.1365-2567.2004.01862.x; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	100	683	717	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					383	392		10.1016/j.immuni.2006.08.010	http://dx.doi.org/10.1016/j.immuni.2006.08.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979570	Bronze			2022-12-18	WOS:000240862200005
J	Doyle, SE; Vaidya, SA; O'Connell, R; Dadgostar, H; Dempsey, PW; Wu, TT; Rao, G; Sun, R; Haberland, ME; Modlin, RL; Cheng, G				Doyle, SE; Vaidya, SA; O'Connell, R; Dadgostar, H; Dempsey, PW; Wu, TT; Rao, G; Sun, R; Haberland, ME; Modlin, RL; Cheng, G			IRF3 mediates a TLR3/TLR4-specific antiviral gene program	IMMUNITY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR-4; INTERFERON REGULATORY FACTOR-3; RESPIRATORY SYNCYTIAL VIRUS; DOUBLE-STRANDED-RNA; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; INDUCIBLE GENES; INNATE IMMUNITY; HUMAN MONOCYTES	We have identified a subset of genes that is specifically induced by stimulation of TLR3 or TLR4 but not by TLR2 or TLR9. Further gene expression analyses established that upregulation of several primary response genes was dependent on NF-kappaB, commonly activated by several TLRs, and interferon regulatory factor 3 (IRF3), which was found to confer TLR3/TLR4 specificity. Also identified was a group of secondary response genes which are part of an autocrine/paracrine loop activated by the primary response gene product, interferon beta (IFNbeta). Selective activation of the TLR3/TLR4-IRF3 pathway potently inhibited viral replication. These results suggest that TLR3 and TLR4 have evolutionarily diverged from other TLRs to activate IRF3, which mediates a specific gene program responsible for innate antiviral responses.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, MSTP Grad Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; Affymetrix Inc, Santa Clara, CA 95051 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Affymetrix	Cheng, G (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X	NATIONAL CANCER INSTITUTE [T32CA009120, R01CA087924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047868, R37AI147868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, R01GM057559] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA87924, 5-T32-CA009120-26] Funding Source: Medline; NIAID NIH HHS [R37 AI47868] Funding Source: Medline; NIGMS NIH HHS [R01 GM57559, GM 08042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AMHEITER H, 1990, CELL, V62, P51; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Dadgostar H, 2000, J BIOL CHEM, V275, P2539, DOI 10.1074/jbc.275.4.2539; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; Gariglio M, 1998, J LEUKOCYTE BIOL, V64, P608, DOI 10.1002/jlb.64.5.608; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; Gordon J, 2000, IMMUNOLOGY, V100, P269, DOI 10.1046/j.1365-2567.2000.00074.x; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Suzuki T, 2000, BLOOD, V96, P2584; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wu TT, 2001, J VIROL, V75, P9262, DOI 10.1128/JVI.75.19.9262-9273.2001; YAEGASHI Y, 1995, J EXP MED, V181, P953, DOI 10.1084/jem.181.3.953; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	55	682	717	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					251	263		10.1016/S1074-7613(02)00390-4	http://dx.doi.org/10.1016/S1074-7613(02)00390-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354379	Bronze			2022-12-18	WOS:000178163100003
J	LIN, JX; MIGONE, TS; TSANG, M; FRIEDMANN, M; WEATHERBEE, JA; ZHOU, L; YAMAUCHI, A; BLOOM, ET; MIETZ, J; JOHN, S; LEONARD, WJ				LIN, JX; MIGONE, TS; TSANG, M; FRIEDMANN, M; WEATHERBEE, JA; ZHOU, L; YAMAUCHI, A; BLOOM, ET; MIETZ, J; JOHN, S; LEONARD, WJ			THE ROLE OF SHARED RECEPTOR MOTIFS AND COMMON STAT PROTEINS IN THE GENERATION OF CYTOKINE PLEIOTROPY AND REDUNDANCY BY IL-2, IL-4, IL-7, IL-13, AND IL-15	IMMUNITY			English	Article							BETA-CHAIN GENE; INTERLEUKIN-2 RECEPTOR; GAMMA-CHAIN; FUNCTIONAL COMPONENT; SIGNAL-TRANSDUCTION; ACTIVATION; PROLIFERATION; LYMPHOCYTES; REQUIREMENT; EXPRESSION	To understand the molecular bases for cytokine redundancy and pleiotropy, we have compared the Stat proteins activated In peripheral blood lymphocytes (PBLs) by cytokines with shared and distinct actions. Interleukin-2 (IL-2) rapidly activated Stat5 in fresh PBL, and Stat3 and Stat5 in preactivated PBL. IL-7 and IL-15 induced the same complexes as IL-2, a feature explained by the existence of similar tyrosine-phosphorylated motifs in the cytoplasmic domains of IL-PRP and IL-7R that can serve as docking sites for Stat proteins. IL-13 induced the same complexes as IL-4, a finding explained by our studies implicating IL-4R as a shared component of the receptors. These studies demonstrate that a single cytokine can activate different combinations of Stat proteins under different physiological conditions, and also indicate two mechanisms by which distinct cytokines can activate the same Stat protein.	R & D SYST,MINNEAPOLIS,MN 55413; US FDA,CTR BIOL EVALUAT & RES,DIV CELL & GENE THERAPY,BETHESDA,MD 20892	US Food & Drug Administration (FDA)	LIN, JX (corresponding author), NHLBI,MOLEC IMMUNOL LAB,BLDG 10,BETHESDA,MD 20892, USA.		Ritz, Jerome/C-7929-2009; Leonard, Warren/AAA-1397-2022	Ritz, Jerome/0000-0001-5526-4669; John, Susan/0000-0002-5620-1982				AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; BOSCO MC, 1994, BLOOD, V83, P3462; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; CASEY LS, 1992, J IMMUNOL, V148, P3418; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEWIT H, 1994, BLOOD, V84, P608; EPLINGBURNETTE PK, 1995, EUR J IMMUNOL, V25, P291, DOI 10.1002/eji.1830250148; GALIZZI JP, 1990, INT IMMUNOL, V2, P669, DOI 10.1093/intimm/2.7.669; GILMOUR KC, 1994, P NATL ACAD SCI USA, V91, P6850, DOI 10.1073/pnas.91.15.6850; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GNARRA JR, 1990, P NATL ACAD SCI USA, V87, P3440, DOI 10.1073/pnas.87.9.3440; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HOFFMAN RC, 1994, FEBS LETT, V347, P17, DOI 10.1016/0014-5793(94)00496-X; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KRUSE N, 1992, EMBO J, V11, P3237, DOI 10.1002/j.1460-2075.1992.tb05401.x; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LEONARD WJ, 1994, IMMUNOL REV, V138, P61, DOI 10.1111/j.1600-065X.1994.tb00847.x; LEONARD WJ, 1994, CURR OPIN IMMUNOL, V6, P631, DOI 10.1016/0952-7915(94)90152-X; LEONARD WJ, 1990, INTERLEUKIN 2 KILLER, P305; LIN JX, 1993, MOL CELL BIOL, V13, P6201, DOI 10.1128/MCB.13.10.6201; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORICE WG, 1993, J BIOL CHEM, V268, P22737; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OTANI H, 1992, P NATL ACAD SCI USA, V89, P2789, DOI 10.1073/pnas.89.7.2789; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; RIGLEY KP, 1991, INT IMMUNOL, V3, P197, DOI 10.1093/intimm/3.2.197; ROTHMAN P, 1994, IMMUNITY, V1, P457, DOI 10.1016/1074-7613(94)90088-4; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YAMAUCHI A, 1993, J IMMUNOL, V151, P5535; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	53	682	693	0	12	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					331	339		10.1016/1074-7613(95)90141-8	http://dx.doi.org/10.1016/1074-7613(95)90141-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719938	Bronze			2022-12-18	WOS:A1995QU61600003
J	MacKenzie, A; Wilson, HL; Kiss-Toth, E; Dower, SK; North, RA; Surprenant, A				MacKenzie, A; Wilson, HL; Kiss-Toth, E; Dower, SK; North, RA; Surprenant, A			Rapid secretion of interleukin-1 beta by microvesicle shedding	IMMUNITY			English	Article							RECEPTOR-ASSOCIATED KINASE; IL-1-BETA RELEASE; DENDRITIC CELLS; PLASMA-MEMBRANE; ANNEXIN-V; ATP; VESICULATION; STIMULATION; EXOCYTOSIS; MATURATION	The proinflammatory cytokine interleukin-1 beta (IL-1 beta) is a secreted protein that lacks a signal peptide and does not follow currently known pathways of secretion. Its efficient release from activated immune cells requires a secondary stimulus such as extracellular ATP acting on P2X(7) receptors. We show that human THP-1 monocytes shed microvesicles from their plasma membrane within 2-5 s of activation of P2X(7) receptors. Two minutes after such stimulation, the released microvesicles contained bioactive IL-1 beta, which only later appeared in the vesicle-free supernatant. We conclude that microvesicle shedding is a major secretory pathway for rapid IL-1 beta release from activated monocytes and may represent a more general mechanism for secretion of similar leaderless secretory proteins.	Univ Sheffield, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Sect Funct Genom, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Surprenant, A (corresponding author), Univ Sheffield, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England.	a.surprenant@sheffield.ac.uk	Wilson, Heather/O-5909-2019; Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020; North, Richard/GQA-6156-2022	Wilson, Heather/0000-0002-7892-3425; Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; dower, steve/0000-0002-4675-4225				ALLEN TM, 1988, P NATL ACAD SCI USA, V85, P8067, DOI 10.1073/pnas.85.21.8067; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Aupeix K, 1997, J CLIN INVEST, V99, P1546, DOI 10.1172/JCI119317; BAHL AK, 1994, AGENTS ACTIONS, V42, P154, DOI 10.1007/BF01983483; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; DACHARYPRIGENT J, 1993, BLOOD, V81, P2554; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Ferrari D, 1997, J IMMUNOL, V159, P1451; Gardella S, 2000, BLOOD, V95, P3809; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Gu B, 1998, BLOOD, V92, P946; HALLAM TJ, 1985, J PHYSIOL-LONDON, V368, P131, DOI 10.1113/jphysiol.1985.sp015850; Hammill AK, 1999, EXP CELL RES, V251, P16, DOI 10.1006/excr.1999.4581; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hibell AD, 2000, BRIT J PHARMACOL, V130, P167, DOI 10.1038/sj.bjp.0703302; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kiss-Toth E, 2000, J IMMUNOL METHODS, V239, P125, DOI 10.1016/S0022-1759(00)00151-4; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Lollike K, 1999, J IMMUNOL METHODS, V232, P111, DOI 10.1016/S0022-1759(99)00169-6; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; MAJNO G, 1995, AM J PATHOL, V146, P3; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rubartelli A., 1997, UNUSUAL SECRETORY PA, P87, DOI [10.1007/978-3-662-22581-3_3, DOI 10.1007/978-3-662-22581-3_3]; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; SATTA N, 1994, J IMMUNOL, V153, P3245; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; WIEDMER T, 1990, BIOCHEMISTRY-US, V29, P623, DOI 10.1021/bi00455a005; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zeuner A, 1999, CELL DEATH DIFFER, V6, P1075, DOI 10.1038/sj.cdd.4400596; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zweifach A, 2000, BIOCHEM J, V349, P255, DOI 10.1042/0264-6021:3490255	52	678	697	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2001	15	5					825	835		10.1016/S1074-7613(01)00229-1	http://dx.doi.org/10.1016/S1074-7613(01)00229-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728343	Bronze			2022-12-18	WOS:000172528200014
J	Sprick, MR; Weigand, MA; Rieser, E; Rauch, CT; Juo, P; Blenis, J; Krammer, PH; Walczak, H				Sprick, MR; Weigand, MA; Rieser, E; Rauch, CT; Juo, P; Blenis, J; Krammer, PH; Walczak, H			FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2	IMMUNITY			English	Article							CYTOTOXIC LIGAND TRAIL; NF-KAPPA-B; FADD-DEPENDENT APOPTOSIS; SIGNALING COMPLEX DISC; HUMAN NK CELLS; HUMAN T-CELLS; DEATH DOMAIN; FAS LIGAND; TUMORICIDAL ACTIVITY; DECOY RECEPTORS	Apoptosis induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL/APO-2L) has been shown to exert important functions during various immunological processes. The involvement of the death adaptor proteins FADD/MORT1,TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial. Analysis of the native TRAIL death-inducing signaling complex (DISC) revealed ligand-dependent recruitment of FADD/MORT1 and caspase-8. Differential precipitation of ligand-stimulated TRAIL receptors demonstrated that FADD/MORT1 and caspase-8 were recruited to TRAIL-R1 and TRAIL-R2 independently of each other. FADD/MORT1- and caspase-8-deficient Jurkat cells expressing only TRAIL-R2 were resistant to TRAIL-induced apoptosis. Thus, FADD/MORT1 and caspase-8 are essential for apoptosis induction via TRAIL-R2.	German Canc Res Ctr, Tumor Immunol Program, D-69120 Heidelberg, Germany; Univ Heidelberg, Anesthesiol Clin, D-69120 Heidelberg, Germany; Immunex Res & Dev Corp, Dept Prot Chem, Seattle, WA 98101 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School	Walczak, H (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Sprick, Martin R./I-7995-2019; Sprick, Martin R./A-8611-2008; Juo, Peter/CJY-3695-2022; Walczak, Henning/AAV-2214-2020	Sprick, Martin R./0000-0001-9691-7574; Sprick, Martin R./0000-0001-9691-7574; Juo, Peter/0000-0002-3039-2266; Walczak, Henning/0000-0002-6312-4591				Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Gliniak B, 1999, CANCER RES, V59, P6153; Griffith TS, 1998, J IMMUNOL, V161, P2833; Griffith TS, 1999, J IMMUNOL, V162, P2597; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Gronbaek K, 2000, BLOOD, V95, P2184; Johnsen AC, 1999, CYTOKINE, V11, P664, DOI 10.1006/cyto.1999.0489; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kashii Y, 1999, J IMMUNOL, V163, P5358; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kayagaki N, 1999, J IMMUNOL, V163, P1906; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer P H, 1999, Adv Immunol, V71, P163; Leverkus M, 2000, CANCER RES, V60, P553; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.3.CO;2-K; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mongkolsapaya J, 1998, J IMMUNOL, V160, P3; Musgrave BL, 1999, EXP CELL RES, V252, P96, DOI 10.1006/excr.1999.4631; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Peter M E, 1999, Results Probl Cell Differ, V23, P25; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Thomas WD, 1998, J IMMUNOL, V161, P2195; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vidalain PO, 2000, J VIROL, V74, P556, DOI 10.1128/JVI.74.1.556-559.2000; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961	61	677	709	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2000	12	6					599	609		10.1016/S1074-7613(00)80211-3	http://dx.doi.org/10.1016/S1074-7613(00)80211-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894160	Bronze			2022-12-18	WOS:000087937300002
J	Amanat, F; Krammer, F				Amanat, Fatima; Krammer, Florian			SARS-CoV-2 Vaccines: Status Report	IMMUNITY			English	Review							ACUTE RESPIRATORY SYNDROME; INFLUENZA VACCINE; SARS CORONAVIRUS; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; IMMUNOGENICITY; INFECTION; SPIKE; LOPINAVIR/RITONAVIR; IMMUNIZATION	SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since infected more than 870,000 individuals and causedmore than 43,000 deaths globally. Here, we discuss therapeutic and prophylactic interventions for SARS-CoV-2 with a focus on vaccine development and its challenges. Vaccines are being rapidly developed but will likely come too late to affect the first wave of a potential pandemic. Nevertheless, critical lessons can be learned for the development of vaccines against rapidly emerging viruses. Importantly, SARS-CoV-2 vaccines will be essential to reducing morbidity and mortality if the virus establishes itself in the population.	[Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X	National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract [75N93019C00051]; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract [HHSN272201400008C]; NIAID grants [AI117287, AI128821]; U.S. Department of Defense; Bill and Melinda Gates Foundation; CEIRS	National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract; NIAID grants; U.S. Department of Defense(United States Department of Defense); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CEIRS	We thank Francesco Berlanda-Scorza for providing feedback on this manuscript. Work on influenza virus vaccines and immunity in the Krammer laboratory is supported by the National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN272201400008C, and NIAID grants AI117287 and AI128821, as well as funding from the U.S. Department of Defense and the Bill and Melinda Gates Foundation. Work on SARS-CoV-2 reagents is supported by CEIRS and institutional seed funding; reagents are being deposited into BEI Resources to support SARS-CoV-2 research and countermeasure development.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688; [Anonymous], 2020, NEW ENGL J MED, DOI [DOI 10.1056/NEJMOA2001316, 10.1056/NEJMc2031364, 10.1056/NEJMoa2001316]; [Anonymous], 2020, NEW ENGL J MED; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Benoit A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv067; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Brown AJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104541; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Centers for Disease Control and Prevention, 2021, CHINA CDC WEEKLY, DOI 10.4258/hir.2022.28.2.160; Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392; Chan K. S., 2003, Hong Kong Medical Journal, V9, P399; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Choe PG, 2017, EMERG INFECT DIS, V23, P1079, DOI 10.3201/eid2307.170310; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; DiazGranados CA, 2013, VACCINE, V31, P861, DOI 10.1016/j.vaccine.2012.12.013; Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103; Fehr A.R., 2015, METHOD MOL BIOL, P1, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Hull MW, 2011, ANN MED, V43, P375, DOI 10.3109/07853890.2011.572905; Jancarikova G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006564; Johnson and Johnson, 2020, WHAT YOU NEED KNOW L; Kadam RU, 2017, P NATL ACAD SCI USA, V114, P206, DOI 10.1073/pnas.1617020114; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lam TT-Y., 2020, IDENTIFICATION 2019; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Lim JK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e92; Lin JT, 2007, ANTIVIR THER, V12, P1107; Liu W, 2006, J INFECT DIS, V193, P792, DOI 10.1086/500469; Luke T, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1061; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Roper RL, 2009, EXPERT REV VACCINES, V8, P887, DOI 10.1586/ERV.09.43; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; Sanofi, 2020, SAN JOINS FORC US DE; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Teissier E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015874; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang QD, 2016, ACS INFECT DIS, V2, P361, DOI 10.1021/acsinfecdis.6b00006; Weingartl H, 2004, J VIROL, V78, P12672, DOI 10.1128/JVI.78.22.12672-12676.2004; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Yong CY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01781; Zhang T., 2020, PANGOLIN HOMOLOGY AS, DOI [10.1101/2020.02.19.950253., 10.1101/2020.02.19.950253, DOI 10.1101/2020.02.19.950253]; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zhou ZM, 2006, VACCINE, V24, P3624, DOI 10.1016/j.vaccine.2006.01.059; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	59	676	706	11	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					583	589		10.1016/j.immuni.2020.03.007	http://dx.doi.org/10.1016/j.immuni.2020.03.007			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32259480	Green Published, Bronze			2022-12-18	WOS:000526782600005
J	Cooper, S; Erickson, AL; Adams, EJ; Kansopon, J; Weiner, AJ; Chien, DY; Houghton, M; Parham, P; Walker, CM				Cooper, S; Erickson, AL; Adams, EJ; Kansopon, J; Weiner, AJ; Chien, DY; Houghton, M; Parham, P; Walker, CM			Analysis of a successful immune response against hepatitis C virus	IMMUNITY			English	Article							T-LYMPHOCYTE RESPONSE; NON-B-HEPATITIS; CIRCULATING ANTIBODIES; NON-A; INFECTION; CHIMPANZEES; DISEASE; EVOLUTION; DIVERSITY; DIAGNOSIS	To investigate the type of immunity responsible for resolution of hepatitis C virus (HCV) infection, we monitored antibody and intrahepatic cytotoxic T lymphocyte (CTL) responses during acute (<20 weeks) infection in chimpanzees. Two animals who terminated infection made strong CTL but poor antibody responses. In both resolvers, CTL targeted at least six viral regions. In contrast, animals developing chronic hepatitis generated weaker acute CTL responses. Extensive analysis of the fine specificity of the CTL in one resolver revealed nine peptide epitopes and restriction by all six MHC class I allotypes. Every specificity shown during acute hepatitis persisted in normal liver tissue more than 1 yr after resolution. These results suggest that CD8(+)CTL are better correlated with protection against HCV infection than antibodies.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Chiron Corp, Emeryville, CA 94608 USA	Stanford University; Stanford University; Novartis	Cooper, S (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Sherman Fairchild Bldg, Stanford, CA 94305 USA.		Yang, Chen/G-1379-2010	Houghton, Michael/0000-0003-3762-6771	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017892, R01AI017892] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-17892] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams G, 1997, PEDIATR INFECT DIS J, V16, P533, DOI 10.1097/00006454-199705000-00021; Alter MJ, 1996, EUR J GASTROEN HEPAT, V8, P319, DOI 10.1097/00042737-199604000-00005; Bassett SE, 1998, J VIROL, V72, P2589, DOI 10.1128/JVI.72.4.2589-2599.1998; BJORO K, 1994, NEW ENGL J MED, V331, P1607, DOI 10.1056/NEJM199412153312402; BONTROP RE, 1995, IMMUNOL REV, V143, P33, DOI 10.1111/j.1600-065X.1995.tb00669.x; CERNY A, 1995, EUR J IMMUNOL, V25, P627, DOI 10.1002/eji.1830250248; CERNY A, 1995, J CLIN INVEST, V95, P521, DOI 10.1172/JCI117694; CHIEN DY, 1992, P NATL ACAD SCI USA, V89, P10011, DOI 10.1073/pnas.89.21.10011; CHIEN DY, 1993, J GASTROEN HEPATOL, V8, pS33; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Christie JML, 1997, CLIN EXP IMMUNOL, V110, P4; Cooper S, 1998, IMMUNOGENETICS, V47, P212, DOI 10.1007/s002510050350; Cooper S, 1996, J EXP MED, V183, P663, DOI 10.1084/jem.183.2.663; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; DOMENA JD, 1993, TISSUE ANTIGENS, V42, P509; Dries V, 1999, HEPATOLOGY, V29, P223, DOI 10.1002/hep.510290118; ERICKSON AL, 1993, J IMMUNOL, V151, P4189; GRETCH DR, 1993, J CLIN MICROBIOL, V31, P289, DOI 10.1128/JCM.31.2.289-291.1993; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; Houghton M, 1997, P INT S VIR HEP LIV, P656; Kobayashi M, 1997, J GASTROEN HEPATOL, V12, P73, DOI 10.1111/j.1440-1746.1997.tb00350.x; KOWALSKI H, 1996, J EXP MED, V183, P1; Koziel MJ, 1997, J INFECT DIS, V176, P859, DOI 10.1086/516546; KOZIEL MJ, 1992, J IMMUNOL, V149, P3339; KUMAR U, 1994, GASTROENTEROLOGY, V106, P1072, DOI 10.1016/0016-5085(94)90770-6; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; LAWLOR DA, 1990, IMMUNOL REV, V113, P147, DOI 10.1111/j.1600-065X.1990.tb00040.x; MINUTELLO MA, 1993, J EXP MED, V178, P17, DOI 10.1084/jem.178.1.17; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; MOORJANKOWSKI J, 1989, J MED PRIMATOL, V18, P1; MUCHMORE E, 1988, J MED PRIMATOL, V17, P235; Nelson DR, 1997, J IMMUNOL, V158, P1473; OKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P6410, DOI 10.1093/nar/20.23.6410; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Rehermann B, 1996, J CLIN INVEST, V98, P1431; Sharara AI, 1996, ANN INTERN MED, V125, P658, DOI 10.7326/0003-4819-125-8-199610150-00006; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Walker CM, 1997, SPRINGER SEMIN IMMUN, V19, P85, DOI 10.1007/BF00945027; WATKINS DI, 1995, CRIT REV IMMUNOL, V15, P1; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755	42	675	698	2	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					439	449		10.1016/S1074-7613(00)80044-8	http://dx.doi.org/10.1016/S1074-7613(00)80044-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229187	Bronze			2022-12-18	WOS:000079989600005
J	Stark, MA; Huo, YQ; Burcin, TL; Morris, MA; Olson, TS; Ley, K				Stark, MA; Huo, YQ; Burcin, TL; Morris, MA; Olson, TS; Ley, K			Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; SELECTIN-DEFICIENT MICE; DOUBLE-NULL MICE; P-SELECTIN; IN-VIVO; T-CELLS; LEUKOCYTE RECRUITMENT; COMMENSAL BACTERIA; DENDRITIC CELLS; FACTOR-RECEPTOR	Homeostatic regulation of neutrophil production is thought to match neutrophil elimination to maintain approximately constant numbers in the blood. Here, we show that IL-17, a cytokine that regulates granulopoiesis through G-CSF, is made by gamma delta T cells and unconventional alpha beta T cells. These neutrophil-regulatory T cells (Tn) are expanded in mice that lack leukocyte adhesion molecules, which have neutrophilia and defective neutrophil trafficking. Normal neutrophils migrate to tissues, where they become apoptotic and are phagocytosed by macrophages and dendritic cells. This curbs phagocyte secretion of IL-23, a cytokine controlling IL-17 production by Tn cells. Adoptive transfer of wild-type, but not adhesion molecule-deficient, neutrophils into mice deficient in beta(2) integrins transiently decreases neutrophilia and reduces levels of serum IL-17. Antibody blockade of the p40 subunit of IL-23 reduces neutrophil numbers in wild-type mice. These findings identify a major homeostatic mechanism for the regulation of neutrophil production in vivo.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Ley, K (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	klausley@virginia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008715] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54136] Funding Source: Medline; NIGMS NIH HHS [T32 GM 08715-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Collins RG, 2001, BLOOD, V98, P727, DOI 10.1182/blood.V98.3.727; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DEMETRI GD, 1991, BLOOD, V78, P2791; Ding ZM, 1999, J IMMUNOL, V163, P5029; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Emoto M, 2003, TRENDS IMMUNOL, V24, P364, DOI 10.1016/S1471-4906(03)00162-5; Forlow SB, 2002, FASEB J, V16, P1488, DOI 10.1096/fj.02-0230com; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Forlow SB, 2001, AM J PHYSIOL-HEART C, V280, pH634, DOI 10.1152/ajpheart.2001.280.2.H634; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Horwitz BH, 2001, BLOOD, V97, P1578, DOI 10.1182/blood.V97.6.1578; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; JOHNSON RC, 1995, BLOOD, V86, P1106; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; MacDonald HR, 2002, CURR OPIN IMMUNOL, V14, P250, DOI 10.1016/S0952-7915(02)00329-1; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Miyamoto M, 2003, J IMMUNOL, V170, P5228, DOI 10.4049/jimmunol.170.10.5228; Moodycliffe AM, 1999, J IMMUNOL, V162, P5156; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oehen S, 1998, J IMMUNOL, V161, P5338; Ohkubo T, 1999, SCAND J IMMUNOL, V49, P73, DOI 10.1046/j.1365-3083.1999.00456.x; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; Ren Y, 2001, J IMMUNOL, V166, P4743, DOI 10.4049/jimmunol.166.7.4743; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Sprent J, 1997, CURR OPIN IMMUNOL, V9, P371, DOI 10.1016/S0952-7915(97)80084-2; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Spriggs MK, 1997, J CLIN IMMUNOL, V17, P366, DOI 10.1023/A:1027360106635; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; WATANABE H, 1995, J IMMUNOL, V155, P2972; Weinmann P, 2003, BLOOD, V101, P739, DOI 10.1182/blood-2002-01-0239; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; YOO ZB, 1995, J IMMUNOL, V155, P5483	57	671	691	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					285	294		10.1016/j.immuni.2005.01.011	http://dx.doi.org/10.1016/j.immuni.2005.01.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780986	Bronze			2022-12-18	WOS:000228105700004
J	Shaffer, AL; Yu, X; He, YS; Boldrick, J; Chan, EP; Staudt, LM				Shaffer, AL; Yu, X; He, YS; Boldrick, J; Chan, EP; Staudt, LM			BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control	IMMUNITY			English	Article							GERMINAL-CENTER FORMATION; DEPENDENT KINASE INHIBITOR; CENTER B-CELLS; TRANSCRIPTIONAL REPRESSION; MICE LACKING; EXPRESSION; PROTEIN; P27(KIP1); MIP-1-ALPHA; BLIMP-1	BCL-6, a transcriptional repressor frequently translocated in lymphomas, regulates germinal center B cell differentiation and inflammation. DNA microarray screening identified genes repressed by BCL-6, including many lymphocyte activation genes, suggesting that BCL-6 modulates B cell receptor signals. BCL-6 repression of two chemokine genes, MIP-1 alpha and IP-10, may also attenuate inflammatory responses. Blimp-1, another BCL-6 target, is important for plasmacytic differentiation. Since BCL-6 expression is silenced in plasma cells, repression of blimp-1 by BCL-6 may control plasmacytic differentiation. Indeed, inhibition of BCL-6 function initiated changes indicative of plasmacytic differentiation, including decreased expression of c-Myc and increased expression of the cell cycle inhibitor p27kip1. These data suggest that malignant transformation by BCL-6 involves inhibition of differentiation and enhanced proliferation.	NCI, Metab Branch, Div Clin Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Div Clin Sci, Bethesda, MD 20892 USA.		Staudt, Louis/AAC-5324-2019					Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; BARONI M, 1995, PROG VET NEUROL, V6, P13; Briegel K, 1996, DEVELOPMENT, V122, P3839; CAMP RL, 1991, J EXP MED, V173, P763, DOI 10.1084/jem.173.3.763; Carman JA, 1996, J IMMUNOL, V156, P4562; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Dalla-Favera R, 1999, CURR TOP MICROBIOL, V246, P257; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; FRANCIS MK, 1995, J BIOL CHEM, V270, P11502, DOI 10.1074/jbc.270.19.11502; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Jun DY, 1997, MOL CELLS, V7, P537; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; Krzysiek R, 1999, J IMMUNOL, V162, P4455; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIU YJ, 1996, HDB EXPT IMMUNOLOGY; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; LUKACS NW, 1995, EUR J IMMUNOL, V25, P245, DOI 10.1002/eji.1830250140; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; MITELMAN F, 1994, CATALOG CHROMOSOMAL; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Quintanilla-Martinez L, 1998, AM J PATHOL, V153, P175, DOI 10.1016/S0002-9440(10)65558-7; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Sanchez-Beato M, 1999, BLOOD, V94, P765, DOI 10.1182/blood.V94.2.765.414a29_765_772; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Soro PG, 1999, J IMMUNOL, V163, P611; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; WAGNER AJ, 1993, CELL GROWTH DIFFER, V4, P879; Wheeler K, 1996, INT IMMUNOL, V8, P815, DOI 10.1093/intimm/8.6.815; WIDMER U, 1993, J IMMUNOL, V150, P4996; Yang CY, 1997, J TRAUMA, V43, P74, DOI 10.1097/00005373-199707000-00017; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	52	663	682	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					199	212		10.1016/S1074-7613(00)00020-0	http://dx.doi.org/10.1016/S1074-7613(00)00020-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981963	Bronze			2022-12-18	WOS:000089132100005
J	Choi, YS; Kageyama, R; Eto, D; Escobar, TC; Johnston, RJ; Monticelli, L; Lao, C; Crotty, S				Choi, Youn Soo; Kageyama, Robin; Eto, Danello; Escobar, Tania C.; Johnston, Robert J.; Monticelli, Laurel; Lao, Christopher; Crotty, Shane			ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor BcI6	IMMUNITY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; IN-VIVO; B-CELLS; HUMORAL IMMUNITY; GERMINAL-CENTERS; C-MAF; IL-21; CD28; SAP; ACTIVATION	The nature of follicular helper CD4(+) T (Tfh) cell differentiation remains controversial, including the minimal signals required for Tfh cell differentiation and the time at which Tfh cell differentiation occurs. Here we determine that Tfh cell development initiates immediately during dendritic cell (DC) priming in vivo. We demonstrate that inducible costimulator (ICOS) provides a critical early signal to induce the transcription factor BcI6, and BcI6 then induces CXCR5, the canonical feature of Tfh cells. Strikingly, a bifurcation between Tfh and effector Th cells was measurable by the second cell division of CD4(+) T cells, at day 2 after an acute viral infection: IL2R alpha(int) cells expressed BcI6 and CXCR5 (Tfh cell program), whereas IL2R alpha(hi) cells exhibited strong Blimp1 expression that repressed BcI6 (effector Th cell program). Virtually complete polarization between BcI6(+) Tfh cells and Blimp1(+) effector Th cell populations developed by 72 hr, even without B cells. Tfh cells were subsequently lost in the absence of B cells, demonstrating a B cell requirement for maintenance of BcI6 and Tfh cell commitment via sequential ICOS signals.	[Choi, Youn Soo; Kageyama, Robin; Eto, Danello; Escobar, Tania C.; Johnston, Robert J.; Monticelli, Laurel; Lao, Christopher; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Johnston, Robert J.; Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@liai.org	Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	NIH; Pew Scholars in Biomedical Research award; Cancer Research Institute; LIAI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063107, R01AI072543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars in Biomedical Research award; Cancer Research Institute; LIAI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Kim, K. Van Gunst, and A. Jose for cell sorting and L. Crickard for animal care. We thank BD for generously providing alpha BcI6 mAb (clone K112-91). We thank M. Pipkin and R. Rickert for advice and discussions. This study was supported by grants from the NIH, a Pew Scholars in Biomedical Research award, a Cancer Research Institute Young Investigator award, and LIAI internal funds.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Awasthi A, 2009, SCIENCE, V325, P953, DOI 10.1126/science.1178752; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	61	659	692	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					932	946		10.1016/j.immuni.2011.03.023	http://dx.doi.org/10.1016/j.immuni.2011.03.023			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21636296	Green Accepted, Bronze			2022-12-18	WOS:000292349700013
J	Wakkach, A; Fournier, N; Brun, V; Breittmayer, JP; Cottrez, F; Groux, H				Wakkach, A; Fournier, N; Brun, V; Breittmayer, JP; Cottrez, F; Groux, H			Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo	IMMUNITY			English	Article							EPITHELIAL-CELLS; LYMPH-NODES; IMMATURE; ANTIGEN; RESPONSES; GENERATION; IMMUNITY; INHIBIT	Active suppression is mediated by a subpopulation of CD4(+) T cells that prevents autoimmunity. However, the mechanisms involved in their differentiation in vivo are currently under intensive research. Here we show that in vitro culture of bone marrow cells in the presence of IL-10 induces the differentiation of a distinct subset of dendritic cells with a specific expression of CD45RB. These CD11c(low)CD45RB(high) DCs are present in the spleen and lymph nodes of normal mice and are significantly enriched in the spleen of IL-10 Tg mice. These natural or in vitro-derived DCs display plasmacytoid morphology and an immature-like phenotype, and secrete high levels of IL-10 after activation. OVA peptide-pulsed CD11c(low)CD45RB(high) DCs specifically induce tolerance through the differentiation of TO cells in vitro and in vivo. Our findings identify a natural DC subset that induces the differentiation of Tr1 cells and suggest their therapeutic use.	Hop Archet, INSERM U576, F-06200 Nice, France; TxCell, F-06200 Nice, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm)	Groux, H (corresponding author), Hop Archet, INSERM U576, F-06200 Nice, France.							Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; COTTREZ F, 1994, J IMMUNOL METHODS, V172, P85, DOI 10.1016/0022-1759(94)90381-6; DING L, 1993, J IMMUNOL, V151, P1224; Groux H, 1999, J IMMUNOL, V162, P1723; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; PARR MB, 1991, BIOL REPROD, V45, P252, DOI 10.1095/biolreprod45.2.252; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Wakkach A, 2001, J IMMUNOL, V167, P3107, DOI 10.4049/jimmunol.167.6.3107; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	30	659	731	4	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					605	617		10.1016/S1074-7613(03)00113-4	http://dx.doi.org/10.1016/S1074-7613(03)00113-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753738	Bronze			2022-12-18	WOS:000182962200006
J	Guarda, G; Braun, M; Staehli, F; Tardivel, A; Mattmann, C; Forster, I; Farlik, M; Decker, T; Du Pasquier, RA; Romero, P; Tschopp, J				Guarda, Greta; Braun, Marion; Staehli, Francesco; Tardivel, Aubry; Mattmann, Chantal; Foerster, Irmgard; Farlik, Matthias; Decker, Thomas; Du Pasquier, Renaud A.; Romero, Pedro; Tschopp, Juerg			Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation	IMMUNITY			English	Article							FAMILIAL MEDITERRANEAN FEVER; MULTIPLE-SCLEROSIS; HOST-DEFENSE; RECOMBINANT INTERLEUKIN-1; BACTERIAL-INFECTION; RECEPTOR ANTAGONIST; CASPASE-1; INNATE; MICE; CRYSTALS	Type I interferon (IFN) is a common therapy for autoimmune and inflammatory disorders, yet the mechanisms of action are largely unknown. Here we showed that type I IFN inhibited interleukin-1 (IL-1) production through two distinct mechanisms. Type I IFN signaling, via the STAT1 transcription factor, repressed the activity of the NLRP1 and NLRP3 inflammasomes, thereby suppressing caspase-1-dependent IL-1 beta maturation. In addition, type I IFN induced IL-10 in a STAT1-dependent manner; autocrine IL-10 then signaled via STAT3 to reduce the abundance of pro-IL-1 alpha and pro-IL-1 beta. In vivo, poly(I:C)-induced type I IFN diminished IL-1 13 production in response to alum and Candida albicans, thus increasing susceptibility to this fungal pathogen. Importantly, monocytes from multiple sclerosis patients undergoing IFN-beta treatment produced substantially less IL-1 beta than monocytes derived from healthy donors. Our findings may thus explain the effectiveness of type I IFN in the treatment of inflammatory diseases but also the observed "weakening" of the immune system after viral infection.	[Guarda, Greta; Staehli, Francesco; Tardivel, Aubry; Mattmann, Chantal; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Braun, Marion; Romero, Pedro] Ludwig Inst Canc Res, CH-1011 Lausanne, Switzerland; [Foerster, Irmgard] Univ Dusseldorf, Inst Umweltmed Forsch gGmbH, D-40225 Dusseldorf, Germany; [Farlik, Matthias; Decker, Thomas] Univ Vienna, Max F Perutz Labs, Dept Genet Microbiol & Immunobiol, A-1030 Vienna, Austria; [Du Pasquier, Renaud A.] Univ Lausanne Hosp, Serv Neurol, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Du Pasquier, Renaud A.] Univ Lausanne Hosp, Serv Immunol, CH-1011 Lausanne, Switzerland	University of Lausanne; Ludwig Institute for Cancer Research; Heinrich Heine University Dusseldorf; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Förster, Irmgard/P-8545-2016; Du Pasquier, Renaud/O-8588-2016; Guarda, Greta/G-1921-2011	Förster, Irmgard/0000-0002-7644-5642; Du Pasquier, Renaud/0000-0002-2786-3434; Guarda, Greta/0000-0001-9243-6116	Swiss National Science Foundation; Institute for Arthritis Research; NCCR Molecular Oncology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute for Arthritis Research; NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	We acknowledge patients and healthy volunteers for their contribution to this study by donating blood. We thank M. Aguet, ISREC (Lausanne), H. Acha-Or-bea, UNIL (Lausanne), A. Suhrbier, Queensland Institute of Medical Research (Brisbane), and P. Ashton-Rickardt, Imperial College London (London) for knockout mice; M. Winter (University of Duesseldorf), R. Castillo, and O. Gross for technical help; and K. Schroder and C. Thomas for critical reading of the manuscript. This work was in part supported by the Swiss National Science Foundation and by the Institute for Arthritis Research. M.B. and P.R. are supported by the Swiss National Science foundation and P.R. also by the NCCR Molecular Oncology.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Barkhof F, 2007, ARCH NEUROL-CHICAGO, V64, P1292, DOI 10.1001/archneur.64.9.1292; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; FANTUZZI G, 1993, MEDIAT INFLAMM, V2, P263, DOI 10.1155/S0962935193000365; Furlan R, 1999, J IMMUNOL, V163, P2403; Furlan R, 1999, J NEUROL NEUROSUR PS, V67, P785, DOI 10.1136/jnnp.67.6.785; Giovannoni G, 1999, J ROY COLL PHYS LOND, V33, P315; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; HUANG YL, 1995, J INTERF CYTOK RES, V15, P317, DOI 10.1089/jir.1995.15.317; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; JENSEN J, 1992, INFECT IMMUN, V60, P4549, DOI 10.1128/IAI.60.11.4549-4557.1992; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kantarci OH, 2002, J NEUROIMMUNOL, V123, P144, DOI 10.1016/S0165-5728(01)00481-7; Kotter I, 2004, SEMIN ARTHRITIS RHEU, V33, P320, DOI 10.1053/S0049-0172(03)00167-7; KULLBERG BJ, 1990, INFECT IMMUN, V58, P3319, DOI 10.1128/IAI.58.10.3319-3324.1990; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; McDermott MF, 2007, TRENDS MOL MED, V13, P381, DOI 10.1016/j.molmed.2007.07.005; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tweezer-Zaks N, 2008, J RHEUMATOL, V35, P1362; VANTWOUT JW, 1988, EUR J IMMUNOL, V18, P1143, DOI 10.1002/eji.1830180728; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; WORTHINGTON M, 1972, INFECT IMMUN, V5, P199, DOI 10.1128/IAI.5.2.199-202.1972; Zang YCQ, 2004, MULT SCLER J, V10, P499, DOI 10.1191/1352458504ms1081oa	44	656	679	2	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					213	223		10.1016/j.immuni.2011.02.006	http://dx.doi.org/10.1016/j.immuni.2011.02.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349431	Bronze			2022-12-18	WOS:000287989500011
J	Butz, EA; Bevan, MJ				Butz, EA; Bevan, MJ			Massive expansion of antigen-specific CD8+ T cells during an acute virus infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CLASS-I MOLECULES; MEMORY; PROLIFERATION; ACTIVATION; RESPONSES; PEPTIDE; SELECTION; TURNOVER; INVIVO	During LCMV infection, CD8(+) T cells expand greatly. Bystander activation has been thought to play a role because few cells score as LCMV specific in limiting dilution analysis. In contrast, we find that at least a quarter of the CD8(+) cells secrete IFN gamma specifically in response to LCMV peptides at the peak of the response. Moreover, by analyzing the expansion of adoptively transferred LCMV-specific, TCR-transgenic CD8(+) T cells in congenic hosts, we have determined that most of the CD8(+) cell expansion is virus specific. Analysis of the effect of the monospecific TCR-transgenic T cells on the host response to three LCMV epitopes suggests that CTL precursors compete for sites on the APC in an epitope-specific fashion and that this competition determines the specificity of the response.	Univ Washington, Dept Immunol, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Howard Hughes Med Inst, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335-19, R01 AI019335] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; ANDERSSON EC, 1995, SCAND J IMMUNOL, V42, P110, DOI 10.1111/j.1365-3083.1995.tb03633.x; BACIK I, 1994, J IMMUNOL, V152, P381; BEVAN MJ, 1995, J EXP MED, V182, P639, DOI 10.1084/jem.182.3.639; Beverley PCL, 1996, CURR OPIN IMMUNOL, V8, P327, DOI 10.1016/S0952-7915(96)80120-8; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; Cauda R, 1987, Viral Immunol, V1, P145; Cose SC, 1997, EUR J IMMUNOL, V27, P2310, DOI 10.1002/eji.1830270927; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; Kedl RM, 1997, J IMMUNOL, V159, P650; KRAMER MD, 1989, EUR J IMMUNOL, V19, P151, DOI 10.1002/eji.1830190124; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LYNCH F, 1989, J IMMUNOL, V142, P3592; MACKETT M, 1985, DNA CLONING PRACTICA, P191; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; MUELLE DL, 1997, CURR BIOL, V7, P255; NAHILL SR, 1993, J EXP MED, V177, P317, DOI 10.1084/jem.177.2.317; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RAZVI ES, 1995, J IMMUNOL, V154, P620; ROTT O, 1995, CELL IMMUNOL, V161, P158, DOI 10.1006/cimm.1995.1022; RUBIN RH, 1981, INT J IMMUNOPHARMACO, V3, P307, DOI 10.1016/0192-0561(81)90024-2; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; SPEISER DE, 1992, J IMMUNOL, V149, P972; STRANG G, 1987, IMMUNOLOGY, V62, P647; Tough DF, 1996, IMMUNOL REV, V150, P129, DOI 10.1111/j.1600-065X.1996.tb00699.x; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TRIPP RA, 1995, J IMMUNOL, V154, P6013; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; YANG H, 1986, J IMMUNOL, V136, P1186; YANG HY, 1989, J IMMUNOL, V142, P1710; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	45	654	663	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					167	175		10.1016/S1074-7613(00)80469-0	http://dx.doi.org/10.1016/S1074-7613(00)80469-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9491998	Green Accepted, Bronze			2022-12-18	WOS:000072201800004
J	Bogunovic, M; Ginhoux, F; Helft, J; Shang, LM; Hashimoto, D; Greter, M; Liu, K; Jakubzick, C; Ingersoll, MA; Leboeuf, M; Stanley, ER; Nussenzweig, M; Lira, SA; Randolph, GJ; Merad, M				Bogunovic, Milena; Ginhoux, Florent; Helft, Julie; Shang, Limin; Hashimoto, Daigo; Greter, Melanie; Liu, Kang; Jakubzick, Claudia; Ingersoll, Molly A.; Leboeuf, Marylene; Stanley, E. Richard; Nussenzweig, Michel; Lira, Sergio A.; Randolph, Gwendalyn J.; Merad, Miriam			Origin of the Lamina Propria Dendritic Cell Network	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; IN-VIVO; SALMONELLA-TYPHIMURIUM; EPITHELIAL-CELLS; T-CELLS; MACROPHAGE; RECEPTOR; MUCOSAL; MICE; POPULATION	CX(3)CR1(+) and CD103(+) dendritic cells (DCs) in intestinal lamina propria play a key role in mucosal immunity. However, the origin and the developmental pathways that regulate their differentiation in the lamina propria remain unclear. We showed that monocytes gave rise exclusively to CD103(-)CX(3)CR1(+) lamina propria DCs under the control of macrophage-colony-stimulating factor receptor (M-CSFR) and Fms-like thyrosine kinase 3 (FIt3) ligands. In contrast, common DC progenitors (CDP) and pre-DCs, which give rise to lymphoid organ DCs but not to monocytes, differentiated exclusively into CD103(+)CX(3)CR1(-) lamina propria DCs under the control of FIt3 and granulocyte-macrophage-colony-stimulating factor receptor (GM-CSFR) ligands. CD103(+)CX(3)CR1(-) DCs but not CD103(-)CX(3)CR1(+) DCs in the lamina propria constitutively expressed CCR7 and were the first DCs to transport pathogenic Salmonella from the intestinal tract to the mesenteric lymph nodes. Altogether, these results underline the diverse origin of the lamina propria DC network and identify mucosal DCs that arise from pre-DCs as key sentinels of the gut immune system.	[Bogunovic, Milena; Ginhoux, Florent; Helft, Julie; Hashimoto, Daigo; Greter, Melanie; Jakubzick, Claudia; Ingersoll, Molly A.; Leboeuf, Marylene; Randolph, Gwendalyn J.; Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Bogunovic, Milena; Ginhoux, Florent; Helft, Julie; Shang, Limin; Hashimoto, Daigo; Greter, Melanie; Jakubzick, Claudia; Ingersoll, Molly A.; Leboeuf, Marylene; Lira, Sergio A.; Randolph, Gwendalyn J.; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Liu, Kang; Nussenzweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Nussenzweig, Michel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Rockefeller University	Merad, M (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10029 USA.	miriam.merad@mssm.edu	Stanley, Evan R/J-9154-2013; Nussenzweig, Michel/AAE-7292-2019; Hashimoto, Daigo/O-1013-2013; Helft, Julie/ABE-6179-2020	Stanley, Evan R/0000-0002-2910-2065; Hashimoto, Daigo/0000-0001-9489-9704; Helft, Julie/0000-0002-2733-1972; Greter, Melanie/0000-0002-7220-5369	NIH [CA112100, CA086899, CA32551, CA26504, A149653]; Amy Strelzer Foundation; Leukemia and Lymphoma Society [LLS 3220-08]; Rockefeller University; NIDDK; AHA Established Investigator grant [0740052];  [P01 DK072201]; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA026504, R01CA112100, R01CA032551] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653, R37AI049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amy Strelzer Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Rockefeller University; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA Established Investigator grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Y. Yokota (University of Fukui, Fukui, Japan) for providing the Id2<SUP>-/-</SUP> mice. M.M. is supported by NIH grants CA112100 and CA086899. E.R.S. is supported by NIH grants CA32551 and CA26504. M.B. is supported by a grant from the Amy Strelzer Foundation. F.G. is supported by a grant from the Leukemia and Lymphoma Society (LLS 3220-08). K.L. was supported by a C.H.Li Memorial Scholarship Award from The Rockefeller University. M.N. is an HHMI investigator. M.A.I. was supported by an institutional training grant from the NIDDK. S.A.L. was supported by P01 DK072201, and G.J.R. was supported by NIH grant A149653 and AHA Established Investigator grant 0740052.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Flores-Langarica A, 2005, P NATL ACAD SCI USA, V102, P19039, DOI 10.1073/pnas.0504253102; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Klebl FH, 2001, J PATHOL, V195, P609, DOI 10.1002/path.991; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, ANN NY ACAD SCI, V1106, P253, DOI 10.1196/annals.1392.015; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Singh SP, 2000, MICROB PATHOGENESIS, V28, P157, DOI 10.1006/mpat.1999.0332; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155	47	653	663	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					513	525		10.1016/j.immuni.2009.08.010	http://dx.doi.org/10.1016/j.immuni.2009.08.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19733489	Green Accepted, Bronze			2022-12-18	WOS:000270525900018
J	Palazon, A; Goldrath, AW; Nizet, V; Johnson, RS				Palazon, Asis; Goldrath, Ananda W.; Nizet, Victor; Johnson, Randall S.			HIF Transcription Factors, Inflammation, and Immunity	IMMUNITY			English	Review							HYPOXIA-INDUCIBLE FACTOR; NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED MACROPHAGES; DENDRITIC CELL ACTIVATION; CHEMOKINE RECEPTOR CXCR4; REGULATORY T-CELLS; FACTOR-I HIF-1; GENE-EXPRESSION; FACTOR 1-ALPHA	The hypoxic response in cells and tissues is mediated by the family of hypoxia-inducible factor (HIF) transcription factors; these play an integral role in the metabolic changes that drive cellular adaptation to low oxygen availability. HIF expression and stabilization in immune cells can be triggered by hypoxia, but also by other factors associated with pathological stress: e. g., inflammation, infectious microorganisms, and cancer. HIF induces a number of aspects of host immune function, from boosting phagocyte microbicidal capacity to driving T cell differentiation and cytotoxic activity. Cellular metabolism is emerging as a key regulator of immunity, and it constitutes another layer of fine-tuned immune control by HIF that can dictate myeloid cell and lymphocyte development, fate, and function. Here we discuss how oxygen sensing in the immune microenvironment shapes immunological response and examine how HIF and the hypoxia pathway control innate and adaptive immunity.	[Palazon, Asis; Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Goldrath, Ananda W.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Johnson, Randall S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	University of Cambridge; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet	Johnson, RS (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	rsj33@cam.ac.uk	Nizet, Victor/AAF-3190-2019; Palazon, Asis/ABI-1748-2020	Palazon, Asis/0000-0002-7172-7229; Johnson, Randall/0000-0002-4084-6639; Nizet, Victor/0000-0003-3847-0422	NIH [A1096852, A1072117]; Wellcome Trust Principal Research Fellowship; Marie Curie IEF fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096852, R01AI093451, U54AI057153, R56AI090863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Principal Research Fellowship(Wellcome Trust); Marie Curie IEF fellowship(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding has been provided by NIH for A. G. (A1096852, A1072117), V.N., and R.S.J. (A1096852), a Wellcome Trust Principal Research Fellowship for R.S.J., and Marie Curie IEF fellowship for A.P.	Ahn GO, 2014, P NATL ACAD SCI USA, V111, P2698, DOI 10.1073/pnas.1320243111; Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bhandari T, 2013, J MOL MED, V91, P1199, DOI 10.1007/s00109-013-1052-y; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Elia AR, 2008, J LEUKOCYTE BIOL, V84, P1472, DOI 10.1189/jlb.0208082; Eubank TD, 2011, BLOOD, V117, P323, DOI 10.1182/blood-2010-01-261792; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hale LP, 2002, AM J PHYSIOL-HEART C, V282, pH1467, DOI 10.1152/ajpheart.00682.2001; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ikejiri A, 2012, INT IMMUNOL, V24, P137, DOI 10.1093/intimm/dxr111; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jantsch J, 2011, J LEUKOCYTE BIOL, V90, P551, DOI 10.1189/jlb.1210683; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kojima H, 2002, P NATL ACAD SCI USA, V99, P2170, DOI 10.1073/pnas.052706699; Kondo S, 2006, CANCER RES, V66, P9870, DOI 10.1158/0008-5472.CAN-06-1679; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lewis CE, 2007, CANCER RES, V67, P8429, DOI 10.1158/0008-5472.CAN-07-1684; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin SS, 2012, CANCER SCI, V103, P904, DOI 10.1111/j.1349-7006.2012.02259.x; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Mancino A, 2008, BLOOD, V112, P3723, DOI 10.1182/blood-2008-02-142091; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Mecklenburgh KI, 2002, BLOOD, V100, P3008, DOI 10.1182/blood-2002-02-0454; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nakamura H, 2005, J IMMUNOL, V174, P7592, DOI 10.4049/jimmunol.174.12.7592; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Noman MZ, 2011, CANCER RES, V71, P5976, DOI 10.1158/0008-5472.CAN-11-1094; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Okumura CYM, 2012, J MOL MED, V90, P1079, DOI 10.1007/s00109-012-0882-3; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Palazon A, 2012, CANCER DISCOV, V2, P608, DOI 10.1158/2159-8290.CD-11-0314; Palazon A, 2011, CANCER RES, V71, P801, DOI 10.1158/0008-5472.CAN-10-1733; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Pina-Oviedo S, 2009, ACTA NEUROPATHOL, V118, P235, DOI 10.1007/s00401-009-0533-0; Qu X, 2005, IMMUNOL CELL BIOL, V83, P668, DOI 10.1111/j.1440-1711.2005.01383.x; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Ricciardi A, 2008, MOL CANCER RES, V6, P175, DOI 10.1158/1541-7786.MCR-07-0391; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Roda JM, 2012, J IMMUNOL, V189, P3168, DOI 10.4049/jimmunol.1103817; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shatrov VA, 2003, BLOOD, V101, P4847, DOI 10.1182/blood-2002-09-2711; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thompson AAR, 2014, BLOOD, V123, P366, DOI 10.1182/blood-2013-05-500207; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Walmsley SR, 2006, BLOOD, V108, P3176, DOI 10.1182/blood-2006-04-018796; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Yoo YG, 2003, J BIOL CHEM, V278, P39076, DOI 10.1074/jbc.M305101200; Zhao WL, 2005, EUR J IMMUNOL, V35, P3468, DOI 10.1002/eji.200526262	115	652	684	11	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					518	528		10.1016/j.immuni.2014.09.008	http://dx.doi.org/10.1016/j.immuni.2014.09.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367569	Green Accepted, Bronze			2022-12-18	WOS:000345504300007
J	Ouyang, W; Ranganath, SH; Weindel, K; Bhattacharya, D; Murphy, TL; Sha, WC; Murphy, KM				Ouyang, W; Ranganath, SH; Weindel, K; Bhattacharya, D; Murphy, TL; Sha, WC; Murphy, KM			Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism	IMMUNITY			English	Article							INTERFERON-GAMMA PROMOTER; TRANSCRIPTION FACTOR GATA-3; CD4+ T-CELLS; NF-KAPPA-B; IFN-GAMMA; REGULATORY ELEMENTS; TYROSINE PHOSPHORYLATION; PHENOTYPE DEVELOPMENT; TARGETED DISRUPTION; DENDRITIC CELLS	Recently, the transcription factor GATA-3 was shown to be selectively expressed in Th2 but not Th1 cells and to augment Th2-specific cytokines. Here, we show that loss of GATA-3 expression by developing Th1 cells requires IL-12 signaling through Stat4 and does not simply result from an absence of IL-4. Moreover, we demonstrate a novel role for GATA-3 in directly repressing Th1 development distinct from its positive actions on Th2-specific cytokines. GATA-3 inhibits Th1 cytokines by a cell-intrinsic mechanism that is not dependent on IL-4 and that may involve repression of IL-12 signaling. Thus, GATA-3 expression and IL-12 signaling are mutually antagonistic, which facilitates rapid dominance of one pathway during early Th development, producing a stable divergence in cytokine profiles.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Ctr Immunol, St Louis, MO 63110 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of California System; University of California Berkeley	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, St Louis, MO 63110 USA.		Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039676, P01AI031238] Funding Source: NIH RePORTER; NIAID NIH HHS [AIDK39676, AI31238] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; CIPPITELLI M, 1995, J BIOL CHEM, V270, P12548, DOI 10.1074/jbc.270.21.12548; Crowe R, 1998, DEVELOPMENT, V125, P767; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; FOX HS, 1991, J IMMUNOL, V146, P4362; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Guler ML, 1997, J IMMUNOL, V159, P1767; Haenlin M, 1997, GENE DEV, V11, P3096, DOI 10.1101/gad.11.22.3096; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; HAWLEY RG, 1994, GENE THER, V1, P136; Heitzler P, 1996, GENETICS, V143, P1271; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1993, INT IMMUNOL, V5, P371; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Lee HJ, 1998, J IMMUNOL, V160, P2343; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Melotti P, 1996, P NATL ACAD SCI USA, V93, P5313, DOI 10.1073/pnas.93.11.5313; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Robey E, 1998, CURR OPIN IMMUNOL, V10, P181, DOI 10.1016/S0952-7915(98)80247-1; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rooke JE, 1998, BIOESSAYS, V20, P209, DOI 10.1002/(SICI)1521-1878(199803)20:3<209::AID-BIES4>3.3.CO;2-I; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; TRIPP CS, 1994, J IMMUNOL, V152, P1883; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WU YJ, 1995, J BIOL CHEM, V270, P5944, DOI 10.1074/jbc.270.11.5944; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Ye JP, 1996, MOL CELL BIOL, V16, P4744; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	651	671	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					745	755		10.1016/S1074-7613(00)80671-8	http://dx.doi.org/10.1016/S1074-7613(00)80671-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846495	Bronze			2022-12-18	WOS:000077298300016
J	Allen, CDC; Okada, T; Cyster, JG				Allen, Christopher D. C.; Okada, Takaharu; Cyster, Jason G.			Germinal-center organization and cellular dynamics	IMMUNITY			English	Review							CENTER B-CELLS; FOLLICULAR DENDRITIC CELLS; PRIMARY IMMUNE-RESPONSE; HELPER T-CELLS; AFFINITY MATURATION; ANTIBODY-RESPONSES; PLASMA-CELL; EXPRESSION PATTERNS; SOMATIC MUTATION; IN-SITU	Germinal centers (GCs) are important sites of antibody affinity maturation. In the classical model, the 14 GC dark zone contains large centroblasts that are rapidly proliferating and undergoing somatic hypermutation of their antibody variable-region genes. Centroblasts give rise to smaller nonproliferating centrocytes in the light zone that compete for binding antigen on follicular dendritic cells. Recently, the approach of real-time imaging of GCs by two-photon microscopy of intact lymph nodes has provided new insights into GC dynamics that both support and challenge fundamental aspects of this model. Here we review recent and older findings on cell migration, proliferation, and interaction dynamics in the GC and discuss a model in which dark- and light-zone cells are morphologically similar, proliferation occurs in both zones, and GC B cells compete for T cell help as well as antigen.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kyoto University	Allen, CDC (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	chris.allen@ucsf.edu; tokada@path1.med.kyoto-u.ac.jp; jason.cyster@ucsf.edu	Okada, Takaharu/N-7931-2015	Allen, Christopher/0000-0002-1879-9047	NIAID NIH HHS [R01 AI045073-07, R37 AI040098-08, R01 AI045073-08, R37 AI040098-09, R37 AI040098-11, R37 AI040098, R01 AI045073-06, R01 AI045073, R01 AI045073-09, R37 AI040098-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI045073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; Balogh P, 2002, ANAT REC, V268, P160, DOI 10.1002/ar.10148; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Benson MJ, 2007, CURR OPIN IMMUNOL, V19, P275, DOI 10.1016/j.coi.2007.04.009; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; BOWEN MB, 1991, HUM IMMUNOL, V31, P67, DOI 10.1016/0198-8859(91)90050-J; Brachtel EF, 1996, SCAND J IMMUNOL, V43, P239; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; Carbone A, 2001, BLOOD, V97, P744, DOI 10.1182/blood.V97.3.744; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Casola S, 2006, CURR TOP MICROBIOL, V308, P155; Castan J, 1997, IMMUNOLOGY, V90, P265, DOI 10.1046/j.1365-2567.1997.00162.x; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chalouni C, 2003, INT IMMUNOL, V15, P457, DOI 10.1093/intimm/dxg037; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; CLOSE PM, 1990, J PATHOL, V162, P209, DOI 10.1002/path.1711620306; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cunningham AF, 2004, EUR J IMMUNOL, V34, P686, DOI 10.1002/eji.200324510; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Fallas JL, 2007, J IMMUNOL, V178, P1488, DOI 10.4049/jimmunol.178.3.1488; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Glazier KS, 2002, J EXP MED, V195, P1063, DOI 10.1084/jem.20012059; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HANNA MG, 1964, LAB INVEST, V13, P95; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; Iwaia Y, 2002, IMMUNOL LETT, V83, P215, DOI 10.1016/S0165-2478(02)00088-3; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kindred JE, 1938, AM J ANAT, V62, P453, DOI 10.1002/aja.1000620403; Koni PA, 1999, J EXP MED, V189, P855, DOI 10.1084/jem.189.5.855; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Kuwahara K, 2000, BLOOD, V95, P2321, DOI 10.1182/blood.V95.7.2321.007k33_2321_2328; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Marinova E, 2007, J IMMUNOL, V178, P5010, DOI 10.4049/jimmunol.178.8.5010; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; MILLIKIN PD, 1966, ARCH PATHOL, V82, P499; Moldenhauer G, 2006, BLOOD, V107, P2470, DOI 10.1182/blood-2005-06-2502; Nakamura M, 1996, EUR J IMMUNOL, V26, P1211, DOI 10.1002/eji.1830260604; Nakayama Y, 2006, J CELL BIOCHEM, V99, P1308, DOI 10.1002/jcb.20952; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; OPSTELTEN D, 1982, CELL TISSUE RES, V224, P505; Or-Guil M, 2007, IMMUNOL REV, V216, P130; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; PHAN TG, 2007, IN PRESS NAT IMMUNOL; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; RADEMAKERS LHPM, 1992, CELL TISSUE RES, V269, P359, DOI 10.1007/BF00319629; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Reiter R, 2002, IMMUNOLOGY, V106, P222, DOI 10.1046/j.1365-2567.2002.01405.x; Riley JL, 2001, J IMMUNOL, V166, P4943, DOI 10.4049/jimmunol.166.8.4943; Rohlich K., 1930, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V20, P287; Rossbacher J, 2006, EUR J IMMUNOL, V36, P2384, DOI 10.1002/eji.200636172; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Shiratsuchi A, 2002, J BIOCHEM, V132, P381, DOI 10.1093/oxfordjournals.jbchem.a003233; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; SZAKAL AK, 1991, RES IMMUNOL, V142, P261, DOI 10.1016/0923-2494(91)90072-Q; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; van Galen JC, 2004, EUR J IMMUNOL, V34, P1870, DOI 10.1002/eji.200424985; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Wang TJ, 2005, ENERG FUEL, V19, P22, DOI 10.1021/ef030116r; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:8<2226::AID-IMMU2226>3.0.CO;2-5; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072; ZAITOUN AM, 1980, J ANAT, V130, P131; ZHANG J, 1988, IMMUNOL LETT, V18, P297, DOI 10.1016/0165-2478(88)90178-2; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	104	648	669	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					190	202		10.1016/j.immuni.2007.07.009	http://dx.doi.org/10.1016/j.immuni.2007.07.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723214	Green Accepted, Bronze			2022-12-18	WOS:000249056300007
J	MULLER, AM; MEDVINSKY, A; STROUBOULIS, J; GROSVELD, F; DZIERZAK, E				MULLER, AM; MEDVINSKY, A; STROUBOULIS, J; GROSVELD, F; DZIERZAK, E			DEVELOPMENT OF HEMATOPOIETIC STEM-CELL ACTIVITY IN THE MOUSE EMBRYO	IMMUNITY			English	Article							YOLK-SAC; BETA-GLOBIN; EXPRESSION PATTERNS; TRANSGENIC MICE; GROWTH-FACTOR; IN-VITRO; C-KIT; PRECURSORS; ONTOGENY; CULTURE	The precise time of appearance of the first hematopoietic stem cell activity in the developing mouse embryo is unknown. Recently the aorta-gonad-mesonephros region of the developing mouse embryo has been shown to possess hematopoietic colony-forming activity (CFU-S) in irradiated recipient mice. To determine whether the mouse embryo possesses definitive hematopoietic stem cell activity in the analogous AGM region and to determine the order of appearance of stem cells in the yolk sac, AGM region, and liver, we transferred these embryonic tissues into adult irradiated recipients. We report here the long-term, complete, and functional hematopoietic repopulation of primary and serial recipients with AGM-derived cells. We observe potent hematopoietic stem cell activity in the AGM region before the appearance of yolk sac and liver stem cell activity and discuss a model for the maturation of stem cell activity in mouse embryogenesis.			MULLER, AM (corresponding author), NATL INST MED RES,MRC,GENE STRUCT & EXPRESS LAB,THE RIDGEWAY,MILL HILL,LONDON NW7 1AA,ENGLAND.		Strouboulis, John/U-4459-2019	Strouboulis, John/0000-0002-6133-2872				COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3; CORMIER F, 1988, DEVELOPMENT, V102, P279; CUDDENEC CA, 1981, P NATL ACAD SCI USA, V78, P2412; CUMANO A, 1993, P NATL ACAD SCI USA, V90, P6429, DOI 10.1073/pnas.90.14.6429; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; GIGUERE V, 1985, EMBO J, V4, P2017, DOI 10.1002/j.1460-2075.1985.tb03886.x; GODIN I, 1991, NATURE, V352, P807, DOI 10.1038/352807a0; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1979, BLOOD, V54, P1152; HOUSSAINT E, 1981, CELL DIFFER DEV, V10, P243, DOI 10.1016/0045-6039(81)90007-5; HUANG H, 1994, EXP HEMATOL, V22, P19; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; JOHNSON GR, 1985, EXP HEMATOL, V13, P200; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; JOHNSON GR, 1973, J EMBRYOL EXP MORPH, V30, P83; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KESHET E, 1991, EMBO J, V10, P2425, DOI 10.1002/j.1460-2075.1991.tb07782.x; KOLLIAS G, 1986, CELL, V46, P89, DOI 10.1016/0092-8674(86)90862-7; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LAMAR EE, 1984, CELL, V37, P171, DOI 10.1016/0092-8674(84)90312-X; LINDENBAUM MH, 1990, GENE DEV, V4, P2075, DOI 10.1101/gad.4.12a.2075; LIU CP, 1991, DEVELOPMENT, V113, P1315; MAENO M, 1985, DEV BIOL, V110, P503, DOI 10.1016/0012-1606(85)90108-3; Maniatis T., 1982, MOL CLONING; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MEDVINSKY A, 1993, SEMIN DEV BIOL, V4, P333; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MICKLEM HS, 1966, PROC R SOC SER B-BIO, V165, P78, DOI 10.1098/rspb.1966.0059; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MULLER AM, 1993, DEVELOPMENT, V118, P1343; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; PALACIOS R, 1993, P NATL ACAD SCI USA, V90, P6581, DOI 10.1073/pnas.90.14.6581; PERAH G, 1977, J CELL PHYSIOL, V91, P193, DOI 10.1002/jcp.1040910205; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ELIZABETH S., 1966, P351; SAMOYLINA NL, 1990, SOV J DEVEL BIOL, V21, P127; SAMOYLINA NL, 1992, MODERN TRENDS HUMAN, P106; SONODA T, 1983, DEV BIOL, V97, P89, DOI 10.1016/0012-1606(83)90066-0; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; SYMANN M, 1978, EXP HEMATOL, V6, P749; TAVASSOLI M, 1994, EXP HEMATOL, V22, P7; TOLES JF, 1989, P NATL ACAD SCI USA, V86, P7456, DOI 10.1073/pnas.86.19.7456; TURPEN JB, 1981, DEV BIOL, V85, P99, DOI 10.1016/0012-1606(81)90239-6; VANASSENDELFT GB, 1989, CELL, V56, P969, DOI 10.1016/0092-8674(89)90630-2; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; WEISSMAN IL, 1977, COLD SPRING HARB SYM, V41, P9; WITTE ON, 1990, CELL, V83, P5; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851	55	648	665	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1994	1	4					291	301		10.1016/1074-7613(94)90081-7	http://dx.doi.org/10.1016/1074-7613(94)90081-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889417	Green Submitted			2022-12-18	WOS:A1994PK16600007
J	Lucas, M; Schachterle, W; Oberle, K; Aichele, P; Diefenbach, A				Lucas, Mathias; Schachterle, William; Oberle, Karin; Aichele, Peter; Diefenbach, Andreas			Dendritic cells prime natural killer cells by trans-presenting interleukin 15	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; CD8(+) T-CELLS; MHC CLASS-I; IFN-GAMMA PRODUCTION; C VIRUS-INFECTION; HUMAN NK CELLS; LYMPH-NODES; BYSTANDER PROLIFERATION; INHIBITORY RECEPTORS; CYTOKINE RESPONSES	Natural killer (NK) cells are important effector cells in the control of infections. The cellular and molecular signals required for NK cell activation in vivo remain poorly defined. By using a mouse model for the inducible ablation of dendritic cells (DCs), we showed that the in vivo priming of NK cell responses to viral and bacterial pathogens required the presence of CD11c(high) DCs. After peripheral Toll-like receptor (TLR) stimulation, NK cells were recruited to local lymph nodes, and their interaction with DCs resulted in the emergence of effector NK cells in the periphery. NK cell priming was dependent on the recognition of type I IFN signals by DCs; and the subsequent production and trans-presentation of IL-15 by DCs to resting NK cells. CD11c(high) DC-derived IL-15 was necessary and sufficient for the priming of NK cells. Our data define a unique in vivo role of DCs for the priming of NK cells, revealing a striking and previously unappreciated homology to T lymphocytes of the adaptive immune system.	NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; Univ Freiburg, Inst Med Mikrobiol & Hyg, D-79104 Freiburg, Germany	New York University; University of Freiburg	Diefenbach, A (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, 540 1st Ave, New York, NY 10016 USA.	andreas.diefenbach@uniklinik-freiburg.de	Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530	NIAID NIH HHS [R01 AI059758, R01-AI059758, R01 AI059758-02, R01 AI059758-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059758] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; CUDKOWICZ G, 1977, J IMMUNOL, V119, P483; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; DJEU JY, 1979, J IMMUNOL, V122, P182; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; Kennedy P, 2000, LAT TRADE, V8, P15; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Koschella M, 2004, J IMMUNOL, V172, P4804, DOI 10.4049/jimmunol.172.8.4804; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI14574; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; WELSH RM, 1978, J EXP MED, V148, P163, DOI 10.1084/jem.148.1.163; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	60	645	664	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					503	517		10.1016/j.immuni.2007.03.006	http://dx.doi.org/10.1016/j.immuni.2007.03.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17398124	Green Accepted, Bronze			2022-12-18	WOS:000246126400014
J	Liao, W; Lin, JX; Leonard, WJ				Liao, Wei; Lin, Jian-Xin; Leonard, Warren J.			Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy	IMMUNITY			English	Review							REGULATORY T-CELLS; RECEPTOR-ALPHA-CHAIN; SEVERE COMBINED IMMUNODEFICIENCY; GAMMA-CHAIN; BETA-CHAIN; IL-2 RECEPTOR; GENE-EXPRESSION; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; IFN-GAMMA	Interleukin-2 (IL-2) is a pleiotropic cytokine produced after antigen activation that plays pivotal roles in the immune response. Discovered as a T cell growth factor, IL-2 additionally promotes CD8(+) T cell and natural killer cell cytolytic activity and modulates T cell differentiation programs in response to antigen, promoting naive CD4(+) T cell differentiation into T helper 1 (Th1) and T helper 2 (Th2) cells while inhibiting T helper 17 (Th17) and T follicular helper (Tfh) cell differentiation. Moreover, IL-2 is essential for the development and maintenance of T regulatory cells and for activation-induced cell death, thereby mediating tolerance and limiting inappropriate immune reactions. In this review, we focus on the molecular mechanisms and complex cellular actions of IL-2, its cooperative and opposing effects with other cytokines, and how both promoting and blocking the actions of IL-2 are being utilized in clinical medicine.	[Liao, Wei; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Liao, Wei; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lin, JX (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	linjx@nhlbi.nih.gov; wjl@helix.nih.gov	Ritz, Jerome/C-7929-2009; Leonard, Warren/AAA-1397-2022	Ritz, Jerome/0000-0001-5526-4669; 	Division of Intramural Research, NHLBI, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005401, ZIAHL005402] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Rosanne Spolski, Chi-Keung Wan, and Erin B. West, all in National Heart, Lung, and Blood Institute (NHLBI), for critical comments. This work was supported by the Division of Intramural Research, NHLBI, NIH. W.J.L. is an inventor on patents related to the identification of JAK kinase inhibitors as immune modulators.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alvarez JD, 2000, GENE DEV, V14, P521; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; ARIMA N, 1992, J EXP MED, V176, P1265, DOI 10.1084/jem.176.5.1265; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BOSCO MC, 1994, BLOOD, V83, P2995, DOI 10.1182/blood.V83.10.2995.2995; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; CAO XQ, 1993, P NATL ACAD SCI USA, V90, P8464, DOI 10.1073/pnas.90.18.8464; Castro I, 2011, J IMMUNOL, V187, P5170, DOI 10.4049/jimmunol.1003961; Cavazzana-Calvo Marina, 2005, Annu Rev Med, V56, P585, DOI 10.1146/annurev.med.56.090203.104142; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; COUSENS LP, 1995, J IMMUNOL, V155, P5690; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; DEPPER JM, 1984, J IMMUNOL, V133, P3054; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Gilmour KC, 2001, BLOOD, V98, P877, DOI 10.1182/blood.V98.3.877; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Gruss HJ, 1996, J IMMUNOL, V157, P851; Harrison C, 2012, BRIT J HAEMATOL, V157, P426, DOI 10.1111/j.1365-2141.2012.09108.x; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kim HP, 2005, J BIOL CHEM, V280, P34042, DOI 10.1074/jbc.M505833200; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kontzias A, 2012, CURR OPIN PHARMACOL, V12, P464, DOI 10.1016/j.coph.2012.06.008; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Leonard WJ, 1996, ANNU REV MED, V47, P229; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LEONARD WJ, 1985, P NATL ACAD SCI USA, V82, P6281, DOI 10.1073/pnas.82.18.6281; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; LIN JX, 1993, MOL CELL BIOL, V13, P6201, DOI 10.1128/MCB.13.10.6201; Lin JX, 1997, MOL CELL BIOL, V17, P3714, DOI 10.1128/MCB.17.7.3714; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; LOWENTHAL JW, 1987, J EXP MED, V166, P1156, DOI 10.1084/jem.166.4.1156; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MINGARI MC, 1984, NATURE, V312, P641, DOI 10.1038/312641a0; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Ndhlovu LC, 2010, J CLIN IMMUNOL, V30, P681, DOI 10.1007/s10875-010-9432-3; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; PALIARD X, 1988, J IMMUNOL, V141, P849; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Samlowski WE, 2011, J IMMUNOTHER, V34, P419, DOI 10.1097/CJI.0b013e31821dcb50; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Sharfe N, 1997, J CLIN INVEST, V100, P3036, DOI 10.1172/JCI119858; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; Thiele S, 2012, EUR J IMMUNOL, V42, P2100, DOI 10.1002/eji.201142203; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; WALDMANN TA, 1984, J CLIN INVEST, V73, P1711, DOI 10.1172/JCI111379; Waldmann TA, 2012, BLOOD; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Wilson CGM, 2011, CURR TOP MICROBIOL, V348, P25, DOI 10.1007/82_2010_93; Wong JC, 2002, ONCOGENE, V21, P2009, DOI 10.1038/sj.onc.1205262; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	150	644	697	11	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					13	25		10.1016/j.immuni.2013.01.004	http://dx.doi.org/10.1016/j.immuni.2013.01.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23352221	Green Accepted, Bronze			2022-12-18	WOS:000314195500006
J	Varma, R; Campi, G; Yokosuka, T; Saito, T; Dustin, ML				Varma, Rajat; Campi, Gabriele; Yokosuka, Tadashi; Saito, Takashi; Dustin, Michael L.			T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster	IMMUNITY			English	Article							CD45 TYROSINE PHOSPHATASE; FC-EPSILON-RI; IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; MONOCLONAL-ANTIBODIES; CONTACT SITE; LCK ACTIVITY; TCR BINDING; RECOGNITION; TRANSDUCTION	T cell receptor (TCR) signaling is initiated and sustained in microclusters; however, it's not known whether signaling also occurs in the TCR-rich central supramolecular activation cluster (cSMAC). We showed that the cSMAC formed by fusion of microclusters contained more CD45 than microclusters and is a site enriched in lysobisphosphatidic acid, a lipid involved in sorting ubiquitinated membrane proteins for degradation. Calcium signaling via TCR was blocked within 2 min by anti-MHCp treatment and 1 min by latrunculin-A treatment. TCR-MHCp interactions in the cSMAC survived these perturbations for 10 min and hence were not sufficient to sustain signaling. TCR microclusters were also resistant to disruption by anti-MHCp and latrunculin-A treatments. We propose that TCR signaling is sustained by stabilized microclusters and is terminated in the cSMAC, a structure from which TCR are sorted for degradation. Our studies reveal a role for F-actin in TCR signaling beyond microcluster formation.	NYU, Sch Med, Dept Pathol, Program Mol Pathogenesis,Skirball Inst Biomol Med, New York, NY 10016 USA; RIKEN, Lab Cell Signaling, RCAI, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	New York University; RIKEN	Dustin, ML (corresponding author), NYU, Sch Med, Dept Pathol, Program Mol Pathogenesis,Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Saito, Takashi/C-9684-2009; Dustin, Michael/AAM-4611-2020; Varma, Rajat/I-1209-2012	Saito, Takashi/0000-0001-9495-3547; Varma, Rajat/0000-0001-5131-0402; Dustin, Michael/0000-0003-4983-6389	NCI NIH HHS [P30 CA016087] Funding Source: Medline; NIAID NIH HHS [R37 AI043542, AI43542, R56 AI044931, R01 AI043542, R01 AI044931, AI44931] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R56AI044931, R37AI043542, R01AI044931] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; D'Oro U, 1999, J IMMUNOL, V162, P1879; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hashemi BB, 1996, J IMMUNOL, V156, P3660; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Metzger H, 1999, IMMUNOL LETT, V68, P53, DOI 10.1016/S0165-2478(99)00030-9; Mobius W, 2003, TRAFFIC, V4, P222; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; MUSTELIN T, 1995, EUR J IMMUNOL, V25, P942, DOI 10.1002/eji.1830250413; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; Sperling AI, 1998, J IMMUNOL, V161, P6459; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; TROWBRIDGE IS, 1978, J EXP MED, V148, P313, DOI 10.1084/jem.148.1.313; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287	53	644	658	2	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					117	127		10.1016/j.immuni.2006.04.010	http://dx.doi.org/10.1016/j.immuni.2006.04.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860761	Green Accepted, Bronze			2022-12-18	WOS:000239713000015
J	Halim, TYF; Steer, CA; Matha, L; Gold, MJ; Martinez-Gonzalez, I; McNagny, KM; McKenzie, ANJ; Takei, F				Halim, Timotheus Y. F.; Steer, Catherine A.; Mathae, Laura; Gold, Matthew J.; Martinez-Gonzalez, Itziar; McNagny, Kelly M.; McKenzie, Andrew N. J.; Takei, Fumio			Group 2 Innate Lymphoid Cells Are Critical for the Initiation of Adaptive T Helper 2 Cell-Mediated Allergic Lung Inflammation	IMMUNITY			English	Article							DENDRITIC CELLS; RECEPTOR-ALPHA; T-CELLS; EXPRESSION; INDUCTION; IL-13; MIGRATION; ASTHMA; DIFFERENTIATION; CYTOKINES	Naive CD4(+) T cell differentiation into distinct subsets of T helper (Th) cells is a pivotal process in the initiation of the adaptive immune response. Allergens predominantly stimulate Th2 cells, causing allergic inflammation. However, why allergens induce Th2 cell differentiation is not well understood. Here we show that group 2 innate lymphoid cells (ILC2s) are required to mount a robust Th2 cell response to the protease-allergen papain. Intranasal administration of papain stimulated ILC2s and Th2 cells, causing allergic lung inflammation and elevated immunoglobulin E titers. This process was severely impaired in ILC2-deficient mice. Whereas interleukin-4 (IL-4) was dispensable for papain-induced Th2 cell differentiation, ILC2-derived IL-13 was critical as it promoted migration of activated lung dendritic cells into the draining lymph node where they primed naive T cells to differentiate into Th2 cells. Papain-induced ILC2 activation and Th2 cell differentiation was IL-33-dependent, suggesting a common pathway in the initiation of Th2 cell responses to allergen.	[Halim, Timotheus Y. F.; Steer, Catherine A.; Mathae, Laura; Martinez-Gonzalez, Itziar; Takei, Fumio] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Halim, Timotheus Y. F.] Univ British Columbia, Genet Grad Program, Coll Interdisciplinary Studies, Vancouver, BC V6T 1Z2, Canada; [Halim, Timotheus Y. F.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Gold, Matthew J.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Takei, Fumio] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada	British Columbia Cancer Agency; University of British Columbia; MRC Laboratory Molecular Biology; University of British Columbia; University of British Columbia	Takei, F (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ftakei@bccrc.ca	Halim, Timotheus/B-3117-2018; McNagny, Kelly/P-5239-2014	Halim, Timotheus/0000-0001-9773-0023; McNagny, Kelly/0000-0003-4737-3499; Martinez Gonzalez, Itziar/0000-0002-1695-5691; Takei, Fumio/0000-0002-3620-5046; Matha, Laura/0000-0002-4399-6851	Canadian Institute of Health Research; AllerGen Network Centre of Excellence; UK Medical Research Council; American Asthma Foundation; Canadian Institutes of Health Research Banting and Best Studentship; Banting Postdoctoral Fellowship; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); AllerGen Network Centre of Excellence; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Asthma Foundation; Canadian Institutes of Health Research Banting and Best Studentship(Canadian Institutes of Health Research (CIHR)); Banting Postdoctoral Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Canadian Institute of Health Research (F. T.), the AllerGen Network Centre of Excellence (K. M. M.), and the UK Medical Research Council, and American Asthma Foundation (A.N.J.M.). K. M. M. is a Michael Smith Foundation for Health Research Senior Scholar. T.Y.F.H. was supported by a Canadian Institutes of Health Research Banting and Best Studentship, and Banting Postdoctoral Fellowship. We thank Seth Scanlon for proofreading and Gerry Krystal for providing us with the OT-II mice.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Jenkins SJ, 2008, J IMMUNOL, V180, P8083, DOI 10.4049/jimmunol.180.12.8083; Jenkins SJ, 2007, J IMMUNOL, V179, P3515, DOI 10.4049/jimmunol.179.6.3515; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kool Mirjam, 2012, F1000 Biol Rep, V4, P6, DOI 10.3410/B4-6; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rey A, 1999, BBA-MOL CELL BIOL L, V1440, P183, DOI 10.1016/S1388-1981(99)00121-3; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Veinotte LL, 2008, BLOOD, V111, P4201, DOI 10.1182/blood-2007-04-087577; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	49	642	672	2	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					425	435		10.1016/j.immuni.2014.01.011	http://dx.doi.org/10.1016/j.immuni.2014.01.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24613091	Green Published, hybrid			2022-12-18	WOS:000333422300015
J	Fuchs, A; Vermi, W; Lee, JS; Lonardi, S; Gilfillan, S; Newberry, RD; Cella, M; Colonna, M				Fuchs, Anja; Vermi, William; Lee, Jacob S.; Lonardi, Silvia; Gilfillan, Susan; Newberry, Rodney D.; Cella, Marina; Colonna, Marco			Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12-and IL-15-Responsive IFN-gamma-Producing Cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MEMORY CD8(+) T; NK CELLS; TISSUE; HOMEOSTASIS; EPITHELIUM; IMMUNITY; MUCOSAL; ANTIGEN; INFLAMMATION	Mucosal innate lymphoid cell (ILC) subsets promote immune responses to pathogens by producing distinct signature cytokines in response to changes in the cytokine microenvironment. We previously identified human ILC3 distinguished by interleukin-22 (IL-22) secretion. Here we characterized a human ILC1 subset that produced interferon-gamma (IFN-gamma) in response to IL-12 and IL-15 and had a unique integrin profile, intraepithelial location, hallmarks of TGF-beta imprinting, and a memory-activated phenotype. Because tissue-resident memory CD8(+) T cells share this profile, intraepithelial ILC1 may be their innate counterparts. In mice, intraepithelial ILC1 were distinguished by CD160 expression and required Nfil3- and Tbx21-encoded transcription factors for development, but not IL-15 receptor-alpha, indicating that intraepithelial ILC1 are distinct from conventional NK cells. Intraepithelial ILC1 were amplified in Crohn's disease patients and contributed to pathology in the anti-CD40-induced colitis model in mice. Thus, intraepithelial ILC1 may initiate IFN- responses against pathogens but contribute to pathology when dysregulated.	[Fuchs, Anja; Vermi, William; Lee, Jacob S.; Gilfillan, Susan; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Newberry, Rodney D.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Vermi, William; Lonardi, Silvia] Univ Brescia, Dept Mol & Translat Med, I-25123 Brescia, Italy	Washington University (WUSTL); Washington University (WUSTL); University of Brescia	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/ABA-8564-2020	Colonna, Marco/0000-0001-5222-4987; Newberry, Rodney/0000-0002-4152-5191; Cella, Marina/0000-0003-1230-1313; VERMI, WILLIAM/0000-0002-2291-2997	NIH [R01 DE021255-01, U01 AI095542-01, R01DK064798, P30DK052574]; PRIN (CKARAL, Ministero dell'Istruzione dell'Universita e della Ricerca); AIRC (Associazione Italiana per la ricerca sul cancro) [IG 11924]; Ruth L. Kirschstein National Research Service Award Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK064798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PRIN (CKARAL, Ministero dell'Istruzione dell'Universita e della Ricerca); AIRC (Associazione Italiana per la ricerca sul cancro)(Fondazione AIRC per la ricerca sul cancro); Ruth L. Kirschstein National Research Service Award Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Paul Rothman, Anthony R. French, Kenneth M. Murphy, Jeffrey I. Gordon, and Takeshi Egawa for mouse lines, Antonius Rolink for antibodies, and William E. Gillanders and Isaiah Turnbull for tissue specimens. This work was supported by NIH grants R01 DE021255-01 and U01 AI095542-01 to M. Co. W. V. was supported by PRIN (CKARAL, Ministero dell'Istruzione dell'Universita e della Ricerca, 2009) and AIRC (Associazione Italiana per la ricerca sul cancro, 2010, IG 11924). J. S. L. was supported by the Ruth L. Kirschstein National Research Service Award Training Grant, and R. D. N. was supported by NIH grant R01DK064798. The Washington University DDRCC Biobank core is supported by NIH grant P30DK052574.	Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; CARMAN PS, 1986, J IMMUNOL, V136, P1548; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P277, DOI 10.1016/j.coi.2012.03.011; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Eiras P, 2000, SCAND J IMMUNOL, V52, P1; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Sheridan Brian S, 2010, Curr Gastroenterol Rep, V12, P513, DOI 10.1007/s11894-010-0148-6; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Silva A, 2008, INT IMMUNOL, V20, P625, DOI 10.1093/intimm/dxn022; Sips M, 2012, MUCOSAL IMMUNOL, V5, P30, DOI 10.1038/mi.2011.40; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; TAGLIABUE A, 1982, J EXP MED, V155, P1785, DOI 10.1084/jem.155.6.1785; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305	49	640	665	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					769	781		10.1016/j.immuni.2013.02.010	http://dx.doi.org/10.1016/j.immuni.2013.02.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23453631	Bronze, Green Accepted			2022-12-18	WOS:000330942100018
J	Martin, B; Hirota, K; Cua, DJ; Stockinger, B; Veldhoen, M				Martin, Bruno; Hirota, Keiji; Cua, Daniel J.; Stockinger, Brigitta; Veldhoen, Marc			Interleukin-17-Producing gamma delta T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR-2; ESCHERICHIA-COLI INFECTION; ARYL-HYDROCARBON RECEPTOR; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; TH17 CELLS; HELPER-CELLS; HOST-DEFENSE; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS	gamma delta T cells are an innate source of interleukin-17 (IL-17), preceding the development of the adaptive T helper 17 (Th17) cell response. Here we show that IL-17-producing T cell receptor gamma delta (TCR gamma delta) T cells share characteristic features with Th17 cells, such as expression of chemokine receptor 6 (CCR6), retinoid orphan receptor (ROR gamma t), aryl hydrocarbon receptor (AhR), and IL-23 receptor. AhR expression in gamma delta T cells was essential for the production of IL-22 but not for optimal IL-17 production. In contrast to Th17 cells, CCR6(+)IL-17-producing gamma delta T cells, but not other gamma delta T cells, express Toll-like receptors TLR1 and TLR2, as well as dectin-1, but not TLR4 and could directly interact with certain pathogens. This process was amplified by IL-23 and resulted in expansion, increased IL-17 production, and recruitment of neutrophils. Thus, innate receptor expression linked with IL-17 production characterizes TCR gamma delta T cells as an efficient first line of defense that can orchestrate an inflammatory response to pathogen-derived as well as environmental signals long before Th17 cells have sensed bacterial invasion.	[Martin, Bruno; Hirota, Keiji; Stockinger, Brigitta; Veldhoen, Marc] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Cua, Daniel J.] Schering Plough Biopharma, Palo Alto, CA 94304 USA	MRC National Institute for Medical Research; Merck & Company	Veldhoen, M (corresponding author), MRC Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	mveldho@nimr.mrc.ac.uk	Veldhoen, Marc/AAM-5357-2021; Veldhoen, Marc/AAJ-2759-2020	Veldhoen, Marc/0000-0002-1478-9562; Martin, Bruno/0000-0003-4013-8998; Hirota, Keiji/0000-0002-4737-0661; Stockinger, Brigitta/0000-0001-8781-336X	Medical Research Council UK	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to A. Rae and G. Preece for FACS sorting, A. Kirby for providing us with anti-Vyl and Vy5 antibody, and A. O'Garra for providing us with CpG and V.Cerundolo for the C. albicans strain. We would also like to thank the Biological Services staff of the National Institute for Medical Research for expert breeding and maintenance of our mouse strains. This work was supported by the Medical Research Council UK. D.J.C. is an employee of Schering-Plough Biopharma.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Deetz CO, 2006, INFECT IMMUN, V74, P4505, DOI 10.1128/IAI.00088-06; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Finnerty CC, 2009, CYTOKINE, V45, P20, DOI 10.1016/j.cyto.2008.10.005; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; King DP, 1999, J IMMUNOL, V162, P5033; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Mokuno Y, 2000, J IMMUNOL, V165, P931, DOI 10.4049/jimmunol.165.2.931; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schwacha MG, 2008, CYTOKINE, V44, P328, DOI 10.1016/j.cyto.2008.09.001; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Toth B, 2004, J LEUKOCYTE BIOL, V76, P545, DOI 10.1189/jlb.0404219; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vasilevsky S, 2008, EUR J IMMUNOL, V38, P3316, DOI 10.1002/eji.200838484; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	56	639	664	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					321	330		10.1016/j.immuni.2009.06.020	http://dx.doi.org/10.1016/j.immuni.2009.06.020			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19682928	Bronze			2022-12-18	WOS:000269338600017
J	Strasser, A; Jost, PJ; Nagata, S				Strasser, Andreas; Jost, Philipp J.; Nagata, Shigekazu			The Many Roles of FAS Receptor Signaling in the Immune System	IMMUNITY			English	Review							FAMILY-MEMBER BIM; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; HEMATOPOIETIC PROGENITOR CELLS; DOMINANT INTERFERING MUTANT; BH3-ONLY PROTEIN BIM; MATURE T-LYMPHOCYTES; VERSUS-HOST-DISEASE; B-CELLS; INDUCED APOPTOSIS; BCL-2 FAMILY	FAS belongs to the subgroup of the tumor necrosis factor receptor (TNF-R) family that contains an intracellular "death domain" and triggers apoptosis. Its physiological ligand FASL is a member of the TNF cytokine family. Studies with mutant mice and cells from human patients have shown that FAS plays critical roles in the immune system, including the killing of pathogen-infected cells and the death of obsolete and potentially dangerous lymphocytes. Fas thereby functions as a guardian against autoimmunity and tumor development. FAS triggers apoptosis through FADD-mediated recruitment and activation of caspase-8. In certain cells such as hepatocytes, albeit not lymphocytes, FAS-induced apoptosis requires amplification through proteolytic activation of the proapoptotic BCL-2 family member BID. Curiously, several components of the FAS signaling machinery have been implicated in nonapoptotic processes, including cellular activation, differentiation, and proliferation. This review describes current understanding of Fas-induced apoptosis signaling and proposes experimental strategies for future advances.	[Strasser, Andreas; Jost, Philipp J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan	Walter & Eliza Hall Institute; Kyoto University	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au; snagata@mfour.med.kyoto-u.ac.jp	Jost, Philipp J./S-4962-2016; Strasser, Andreas/C-7581-2013; Nagata, Shigekazu/AAG-3203-2019	Jost, Philipp J./0000-0003-2454-0362; Strasser, Andreas/0000-0002-5020-4891; Nagata, Shigekazu/0000-0001-9758-8426	National Health and Medical Research Council [257502, 461263, 356214]; Leukemia and Lymphoma Society [7015]; National Cancer Institute [CA 80188, CA 43540]; Mildred Scheel-Stiftung/Deutsche Krebshilfe; Ministry of Education, Science, Sports, and Culture in Japan; Japan Science and Technology Agency (SORST); NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mildred Scheel-Stiftung/Deutsche Krebshilfe(Deutsche Krebshilfe); Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (SORST)(Japan Science & Technology Agency (JST)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in our laboratories was supported by fellowships and grants from the National Health and Medical Research Council (Australia; #257502, #461263, and #356214); the Leukemia and Lymphoma Society (New York; SCOR grant #7015); the National Cancer Institute (NIH, US; CA 80188 and CA 43540); the Mildred Scheel-Stiftung/Deutsche Krebshilfe; the Ministry of Education, Science, Sports, and Culture in Japan (Specially Promoted Research); and the Japan Science and Technology Agency (SORST).	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Allison J, 1997, P NATL ACAD SCI USA, V94, P3943, DOI 10.1073/pnas.94.8.3943; Allison J, 1998, P NATL ACAD SCI USA, V95, P13818, DOI 10.1073/pnas.95.23.13818; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Beisner DR, 2003, J IMMUNOL, V171, P247, DOI 10.4049/jimmunol.171.1.247; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bellairs P, 1995, AUSTRALAS I MIN MET, V95, P63; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; CHINNAIYAN AM, 1995, CELL, V81, P512; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fukuyama H, 2002, EUR J IMMUNOL, V32, P223, DOI 10.1002/1521-4141(200201)32:1<223::AID-IMMU223>3.0.CO;2-4; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hattori K, 1998, BLOOD, V91, P4051, DOI 10.1182/blood.V91.11.4051.411k16_4051_4055; Hennino A, 2001, J EXP MED, V193, P447, DOI 10.1084/jem.193.4.447; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Ichikawa K, 2000, INT IMMUNOL, V12, P555, DOI 10.1093/intimm/12.4.555; Igney FH, 2000, EUR J IMMUNOL, V30, P725, DOI 10.1002/1521-4141(200003)30:3<725::AID-IMMU725>3.3.CO;2-4; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kagi D, 1997, J EXP MED, V186, P989, DOI 10.1084/jem.186.7.989; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Koenig A, 2008, CELL DEATH DIFFER, V15, P1701, DOI 10.1038/cdd.2008.100; Komano H, 1999, INT IMMUNOL, V11, P1035, DOI 10.1093/intimm/11.7.1035; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mabrouk I, 2008, IMMUNITY, V29, P922, DOI 10.1016/j.immuni.2008.10.007; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; Mori T, 1997, BLOOD, V89, P3565, DOI 10.1182/blood.V89.10.3565.3565_3565_3573; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 2000, J EXP MED, V191, P195, DOI 10.1084/jem.191.1.195; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Newton K, 2001, CURR BIOL, V11, P273, DOI 10.1016/S0960-9822(01)00067-7; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Rubio CF, 1996, J IMMUNOL, V157, P65; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Su X, 2000, J IMMUNOL, V164, P2523, DOI 10.4049/jimmunol.164.5.2523; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; WATANABEFUKUNAG.R, 1992, NATURE, V356, P317; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117; Zhu BM, 2000, EUR J IMMUNOL, V30, P1778, DOI 10.1002/1521-4141(200006)30:6<1778::AID-IMMU1778>3.0.CO;2-D	104	635	672	2	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 20	2009	30	2					180	192		10.1016/j.immuni.2009.01.001	http://dx.doi.org/10.1016/j.immuni.2009.01.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19239902	Green Accepted, Bronze			2022-12-18	WOS:000263710500006
J	Marigo, I; Bosio, E; Solito, S; Mesa, C; Fernandez, A; Dolcetti, L; Ugel, S; Sonda, N; Bicciato, S; Falisi, E; Calabrese, F; Basso, G; Zanovello, P; Cozzi, E; Mandruzzato, S; Bronte, V				Marigo, Ilaria; Bosio, Erika; Solito, Samantha; Mesa, Circe; Fernandez, Audry; Dolcetti, Luigi; Ugel, Stefano; Sonda, Nada; Bicciato, Silvio; Falisi, Erika; Calabrese, Fiorella; Basso, Giuseppe; Zanovello, Paola; Cozzi, Emanuele; Mandruzzato, Susanna; Bronte, Vincenzo			Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBP beta Transcription Factor	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; T-CELL RESPONSES; DIFFERENTIATION; ISOFORMS; CANCER; INHIBITION; INDUCTION; SUBSETS; ANTIGEN	Tumor growth is associated with a profound alteration in myelopoiesis, leading to recruitment of immunosuppressive cells known as myeloid-derived suppressor cells (MDSCs). We showed that among factors produced by various experimental tumors, the cytokines GM-CSF, G-CSF, and IL-6 allowed a rapid generation of MDSCs from precursors present in mouse and human bone marrow (BM). BM-MDSCs induced by GM-CSF+IL-6 possessed the highest tolerogenic activity, as revealed by the ability to impair the priming of CD8(+) T cells and allow long term acceptance of pancreatic islet allografts. Cytokines inducing MDSCs acted on a common molecular pathway and the immunoregulatory activity of both tumor-induced and BM-derived MDSCs was entirely dependent on the C/EBP beta transcription factor. Adoptive transfer of tumor antigen-specific CD8(+) T lymphocytes resulted in therapy of established tumors only in mice lacking C/EBP beta in the myeloid compartment, suggesting that C/EBP beta is a critical regulator of the immunosuppressive environment created by growing cancers.	[Zanovello, Paola; Mandruzzato, Susanna; Bronte, Vincenzo] IRCCS, IOV, I-35128 Padua, Italy; [Marigo, Ilaria; Solito, Samantha; Ugel, Stefano; Falisi, Erika; Zanovello, Paola; Mandruzzato, Susanna] Univ Padua, Dept Oncol & Surg Sci, I-35128 Padua, Italy; [Bosio, Erika; Calabrese, Fiorella] Univ Padua, Dept Med Diagnost Sci & Special Therapies, I-35128 Padua, Italy; [Mesa, Circe; Fernandez, Audry] Ctr Mol Immunol, Havana 16040, Cuba; [Dolcetti, Luigi; Ugel, Stefano; Sonda, Nada] Venetian Inst Mol Med, I-35129 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy; [Basso, Giuseppe] Univ Padua, Dept Pediat, I-35100 Padua, Italy; [Cozzi, Emanuele] Padua Hosp, Direz Sanit, I-35128 Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV); IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; Veneto Institute Molecular Medicine; Universita di Modena e Reggio Emilia; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova	Bronte, V (corresponding author), IRCCS, IOV, I-35128 Padua, Italy.	enzo.bronte@unipd.it	BICCIATO, Silvio/J-4466-2019; Ugel, Stefano/J-5535-2016; Bronte, Vincenzo/K-7902-2016; Bicciato, Silvio/C-9825-2009; Marigo, Ilaria/H-5741-2018	BICCIATO, Silvio/0000-0002-1944-7078; Ugel, Stefano/0000-0002-6639-7608; Bronte, Vincenzo/0000-0002-3741-5141; Bicciato, Silvio/0000-0002-1944-7078; Marigo, Ilaria/0000-0003-2948-3678; SOLITO, SAMANTHA/0000-0003-2544-1673; Cozzi, Emanuele/0000-0001-7855-5055; Bosio, Erika/0000-0001-9985-7829; MANDRUZZATO, SUSANNA/0000-0002-0707-995X; Zanovello, Paola/0000-0002-9996-2669; BASSO, GIUSEPPE/0000-0002-2634-9302	Italian Ministry of Health; Fondazione Cassa di Risparmio di Padova e Rovigo; Italian Association for Cancer Research (AIRC); Fondazione Italiana Sclerosi Multipla (FISM) [RSF/2005/R/5]; Association for International Cancer Research (AICR) [08-0518]; Istituto Superiore Sanita-Alleanza Contro il Cancro [ACC8]	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Association for International Cancer Research (AICR); Istituto Superiore Sanita-Alleanza Contro il Cancro	We thank Dr. A. Corradin for support in statistical analysis and E. Peranzoni and S. Zilio for help with cytofluorimetric studies. This work was supported by grants from the Italian Ministry of Health, Fondazione Cassa di Risparmio di Padova e Rovigo, Italian Association for Cancer Research (AIRC), project RSF/2005/R/5 from Fondazione Italiana Sclerosi Multipla (FISM), Association for International Cancer Research (AICR, Grant 08-0518), and Istituto Superiore Sanita-Alleanza Contro 1 Cancro (project no. ACC8).	Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 1999, J IMMUNOL, V162, P5728; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Eighetany MT, 2004, J CLIN LAB ANAL, V18, P36, DOI 10.1002/jcla.20001; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Gupta AK, 1999, AM J PHYSIOL-RENAL, V276, pF599, DOI 10.1152/ajprenal.1999.276.4.F599; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Machen J, 2004, GENE THER, V11, P1506, DOI 10.1038/sj.gt.3302320; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mennuni C, 2008, CANCER RES, V68, P9865, DOI 10.1158/0008-5472.CAN-08-1603; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Qiu X, 2008, J BIOL CHEM, V283, P25774, DOI 10.1074/jbc.M801178200; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Stetler-Stevenson M, 2001, BLOOD, V98, P979, DOI 10.1182/blood.V98.4.979; Teng XW, 2002, CIRC RES, V90, P125, DOI 10.1161/hh0202.103647; Ugel S, 2010, BLOOD, V115, P1374, DOI 10.1182/blood-2009-07-233270; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	35	629	655	4	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					790	802		10.1016/j.immuni.2010.05.010	http://dx.doi.org/10.1016/j.immuni.2010.05.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20605485	Bronze			2022-12-18	WOS:000279365800010
J	Malek, TR; Yu, AX; Vincek, V; Scibelli, P; Kong, L				Malek, TR; Yu, AX; Vincek, V; Scibelli, P; Kong, L			CD4 regulatory T cells prevent lethal autoimmunity in IL-2R beta-deficient mice: implications for the nonredundant function of IL-2	IMMUNITY			English	Article							INTERLEUKIN-2 RECEPTOR-BETA; IMMUNOLOGICAL SELF-TOLERANCE; THYMIC SELECTION; HOMEOSTASIS; ACTIVATION; APOPTOSIS; CHAIN; LYMPHOCYTES; EXPRESSION; EXPANSION	Lethal autoimmunity associated with IL-2Rbeta-deficient mice is prevented after thymic transgenic expression of wild-type IL-2Rbeta in IL-2Rbeta(-/-) mice (Tg -/- mice). Here, we show that CD4(+)CD25(+) regulatory T cells were not readily detected in IL-2Rbeta(-/-) mice, but the production of functional CD4(+)CD25(+) T cells was reconstituted in Tg -/- mice. Adoptive transfer of normal CD4(+) CD25(+) T cells into neonatal IL-2Rbeta-deficient mice prevented this lethal autoimmune syndrome. The CD4(+) CD25(+) T cells in disease-free adult IL-2Rbeta-deficient recipient mice were present at a near normal frequency, were solely donor-derived, and depended on IL-2 for expansion. These observations indicate that the essential function of the IL-2/IL-2R system primarily lies at the level of the production of CD4(+)CD25(+) regulatory T cells.	Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA	University of Miami; University of Miami	Malek, TR (corresponding author), Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA.				NCI NIH HHS [CA45947] Funding Source: Medline; NIAID NIH HHS [AI 40114] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040114, R01AI040114] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bassiri H, 2001, J IMMUNOL, V166, P5945, DOI 10.4049/jimmunol.166.10.5945; HANKE T, 1994, J EXP MED, V180, P1629, DOI 10.1084/jem.180.5.1629; He YW, 1998, CRIT REV IMMUNOL, V18, P503, DOI 10.1615/CritRevImmunol.v18.i6.20; HE YW, 1995, J IMMUNOL, V154, P1596; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; KRAMER S, 1994, EUR J IMMUNOL, V24, P2317, DOI 10.1002/eji.1830241009; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694; Malek TR, 2000, J IMMUNOL, V164, P2905, DOI 10.4049/jimmunol.164.6.2905; Malek TR, 2001, J IMMUNOL, V166, P1675, DOI 10.4049/jimmunol.166.3.1675; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Suzuki H, 1999, J EXP MED, V190, P1561, DOI 10.1084/jem.190.11.1561; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Suzuki H, 1997, INT IMMUNOL, V9, P1367, DOI 10.1093/intimm/9.9.1367; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Van Parijs L, 1998, SCIENCE, V280, P243; VanParijs L, 1997, J IMMUNOL, V158, P3738; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yang SW, 1998, J UNIV SCI TECHNOL B, V5, P223; [No title captured]	33	629	660	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2002	17	2					167	178		10.1016/S1074-7613(02)00367-9	http://dx.doi.org/10.1016/S1074-7613(02)00367-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196288	Bronze			2022-12-18	WOS:000177669400005
J	Novick, D; Kim, SH; Fantuzzi, G; Reznikov, LL; Dinarello, CA; Rubinstein, M				Novick, D; Kim, SH; Fantuzzi, G; Reznikov, LL; Dinarello, CA; Rubinstein, M			Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response	IMMUNITY			English	Article							GAMMA-INDUCING FACTOR; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MEMBRANE ANCHOR ATTACHMENT; INTERFERON-GAMMA; MOLECULAR-CLONING; HUMAN-URINE; T-CELLS; RECEPTOR; KINASE	An interleukin-18 binding protein (IL-18BP) was purified from urine by chromatography on IL-18 beads, sequenced, cloned, and expressed in COS7 cells. IL-18BP abolished IL-18 induction of interferon-gamma (IFN gamma), IL-8, and activation of NF-kappa B in vitro. Administration of IL-18BP to mice abrogated circulating IFN gamma following LPS. Thus, IL-18BP functions as an inhibitor of the early Th1 cytokine response, IL-18BP is constitutively expressed in the spleen, belongs to the immunoglobulin superfamily, and has limited homology to the IL-1 type II receptor. Its gene was localized on human chromosome 11q13, and no exon coding for a transmembrane domain was found in an 8.3 kb genomic sequence. Several Poxviruses encode putative proteins highly homologous to IL-18BP, suggesting that viral products may attenuate IL-18 and interfere with the cytotoxic T cell response.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80262 USA	Weizmann Institute of Science; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Rubinstein, M (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	lvrub@weizmann.weizmann.ac.il	Dinarello, Charles/C-8524-2013; Fantuzzi, Giamila/A-1758-2009	Fantuzzi, Giamila/0000-0001-5334-0082; Rubinstein, Menachem/0000-0002-3472-6614	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R37AI015614] Funding Source: NIH RePORTER; NIAID NIH HHS [AI15614, AI2532359] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bailly S, 1990, Eur Cytokine Netw, V1, P47; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Elson GCA, 1998, J IMMUNOL, V161, P1371; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; GUTKIND JS, 1991, MOL CELL BIOL, V11, P1500, DOI 10.1128/MCB.11.3.1500; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Konishi K, 1997, J IMMUNOL METHODS, V209, P187, DOI 10.1016/S0022-1759(97)00164-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORAN P, 1991, J CELL BIOL, V115, P1595, DOI 10.1083/jcb.115.6.1595; MORAN P, 1991, J BIOL CHEM, V266, P1250; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; NAKAMURA K, 1989, INFECT IMMUN, V57, P590, DOI 10.1128/IAI.57.2.590-595.1989; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; NOVICK D, 1983, EMBO J, V2, P1527, DOI 10.1002/j.1460-2075.1983.tb01618.x; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Parnet P, 1996, J BIOL CHEM, V271, P3967; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; REESE MG, 1997, P 1 ANN INT C COMP M; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rothe H, 1997, J AUTOIMMUN, V10, P251, DOI 10.1006/jaut.1997.0135; Rothe H, 1997, J CLIN INVEST, V99, P469, DOI 10.1172/JCI119181; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; Sareneva T, 1998, J IMMUNOL, V160, P6032; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SIMS JE, 1994, CLIN IMMUNOL IMMUNOP, V72, P9, DOI 10.1006/clin.1994.1100; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; SPARKS CA, 1993, GENOMICS, V17, P222, DOI 10.1006/geno.1993.1307; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Tsutsui H, 1996, J IMMUNOL, V157, P3967; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	51	628	690	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					127	136		10.1016/S1074-7613(00)80013-8	http://dx.doi.org/10.1016/S1074-7613(00)80013-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023777	Bronze			2022-12-18	WOS:000078428700013
J	Lu, LF; Thai, TH; Calado, DP; Chaudhry, A; Kubo, M; Tanaka, K; Loeb, GB; Lee, H; Yoshimura, A; Rajewsky, K; Rudensky, AY				Lu, Li-Fan; Thai, To-Ha; Calado, Dinis Pedro; Chaudhry, Ashutosh; Kubo, Masato; Tanaka, Kentaro; Loeb, Gabriel B.; Lee, Hana; Yoshimura, Akihiko; Rajewsky, Klaus; Rudensky, Alexander Y.			Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 Protein	IMMUNITY			English	Article							CYTOKINE SIGNALING-1; IMMUNE REGULATION; HIGH EXPRESSION; DIFFERENTIATION; DICER; SUPPRESSOR; MICE; AUTOIMMUNITY; LYMPHOMA; LINEAGE	Foxp3(+) regulatory T (Treg) cells limit pathogenic immune responses to self-antigens and foreign antigens. An essential role for microRNA (miRNA) in the maintenance and function of Treg cells, revealed by the Treg cell-specific Dicer ablation, raised a question as to a specific miRNA contribution. We found that Foxp3 controlled the elevated miR155 expression required for maintaining Treg cell proliferative activity and numbers under nonlymphopenic conditions. Moreover, miR155 deficiency in Treg cells resulted in increased suppressor of cytokine signaling 1 (SOCS1) expression accompanied by impaired activation of signal transducer and activator of transcription 5 (STAT5) transcription factor in response to limiting amounts of interleukin-2. Our studies suggest that Foxp3-dependent regulation of miR155 maintains competitive fitness of Treg cells by targeting SOCS1, and they provide experimental support for a proposed role for miRNAs in ensuring the robustness of cellular phenotypes.	[Lu, Li-Fan; Chaudhry, Ashutosh; Loeb, Gabriel B.; Lee, Hana; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Lu, Li-Fan; Chaudhry, Ashutosh; Loeb, Gabriel B.; Lee, Hana; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Thai, To-Ha; Calado, Dinis Pedro; Rajewsky, Klaus] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Kubo, Masato] Riken Yokohama Inst, Riken Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Kentaro; Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Lu, Li-Fan; Thai, To-Ha; Calado, Dinis Pedro] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjyuku Ku, Tokyo 1608582, Japan	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; RIKEN; Kyushu University; Keio University	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	rudenska@mskcc.org	Calado, Dinis/U-8379-2019; Yoshimura, Akihiko/K-5515-2013; Kubo, Masato/A-5918-2016	Calado, Dinis/0000-0001-8239-7184; Tanaka, Kentaro/0000-0003-4602-4465; Chaudhry, Ashutosh/0000-0003-3379-5236; Lu, Li-Fan/0000-0002-9727-0036; Rajewsky, Klaus/0000-0002-6633-6370	National Institutes of Health; European Union through MUGEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Leukemia and Lymphoma Society; Portuguese Foundation for Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union through MUGEN(European Commission); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Josefowicz for the help in key experiments, T. Chu, L. Karpik, and K. Forbush for superb technical assistance, and all members of our laboratory for discussions. This work was supported by grants from the National Institutes of Health (to A.Y.R. and K.R.), from the European Union through MUGEN (to K.R.), and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to A.Y.). L.L.F. is a Leukemia and Lymphoma Society Fellow. D.P.C. is supported by the Portuguese Foundation for Science and Technology (FCT-MCES). A.Y.R. is a Howard Hughes Medical Institute investigator.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Harada M, 2007, AM J RESP CELL MOL, V36, P491, DOI 10.1165/rcmb.2006-0090OC; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Inagaki-Ohara K, 2006, GUT, V55, P212, DOI 10.1136/gut.2004.062653; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	39	627	706	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					80	91		10.1016/j.immuni.2008.11.010	http://dx.doi.org/10.1016/j.immuni.2008.11.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144316	Bronze, Green Accepted			2022-12-18	WOS:000262769900012
J	Ni, L; Ye, F; Cheng, ML; Feng, Y; Deng, YQ; Zhao, H; Wei, P; Ge, JW; Gou, MT; Li, XL; Sun, L; Cao, TS; Wang, PZ; Zhou, C; Zhang, RR; Liang, P; Guo, H; Wang, XQ; Qin, CF; Chen, F; Dong, C				Ni, Ling; Ye, Fang; Cheng, Meng-Li; Feng, Yu; Deng, Yong-Qiang; Zhao, Hui; Wei, Peng; Ge, Jiwan; Gou, Mengting; Li, Xiaoli; Sun, Lin; Cao, Tianshu; Wang, Pengzhi; Zhou, Chao; Zhang, Rongrong; Liang, Peng; Guo, Han; Wang, Xinquan; Qin, Cheng-Feng; Chen, Fang; Dong, Chen			Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals	IMMUNITY			English	Article							RESPIRATORY SYNDROME; SARS-CORONAVIRUS; RESPONSES; OUTBREAK	The World Health Organization has declared SARS-CoV-2 virus outbreak a worldwide pandemic. However, there is very limited understanding on the immune responses, especially adaptive immune responses to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients who have recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific humoral and cellular immunity in eight newly discharged patients. Follow-up analysis on another cohort of six patients 2 weeks post discharge also revealed high titers of immunoglobulin G (IgG) antibodies. In all 14 patients tested, 13 displayed serum-neutralizing activities in a pseudotype entry assay. Notably, there was a strong correlation between neutralization antibody titers and the numbers of virus-specific T cells. Our work provides a basis for further analysis of protective immunity to SARS-CoV-2, and understanding the pathogenesis of COVID-19, especially in the severe cases. It also has implications in developing an effective vaccine to SARS-CoV-2 infection.	[Ni, Ling; Feng, Yu; Wei, Peng; Gou, Mengting; Li, Xiaoli; Sun, Lin; Wang, Pengzhi; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Ni, Ling; Feng, Yu; Wei, Peng; Gou, Mengting; Li, Xiaoli; Sun, Lin; Wang, Pengzhi; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ni, Ling; Dong, Chen] Beijing Friendship Hosp, Ctr Human Dis Immunomonitoring, Beijing 100050, Peoples R China; [Ye, Fang] Tsinghua Univ, Dept Hematol, Chui Yang Liu Hosp, Beijing 100022, Peoples R China; [Cheng, Meng-Li; Deng, Yong-Qiang; Zhao, Hui; Cao, Tianshu; Zhou, Chao; Zhang, Rongrong; Qin, Cheng-Feng] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Ge, Jiwan; Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Beijing 100022, Peoples R China; [Liang, Peng; Chen, Fang] Tsinghua Univ, Dept Cardiol, Chui Yang Liu Hosp, Beijing 100022, Peoples R China; [Guo, Han] Tsinghua Univ, Dept Orthoped, Chui Yang Liu Hosp, Beijing 100022, Peoples R China; [Dong, Chen] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Capital Medical University; Tsinghua University; Academy of Military Medical Sciences - China; Tsinghua University; Tsinghua University; Tsinghua University	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Beijing Friendship Hosp, Ctr Human Dis Immunomonitoring, Beijing 100050, Peoples R China.; Qin, CF (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Chen, F (corresponding author), Tsinghua Univ, Dept Cardiol, Chui Yang Liu Hosp, Beijing 100022, Peoples R China.; Dong, C (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	qincf@bmi.ac.cn; anzhenchenfang@163.com; chendong@tsinghua.edu.cn	Li, Xiaoli/GYQ-7384-2022; dong, chen/B-3181-2009; Qin, Cheng-Feng/I-6839-2019	dong, chen/0000-0002-0084-9130; Qin, Cheng-Feng/0000-0002-0632-2807; zhou, chao/0000-0001-8839-980X	National Key Research and Development Program of China [2016YFC0906200, 2016YFC130390, 2020YFA0707800]; Natural Science Foundation of China [31991173, 31821003, 31991170]; Beijing Municipal Science and Technology [Z181100001318007, Z181100006318015, Z171100000417005]; Zhejiang University Foundation [2020XGZX014]; Tsinghua University	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology; Zhejiang University Foundation; Tsinghua University	We thank Drs. Rong Mu and Zhinan Ying for sharing secondary detection antibodies. We also thank Weijin Huang and Jianhui Nie from the procuratorate for sharing the plasmids for pseudovirus package. This work was supported in part by grants from the National Key Research and Development Program of China (2016YFC0906200 to C.D., 2016YFC130390 to L.N., and 2020YFA0707800 to X.W.), Natural Science Foundation of China (31991173, 31821003, and 31991170 to C.D.), Beijing Municipal Science and Technology (Z181100001318007, Z181100006318015, and Z171100000417005 to C.D.), Zhejiang University Foundation (2020XGZX014 to C.D.), and award from Tsinghua University (to C.D.).	Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Di Pierro F, 2020, MINERVA GASTROENT D, V66, P172, DOI 10.23736/S1121-421X.20.02697-5; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; Ko JH, 2017, DIAGN MICR INFEC DIS, V89, P106, DOI 10.1016/j.diagmicrobio.2017.07.006; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nie JH, 2020, EMERG MICROBES INFEC, V9, P680, DOI 10.1080/22221751.2020.1743767; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Shi YL, 2004, J CLIN VIROL, V31, P66, DOI 10.1016/j.jcv.2004.05.006; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Vijay R, 2016, CURR OPIN VIROL, V16, P70, DOI 10.1016/j.coviro.2016.01.011; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang WL, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.114; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Woo PCY, 2004, J CLIN MICROBIOL, V42, P2306, DOI 10.1128/JCM.42.5.2306-2309.2004; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xie S, 2018, CANCER IMMUNOL IMMUN, V67, P1685, DOI 10.1007/s00262-018-2227-8; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	25	624	651	9	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					971	+		10.1016/j.immuni.2020.04.023	http://dx.doi.org/10.1016/j.immuni.2020.04.023			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32413330	Bronze, Green Published			2022-12-18	WOS:000541890000012
J	Nourshargh, S; Alon, R				Nourshargh, Sussan; Alon, Ronen			Leukocyte Migration into Inflamed Tissues	IMMUNITY			English	Review							CADHERIN TYROSINE PHOSPHORYLATION; FUNCTION-ASSOCIATED ANTIGEN-1; T-CELL RECRUITMENT; NEUTROPHIL RECRUITMENT; ENDOTHELIAL-CELLS; BLOOD-VESSELS; MAST-CELL; IN-VIVO; TRANSENDOTHELIAL MIGRATION; DIFFERENTIAL REGULATION	Leukocyte migration through activated venular walls is a fundamental immune response that is prerequisite to the entry of effector cells such as neutrophils, monocytes, and effector T cells to sites of infection, injury, and stress within the interstitium. Stimulation of leukocytes is instrumental in this process with enhanced temporally controlled leukocyte adhesiveness and shape-changes promoting leukocyte attachment to the inner wall of blood vessels under hydrodynamic forces. This initiates polarized motility of leukocytes within and through venular walls and transient barrier disruption facilitated sequentially by stimulated vascular cells, i.e., endothelial cells and their associated pericytes. Perivascular cells such as macrophages and mast cells that act as tissue inflammatory sentinels can also directly and indirectly regulate the exit of leukocytes from the vascular lumen. In this review, we discuss current knowledge and open questions regarding the mechanisms involved in the interactions of different effector leukocytes with peripheral vessels in extralymphoid organs.	[Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	University of London; Queen Mary University London; Weizmann Institute of Science	Nourshargh, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.	s.nourshargh@qmul.ac.uk; ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369; Nourshargh, Sussan/0000-0001-5677-1806	Wellcome Trust [098291/Z/12/Z]; Israel Science Foundation; US Israel Binational Science Foundation; Flight Attendant Medical Research Institute Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Israel Science Foundation(Israel Science Foundation); US Israel Binational Science Foundation(US-Israel Binational Science Foundation); Flight Attendant Medical Research Institute Foundation	We wish to thank H. Vega for help with figures, S. Feigelson for helpful suggestions, and A. Woodfin and M.-B. Voisin for providing the confocal images. S.N.'s research is generously funded by a Wellcome Trust Senior Investigator Award (Ref. 098291/Z/12/Z). R.A. is an incumbent of the Linda Jacobs Chair in Immune and Stem Cell Research, and his research is supported by the Israel Science Foundation, the US Israel Binational Science Foundation, and the Flight Attendant Medical Research Institute Foundation.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Alon R, 2009, MICROCIRCULATION, V16, P3, DOI 10.1080/10739680802026076; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Azcutia V, 2012, J IMMUNOL, V189, P2553, DOI 10.4049/jimmunol.1103606; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Block H, 2012, J EXP MED, V209, P407, DOI 10.1084/jem.20111493; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Deem TL, 2007, J IMMUNOL, V178, P3865, DOI 10.4049/jimmunol.178.6.3865; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Deng Q, 2012, J CELL SCI, V125, P3949, DOI 10.1242/jcs.093633; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Dixit N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00188; Dixit N, 2011, J IMMUNOL, V187, P472, DOI 10.4049/jimmunol.1004197; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Duffy D, 2012, IMMUNITY, V37, P917, DOI 10.1016/j.immuni.2012.07.015; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Garcia-Bernal D, 2006, J IMMUNOL, V177, P5215, DOI 10.4049/jimmunol.177.8.5215; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; HUANG AJ, 1993, J CELL BIOL, V120, P1371, DOI 10.1083/jcb.120.6.1371; Huttenlocher A, 2008, TRENDS CELL BIOL, V18, P298, DOI 10.1016/j.tcb.2008.04.001; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Jakus Z, 2009, J EXP MED, V206, P577, DOI 10.1084/jem.20081859; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lee JY, 2009, J LEUKOCYTE BIOL, V86, P1285, DOI 10.1189/jlb.0309214; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Lek HS, 2013, J BIOL CHEM, V288, P14698, DOI 10.1074/jbc.M112.430918; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; LORANT DE, 1991, J CELL BIOL, V115, P223, DOI 10.1083/jcb.115.1.223; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Marelli-Berg FM, 2004, IMMUNOL LETT, V93, P109, DOI 10.1016/j.imlet.2004.03.014; Martinelli R, 2009, MOL BIOL CELL, V20, P995, DOI 10.1091/mbc.E08-06-0636; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Molteni R, 2009, BLOOD, V114, P1073, DOI 10.1182/blood-2008-10-183699; Montresor A, 2013, J CELL BIOL, V203, P1003, DOI 10.1083/jcb.201303067; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Ostrovsky L, 1998, BLOOD, V91, P3028, DOI 10.1182/blood.V91.8.3028.3028_3028_3036; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; PFAU S, 1995, J CELL BIOL, V128, P969, DOI 10.1083/jcb.128.5.969; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Pober JS, 2001, ANN NY ACAD SCI, V941, P12; Porter JC, 1997, J CELL BIOL, V138, P1437, DOI 10.1083/jcb.138.6.1437; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Randolph GJ, 1996, J EXP MED, V183, P451, DOI 10.1084/jem.183.2.451; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Saito H, 2002, J LEUKOCYTE BIOL, V72, P829; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Savinov AY, 2003, J EXP MED, V197, P643, DOI 10.1084/jem.20021378; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Shulman Z, 2011, METHODS MOL BIOL, V757, P31, DOI 10.1007/978-1-61779-166-6_3; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sriramarao P, 1996, ANN NY ACAD SCI, V796, P218, DOI 10.1111/j.1749-6632.1996.tb32584.x; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Stoler-Barak L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085699; STRAMM LE, 1987, EXP EYE RES, V44, P17, DOI 10.1016/S0014-4835(87)80021-0; Sumagin R, 2011, AM J PHYSIOL-CELL PH, V301, pC804, DOI 10.1152/ajpcell.00135.2011; Sumagin R, 2010, J IMMUNOL, V185, P7057, DOI 10.4049/jimmunol.1001638; Sundd P, 2012, NATURE, V488, P399, DOI 10.1038/nature11248; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vockel M, 2013, BLOOD, V122, P2512, DOI 10.1182/blood-2013-04-499228; Voisin MB, 2013, J INNATE IMMUN, V5, P336, DOI 10.1159/000346659; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Voisin MB, 2009, ARTERIOSCL THROM VAS, V29, P1193, DOI 10.1161/ATVBAHA.109.187450; Walch JM, 2013, J CLIN INVEST, V123, P2663, DOI 10.1172/JCI66722; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wang J, 2013, NAT IMMUNOL, V14, P34, DOI 10.1038/ni.2456; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2014, NAT REV IMMUNOL, V14, P232, DOI 10.1038/nri3641; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Yao LB, 2013, BLOOD, V122, P3832, DOI 10.1182/blood-2012-12-473835; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	146	624	639	7	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					694	707		10.1016/j.immuni.2014.10.008	http://dx.doi.org/10.1016/j.immuni.2014.10.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517612	Bronze			2022-12-18	WOS:000345504900008
J	Abt, MC; Osborne, LC; Monticelli, LA; Doering, TA; Alenghat, T; Sonnenberg, GF; Paley, MA; Antenus, M; Williams, KL; Erikson, J; Wherry, EJ; Artis, D				Abt, Michael C.; Osborne, Lisa C.; Monticelli, Laurel A.; Doering, Travis A.; Alenghat, Theresa; Sonnenberg, Gregory F.; Paley, Michael A.; Antenus, Marcelo; Williams, Katie L.; Erikson, Jan; Wherry, E. John; Artis, David			Commensal Bacteria Calibrate the Activation Threshold of Innate Antiviral Immunity	IMMUNITY			English	Article							INFLUENZA-VIRUS INFECTION; T-CELL EXHAUSTION; CHRONIC VIRAL-INFECTION; INTESTINAL MICROBIOTA; GUT; RESPONSES; DISEASE; MICE; INFLAMMATION; HOMEOSTASIS	Signals from commensal bacteria can influence immune cell development and susceptibility to infectious or inflammatory diseases. However, the mechanisms by which commensal bacteria regulate protective immunity after exposure to systemic pathogens remain poorly understood. Here, we demonstrate that antibiotic-treated (ABX) mice exhibit impaired innate and adaptive antiviral immune responses and substantially delayed viral clearance after exposure to systemic LCMV or mucosal influenza virus. Furthermore, ABX mice exhibited severe bronchiole epithelial degeneration and increased host mortality after influenza virus infection. Genome-wide transcriptional profiling of macrophages isolated from ABX mice revealed decreased expression of genes associated with antiviral immunity. Moreover, macrophages from ABX mice exhibited defective responses to type I and type II IFNs and impaired capacity to limit viral replication. Collectively, these data indicate that commensal-derived signals provide tonic immune stimulation that establishes the activation threshold of the innate immune system required for optimal antiviral immunity.	[Abt, Michael C.; Osborne, Lisa C.; Monticelli, Laurel A.; Doering, Travis A.; Alenghat, Theresa; Sonnenberg, Gregory F.; Paley, Michael A.; Wherry, E. John; Artis, David] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Abt, Michael C.; Osborne, Lisa C.; Monticelli, Laurel A.; Doering, Travis A.; Alenghat, Theresa; Sonnenberg, Gregory F.; Paley, Michael A.; Wherry, E. John; Artis, David] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Antenus, Marcelo] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Williams, Katie L.; Erikson, Jan] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; The Wistar Institute	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu; dartis@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Osborne, Lisa/K-3027-2015	Osborne, Lisa/0000-0002-7170-3235; Abt, Michael/0000-0002-7351-2061; Paley, Michael/0000-0001-8724-3176; Artis, David/0000-0002-1753-4100	US National Institutes of Health [AI061570, AI087990, AI074878, AI095608, AI091759, AI095466, AI071309, AI078897, AI083022, AI077098, HHSN266200500030C, T32-AI05528, T32-AI007532, T32-RR007063, K08-DK093784, T32-AI007324]; Irvington Institute Postdoctoral Fellowship of Cancer Research Institute; Burroughs Wellcome Fund; National Institute of Diabetes and Digestive and Kidney Disease; Center for the Molecular Studies in Digestive and Liver Disease; Molecular Pathology and Imaging Core [DK50306]; NCI Comprehensive Cancer Center Support grant [2-P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, U01AI095608, R01AI061570, T32AI007324, R01AI091759, R21AI087990, R01AI074878, R21AI077098, R01AI071309, U19AI083022, T32AI007532, P01AI078897, R01AI102942, R21AI083480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, K08DK093784] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Postdoctoral Fellowship of Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for the Molecular Studies in Digestive and Liver Disease; Molecular Pathology and Imaging Core; NCI Comprehensive Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge members of the Artis and Wherry laboratory for helpful discussions and critical reading of the manuscript and D. Kobuley for care of the germ-free facility. This research is supported by the US National Institutes of Health (grants AI061570, AI087990, AI074878, AI095608, AI091759, and AI095466 to D.A.; grants AI071309, AI078897, AI095608, AI083022, AI077098, and HHSN266200500030C to E.J.W.; T32-AI05528 to M.C.A.; T32-AI007532 to G.F.S and L.A.M.; T32-RR007063 and K08-DK093784 to TA.; T32-AI007324 to M.A.P.), Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute (L.C.O.), the Burroughs Wellcome Fund (D.A.), the National Institute of Diabetes and Digestive and Kidney Disease, Center for the Molecular Studies in Digestive and Liver Disease, and the Molecular Pathology and Imaging Core (DK50306). We thank N. Cohen for assistance with tracheal isolation and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory (partially supported by NCI Comprehensive Cancer Center Support grant #2-P30 CA016520), the Wistar flow cytometry core, the UPenn Vet School Pathology Service, UPenn microarray facility, and UPenn human immunology core for invaluable technical assistance and expertise.	Abt MC, 2009, CURR OPIN GASTROEN, V25, P496, DOI 10.1097/MOG.0b013e328331b6b4; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amaral FA, 2008, P NATL ACAD SCI USA, V105, P2193, DOI 10.1073/pnas.0711891105; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cuddapah S, 2010, CURR OPIN IMMUNOL, V22, P341, DOI 10.1016/j.coi.2010.02.007; de Vrese M, 2006, VACCINE, V24, P6670, DOI 10.1016/j.vaccine.2006.05.048; Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063; DOLOWY WC, 1964, P SOC EXP BIOL MED, V116, P365, DOI 10.3181/00379727-116-29249; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fang SB, 2009, J TROP PEDIATRICS, V55, P297, DOI 10.1093/tropej/fmp001; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; SPENCER JC, 1977, J INFECT DIS, V136, P171, DOI 10.1093/infdis/136.2.171; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Szajewska Hania, 2005, Paediatr Drugs, V7, P111, DOI 10.2165/00148581-200507020-00004; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	60	624	654	9	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					158	170		10.1016/j.immuni.2012.04.011	http://dx.doi.org/10.1016/j.immuni.2012.04.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22705104	Green Accepted, Bronze			2022-12-18	WOS:000307133200018
J	Hoeffel, G; Chen, JM; Lavin, Y; Low, D; Almeida, FF; See, P; Beaudin, AE; Lum, J; Low, I; Forsberg, EC; Poidinger, M; Zolezzi, F; Larbi, A; Ng, LG; Chan, JKY; Greter, M; Becher, B; Samokhvalov, IM; Merad, M; Ginhoux, F				Hoeffel, Guillaume; Chen, Jinmiao; Lavin, Yonit; Low, Donovan; Almeida, Francisca F.; See, Peter; Beaudin, Anna E.; Lum, Josephine; Low, Ivy; Forsberg, E. Camilla; Poidinger, Michael; Zolezzi, Francesca; Larbi, Anis; Ng, Lai Guan; Chan, Jerry K. Y.; Greter, Melanie; Becher, Burkhard; Samokhvalov, Igor M.; Merad, Miriam; Ginhoux, Florent			C-Myb(+) Erythro-Myeloid Progenitor-Derived Fetal Monocytes Give Rise to Adult Tissue-Resident Macrophages	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MOUSE YOLK-SAC; CIRCULATING MONOCYTES; ALVEOLAR MACROPHAGES; STEADY-STATE; GM-CSF; DIFFERENTIATION; MYB; SYSTEM; BLOOD	Although classified as hematopoietic cells, tissue-resident macrophages (MFs) arise from embryonic precursors that seed the tissues prior to birth to generate a self-renewing population, which is maintained independently of adult hematopoiesis. Here we reveal the identity of these embryonic precursors using an in utero MF-depletion strategy and fate-mapping of yolk sac (YS) and fetal liver (FL) hematopoiesis. We show that YS MFs are the main precursors of microglia, while most other MFs derive from fetal monocytes (MOs). Both YS MFs and fetal MOs arise from erythro-myeloid progenitors (EMPs) generated in the YS. In the YS, EMPs gave rise to MFs without monocytic intermediates, while EMP seeding the FL upon the establishment of blood circulation acquired c-Myb expression and gave rise to fetal MOs that then seeded embryonic tissues and differentiated into MFs. Thus, adult tissue-resident MFs established from hematopoietic stem cell-independent embryonic precursors arise from two distinct developmental programs.	[Hoeffel, Guillaume; Chen, Jinmiao; Low, Donovan; Almeida, Francisca F.; See, Peter; Lum, Josephine; Low, Ivy; Poidinger, Michael; Zolezzi, Francesca; Larbi, Anis; Ng, Lai Guan; Chan, Jerry K. Y.; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, BIOPOLIS, Singapore 138648, Singapore; [Lavin, Yonit; Merad, Miriam] Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Lavin, Yonit; Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Beaudin, Anna E.; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Singapore 119228, Singapore; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Reprod Med, Singapore 229899, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Singapore & Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Greter, Melanie; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Samokhvalov, Igor M.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Icahn School of Medicine at Mount Sinai; University of California System; University of California Santa Cruz; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; University of Zurich; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, BIOPOLIS, 8A Biomed Grove,IMMUNOS Bldg 3-4, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Ng, Lai Guan/N-6980-2019; Ng, Lai Guan/E-5673-2011; Hoeffel, Guillaume/ABG-4881-2021; Becher, Burkhard/ABE-4225-2020; Chen, Jinmiao/ABE-5601-2021; Larbi, Anis/ABE-5868-2020	Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Hoeffel, Guillaume/0000-0002-2534-4972; Becher, Burkhard/0000-0002-1541-7867; F. de Almeida, Francisca/0000-0001-6632-7610; Greter, Melanie/0000-0002-7220-5369; See, Peter/0000-0003-4428-7763; Lavin, Yonit/0000-0003-0593-3910; Poidinger, Michael/0000-0002-1047-2277	Singapore Immunology Network; NIH [CA112100, HL086899, AI080884]; NMRC Singapore [NMRC/CSA/012/2009]; NATIONAL CANCER INSTITUTE [R01CA112100, R01CA190400, R01CA173861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100917] Funding Source: NIH RePORTER	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NMRC Singapore(National Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by core grants of the Singapore Immunology Network to F.G., by NIH grants CA112100, HL086899, and AI080884 to M.M., by the NMRC Singapore (NMRC/CSA/012/2009) for J.K.Y.C. Runx1-MerCreMer mice have RIKEN CDB Acc. No. CDB0524K. We thank Dr. Lucy Robinson of Insight Editing London for her assistance in preparing the manuscript.	Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Clarke D, 2000, ONCOGENE, V19, P3343, DOI 10.1038/sj.onc.1203661; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Golub R, 2013, BLOOD CELL MOL DIS, V51, P226, DOI 10.1016/j.bcmd.2013.08.004; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lavin Y, 2013, CANCER IMMUNOL RES, V1, P201, DOI 10.1158/2326-6066.CIR-13-0117; Lin Y, 2014, STEM CELLS DEV, V23, P1168, DOI 10.1089/scd.2013.0536; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Molawi K, 2013, ADV IMMUNOL, V120, P269, DOI 10.1016/B978-0-12-417028-5.00010-7; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAITO M, 1990, J LEUKOCYTE BIOL, V48, P27, DOI 10.1002/jlb.48.1.27; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Sudo T, 1995, ONCOGENE, V11, P2469; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tavian M, 2005, INT J DEV BIOL, V49, P243, DOI 10.1387/ijdb.041957mt; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	52	623	639	4	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					665	678		10.1016/j.immuni.2015.03.011	http://dx.doi.org/10.1016/j.immuni.2015.03.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902481	Green Accepted, Bronze			2022-12-18	WOS:000353347500013
J	Vigorito, E; Perks, KL; Abreu-Goodger, C; Bunting, S; Xiang, Z; Kohlhaas, S; Das, PP; Miska, EA; Rodriguez, A; Bradley, A; Smith, KGC; Rada, C; Enright, AJ; Toellner, KM; MacLennan, ICM; Turner, M				Vigorito, Elena; Perks, Kerry L.; Abreu-Goodger, Cei; Bunting, Sam; Xiang, Zou; Kohlhaas, Susan; Das, Partha P.; Miska, Eric A.; Rodriguez, Antony; Bradley, Allan; Smith, Kenneth G. C.; Rada, Cristina; Enright, Anton J.; Toellner, Kai-Michael; MacLennan, Ian C. M.; Turner, Martin			MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells	IMMUNITY			English	Article							MEMORY B-CELLS; GERMINAL-CENTERS; HIGH EXPRESSION; DIFFERENTIATION; PU.1; MICE; RECEPTOR; LYMPHOMA; ABSENCE; DICER	microRNA-155 (miR-155) is expressed by cells of the immune system after activation and has been shown to be required for antibody production after vaccination with attenuated Salmonella. Here we show the intrinsic requirement for miR-155 in B cell responses to thymus-dependent and -independent antigens. B cells lacking miR-155 generated reduced extrafollicular and germinal center responses and failed to produce high-affinity IgG1 antibodies. Gene-expression profiling of activated B cells indicated that miR-155 regulates an array of genes with diverse function, many of which are predicted targets of miR-155. The transcription factor Pu.1 is validated as a direct target of miR155-mediated inhibition. When Pu.1 is over-expressed in wild-type B cells, fewer IgG1 cells are produced, indicating that loss of Pu.1 regulation is a contributing factor to the miR-155-deficient phenotype. Our results implicate post-transcriptional regulation of gene expression for establishing the terminal differentiation program of B cells.	[Vigorito, Elena; Kohlhaas, Susan; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Bunting, Sam] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England; [Perks, Kerry L.; Toellner, Kai-Michael; MacLennan, Ian C. M.] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Abreu-Goodger, Cei; Rodriguez, Antony; Bradley, Allan; Enright, Anton J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Xiang, Zou; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Xiang, Zou; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge CB2 0XY, England; [Das, Partha P.; Miska, Eric A.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Das, Partha P.; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Rada, Cristina] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Birmingham; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; MRC Laboratory Molecular Biology	Vigorito, E (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England.	elena.vigorito@bbsrc.ac.uk; martin.turner@bbsrc.ac.uk	Abreu-Goodger, Cei/A-1268-2010; Toellner, Kai-Michael/F-1519-2011; Turner, Martin/N-9976-2014; Enright, Anton/F-3094-2011	Abreu-Goodger, Cei/0000-0001-8302-9893; Toellner, Kai-Michael/0000-0001-8404-645X; Turner, Martin/0000-0002-3801-9896; Enright, Anton/0000-0002-6090-3100; Xiang, Zou/0000-0003-3925-0296; Das, Partha Pratim/0000-0003-3544-2629; Miska, Eric/0000-0002-4450-576X; Smith, Kenneth/0000-0003-3829-4326; Bradley, Allan/0000-0002-2349-8839	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M940, BBS/E/B/0000C223, BBS/E/B/00001206, BBS/E/B/0000M206] Funding Source: Medline; Medical Research Council [G8402371, MC_U105178806, G0700287, G117/424] Funding Source: Medline; Wellcome Trust [079643] Funding Source: Medline; BBSRC [BBS/E/B/0000M206, BBS/E/B/0000C223] Funding Source: UKRI; MRC [G0700287, G8402371, G117/424, MC_U105178806] Funding Source: UKRI; Medical Research Council [G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Cunningham AF, 2002, J IMMUNOL, V169, P2900, DOI 10.4049/jimmunol.169.6.2900; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffen TD, 2004, J INDO-EUR STUD, V32, P11; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Polli M, 2005, BLOOD, V106, P2083, DOI 10.1182/blood-2005-01-0283; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; van Essen D, 2000, J IMMUNOL, V165, P3640; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; WEIBEL ER, 1963, LAB INVEST, V12, P131; Wen RR, 2003, J BIOL CHEM, V278, P43654, DOI 10.1074/jbc.M307318200; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	46	623	671	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	2007	27	6					847	859		10.1016/j.immuni.2007.10.009	http://dx.doi.org/10.1016/j.immuni.2007.10.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18055230	Green Accepted, Bronze			2022-12-18	WOS:000251907300006
J	Hurst, SM; Wilkinson, TS; McLoughlin, RM; Jones, S; Horiuchi, S; Yamamoto, N; Rose-John, S; Fuller, GM; Topley, N; Jones, SA				Hurst, SM; Wilkinson, TS; McLoughlin, RM; Jones, S; Horiuchi, S; Yamamoto, N; Rose-John, S; Fuller, GM; Topley, N; Jones, SA			IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation	IMMUNITY			English	Article							PERITONEAL MESOTHELIAL CELLS; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-6 RECEPTOR; IN-VIVO; DESIGNER CYTOKINE; MESSENGER-RNA; T-CELL; ANTIINFLAMMATORY CYTOKINE; INDUCTION	During acute inflammation, leukocyte recruitment is characterized by an initial infiltration of neutrophils, which are later replaced by a more sustained population of mononuclear cells. Based on both clinical and experimental evidence, we present a role for IL-6 and its soluble receptor (sIL-6R) in controlling this pattern of leukocyte recruitment during peritoneal inflammation. Liberation of sIL-6R from the initial neutrophil infiltrate acts as a regulator of CXC and CC chemokine expression, which contributes to a suppression of neutrophil recruitment and the concurrent attraction of mononuclear leukocytes. Soluble IL-6R-mediated signaling is therefore an important intermediary in the resolution of inflammation and supports transition between the early predominantly neutrophilic stage of an infection and the more sustained mononuclear cell influx.	Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; Univ Wales Coll Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; Tokyo Med & Dent Univ, Dept Microbiol, Tokyo 113, Japan; Univ Kiel, Kiel Inst Biochem, D-24098 Kiel, Germany; Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Cardiff University; Cardiff University; Tokyo Medical & Dental University (TMDU); University of Kiel; University of Alabama System; University of Alabama Birmingham	Jones, SA (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales.		Rose-John, Stefan/A-7998-2010; Wilkinson, Thomas S/C-5237-2013; Jones, Simon Arnett/Q-7017-2018	Rose-John, Stefan/0000-0002-7519-3279; Wilkinson, Thomas S/0000-0003-0397-6079; Jones, Simon Arnett/0000-0001-7297-9711; McLoughlin, Rachel/0000-0003-4553-018X				Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Desgeorges A, 1997, J RHEUMATOL, V24, P1510; DiTirro J, 1998, INFECT IMMUN, V66, P2284, DOI 10.1128/IAI.66.5.2284-2289.1998; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Horiuchi S, 1998, IMMUNOLOGY, V95, P360, DOI 10.1046/j.1365-2567.1998.00622.x; Jones SA, 1998, EUR J IMMUNOL, V28, P3514, DOI 10.1002/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.3.CO;2-K; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Keane WF, 2000, PERITON DIALYSIS INT, V20, P396; Klouche M, 2000, CIRCULATION, V101, P1799, DOI 10.1161/01.CIR.101.15.1799; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; MACKENZIE RK, 1990, KIDNEY INT, V37, P1316, DOI 10.1038/ki.1990.117; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1995, J IMMUNOL, V155, P5198; Muller-Newen G, 1998, J IMMUNOL, V161, P6347; Peters M, 1996, J EXP MED, V183, P1399, DOI 10.1084/jem.183.4.1399; Peters M, 1998, J IMMUNOL, V161, P3575; Rakemann T, 1999, J BIOL CHEM, V274, P1257, DOI 10.1074/jbc.274.3.1257; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; SCHINDLER R, 1990, BLOOD, V75, P40; TILG H, 1994, BLOOD, V83, P113; Topley N, 1996, KIDNEY INT, V50, pS17; TOPLEY N, 1993, AM J PATHOL, V142, P1876; ULICH TR, 1991, AM J PATHOL, V138, P1097; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; Witowski J, 1996, KIDNEY INT, V50, P1212, DOI 10.1038/ki.1996.430; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	36	623	644	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					705	714		10.1016/S1074-7613(01)00151-0	http://dx.doi.org/10.1016/S1074-7613(01)00151-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420041	Bronze			2022-12-18	WOS:000169495100007
J	Taylor, GA; Carballo, E; Lee, DM; Lai, WS; Thompson, MJ; Patel, DD; Schenkman, DI; Gilkeson, GS; Broxmeyer, HE; Haynes, BF; Blackshear, PJ				Taylor, GA; Carballo, E; Lee, DM; Lai, WS; Thompson, MJ; Patel, DD; Schenkman, DI; Gilkeson, GS; Broxmeyer, HE; Haynes, BF; Blackshear, PJ			A pathogenetic role for TNF alpha In the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency	IMMUNITY			English	Article							MONOCLONAL-ANTIBODIES; NUCLEOTIDE-SEQUENCE; STEM-CELLS; PROTEIN; GENES; MOUSE; FAMILY; TIS11	Tristetraprolin (TTF) is a widely expressed potential transcription factor that contains two unusual CCCH zinc fingers and is encoded by the immediate-early response gene, Zfp-36. Mice made deficient in TTF by gene targeting appeared normal at birth, but soon manifested marked medullary and extramedullary myeloid hyperplasia associated with cachexia, erosive arthritis, dermatitis, conjunctivitis, glomerular mesangial thickening, and high titers of anti-DNA and antinuclear antibodies. Myeloid progenitors from these mice showed no increase in sensitivity to growth factors. Treatment of young TTF-deficient mice with antibodies to tumor necrosis factor alpha (TNF alpha) prevented the development of essentially all aspects of the phenotype. These results indicate a role for TTF in regulating TNF alpha synthesis, secretion, turnover, or action. TTP-deficient mice may serve as useful models of the autoimmune inflammatory state resulting from chronic effective TNF alpha excess.	DUKE UNIV,MED CTR,DEPT MED,DIV ENDOCRINOL METAB & NUTR,SECT DIABET & METAB,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710; DUKE UNIV,MED CTR,SARAH W STEDMAN CTR NUTR STUDIES,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DIV RHEUMATOL ALLERGY & CLIN IMMUNOL,DURHAM,NC 27710; VET ADM MED CTR,MED RES SERV,DURHAM,NC 27705; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27705; DUKE UNIV,MED CTR,DIV LAB ANIM RESOURCES,DURHAM,NC 27705; INDIANA UNIV,SCH MED,DEPT MED HEMATOL ONCOL MICROBIOL IMMUNOL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,WALTHER ONCOL CTR,INDIANAPOLIS,IN 46202	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Taylor, GA (corresponding author), DUKE UNIV,MED CTR,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710, USA.		Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NCI NIH HHS [R37 CA36464] Funding Source: Medline; NHLBI NIH HHS [R01 HL465449, R01 HL49202] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA036464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049202] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREWS AG, 1994, VET PATHOL, V31, P293, DOI 10.1177/030098589403100301; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER S, 1994, EXP HEMATOL, V22, P186; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; GILKESON GS, 1993, J IMMUNOL, V151, P1343; GOMPERTS M, 1990, ONCOGENE, V5, P1081; HAYNES BF, 1981, NEW ENGL J MED, V304, P1319, DOI 10.1056/NEJM198105283042202; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; LAI WS, 1990, J BIOL CHEM, V265, P16556; MA QF, 1994, ONCOGENE, V9, P3329; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Robertson E, 1987, TERATOCARCINOMAS EMB; ROSENBERG AE, 1994, ROBBINS PATHOLOGIC B, P1247; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THOMPSON MJ, 1996, IN PRESS GENE; TSE HE, 1980, SELECTED METHODS CEL, P201; ULICH TR, 1993, RES IMMUNOL, V144, P347, DOI 10.1016/S0923-2494(93)80079-E; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; VARNUM BC, 1989, ONCOGENE, V4, P119	26	622	636	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1996	4	5					445	454		10.1016/S1074-7613(00)80411-2	http://dx.doi.org/10.1016/S1074-7613(00)80411-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630730	Bronze			2022-12-18	WOS:A1996UM67800004
J	Li, MO; Sanjabi, S; Flavell, RA				Li, Ming O.; Sanjabi, Shomyseh; Flavell, Richard A.			Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; TGF-BETA; II RECEPTOR; CUTTING EDGE; LINEAGE COMMITMENT; GATA-3 EXPRESSION; IMMUNE-RESPONSES; MICE CAUSES; IN-VIVO; DIFFERENTIATION	The role of transforming growth factor-beta (TGF-beta) in inhibiting T cell functions has been studied with dominant-negative TGF-beta receptor transgenic models; however, the full impact of TGF-beta signaling on T cells and the mechanisms by which TGF-beta signals remain poorly understood. Here we show that mice with T cell-specific deletion of TGF-beta receptor II developed lethal inflammation associated with T cell activation and differentiation. In addition, TGF-beta signaling positively regulated T cell development and homeostasis. Development of CD8(+) T cells and NKT cells, maintenance of peripheral Foxp3-expressing regulatory T cells, and survival of CD4(+) T cells all depended on TGF-beta signaling. Both T helper 1 (Th1) differentiation and survival of activated CD4(+) T cells required T-bet, the TGF-beta-regulated transcription factor, which controlled CD122 expression and IL-15 signaling in Th1 cells. This study reveals pleiotropic functions of TGF-beta signaling in T cells that may ensure a diverse and self-tolerant T cell repertoire in vivo.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	richard.flavell@yale.edu		li, ming/0000-0002-1383-0535	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR060723] Funding Source: Medline; NIDDK NIH HHS [R01DK51665] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aliahmad P, 2006, IMMUNOL REV, V209, P253, DOI 10.1111/j.0105-2896.2006.00345.x; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Cerwenka A, 1996, J IMMUNOL, V156, P459; CERWENKA A, 1994, J IMMUNOL, V153, P4367; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; DANG H, 1995, J IMMUNOL, V155, P3205; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Halverson DC, 1997, BLOOD, V90, P2089, DOI 10.1182/blood.V90.5.2089; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kobayashi S, 1999, J IMMUNOL, V163, P4013; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Leveen P, 2005, BLOOD, V106, P4234, DOI 10.1182/blood-2005-05-1871; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lingnau K, 1998, J IMMUNOL, V161, P4709; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; PATERSON DJ, 1987, J EXP MED, V166, P1603, DOI 10.1084/jem.166.5.1603; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	60	619	662	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					455	471		10.1016/j.immuni.2006.07.011	http://dx.doi.org/10.1016/j.immuni.2006.07.011			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16973386	Bronze			2022-12-18	WOS:000240862200014
J	Chaudhry, A; Samstein, RM; Treuting, P; Liang, YQ; Pils, MC; Heinrich, JM; Jack, RS; Wunderlich, FT; Bruning, JC; Muller, W; Rudensky, AY				Chaudhry, Ashutosh; Samstein, Robert M.; Treuting, Piper; Liang, Yuqiong; Pils, Marina C.; Heinrich, Jan-Michael; Jack, Robert S.; Wunderlich, F. Thomas; Bruening, Jens C.; Mueller, Werner; Rudensky, Alexander Y.			Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; IL-10 PRODUCTION; BOWEL-DISEASE; CYTOKINES; STAT3; GENERATION; STABILITY; RESPONSES; LINEAGE; TARGET	Effector CD4(+) T cell subsets, whose differentiation is facilitated by distinct cytokine cues, amplify the corresponding type of inflammatory response. Regulatory T (Treg) cells integrate environmental cues to suppress particular types of inflammation. In this regard, STAT3, a transcription factor essential for T helper 17 (Th17) cell differentiation, is necessary for Treg cell-mediated control of Th17 cell responses. Here, we showed that anti-inflammatory interleukin-10 (IL-10), and not proinflammatory IL-6 and IL-23 cytokine signaling, endowed Treg cells with the ability to suppress pathogenic Th17 cell responses. Ablation of the IL-10 receptor in Treg cells resulted in selective dysregulation of Th17 cell responses and colitis similar to that observed in mice harboring STAT3-deficient Treg cells. Thus, Treg cells limit Th17 cell inflammation by serving as principal amplifiers of negative regulatory circuits operating in immune effector cells.	[Chaudhry, Ashutosh; Samstein, Robert M.; Liang, Yuqiong; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10065 USA; [Chaudhry, Ashutosh; Samstein, Robert M.; Liang, Yuqiong; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Pils, Marina C.] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Heinrich, Jan-Michael; Jack, Robert S.] Ernst Moritz Arndt Univ Greifswald, Dept Immunol, D-17487 Greifswald, Germany; [Wunderlich, F. Thomas; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Preventat Med CEDP, Max Planck Inst Neurol Res Cologne,Inst Genet,CMM, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center for Infection Research; Ernst Moritz Arndt Universitat Greifswald; Max Planck Society; University of Cologne; University of Manchester	Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Treuting, Piper M./AAB-2721-2019; Muller, Werner/B-9044-2008	Treuting, Piper M./0000-0002-1812-1519; Muller, Werner/0000-0002-1297-9725; Samstein, Robert/0000-0001-6860-2401; Chaudhry, Ashutosh/0000-0003-3379-5236	DFG; Sonderfor-schungsbereich [621]; Project A2; European Union [MUGEN LSHG-CT-2005-005203]; National Institutes of Health [GM07739]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Sonderfor-schungsbereich(German Research Foundation (DFG)); Project A2; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank A. Bravo, J. Herlihy, J. Gerard, and P. Zarin for help with the mouse colony management; H. Lee for superb technical assistance; J.-C. Renauld for anti-IL-22; V. Kuchroo for II23r<SUP>-/-</SUP> mice; and D. Schenten, S. Nish, and R. Medzhitov for help in facilitating key experiments. The generation of the conditional IL-10R1 mouse mutant was supported by the DFG, Sonderfor-schungsbereich 621, Project A2, and the European Union Grant MUGEN LSHG-CT-2005-005203. This work was supported by grants from the National Institutes of Health (A.Y.R.). A.C. is supported by the Irvington Institute Fellowship Program of the Cancer Research Institute. R.M.S. was supported by NIH MSTP grant GM07739. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fasnacht N, 2009, EUR J IMMUNOL, V39, P2173, DOI 10.1002/eji.200838710; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2010, MUCOSAL IMMUNOL, V3, P443, DOI 10.1038/mi.2010.27; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stehr M, 2009, LAB ANIM-UK, V43, P362, DOI 10.1258/la.2009.0080075; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	47	617	638	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 22	2011	34	4					566	578		10.1016/j.immuni.2011.03.018	http://dx.doi.org/10.1016/j.immuni.2011.03.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511185	Green Accepted, Bronze			2022-12-18	WOS:000290367300015
J	Nagai, Y; Garrett, KP; Ohta, S; Bahrun, U; Kouro, T; Akira, S; Takatsu, K; Kincade, PW				Nagai, Yoshinori; Garrett, Karla P.; Ohta, Shoichiro; Bahrun, Uleng; Kouro, Taku; Akira, Shizuo; Takatsu, Kiyoshi; Kincade, Paul W.			Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; BONE-MARROW; CUTTING EDGE; STEM-CELLS; TRANSCRIPTIONAL REGULATION; COMMITTED PROGENITORS; NEGATIVE REGULATION; WALL COMPONENTS; VIRUS-INFECTION; TNF-ALPHA	Toll-like receptors (TLRs) are best known for their ability to recognize microbial or viral components and initiate innate immune responses. We showed here that TLRs and their coreceptors were expressed by multipotential hematopoietic stem cells, whose cell cycle entry was triggered by TLR ligation. TLR expression also extended to some of the early hematopoietic progenitors, although not the progenitor cells dedicated to megakaryocyte and erythroid differentiation. TLR signaling via the Myd88 adaptor protein drove differentiation of myeloid progenitors, bypassing some normal growth and differentiation requirements, and also drove lymphoid progenitors to become dendritic cells. CD14 contributed to the efficiency of lipopolysaccharide (ILPS) recognition by stem and progenitor cells, and LPS interacted directly with the TLR4/MD-2 complex on these cells in bone marrow. Thus, the preferential pathogen-mediated stimulation of myeloid differentiation pathways may provide a means for rapid replenishment of the innate immune system during infection.	Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; Saga Med Sch, Dept Biomol Sci, Div Immunol, Saga 8498501, Japan; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Immunol, Tokyo 1088639, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Oklahoma Medical Research Foundation; Saga University; University of Tokyo; Osaka University	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu	Akira, Shizuo/C-3134-2009; Kouro, Taku/AAX-7867-2021; Bahrun, Uleng/GQQ-6236-2022	Kouro, Taku/0000-0003-1526-575X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI058162, R01AI020069] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI020069, AI 20069, R01 AI058162, AI 058162] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Hayashi SI, 2003, J IMMUNOL, V171, P5130, DOI 10.4049/jimmunol.171.10.5130; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hoshino K, 1999, J IMMUNOL, V162, P3749; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kawada H, 2001, BLOOD, V98, P2008, DOI 10.1182/blood.V98.7.2008; Kim JM, 2005, INT IMMUNOL, V17, P1525, DOI 10.1093/intimm/dxh345; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kouro T, 2002, BLOOD, V100, P3672, DOI 10.1182/blood-2002-02-0653; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Means TK, 1999, J IMMUNOL, V163, P6748; Nagai Y, 2005, J IMMUNOL, V174, P7043, DOI 10.4049/jimmunol.174.11.7043; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Qiu P, 1998, DEVELOPMENT, V125, P1909; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Sedger LM, 2002, J IMMUNOL, V169, P6193, DOI 10.4049/jimmunol.169.11.6193; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor FB, 2001, CRIT CARE MED, V29, P326, DOI 10.1097/00003246-200102000-00020; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	49	617	633	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					801	812		10.1016/j.immuni.2006.04.008	http://dx.doi.org/10.1016/j.immuni.2006.04.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782035	Green Accepted, Bronze			2022-12-18	WOS:000238592200017
J	Robinson, D; Shibuya, K; Mui, A; Zonin, F; Murphy, E; Sana, T; Hartley, SB; Menon, S; Kastelein, R; Bazan, F; OGarra, A				Robinson, D; Shibuya, K; Mui, A; Zonin, F; Murphy, E; Sana, T; Hartley, SB; Menon, S; Kastelein, R; Bazan, F; OGarra, A			IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF kappa B	IMMUNITY			English	Article							CD4+ T-CELLS; STIMULATORY FACTOR INTERLEUKIN-12; TUMOR-NECROSIS-FACTOR; NATURAL-KILLER; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; MOLECULAR CHARACTERIZATION; T-HELPER-2 POPULATIONS; LEISHMANIA-MAJOR; TRANSGENIC MICE	In these studies, IFN gamma-inducing factor (IGIF), unlike IL-12, did not drive Th1 development in BALB/c or C57Bl/6 mice, but like IL-1 alpha, potentiated IL-12-driven Th1 development in BALB/c mice. IGIF and IL-12 synergized for IFN gamma production from Th1 cells. Unlike IL-1 alpha, IGIF had no effect on Th2 cells. IGIF signaled through IRAK, IL-1 receptor-associated kinase, to induce nuclear translocation of p65/p50 NFB in Th1 cells. IL-1 alpha had no effect on proliferation, cytokine production, or NFKB activation in Th1 cells but activated NFKB and proliferation in Th2 cells. Thus, Th1 and Th2 cells may differ in responsiveness and receptor expression for IL-1 family molecules. IGIF and IL-1 alpha may differentially amplify Th1 and Th2 effector responses, respectively.	DNAX RES INST MOL & CELLULAR BIOL INC,DEPT IMMUNOBIOL,PALO ALTO,CA 94304; DNAX RES INST MOL & CELLULAR BIOL INC,DEPT MOL BIOL,PALO ALTO,CA 94304	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.			Bazan, J. Fernando/B-4562-2010	O'Garra, Anne/0000-0001-9845-6134				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ABRAMS J, 1995, CURR PROTOCOLS IMMUN, V13; ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; BANCROFT GJ, 1989, J IMMUNOL, V143, P127; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GREENBAUM LA, 1988, J IMMUNOL, V140, P1555; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guler ML, 1997, J IMMUNOL, V159, P1767; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; Hardiman G, 1996, ONCOGENE, V13, P2467; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUNTER CA, 1997, IN PRESS J IMMUNOL; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kohno K, 1997, J IMMUNOL, V158, P1541; Lederer JA, 1996, J IMMUNOL, V156, P56; LICHTMAN AH, 1988, P NATL ACAD SCI USA, V85, P9699, DOI 10.1073/pnas.85.24.9699; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; MACATONIA SE, 1989, J EXP MED, V169, P1255, DOI 10.1084/jem.169.4.1255; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MCARTHUR JG, 1993, J EXP MED, V178, P1645, DOI 10.1084/jem.178.5.1645; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OGARRA A, 1994, CURR OPIN IMMUNOL, V6, P458, DOI 10.1016/0952-7915(94)90128-7; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; OZMEN L, 1994, J EXP MED, V180, P907, DOI 10.1084/jem.180.3.907; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Roberts LJ, 1997, J EXP MED, V185, P1705, DOI 10.1084/jem.185.9.1705; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; SLADE SJ, 1989, IMMUNOBIOLOGY, V179, P353, DOI 10.1016/S0171-2985(89)80041-5; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Ushio S, 1996, J IMMUNOL, V156, P4274; WEAVER CT, 1988, P NATL ACAD SCI USA, V85, P8181, DOI 10.1073/pnas.85.21.8181; WILSON I, 1997, CURR BIOL, V7, P175; Young HA, 1996, J INTERF CYTOK RES, V16, P563, DOI 10.1089/jir.1996.16.563; [No title captured]	69	617	634	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					571	581		10.1016/S1074-7613(00)80378-7	http://dx.doi.org/10.1016/S1074-7613(00)80378-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354477	Bronze			2022-12-18	WOS:A1997YD59300013
J	KHAN, WN; ALT, FW; GERSTEIN, RM; MALYNN, BA; LARSSON, I; RATHBUN, G; DAVIDSON, L; MULLER, S; KANTOR, AB; HERZENBERG, LA; ROSEN, FS; SIDERAS, P				KHAN, WN; ALT, FW; GERSTEIN, RM; MALYNN, BA; LARSSON, I; RATHBUN, G; DAVIDSON, L; MULLER, S; KANTOR, AB; HERZENBERG, LA; ROSEN, FS; SIDERAS, P			DEFECTIVE B-CELL DEVELOPMENT AND FUNCTION IN BTK-DEFICIENT MICE	IMMUNITY			English	Review							X-LINKED AGAMMAGLOBULINEMIA; CBA-N MICE; PROTEIN-TYROSINE KINASES; HEAT-STABLE ANTIGEN(HI); BONE-MARROW CELLS; PRE-B; LYMPHOCYTES-B; LIGHT-CHAIN; SRC FAMILY; SIGNALING PROTEINS	Mutations in the Bruton's tyrosine kinase (Btk) gene have been linked to severe early B cell developmental blocks in human X-linked agammaglobulinemia (XLA), and to milder B cell activation deficiencies in murine X-linked immune deficiency (Xid). To elucidate unequivocally potential Btk functions in mice, we generated mutations in embryonic stem cells, which eliminated the ability to encode Btk pleckstrin homology or kinase domains, and assayed their effects by RAG2-deficient blastocyst complementation or introduction into the germline. Both mutations block expression of Btk protein and lead to reduced numbers of mature conventional B cells, severe B1 cell deficiency, serum IgM and lgG3 deficiency, and defective responses in vitro to various B cell activators and in vivo to immunization with thymus-independent type II antigens. These results prove that lack of Btk function results in an Xid phenotype and further suggest a differential requirement for Btk during the early stages of murine versus human B lymphocyte development.	CTR BLOOD RES,BOSTON,MA 02115; STANFORD UNIV,MED CTR,BECKMAN CTR,DEPT GENET,STANFORD,CA 94305; UMEA UNIV,APPL CELL & MOLEC BIOL UNIT,S-90187 UMEA,SWEDEN	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Stanford University; Umea University	KHAN, WN (corresponding author), CHILDRENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115, USA.		Jones, Jeffrey A/E-9827-2013		NIAID NIH HHS [P01AI35714, AI34762, AI20047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R01AI034762, P01AI035714, R37AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; AMSBAUGH DF, 1972, J EXP MED, V136, P931, DOI 10.1084/jem.136.4.931; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; BOSWELL HS, 1980, J EXP MED, V152, P1194, DOI 10.1084/jem.152.5.1194; BRUTON OC, 1952, PEDIATRICS, V9, P722; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMPANA D, 1990, J IMMUNOL, V145, P1675; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; CLARK K, 1993, CELL, V73, P629; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; CONLEY ME, 1985, J IMMUNOL, V134, P3070; CONLEY ME, 1994, IMMUNOL REV, V138, P5, DOI 10.1111/j.1600-065X.1994.tb00844.x; COOPER MD, 1993, PROGR IMMUNOLOGY, P1535; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; DONG ZJ, 1994, J IMMUNOL, V153, P1441; FORRESTER LM, 1987, J EXP MED, V165, P949, DOI 10.1084/jem.165.4.949; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; GOLD MR, 1994, ADV IMMUNOL, V55, P221; Hardy R. R., 1986, HDB EXPT IMMUNOLOGY; HARDY RR, 1982, NATURE, V297, P589, DOI 10.1038/297589a0; HARDY RR, 1983, NATURE, V306, P270, DOI 10.1038/306270a0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HASBOLD J, 1994, EUR J IMMUNOL, V24, P152, DOI 10.1002/eji.1830240123; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; HAWRYLOWICZ CM, 1984, EUR J IMMUNOL, V14, P244, DOI 10.1002/eji.1830140308; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423; HERZENBERG LA, 1993, IMMUNOL TODAY, V14, P79, DOI 10.1016/0167-5699(93)90063-Q; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; HUBER B, 1979, EUR J IMMUNOL, V9, P827, DOI 10.1002/eji.1830091016; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JANEWAY CA, 1975, J IMMUNOL, V115, P898; KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; KARAGOGEOS D, 1986, EUR J IMMUNOL, V16, P1125, DOI 10.1002/eji.1830160916; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KHAN WN, 1995, IN PRESS ANN NY ACAD; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KLAUS GGB, 1988, TRANSPLANTATION, V46, pS11; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; LUZKAR S, 1988, CELL, V53, P177; MANDLER R, 1993, J EXP MED, V178, P1577, DOI 10.1084/jem.178.5.1577; MANO H, 1993, ONCOGENE, V8, P417; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MILILI M, 1993, J CLIN INVEST, V91, P1616, DOI 10.1172/JCI116369; MOND JJ, 1982, IMMUNOL REV, V64, P99, DOI 10.1111/j.1600-065X.1982.tb00420.x; MOND JJ, 1983, J IMMUNOL, V131, P2107; MOORE WA, 1986, HDB EXPT IMMUNOLOGY; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NOELLE R, 1992, CURR OPIN IMMUNOL, V4, P333, DOI 10.1016/0952-7915(92)90085-S; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PARKS DR, 1989, FUNDAMENTAL IMMUNOLO, P781; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PEARL ER, 1978, J IMMUNOL, V120, P1169; PERLMUTTER RM, 1979, J EXP MED, V149, P993, DOI 10.1084/jem.149.4.993; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; PRESS JL, 1981, J IMMUNOL, V126, P1234; PRESS JL, 1986, J IMMUNOL, V137, P784; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RIGLEY KP, 1989, EUR J IMMUNOL, V19, P2081, DOI 10.1002/eji.1830191117; ROSEN FS, 1984, NEW ENGL J MED, V311, P235, DOI 10.1056/NEJM198407263110406; ROSENBERG N, 1976, J EXP MED, V143, P1453, DOI 10.1084/jem.143.6.1453; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; SANTOSARGUMEDO L, 1995, INT IMMUNOL, V7, P163, DOI 10.1093/intimm/7.2.163; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2; SCHER I, 1979, J IMMUNOL, V123, P477; SCHER I, 1975, J EXP MED, V142, P637, DOI 10.1084/jem.142.3.637; SCHUURMAN RGJ, 1993, EUR J IMMUNOL, V23, P3109; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIDERAS P, 1995, IN PRESS ADV IMMUNOL; SIDERAS P, 1995, J IMMUNOL, V153, P5607; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; SMITH CIE, 1994, J IMMUNOL, V152, P557; SPRENT J, 1984, J EXP MED, V160, P711, DOI 10.1084/jem.160.3.711; TAKEMORI T, 1990, EMBO J, V9, P2493, DOI 10.1002/j.1460-2075.1990.tb07428.x; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TESTI R, 1989, J IMMUNOL, V142, P1854; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1994, FEBS LETT, V350, P263, DOI 10.1016/0014-5793(94)00783-7; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WELLS SM, 1994, J IMMUNOL, V153, P5503; WORTIS HH, 1982, J EXP MED, V155, P903, DOI 10.1084/jem.155.3.903; YING-ZI C, 1991, International Immunology, V3, P467, DOI 10.1093/intimm/3.5.467; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	100	617	665	2	31	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					283	299		10.1016/1074-7613(95)90114-0	http://dx.doi.org/10.1016/1074-7613(95)90114-0			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552994	Bronze			2022-12-18	WOS:A1995RX64500004
J	Stinchcombe, JC; Bossi, G; Booth, S; Griffiths, GM				Stinchcombe, JC; Bossi, G; Booth, S; Griffiths, GM			The immunological synapse of CTL contains a secretory domain and membrane bridges	IMMUNITY			English	Article							CELL-MEDIATED CYTOTOXICITY; CYTOLYTIC LYMPHOCYTES-T; TIME-LAPSE MICROCINEMATOGRAPHY; MICROTUBULE-ORGANIZING CENTER; NATURAL-KILLER-CELLS; TARGET-CELLS; GOLGI-APPARATUS; LYTIC GRANULES; ULTRASTRUCTURAL ALTERATION; EFFECTOR CELL	Cytotoxic T lymphocytes (CTL) rapidly destroy their targets. Here we show that although target cell death occurs within 5 min of CTL-target cell contact, an immunological synapse similar to that seen in CD4 cells rapidly forms in CTL, with a ring of adhesion proteins surrounding an inner signaling molecule domain. Lytic granule secretion occurs in a separate domain within the adhesion ring, maintaining signaling protein organization during exocytosis. Live and fixed cell studies show target cell plasma membrane markers are transferred to the CTL as the cells separate. Electron microscopy reveals continuities forming membrane bridges between the CTL and target cell membranes, suggesting a possible mechanism for this transfer.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Griffiths, GM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gillian.griffiths@path.ox.ac.uk		stinchcombe, jane/0000-0003-1459-9299; Griffiths, Gillian/0000-0003-0434-5842				BAETZ K, 1995, J IMMUNOL, V154, P6122; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; BYKOVSKAJA SN, 1978, CELL IMMUNOL, V40, P164, DOI 10.1016/0008-8749(78)90324-6; BYKOVSKAJA SN, 1978, CELL IMMUNOL, V40, P175, DOI 10.1016/0008-8749(78)90325-8; Darmon AJ, 1998, CRIT REV IMMUNOL, V18, P255, DOI 10.1615/CritRevImmunol.v18.i3.50; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Delon J, 2000, CURR BIOL, V10, pR214, DOI 10.1016/S0960-9822(00)00392-4; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; FRUTH U, 1987, EUR J IMMUNOL, V17, P613, DOI 10.1002/eji.1830170506; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; ISAAZ S, 1995, EUR J IMMUNOL, V25, P1071, DOI 10.1002/eji.1830250432; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER A, 1984, J IMMUNOL, V133, P2762; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; KUPFER A, 1986, J EXP MED, V163, P489, DOI 10.1084/jem.163.3.489; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; MATTER A, 1979, IMMUNOLOGY, V36, P179; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Page LJ, 1998, BBA-MOL CELL RES, V1401, P146, DOI 10.1016/S0167-4889(97)00138-9; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; SANDERSON CJ, 1979, IMMUNOLOGY, V36, P119; SANDERSON CJ, 1976, PROC R SOC SER B-BIO, V192, P241, DOI 10.1098/rspb.1976.0011; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; YANNELLI JR, 1986, J IMMUNOL, V136, P377; ZAGURY D, 1975, EUR J IMMUNOL, V5, P818, DOI 10.1002/eji.1830051205	36	615	630	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2001	15	5					751	761		10.1016/S1074-7613(01)00234-5	http://dx.doi.org/10.1016/S1074-7613(01)00234-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728337	Bronze			2022-12-18	WOS:000172528200008
J	Ernst, B; Lee, DS; Chang, JM; Sprent, J; Surh, CD				Ernst, B; Lee, DS; Chang, JM; Sprent, J; Surh, CD			The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery	IMMUNITY			English	Article							SINGLE MHC/PEPTIDE LIGAND; CLASS-II MOLECULES; TRANSGENIC MICE; ANTIGEN PRESENTATION; LYMPHOCYTES-T; LIFE-SPANS; REPERTOIRE; RECEPTOR; NAIVE; TOLERANCE	Positive selection to self-MHC/peptide complexes has long been Viewed as a device for skewing the T cell repertoire toward recognition of foreign peptides presented by self-MHC molecules. Here, we provide evidence for an alternative possibility, namely, that the self-peptides controlling positive selection in the thymus serve to maintain the longevity of mature T cells in the periphery. Surprisingly, when total T cell numbers are reduced, these self-ligands become overtly stimulatory and cause naive T cells to proliferate and undergo homeostatic expansion.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Surh, CD (corresponding author), Scripps Res Inst, Dept Immunol, IMM26, La Jolla, CA 92037 USA.		Lee, Dong-Sup/J-2777-2012		NATIONAL CANCER INSTITUTE [R01CA038355, R37CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038385, R01AI041079] Funding Source: NIH RePORTER; NCI NIH HHS [CA38355] Funding Source: Medline; NIAID NIH HHS [AI41079, AI38385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bell E B, 1997, Semin Immunol, V9, P347, DOI 10.1006/smim.1997.0092; BELL EB, 1987, J IMMUNOL, V139, P1379; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHEN FW, 1981, MONOCLONAL ANTIBODIE, P25; Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x; SPRENT J, 1987, ADV IMMUNOL, V41, P39, DOI 10.1016/S0065-2776(08)60030-9; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Van Parijs L, 1998, SCIENCE, V280, P243; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; ZILJSTRA M, 1990, NATURE, V344, P742	41	615	623	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					173	181		10.1016/S1074-7613(00)80092-8	http://dx.doi.org/10.1016/S1074-7613(00)80092-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485652	Bronze			2022-12-18	WOS:000082383400006
J	Haziot, A; Ferrero, E; Kontgen, F; Hijiya, N; Yamamoto, S; Silver, J; Stewart, CL; Goyert, SM				Haziot, A; Ferrero, E; Kontgen, F; Hijiya, N; Yamamoto, S; Silver, J; Stewart, CL; Goyert, SM			Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; MONOCYTE DIFFERENTIATION ANTIGEN; SOLUBLE CD14; LIPOPOLYSACCHARIDE LPS; MURINE SPLENOCYTES; BINDING-PROTEIN; FACTOR-ALPHA; CELLS; ACTIVATION; RECEPTORS	Endotoxin shock is the result of activation of the immune system by endotoxin/LPS, a component of Gram-negative bacteria. CD14, a GPI-anchored glycoprotein expressed strongly by monocyte/macrophages, is one of several receptors for endotoxin/LPS. The role of CD14 in bacterial-induced and LPS-induced shock was tested in CD14-deficient mice produced by gene targeting in embryonic stem cells. CD14-deficient mice were found to be highly resistant to shock induced by either live Gram-negative bacteria or LPS; however, at very high concentrations of LPS or bacteria, responses through non-CD14 receptors could be detected. Surprisingly, CD14-deficient mice also showed dramatically reduced levels of bacteremia, suggesting an unexpected role for CD14 in the dissemination of Gram-negative bacteria.	ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110; OITA MED UNIV,DEPT PATHOL,HASAMA,OITA 87955,JAPAN	Oita University	Haziot, A (corresponding author), CORNELL UNIV,COLL MED,N SHORE UNIV HOSP,DIV MOLEC MED,MANHASSET,NY 11030, USA.		Haziot, Alain/AAF-5507-2021; Goyert, Sanna/P-8351-2017	Goyert, Sanna/0000-0002-0994-7757; Haziot, Alain/0000-0002-4031-7446	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047175] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23859] Funding Source: Medline; NIGMS NIH HHS [GM47175] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; BRIGHT SW, 1990, J IMMUNOL, V145, P1; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; FERRERO E, 1993, P NATL ACAD SCI USA, V90, P2380, DOI 10.1073/pnas.90.6.2380; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; GALANOS C, 1993, IMMUNOBIOLOGY, V187, P346, DOI 10.1016/S0171-2985(11)80349-9; GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876; GRUNWALD U, 1992, J IMMUNOL METHODS, V155, P225, DOI 10.1016/0022-1759(92)90289-6; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; HAZIOT A, 1995, J IMMUNOL, V154, P6529; HAZIOT A, 1988, J IMMUNOL, V141, P547; HAZIOT A, 1994, J IMMUNOL, V152, P5868; HAZIOT A, 1993, J IMMUNOL, V150, P5556; HAZIOT A, 1993, J IMMUNOL, V151, P1500; HOGAN MM, 1988, J IMMUNOL, V141, P4196; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KOCH T, 1993, INFECT IMMUN, V61, P3143, DOI 10.1128/IAI.61.8.3143-3148.1993; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; LEI MG, 1988, J IMMUNOL, V141, P996; LEI MG, 1991, J IMMUNOL, V147, P1925; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LUO GY, 1993, INFECT IMMUN, V61, P830, DOI 10.1128/IAI.61.3.830-835.1993; MATSUURA K, 1994, J EXP MED, V179, P1671, DOI 10.1084/jem.179.5.1671; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; SUN XM, 1991, J IMMUNOL, V147, P509; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; WALLIS RS, 1991, J IMMUNOL METHODS, V65, P55; WENDEL A, 1990, METHOD ENZYMOL, V186, P675; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	38	615	641	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					407	414		10.1016/S1074-7613(00)80254-X	http://dx.doi.org/10.1016/S1074-7613(00)80254-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612135	hybrid			2022-12-18	WOS:A1996UH52200009
J	Zenewicz, LA; Yancopoulos, GD; Valenzuela, DM; Murphy, AJ; Stevens, S; Flavell, RA				Zenewicz, Lauren A.; Yancopoulos, George D.; Valenzuela, David M.; Murphy, Andrew J.; Stevens, Sean; Flavell, Richard A.			Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease	IMMUNITY			English	Article							CD4(+) T-CELLS; COMBINED IMMUNODEFICIENT MICE; SODIUM-INDUCED COLITIS; RECEPTOR-GAMMA CHAIN; INTESTINAL INFLAMMATION; LYMPHOID DEVELOPMENT; PROVIDES PROTECTION; MEDIATED PATHOLOGY; CUTTING EDGE; MOUSE MODEL	Inflammatory bowel disease (IBD) is a chronic inflammatory disease thought to be mediated by dysfunctional innate and/or adaptive immunity. This aberrant immune response leads to the secretion of harmful cytokines that destroy the epithelium of the gastrointestinal tract and thus cause further inflammation. Interleukin-22 (IL-22) is a T helper 17 (Th17) T cell-associated cytokine that is bifunctional in that it has both proinflammatory and protective effects on tissues depending on the inflammatory context. We show herein that IL-22 protected mice from IBD. Interestingly, not only was this protection mediated by CD4(+) T cells, but IL-22-expressing natural killer (NK) cells also conferred protection. In addition, IL-22 expression was differentially regulated between NK cell subsets. Thus, both the innate and adaptive immune responses have developed protective mechanisms to counteract the damaging effects of inflammation on tissues.	[Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Yancopoulos, George D.; Valenzuela, David M.; Murphy, Andrew J.; Stevens, Sean] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Yale University; Howard Hughes Medical Institute; Yale University; Regeneron	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu		Murphy, Andrew/0000-0003-4152-4081; Zenewicz, Lauren/0000-0002-8787-5955	National Research Service Award [2 T32 AI07019-29]; American Liver Foundation; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L.A.Z. was supported by a National Research Service Award Training Grant (2 T32 AI07019-29) and postdoctoral fellowships from the American Liver Foundation and the American Cancer Society. R.A.F. is an Investigator of the Howard Hughes Medical Institute. L.A.Z. and R.A.F. declare no conflict of interest. G.D.Y., D.M.V., A.J.M. and S.S. were employees of Regeneron Pharmaceuticals at the time this work was performed.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, EUR CYTOKINE NETW, V16, P309; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; COOPER HS, 1993, LAB INVEST, V69, P238; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fort MM, 1998, J IMMUNOL, V161, P3256; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Laan M, 1999, J IMMUNOL, V162, P2347; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Simpson SJ, 1997, EUR J IMMUNOL, V27, P17, DOI 10.1002/eji.1830270104; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	48	614	650	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					947	957		10.1016/j.immuni.2008.11.003	http://dx.doi.org/10.1016/j.immuni.2008.11.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100701	Bronze, Green Accepted			2022-12-18	WOS:000262012400014
J	Valiante, NM; Uhrberg, M; Shilling, HG; Lienert-Weidenbach, K; Arnett, KL; D'Andrea, A; Phillips, JH; Lanier, LL; Parham, P				Valiante, NM; Uhrberg, M; Shilling, HG; Lienert-Weidenbach, K; Arnett, KL; D'Andrea, A; Phillips, JH; Lanier, LL; Parham, P			Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors	IMMUNITY			English	Article							NATURAL-KILLER-CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHIC HLA-B; CLASS-I MOLECULES; ALLOANTIGEN RECOGNITION; ANTIGEN RECOGNITION; GENE-COMPLEX; C MOLECULES; CLONES; FAMILY	The expression of KIR and CD94:NKG2 receptors was determined for more than 100 natural killer (NK) cell clones obtained from two blood donors who differ in their HLA class I and KIR genes. More than 98% of the clones were inhibited by individual autologous class I allotypes, and every clone was inhibited by the combination of autologous allotypes. The patterns of inhibition correlate with expression of inhibitory receptors of defined specificity. One donor possesses three class I ligands for KIR, and a majority of NK cells use KIR as their inhibitory receptor; the second donor possesses only a single ligand for KIR, and a majority of NK cells use the more broadly reactive CD94:NKG2a as their inhibitory receptor. Because of these differences, the first donor has subpopulations of NK cells that kill cells of the second donor, whereas the NK cells of the second donor are universally tolerant of cells from the first donor.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94306 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94306 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94306 USA	Stanford University; Stanford University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Parham, P (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94306 USA.		D'Andrea, Annalisa/F-9836-2011; Lanier, Lewis L/E-2139-2014; Arnett, Kelly/C-4816-2012	Lanier, Lewis L/0000-0003-1308-3952; Arnett, Kelly/0000-0001-5117-3647	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI017892, R37AI017892, R01AI022039] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22039, AI-17892, 5T32 AI-07290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELLONE G, 1993, J EXP MED, V177, P1117, DOI 10.1084/jem.177.4.1117; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Brennan J, 1996, J EXP MED, V184, P2085, DOI 10.1084/jem.184.6.2085; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; CICCONE E, 1992, J EXP MED, V175, P709, DOI 10.1084/jem.175.3.709; CICCONE E, 1988, J EXP MED, V168, P2403, DOI 10.1084/jem.168.6.2403; CICCONE E, 1990, P NATL ACAD SCI USA, V87, P9794, DOI 10.1073/pnas.87.24.9794; CICCONE E, 1990, J EXP MED, V172, P47, DOI 10.1084/jem.172.1.47; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P7983, DOI 10.1073/pnas.89.17.7983; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; DANDREA A, 1995, J IMMUNOL, V155, P2306; Dissen E, 1996, J EXP MED, V183, P2197, DOI 10.1084/jem.183.5.2197; Dohring C, 1996, J IMMUNOL, V156, P3098; DOMENA JD, 1993, TISSUE ANTIGENS, V42, P509; ENNIS PD, 1990, P NATL ACAD SCI USA, V87, P2833, DOI 10.1073/pnas.87.7.2833; George T, 1997, IMMUNOL REV, V155, P29, DOI 10.1111/j.1600-065X.1997.tb00937.x; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; Gumperz JE, 1996, J EXP MED, V183, P1817, DOI 10.1084/jem.183.4.1817; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; LANIER LL, 1995, J IMMUNOL, V154, P3320; Lazetic S, 1996, J IMMUNOL, V157, P4741; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; LITWIN V, 1993, J EXP MED, V178, P1321, DOI 10.1084/jem.178.4.1321; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Olcese L, 1997, J IMMUNOL, V158, P5083; Pende D, 1996, J EXP MED, V184, P505, DOI 10.1084/jem.184.2.505; PerezVillar JJ, 1997, J IMMUNOL, V158, P5736; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Selvakumar A, 1996, TISSUE ANTIGENS, V48, P285, DOI 10.1111/j.1399-0039.1996.tb02647.x; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Soderstrom K, 1997, J IMMUNOL, V159, P1072; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; VALLANTE NM, 1997, IMMUNOL REV, V155, P155; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; YOKOYAMA WM, 1995, J EXP MED, V182, P273, DOI 10.1084/jem.182.2.273; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	56	614	633	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					739	751		10.1016/S1074-7613(00)80393-3	http://dx.doi.org/10.1016/S1074-7613(00)80393-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430220	Bronze			2022-12-18	WOS:000071351300002
J	Salmon, H; Idoyaga, J; Rahman, A; Leboeuf, M; Remark, R; Jordan, S; Casanova-Acebes, M; Khudoynazarova, M; Agudo, J; Tung, N; Chakarov, S; Rivera, C; Hogstad, B; Bosenberg, M; Hashimoto, D; Gnjatic, S; Bhardwaj, N; Palucka, AK; Brown, BD; Brody, J; Ginhoux, F; Merad, M				Salmon, Helene; Idoyaga, Juliana; Rahman, Adeeb; Leboeuf, Marylene; Remark, Romain; Jordan, Stefan; Casanova-Acebes, Maria; Khudoynazarova, Makhzuna; Agudo, Judith; Tung, Navpreet; Chakarov, Svetoslav; Rivera, Christina; Hogstad, Brandon; Bosenberg, Marcus; Hashimoto, Daigo; Gnjatic, Sacha; Bhardwaj, Nina; Palucka, Anna Karolina; Brown, Brian D.; Brody, Joshua; Ginhoux, Florent; Merad, Miriam			Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition	IMMUNITY			English	Article							ANTITUMOR IMMUNITY; METASTATIC MELANOMA; CANCER-THERAPY; BONE-MARROW; IN-VIVO; REVEALS; LINEAGE; STRATEGIES; TOLERANCE; ONTOGENY	Large numbers of melanoma lesions develop resistance to targeted inhibition of mutant BRAF or fail to respond to checkpoint blockade. We explored whether modulation of intratumoral antigen-presenting cells (APCs) could increase responses to these therapies. Using mouse melanoma models, we found that CD103(+) dendritic cells (DCs) were the only APCs transporting intact antigens to the lymph nodes and priming tumor-specific CD8(+) T cells. CD103(+) DCs were required to promote anti-tumoral effects upon blockade of the checkpoint ligand PD-L1; however, PD-L1 inhibition only led to partial responses. Systemic administration of the growth factor FLT3L followed by intratumoral poly I:C injections expanded and activated CD103(+) DC progenitors in the tumor, enhancing responses to BRAF and PD-L1 blockade and protecting mice from tumor rechallenge. Thus, the paucity of activated CD103(+) DCs in tumors limits checkpoint-blockade efficacy and combined FLT3L and poly I:C therapy can enhance tumor responses to checkpoint and BRAF blockade.	[Salmon, Helene; Leboeuf, Marylene; Jordan, Stefan; Casanova-Acebes, Maria; Khudoynazarova, Makhzuna; Tung, Navpreet; Rivera, Christina; Hogstad, Brandon; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Salmon, Helene; Leboeuf, Marylene; Remark, Romain; Jordan, Stefan; Casanova-Acebes, Maria; Khudoynazarova, Makhzuna; Agudo, Judith; Tung, Navpreet; Rivera, Christina; Hogstad, Brandon; Gnjatic, Sacha; Bhardwaj, Nina; Brown, Brian D.; Brody, Joshua; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Salmon, Helene; Leboeuf, Marylene; Remark, Romain; Jordan, Stefan; Casanova-Acebes, Maria; Khudoynazarova, Makhzuna; Agudo, Judith; Tung, Navpreet; Rivera, Christina; Hogstad, Brandon; Gnjatic, Sacha; Bhardwaj, Nina; Brown, Brian D.; Brody, Joshua; Merad, Miriam] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Rahman, Adeeb; Agudo, Judith; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Idoyaga, Juliana] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA; [Hashimoto, Daigo] Hokkaido Univ, Dept Hematol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Palucka, Anna Karolina] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Chakarov, Svetoslav; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis 138648, Singapore	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Yale University; Hokkaido University; Jackson Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA.	miriam.merad@mssm.edu	Jordan, Stefan/AAI-1073-2021; Acebes, Maria Casanova/AAH-1929-2019; Chakarov, Svetoslav/AAC-9283-2019; Jordan, Stefan/AAH-8261-2021; Hashimoto, Daigo/O-1013-2013; Jordan, Stefan/G-6243-2011	Jordan, Stefan/0000-0001-9330-1715; Acebes, Maria Casanova/0000-0002-5790-1163; Chakarov, Svetoslav/0000-0002-0665-5417; Jordan, Stefan/0000-0001-9330-1715; Hashimoto, Daigo/0000-0001-9489-9704; Jordan, Stefan/0000-0001-9330-1715; Gnjatic, Sacha/0000-0001-5643-9520; Bhardwaj, Nina/0000-0003-1865-4187	NIH [R01 CA154947A, R01CA190400, R01 CA173861, U01AI095611, R01AI104848]; Association pour la Recherche contre le Cancer; Irvington postdoctoral fellowship of the Cancer Research Institute; Japan Society for the Promotion of Science KAKENHI program [26461438]; project "The Tenure-Track System Promotion Program'' - Ministry of Education, Culture, Sports, Science and Technology; Celldex; NATIONAL CANCER INSTITUTE [R01CA154947, R01CA173861, P30CA034196, P30CA016359, R01CA190400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, U01AI095611] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Irvington postdoctoral fellowship of the Cancer Research Institute; Japan Society for the Promotion of Science KAKENHI program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); project "The Tenure-Track System Promotion Program'' - Ministry of Education, Culture, Sports, Science and Technology; Celldex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.M. was supported by NIH grants R01 CA154947A, R01CA190400, R01 CA173861, U01AI095611, and R01AI104848. H.S. was supported by a postdoctoral fellowship from the Association pour la Recherche contre le Cancer and by the Irvington postdoctoral fellowship of the Cancer Research Institute. D.H. was supported by grants from the Japan Society for the Promotion of Science KAKENHI program (no. 26461438) and the project "The Tenure-Track System Promotion Program'' funded by the Ministry of Education, Culture, Sports, Science and Technology. We thank Jill Gregory, manager of academic medical illustration at the Icahn School of Medicine at Mount Sinai, for the graphical abstract. N.B. is co-founder of Checkpoint Sciences and J.B.'s lab receives research funding from Celldex.	Bogunovic D, 2011, CANCER RES, V71, P5467, DOI 10.1158/0008-5472.CAN-10-3988; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cooper ZA, 2014, CANCER IMMUNOL RES, V2, P643, DOI 10.1158/2326-6066.CIR-13-0215; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; FREI E, 1958, BLOOD, V13, P1126, DOI 10.1182/blood.V13.12.1126.1126; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sluijter BJR, 2015, CANCER IMMUNOL RES, V3, P495, DOI 10.1158/2326-6066.CIR-14-0165; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	45	613	631	11	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					924	938		10.1016/j.immuni.2016.03.012	http://dx.doi.org/10.1016/j.immuni.2016.03.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096321	Bronze, Green Accepted			2022-12-18	WOS:000374444300022
J	Hoyler, T; Klose, CSN; Souabni, A; Turqueti-Neves, A; Pfeifer, D; Rawlins, EL; Voehringer, D; Busslinger, M; Diefenbach, A				Hoyler, Thomas; Klose, Christoph S. N.; Souabni, Abdallah; Turqueti-Neves, Adriana; Pfeifer, Dietmar; Rawlins, Emma L.; Voehringer, David; Busslinger, Meinrad; Diefenbach, Andreas			The Transcription Factor GATA3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid Cells	IMMUNITY			English	Article							FUNCTION-ASSOCIATED ANTIGEN; ROR-GAMMA-T; CUTTING EDGE; KILLER-CELL; EXPRESSION; HOMEOSTASIS; POPULATION; IMMUNITY; CADHERIN; FAMILY	Innate lymphoid cells (ILCs) reside at mucosal surfaces and control immunity to intestinal infections. Type 2 innate lymphoid cells (ILC2s) produce cytokines such as IL-5 and IL-13, are required for immune defense against helminth infections, and are involved in the pathogenesis of airway hyperre-activity. Here, we have investigated the role of the transcription factor GATA-3 for ILC2 differentiation and maintenance. We showed that ILC2s and their lineage-specified bone marrow precursors (ILC2Ps), as identified here, were characterized by continuous high expression of GATA-3. Analysis of mice with temporary deletion of GATA-3 in all ILCs showed that GATA-3 was required for the differentiation and maintenance of ILC2s but not for ROR gamma t(+) ILCs. Thus, our data demonstrate that GATA-3 is essential for ILC2 fate decisions and reveal similarities between the transcriptional programs controlling ILC and T helper cell fates.	[Hoyler, Thomas; Klose, Christoph S. N.; Diefenbach, Andreas] Univ Freiburg, IMMH, D-79104 Freiburg, Germany; [Hoyler, Thomas; Diefenbach, Andreas] Univ Freiburg, Res Training Grp Organogenesis GRK1104, D-79104 Freiburg, Germany; [Klose, Christoph S. N.; Diefenbach, Andreas] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Souabni, Abdallah; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1020 Vienna, Austria; [Turqueti-Neves, Adriana; Voehringer, David] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Turqueti-Neves, Adriana; Voehringer, David] Univ Klinikum Erlangen, Inst Med Microbiol Immunol & Hyg, Dept Infect Biol, D-91054 Erlangen, Germany; [Pfeifer, Dietmar] Univ Freiburg, Med Ctr Freiburg, Dept Internal Med 1, Core Facil Genom, D-79106 Freiburg, Germany; [Rawlins, Emma L.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Diefenbach, Andreas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Freiburg; University of Cambridge; University of Freiburg	Diefenbach, A (corresponding author), Univ Freiburg, IMMH, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	Busslinger, Meinrad J./J-1249-2016; Diefenbach, Andreas/T-2589-2018; Voehringer, David/K-2776-2019; Klose, Christoph/ABE-6396-2020	Busslinger, Meinrad J./0000-0002-9111-9351; Diefenbach, Andreas/0000-0002-9176-9530; Rawlins, Emma Louise/0000-0001-7426-3792; Hoyler, Thomas/0000-0003-4798-3692	Deutsche Forschungsgemeinschaft (SGBM) [SFB620/A14, GRK1104]; Bundesministerium fur Bildung und Forschung Centrum fur Chronische Immundefizienz; EU [PAS_241506]; Boehringer Ingelheim; Medical Research Council [G0800784, G0800784B, G0900424] Funding Source: researchfish; MRC [G0800784, G0900424] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (SGBM)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung Centrum fur Chronische Immundefizienz(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Hacker for support; the members of the A.D. laboratory for valuable discussions; C.A. Connor and H. Pircher for comments on the manuscript; and N. Goppert for technical assistance. We are grateful to B. Hogan for providing Id2<SUP>CreERt2/+</SUP> and Id2<SUP>Gfp/+</SUP> mice and to J. Wersing for cell sorting. The work was supported by the Deutsche Forschungsgemeinschaft (SGBM, SFB620/A14 and GRK1104 to A.D., T.H., and C.S.N.K.), the Bundesministerium fur Bildung und Forschung Centrum fur Chronische Immundefizienz (to A.D.), an EU grant (PAS_241506 to DV.), and Boehringer Ingelheim (to M.B.).	Blaser C, 1998, J IMMUNOL, V161, P6451; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI 10.4049/jimmunol.1102242; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Grundemann C, 2006, J IMMUNOL, V176, P1311, DOI 10.4049/jimmunol.176.3.1311; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hanke T, 1998, EUR J IMMUNOL, V28, P4409, DOI 10.1002/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO;2-3; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	39	613	634	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					634	648		10.1016/j.immuni.2012.06.020	http://dx.doi.org/10.1016/j.immuni.2012.06.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23063333	Bronze, Green Accepted			2022-12-18	WOS:000310185400009
J	Locci, M; Havenar-Daughton, C; Landais, E; Wu, J; Kroenke, MA; Arlehamn, CL; Su, LF; Cubas, R; Davis, MM; Sette, A; Haddad, EK; Poignard, P; Crotty, S				Locci, Michela; Havenar-Daughton, Colin; Landais, Elise; Wu, Jennifer; Kroenke, Mark A.; Arlehamn, Cecilia L.; Su, Laura F.; Cubas, Rafael; Davis, Mark M.; Sette, Alessandro; Haddad, Elias K.; Poignard, Pascal; Crotty, Shane		Int AIDS Vaccine Initiative Protoc	Human Circulating PD-1(+)CXCR3(-)CXCR5(+) Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses	IMMUNITY			English	Article							T-FOLLICULAR HELPER; B-CELLS; EXPRESSION; BCL6; LYMPHOCYTES; COMMITMENT; REGULATORS; PROTECTION; DYNAMICS; PROGRAM	The vast majority of currently licensed human vaccines work on the basis of long-term protective antibody responses. It is now conceivable that an antibody-dependent HIV vaccine might be possible, given the discovery of HIV broadly neutralizing antibodies (bnAbs) in some HIV-infected individuals. However, these antibodies are difficult to develop and have characteristics indicative of a high degree of affinity maturation in germinal centers (GCs). CD4(+) T follicular helper (Tfh) cells are specialized for B cell help and necessary for GCs. Therefore, the development of HIV bnAbs might depend on Tfh cells. Here, we identified in normal individuals a subpopulation of circulating memory PD-1(+)CXCR5(+) CD4(+) T cells that are resting memory cells most related to bona fide GC Tfh cells by gene expression profile, cytokine profile, and functional properties. Importantly, the frequency of these cells correlated with the development of bnAbs against HIV in a large cohort of HIV+ individuals.	[Locci, Michela; Havenar-Daughton, Colin; Wu, Jennifer; Kroenke, Mark A.; Arlehamn, Cecilia L.; Sette, Alessandro; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Locci, Michela; Havenar-Daughton, Colin; Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92037 USA; [Crotty, Shane] Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Poignard, Pascal] Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA; [Poignard, Pascal] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Su, Laura F.; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94304 USA; [Su, Laura F.; Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94304 USA; [Cubas, Rafael] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA; [Int AIDS Vaccine Initiative Protoc] Int AIDS Vaccine Initiat, New York, NY 10038 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; International AIDS Vaccine Initiative; Scripps Research Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Vaccine & Gene Therapy Institute of Florida; International AIDS Vaccine Initiative	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@lji.org	Crotty, Shane/AAC-6703-2019; Price, Matt/AAK-6881-2021; poignard, pascal/N-6678-2013; Crotty, Shane/AAE-8446-2019; poignard, pascal/AAB-4613-2020; Sette, Alessandro/AFO-8916-2022	Crotty, Shane/0000-0002-6484-6262; Price, Matt/0000-0002-2918-1373; Havenar-Daughton, Colin/0000-0002-2880-3927; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002; Poignard, Pascal/0000-0002-0021-7192; Davis, Mark/0000-0001-6868-657X; Cubas, Rafael/0000-0002-3450-9054	NIAID [AI090970]; IAVI; CHAVI-ID [UM1-AI10066]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, U19AI090970] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IAVI; CHAVI-ID; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank all IAVI Protocol C project study volunteers, clinical team members, and site team members, specifically Melissa Simek and Emmanuel Cormier for sample tracking coordination. We thank Terri Wrin from Monogram Biosciences for generating neutralization data and Khader Ghneim from VGTI for assisting with microarray data. We thank the LIAI flow cytometry core, Anthony Jose, and Kayla Kendric for technical assistance. This work was supported by NIAID grants (AI090970), IAVI, and the CHAVI-ID (UM1-AI10066).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Grohskopf Lisa, 2011, Morbidity and Mortality Weekly Report, V60, P1128; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hessell AJ, 2012, CURR HIV-AIDS REP, V9, P64, DOI [10.1007/s11904-011-0105-5, 10.1007/s11904-011-0105]; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Langenkamp A, 2003, EUR J IMMUNOL, V33, P474, DOI 10.1002/immu.200310023; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	52	609	619	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					758	769		10.1016/j.immuni.2013.08.031	http://dx.doi.org/10.1016/j.immuni.2013.08.031			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24035365	Bronze, Green Accepted			2022-12-18	WOS:000330950000016
J	Mlecnik, B; Bindea, G; Angell, HK; Maby, P; Angelova, M; Tougeron, D; Church, SE; Lafontaine, L; Fischer, M; Fredriksen, T; Sasso, M; Bilocq, AM; Kirilovsky, A; Obenauf, AC; Hamieh, M; Berger, A; Bruneval, P; Tuech, JJ; Sabourin, JC; Le Pessot, F; Mauillon, J; Rafii, A; Laurent-Puig, P; Speicher, MR; Trajanoski, Z; Michel, P; Sesboue, R; Frebourg, T; Pages, F; Valge-Archer, V; Latouche, JB; Galon, J				Mlecnik, Bernhard; Bindea, Gabriela; Angell, Helen K.; Maby, Pauline; Angelova, Mihaela; Tougeron, David; Church, Sarah E.; Lafontaine, Lucie; Fischer, Maria; Fredriksen, Tessa; Sasso, Maristella; Bilocq, Amelie M.; Kirilovsky, Amos; Obenauf, Anna C.; Hamieh, Mohamad; Berger, Anne; Bruneval, Patrick; Tuech, Jean-Jacques; Sabourin, Jean-Christophe; Le Pessot, Florence; Mauillon, Jacques; Rafii, Arash; Laurent-Puig, Pierre; Speicher, Michael R.; Trajanoski, Zlatko; Michel, Pierre; Sesbouee, Richard; Frebourg, Thierry; Pages, Franck; Valge-Archer, Viia; Latouche, Jean-Baptiste; Galon, Jerome			Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability	IMMUNITY			English	Article							IMMUNE CELLS; T-CELLS; BLOCKADE; TUMORS; COLON; CLASSIFICATION; IMMUNOTHERAPY; CYTOSCAPE; IMMUNOSURVEILLANCE; MICROENVIRONMENT	Microsatellite instability in colorectal cancer predicts favorable outcomes. However, the mechanistic relationship between microsatellite instability, tumor-infiltrating immune cells, Immunoscore, and their impact on patient survival remains to be elucidated. We found significant differences in mutational patterns, chromosomal instability, and gene expression that correlated with patient microsatellite instability status. A prominent immune gene expression was observed in microsatellite-instable (MSI) tumors, as well as in a subgroup of microsatellite-stable (MSS) tumors. MSI tumors had increased frameshift mutations, showed genetic evidence of immunoediting, had higher densities of Th1, effector-memory T cells, in situ proliferating T cells, and inhibitory PD1-PDL1 cells, had high Immunoscores, and were infiltrated with mutation-specific cytotoxic T cells. Multivariate analysis revealed that Immunoscore was superior to microsatellite instability in predicting patients' disease-specific recurrence and survival. These findings indicate that assessment of the immune status via Immunoscore provides a potent indicator of tumor recurrence beyond microsatellite-instability staging that could be an important guide for immunotherapy strategies.	[Mlecnik, Bernhard; Bindea, Gabriela; Angell, Helen K.; Maby, Pauline; Angelova, Mihaela; Church, Sarah E.; Lafontaine, Lucie; Fredriksen, Tessa; Sasso, Maristella; Bilocq, Amelie M.; Kirilovsky, Amos; Berger, Anne; Pages, Franck; Galon, Jerome] INSERM, UMRS1138, Lab Integrat Canc Immunol, F-75006 Paris, France; [Mlecnik, Bernhard; Bindea, Gabriela; Angell, Helen K.; Maby, Pauline; Angelova, Mihaela; Church, Sarah E.; Lafontaine, Lucie; Fredriksen, Tessa; Sasso, Maristella; Bilocq, Amelie M.; Kirilovsky, Amos; Laurent-Puig, Pierre; Pages, Franck; Galon, Jerome] Univ Paris 05, UMRS1138, Sorbonne Paris Cite, F-75006 Paris, France; [Mlecnik, Bernhard; Bindea, Gabriela; Angell, Helen K.; Maby, Pauline; Angelova, Mihaela; Church, Sarah E.; Lafontaine, Lucie; Fredriksen, Tessa; Sasso, Maristella; Bilocq, Amelie M.; Kirilovsky, Amos; Pages, Franck; Galon, Jerome] Univ Paris 06, UMRS1138, Sorbonne Paris Cite, Ctr Rech Cordeliers, F-75006 Paris, France; [Angell, Helen K.; Valge-Archer, Viia] AstraZeneca, Innovat Med & Early Dev, Oncol, Cambridge CB4 OWG, England; [Maby, Pauline; Tougeron, David; Hamieh, Mohamad; Sesbouee, Richard; Frebourg, Thierry; Latouche, Jean-Baptiste] Univ Rouen, Fac Med, INSERM, U1079, F-76000 Rouen, France; [Maby, Pauline; Tougeron, David; Hamieh, Mohamad; Sesbouee, Richard; Frebourg, Thierry; Latouche, Jean-Baptiste] IRIB, F-76000 Rouen, France; [Angelova, Mihaela; Fischer, Maria; Trajanoski, Zlatko] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Tougeron, David; Michel, Pierre] Rouen Univ Hosp, Dept Gastroenterol, F-76000 Rouen, France; [Tougeron, David; Latouche, Jean-Baptiste] Rouen Univ Hosp, Dept Genet, F-76000 Rouen, France; [Obenauf, Anna C.; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Berger, Anne] Hop Europeen Georges Pompidou, AP HP, Dept Gen & Digest Surg, F-75015 Paris, France; [Bruneval, Patrick] Hop Europeen Georges Pompidou, AP HP, Dept Anatomopathol, F-75015 Paris, France; [Tuech, Jean-Jacques] Rouen Univ Hosp, Dept Digest Surg, F-76000 Rouen, France; [Sabourin, Jean-Christophe; Le Pessot, Florence; Mauillon, Jacques] Rouen Univ Hosp, Dept Anatomopathol, F-76000 Rouen, France; [Mauillon, Jacques] La Havre Hosp, Dept Gastroenterol, F-76600 Le Havre, France; [Rafii, Arash] Qatar Fdn, Educ City, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironment Lab, Doha 3263, Qatar; [Laurent-Puig, Pierre; Frebourg, Thierry] INSERM, UMRS775, Bases Mol Reponse Xenobiot, F-75006 Paris, France; [Pages, Franck] Hopital Europeen Georges Pompidou, AP HP, Dept Immunol, F-75015 Paris, France; [Valge-Archer, Viia] MedImmune, Cambridge CB21 GGH, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Medical University of Innsbruck; CHU de Rouen; CHU de Rouen; Medical University of Graz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; CHU de Rouen; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; AstraZeneca; Medimmune	Galon, J (corresponding author), INSERM, UMRS1138, Lab Integrat Canc Immunol, F-75006 Paris, France.; Galon, J (corresponding author), Univ Paris 05, UMRS1138, Sorbonne Paris Cite, F-75006 Paris, France.; Galon, J (corresponding author), Univ Paris 06, UMRS1138, Sorbonne Paris Cite, Ctr Rech Cordeliers, F-75006 Paris, France.	jerome.galon@crc.jussieu.fr	mlecnik, bernhard/AAT-7467-2021; Laurent-Puig, Pierre/K-3641-2019; Galon, Jerome/G-9838-2019; tougeron, david/ABF-3217-2020; Hamieh, Mohamad/AAX-3056-2020; Trajanoski, Zlatko/AAT-6703-2021; Frebourg, Thierry/AAK-8390-2020; Speicher, Michael R/B-5362-2013	Laurent-Puig, Pierre/0000-0001-8475-5459; Galon, Jerome/0000-0001-9635-1339; tougeron, david/0000-0002-8065-9635; Speicher, Michael R/0000-0003-0105-955X; Frebourg, Thierry/0000-0003-0399-4007; Angelova, Mihaela/0000-0002-0495-9695; Latouche, Jean-Baptiste/0000-0003-4802-5429; Obenauf, Anna/0000-0002-9556-5914	National Cancer Institute of France (INCa); Canceropole Ile de France; MedImmune; INSERM; Austrian Federal Ministry of Science and Research (GEN-AU project Bioinformatics Integration Network); Qatar National Research Fund under its National Priorities Research Program [NPRP09-1174-3-291]; European Commission (7FP, Geninca Consortium) [202230]; Transcan ERAnet European project; Association pour la Recherche contre le Cancer (ARC); Advanced Bioinformatics Platform for Personalised Cancer Immunotherapy (APERIM); Horizon 2020 [PHC-32, 633592]; Haute-Normandie Region; La Ligue Contre le Cancer de Haute-Normandie; Cancer Research For Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); LabEx Immuno-oncology	National Cancer Institute of France (INCa); Canceropole Ile de France(Region Ile-de-France); MedImmune(AstraZenecaMedimmune); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Austrian Federal Ministry of Science and Research (GEN-AU project Bioinformatics Integration Network); Qatar National Research Fund under its National Priorities Research Program(Qatar National Research Fund (QNRF)); European Commission (7FP, Geninca Consortium); Transcan ERAnet European project; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Advanced Bioinformatics Platform for Personalised Cancer Immunotherapy (APERIM); Horizon 2020; Haute-Normandie Region(Region Normandie); La Ligue Contre le Cancer de Haute-Normandie; Cancer Research For Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); LabEx Immuno-oncology	This work was supported by grants from the National Cancer Institute of France (INCa), the Canceropole Ile de France, MedImmune, INSERM, the Austrian Federal Ministry of Science and Research (GEN-AU project Bioinformatics Integration Network), the Qatar National Research Fund under its National Priorities Research Program award number NPRP09-1174-3-291, the European Commission (7FP, Geninca Consortium, grant 202230), the Transcan ERAnet European project, the Association pour la Recherche contre le Cancer (ARC), the Advanced Bioinformatics Platform for Personalised Cancer Immunotherapy (APERIM), Horizon 2020 (PHC-32 grant 633592), INSERM and the Haute-Normandie Region (who provided a PhD fellowship for P.M.), La Ligue Contre le Cancer de Haute-Normandie, the Cancer Research For Personalized Medicine (CARPEM), the Paris Alliance of Cancer Research Institutes (PACRI), and the LabEx Immuno-oncology.	Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; [Anonymous], CURR OPIN IMMUNOL, V25, P261; Atreya I, 2008, EXPERT REV ANTICANC, V8, P561, DOI 10.1586/14737140.8.4.561; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Berghoff AS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1057388; Bindea G, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27456; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Broussard EK, 2011, J CLIN ONCOL, V29, P601, DOI 10.1200/JCO.2010.32.9078; Church SE, 2015, IMMUNITY, V43, P631, DOI 10.1016/j.immuni.2015.10.004; Des Guetz G, 2009, EUR J CANCER, V45, P1890, DOI 10.1016/j.ejca.2009.04.018; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Finn OJ, 2006, IMMUNOL RES, V36, P73, DOI 10.1385/IR:36:1:73; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagtegaal ID, 2012, NAT REV CLIN ONCOL, V9, P119, DOI 10.1038/nrclinonc.2011.157; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sobin, 2009, UICC TNM CLASSIFICAT; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tougeron D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061001; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P179, DOI 10.4161/onci.1.2.19026; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Westra Jantine L, 2004, Clin Colorectal Cancer, V4, P252, DOI 10.3816/CCC.2004.n.024; Williams DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016012; Zlobec I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014282	59	608	629	7	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					698	711		10.1016/j.immuni.2016.02.025	http://dx.doi.org/10.1016/j.immuni.2016.02.025			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982367	Bronze			2022-12-18	WOS:000372784200025
J	Shapiro-Shelef, M; Lin, KI; McHeyzer-Williams, LJ; Liao, J; McHeyzer-Williams, MG; Calame, K				Shapiro-Shelef, M; Lin, KI; McHeyzer-Williams, LJ; Liao, J; McHeyzer-Williams, MG; Calame, K			Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells	IMMUNITY			English	Article							MATURATION PROTEIN-1 BLIMP-1; CHAIN MESSENGER-RNA; GENE-EXPRESSION; BONE-MARROW; C-MYC; DIFFERENTIATION; TRANSCRIPTION; REPRESSION; ANTIGEN; LYMPHOCYTES	Blimp-1 is a transcriptional repressor able to drive the terminal differentiation of B cells into Ig-secreting plasma cells. We have created mice with a B cell-specific deletion of prdm1, the gene encoding Blimp-1. B cell development and the number of B cells responding to antigen appear to be normal in these mice. However, in response to either TD or TI antigen, serum Ig, short-lived plasma cells, post-GC plasma cells, and plasma cells in a memory response are virtually absent, demonstrating that Blimp-1 is required for plasmacytic differentiation and Ig secretion. In the absence of Blimp-1, CD79b(+)B220(-) pre-plasma memory B cell development is also defective, providing evidence that this subset is an intermediate in plasma cell development. B cells lacking Blimp-1 cannot secrete Ig or induce muS mRNA when stimulated ex vivo. Furthermore, although prdm1(-/-) B cells fail to induce XBP-1, XBP-1 cannot rescue plasmacytic differentiation without Blimp-1.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Scripps Research Institute; Columbia University	Calame, K (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	klc1@columbia.edu	Lin, KUO-I/C-6928-2009	Shelef, Miriam/0000-0002-8842-0303	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050659, T32AI007525, R01AI043576, R01AI047231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 43576, 5T32 AI 07525, AI 47231, AI 50659] Funding Source: Medline; NIGMS NIH HHS [2T32 GM 07367] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Angelin-Duclos C, 2002, EUR J IMMUNOL, V32, P3765, DOI 10.1002/1521-4141(200212)32:12<3765::AID-IMMU3765>3.0.CO;2-I; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; BERBERICH I, 1990, EUR J IMMUNOL, V20, P445, DOI 10.1002/eji.1830200233; BERKEN A, 1966, J EXP MED, V123, P119, DOI 10.1084/jem.123.1.119; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BOYDEN SV, 1960, IMMUNOLOGY, V3, P272; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Hadjantonakis AK, 1999, METH MOL B, V97, P101, DOI 10.1385/1-59259-270-8:101; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; LEE AH, 2003, IN PRESS MOL CELL BI; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; Phillips C, 2001, EMBO J, V20, P6443, DOI 10.1093/emboj/20.22.6443; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; Soro PG, 1999, J IMMUNOL, V163, P611; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; Tunyaplin C, 2000, NUCLEIC ACIDS RES, V28, P4846, DOI 10.1093/nar/28.24.4846; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wallin JJ, 1999, J BIOL CHEM, V274, P15959, DOI 10.1074/jbc.274.22.15959; YAN DH, 1995, MOL CELL BIOL, V15, P1901; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	56	608	635	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					607	620		10.1016/S1074-7613(03)00267-X	http://dx.doi.org/10.1016/S1074-7613(03)00267-X			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563324	Bronze			2022-12-18	WOS:000186051900016
J	PUGIN, J; HEUMANN, D; TOMASZ, A; KRAVCHENKO, VV; AKAMATSU, Y; NISHIJIMA, M; GLAUSER, MP; TOBIAS, PS; ULEVITCH, RJ				PUGIN, J; HEUMANN, D; TOMASZ, A; KRAVCHENKO, VV; AKAMATSU, Y; NISHIJIMA, M; GLAUSER, MP; TOBIAS, PS; ULEVITCH, RJ			CD14 IS A PATTERN-RECOGNITION RECEPTOR	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; LIPOPOLYSACCHARIDE-BINDING-PROTEIN; FACTOR-ALPHA; LPS-BINDING; HUMAN-MONOCYTES; ENDOTHELIAL-CELL; SOLUBLE CD14; STIMULATION; ACTIVATION; ENDOTOXIN	Septic shock caused by a diverse group of bacterial pathogens is a serious human disease. Recognition of bacterial envelope constituents is one mechanism used by mammalian cells to initiate responses leading to bacterial killing or, unfortunately, responses that also cause fatal septic shock. Here we show that CD14 plays a key role in initiating cell activation by a group of bacterial envelope components from Gram-negative and Gram-positive microorganisms, as well as mycobacteria. We propose that CD14 is a receptor used by mammalian cells to recognize and signal responses to a diverse array of bacterial constituents. This finding defines the molecular basis for innate microbial immunity; implicit in these findings are new possibilities for therapeutics.	CHU VAUDOIS, DIV INFECT DIS, CH-1010 LAUSANNE, SWITZERLAND; ROCKEFELLER UNIV HOSP, MICROBIOL LAB, NEW YORK, NY 10021 USA; NATL INST HLTH, DEPT BIOCHEM & CELL BIOL, TOKYO 162, JAPAN	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Rockefeller University; National Institute of Health Sciences - Japan	PUGIN, J (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.		Ulevitch, Richard J/Q-3393-2017	Tomasz, Alexander/0000-0003-1520-1983	NHLBI NIH HHS [HL23586] Funding Source: Medline; NIAID NIH HHS [AI15136] Funding Source: Medline; NIGMS NIH HHS [GM28485] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028485, R01GM028485] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREW SM, 1991, CURRENT PROTOCOLS IM; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; BONE RC, 1991, CHEST, V100, P802, DOI 10.1378/chest.100.3.802; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; BUSTOS JFG, 1987, J BIOL CHEM, V262, P15400; CHATTERJEE D, 1992, INFECT IMMUN, V60, P1249, DOI 10.1128/IAI.60.3.1249-1253.1992; CHIN J, 1993, J IMMUNOL, V151, P5574; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DING AH, 1988, J IMMUNOL, V141, P2407; ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FREUDENBERG MA, 1991, INFECT IMMUN, V59, P2110, DOI 10.1128/IAI.59.6.2110-2115.1991; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; HAN JH, 1993, J BIOL CHEM, V268, P25009; HARAKUGE S, 1990, J BIOL CHEM, V265, P6606; HEUMANN D, 1994, INFECT IMMUN, V62, P2715, DOI 10.1128/IAI.62.7.2715-2721.1994; HUGHES CCW, 1990, IMMUNOL REV, V117, P85, DOI 10.1111/j.1600-065X.1990.tb00568.x; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; MATSUURA K, 1989, NUCLEIC ACIDS RES, V17, P2132, DOI 10.1093/nar/17.5.2132; MATTSSON E, 1993, FEMS IMMUNOL MED MIC, V7, P281, DOI 10.1016/0928-8244(93)90023-W; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OTTERLEI M, 1993, INFECT IMMUN, V61, P1917, DOI 10.1128/IAI.61.5.1917-1925.1993; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; ROTTA J, 1975, IMMUNOBIOLOGY, V149, P230; SCHABERG DR, 1991, AM J MED, V91, pS72; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SKELLY RR, 1979, INFECT IMMUN, V23, P287, DOI 10.1128/IAI.23.2.287-293.1979; STANDIFORD TJ, 1990, J IMMUNOL, V145, P1435; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; TOBIAS PS, 1992, AM J RESP CELL MOL, V7, P239, DOI 10.1165/ajrcmb/7.3.239; ULEVITCH RJ, 1994, CURR OPIN IMMUNOL, V6, P125, DOI 10.1016/0952-7915(94)90043-4; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; ZHANG YH, 1993, J CLIN INVEST, V91, P2076, DOI 10.1172/JCI116430	39	608	626	2	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1994	1	6					509	516		10.1016/1074-7613(94)90093-0	http://dx.doi.org/10.1016/1074-7613(94)90093-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7534618				2022-12-18	WOS:A1994PK17100008
J	Plantinga, M; Guilliams, M; Vanheerswynghels, M; Deswarte, K; Branco-Madeira, F; Toussaint, W; Vanhoutte, L; Neyt, K; Killeen, N; Malissen, B; Hammad, H; Lambrecht, BN				Plantinga, Maud; Guilliams, Martin; Vanheerswynghels, Manon; Deswarte, Kim; Branco-Madeira, Filipe; Toussaint, Wendy; Vanhoutte, Leen; Neyt, Katrijn; Killeen, Nigel; Malissen, Bernard; Hammad, Hamida; Lambrecht, Bart N.			Conventional and Monocyte-Derived CD11b(+) Dendritic Cells Initiate and Maintain T Helper 2 Cell-Mediated Immunity to House Dust Mite Allergen	IMMUNITY			English	Article							CHEMOKINE RECEPTOR CCR2; AIRWAY INFLAMMATION; TH2 RESPONSES; INHALED ALLERGENS; VIRAL-INFECTION; LYMPH-NODES; BONE-MARROW; URIC-ACID; T-CELLS; MICE	Dendritic cells (DCs) are crucial for mounting allergic airway inflammation, but it is unclear which subset of DCs performs this task. By using CD64 and MAR-1 staining, we reliably separated CD11b(+) monocyte-derived DCs (moDCs) from conventional DCs (cDCs) and studied antigen uptake, migration, and presentation assays of lung and lymph node (LN) DCs in response to inhaled house dust mite (HDM). Mainly CD11b(+) cDCs but not CD103(+) cDCs induced T helper 2 (Th2) cell immunity in HDM-specific T cells in vitro and asthma in vivo. Studies in Flt3l(-/-) mice, lacking all cDCs, revealed that moDCs were also sufficient to induce Th2 cell-mediated immunity but only when high-dose HDM was given. The main function of moDCs was the production of proinflammatory chemokines and allergen presentation in the lung during challenge. Thus, we have identified migratory CD11b(+) cDCs as the principal subset inducing Th2 cell-mediated immunity in the LN, whereas moDCs orchestrate allergic inflammation in the lung.	[Plantinga, Maud; Guilliams, Martin; Vanheerswynghels, Manon; Deswarte, Kim; Branco-Madeira, Filipe; Toussaint, Wendy; Vanhoutte, Leen; Neyt, Katrijn; Hammad, Hamida; Lambrecht, Bart N.] VIB, Dept Mol Biomed Res, Lab Immunoregulat & Mucosal Immunol, B-9050 Ghent, Belgium; [Plantinga, Maud; Deswarte, Kim; Branco-Madeira, Filipe; Toussaint, Wendy; Vanhoutte, Leen; Neyt, Katrijn; Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Dept Pulm Med, B-9000 Ghent, Belgium; [Guilliams, Martin; Malissen, Bernard] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, CNRS, INSERM, F-13288 Marseille, France; [Vanhoutte, Leen] Ghent Univ Hosp, Dept Clin Genet, B-9000 Ghent, Belgium; [Killeen, Nigel] Trianni Inc, Emeryville, CA 94143 USA; [Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulm Med, NL-3015 Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), VIB, Dept Mol Biomed Res, Lab Immunoregulat & Mucosal Immunol, B-9050 Ghent, Belgium.	bart.lambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014; Guilliams, Martin/N-7803-2013; Hammad, Hamida/J-9391-2015; Malissen, Bernard/AAK-4659-2020	Lambrecht, Bart N/0000-0003-4376-6834; Guilliams, Martin/0000-0003-3525-7570; Hammad, Hamida/0000-0003-3762-8603; Deswarte, Kim/0000-0002-9761-6973; Malissen, Bernard/0000-0003-1340-9342	ERC consolidator grant; University of Gent MRP grant (GROUP-ID consortium); Marie Curie Career Integration Grant (CIG); BELSPO Return Grant; FWO Post-Doc Fellowship; FWO project grant	ERC consolidator grant; University of Gent MRP grant (GROUP-ID consortium); Marie Curie Career Integration Grant (CIG); BELSPO Return Grant; FWO Post-Doc Fellowship; FWO project grant	This work was supported by an ERC consolidator grant to B.N.L., by a University of Gent MRP grant (GROUP-ID consortium) to B.N.L., by a Marie Curie Career Integration Grant (CIG), a BELSPO Return Grant, and FWO Post-Doc Fellowship to M. G., and by a FWO project grant to H.H.	Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Grinnan D, 2006, J ALLERGY CLIN IMMUN, V118, P1234, DOI 10.1016/j.jaci.2006.07.036; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Ortiz-Stern A, 2011, MUCOSAL IMMUNOL, V4, P343, DOI 10.1038/mi.2010.73; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; van Rijt LS, 2011, AM J RESP CRIT CARE, V184, P303, DOI 10.1164/rccm.201101-0019OC; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Walzer T, 2005, J ALLERGY CLIN IMMUN, V115, P192, DOI 10.1016/j.jaci.2004.08.046; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wuthrich M, 2012, IMMUNITY, V36, P680, DOI 10.1016/j.immuni.2012.02.015	42	606	617	7	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					322	335		10.1016/j.immuni.2012.10.016	http://dx.doi.org/10.1016/j.immuni.2012.10.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23352232	Bronze			2022-12-18	WOS:000330940800014
J	Zitvogel, L; Galluzzi, L; Smyth, MJ; Kroemer, G				Zitvogel, Laurence; Galluzzi, Lorenzo; Smyth, Mark J.; Kroemer, Guido			Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance	IMMUNITY			English	Review							REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; NATURAL-KILLER-CELL; GASTROINTESTINAL STROMAL TUMOR; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; DENDRITIC CELLS; BREAST-CANCER; CHEMOTHERAPEUTIC-AGENTS; CALRETICULIN EXPOSURE	Conventional chemotherapeutics and targeted antineoplastic agents have been developed based on the simplistic notion that cancer constitutes a cell-autonomous genetic or epigenetic disease. However, it is becoming clear that many of the available anticancer drugs that have collectively saved millions of life-years mediate therapeutic effects by eliciting de novo or reactivating pre-existing tumor-specific immune responses. Here, we discuss the capacity of both conventional and targeted anticancer therapies to enhance the immunogenic properties of malignant cells and to stimulate immune effector cells, either directly or by subverting the immunosuppressive circuitries that preclude antitumor immune responses in cancer patients. Accumulating evidence indicates that the therapeutic efficacy of several antineoplastic agents relies on their capacity to influence the tumor-host interaction, tipping the balance toward the activation of an immune response specific for malignant cells. We surmise that the development of successful anticancer therapies will be improved and accelerated by the immunological characterization of candidate agents.	[Zitvogel, Laurence] INSERM, U1015, F-94805 Villejuif, France; [Zitvogel, Laurence] Inst Gustave Roussy, Ctr Clin Invest CBT507, F-94805 Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol Platform, F-94805 Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Cell Biol Platform, F-94805 Villejuif, France; [Zitvogel, Laurence] Univ Paris 11, F-94270 Le Kremlin Bicetre, France; [Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellise Ligue Natl Canc 11, F-75006 Paris, France; [Smyth, Mark J.] Queensland Inst Med Res, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia; [Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Kroemer, Guido] Hop Europe Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; QIMR Berghofer Medical Research Institute; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, Metabol Platform, F-94805 Villejuif, France.	kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/AAH-3286-2021; Smyth, Mark J/H-8709-2014; Galluzzi, Lorenzo/AAG-6294-2019; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; Smyth, Mark J/0000-0001-7098-7240; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche; AXA Chair for Longevity Research; Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale; European Commission (ArtForce); European Research Council; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (Socrate); Cancer Research and Personalized Medicine (Carpem); Paris Alliance of Cancer Research Institutes; National Health and Medical Research Council of Australia; Susan G. Komen Foundation; Victorian Cancer Agency	Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche(French National Research Agency (ANR)); AXA Chair for Longevity Research(AXA Research Fund); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation Bettencourt-Schueller; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (Socrate); Cancer Research and Personalized Medicine (Carpem); Paris Alliance of Cancer Research Institutes; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Victorian Cancer Agency	The authors are supported by the Ligue contre le Cancer (equipe labellisee), Agence National de la Recherche, AXA Chair for Longevity Research, Canceropole Ile-de-France, Institut National du Cancer (INCa), Fondation Bettencourt-Schueller, Fondation de France, Fondation pour la Recherche Medicale, the European Commission (ArtForce), the European Research Council, the LabEx Immuno-Oncology, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (Socrate) and Cancer Research and Personalized Medicine (Carpem), the Paris Alliance of Cancer Research Institutes, the National Health and Medical Research Council of Australia, the Susan G. Komen Foundation, and the Victorian Cancer Agency.	Altvater B, 2012, CANCER IMMUNOL IMMUN, V61, P385, DOI 10.1007/s00262-011-1111-6; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Benson DM, 2011, BLOOD, V118, P6387, DOI 10.1182/blood-2011-06-360255; Benzaid I, 2011, CANCER RES, V71, P4562, DOI 10.1158/0008-5472.CAN-10-3862; Bererhi L, 2012, TRANSPL INT, V25, P545, DOI 10.1111/j.1432-2277.2012.01451.x; Berghuis D, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-8; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Cabillic F, 2010, CANCER IMMUNOL IMMUN, V59, P1611, DOI 10.1007/s00262-010-0887-0; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Catellani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018925; Chan CJ, 2010, J IMMUNOL, V184, P902, DOI 10.4049/jimmunol.0903225; Chanan-Khan AA, 2012, INT J HEMATOL, V96, P254, DOI 10.1007/s12185-012-1125-7; Chen CIU, 2008, BLOOD, V111, P5342, DOI 10.1182/blood-2007-12-128397; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Chen J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-36; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Demaria S, 2001, CLIN CANCER RES, V7, P3025; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Emens LA, 2009, J CLIN ONCOL, V27, P5911, DOI 10.1200/JCO.2009.23.3494; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Foy KC, 2012, ONCOIMMUNOLOGY, V1, P1004, DOI 10.4161/onci.21057; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P306, DOI 10.4161/onci.19549; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gonzalez-Aparicio M, 2011, GUT, V60, P341, DOI 10.1136/gut.2010.211722; Granados DP, 2012, BLOOD, V119, pE181, DOI 10.1182/blood-2012-02-412593; Greuber EK, 2012, J IMMUNOL, V189, P5382, DOI 10.4049/jimmunol.1200974; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He Y, 2013, CANCER RES, V73, P629, DOI 10.1158/0008-5472.CAN-12-2704; Hellwig CT, 2012, MOL CANCER THER, V11, P3, DOI 10.1158/1535-7163.MCT-11-0434; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Ignatiadis M, 2012, J CLIN ONCOL, V30, P1996, DOI 10.1200/JCO.2011.39.5624; Jackaman C, 2012, CANCER IMMUNOL IMMUN, V61, P2343, DOI 10.1007/s00262-012-1307-4; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kan S, 2012, ANTICANCER RES, V32, P5363; Kaneno R, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-58; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Kodumudi KN, 2012, J IMMUNOL, V189, P5147, DOI 10.4049/jimmunol.1200274; Kodumudi KN, 2010, CLIN CANCER RES, V16, P4583, DOI 10.1158/1078-0432.CCR-10-0733; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2010, APOPTOSIS, V15, P995, DOI 10.1007/s10495-010-0524-6; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; Lesterhuis WJ, 2010, BRIT J CANCER, V103, P1415, DOI 10.1038/sj.bjc.6605935; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Liu WM, 2010, BRIT J CANCER, V102, P115, DOI 10.1038/sj.bjc.6605465; Loi S., 2013, P NATL ACAD SCI US; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maeda K, 2011, ANTICANCER RES, V31, P4569; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Maio M, 2013, CURR OPIN ONCOL, V25, P166, DOI 10.1097/CCO.0b013e32835dae4f; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Martins I., 2013, CELL DEATH DIFFER; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Menger L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003807; Michaud M, 2012, ONCOIMMUNOLOGY, V1, P392, DOI 10.4161/onci.19070; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Michels T, 2012, J IMMUNOTOXICOL, V9, P292, DOI 10.3109/1547691X.2011.642418; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Moschetta M, 2012, CANCER RES, V72, P1814, DOI 10.1158/0008-5472.CAN-11-1919; Mustjoki S., 2013, LEUKEMIA; Nussbaumer O, 2011, BLOOD, V118, P2743, DOI 10.1182/blood-2011-01-328526; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Poole CJ, 2006, NEW ENGL J MED, V355, P1851, DOI 10.1056/NEJMoa052084; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Pulte D, 2011, CL LYMPH MYELOM LEUK, V11, P367, DOI 10.1016/j.clml.2011.06.005; Ramakrishnan R, 2012, CANCER RES, V72, P5483, DOI 10.1158/0008-5472.CAN-12-2236; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rousseau B, 2012, ANN ONCOL, V23, P450, DOI 10.1093/annonc/mdr141; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Senovilla L, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22409; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Sevko A, 2013, J IMMUNOL, V190, P2464, DOI 10.4049/jimmunol.1202781; Sharma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028217; Shurin GV, 2009, J IMMUNOL, V183, P137, DOI 10.4049/jimmunol.0900734; Soeda A, 2009, JPN J CLIN ONCOL, V39, P797, DOI 10.1093/jjco/hyp112; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Sukkurwala A. Q., 2013, CELL DEATH DIFFER; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Suzuki E, 2007, CANCER BIOL THER, V6, P880, DOI 10.4161/cbt.6.6.4090; Suzuki Y, 2012, CANCER RES, V72, P3967, DOI 10.1158/0008-5472.CAN-12-0851; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Tanaka H, 2009, CANCER RES, V69, P6978, DOI 10.1158/0008-5472.CAN-09-1101; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Thomas-Schoemann A, 2012, J IMMUNOL, V189, P5171, DOI 10.4049/jimmunol.1103094; Tjon ASW, 2010, LIVER TRANSPLANT, V16, P837, DOI 10.1002/lt.22064; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; van de Ven R, 2012, CANCER IMMUNOL IMMUN, V61, P181, DOI 10.1007/s00262-011-1039-x; van der Most RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006982; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; von Boehmer L, 2012, LUNG CANCER, V76, P118, DOI 10.1016/j.lungcan.2011.10.001; Waitz R, 2012, CANCER RES, V72, P430, DOI 10.1158/0008-5472.CAN-11-1782; Wan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032542; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072; Westervelt P, 2002, P NATL ACAD SCI USA, V99, P9468, DOI 10.1073/pnas.132657799; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Yamazaki T., 2013, CELL DEATH DIFFER; Yang Y, 2012, BLOOD, V120, P4533, DOI 10.1182/blood-2012-02-407163; Yuan L, 2010, VACCINE, V28, P4402, DOI 10.1016/j.vaccine.2010.04.046; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	162	605	639	4	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					74	88		10.1016/j.immuni.2013.06.014	http://dx.doi.org/10.1016/j.immuni.2013.06.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890065	Bronze			2022-12-18	WOS:000330948300007
J	Mauri, DN; Ebner, R; Montgomery, RI; Kochel, KD; Cheung, TC; Yu, GL; Ruben, S; Murphy, M; Eisenberg, RJ; Cohen, GH; Spear, PG; Ware, CF				Mauri, DN; Ebner, R; Montgomery, RI; Kochel, KD; Cheung, TC; Yu, GL; Ruben, S; Murphy, M; Eisenberg, RJ; Cohen, GH; Spear, PG; Ware, CF			LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; PERIPHERAL LYMPHOID ORGANS; T-CELL HYBRIDOMAS; SURFACE LYMPHOTOXIN; HETEROMERIC COMPLEX; 33-KDA GLYCOPROTEIN; MOLECULAR-CLONING; RECEPTOR-BINDING; GERMINAL-CENTERS; SIMPLEX VIRUS-1	Herpes simplex virus (HSV) 1 and 2 infect activated T lymphocytes by attachment of the HSV envelope glycoprotein D (gD) to the cellular herpesvirus entry mediator (HVEM), an orphan member of the tumor necrosis factor receptor superfamily. Here, we demonstrate that HVEM binds two cellular ligands, secreted lymphotoxin alpha (LT alpha) and LIGHT, a new member of the TNF superfamily. LIGHT is a 29 kDa type II transmembrane protein produced by activated T cells that also engages the receptor for the LT alpha beta heterotrimer but does not form complexes with either LT alpha or LT beta. HSV1 go inhibits the interaction of HVEM with LIGHT, and LIGHT and go interfere with HVEM-dependent cell entry by HSV1. This characterizes herpesvirus go as a membrane-bound viokine and establishes LIGHT-HVEM as integral components of the lymphotoxin cytokine-receptor system.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; Dept Prot Therapeut, Rockville, MD 20850 USA; Dept Cell Biol Human Genome Sci, Rockville, MD 20850 USA	La Jolla Institute for Immunology; Northwestern University; University of Pennsylvania; University of Pennsylvania	Ware, CF (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.	carl_ware@liai.org			NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R01AI036293, R01AI033068, R37AI036293] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA69381] Funding Source: Medline; NIAID NIH HHS [AI33068, AI36293] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; ANDROLEWICZ MJ, 1992, J BIOL CHEM, V267, P2542; BANKS TA, 1995, J IMMUNOL, V155, P1685; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BROWNING J, 1989, J IMMUNOL, V143, P1859; Browning JL, 1996, J BIOL CHEM, V271, P8618, DOI 10.1074/jbc.271.15.8618; BROWNING JL, 1991, J IMMUNOL, V147, P1230; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; BROWNING JL, 1995, J IMMUNOL, V154, P33; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CAMPADELLIFIUME G, 1988, J VIROL, V62, P159, DOI 10.1128/JVI.62.1.159-167.1988; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; CROWE PD, 1994, J IMMUNOL METHODS, V168, P79, DOI 10.1016/0022-1759(94)90212-7; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DegliEsposti MA, 1997, J IMMUNOL, V158, P1756; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; FORCE WR, 1995, J IMMUNOL, V155, P5280; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; GOH CR, 1991, PROTEIN ENG, V4, P785; GOODING LR, 1992, CELL, V71, P5; GRAY PW, 1984, NATURE, V312, P721, DOI 10.1038/312721a0; Hochman PS, 1996, J INFLAMM, V46, P220; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; JOHNSON RM, 1989, J VIROL, V63, P818; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; LAWTON P, 1995, J IMMUNOL, V154, P239; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MARIATHASAN S, 1995, J INFLAMM, V45, P72; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Matsumoto M, 1997, IMMUNOL REV, V156, P137, DOI 10.1111/j.1600-065X.1997.tb00965.x; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; MATSUMOTO M, 1997, P NATL ACAD SCI USA, V71, P1301; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; MURPHY M, 1998, IN PRESS CELL DEATH; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; PKNCKARD JK, 1997, J BIOL CHEM, V272, P10784; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Schreiber M, 1997, J VIROL, V71, P2171, DOI 10.1128/JVI.71.3.2171-2181.1997; Shisler J, 1997, J VIROL, V71, P8299, DOI 10.1128/JVI.71.11.8299-8306.1997; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SPEAR PG, 1993, SEMIN VIROL, V4, P167, DOI 10.1006/smvy.1993.1012; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; WARE CF, 1986, LYMPHOKINE RES, V5, P313; WARE CF, 1992, J IMMUNOL, V149, P3881; WARE CF, 1995, PATHWAYS CYTOLYSIS, P175; Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997; WilliamsAbbott L, 1997, J BIOL CHEM, V272, P19451, DOI 10.1074/jbc.272.31.19451	65	605	685	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					21	30		10.1016/S1074-7613(00)80455-0	http://dx.doi.org/10.1016/S1074-7613(00)80455-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462508	hybrid			2022-12-18	WOS:000071765700003
J	Perez, VL; VanParijs, L; Biuckians, A; Zheng, XX; Strom, TB; Abbas, AK				Perez, VL; VanParijs, L; Biuckians, A; Zheng, XX; Strom, TB; Abbas, AK			Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement	IMMUNITY			English	Article							IN-VIVO; CD28 COSTIMULATION; ANTIGEN RECEPTOR; CLONAL EXPANSION; ACTIVATION; MICE; ALLOGRAFTS; SURVIVAL; CTLA4IG; INVIVO	Studies of T cell anergy in vitro have led to the widely accepted view that anergy is induced by T cell antigen recognition without costimulation. We show that the induction of T cell anergy in vivo is due to an abortive T eel response that requires recognition of B7 molecules, since blocking B7 maintains T cells in an unactivated but functionally competent state. Furthermore, the induction of anergy is prevented by blocking CTLA-4, the inhibitory T cell receptor for B7 molecules. Thus, in vivo T cell anergy may be induced not because of a lack of costimulation, but as a result of specific recognition of B7 molecules by CTLA-4. In contrast, blocking CD28 on T cells prevents priming but not the induction of tolerance. Therefore, the outcome of antigen recognition by T cells is determined by the interaction of CD28 or CTLA-4 on the T cells with B7 molecules.	HARVARD UNIV, BRIGHAM & WOMENS HOSP, DEPT PATHOL, DIV IMMUNOL RES, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, DEPT MED, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037798, P01AI035297, R01AI025022, R37AI025022] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37798, AI25022, AI35297] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1995, J EXP MED, V182, P289, DOI 10.1084/jem.182.2.289; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; MILLER JFAP, 1994, CURR OPIN IMMUNOL, V6, P892, DOI 10.1016/0952-7915(94)90010-8; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; PEREZ VL, 1995, INT IMMUNOL, V7, P869, DOI 10.1093/intimm/7.5.869; Perrin PJ, 1996, J IMMUNOL, V157, P1333; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; STEURER W, 1995, J IMMUNOL, V155, P1165; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	30	602	620	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1997	6	4					411	417		10.1016/S1074-7613(00)80284-8	http://dx.doi.org/10.1016/S1074-7613(00)80284-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133420	Bronze			2022-12-18	WOS:A1997XC61900006
J	Bolland, S; Ravetch, JV				Bolland, S; Ravetch, JV			Spontaneous autoimmune disease in Fc gamma RIIB-deficient mice results from strain-specific epistasis	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; GENETIC DISSECTION; CD22-DEFICIENT MICE; SIGNAL-TRANSDUCTION; IMMUNE-SYSTEM; B-CELLS; RECEPTORS; RESPONSES; SHIP	By virtue of its ability to couple the BCR to an inhibitory pathway, Fc gamma RIIB can potentially determine the fate of B cells upon IgG immune complex engagement. We now provide evidence for Fc gamma RIIB as a component of a peripheral tolerance pathway with the observation that RIIB-/- mice develop autoantibodies and autoimmune glomerulonephritis in a strain-dependent fashion. Transfer of the autoimmune phenotype is associated with the presence of donor RIIB-/- B cells, with the RIIB+/+ myeloid cells primarily derived from the recipient. These results suggest that deficiency of RIIB on B cells leads to autoimmune disease in specific genetic backgrounds, thus identifying it as a susceptibility factor under the influence of epistatic modifiers for the development of autoimmunity.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.		Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000912, ZIAAI000912] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DRAKE CG, 1995, IMMUNOL REV, V144, P51, DOI 10.1111/j.1600-065X.1995.tb00065.x; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Ibnou-Zekri N, 1999, CURR TOP MICROBIOL, V246, P275; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Mohan C, 1998, J CLIN INVEST, V101, P1362; Morel L, 1997, J IMMUNOL, V158, P6019; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Schiller C, 2000, EUR J IMMUNOL, V30, P481; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Vyse TJ, 1998, J IMMUNOL, V160, P2757; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	39	601	623	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					277	285		10.1016/S1074-7613(00)00027-3	http://dx.doi.org/10.1016/S1074-7613(00)00027-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981970	Bronze			2022-12-18	WOS:000089132100012
J	Futterer, A; Mink, K; Luz, A; Kosco-Vilbois, MH; Pfeffer, K				Futterer, A; Mink, K; Luz, A; Kosco-Vilbois, MH; Pfeffer, K			The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-DEFICIENT MICE; HUMORAL IMMUNE-RESPONSE; GERMINAL-CENTERS; TNF RECEPTOR; LIGAND; EXPRESSION; SURFACE; ORGANS; MONOCYTOGENES	Lymphotoxin beta receptor (LT beta R)(-/-) mice were created by gene targeting. LTPR-/- mice lacked Peyer's patches, colon-associated lymphoid tissues, and ail lymph nodes. Mucosa patrolling alpha(E)beta(7)(high) integrin(+) T cells were virtually absent. Spleens lost marginal zones; T/B eel segregation and follicular dendritic cell networks were absent. Peanut agglutinin(+) cells were aberrantly detectable around central arterioles. In contrast to TNF receptor p55(-/-) mice, antibody affinity maturation was impaired. Since LT beta R-/- mice exhibit distinct defects when compared to LT alpha(-/-) and LT beta(-/-) mice, it is suggested that the LT beta R integrates signals from other TNF family members. Thus, the LT beta R proves pivotal for the ontogeny of the secondary lymphoid tissues. Furthermore, affinity maturation is dependent on LT alpha(1)beta(2) rather than on LT alpha(3).	Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; GSF, Natl Res Inst Environm & Hyg, Dept Mammal Genet, D-85758 Oberschleissheim, Germany; GSF, Natl Res Inst Environm & Hyg, Dept Pathol, D-85758 Oberschleissheim, Germany; Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pfeffer, K (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Trogerstr 9, D-81675 Munich, Germany.			Pfeffer, Klaus/0000-0002-5652-6330; Futterer, Agnes/0000-0003-3980-8763				Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; ARNIOT F, 1997, EUR J IMMUNOL, V27, P1035; BANKS TA, 1995, J IMMUNOL, V155, P1685; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; BROWNING JL, 1995, J IMMUNOL, V154, P33; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DegliEsposti MA, 1997, J IMMUNOL, V158, P1756; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; FORCE WR, 1995, J IMMUNOL, V155, P5280; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; HAMANN A, 1994, J IMMUNOL, V152, P3282; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; KoscoVilbois MH, 1997, IMMUNOL TODAY, V18, P225; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Liu YJ, 1996, J EXP MED, V184, P1207, DOI 10.1084/jem.184.4.1207; Mackay CR, 1997, CURR BIOL, V7, pR384, DOI 10.1016/S0960-9822(06)00181-3; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matsumoto M, 1997, IMMUNOL REV, V156, P137, DOI 10.1111/j.1600-065X.1997.tb00965.x; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Neumann B, 1996, J IMMUNOL, V156, P1587; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; POKHOLOK DK, 1995, P NATL ACAD SCI USA, V92, P674, DOI 10.1073/pnas.92.3.674; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; ROBERTS K, 1993, EUR J IMMUNOL, V23, P1630, DOI 10.1002/eji.1830230735; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; RUDDLE NH, 1992, CURR OPIN IMMUNOL, V4, P327, DOI 10.1016/0952-7915(92)90084-R; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Tarlinton D, 1997, CURR BIOL, V7, pR155, DOI 10.1016/S0960-9822(97)70077-0; Tkachuk M, 1998, J EXP MED, V187, P469, DOI 10.1084/jem.187.4.469; vonBoehmer H, 1997, P NATL ACAD SCI USA, V94, P8926, DOI 10.1073/pnas.94.17.8926; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wallach D, 1997, FEBS LETT, V410, P96, DOI 10.1016/S0014-5793(97)00553-X; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175	57	601	616	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					59	70		10.1016/S1074-7613(00)80588-9	http://dx.doi.org/10.1016/S1074-7613(00)80588-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697836	Bronze			2022-12-18	WOS:000075066600006
J	Hadis, U; Wahl, B; Schulz, O; Hardtke-Wolenski, M; Schippers, A; Wagner, N; Muller, W; Sparwasser, T; Forster, R; Pabst, O				Hadis, Usriansyah; Wahl, Benjamin; Schulz, Olga; Hardtke-Wolenski, Matthias; Schippers, Angela; Wagner, Norbert; Mueller, Werner; Sparwasser, Tim; Foerster, Reinhold; Pabst, Oliver			Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3(+) Regulatory T Cells in the Lamina Propria	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; TRANSCRIPTION FACTOR FOXP3; MESENTERIC LYMPH-NODES; ORAL TOLERANCE; RETINOIC-ACID; PERIPHERAL TOLERANCE; IN-VIVO; ANTIGEN; INDUCTION; RESPONSES	Tolerance to food antigen manifests in the absence and/or suppression of antigen-specific immune responses locally in the gut but also systemically, a phenomenon known as oral tolerance. Oral tolerance is thought to originate in the gut-draining lymph nodes, which support the generation of FoxP3(+) regulatory T (Treg) cells. Here we use several mouse models to show that Treg cells, after their generation in lymph nodes, need to home to the gut to undergo local expansion to install oral tolerance. Proliferation of Treg cells in the intestine and production of interleukin-10 by gut-resident macrophages was blunted in mice deficient in the chemokine (C-X3-C motif) receptor 1 (CX3CR1). We propose a model of stepwise oral tolerance induction comprising the generation of Treg cells in the gut-draining lymph nodes, followed by migration into the gut and subsequent expansion of Treg cells driven by intestinal macrophages.	[Hadis, Usriansyah; Wahl, Benjamin; Schulz, Olga; Foerster, Reinhold; Pabst, Oliver] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Hardtke-Wolenski, Matthias] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Schippers, Angela; Wagner, Norbert] Rhein Westfal TH Aachen, Fac Med, Dept Pediat, D-52074 Aachen, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School; RWTH Aachen University; University of Manchester; Helmholtz Association; Helmholtz-Center for Infection Research	Pabst, O (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	pabst.oliver@mh-hannover.de	Hardtke-Wolenski, Matthias/I-2993-2019; Förster, Reinhold/D-6770-2011; Pabst, Oliver/H-5014-2016; Sparwasser, Tim/AAF-7085-2019; Lindner, Benjamin/L-2179-2014; Muller, Werner/B-9044-2008; Sparwasser, Tim D/AAA-4306-2022	Hardtke-Wolenski, Matthias/0000-0002-2827-7787; Pabst, Oliver/0000-0002-5533-883X; Sparwasser, Tim/0000-0001-5645-902X; Lindner, Benjamin/0000-0002-4609-3105; Muller, Werner/0000-0002-1297-9725; Forster, Reinhold/0000-0001-6190-7923; Halle, Olga/0000-0003-3814-7844	Deutsche Forschungsgemeinschaft [SFB621-A1, SF8621-A11, SFB587-B15, 1127/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB621-A1 and SF8621-A11 to R.F. and O.P, SFB587-B15 to T.S., and WA 1127/2-1 to N.W. We thank I. Prinz, A. Krueger, G. Bernhardt, W.W. Agace, A. Mowat, and S. Jung for discussion and comments on the manuscript. We thank J. Farache and K. Kim for checking oral tolerance in CX3CR1-deficient mice in another animal facility. The TWINCORE is a joint venture between the Helmholtz Centre for Infection Research (HZI) Braunschweig and the Hannover Medical School (MHH). U.H. designed and performed experiments. B.W. and O.S. performed experiments. A.S., W.M., N.W., and T.S. provided transgenic mice. R.F. provided guidance and reagents and helped to prepare the manuscript. O.P. designed the study and wrote the manuscript.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; CHASE MW, 1946, P SOC EXP BIOL MED, V61, P257; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Guo Z, 2008, INT IMMUNOL, V20, P307, DOI 10.1093/intimm/dxm143; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hauet-Broere F, 2003, EUR J IMMUNOL, V33, P2801, DOI 10.1002/eji.200324115; HUSBY S, 1994, J IMMUNOL, V152, P4663; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Mizutani N, 2007, J IMMUNOL, V179, P7478, DOI 10.4049/jimmunol.179.11.7478; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Onodera T, 2009, J IMMUNOL, V183, P5608, DOI 10.4049/jimmunol.0804116; Schippers A, 2009, GASTROENTEROLOGY, V137, P924, DOI 10.1053/j.gastro.2009.05.039; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Strobel S, 2006, CURR OPIN ALLERGY CL, V6, P207, DOI 10.1097/01.all.0000225162.98391.81; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun JB, 2006, J IMMUNOL, V177, P7634, DOI 10.4049/jimmunol.177.11.7634; Tang AL, 2008, J IMMUNOL, V181, P1806, DOI 10.4049/jimmunol.181.3.1806; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	51	600	612	4	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 25	2011	34	2					237	246		10.1016/j.immuni.2011.01.016	http://dx.doi.org/10.1016/j.immuni.2011.01.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21333554	Bronze			2022-12-18	WOS:000287989500013
J	Weichhart, T; Costantino, G; Poglitsch, M; Rosner, M; Zeyda, M; Stuhlmeier, KM; Kolbe, T; Stulnig, TM; Horl, WH; Hengstschlager, M; Muller, M; Saemann, MD				Weichhart, Thomas; Costantino, Giuseppina; Poglitsch, Marko; Rosner, Margit; Zeyda, Maximilian; Stuhlmeier, Karl M.; Kolbe, Thomas; Stulnig, Thomas M.; Hoerl, Walter H.; Hengstschlaeger, Markus; Mueller, Mathias; Saeemann, Marcus D.			The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response	IMMUNITY			English	Article							NF-KAPPA-B; TUBEROUS SCLEROSIS; LISTERIA-MONOCYTOGENES; MAMMALIAN TARGET; IL-10 GENE; RAPAMYCIN; ACTIVATION; STAT3; SIROLIMUS; CELLS	The innate inflammatory immune response must be tightly controlled to avoid damage to the host. Here, we showed that the tuberous sclerosis complex-mammalian target of rapamycin (TSC-mTOR) pathway regulated inflammatory responses after bacterial stimulation in monocytes, macrophages, and primary dendritic cells. Inhibition of mTOR by rapamycin promoted production of proinflammatory cytokines via the transcription factor NF-kappa B but blocked the release of interleukin-10 via the transcription factor STAT3. Conversely, deletion of TSC2, the key negative regulator of mTOR, diminished NF-kappa B but enhanced STAT3 activity and reversed this proinflammatory cytokine shift. Rapamycin-hyperactivated monocytes displayed a strong T helper 1 (Th1) cell- and Th17 cell-polarizing potency. Inhibition of mTOR in vivo regulated the inflammatory response and protected genetically susceptible mice against lethal Listeria monocytogenes infection. These data identify the TSC2-mTOR pathway as a key regulator of innate immune homeostasis with broad clinical implications for infectious and autoimmune diseases, vaccination, cancer, and transplantation.	[Weichhart, Thomas; Poglitsch, Marko; Hoerl, Walter H.; Saeemann, Marcus D.] Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, A-1090 Vienna, Austria; [Costantino, Giuseppina; Kolbe, Thomas; Mueller, Mathias] Vet Univ Vienna, Biomodels Austria VUW & Inst Anim Breeding & Gene, A-1210 Vienna, Austria; [Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Internal Med 3, Clin Div Endocrinol & Metab, A-1090 Vienna, Austria; [Stuhlmeier, Karl M.] Ludwig Boltzmann Inst Rheumatol & Balneol, A-1100 Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; Ludwig Boltzmann Institute	Saemann, MD (corresponding author), Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	marcus.saemann@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014	Weichhart, Thomas/0000-0002-4349-0797; Muller, Mathias/0000-0002-7879-3552; Stulnig, Thomas/0000-0003-3300-6161; Zeyda, Maximilian/0000-0001-5000-1974	Else-Kroner Fresensius Stiftung; Austrian Ministry of Education, Science, and Culture [SFB F28, BM_WFa, GZ200.112/1VI/l/2004]; Austrian Science Fund [P18776-B11, P18894-B12]; European Community's 7th Framework [201608]; Austrian Science Fund (FWF) [F 2808] Funding Source: researchfish	Else-Kroner Fresensius Stiftung; Austrian Ministry of Education, Science, and Culture; Austrian Science Fund(Austrian Science Fund (FWF)); European Community's 7th Framework; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank B. Weissenhorn and M. Merio for excellent technical assistance, G. Zlabinger for ELISAs, A. Soleiman for help with histology, and B. Gerstmayer and Silvia Ruberg for microarray analysis at Miltenyi Biotec. We want to thank G. Staffler, M. Hecking, and J.S. Smolen for critical review of the manuscript. Stad"'Iflox mice were a kind gift of V. Poli. T.W. and M.D.S. are supported by the Else-Kroner Fresensius Stiftung. M.M. is supported by the grants SFB F28 and BM_WFa (Austrian Ministry of Education, Science, and Culture [GZ200.112/1VI/l/2004]). T. M.S. is supported by the Austrian Science Fund (P18776-B11) and the European Community's 7th Framework Programme (grant no. 201608). M.H. is supported by the Austrian Science Fund (P18894-B12).	[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P2177; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Dai WJ, 1997, J IMMUNOL, V158, P2259; Dittrich E, 2004, TRANSPL INT, V17, P215, DOI 10.1007/s00147-004-0700-0; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Izzedine H, 2005, NEW ENGL J MED, V353, P2088, DOI 10.1056/NEJM200511103531922; Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Mayo MW, 2002, J BIOL CHEM, V277, P11116, DOI 10.1074/jbc.M108670200; Monti P, 2003, TRANSPLANTATION, V75, P137, DOI 10.1097/00007890-200301150-00025; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Paul E, 2008, NEW ENGL J MED, V358, P190, DOI 10.1056/NEJMe0707153; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Sekulic A, 2000, CANCER RES, V60, P3504; Singer SJ, 2000, NEW ENGL J MED, V343, P1815; Strobl B, 2005, J IMMUNOL, V175, P4000, DOI 10.4049/jimmunol.175.6.4000; Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x; Thaunat O, 2005, TRANSPLANTATION, V80, P1212, DOI 10.1097/01.tp.0000179106.07382.6a; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; TRIPP CS, 1994, J IMMUNOL, V152, P1883; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	47	600	632	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					565	577		10.1016/j.immuni.2008.08.012	http://dx.doi.org/10.1016/j.immuni.2008.08.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18848473	Bronze			2022-12-18	WOS:000260316700010
J	Meresse, B; Chen, ZG; Ciszewski, C; Tretiakova, M; Bhagat, G; Krausz, TN; Raulet, DH; Lanier, LL; Groh, V; Spies, T; Ebert, EC; Green, PH; Jabri, B				Meresse, B; Chen, ZG; Ciszewski, C; Tretiakova, M; Bhagat, G; Krausz, TN; Raulet, DH; Lanier, LL; Groh, V; Spies, T; Ebert, EC; Green, PH; Jabri, B			Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease	IMMUNITY			English	Article							NATURAL-KILLER; T-CELLS; HLA-E; INTRAEPITHELIAL LYMPHOCYTES; MOLECULAR-BASIS; MIC LIGANDS; NK CELLS; INTERLEUKIN-15; EXPRESSION; CYTOTOXICITY	A major function of NKG2D linking innate and adaptive immunity is to upregulate antigen-specific CTL-mediated cytotoxicity in tissues expressing stress-induced NKG2D ligands, such as MIC, by coactivating TCR signaling. Here, we show that, under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR specificity in effector CD8 T cells. These findings may not only explain previous reports of transformation of CTL into NK-like "lymphokine-activated killers" (LAK cells) under high doses of IL2 (a substitute for IL15) but may also have significant implications for understanding and treating immunopathological diseases.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Calif Berkeley, Canc Res Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Canc Res Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA	University of Chicago; University of Chicago; University of Chicago; Columbia University; Columbia University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jabri, B (corresponding author), Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Chen, Zhangguo/AAW-2032-2021; Lanier, Lewis L/E-2139-2014; Tretiakova, Maria/U-3320-2019; Meresse, Bertrand/N-6325-2017; Bhagat, Govind/AAE-9493-2021	Lanier, Lewis L/0000-0003-1308-3952; Meresse, Bertrand/0000-0002-8978-8636; Bhagat, Govind/0000-0001-6250-048X; Chen, Zhangguo/0000-0002-2741-0080; Raulet, David/0000-0002-1257-8649	NCI NIH HHS [CA89294, CA093678] Funding Source: Medline; NIDDK NIH HHS [R01 DK 58727-01A1] Funding Source: Medline; PHS HHS [R01 A1 30581] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093678, R01CA089294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058727] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; BROOKS CG, 1983, NATURE, V305, P155, DOI 10.1038/305155a0; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; GAMERO AM, 1995, CANCER RES, V55, P4988; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Koning F, 2003, J MOL RECOGNIT, V16, P333, DOI 10.1002/jmr.641; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; TAUNK J, 1992, GASTROENTEROLOGY, V102, P69, DOI 10.1016/0016-5085(92)91785-3; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Yano S, 2003, BIOCHEM BIOPH RES CO, V301, P841, DOI 10.1016/S0006-291X(03)00060-3; Yokoyama WM, 2000, NAT IMMUNOL, V1, P95, DOI 10.1038/77878; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	40	596	624	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					357	366		10.1016/j.immuni.2004.06.020	http://dx.doi.org/10.1016/j.immuni.2004.06.020			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357947	Bronze			2022-12-18	WOS:000224034900007
J	Chaudhary, PM; Eby, M; Jasmin, A; Bookwalter, A; Murray, J; Hood, L				Chaudhary, PM; Eby, M; Jasmin, A; Bookwalter, A; Murray, J; Hood, L			Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappa B pathway	IMMUNITY			English	Article							1-ASSOCIATED PROTEIN TRADD; DOMAIN-CONTAINING RECEPTOR; SIGNALS CELL-DEATH; MUTATIONAL ANALYSIS; CD95 FAS/APO-1; FAS; SUPERFAMILY; INTERACTS; INVOLVEMENT; LIGAND	Death receptor 4 (DR4) is a recently described receptor for the cytotoxic ligand TRAIL that reportedly uses a FADD-independent pathway to induce apoptosis and does not activate the NF-kappa B pathway. We have isolated a new member of the tumor necrosis factor receptor (TNFR) family, designated DR5, which bears a high degree of sequence homology to DR4. However, contrary to the previous reports, both DR4- and DR5-induced apoptosis can be blocked by dominant-negative FADD, and both receptors can activate NF-kappa B using a TRADD-dependent pathway. Finally, both receptors can interact with FADD, TRADD, and RIP. Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hood, L (corresponding author), Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA.		Chaudhary, Preet/E-1970-2018					Baker SJ, 1996, ONCOGENE, V12, P1; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; CLEVELAND JL, 1995, CELL, V81, P479, DOI 10.1016/0092-8674(95)90068-3; DRAPPAJ, 1996, N ENGL J MED, V335, P1643; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; ITOH N, 1993, J BIOL CHEM, V268, P10932; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0	39	594	630	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					821	830		10.1016/S1074-7613(00)80400-8	http://dx.doi.org/10.1016/S1074-7613(00)80400-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430227	Bronze			2022-12-18	WOS:000071351300009
J	Ting, JPY; Lovering, RC; Alnemri, ES; Bertin, J; Boss, JM; Davis, BK; Flavell, RA; Girardin, SE; Godzik, A; Harton, JA; Hoffman, HM; Hugot, JP; Inohara, N; MacKenzie, A; Maltais, LJ; Nunez, G; Ogura, Y; Otten, LA; Philpott, D; Reed, JC; Reith, W; Schreiber, S; Steimle, V; Ward, PA				Ting, Jenny P. -Y.; Lovering, Ruth C.; Alnemri, Emad S.; Bertin, John; Boss, Jeremy M.; Davis, Beckley K.; Flavell, Richard A.; Girardin, Stephen E.; Godzik, Adam; Harton, Jonathan A.; Hoffman, Hal M.; Hugot, Jean-Pierre; Inohara, Naohiro; MacKenzie, Alex; Maltais, Lois J.; Nunez, Gabriel; Ogura, Yasunori; Otten, Luc A.; Philpott, Dana; Reed, John C.; Reith, Walter; Schreiber, Stefan; Steimle, Viktor; Ward, Peter A.			The NLR gene family: A standard nomenclature	IMMUNITY			English	Letter									[Ting, Jenny P. -Y.; Davis, Beckley K.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lovering, Ruth C.] UCL, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; [Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; [Bertin, John] Synta Pharmaceut, Lexington, MA 02421 USA; [Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA; [Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Godzik, Adam; Reed, John C.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbiol Dis, Albany, NY 12208 USA; [Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Hugot, Jean-Pierre] Hop Robert Debre, Fac Med Paris Diderot, INSERM, U843, F-75019 Paris, France; [Inohara, Naohiro; Nunez, Gabriel; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [MacKenzie, Alex] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Maltais, Lois J.] Jackson Lab, Mouse Genom Nomenclature Comm, Bar Harbor, ME 04860 USA; [Ogura, Yasunori] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; [Otten, Luc A.] Univ Lausanne, Fac Biol & Med, Dept Biochim, CH-1066 Epalinges, Switzerland; [Philpott, Dana] Univ Toronto, Dept Immunol, MSB Room 4366, Toronto, ON M5S 1A8, Canada; [Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Steimle, Viktor] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; Jefferson University; Emory University; Howard Hughes Medical Institute; Yale University; University of Toronto; Sanford Burnham Prebys Medical Discovery Institute; Albany Medical College; University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; University of Ottawa; Children's Hospital of Eastern Ontario; Jackson Laboratory; Yale University; University of Lausanne; University of Toronto; University of Geneva; University of Kiel; University of Sherbrooke	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.		Harton, Jonathan A/AAW-5283-2021; Hugot, Jean-Pierre/F-6594-2012; Harton, Jonathan/F-2848-2010; Nuñez, Gabriel/A-7160-2014; Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009; Alnemri, Emad S/B-4526-2010	Harton, Jonathan A/0000-0002-0350-1877; Harton, Jonathan/0000-0002-0350-1877; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Hugot, Jean-Pierre/0000-0002-8446-6056; Lovering, Ruth/0000-0002-9791-0064	NIAID NIH HHS [R01 AI034000-14, R37 AI029564, R01 AI034000] Funding Source: Medline; NIGMS NIH HHS [R01 GM047310, R01 GM047310-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564, R01AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	592	636	4	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					285	287		10.1016/j.immuni.2008.02.005	http://dx.doi.org/10.1016/j.immuni.2008.02.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18341998	Green Accepted, Bronze			2022-12-18	WOS:000254142500001
J	Pitt, JM; Vetizou, M; Daillere, R; Roberti, MP; Yamazaki, T; Routy, B; Lepage, P; Boneca, IG; Chamaillard, M; Kroemer, G; Zitvogel, L				Pitt, Jonathan M.; Vetizou, Marie; Daillere, Romain; Roberti, Maria Paula; Yamazaki, Takahiro; Routy, Bertrand; Lepage, Patricia; Boneca, Ivo Gomperts; Chamaillard, Mathias; Kroemer, Guido; Zitvogel, Laurence			Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors	IMMUNITY			English	Review							REGULATORY T-CELLS; MYELOID-DERIVED SUPPRESSOR; EXOME ANALYSIS REVEALS; DENDRITIC CELLS; GUT MICROBIOTA; PD-1 BLOCKADE; ANTITUMOR IMMUNITY; MELANOMA PATIENTS; CTLA-4 BLOCKADE; I INTERFERON	Inhibition of immune regulatory checkpoints, such as CTLA-4 and the PD-1-PD-L1 axis, is at the forefront of immunotherapy for cancers of various histological types. However, such immunotherapies fail to control neoplasia in a significant proportion of patients. Here, we review how a range of cancer-cell-autonomous cues, tumor-microenvironmental factors, and host-related influences might account for the heterogeneous responses and failures often encountered during therapies using immune-checkpoint blockade. Furthermore, we describe the emerging evidence of how the strong interrelationship between the immune system and the host microbiota can determine responses to cancer therapies, and we introduce a concept by which prior or concomitant modulation of the gut microbiome could optimize therapeutic outcomes upon immune-checkpoint blockade.	[Pitt, Jonathan M.; Vetizou, Marie; Daillere, Romain; Roberti, Maria Paula; Yamazaki, Takahiro; Routy, Bertrand; Zitvogel, Laurence] Inst Cancerol, Gustave Roussy Canc Campus, F-94800 Villejuif, France; [Pitt, Jonathan M.; Vetizou, Marie; Daillere, Romain; Roberti, Maria Paula; Yamazaki, Takahiro; Routy, Bertrand; Zitvogel, Laurence] INSERM U1015, F-94800 Villejuif, France; [Pitt, Jonathan M.; Vetizou, Marie; Daillere, Romain; Routy, Bertrand; Zitvogel, Laurence] Univ Paris 11, Univ Paris Saclay, Fac Med, F-94276 Le Kremlin Bicetre, France; [Lepage, Patricia] INRA, Micalis UMR 1319, F-78360 Jouy En Josas, France; [Boneca, Ivo Gomperts] Inst Pasteur, Unit Biol & Genet Bacterial Cell Wall, F-75015 Paris, France; [Boneca, Ivo Gomperts] INSERM, Equipe Avenir, F-75015 Paris, France; [Chamaillard, Mathias] Univ Lille, Ctr Hosp Univ Lille, Ctr Infect & Immun Lille, Inst Pasteur Lille,CNRS,INSERM,U1019,UMR 8204, F-59000 Lille, France; [Kroemer, Guido] INSERM U848, F-94800 Villejuif, France; [Kroemer, Guido] Metabol Platform, Gustave Roussy Canc Campus, F-94800 Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, INSERM U1138, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Kroemer, Guido] Univ Paris 06, F-75005 Paris, France; [Kroemer, Guido] Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Zitvogel, Laurence] Ctr Clin Invest CICBT1428, Gustave Roussy Canc Campus, F-94805 Villejuif 05, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Karolinska Institutet; Karolinska University Hospital	Zitvogel, L (corresponding author), Inst Cancerol, Gustave Roussy Canc Campus, F-94800 Villejuif, France.; Zitvogel, L (corresponding author), INSERM U1015, F-94800 Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris 11, Univ Paris Saclay, Fac Med, F-94276 Le Kremlin Bicetre, France.; Zitvogel, L (corresponding author), Ctr Clin Invest CICBT1428, Gustave Roussy Canc Campus, F-94805 Villejuif 05, France.	laurence.zitvogel@gustaveroussy.fr	Kroemer, Guido/AAY-9859-2020; Chamaillard, Mathias/L-6542-2013; KROEMER, Guido/B-4263-2013; Boneca, Ivo G/H-1677-2014; Lepage, Patricia/D-4362-2014	Chamaillard, Mathias/0000-0002-0243-9717; KROEMER, Guido/0000-0002-9334-4405; Boneca, Ivo G/0000-0001-8122-509X; Lepage, Patricia/0000-0002-9501-6771; ZITVOGEL, laurence/0000-0003-1596-0998; YAMAZAKI, Takahiro/0000-0002-7420-4394	Association pour la Recherche sur le Cancer (ARC); Ligue contre le Cancer; Ligue Nationale contre le Cancer (Equipes labellisees); Agence Nationale pour la Recherche (ANR AUTOPH); Agence Nationale pour la Recherche (ANR Emergence); European Commission (ArtForce); European Research Council Advanced Investigator Grant; Fondation pour la Recherche Medicale (FRM); Institut National du Cancer; Fondation de France; Canceropole Ile-de-France; Fondation Bettencourt-Schueller; Swiss Bridge Foundation; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination; SIRIC Cancer Research and Personalized Medicine; Paris Alliance of Cancer Research Institutes; ARC [PGA120140200851]; FRM; Fondation ARC pour la Recherche sur le Cancer	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer(Ligue nationale contre le cancer); Ligue Nationale contre le Cancer (Equipes labellisees); Agence Nationale pour la Recherche (ANR AUTOPH)(French National Research Agency (ANR)); Agence Nationale pour la Recherche (ANR Emergence)(French National Research Agency (ANR)); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council Advanced Investigator Grant(European Research Council (ERC)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; Swiss Bridge Foundation; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination; SIRIC Cancer Research and Personalized Medicine; Paris Alliance of Cancer Research Institutes; ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	J.M.P. is supported by Association pour la Recherche sur le Cancer (ARC). M.V. and R.D. are supported by the Ligue contre le Cancer. L.Z. received a special prize from the Swiss Bridge Foundation and the Swiss Institute for Experimental Cancer Research (ISREC). G.K. and L.Z. were supported by the Ligue Nationale contre le Cancer (Equipes labellisees), Agence Nationale pour la Recherche (ANR AUTOPH, ANR Emergence), European Commission (ArtForce), European Research Council Advanced Investigator Grant (to G.K.), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer, Fondation de France, Canceropole Ile-de-France, Fondation Bettencourt-Schueller, Swiss Bridge Foundation, LabEx Immuno-Oncology, SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination, SIRIC Cancer Research and Personalized Medicine, and Paris Alliance of Cancer Research Institutes. L.Z. and G.K. are sponsored by the ARC (PGA120140200851). L'Oreal awarded a prize to M.V., and M.C. was supported by the FRM and the Fondation ARC pour la Recherche sur le Cancer.	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Auclair J, 2015, CLIN INFECT DIS, V60, pS135, DOI 10.1093/cid/civ179; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Berman David, 2010, Cancer Immun, V10, P11; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bioley G, 2009, CLIN CANCER RES, V15, P299, DOI 10.1158/1078-0432.CCR-08-1747; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Buque A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008814; Burrows MP, 2015, P NATL ACAD SCI USA, V112, P9973, DOI 10.1073/pnas.1508740112; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133184; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Corrales L, 2015, CLIN CANCER RES, V21, P4774, DOI 10.1158/1078-0432.CCR-15-1362; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fucikova J, 2016, CANCER RES, V76, P1746, DOI 10.1158/0008-5472.CAN-15-1142; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Fulop T, 2011, DISCOV MED, V11, P537, DOI 10.1016/j.coi.2004.01.009; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gophna U, 2011, SCIENCE, V334, P45, DOI 10.1126/science.1213799; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hargreaves CE, 2015, IMMUNOL REV, V268, P6, DOI 10.1111/imr.12341; Haworth KB, 2015, PEDIATR BLOOD CANCER, V62, P571, DOI 10.1002/pbc.25359; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Hursting SD, 2010, J CLIN ONCOL, V28, P4058, DOI 10.1200/JCO.2010.27.9935; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kabouridis PS, 2015, J CLIN INVEST, V125, P956, DOI 10.1172/JCI76308; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kroemer G, 2015, NAT MED, V21, P1128, DOI 10.1038/nm.3944; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Ladoire S, 2015, AUTOPHAGY, V11, P1878, DOI 10.1080/15548627.2015.1082022; Lagier JC, 2015, CLIN MICROBIOL REV, V28, P237, DOI 10.1128/CMR.00014-14; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Lopez-Albaitero A, 2009, CANCER IMMUNOL IMMUN, V58, P1855, DOI 10.1007/s00262-009-0697-4; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Malmberg KJ, 2002, CLIN CANCER RES, V8, P1772; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Martens A, 2016, CLIN CANC RES; Mathur H, 2014, GUT MICROBES, V5, P696, DOI 10.4161/19490976.2014.983768; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Menetrier-Caux C, 2012, TARGET ONCOL, V7, P15, DOI 10.1007/s11523-012-0208-y; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; MITCHELL MS, 1992, J CLIN ONCOL, V10, P1158, DOI 10.1200/JCO.1992.10.7.1158; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nagarsheth N, 2016, CANCER RES, V76, P275, DOI 10.1158/0008-5472.CAN-15-1938; Ngiow SF, 2015, CANCER RES, V75, P3800, DOI 10.1158/0008-5472.CAN-15-1082; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Nishijima TF, 2016, CANCER TREAT REV, V45, P30, DOI 10.1016/j.ctrv.2016.02.006; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pawelec G, 2010, CRIT REV ONCOL HEMAT, V75, P165, DOI 10.1016/j.critrevonc.2010.06.012; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Ragab D, 2013, CYTOKINE, V63, P105, DOI 10.1016/j.cyto.2013.04.016; Rescigno M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0256-x; Riva A, 2014, HEPATOLOGY, V60, P487, DOI 10.1002/hep.27139; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rubio-Godoy V, 2002, J IMMUNOL, V169, P5696, DOI 10.4049/jimmunol.169.10.5696; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Santegoetst SJAM, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0031-3; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sender Ron, 2016, BIORXIV; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tarhini AA, 2012, J IMMUNOTHER, V35, P702, DOI 10.1097/CJI.0b013e318272569b; Tarhini AA, 2012, J CLIN ONCOL, V30, P322, DOI 10.1200/JCO.2011.37.5394; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Tomihara Kei, 2013, Critical Reviews in Oncogenesis, V18, P573; Topalian SL, 2015, CELL, V161, P185; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Touchefeu Y, 2014, ALIMENT PHARM THER, V40, P409, DOI 10.1111/apt.12878; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang JL, 2014, INT J CANCER, V135, P956, DOI 10.1002/ijc.28738; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xiao YP, 2014, J EXP MED, V211, P943, DOI 10.1084/jem.20130790; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zitvogel L, 2016, CELL, V165, P276, DOI 10.1016/j.cell.2016.03.001; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	167	590	625	12	187	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1255	1269		10.1016/j.immuni.2016.06.001	http://dx.doi.org/10.1016/j.immuni.2016.06.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332730	Bronze			2022-12-18	WOS:000378341200007
J	Halim, TYF; Krauss, RH; Sun, AC; Takei, F				Halim, Timotheus Y. F.; Krauss, Ramona H.; Sun, Ann C.; Takei, Fumio			Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; IN-VIVO; ADAPTIVE IMMUNITY; KILLER-CELLS; ASTHMA; IL-33; RESPONSES; IL-25; HYPERRESPONSIVENESS; HYPERREACTIVITY	Overproduction of cytokines by T helper 2 (Th2) cells in the lung is thought to be a cause of asthma. Here we report that innate lymphocytes termed lung natural helper (LNH) cells are a T cell-independent source of Th2 cell-type cytokines in protease allergen-treated lungs. LNH (Lin(-)Sca-1(+)c-kit(+/lo) CD25(+)CD127(+)) cells, when stimulated by IL-33 plus IL-2, IL-7, or thymic stroma lymphopoietin (TSLP), produced large amounts of IL-5 and IL-13. Intranasal administration of protease allergen papain induced eosinophil infiltration and mucus hyperproduction in the lung of wild-type and Rag1(-/-) mice, but not in Rag2(-/-)Il2rg(-/-) mice that lack LNH cells. LNH cell depletion inhibited papain-induced airway inflammation in Rag1(-/-) mice whereas adoptive transfer of LNH cells enabled Rag2(-/-)Il2rg(-/-) mice to respond to papain. Treatment of lung explants with papain induced IL-33 and TSLP production by stroma cells and IL-5 and IL-13 production by LNH cells. Thus, LNH cells are critical for protease allergen-induced airway inflammation.	[Halim, Timotheus Y. F.; Krauss, Ramona H.; Sun, Ann C.; Takei, Fumio] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Halim, Timotheus Y. F.] Univ British Columbia, Coll Interdisciplinary Studies, Grad Program Genet, Vancouver, BC V6T 1Z2, Canada; [Krauss, Ramona H.] Hannover Med Sch, D-30625 Hannover, Germany; [Takei, Fumio] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada	British Columbia Cancer Agency; University of British Columbia; Hannover Medical School; University of British Columbia	Takei, F (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ftakei@bccrc.ca	Halim, Timotheus/B-3117-2018	Halim, Timotheus/0000-0001-9773-0023; Takei, Fumio/0000-0002-3620-5046	Canadian Cancer Society Research Institute; Canadian Institute for Health Research	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	We thank K. McNagny for critical reading of the manuscript and J. Wright for helpful advice. This work was supported by the Canadian Cancer Society Research Institute. T.Y.F.H. was supported by a Canadian Institute for Health Research studentship. T.Y.F.H. designed and did experiments and analyzed the data. A.C.S. and R.H.K. did experiments. F.T. designed experiments and analyzed the data. T.Y.F.H. and F.T. prepared the manuscript.	Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hamelmann E, 2001, IMMUNOL REV, V179, P182, DOI 10.1034/j.1600-065X.2001.790118.x; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaiko GE, 2011, CURR OPIN ALLERGY CL, V11, P39, DOI 10.1097/ACI.0b013e328342322f; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; KOO GC, 1980, J IMMUNOL, V125, P1003; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider E, 2009, J IMMUNOL, V183, P3591, DOI 10.4049/jimmunol.0900328; Steinke JW, 2001, RESP RES, V2, P66, DOI 10.1186/rr40; Strickland DH, 2010, CURR OPIN IMMUNOL, V22, P789, DOI 10.1016/j.coi.2010.10.019; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Thompson P. J., 2001, Clinical and Experimental Allergy Reviews, V1, P107, DOI 10.1046/j.1472-9725.2001.00018.x; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Veinotte LL, 2008, BLOOD, V111, P4201, DOI 10.1182/blood-2007-04-087577; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	36	590	613	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					451	463		10.1016/j.immuni.2011.12.020	http://dx.doi.org/10.1016/j.immuni.2011.12.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22425247	Bronze			2022-12-18	WOS:000302048400016
J	Schenkel, JM; Masopust, D				Schenkel, Jason M.; Masopust, David			Tissue-Resident Memory T Cells	IMMUNITY			English	Review							MATURE DENDRITIC CELLS; GROWTH-FACTOR-BETA; CUTTING EDGE; LYMPHOCYTE EGRESS; E-CADHERIN; TGF-BETA; FACTOR-ALPHA; B-CELLS; MIGRATION; VIRUS	Tissue-resident memory T (Trm) cells constitute a recently identified lymphocyte lineage that occupies tissues without recirculating. They provide a first response against infections reencountered at body surfaces, where they accelerate pathogen clearance. Because Trm cells are not present within peripheral blood, they have not yet been well characterized, but are transcriptionally, phenotypically, and functionally distinct from recirculating central and effector memory T cells. In this review, we will summarize current knowledge of Trm cell ontogeny, regulation, maintenance, and function and will highlight technical considerations for studying this population.	[Schenkel, Jason M.; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Schenkel, Jason M.; Masopust, David] Univ Minnesota, Ctr Immunol, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008; Schenkel, Jason/AAV-8184-2020	Schenkel, Jason/0000-0003-4641-6872	National Institutes of Health [R01AI084913, R01AI111671]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI111671, R01AI084913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01AI084913 and R01AI111671 (to D.M.)	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Brunner T, 2001, CELL DEATH DIFFER, V8, P706, DOI 10.1038/sj.cdd.4400854; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hawke S, 1998, J EXP MED, V187, P1575, DOI 10.1084/jem.187.10.1575; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HOGG JC, 1994, J APPL PHYSIOL, V77, P1795, DOI 10.1152/jappl.1994.77.4.1795; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Knudson CJ, 2014, J VIROL, V88, P9010, DOI 10.1128/JVI.00329-14; Kobayashi A, 2002, AM J PATHOL, V160, P151, DOI 10.1016/S0002-9440(10)64359-3; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; KOYAMA S, 1989, J CLIN INVEST, V83, P1768, DOI 10.1172/JCI114080; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li ZX, 2008, J IMMUNOL, V180, P2504, DOI 10.4049/jimmunol.180.4.2504; LIANG SH, 1994, J IMMUNOL, V152, P1653; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Montufar-Solis D, 2007, IMMUNOL REV, V215, P189, DOI 10.1111/j.1600-065X.2006.00471.x; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Nanan R, 2000, J GEN VIROL, V81, P1313, DOI 10.1099/0022-1317-81-5-1313; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Preston GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077537; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Saeki H, 1999, J IMMUNOL, V162, P2472; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Scanlon ST, 2011, J EXP MED, V208, P2113, DOI 10.1084/jem.20110522; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schober SL, 1999, J IMMUNOL, V163, P3662; Schon MP, 1999, J IMMUNOL, V162, P6641; SEGEL GB, 1981, BLOOD, V57, P894; SELBY WS, 1984, GUT, V25, P32, DOI 10.1136/gut.25.1.32; Shannon LA, 2012, J BIOL CHEM, V287, P11656, DOI 10.1074/jbc.M111.310045; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stahl FR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003828; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takamura S, 2010, J EXP MED, V207, P1153, DOI 10.1084/jem.20090283; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Ugur M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5821; van der Most RG, 2003, INT IMMUNOL, V15, P119, DOI 10.1093/intimm/dxg009; Van Epps HL, 2002, J EXP MED, V196, P579, DOI 10.1084/jem.20011255; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	130	588	602	4	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					886	897		10.1016/j.immuni.2014.12.007	http://dx.doi.org/10.1016/j.immuni.2014.12.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526304	Green Accepted, Bronze			2022-12-18	WOS:000346654100008
J	Becker, C; Fantini, MC; Schramm, C; Lehr, HA; Wirtz, S; Nikolaev, A; Burg, J; Strand, S; Kiesslich, R; Huber, S; Ito, H; Nishimoto, N; Yoshizaki, K; Nishimoto, N; Galle, PR; Blessing, M; Rose-John, S; Neurath, MF				Becker, C; Fantini, MC; Schramm, C; Lehr, HA; Wirtz, S; Nikolaev, A; Burg, J; Strand, S; Kiesslich, R; Huber, S; Ito, H; Nishimoto, N; Yoshizaki, K; Nishimoto, N; Galle, PR; Blessing, M; Rose-John, S; Neurath, MF			TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling	IMMUNITY			English	Article							SOLUBLE INTERLEUKIN-6 RECEPTOR; T-CELL; PROGNOSTIC-SIGNIFICANCE; GROWTH-FACTORS; ACTIVATION; INFLAMMATION; DISEASE; ALPHA; GP130; TACE	Alterations of TGF-beta signaling have been described in colorectal cancer, although the molecular consequences are largely unknown. By using transgenic mice over-expressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy. At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6. IL-6 signaling required tumor cell-derived soluble IL-6R rather than membrane bound IL-6R and suppression of such TGFbeta-dependent IL-6 trans-signaling prevented tumor progression in vivo. Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.	Johannes Gutenberg Univ Mainz, Med Clin 1, Immunol Lab, D-55131 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Pathol, D-55131 Mainz, Germany; Osaka Univ, Suita, Osaka 5650871, Japan; Univ Leipzig, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; Univ Kiel, Dept Biochem, D-24118 Kiel, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Osaka University; Leipzig University; University of Kiel	Neurath, MF (corresponding author), Johannes Gutenberg Univ Mainz, Med Clin 1, Immunol Lab, Langenbeckstr 1, D-55131 Mainz, Germany.	neurath@1-med.klinik.uni-mainz.de	Rose-John, Stefan/A-7998-2010; Galle, Peter/ABE-2872-2021; Ralf Kiesslich, Dr./AAK-9313-2021; Becker, Christoph/A-6694-2008; Becker, Christoph/L-2996-2016; Galle, Peter R/T-5292-2018	Rose-John, Stefan/0000-0002-7519-3279; Galle, Peter/0000-0001-8294-0992; Becker, Christoph/0000-0002-1388-1041; Galle, Peter R/0000-0001-8294-0992; Schramm, Christoph/0000-0002-4264-1928; Huber, Samuel/0000-0001-9325-8227; Wirtz, Stefan/0000-0001-6936-7431				Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; COFFEY RJ, 1986, CANCER RES, V46, P1164; Dowdall JF, 2002, J SURG RES, V107, P1, DOI 10.1006/jsre.2001.6222; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Funada Y, 2003, ONCOL REP, V10, P309; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Glimcher LH, 2000, GENE DEV, V14, P1693; Grady WM, 1999, CANCER RES, V59, P320; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rose-John S, 2004, IMMUNITY, V20, P2, DOI 10.1016/S1074-7613(04)00003-2; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Schramm C, 2003, AM J PHYSIOL-GASTR L, V284, pG525, DOI 10.1152/ajpgi.00286.2002; Seder RA, 1998, J IMMUNOL, V160, P5719; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	32	585	626	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					491	501		10.1016/j.immuni.2004.07.020	http://dx.doi.org/10.1016/j.immuni.2004.07.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485627	Bronze			2022-12-18	WOS:000224744400006
J	SAD, S; MARCOTTE, R; MOSMANN, TR				SAD, S; MARCOTTE, R; MOSMANN, TR			CYTOKINE-INDUCED DIFFERENTIATION OF PRECURSOR MOUSE CD8(+) T-CELLS INTO CYTOTOXIC CD8(+) T-CELLS SECRETING TH1 OR TH2 CYTOKINES	IMMUNITY			English	Article							STIMULATORY FACTOR-I; LYMPHOCYTE-T; INTERFERON-GAMMA; MONOCLONAL-ANTIBODIES; LYMPHOKINE SECRETION; GROWTH-FACTOR; B-CELLS; FUNCTIONAL SUBSETS; MEDIATED-IMMUNITY; ACTIVATING FACTOR	Alloantigen-stimulated CD8(+) mouse spleen cells, either spontaneously or in the presence of IL-12 or IFN gamma plus anti-IL-4, differentiate into CD8(+) T cells secreting a Th1-like cytokine pattern (IL-2 and IFN gamma). IL-4 induced differentiation into CD8(+) T cells secreting Th2 cytokines (IL-4, IL-5, IL-6, and IL-10), whereas anti-IFN gamma suppressed the development of CD8(+) cells secreting lFN gamma. Clones of IL-4- or IFN gamma-producing CD8(+) T cells were relatively stable, as IL-4 or IFN gamma did not cause interconversion of committed CD8(+) T cells. Both CD8(+) subsets were cytotoxic, failed to provide cognate help for B cell antibody production, and remained CD4(-), CD8 alpha(+)CD8 beta(+). We propose the names TC1 and TC2 for cytotoxic CD8(+) T cells secreting Th1-like and Th2-like cytokines, respectively.			SAD, S (corresponding author), UNIV ALBERTA,DEPT IMMUNOL,EDMONTON,AB,CANADA.			Sad, Subash/0000-0002-2462-7137				ANDRUS L, 1984, J EXP MED, V159, P647, DOI 10.1084/jem.159.2.647; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; CHER DJ, 1987, J IMMUNOL, V138, P3688; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; COFFMAN RL, 1986, J IMMUNOL, V136, P949; DELPRETE GF, 1991, J CLIN INVEST, V88, P346, DOI 10.1172/JCI115300; ELSE KJ, 1992, IMMUNOLOGY, V75, P232; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FARRAR WL, 1980, J IMMUNOL, V124, P1371; FIRESTEIN GS, 1989, J IMMUNOL, V143, P518; FONG TAT, 1990, J IMMUNOL, V144, P1744; GLIMCHER LH, 1983, J EXP MED, V158, P1573, DOI 10.1084/jem.158.5.1573; HAANEN JBAG, 1991, J EXP MED, V174, P583, DOI 10.1084/jem.174.3.583; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HOROHOV DW, 1988, J IMMUNOL, V141, P4217; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; KELSO A, 1984, J IMMUNOL, V132, P2924; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LI L, 1994, J IMMUNOL, V153, P3967; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; MAGGI E, 1994, J EXP MED, V180, P489, DOI 10.1084/jem.180.2.489; MEHROTRA PT, 1993, J IMMUNOL, V151, P2444; MINGARI MC, 1984, EUR J IMMUNOL, V14, P1066, DOI 10.1002/eji.1830141121; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1990, J IMMUNOL, V145, P2938; MOSMANN TR, 1989, J IMMUNOL METHODS, V116, P151, DOI 10.1016/0022-1759(89)90198-1; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; PALLIARD X, 1988, J IMMUNOL, V141, P849; PFEIFER JD, 1987, J EXP MED, V166, P1464, DOI 10.1084/jem.166.5.1464; POWRIE F, 1993, EUR J IMMUNOL, V23, P2223, DOI 10.1002/eji.1830230926; PRYSTOWSKY MB, 1982, J IMMUNOL, V129, P2337; SAD S, 1994, J IMMUNOL, V153, P3514; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; SEDER RA, 1992, J IMMUNOL, V148, P1652; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHER A, 1992, IMMUNOL REV, V127, P183, DOI 10.1111/j.1600-065X.1992.tb01414.x; SIMON MM, 1986, J IMMUNOL, V136, P2755; STREET NE, 1990, J IMMUNOL, V144, P1629; SWAIN SL, 1990, J IMMUNOL, V144, P1788; SWAIN SL, 1991, J IMMUNOL, V147, P2991; TRENN G, 1988, J IMMUNOL, V140, P1101; WIDMER MB, 1987, NATURE, V326, P795, DOI 10.1038/326795a0; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; YOKOTA T, 1988, IMMUNOL REV, V102, P137, DOI 10.1111/j.1600-065X.1988.tb00744.x; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354	53	585	612	0	13	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1995	2	3					271	279		10.1016/1074-7613(95)90051-9	http://dx.doi.org/10.1016/1074-7613(95)90051-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7697544	Bronze			2022-12-18	WOS:A1995QP27600006
J	Goerdt, S; Orfanos, CE				Goerdt, S; Orfanos, CE			Other functions, other genes: Alternative activation of antigen-presenting cells	IMMUNITY			English	Review							MOLECULAR-WEIGHT PROTEIN; INTERFERON-GAMMA; HUMAN MONOCYTES; SUPPRESSOR MACROPHAGES; ENDOTHELIAL-CELLS; DENDRITIC CELLS; EXPRESSION; TOLERANCE; INTERLEUKIN-4; INHIBITION		Free Univ Berlin, Klinikum Benjamin Franklin, Dermatol Klin & Poliklin, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Goerdt, S (corresponding author), Free Univ Berlin, Klinikum Benjamin Franklin, Dermatol Klin & Poliklin, Hindenburgdamm 30, D-12200 Berlin, Germany.	goerdt@zedat.fu-berlin.de						Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; BAADSGAARD O, 1988, J IMMUNOL, V140, P1738; BECKER S, 1990, CELL IMMUNOL, V129, P351, DOI 10.1016/0008-8749(90)90211-9; BEISSERT S, 1995, J IMMUNOL, V154, P1280; Bonder CS, 1998, J IMMUNOL, V160, P4048; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; CHANG MDY, 1993, P NATL ACAD SCI USA, V90, P462, DOI 10.1073/pnas.90.2.462; CHANG ZL, 1988, CELL IMMUNOL, V114, P282, DOI 10.1016/0008-8749(88)90322-X; CHEUNG DL, 1990, IMMUNOLOGY, V71, P70; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Cua DJ, 1997, J IMMUNOL, V159, P5834; Dai RP, 1997, J INVEST DERMATOL, V108, P721, DOI 10.1111/1523-1747.ep12292099; Desvignes C, 1996, EUR J IMMUNOL, V26, P1756, DOI 10.1002/eji.1830260814; DjemadjiOudjiel N, 1996, ARCH DERMATOL RES, V288, P757, DOI 10.1007/s004030050137; ENK AH, 1993, J IMMUNOL, V151, P2390; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FENTON MJ, 1992, J IMMUNOL, V149, P1283; GENG YJ, 1992, J CLIN INVEST, V89, P1322, DOI 10.1172/JCI115718; GOERDT S, 1993, J PATHOL, V170, P421, DOI 10.1002/path.1711700404; GOERDT S, 1993, AM J PATHOL, V142, P1409; GOERDT S, 1991, J CELL BIOL, V113, P1425, DOI 10.1083/jcb.113.6.1425; Hogger P, 1998, J IMMUNOL, V161, P1883; HOLT PG, 1988, J EXP MED, V167, P262, DOI 10.1084/jem.167.2.262; KIRSCHMANN DA, 1994, IMMUNOLOGY, V82, P238; KNOP J, 1987, J IMMUNOL, V138, P3684; Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0; Kodelja V, 1998, J IMMUNOL, V160, P1411; Laing IA, 1998, J MED GENET, V35, P463, DOI 10.1136/jmg.35.6.463; MOSSER DM, 1992, J LEUKOCYTE BIOL, V52, P369, DOI 10.1002/jlb.52.4.369; MUES B, 1989, IMMUNOLOGY, V67, P303; Munder M, 1998, J IMMUNOL, V160, P5347; NAKAMURA M, 1995, P NATL ACAD SCI USA, V92, P9463; OEHLER JR, 1977, CELL IMMUNOL, V29, P238, DOI 10.1016/0008-8749(77)90319-7; SAHA B, 1994, EUR J IMMUNOL, V24, P2618, DOI 10.1002/eji.1830241108; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; SCHMIDTPAK A, 1995, CANCER RES, V55, P885; SIMON JC, 1990, J IMMUNOL, V145, P2087; STADECKER MJ, 1994, IMMUNOL TODAY, V15, P571, DOI 10.1016/0167-5699(94)90219-4; STANDIFORD TJ, 1993, AM J RESP CELL MOL, V9, P192, DOI 10.1165/ajrcmb/9.2.192; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 1996, J EXP MED, V183, P759, DOI 10.1084/jem.183.3.759; STEVENS SR, 1995, J IMMUNOL, V155, P5601; SZEKANECZ Z, 1994, ARTHRITIS RHEUM, V37, P221, DOI 10.1002/art.1780370211; VILLANUEVA POF, 1994, J IMMUNOL, V152, P1847; WALSH LJ, 1991, LAB INVEST, V65, P732; Wilckens T, 1997, IMMUNOL TODAY, V18, P418, DOI 10.1016/S0167-5699(97)01111-0	47	584	607	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					137	142		10.1016/S1074-7613(00)80014-X	http://dx.doi.org/10.1016/S1074-7613(00)80014-X			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072066	Bronze			2022-12-18	WOS:000078972200001
J	Schneider, P; Thome, M; Burns, K; Bodmer, JL; Hofmann, K; Kataoka, T; Holler, N; Tschopp, J				Schneider, P; Thome, M; Burns, K; Bodmer, JL; Hofmann, K; Kataoka, T; Holler, N; Tschopp, J			TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappa B	IMMUNITY			English	Article							DEATH-DOMAIN; INTERACTS; CONTAINS; PROTEINS; MEMBER; FAMILY	TRAIL induces apoptosis through two closely related receptors, TRAIL-RI (DR4) and TRAIL-R2 (DR5). Here we show that TRAIL-RI can associate with TRAIL-RP, suggesting that TRAIL may signal through heteroreceptor signaling complexes. Both TRAIL receptors bind the adaptor molecules FADD and TRADD, and both death signals are interrupted by a dominant negative form of FADD and by the FLICE-inhibitory protein FLIP. The recruitment of TRADD may explain the potent activation of NF-kappa B observed by TRAIL receptors. Thus, TRAIL receptors can signal both death and gene transcription, functions reminiscent of those of TNFR1 and TRAMP, two other members of the death receptor family.	Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Swiss Inst Expt Canc Res, BIL Res Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne; Swiss Institute Experimental Cancer Research	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@ib.unil.ch	Hofmann, Kay/D-6714-2011; Thome, Margot/F-8167-2011	Hofmann, Kay/0000-0002-2289-9083; Thome, Margot/0000-0002-5656-2139; Schneider, Pascal/0000-0003-0677-9409				Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; DHEIN J, 1995, BEHRING I MITT, V96, P13; Hu SM, 1997, J BIOL CHEM, V272, P9621; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; SAMBROOK J, 1989, MOL CLONING LAB MANU, P1633; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	30	584	615	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					831	836		10.1016/S1074-7613(00)80401-X	http://dx.doi.org/10.1016/S1074-7613(00)80401-X			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430228	Bronze, Green Published			2022-12-18	WOS:000071351300010
J	Hegde, PS; Chen, DS				Hegde, Priti S.; Chen, Daniel S.			Top 10 Challenges in Cancer Immunotherapy	IMMUNITY			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL; PD-1 BLOCKADE; LUNG-CANCER; MOUSE MODELS; ANTI-PD-L1 ANTIBODY; ACQUIRED-RESISTANCE; RESPONSE CRITERIA; BREAST-CANCER; SINGLE-ARM	Cancer immunotherapy is a validated and critically important approach for treating patients with cancer. Given the vast research and clinical investigation efforts dedicated to advancing both endogenous and synthetic immunotherapy approaches, there is a need to focus on crucial questions and define roadblocks to the basic understanding and clinical progress. Here, we define ten key challenges facing cancer immunotherapy, which range from lack of confidence in translating pre-clinical findings to identifying optimal combinations of immune-based therapies for any given patient. Addressing these challenges will require the combined efforts of basic researchers and clinicians, and the focusing of resources to accelerate understanding of the complex interactions between cancer and the immune system and the development of improved treatment options for patients with cancer.	[Hegde, Priti S.] Genentech Inc, San Francisco, CA 94080 USA; [Chen, Daniel S.] IGM Biosci, Mountain View, CA 94043 USA	Roche Holding; Genentech	Chen, DS (corresponding author), IGM Biosci, Mountain View, CA 94043 USA.	dschen@igmbio.com	Chen, Daniel Shin-Yu/AGD-8923-2022	Chen, Daniel Shin-Yu/0000-0001-5085-3579	F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	We recognize Jean-Charles Soria for the original concept of a top-ten manuscript. We thank Fabiola Rivas and members of the imCORE network for providing additional thoughts and input. We thank the cancer immunotherapy committee and cancer immunotherapy biomarker group at Genentech/Roche for ideas, discussion, and ongoing work on the challenges, and the larger CIT community as represented by many of the groups listed in this manuscript for the degree of collaboration and scientific discourse over the past several years. Histologic images and staining for CD8 T cells representing cancer immune phenotypes are provided by H. Koeppen MD PhD (personal communication). Medical writing assistance for this manuscript was provided by Jessica B Bessler, PhD, of Health Interactions and funded by F. Hoffmann-La Roche Ltd.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Aptsiauri N, 2018, CURR OPIN IMMUNOL, V51, P123, DOI 10.1016/j.coi.2018.03.006; Argiles G, 2017, ANN ONCOL, V28; Atkins MB, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4505; Ayers M, 2019, CLIN CANCER RES, V25, P1564, DOI 10.1158/1078-0432.CCR-18-1316; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bacac M, 2016, CLIN CANCER RES, V22, P3286, DOI 10.1158/1078-0432.CCR-15-1696; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barlesi F, 2018, LANCET ONCOL, V19, P1468, DOI 10.1016/S1470-2045(18)30673-9; Botticelli A, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1847-x; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Carvajal-Hausdorf D, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0540-1; Cary C, 2018, CLIN GENITOURIN CANC, V16, pE307, DOI 10.1016/j.clgc.2017.10.008; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chau I, 2018, ANN ONCOL, V29; Chawla A, 2018, J MED ECON, V21, P543, DOI 10.1080/13696998.2017.1423488; Chen D.S, 2017, MEET EXPERT CANC IMM; Chen DS, 2018, CANCER J, V24, P193, DOI 10.1097/PPO.0000000000000327; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen TT, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-18; Cherkasova E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00243; Chong EA, 2017, BLOOD, V129, P1039, DOI 10.1182/blood-2016-09-738245; Claret L, 2018, CLIN CANCER RES, V24, P3292, DOI 10.1158/1078-0432.CCR-17-3662; Crispe IN, 2014, HEPATOLOGY, V60, P2109, DOI 10.1002/hep.27254; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Czuczman MS, 2004, J CLIN ONCOL, V22, P4711, DOI 10.1200/JCO.2004.04.020; Dirix LY, 2018, BREAST CANCER RES TR, V167, P671, DOI 10.1007/s10549-017-4537-5; Dong YN, 2017, ONCOTARGET, V8, P2171, DOI 10.18632/oncotarget.13895; Dranoff G, 2012, NAT REV IMMUNOL, V12, P61, DOI 10.1038/nri3129; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Ebrahimi-Nik H, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129152; Efremova M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02424-0; Eng C, 2019, LANCET ONCOL, V20, P849, DOI 10.1016/S1470-2045(19)30027-0; Eroglu Z, 2018, NATURE, V553, P347, DOI 10.1038/nature25187; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Flippot R, 2016, EUR J CANCER, V61, P61, DOI 10.1016/j.ejca.2016.03.086; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Freeman-Keller M, 2016, CLIN CANCER RES, V22, P886, DOI 10.1158/1078-0432.CCR-15-1136; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Gandara DR, 2018, NAT MED, V24, P1441, DOI 10.1038/s41591-018-0134-3; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; GARRIDO F, 1993, IMMUNOL TODAY, V14, P491, DOI 10.1016/0167-5699(93)90264-L; Gauci ML, 2019, CLIN CANCER RES, V25, P946, DOI 10.1158/1078-0432.CCR-18-0793; Gentilini A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102885; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gokbuget N, 2018, BLOOD, V131, P1522, DOI 10.1182/blood-2017-08-798322; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Graeber C, 2019, BREAKTHROUGH IMMUNOT; Grasso CS, 2018, CANCER DISCOV, V8, P730, DOI 10.1158/2159-8290.CD-17-1327; Griss J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12160-2; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Haanen JBAG, 2017, ANN ONCOL, V28, P119, DOI 10.1093/annonc/mdx225; Hamid O, 2018, J CLIN ONCOL S, V36; Hamid O, 2019, CLIN CANCER RES, V25, P6061, DOI 10.1158/1078-0432.CCR-18-3488; Hansen AR, 2018, ANN ONCOL, V29, P1807, DOI 10.1093/annonc/mdy232; Hegde PS, 2018, SEMIN CANCER BIOL, V52, P117, DOI 10.1016/j.semcancer.2017.12.002; Hegde PS, 2016, CLIN CANCER RES, V22, P1865, DOI 10.1158/1078-0432.CCR-15-1507; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Herbst R.S, 2019, ANN ONCOL, V30, pv851; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; HOCHSTER HS, 2017, J CLIN ONCOL, V35; Hodi FS, 2018, J CLIN ONCOL, V36, P850, DOI 10.1200/JCO.2017.75.1644; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Hodi FS, 2018, LANCET ONCOL, V19, P1480, DOI 10.1016/S1470-2045(18)30700-9; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Iglesia MD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw144; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Joshi K, 2019, NAT MED, V25, P1549, DOI 10.1038/s41591-019-0592-2; Jotte RM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA9000; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kersten K, 2017, EMBO MOL MED, V9, P137, DOI 10.15252/emmm.201606857; Kim JM, 2016, ANN ONCOL, V27, P1492, DOI 10.1093/annonc/mdw217; Kobold S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00285; Kohnke T, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0213-6; Kowanetz M, 2018, P NATL ACAD SCI USA, V115, pE10119, DOI 10.1073/pnas.1802166115; Landi L, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0793-8; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Lee CH, 2018, ANN ONCOL, V29; Lee M., 2019, ANN ONCOL, V30, pv851, DOI [10.1093/annonc/mdz394, DOI 10.1093/ANNONC/MDZ446.006]; Lemery S, 2017, NEW ENGL J MED, V377, P1409, DOI 10.1056/NEJMp1709968; Li JZ, 2019, SUSTAINABILITY-BASEL, V11, DOI [10.1126/scitranslmed.aax8861, 10.3390/su11185015]; Lin RS, 2017, CONT CLIN TRIAL COMM, V8, P147, DOI 10.1016/j.conctc.2017.09.004; Linnemann C, 2014, IMMUNOL REV, V257, P72, DOI 10.1111/imr.12140; Liu SV, 2018, EUR J CANCER, V101, P114, DOI 10.1016/j.ejca.2018.06.033; Llovet KVSJ, 2019, ANN ONCOL, V30, P286, DOI [10.1093/annonc/mdz247.073, DOI 10.1093/ANNONC/MDZ247.073]; Long GV, 2019, LANCET ONCOL, V20, P1083, DOI 10.1016/S1470-2045(19)30274-8; Lukas RV, 2018, J NEURO-ONCOL, V140, P317, DOI 10.1007/s11060-018-2955-9; Marabelle A., 2019, ANN ONCOL, V30, pv477, DOI [10.1093/annonc/mdz253, 10.1093/annonc/mdz253.018, DOI 10.1093/ANNONC/MDZ253.018]; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Massard C, 2016, J CLIN ONCOL, V34, P3119, DOI 10.1200/JCO.2016.67.9761; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Mellman I, 2016, CANCER IMMUNOL RES, V4, P279, DOI 10.1158/2326-6066.CIR-16-0045; Moreno BH, 2016, CANCER IMMUNOL RES, V4, P845, DOI 10.1158/2326-6066.CIR-16-0060; Mosely SIS, 2017, CANCER IMMUNOL RES, V5, P29, DOI 10.1158/2326-6066.CIR-16-0114; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Nass SJ, 2018, NAT REV CLIN ONCOL, V15, P777, DOI 10.1038/s41571-018-0102-3; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Oliver AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00070; Olnes MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23002; Oyama T, 1998, J IMMUNOL, V160, P1224; Panda A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121522; Pao W, 2018, CANCER DISCOV, V8, P395, DOI 10.1158/2159-8290.CD-17-1320; Parsons BL, 2018, MUTAT RES-REV MUTAT, V777, P1, DOI 10.1016/j.mrrev.2018.05.001; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Perea F, 2017, INT J CANCER, V140, P888, DOI 10.1002/ijc.30489; Pereira C, 2017, CLIN CANCER RES, V23, P3203, DOI 10.1158/1078-0432.CCR-16-1946; Peters S, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT074; Pillai R.N, 2016, J CLIN ONCOL, V34; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pradel LP, 2016, MOL CANCER THER, V15, P3077, DOI 10.1158/1535-7163.MCT-16-0157; Pui CH, 2015, J CLIN ONCOL, V33, P2938, DOI 10.1200/JCO.2014.59.1636; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reck M, 2019, LANCET RESP MED, V7, P387, DOI 10.1016/S2213-2600(19)30084-0; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Redman JM, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0409-8; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Riley RS, 2019, NAT REV DRUG DISCOV, V18, P175, DOI 10.1038/s41573-018-0006-z; Rini B.I, 2017, J CLIN ONCOL S, V35; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rizvi NA, 2018, ANN ONCOL, V29; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sakai, 2019, ANN ONCOL, V30, pv851; Salmon H, 2019, NAT REV CANCER, V19, P215, DOI 10.1038/s41568-019-0125-9; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Schuster SJ, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-115252; Seymour L, 2017, LANCET ONCOL, V18, pE143, DOI 10.1016/S1470-2045(17)30074-8; Shields AF, 2018, J NUCL MED, V59, P410, DOI 10.2967/jnumed.117.195610; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Shrimali RK, 2017, CANCER IMMUNOL RES, V5, P755, DOI 10.1158/2326-6066.CIR-17-0292; Simon R, 2017, CLIN PHARMACOL THER, V102, P934, DOI 10.1002/cpt.814; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Simonsen KL, 2018, EUR J CANCER, V103, P259, DOI 10.1016/j.ejca.2018.07.127; Smith CC, 2018, J CLIN INVEST, V128, P4804, DOI 10.1172/JCI121476; Sosa A, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918764628; SPIGEL D, 2019, ANN ONCOL, V30, P851, DOI DOI 10.1093/annonc/mdz293; Spigel DR, 2018, J THORAC ONCOL, V13, P1733, DOI 10.1016/j.jtho.2018.05.004; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Sugiura A, 2018, J IMMUNOL, V200, P400, DOI 10.4049/jimmunol.1701041; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Tang J, 2018, ANN ONCOL, V29, P84, DOI 10.1093/annonc/mdx755; Tao JJ, 2018, ANNU REV MED, V69, P319, DOI 10.1146/annurev-med-062016-050343; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tsao MS, 2018, J THORAC ONCOL, V13, P1302, DOI 10.1016/j.jtho.2018.05.013; Tsimberidou AM, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0426-7; Tumeh PC, 2017, CANCER IMMUNOL RES, V5, P417, DOI 10.1158/2326-6066.CIR-16-0325; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; von Pawel J, 2017, ANN ONCOL, V28; Wang DY, 2018, CANCER J, V24, P36, DOI 10.1097/PPO.0000000000000296; Wang DY, 2017, CANCER IMMUNOL RES, V5, P357, DOI 10.1158/2326-6066.CIR-16-0287; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weber JS, 2017, J CLIN ONCOL, V35, P785, DOI 10.1200/JCO.2015.66.1389; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Xiang LS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040999; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou J, 2019, IMMUNITY, V50, P403, DOI 10.1016/j.immuni.2018.12.024; Zhou X, 2008, CLIN TRIALS, V5, P181, DOI 10.1177/1740774508091815; Zhukovsky EA, 2016, CURR OPIN IMMUNOL, V40, P24, DOI 10.1016/j.coi.2016.02.006; Zitvogel L, 2016, NAT REV CANCER, V16, P759, DOI 10.1038/nrc.2016.91; Zloza A, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0278-6	193	582	603	84	589	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					17	35		10.1016/j.immuni.2019.12.011	http://dx.doi.org/10.1016/j.immuni.2019.12.011			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940268	Bronze			2022-12-18	WOS:000507384600007
J	Agarwal, S; Rao, A				Agarwal, S; Rao, A			Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; INTERFERON-GAMMA GENE; LOCUS-CONTROL REGION; MURINE IL-4 GENE; TH2 CELLS; HYPERSENSITIVE SITE; ERYTHROID-CELLS; INTERLEUKIN-4; ACTIVATION; RESPONSES	Differentiating cells undergo programmed alterations in their patterns of gene expression, which are often regulated by structural changes in chromatin. Here we demonstrate that T cell differentiation results in long-range changes in the chromatin structure of effector cytokine genes, which persist in resting Th1 and Th2 cells in the absence of further stimulation. Differentiation of naive T helper cells into mature Th2 cells is associated with chromatin remodeling of the IL-4 and IL-13 genes, whereas differentiation into Th1 cells evokes remodeling of the IFN gamma but not IL-4 or IL-13 genes. IL-4 locus remodeling is accompanied by demethylation and requires both antigen stimulation and STAT6 activation. We propose that chromatin remodeling of cytokine gene loci is functionally associated with productive T cell differentiation and may explain the coordinate regulation of Th2 cytokine genes.	Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA42471] Funding Source: Medline; NIAID NIH HHS [P01 AI35297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bergman Y, 1998, BIOL CHEM, V379, P401; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; BRUEGGE B, 1995, IEEE COMPUT SCI ENG, V2, P55, DOI 10.1109/99.414880; BRUNVAND MW, 1993, NUCLEIC ACIDS RES, V21, P4824, DOI 10.1093/nar/21.20.4824; CASOLARO V, 1996, FORMA, V7, P11; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; CROFT M, 1995, J IMMUNOL, V154, P4269; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; ERNST P, 1995, IMMUNITY, V2, P311, DOI 10.1016/1074-7613(95)90139-6; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; GROUDINE M, 1983, P NATL ACAD SCI-BIOL, V80, P7551, DOI 10.1073/pnas.80.24.7551; Hagstrom K, 1997, CURR OPIN GENET DEV, V7, P814, DOI 10.1016/S0959-437X(97)80045-7; HARDY KJ, 1985, P NATL ACAD SCI USA, V82, P8173, DOI 10.1073/pnas.82.23.8173; HARDY KJ, 1987, J IMMUNOL, V138, P2353; HENKEL G, 1992, J IMMUNOL, V149, P3239; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kim KK, 1996, J BIOL CHEM, V271, P29255, DOI 10.1074/jbc.271.46.29255; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; RAO A, 1984, J EXP MED, V159, P479, DOI 10.1084/jem.159.2.479; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Szabo SJ, 1997, CURR OPIN IMMUNOL, V9, P776, DOI 10.1016/S0952-7915(97)80177-X; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Wenner CA, 1997, J IMMUNOL, V158, P765; WOLFFE AP, 1994, DEV GENET, V15, P463, DOI 10.1002/dvg.1020150604; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	70	582	596	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					765	775		10.1016/S1074-7613(00)80642-1	http://dx.doi.org/10.1016/S1074-7613(00)80642-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881967	Bronze			2022-12-18	WOS:000077836600002
J	Ikeda, H; Lethe, B; Lehmann, F; VanBaren, N; Baurain, JF; DeSmet, C; Chambost, H; Vitale, M; Moretta, A; Boon, T; Coulie, PG				Ikeda, H; Lethe, B; Lehmann, F; VanBaren, N; Baurain, JF; DeSmet, C; Chambost, H; Vitale, M; Moretta, A; Boon, T; Coulie, PG			Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor	IMMUNITY			English	Article							CYTOLYTIC T-LYMPHOCYTES; NATURAL-KILLER-CELLS; CLASS-I MOLECULES; TUMOR-INFILTRATING LYMPHOCYTES; HUMAN GENE MAGE-3; PEPTIDE MOTIFS; C MOLECULES; IDENTIFICATION; CLONING; CLONES	Melanoma lines MEL.A and MEL.B were derived from metastases removed from patient LB33 in 1988 and 1993, respectively. The MEL.A cells express several antigens recognized by autologous cytolytic T lymphocytes (CTL) on HLA class I molecules. The MEL.B cells have lost expression of all class I molecules except for HLA-A24. By stimulating autologous lymphocytes with MEL.B, we obtained an HLA-A24-restricted CTL done that lysed these cells. A novel gene, FRAME, encodes the antigen. It is expressed in a large proportion of tumors and also in some normal tissues, albeit at a lower level. Surprisingly, the CTL failed to lyse MEL.A, even though these cells expressed the gene FRAME. The CTL expresses an NK inhibitory receptor that inhibits its lytic activity upon interaction with HLA-Cw7 molecules, which are present on MEL.A cells and not on MEL.B. Such CTL, active against tumor cells showing partial HLA loss, may constitute an intermediate line of anti-tumor defense between the CTL, which recognize highly specific tumor antigens, and the NK cells, which recognize HLA loss variants.	UNIV CATHOLIQUE LOUVAIN,LUDWIG INST CANC RES,BRUSSELS BRANCH,B-1200 BRUSSELS,BELGIUM; INST J PAOLI I CALMETTES,F-13009 MARSEILLE,FRANCE; INSERM U119,F-13009 MARSEILLE,FRANCE; IST NAZL RIC CANC,I-16132 GENOA,ITALY; CTR BIOL AVANZATE,I-16132 GENOA,ITALY; UNIV GENOA,IST ISTOL,I-16126 GENOA,ITALY; UNIV BRESCIA,DIPARTIMENTO SCI BIOMED & BIOTECNOL,I-25123 BRESCIA,ITALY	Ludwig Institute for Cancer Research; Universite Catholique Louvain; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Brescia	Ikeda, H (corresponding author), UNIV CATHOLIQUE LOUVAIN,CELLULAR GENET UNIT,74 AVE HIPPOCRATE,B-1200 BRUSSELS,BELGIUM.		Vitale, Massimo/G-5135-2016	Vitale, Massimo/0000-0001-5372-7885; CHAMBOST, HERVE/0000-0002-5319-1969				Atherton E., 1981, J CHEM SOC P1, V1, P538; BIASSONI R, 1995, J EXP MED, V182, P605, DOI 10.1084/jem.182.2.605; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; BOTTINO C, 1996, IN PRESS EUR J IMMUN; Brandle D, 1996, J EXP MED, V183, P2501, DOI 10.1084/jem.183.6.2501; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Brichard VG, 1996, EUR J IMMUNOL, V26, P224, DOI 10.1002/eji.1830260135; CASTELLI C, 1995, J EXP MED, V181, P363, DOI 10.1084/jem.181.1.363; CHAMBOST H, 1993, BRIT J HAEMATOL, V84, P524, DOI 10.1111/j.1365-2141.1993.tb03111.x; CHOMEZ P, 1995, IMMUNOGENETICS, V43, P97; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; Colonna M, 1996, CURR OPIN IMMUNOL, V8, P101, DOI 10.1016/S0952-7915(96)80112-9; COULIE PG, 1992, INT J CANCER, V50, P289, DOI 10.1002/ijc.2910500220; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DANDREA A, 1995, J IMMUNOL, V155, P2306; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FALK CS, 1995, J EXP MED, V182, P1005, DOI 10.1084/jem.182.4.1005; Garrido F, 1995, ADV CANCER RES, V67, P155, DOI 10.1016/S0065-230X(08)60713-7; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Herman J, 1996, IMMUNOGENETICS, V43, P377, DOI 10.1007/s002510050078; KANG XQ, 1995, J IMMUNOL, V155, P1343; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3961; KUBO RT, 1994, J IMMUNOL, V152, P3913; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; LEMONNIER FA, 1982, J IMMUNOL METHODS, V54, P9, DOI 10.1016/0022-1759(82)90108-9; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; MAIER R, 1994, IMMUNOGENETICS, V40, P306, DOI 10.1007/BF00189978; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; MINGARI MC, 1996, P NATL ACAD SCI US, V93; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1990, J EXP MED, V171, P695, DOI 10.1084/jem.171.3.695; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MORETTA L, 1992, IMMUNOL TODAY, V13, P300, DOI 10.1016/0167-5699(92)90042-6; MURAKAWA K, 1994, GENOMICS, V23, P379, DOI 10.1006/geno.1994.1514; PAWLAK A, 1995, GENOMICS, V26, P151, DOI 10.1016/0888-7543(95)80096-5; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; REBAI N, 1983, TISSUE ANTIGENS, V22, P107; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shichijo S, 1996, INT J CANCER, V65, P709; SMITH MEF, 1989, COLD SPRING HARB SYM, V54, P581; TAKAHASHI K, 1995, CANCER RES, V55, P3478; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P2134; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P3038, DOI 10.1002/eji.1830241218; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; WOLFEL T, 1994, EUR J IMMUNOL, V24, P759, DOI 10.1002/eji.1830240340	60	578	620	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					199	208		10.1016/S1074-7613(00)80426-4	http://dx.doi.org/10.1016/S1074-7613(00)80426-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047241	Bronze			2022-12-18	WOS:A1997XC61600009
J	Porgador, A; Yewdell, JW; Deng, YP; Bennink, JR; Germain, RN				Porgador, A; Yewdell, JW; Deng, YP; Bennink, JR; Germain, RN			Localization, quantitation, and in situ detection of specific peptide MHC class I complexes using a monoclonal antibody	IMMUNITY			English	Article							T-CELL RECEPTOR; VIRAL PEPTIDES; ANTIGEN; MOLECULES; AFFINITY; BINDING; RECOGNITION; ACTIVATION; EXPRESSION; RESPONSES	CD8(+) T lymphocytes recognize antigens as short peptides bound to MHC class I molecules. Available methods cannot determine the number and distribution of these ligands on individual cells or detect antigen-presenting cells in tissues. Here we describe a method for eliciting and identifying monoclonal antibodies specific for a particular peptide-MHC class I combination. One such antibody can identify antigen complexes with a limit of detection approaching that of T cells. We used this antibody to determine the number of peptide-class I complexes generated upon viral infection, to identify antigen-presenting cells in cell mixtures, to determine the site of peptide-MHC class I interaction inside cells, and to visualize cells bearing specific peptide-MHC class I complexes after in vivo infection. Similar antibodies may prove useful for diagnostic or therapeutic purposes in cancer, infectious diseases, and autoimmune disorders.	NIAID,LYMPHOCYTE BIOL SECT,IMMUNOL LAB,NIH,BETHESDA,MD 20892; NIAID,VIRAL DIS LAB,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Porgador, Angel/0000-0003-1540-4449				AHARONI R, 1991, NATURE, V351, P147, DOI 10.1038/351147a0; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Andersen PS, 1996, P NATL ACAD SCI USA, V93, P1820, DOI 10.1073/pnas.93.5.1820; ANTON LC, 1997, IN PRESS J IMMUNOL; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BLUESTONE JA, 1992, J EXP MED, V176, P1757, DOI 10.1084/jem.176.6.1757; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CATIPOVIC B, 1992, J EXP MED, V176, P1611, DOI 10.1084/jem.176.6.1611; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; COLIGAN JE, 1996, CURRENT PROTOCOLS IM, V1; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; COUPAR BEH, 1988, GENE, V68, P1, DOI 10.1016/0378-1119(88)90593-8; COX JH, 1994, VIROLOGY, V204, P558, DOI 10.1006/viro.1994.1569; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DUC HT, 1993, INT IMMUNOL, V5, P427, DOI 10.1093/intimm/5.4.427; Eastman S, 1996, EUR J IMMUNOL, V26, P385, DOI 10.1002/eji.1830260218; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HOGQUIST KA, 1993, EUR J IMMUNOL, V23, P3028, DOI 10.1002/eji.1830231145; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; LE AXT, 1989, J IMMUNOL, V142, P1366; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MALARKANNAN S, 1995, J EXP MED, V182, P1739, DOI 10.1084/jem.182.6.1739; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY DB, 1992, J IMMUNOL, V148, P3483; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHEIL JM, 1994, EUR J IMMUNOL, V24, P2141, DOI 10.1002/eji.1830240931; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; VITELLO A, 1991, J EXP MED, V173, P1007; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; YEWDELL JW, 1990, CELL, V62, P203, DOI 10.1016/0092-8674(90)90356-J	55	577	606	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					715	726		10.1016/S1074-7613(00)80447-1	http://dx.doi.org/10.1016/S1074-7613(00)80447-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208844	Bronze			2022-12-18	WOS:A1997XG57900007
J	Palucka, K; Banchereau, J				Palucka, Karolina; Banchereau, Jacques			Dendritic-Cell-Based Therapeutic Cancer Vaccines	IMMUNITY			English	Review							CD8(+) T-CELLS; HUMAN LANGERHANS CELLS; LONG PEPTIDE VACCINE; CROSS-PRESENTATION; IN-VIVO; NONLYMPHOID TISSUE; MELANOMA PATIENTS; IMMUNE-RESPONSES; ANTIGEN; MEMORY	The past decade has seen tremendous developments in novel cancer therapies through the targeting of tumor-cell-intrinsic pathways whose activity is linked to genetic alterations and the targeting of tumor-cell-extrinsic factors, such as growth factors. Furthermore, immunotherapies are entering the clinic at an unprecedented speed after the demonstration that T cells can efficiently reject tumors and that their antitumor activity can be enhanced with antibodies against immune-regulatory molecules (checkpoint blockade). Current immunotherapy strategies include monoclonal antibodies against tumor cells or immune-regulatory molecules, cell-based therapies such as adoptive transfer of ex-vivo-activated T cells and natural killer cells, and cancer vaccines. Herein, we discuss the immunological basis for therapeutic cancer vaccines and how the current understanding of dendritic cell and T cell biology might enable the development of next-generation curative therapies for individuals with cancer.	[Palucka, Karolina; Banchereau, Jacques] Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX 75204 USA; [Palucka, Karolina] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Baylor Scott & White Health; Baylor University Medical Center; Icahn School of Medicine at Mount Sinai	Palucka, K (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX 75204 USA.	karolinp@baylorhealth.edu; jacques.banchereau@gmail.com			NIH [P01 CA084514, U19 AIO57234, R01 CA089440, CA078846]; Dana Foundation; Susan Komen Foundation; Baylor Health Care System; Baylor Health Care System Foundation; ANRS; INSERM; NATIONAL CANCER INSTITUTE [R01CA089440, P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Baylor Health Care System; Baylor Health Care System Foundation; ANRS(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We dedicate this work to the affected individuals and volunteers who participated in our studies and clinical trials. We thank Robert Coffman, Hideki Ueno, and Romain Banchereau for critical reading of the manuscript. We thank former and current members of BIIR for their contributions, particularly Hideki Ueno, Joseph Fay, Sangkon Oh, Virginia Pascual, Lee Roberts, and Gerard Zurawski. This work was supported by the NIH (P01 CA084514, U19 AIO57234, R01 CA089440, and CA078846), the Dana Foundation, the Susan Komen Foundation, the Baylor Health Care System, the Baylor Health Care System Foundation, the ANRS, and INSERM. K. P. holds the Michael A. Ramsay Chair for Cancer Immunology Research. As a result of space limitations, we could only cite a portion of the rich literature relevant to this topic.	Aarntzen EHJG, 2008, CANCER IMMUNOL IMMUN, V57, P1559, DOI 10.1007/s00262-008-0553-y; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2012, P NATL ACAD SCI USA, V109, P18885, DOI 10.1073/pnas.1205785109; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brichard VG, 2007, VACCINE, V25, pB61, DOI 10.1016/j.vaccine.2007.06.038; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Caielli S, 2012, CURR OPIN IMMUNOL, V24, P671, DOI 10.1016/j.coi.2012.09.008; Caminschi I, 2012, MOL IMMUNOL, V50, P9, DOI 10.1016/j.molimm.2011.11.008; Chatterjee B, 2012, BLOOD, V120, P2011, DOI 10.1182/blood-2012-01-402370; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dakappagari N, 2006, J IMMUNOL, V176, P426, DOI 10.4049/jimmunol.176.1.426; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fehervari Z, 2004, J CLIN INVEST, V114, P1209, DOI 10.1172/JCI200434495; Filipazzi P, 2012, CLIN CANCER RES, V18, P6485, DOI 10.1158/1078-0432.CCR-12-1516; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Finn OJ, 2009, NEW ENGL J MED, V361, P1899, DOI 10.1056/NEJMe0907480; Flacher V, 2009, CANCER IMMUNOL IMMUN, V58, P1137, DOI 10.1007/s00262-008-0563-9; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kalinski P, 2013, EXPERT REV VACCINES, V12, P285, DOI [10.1586/erv.13.22, 10.1586/ERV.13.22]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; KWAK LW, 1992, NEW ENGL J MED, V327, P1209, DOI 10.1056/NEJM199210223271705; Larocca C, 2011, CANCER J, V17, P359, DOI 10.1097/PPO.0b013e3182325e63; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Le DT, 2012, SEMIN ONCOL, V39, P311, DOI 10.1053/j.seminoncol.2012.02.008; Le DT, 2010, CANCER J, V16, P304, DOI 10.1097/PPO.0b013e3181eb33d7; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lizee G, 2013, ANNU REV MED, V64, P71, DOI 10.1146/annurev-med-112311-083918; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Meixlsperger S, 2013, BLOOD, V121, P5034, DOI 10.1182/blood-2012-12-473413; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Mullins IM, 2004, CANCER RES, V64, P7697, DOI 10.1158/0008-5472.CAN-04-2059; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ni L, 2010, J IMMUNOL, V185, P3504, DOI 10.4049/jimmunol.1000999; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Quakkelaar ED, 2012, ADV IMMUNOL, V114, P77, DOI 10.1016/B978-0-12-396548-6.00004-4; Romano E, 2012, BLOOD, V119, P5182, DOI 10.1182/blood-2011-09-382200; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2013, CURR OPIN IMMUNOL, V25, P46, DOI 10.1016/j.coi.2012.12.007; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sandoval F., 2013, SCI TRANSL MED, V5; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schreiber H, 2011, BLOOD, V118, P830, DOI 10.1182/blood-2011-06-357541; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sheasley-O'Neill SL, 2007, J IMMUNOL, V178, P1512, DOI 10.4049/jimmunol.178.3.1512; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Tacken PJ, 2011, SEMIN IMMUNOL, V23, P12, DOI 10.1016/j.smim.2011.01.001; Tanchot C., 2012, CANC MICROENVIRON; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tel J, 2013, CANCER RES, V73, P1063, DOI 10.1158/0008-5472.CAN-12-2583; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; van der Aar AMG, 2011, J IMMUNOL, V187, P3488, DOI 10.4049/jimmunol.1101105; Wada S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-89; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walter S., 2012, NAT MED; Wei S, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19440; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Yamazaki T., 2013, CELL DEATH DIFFER; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zeestraten ECM, 2013, INT J CANCER, V132, P1581, DOI 10.1002/ijc.27819; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027	140	576	603	15	160	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					38	48		10.1016/j.immuni.2013.07.004	http://dx.doi.org/10.1016/j.immuni.2013.07.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890062	Bronze, Green Accepted			2022-12-18	WOS:000330948300004
J	Geuking, MB; Cahenzli, J; Lawson, MAE; Ng, DCK; Slack, E; Hapfelmeier, S; McCoy, KD; Macpherson, AJ				Geuking, Markus B.; Cahenzli, Julia; Lawson, Melissa A. E.; Ng, Derek C. K.; Slack, Emma; Hapfelmeier, Siegfried; McCoy, Kathy D.; Macpherson, Andrew J.			Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses	IMMUNITY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; DENDRITIC CELLS; IMMUNE-RESPONSES; NAIVE-LIKE; MICROBIOTA; FOXP3(+); MICE; DIFFERENTIATION; BACTEROIDES; IGA	Mammals harbor a dense commensal microbiota in the colon. Regulatory T (Treg) cells are known to limit microbe-triggered intestinal inflammation and the CD4(+) T cell compartment is shaped by the presence of particular microbes or bacterial compounds. It is, however, difficult to distinguish whether these effects reflect true mutualistic immune adaptation to intestinal colonization or rather idiosyncratic immune responses. To investigate truly mutualistic CD4+ T cell adaptation, we used the altered Schaedler flora (ASF). Intestinal colonization resulted in activation and de novo generation of colonic Treg cells. Failure to activate Treg cells resulted in the induction of T helper 17 (Th17) and Th1 cell responses, which was reversed by wild-type Treg cells. Efficient Treg cell induction was also required to maintain intestinal homeostasis upon dextran sulfate sodium-mediated damage in the colon. Thus, microbiota colonization-induced Treg cell responses are a fundamental intrinsic mechanism to induce and maintain host-intestinal microbial T cell mutualism.	[Geuking, Markus B.; Cahenzli, Julia; Lawson, Melissa A. E.; Slack, Emma; Hapfelmeier, Siegfried; McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Inselspital, Univ Klin Viszerale Chirurg & Med, Maurice Muller Labs DKF, CH-3010 Bern, Switzerland; [Geuking, Markus B.; Cahenzli, Julia; Lawson, Melissa A. E.; Ng, Derek C. K.; Slack, Emma; Hapfelmeier, Siegfried; McCoy, Kathy D.; Macpherson, Andrew J.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada	University of Bern; University Hospital of Bern; McMaster University	Geuking, MB (corresponding author), Univ Bern, Inselspital, Univ Klin Viszerale Chirurg & Med, Maurice Muller Labs DKF, Murtenstr 35, CH-3010 Bern, Switzerland.	geuking@dkf.unibe.ch; andrew.macpherson@insel.ch	Hapfelmeier, Siegfried/B-6005-2011; Slack, Emma/AAD-5837-2019; McCoy, Kathy/ABD-5814-2021; Slack, Emma/B-1612-2016; Lawson, Melissa/K-5848-2014	Hapfelmeier, Siegfried/0000-0002-6913-7932; Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Lawson, Melissa/0000-0001-9882-8663	Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation; Crohn's and Colitis Foundation of Canada (CCFC); Juvenile Diabetes Research Foundation (JDRF); Genome Canada; Swiss National Science Foundation (SNF); Canadian Association of Gastroenterology (CAG); Canada Research Chairs program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Crohn's and Colitis Foundation of Canada (CCFC); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Genome Canada(Genome Canada); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Canadian Association of Gastroenterology (CAG); Canada Research Chairs program(Canada Research Chairs)	We thank J. Kirundi and the animal caretakers for axenic and gnotobiotic animal husbandry. We thank A. Mowat, P. Poussier, W.-D. Hardt, and C. Muller for helpful comments and critical reading of the manuscript and B. Beutler for providing the Myd88<SUP>-/-</SUP>Ticam1<SUP>-/-</SUP> mice. We thank B. Haenni, D. Studer, and A. Schopfer for technical assistance. This work was supported by grants from the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for Innovation, the Crohn's and Colitis Foundation of Canada (CCFC), the Juvenile Diabetes Research Foundation (JDRF), Genome Canada, and the Swiss National Science Foundation (SNF). M.B.G. was supported by an SNF Ambizione grant and a joint fellowship from the Canadian Association of Gastroenterology (CAG), CCFC, and CIHR. This research was also supported with funding from the Canada Research Chairs program to K.D.M. and A.J.M. M.B.G. designed and performed the research, analyzed the data, and wrote the paper. J.C., M.A.E.L., D.C.K.N., E.S., and S.H. helped performing experiments and discussed results. K.D.M. and A.J.M. directed the laboratories and helped write the paper.	ATARASHI K, 2011, IMMUNITY, V331, P401; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Chinen T, 2010, J EXP MED, V207, P2323, DOI 10.1084/jem.20101235; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; KONNO R, 1993, AM J PHYSIOL, V265, pG699, DOI 10.1152/ajpgi.1993.265.4.G699; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; POLK BF, 1977, ANN INTERN MED, V86, P569, DOI 10.7326/0003-4819-86-5-569; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tannock GW, 2007, SEMIN IMMUNOL, V19, P94, DOI 10.1016/j.smim.2006.09.001; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277	46	576	647	4	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					794	806		10.1016/j.immuni.2011.03.021	http://dx.doi.org/10.1016/j.immuni.2011.03.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21596591	Bronze			2022-12-18	WOS:000291456500017
J	Tokoyoda, K; Egawa, T; Sugiyama, T; Choi, BI; Nagasawa, T				Tokoyoda, K; Egawa, T; Sugiyama, T; Choi, BI; Nagasawa, T			Cellular niches controlling B lymphocyte behavior within bone marrow during development	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; CHEMOKINE RECEPTOR CXCR4; FACTOR-I; INHIBITS DIFFERENTIATION; PROGENITOR CELLS; RETICULAR CELLS; MICE LACKING; MOUSE; LINEAGE; LYMPHOPOIESIS	In bone marrow, hematopoiesis is thought to depend on special microenvironments known as niches that maintain blood cells. However, the identity of niches and interaction of blood cells with niches remain poorly understood. Here we identify stage-specific cellular niches for B lymphopoiesis. The earliest precursors, pre-pro-B cells and end-stage B cells, plasma cells require CXC chemokine ligand (CXCL)12. CXCL12-expressing cells are a small population of stromal cells, scattered throughout bone marrow and located some distance from the cells expressing interleukin (IL)-7. Multipotent hematopoietic progenitors are attached to the processes of CXCL12-expressing cells and pre-pro-B cells adjoin their cell bodies. Maturer pro-B cells that require IL-7 have moved away and adjoin the IL-7-expressing cells. Plasma cells again seed CXCL12-expressing cells. We demonstrate the B lymphocyte characteristic location and movement between specific niches within bone marrow during development and suggest that CXCL12 maintains the cells in the niche.	Kyoto Univ, Inst Frontier Med Sci, Dept Med Syst Control, Sakyo Ku, Kyoto 6068507, Japan; Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Immunol, Izumi, Osaka 5941101, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan	Kyoto University; University of Tokyo	Nagasawa, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Med Syst Control, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Tokoyoda, Koji/0000-0001-6101-4826; Nagasawa, Takashi/0000-0002-1085-0960; Sugiyama, Tatsuki/0000-0002-9349-0824				Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FUNK PE, 1995, BLOOD, V86, P2661; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; HERMANS MHA, 1989, J IMMUNOL, V142, P67; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jacobsen K, 1996, BLOOD, V87, P73; JACOBSEN K, 1990, EUR J IMMUNOL, V20, P2395, DOI 10.1002/eji.1830201106; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; LORD B I, 1975, Blood, V46, P65; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Nagasawa T, 1999, Adv Immunol, V71, P211; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2000, INT J HEMATOL, V72, P408; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; PILARSKI LM, 1984, J CLIN INVEST, V74, P1301, DOI 10.1172/JCI111540; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; tenBoekel E, 1997, IMMUNITY, V7, P357; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	61	576	592	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					707	718		10.1016/j.immuni.2004.05.001	http://dx.doi.org/10.1016/j.immuni.2004.05.001			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189736	Bronze			2022-12-18	WOS:000222205300007
J	Flynn, KJ; Belz, GT; Altman, JD; Ahmed, R; Woodland, DL; Doherty, PC				Flynn, KJ; Belz, GT; Altman, JD; Ahmed, R; Woodland, DL; Doherty, PC			Virus-specific CD8(+) T cells in primary and secondary influenza pneumonia	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SENDAI VIRUS; VACCINIA VIRUS; LYMPH-NODE; INFECTED MICE; IN-VIVO; MEMORY; ANTIGEN; HEMAGGLUTININ; NUCLEOPROTEIN	Virus-specific CD8(+) effector T cells (eCTL) are enriched in the lungs of mice with primary influenza pneumonia, though later detection of memory T cells (mCTL) in the mediastinal lymph nodes (MLN) or spleen by peptide-based staining protocols is at the limits of flow cytometric analysis. Respiratory challenge with an H3N2 virus months after H1N1 priming induces a massive recall response, which reduces virus titers 2-3 days earlier than in nave controls. Influenza-specific mCTL produce interferon-gamma within 6 hr, but still take 4-5 days to localize to the infected respiratory tract. The delay reflects that the recall response develops first in the MLN, which contains relatively few mCTL. The response to a subdominant epitope is less obvious after secondary challenge.	St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	St Jude Children's Research Hospital; Emory University	Doherty, PC (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.doherty@stjude.org	Belz, Gabrielle T/C-9350-2013; Doherty, Peter Charles/C-4185-2013	Belz, Gabrielle T/0000-0002-9660-9587; Doherty, Peter Charles/0000-0002-5028-3489	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI037597, R01AI029579, R01AI038359, R01AI037597, R37AI029579] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37597, AI29579, AI38359] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; ALLAN W, 1993, MICROB PATHOGENESIS, V14, P75, DOI 10.1006/mpat.1993.1008; ALLAN W, 1990, J IMMUNOL, V144, P3980; ALLOUCHE M, 1982, J IMMUNOL, V129, P689; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; ANDREW ME, 1987, SCAND J IMMUNOL, V25, P21, DOI 10.1111/j.1365-3083.1987.tb01042.x; ASKONAS BA, 1982, IMMUNOLOGY, V45, P79; BENDER BS, 1995, J LAB CLIN MED, V126, P169; BENNINK J, 1978, IMMUNOLOGY, V35, P503; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; COLE GA, 1994, J VIROL, V68, P6863, DOI 10.1128/JVI.68.11.6863-6870.1994; Cole GA, 1997, J IMMUNOL, V158, P4301; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DOHERTY PC, 1978, J EXP MED, V148, P534, DOI 10.1084/jem.148.2.534; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; DOHERTY PC, 1989, J INFECT DIS, V159, P1119, DOI 10.1093/infdis/159.6.1119; EICHELBERGER MC, 1991, J GEN VIROL, V72, P1695, DOI 10.1099/0022-1317-72-7-1695; GRESSER I, 1981, J IMMUNOL, V127, P1569; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; HORIMOTO T, 1995, VIROLOGY, V210, P466, DOI 10.1006/viro.1995.1363; HOU S, 1992, J IMMUNOL, V149, P1319; HOU S, 1993, J IMMUNOL, V150, P5494; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; KORNGOLD R, 1983, J IMMUNOL, V130, P2236; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LYNCH F, 1989, J IMMUNOL, V142, P3592; MACKAY CR, 1992, EUR J IMMUNOL, V22, P887, DOI 10.1002/eji.1830220402; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McHeyzerWilliams MG, 1996, CURR OPIN IMMUNOL, V8, P278, DOI 10.1016/S0952-7915(96)80068-9; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Topham DJ, 1998, J VIROL, V72, P882, DOI 10.1128/JVI.72.1.882-885.1998; Topham DJ, 1997, J IMMUNOL, V159, P5197; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TRIPP RA, 1995, J IMMUNOL, V155, P3719; TRIPP RA, 1995, J IMMUNOL, V154, P6013; TRIPP RA, 1995, J IMMUNOL, V154, P5870; Vitiello A, 1996, J IMMUNOL, V157, P5555; WALKER JA, 1992, VIROLOGY, V190, P278, DOI 10.1016/0042-6822(92)91214-F; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNA.RM, 1973, J EXP MED, V138, P1266, DOI 10.1084/jem.138.5.1266	57	576	583	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1998	8	6					683	691		10.1016/S1074-7613(00)80573-7	http://dx.doi.org/10.1016/S1074-7613(00)80573-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655482	Bronze			2022-12-18	WOS:000074396300004
J	Cerwenka, A; Bakker, ABH; McClanahan, T; Wagner, J; Wu, J; Phillips, JH; Lanier, LL				Cerwenka, A; Bakker, ABH; McClanahan, T; Wagner, J; Wu, J; Phillips, JH; Lanier, LL			Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; SEQUENCE-DERIVED PEPTIDES; DELTA T-CELLS; HLA-E BINDS; CDNA CLONES; SURFACE PROTEINS; NK CELLS; F9 CELLS; COMPLEX; RECOGNITION	Here we describe a family of GPI-anchored cell surface proteins that function as ligands for the mouse activating NKG2D receptor. These molecules are encoded by the retinoic acid early inducible (RAE-1) and H60 minor histocompatibility antigen genes on mouse chromosome 10 and show weak homology with MHC class I. Expression of the NKG2D ligands is low or absent on normal, adult tissues; however, they are constitutively expressed on some tumors and upregulated by retinoic acid. Ectopic expression of RAE-1 and H60 confers target susceptibility to NK cell attack. These studies identify a family of ligands for the activating NKG2D receptor on NK and T cells, which may play an important role in innate and adaptive immunity.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Mol Biol, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Box 0128, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Bakker, Arnold B./F-8494-2010; Lanier, Lewis L/E-2139-2014	Bakker, Arnold B./0000-0003-1489-1847; Lanier, Lewis L/0000-0003-1308-3952; Cerwenka, Adelheid/0000-0001-6977-3536				ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Bahram S, 1996, RES IMMUNOL, V147, P328, DOI 10.1016/0923-2494(96)89646-5; Bakker ABH, 2000, HUM IMMUNOL, V61, P18, DOI 10.1016/S0198-8859(99)00160-3; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berg SF, 1998, INT IMMUNOL, V10, P379, DOI 10.1093/intimm/10.4.379; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1; LANIER LL, 1983, J IMMUNOL, V131, P1789; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Onishi M, 1996, EXP HEMATOL, V24, P324; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; SONGYANG Z, 1996, CELL, V72, P767; Steinle A, 1998, P NATL ACAD SCI USA, V95, P12510, DOI 10.1073/pnas.95.21.12510; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	32	574	594	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					721	727		10.1016/S1074-7613(00)80222-8	http://dx.doi.org/10.1016/S1074-7613(00)80222-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894171	Bronze			2022-12-18	WOS:000087937300013
J	Shan, L; Deng, K; Shroff, NS; Durand, CM; Rabi, SA; Yang, HC; Zhang, H; Margolick, JB; Blankson, JN; Siliciano, RF				Shan, Liang; Deng, Kai; Shroff, Neeta S.; Durand, Christine M.; Rabi, S. Alireza.; Yang, Hung-Chih; Zhang, Hao; Margolick, Joseph B.; Blankson, Joel N.; Siliciano, Robert F.			Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation	IMMUNITY			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IN-VITRO SYSTEM; HIV-INFECTION; VALPROIC ACID; HIV-1-INFECTED PATIENTS; CYTOTOXIC LYMPHOCYTES; IMMUNOLOGICAL CONTROL; GENE-EXPRESSION; CELL DEPLETION; VIREMIA	Highly active antiretroviral therapy (HAART) suppresses HIV-1 replication but cannot eliminate the virus because HIV-1 establishes latent infection. Interruption of HAART leads to a rapid rebound of viremia, so life-long treatment is required. Efforts to purge the latent reservoir have focused on reactivating latent proviruses without inducing global T cell activation. However, the killing of the infected cells after virus reactivation, which is essential for elimination of the reservoir, has not been assessed. Here we show that after reversal of latency in an in vitro model, infected resting CD4(+) T cells survived despite viral cytopathic effects, even in the presence of autologous cytolytic T lymphocytes (CTLs) from most patients on HAART. Antigen-specific stimulation of patient CTLs led to efficient killing of infected cells. These results demonstrate that stimulating HIV-1-specific CTLs prior to reactivating latent HIV-1 may be essential for successful eradication efforts and should be considered in future clinical trials.	[Shan, Liang; Deng, Kai; Shroff, Neeta S.; Durand, Christine M.; Rabi, S. Alireza.; Blankson, Joel N.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Shan, Liang] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yang, Hung-Chih] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 100, Taiwan; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; National Taiwan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu	qiao, zhixin/I-3408-2012; Deng, Kai/AAK-4404-2020; Shan, Liang/ABB-9210-2021	Deng, Kai/0000-0002-9973-8130; YANG, HUNG-CHIH/0000-0003-3864-9895; Durand, Christine M./0000-0003-2605-9257	NIH [AI43222]; Howard Hughes Medical Institute; amfAR (The Foundation for AIDS Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247, R01AI043222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); amfAR (The Foundation for AIDS Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Alston for coordinating patient recruitment. This work was supported by NIH grant AI43222, by the Howard Hughes Medical Institute, and by an ARCHE grant from amfAR (The Foundation for AIDS Research).	Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Bolton DL, 2002, J VIROL, V76, P5094, DOI 10.1128/JVI.76.10.5094-5107.2002; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Goping IS, 2008, BLOOD, V111, P2142, DOI 10.1182/blood-2007-08-105221; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Marini A, 2008, J IMMUNOL, V181, P7713, DOI 10.4049/jimmunol.181.11.7713; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Roshal M, 2001, APOPTOSIS, V6, P103, DOI 10.1023/A:1009636530839; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Sahu GK, 2006, VIROLOGY, V355, P127, DOI 10.1016/j.virol.2006.07.020; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shedlock DJ, 2008, APOPTOSIS, V13, P1088, DOI 10.1007/s10495-008-0239-0; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Taylor JJ, 2011, CURR OPIN IMMUNOL, V23, P319, DOI 10.1016/j.coi.2011.03.010; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhou Y, 2008, J VIROL, V82, P9154, DOI 10.1128/JVI.00773-08	60	573	589	1	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					491	501		10.1016/j.immuni.2012.01.014	http://dx.doi.org/10.1016/j.immuni.2012.01.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22406268	Bronze, Green Accepted			2022-12-18	WOS:000302048400019
J	Babcock, GJ; Decker, LL; Volk, M; Thorley-Lawson, DA				Babcock, GJ; Decker, LL; Volk, M; Thorley-Lawson, DA			EBV persistence in memory B cells in vivo	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; BURKITT-LYMPHOMA CELLS; IN-VIVO; INFECTIOUS-MONONUCLEOSIS; PERIPHERAL-BLOOD; LATENCY; TRANSCRIPTION; ACTIVATION; EBNA-1; SITE	Epstein-Barr virus establishes latency in vitro by activating human B cells to become proliferating blasts, but in vivo it is benign. In the peripheral blood, the virus resides latently in resting B cells that we now show are restricted to the slgD(-) memory subset. However, in tonsils the virus shows no such restriction. We propose that EBV indiscriminately infects B cells in mucosal lymphoid tissue and that these cells differentiate to become resting memory B cells that then enter the circulation. Activation to the blastoid stage of latency is an essential intermediate step in this process. Thus, EBV may persist by exploiting the mechanisms that produce and maintain long-term B cell memory.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Otolaryngol, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Thorley-Lawson, DA (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	DThorley-Lawson@Infonet.Tufts.Edu	Volk, Mark/AAF-9425-2019	Volk, Mark/0000-0001-5708-5808	NATIONAL CANCER INSTITUTE [R01CA065883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018757] Funding Source: NIH RePORTER; NCI NIH HHS [CA 65883] Funding Source: Medline; NIAID NIH HHS [AI 18757] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANAGNOSTOPOULOS I, 1995, BLOOD, V85, P744, DOI 10.1182/blood.V85.3.744.bloodjournal853744; BEAUFILS P, 1993, EMBO J, V12, P5105, DOI 10.1002/j.1460-2075.1993.tb06205.x; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; DEACON EM, 1993, J EXP MED, V177, P339, DOI 10.1084/jem.177.2.339; Decker LL, 1996, J VIROL, V70, P3286, DOI 10.1128/JVI.70.5.3286-3289.1996; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; HURLEY EA, 1988, J EXP MED, V168, P2059, DOI 10.1084/jem.168.6.2059; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Khanna R, 1997, J VIROL, V71, P8340, DOI 10.1128/JVI.71.11.8340-8346.1997; Kieff E., 1996, FIELDS VIROLOGY, P2343; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; LAM KMC, 1994, IMMUNOLOGY, V82, P383; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liu Y J, 1996, Semin Immunol, V8, P169, DOI 10.1006/smim.1996.0021; MACLENNAN ICM, 1988, CURR TOP MICROBIOL, V141, P138; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martin G, 1996, ARCH SUICIDE RES, V2, P183, DOI 10.1080/13811119608259000; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Polack A, 1996, P NATL ACAD SCI USA, V93, P10411, DOI 10.1073/pnas.93.19.10411; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; RICKINSON AB, 1977, INT J CANCER, V20, P861, DOI 10.1002/ijc.2910200607; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; SCHAEFER BC, 1995, P NATL ACAD SCI USA, V92, P10565, DOI 10.1073/pnas.92.23.10565; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494; YAO QY, 1989, INT J CANCER, V43, P67, DOI 10.1002/ijc.2910430115	30	570	594	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					395	404		10.1016/S1074-7613(00)80622-6	http://dx.doi.org/10.1016/S1074-7613(00)80622-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768759	Bronze			2022-12-18	WOS:000076202300012
J	Cosman, D; Fanger, N; Borges, L; Kubin, M; Chin, W; Peterson, L; Hsu, ML				Cosman, D; Fanger, N; Borges, L; Kubin, M; Chin, W; Peterson, L; Hsu, ML			A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; PROTEIN-TYROSINE PHOSPHATASES; INHIBITS ANTIGEN PRESENTATION; FC-GAMMA RECEPTOR; HUMAN B-CELLS; HUMAN CYTOMEGALOVIRUS; HEAVY-CHAINS; MOTH-EATEN; EXPRESSION; SURFACE	The human cytomegalovirus UL18 gene product is a homolog of cellular major histocompatibility (MHC) class I antigens. UL18 has been proposed to protect virus-infected cells against natural killer (NK) cell cytotoxicity by engaging NK cell killer inhibitory receptors (KIR) for MHC class I. UL18 binds to a novel immunoglobulin superfamily glycoprotein, designated Leukocyte Immunoglobulin-like Receptor (LIR-1). This protein is distinct from, but related to, known KIRs and binds cellular MHC class I antigens. The cytoplasmic domain of LIR-1 contains four putative immunoreceptor tyrosine-based inhibitory motifs. Upon tyrosine phosphorylation, LIR-1 associates with the tyrosine phosphatase SHP-1. In contrast to KIRs, LIR-1 is expressed predominantly on monocytic and B lymphoid cell types, suggesting a distinct biological function.			Cosman, D (corresponding author), IMMUNEX RES & DEV CORP,51 UNIV ST,SEATTLE,WA 98101, USA.							Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; ARAMBURU J, 1990, J IMMUNOL, V144, P3238; BARNES PD, 1992, J GEN VIROL, V73, P2395, DOI 10.1099/0022-1317-73-9-2395; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; BENJAMIN D, 1990, BLOOD, V75, P2017; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; BROWNE H, 1992, J VIROL, V66, P6784, DOI 10.1128/JVI.66.11.6784-6787.1992; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; CASTELLS MC, 1994, J BIOL CHEM, V269, P8393; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9; FANSLOW WC, 1992, J IMMUNOL, V149, P655; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; GRAGEGRIEBENOW E, 1993, EUR J IMMUNOL, V23, P3126, DOI 10.1002/eji.1830231213; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MACKINTOSH FR, 1993, EXP HEMATOL, V21, P243; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MEIER T, 1992, ANAL BIOCHEM, V204, P220, DOI 10.1016/0003-2697(92)90165-4; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Movassagh M, 1996, BLOOD, V88, P1277, DOI 10.1182/blood.V88.4.1277.bloodjournal8841277; Olcese L, 1996, J IMMUNOL, V156, P4531; Orange JS, 1996, J IMMUNOL, V156, P4746; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Plachter B, 1996, ADV VIRUS RES, V46, P195, DOI 10.1016/S0065-3527(08)60073-1; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; Rojo S, 1997, J IMMUNOL, V158, P9; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sindre H, 1996, BLOOD, V88, P4526, DOI 10.1182/blood.V88.12.4526.bloodjournal88124526; Sivori S, 1996, EUR J IMMUNOL, V26, P2487, DOI 10.1002/eji.1830261032; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Wang LL, 1997, J IMMUNOL, V158, P13; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yao ZB, 1996, J IMMUNOL, V156, P3260; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1; ZHANG GP, 1995, J IMMUNOL, V155, P1534	60	569	583	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					273	282		10.1016/S1074-7613(00)80529-4	http://dx.doi.org/10.1016/S1074-7613(00)80529-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285411	Bronze			2022-12-18	WOS:A1997XT49200010
J	Biron, CA				Biron, CA			Interferons alpha and beta as immune regulators - A new look	IMMUNITY			English	Article							CD8(+) T-CELLS; IFN-ALPHA; I INTERFERON; GAMMA PRODUCTION; RECEPTOR EXPRESSION; VIRAL-INFECTION; GENE-EXPRESSION; IL-12; INTERLEUKIN-12; TRANSCRIPTION		Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA	Brown University	Biron, CA (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA.		Yang, Chen/G-1379-2010					BIRON C, 2001, FIELDS VIROLOGY; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cho SS, 1996, J IMMUNOL, V157, P4781; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fantuzzi L, 2000, J LEUKOCYTE BIOL, V68, P707; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; FEHNIGER TA, 1999, NAT MED, V5, P1249; Gollob JA, 1997, EUR J IMMUNOL, V27, P647, DOI 10.1002/eji.1830270311; Hermann P, 1998, J IMMUNOL, V161, P2011; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; MARIE I, 1998, J IMMUNOL, V160, P4298; McRae BL, 1998, J IMMUNOL, V160, P4298; Milone MC, 1998, J IMMUNOL, V161, P2391; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Orange JS, 1996, J IMMUNOL, V156, P4746; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rogge L, 1998, J IMMUNOL, V161, P6567; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sareneva T, 1998, J IMMUNOL, V160, P6032; Sareneva T, 2000, J IMMUNOL, V165, P1933, DOI 10.4049/jimmunol.165.4.1933; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Wenner CA, 1996, J IMMUNOL, V156, P1442; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	36	568	604	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					661	664		10.1016/S1074-7613(01)00154-6	http://dx.doi.org/10.1016/S1074-7613(01)00154-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420036	Bronze			2022-12-18	WOS:000169495100002
J	Thien, M; Phan, TG; Gardam, S; Amesbury, M; Basten, A; Mackay, F; Brink, R				Thien, M; Phan, TG; Gardam, S; Amesbury, M; Basten, A; Mackay, F; Brink, R			Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches	IMMUNITY			English	Article							LYMPHOCYTES-B; TRANSGENIC MICE; AUTOIMMUNE-DISEASE; BONE-MARROW; T-CELLS; RECEPTOR; SURVIVAL; MATURATION; DIFFERENTIATION; ELIMINATION	The role of BAFF in B cell self tolerance was examined by tracking the fate of anti-HEL self-reactive B cells in BAFF transgenic mice using four different models of self-reactive B cell deletion. BAFF overexpression did not affect the development of self-reactive B cells normally deleted in the bone marrow or during the early stages of peripheral development. By contrast, self-reactive B cells normally deleted around the late T2 stage of peripheral development were rescued from deletion, matured, and colonized the splenic follicle. Furthermore, self-reactive B cells normally selectively deleted from the marginal zone repopulated this compartment when excess BAFF was present. Self-reactive B cells rescued by excess BAFF were not anergic. BAFF overexpression therefore rescued only self-reactive B cells normally deleted with relatively low stringency and facilitated their migration into otherwise forbidden microenvironments. This partial subversion of B cell self tolerance is likely to underlie the autoimmunity associated with BAFF overexpression.	Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia; Garvan Inst Med Res, Dept Arthrit & Inflammat, Darlinghurst, NSW 2030, Australia	University of Sydney; Centenary Institute; Garvan Institute of Medical Research	Brink, R (corresponding author), Centenary Inst Canc Med & Cell Biol, Locked Bag 6, Newtown, NSW 2042, Australia.	r.brink@centenary.usyd.edu.au	Phan, Tri Giang/G-3937-2012; Brink, Robert/B-7910-2010; Mackay, Fabienne/B-7440-2008	Phan, Tri Giang/0000-0002-4909-2984; Brink, Robert/0000-0002-9586-3655; Mackay, Fabienne/0000-0002-6074-2693				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Cook MC, 1997, J EXP MED, V186, P631, DOI 10.1084/jem.186.5.631; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cyster JG, 2000, NAT IMMUNOL, V1, P9, DOI 10.1038/76859; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1990, SCIENCE, V248, P1373, DOI 10.1126/science.2356469; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1994, INT IMMUNOL, V6, P1417, DOI 10.1093/intimm/6.9.1417; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965	33	567	577	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					785	798		10.1016/j.immuni.2004.05.010	http://dx.doi.org/10.1016/j.immuni.2004.05.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189742	Bronze			2022-12-18	WOS:000222205300013
J	Burshtyn, DN; Scharenberg, AM; Wagtmann, N; Rajagopalan, S; Berrada, K; Yi, TL; Kinet, JP; Long, EO				Burshtyn, DN; Scharenberg, AM; Wagtmann, N; Rajagopalan, S; Berrada, K; Yi, TL; Kinet, JP; Long, EO			Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor	IMMUNITY			English	Article							LYMPHOCYTE-ACTIVATION; SIGNAL-TRANSDUCTION; FC-RECEPTORS; SH2 DOMAINS; PROTEIN; EXPRESSION; PHOSPHORYLATION; LOCALIZATION; ASSOCIATION; RECOGNITION	Cytolysis of target cells by natural killer (NK) cells and by some cytotoxic T cells occurs unless prevented by inhibitory receptors that recognize MHC class I on target cells. Human NK cells express a p58 inhibitory receptor specific for HLA-C. We report association of the tyrosine phosphatase HCP with the p58 receptor in NK cells. HCP association was dependent on tyrosine phosphorylation of p58. Phosphotyrosyl peptides corresponding to the p58 tail bound and activated HCP in vitro. Furthermore, introduction of an inactive mutant HCP into an NK cell line prevented the p58-mediated inhibition of target cell lysis. These data imply that the inhibitory function of p58 is dependent on its tyrosine phosphorylation and on recruitment and activation of HCP.	NIAID, MOLEC ALLERGY & IMMUNOL SECT, ROCKVILLE, MD 20852 USA; CLEVELAND CLIN FDN, RES INST, DEPT CANC BIOL, CLEVELAND, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cleveland Clinic Foundation	Burshtyn, DN (corresponding author), NIAID, IMMUNOGENET LAB, 12441 PARKLAWN DR, ROCKVILLE, MD 20852 USA.		Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728; Burshtyn, Deborah/0000-0003-4829-3351	Intramural NIH HHS [Z01 AI000525-20] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; BEAVEN MA, 1993, IMMUNOL TODAY, V14, P222, DOI 10.1016/0167-5699(93)90167-J; BOTTINO C, 1994, EUR J IMMUNOL, V24, P2527, DOI 10.1002/eji.1830241040; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; CONE JC, 1993, EUR J IMMUNOL, V23, P2488; CORREA I, 1994, EUR J IMMUNOL, V24, P1323, DOI 10.1002/eji.1830240613; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DANDREA A, 1995, J IMMUNOL, V155, P2306; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; EARL PL, 1988, CURRENT PROTOCOLS MO; EINSPAHR KJ, 1991, P NATL ACAD SCI USA, V88, P6279, DOI 10.1073/pnas.88.14.6279; EISEMAN E, 1990, CANCER CELL-MON REV, V2, P303; FERRINI S, 1994, EUR J IMMUNOL, V24, P2294, DOI 10.1002/eji.1830241005; GONG JH, 1994, LEUKEMIA, V8, P652; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KAUFMAN DS, 1995, P NATL ACAD SCI USA, V92, P6484, DOI 10.1073/pnas.92.14.6484; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; LANIER LL, 1983, J IMMUNOL, V131, P1789; LJUNGGREN HG, 1988, J IMMUNOL, V140, P671; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; MALNATI MS, 1993, J EXP MED, V178, P961, DOI 10.1084/jem.178.3.961; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MELERO I, 1994, J IMMUNOL, V152, P1662; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; PIGNATA C, 1993, J IMMUNOL, V151, P6794; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; SALCEDO TW, 1993, J EXP MED, V177, P1475, DOI 10.1084/jem.177.5.1475; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STAHLS A, 1992, EUR J IMMUNOL, V22, P611, DOI 10.1002/eji.1830220249; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; TING AT, 1991, J IMMUNOL, V147, P3122; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; VITALE M, 1995, P NATL ACAD SCI USA, V92, P3536, DOI 10.1073/pnas.92.8.3536; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; YABE T, 1993, IMMUNOGENETICS, V37, P455; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	56	567	582	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1996	4	1					77	85		10.1016/S1074-7613(00)80300-3	http://dx.doi.org/10.1016/S1074-7613(00)80300-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574854	Green Accepted, Bronze			2022-12-18	WOS:A1996TT31900008
J	Pfirschke, C; Engblom, C; Rickelt, S; Cortez-Retamozo, V; Garris, C; Pucci, F; Yamazaki, T; Poirier-Colame, V; Newton, A; Redouane, Y; Lin, YJ; Wojtkiewicz, G; Iwamoto, Y; Mino-Kenudson, M; Huynh, TG; Hynes, RO; Freeman, GJ; Kroemer, G; Zitvogel, L; Weissleder, R; Pittet, MJ				Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen; Cortez-Retamozo, Virna; Garris, Christopher; Pucci, Ferdinando; Yamazaki, Takahiro; Poirier-Colame, Vichnou; Newton, Andita; Redouane, Younes; Lin, Yi-Jang; Wojtkiewicz, Gregory; Iwamoto, Yoshiko; Mino-Kenudson, Mari; Huynh, Tiffany G.; Hynes, Richard O.; Freeman, Gordon J.; Kroemer, Guido; Zitvogel, Laurence; Weissleder, Ralph; Pittet, Mikael J.			Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy	IMMUNITY			English	Article							PD-1 BLOCKADE; MOUSE MODEL; T-CELLS; RESPONSES; IMMUNOTHERAPY; INHIBITION; IPILIMUMAB; PROGNOSIS; NIVOLUMAB; DELIVERY	Checkpoint blockade immunotherapies can be extraordinarily effective, but might benefit only the minority of patients whose tumors are pre-infiltrated by T cells. Here, using lung adenocarcinoma mouse models, including genetic models, we show that autochthonous tumors that lacked T cell infiltration and resisted current treatment options could be successfully sensitized to host antitumor T cell immunity when appropriately selected immunogenic drugs (e.g., oxaliplatin combined with cyclophosphamide for treatment against tumors expressing oncogenic Kras and lacking Trp53) were used. The antitumor response was triggered by direct drug actions on tumor cells, relied on innate immune sensing through toll-like receptor 4 signaling, and ultimately depended on CD8(+) T cell antitumor immunity. Furthermore, instigating tumor infiltration by T cells sensitized tumors to checkpoint inhibition and controlled cancer durably. These findings indicate that the proportion of cancers responding to checkpoint therapy can be feasibly and substantially expanded by combining checkpoint blockade with immunogenic drugs.	[Pfirschke, Christina; Engblom, Camilla; Cortez-Retamozo, Virna; Garris, Christopher; Pucci, Ferdinando; Newton, Andita; Redouane, Younes; Lin, Yi-Jang; Wojtkiewicz, Gregory; Iwamoto, Yoshiko; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA; [Pfirschke, Christina; Engblom, Camilla; Cortez-Retamozo, Virna; Garris, Christopher; Pucci, Ferdinando; Newton, Andita; Redouane, Younes; Lin, Yi-Jang; Wojtkiewicz, Gregory; Iwamoto, Yoshiko; Weissleder, Ralph; Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Engblom, Camilla; Garris, Christopher] Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA; [Rickelt, Steffen; Hynes, Richard O.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yamazaki, Takahiro; Poirier-Colame, Vichnou; Kroemer, Guido; Zitvogel, Laurence] Gustave Roussy Canc Campus, F-94805 Villejuif, France; [Mino-Kenudson, Mari; Huynh, Tiffany G.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); UNICANCER; Gustave Roussy; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA.; Pittet, MJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; Pittet, Mikael/ABD-6300-2021; Freeman, Gordon/AAC-5380-2019; Wojtkiewicz, Gregory/L-3660-2018	KROEMER, Guido/0000-0002-9334-4405; Freeman, Gordon/0000-0002-7210-5616; Wojtkiewicz, Gregory/0000-0002-3148-8411; /0000-0003-0828-4143; Rickelt, Steffen/0000-0002-5224-7764; ZITVOGEL, laurence/0000-0003-1596-0998; YAMAZAKI, Takahiro/0000-0002-7420-4394	Samana Cay MGH Research Scholar Fund; NIH [P50-CA86355, R01-AI084880, U54-CA126515, 5U54CA163125, 5U54-CA163109]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft (DFG) [PF809/1-1]; Boehringer Ingelheim Fonds; DFG [RI2408/1-1]; NATIONAL CANCER INSTITUTE [F31CA196035, U54CA126515, P50CA086355, R01CA204019, U54CA163125, P30CA014051, R21CA190344, U54CA163109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Samana Cay MGH Research Scholar Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the members of the Hope Babette Tang Histology Facility at the Koch Institute Swanson Biotechnology Center for technical support. This work was supported in part by the Samana Cay MGH Research Scholar Fund (to M.J.P.), NIH grants P50-CA86355 and R01-AI084880 (to M.J.P.), U54-CA126515 (to R.W.), 5U54CA163125 (to G.J.F.), and 5U54-CA163109 and the Howard Hughes Medical Institute (to R.O.H.). C.P. was supported by the Deutsche Forschungsgemeinschaft (DFG) PF809/1-1, C.E. by the Boehringer Ingelheim Fonds, and S.R. by the DFG RI2408/1-1.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Broz ML, 2015, CANCER IMMUNOL RES, V3, P313, DOI 10.1158/2326-6066.CIR-15-0041; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/nnano.2012.45, 10.1038/NNANO.2012.45]; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Gou HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085789; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lu L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-36; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	40	566	585	5	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					343	354		10.1016/j.immuni.2015.11.024	http://dx.doi.org/10.1016/j.immuni.2015.11.024			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26872698	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000370294000016
J	Di Virgilio, F; Dal Ben, D; Sarti, AC; Giuliani, AL; Falzoni, S				Di Virgilio, Francesco; Dal Ben, Diego; Sarti, Alba Clara; Giuliani, Anna Lisa; Falzoni, Simonetta			The P2X7 Receptor in Infection and Inflammation	IMMUNITY			English	Review							IMMUNOGENIC CELL-DEATH; HUMAN DENDRITIC CELLS; GAIN-OF-FUNCTION; P2X(7) RECEPTOR; EXTRACELLULAR ATP; NLRP3 INFLAMMASOME; PURINERGIC RECEPTORS; NUCLEOTIDE RECEPTOR; PHOSPHOLIPASE-D; RHEUMATOID-ARTHRITIS	A denosine triphosphate (ATP) accumulates at sites of tissue injury and inflammation. Effects of extracellular ATP are mediated by plasma membrane receptors named P2 receptors (P2Rs). The P2R most involved in inflammation and immunity is the P2X7 receptor (P2X7R), expressed by virtually all cells of innate and adaptive immunity. P2X7R mediates NLRP3 inflammasome activation, cytokine and chemokine release, T lymphocyte survival and differentiation, transcription factor activation, and cell death. Ten human P2RX7 gene splice variants and several SNPs that produce complex haplotypes are known. The P2X7R is a potent stimulant of inflammation and immunity and a promoter of cancer cell growth. This makes P2X7R an appealing target for anti-inflammatory and anti-cancer therapy. However, an in-depth knowledge of its structure and of the associated signal transduction mechanisms is needed for an effective therapeutic development.	[Di Virgilio, Francesco; Sarti, Alba Clara; Giuliani, Anna Lisa; Falzoni, Simonetta] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Dal Ben, Diego] Univ Camerino, Sch Pharm, Camerino, Italy	University of Ferrara; University of Camerino	Di Virgilio, F (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy.	fdv@unife.it	Giuliani, Anna Lisa/HHS-0401-2022; Di Virgilio, Francesco/J-3754-2018; Dal Ben, Diego/F-6944-2010; Sarti, Alba Clara/AAO-7737-2020; DI VIRGILIO, Francesco/O-4634-2019	Di Virgilio, Francesco/0000-0003-3566-1362; Dal Ben, Diego/0000-0002-6616-6885; DI VIRGILIO, Francesco/0000-0003-3566-1362; Giuliani, Anna Lisa/0000-0003-4988-9181	Italian Association for Cancer Research [IG 13025, IG 18581]; Telethon of Italy [GGP06070]; ERA-NET Neuron Joint Transnational Project "Nanostroke"; Ministry of Health of Italy [RF-2011-02348435]; Italian Ministry of Education, University and Research [RBAP11FXBC_001]; University of Ferrara	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); ERA-NET Neuron Joint Transnational Project "Nanostroke"; Ministry of Health of Italy(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Ferrara	F.D.V. is supported by grants from the Italian Association for Cancer Research (IG 13025 and IG 18581), Telethon of Italy (GGP06070), ERA-NET Neuron Joint Transnational Project "Nanostroke," the Ministry of Health of Italy (RF-2011-02348435), the Italian Ministry of Education, University and Research (RBAP11FXBC_001), and institutional funds from the University of Ferrara. F.D.V. serves a member of the Scientific Advisory Board of Biosceptre International Limited and is a consultant for Janssen Pharmaceutica.	Abramowski P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104692; Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2015, CANCER RES, V75, P635, DOI 10.1158/0008-5472.CAN-14-1259; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; Alzola E, 1998, J BIOL CHEM, V273, P30208, DOI 10.1074/jbc.273.46.30208; Amaral EP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004188; Amoroso F, 2015, ONCOGENE, V34, P5240, DOI 10.1038/onc.2014.444; Amoroso F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.105; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Barbera-Cremades M, 2016, J LEUKOCYTE BIOL, V99, P289, DOI 10.1189/jlb.1A0514-267RR; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Bianchi G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.109; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chataigneau T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00273; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; COCKCROFT S, 1979, NATURE, V279, P541, DOI 10.1038/279541a0; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Coutinho-Silva R, 2012, MICROBES INFECT, V14, P1271, DOI 10.1016/j.micinf.2012.05.009; Csoka B, 2015, FASEB J, V29, P3626, DOI 10.1096/fj.15-272450; Dal Ben D, 2015, EUR J MED CHEM, V89, P561, DOI 10.1016/j.ejmech.2014.10.071; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Danquah W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8463; De Marchi E, 2016, ADV PROTEIN CHEM STR, V104, P39, DOI 10.1016/bs.apcsb.2015.11.004; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Di Virgilio F, 2017, ONCOGENE, V36, P293, DOI 10.1038/onc.2016.206; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; ELMOATASSIM C, 1992, J BIOL CHEM, V267, P23664; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Eser A, 2015, INFLAMM BOWEL DIS, V21, P2247, DOI 10.1097/MIB.0000000000000514; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Fan ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35804; Fantoni ER, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0275-2; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 2004, J IMMUNOL, V173, P4652, DOI 10.4049/jimmunol.173.7.4652; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Franceschini A, 2015, FASEB J, V29, P2450, DOI 10.1096/fj.14-268714; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Garcia-Marcos M, 2006, CELL SIGNAL, V18, P2098, DOI 10.1016/j.cellsig.2006.05.008; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gilbert S. M., 2017, PHASE I CLIN TRIAL D; Gourine AV, 2005, BRIT J PHARMACOL, V146, P139, DOI 10.1038/sj.bjp.0706287; Graziano F, 2015, P NATL ACAD SCI USA, V112, pE3265, DOI 10.1073/pnas.1500656112; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Harkat M, 2017, P NATL ACAD SCI USA, V114, pE3786, DOI 10.1073/pnas.1701379114; Hashimoto-Hill S, 2017, MUCOSAL IMMUNOL, V10, P912, DOI 10.1038/mi.2016.109; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Humphreys BD, 1996, J IMMUNOL, V157, P5627; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jacobson KA, 2016, NEUROPHARMACOLOGY, V104, P31, DOI 10.1016/j.neuropharm.2015.12.001; Jiang LH, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00055; Jimenez-Mateos EM, 2015, SCI REP-UK, V5, DOI 10.1038/srep17486; Jorgensen NR, 2012, EUR J HUM GENET, V20, P675, DOI 10.1038/ejhg.2011.253; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kasuya G, 2016, CELL REP, V14, P932, DOI 10.1016/j.celrep.2015.12.087; Kataoka A, 2009, J NEUROCHEM, V108, P115, DOI 10.1111/j.1471-4159.2008.05744.x; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Killeen ME, 2013, J IMMUNOL, V190, P4324, DOI 10.4049/jimmunol.1202045; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Laliberte RE, 1997, J LEUKOCYTE BIOL, V62, P227, DOI 10.1002/jlb.62.2.227; Ledderose C, 2016, PURINERG SIGNAL, V12, P439, DOI 10.1007/s11302-016-9510-y; Ledderose C, 2016, J INFECT DIS, V213, P456, DOI 10.1093/infdis/jiv373; Lenertz LY, 2010, BIOCHEMISTRY-US, V49, P4611, DOI 10.1021/bi902083n; Liang X, 2015, J BIOL CHEM, V290, P7930, DOI 10.1074/jbc.M114.627810; LIN J, 1985, J IMMUNOL, V135, P3403; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Maitre B, 2015, J IMMUNOL, V194, P739, DOI 10.4049/jimmunol.1401786; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Masin M, 2012, BRIT J PHARMACOL, V165, P978, DOI 10.1111/j.1476-5381.2011.01624.x; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; Moore SF, 2007, CELL SIGNAL, V19, P855, DOI 10.1016/j.cellsig.2006.10.010; Mortimer L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004887; MUNERATI M, 1994, BBA-MOL CELL RES, V1224, P269, DOI 10.1016/0167-4889(94)90200-3; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Norde WJ, 2009, BLOOD, V113, P2312, DOI 10.1182/blood-2008-04-153825; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Omosun Y, 2015, INFECT IMMUN, V83, P4662, DOI 10.1128/IAI.00993-15; Ory D, 2016, J NUCL MED, V57, P1436, DOI 10.2967/jnumed.115.169995; Pandolfi JB, 2016, J IMMUNOL, V196, P3287, DOI 10.4049/jimmunol.1502506; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Park JH, 2017, EXPERT OPIN THER PAT, V27, P257, DOI 10.1080/13543776.2017.1246538; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Pippel A, 2017, P NATL ACAD SCI USA, V114, pE2156, DOI 10.1073/pnas.1610414114; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; Rissiek B, 2014, J LEUKOCYTE BIOL, V95, P543, DOI 10.1189/jlb.0713407; Rizzo R, 2009, J IMMUNOL, V183, P4302, DOI 10.4049/jimmunol.0804265; Robinson LE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00233; Roger S, 2015, BBA-BIOMEMBRANES, V1848, P2584, DOI 10.1016/j.bbamem.2014.10.029; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Shenker BJ, 2015, INFECT IMMUN, V83, P1487, DOI 10.1128/IAI.03132-14; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Shiratori M, 2010, J NEUROCHEM, V114, P810, DOI 10.1111/j.1471-4159.2010.06809.x; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Sinadinos A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001888; Sluyter Ronald, 2011, Recent Pat DNA Gene Seq, V5, P41; Solini A, 1999, J CELL SCI, V112, P297; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; SUNG SSJ, 1985, J BIOL CHEM, V260, P3442; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Syberg S, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/391097; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; Taylor SRJ, 2009, J LEUKOCYTE BIOL, V85, P978, DOI 10.1189/jlb.0408251; Territo PR, 2017, J NUCL MED, V58, P458, DOI 10.2967/jnumed.116.181354; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Vergani A, 2013, CIRCULATION, V127, P463, DOI 10.1161/CIRCULATIONAHA.112.123653; Verkhratsky A, 2014, BIOESSAYS, V36, P697, DOI 10.1002/bies.201400024; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wei W, 2008, CANCER LETT, V260, P79, DOI 10.1016/j.canlet.2007.10.025; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; ZANOVELLO P, 1990, J IMMUNOL, V145, P1545	192	565	568	18	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					15	31		10.1016/j.immuni.2017.06.020	http://dx.doi.org/10.1016/j.immuni.2017.06.020			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723547	Bronze			2022-12-18	WOS:000405712800007
J	Gur, C; Ibrahim, Y; Isaacson, B; Yamin, R; Abed, J; Gamliel, M; Enk, J; Bar-On, Y; Stanietsky-Kaynan, N; Coppenhagen-Glazer, S; Shussman, N; Almogy, G; Cuapio, A; Hofer, E; Mevorach, D; Tabib, A; Ortenberg, R; Markel, G; Miklic, K; Jonjic, S; Brennan, CA; Garrett, WS; Bachrach, G; Mandelboim, O				Gur, Chamutal; Ibrahim, Yara; Isaacson, Batya; Yamin, Rachel; Abed, Jawad; Gamliel, Moriya; Enk, Jonatan; Bar-On, Yotam; Stanietsky-Kaynan, Noah; Coppenhagen-Glazer, Shunit; Shussman, Noam; Almogy, Gideon; Cuapio, Angelica; Hofer, Erhard; Mevorach, Dror; Tabib, Adi; Ortenberg, Rona; Markel, Gal; Miklic, Karmela; Jonjic, Stipan; Brennan, Caitlin A.; Garrett, Wendy S.; Bachrach, Gilad; Mandelboim, Ofer			Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack	IMMUNITY			English	Article							ORAL BACTERIA; CYTOTOXICITY; CANCER; MICE; FADA	Bacteria, such as Fusobacterium nucleatum, are present in the tumor microenvironment. However, the immunological consequences of intra-tumoral bacteria remain unclear. Here, we have shown that natural killer (NK) cell killing of various tumors is inhibited in the presence of various F. nucleatum strains. Our data support that this F. nucleatum- mediated inhibition is mediated by human, but not by mouse TIGIT, an inhibitory receptor present on all human NK cells and on various T cells. Using a library of F. nucleatum mutants, we found that the Fap2 protein of F. nucleatum directly interacted with TIGIT, leading to the inhibition of NK cell cytotoxicity. We have further demonstrated that tumor- infiltrating lymphocytes expressed TIGIT and that T cell activities were also inhibited by F. nucleatum via Fap2. Our results identify a bacterium- dependent, tumorimmune evasion mechanism in which tumors exploit the Fap2 protein of F. nucleatum to inhibit immune cell activity via TIGIT.	[Gur, Chamutal; Isaacson, Batya; Yamin, Rachel; Gamliel, Moriya; Enk, Jonatan; Bar-On, Yotam; Stanietsky-Kaynan, Noah; Mandelboim, Ofer] Hebrew Univ Hadassah Med Sch, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; [Gur, Chamutal; Mevorach, Dror; Tabib, Adi] Hadassah Hebrew Univ, Rheumatol Res Ctr, IL-91120 Jerusalem, Israel; [Ibrahim, Yara; Abed, Jawad; Coppenhagen-Glazer, Shunit; Bachrach, Gilad] Hebrew Univ Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel; [Shussman, Noam; Almogy, Gideon] Hadassah Hebrew Univ Med Ctr, Dept Gen Surg, IL-91120 Jerusalem, Israel; [Cuapio, Angelica; Hofer, Erhard] Univ Vienna, Dept Vasc Biol & Thrombosis Res Med, A-1090 Vienna, Austria; [Ortenberg, Rona; Markel, Gal] Sheba Med Ctr, Ella Inst Melanoma, IL-526260 Ramat Gan, Israel; [Miklic, Karmela; Jonjic, Stipan] Univ Rijeka, Fac Med, Ctr Prote, Dept Histol & Embryol, Rijeka 51000, Croatia; [Brennan, Caitlin A.; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Boston, MA 02115 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Vienna; Chaim Sheba Medical Center; University of Rijeka; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Bachrach, G (corresponding author), Hebrew Univ Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel.	giladba@ekmd.huji.ac.il; oferm@ekmd.huji.ac.il	Jonjic, Stipan/C-5657-2016	Jonjic, Stipan/0000-0001-5003-3108; Mandelboim, Ofer/0000-0002-9354-1855; Garrett, Wendy/0000-0002-5092-0150; Brennan, Caitlin/0000-0002-6074-9502; Cuapio, Angelica/0000-0002-9451-1914; Bachrach, Gilad/0000-0003-1350-2280	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC [320473-BacNK]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation; I-Core on Chromatin and RNA in Gene Regulation; GIF Foundation; Lewis family Foundation; ICRF professorship grant; Israeli Science Foundation; Helmholtz Israel grant; Rosetrees Trust; ICRF project grant; Israeli Science Foundation (Morasha); Foulkes Foundation; Hoffman-LaRoche; Marie Curie European Research Council program [FP7-MC-ITN-317013-NATURIMMUN]; ERC Advanced Grant [322693];  [R01CA154426]; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC(European Research Council (ERC)); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); I-Core on Chromatin and RNA in Gene Regulation; GIF Foundation(German-Israeli Foundation for Scientific Research and Development); Lewis family Foundation; ICRF professorship grant; Israeli Science Foundation(Israel Science Foundation); Helmholtz Israel grant; Rosetrees Trust(Rosetrees Trust); ICRF project grant; Israeli Science Foundation (Morasha)(Israel Science Foundation); Foulkes Foundation; Hoffman-LaRoche; Marie Curie European Research Council program(European Research Council (ERC)); ERC Advanced Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement number 320473-BacNK. Further support came from the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation and by the I-Core on Chromatin and RNA in Gene Regulation, the GIF Foundation, the Lewis family Foundation, the ICRF professorship grant, the Israeli Science Foundation, the Helmholtz Israel grant and the Rosetrees Trust (all to O.M.). O.M. is a Crown Professor of Molecular Immunology. This project was also supported by the Israeli Science Foundation and the ICRF project grant to G. B. The work was also supported by the Israeli Science Foundation (Morasha) and by the Foulkes Foundation to C.G. This work was supported by R01CA154426 and a grant from Hoffman-LaRoche to W.S.G., and A.C., E.H. and O.M are further supported by the Marie Curie European Research Council program (FP7-MC-ITN-317013-NATURIMMUN). S.J. is supported by the ERC Advanced Grant (grant number 322693). We thank Dr. Stern-Ginossar for her help in performing the pp65 proliferation assays.	Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601; Coley W. B., 1910, P ROY SOC MED, V3, P1, DOI DOI 10.1177/003591571000301601; Coppenhagen-Glazer S., 2015, INFECT IMMUN; Elias S, 2014, BLOOD, V123, P1535, DOI 10.1182/blood-2013-09-526590; Gardiner CM, 2008, INT J IMMUNOGENET, V35, P1, DOI 10.1111/j.1744-313X.2007.00739.x; Gonen-Gross T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008941; Grange JM, 2008, VACCINE, V26, P4984, DOI 10.1016/j.vaccine.2008.06.092; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jobin C, 2013, CANCER DISCOV, V3, P384, DOI 10.1158/2159-8290.CD-13-0042; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lankry D, 2010, METHODS MOL BIOL, V612, P249, DOI 10.1007/978-1-60761-362-6_17; Lee P, 2014, J DENT RES, V93, P162, DOI 10.1177/0022034513516346; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Seidel E, 2012, CELL MOL LIFE SCI, V69, P3911, DOI 10.1007/s00018-012-1001-x; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Tannock GW, 2008, TRENDS MICROBIOL, V16, P488, DOI 10.1016/j.tim.2008.07.005; Temoin S, 2012, JCR-J CLIN RHEUMATOL, V18, P117, DOI 10.1097/RHU.0b013e3182500c95; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200	32	565	606	8	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					344	355		10.1016/j.immuni.2015.01.010	http://dx.doi.org/10.1016/j.immuni.2015.01.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680274	Green Accepted, Bronze			2022-12-18	WOS:000349916400017
J	Krug, A; French, AR; Barchet, W; Fischer, JAA; Dzionek, A; Pingel, JT; Orihuela, MM; Akira, S; Yokoyama, WM; Colonna, M				Krug, A; French, AR; Barchet, W; Fischer, JAA; Dzionek, A; Pingel, JT; Orihuela, MM; Akira, S; Yokoyama, WM; Colonna, M			TL-139-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; TOLL-LIKE RECEPTORS; MURINE CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELLS; SINGLE-STRANDED RNA; BACTERIAL CPG-DNA; IFN-ALPHA-BETA; CUTTING EDGE; T-CELLS	Natural interferon-producing cells (IPC) respond to viruses by secreting type I interferon (IFN) and interleukin-12 (IL-12). Toll-like receptor (TLR) 9 mediates IPC recognition of some of these viruses in vitro. However, whether TLR9-induced activation of IPC is necessary for an effective antiviral response in vivo is not clear. Here, we demonstrate that IPC and dendritic cells (DC) recognize murine cytomegalovirus (MCMV) through TLR9. TLR9-mediated cytokine secretion promotes viral clearance by NK cells that express the MCMV-specific receptor Ly49H. Although depletion of IPC leads to a drastic reduction of the IFN-alpha response, this allows other cell types to secrete IL-12, ensuring normal IFN-gamma and NK cell responses to MCMV. We conclude that the TLR9/MyD88 pathway mediates antiviral cytokine responses by IPC, DC, and possibly other cell types, which are coordinated to promote effective NK cell function and MCMV clearance.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Japan; Miltenyi Bioec, Bergisch Gladbach, Germany	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Osaka University; Miltenyi Biotec	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Akira, Shizuo/C-3134-2009	Krug, Anne/0000-0002-9556-7207; Colonna, Marco/0000-0001-5222-4987; Barchet, Winfried/0000-0002-6745-6606				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Alcami A, 2000, MOL MED TODAY, V6, P365, DOI 10.1016/S1357-4310(00)01775-5; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Andrews DM, 2001, J IMMUNOL, V166, P1796, DOI 10.4049/jimmunol.166.3.1796; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Facchetti F, 2003, VIRCHOWS ARCH, V443, P703, DOI 10.1007/s00428-003-0918-8; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ito T, 1999, J IMMUNOL, V163, P1409; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lundberg P, 2003, J VIROL, V77, P11158, DOI 10.1128/JVI.77.20.11158-11169.2003; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; RONNBLOM L, 1983, EUR J IMMUNOL, V13, P471, DOI 10.1002/eji.1830130608; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siegal FP, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200100005-00016; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Strobl H, 1998, J IMMUNOL, V161, P740; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tay CH, 1998, CURR TOP MICROBIOL, V230, P193; VOLLENWEIDER R, 1983, VIRCHOWS ARCH B, V44, P1, DOI 10.1007/BF02890155; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zheng M, 2002, P NATL ACAD SCI USA, V99, P8944, DOI 10.1073/pnas.132605599; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	83	565	595	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					107	119		10.1016/j.immuni.2004.06.007	http://dx.doi.org/10.1016/j.immuni.2004.06.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345224	Bronze			2022-12-18	WOS:000222975500012
J	Sadasivan, B; Lehner, PJ; Ortmann, B; Spies, T; Cresswell, P				Sadasivan, B; Lehner, PJ; Ortmann, B; Spies, T; Cresswell, P			Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP	IMMUNITY			English	Article							MUTANT-CELL LINE; HLA CLASS-I; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; CHAPERONE FUNCTION; BINDING PEPTIDE; SIGNAL SEQUENCE; QUALITY-CONTROL; T-CELL; CALNEXIN	Assembly of MHC class I-beta(2) microglobulin (beta(2)m) dimers in the endoplasmic reticulum involves two chaperones. Calnexin has previously been shown to interact with free class I heavy chains. Here, we show that the related chaperone, calreticulin, binds human class I-beta(2)m dimers prior to peptide loading. Calreticulin remains associated with at least a subset of class I molecules when they, in turn, bind to TAP. Further evidence suggests that the interaction of class I-beta(2)m dimers with TAP occurs via a novel uncharacterized 48 kDa glycoprotein, tapasin, which can bind independently to TAP and class I-beta(2)m-calreticulin complexes. Tapasin is absent from the mutant cell line .220, in which class I-TAP association and peptide loading is defective.	FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	Fred Hutchinson Cancer Center	Sadasivan, B (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.			Lehner, Paul Joseph/0000-0001-9383-1054				ANDERSON KS, 1993, J IMMUNOL, V151, P3407; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2782; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BUCHMEIER MJ, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142; CARRENO BM, 1995, J IMMUNOL, V155, P4726; CLICK EM, 1992, COLD SPRING HARB SYM, V57, P571, DOI 10.1101/SQB.1992.057.01.063; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HUCZKO EL, 1993, J IMMUNOL, V151, P2572; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; Neisig A, 1996, J IMMUNOL, V156, P3196; Noessner Elfriede, 1995, Journal of Experimental Medicine, V181, P327; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PARHAM P, 1979, J IMMUNOL, V123, P342; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; RADKA SF, 1982, J IMMUNOL, V128, P2804; Sadasivan BK, 1995, COLD SPRING HARB SYM, V60, P267, DOI 10.1101/SQB.1995.060.01.031; SCOTT JE, 1995, J IMMUNOL, V155, P143; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TECTOR M, 1995, J BIOL CHEM, V270, P19638, DOI 10.1074/jbc.270.33.19638; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Townsend A, 1993, Semin Cell Biol, V4, P53, DOI 10.1006/scel.1993.1007; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; WILLIAMS DB, 1995, CURR OPIN IMMUNOL, V7, P77, DOI 10.1016/0952-7915(95)80032-8; ZHANG Q, 1995, J BIOL CHEM, V270, P3944, DOI 10.1074/jbc.270.8.3944	48	565	575	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					103	114		10.1016/S1074-7613(00)80487-2	http://dx.doi.org/10.1016/S1074-7613(00)80487-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769474	hybrid			2022-12-18	WOS:A1996VE58900001
J	Itano, AA; McSorley, SJ; Reinhardt, RL; Ehst, BD; Ingulli, E; Rudensky, AY; Jenkins, MK				Itano, AA; McSorley, SJ; Reinhardt, RL; Ehst, BD; Ingulli, E; Rudensky, AY; Jenkins, MK			Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity	IMMUNITY			English	Article							LYMPH-NODES; IN-VIVO; CLONAL EXPANSION; LANGERHANS CELLS; LIFE-SPAN; PEPTIDE; SPLEEN; CD8(+); ACCUMULATION; TRANSPORT	Peptide: MHC II complexes derived from a fluorescent antigen were detected in vivo to identify the cells that present subcutaneously injected antigen to CD4 T cells. Skin-derived dendritic cells (DCs) that acquired the antigen while in the draining lymph nodes were the first cells to display peptide:MHC II complexes. Presentation by these cells induced CD69, IL-2 production, and maximal proliferation by the T cells. Later, DCs displaying peptide:MHC II complexes migrated from the injection site via a G protein-dependent mechanism. Presentation by these migrants sustained expression of the IL-2 receptor and promoted delayed type hypersensitivity. Therefore, presentation of peptide:MHC II complexes derived from a subcutaneous antigen occurs in two temporally distinct waves with different functional consequences.	Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Pediat, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Itano, AA (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA.	itano001@umn.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; McSorley, Stephen/0000-0002-6363-3222; Itano, Andrea/0000-0002-4766-6876				AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Ardavin C, 2001, TRENDS IMMUNOL, V22, P691, DOI 10.1016/S1471-4906(01)02059-2; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Balfour B M, 1974, Monogr Allergy, V8, P27; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dittel BN, 1999, J IMMUNOL, V163, P32; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; MACHER E, 1969, J EXP MED, V129, P103, DOI 10.1084/jem.129.1.103; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merica R, 2000, J IMMUNOL, V164, P4551, DOI 10.4049/jimmunol.164.9.4551; Muderspach L, 2000, CLIN CANCER RES, V6, P3406; MURPHY DB, 1992, J IMMUNOL, V148, P3483; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Picker Louis J., 1993, P145; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Randolph GJ, 2002, J EXP MED, V196, P413, DOI 10.1084/jem.20021240; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Ruedl C, 2001, J IMMUNOL, V166, P7178, DOI 10.4049/jimmunol.166.12.7178; Salomon B, 1998, J IMMUNOL, V160, P708; Sato K, 2001, INT IMMUNOL, V13, P167, DOI 10.1093/intimm/13.2.167; Sousa CRE, 1999, J IMMUNOL, V162, P6552; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; STEWART SJ, 1989, J CLIN INVEST, V83, P234, DOI 10.1172/JCI113865; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 1997, J IMMUNOL, V159, P565; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	55	564	575	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2003	19	1					47	57		10.1016/S1074-7613(03)00175-4	http://dx.doi.org/10.1016/S1074-7613(03)00175-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871638	Bronze			2022-12-18	WOS:000184260400007
J	YANG, YP; ERTL, HCJ; WILSON, JM				YANG, YP; ERTL, HCJ; WILSON, JM			MHC CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTES TO VIRAL-ANTIGENS DESTROY HEPATOCYTES IN MICE INFECTED WITH E1-DELETED RECOMBINANT ADENOVIRUSES	IMMUNITY			English	Article							CYSTIC-FIBROSIS; GENE-TRANSFER; DEFICIENT MICE; CELLS; HEPATITIS; VIRUS; EXPRESSION; INFLUENZA; CLEARANCE; EPITHELIA	The use of E1-deleted recombinant adenoviruses in gene therapy has consistently been associated with transient gene expression and inflammation due to immune-based destruction of the infected cells. We have used murine models of adenovirus-mediated gene transfer to liver to Investigate these immunologic mechanisms. Adoptive transfer experiments, as well as studies involving genetic knockout mice, confirmed the original hypothesis that cell-mediated immunity induced by E1-deleted adenovirus destroyed transgene-expressing hepatocytes and defined MHC class I-restricted CD8(+) cytolytic lymphocytes as the primary immune effecters for hepatocyte destruction. Responses mediated by CD4(+) cells per se were insufficient to mediate destruction of hepatocytes in vivo, despite the activation of virus-specific T helper cells of Th1 subsets. A better understanding of the response of the host to in vivo gene therapy is important in evaluating its usefulness in humans.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	The Wistar Institute	YANG, YP (corresponding author), UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104, USA.		Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Ertl, Hildegund/0000-0001-9795-5206				ALLAN W, 1990, J IMMUNOL, V144, P3980; ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; BERTOLETTI A, 1991, P NATL ACAD SCI USA, V88, P10445, DOI 10.1073/pnas.88.23.10445; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; DOHERTY PC, 1990, IMMUNOL TODAY, V11, P55; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; ENGELHARDT JF, 1993, HUM GENE THER, V4, P759, DOI 10.1089/hum.1993.4.6-759; ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196, DOI 10.1073/pnas.91.13.6196; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HORWITZ MS, 1990, VIROLOGY, P01679; HOU S, 1992, J IMMUNOL, V149, P1319; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KOZARSKY K, 1993, SOMAT CELL MOLEC GEN, V19, P449, DOI 10.1007/BF01233250; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; KOZARSKY KF, 1994, J BIOL CHEM, V269, P1; MORIYAMA T, 1990, SCIENCE, V248, P361, DOI 10.1126/science.1691527; QUINN DG, 1993, INT IMMUNOL, V5, P1193, DOI 10.1093/intimm/5.10.1193; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; WILSON JM, 1993, NATURE, V365, P691, DOI 10.1038/365691a0; XIANG ZQ, 1994, VIROLOGY, V199, P132, DOI 10.1006/viro.1994.1105; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1993, P NATL ACAD SCI USA, V90, P4601, DOI 10.1073/pnas.90.10.4601; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	33	564	577	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					433	442		10.1016/1074-7613(94)90074-4	http://dx.doi.org/10.1016/1074-7613(94)90074-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7533647				2022-12-18	WOS:A1994PK16800012
J	Townsend, MJ; Weinmann, AS; Matsuda, JL; Salomon, R; Farnham, PJ; Biron, CA; Gapin, L; Glimcher, LH				Townsend, MJ; Weinmann, AS; Matsuda, JL; Salomon, R; Farnham, PJ; Biron, CA; Gapin, L; Glimcher, LH			T-bet regulates the terminal maturation and homeostasis of NK and V alpha 14i NKT cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; RUNX1 BINDING-SITE; TRANSCRIPTION FACTOR; NKG2D IMMUNORECEPTOR; INTERFERON-GAMMA; DISTINCT ROLES; CUTTING EDGE; IN-VIVO; EXPRESSION	Natural killer (NK) and CD1d-restricted Valpha14i natural killer T (NKT) cells play a critical early role in host defense. Here we show that mice with a targeted deletion of T-bet, a T-box transcription factor required for Th1 cell differentiation, have a profound, stem cell-intrinsic defect in their ability to generate mature NK and Valpha14i NKT cells. Both cell types fail to complete normal terminal maturation and are present in decreased numbers in peripheral lymphoid organs of T-bet(-/-) mice. T-bet expression is regulated during NK cell differentiation by NK-activating receptors and cytokines known to control NK development and effector function. Our results identify T-bet as a key factor in the terminal maturation and peripheral homeostasis of NK and Valpha14i NKT cells.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Wisconsin, Sch Med, McArdle Lab Canc Res, Madison, WI 53706 USA; Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Brown University	Gapin, L (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA.	gapinl@njc.org; lglimche@hsph.harvard.edu		Townsend, Michael/0000-0003-0240-4562; Farnham, Peggy/0000-0003-4469-7914	NCI NIH HHS [R01 CA041268, CA41268, CA09681] Funding Source: Medline; NIAID NIH HHS [5 T32 AI00048, AI48126] Funding Source: Medline; NIGMS NIH HHS [GM20760] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009681, R01CA041268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI000048, R01AI048126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020760] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boggs SS, 1998, NAT IMMUN, V16, P137, DOI 10.1159/000069438; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Conlon FL, 2002, GENOME BIOL, V3; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Erlebacher A, 2002, P NATL ACAD SCI USA, V99, P16940, DOI 10.1073/pnas.222652199; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Gadue P, 2002, J IMMUNOL, V169, P2397, DOI 10.4049/jimmunol.169.5.2397; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lauwerys BR, 1999, CYTOKINE, V11, P822, DOI 10.1006/cyto.1999.0501; Lian RH, 2002, SEMIN IMMUNOL, V14, P453, DOI 10.1016/S1044532302000805; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lodolce J, 2002, MOL IMMUNOL, V39, P537, DOI 10.1016/S0161-5890(02)00211-0; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Minagawa M, 2002, J IMMUNOL, V169, P4153, DOI 10.4049/jimmunol.169.8.4153; Nakamura MC, 2000, J EXP MED, V192, P447, DOI 10.1084/jem.192.3.447; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ortaldo JR, 2003, J IMMUNOL, V170, P1763, DOI 10.4049/jimmunol.170.4.1763; Ortaldo JR, 2001, J IMMUNOL, V166, P4994, DOI 10.4049/jimmunol.166.8.4994; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Seaman WE, 2000, ARTHRITIS RHEUM-US, V43, P1204, DOI 10.1002/1529-0131(200006)43:6<1204::AID-ANR3>3.0.CO;2-I; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tay CH, 1999, J IMMUNOL, V162, P718; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Yin ZN, 2002, J IMMUNOL, V168, P1566, DOI 10.4049/jimmunol.168.4.1566; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; YOKOYAMA WM, 2003, ANNU REV IMMUNOL, V22, P703; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	80	563	579	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					477	494		10.1016/S1074-7613(04)00076-7	http://dx.doi.org/10.1016/S1074-7613(04)00076-7			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084276	Bronze			2022-12-18	WOS:000221442800013
J	Fukada, T; Hibi, M; Yamanaka, Y; TakahashiTezuka, M; Fujitani, Y; Yamaguchi, T; Nakajima, K; Hirano, T				Fukada, T; Hibi, M; Yamanaka, Y; TakahashiTezuka, M; Fujitani, Y; Yamaguchi, T; Nakajima, K; Hirano, T			Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TRANSDUCER GP130; TRANSCRIPTIONAL ACTIVATION; MOLECULAR-CLONING; GROWTH-FACTOR; BETA CHAIN; SH2 DOMAIN; C-MYC; INTERLEUKIN-6; KINASE	gp130 is a common signal transducer for the interleukin-6-related cytokines. To delineate the gp130-mediated growth signal, we established a series of pro-B cell lines expressing chimeric receptors composed of the extracellular domain of the granulocyte colony-stimulating factor receptor and the transmembrane and cytoplasmic domains of gp130. The second tyrosine (from the membrane) of gp130, which was required for the tyrosine phosphorylation of SHP-2, its association with GRB2, and activation of a MAP kinase, was essential for mitogenesis, but not for anti-apoptosis. On the other hand, the tyrosine in the YXXQ motifs essential for STAT3 activation was required for bcl-2 induction and anti-apoptosis. Furthermore, dominant-negative STAT3 inhibited anti-apoptosis. These data demonstrate that two distinct signals, mitogenesis and anti-apoptosis, are required for gp130-induced cell growth and that STAT3 is involved in anti-apoptosis.	OSAKA UNIV,SCH MED,BIOMED RES CTR,DEPT MOL ONCOL,SUITA,OSAKA 565,JAPAN	Osaka University			Hirano, Toshio/C-8194-2009; Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444; Yamanaka, Yojiro/0000-0003-1483-8691				Adachi M, 1996, CELL, V85, P15; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Ali S, 1996, EMBO J, V15, P135, DOI 10.1002/j.1460-2075.1996.tb00341.x; [Anonymous], 1989, Ann N Y Acad Sci, V557, P1; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; FUJITANI Y, 1994, BIOCHEM BIOPH RES CO, V202, P1181, DOI 10.1006/bbrc.1994.2053; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; HAEGEMAN G, 1986, EUR J BIOCHEM, V159, P625, DOI 10.1111/j.1432-1033.1986.tb09931.x; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIBI M, 1996, J MOL MED, V74, P11; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HIRANO T, 1994, STEM CELLS, V12, P262, DOI 10.1002/stem.5530120303; HIRANO T, 1994, CYTOKINE HDB, P145; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KUMAR G, 1994, J IMMUNOL, V153, P4436; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MATSUDA T, 1994, BIOCHEM BIOPH RES CO, V200, P821, DOI 10.1006/bbrc.1994.1525; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nakajima K, 1995, ANN NY ACAD SCI, V762, P55; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SHEN SH, 1991, NATURE, V353, P868, DOI 10.1038/353868b0; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHIBUYA H, 1992, CELL, V70, P57, DOI 10.1016/0092-8674(92)90533-I; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YIN TG, 1993, J IMMUNOL, V151, P2555; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; ZILBERSTEIN A, 1986, EMBO J, V5, P2529, DOI 10.1002/j.1460-2075.1986.tb04531.x	72	563	586	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					449	460		10.1016/S1074-7613(00)80501-4	http://dx.doi.org/10.1016/S1074-7613(00)80501-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934572	Bronze			2022-12-18	WOS:A1996VV65800006
J	Delovitch, TL; Singh, B				Delovitch, TL; Singh, B			The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD	IMMUNITY			English	Review							GLUTAMIC-ACID DECARBOXYLASE; NK1.1(+) T-CELLS; ANTIGEN-PRESENTING CELLS; PROLIFERATIVE UNRESPONSIVENESS; ADOPTIVE TRANSFER; GENETIC-ANALYSIS; SELF-TOLERANCE; ALPHA-CHAIN; BETA-CHAIN; MICE		Univ Western Ontario, John P Robarts Res Inst, Dept Microbiol & Immunol, Autoimmun Diabet Grp, London N6G 2V4, England; Univ Western Ontario, Dept Med, London N6G 2V4, England		Delovitch, TL (corresponding author), Univ Western Ontario, John P Robarts Res Inst, Dept Microbiol & Immunol, Autoimmun Diabet Grp, London N6G 2V4, England.	del@rri.on.ca	Singh, Bhagirath/C-4010-2013	Singh, Bhagirath/0000-0002-9792-8694				AKHTAR I, 1995, J EXP MED, V182, P87, DOI 10.1084/jem.182.1.87; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Arreaza GA, 1997, J CLIN INVEST, V100, P2243, DOI 10.1172/JCI119762; ARREAZA GA, 1996, CLIN IMMUNOTHER, V4, P251; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Atkinson MA, 1997, RES IMMUNOL, V148, P301, DOI 10.1016/S0923-2494(97)87238-0; ATKINSON MA, 1994, J CLIN INVEST, V94, P2125, DOI 10.1172/JCI117567; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 1997, RES IMMUNOL, V148, P332, DOI 10.1016/S0923-2494(97)87243-4; Bach JF, 1997, RES IMMUNOL, V148, P285, DOI 10.1016/S0923-2494(97)87235-5; BAXTER AG, 1989, DIABETES, V38, P1296, DOI 10.2337/diabetes.38.10.1296; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bergerot I, 1997, RES IMMUNOL, V148, P348, DOI 10.1016/S0923-2494(97)87245-8; BERGEROT I, 1994, J AUTOIMMUN, V7, P65; BERMAN MA, 1996, J IMMUNOL, V157, P4691; BOITARD C, 1989, J EXP MED, V169, P1669, DOI 10.1084/jem.169.5.1669; BOWMAN MA, 1994, IMMUNOL TODAY, V15, P115, DOI 10.1016/0167-5699(94)90154-6; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Buckner J, 1996, J IMMUNOL, V157, P4940; BURTLES SS, 1992, J IMMUNOL, V149, P2185; Cameron MJ, 1997, J IMMUNOL, V159, P4686; CAMERON MJ, 1997, IN PRESS CRIT REV IM; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; CarrascoMarin E, 1997, RES IMMUNOL, V148, P291, DOI 10.1016/S0923-2494(97)87237-9; CHARLTON B, 1989, DIABETES, V38, P441, DOI 10.2337/diabetes.38.4.441; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; CHOSICH N, 1993, DIABETOLOGIA, V36, P716, DOI 10.1007/BF00401141; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Cohen IR, 1997, RES IMMUNOL, V148, P286, DOI 10.1016/S0923-2494(97)87236-7; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; Conrad B, 1997, CELL, V90, P303, DOI 10.1016/S0092-8674(00)80338-4; Cope A, 1997, RES IMMUNOL, V148, P307, DOI 10.1016/S0923-2494(97)87239-2; COPE AP, 1997, IN PRESS J EXP MED; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; ELIAS D, 1995, EUR J IMMUNOL, V25, P2851, DOI 10.1002/eji.1830251021; ELIAS D, 1997, IN PRESS DIABETES, V46; ELLIOTT JF, 1994, DIABETES, V43, P1494, DOI 10.2337/diabetes.43.12.1494; FORREST JM, 1971, LANCET, V2, P332; Fox CJ, 1997, J IMMUNOL, V158, P2414; GALLEY KA, 1995, J IMMUNOL, V154, P2969; GAMBLE DR, 1973, BRIT MED J, V4, P260, DOI 10.1136/bmj.4.5887.260; GASKINS HR, 1992, J CLIN INVEST, V90, P2220, DOI 10.1172/JCI116107; GAZDA LM, 1997, IN PRESS J AUTOIMMUN, V10; GILL BM, 1995, DIABETES, V44, P614, DOI 10.2337/diabetes.44.6.614; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gombert JM, 1996, INT IMMUNOL, V8, P1751, DOI 10.1093/intimm/8.11.1751; Graves PM, 1997, DIABETES, V46, P161, DOI 10.2337/diabetes.46.2.161; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P538; Harrison LC, 1997, J EXP MED, V185, P1013, DOI 10.1084/jem.185.6.1013; Harrison LC, 1996, J EXP MED, V184, P2167, DOI 10.1084/jem.184.6.2167; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; HUTCHINGS PR, 1990, J AUTOIMMUN, V3, P175, DOI 10.1016/0896-8411(90)90139-J; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KAY TW, 1997, RES IMMUNOL, V148, P327; Kay TWH, 1996, J IMMUNOL, V157, P3688; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Komagata Y, 1996, INT IMMUNOL, V8, P807, DOI 10.1093/intimm/8.6.807; Lafferty KJ, 1997, RES IMMUNOL, V148, P313, DOI 10.1016/S0923-2494(97)87240-9; LARGER E, 1995, J EXP MED, V181, P1635, DOI 10.1084/jem.181.5.1635; Leiter Edward H., 1992, Regional Immunology, V4, P263; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; MAEDA T, 1991, DIABETES, V40, P1580, DOI 10.2337/diabetes.40.12.1580; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Mieza MA, 1996, J IMMUNOL, V156, P4035; MILICH DR, 1989, J IMMUNOL, V143, P3148; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; MUIR A, 1995, J CLIN INVEST, V95, P628, DOI 10.1172/JCI117707; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; NISTIC L, 1996, HUM MOL GENET, V7, P1075; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; NOTKINS AL, 1984, CONCEPTS VIRAL PATHO, P210; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; OLDSTONE MBA, 1997, IN PRESS SCAND J IMM; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; PILSTROM B, 1995, CYTOKINE, V7, P806, DOI 10.1006/cyto.1995.0097; PLOIX C, 1997, IN PRESS DIABETES, V46; QIN HY, 1993, J IMMUNOL, V150, P2072; RABINOVITCH A, 1994, DIABETES, V43, P613, DOI 10.2337/diabetes.43.5.613; RAPOPORT MJ, 1993, J EXP MED, V177, P1221, DOI 10.1084/jem.177.4.1221; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; REICH EP, 1994, J IMMUNOL, V152, P2279; Reizis B, 1997, INT IMMUNOL, V9, P43, DOI 10.1093/intimm/9.1.43; Ridgway WM, 1996, J EXP MED, V183, P1657, DOI 10.1084/jem.183.4.1657; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; ROHANE PW, 1995, DIABETES, V44, P550, DOI 10.2337/diabetes.44.5.550; Sakaguchi S, 1996, J AUTOIMMUN, V9, P211, DOI 10.1006/jaut.1996.0026; Salojin K, 1997, J EXP MED, V186, P887, DOI 10.1084/jem.186.6.887; SALOJIN K, 1997, IN PRESS IMMUNOL TOD, V19; SANTAMARIA P, 1995, J IMMUNOL, V154, P2494; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; SEMPE P, 1994, DIABETOLOGIA, V37, P337, DOI 10.1007/BF00408468; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SERREZE DV, 1994, CURR OPIN IMMUNOL, V6, P900, DOI 10.1016/0952-7915(94)90011-6; SERREZE DV, 1993, FASEB J, V7, P1092, DOI 10.1096/fasebj.7.11.8370480; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; SERREZE DV, 1988, J IMMUNOL, V140, P3801; SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625; SERREZE DV, 1993, J IMMUNOL, V150, P2534; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Shimada A, 1996, DIABETES, V45, P71, DOI 10.2337/diabetes.45.1.71; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; SINGH B, 1998, IN PRESS SEMIN IMMUN; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; TAKEDA K, 1993, J EXP MED, V177, P155, DOI 10.1084/jem.177.1.155; Tan KN, 1996, INT IMMUNOL, V8, P689, DOI 10.1093/intimm/8.5.689; Taub DD, 1996, J IMMUNOL, V156, P2095; TIAN J, 1994, J EXP MED, V180, P1979, DOI 10.1084/jem.180.5.1979; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Tivol EA, 1996, CURR OPIN IMMUNOL, V8, P822, DOI 10.1016/S0952-7915(96)80011-2; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Todd JA, 1996, HUM MOL GENET, V5, P1443, DOI 10.1093/hmg/5.Supplement_1.1443; TOYODA H, 1992, IMMUNOL LETT, V32, P241, DOI 10.1016/0165-2478(92)90056-T; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; Vicari AP, 1996, INT IMMUNOL, V8, P1759, DOI 10.1093/intimm/8.11.1759; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; vonHerrath MG, 1996, CURR OPIN IMMUNOL, V8, P878, DOI 10.1016/S0952-7915(96)80019-7; vonHerrath MG, 1997, J EXP MED, V185, P531, DOI 10.1084/jem.185.3.531; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WATERS SH, 1992, DIABETES, V41, P308, DOI 10.2337/diabetes.41.3.308; WECKERLE HM, 1996, IMMUNOL REV, V149, P231; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; WICKER LS, 1986, DIABETES, V35, P855, DOI 10.2337/diabetes.35.8.855; Wicker LS, 1997, J EXP MED, V186, P973, DOI 10.1084/jem.186.7.973; WILSON SB, 1997, IN PRESS NATURE; Wong FS, 1997, RES IMMUNOL, V148, P327, DOI 10.1016/S0923-2494(97)87242-2; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; YANG Y, 1996, CELL, V4, P189; Zechel MA, 1997, RES IMMUNOL, V148, P338, DOI 10.1016/S0923-2494(97)87244-6; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252; ZHANG ZL, 1994, AUTOIMMUNITY, V17, P41, DOI 10.3109/08916939409014657; ZIPRIS D, 1991, DIABETES, V40, P429, DOI 10.2337/diabetes.40.4.429; ZIPRIS D, 1991, J IMMUNOL, V146, P3763	155	561	582	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1997	7	6					727	738		10.1016/S1074-7613(00)80392-1	http://dx.doi.org/10.1016/S1074-7613(00)80392-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430219	Bronze			2022-12-18	WOS:000071351300001
J	Schlitzer, A; McGovern, N; Teo, P; Zelante, T; Atarashi, K; Low, D; Ho, AWS; See, P; Shin, A; Wasan, PS; Hoeffel, G; Malleret, B; Heiseke, A; Chew, S; Jardine, L; Purvis, HA; Hilkens, CMU; Tam, J; Poidinger, M; Stanley, ER; Krug, AB; Renia, L; Sivasankar, B; Ng, LG; Collin, M; Ricciardi-Castagnoli, P; Honda, K; Haniffa, M; Ginhoux, F				Schlitzer, Andreas; McGovern, Naomi; Teo, Pearline; Zelante, Teresa; Atarashi, Koji; Low, Donovan; Ho, Adrian W. S.; See, Peter; Shin, Amanda; Wasan, Pavandip Singh; Hoeffel, Guillaume; Malleret, Benoit; Heiseke, Alexander; Chew, Samantha; Jardine, Laura; Purvis, Harriet A.; Hilkens, Catharien M. U.; Tam, John; Poidinger, Michael; Stanley, E. Richard; Krug, Anne B.; Renia, Laurent; Sivasankar, Baalasubramanian; Lai Guan Ng; Collin, Matthew; Ricciardi-Castagnoli, Paola; Honda, Kenya; Haniffa, Muzlifah; Ginhoux, Florent			IRF4 Transcription Factor- Dependent CD11b(+) Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses	IMMUNITY			English	Article							REGULATORY FACTOR-4; SIGNALING CONTROLS; STEADY-STATE; EXPRESSION; DIFFERENTIATION; TH17; HOMEOSTASIS; PHENOTYPE; IMMUNITY; PROMOTES	Mouse and human dendritic cells (DCs) are composed of functionally specialized subsets, but precise inter-species correlation is currently incomplete. Here, we showed that murine lung and gut lamina propria CD11b(+) DC populations were comprised of two subsets: FLT3- and IRF4-dependent CD24(+)CD64(-) DCs and contaminating CSF-1R-dependent CD24(-)CD64(+) macrophages. Functionally, loss of CD24(+)CD11b(+) DCs abrogated CD4(+) T cell-mediated interleukin-17 (IL-17) production in steady state and after Aspergillus fumigatus challenge. Human CD1c(+) DCs, the equivalent of murine CD24(+)CD11b(+) DCs, also expressed IRF4, secreted IL-23, and promoted T helper 17 cell responses. Our data revealed heterogeneity in the mouse CD11b(+) DC compartment and identifed mucosal tissues IRF4-expressing DCs specialized in instructing IL-17 responses in both mouse and human. The demonstration of mouse and human DC subsets specialized in driving IL-17 responses high-lights the conservation of key immune functions across species and will facilitate the translation of mouse in vivo findings to advance DC-based clinical therapies.	[Schlitzer, Andreas; Teo, Pearline; Zelante, Teresa; Low, Donovan; Ho, Adrian W. S.; See, Peter; Shin, Amanda; Wasan, Pavandip Singh; Hoeffel, Guillaume; Malleret, Benoit; Chew, Samantha; Poidinger, Michael; Renia, Laurent; Lai Guan Ng; Ricciardi-Castagnoli, Paola; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [McGovern, Naomi; Jardine, Laura; Purvis, Harriet A.; Hilkens, Catharien M. U.; Collin, Matthew; Haniffa, Muzlifah] Newcastle Univ, Inst Celular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Atarashi, Koji; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Heiseke, Alexander; Krug, Anne B.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany; [Tam, John] Natl Univ Singapore Hosp, Singapore 119074, Singapore; [Tam, John] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119077, Singapore; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Sivasankar, Baalasubramanian] ASTAR, Singapore Inst Clin Sci, Singapore 529825, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Newcastle University - UK; University of Tokyo; Technical University of Munich; National University of Singapore; National University of Singapore; Yeshiva University; Albert Einstein College of Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Hoeffel, Guillaume/ABG-4881-2021; Tam, John/B-6048-2012; Schlitzer, Andreas/R-2237-2016; Malleret, Benoit/E-9159-2011; Stanley, Evan R/J-9154-2013; Ng, Lai Guan/N-6980-2019; Ng, Lai Guan/E-5673-2011; Renia, Laurent/E-2117-2011; Honda, Kenya/N-5297-2015; zelante, teresa/F-7933-2017; Atarashi, Koji/I-5363-2014	Hoeffel, Guillaume/0000-0002-2534-4972; Schlitzer, Andreas/0000-0001-7662-3712; Malleret, Benoit/0000-0001-9658-7528; Stanley, Evan R/0000-0002-2910-2065; Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Renia, Laurent/0000-0003-0349-1557; zelante, teresa/0000-0002-7071-0302; Atarashi, Koji/0000-0001-5422-0736; McGovern, Naomi/0000-0001-5200-2698; See, Peter/0000-0003-4428-7763; Poidinger, Michael/0000-0002-1047-2277; Teo, Pearline/0000-0002-8283-6308; Ho, Adrian/0000-0002-6501-5196; Krug, Anne/0000-0002-9556-7207; Hilkens, Catharien/0000-0003-2283-8886	Wellcome Trust, UK [WT088555MA]; Singapore Immunology Network core grant; Histiocytosis Association and Histiocytosis Research Trust; National Institutes of Health [CA26504]; JGW Patterson Foundation; NATIONAL CANCER INSTITUTE [R01CA026504, R37CA026504] Funding Source: NIH RePORTER; Versus Arthritis [20218] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); Singapore Immunology Network core grant; Histiocytosis Association and Histiocytosis Research Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JGW Patterson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Versus Arthritis(Versus Arthritis)	This work was supported by The Wellcome Trust, UK (WT088555MA; M. H. and N.M.); Singapore Immunology Network core grant (F. G., P. R.-C., L.G.N. and L. R.); Histiocytosis Association and Histiocytosis Research Trust (M. C.), by the National Institutes of Health grant (CA26504; E. R. S.), and by JGW Patterson Foundation (H. A. P. and C. M. U. H.). We thank R. Basu for technical assistance; L. Robinson for critical review and editing of the manuscript; M. L. Ng, S. H. Tan, and T. B. Lu from the Electron Microscopy Unit of the National University of Singapore; S. Pettersson of the Singapore General Hospital and I. Dimmick and D. McDonald at the Flow Cytometry Core Facility of the Faculty of Medicine Newcastle University; A. Larbi, I. Low, and N. Binte Shadan at the Flow Cytometry Core Service; J. Connolly and K. Ng at the Immunomonitoring platform, J. Lum and F. Zolezzi at the Functional Genomics Laboratory of SIgN; S. Stamenkovic and S. Barnard from the Freeman Hospital Cardothoracic Unit; J. Majo, N. Thampy, and F. Black from the Royal Victoria Infirmary Department of Cellular Pathology at Newcastle upon Tyne.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dillon SM, 2010, J IMMUNOL, V184, P6612, DOI 10.4049/jimmunol.1000041; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moreira AP, 2011, J CLIN INVEST, V121, P4420, DOI 10.1172/JCI44999; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sallusto F, 2012, EUR J IMMUNOL, V42, P2215, DOI 10.1002/eji.201242741; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Zeng R, 2013, MUCOSAL IMMUNOL, V6, P847, DOI 10.1038/mi.2012.123; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	51	560	574	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					970	983		10.1016/j.immuni.2013.04.011	http://dx.doi.org/10.1016/j.immuni.2013.04.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706669	Green Published, hybrid			2022-12-18	WOS:000330942500015
J	Hu, XY; Ivashkiv, LB				Hu, Xiaoyu; Ivashkiv, Lionel B.			Cross-regulation of Signaling Pathways by Interferon-gamma: Implications for Immune Responses and Autoimmune Diseases	IMMUNITY			English	Review							COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTOR; RECEPTOR-DEFICIENT MICE; NECROSIS-FACTOR-ALPHA; GENE-SPECIFIC CONTROL; TOLL-LIKE RECEPTOR; NF-KAPPA-B; IFN-GAMMA; T-CELLS; MACROPHAGE ACTIVATION	Interferon-gamma (IFN-gamma) is an important mediator of immunity and inflammation that utilizes the JAK-STAT signaling pathway to activate the STAT1 transcription factor. Many functions of IFN-gamma have been ascribed to direct STAT1-mediated induction of immune effector genes, but recently it has become clear that key IFN-gamma functions are mediated by cross-regulation of cellular responses to other cytokines and inflammatory factors. Here, we review mechanisms by which IFN-gamma and STAT1 regulate signaling by Toll-like receptors, inflammatory factors, tissue-destructive cytokines, anti-inflammatory cytokines, and cytokines that activate opposing STATs. These signaling mechanisms reveal insights about how IFN-gamma regulates macrophage activation, inflammation, tissue remodeling, and helper and regulatory T cell differentiation and how Th1 and Th17 cell responses are integrated in autoimmune diseases.	[Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Hu, Xiaoyu; Ivashkiv, Lionel B.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA	Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998	American College of Rheumatology; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938, R01AI046712, R01AI059636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420] Funding Source: NIH RePORTER	American College of Rheumatology(General Electric); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	X.H. is supported by a Within Our Reach rheumatoid arthritis research grant from the American College of Rheumatology, and L.B.I. is supported by grants from the National Institutes of Health.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Aliprantis AO, 2007, P NATL ACAD SCI USA, V104, P2827, DOI 10.1073/pnas.0700021104; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; BACCARINI M, 1992, J IMMUNOL, V149, P2656; Barnes MJ, 2009, NAT IMMUNOL, V10, P563, DOI 10.1038/ni0609-563; Barrios-Rodiles M, 1998, J IMMUNOL, V161, P2441; BOISSIER MC, 1995, EUR J IMMUNOL, V25, P1184, DOI 10.1002/eji.1830250508; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; BROWNING JL, 1987, J IMMUNOL, V138, P2857; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Ferber IA, 1996, J IMMUNOL, V156, P5; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finnegan A, 2002, J IMMUNOL, V169, P3345, DOI 10.4049/jimmunol.169.6.3345; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; Ghosh S, 2006, GUT, V55, P1071, DOI 10.1136/gut.2005.090134; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gough DJ, 2007, J BIOL CHEM, V282, P938, DOI 10.1074/jbc.M607674200; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Guedez YB, 2001, ARTHRITIS RHEUM, V44, P2413, DOI 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hu XY, 2005, J IMMUNOL, V175, P3637, DOI 10.4049/jimmunol.175.6.3637; Hu XY, 2005, J IMMUNOL, V175, P131, DOI 10.4049/jimmunol.175.1.131; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; INABA T, 1995, J CLIN INVEST, V95, P1133, DOI 10.1172/JCI117761; Irmler IM, 2007, J IMMUNOL, V179, P6228, DOI 10.4049/jimmunol.179.9.6228; Ivanov K, 2001, INFORM SYST FRONT, V3, P7, DOI 10.1023/A:1011437302136; Kelchtermans H, 2005, ARTHRITIS RES THER, V7, pR402, DOI 10.1186/ar1500; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kelchtermans H, 2007, J LEUKOCYTE BIOL, V81, P1044, DOI 10.1189/jlb.0806486; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lauw FN, 2000, J IMMUNOL, V165, P2783, DOI 10.4049/jimmunol.165.5.2783; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Losman JA, 1999, J IMMUNOL, V162, P3770; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Ma ZD, 2005, J LEUKOCYTE BIOL, V78, P515, DOI 10.1189/jlb.0205112; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matthys P, 1999, J IMMUNOL, V163, P3503; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Nishibori T, 2004, J EXP MED, V199, P25, DOI 10.1084/jem.20020509; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Pajkrt D, 1997, J IMMUNOL, V158, P3971; PANITCH HS, 1987, LANCET, V1, P893; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; RADZIOCH D, 1991, MOL CELL BIOL, V11, P2718, DOI 10.1128/MCB.11.5.2718; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; So EY, 2000, J IMMUNOL, V165, P5472, DOI 10.4049/jimmunol.165.10.5472; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; TAKAHASHI N, 1986, J IMMUNOL, V137, P3544; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, IMMUNOL REV, V208, P181, DOI 10.1111/j.0105-2896.2005.00337.x; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Vermeire K, 1997, J IMMUNOL, V158, P5507; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Wu HJ, 2007, J EXP MED, V204, P1911, DOI 10.1084/jem.20070285; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou M, 2003, J BIOL CHEM, V278, P45406, DOI 10.1074/jbc.M309075200; Zimmerer JM, 2007, J IMMUNOL, V178, P4832, DOI 10.4049/jimmunol.178.8.4832	120	560	572	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					539	550		10.1016/j.immuni.2009.09.002	http://dx.doi.org/10.1016/j.immuni.2009.09.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833085	Bronze, Green Accepted			2022-12-18	WOS:000271403900006
J	Galon, J; Angell, HK; Bedognetti, D; Marincola, FM				Galon, Jerome; Angell, Helen K.; Bedognetti, Davide; Marincola, Francesco M.			The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures	IMMUNITY			English	Review							TUMOR-INFILTRATING LYMPHOCYTES; GENE-EXPRESSION; MELANOMA METASTASES; COLORECTAL-CANCER; IMMUNE CELLS; IMMUNOLOGICAL CONSTANT; MONOCLONAL-ANTIBODIES; ALLOGRAFT-REJECTION; CLINICAL ACTIVITY; CHEMOKINE SYSTEM	Numerous analyses of large patient cohorts identified specific patterns of immune activation associated with patient survival. We established these as the immune contexture, encompassing the type, functional orientation, density, and location of adaptive immune cells within distinct tumor regions. Based on the immune contexture, a standardized, powerful immune stratification system, the Immunoscore, was delineated. The immune contexture is characterized by immune signatures also observed in association with the broader phenomenon of immune-mediated, tissue-specific destruction. We defined these as the immunologic constant of rejection. Predictive, prognostic, and mechanistic immune signatures overlap, and a continuum of intratumor immune reactions exists. The balance between tumor cell growth and elimination may be tipped upon a crescendo induced by immune manipulations aimed at enhancing naturally occurring immunosurveillance. Here, we propose a broader immunological interpretation of these three concepts-immune contexture, Immunoscore, and immunologic constant of rejection-that segregates oncogenic processes independently of their tissue origin.	[Galon, Jerome; Angell, Helen K.] INSERM, Lab Integrat Canc Immunol, U872, F-75006 Paris, France; [Galon, Jerome; Angell, Helen K.] Univ Paris 05, F-75006 Paris, France; [Galon, Jerome; Angell, Helen K.] Univ Paris 06, Ctr Rech Cordeliers, F-75006 Paris, France; [Bedognetti, Davide; Marincola, Francesco M.] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Bedognetti, Davide; Marincola, Francesco M.] NIH, Trans NIH Ctr Human Immunol, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Res Branch, Doha, Qatar	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; Sidra Medical & Research Center	Galon, J (corresponding author), INSERM, Lab Integrat Canc Immunol, U872, F-75006 Paris, France.	jerome.galon@crc.jussieu.fr; fmarincola@sidra.org	Galon, Jerome/G-9838-2019; Bedognetti, Davide/GLQ-9410-2022; Bedognetti, Davide/ADI-1011-2022	Galon, Jerome/0000-0001-9635-1339; Bedognetti, Davide/0000-0002-5857-773X	Institut National du Cancer (INCa); INSERM; MedImmune; Qatar National Research Fund under its National Priorities Research Program [NPRP09-1174-3-291]; European Commission (7FP, Geninca Consortium) [202230]; Cancer Research for Personalized Medicine (CARPEM); Canceropole Ile-de-France; Paris Alliance of Cancer Research Institutes (PACRI); LabEx Immuno-Oncology; Intramural Research Program of the National Institutes of Health; Conquer Cancer Foundation of the American Society of Clinical Oncology	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MedImmune(AstraZenecaMedimmune); Qatar National Research Fund under its National Priorities Research Program(Qatar National Research Fund (QNRF)); European Commission (7FP, Geninca Consortium); Cancer Research for Personalized Medicine (CARPEM); Canceropole Ile-de-France(Region Ile-de-France); Paris Alliance of Cancer Research Institutes (PACRI); LabEx Immuno-Oncology; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conquer Cancer Foundation of the American Society of Clinical Oncology	We acknowledge all the scientists who made contributions to the area of research reviewed here that were not cited due to space constraints. J.G. and H. A. thank the members of the Laboratory of Integrative Cancer Immunology for their invaluable contribution. The work performed in the Laboratory of Integrative Cancer Immunology was supported by grants from the Institut National du Cancer (INCa), INSERM, MedImmune, the Qatar National Research Fund under its National Priorities Research Program award number NPRP09-1174-3-291, the European Commission (7FP, Geninca Consortium, grant 202230), Cancer Research for Personalized Medicine (CARPEM), Canceropole Ile-de-France, the Paris Alliance of Cancer Research Institutes (PACRI), and the LabEx Immuno-Oncology. D. B. and F. M. M thank Ena Wang (Infectious Diseases and Immunogenetics Section) for her outstanding contribution in the field. The work performed in the Infectious Diseases and Immunogenetics Section was supported by the Intramural Research Program of the National Institutes of Health. D.B.'s research was supported by the Conquer Cancer Foundation of the American Society of Clinical Oncology (2011 Young Investigator Award).	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Ajuebor MN, 2006, J IMMUNOL, V177, P2039, DOI 10.4049/jimmunol.177.4.2039; Angel H, 2013, CURR OPIN IMMUNOL, V25, P261, DOI 10.1016/j.coi.2013.03.004; Ascierto ML, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-145; Ascierto ML, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-146; Ascierto ML, 2012, BREAST CANCER RES TR, V131, P871, DOI 10.1007/s10549-011-1470-x; Ascierto PA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-115; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bedognetti D, 2010, EXPERT REV VACCINES, V9, P555, DOI [10.1586/erv.10.55, 10.1586/ERV.10.55]; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bindea G, 2010, CURR OPIN IMMUNOL, V22, P215, DOI 10.1016/j.coi.2010.02.006; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Broussard EK, 2011, J CLIN ONCOL, V29, P601, DOI 10.1200/JCO.2010.32.9078; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Carretero R, 2012, INT J CANCER, V131, P387, DOI 10.1002/ijc.26471; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Castiello L, 2011, CANCER IMMUNOL IMMUN, V60, P457, DOI 10.1007/s00262-010-0954-6; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coley WB, 1893, AM J MED SCI, V105, P487, DOI [DOI 10.1097/00000441-189305000-00001, 10.1097/00000441-189305000-00001]; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Costa C, 2008, CHEST, V133, P26, DOI 10.1378/chest.07-0393; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Florholmen J, 2011, CLIN MICROBIOL INFEC, V17, P204, DOI 10.1111/j.1469-0691.2010.03206.x; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P306, DOI 10.4161/onci.19549; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P28, DOI 10.4161/onci.1.1.17938; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2007, CANCER RES, V67, P1883, DOI 10.1158/0008-5472.CAN-06-4806; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; Gorer PA, 1942, J PATHOL BACTERIOL, V54, P51, DOI 10.1002/path.1700540107; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ignatiadis M, 2012, J CLIN ONCOL, V30, P1996, DOI 10.1200/JCO.2011.39.5624; Imanguli MM, 2009, BLOOD, V113, P3620, DOI 10.1182/blood-2008-07-168351; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jiang Z, 2010, MOL BIOL REP, V37, P3029, DOI 10.1007/s11033-009-9873-z; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kim HS, 2013, CELL, V152, P387, DOI 10.1016/j.cell.2013.01.027; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lake RA, 2006, NEW ENGL J MED, V354, P2503, DOI 10.1056/NEJMcibr061443; Leffers N, 2010, BRIT J CANCER, V103, P685, DOI 10.1038/sj.bjc.6605820; Lesinski GB, 2007, CLIN CANCER RES, V13, P5010, DOI 10.1158/1078-0432.CCR-06-3092; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Marincola FM, 2011, J INTERN MED, V270, P123, DOI 10.1111/j.1365-2796.2011.02402.x; Medawar PB, 1944, J ANAT, V78, P176; Melero I, 2013, CLIN CANCER RES, V19, P997, DOI 10.1158/1078-0432.CCR-12-2214; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Mlecnik B, 2011, CANCER METAST REV, V30, P5, DOI 10.1007/s10555-011-9270-7; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Monsurro V, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-10; Moran CJ, 2002, CLIN CANCER RES, V8, P3803; Morris M, 2008, CLIN CANCER RES, V14, P1413, DOI 10.1158/1078-0432.CCR-07-1994; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Mueller TF, 2007, AM J TRANSPLANT, V7, P2712, DOI 10.1111/j.1600-6143.2007.02005.x; Murtas D, 2013, BRIT J CANCER, V109, P76, DOI 10.1038/bjc.2013.335; Muthuswamy R, 2012, CANCER RES, V72, P3735, DOI 10.1158/0008-5472.CAN-11-4136; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagtegaal ID, 2012, NAT REV CLIN ONCOL, V9, P119, DOI 10.1038/nrclinonc.2011.157; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Panelli MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r8; Panelli MC, 2002, GENOME BIOL, V3; PREHN RT, 1957, J NATL CANCER I, V18, P769; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ribas A, 2013, CURR OPIN IMMUNOL, V25, P291, DOI 10.1016/j.coi.2013.02.011; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rotondi M, 2011, CURR PHARM DESIGN, V17, P3202, DOI 10.2174/138161211798157559; Saint-Mezard P, 2009, TRANSPL INT, V22, P293, DOI 10.1111/j.1432-2277.2008.00790.x; SALK J, 1969, ANN NY ACAD SCI, V164, P365, DOI 10.1111/j.1749-6632.1969.tb14051.x; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Senovilla L, 2012, ONCOIMMUNOLOGY, V1, P1323, DOI 10.4161/onci.22009; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma A, 2012, DRUGS, V72, P2207, DOI 10.2165/11640870-000000000-00000; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Spivey TL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-156; Spivey TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-174; Stutman O, 1975, Adv Cancer Res, V22, P261; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; Terme M, 2013, CANCER RES, V73, P539, DOI 10.1158/0008-5472.CAN-12-2325; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; THOMAS L, 1982, YALE J BIOL MED, V55, P329; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Uccellini L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-170; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P1557, DOI 10.4161/onci.22428; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P179, DOI 10.4161/onci.1.2.19026; van den Boorn JG, 2013, IMMUNITY, V39, P27, DOI 10.1016/j.immuni.2013.07.011; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANPEL A, 1983, J EXP MED, V157, P1992, DOI 10.1084/jem.157.6.1992; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wang E, 2002, CANCER RES, V62, P3581; Wang E, 2008, TRENDS IMMUNOL, V29, P256, DOI 10.1016/j.it.2008.03.002; Wang E, 2013, J CLIN ONCOL, V31, P2369, DOI 10.1200/JCO.2013.49.2157; Wang E, 2013, ANN NY ACAD SCI, V1284, P75, DOI 10.1111/nyas.12063; Wang E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040805; Weiss GR, 2011, CLIN CANCER RES, V17, P7440, DOI 10.1158/1078-0432.CCR-11-1650; Wittekind C, 2002, CANCER-AM CANCER SOC, V94, P2511, DOI 10.1002/cncr.10492.abs; Yoshida S, 2012, SCAND J RHEUMATOL, V41, P170, DOI 10.3109/03009742.2011.623137; Zeimet AG, 2009, INT J CANCER, V124, P2353, DOI 10.1002/ijc.24214; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	145	559	586	5	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					11	26		10.1016/j.immuni.2013.07.008	http://dx.doi.org/10.1016/j.immuni.2013.07.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890060	Bronze			2022-12-18	WOS:000330948300002
J	Tang, Q; Adams, JY; Penaranda, C; Melli, K; Piaggio, E; Sgouroudis, E; Piccirillo, CA; Salomon, BL; Bluestone, JA				Tang, Qizhi; Adams, Jason Y.; Penaranda, Cristina; Melli, Kristin; Piaggio, Eliane; Sgouroudis, Evridiki; Piccirillo, Ciriaco A.; Salomon, Benoit L.; Bluestone, Jeffrey A.			Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction	IMMUNITY			English	Article							REGULATORY T-CELLS; NOD MICE; DISEASE; LOCUS; SUSCEPTIBILITY; TOLERANCE; PREVENTS; BCL-2; COSTIMULATION; HOMEOSTASIS	The dynamics of CD4(+) effector T cells (Teff cells) and CD4(+)Foxp3(+) regulatory T cells (Treg cells) during diabetes progression in nonobese diabetic mice was investigated to determine whether an imbalance of Treg cells and Teff cells contributes to the development of type 1 diabetes. Our results demonstrated a progressive decrease in the Treg cell:Teff cell ratio in inflamed islets but not in pancreatic lymph nodes. Intra-islet Treg cells expressed reduced amounts of CD25 and Bcl-2, suggesting that their decline was due to increased apoptosis. Additionally, administration of low-dose interleukin-2 (IL-2) promoted Treg cell survival and protected mice from developing diabetes. Together, these results suggest intra-islet Treg cell dysfunction secondary to defective IL-2 production is a root cause of the progressive breakdown of self-tolerance and the development of diabetes in nonobese diabetic mice.	[Adams, Jason Y.; Penaranda, Cristina; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Tang, Qizhi; Melli, Kristin] Univ Calif San Francisco, Dept Med, Dept Surg, San Francisco, CA 94143 USA; [Piaggio, Eliane; Salomon, Benoit L.] Univ Paris 06, Hop La Pitie Salpetriere, UMR 7087, CNRS, F-75005 Paris, France; [Sgouroudis, Evridiki; Piccirillo, Ciriaco A.] McGill Univ, Dept Microbiol & Immunol, Ctr Study Host Resistance, Montreal, PQ H3A 2B4, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; McGill University	Bluestone, JA (corresponding author), Univ Calif San Francisco, Dept Med, UCSF Diabet Ctr, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu	Salomon, Benoit L/M-2421-2017; Salomon, Benoit/AAP-5209-2021; Piaggio, Eliane/E-5260-2016	Salomon, Benoit L/0000-0001-9673-5578; Salomon, Benoit/0000-0001-9673-5578; Piaggio, Eliane/0000-0002-2455-8442; Tang, Qizhi/0000-0001-7313-3574; Penaranda, Cristina/0000-0002-2595-2863	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [S10 RR014884-01] Funding Source: Medline; NIAID NIH HHS [P01 AI035297, R01 AI050834-06A1, T32 AI007090, R37 AI046643-10, T32 AI007090-21, R37 AI046643, P01 AI035297-109002, R01 AI050834] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720-01, P30 DK063720] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050834, R37AI046643, P01AI035297, T32AI007090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aluvihare VR, 2006, IMMUNOL REV, V212, P330, DOI 10.1111/j.0105-2896.2006.00408.x; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Arkwright PD, 2002, BLOOD, V99, P2694, DOI 10.1182/blood.V99.8.2694; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chatenoud Lucienne, 2003, Novartis Found Symp, V252, P279; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; Dupuis-Girod S, 2003, PEDIATRICS, V111, pE622, DOI 10.1542/peds.111.5.e622; Fisher RI, 2000, CANCER J SCI AM, V6, pS55; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; GARCHON HJ, 1994, EUR J IMMUNOL, V24, P380, DOI 10.1002/eji.1830240217; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Horak I, 1995, IMMUNOL REV, V148, P35, DOI 10.1111/j.1600-065X.1995.tb00092.x; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI200213605; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Munn DH, 2006, IMMUNOL REV, V213, P146, DOI 10.1111/j.1600-065X.2006.00444.x; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Qin HY, 1997, J AUTOIMMUN, V10, P271, DOI 10.1006/jaut.1997.0136; Rabinovitch A, 2002, DIABETES, V51, P638, DOI 10.2337/diabetes.51.3.638; Rietz C, 2003, SCAND J IMMUNOL, V57, P342, DOI 10.1046/j.1365-3083.2003.01244.x; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Sheu BC, 2001, CANCER RES, V61, P237; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Wei S, 2007, CANCER RES, V67, P7487, DOI 10.1158/0008-5472.CAN-07-0565; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684	61	559	581	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					687	697		10.1016/j.immuni.2008.03.016	http://dx.doi.org/10.1016/j.immuni.2008.03.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18468463	Green Accepted, Bronze			2022-12-18	WOS:000256003900015
J	WAGTMANN, N; BIASSONI, R; CANTONI, C; VERDIANI, S; MALNATI, MS; VITALE, M; BOTTINO, C; MORETTA, L; MORETTA, A; LONG, EO				WAGTMANN, N; BIASSONI, R; CANTONI, C; VERDIANI, S; MALNATI, MS; VITALE, M; BOTTINO, C; MORETTA, L; MORETTA, A; LONG, EO			MOLECULAR CLONES OF THE P58 NK CELL-RECEPTOR REVEAL IMMUNOGLOBULIN-RELATED MOLECULES WITH DIVERSITY IN BOTH THE EXTRACELLULAR AND INTRACELLULAR DOMAINS	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; ANTIGEN RECOGNITION; I ALLELES; EXPRESSION; HLA; SPECIFICITY; LYSIS; SUPERFAMILY; PROTECTION; ACTIVATION	Recognition of major histocompatibility class I molecules on target cells by natural killer (NK) cells confers selective protection from NK-mediated lysis. Crosslinking of the p58 NK receptor, involved in the recognition of HLA-C alleles, delivers a negative signal that prevents target cell lysis. Molecular cloning of the p58 NK receptor reported here revealed a new member of the immunoglobulin superfamily. Five distinct p58 receptors, with sequence diversity in the immunoglobulin-related domains, were identified in a single individual. All NK clones tested expressed at least one p58 member. Three different types of transmembrane and cytoplasmic domains exist, even among receptors with closely related extracellular domains. These data revealed a repertoire of NK cells with clonally distributed p58 receptors exhibiting diversity in both extracellular and intracellular domains.	IST NAZL RIC CANC,I-16132 GENOA,ITALY; UNIV GENOA,IST ISTOL & EMBRIOL GEN,I-16132 GENOA,ITALY	University of Genoa; IRCCS AOU San Martino IST; University of Genoa	WAGTMANN, N (corresponding author), NIAID,IMMUNOGENET LAB,12441 PARKLAWN DR,ROCKVILLE,MD 20852, USA.		Moretta, Lorenzo/AAA-7239-2020; Malnati, Mauro/AAN-4207-2020; Vitale, Massimo/G-5135-2016; BIASSONI, ROBERTO/J-4677-2018; Long, Eric O/G-5475-2011; Cantoni, Claudia/J-8732-2018; Bottino, Cristina/J-9977-2016	Moretta, Lorenzo/0000-0003-4658-1747; Vitale, Massimo/0000-0001-5372-7885; BIASSONI, ROBERTO/0000-0002-4365-8166; Long, Eric O/0000-0002-7793-3728; Cantoni, Claudia/0000-0001-6471-1424; Malnati, mauro/0000-0001-5355-1680; Bottino, Cristina/0000-0001-6695-1739				BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; BIASSONI R, 1993, EUR J IMMUNOL, V23, P1083, DOI 10.1002/eji.1830230516; BOTTINO C, 1994, EUR J IMMUNOL, V24, P2527, DOI 10.1002/eji.1830241040; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CICCONE E, 1992, J EXP MED, V175, P709, DOI 10.1084/jem.175.3.709; CICCONE E, 1992, J EXP MED, V176, P963, DOI 10.1084/jem.176.4.963; CICCONE E, 1994, EUR J IMMUNOL, V24, P1003, DOI 10.1002/eji.1830240434; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; CORREA I, EUR J IMMUNOL, V1323, P94; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; DORSHKIND K, 1985, J IMMUNOL, V134, P3798; ELROYSTEIN O, 1989, CURRENT PROTOCOLS MO; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; KORNBLUTH J, 1982, J IMMUNOL, V129, P2831; LANIER LL, 1995, J IMMUNOL, V154, P3320; LANIER LL, 1994, J IMMUNOL, V153, P2417; LITWIN V, 1993, J EXP MED, V178, P1321, DOI 10.1084/jem.178.4.1321; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; LONG EO, 1991, HUM IMMUNOL, V31, P229, DOI 10.1016/0198-8859(91)90092-N; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; MALNATI MS, 1993, J EXP MED, V178, P961, DOI 10.1084/jem.178.3.961; MALNATI MS, 1995, SCIENCE, V267, P101; MOOS M, 1991, ISOLATION PROTEINS M; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1990, J EXP MED, V171, P695, DOI 10.1084/jem.171.3.695; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROBINSON MA, 1993, P NATL ACAD SCI USA, V90, P2433, DOI 10.1073/pnas.90.6.2433; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; VITALE M, 1995, P NATL ACAD SCI USA, V92, P3536, DOI 10.1073/pnas.92.8.3536; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YABE T, 1993, IMMUNOGENETICS, V37, P455; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145	43	559	576	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					439	449		10.1016/1074-7613(95)90025-X	http://dx.doi.org/10.1016/1074-7613(95)90025-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749980	Bronze			2022-12-18	WOS:A1995QZ43000002
J	Martin-Orozco, N; Muranski, P; Chung, Y; Yang, XXO; Yamazaki, T; Lu, SJ; Hwu, P; Restifo, NP; Overwijk, WW; Dong, C				Martin-Orozco, Natalia; Muranski, Pawel; Chung, Yeonseok; Yang, Xuexian O.; Yamazaki, Tomohide; Lu, Sijie; Hwu, Patrick; Restifo, Nicholas P.; Overwijk, Willem W.; Dong, Chen			T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity	IMMUNITY			English	Article							POTENT ANTITUMOR IMMUNITY; DENDRITIC CELLS; IN-VIVO; TH17 CELLS; CROSS-PRESENTATION; LYMPHOPENIC HOSTS; CUTTING EDGE; CANCER; INTERLEUKIN-17; MELANOMA	Although T helper 17 (Th17) cells have been found in tumor tissues, their function in cancer immunity is unclear. We found that interleukin-17A (IL-17A)-deficient mice were more susceptible to developing lung melanoma. Conversely, adoptive T cell therapy with tumor-specific Th17 cells prevented tumor development. Importantly, the Th17 cells retained their cytokine signature and exhibited stronger therapeutic efficacy than Th1 cells. Unexpectedly, therapy using Th17 cells elicited a remarkable activation of tumor-specific CD8(+) T cells, which were necessary for the antitumor effect. Th17 cells promoted dendritic cell recruitment into the tumor tissues and in draining lymph nodes increased CD8 alpha(+) dendritic cells containing tumor material. Moreover, Th17 cells promoted CCL20 chemokine production by tumor tissues, and tumor-bearing CCR6-deficient mice did not respond to Th17 cell therapy. Thus, 17 cells elicited a protective inflammation that promotes the activation of tumor-specific CD8(+) T cells. These findings have important implications in antitumor immunotherapies.	[Martin-Orozco, Natalia; Chung, Yeonseok; Yang, Xuexian O.; Yamazaki, Tomohide; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Lu, Sijie] Univ Texas Houston, MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cell Therapy, Houston, TX 77030 USA; [Hwu, Patrick; Overwijk, Willem W.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Muranski, Pawel; Restifo, Nicholas P.] NCI, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	cdong@mdanderson.org	Restifo, Nicholas Phillip/M-6549-2019; Martin Orozco, Natalia/E-4794-2010; Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/Z-1614-2019; Yang, Xuexian/Y-2472-2019; Muranski, Pawel/E-5572-2010; dong, chen/B-3181-2009	Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841; Restifo, Nicholas P./0000-0003-4229-4580	National Institute of Health; Targeted Therapy of MID Anderson Cancer Center; Leukemia and Lymphoma Society Scholar award; MD Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050761, R01AI054912, U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Targeted Therapy of MID Anderson Cancer Center; Leukemia and Lymphoma Society Scholar award(Leukemia and Lymphoma Society); MD Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the entire Dong lab for their help and discussion. This work is supported in part by grants from the National Institute of Health (to W.W.O. and C.D.) and a grant from the Center for Targeted Therapy of MID Anderson Cancer Center (to C.D. and N.M.O.). C.D. received a Leukemia and Lymphoma Society Scholar award and a Trust Fellowship of the MD Anderson Cancer Center.	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dudley ME, 2007, SEMIN ONCOL, V34, P524, DOI 10.1053/j.seminoncol.2007.09.002; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Hu JW, 2006, CANCER RES, V66, P8887, DOI 10.1158/0008-5472.CAN-05-3448; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lotze MT, 1997, ANN SURG, V226, P1, DOI 10.1097/00000658-199707000-00001; Lou YY, 2004, CANCER RES, V64, P6783, DOI 10.1158/0008-5472.CAN-04-1621; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva R, 2009, J IMMUNOL, V182, P2565, DOI 10.4049/jimmunol.0803931; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	40	558	595	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					787	798		10.1016/j.immuni.2009.09.014	http://dx.doi.org/10.1016/j.immuni.2009.09.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19879162	Green Accepted, Bronze			2022-12-18	WOS:000272097900013
J	Hsieh, CS; Liang, YQ; Tyznik, AJ; Self, SG; Liggitt, D; Rudensky, AY				Hsieh, CS; Liang, YQ; Tyznik, AJ; Self, SG; Liggitt, D; Rudensky, AY			Recognition of the peripheral self by naturally arising CD25(+) CD4(+) T cell receptors	IMMUNITY			English	Article							POSITIVE SELECTION; IN-VIVO; INDUCTION; TOLERANCE; DISEASE; PROLIFERATION; COMPETITION; ACTIVATION; IMMUNITY; FOXP3	Naturally arising CD25(+) CD4(+) regulatory T cells (T-R) play an important role in the prevention of autoimmunity. TCR specificity is thought to play a critical role in T-R development and function, but the repertoire and specificity of T-R TCRs remain largely unknown. We find by sequencing of TRAV14 (Valpha2) TCRalpha chains associated with a transgenic TCRbeta chain that the T-R and CD25(-) CD4(+) TCR repertoires are similarly diverse, yet only partially overlapping. Retroviral expression of TCRalpha genes in TCR transgenic RAG-deficient T cells revealed that a high frequency of TCRs derived from CD25(+) but not CD25(-) CD4(+) T cells confers the ability to rapidly expand upon transfer into a lymphopenic host. Thus, these data show that a large proportion of naturally arising T-R have substantially more efficient interactions with MHC class II bound peptides from the peripheral self than CD25(-) T cells.	Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu						Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barton GM, 2002, P NATL ACAD SCI USA, V99, P6937, DOI 10.1073/pnas.102645699; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Colwell R.K, 1997, ESTIMATES STAT ESTIM; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Dubois B, 2003, BLOOD, V102, P3295, DOI 10.1182/blood-2003-03-0727; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fujio K, 2000, J IMMUNOL, V165, P528, DOI 10.4049/jimmunol.165.1.528; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gough PJ, 2003, BLOOD, V101, P485, DOI 10.1182/blood-2002-07-2131; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kovats S, 1998, J EXP MED, V187, P245, DOI 10.1084/jem.187.2.245; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; TAGUCHI O, 1994, IMMUNOLOGY, V82, P365; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Uraushihara K, 2003, J IMMUNOL, V171, P708, DOI 10.4049/jimmunol.171.2.708; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252	43	558	578	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					267	277		10.1016/j.immuni.2004.07.009	http://dx.doi.org/10.1016/j.immuni.2004.07.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308106	Bronze			2022-12-18	WOS:000223441900014
J	Goubau, D; Deddouche, S; Sousa, CRE				Goubau, Delphine; Deddouche, Safia; Reis e Sousa, Caetano			Cytosolic Sensing of Viruses	IMMUNITY			English	Review							INNATE IMMUNE-RESPONSE; DOUBLE-STRANDED-RNA; CYCLIC-DI-GMP; ANTIVIRAL SIGNALING PROTEIN; INDUCIBLE GENE-I; HEPATITIS-C VIRUS; RECEPTOR RIG-I; NF-KAPPA-B; DENDRITIC CELLS; INTRACELLULAR DNA	Cells are equipped with mechanisms that allow them to rapidly detect and respond to viruses. These defense mechanisms rely partly on receptors that monitor the cytosol for the presence of atypical nucleic acids associated with virus infection. RIG-I-like receptors detect RNA molecules that are absent from the uninfected host. DNA receptors alert the cell to the abnormal presence of that nucleic acid in the cytosol. Signaling by RNA and DNA receptors results in the induction of restriction factors that prevent virus replication and establish cell-intrinsic antiviral immunity. In light of these formidable obstacles, viruses have evolved mechanisms of evasion, masking nucleic acid structures recognized by the host, sequestering themselves away from the cytosol or targeting host sensors, and signaling adaptors for deactivation or degradation. Here, we detail recent advances in the molecular understanding of cytosolic nucleic acid detection and its evasion by viruses.	[Goubau, Delphine; Deddouche, Safia; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Immunobiol Lab, London WC2A 3LY, England	Cancer Research UK	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119	Cancer Research UK; Fondation Baxter Alma Ricard; Marie-Curie long-term fellowships; European Research Council; Fondation Bettencourt-Schueller; Cancer Research UK [15689] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Fondation Baxter Alma Ricard; Marie-Curie long-term fellowships(European Commission); European Research Council(European Research Council (ERC)European Commission); Fondation Bettencourt-Schueller; Cancer Research UK(Cancer Research UK)	We thank members of the Immunobiology laboratory for discussions, as well as Jan Rehwinkel and Cecilia Johansson for critical reading of the manuscript. D. G. is a recipient of Cancer Research UK and Fondation Baxter & Alma Ricard fellowships. S. D. is a recipient of Marie-Curie long-term fellowships. The C. R. S. laboratory is funded by Cancer Research UK, the European Research Council, and Fondation Bettencourt-Schueller.	Abdullah Z, 2012, EMBO J, V31, P4153, DOI 10.1038/emboj.2012.274; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Bozym RA, 2012, CELL HOST MICROBE, V11, P153, DOI 10.1016/j.chom.2012.01.008; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chen H, 2013, J MOL CELL BIOL, V5, P111, DOI 10.1093/jmcb/mjt006; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Cristea IM, 2010, J VIROL, V84, P7803, DOI 10.1128/JVI.00139-10; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Ferrage F, 2012, STRUCTURE, V20, P2048, DOI 10.1016/j.str.2012.09.003; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Gu LL, 2013, MOL CELL BIOL, V33, P2004, DOI 10.1128/MCB.01603-12; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Inn KS, 2011, J VIROL, V85, P10899, DOI 10.1128/JVI.00690-11; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang M, 2011, J IMMUNOL, V187, P1713, DOI 10.4049/jimmunol.1100361; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jong JE, 2010, J MICROBIOL, V48, P206, DOI 10.1007/s12275-010-0021-1; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; KNIPE DM, 2007, FIELDS VIROLOGY, V1; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; Leung DW, 2012, TRENDS MICROBIOL, V20, P139, DOI 10.1016/j.tim.2011.12.005; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; Lind K, 2012, CLIN EXP IMMUNOL, V168, P30, DOI 10.1111/j.1365-2249.2011.04557.x; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Luo DH, 2013, RNA BIOL, V10, P111, DOI 10.4161/rna.22706; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Motz C, 2013, SCIENCE, V339, P690, DOI 10.1126/science.1230949; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Oshiumi H, 2012, J BIOCHEM, V151, P5, DOI 10.1093/jb/mvr111; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schneider U, 2007, CELL MOL LIFE SCI, V64, P1038, DOI 10.1007/s00018-007-6545-9; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Soares F., 2012, INNATE IMMUN; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Triantafilou K, 2012, J CELL SCI, V125, P4761, DOI 10.1242/jcs.103887; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; van Kasteren PB, 2012, J VIROL, V86, P773, DOI 10.1128/JVI.06277-11; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Vela A, 2012, J BIOL CHEM, V287, P42564, DOI 10.1074/jbc.M112.385146; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Wang H, 2011, J GEN VIROL, V92, P1199, DOI 10.1099/vir.0.029405-0; Wang LJ, 2013, J VIROL, V87, P4507, DOI 10.1128/JVI.00031-13; Wang YT, 2012, J IMMUNOL, V189, P5304, DOI 10.4049/jimmunol.1201445; Wang YT, 2012, J BIOL CHEM, V287, P34626, DOI 10.1074/jbc.M112.390401; Wang YT, 2012, EUR J IMMUNOL, V42, P1304, DOI 10.1002/eji.201142125; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Welz PS, 2012, CELL HOST MICROBE, V11, P223, DOI 10.1016/j.chom.2012.02.003; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiao TS, 2012, IMMUNITY, V36, P311, DOI 10.1016/j.immuni.2012.03.002; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang NN, 2008, P NATL ACAD SCI USA, V105, P10553, DOI 10.1073/pnas.0804895105; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	171	556	566	6	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					855	869		10.1016/j.immuni.2013.05.007	http://dx.doi.org/10.1016/j.immuni.2013.05.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706667	Green Published, Bronze			2022-12-18	WOS:000330942500006
J	Sathaliyawala, T; Kubota, M; Yudanin, N; Turner, D; Camp, P; Thome, JJC; Bickham, KL; Lerner, H; Goldstein, M; Sykes, M; Kato, T; Farber, DL				Sathaliyawala, Taheri; Kubota, Masaru; Yudanin, Naomi; Turner, Damian; Camp, Philip; Thome, Joseph J. C.; Bickham, Kara L.; Lerner, Harvey; Goldstein, Michael; Sykes, Megan; Kato, Tomoaki; Farber, Donna L.			Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets	IMMUNITY			English	Article							CUTTING EDGE; GENERATION; EXPRESSION; INFECTION; DIFFERENTIATION; EXPANSION	Knowledge of human T cells derives chiefly from studies of peripheral blood, whereas their distribution and function in tissues remains largely unknown. Here, we present a unique analysis of human T cells in lymphoid and mucosal tissues obtained from individual organ donors, revealing tissue-intrinsic compartmentalization of naive, effector, and memory subsets conserved between diverse individuals. Effector memory CD4(+) T cells producing IL-2 predominated in mucosal tissues and accumulated as central memory subsets in lymphoid tissue, whereas CD8(+) T cells were maintained as naive subsets in lymphoid tissues and IFN-gamma-producing effector memory CD8(+) T cells in mucosal sites. The T cell activation marker CD69 was constitutively expressed by memory T cells in all tissues, distinguishing them from circulating subsets, with mucosa! memory T cells exhibiting additional distinct phenotypic and functional properties. Our results provide an assessment of human T cell compartmentalization as a new baseline for understanding human adaptive immunity.	[Sathaliyawala, Taheri; Yudanin, Naomi; Turner, Damian; Camp, Philip; Thome, Joseph J. C.; Bickham, Kara L.; Sykes, Megan; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Kubota, Masaru; Sykes, Megan; Kato, Tomoaki; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Yudanin, Naomi; Thome, Joseph J. C.; Sykes, Megan] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Sykes, Megan] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Lerner, Harvey; Goldstein, Michael] NYODN, New York, NY 10001 USA; [Goldstein, Michael] Mt Sinai Med Ctr, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Farber, DL (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA.	df2396@columbia.edu	Yudanin, Naomi/U-2757-2019; Yudanin, Naomi/D-1809-2014	Yudanin, Naomi/0000-0002-5019-2851; Yudanin, Naomi/0000-0002-5019-2851; Farber, Donna/0000-0001-8236-9183	NIH [RC1AI086164]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086164] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH "Challenge" grant RC1AI086164 awarded to D.L.F. We wish to gratefully acknowledge the generosity of the donor families and the outstanding efforts of the NYODN transplant coordinators and staff for making this study possible. We also wish to thank D. Corrigan and M. Yu for help with the tissue processing, S.-H. Ho for help with the flow cytometry, and S. Reiner for critical reading of this manuscript.	Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Campbell DJ, 2003, SEMIN IMMUNOL, V15, P277, DOI 10.1016/j.smim.2003.08.005; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krishnan S, 2001, BLOOD, V97, P3851, DOI 10.1182/blood.V97.12.3851; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Marks BR, 2009, SEMIN IMMUNOL, V21, P164, DOI 10.1016/j.smim.2009.03.001; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Merkenschlager M, 1989, Int Immunol, V1, P450, DOI 10.1093/intimm/1.4.450; Onoe T, 2010, J IMMUNOL, V184, P6756, DOI 10.4049/jimmunol.0901711; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schon MP, 1999, J IMMUNOL, V162, P6641; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sun SQ, 1998, J EXP MED, V188, P2335, DOI 10.1084/jem.188.12.2335; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243	39	555	567	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					187	197		10.1016/j.immuni.2012.09.020	http://dx.doi.org/10.1016/j.immuni.2012.09.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23260195	Green Accepted, Bronze			2022-12-18	WOS:000314195500020
J	Vogelzang, A; McGuire, HM; Yu, D; Sprent, J; Mackay, CR; King, C				Vogelzang, Alexis; McGuire, Helen M.; Yu, Di; Sprent, Jonathan; Mackay, Charles R.; King, Cecile			A fundamental role for interleukin-21 in the generation of T follicular helper cells	IMMUNITY			English	Article							GERMINAL-CENTER DEVELOPMENT; CXC CHEMOKINE RECEPTOR-5; IN-VIVO; B-CELLS; IMMUNE-RESPONSES; IMMUNOGLOBULIN PRODUCTION; DEFICIENT MICE; CUTTING EDGE; TH17 CELLS; IL-21	T cell help to B cells is a fundamental property of adaptive immunity, yet only recently have many of the cellular and molecular mechanisms of T cell help emerged. T follicular helper (Tfh) cells are the CD4(+) T helper cells that provide cognate help to B cells for high-affinity antibody production in germinal centers (GC). Tfh cells produce interleukin-21 (IL-21), and we show that IL-21 was necessary for GC formation. However, the central role of IL-21 in GC formation reflected its effects on Tfh cell generation rather than on B cells. Expression of the inducible costimulator (1COS) was necessary for optimal production of IL-21, indicative of interplay between these two Tfh cell-expressed molecules. Finally, we demonstrate that IL-21's costimulatory capacity for T helper cell differentiation operated at the level of the T cell receptor signalosome through Vav1, a signaling molecule that controls T cell helper function. This study reveals a previously unappreciated role for Tfh cells in the formation of the GC and isotype switching through a CD4+ T cell-intrinsic requirement for IL-21.	[Vogelzang, Alexis; McGuire, Helen M.; Yu, Di; Sprent, Jonathan; Mackay, Charles R.; King, Cecile] St Vincents Hosp, Garvan Inst Med Res, Dept Immunol, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	King, C (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Dept Immunol, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	c.king@garvan.org.au	Vogelzang, Alexis/C-5440-2017; Mackay, Charles R/A-9673-2008; McGuire, Helen/L-6877-2019; King, Cecile/Q-9794-2019; Yu, Di/C-2163-2009	Mackay, Charles R/0000-0002-6338-7340; McGuire, Helen/0000-0003-2047-6543; King, Cecile/0000-0003-2193-2563; Yu, Di/0000-0003-1721-8922; Vogelzang, Alexis/0000-0002-2921-1755				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ebert LM, 2004, EUR J IMMUNOL, V34, P3562, DOI 10.1002/eji.200425478; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Gulbranson-Judge A, 1999, EUR J IMMUNOL, V29, P477, DOI 10.1002/(SICI)1521-4141(199902)29:02&lt;477::AID-IMMU477&gt;3.0.CO;2-V; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; KELSOE G, 1995, IMMUNOL TODAY, V16, P324, DOI 10.1016/0167-5699(95)80146-4; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Moser B, 2003, IMMUNOL LETT, V85, P105, DOI 10.1016/S0165-2478(02)00233-X; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Prisco A, 2005, IMMUNITY, V23, P263, DOI 10.1016/j.immuni.2005.07.007; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; ROSE ML, 1981, BRIT J CANCER, V44, P68, DOI 10.1038/bjc.1981.149; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SONDEREGGER I, 2008, EUR J IMMUN IN PRESS, DOI DOI 10.1002/EJI.20083851; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tanaka Y, 2005, BLOOD, V106, P1286, DOI 10.1182/blood-2004-10-4074; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	70	555	588	3	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					127	137		10.1016/j.immuni.2008.06.001	http://dx.doi.org/10.1016/j.immuni.2008.06.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18602282	Bronze			2022-12-18	WOS:000257905400016
J	Ouyang, WJ; Lohning, M; Gao, ZG; Assenmacher, M; Ranganath, S; Radbruch, A; Murphy, KM				Ouyang, WJ; Lohning, M; Gao, ZG; Assenmacher, M; Ranganath, S; Radbruch, A; Murphy, KM			Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment	IMMUNITY			English	Article							IMMUNOGLOBULIN-E PRODUCTION; NK1.1(+) T-CELLS; TRANSCRIPTION FACTOR GATA-3; PHENOTYPE DEVELOPMENT; GENE-EXPRESSION; C-MAF; IL-4; INTERLEUKIN-4; MICE; RESPONSES	The initial source of IL-4-inducing Th2 development and the mechanism of stable Th2 commitment remain obscure. We found the reduced level of IL-4 production in Stat6-deficient T cells to be significantly higher than in Th1 controls. Using a novel cell surface affinity matrix technique, we found that IL-4-secreting Stat6-deficient T cells stably expressed GATA-3 and Th2 phenotype. Introducing GATA-3 into Stat6-deficient T cells completely restored Th2 development, inducing c-Maf, Th2-specific DNase I hypersensitive sites in the IL-4 locus, and Th2 cytokine expression. The fact that GATA-3 fully reconstitutes Th2 development in Stat6-deficient T cells indicates it is a master switch in Th2 development. Finally, GATA-3 exerts Stat6-independent autoactivation, creating a feedback pathway stabilizing Th2 commitment.	Deutsch Rhemaforschungszentrum, D-10115 Berlin, Germany; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Ctr Immunol, St Louis, MO 63110 USA; Miltenyi Biotec, D-51429 Bergisch Gladbach, Germany; Humboldt Univ, Charite, Dept Expt Rheumatol, D-10115 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Miltenyi Biotec; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Radbruch, A (corresponding author), Deutsch Rhemaforschungszentrum, Hannoversche Str 27, D-10115 Berlin, Germany.		Ouyang, Wenjun/ABA-8763-2020; Löhning, Max/AAL-2967-2021	Löhning, Max/0000-0001-6382-7281; Ouyang, Wenjun/0000-0002-1811-5864; Radbruch, Andreas/0000-0001-5753-0000	NHLBI NIH HHS [HL56419] Funding Source: Medline; NIAID NIH HHS [AI34580] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI034580, U01AI034580] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; AGARWAL S, 1998, IMMUNITY, V28, P1534; Assenmacher M, 1998, EUR J IMMUNOL, V28, P1534, DOI 10.1002/(SICI)1521-4141(199805)28:05<1534::AID-IMMU1534>3.0.CO;2-R; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Brosterhus H, 1999, EUR J IMMUNOL, V29, P4053, DOI 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.3.CO;2-3; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; COFFMAN RL, 1997, J EXP MED, V185, P393; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HSIEH CS, 1993, INT IMMUNOL, V5, P371; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Huang H, 1997, J IMMUNOL, V159, P3731; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KURSCHNER C, 1995, MOL CELL BIOL, V15, P246, DOI 10.1128/MCB.15.1.246; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LIM JI, 1999, P NATL ACAD SCI USA, V96, P3781; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rincon Mercedes, 1997, Genes and Function, V1, P51; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; SANDER B, 1993, J IMMUNOL METHODS, V166, P201, DOI 10.1016/0022-1759(93)90361-A; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; vonderWeid T, 1996, J IMMUNOL, V157, P4421; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	46	555	571	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					27	37		10.1016/S1074-7613(00)80156-9	http://dx.doi.org/10.1016/S1074-7613(00)80156-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661403	Bronze			2022-12-18	WOS:000085011900004
J	Varol, C; Vallon-Eberhard, A; Elinav, E; Aychek, T; Shapira, Y; Luche, H; Fehling, HJ; Hardt, WD; Shakhar, G; Jung, S				Varol, Chen; Vallon-Eberhard, Alexandra; Elinav, Eran; Aychek, Tegest; Shapira, Yami; Luche, Herve; Fehling, Hans Joerg; Hardt, Wolf-Dietrich; Shakhar, Guy; Jung, Steffen			Intestinal Lamina Propria Dendritic Cell Subsets Have Different Origin and Functions	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; BLOOD MONOCYTE SUBSETS; IN-VIVO; FLUORESCENT PROTEIN; ULCERATIVE-COLITIS; T-CELLS; MICE; DISTINCT; MUCOSAL; IMMUNE	The intestinal immune system discriminates between tolerance toward the commensal microflora and robust responses to pathogens. Maintenance of this critical balance is attributed to mucosal dendritic cells (DCs) residing in organized lymphoid tissue and dispersed in the subepithelial lamina propria. In situ parameters of lamina propria DCs (IpDCs) remain poorly understood. Here, we combined conditional cell ablation and precursor-mediated in vivo reconstitution to establish that IpDC subsets have distinct origins and functions. CD103(+) CX(3)CR1(-) IpDCs arose from macrophage-DC precursors (MDPs) via DC-committed intermediates (pre-cDCs) through a FIt3L growth-factor-mediated pathway. CD11b(+) CD14(+) hi CX(3)CR1(+) IpDCs were derived from grafted Ly6C(hi) but not Ly6C(lo) monocytes under the control of GMCSF. Mice reconstituted exclusively with CX(3)CR1(+) IpDCs when challenged in an innate colitis model developed severe intestinal inflammation that was driven by graft-derived TNF-alpha-secreting CX(3)CR1(+) IpDCs. Our results highlight the critical importance of the IpDC subset balance for robust gut homeostasis.	[Varol, Chen; Vallon-Eberhard, Alexandra; Elinav, Eran; Aychek, Tegest; Shakhar, Guy; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Elinav, Eran; Shapira, Yami] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Gastroenterol & Hepatol Inst, IL-69978 Tel Aviv, Israel; [Luche, Herve; Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; [Hardt, Wolf-Dietrich] ETH, Inst Microbiol, D BIOL, CH-8093 Zurich, Switzerland	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ulm University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	LUCHE, Herve/GLT-1401-2022; Varol, Chen/ABH-6487-2020; Varol, Chen/AAW-4202-2021; Elinav, Eran/ABE-8881-2020; Elinav, Eran/C-8077-2011; Jung, Steffen/K-1409-2012	Elinav, Eran/0000-0002-5775-2110; Jung, Steffen/0000-0003-4290-5716; LUCHE, Herve/0000-0003-4309-8338; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Israel Science Foundation; MINERVA foundation; Association of the Swiss Friends of the Weizmann Institute	Israel Science Foundation(Israel Science Foundation); MINERVA foundation; Association of the Swiss Friends of the Weizmann Institute	We thank A. Mahler and the Jung laboratory for critical reading of the manuscript and are grateful to Y. Chermesh and O. Amram for animal husbandry. We thank Z. Eshhar and Z. Halpern for establishing the endoscopy suite, B. Reizis for sharing his CD11c-Cre mice, N. Shpigei for providing Tnf<SUP>-/-</SUP> mice, and M. Manz for providing Flt3<SUP>-/-</SUP> BM. We are grateful to V. Temper, Hadassah-Hebrew University Medical Center, for Salmonella typing and E. Ariel and A. Sharp for help with flow cytometry. This work was supported by the Israel Science Foundation, the MINERVA foundation, and the Fritz Thyssen Stiftung (S.J.). A.V.-E. was supported by the Association of the Swiss Friends of the Weizmann Institute. S.J. is the incumbent of the Pauline Recanati Career Development Chair.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; COOPER HS, 1993, LAB INVEST, V69, P238; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Hieronymus T, 2005, J IMMUNOL, V174, P2552, DOI 10.4049/jimmunol.174.5.2552; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mach N, 2000, CANCER RES, V60, P3239; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Miller G, 2003, J IMMUNOL, V170, P3554, DOI 10.4049/jimmunol.170.7.3554; Miller G, 2002, J IMMUNOL, V169, P2875, DOI 10.4049/jimmunol.169.6.2875; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vasquez N, 2007, INFLAMM BOWEL DIS, V13, P684, DOI 10.1002/ibd.20084; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428	53	554	559	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					502	512		10.1016/j.immuni.2009.06.025	http://dx.doi.org/10.1016/j.immuni.2009.06.025			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19733097	Bronze			2022-12-18	WOS:000270525900017
J	Schlee, M; Roth, A; Hornung, V; Hagmann, CA; Wimmenauer, V; Barchet, W; Coch, C; Janke, M; Mihailovic, A; Wardle, G; Juranek, S; Kato, H; Kawai, T; Poeck, H; Fitzgerald, KA; Takeuchi, O; Akira, S; Tuschl, T; Latz, E; Ludwig, J; Hartmann, G				Schlee, Martin; Roth, Andreas; Hornung, Veit; Hagmann, Cristina Amparo; Wimmenauer, Vera; Barchet, Winfried; Coch, Christoph; Janke, Markus; Mihailovic, Aleksandra; Wardle, Greg; Juranek, Stefan; Kato, Hiroki; Kawai, Taro; Poeck, Hendrik; Fitzgerald, Katherine A.; Takeuchi, Osamu; Akira, Shizuo; Tuschl, Thomas; Latz, Eicke; Ludwig, Janos; Hartmann, Gunther			Recognition of 5 ' Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus	IMMUNITY			English	Article							CAENORHABDITIS-ELEGANS; INTERFERON INDUCTION; ANTIVIRAL RESPONSES; PHAGE POLYMERASE; INNATE IMMUNITY; ACTIVATION; TOLL-LIKE-RECEPTOR-9; TRANSCRIPTS; LIGAND; MDA-5	Antiviral immunity is triggered by immunorecognition of viral nucleic acids. The cytosolic helicase RIG-I is a key sensor of viral infections and is activated by RNA containing a triphosphate at the 5' end. The exact structure of RNA activating RIG-I remains controversial. Here, we established a chemical approach for 5' triphosphate oligoribonucleotide synthesis and found that synthetic single-stranded 5' triphosphate oligoribonucleotides were unable to bind and activate RIG-I. Conversely, the addition of the synthetic complementary strand resulted in optimal binding and activation of RIG-I. Short double-strand conformation with base pairing of the nucleoside carrying the 5' triphosphate was required. RIG-I activation was impaired by a 3' overhang at the 5' triphosphate end. These results define the structure of RNA for full RIG-I activation and explain how RIG-I detects negative-strand RNA viruses that lack long double-stranded RNA but do contain blunt short double-stranded 5' triphosphate RNA in the panhandle region of their single-stranded genome.	[Schlee, Martin; Roth, Andreas; Hornung, Veit; Hagmann, Cristina Amparo; Wimmenauer, Vera; Barchet, Winfried; Coch, Christoph; Janke, Markus; Poeck, Hendrik; Ludwig, Janos; Hartmann, Gunther] Univ Bonn, Univ Hosp, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Fitzgerald, Katherine A.; Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Kato, Hiroki; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Mihailovic, Aleksandra; Wardle, Greg; Juranek, Stefan; Tuschl, Thomas; Ludwig, Janos] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Biol, New York, NY 10021 USA	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Osaka University; Howard Hughes Medical Institute; Rockefeller University	Hartmann, G (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany.	gunther.hartmann@ukb.uni-bonn.de	Coch, Christoph/AAW-5336-2021; Akira, Shizuo/C-3134-2009; Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020; Ludwig, Janos/I-3544-2013; Hornung, Veit/C-3565-2012; Hartmann, Gunther/P-7492-2017; Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019; Schlee, Martin/AAL-1238-2021	Latz, Eicke/0000-0003-1488-5666; Hornung, Veit/0000-0002-4150-194X; Hartmann, Gunther/0000-0003-1021-2018; Takeuchi, Osamu/0000-0002-1260-6232; Fitzgerald, Kate/0000-0003-3175-609X; Schlee, Martin/0000-0003-3671-7639; Kawai, Taro/0000-0001-7510-4662; Barchet, Winfried/0000-0002-6745-6606	BMBF Biofuture [0311896, SFB 670, SFB 704, KFO115, KFO 177]; German Research Foundation DFG [BA3544/1-1]; National Institutes of Health [Al-065483, Al-067497]; Memorial Sloan-Kettering Cancer Center (MSKCC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067497, R37AI067497, R01AI067497, R01AI065483] Funding Source: NIH RePORTER	BMBF Biofuture(Federal Ministry of Education & Research (BMBF)); German Research Foundation DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan-Kettering Cancer Center (MSKCC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants BMBF Biofuture 0311896, SFB 670, SFB 704, KFO115, and KFO 177 to G.H. and grants from German Research Foundation DFG BA3544/1-1 (to W. B.), and by National Institutes of Health grants Al-065483 (to E.L.) and Al-067497 (to K.A.F). This work is part of the theses of A.R. and C.A.H. at the University of Bonn. We thank A. Harmer, C. Schuberth, K. Conzelmann, B. Kummerer, and C. Drosten for helpful discussion. We thank A. Viales at the Genomics Core Laboratory at Memorial Sloan-Kettering Cancer Center (MSKCC) for 454 Sequencing and R. Sheridan (MSKCC) for bioinformatic processing of the sequencing data.	Bonin M, 2000, RNA, V6, P563, DOI 10.1017/S1355838200992318; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gondai T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1043; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hofacker IL, 2004, BIOINFORMATICS, V20, P1495, DOI 10.1093/bioinformatics/bth108; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; PATTNAIK AK, 1992, CELL, V69, P1011, DOI 10.1016/0092-8674(92)90619-N; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; Vigneault F, 2008, NAT METHODS, V5, P777, DOI 10.1038/NMETH.1244; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	35	554	577	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					25	34		10.1016/j.immuni.2009.05.008	http://dx.doi.org/10.1016/j.immuni.2009.05.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19576794	Bronze, Green Accepted			2022-12-18	WOS:000268219900009
J	Paludan, SR; Bowie, AG				Paludan, Soren R.; Bowie, Andrew G.			Immune Sensing of DNA	IMMUNITY			English	Review							CYCLIC DI-GMP; TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; I IFN PRODUCTION; CYTOSOLIC DNA; RIG-I; STRUCTURAL BASIS; AIM2 INFLAMMASOME; DAMAGE RESPONSE; DENDRITIC CELLS	Although it has been appreciated for some years that cytosolic DNA is immune stimulatory, it is only in the past five years that the molecular basis of DNA sensing by the innate immune system has begun to be revealed. In particular it has been described how DNA induces type I interferon, central in antiviral responses and a mediator of autoimmunity. To date more than ten cytosolic receptors of DNA have been proposed, but STING is a key adaptor protein for most DNA-sensing pathways, and we are now beginning to understand the signaling mechanisms for STING. In this review we describe the recent progress in understanding signaling mechanisms activated by DNA and the relevance of DNA sensing to pathogen responses and autoimmunity. We highlight new insights gained into how and why the immune system responds to both pathogen and self DNA and define important questions that now need to be addressed in the field of innate immune activation by DNA.	[Paludan, Soren R.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Paludan, Soren R.] Univ Aarhus, Aarhus Res Ctr Innate Immunol, DK-8000 Aarhus, Denmark; [Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Aarhus University; Aarhus University; Trinity College Dublin	Paludan, SR (corresponding author), Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark.	srp@microbiology.au.dk; agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Danish Medical Research Council [09-072636, 12-124330]; Lundbeck Foundation [R83-A7598]; Novo Nordisk Foundation; Aase og Ejnar Danielsens Fond; Aarhus University Research Foundation; National Institutes of Health [AI093752]; Science Foundation Ireland [11/PI/1056]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093752] Funding Source: NIH RePORTER	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase og Ejnar Danielsens Fond; Aarhus University Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work in the S. R. P. laboratory is supported by grants from The Danish Medical Research Council (09-072636, 12-124330), The Lundbeck Foundation (R83-A7598), The Novo Nordisk Foundation, Aase og Ejnar Danielsens Fond, and Aarhus University Research Foundation. A. G. B. is funded by grants from the National Institutes of Health (AI093752) and Science Foundation Ireland (11/PI/1056).	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Aglipay JA, 2003, ONCOGENE, V22, P8931, DOI 10.1038/sj.onc.1207057; Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; ISAACS A, 1963, LANCET, V2, P113; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mondini M, 2010, AUTOIMMUNITY, V43, P226, DOI 10.3109/08916930903510922; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Park HH, 2012, APOPTOSIS, V17, P1247, DOI 10.1007/s10495-012-0775-5; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; ROTEM Z, 1963, NATURE, V197, P564, DOI 10.1038/197564a0; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wenzel M, 2012, J IMMUNOL, V188, P394, DOI 10.4049/jimmunol.1100523; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yan ZY, 2002, J VIROL, V76, P2043, DOI 10.1128/JVI.76.5.2043-2053.2002; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Yu P, 2006, INT IMMUNOL, V18, P1211, DOI 10.1093/intimm/dxl067; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	113	551	576	9	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					870	880		10.1016/j.immuni.2013.05.004	http://dx.doi.org/10.1016/j.immuni.2013.05.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706668	Green Accepted, Bronze			2022-12-18	WOS:000330942500007
J	Sixt, M; Kanazawa, N; Seig, M; Samson, T; Roos, G; Reinhardt, DP; Pabst, R; Lutz, MB; Sorokin, L				Sixt, M; Kanazawa, N; Seig, M; Samson, T; Roos, G; Reinhardt, DP; Pabst, R; Lutz, MB; Sorokin, L			The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node	IMMUNITY			English	Article							HIGH ENDOTHELIAL VENULES; MOUSE BONE-MARROW; RETICULAR FIBERS; MEDIATED-IMMUNITY; LAMININ ISOFORMS; RAT; MOLECULES; COMPONENT; ORGANIZATION; FIBRONECTIN	Resident dendritic cells (DC) within the T cell area of the lymph node take up soluble antigens that enter via the afferent lymphatics before antigen carrying DC arrive from the periphery. The reticular network within the lymph node is a conduit system forming the infrastructure for the fast delivery of soluble substances from the afferent lymph to the lumen of high endothelial venules (HEVs). Using high-resolution light microscopy and 3D reconstruction, we show here that these conduits are unique basement membrane-like structures ensheathed by fibroblastic reticular cells with occasional resident DC embedded within this cell layer. Conduit-associated DC are capable of taking up and processing soluble antigens transported within the conduits, whereas immigrated mature DC occur remote from the reticular fibers. The conduit system is, therefore, not a closed compartment that shuttles substances through the lymph node but represents the morphological equivalent to the filtering function of the lymph node.	Lund Univ, Dept Expt Pathol, S-22185 Lund, Sweden; Univ Erlangen Nurnberg, Dept Dermatol, D-91052 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Expt Med 1, D-91052 Erlangen, Germany; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Hannover Med Sch, Dept Funct & Appl Anat, D-30625 Hannover, Germany	Lund University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; McGill University; Hannover Medical School	Sixt, M (corresponding author), Lund Univ, Dept Expt Pathol, S-22185 Lund, Sweden.	sixt@biochem.mpg.de	Kanazawa, Nobuo/AAM-7353-2021; Reinhardt, Dieter P/A-3102-2008; Sixt, Michael/F-3925-2010	Kanazawa, Nobuo/0000-0003-3000-9711; Reinhardt, Dieter P/0000-0001-6535-9872; Sorokin, Lydia/0000-0001-7704-7921; Sixt, Michael/0000-0002-6620-9179; Lutz, Manfred B./0000-0001-9193-1772				Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; ANDERSON AO, 1975, AM J PATHOL, V80, P387; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BOTTGER BA, 1989, DIFFERENTIATION, V41, P158, DOI 10.1111/j.1432-0436.1989.tb00743.x; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GLAZYRIN AL, 1995, ANAT REC, V241, P175, DOI 10.1002/ar.1092410205; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; HAYAKAWA M, 1988, ARCH HISTOL CYTOL, V51, P233, DOI 10.1679/aohc.51.233; HAYAKAWA M, 1990, CELL TISSUE RES, V262, P199, DOI 10.1007/BF00327763; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; KARTTUNEN T, 1989, J HISTOCHEM CYTOCHEM, V37, P279, DOI 10.1177/37.3.2918219; KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; LI G, 2002, J BIOL CHEM, V277, P50798; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Manickasingham SP, 2001, IMMUNOLOGY, V102, P381, DOI 10.1046/j.1365-2567.2001.01219.x; Maurer T, 2002, EUR J IMMUNOL, V32, P2356, DOI 10.1002/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z; MOE RE, 1964, AM J ANAT, V114, P341, DOI 10.1002/aja.1001140211; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pior J, 1999, J INVEST DERMATOL, V113, P888, DOI 10.1046/j.1523-1747.1999.00770.x; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Pribila JT, 2004, J IMMUNOL, V172, P282, DOI 10.4049/jimmunol.172.1.282; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; SAINTEMARIE G, 1986, CELL TISSUE RES, V245, P481; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SCHULER F, 1995, J CELL SCI, V108, P3795; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Sixt M, 2001, J BIOL CHEM, V276, P18878, DOI 10.1074/jbc.M010898200; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; USHIKI T, 1995, ANAT REC, V241, P113, DOI 10.1002/ar.1092410115; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	52	551	562	1	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2005	22	1					19	29		10.1016/j.immuni.2004.11.013	http://dx.doi.org/10.1016/j.immuni.2004.11.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664156	Bronze			2022-12-18	WOS:000226682900004
J	Guerra, N; Tan, YX; Joncker, NT; Choy, A; Gallardo, F; Xiong, N; Knoblaugh, S; Cado, D; Greenberg, NR; Raulet, DH				Guerra, Nadia; Tan, Ying Xim; Joncker, Nathalie T.; Choy, Augustine; Gallardo, Fermin; Xiong, Na; Knoblaugh, Susan; Cado, Dragana; Greenberg, Norman R.; Raulet, David H.			NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy	IMMUNITY			English	Article							ACTIVATING NKG2D RECEPTOR; CELL-MEDIATED REJECTION; NATURAL-KILLER-CELLS; DNA-DAMAGE RESPONSE; NK CELLS; T-CELLS; PROSTATE-CANCER; C-MYC; TRANSGENIC MOUSE; EXPRESSION	Ligands for the NKG2D stimulatory receptor are frequently upregulated on tumor lines, rendering them sensitive to natural killer (NK) cells, but the role of NKG2D in tumor surveillance has not been addressed in spontaneous cancer models. Here, we provided the first characterization of NKG2D-deficient mice, including evidence that NKG2D was not necessary for NK cell development but was critical for immunosurveillance of epithelial and lymphoid malignancies in two transgenic models of de novo tumorigenesis. In both models, we detected NKG2D ligands on the tumor cell surface ex vivo, providing needed evidence for ligand expression by primary tumors. In a prostate cancer model, aggressive tumors arising in NKG2D-deficient mice expressed higher amounts of NKG2D ligands than did similar tumors in wild-type mice, suggesting an NKG2D-dependent immunoediting of tumors in this model. These findings provide important genetic evidence for surveillance of primary tumors by an NK receptor.	[Guerra, Nadia; Tan, Ying Xim; Joncker, Nathalie T.; Choy, Augustine; Gallardo, Fermin; Xiong, Na; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Guerra, Nadia; Tan, Ying Xim; Joncker, Nathalie T.; Choy, Augustine; Gallardo, Fermin; Xiong, Na; Raulet, David H.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Greenberg, Norman R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Fred Hutchinson Cancer Center	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@berkeley.edu		Raulet, David/0000-0002-1257-8649	NCI NIH HHS [R01 CA093678] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093678] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Degrassi A, 2007, PROSTATE, V67, P396, DOI 10.1002/pros.20511; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Farag SS, 2002, CLIN CANCER RES, V8, P2812; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Huss WJ, 2001, SEMIN CANCER BIOL, V11, P245, DOI 10.1006/scbi.2001.0373; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Ogasawara K, 2005, NAT IMMUNOL, V6, P938, DOI 10.1038/ni1236; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; PENCE D, 2001, EUR J IMMUNOL, V31, P1076; Pende D, 2002, CANCER RES, V62, P6178; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PREHN RT, 1975, J NATL CANCER I, V55, P189, DOI 10.1093/jnci/55.1.189; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Siren J, 2004, J GEN VIROL, V85, P2357, DOI 10.1099/vir.0.80105-0; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Spiewak R, 2001, ANN AGR ENV MED, V8, P255; Tani Y, 2005, VET PATHOL, V42, P306, DOI 10.1354/vp.42-3-306; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Zhang T, 2006, CANCER RES, V66, P5927, DOI 10.1158/0008-5472.CAN-06-0130; Zhou H, 2006, BLOOD, V107, P3251, DOI 10.1182/blood-2005-10-4231; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	64	550	578	3	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					571	580		10.1016/j.immuni.2008.02.016	http://dx.doi.org/10.1016/j.immuni.2008.02.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18394936	Green Accepted, Bronze			2022-12-18	WOS:000254939400017
J	Herbert, DR; Holscher, C; Mohrs, M; Arendse, B; Schwegmann, A; Radwanska, M; Leeto, M; Kirsch, R; Hall, P; Mossmann, H; Clausen, BE; Forster, I; Brombacher, F				Herbert, DR; Holscher, C; Mohrs, M; Arendse, B; Schwegmann, A; Radwanska, M; Leeto, M; Kirsch, R; Hall, P; Mossmann, H; Clausen, BE; Forster, I; Brombacher, F			Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology	IMMUNITY			English	Article							SYNTHASE ARGINASE BALANCE; TYPE-2 CYTOKINE RESPONSES; MOUSE BONE-MARROW; NITRIC-OXIDE; GRANULOMATOUS PATHOLOGY; RECEPTOR EXPRESSION; LEISHMANIA-MAJOR; IN-VIVO; T-CELLS; MICE	Macrophage/neutrophil-specific IL-4 receptor a-deficient mice (LysM(Cre)IL-4Ralpha(-/flox)) were generated to understand the role of IL-4/IL-13 responsive myeloid cells during Type 2 immune responses. LysM(Cre) IL4-Ralpha(-/flox) mice developed protective immunity against Nippostrongylus brasiliensis accompanied by T(H)2 development and goblet cell hyperplasia. In contrast, LysM(Cre)IL-4Ralpha(-/flox) mice were extremely susceptible to Schistosoma mansoni infection with 100% mortality during acute infection. Mortality was not dependent on neutrophils and occurred in the presence of T(H)2/Type 2 responses, granuloma formation, and egg-induced fibrosis. Death was associated with increased T(H)1 cytokines, hepatic and intestinal histopathology, increased NOS-2 activity, impaired egg expulsion, and sepsis. IL-10 was not able to compensate for the absence of IL-4/IL-13-activated alternative macrophages. Together, this shows that alternative macrophages are essential during schistosomiasis for protection against organ injury through downregulation of egg-induced inflammation.	Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	University of Cape Town; Max Planck Society; University of Munich	Herbert, DR (corresponding author), Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	fbrombac@uctgsh1.uct.ac.za	Herbert, DeBroski/AAD-3035-2019; Herbert, De'Broski/J-7357-2012; Förster, Irmgard/P-8545-2016; Hölscher, Christoph/O-1732-2018; CLAUSEN, Björn Erik/A-8229-2010; Radwanska, Magdalena/Q-4279-2018; Kirsch, Richard/J-2335-2016	Herbert, DeBroski/0000-0002-2449-5365; Herbert, De'Broski/0000-0002-2449-5365; Förster, Irmgard/0000-0002-7644-5642; Hölscher, Christoph/0000-0002-7520-9146; CLAUSEN, Björn Erik/0000-0002-2484-7842; Radwanska, Magdalena/0000-0002-0797-6001; 				Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; BERGMAN I, 1963, ANAL CHEM, V35, P1; BLACK CDV, 1991, FREE RADICAL RES COM, V12-3, P27, DOI 10.3109/10715769109145764; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Brunet LR, 1999, J IMMUNOL, V163, P4976; Brunet LR, 1997, J IMMUNOL, V159, P777; Chatterjee S, 2001, TROP MED INT HEALTH, V6, P1008, DOI 10.1046/j.1365-3156.2001.00744.x; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dunne DW, 1999, MICROBES INFECT, V1, P553, DOI 10.1016/S1286-4579(99)80095-1; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fallon PG, 1999, J IMMUNOL, V162, P4122; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FLAMME ACL, 2001, J IMMUNOL, V166, P1903; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; HARRIS RI, 1983, J CLIN PATHOL, V36, P1145, DOI 10.1136/jcp.36.10.1145; Hayashi N, 1999, J IMMUNOL, V163, P6702; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Jankovic D, 1999, J IMMUNOL, V163, P337; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Linehan SA, 2003, LAB INVEST, V83, P1223, DOI 10.1097/01.LAB.0000081392.93701.6F; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Louis J, 1998, CURR OPIN IMMUNOL, V10, P459, DOI 10.1016/S0952-7915(98)80121-0; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Mohrs M, 1999, J IMMUNOL, V162, P7302; Mohrs M, 2000, INFECT IMMUN, V68, P1773, DOI 10.1128/IAI.68.4.1773-1780.2000; Munder M, 1998, J IMMUNOL, V160, P5347; Murata T, 1998, INT IMMUNOL, V10, P1103, DOI 10.1093/intimm/10.8.1103; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Patton EA, 2002, INFECT IMMUN, V70, P177, DOI 10.1128/IAI.70.1.177-184.2002; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Stumpo R, 2003, CYTOKINE, V24, P46, DOI 10.1016/S1043-4666(03)00270-9; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078	44	548	567	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					623	635		10.1016/S1074-7613(04)00107-4	http://dx.doi.org/10.1016/S1074-7613(04)00107-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142530	Bronze			2022-12-18	WOS:000221631900012
J	Qiu, J; Heller, JJ; Guo, XH; Chen, ZME; Fish, K; Fu, YX; Zhou, L				Qiu, Ju; Heller, Jennifer J.; Guo, Xiaohuan; Chen, Zong-ming E.; Fish, Kamonwan; Fu, Yang-Xin; Zhou, Liang			The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid Cells	IMMUNITY			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; TH17 CELLS; NKP46(+) CELLS; HOST-DEFENSE; IL-22; DIFFERENTIATION; ACTIVATION; RESPONSES	Innate lymphoid cells (ILCs) expressing the nuclear receptor ROR gamma t are essential for gut immunity presumably through production of interleukin-22 (IL-22). The molecular mechanism underlying the development of ROR gamma t(+) ILCs is poorly understood. Here, we have shown that the aryl hydrocarbon receptor (Ahr) plays an essential role in ROR gamma t(+) ILC maintenance and function. Expression of Ahr in the hematopoietic compartment was important for accumulation of adult but not fetal intestinal ROR gamma t(+) ILCs. Without Ahr, ROR gamma t(+) ILCs had increased apoptosis and less production of IL-22. ROR gamma t interacted with Ahr and promoted Ahr binding at the 1122 locus. Upon IL-23 stimulation, Ahr-deficient ROR gamma t(+) ILCs had reduced IL-22 expression, consistent with downregulation of IL-23R in those cells. Ahr-deficient mice succumbed to Citrobacter rodentium infection, whereas ectopic expression of IL-22 protected animals from early mortality. Our data uncover a previously unrecognized physiological role for Ahr in promoting innate gut immunity by regulating ROR gamma t(+) ILCs.	[Qiu, Ju; Heller, Jennifer J.; Chen, Zong-ming E.; Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Qiu, Ju; Heller, Jennifer J.; Fish, Kamonwan; Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA; [Guo, Xiaohuan; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago	Zhou, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.	l-zhou@northwestern.edu	Qiu, Ju/AAW-7301-2021; Guo, Xiaohuan/I-3710-2017	Guo, Xiaohuan/0000-0001-5152-3010; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [AI 089954, AI091962, CA141975, AI090392]; Pew Scholarship; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA141975, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090392, R01AI089954, R21AI091962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholarship; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank entire L.Z. laboratory for their assistance and J. Marvin at Flow Cytometry Facility (Northwestern University) for cell sorting support. We are grateful to D. Liftman, G. Diehl, F. Gonzalez, W. Ouyang, Q. Zhou, and W. Muller for reagents, technical support, and discussion. Our special thanks to P. Stein for advice. We thank P. Stein and C.-R. Wang for critical reading of the manuscript. The work was supported by the National Institutes of Health (AI 089954 and AI091962 to L.Z., CA141975 and AI090392 to Y.-X.F.). This work was also supported by a Pew Scholarship and a Cancer Research Institute Investigator Award to L.Z.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen LP, 2009, CHEM RES TOXICOL, V22, P1897, DOI 10.1021/tx900043s; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; PERDEW GH, 1991, NUTR CANCER, V16, P209, DOI 10.1080/01635589109514159; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	55	547	563	5	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					92	104		10.1016/j.immuni.2011.11.011	http://dx.doi.org/10.1016/j.immuni.2011.11.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22177117	Green Accepted, Bronze			2022-12-18	WOS:000299766000013
J	Mebius, RE; Rennert, P; Weissman, IL				Mebius, RE; Rennert, P; Weissman, IL			Developing lymph nodes collect CD4(+)CD3(-) LT beta(+) cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; NATURAL-KILLER-CELLS; RECEPTOR-GAMMA-CHAIN; VASCULAR ADDRESSIN EXPRESSION; TUMOR-NECROSIS-FACTOR; ALPHA-DEFICIENT MICE; DENDRITIC CELLS; MONOCLONAL-ANTIBODY; GERMINAL-CENTERS; PRECURSOR CELLS	For a brief period during fetal lymph node organogenesis in mice, lymph node postcapillary high endothelial venules surprisingly express the Peyer's patch addressin MAdCAM-1. This expression allows initial seeding of this incipient structure by two unusual lymphocyte populations selectively expressing the Peyer's patch homing receptor integrin alpha 4 beta 7: CD4(+)CD3(-) oligolineage progenitors and TCR gamma delta(+) T cells. We show here that CD4(+)CD3(-) cells are lineage-restricted progenitors that express surface lymphotoxin-P (LTP) and the chemokine receptor BLR1 and that can become natural killer cells, dendritic antigen-presenting cells, and follicular cells of unknown outcome, but these cells do not become T or B lymphocytes. Since the necessity of lymphotoxin in lymphoid organ development has been shown, we propose that the novel subset of CD4(+) CD3(-)LT beta(+) fetal cells is instrumental in the development of lymphoid tissue architecture.	BIOGEN INC,CAMBRIDGE,MA 02142; STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305	Biogen; Stanford University; Stanford University	Mebius, RE (corresponding author), VRIJE UNIV AMSTERDAM,FAC MED,DEPT CELL BIOL & IMMUNOL,VAN DER BOECHORSTSTR 7,NL-1081 BT AMSTERDAM,NETHERLANDS.			Mebius, Reina/0000-0003-0451-7464	NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NCI NIH HHS [CA42551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Aguila HL, 1996, BLOOD, V87, P1225, DOI 10.1182/blood.V87.4.1225.bloodjournal8741225; Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; ANTICA M, 1993, J IMMUNOL, V151, P5887; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BANKS TA, 1995, J IMMUNOL, V155, P1685; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Browning JL, 1997, J IMMUNOL, V159, P3288; Bruno L, 1997, J EXP MED, V185, P875, DOI 10.1084/jem.185.5.875; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CHANG HL, 1991, J IMMUNOL, V147, P1687; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FRIEDBER.SH, 1974, J IMMUNOL, V113, P1477; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; HUMPHREY JH, 1984, EUR J IMMUNOL, V14, P859, DOI 10.1002/eji.1830140916; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; KNIGHT SC, 1983, P NATL ACAD SCI-BIOL, V80, P6032, DOI 10.1073/pnas.80.19.6032; KONDO M, 1994, EUR J IMMUNOL, V24, P2026, DOI 10.1002/eji.1830240914; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; KRAAL G, 1996, ADV IMMUNOL, V65, P347; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0; LO D, 1992, AM J PATHOL, V141, P1237; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; RENNERT PD, 1997, IN PRESS INT IMMUNOL; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saunders D, 1996, J EXP MED, V184, P2185, DOI 10.1084/jem.184.6.2185; SCHRIEVER F, 1991, BLOOD, V77, P787; SPANGRUDE GJ, 1992, BLOOD, V80, P1957; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPENCER J, 1986, CLIN EXP IMMUNOL, V64, P536; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Szabo MC, 1997, J IMMUNOL, V158, P5584; Togni PD, 1994, SCIENCE, V264, P703; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145	64	547	559	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					493	504		10.1016/S1074-7613(00)80371-4	http://dx.doi.org/10.1016/S1074-7613(00)80371-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354470	Bronze			2022-12-18	WOS:A1997YD59300006
J	Cao, XF; Cai, SF; Fehniger, TA; Song, JL; Collins, LI; Piwnica-Worms, DR; Ley, TJ				Cao, Xuefang; Cai, Sheng F.; Fehniger, Todd A.; Song, Jiling; Collins, Lynne I.; Piwnica-Worms, David R.; Ley, Timothy J.			Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; CASPASE ACTIVATION; NK CELLS; CYTOTOXICITY; APOPTOSIS; SURVEILLANCE; REJECTION; REQUIRES; IMMUNITY; GROWTH	Granzyme B is important for the ability of NK cells and CD8(+) T cells to kill their targets. However, we showed here that granzyme B-deficient mice clear both allogeneic and syngeneic tumor cell lines more efficiently than do wild-type (WT) mice. To determine whether regulatory T (Treg) cells utilize granzyme B to suppress immune responses against these tumors, we examined the expression and function of granzyme B in Treg cells. Granzyme B was not expressed in naive Treg cells but was highly expressed in 5%-30% of CD4(+)Foxp3(+) Treg cells in the tumor environment. Adoptive transfer of WT Treg cells, but not granzyme B- or perforin-deficient Treg cells, into granzyme B-cleficient mice partially restored susceptibility to tumor growth; Treg cells derived from the tumor environment could induce NK and CD8+ T cell death in a granzyme B- and perforin -dependent fashion. Granzyme B and perforin are therefore relevant for Treg cell-mediated suppression of tumor clearance in vivo.	Washington Univ, Sch Med, Div Oncol, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol,Mol Imaging Ctr, Mallinckrodt Inst Radiol,Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Div Oncol, Dept Internal Med, St Louis, MO 63110 USA.	tley@im.wustl.edu	Calabrese, Massimiliano/I-6195-2012	Fehniger, Todd/0000-0002-8705-2887; Cai, Sheng/0000-0002-2708-887X	NCI NIH HHS [P50 CA94056] Funding Source: Medline; NIAMS NIH HHS [P30 AR048335] Funding Source: Medline; NIDDK NIH HHS [DK49786] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049786] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Barao I, 2006, P NATL ACAD SCI USA, V103, P5460, DOI 10.1073/pnas.0509249103; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Grundy MA, 2007, CANCER IMMUNOL IMMUN, V56, P1153, DOI 10.1007/s00262-006-0264-1; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jans DA, 1999, J BIOL CHEM, V274, P3953, DOI 10.1074/jbc.274.7.3953; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; KOBAYASHI H, 1990, CELL IMMUNOL, V128, P589, DOI 10.1016/0008-8749(90)90051-R; LAW P, 1989, INT J CELL CLONING, V7, P100, DOI 10.1002/stem.5530070204; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Okada CY, 1997, J IMMUNOL, V159, P5516; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Rosen D, 2000, J IMMUNOL, V164, P3229, DOI 10.4049/jimmunol.164.6.3229; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Screpanti V, 2001, J IMMUNOL, V167, P2068, DOI 10.4049/jimmunol.167.4.2068; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; Shresta S, 1997, J BIOL CHEM, V272, P20236, DOI 10.1074/jbc.272.32.20236; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Yamaguchi T, 2006, SEMIN CANCER BIOL, V16, P115, DOI 10.1016/j.semcancer.2005.11.005; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	45	545	581	5	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					635	646		10.1016/j.immuni.2007.08.014	http://dx.doi.org/10.1016/j.immuni.2007.08.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17919943	Bronze			2022-12-18	WOS:000250490700014
J	Korganow, AS; Ji, H; Mangialaio, S; Duchatelle, V; Pelanda, R; Martin, T; Degott, C; Kikutani, H; Rajewsky, K; Pasquali, JL; Benoist, C; Mathis, D				Korganow, AS; Ji, H; Mangialaio, S; Duchatelle, V; Pelanda, R; Martin, T; Degott, C; Kikutani, H; Rajewsky, K; Pasquali, JL; Benoist, C; Mathis, D			From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins	IMMUNITY			English	Article							COLLAGEN-INDUCED ARTHRITIS; B-CELLS; RHEUMATOID-ARTHRITIS; II COLLAGEN; MICE; SYNOVITIS; ANTIGEN; AUTOANTIBODY; ORIGINS; MOUSE	Rheumatoid arthritis is a common and debilitating autoimmune disease whose cause and mechanism remain a mystery. We recently described a T cell receptor transgenic mouse model that spontaneously develops a disease with most of the clinical, histological, and immunological features of rheumatoid arthritis in humans. Disease development in K/BxN mice is initiated by systemic T cell self-reactivity; it requires T cells, as expected, but B cells are also needed, more surprisingly. Here, we have identified the role of B cells as the secretion of arthritogenic immunoglobulins. We suggest that a similar scenario may unfold in some other arthritis models and in human patients, beginning with pervasive T cell autoreactivity and ending in immunoglobulin-provoked joint destruction.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire,CU Strasbourg, F-67404 Illkirch Graffenstaden, France; Hop Civil, Ctr Rech ImmunoHematol, F-67000 Strasbourg, France; Hop Beaujon, Serv Anat Pathol, F-92110 Clichy, France; Univ Cologne, Dept Immunol, Inst Genet, D-50931 Cologne, Germany; Osaka Univ, Microbial Dis Res Inst, Div Mol Immunol, Suita, Osaka 565, Japan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Cologne; Osaka University	Benoist, C (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire,CU Strasbourg, BP 163, F-67404 Illkirch Graffenstaden, France.		Kikutani, Hitoshi/C-9525-2009	Korganow, Anne-Sophie/0000-0002-1664-6311; Martin, Thierry/0000-0002-2776-2641; Rajewsky, Klaus/0000-0002-6633-6370				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Amigorena S, 1998, CURR OPIN IMMUNOL, V10, P88, DOI 10.1016/S0952-7915(98)80037-X; Burmester GR, 1997, ARTHRITIS RHEUM, V40, P5, DOI 10.1002/art.1780400104; CLAQUE RB, 1984, ARTHRITIS RHEUM, V27, P1370; Clark LB, 1996, ADV IMMUNOL, V63, P43; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FIRESTEIN GS, 1990, ARTHRITIS RHEUM, V33, P768, DOI 10.1002/art.1780330602; Fox DA, 1997, ARTHRITIS RHEUM, V40, P598, DOI 10.1002/art.1780400403; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; KADOWAKI KM, 1994, CLIN EXP IMMUNOL, V97, P212; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Plows D, 1999, J IMMUNOL, V162, P1018; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Rudolphi U, 1997, ARTHRITIS RHEUM, V40, P1409, DOI 10.1002/art.1780400808; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; STUART JM, 1982, J EXP MED, V155, P1, DOI 10.1084/jem.155.1.1; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; TAYLOR PC, 1995, EUR J IMMUNOL, V25, P763, DOI 10.1002/eji.1830250321; Thomas PG, 1996, CAN PUBLIC ADMIN, V39, P1, DOI 10.1300/J021v16n03_01; TRENTHAM DE, 1995, MECH MODELS RHEUMATO, P447; VAUGHAN JH, 1993, ARTHRITIS RHEUM, V36, P1, DOI 10.1002/art.1780360102; VIDARD L, 1992, J IMMUNOL, V149, P1905; ZOU YR, 1993, SCIENCE, V262, P1271, DOI 10.1126/science.8235658; Zvaifler N J, 1973, Adv Immunol, V16, P265, DOI 10.1016/S0065-2776(08)60299-0	38	544	570	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					451	461		10.1016/S1074-7613(00)80045-X	http://dx.doi.org/10.1016/S1074-7613(00)80045-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229188	Bronze			2022-12-18	WOS:000079989600006
J	Sykulev, Y; Joo, M; Vturina, I; Tsomides, TJ; Eisen, HN				Sykulev, Y; Joo, M; Vturina, I; Tsomides, TJ; Eisen, HN			Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response	IMMUNITY			English	Article							CLASS-I MHC; CYTOTOXIC LYMPHOCYTES-T; MONOCLONAL-ANTIBODIES; ANTIGEN; ACTIVATION; PROTEIN; QUANTITATION; STIMULATION; EPITOPE; CLONE	Using a chemically homogeneous radiolabeled peptide of high specific activity (I-125-QLSPYPFDL, 3.5 x 10(18) cpm per mole) we show that at a peptide concentration (5 pM) causing half-maximal lysis of target cells by a cytolytic T lymphocyte (CTL) clone that recognizes the peptide in association with L(d), a class I MHC protein, only 3 peptide molecules on average are bound by L(d) per target cell. From the distribution of L(d) on the target cells, we suggest that a single peptide-MHC complex per target cell can trigger activation of the T cell cytolytic response.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	Sykulev, Y (corresponding author), MIT,CTR CANC RES,CAMBRIDGE,MA 02139, USA.				NCI NIH HHS [CA60686] Funding Source: Medline; NIAID NIH HHS [AI0746, AI34247] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034247] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DUTZ JP, 1992, INT IMMUNOL, V4, P571, DOI 10.1093/intimm/4.5.571; FIELDS BA, 1995, SCIENCE, V270, P1821, DOI 10.1126/science.270.5243.1821; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MORRISON J, 1992, EUR J IMMUNOL, V22, P90; OETTGEN HC, 1985, CELL, V40, P583, DOI 10.1016/0092-8674(85)90206-5; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; OZATO K, 1980, J IMMUNOL, V125, P2473; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; ROJO JM, 1988, J IMMUNOL, V140, P1081; Schumacher T.N.M., 1995, CURRENT PROTOCOLS PR, V00, P331; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; TAMURA T, 1992, J IMMUNOL, V148, P2370; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; TSOMIDES TJ, 1993, ANAL BIOCHEM, V210, P129, DOI 10.1006/abio.1993.1162; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WILLIAMS AF, 1992, NATURE, V356, P746, DOI 10.1038/356746a0; ZYCHLINSKY A, 1991, J IMMUNOL, V146, P393	37	544	559	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1996	4	6					565	571		10.1016/S1074-7613(00)80483-5	http://dx.doi.org/10.1016/S1074-7613(00)80483-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673703	Bronze			2022-12-18	WOS:A1996UU44300005
J	GALY, A; TRAVIS, M; CEN, DZ; CHEN, B				GALY, A; TRAVIS, M; CEN, DZ; CHEN, B			HUMAN T-CELLS, B-CELLS, NATURAL-KILLER, AND DENDRITIC CELLS ARISE FROM A COMMON BONE-MARROW PROGENITOR-CELL SUBSET	IMMUNITY			English	Article							STEM-CELLS; PRECURSOR CELLS; THYMUS; MOUSE; DIFFERENTIATION; POPULATIONS; MACROPHAGES; ONTOGENY; CULTURE	The early stages of lymphoid cell formation were studied by testing the differentiative potential of phenotypically defined subsets of CD34(+) bone marrow cells, a subpopulation of CD34(+) Lin(-) CD45RA(+) cells expressing CD10 was isolated by flow cytometry, Such cells are CD38(+), HLA-DR(+), do not express significant levels of Thy-1 and c-kit, lack erythroid, myeloid, megakaryocytic potential, and give rise only to lymphoid T, B, natural killer (NK), and dendritic cells (DC) in kinetics and titration experiments, Limiting dilution analysis demonstrates the existence of multipotential B/NK/DC progenitor clones in the CD34(hi) Lin(-)CD10(+) adult bone marrow cell population, Thus, nonprimitive progenitors for lymphoid cells and for DCs can be distinct from those of myeloid, megakaryocytic, and erythroid cells, implying that the DC lineage is developmentally more closely related to the lymphoid lineage than to the myeloid lineage, This study provides new insights into the organization and development of the human lympho-hematopoietic system.			GALY, A (corresponding author), SYSTEMIX INC, EXPTL CELLULAR THERAPY GRP, 3155 PORTER DR, PALO ALTO, CA 94304 USA.		Galy, Anne HM/J-4439-2013	Galy, Anne HM/0000-0002-0153-4392				ANTICA M, 1993, J IMMUNOL, V151, P5887; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; CHEN BP, 1994, BLOOD, V84, P2497, DOI 10.1182/blood.V84.8.2497.bloodjournal8482497; CHICK SE, 1995, THESIS U CALIFORNIA; Civin C I, 1993, J Hematother, V2, P137, DOI 10.1089/scd.1.1993.2.137; DIGIUSTO D, 1994, BLOOD, V84, P421; FOLKS TM, 1988, SCIENCE, V242, P919, DOI 10.1126/science.2460922; GALY A, 1993, J EXP MED, V178, P391, DOI 10.1084/jem.178.2.391; GALY AHM, 1995, BLOOD, V85, P2770, DOI 10.1182/blood.V85.10.2770.bloodjournal85102770; GALY AHM, 1994, BLOOD, V84, P104; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GORE SD, 1991, BLOOD, V77, P1681; GOYERT SM, 1989, LEUCOCYTE TYPING, V4, P789; GUNJI Y, 1993, BLOOD, V82, P3283; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; JANOSSY G, 1986, J IMMUNOL, V136, P4354; KAMPINGA J, 1990, J IMMUNOL, V145, P1659; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KINCADE PW, 1994, P NATL ACAD SCI USA, V91, P2888, DOI 10.1073/pnas.91.8.2888; LAFONTAINE M, 1992, CELL IMMUNOL, V142, P238, DOI 10.1016/0008-8749(92)90286-X; LANIER LL, 1992, IMMUNOL TODAY, V13, P392, DOI 10.1016/0167-5699(92)90087-N; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; LANSDORP PM, 1992, J EXP MED, V175, P1501, DOI 10.1084/jem.175.6.1501; LEBIEN TW, 1989, BLOOD, V73, P625; LEDOUARIN NM, 1973, NATURE-NEW BIOL, V246, P25, DOI 10.1038/newbio246025b0; Loken MR, 1992, FLOW CYTOMETRY HEMAT, P31; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; MARQUEZ C, 1995, J EXP MED, V181, P475, DOI 10.1084/jem.181.2.475; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MURRAY L, 1995, BLOOD, V85, P368; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; ODOHERTY U, 1993, J EXP MED, V178, P1067, DOI 10.1084/jem.178.3.1067; OGAWA M, 1993, BLOOD, V81, P2844; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; SPANGRUDE GJ, 1988, J EXP MED, V167, P1671, DOI 10.1084/jem.167.5.1671; SROUR EF, 1993, BLOOD, V82, P3333; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; TASWELL C, 1981, J IMMUNOL, V126, P1614; TERSTAPPEN LWMM, 1992, BLOOD, V79, P666; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; UCKUN FM, 1990, BLOOD, V76, P1908; VISSER JWM, 1992, FLOW CYTOMETRY HEMAT, P9; WINKEL K, 1994, IMMUNOL LETT, V40, P93, DOI 10.1016/0165-2478(94)90178-3; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	49	544	562	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1995	3	4					459	473		10.1016/1074-7613(95)90175-2	http://dx.doi.org/10.1016/1074-7613(95)90175-2			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584137	Bronze			2022-12-18	WOS:A1995TB60800007
J	Kawalekar, OU; O'Connor, RS; Fraietta, JA; Guo, L; McGettigan, SE; Posey, AD; Patel, PR; Guedan, S; Scholler, J; Keith, B; Snyder, N; Blair, I; Milone, MC; June, CH				Kawalekar, Omkar U.; O'Connor, Roddy S.; Fraietta, Joseph A.; Guo, Lili; McGettigan, Shannon E.; Posey, Avery D., Jr.; Patel, Prachi R.; Guedan, Sonia; Scholler, John; Keith, Brian; Snyder, Nathaniel; Blair, Ian; Milone, Michael C.; June, Carl H.			Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells	IMMUNITY			English	Article							SPARE RESPIRATORY CAPACITY; CHIMERIC ANTIGEN RECEPTORS; MITOCHONDRIAL COMPLEX-I; ADOPTIVE IMMUNOTHERAPY; SUSTAINED REMISSIONS; ANTITUMOR-ACTIVITY; OXIDATIVE STRESS; ACTIVATION; IMMUNOGLOBULIN; COSTIMULATION	Chimeric antigen receptors (CARs) redirect T cell cytotoxicity against cancer cells, providing a promising approach to cancer immunotherapy. Despite extensive clinical use, the attributes of CAR co-stimulatory domains that impact persistence and resistance to exhaustion of CAR-T cells remain largely undefined. Here, we report the influence of signaling domains of coreceptors CD28 and 4-1BB on the metabolic characteristics of human CAR T cells. Inclusion of 4-1BB in the CAR architecture promoted the outgrowth of CD8(+) central memory T cells that had significantly enhanced respiratory capacity, increased fatty acid oxidation and enhanced mitochondrial biogenesis. In contrast, CAR T cells with CD28 domains yielded effector memory cells with a genetic signature consistent with enhanced glycolysis. These results provide, at least in part, a mechanistic insight into the differential persistence of CAR-T cells expressing 4-1BB or CD28 signaling domains in clinical trials and inform the design of future CAR T cell therapies.	[Kawalekar, Omkar U.; Fraietta, Joseph A.; McGettigan, Shannon E.; Posey, Avery D., Jr.; Patel, Prachi R.; Guedan, Sonia; Scholler, John; Keith, Brian; Milone, Michael C.; June, Carl H.] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [O'Connor, Roddy S.; Milone, Michael C.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Guo, Lili; Snyder, Nathaniel; Blair, Ian] Univ Penn, Perelman Sch Med, Penn SRP Ctr, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Guo, Lili; Snyder, Nathaniel; Blair, Ian] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Snyder, Nathaniel] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Drexel University	June, CH (corresponding author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu	patel, prachi/GRY-0386-2022; Guedan, Sonia/O-9645-2018; Posey, Avery D./P-4890-2019	Guedan, Sonia/0000-0002-9605-0760; Posey, Avery D./0000-0001-8711-629X; McGettigan, Shannon/0000-0003-1421-0511; Snyder, Nathaniel/0000-0001-5643-8747	NIH [5R01CA120409]; National Cancer Institute [NCI T32CA009140]; Novartis; NATIONAL CANCER INSTITUTE [T32CA009140, R01CA120409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the NIH (5R01CA120409), National Cancer Institute (NCI T32CA009140 to J.A.F.), and Novartis. The authors would like to thank Li Liu, Felipe Bedoya, and Jos Melenhorst for the generous gift of the CD19 anti-idiotype; Yangbing Zhao, Daniel Powell, Jose Conejo-Garcia, and Andrew Wells for helpful discussions; Biao Zuo and Raymond Meade at Penn's Electron Microscope Resource Laboratory; Xinyu Zhao (Jasmine) and Andrea Stout from CBD Microscopy Core Facility; Joyce Lee and Kathryn E. Wellen for expert technical assistance; and the Human Immunology Core for reagents. The authors also express their gratitude to Brian Dranka and David Ferrick from Seahorse Bioscience for technical assistance in the metabolic flux assays. O.U.K., J.A.F., S.E.M., A.D.P., S.G., J.S., M.C.M., and C.H.J. are inventors of intellectual property licensed by the University of Pennsylvania to Novartis. This work was supported in part by a grant from Novartis.	Basu SS, 2012, NAT PROTOC, V7, P1, DOI 10.1038/nprot.2011.421; Basu SS, 2011, ANAL CHEM, V83, P1363, DOI 10.1021/ac1027353; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brocker T, 2000, BLOOD, V96, P1999, DOI 10.1182/blood.V96.5.1999.h8001999_1999_2001; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dotti G, 2014, IMMUNOL REV, V257, P107, DOI 10.1111/imr.12131; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guedan S, 2014, BLOOD, V124, P1070, DOI 10.1182/blood-2013-10-535245; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hassan R, 2002, CLIN CANCER RES, V8, P3520; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KUWANA Y, 1987, BIOCHEM BIOPH RES CO, V149, P960, DOI 10.1016/0006-291X(87)90502-X; Lamers C.H.J., 2006, J CLIN ONCOL, V24, pe20, DOI [DOI 10.1200/JCO.2006.05.9964, 10.1200/JCO.2006.05.9964]; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Martinez-Forero I, 2013, J IMMUNOL, V190, P6694, DOI 10.4049/jimmunol.1203010; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2013, CANCER IMMUNOL RES, V1, P26, DOI 10.1158/2326-6066.CIR-13-0006; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Worth AJ, 2014, J BIOL CHEM, V289, P26895, DOI 10.1074/jbc.M114.591354; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007	48	543	576	11	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					380	390		10.1016/j.immuni.2016.01.021	http://dx.doi.org/10.1016/j.immuni.2016.01.021			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885860	Bronze			2022-12-18	WOS:000370294000019
J	Sica, GL; Choi, IH; Zhu, GF; Tamada, K; Wang, SD; Tamura, H; Chapoval, AI; Flies, DB; Bajorath, J; Chen, LP				Sica, GL; Choi, IH; Zhu, GF; Tamada, K; Wang, SD; Tamura, H; Chapoval, AI; Flies, DB; Bajorath, J; Chen, LP			B7-H4, a molecule of the B7 family, negatively regulates T cell immunity	IMMUNITY			English	Article							CO-STIMULATION; TUMOR; PROTEIN; ICOS; COSTIMULATION; INHIBITION; IDENTIFICATION; ACTIVATION; ENGAGEMENT; PATHWAYS	We identify a B7 family molecule, B7-H4, by protein sequence analysis and comparative molecular modeling. While B7-H4 mRNA is widely distributed in mouse and human peripheral tissues, cell surface expression of B7-H4 protein is limited and shows an inducible pattern on hematopoietic cells. Putative receptor of B7-H4 can be upregulated on activated T cells. By arresting cell cycle, B7-H4 ligation of T cells has a profound inhibitory effect on the growth, cytokine secretion, and development of cytotoxicity. Administration of B7-H4Ig into mice impairs antigen-specific T cell responses whereas blockade of endogenous B7-H4 by specific monoclonal antibody promotes T cell responses. B7-H4 thus may participate in negative regulation of cell-mediated immunity in peripheral tissues.	Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Grad Sch, Dept Immunol, Rochester, MN 55905 USA; Inje Univ, Coll Med, Dept Microbiol, Pusan 614735, South Korea; Albany Mol Res Inc, Bothell Res Ctr, Bothell, WA 98011 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Mayo Clinic; Mayo Clinic; Inje University; University of Washington; University of Washington Seattle	Chen, LP (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	chen.lieping@mayo.edu	Chapoval, Andrei/N-9568-2013; Bajorath, Jürgen/F-7493-2014; Tamura, Hideto/AAV-3532-2020	Chapoval, Andrei/0000-0002-3426-1036; 	NATIONAL CANCER INSTITUTE [R01CA097085, R01CA098731] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA98731, R01 CA97085, CA09127] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chapoval AI, 2000, BLOOD, V95, P2346, DOI 10.1182/blood.V95.7.2346.007k05_2346_2351; Chapoval AI, 2002, MOL BIOTECHNOL, V21, P259, DOI 10.1385/MB:21:3:259; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fahrer AM, 2001, NATURE, V409, P836, DOI 10.1038/35057020; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hurwitz AA, 2000, CURR OPIN IMMUNOL, V12, P589, DOI 10.1016/S0952-7915(00)00147-3; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; SHIN T, 2003, IN PRESS J EXP MED; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tamada K, 2000, NAT MED, V6, P283; Tamada K, 2002, J CLIN INVEST, V109, P549, DOI 10.1172/JCI200213604; Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Wang SD, 2000, BLOOD, V96, P2808; Wang SD, 2002, J EXP MED, V195, P1033, DOI 10.1084/jem.20011607; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	39	543	698	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2003	18	6					849	861		10.1016/S1074-7613(03)00152-3	http://dx.doi.org/10.1016/S1074-7613(03)00152-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818165	Bronze			2022-12-18	WOS:000183767700014
J	Deeks, SG; Walker, BD				Deeks, Steven G.; Walker, Bruce D.			Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy	IMMUNITY			English	Review							T-CELL RESPONSES; LONG-TERM NONPROGRESSORS; PLASMACYTOID DENDRITIC CELLS; HIV-1 RNA LEVELS; VIRAL LOAD; HLA-B; LYMPHOCYTE ACTIVATION; DISEASE PROGRESSION; GENETIC RESTRICTION; ELITE SUPPRESSORS	Chronic viral infections can appear in two very different forms: those that are typically immunologically contained after acute symptomatic infection, such as Epstein-Barr virus (EBV), and those that predictably lead to persistent viremia and progressive clinical disease. Human immunodeficiency virus (HIV) infection is typical of the latter and has resulted in more than 20 million deaths worldwide. Here we review a remarkable subset of persons infected with HIV who are able to achieve long-term control of viremia and avoid immunodeficiency without the need for antiviral therapy. We review the contributing role of host genetic factors, innate and adaptive immune responses, and viral factors that may contribute to this phenotype. These individuals indicate that as with other potentially pathogenic chronic viral infections, the human immune system is able to fully control HIV and prevent HIV-associated disease, at least in some individuals. Further understanding of the mechanisms whereby this occurs should yield critical insights for prophylactic and therapeutic antiviral interventions.	Univ Calif San Francisco, San Francisco, CA 94110 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Walker, BD (corresponding author), Univ Calif San Francisco, San Francisco, CA 94110 USA.	bwalker@partners.org			NIAID NIH HHS [K24 AI69994, R01 AI052745, R01 AI060354-03] Funding Source: Medline; NIMH NIH HHS [P30 MH59037] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI052745, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Churchill MJ, 2006, J VIROL, V80, P1047, DOI 10.1128/JVI.80.2.1047-1052.2006; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Deeks SG, 2004, J CLIN INVEST, V113, P808, DOI 10.1172/JCI200421318; DOLAN MJ, 2007, IN PRESS NAT IMMUNOL; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; EMU B, 2006, 13 C RETR OPP INF FE; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goudsmit J, 2002, AIDS, V16, P791, DOI 10.1097/00002030-200203290-00016; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hassaine G, 2000, VIROLOGY, V276, P169, DOI 10.1006/viro.2000.0543; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; HUNT PW, 2007, IN PRESS J INFECT DI; Jansen CA, 2005, EUR J IMMUNOL, V35, P150, DOI 10.1002/eji.200425487; KAUFMANN DE, 2007, IN PRESS NAT IMMUNOL; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2005, CLIN INFECT DIS, V40, P1350, DOI 10.1086/429318; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; MUNOZ A, 1995, J ACQ IMMUN DEF SYND, V8, P496, DOI 10.1097/00042560-199504120-00010; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PEREYRA F, 2007, IN PRESS J INFECT DI; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Plenge R, 2006, IMMUNOL REV, V210, P40, DOI 10.1111/j.0105-2896.2006.00372.x; Pontesilli O, 1999, AIDS RES HUM RETROV, V15, P973, DOI 10.1089/088922299310485; Prins M, 1997, AIDS, V11, P621, DOI 10.1097/00002030-199705000-00010; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Schmidt B, 2006, J CLIN IMMUNOL, V26, P55, DOI 10.1007/s10875-006-8401-3; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SHEPPARD HW, 1993, AIDS, V7, P1159, DOI 10.1097/00002030-199309000-00002; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Wang B, 1996, VIROLOGY, V223, P224, DOI 10.1006/viro.1996.0471; Wilson JDK, 2000, J INFECT DIS, V182, P792, DOI 10.1086/315764; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Yamada T, 2000, ARCH VIROL, V145, P1021, DOI 10.1007/s007050050692; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	102	542	560	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					406	416		10.1016/j.immuni.2007.08.010	http://dx.doi.org/10.1016/j.immuni.2007.08.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892849	Bronze			2022-12-18	WOS:000249843400006
J	Ma, Q; Jones, D; Springer, TA				Ma, Q; Jones, D; Springer, TA			The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment	IMMUNITY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; LYMPHOCYTE CHEMOATTRACTANT; LYMPHOPOIESIS; SDF-1; HIV-1; MYELOPOIESIS; LESTR/FUSIN; ASSOCIATION; MOLECULES; CYTOKINES	We report that the chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within fetal liver and bone marrow microenvironment, in CXCR4-deficient embryos, pro-B cells are present in blood but hardly detectable in liver; myeloid cells are elevated in blood and reduced in liver compared to wild-type embryos. Mice reconstituted with CXCR4-deficient fetal liver cells have reduced donor-derived mature B lymphocytes in blood and lymphoid organs. The numbers of pro-B and pre-B cells are reduced in bone marrow and abnormally high in blood. Granulocytic cells are reduced in bone marrow but elevated and less mature in the blood. B lineage and granulocytic precursors are released into the periphery in absence of CXCR4.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.		Jones, Daniel/I-7399-2015		NHLBI NIH HHS [HL-48675] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Berliner N, 1998, Curr Opin Hematol, V5, P49, DOI 10.1097/00062752-199801000-00009; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Deichmann M, 1997, BLOOD, V89, P3522, DOI 10.1182/blood.V89.10.3522.3522_3522_3528; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Hori T, 1998, J IMMUNOL, V160, P180; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; KEE BL, 1995, INT REV CYTOL, V157, P129, DOI 10.1016/S0074-7696(08)62158-0; KINCADE PW, 1989, ANNU REV IMMUNOL, V7, P111, DOI 10.1146/annurev.iy.07.040189.000551; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MARMONT AM, 1988, ATLAS BLOOD CELLS FU, P159; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OTTEN G, 1992, CURRENT PROTOCOLS IM; ROLINK A, 1993, ADV IMMUNOL, V53, P123, DOI 10.1016/S0065-2776(08)60499-X; RYAN DH, 1995, LEUKEMIA LYMPHOMA, V17, P375, DOI 10.3109/10428199509056848; SPRINGER TA, 1995, HARVEY LECTURES SERI, V89, P53; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	32	541	581	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					463	471		10.1016/S1074-7613(00)80046-1	http://dx.doi.org/10.1016/S1074-7613(00)80046-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229189	Bronze			2022-12-18	WOS:000079989600007
J	He, B; Xu, W; Santini, PA; Polydorides, AD; Chiu, A; Estrella, J; Shan, M; Chadburn, A; Villanacci, V; Plebani, A; Knowles, DM; Rescigno, M; Cerutti, A				He, Bing; Xu, Weifeng; Santini, Paul A.; Polydorides, Alexandros D.; Chiu, April; Estrella, Jeannelyn; Shan, Meimei; Chadburn, Amy; Villanacci, Vincenzo; Plebani, Alessandro; Knowles, Daniel M.; Rescigno, Maria; Cerutti, Andrea			Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL	IMMUNITY			English	Article							IGA-PRODUCING CELLS; GUT LAMINA PROPRIA; NAIVE B-CELLS; DENDRITIC CELLS; SOMATIC HYPERMUTATION; COMMENSAL BACTERIA; DNA RECOMBINATION; DIFFERENTIATION; HOMEOSTASIS; ACTIVATION	Bacteria colonize the intestine shortly after birth and thereafter exert several beneficial functions, including induction of protective immunoglobulin A (IgA) antibodies. The distal intestine contains IgA(2), which is more resistant to bacterial proteases than is IgA(1). The mechanism by which B cells switch from IgM to IgA(2) remains unknown. We found that human intestinal epithelial cells (IECs) triggered IgA(2) class switching in B cells, including IgA(1)-expressing B cells arriving from mucosal follicles, through a CD4(+) T cell-independent pathway involving a proliferation-inducing ligand (APRIL). IECs released APRIL after sensing bacteria through Toll-like receptors (TLRs) and further increased APRIL production by activating dendritic cells via thymic stromal lymphopoietin. Our data indicate that bacteria elicit IgA2 class switching by linking lamina propria B cells with IECs through a TLR-inducible signaling program requiring APRIL. Thus, mucosal vaccines should activate IECs to induce more effective IgA(2) responses.	Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Immunol Microbiol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; Spedali Civil Brescia, Serv Anat Patol 2, I-25123 Brescia, Italy; Univ Brescia, Pediat Clin, I-25123 Brescia, Italy; Univ Brescia, Ist Med Mol A Nocivelli, I-25123 Brescia, Italy; IEO, I-20141 Milan, Italy	Cornell University; Cornell University; Cornell University; Hospital Spedali Civili Brescia; University of Brescia; University of Brescia; IRCCS European Institute of Oncology (IEO)	Cerutti, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10021 USA.	acerutti@med.cornell.edu	Rescigno, Maria/J-9704-2012; Plebani, Alessandro/C-8593-2011	Rescigno, Maria/0000-0002-6464-509X; Cerutti, Andrea/0000-0003-3026-4704; Xu, Weifeng/0000-0001-7598-1489	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057653, R01AI074378, R21AI057130, T32AI007621] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI074378, AI057653, R01 AI057653, R21 AI057130, T32 AI07621] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Cerutti A, 2002, J IMMUNOL, V169, P6594, DOI 10.4049/jimmunol.169.11.6594; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CRAGO SS, 1984, J IMMUNOL, V132, P16; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI200421345; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; KETT K, 1986, J IMMUNOL, V136, P3631; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LUE C, 1988, J IMMUNOL, V140, P3793; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; TARKOWSKI A, 1990, J IMMUNOL, V144, P3770; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wilson E, 2004, J EXP MED, V200, P805, DOI 10.1084/jem.20041069; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	46	540	569	3	47	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2007	26	6					812	826		10.1016/j.immuni.2007.04.014	http://dx.doi.org/10.1016/j.immuni.2007.04.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17570691	Bronze			2022-12-18	WOS:000247646900016
J	Yurkovetskiy, L; Burrows, M; Khan, AA; Graham, L; Volchkov, P; Becker, L; Antonopoulos, D; Umesaki, Y; Chervonsky, AV				Yurkovetskiy, Leonid; Burrows, Michael; Khan, Aly A.; Graham, Laura; Volchkov, Pavel; Becker, Lev; Antonopoulos, Dionysios; Umesaki, Yoshinori; Chervonsky, Alexander V.			Gender Bias in Autoimmunity Is Influenced by Microbiota	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; PANCREATIC LYMPH-NODES; SEGMENTED FILAMENTOUS BACTERIA; T-CELLS; SEX-DIFFERENCES; GUT MICROBIOME; B-LYMPHOCYTES; MOUSE; MACROPHAGES; ACTIVATION	Gender bias and the role of sex hormones in autoimmune diseases are well established. In specific pathogen-free nonobese diabetic (NOD) mice, females have 1.3-4.4 times higher incidence of type 1 diabetes (T1D). Germ-free (GF) mice lost the gender bias (female-to-male ratio 1.1-1.2). Gut microbiota differed in males and females, a trend reversed by male castration, confirming that androgens influence gut microbiota. Colonization of GF NOD mice with defined microbiota revealed that some, but not all, lineages overrepresented in male mice supported a gender bias in T1D. Although protection of males did not correlate with blood androgen concentration, hormone-supported expansion of selected microbial lineages may work as a positive-feedback mechanism contributing to the sexual dimorphism of autoimmune diseases. Gene-expression analysis suggested pathways involved in protection of males from T1D by microbiota. Our results favor a two-signal model of gender bias, in which hormones and microbes together trigger protective pathways.	[Yurkovetskiy, Leonid] Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; [Yurkovetskiy, Leonid; Burrows, Michael; Graham, Laura; Volchkov, Pavel; Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Burrows, Michael; Chervonsky, Alexander V.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Khan, Aly A.; Antonopoulos, Dionysios] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Khan, Aly A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Becker, Lev] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Antonopoulos, Dionysios] Argonne Natl Lab, Lemont, IL 60439 USA; [Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 1868650, Japan	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Yakult Honsha Company, Limited	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu	Antonopoulos, Dionysios/ABE-6212-2020; Volchkov, Pavel Y/H-4743-2013	Antonopoulos, Dionysios/0000-0002-2238-5031; Yurkovetskiy, Leonid/0000-0001-5078-493X; Chervonsky, Alexander/0000-0001-7547-871X	National Institutes of Health [AI082418]; Juvenile Diabetes Research Foundation [17-2011-519]; NIH/NIDDK Digestive Disease Research Core Center [DK42086]; Molecular and Cellular Biology training grant [T32 GM007183]; Clinical Translational Science Award TL1 training grant [TL1TR000432]; NIH [p50 GM081892]; Searle Funds at the Chicago Community Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892, T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH/NIDDK Digestive Disease Research Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Molecular and Cellular Biology training grant; Clinical Translational Science Award TL1 training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Funds at the Chicago Community Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Claudio De Simone for his help with VSL3, Anuradha Nadimpalli and Sarah Owens for help with sequencing sample preparations, and Joseph Pickard for editing the manuscript. A.V.C. is supported by National Institutes of Health grant AI082418 and by the Juvenile Diabetes Research Foundation grant 17-2011-519. A.V.C. and D.A. are supported by NIH/NIDDK Digestive Disease Research Core Center grant DK42086. L.Y. and M.B. were supported by Molecular and Cellular Biology training grant (T32 GM007183) and Clinical Translational Science Award TL1 training grant (TL1TR000432), respectively. A.A.K. is supported by NIH grant p50 GM081892 and the Chicago Biomedical Consortium supported by Searle Funds at the Chicago Community Trust.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; BARTKE A, 1973, ENDOCRINOLOGY, V92, P1223, DOI 10.1210/endo-92-4-1223; Becker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033297; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Chatenoud L, 2001, IMMUNOL REV, V182, P149, DOI 10.1034/j.1600-065X.2001.1820112.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dong BJ, 2012, AM J PHYSIOL-HEART C, V303, pH732, DOI 10.1152/ajpheart.00948.2011; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; FITZPATRICK F, 1991, ENDOCRINOLOGY, V129, P1382, DOI 10.1210/endo-129-3-1382; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kanda N, 1997, ARTHRITIS RHEUM-US, V40, P1703, DOI 10.1002/art.1780400921; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kloting N, 2004, DIABETOLOGIA, V47, P151, DOI 10.1007/s00125-003-1251-0; Kovats S, 2008, CELL IMMUNOL, V252, P81, DOI 10.1016/j.cellimm.2007.10.008; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Makino S, 1981, Jikken Dobutsu, V30, P137; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mathis D, 2012, IMMUNOL REV, V245, P239, DOI 10.1111/j.1600-065X.2011.01084.x; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Qin HY, 2004, INT IMMUNOL, V16, P1723, DOI 10.1093/intimm/dxh173; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Serreze DV, 1998, J IMMUNOL, V161, P3912; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Snyder D L, 1985, Prog Clin Biol Res, V181, P95; Sobel DO, 2002, J AUTOIMMUN, V19, P129, DOI 10.1006/jaut.2002.0604; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varanasi V, 2012, DIABETES, V61, P2862, DOI 10.2337/db11-1784; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	51	539	548	14	128	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					400	412		10.1016/j.immuni.2013.08.013	http://dx.doi.org/10.1016/j.immuni.2013.08.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973225	Bronze, Green Accepted			2022-12-18	WOS:000330948800020
J	Thorburn, AN; Macia, L; Mackay, CR				Thorburn, Alison N.; Macia, Laurence; Mackay, Charles R.			Diet, Metabolites, and "Western-Lifestyle" Inflammatory Diseases	IMMUNITY			English	Review							CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; GERMINATED BARLEY FOODSTUFF; GUT MICROBIOTA; IMMUNE-RESPONSES; AIRWAY INFLAMMATION; ULCERATIVE-COLITIS; NICOTINIC-ACID; FIBER INTAKE; ASTHMA	One explanation for the increased incidence of allergies, asthma, and even some autoimmune diseases has been the hygiene hypothesis. However, recent studies also highlight an important role for diet and bacterial metabolites in controlling various immune pathways, including gut and immune homeostasis, regulatory T cell biology, and inflammation. Dietary-related metabolites engage "metabolite-sensing'' G-protein-coupled receptors, such as GPR43, GPR41, GPR109A, GPR120, and GPR35. These receptors are expressed on immune cells and some gut epithelial cells and generally mediate a direct anti-inflammatory effect. Insufficient intake of "healthy foodstuffs'' adversely affects the production of bacterial metabolites. These metabolites and those derived directly from food drive beneficial downstream effects on immune pathways. We propose that insufficient exposure to dietary and bacterial metabolites might underlie the development of inflammatory disorders in Western countries. This review highlights what is currently known about diet, metabolites, and their associated immune pathways in relation to the development of inflammatory disease.	[Thorburn, Alison N.; Macia, Laurence; Mackay, Charles R.] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Monash University	Mackay, CR (corresponding author), Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia.	charles.mackay@monash.edu	Mackay, Charles R/A-9673-2008; Macia, laurence/D-5983-2016	Mackay, Charles R/0000-0002-6338-7340; Macia, laurence/0000-0003-0835-851X	Australian National Health and Medical Research Council; Australian Research Council; CRC for Asthma and Airways	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); CRC for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	We have been supported by Australian National Health and Medical Research Council, the Australian Research Council, and the CRC for Asthma and Airways.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berthon BS, 2013, RESPIROLOGY, V18, P447, DOI 10.1111/resp.12015; Boulet LP, 2013, CLIN EXP ALLERGY, V43, P8, DOI 10.1111/j.1365-2222.2012.04040.x; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gambhir D, 2012, INVEST OPHTH VIS SCI, V53, P2208, DOI 10.1167/iovs.11-8447; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Geuking MB, 2013, CELL RES, V23, P1339, DOI 10.1038/cr.2013.125; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ishikawa T, 2009, BIOSCI BIOTECH BIOCH, V73, P677, DOI 10.1271/bbb.80733; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jensen ME, 2012, CURR OPIN ALLERGY CL, V12, P186, DOI 10.1097/ACI.0b013e3283508df5; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanauchi O, 2002, J GASTROENTEROL, V37, P67, DOI 10.1007/BF03326417; Kanauchi O, 2001, J GASTROEN HEPATOL, V16, P160, DOI 10.1046/j.1440-1746.2001.02427.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; King DE, 2012, J ACAD NUTR DIET, V112, P642, DOI 10.1016/j.jand.2012.01.019; King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nagel G, 2010, THORAX, V65, P516, DOI 10.1136/thx.2009.128256; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rook GAW, 2003, CURR OPIN ALLERGY CL, V3, P337, DOI [10.1097/00130832-200310000-00003, 10.1097/01.all.0000092602.76804.ad]; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Scheppach W, 1996, DIGEST DIS SCI, V41, P2254, DOI 10.1007/BF02071409; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; TREEM WR, 1994, J PEDIATR GASTR NUTR, V18, P159, DOI 10.1097/00005176-199402000-00007; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wood LG, 2012, AM J CLIN NUTR, V96, P534, DOI 10.3945/ajcn.111.032623; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zandi-Nejad K, 2013, FASEB J, V27, P4366, DOI 10.1096/fj.12-223933; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	97	538	558	11	182	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					833	842		10.1016/j.immuni.2014.05.014	http://dx.doi.org/10.1016/j.immuni.2014.05.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950203	Bronze			2022-12-18	WOS:000341440200003
J	Pichlmair, A; Sousa, CRE				Pichlmair, Andreas; Sousa, Caetano Reis e			Innate recognition of viruses	IMMUNITY			English	Review							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; PLASMACYTOID DENDRITIC CELLS; ACTIVATE B-CELLS; NF-KAPPA-B; MEDIATED ANTIVIRAL RESPONSES; INFLUENZA-A VIRUS; RIG-I; ADAPTER PROTEIN; CUTTING EDGE	Virus infection elicits potent responses in all cells intended to contain virus spread before intervention by the adaptive immune system. Central to this process is the virus-elicited production of type I interferons (IFNs) and other cytokines. The sensors involved in coupling recognition of viruses to the induction of the type I IFN genes have only recently been uncovered and include endosomal and cytosolic receptors for RNA and DNA. Here, we review their properties and discuss how their ability to recognize the unusual presence of atypical nucleic acids in particular subcellular compartments is used by the body to detect virus presence.	London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England		Sousa, CRE (corresponding author), London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fuiel, London WC2A 3PX, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119				Alberts B., 2002, MOL BIOL CELL, V4th; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; [Anonymous], 2001, FIELDS VIROLOGY; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; DER SD, 1995, P NATL ACAD SCI USA, V92, P8841, DOI 10.1073/pnas.92.19.8841; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; ESOUSA CR, 2004, IMMUNOLOGY, V16, P27; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hidmark AS, 2005, J VIROL, V79, P10376, DOI 10.1128/JVI.79.16.10376-10385.2005; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Iacobelli-Martinez M, 2007, J VIROL, V81, P1305, DOI 10.1128/JVI.01926-06; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1963, LANCET, V2, P113; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Johansson C, 2007, J EXP MED, V204, P1349, DOI 10.1084/jem.20061587; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; LATZ E, 2007, LIGAND INDUCED CONFO, V8, P772; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pichlmair A, 2004, J VIROL, V78, P11422, DOI 10.1128/JVI.78.20.11422-11424.2004; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rassa JC, 2003, MICROBES INFECT, V5, P961, DOI 10.1016/S1286-4579(03)00193-X; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Richer MJ, 2006, CLIN IMMUNOL, V121, P339, DOI 10.1016/j.clim.2006.07.009; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang JP, 2007, J IMMUNOL, V178, P3363, DOI 10.4049/jimmunol.178.6.3363; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Wild K, 2002, CURR OPIN STRUC BIOL, V12, P72, DOI 10.1016/S0959-440X(02)00292-0; WILLIAMS BR, 2001, SCI STKE 2002; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173	157	538	558	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					370	383		10.1016/j.immuni.2007.08.012	http://dx.doi.org/10.1016/j.immuni.2007.08.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892846	Bronze			2022-12-18	WOS:000249843400003
J	Firestein, GS; McInnes, IB				Firestein, Gary S.; McInnes, Iain B.			Immunopathogenesis of Rheumatoid Arthritis	IMMUNITY			English	Review							FIBROBLAST-LIKE SYNOVIOCYTES; SHARED EPITOPE ALLELES; CITRULLINATED PEPTIDE ANTIBODIES; DNA METHYLOME SIGNATURE; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR; SYNOVIAL FIBROBLASTS; T-CELLS; AUTOIMMUNE-DISEASE; INFLAMMATORY ARTHRITIS	Rheumatoid arthritis (RA) is the most common inflammatory arthropathy. The majority of evidence, derived from genetics, tissue analyses, models, and clinical studies, points to an immune-mediated etiology associated with stromal tissue dysregulation that together propogate chronic inflammation and articular destruction. A pre-RA phase lasting months to years may be characterized by the presence of circulating autoantibodies, increasing concentration and range of inflammatory cytokines and chemokines, and altered metabolism. Clinical disease onset comprises synovitis and systemic comorbidities affecting the vasculature, metabolism, and bone. Targeted immune therapeutics and aggressive treatment strategies have substantially improved clinical outcomes and informed pathogenetic understanding, but no cure as yet exists. Herein we review recent data that support intriguing models of disease pathogenesis. They allude to the possibility of restoration of immunologic homeostasis and thus a state of tolerance associated with drugfree remission. This target represents a bold vision for the future of RA therapeutics.	[Firestein, Gary S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [McInnes, Iain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G128QQ, Lanark, Scotland	University of California System; University of California San Diego; University of Glasgow	Firestein, GS (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.; McInnes, IB (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G128QQ, Lanark, Scotland.	gfirestein@ucsd.edu; iain.mcinnes@glasgow.ac.uk			Medical Research Council [MR/N005813/1] Funding Source: Medline; NIAID NIH HHS [R01 AI070555] Funding Source: Medline; NIAMS NIH HHS [R01 AR065466] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065466] Funding Source: NIH RePORTER; MRC [MR/N005813/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed A, 2016, ARTHRITIS RHEUMATOL, V68, P1361, DOI 10.1002/art.39574; Ai R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11849; Ai RZ, 2015, ARTHRITIS RHEUMATOL, V67, P1978, DOI 10.1002/art.39123; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Astorri E, 2015, CURR PHARM DESIGN, V21, P2216, DOI 10.2174/1381612821666150310145758; Benham H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9301; Bombardieri M, 2011, ANN RHEUM DIS, V70, P1857, DOI 10.1136/ard.2011.150219; Bottini N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0372-9; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Byng-Maddick R, 2015, RHEUMATOLOGY, V54, P768, DOI 10.1093/rheumatology/keu487; Catrina AI, 2016, IMMUNOL REV, V269, P162, DOI 10.1111/imr.12379; Catrina AI, 2014, NAT REV RHEUMATOL, V10, P645, DOI 10.1038/nrrheum.2014.115; Charles-Schoeman C, 2015, ARTHRITIS RHEUMATOL, V67, P616, DOI 10.1002/art.38974; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Corsiero E, 2016, ANN RHEUM DIS, V75, P1866, DOI 10.1136/annrheumdis-2015-208356; Croft AP, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1156-1; de Aquino SG, 2014, J IMMUNOL, V192, P4103, DOI 10.4049/jimmunol.1301970; de Hair MJH, 2014, ARTHRITIS RHEUMATOL, V66, P513, DOI 10.1002/art.38273; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ekwall AKH, 2015, ARTHRITIS RHEUMATOL, V67, P1193, DOI 10.1002/art.39060; El-Gabalawy HS, 2009, J RHEUMATOL, V36, P1130, DOI 10.3899/jrheum.080855; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Filer A, 2013, CURR OPIN PHARMACOL, V13, P413, DOI 10.1016/j.coph.2013.02.006; Firestein GS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4593; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 2002, ARTHRITIS RHEUM, V46, P298, DOI 10.1002/art.502; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Firestein GS, 1997, P NATL ACAD SCI USA, V94, P10895, DOI 10.1073/pnas.94.20.10895; Fonseca JE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2173; Franz JK, 2000, ARTHRITIS RHEUM, V43, P599, DOI 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T; Genovese MC, 2016, NEW ENGL J MED, V374, P1243, DOI 10.1056/NEJMoa1507247; Hammaker D, 2016, ARTHRITIS RHEUMATOL, V68, P2637, DOI 10.1002/art.39746; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Huber LC, 2007, ARTHRITIS RHEUM, V56, P1087, DOI 10.1002/art.22512; Joosten LAB, 2011, MOL MED, V17, P391, DOI 10.2119/molmed.2011.00058; Juarez M, 2016, ANN RHEUM DIS, V75, P1099, DOI 10.1136/annrheumdis-2014-206785; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Karouzakis E, 2011, GENES IMMUN, V12, P643, DOI 10.1038/gene.2011.45; Kelly S, 2015, ANN RHEUM DIS, V74, P611, DOI 10.1136/annrheumdis-2013-204603; Kiener HP, 2009, ARTHRITIS RHEUM-US, V60, P1305, DOI 10.1002/art.24453; Kim K, 2017, NAT REV RHEUMATOL, V13, P13, DOI 10.1038/nrrheum.2016.176; Kinslow JD, 2016, ARTHRITIS RHEUMATOL, V68, P2372, DOI 10.1002/art.39771; KIRSCHMANN DA, 1995, J IMMUNOL, V155, P5655; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Konig MF, 2016, ANN RHEUM DIS, V75, P2022, DOI 10.1136/annrheumdis-2015-208529; Krishnadas R, 2016, BRAIN BEHAV IMMUN, V51, P29, DOI 10.1016/j.bbi.2015.08.005; Krishnamurthy A, 2016, ANN RHEUM DIS, V75, P721, DOI 10.1136/annrheumdis-2015-208093; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Liu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30594; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2016, NAT REV RHEUMATOL, V12, P63, DOI 10.1038/nrrheum.2015.171; McInnes IB, 2015, LANCET, V386, P1137, DOI 10.1016/S0140-6736(15)61134-5; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakano K, 2013, J IMMUNOL, V190, P1297, DOI 10.4049/jimmunol.1202572; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pap T, 2000, ARTHRITIS RES, V2, P59, DOI 10.1186/ar69; Perlman H, 2003, J IMMUNOL, V170, P838, DOI 10.4049/jimmunol.170.2.838; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; RANDEN I, 1992, J IMMUNOL, V148, P3296; Rawlings DJ, 2015, J IMMUNOL, V194, P2977, DOI 10.4049/jimmunol.1403034; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Robertson J, 2013, NAT REV RHEUMATOL, V9, P513, DOI 10.1038/nrrheum.2013.91; Rodriguez-Carrio J, 2017, ARTHRITIS RHEUMATOL, V69, P70, DOI 10.1002/art.39811; Rombouts Y, 2015, ANN RHEUM DIS, V74, P234, DOI 10.1136/annrheumdis-2013-203565; Rossetti M, 2017, ANN RHEUM DIS, V76, P435, DOI 10.1136/annrheumdis-2015-208992; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Stanczyk J, 2011, ARTHRITIS RHEUM-US, V63, P373, DOI 10.1002/art.30115; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tan EM, 2016, J EXP MED, V213, P1937, DOI 10.1084/jem.20160792; Tran CN, 2007, ARTHRITIS RHEUM, V56, P1497, DOI 10.1002/art.22573; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van Beers JJBC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4322; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; Vassallo R, 2014, CLIN IMMUNOL, V152, P25, DOI 10.1016/j.clim.2014.02.002; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; Yamamoto K, 2015, NAT REV RHEUMATOL, V11, P375, DOI 10.1038/nrrheum.2015.7; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; ZVAIFLER NJ, 1994, SEMIN ARTHRITIS RHEU, V23, P11, DOI 10.1016/0049-0172(94)90080-9	114	537	572	18	235	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					183	196		10.1016/j.immuni.2017.02.006	http://dx.doi.org/10.1016/j.immuni.2017.02.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228278	Green Accepted, Bronze			2022-12-18	WOS:000396410900008
J	Crotty, S				Crotty, Shane			T Follicular Helper Cell Biology: A Decade of Discovery and Diseases	IMMUNITY			English	Review							GERMINAL CENTER RESPONSES; CENTER B-CELLS; NEUTRALIZING ANTIBODY-RESPONSES; TRANSCRIPTION FACTOR; TFH CELLS; FH CELLS; DYNAMIC REGULATION; HUMORAL RESPONSES; NONHUMAN-PRIMATES; REGULATORY CELLS	Helping B cells and antibody responses is a major function of CD4(+) T cells. It has been 10 years since the publication of Bcl6 as the lineage-defining transcription factor for T follicular helper (Tfh) differentiation and the requirement of Tfh cells as the specialized subset of CD4(+) T cells needed for germinal centers (the microanatomical sites of B cell mutation and antibody affinity maturation) and related B cell responses. A great deal has been learned about Tfh cells in the past 10 years, particularly regarding their roles in a surprising range of diseases. Advances in the understanding of Tfh cell differentiation and function are discussed, as are the understanding of Tfh cells in infectious diseases, vaccines, autoimmune diseases, allergies, atherosclerosis, organ transplants, and cancer. This includes discussion of Tfh cells in the human immune system. Based on the discoveries to date, the next decade of Tfh research surely holds many more surprises.	[Crotty, Shane] La Jolla Inst Immunol LJI, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Crotty, Shane] Scripps Res, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Immunol LJI, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), Scripps Res, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA.	shane@lji.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	USA National Institutes of Health (NIH) [NIAID U19AI109976, R01AI135193, UM1AI100663]; LJI funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, U19AI109976, R01AI135193] Funding Source: NIH RePORTER	USA National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LJI funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Thanks to input from Crotty lab members, helpful feedback from multiple experts in the field, and graphics assistance by Christina Corbaci. This work was funded by grants from the USA National Institutes of Health (NIH), including NIAID U19AI109976, R01AI135193, and UM1AI100663, as well as LJI funds to S.C.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Ali JM, 2016, CELL REP, V14, P1232, DOI 10.1016/j.celrep.2015.12.099; Aloulou M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10579; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bombardieri M, 2017, NAT REV RHEUMATOL, V13, P141, DOI 10.1038/nrrheum.2016.217; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Butt D, 2015, IMMUNITY, V42, P890, DOI 10.1016/j.immuni.2015.04.010; Chakarov S, 2014, EMBO MOL MED, V6, P590, DOI 10.1002/emmm.201403841; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chenouard A, 2017, AM J TRANSPLANT, V17, P1490, DOI 10.1111/ajt.14142; Choi JY, 2017, J IMMUNOL, V198, P2578, DOI 10.4049/jimmunol.1601687; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Clement M, 2015, CIRCULATION, V131, P560, DOI 10.1161/CIRCULATIONAHA.114.010988; Conlon TM, 2012, J IMMUNOL, V188, P2643, DOI 10.4049/jimmunol.1102830; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Cortes JR, 2018, CANCER CELL, V33, P259, DOI 10.1016/j.ccell.2018.01.001; Crotty S, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032102; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dan JM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau3776; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; de Graav GN, 2015, CLIN EXP IMMUNOL, V180, P329, DOI 10.1111/cei.12576; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Dolence JJ, 2018, J ALLERGY CLIN IMMUN, V142, P1144, DOI 10.1016/j.jaci.2017.11.020; Dullaers M, 2017, J ALLERGY CLIN IMMUN, V140, P76, DOI 10.1016/j.jaci.2016.09.020; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Flynn R, 2014, BLOOD, V123, P3988, DOI 10.1182/blood-2014-03-562231; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; Gaddis DE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03493-5; Garaud S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02660; Gavillet BM, 2015, J IMMUNOL, V194, P4836, DOI 10.4049/jimmunol.1402071; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Gensous N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01637; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gould HJ, 2018, SCIENCE, V362, P1247, DOI 10.1126/science.aav3709; Greczmiel U, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8686; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Havenar-Daughton C, 2016, J IMMUNOL, V197, P994, DOI 10.4049/jimmunol.1600320; Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113; Heesters BA, 2016, TRENDS IMMUNOL, V37, P844, DOI 10.1016/j.it.2016.10.003; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Heit A, 2017, J EXP MED, V214, P2139, DOI 10.1084/jem.20161794; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Hong S, 2018, IMMUNITY, V49, P695, DOI 10.1016/j.immuni.2018.08.012; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kato Y, 2015, J IMMUNOL, V195, P1006, DOI 10.4049/jimmunol.1500767; Kenefeck R, 2015, J CLIN INVEST, V125, P292, DOI 10.1172/JCI76238; Kim CJ, 2018, IMMUNITY, V49, P1034, DOI 10.1016/j.immuni.2018.10.012; Kim ST, 2018, J IMMUNOL, V201, P1359, DOI 10.4049/jimmunol.1701217; Kim SJ, 2017, NAT IMMUNOL, V18, P1016, DOI 10.1038/ni.3793; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Kobayashi S, 2016, EUR J IMMUNOL, V46, P360, DOI 10.1002/eji.201546043; Kobayashi S, 2013, ARTHRITIS RHEUM-US, V65, P3063, DOI 10.1002/art.38173; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Leavenworth JW, 2015, NAT IMMUNOL, V16, P96, DOI 10.1038/ni.3050; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Leroux-Roels G, 2016, CLIN IMMUNOL, V169, P16; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Maceiras AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15067; Macpherson AJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029363; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; McKee AS, 2017, CURR OPIN IMMUNOL, V47, P44, DOI 10.1016/j.coi.2017.06.005; Meli AP, 2017, J IMMUNOL, V199, P244, DOI 10.4049/jimmunol.1700141; Meli AP, 2016, IMMUNITY, V45, P831, DOI 10.1016/j.immuni.2016.09.018; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moody MA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag0851; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Nus M, 2017, NAT MED, V23, P601, DOI 10.1038/nm.4315; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Polonskaya Z, 2017, J CLIN INVEST, V127, P1491, DOI 10.1172/JCI91192; Preite S, 2018, NAT IMMUNOL, V19, P986, DOI 10.1038/s41590-018-0182-3; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Quinn JL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00382; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Reef SE, 2018, PLOTKINS VACCINES; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Riteau N, 2016, J IMMUNOL, V197, P3884, DOI 10.4049/jimmunol.1600883; Ritvo PGG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan0368; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Ryu H, 2018, NAT IMMUNOL, V19, P583, DOI 10.1038/s41590-018-0102-6; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sayin I, 2018, J EXP MED, V215, P1531, DOI 10.1084/jem.20171940; Schmitt N, 2016, CELL REP, V16, P1082, DOI 10.1016/j.celrep.2016.06.063; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Suto A, 2002, BLOOD, V100, P4565, DOI 10.1182/blood-2002-04-1115; Takatsuka S, 2018, NAT IMMUNOL, V19, P1025, DOI 10.1038/s41590-018-0177-0; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Tangye SG, 2015, CURR OPIN IMMUNOL, V34, P107, DOI 10.1016/j.coi.2015.02.010; Tarlinton D, 2019, NAT REV IMMUNOL, V19, P85, DOI 10.1038/s41577-018-0107-2; Taylor DK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaf5307; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Tubo NJ, 2016, SCIENCE, V351, P511, DOI 10.1126/science.aad0483; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Ugolini M, 2018, NAT IMMUNOL, V19, P386, DOI 10.1038/s41590-018-0068-4; van den Berg VJ, 2018, EBIOMEDICINE, V36, P63, DOI 10.1016/j.ebiom.2018.08.023; Velu V, 2016, J IMMUNOL, V197, P1832, DOI 10.4049/jimmunol.1600143; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vijayan D, 2016, J IMMUNOL, V197, P3008, DOI 10.4049/jimmunol.1600652; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vono M, 2013, P NATL ACAD SCI USA, V110, P21095, DOI 10.1073/pnas.1319784110; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Wing JB, 2017, P NATL ACAD SCI USA, V114, pE6400, DOI 10.1073/pnas.1705551114; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wu H, 2016, EUR J IMMUNOL, V46, P1152, DOI 10.1002/eji.201546094; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Xin G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07492-4; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yamamoto T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3964; Yao Y, 2019, J ALLERGY CLIN IMMUN, V144, P118, DOI 10.1016/j.jaci.2019.02.008; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832; [No title captured], DOI DOI 10.1016/J.IMMUNI.2015.11.017; [No title captured], DOI DOI 10.1016/J.IMMUNI.2013.08.031; [No title captured], DOI DOI 10.1084/JEM.20161533; [No title captured]; [No title captured], DOI DOI 10.1016/J.IMMUNI.2013.09.007; [No title captured], DOI DOI 10.2337/DB16-0714; [No title captured], DOI DOI 10.1038/NI.3461; [No title captured], DOI DOI 10.1016/J.CCELL.2016.07.006; [No title captured]; [No title captured], DOI DOI 10.1038/NATURE19317	202	536	547	12	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1132	1148		10.1016/j.immuni.2019.04.011	http://dx.doi.org/10.1016/j.immuni.2019.04.011			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31117010	Green Accepted, Bronze			2022-12-18	WOS:000468429500007
J	Buckley, CD; Gilroy, DW; Serhan, CN				Buckley, Christopher D.; Gilroy, Derek W.; Serhan, Charles N.			Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation	IMMUNITY			English	Review							ACUTE LUNG INJURY; REGULATORY T-CELLS; NF-KAPPA-B; POLYUNSATURATED FATTY-ACIDS; ACTIVATED RECEPTOR-GAMMA; PRO-RESOLVING MEDIATORS; GROWTH-FACTOR-BETA; IN-VIVO; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); MARESIN 1	Inflammatory responses, like all biological cascades, are shaped by a delicate balance between positive and negative feedback loops. It is now clear that in addition to positive and negative checkpoints, the inflammatory cascade rather unexpectedly boasts an additional checkpoint, a family of chemicals that actively promote resolution and tissue repair without compromising host defense. Indeed, the resolution phase of inflammation is just as actively orchestrated and carefully choreographed as its induction and inhibition. In this review, we explore the immunological consequences of omega-3-derived specialized proresolving mediators (SPMs) and discuss their place within what is currently understood of the role of the arachidonic acid-derived prostaglandins, lipoxins, and their natural C15-epimers. We propose that treatment of inflammation should not be restricted to the use of inhibitors of the acute cascade (antagonism) but broadened to take account of the enormous therapeutic potential of inducers (agonists) of the resolution phase of inflammation.	[Buckley, Christopher D.] Queen Elizabeth Hosp, Rheumatol Res Grp, Ctr Translat Inflammat Res, Birmingham B15 2WD, W Midlands, England; [Gilroy, Derek W.] UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London WC1E 6JJ, England; [Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Birmingham; University of London; University College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Gilroy, Derek W/C-2588-2009; Buckley, Christopher/AAN-6378-2021; Gilroy, Derek/AAP-7227-2020	Buckley, Christopher/0000-0001-6924-6402; Gilroy, Derek/0000-0003-3476-0844	National Institutes of Health [P01GM095467, R01GM38765]; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; Versus Arthritis [19791] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.N.S. thanks Mary Halm Small for expert assistance in manuscript preparation and support from National Institutes of Health grants P01GM095467 and R01GM38765 (C.N.S.). D. W. G. is a Wellcome Trust Funded Senior Research Fellow. C.N.S. is inventor on patents [resolvins] assigned to BWH and licensed to Resolvyx Pharmaceuticals. C.N.S. was scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. C.N.S.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Aronoff DM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/696897; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Benjamim CF, 2005, J IMMUNOL, V174, P1616, DOI 10.4049/jimmunol.174.3.1616; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bitto A, 2012, CRIT CARE, V16, DOI 10.1186/1364-8535-16-R32; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Colgan SP, 2013, IMMUNOL RES, V55, P75, DOI 10.1007/s12026-012-8350-2; Crawford MA, 2013, PROSTAG LEUKOTR ESS, V88, P5, DOI 10.1016/j.plefa.2012.08.005; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; DIAZ A, 1989, J BIOL CHEM, V264, P11554; Eisen DP, 2012, INTENS CARE MED, V38, P1249, DOI 10.1007/s00134-012-2570-8; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haas-Stapleton EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001316; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Hayek MG, 1997, J IMMUNOL, V159, P2445; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2008, J IMMUNOL, V180, P3512, DOI 10.4049/jimmunol.180.5.3512; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Jones CN, 2012, P NATL ACAD SCI USA, V109, P20560, DOI 10.1073/pnas.1210269109; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kessel A, 2009, J AUTOIMMUN, V32, P211, DOI 10.1016/j.jaut.2009.02.014; Khan MM, 1995, ADV EXP MED BIOL, V383, P35; Kim EH, 2006, ANN NY ACAD SCI, V1090, P375, DOI 10.1196/annals.1378.041; Krishnamurthy VR, 2011, J ORG CHEM, V76, P5433, DOI 10.1021/jo2002243; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lawrence T, 2002, INFLAMM RES, V51, P108, DOI 10.1007/BF02684012; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; Majno G., 2004, CELLS TISSUES DIS PR; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Medjane S, 2005, AM J PHYSIOL-LUNG C, V289, pL816, DOI 10.1152/ajplung.00466.2004; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; O'Sullivan TP, 2007, J MED CHEM, V50, P5894, DOI 10.1021/jm060270d; Ogawa N, 2011, TETRAHEDRON LETT, V52, P3001, DOI 10.1016/j.tetlet.2011.03.152; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Raatz SK, 2011, J AGR FOOD CHEM, V59, P11278, DOI 10.1021/jf202576k; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rajakariarl R, 2008, BLOOD, V111, P4184, DOI 10.1182/blood-2007-08-108936; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rios-Santos F, 2003, SHOCK, V19, P61, DOI 10.1097/00024382-200301000-00012; Rodriguez AR, 2012, TETRAHEDRON LETT, V53, P4169, DOI 10.1016/j.tetlet.2012.05.143; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rossi AG, 1998, J IMMUNOL, V160, P3562; Ryan AD, 2010, CURR OPIN PHARMACOL, V10, P166, DOI 10.1016/j.coph.2010.02.005; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; STARCZEWSKI M, 1984, PROSTA LEUKOTR MED, V13, P249, DOI 10.1016/0262-1746(84)90037-4; Strandvik B, 1996, PROSTAG LEUKOTR ESS, V55, P419, DOI 10.1016/S0952-3278(96)90125-8; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Walker J, 2011, SHOCK, V36, P410, DOI 10.1097/SHK.0b013e31822798c1; Wang B, 2011, PULM PHARMACOL THER, V24, P434, DOI 10.1016/j.pupt.2011.04.001; Wang LM, 2012, AM J RESP CRIT CARE, V186, P989, DOI 10.1164/rccm.201202-0261OC; WEINBERG DA, 1985, J LEUKOCYTE BIOL, V37, P151, DOI 10.1002/jlb.37.2.151; Weiss GA, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-89; Xu MX, 2013, CNS NEUROSCI THER, V19, P235, DOI 10.1111/cns.12069; Xu XJ, 2008, J IMMUNOL, V180, P2125, DOI 10.4049/jimmunol.180.4.2125; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726	125	536	552	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					315	327		10.1016/j.immuni.2014.02.009	http://dx.doi.org/10.1016/j.immuni.2014.02.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656045	Bronze, Green Accepted			2022-12-18	WOS:000333422300006
J	Omatsu, Y; Sugiyama, T; Kohara, H; Kondoh, G; Fujii, N; Kohno, K; Nagasawa, T				Omatsu, Yoshiki; Sugiyama, Tatsuki; Kohara, Hiroshi; Kondoh, Gen; Fujii, Nobutaka; Kohno, Kenji; Nagasawa, Takashi			The Essential Functions of Adipo-osteogenic Progenitors as the Hematopoietic Stem and Progenitor Cell Niche	IMMUNITY			English	Article							CHEMOKINE RECEPTOR CXCR4; BONE-MARROW NICHE; SELF-RENEWAL; B-LYMPHOCYTE; IN-VIVO; DIFFERENTIATION; MAINTENANCE; MICE; EXPRESSION; OSTEOBLASTS	Hematopoietic stem cells (HSCs) and their lympho-hematopoietic progeny are supported by microenvironmental niches within bone marrow; however, the identity, nature, and function of these niches remain unclear. Short-term ablation of CXC chemokine ligand (CXCL)12-abundant reticular (CAR) cells in vivo did not affect the candidate niches, bone-lining osteoblasts, or endothelial cells but severely impaired the adipogenic and osteogenic differentiation potential of marrow cells and production of the cytokines SCF and CXCL12 and led to a marked reduction in cycling lymphoid and erythroid progenitors. HSCs from CAR cell-depleted mice were reduced in number and cell size, were more quiescent, and had increased expression of early myeloid selector genes, similar to the phenotype of wild-type HSCs cultured without a niche. Thus, the niche composed of adipo-osteogenic progenitors is required for proliferation of HSCs and lymphoid and erythroid progenitors, as well as maintenance of HSCs in an undifferentiated state.	[Omatsu, Yoshiki; Sugiyama, Tatsuki; Kohara, Hiroshi; Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Sakyo Ku, Kyoto 6068507, Japan; [Kondoh, Gen] Kyoto Univ, Inst Frontier Med Sci, Lab Anim Expt Regenerat, Sakyo Ku, Kyoto 6068507, Japan; [Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, Nara 6300192, Japan	Kyoto University; Kyoto University; Kyoto University; Nara Institute of Science & Technology	Nagasawa, T (corresponding author), Kyoto Univ, Dept Immunobiol & Hematol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tnagasa@frontier.kyoto-u.ac.jp	Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Omatsu, Yoshiki/0000-0002-6212-0441; Sugiyama, Tatsuki/0000-0002-9349-0824; Nagasawa, Takashi/0000-0002-1085-0960	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [22390096] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Egawa, K. Tokoyoda, M. Noda, R. Kamimura, T. Ishii, and S. Uemoto for technical assistance. This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan. Y. O., T. S., and T. N. designed and performed the experiments, analyzed the data, and prepared the paper; T. N. supervised the study; H.K. performed the experiments; G. K., N.F., and K. K. contributed materials and tools.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BIANCO P, 1988, BRIT J HAEMATOL, V68, P401, DOI 10.1111/j.1365-2141.1988.tb04225.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Iritani BM, 2002, EMBO J, V21, P4820, DOI 10.1093/emboj/cdf492; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohara H, 2007, BLOOD, V110, P4153, DOI 10.1182/blood-2007-04-084210; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Miller CL, 1996, EXP HEMATOL, V24, P185; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2008, NAT IMMUNOL, V9, P345, DOI 10.1038/ni0408-345; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; ROULEAU MF, 1990, J BONE MINER RES, V5, P1043; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	536	556	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					387	399		10.1016/j.immuni.2010.08.017	http://dx.doi.org/10.1016/j.immuni.2010.08.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20850355	Bronze			2022-12-18	WOS:000282798500013
J	Thomas, PG; Dash, P; Aldridge, JR; Ellebedy, AH; Reynolds, C; Funk, AJ; Martin, WJ; Lamkanfi, M; Webby, RJ; Boyd, KL; Doherty, PC; Kanneganti, TD				Thomas, Paul G.; Dash, Pradyot; Aldridge, Jerry R., Jr.; Ellebedy, Ali H.; Reynolds, Cory; Funk, Amy J.; Martin, William J.; Lamkanfi, Mohamed; Webby, Richard J.; Boyd, Kelli L.; Doherty, Peter C.; Kanneganti, Thirumala-Devi			The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1	IMMUNITY			English	Article							RIG-I; IL-1-BETA-CONVERTING ENZYME; ANTIVIRAL RESPONSES; ADAPTIVE IMMUNITY; HUMAN MACROPHAGES; MICE DEFICIENT; INFECTION; IL-1-BETA; RNA; INTERLEUKIN-1-BETA	Virus-induced interlukin-1 beta (IL-1 beta) and IL-18 production in macrophages are mediated via caspase-1 pathway. Multiple microbial components, including viral RNA, are thought to trigger assembly of the cryopyrin inflammasome resulting in caspase-1 activation. Here, we demonstrated that NIrp3(-/-) and Casp1(-/-) mice were more susceptible than wildtype mice after infection with a pathogenic influenza A virus. This enhanced morbidity correlated with decreased neutrophil and monocyte recruitment and reduced cytokine and chemokine production. Despite the effect on innate immunity, cryopyrin-deficiency was not associated with any obvious defect in virus control or on the later emergence of the adaptive response. Early epithelial necrosis was, however, more severe in the infected mutants, with extensive collagen deposition leading to later respiratory compromise. These findings reveal a function of the cryopyrin inflammasome in healing responses. Thus, cryopyrin and caspase-1 are central to both innate immunity and to moderating lung pathology in influenza pneumonia.	[Thomas, Paul G.; Dash, Pradyot; Reynolds, Cory; Doherty, Peter C.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Aldridge, Jerry R., Jr.; Ellebedy, Ali H.; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Funk, Amy J.; Martin, William J.] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Lamkanfi, Mohamed] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Doherty, Peter C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Roche Holding; Genentech; University of Melbourne	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Webby, Richard J/N-5657-2018; Thomas, Paul G./H-1063-2018; Aldridge, Jerry/B-4777-2013; Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Doherty, Peter Charles/C-4185-2013	Thomas, Paul G./0000-0001-7955-0256; Aldridge, Jerry/0000-0002-9653-1775; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Dash, Pradyot/0000-0001-5467-0657; Doherty, Peter Charles/0000-0002-5028-3489	National Institutes of Health [AR056296, A1065097, A1170251]; National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI065097, R01AI070251, F32AI078667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Coyle, E. Grant, J. Berlin (Millennium Pharmaceuticals), G. Nunez (University of Michigan) and R. Flavell (Yale) for the generous supply of mutant mice and J. Rogers from the Cellular Immunology Core Facility of St. Jude Children's research hospital for technical support. This work was supported by National Institutes of Health grant AR056296 to T.-D.K., A1065097 to P.G.T., A1170251 to P.C.D., and National Institute of Allergy and Infectious Diseases Contract No. HHSN266200700005C.	ALLAN W, 1990, J IMMUNOL, V144, P3980; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Denton AE, 2007, EUR J IMMUNOL, V37, P368, DOI 10.1002/eji.200636766; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Geiser T, 2000, AM J PHYSIOL-LUNG C, V279, pL1184, DOI 10.1152/ajplung.2000.279.6.L1184; Hampton T, 2007, JAMA-J AM MED ASSOC, V297, P580, DOI 10.1001/jama.297.6.580; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; IIDA N, 1990, MOL CELL BIOL, V10, P5596, DOI 10.1128/MCB.10.10.5596; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pirhonen J, 2001, EUR J IMMUNOL, V31, P726, DOI 10.1002/1521-4141(200103)31:3<726::AID-IMMU726>3.0.CO;2-5; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shanley TP, 1997, J IMMUNOL, V158, P3439; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thickett DR, 2008, THORAX, V63, P750; THOMBERRY NA, 1992, NATURE, V356, P768; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; Wewers MD, 1997, J IMMUNOL, V159, P5964; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	57	535	561	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					566	575		10.1016/j.immuni.2009.02.006	http://dx.doi.org/10.1016/j.immuni.2009.02.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19362023	Green Accepted, Bronze			2022-12-18	WOS:000265319000013
J	Li, MO; Wan, YSY; Flavell, RA				Li, Ming O.; Wan, Yisong Y.; Flavell, Richard A.			T cell-produced transforming growth factor-beta 1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; TGF-BETA; AUTOIMMUNE INFLAMMATION; IMMUNE-RESPONSES; INTESTINAL INFLAMMATION; SUPPRESSOR FUNCTION; DEPENDENT COLITIS; MICE; DISEASE	TGF-beta 1 is a regulatory cytokine with a pleiotropic role in immune responses. TGF-beta 1 is widely expressed in leukocytes and stromal cells. However, the functions of TGF-beta 1 expressed by specific lineages of cells remain unknown in vivo. Here, we show that mice with a T cell-specific deletion of the Tgfb1 gene developed lethal immunopathology in multiple organs, and this development was associated with enhanced T cell proliferation, activation, and CD4(+) T cell differentiation into T helper 1 (Th1) and Th2 cells. TGF-beta 1 produced by Foxp3-expressing regulatory T cells was required to inhibit Th1-cell differentiation and inflammatory-bowel disease in a transfer model. In addition, T cell-produced TGF-beta 1 promoted Th17-cell differentiation and was indispensable for the induction of experimental autoimmune encephalomyelitis. These findings reveal essential roles for T cell-produced TGF-beta 1 in controlling differentiation of T helper cells and controlling inflammatory diseases.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Wan, Yisong/ABE-1200-2021	Wan, Yisong/0000-0003-4346-9717; li, ming/0000-0002-1383-0535	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR060723] Funding Source: Medline; NIDDK NIH HHS [R01DK51665] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DANG H, 1995, J IMMUNOL, V155, P3205; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Longenecker G, 2002, CYTOKINE, V18, P43, DOI 10.1006/cyto.2002.1025; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; Taylor PA, 2004, J IMMUNOL, V172, P34, DOI 10.4049/jimmunol.172.1.34; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	49	535	573	2	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					579	591		10.1016/j.immuni.2007.03.014	http://dx.doi.org/10.1016/j.immuni.2007.03.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17481928	Bronze			2022-12-18	WOS:000246895900011
J	Allan, RS; Waithman, J; Bedoui, S; Jones, CM; Villadangos, JA; Zhan, YF; Lew, AM; Shortman, K; Heath, WR; Carbone, FR				Allan, Rhys S.; Waithman, Jason; Bedoui, Sammy; Jones, Claerwen M.; Villadangos, Jose A.; Zhan, Yifan; Lew, Andrew M.; Shortman, Ken; Heath, William R.; Carbone, Francis R.			Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming	IMMUNITY			English	Article							HERPES-SIMPLEX-VIRUS; EPIDERMAL LANGERHANS CELLS; CD8(+) T-CELLS; IN-VIVO; CUTTING EDGE; ANTIVIRAL IMMUNITY; CROSS-PRESENTATION; INFECTION; SKIN; ACTIVATION	Skin dendritic cells (DCs) are thought to act as key initiators of local T cell immunity. Here we show that after skin infection with herpes simplex virus (HSV), cytotoxic T lymphocyte (CTL) activation required MHC class I-restricted presentation by nonmigratory CD8(+) DCs rather than skin-derived DCs. Despite a lack of direct presentation by migratory DCs, blocking their egress from infected skin substantially inhibited class I-restricted presentation and HSV-specific CTL responses. These results support the argument for initial transport of antigen by migrating DCs, followed by its transfer to the lymphoid-resident DCs for presentation and CTL priming. Given that relatively robust CTL responses were seen with small numbers of skin-emigrant DCs, we propose that this inter-DC antigen transfer functions to amplify presentation across a larger network of lymphoid-resident DCs for efficient T cell activation.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia	University of Melbourne; Walter & Eliza Hall Institute	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	heath@wehi.edu.au; fcarbone@unimelb.edu.au	Lew, Andrew M/C-7248-2013; Carbone, Francis/ABF-2141-2020; Villadangos, Jose A/AAU-1404-2020	Lew, Andrew M/0000-0002-2198-8164; Villadangos, Jose A/0000-0001-6771-8891; Zhan, Yifan/0000-0001-6974-0486; BEDOUI, SAMMY/0000-0002-7443-0543; Waithman, Jason/0000-0003-4940-0155; Heath, William/0000-0001-9670-259X; Allan, Rhys/0000-0003-0906-2980; Jones, Claerwen/0000-0001-8594-9554				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Bacci S, 1997, EUR J IMMUNOL, V27, P442, DOI 10.1002/eji.1830270214; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Orr MT, 2005, PLOS PATHOG, V1, P62, DOI 10.1371/journal.ppat.0010007; Pulendran B, 1997, J IMMUNOL, V159, P2222; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Salomon B, 1998, J IMMUNOL, V160, P708; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stock AT, 2004, J IMMUNOL, V173, P2241, DOI 10.4049/jimmunol.173.4.2241; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	53	535	548	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					153	162		10.1016/j.immuni.2006.04.017	http://dx.doi.org/10.1016/j.immuni.2006.04.017			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860764	Bronze			2022-12-18	WOS:000239713000018
J	Mendiratta, SK; Martin, WD; Hong, S; Boesteanu, A; Joyce, S; VanKaer, L				Mendiratta, SK; Martin, WD; Hong, S; Boesteanu, A; Joyce, S; VanKaer, L			CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; THYMUS LEUKEMIA ANTIGEN; MARROW GRAFT-REJECTION; RECEPTOR-ALPHA-CHAIN; BONE-MARROW; POSITIVE SELECTION; RECEPTOR-ALPHA/BETA(+) CELLS; EXTRATHYMIC DEVELOPMENT; HEMATOPOIETIC-CELLS	Murine CD1 has been implicated in the development end function of an unusual subset of T cells, termed natural T (NT) cells, that coexpress the T cell receptor (TCR) and the natural killer cell receptor NK1.1. Activated NT cells promptly produce large amounts of IL-4, suggesting that these cells can influence the differentiation of CD4(+) effector T cell subsets. We have generated mice that carry a mutant CD1d1 gene. NT cell numbers in the thymus, spleen, and liver of these mice were dramatically reduced. Activated splenocytes from mutant mice did not produce IL-4, whereas similarly treated wild-type splenocytes secreted large amounts of this cytokine. These results demonstrate a critical role for CD1 in the positive selection and function of NT cells.	PENN STATE UNIV,COLL MED,DEPT MICROBIOL & IMMUNOL,MILTON S HERSHEY MED CTR,HERSHEY,PA 17003	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mendiratta, SK (corresponding author), VANDERBILT UNIV,HOWARD HUGHES MED INST,DEPT IMMUNOL & MICROBIOL,SCH MED,221 KIRKLAND HALL,NASHVILLE,TN 37232, USA.		Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; JOYCE, Sebastian/0000-0002-3183-1451	NHLBI NIH HHS [HL54977-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054977] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI Y, 1995, P NATL ACAD SCI USA, V92, P1200, DOI 10.1073/pnas.92.4.1200; ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P267; BIX M, 1995, J IMMUNOL, V155, P1020; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; BRADBURY A, 1990, EUR J IMMUNOL, V20, P1831, DOI 10.1002/eji.1830200830; BRADBURY A, 1988, EMBO J, V7, P3081, DOI 10.1002/j.1460-2075.1988.tb03173.x; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; BUDD RC, 1987, J EXP MED, V166, P577, DOI 10.1084/jem.166.2.577; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; Crispe IN, 1996, IMMUNOL TODAY, V17, P522, DOI 10.1016/S0167-5699(96)80906-6; DENKERS EY, 1996, CRIT REV IMMUNOL, V184, P131; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; HASHIMOTO W, 1995, J IMMUNOL, V154, P4333; HAYAKAWA K, 1992, J EXP MED, V176, P269, DOI 10.1084/jem.176.1.269; HEINZEL FP, 1995, J IMMUNOL, V155, P730; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; HOLCOMBE HR, 1995, J EXP MED, V181, P1433, DOI 10.1084/jem.181.4.1433; Joyce S, 1996, J EXP MED, V184, P1579, DOI 10.1084/jem.184.4.1579; KIKLY K, 1992, J IMMUNOL, V149, P403; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LEVITSKY HI, 1991, J IMMUNOL, V146, P1113; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Makino Y, 1996, P NATL ACAD SCI USA, V93, P6516, DOI 10.1073/pnas.93.13.6516; Mieza MA, 1996, J IMMUNOL, V156, P4035; MOQBEL R, 1995, J IMMUNOL, V155, P4939; Morawetz RA, 1996, J EXP MED, V184, P1651, DOI 10.1084/jem.184.5.1651; OBATA Y, 1985, P NATL ACAD SCI USA, V82, P5475, DOI 10.1073/pnas.82.16.5475; OHTEKI T, 1992, J IMMUNOL, V149, P1562; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; OLD LJ, 1963, JNCI-J NATL CANCER I, V31, P977; PONTAROTTI PA, 1986, P NATL ACAD SCI USA, V83, P1782, DOI 10.1073/pnas.83.6.1782; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759; SCHMITZ J, 1994, J EXP MED, V179, P1346; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEKI S, 1991, J IMMUNOL, V147, P1214; Sharma P, 1996, J IMMUNOL, V156, P987; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; STROYNOWSKI I, 1990, ANNU REV IMMUNOL, V8, P501, DOI 10.1146/annurev.iy.08.040190.002441; SWAIN SL, 1995, CURR BIOL, V5, P849, DOI 10.1016/S0960-9822(95)00170-9; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SYKES M, 1990, J IMMUNOL, V145, P3209; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TAKAHAMA Y, 1991, J IMMUNOL, V147, P2883; Takeda K, 1996, J IMMUNOL, V156, P3366; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; WU M, 1991, J EXP MED, V174, P213, DOI 10.1084/jem.174.1.213; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	76	535	538	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					469	477		10.1016/S1074-7613(00)80290-3	http://dx.doi.org/10.1016/S1074-7613(00)80290-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133426	Bronze			2022-12-18	WOS:A1997XC61900012
J	Ji, H; Ohmura, K; Mahmood, U; Lee, DM; Hofhuis, FMA; Boackle, SA; Takahashi, K; Holers, VM; Walport, M; Gerard, C; Ezekowitz, A; Carroll, MC; Brenner, M; Weissleder, R; Verbeek, JS; Duchatelle, V; Degott, C; Benoist, C; Mathis, D				Ji, H; Ohmura, K; Mahmood, U; Lee, DM; Hofhuis, FMA; Boackle, SA; Takahashi, K; Holers, VM; Walport, M; Gerard, C; Ezekowitz, A; Carroll, MC; Brenner, M; Weissleder, R; Verbeek, JS; Duchatelle, V; Degott, C; Benoist, C; Mathis, D			Arthritis critically dependent on innate immune system players	IMMUNITY			English	Article							COLLAGEN-INDUCED ARTHRITIS; ALTERNATIVE COMPLEMENT PATHWAY; FC-GAMMA-RII; B-CELL RESPONSE; RHEUMATOID-ARTHRITIS; T-CELL; AUTOIMMUNE-DISEASE; ARTHUS REACTION; DEFICIENT MICE; IN-VIVO	Disease in these animals is focused specifically on the joints but stems from autoreactivity to a ubiquitously expressed antigen, glucose-6-phosphate isomerase (GPI). T and B cells are both required for disease initiation, but anti-GPI immunoglobulins; (Igs), alone, can induce arthritis in lymphocyte-deficient recipients. Here, we show that the arthritogenic Igs act through both Fc receptors (in particular, FcgammaRIII) and the complement network (C5a). Surprisingly, the alternative pathway of complement activation is critical, while classical pathway components are entirely dispensable. We suggest that autoimmune disease, even one that is organ specific, can occur when mobilization of an adaptive immune response results in runaway activation of the innate response.	Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA; Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Univ Colorado, Hlth Sci Ctr, Dept Rheumatol, Denver, CO 80262 USA; Massachusetts Gen Hosp, Div Pediat, Boston, MA 02115 USA; Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Div Med, London W12 0NN, England; Childrens Hosp, Div Pulm, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Hop Beaujon, Serv Anat & Cytol Pathol, F-92118 Clichy, France	Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts General Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Massachusetts General Hospital; Imperial College London; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Benoist, C (corresponding author), Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Immunol & Immunogenet, 75 Francis St, Boston, MA 02115 USA.			Mahmood, Umar/0000-0001-7414-6123; Walport, Mark/0000-0001-7220-5273; /0000-0003-0828-4143	NATIONAL CANCER INSTITUTE [P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA86355] Funding Source: Medline; NIAMS NIH HHS [1R01 AR/AI46580-01] Funding Source: Medline; NIDDK NIH HHS [5 P30 DK36836-15] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aggarwal A, 2000, RHEUMATOLOGY, V39, P189, DOI 10.1093/rheumatology/39.2.189; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ANDERSSON M, 1991, IMMUNOLOGY, V73, P191; Arend WP, 1997, ARTHRITIS RHEUM, V40, P595, DOI 10.1002/art.1780400402; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; COOKE TD, 1975, ARTHRITIS RHEUM, V18, P541, DOI 10.1002/art.1780180603; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DAFFERN PJ, 1995, J EXP MED, V181, P2119, DOI 10.1084/jem.181.6.2119; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Edwards JCW, 1997, CLIN EXP IMMUNOL, V108, P401, DOI 10.1046/j.1365-2249.1997.3941286.x; Fischer MB, 1996, J IMMUNOL, V157, P549; FREI Y, 1987, MOL CELL PROBE, V1, P141, DOI 10.1016/0890-8508(87)90022-3; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERVAIS F, 1989, J IMMUNOL, V142, P2057; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Hazevoet C. J., 1996, Bird Conservation International, V6, P181; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Jelezarova E, 2000, BIOCHEM J, V349, P217, DOI 10.1042/0264-6021:3490217; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; JOSE PJ, 1990, ANN RHEUM DIS, V49, P747, DOI 10.1136/ard.49.10.747; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Kohl J, 1999, MOL IMMUNOL, V36, P893, DOI 10.1016/S0161-5890(99)00111-X; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Luan JJ, 1996, J IMMUNOL, V157, P4707; Malfait AM, 1999, J IMMUNOL, V162, P6278; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Nieto A, 2000, ARTHRITIS RHEUM, V43, P735, DOI 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q; Olsson N, 2001, ANN RHEUM DIS, V60, P187, DOI 10.1136/ard.60.3.187; Orren A, 1989, COMPLEMENT INFLAMM, V6, P295; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; RIJNTJES NVM, 1979, J IMMUNOL METHODS, V30, P263, DOI 10.1016/0022-1759(79)90100-5; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Schiller C, 2000, EUR J IMMUNOL, V30, P481; Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; van Lent PLEM, 2000, ARTHRITIS RHEUM-US, V43, P740, DOI 10.1002/1529-0131(200004)43:4<740::AID-ANR4>3.0.CO;2-0; Vivanco F, 1999, MOL IMMUNOL, V36, P843, DOI 10.1016/S0161-5890(99)00105-4; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; Watanabe H, 2000, J IMMUNOL, V164, P786, DOI 10.4049/jimmunol.164.2.786; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WETSEL RA, 1983, J EXP MED, V157, P2029, DOI 10.1084/jem.157.6.2029; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922; Zvaifler N J, 1973, Adv Immunol, V16, P265, DOI 10.1016/S0065-2776(08)60299-0	56	534	558	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					157	168		10.1016/S1074-7613(02)00275-3	http://dx.doi.org/10.1016/S1074-7613(02)00275-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869678	Bronze			2022-12-18	WOS:000174039600001
J	Coxon, A; Rieu, P; Barkalow, FJ; Askari, S; Sharpe, AH; vonAndrian, UH; Arnaout, MA; Mayadas, TN				Coxon, A; Rieu, P; Barkalow, FJ; Askari, S; Sharpe, AH; vonAndrian, UH; Arnaout, MA; Mayadas, TN			A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: A homeostatic mechanism in inflammation	IMMUNITY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; LEUKOCYTE ADHESION MOLECULES; PROGRAMMED CELL-DEATH; RECURRENT BACTERIAL-INFECTIONS; SELECTIN-DEFICIENT MICE; RESPIRATORY BURST; TYROSINE PHOSPHORYLATION; VITRONECTIN RECEPTOR; INHERITED DEFECT; CR3 CD11B/CD18	In mice selectively deficient in CD11b/CD18, a beta 2 integrin, chemoattractant-induced leukocyte adhesion to microvascular endothelium in vivo was reduced. Paradoxically, thioglycollate-induced neutrophil accumulation in the peritoneal cavity was increased and was associated with a significant delay in apoptosis of extravasated cells. The extravasated cells had a near absence of neutrophil phagocytosis and a reduction in oxygen free radical generation, which may contribute to the observed defect in apoptosis, This is supported by our in vitro studies, in which phagocytosis of opsonized particles by human neutrophils rapidly induced apoptosis that could be blocked with CD11b/CD18 antibodies, Reactive oxygen species are the intracellular link in this process: phagocytosis-induced apoptosis was blocked both in neutrophils treated with the flavoprotein inhibitor diphenylene iodonium and in neutrophils from patients with chronic granulomatous disease, which lack NADPH oxidase. Thus, CD11b/CD18 plays a novel and unsuspected homeostatic role in inflammation by accelerating the programmed elimination of extravasated neutrophils.	HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, CTR BLOOD RES, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, MASSACHUSETTS GEN HOSP,SCH MED, LEUKOCYTE BIOL & INFLAMMAT PROGRAM,RENAL DIV, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital			von Andrian, Ulrich H/A-5775-2008		NIDDK NIH HHS [DK-48549] Funding Source: Medline; NINDS NIH HHS [NS33296] Funding Source: Medline; PHS HHS [P0150305] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033296] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; AFFORD SC, 1992, J BIOL CHEM, V267, P21612; ANDERSON DC, 1985, J INFECT DIS, V152, P668, DOI 10.1093/infdis/152.4.668; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; ARNAOUT MA, 1990, BLOOD, V75, P1037; ARNAOUT MA, 1988, J CELL PHYSIOL, V137, P305, DOI 10.1002/jcp.1041370214; ARNAOUT MA, 1983, J CLIN INVEST, V72, P171, DOI 10.1172/JCI110955; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; ARNAOUT MA, 1982, NEW ENGL J MED, V306, P693, DOI 10.1056/NEJM198203253061201; BABIOR BM, 1992, ADV ENZYMOL RAMB, V65, P49; BAEHNER RL, 1968, NEW ENGL J MED, V278, P971, DOI 10.1056/NEJM196805022781801; Bullard DC, 1996, P NATL ACAD SCI USA, V93, P2116, DOI 10.1073/pnas.93.5.2116; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CARLOS TM, 1994, BLOOD, V84, P2068; CHAPES SK, 1983, CELL IMMUNOL, V75, P367, DOI 10.1016/0008-8749(83)90334-9; COLOTTA F, 1992, BLOOD, V80, P2012; COX G, 1995, AM J RESP CELL MOL, V12, P232, DOI 10.1165/ajrcmb.12.2.7865221; CROSS AR, 1990, FREE RADICAL BIO MED, V8, P71, DOI 10.1016/0891-5849(90)90147-B; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; FADOK VA, 1992, J IMMUNOL, V149, P4029; FALLMAN M, 1993, J IMMUNOL, V151, P330; FIRESTEIN GS, 1995, J CLIN INVEST, V96, P1631, DOI 10.1172/JCI118202; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GABOURY JP, 1994, BLOOD, V83, P345; GIGER U, 1987, BLOOD, V69, P1622; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; GRESHAM HD, 1991, J CLIN INVEST, V88, P588, DOI 10.1172/JCI115343; GRIGG JM, 1991, LANCET, V338, P720, DOI 10.1016/0140-6736(91)91443-X; HENDERSON WR, 1983, J BIOL CHEM, V258, P3522; HENSON PM, 1991, CHEST, V99, pS2, DOI 10.1378/chest.99.3.2S; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; IWAI K, 1994, BLOOD, V84, P1201; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; KEHRLI ME, 1990, AM J VET RES, V51, P1826; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LILES WC, 1995, J IMMUNOL, V155, P3289; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MENTZER SJ, 1986, J IMMUNOL, V137, P108; MULLIGAN MS, 1994, AM J PATHOL, V144, P1008; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; PEMBERTON M, 1993, J IMMUNOL, V150, P5104; PETTY HR, 1993, J LEUKOCYTE BIOL, V54, P492, DOI 10.1002/jlb.54.5.492; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PRIES AR, 1988, INT J MICROCIRC, V7, P327; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; RIEU P, 1994, J CELL BIOL, V127, P2081, DOI 10.1083/jcb.127.6.2081; SANUI H, 1982, BRIT J EXP PATHOL, V63, P278; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; SQUIER MKT, 1995, J LEUKOCYTE BIOL, V57, P2, DOI 10.1002/jlb.57.1.2; Stossel T P, 1986, Methods Enzymol, V132, P192; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Um HD, 1996, J IMMUNOL, V156, P3469; VONANDRIAN UH, 1993, J CLIN INVEST, V91, P2893, DOI 10.1172/JCI116535; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; Watson RWG, 1996, J IMMUNOL, V156, P3986; WHYTE MKB, 1993, J CLIN INVEST, V92, P446, DOI 10.1172/JCI116587; WILSON RW, 1993, J IMMUNOL, V151, P1571; WITTE T, 1993, J CLIN INVEST, V92, P1181, DOI 10.1172/JCI116688; YOUSEFI S, 1994, P NATL ACAD SCI USA, V91, P10868, DOI 10.1073/pnas.91.23.10868; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	73	534	557	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1996	5	6					653	666		10.1016/S1074-7613(00)80278-2	http://dx.doi.org/10.1016/S1074-7613(00)80278-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986723	Bronze			2022-12-18	WOS:A1996WA65100014
J	Iyer, SS; He, Q; Janczy, JR; Elliott, EI; Zhong, Z; Olivier, AK; Sadler, JJ; Knepper-Adrian, V; Han, RZ; Qiao, L; Eisenbarth, SC; Nauseef, WM; Cassel, SL; Sutterwala, FS				Iyer, Shankar S.; He, Qiong; Janczy, John R.; Elliott, Eric I.; Zhong, Zhenyu; Olivier, Alicia K.; Sadler, Jeffrey J.; Knepper-Adrian, Vickie; Han, Renzhi; Qiao, Liang; Eisenbarth, Stephanie C.; Nauseef, William M.; Cassel, Suzanne L.; Sutterwala, Fayyaz S.			Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation	IMMUNITY			English	Article							CYTOCHROME-C RELEASE; NALP3 INFLAMMASOME; PROTEIN-SYNTHESIS; OXIDATIVE STRESS; APOPTOSIS; CASPASE-1; TOXICITY; INNATE; OXAZOLIDINONES; INFECTIONS	Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic linezolid as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically the mitochondrial lipid cardiolipin. Cardiolipin bound to Nlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.	[Iyer, Shankar S.; He, Qiong; Janczy, John R.; Elliott, Eric I.; Sadler, Jeffrey J.; Knepper-Adrian, Vickie; Nauseef, William M.; Cassel, Suzanne L.; Sutterwala, Fayyaz S.] Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [He, Qiong; Janczy, John R.; Nauseef, William M.; Sutterwala, Fayyaz S.] Univ Iowa, Carver Coll Med, Grad Program Immunol, Iowa City, IA 52242 USA; [Elliott, Eric I.; Sutterwala, Fayyaz S.] Univ Iowa, Carver Coll Med, Grad Program Mol & Cellular Biol, Iowa City, IA 52242 USA; [Olivier, Alicia K.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Nauseef, William M.; Cassel, Suzanne L.; Sutterwala, Fayyaz S.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zhong, Zhenyu; Qiao, Liang] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Han, Renzhi] Loyola Univ Chicago, Stritch Sch Med, Dept Cell Biol & Physiol, Maywood, IL 60153 USA; [Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Nauseef, William M.; Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52241 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Loyola University Chicago; Loyola University Chicago; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA.	suzanne-cassel@uiowa.edu; fayyaz-sutterwala@uiowa.edu	Sutterwala, Fayyaz/AAH-5859-2021; Zhong, Zhenyu/A-8339-2017; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Eisenbarth, Stephanie/0000-0002-1244-208X; Zhong, Zhenyu/0000-0002-9441-7645; Elliott, Eric/0000-0003-0630-3478; Han, Renzhi/0000-0002-8202-9186; Nauseef, William/0000-0003-4032-757X	National Institutes of Health [R01 AI087630, K08 AI067736, R01 AR064241, R01 HL116546, T32 AI007485]; American Heart Association Scientist Development Grant [10SDG4140138]; Muscular Dystrophy Association [MDA171667]; Asthma and Allergy Foundation of America fellowship; Edward Mallinckrodt, Jr. Foundation scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116546, T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI067736, R01AI087630, T32AI007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Asthma and Allergy Foundation of America fellowship; Edward Mallinckrodt, Jr. Foundation scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Flavell, J. Bertin, and Millennium Pharmaceuticals for providing knockout mice, F. Martinon for providing Flag-tagged Nlrp3 constructs, T. Gioannini for providing His-tagged TLR4, and P. Rothman and R. Mallampalli for helpful discussion. National Institutes of Health grants R01 AI087630 (F.S.S.), K08 AI067736 (S.L.C.), R01 AR064241 (R.H.), R01 HL116546 (R.H.), and T32 AI007485 (J.R.J.), American Heart Association Scientist Development Grant 10SDG4140138 (R.H.), Muscular Dystrophy Association grant MDA171667 (R.H.), Asthma and Allergy Foundation of America fellowship (S.L.C.), and an Edward Mallinckrodt, Jr. Foundation scholarship (F.S.S.) supported this work. The Inflammation Program (W.M.N., S.L.C., and F.S.S.) is supported by resources and use of facilities at the Veterans Affairs Medical Center, Iowa City, IA.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Ament PW, 2002, AM FAM PHYSICIAN, V65, P663; Attassi K, 2002, CLIN INFECT DIS, V34, P695, DOI 10.1086/338403; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dawson MA, 2005, INTERN MED J, V35, P626, DOI 10.1111/j.1445-5994.2005.00912.x; De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gerson SL, 2002, ANTIMICROB AGENTS CH, V46, P2723, DOI 10.1128/AAC.46.8.2723-2726.2002; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Green SL, 2001, JAMA-J AM MED ASSOC, V285, P1291, DOI 10.1001/jama.285.10.1291; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Iyer SS, 1999, J BIOL CHEM, V274, P2350, DOI 10.1074/jbc.274.4.2350; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; MacGowan AP, 2003, J ANTIMICROB CHEMOTH, V51, P17, DOI 10.1093/jac/dkg248; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sood R., 2006, Infectious Disorders - Drug Targets, V6, P343, DOI 10.2174/187152606779025860; Soriano A, 2005, NEW ENGL J MED, V353, P2305, DOI 10.1056/NEJM200511243532123; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taketani T, 2009, J PEDIAT HEMATOL ONC, V31, P684, DOI 10.1097/MPH.0b013e3181b1ed42; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Wang XD, 2001, GENE DEV, V15, P2922; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	55	531	561	8	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					311	323		10.1016/j.immuni.2013.08.001	http://dx.doi.org/10.1016/j.immuni.2013.08.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23954133	Green Accepted, Bronze			2022-12-18	WOS:000330948800013
J	Zhang, N; Bevan, MJ				Zhang, Nu; Bevan, Michael J.			CD8(+) T Cells: Foot Soldiers of the Immune System	IMMUNITY			English	Review							CHRONIC VIRAL-INFECTION; INFLUENZA-VIRUS INFECTION; IN-VITRO CYTOTOXICITY; LYMPH-NODES; TRANSCRIPTION FACTORS; DENDRITIC CELLS; LYMPHOCYTIC CHORIOMENINGITIS; EFFECTOR FUNCTION; MAMMALIAN TARGET; IL-10 PRODUCTION	Resting naive CD8(+) T cells have an astounding capacity to react to pathogens by massive expansion and differentiation into cytotoxic effector cells that migrate to all corners of the body to clear the infection. The initial interaction with antigen-presenting cells in the central lymphoid organs drives an orchestrated program of differentiation aimed at producing sufficient numbers of effectors to get the job done without resulting in clonal exhaustion. Interactions with antigen-presenting cells and other immune cells continue at the site of infection to regulate further on-site expansion and differentiation, all with the goal of protecting the host with minimal bystander tissue damage. Here we review recent advances in CD8(+) T cell recognition of antigen in lymphoid as well as in nonlymphoid tissues in the periphery, and how CD8(+) T cell expansion and differentiation are controlled in these contexts.	[Zhang, Nu; Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Zhang, Nu; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zhang, N (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	nuz@uw.edu; mbevan@uw.edu		Zhang, Nu/0000-0001-9695-210X	NIAID NIH HHS [R01 AI019335-19, R01 AI019335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bartholdy C, 2009, J GEN VIROL, V90, P423, DOI 10.1099/vir.0.004960-0; Bedoui S, 2011, CURR OPIN IMMUNOL, V23, P124, DOI 10.1016/j.coi.2010.11.001; Beuneu H, 2010, IMMUNITY, V33, P412, DOI 10.1016/j.immuni.2010.08.016; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; CANTOR H, 1975, J EXP MED, V141, P1376, DOI 10.1084/jem.141.6.1376; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; CEROTTINI JC, 1970, NATURE, V228, P1308, DOI 10.1038/2281308a0; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Gebhardt T, 2009, NATURE, V462, P418, DOI 10.1038/462418a; Geng DG, 2010, BLOOD, V116, P3494, DOI 10.1182/blood-2010-02-268169; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; GOLSTEIN P, 1972, J EXP MED, V135, P890, DOI 10.1084/jem.135.4.890; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Palmer EM, 2010, VIROLOGY, V404, P225, DOI 10.1016/j.virol.2010.05.004; Parish IA, 2009, CURR OPIN IMMUNOL, V21, P291, DOI 10.1016/j.coi.2009.05.008; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Rahman AH, 2011, BLOOD, V117, P3123, DOI 10.1182/blood-2010-11-318485; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423; Zhao Y, 2009, J IMMUNOL, V182, P6278, DOI 10.4049/jimmunol.0803682; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	87	529	544	1	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					161	168		10.1016/j.immuni.2011.07.010	http://dx.doi.org/10.1016/j.immuni.2011.07.010			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867926	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000294387900007
J	McGeachy, MJ; Cua, DJ				McGeachy, Mandy J.; Cua, Daniel J.			Th17 cell differentiation: The long and winding road	IMMUNITY			English	Review							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; REGULATORY T-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TGF-BETA; AUTOIMMUNE ENCEPHALOMYELITIS; RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA; INNATE IMMUNITY; IL-23	The characterization of the new lineage of IL-17-producing CD4(+) T helper (Th17) cells has revolutionized our current understanding of T cell-mediated immunity. Over the past five years, there have been many twists and turns as the pathways that lead to Th17 cell differentiation have been elucidated. Not least of these was the discovery that TGF-beta is a crucial cytokine for Th17 cell development, suggesting that Th17 and regulatory T cell subsets share reciprocal developmental pathways during the pathogenesis or control of inflammation. This review aims to bring together the observations that have formed current opinion on factors that promote and contain Th17 cell development, in both mouse and man. Unresolved controversies in this field are also discussed: For example, IL-23 is absolutely required for disease pathogenesis in many models of Th17-cell-mediated autoimmunity, yet its role in Th17 cell development is relatively unclear.	[McGeachy, Mandy J.; Cua, Daniel J.] Schering Plough Biopharma, Palo Alto, CA 94304 USA	Merck & Company	McGeachy, MJ (corresponding author), Schering Plough Biopharma, 901 Calif Ave, Palo Alto, CA 94304 USA.	mandy.mcgeachy@spcorp.com; daniel.cua@spcorp.com						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; [Anonymous], 2007, NAT GENET, V39, P1329; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Baecher-Allan C, 2004, J EXP MED, V200, P273, DOI 10.1084/jem.20040812; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; COFFMAN RL, 1986, J IMMUNOL, V136, P949; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Gran B, 2004, J NEUROIMMUNOL, V156, P123, DOI 10.1016/j.jneuroim.2004.07.019; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Illes Z, 2008, NEUROSCI LETT, V431, P36, DOI 10.1016/j.neulet.2007.11.015; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim KW, 2007, IMMUNOL LETT, V110, P54, DOI 10.1016/j.imlet.2007.03.004; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Smith RL, 2008, J INVEST DERMATOL, V128, P1325, DOI 10.1038/sj.jid.5701140; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Visser L, 2005, J IMMUNOL, V174, P808, DOI 10.4049/jimmunol.174.2.808; VOORTHUIS JAC, 1990, CLIN EXP IMMUNOL, V81, P183; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang GX, 2003, J IMMUNOL, V171, P4485, DOI 10.4049/jimmunol.171.9.4485; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	96	526	566	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					445	453		10.1016/j.immuni.2008.03.001	http://dx.doi.org/10.1016/j.immuni.2008.03.001			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400187	Bronze			2022-12-18	WOS:000254939400003
J	Saijo, S; Ikeda, S; Yamabe, K; Kakuta, S; Ishigame, H; Akitsu, A; Fujikado, N; Kusaka, T; Kubo, S; Chung, SH; Komatsu, R; Miura, N; Adachi, Y; Ohno, N; Shibuya, K; Yamamoto, N; Kawakami, K; Yamasaki, S; Saito, T; Akira, S; Iwakura, Y				Saijo, Shinobu; Ikeda, Satoshi; Yamabe, Keiko; Kakuta, Shigeru; Ishigame, Harumichi; Akitsu, Aoi; Fujikado, Noriyuki; Kusaka, Toshimasa; Kubo, Sachiko; Chung, Soo-hyun; Komatsu, Ryohei; Miura, Noriko; Adachi, Yoshiyuki; Ohno, Naohito; Shibuya, Kazutoshi; Yamamoto, Natsuo; Kawakami, Kazuyoshi; Yamasaki, Sho; Saito, Takashi; Akira, Shizuo; Iwakura, Yoichiro			Dectin-2 Recognition of alpha-Mannans and Induction of Th17 Cell Differentiation Is Essential for Host Defense against Candida albicans	IMMUNITY			English	Article							T-HELPER-CELLS; RECEPTOR; RESPONSES; INNATE; IL-17; IMMUNITY; IL-23; INTERLEUKIN-17A; REQUIREMENT; ASSOCIATION	Dectin-2 (gene symbol Clec4n) is a C-type lectin expressed by dendritic cells (DCs) and macrophages. However, its functional roles and signaling mechanisms remain to be elucidated. Here, we generated Clec4n(-/-) mice and showed that this molecule is important for host defense against Candida albicans (C. albicans). Clec4n(-/-) DCs had virtually no fungal alpha-mannan-induced cytokine production. Dectin-2 signaling induced cytokines through an FcR gamma chain and Syk-CARD9-NF-kappa B-dependent signaling pathway without involvement of MAP kinases. The yeast form of C. albicans induced interleukin-1 beta (IL-1 beta) and IL-23 secretion in a Dectin-2-dependent manner. In contrast, cytokine production induced by the hyphal form was only partially dependent on this lectin. Both yeast and hyphae induced Th17 cell differentiation, in which Dectin-2, but not Dectin-1, was mainly involved. Because IL-17A-deficient mice were highly susceptible to systemic candida infection, this study suggests that Dectin-2 is important in host defense against C. albicans by inducing Th17 cell differentiation.	[Saijo, Shinobu; Ikeda, Satoshi; Yamabe, Keiko; Kakuta, Shigeru; Ishigame, Harumichi; Akitsu, Aoi; Fujikado, Noriyuki; Kusaka, Toshimasa; Kubo, Sachiko; Chung, Soo-hyun; Komatsu, Ryohei; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Minato Ku, Tokyo 1088639, Japan; [Miura, Noriko; Adachi, Yoshiyuki; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo 1920392, Japan; [Shibuya, Kazutoshi] Toho Univ, Fac Med, Sch Med, Dept Surg Pathol,Ota Ku, Tokyo 1438541, Japan; [Yamamoto, Natsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yamamoto, Natsuo] Tohoku Univ, Grad Sch Med, Diagnost Lab, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawakami, Kazuyoshi] Tohoku Univ, Sch Hlth Sci, Dept Med Technol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yamasaki, Sho; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa 2300045, Japan; [Saito, Takashi; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Tokyo University of Pharmacy & Life Sciences; Tohoku University; Tohoku University; Tohoku University; RIKEN; Osaka University; Japan Science & Technology Agency (JST)	Iwakura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iwakura@ims.u-tokyo.ac.jp	Kakuta, Shigeru/L-2241-2018; Akira, Shizuo/C-3134-2009; Iwakura, Yoichiro/E-5457-2011; Saijo, Shinobu/I-1501-2017; Saito, Takashi/C-9684-2009	Kakuta, Shigeru/0000-0002-5900-1425; Iwakura, Yoichiro/0000-0002-9934-5775; Saijo, Shinobu/0000-0002-3802-8821; Saito, Takashi/0000-0001-9495-3547; Fujikado, Noriyuki/0000-0002-3183-5866; Fujikado, Noriyuki/0000-0002-0415-5929; Chung, Soo-Hyun/0000-0003-2808-1327	Japan Science and Technology Corporation; Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Health Science Research Grant for Research on Emerging and Re-emerging Infectious Diseases; Ministry of Health, Labour, and Welfare of Japan	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Science Research Grant for Research on Emerging and Re-emerging Infectious Diseases; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We deeply thank G.N. Barber for critical reading of the manuscript; N. Sato and A. Shibuya for their technical assistance; Y. Ishii for cell sorting; T. Chibana for SC5314 strain of C. albicans; and all of the members of our laboratory for animal care. This work was supported by CREST of the Japan Science and Technology Corporation, the Promotion of Basic Research Activities for Innovative Biosciences, Grants-in Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Health Science Research Grant for Research on Emerging and Re-emerging Infectious Diseases, The Health Science Research Grant for Measures for Intractable Diseases from Ministry of Health, Labour, and Welfare of Japan, and The Grant of the Strategic Basis on Research Grounds from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BAGHIAN A, 1989, J MED VET MYCOL, V27, P51; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cutler JE, 2001, MED MYCOL, V39, P75, DOI 10.1080/714030992; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KOBAYASHI H, 1989, ARCH BIOCHEM BIOPHYS, V272, P364, DOI 10.1016/0003-9861(89)90230-0; Lee SJ, 2003, INFECT IMMUN, V71, P437, DOI 10.1128/IAI.71.1.437-445.2003; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; ODDS FC, 1988, CANDIA CANDIDOSIS; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Shibata N, 2003, EUR J BIOCHEM, V270, P2565, DOI 10.1046/j.1432-1033.2003.03622.x; Shinohara H, 2006, BIOL PHARM BULL, V29, P1854, DOI 10.1248/bpb.29.1854; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tada R, 2008, MICROB PATHOGENESIS, V44, P379, DOI 10.1016/j.micpath.2007.10.013; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	42	525	553	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					681	691		10.1016/j.immuni.2010.05.001	http://dx.doi.org/10.1016/j.immuni.2010.05.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20493731	Bronze			2022-12-18	WOS:000278280500013
J	Schmid, D; Pypaert, M; Munz, C				Schmid, Dorothee; Pypaert, Marc; Munz, Christian			Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes	IMMUNITY			English	Article							T-CELL RESPONSE; IN-VIVO; DENDRITIC CELLS; RESTRICTED PRESENTATION; CYTOPLASMIC ANTIGENS; CYTOSOLIC ANTIGEN; NUCLEAR ANTIGEN; PROTEINS; EXPRESSION; PEPTIDES	Major histocompatibility complex (MHC) class II molecules present products of lysosomal proteolysis to CD4(+) T cells. Although extracellular antigen uptake is considered to be the main source of MHC class II ligands, a few intracellular antigens have been described to gain access to MHC class II loading after macroautophagy. However, the general relevance and efficacy of this pathway is unknown. Here we demonstrated constitutive autophagosome formation in MHC class II-positive cells, including dendritic, B, and epithelial cells. The autophagosomes continuously fuse with multivesicular MHC class II-loading compartments. This pathway was of functional relevance, because targeting of the influenza matrix protein 1 to autophagosomes via fusion to the autophagosome-associated protein Atg8/LC3 led to strongly enhanced MHC class II presentation to CD4(+) T cell clones. We suggest that macroautophagy constitutively and efficiently delivers cytosolic proteins for MHC class II presentation and can be harnessed for improved helper T cell stimulation.	Rockefeller Univ, Lab Viral Immunobiol, New York, NY 10021 USA; Rockefeller Univ, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Rockefeller University; Rockefeller University; Yale University	Munz, C (corresponding author), Rockefeller Univ, Lab Viral Immunobiol, New York, NY 10021 USA.	munzc@rockefeller.edu	Münz, Christian/W-4881-2017	Dormann, Dorothee/0000-0002-9260-2775; Munz, Christian/0000-0001-6419-1940	NCI NIH HHS [R01 CA108609, R01CA108609, R01CA101741, R01 CA101741] Funding Source: Medline; NCRR NIH HHS [M01-RR00102, M01 RR000102] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108609, R01CA101741] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Chen M, 1998, J VIROL, V72, P8301, DOI 10.1128/JVI.72.10.8301-8308.1998; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Friede T, 1996, BBA-MOL BASIS DIS, V1316, P85, DOI 10.1016/0925-4439(96)00010-5; Fu TH, 2004, J CLIN INVEST, V114, P542, DOI 10.1172/JCI200422053; Gueguen M, 1996, P NATL ACAD SCI USA, V93, P14692, DOI 10.1073/pnas.93.25.14692; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; Lechler R, 1996, IMMUNOL REV, V151, P51, DOI 10.1111/j.1600-065X.1996.tb00703.x; Li P, 2005, IMMUNOL REV, V207, P206, DOI 10.1111/j.0105-2896.2005.00297.x; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Muntasell A, 2004, J IMMUNOL, V173, P1085, DOI 10.4049/jimmunol.173.2.1085; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; Qi L, 2000, J IMMUNOL, V165, P5451, DOI 10.4049/jimmunol.165.10.5451; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Schmid D, 2005, CELL DEATH DIFFER, V12, P1519, DOI 10.1038/sj.cdd.4401727; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sparks-Thissen RL, 2004, J VIROL, V78, P6827, DOI 10.1128/JVI.78.13.6827-6835.2004; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Yawalkar N, 2001, AM J PATHOL, V158, P803, DOI 10.1016/S0002-9440(10)64027-8; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	50	525	559	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2007	26	1					79	92		10.1016/j.immuni.2006.10.018	http://dx.doi.org/10.1016/j.immuni.2006.10.018			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17182262	Green Accepted, Bronze			2022-12-18	WOS:000243959000011
J	Nakagawa, R; Naka, T; Tsutsui, H; Fujimoto, M; Kimura, A; Abe, T; Seki, E; Sato, S; Takeuchi, O; Takeda, K; Akira, S; Yamanishi, K; Kawase, I; Nakanishi, K; Kishimoto, T				Nakagawa, R; Naka, T; Tsutsui, H; Fujimoto, M; Kimura, A; Abe, T; Seki, E; Sato, S; Takeuchi, O; Takeda, K; Akira, S; Yamanishi, K; Kawase, I; Nakanishi, K; Kishimoto, T			SOCS-1 participates in negative regulation of LPS responses	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; STAT INHIBITOR-1 (SSI-1)/SUPPRESSOR; FACTOR-KAPPA-B; CYTOKINE SIGNALING-1; INTERFERON-GAMMA; IFN-GAMMA; DEFECTIVE INTERLEUKIN-1; ENDOTOXIN TOLERANCE; TARGETED DISRUPTION	SOCS-1 is a negative regulatory molecule of the JAK-STAT signal cascade. Here, we demonstrate that SOCS-1 is a critical downregulating factor for LPS signal pathways. SOCS-1 expression was promptly induced in macrophages upon LPS stimulation. SOCS1-deficient mice were highly sensitive to LPS-induced shock and produced increased levels of inflammatory cytokines. Introduction of SOCS-1 inhibited LPS-induced NF-kappaB and STAT1 activation in macrophages. Furthermore, LIPS tolerance, a refractory state to second LPS stimulation, was not observed in SOCS(-1-)deficient mice. These results suggest SOCS-1 as an essential, negative regulator in LPS responses that protects the host from harmful overresponses to LPS and may provide new insight into the endotoxin-induced fatal syndrome that occasionally occurs following infection.	Osaka Univ, Grad Sch Med, Dept Mol Med, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Microbiol, Osaka 5650871, Japan; Osaka Univ, Grad Sch, Dept Host Def, Res Inst Mol Microbial Dis, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1010062, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Naka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Med, Osaka 5650871, Japan.	naka@imed3.med.osaka-u.ac.jp	Seki, Ekihiro/K-2481-2016; Takeuchi, Osamu/AAG-9359-2019; Kishimoto, Tadamitsu/C-8470-2009; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011; Nakagawa, Reiko/C-4214-2017; Takeda, Kiyoshi/C-9331-2009	Seki, Ekihiro/0000-0002-9472-6085; Takeuchi, Osamu/0000-0002-1260-6232; Nakagawa, Reiko/0000-0002-6178-2945; Tsutsui, Hiroko/0000-0001-7928-4875; FUJIMOTO, MINORU/0000-0002-6390-8863; Naka, Tetsuji/0000-0002-1269-3997; Sato, Shintaro/0000-0001-5156-3354; Kimura, Akihiro/0000-0001-5614-8547				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Biberstine KJ, 1996, INFECT IMMUN, V64, P3641, DOI 10.1128/IAI.64.9.3641-3645.1996; Blackwell TS, 1996, BRIT J ANAESTH, V77, P110, DOI 10.1093/bja/77.1.110; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Crespo A, 2000, BIOCHEM J, V349, P99, DOI 10.1042/0264-6021:3490099; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; FRAKER DL, 1988, J EXP MED, V168, P95, DOI 10.1084/jem.168.1.95; FREUDENBERG MA, 1986, INFECT IMMUN, V51, P891, DOI 10.1128/IAI.51.3.891-895.1986; FREUDENBERG MA, 1991, INFECT IMMUN, V59, P2110, DOI 10.1128/IAI.59.6.2110-2115.1991; Fujimoto M, 2000, J IMMUNOL, V165, P1799, DOI 10.4049/jimmunol.165.4.1799; Fujimoto M, 2002, INT IMMUNOL, V14, P1343, DOI 10.1093/intimm/dxf094; GALANOS C, 1993, IMMUNOBIOLOGY, V187, P346, DOI 10.1016/S0171-2985(11)80349-9; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Goldring CE, 1998, EUR J IMMUNOL, V28, P2960, DOI 10.1002/(SICI)1521-4141(199809)28:09<2960::AID-IMMU2960>3.0.CO;2-B; HINSHAW LB, 1985, HDB ENDOTOXIN, V2; HINSHAW LB, 1990, ENDOTOXIN RES SERIES, V1, P418; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Kreutz M, 1997, IMMUNOLOGY, V92, P396, DOI 10.1046/j.1365-2567.1997.00365.x; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsuda T, 2000, FEBS LETT, V472, P235, DOI 10.1016/S0014-5793(00)01444-7; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MICHALEK SM, 1980, J INFECT DIS, V141, P55, DOI 10.1093/infdis/141.1.55; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; NAKA T, 2001, IRBM, P241; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nicola NA, 2000, EXP HEMATOL, V28, P1105, DOI 10.1016/S0301-472X(00)00525-7; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Ohya K, 1997, J BIOL CHEM, V272, P27178, DOI 10.1074/jbc.272.43.27178; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; SEPULVEDA PD, 1999, EMBO J, V18, P904; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STARR R, 2001, CYTOKINE INHIBITOR I, P261; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Tsutsui H, 1997, J IMMUNOL, V159, P3961; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Zeisberger E, 1998, ANN NY ACAD SCI, V856, P116, DOI 10.1111/j.1749-6632.1998.tb08320.x; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	69	525	563	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2002	17	5					677	687		10.1016/S1074-7613(02)00449-1	http://dx.doi.org/10.1016/S1074-7613(02)00449-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433373	Bronze			2022-12-18	WOS:000179335100013
J	FREEMAN, GJ; BOUSSIOTIS, VA; ANUMANTHAN, A; BERNSTEIN, GM; KE, XY; RENNERT, PD; GRAY, GS; GRIBBEN, JG; NADLER, LM				FREEMAN, GJ; BOUSSIOTIS, VA; ANUMANTHAN, A; BERNSTEIN, GM; KE, XY; RENNERT, PD; GRAY, GS; GRIBBEN, JG; NADLER, LM			B7-1 AND B7-2 DO NOT DELIVER IDENTICAL COSTIMULATORY SIGNALS, SINCE B7-2 BUT NOT B7-1 PREFERENTIALLY COSTIMULATES THE INITIAL PRODUCTION OF IL-4	IMMUNITY			English	Article							T-CELL ACTIVATION; ANTIGEN-PRESENTING CELL; DIFFERENTIAL REGULATION; CYTOKINE PRODUCTION; COUNTER-RECEPTOR; LYMPHOCYTES-T; INTERLEUKIN-4; EXPRESSION; CD28; MOLECULES	The functional necessity for two CD28 counterreceptors (B7-1 and B7-2) is presently unknown. B7-1 and B7-2 equivalently costimulate IL-2 and interferon-gamma (IFN gamma) production and IL-2 receptor alpha and gamma chain expression. B7-2 induces significantly more IL-4 production than B7-1, with the greatest difference seen in naive T cells. Repetitive costimulation of CD4(+) CD45RA(+) T cells with B7-2 results in moderate levels of both IL-4 and IL-2, whereas repetitive costimulation with B7-1 results in high levels of IL-2 and low levels of IL-4. Therefore, B7-1 and B7-2 costimulation mediate distinct outcomes, since B7-2 provides an initial signal to induce naive T cells to become IL-4 producers, thereby directing the immune response more towards Th0/Th2, whereas B7-1 is a more neutral differentiative signal.	REPLIGEN CORP,CAMBRIDGE,MA 02139		FREEMAN, GJ (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,DIV HEMATOL MALIGNANCIES,44 BINNEY ST,BOSTON,MA 02115, USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NATIONAL CANCER INSTITUTE [P01CA034183] Funding Source: NIH RePORTER; NCI NIH HHS [CA 34183, CA 40416] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BASKAR S, 1993, P NATL ACAD SCI USA, V90, P5687, DOI 10.1073/pnas.90.12.5687; BOUSSIOTIS VA, 1994, J EXP MED, V180, P1665, DOI 10.1084/jem.180.5.1665; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; BOUSSIOTIS VA, 1993, J EXP MED, V178, P1753, DOI 10.1084/jem.178.5.1753; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; CERDAN C, 1995, J IMMUNOL, V154, P1007; CERDAN C, 1992, J IMMUNOL, V149, P2255; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORRY DB, 1994, J IMMUNOL, V153, P4142; DAMLE NK, 1989, J IMMUNOL, V143, P1761; DEBECKER G, 1994, EUR J IMMUNOL, V24, P1523, DOI 10.1002/eji.1830240710; DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468; DING L, 1993, J IMMUNOL, V151, P1224; EHLERS S, 1991, J EXP MED, V173, P25, DOI 10.1084/jem.173.1.25; ENGEL P, 1994, BLOOD, V84, P1402, DOI 10.1182/blood.V84.5.1402.bloodjournal8451402; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FREEDMAN AS, 1987, J IMMUNOL, V137, P3260; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GIMMI CD, 1993, P NATL ACAD SCI USA, V90, P6586, DOI 10.1073/pnas.90.14.6586; GORONZY J, 1987, METHOD ENZYMOL, V150, P333; HART DNJ, 1993, IMMUNOLOGY, V79, P616; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LARSEN CP, 1994, J IMMUNOL, V152, P5208; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LU P, 1994, J EXP MED, V180, P693, DOI 10.1084/jem.180.2.693; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATULONIS UA, 1995, BLOOD, V85, P2507, DOI 10.1182/blood.V85.9.2507.bloodjournal8592507; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; MILICH DR, 1994, J IMMUNOL, V153, P429; MORIMOTO C, 1993, CLIN EXP RHEUMATOL, V11, P241; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; NAKARAI T, 1994, J EXP MED, V180, P241, DOI 10.1084/jem.180.1.241; NOZAWA Y, 1993, J PATHOL, V169, P309, DOI 10.1002/path.1711690306; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; OSWALD IP, 1994, J IMMUNOL, V153, P1707; POWRIE F, 1993, EUR J IMMUNOL, V23, P3043, DOI 10.1002/eji.1830231147; REISER H, 1992, P NATL ACAD SCI USA, V89, P271, DOI 10.1073/pnas.89.1.271; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SIEBERT PD, 1993, BIOTECHNIQUES, V14, P244; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SWAIN SL, 1990, J IMMUNOL, V145, P3796; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; VANDERPOUWKRAAN T, 1993, EUR J IMMUNOL, V23, P1, DOI 10.1002/eji.1830230102; VANDERPOUWKRAAN T, 1992, EUR J IMMUNOL, V22, P1237, DOI 10.1002/eji.1830220519	61	525	538	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					523	532		10.1016/1074-7613(95)90032-2	http://dx.doi.org/10.1016/1074-7613(95)90032-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7538442	Bronze			2022-12-18	WOS:A1995QZ43000009
J	Belkaid, Y; Harrison, OJ				Belkaid, Yasmine; Harrison, Oliver J.			Homeostatic Immunity and the Microbiota	IMMUNITY			English	Review							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; INNATE LYMPHOID-CELLS; SEGMENTED FILAMENTOUS BACTERIA; GERM-FREE-MICE; CD103(+)CD11B(+) DENDRITIC CELLS; LECTIN REGIII-GAMMA; CHAIN FATTY-ACIDS; GUT MICROBIOTA; COMMENSAL BACTERIA	The microbiota plays a fundamental role in the induction, education, and function of the host immune system. In return, the host immune system has evolved multiple means by which to maintain its symbiotic relationship with the microbiota. The maintenance of this dialogue allows the induction of protective responses to pathogens and the utilization of regulatory pathways involved in the sustained tolerance to innocuous antigens. The ability of microbes to set the immunological tone of tissues, both locally and systemically, requires tonic sensing of microbes and complex feedback loops between innate and adaptive components of the immune system. Here we review the dominant cellular mediators of these interactions and discuss emerging themes associated with our current understanding of the homeostatic immunological dialogue between the host and its microbiota.	[Belkaid, Yasmine; Harrison, Oliver J.] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, Microbiome Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.; Belkaid, Y (corresponding author), NIAID, Microbiome Program, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571; Harrison, Oliver/0000-0003-1515-9586	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to apologize to our colleagues whose work we could not cite because of space constraints. This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID). We thank Jacqueline Kehr, Dr. Nicholas Collins, and Dr. Seong-Ji Han for editorial comments and help with figure design.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eloe-Fadrosh EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062026; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Fink LN, 2012, AM J PHYSIOL-GASTR L, V302, pG55, DOI 10.1152/ajpgi.00428.2010; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; GORIS H, 1985, INFECT IMMUN, V50, P437, DOI 10.1128/IAI.50.2.437-441.1985; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; HORNQUIST E, 1995, ADV EXP MED BIOL, V371, P1507; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwamura C, 2017, BLOOD, V129, P171, DOI 10.1182/blood-2016-06-723742; Jeffries TL, 2016, MUCOSAL IMMUNOL, V9, P414, DOI 10.1038/mi.2015.70; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kabelitz D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00371; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kilian E., 2017, EUR J IMMUNOL; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KIYONO H, 1982, J EXP MED, V155, P605, DOI 10.1084/jem.155.2.605; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Laborel-Preneron E., 2015, PLOS ONE, V10; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li FL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13839; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/NCHEMBIO.1884, 10.1038/nchembio.1884]; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Narushima S, 2014, GUT MICROBES, V5, P333, DOI 10.4161/gmic.28572; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Paget C, 2015, IMMUNOL CELL BIOL, V93, P198, DOI 10.1038/icb.2014.94; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Seekatz AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064212; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Skabytska Y, 2014, IMMUNITY, V41, P762, DOI 10.1016/j.immuni.2014.10.009; Smeekens SP, 2014, J INNATE IMMUN, V6, P253, DOI 10.1159/000351912; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sudo N, 1997, J IMMUNOL, V159, P1739; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutherland DB, 2016, IMMUNOL REV, V270, P20, DOI 10.1111/imr.12384; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tada T, 1996, CELL IMMUNOL, V173, P155, DOI 10.1006/cimm.1996.0261; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Valdezi Y, 2014, TRENDS IMMUNOL, V35, P526, DOI 10.1016/j.it.2014.07.003; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wade TK, 2008, MICROBIOL IMMUNOL, V52, P611, DOI 10.1111/j.1348-0421.2008.00078.x; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; WANNEMUEHLER MJ, 1982, J IMMUNOL, V129, P959; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wohlfert E. A., 2011, J CLIN INVEST; Wojno EDT, 2016, J EXP MED, V213, P2229, DOI 10.1084/jem.20160525; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yockey LJ, 2013, J INVEST DERMATOL, V133, P2714, DOI 10.1038/jid.2013.228; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	196	524	552	12	164	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					562	576		10.1016/j.immuni.2017.04.008	http://dx.doi.org/10.1016/j.immuni.2017.04.008			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423337	Green Accepted, Bronze			2022-12-18	WOS:000399451100010
J	Pipkin, ME; Sacks, JA; Cruz-Guilloty, F; Lichtenheld, MG; Bevan, MJ; Rao, A				Pipkin, Matthew E.; Sacks, Jilian A.; Cruz-Guilloty, Fernando; Lichtenheld, Mathias G.; Bevan, Michael J.; Rao, Anjana			Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells	IMMUNITY			English	Article							HISTONE ACETYLATION; MEMORY DEVELOPMENT; CLONAL EXPANSION; CD8(+) MEMORY; CUTTING EDGE; BET; EXPRESSION; PROLIFERATION; GENERATION; PERFORIN	Interleukin(IL)-2 and inflammation regulate effector and memory cytolytic T-lymphocyte (CTL) generation during infection. We demonstrate a complex interplay between IL-2 and inflammatory signals during CTL differentiation. IL-2 stimulation induced the transcription factor eomesodermin (Eomes), upregulated perforin (Prf1) transcription, and repressed re-expression of memory CTL markers Bcl6 and IL-7R alpha. Binding of Eomes and STAT5 to Prf1 cis-regulatory regions correlated with transcriptional initiation (increased recruitment of RNA polymerase II to the Prf1 promoter). Inflammation (CpG, IL-12) enhanced expression of IL-2R alpha and the transcription factor T-bet, but countered late Eomes and perforin induction while preventing IL-7R alpha repression by IL-2. After infection of mice with lymphocytic choriomeningitis virus, IL-2R alpha-deficient effector CD8(+) T cells expressed more Bcl6 but less perforin and granzyme B, formed fewer KLRG-1(+) and T-bet-expressing CTL, and killed poorly. Thus, inflammation influences both effector and memory CTL differentiation, whereas persistent IL-2 stimulation promotes effector at the expense of memory CTL development.	[Pipkin, Matthew E.; Cruz-Guilloty, Fernando; Rao, Anjana] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pipkin, Matthew E.; Cruz-Guilloty, Fernando; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Sacks, Jilian A.; Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Sacks, Jilian A.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Lichtenheld, Mathias G.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Dev Ctr AIDS Res,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Miami	Rao, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu		Pipkin, Matthew/0000-0002-9688-0190	NIH [AI44432, AI707088, AI19335]; University of Miami Developmental Center for AIDS Research [5P30AI073961]; National Cancer Institute [F32CA126247]; Ford Foundation Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA055811, F32CA126247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432, R01AI070788, R01AI019335, R37AI019335, P30AI073961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami Developmental Center for AIDS Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ford Foundation Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. S. Reiner for generously providing the Eomes-VP16 retroviral construct. This work was funded by NIH grants AI44432 and AI707088 A.R.) and AI19335 (to M.J.B.); University of Miami Developmental Center for AIDS Research 5P30AI073961 (to M.G.L.); and the National Cancer Institute F32CA126247 (to M.E.P). F.C.G. was a predoctoral fellow of the Ryan Foundation and was supported by a Ford Foundation Predoctoral Fellowship.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Badovinac VP, 2007, J IMMUNOL, V179, P53, DOI 10.4049/jimmunol.179.1.53; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Malek TR, 2001, J IMMUNOL, V166, P1675, DOI 10.4049/jimmunol.166.3.1675; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pipkin ME, 2007, IMMUNITY, V26, P29, DOI 10.1016/j.immuni.2006.11.009; Pipkin ME, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl006; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Zaiss DMW, 2008, INFECT IMMUN, V76, P4609, DOI 10.1128/IAI.00563-08; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297	50	524	536	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					79	90		10.1016/j.immuni.2009.11.012	http://dx.doi.org/10.1016/j.immuni.2009.11.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20096607	Green Accepted, Bronze			2022-12-18	WOS:000274119900013
J	Kunkel, EJ; Butcher, EC				Kunkel, EJ; Butcher, EC			Chemokines and the tissue-specific migration of lymphocytes	IMMUNITY			English	Review							THYMUS-EXPRESSED CHEMOKINE; MUCOSAL IMMUNE-SYSTEM; MEMORY T-CELLS; REGIONAL IMMUNITY; RECEPTOR CCR9; IDENTIFICATION; RECOGNITION; CHEMOTAXIS; THYMOCYTES; DIVERSITY	Tissue-selective trafficking of memory and effector T and B lymphocytes is mediated by unique combinations of adhesion molecules and chemokines. The discovery of several related epithelial-expressed chemokines (TECK/CCL25 in small intestine, CTACK/CCL27 in skin, and MEC/CCL28 in diverse mucosal sites) now highlights an important role for epithelial cells in controlling homeostatic lymphocyte trafficking, including the localization of cutaneous and intestinal memory T cells, and of IgA plasma cells. Consitutively expressed epithelial chemokines may help determine the character of local immune responses and contribute to the systemic organization of the immune system.	Stanford Univ, Lab Immunol & Vasc Biol, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kunkel, EJ (corresponding author), Stanford Univ, Lab Immunol & Vasc Biol, Dept Pathol, Sch Med, Stanford, CA 94305 USA.							BOWMAN EP, 2002, IN PRESS J EXP MED, V195; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CAHILL RNP, 1977, J EXP MED, V145, P420, DOI 10.1084/jem.145.2.420; CAMPBELL DJ, 2002, IN PRESS J EXP MED, V195; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; CZINN SJ, 1986, J IMMUNOL, V136, P3607; Finke D, 2001, J IMMUNOL, V166, P6266, DOI 10.4049/jimmunol.166.10.6266; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Jarmin DI, 2000, J IMMUNOL, V164, P3460, DOI 10.4049/jimmunol.164.7.3460; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Pitman RS, 2000, J GASTROENTEROL, V35, P805, DOI 10.1007/s005350070017; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	26	522	539	3	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					1	4		10.1016/S1074-7613(01)00261-8	http://dx.doi.org/10.1016/S1074-7613(01)00261-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825560	Bronze			2022-12-18	WOS:000173575700001
J	BOEL, P; WILDMANN, C; SENSI, ML; BRASSEUR, R; RENAULD, JC; COULIE, P; BOON, T; VANDERBRUGGEN, P				BOEL, P; WILDMANN, C; SENSI, ML; BRASSEUR, R; RENAULD, JC; COULIE, P; BOON, T; VANDERBRUGGEN, P			BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES	IMMUNITY			English	Article							LEUKEMIA-VIRUS; EXPRESSION; RECEPTOR; SEGMENT; FUSION; CHAIN; CELLS; P815	Several tumor antigens are recognized by autologous cytolytic T lymphocytes (CTL) on human melanoma MZ2-MEL. Some of them are encoded by genes MAGE-1 and MAGE-3, which are not expressed in normal tissues except in testis. Here, we report the identification of a new gene that codes for another of these antigens. This gene, named SAGE, codes for a putative protein of 43 aa and seems to belong to a family of several genes. The antigen recognized by the autologous CTL consists of BAGE-encoded peptide AARAVFLAL bound to an HLA-Cw*1601 molecule. Gene BAGE is expressed in 22% of melanomas, 30% of infiltrating bladder carcinomas, 10% of mammary carcinomas, 8% of head and neck squamous cell carcinomas, and 6% of non-small cell lung carcinomas. Like the MAGE genes, it is silent in normal tissues with the exception of testis. Because of its tumor-specific expression, the BAGE-encoded antigen may prove useful for cancer immunotherapy.	UNIV CATHOLIQUE LOUVAIN,CELLULAR GENET UNIT,B-1200 BRUSSELS,BELGIUM; IST NAZL STUDIO & CURA TUMORI,DIV EXPTL ONCOL D,I-20133 MILAN,ITALY; FAC SCI AGRON ETAT GEMBLOUX,CTR BIOPHYS MOLEC NUMER,B-5030 GEMBLOUX,BELGIUM	Universite Catholique Louvain; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Liege	BOEL, P (corresponding author), UNIV CATHOLIQUE LOUVAIN,LUDWIG INST CANC RES,BRUSSELS BRANCH,74 AVE HIPPOCRATE,B-1200 BRUSSELS,BELGIUM.		Sensi, Marialuisa/K-5631-2014; Renauld, Jean-Christophe/B-7268-2012	Sensi, Marialuisa/0000-0002-7643-0248; Renauld, Jean-Christophe/0000-0003-1736-2131				Atherton E., 1981, J CHEM SOC P1, V1, P538; BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; BOON T, 1980, J EXP MED, V152, P1184, DOI 10.1084/jem.152.5.1184; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DAVIS LG, 1986, BASIC METHODS MOL BI, P130; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; DESMET C, 1994, IMMUNOGENETICS, V39, P121, DOI 10.1007/BF00188615; ESPAVIK T, 1986, J IMMUNOL METHODS, V95, P99; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GENEVEE C, 1992, EUR J IMMUNOL, V22, P1261, DOI 10.1002/eji.1830220522; HAAS GG, 1988, AM J REPROD IMMUNOL, V18, P47; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; HORTH M, 1991, EMBO J, V10, P2747, DOI 10.1002/j.1460-2075.1991.tb07823.x; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Mostofi FK, 1973, HISTOLOGICAL TYPING; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; NICOLAS JF, 1983, COLD SPRING HARBOR C, V10, P469; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PATARD JJ, IN PRESS INT J CANCE; ROBBINS PF, 1994, CANCER RES, V54, P3124; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANDENEYNDE B, 1989, INT J CANCER, V44, P634; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P2134; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P3038, DOI 10.1002/eji.1830241218; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANPEL A, 1985, SOMAT CELL MOLEC GEN, V11, P467; VONECHE V, 1992, P NATL ACAD SCI USA, V89, P3810, DOI 10.1073/pnas.89.9.3810; WOLFEL T, 1994, EUR J IMMUNOL, V24, P759, DOI 10.1002/eji.1830240340	37	522	562	0	8	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1995	2	2					167	175		10.1016/S1074-7613(95)80053-0	http://dx.doi.org/10.1016/S1074-7613(95)80053-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895173	Bronze			2022-12-18	WOS:A1995QH13200005
J	Uhlig, HH; McKenzie, BS; Hue, S; Thompson, C; Joyce-Shaikh, B; Stepankova, R; Robinson, N; Buonocore, S; Tlaskalova-Hogenova, H; Cua, DJ; Powrie, F				Uhlig, Holm H.; McKenzie, Brent S.; Hue, Sophie; Thompson, Claire; Joyce-Shaikh, Barbara; Stepankova, Renata; Robinson, Nicolas; Buonocore, Sofia; Tlaskalova-Hogenova, Helena; Cua, Daniel J.; Powrie, Fiona			Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CD4(+) T-CELLS; EXPERIMENTAL COLITIS; DENDRITIC CELLS; INTERLEUKIN-12 PRODUCTION; CYTOKINE; CD40; MICE; INHIBITION; EXPRESSION	The CD40-CD154 pathway is important in the pathogenesis of inflammatory bowel disease. Here we show that injection of an agonistic CD40 mAb to T and B cell-deficient mice was sufficient to induce a pathogenic systemic and intestinal innate inflammatory response that was functionally dependent on tumor necrosis factor-alpha and interferon-gamma as well as interleukin-12 p40 and interleukin-23 p40 secretion. CD40-induced colitis, but not wasting disease or serum proinflammatory cytokine production, depended on interleukin-23 p19 secretion, whereas interleukin-12 p35 secretion controlled wasting disease and serum cytokine production but not mucosal immunopathology. Intestinal inflammation was associated with IL-23 (p19) mRNA-producing intestinal dendritic cells and IL-17A mRNA within the intestine. Our experiments identified IL-23 as an effector cytokine within the innate intestinal immune system. The differential role of IL-23 in local but not systemic inflammation suggests that it may make a more specific target for the treatment of IBD.	Schering Plough Biopharma, Palo Alto, CA 94304 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Acad Sci Czech Republ, Inst Microbiol & Gnotobiol, Prague 54922, Czech Republic; Acad Sci Czech Republ, Inst Microbiol & Gnotobiol, Novy Hradek, Czech Republic	Merck & Company; University of Oxford; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Cua, DJ (corresponding author), Schering Plough Biopharma, 901 Calif Ave, Palo Alto, CA 94304 USA.	daniel.cua@dnax.org; fiona.powrie@path.ox.ac.uk	stepankova, renata/J-9735-2014; Tlaskalová-Hogenová, Helena/J-8008-2014	stepankova, renata/0000-0001-7504-6300; HUE, Sophie/0000-0002-2530-7346; Uhlig, Holm/0000-0002-6111-7355	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cong YZ, 2000, J IMMUNOL, V165, P2173, DOI 10.4049/jimmunol.165.4.2173; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Jong YP, 2000, GASTROENTEROLOGY, V119, P715, DOI 10.1053/gast.2000.16485; Diehl L, 2000, J MOL MED, V78, P363, DOI 10.1007/s001090000126; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Ferlin WG, 1996, EUR J IMMUNOL, V26, P2911, DOI 10.1002/eji.1830261216; Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Isler P, 1999, AM J RESP CELL MOL, V20, P270, DOI 10.1165/ajrcmb.20.2.3313; Kelsall BL, 1996, ANN NY ACAD SCI, V795, P116, DOI 10.1111/j.1749-6632.1996.tb52660.x; Krajina T, 2003, EUR J IMMUNOL, V33, P1073, DOI 10.1002/eji.200323518; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu ZJ, 1999, J IMMUNOL, V163, P4049; Liu ZJ, 2000, J IMMUNOL, V164, P6005, DOI 10.4049/jimmunol.164.11.6005; Ma XJ, 2001, MICROBES INFECT, V3, P121, DOI 10.1016/S1286-4579(00)01359-9; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mason N, 2002, J IMMUNOL, V168, P2590, DOI 10.4049/jimmunol.168.6.2590; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1996, ANN NY ACAD SCI, V795, P368, DOI 10.1111/j.1749-6632.1996.tb52695.x; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park SH, 2005, CHEM MATER, V17, P6, DOI 10.1021/cm048433e; Polese L, 2002, EUR J GASTROEN HEPAT, V14, P237, DOI 10.1097/00042737-200203000-00006; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Sandborn WJ, 2004, GUT, V53, P1366, DOI 10.1136/gut.2003.025452; Schmidt C, 2002, PATHOBIOLOGY, V70, P177, DOI 10.1159/000068151; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2	41	521	540	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					309	318		10.1016/j.immuni.2006.05.017	http://dx.doi.org/10.1016/j.immuni.2006.05.017			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16919486	Bronze			2022-12-18	WOS:000240047500016
J	Xu, JL; Davis, MM				Xu, JL; Davis, MM			Diversity in the CDR3 region of V-H is sufficient for most antibody specificities	IMMUNITY			English	Article							T-CELL RECEPTOR; MHC CLASS-II; IMMUNE-RESPONSE; COMBINING SITES; HYPERVARIABLE REGIONS; IMMUNOGLOBULIN HEAVY; ID-460 EXPRESSION; SOMATIC MUTATION; ANTIGEN RECEPTOR; VARIABLE REGION	All rearranging antigen receptor genes have one or two highly diverse complementarity determining regions (CDRs) among the six that typically form the ligand binding surface. We report here that, in the case of antibodies, diversity at one of these regions, CDR3 of the V-H domain, is sufficient to permit otherwise identical IgM molecules to distinguish between a variety of hapten and protein antigens. Furthermore, we find that somatic mutation can allow such antibodies to achieve surprisingly high affinities. These results are consistent with a model in which the highly diverse CDR3 loops are the key determinant of specificity in antigen recognition in both T cell receptors (TCR) and antibodies, whereas the germline-encoded CDR1 and CDR2 sequences are much more cross-reactive.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Davis, Mark/0000-0001-6868-657X				AKOLKAR PN, 1987, J IMMUNOL, V138, P4472; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BLOMBERG B, 1972, SCIENCE, V177, P178, DOI 10.1126/science.177.4044.178; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; Cohn M., 1980, PROGR IMMUNOLOGY, V4, P153; CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Davis MM, 1997, CIBA F SYMP, V204, P94; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DAVIS MM, 1999, FUNDAMENTAL IMMUNOLO, P341; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; DZIERZAK EA, 1980, J EXP MED, V152, P720, DOI 10.1084/jem.152.3.720; DZIERZAK EA, 1985, J EXP MED, V162, P1494, DOI 10.1084/jem.162.5.1494; FATHMAN CG, 1977, J EXP MED, V145, P569, DOI 10.1084/jem.145.3.569; FERNANDEZ C, 1977, IMMUNOLOGY, V33, P59; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GRANFORS K, 1982, CLIN IMMUNOL IMMUNOP, V23, P459, DOI 10.1016/0090-1229(82)90130-1; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HEDRICK SM, 1988, SCIENCE, V239, P1541, DOI 10.1126/science.2832942; HOOD L, 1974, SCIENCE, V183, P962; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; HOWARD JG, 1975, IMMUNOLOGY, V29, P585; IMANISHI T, 1975, J EXP MED, V141, P840; IMANISHI T, 1974, J EXP MED, V140, P1498, DOI 10.1084/jem.140.6.1498; JALKANEN S, 1983, CELL IMMUNOL, V80, P363, DOI 10.1016/0008-8749(83)90124-7; Janeway CA., 2021, IMMUNOBIOLOGY IMMUNE; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jeurissen SHM, 1998, IMMUNOBIOLOGY, V198, P385, DOI 10.1016/S0171-2985(98)80047-8; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; KABAT EA, 1977, J BIOL CHEM, V252, P6609; LANGMAN RE, 1987, MOL IMMUNOL, V24, P675, DOI 10.1016/0161-5890(87)90050-2; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Lopez-Macias C, 1999, J EXP MED, V189, P1791, DOI 10.1084/jem.189.11.1791; MAKELA O, 1978, J EXP MED, V148, P1644, DOI 10.1084/jem.148.6.1644; MAKELA O, 1976, J EXP MED, V143, P316, DOI 10.1084/jem.143.2.316; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; MANSER T, 1990, MOL IMMUNOL, V27, P503, DOI 10.1016/0161-5890(90)90069-C; MASON DW, 1986, HDB EXPT IMMUNOLOGY, V1; MCCORMACK WT, 1991, ANNU REV IMMUNOL, V9, P219; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Noel D, 1996, J IMMUNOL METHODS, V193, P177, DOI 10.1016/0022-1759(96)00043-9; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PAWLAK LL, 1973, J EXP MED, V137, P22, DOI 10.1084/jem.137.1.22; POTTER M, 1970, J EXP MED, V132, P737, DOI 10.1084/jem.132.4.737; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; RIBLET R, 1975, EUR J IMMUNOL, V5, P775, DOI 10.1002/eji.1830051109; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; SHER A, 1972, EUR J IMMUNOL, V2, P319, DOI 10.1002/eji.1830020405; TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WALLICK SC, 1989, J IMMUNOL, V142, P1235; WANG DN, 1990, J IMMUNOL, V145, P3002; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WEILL JC, 1987, SCIENCE, V238, P1094, DOI 10.1126/science.3317827; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1	76	520	772	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					37	45		10.1016/S1074-7613(00)00006-6	http://dx.doi.org/10.1016/S1074-7613(00)00006-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933393	Bronze			2022-12-18	WOS:000088463600005
J	Ohkura, N; Kitagawa, Y; Sakaguchi, S				Ohkura, Naganari; Kitagawa, Yohko; Sakaguchi, Shimon			Development and Maintenance of Regulatory T cells	IMMUNITY			English	Review							TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; GENE; EXPRESSION; PLASTICITY; LINEAGE; DIFFERENTIATION; PROTEIN; T(H)17; NAIVE	Regulatory T (Treg) cells are a developmentally and functionally distinct T cell subpopulation that is engaged in sustaining immunological self-tolerance and homeostasis. The transcription factor Foxp3 plays a key role in Treg cell development and function. However, expression of Foxp3 alone is not sufficient for conferring and maintaining Treg cell function and phenotype. Complementing the insufficiency, Treg-cell-specific epigenetic changes are also critical in the process of Treg cell specification, in regulating its potential plasticity, and hence in establishing a stable lineage. Understanding how epigenetic alterations and Foxp3 expression coordinately control Treg-cell-specific gene regulation will enable better control of immune responses by targeting the generation and maintenance of Treg cells.	[Ohkura, Naganari; Kitagawa, Yohko; Sakaguchi, Shimon] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Osaka University; Kyoto University	Ohkura, N (corresponding author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan.	nohkura@ifrec.osaka-u.ac.jp; shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Musri MM, 2012, CURR OPIN CLIN NUTR, V15, P342, DOI 10.1097/MCO.0b013e3283546fba; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Thomas RM, 2012, J BIOL CHEM, V287, P25049, DOI 10.1074/jbc.M112.351916; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tost J, 2010, MOL BIOTECHNOL, V44, P71, DOI 10.1007/s12033-009-9216-2; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhao JX, 2011, J EXP MED, V208, P1571, DOI 10.1084/jem.20110236; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou PJ, 2009, CLIN EXP IMMUNOL, V157, P40, DOI 10.1111/j.1365-2249.2009.03942.x; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	77	518	550	18	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					414	423		10.1016/j.immuni.2013.03.002	http://dx.doi.org/10.1016/j.immuni.2013.03.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521883	Bronze			2022-12-18	WOS:000330941500008
J	O'Shea, JJ; Murray, PJ				O'Shea, John J.; Murray, Peter J.			Cytokine signaling modules in inflammatory responses	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; SOCS BOX; G-CSF; TH17 CELLS; NEGATIVE REGULATOR; INTERLEUKIN-10-DEFICIENT MICE; RHEUMATOID-ARTHRITIS; INNATE IMMUNITY; CUTTING EDGE; HOST-DEFENSE	Cytokine signaling via a restricted number of Jak-Stat pathways positively and negatively regulates all cell types involved in the initiation, propagation, and resolution of inflammation. Here, we focus on Jak-Stat signaling in three major cell types involved in inflammatory responses: T cells, neutrophils, and macrophages. We summarize how the Jak-Stat pathways in these cells are negatively regulated by the Suppressor of cytokine signaling (Socs) proteins. We emphasize that common Jak-Stat-Socs signaling modules can have diverse developmental, pro- and anti-inflammatory outcomes depending on the cytokine receptor activated and which genes are accessible at a given time in a cell's life. Because multiple components of Jak-Stat-Socs pathways are mutated or closely associated with human inflammatory diseases, and cytokine-based therapies are increasingly deployed to treat inflammation, understanding cytokine signaling will continue to advance our ability to manipulate chronic and acute inflammatory diseases.	[O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20852 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); St Jude Children's Research Hospital; St Jude Children's Research Hospital	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20852 USA.	osheajo@mail.nih.gov; peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802	Intramural NIH HHS [Z01 AR041106-13] Funding Source: Medline; NCI NIH HHS [P30 CA21765, P30 CA021765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, ZIAAR041159] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Boyle K, 2007, BLOOD, V110, P1466, DOI 10.1182/blood-2007-03-079178; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; DENNING TL, 2007, CELL, V1094, P597; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hirano T, 2006, DEV CELL, V10, P542, DOI 10.1016/j.devcel.2006.04.011; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; HORNER M, 2002, J IMMUNOL, V169, P1219; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kimura A, 2004, J BIOL CHEM, V279, P6905, DOI 10.1074/jbc.C300496200; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mayack SR, 2006, J IMMUNOL, V176, P2059, DOI 10.4049/jimmunol.176.4.2059; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Metcalf D, 2000, P NATL ACAD SCI USA, V97, P9174, DOI 10.1073/pnas.160255197; MILNER JD, 2008, IN PRESS NATURE; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Notorangelo LD, 2001, HUM MUTAT, V18, P255; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; O'Shea JJ, 2004, MOL IMMUNOL, V41, P727, DOI 10.1016/j.molimm.2004.04.014; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Ramanathan S, 2006, J IMMUNOL, V176, P4029, DOI 10.4049/jimmunol.176.7.4029; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Stross C, 2006, J BIOL CHEM, V281, P8458, DOI 10.1074/jbc.M511212200; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Watford WT, 2006, IMMUNITY, V25, P695, DOI 10.1016/j.immuni.2006.10.007; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; YANG XO, 2008, RORALPHA RORGAMMA IM, V28, P29; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	101	518	548	11	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					477	487		10.1016/j.immuni.2008.03.002	http://dx.doi.org/10.1016/j.immuni.2008.03.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400190	Bronze, Green Accepted			2022-12-18	WOS:000254939400006
J	Kinjyo, I; Hanada, T; Inagaki-Ohara, K; Mori, H; Aki, D; Ohishi, M; Yoshida, H; Kubo, M; Yoshimura, A				Kinjyo, I; Hanada, T; Inagaki-Ohara, K; Mori, H; Aki, D; Ohishi, M; Yoshida, H; Kubo, M; Yoshimura, A			SOCS1/JAB is a negative regulator of LPS-induced macrophage activation	IMMUNITY			English	Article							STAT INHIBITOR-1 (SSI-1)/SUPPRESSOR; MONOPHOSPHORYL-LIPID-A; I-KAPPA-B; CYTOKINE SIGNALING-1; GENE-EXPRESSION; HOST-DEFENSE; CROSS-TALK; IFN-GAMMA; SOCS BOX; LIPOPOLYSACCHARIDE	Bacterial lipopolysaccharide (LPS) triggers innate immune responses through Toll-like receptor (TLR) 4. We show here that the suppressor of cytokine-signaling-1 (SOCS1/JAB) is rapidly induced by LIPS and negatively regulates LPS signaling. SOCS+/- mice or SOCSi-/- mice with interferon-gamma (IFNgamma)-deficient background were more sensitive to LPS-induced lethal effects than were wild-type littermates. LPS-induced NO2- synthesis and TNFalpha production were augmented in SOCS1(-/-)Imacrophages. Furthermore, LPS tolerance, a protection mechanism against endotoxin shock, was also strikingly reduced in SOCS1(-/-) cells. LPS-induced I-kappaB and p38 phosphorylation was upregulated in SOCS1(-/-) macrophages, and forced expression of SOCS1 suppressed LPS-induced NF-kappaB activation. Thus, SOCS1 directly suppresses TLR4 signaling and modulates innate immunity.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Tokyo Univ Sci, Div Immunobiol, Res Inst Biol sci, Noda, Chiba 2780022, Japan	Kyushu University; Tokyo University of Science	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yaidhiko@bioreg.kyushu-u.ac.jp	MORI, HIROYUKI/D-3343-2013; Eckhardt, Erik/G-1567-2010; Yoshimura, Akihiko/K-5515-2013	Kinjyo, Ichiko/0000-0001-7051-3790				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; Berczi I, 1998, ANN NY ACAD SCI, V840, P787, DOI 10.1111/j.1749-6632.1998.tb09617.x; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Crespo A, 2000, BIOCHEM J, V349, P99, DOI 10.1042/0264-6021:3490099; Crespo A, 2002, EUR J IMMUNOL, V32, P710, DOI 10.1002/1521-4141(200203)32:3<710::AID-IMMU710>3.0.CO;2-T; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; EDEN CS, 1988, J IMMUNOL, V140, P3180; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Goldring CE, 1998, EUR J IMMUNOL, V28, P2960, DOI 10.1002/(SICI)1521-4141(199809)28:09<2960::AID-IMMU2960>3.0.CO;2-B; GREISMAN SE, 1966, J EXP MED, V124, P983, DOI 10.1084/jem.124.5.983; Gustafson G L, 1995, Prog Clin Biol Res, V392, P567; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429, DOI 10.1128/IAI.58.8.2429-2437.1990; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kastenbauer S, 1999, INFECT IMMUN, V67, P1553; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Stoiber D, 1999, J IMMUNOL, V163, P2640; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Ziegler-Heitbrock HWL, 1997, IMMUNOBIOLOGY, V198, P73; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13	51	518	567	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2002	17	5					583	591		10.1016/S1074-7613(02)00446-6	http://dx.doi.org/10.1016/S1074-7613(02)00446-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433365	Bronze			2022-12-18	WOS:000179335100005
J	Hue, S; Mention, JJ; Monteiro, RC; Zhang, SL; Cellier, C; Schmitz, J; Verkarre, V; Fodil, N; Bahram, S; Cerf-Bensussan, N; Caillat-Zucman, S				Hue, S; Mention, JJ; Monteiro, RC; Zhang, SL; Cellier, C; Schmitz, J; Verkarre, V; Fodil, N; Bahram, S; Cerf-Bensussan, N; Caillat-Zucman, S			A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease	IMMUNITY			English	Article							I-RELATED CHAIN; TRIPLET REPEAT POLYMORPHISM; DELTA T-CELLS; GENE-A MICA; INTRAEPITHELIAL LYMPHOCYTES; TISSUE TRANSGLUTAMINASE; IMMUNE RECOGNITION; EPITHELIAL-CELLS; REFRACTORY SPRUE; GLIADIN PEPTIDES	MICA molecules interact with the NKG2D-activating receptor on human NK and CD8 T cells. We investigated the participation of the MICA/NKG2D pathway in the destruction of intestinal epithelium by intraepithelial T lymphocytes (IEL) in Celiac disease and its premalignant complication, refractory sprue. We show that MICA is strongly expressed at epithelial cell surface in patients with active disease and is induced by gliadin or its p31-49 derived peptide upon in vitro challenge, an effect relayed by IL-15. This triggers direct activation and costimulation of IEL through engagement of NKG2D, leading to an innate-like cytotoxicity toward epithelial targets and enhanced TCR-dependent CD8 T cell-mediated adaptive response. Villous atrophy in Celiac disease might thus be ascribed to an IEL-medlated damage to enterocytes involving NKG2D/MICA interaction after gliadin-induced expression of MICA on gut epithelium. This supports a key role for MIC/NKG2D in the activation of intraepithelial immunity in response to danger.	Hop Necker Enfants Malad, INSERM, Equipe Avenir, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, EMI 0212, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Gastroenterol Pediat, F-75015 Paris, France; Fac Bichat, INSERM, E0225, F-75018 Paris, France; Hop Europeen Georges Pompidou, Dept Hepatogastroenterol, F-75015 Paris, France; Ctr Rech Immunol & Hematol, INSERM, CreS, F-67000 Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Caillat-Zucman, S (corresponding author), Hop Necker Enfants Malad, INSERM, Equipe Avenir, F-75015 Paris, France.	caillat@necker.fr	Bahram, Seiamak/GZA-7150-2022; Cerf-Bensussan, nadine/H-9505-2017; Monteiro, Renato C/U-8633-2017	Cerf-Bensussan, nadine/0000-0003-0665-1245; Monteiro, Renato C/0000-0001-5202-5646; Bahram, Seiamak/0000-0002-6928-9952; christophe, Cellier/0000-0003-0784-2318; HUE, Sophie/0000-0002-2530-7346; Caillat-Zucman, Sophie/0000-0002-4535-3550				BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bahram S, 2000, Adv Immunol, V76, P1; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bilbao JR, 2002, TISSUE ANTIGENS, V60, P71, DOI 10.1034/j.1399-0039.2002.600109.x; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Ciccocioppo R, 2001, AM J CLIN PATHOL, V115, P494; Colgan SP, 2003, J CLIN INVEST, V112, P745, DOI 10.1172/JC1200317241; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Daum S, 1999, GUT, V44, P17, DOI 10.1136/gut.44.1.17; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Djilali-Saiah I, 1998, GUT, V43, P187, DOI 10.1136/gut.43.2.187; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Ebert EC, 1998, GASTROENTEROLOGY, V115, P1439, DOI 10.1016/S0016-5085(98)70022-8; FERNANDEZ L, 2002, TRIPLET REPEAT POLYM; Fodil N, 1999, IMMUNOGENETICS, V49, P557, DOI 10.1007/s002510050536; Gianfrani C, 2003, J IMMUNOL, V170, P2719, DOI 10.4049/jimmunol.170.5.2719; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hue S, 2003, J IMMUNOL, V171, P1909, DOI 10.4049/jimmunol.171.4.1909; Iltanen S, 1999, AUTOIMMUNITY, V31, P125, DOI 10.3109/08916939908994056; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Lopez-Vazquez A, 2002, GUT, V50, P336, DOI 10.1136/gut.50.3.336; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Maccalli C, 2003, EUR J IMMUNOL, V33, P2033, DOI 10.1002/eji.200323909; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 1998, GASTROENTEROLOGY, V115, P564, DOI 10.1016/S0016-5085(98)70135-0; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; MCNEISH AS, 1979, ARCH DIS CHILD, V54, P783, DOI 10.1136/adc.54.10.783; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Monteleone G, 2001, EUR J IMMUNOL, V31, P2247, DOI 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Sugimura K, 2001, TISSUE ANTIGENS, V57, P9, DOI 10.1034/j.1399-0039.2001.057001009.x; Vetter CS, 2002, J INVEST DERMATOL, V118, P600, DOI 10.1046/j.1523-1747.2002.01700.x; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	58	517	544	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					367	377		10.1016/j.immuni.2004.06.018	http://dx.doi.org/10.1016/j.immuni.2004.06.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357948	Bronze			2022-12-18	WOS:000224034900008
J	Vonarbourg, C; Mortha, A; Bui, VL; Hernandez, PP; Kiss, EA; Hoyler, T; Flach, M; Bengsch, B; Thimme, R; Holscher, C; Honig, M; Pannicke, U; Schwarz, K; Ware, CF; Finke, D; Diefenbach, A				Vonarbourg, Cedric; Mortha, Arthur; Bui, Viet L.; Hernandez, Pedro P.; Kiss, Elina A.; Hoyler, Thomas; Flach, Melanie; Bengsch, Bertram; Thimme, Robert; Hoelscher, Christoph; Hoenig, Manfred; Pannicke, Ulrich; Schwarz, Klaus; Ware, Carl F.; Finke, Daniela; Diefenbach, Andreas			Regulated Expression of Nuclear Receptor ROR gamma t Confers Distinct Functional Fates to NK Cell Receptor-Expressing ROR gamma t(+) Innate Lymphocytes	IMMUNITY			English	Article							TISSUE-INDUCER CELLS; INFLAMMATORY-BOWEL-DISEASE; SEVERE COMBINED IMMUNODEFICIENCY; LYMPHOID-ORGAN DEVELOPMENT; NATURAL-KILLER; INTESTINAL INFLAMMATION; COMMENSAL MICROFLORA; NODE DEVELOPMENT; TYPE-2 IMMUNITY; NKP46(+) CELLS	Whether the recently identified innate lymphocyte population coexpressing natural killer cell receptors (NKRs) and the nuclear receptor ROR gamma t is part of the NK or lymphoid tissue inducer (LTi) cell lineage remains unclear. By using adoptive transfer of genetically tagged LTi-like cells, we demonstrate that NKR-ROR gamma t(+) innate lymphocytes but not NK cells were direct progenitors to NKR+ROR gamma t(+) cells in vivo. Genetic lineage tracing revealed that the differentiation of LTi-like cells was characterized by the stable upregulation of NKRs and a progressive loss of ROR gamma t expression. Whereas interleukin-7 (IL-7) and intestinal microbiota stabilized ROR gamma t expression within such NKR-LTi cells, IL-12 and IL-15 accelerated ROR gamma t loss. ROR gamma t(+) NKR-LTi cells produced IL-22, whereas ROR gamma t(-) NKR-LTi cells released IFN-gamma and were potent inducers of colitis. Thus, the ROR gamma t gradient in NKR-LTi cells serves as a tunable rheostat for their functional program. Our data also define a previously unappreciated role of ROR gamma t(-) NKR-LTi cells for the onset or maintenance of inflammatory bowel diseases.	[Vonarbourg, Cedric; Mortha, Arthur; Bui, Viet L.; Hernandez, Pedro P.; Kiss, Elina A.; Hoyler, Thomas; Flach, Melanie; Diefenbach, Andreas] Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Mortha, Arthur; Kiss, Elina A.; Bengsch, Bertram; Diefenbach, Andreas] Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Mortha, Arthur; Kiss, Elina A.; Hoyler, Thomas; Diefenbach, Andreas] Res Training Grp Organogenesis GRK1104, D-79104 Freiburg, Germany; [Bui, Viet L.; Diefenbach, Andreas] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Hernandez, Pedro P.; Diefenbach, Andreas] Max Planck Inst Immunobiol, IMPRS MCB, D-79108 Freiburg, Germany; [Bengsch, Bertram; Thimme, Robert] Univ Freiburg, Med Ctr, Dept Med 2, D-79106 Freiburg, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Div Infect Immunol, D-23845 Borstel, Germany; [Hoenig, Manfred] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, D-89075 Ulm, Germany; [Pannicke, Ulrich; Schwarz, Klaus] Univ Hosp Ulm, Inst Transfus Med, D-89081 Ulm, Germany; [Pannicke, Ulrich; Schwarz, Klaus] Inst Clin Transfus Med & lmmunogenet, D-89081 Ulm, Germany; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Res Ctr, La Jolla, CA 92037 USA; [Finke, Daniela] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland	University of Freiburg; New York University; Max Planck Society; University of Freiburg; Forschungszentrum Borstel; Ulm University; Ulm University; Sanford Burnham Prebys Medical Discovery Institute; University of Basel	Vonarbourg, C (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany.	cedric.vonarbourg@uniklinik-freiburg.de; andreas.diefenbach@uniklinik-freiburg.de	Mortha, Arthur/ABE-6250-2020; Hölscher, Christoph/O-1732-2018; Hernandez, Pedro/X-2121-2019; Hernandez, Pedro P/K-4783-2015; Diefenbach, Andreas/T-2589-2018; Pannicke, Ulrich/D-7348-2014; Bengsch, Bertram/ABF-2142-2020	Hölscher, Christoph/0000-0002-7520-9146; Hernandez, Pedro/0000-0002-2873-4298; Hernandez, Pedro P/0000-0002-2873-4298; Diefenbach, Andreas/0000-0002-9176-9530; Bengsch, Bertram/0000-0003-2552-740X; Bui, Viet/0000-0002-8211-4911; Mortha, Arthur/0000-0003-2673-0485	Deutsche Forschungsgemeinschaft [Di764/3, GRK1104, SGBM, CRC620]; BMBF; Max-Planck-Society (IMPRS-MCB); Swiss National Science Foundation [PP00A-116894/1]; National Institutes of Health [R37AI033068, CA069381, AI088445]; Cluster of Excellence Inflammation at Interfaces [EXC306]; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088445, R37AI033068, R01AI033068] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Max-Planck-Society (IMPRS-MCB)(Max Planck Society); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cluster of Excellence Inflammation at Interfaces; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Hacker for support and for critically reading the manuscript; the members of the A.D. laboratory for valuable discussions; A. Fischer, H. Pircher, and K. Connor for comments on the manuscript; J. Brandel for help with the figures; and N. Goppert and K. Oberle for technical assistance. We are grateful to D. Littman and F. Santori for discussion and providing crucial reagents, to G. Niedermann and C. Johner for experimental support, and to M. Folio, K. Geiger, and J. Wersing for cell sorting. The work was supported by the Deutsche Forschungsgemeinschaft (Di764/3, GRK1104, SGBM, CRC620 to A.D., A.M., T.H., E.A.K., M.F.), the BMBF (CCI, A.D.), the Max-Planck-Society (IMPRS-MCB), the Swiss National Science Foundation grant PP00A-116894/1 (D.F.), the National Institutes of Health (grants R37AI033068, CA069381, and AI088445 to C.F.W.) and the Cluster of Excellence Inflammation at Interfaces (Borstel-Kiel-Lubeck-Plon; EXC306 to C.H.).	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chappaz S, 2010, J IMMUNOL, V184, P3562, DOI 10.4049/jimmunol.0901647; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Diefenbach A, 2010, IMMUNOL CELL BIOL, V88, P694, DOI 10.1038/icb.2010.82; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim MY, 2008, IMMUNOLOGY, V124, P166, DOI 10.1111/j.1365-2567.2007.02750.x; Lai SY, 1997, J CLIN INVEST, V99, P169, DOI 10.1172/JCI119144; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sanos SL, 2010, METHODS MOL BIOL, V612, P505, DOI 10.1007/978-1-60761-362-6_32; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	48	516	529	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 24	2010	33	5					736	751		10.1016/j.immuni.2010.10.017	http://dx.doi.org/10.1016/j.immuni.2010.10.017			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093318	Green Accepted, Bronze			2022-12-18	WOS:000286082600012
J	Haniffa, M; Shin, A; Bigley, V; McGovern, N; Teo, P; See, P; Wasan, PS; Wang, XN; Malinarich, F; Malleret, B; Larbi, A; Tan, P; Zhao, H; Poidinger, M; Pagan, S; Cookson, S; Dickinson, R; Dimmick, I; Jarrett, RF; Renia, L; Tam, J; Song, CL; Connolly, J; Chan, JKY; Gehring, A; Bertoletti, A; Collin, M; Ginhoux, F				Haniffa, Muzlifah; Shin, Amanda; Bigley, Venetia; McGovern, Naomi; Teo, Pearline; See, Peter; Wasan, Pavandip Singh; Wang, Xiao-Nong; Malinarich, Frano; Malleret, Benoit; Larbi, Anis; Tan, Pearlie; Zhao, Helen; Poidinger, Michael; Pagan, Sarah; Cookson, Sharon; Dickinson, Rachel; Dimmick, Ian; Jarrett, Ruth F.; Renia, Laurent; Tam, John; Song, Colin; Connolly, John; Chan, Jerry K. Y.; Gehring, Adam; Bertoletti, Antonio; Collin, Matthew; Ginhoux, Florent			Human Tissues Contain CD141(hi) Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103(+) Nonlymphoid Dendritic Cells	IMMUNITY			English	Article							EPIDERMAL LANGERHANS CELLS; IN-VIVO; T-CELLS; SUBSETS; RECEPTOR; EXPRESSION; RESIDENT; ANTIGEN; BLOOD; IDENTIFICATION	Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8(+) T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141(hi) DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c(+) and CD14(+) tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141(hi) DCs were closely related to blood CD141(+) DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted innmunotherapies and facilitate translation of mouse functional DC biology to the human setting.	[Haniffa, Muzlifah; Bigley, Venetia; McGovern, Naomi; Wang, Xiao-Nong; Pagan, Sarah; Cookson, Sharon; Dickinson, Rachel; Dimmick, Ian; Collin, Matthew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Haniffa, Muzlifah; Shin, Amanda; Teo, Pearline; See, Peter; Wasan, Pavandip Singh; Malinarich, Frano; Malleret, Benoit; Larbi, Anis; Zhao, Helen; Poidinger, Michael; Renia, Laurent; Connolly, John; Ginhoux, Florent] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Tan, Pearlie; Song, Colin] Singapore Gen Hosp, Singapore 169608, Singapore; [Jarrett, Ruth F.] Univ Glasgow, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland; [Tam, John] Natl Univ Singapore Hosp, Singapore 119074, Singapore; [Tam, John; Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119077, Singapore; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Singapore 229989, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Gehring, Adam; Bertoletti, Antonio] ASTAR, Singapore Inst Clin Sci, Singapore 117609, Singapore	Newcastle University - UK; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Singapore General Hospital; University of Glasgow; National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Collin, M (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	matthew.collin@newcastle.ac.uk; florent_ginhoux@immunol.a-star.edu.sg	Tam, John/B-6048-2012; Larbi, Anis/ABE-5868-2020; Bertoletti, Antonio/AAD-4830-2022; Connolly, John/B-8099-2014; Renia, Laurent/E-2117-2011; Bigley, Venetia/AAU-9738-2020; Malleret, Benoit/E-9159-2011; Jarrett, Ruth F/A-5570-2012	Bertoletti, Antonio/0000-0002-2942-0485; Renia, Laurent/0000-0003-0349-1557; Bigley, Venetia/0000-0002-3017-2474; Malleret, Benoit/0000-0001-9658-7528; McGovern, Naomi/0000-0001-5200-2698; Poidinger, Michael/0000-0002-1047-2277; Gehring, Adam/0000-0003-1150-5840; See, Peter/0000-0003-4428-7763; Jarrett, Ruth/0000-0003-0390-3478; Teo, Pearline/0000-0002-8283-6308; Cookson, Sharon/0000-0001-9476-6741	The Wellcome Trust, UK [WT088555MA]; Singapore Immunology Network core grant; George Walker Fellowship; British Society for Haematology; NMRC, Singapore [NMRC/CSA/012/2009]; Leukaemia and Lymphoma Research UK; Histiocytosis Association; Histiocytosis Research Trust; MRC [G0800358] Funding Source: UKRI; Medical Research Council [G0800358] Funding Source: researchfish	The Wellcome Trust, UK(Wellcome Trust); Singapore Immunology Network core grant; George Walker Fellowship; British Society for Haematology; NMRC, Singapore(National Medical Research Council, Singapore); Leukaemia and Lymphoma Research UK; Histiocytosis Association; Histiocytosis Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Wellcome Trust, UK (WT088555MA; M.H. and N.McG.); Singapore Immunology Network core grant (F.G., J.C., and L.R.); George Walker Fellowship and British Society for Haematology (VB.); NMRC, Singapore (NMRC/CSA/012/2009; J.K.Y.C.); Leukaemia and Lymphoma Research UK (S.F.); and Histiocytosis Association and Histiocytosis Research Trust (M.C. and S.C.). We thank the following for assistance: M.L. Ng, S.H. Tan, and T.B. Lu from the Electron Microscopy Unit of the National University of Singapore; I. Harvey and O. Hughes at the Flow Cytometry Core Facility of the Faculty of Medicine Newcastle University; I. Low and N. Binte Shadan at the Flow Cytometry Core Service; J. Lum and F. Zolezzi at the Functional Genomics Laboratory of the Singapore Immunology Network; and Nikon Imaging Centre, Biopolis, Singapore. We thank the following for sharing reagents or materials: K. Shortman and M. Lahoud, Walter and Eliza Hall Institute, Melbourne; C. Reis e Sousa, Cancer Research UK, London; G. Brown, University of Aberdeen; S. Todryk, Northumbria University; and L. Mori and G. de Libero, Singapore Immunology Network.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Ebner S, 2001, J IMMUNOL, V166, P633, DOI 10.4049/jimmunol.166.1.633; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eisenwort G, 2011, J INVEST DERMATOL, V131, P2049, DOI 10.1038/jid.2011.164; Fiore N, 2008, MOL IMMUNOL, V45, P259, DOI 10.1016/j.molimm.2007.04.029; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Tsoumakidou M, 2006, IMMUNOL CELL BIOL, V84, P267, DOI 10.1111/j.1440-1711.2006.01428.x; Tsuji T, 2011, J IMMUNOL, V186, P1218, DOI 10.4049/jimmunol.1000808; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	53	515	520	2	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					60	73		10.1016/j.immuni.2012.04.012	http://dx.doi.org/10.1016/j.immuni.2012.04.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22795876	Green Published, hybrid			2022-12-18	WOS:000307133200010
J	Kang, JY; Nan, X; Jin, MS; Youn, SJ; Ryu, YH; Mah, S; Han, SH; Lee, H; Paik, SG; Lee, JO				Kang, Jin Young; Nan, Xuehua; Jin, Mi Sun; Youn, Suk-Jun; Ryu, Young Hee; Mah, Shinjee; Han, Seung Hyun; Lee, Hayyoung; Paik, Sang-Gi; Lee, Jie-Oh			Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer	IMMUNITY			English	Article							PNEUMOCOCCAL LIPOTEICHOIC ACID; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CELL ACTIVATION; LIPOPROTEIN; BINDING; LIGAND; SOFTWARE; COMPLEX; PROTEIN	Toll-like receptor 2 (TLR2) initiates potent immune responses by recognizing diacylated and triacylated lipopeptides. Its ligand specificity is controlled by whether it heterodimerizes with TLR1 or TLR6. We have determined the crystal structures of TLR2-TLR6-diacylated lipopeptide, TLR2-lipoteichoic acid, and TLR2-PE-DTPA complexes. PE-DTPA, 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-diethy-lenetriaminepentaacetic acid, is a synthetic phospholipid derivative. Two major factors contribute to the ligand specificity of TLR2-TLR1 or TLR2-TLR6 heterodimers. First, the lipid channel of TLR6 is blocked by two phenylalanines. Simultaneous mutation of these phenylalanines made TLR2-TLR6 fully responsive not only to diacylated but also to triacylated lipopeptides. Second, the hydrophobic dimerization interface of TLR2-TLR6 is increased by 80%, which compensates for the lack of amide lipid interaction between the lipopeptide and TLR2-TLR6. The structures of the TLR2-lipoteichoic acid and the TLR2-PE-DTPA complexes demonstrate that a precise interaction pattern of the head group is essential for a robust immune response by TLR2 heterodimers.	[Nan, Xuehua; Lee, Hayyoung; Paik, Sang-Gi] Chungnam Natl Univ, Dept Biol, Daedeok R&D Innopolis Bio Brain Ctr BK21, Coll Biosci & Biotechnol, Taejon 305764, South Korea; [Kang, Jin Young; Jin, Mi Sun; Youn, Suk-Jun; Mah, Shinjee; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, WCU, Taejon 305701, South Korea; [Ryu, Young Hee; Han, Seung Hyun] Seoul Natl Univ, Dept Oral Microbiol & Immunol, Program BK21, Seoul 110749, South Korea; [Ryu, Young Hee; Han, Seung Hyun] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul 110749, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Int Vaccine Inst, Seoul 151919, South Korea	Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); International Vaccine Institute; Seoul National University (SNU)	Paik, SG (corresponding author), Chungnam Natl Univ, Dept Biol, Daedeok R&D Innopolis Bio Brain Ctr BK21, Coll Biosci & Biotechnol, Taejon 305764, South Korea.		Lee, Jie-Oh/C-1581-2011; Lee, Jie-Oh/AAG-4302-2020; Kang, Jin Young/E-4384-2019	Lee, Jie-Oh/0000-0001-6519-6049	Creative Research Initiative (Center for Membrane Receptor Research) of the Ministry of Education, Science and Technology of Korea	Creative Research Initiative (Center for Membrane Receptor Research) of the Ministry of Education, Science and Technology of Korea	We thank the staff of the beam lines 4A at the Pohang Accelerator Laboratory, BL41XU at SPring-8, and ID23-2 at ESRF for help with data collection We thank J Gross for critical reading of the manuscript This work is supported by the Creative Research Initiative (Center for Membrane Receptor Research) of the Ministry of Education, Science and Technology of Korea	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; BESSLER WG, 1985, J IMMUNOL, V135, P1900; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Ryu YH, 2009, INT IMMUNOPHARMACOL, V9, P127, DOI 10.1016/j.intimp.2008.10.014; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Spohn R, 2004, VACCINE, V22, P2494, DOI 10.1016/j.vaccine.2003.11.074; Stadelmaier A, 2006, BIOORGAN MED CHEM, V14, P6239, DOI 10.1016/j.bmc.2006.05.055; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	43	513	533	3	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					873	884		10.1016/j.immuni.2009.09.018	http://dx.doi.org/10.1016/j.immuni.2009.09.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	19931471	Bronze			2022-12-18	WOS:000273616400008
J	Gross, JA; Dillon, SR; Mudri, S; Johnston, J; Littau, A; Roque, R; Rixon, M; Schou, O; Foley, KP; Haugen, H; McMillen, S; Waggie, K; Schreckhise, RW; Shoemaker, K; Vu, T; Moore, M; Grossman, A; Clegg, CH				Gross, JA; Dillon, SR; Mudri, S; Johnston, J; Littau, A; Roque, R; Rixon, M; Schou, O; Foley, KP; Haugen, H; McMillen, S; Waggie, K; Schreckhise, RW; Shoemaker, K; Vu, T; Moore, M; Grossman, A; Clegg, CH			TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS	IMMUNITY			English	Article							NECROSIS-FACTOR FAMILY; AFFINITY FC-RECEPTOR; MARGINAL ZONE; LYMPHOCYTE STIMULATOR; DEFICIENT MICE; CUTTING EDGE; B-1 CELLS; APRIL; MEMBER; BAFF	BLyS and APRIL have similar but distinct biological roles, mediated through two known TNF receptor family members, TACI and BCMA. We show that mice treated with TACI-Ig and TACI-Ig transgenic mice have fewer transitional T2 and mature B cells and reduced levels of circulating immunoglobulin. TACI-Ig treatment inhibits both the production of collagen-specific Abs and the progression of disease in a mouse model of rheumatoid arthritis. In BLyS-deficient mice, B cell development is blocked at the transitional T1 stage such that virtually no mature B cells are present, while B-1 cell numbers are relatively normal. These findings further elucidate the roles of BLyS and APRIL in modulating B cell development and suggest that BLyS is required for the development of most but not all mature B cell populations found in the periphery.	Zymogenet Inc, Dept Immunol, Seattle, WA 98102 USA; Zymogenet Inc, Dept In Vivo Biol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Prot Biochem, Seattle, WA 98102 USA; Zymogenet Inc, Dept Bioproc Res, Seattle, WA 98102 USA; Zymogenet Inc, Dept Genet, Seattle, WA 98102 USA; Zymogenet Inc, Dept Prod Dev & Mfg, Seattle, WA 98102 USA; Zymogenet Inc, Dept Nucle Acid Technol, Seattle, WA 98102 USA	Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.	Gross, JA (corresponding author), Zymogenet Inc, Dept Immunol, 1201 Eastlake Ave E, Seattle, WA 98102 USA.	grossj@zgi.com	Foley, Kevin/ABC-1041-2020					ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bram RJ, 2000, BLOOD, V96, p133A; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Cheema GS, 2000, ARTHRITIS RHEUM, V43, pS94; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; HARDY RR, 1982, NATURE, V297, P589, DOI 10.1038/297589a0; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; Hayakawa K, 1997, ANN NY ACAD SCI, V815, P15, DOI 10.1111/j.1749-6632.1997.tb52041.x; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Matalon R, 2000, J GENE MED, V2, P165; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Ware CF, 2000, J EXP MED, V192, pF35, DOI 10.1084/jem.192.11.F35; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313; Wortis HH, 2001, J IMMUNOL, V166, P2163, DOI 10.4049/jimmunol.166.4.2163; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yankee T M, 2000, Rev Immunogenet, V2, P185; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	49	509	552	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2001	15	2					289	302		10.1016/S1074-7613(01)00183-2	http://dx.doi.org/10.1016/S1074-7613(01)00183-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520463	Bronze			2022-12-18	WOS:000170717200010
J	Luthi, AU; Cullen, SP; McNeela, EA; Duriez, PJ; Afonina, IS; Sheridan, C; Brumatti, G; Taylor, RC; Kersse, K; Vandenabeele, P; Lavelle, EC; Martin, SJ				Luethi, Alexander U.; Cullen, Sean P.; McNeela, Edel A.; Duriez, Patrick J.; Afonina, Inna S.; Sheridan, Clare; Brumatti, Gabriela; Taylor, Rebecca C.; Kersse, Kristof; Vandenabeele, Peter; Lavelle, Ed C.; Martin, Seamus J.			Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases	IMMUNITY			English	Article							RECEPTOR ACCESSORY PROTEIN; INNATE IMMUNE-SYSTEM; T-CELLS; INFLAMMATORY CASPASES; MAST-CELLS; IL-33; ST2; ACTIVATION; CYTOKINE; EXPRESSION	Interleukin-33 (IL-33) is a member of the IL-1 family and is involved in polarization of T cells toward a T helper 2 (Th2) cell phenotype. IL-33 is thought to be activated via caspase-1-dependent proteolysis, similar to the proinflammatory cytokines IL-1 beta and IL-1 8, but this remains unproven. Here we showed that IL-33 was processed by caspases activated during apoptosis (caspase-3 and -7) but was not a physiological substrate for caspases associated with inflammation (caspase-1, -4, and -5). Furthermore, caspase-dependent processing of IL-33 was not required for ST2 receptor binding or ST2-dependent activation of the NF-kappa B transcription factor. Indeed, caspase-dependent proteolysis of IL-33 dramatically attenuated IL-33 bioactivity in vitro and in vivo. These data suggest that IL-33 does not require proteolysis for activation, but rather, that IL-33 bioactivity is diminished through caspase-dependent proteolysis within apoptotic cells. Thus, caspase-mediated proteolysis acts as a switch to dampen the proinflammatory properties of IL-33.	[Luethi, Alexander U.; Cullen, Sean P.; Duriez, Patrick J.; Afonina, Inna S.; Sheridan, Clare; Brumatti, Gabriela; Taylor, Rebecca C.; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland; [McNeela, Edel A.; Lavelle, Ed C.] Trinity Coll Dublin, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin 2, Ireland; [Kersse, Kristof; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Kersse, Kristof; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Trinity College Dublin; Trinity College Dublin; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Vandenabeele, Peter/C-8597-2009; Lavelle, Ed/A-1716-2008; Vandenabeele, Peter/AAD-5793-2022; Afonina, Inna/AAM-8978-2020	Lavelle, Ed/0000-0002-3167-1080; Vandenabeele, Peter/0000-0002-6669-8822; Afonina, Inna/0000-0001-8894-5305; Martin, Seamus/0000-0002-8539-3143; McNeela, Edel/0000-0002-8700-3575; Taylor, Rebecca/0000-0003-3429-3123	Science Foundation Ireland [PI1/B038]; Health Research Board of Ireland [RP/2006/233]; Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank K. Yanagisawa for provision of ST2 expression plasmid and L. O'Neill and K. Mills for helpful discussions and for provision of reagents. We thank Science Foundation Ireland (PI1/B038) and The Health Research Board of Ireland (RP/2006/233) for their support of this work. S.J.M is a Science Foundation Ireland Fellow.	Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chow SC, 1999, EXP CELL RES, V246, P491, DOI 10.1006/excr.1998.4333; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lavelle EC, 2001, IMMUNOLOGY, V102, P77, DOI 10.1046/j.1365-2567.2001.01157.x; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; MAIER JAM, 1994, MOL CELL BIOL, V14, P1845, DOI 10.1128/MCB.14.3.1845; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shechter Y, 2001, P NATL ACAD SCI USA, V98, P1212, DOI 10.1073/pnas.98.3.1212; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	24	507	528	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					84	98		10.1016/j.immuni.2009.05.007	http://dx.doi.org/10.1016/j.immuni.2009.05.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19559631	Bronze, Green Submitted			2022-12-18	WOS:000268219900014
J	Savage, AK; Constantinides, MG; Han, J; Picard, D; Martin, E; Li, BF; Lantz, O; Bendelac, A				Savage, Adam K.; Constantinides, Michael G.; Han, Jin; Picard, Damien; Martin, Emmanuel; Li, Bofeng; Lantz, Olivier; Bendelac, Albert			The transcription factor PLZF directs the effector program of the NKT cell lineage	IMMUNITY			English	Article							T-LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION; NATURAL-KILLER; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; REGULATES CD4; DIFFERENTIATION; RECOGNITION; COMMITMENT; GATA-3	The transcriptional control of CD1d-restricted NKT cell development has remained elusive. We report that PLZF (promyelocytic leukemia zinc finger, Zbtb16), a member of the BTB/POZ-ZF family of transcription factors that includes the CD4-lineage-specific c-Krox (Th-POK), is exquisitely specific to CD1d-restricted NKT cells and human MR1-specific MAIT cells. PLZF was induced immediately after positive selection of NKT cell precursors, and PLZF-deficient NKT cells failed to undergo the intrathymic expansion and effector differentiation that characterize their lineage. Instead, they preserved a naive phenotype and were directed to lymph nodes. Conversely, transgenic expression of PLZF induced CD4(+) thymocytes to acquire effector differentiation and migrate to nonlymphoid tissues. We suggest that PLZF is a transcriptional signature of NKT cells that directs their innate-like effector differentiation during thymic development.	[Savage, Adam K.; Constantinides, Michael G.; Han, Jin; Picard, Damien; Bendelac, Albert] Univ Chicago, Dept Pathol, Comm Immunol, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Martin, Emmanuel; Lantz, Olivier] Inst Curie, INSERM, Immunol Lab, F-75005 Paris, France; [Martin, Emmanuel; Lantz, Olivier] Inst Curie, INSERM, Unite 653, F-75005 Paris, France; [Li, Bofeng] Univ Chicago, Comm Immunol, Dept Med Pathol & Pediat, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Martin, Emmanuel/F-9743-2016; Lantz, Olivier J/J-4960-2012	Martin, Emmanuel/0000-0003-4211-7373; Lantz, Olivier J/0000-0003-3161-7719; li, bofeng/0000-0002-9110-8804; Savage, Adam/0000-0003-1913-5485; Constantinides, Michael/0000-0003-4770-7751; Han, Jin/0000-0003-0662-006X	National Institutes of Health [RO1 A1038339]; University of Chicago Digestive Diseases Research Core Center [P30 DK42086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Digestive Diseases Research Core Center(University of Chicago); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Bendelac and Lantz laboratories for help and advice; B. Jabri, E. Bertolino and H. Singh for discussions; R. Duggan, D. Leclerc; and M. Olson for expert assistance with cell sorting; the MAID tetramer facility for CD1d tetramers; and the University of Chicago Functional Genomics Facility, Transgenic Mouse Facility, and Animal Resource Center. This work was supported by grants from the National Institutes of Health (RO1 A1038339, to A.B.) and the University of Chicago Digestive Diseases Research Core Center (P30 DK42086). A.B. is an investigator of the Howard Hughes Medical Institute.	Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GREEN MC, 1961, J HERED, V52, P297, DOI 10.1093/oxfordjournals.jhered.a107103; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He X, 2006, CURR OPIN IMMUNOL, V18, P135, DOI 10.1016/j.coi.2006.02.003; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park SH, 1998, J IMMUNOL, V160, P3128; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Singer A, 2004, ADV IMMUNOL, V83, P91; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	46	507	519	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					391	403		10.1016/j.immuni.2008.07.011	http://dx.doi.org/10.1016/j.immuni.2008.07.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18703361	Green Accepted, Bronze			2022-12-18	WOS:000259708900010
J	Adolfsson, J; Borge, OJ; Bryder, D; Theilgaard-Monch, K; Astrand-Grundstrom, I; Sitnicka, E; Sasaki, Y; Jacobsen, SEW				Adolfsson, J; Borge, OJ; Bryder, D; Theilgaard-Monch, K; Astrand-Grundstrom, I; Sitnicka, E; Sasaki, Y; Jacobsen, SEW			Upregulation of flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity	IMMUNITY			English	Article							MURINE HEMATOPOIETIC STEM; RECEPTOR TYROSINE KINASE; C-KIT LIGAND; PROGENITOR CELLS; FLT3/FLK-2 LIGAND; MICE LACKING; IN-VITRO; SURVIVAL; MOUSE; DEFICIENCIES	Flt3 has emerged as a potential regulator of hematopoietic stem cells (HSC). Sixty percent of cells in the mouse marrow Lin(-)Sca1(+)c-kit(+) HSC pool expressed fIt3. Although single cell cloning showed comparable high proliferative, myeloid, B, and T cell potentials of Lin(-)Sca1(+)c-kit(+)flt3(+) and Lin(-)Sca1(+)c-kit(+)flt3(-) cells, only Lin(-)Sca1(+)c-kit(+)flt3(-) cells supported sustained multilineage reconstitution. In striking contrast, Lin(-)Sca1(+)c-kit(+)fIt3(+) cells rapidly and efficiently reconstituted B and T lymphopoiesis, whereas myeloid reconstitution was exclusively short term. Unlike c-kit, activation of fIt3 failed to support survival of HSC, whereas only fIt3 mediated survival of Lin(-)Sca1(+)c-kit(+)flt3(+) reconstituting cells. Phenotypic and functional analysis support that Lin-Sca1(+)c-kit(+)flt3(+) cells are progenitors for the common lymphoid progenitor. Thus, upregulation of fIt3 expression on Lin(-)Sca1(+)c-kit(+) HSC cells is accompanied by loss of self-renewal capacity but sustained lymphoid-restricted reconstitution potential.	Univ Lund Hosp, Inst Lab Med, Dept Stem Cell Biol, S-22185 Lund, Sweden; Univ Copenhagen, Rigshosp, Granulocyte Res Lab, DK-2100 Copenhagen, Denmark	Lund University; Skane University Hospital; Rigshospitalet; University of Copenhagen	Jacobsen, SEW (corresponding author), Univ Lund Hosp, Inst Lab Med, Dept Stem Cell Biol, S-22185 Lund, Sweden.	sten.jacobsen@stemcell.lu.se	Jacobsen, Sten Eirik W/D-3974-2018; Bryder, David/Q-6292-2019	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Theilgaard-Monch, Kim/0000-0002-4239-4939; Bryder, David/0000-0002-8761-4237				Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; BODINE DM, 1992, BLOOD, V79, P913; Borge OJ, 1999, BLOOD, V94, P3781, DOI 10.1182/blood.V94.11.3781.423k04_3781_3790; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Dao MA, 1997, BLOOD, V89, P446, DOI 10.1182/blood.V89.2.446; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Elwood NJ, 1996, BLOOD, V88, P4452, DOI 10.1182/blood.V88.12.4452.bloodjournal88124452; GEISSLER EN, 1983, EXP HEMATOL, V11, P452; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; KELLER JR, 1995, BLOOD, V86, P1757, DOI 10.1182/blood.V86.5.1757.bloodjournal8651757; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsunaga T, 1998, BLOOD, V92, P452, DOI 10.1182/blood.V92.2.452.414k09_452_461; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; METCALF D, 1993, BLOOD, V82, P3515; Miller CL, 1996, EXP HEMATOL, V24, P185; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; OKADA S, 1991, BLOOD, V78, P1706; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Petzer AL, 1996, J EXP MED, V183, P2551, DOI 10.1084/jem.183.6.2551; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Theilgaard-Monch K, 2001, J IMMUNOL METHODS, V252, P175, DOI 10.1016/S0022-1759(01)00340-4; Veiby OP, 1997, BLOOD, V90, P4321; Veiby OP, 1996, J IMMUNOL, V157, P2953; Yonemura Y, 1997, BLOOD, V89, P1915, DOI 10.1182/blood.V89.6.1915; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422; Zhang SL, 2000, J EXP MED, V192, P719, DOI 10.1084/jem.192.5.719	42	507	515	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					659	669		10.1016/S1074-7613(01)00220-5	http://dx.doi.org/10.1016/S1074-7613(01)00220-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672547	Bronze			2022-12-18	WOS:000171757800016
J	Refaeli, Y; Van Parijs, L; London, CA; Tschopp, J; Abbas, AK				Refaeli, Y; Van Parijs, L; London, CA; Tschopp, J; Abbas, AK			Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis	IMMUNITY			English	Article							DEATH DOMAIN; LYMPHOPROLIFERATIVE SYNDROME; MICE; ACTIVATION; INTERACTS; MUTATIONS; PROTEIN; LIGAND; CD95; AUTOIMMUNITY	Activation-induced cell death (AICD) of lymphocytes is an important mechamism of self-tolerance. In CD4(+) T cells, AICD is mediated by the Fas pathway and is enhanced by IL-2. To define the mechanisms of this pro-apoptotic action of IL-2, we analyzed CD4(+) T cells from wild-type and IL-2(-/-) mice expressing a transgenic T cell receptor. T cells become sensitive to AICD after activation by antigen and IL-2. IL-2 increases transcription and surface expression of Fas ligand (FasL) and suppresses transcription and expression of FLIP, the inhibitor of apoptosis. The ability of IL-2 to enhance expression of a pro-apoptotic molecule, Fast, and to suppress an inhibitor of Fas signaling, FLIP, likely accounts for the role of this cytokine in potentiating T cell apoptosis.	Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Lausanne, Inst Biochem, Lausanne Branch, CH-1066 Epalinges, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Lausanne	Abbas, AK (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, 75 Francis St, Boston, MA 02115 USA.	aabbas@rics.bwh.harvard.edu	London, Cheryl/E-6561-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07627] Funding Source: Medline; NIAID NIH HHS [AI35297, AI32531] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fournel S, 1996, J IMMUNOL, V157, P4309; GOLSTEV YV, 1997, J BIOL CHEM, V272, P19641; HAHNE M, 1995, INT IMMUNOL, V7, P1381, DOI 10.1093/intimm/7.9.1381; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; Latinis KM, 1997, J IMMUNOL, V158, P4602; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sambrook J, 1989, MOL CLONING LAB MANU; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Van Parijs L, 1998, J IMMUNOL, V160, P2065; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; VanParijs L, 1997, J IMMUNOL, V158, P3738; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Zheng LX, 1998, J IMMUNOL, V160, P763	40	506	523	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					615	623		10.1016/S1074-7613(00)80566-X	http://dx.doi.org/10.1016/S1074-7613(00)80566-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620682	Bronze			2022-12-18	WOS:000073885400009
J	Bronte, V; Pittet, MJ				Bronte, Vincenzo; Pittet, Mikael J.			The Spleen in Local and Systemic Regulation of Immunity	IMMUNITY			English	Review							TUMOR-ASSOCIATED MACROPHAGES; DENDRITIC CELLS; MARGINAL ZONE; HEMATOPOIETIC STEM; T-CELLS; B-CELLS; MYELOID CELLS; EXTRAMEDULLARY HEMATOPOIESIS; INFLAMMATORY MONOCYTES; MYOCARDIAL-INFARCTION	The spleen is the main filter for blood-borne pathogens and antigens, as well as a key organ for iron metabolism and erythrocyte homeostasis. Also, immune and hematopoietic functions have been recently unveiled for the mouse spleen, suggesting additional roles for this secondary lymphoid organ. Here we discuss the integration of the spleen in the regulation of immune responses locally and in the whole body and present the relevance of findings for our understanding of inflammatory and degenerative diseases and their treatments. We consider whether equivalent activities in humans are known, as well as initial therapeutic attempts to target the spleen for modulating innate and adaptive immunity.	[Bronte, Vincenzo] Verona Univ Hosp, I-37134 Verona, Italy; [Bronte, Vincenzo] Dept Pathol, I-37134 Verona, Italy; [Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Bronte, V (corresponding author), Verona Univ Hosp, I-37134 Verona, Italy.	vincenzo.bronte@univr.it; mpittet@mgh.harvard.edu	Bronte, Vincenzo/K-7902-2016; Pittet, Mikael/ABD-6300-2021	Bronte, Vincenzo/0000-0002-3741-5141; 	Italian Ministry of Education, University and Research (FIRB project) [RBAP11T3WB_003]; Fondazione Cariverona; Italian Association for Cancer Research (AIRC) [IG10400, 12182, AGIMM 100005, 6599]; US National Institutes of Health (NIH) [R01-AI084880, P50-CA086355, N01-HV08235]; project Verona Nanomedicine Initiative; NATIONAL CANCER INSTITUTE [P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER	Italian Ministry of Education, University and Research (FIRB project)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona(Fondazione Cariverona); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); project Verona Nanomedicine Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of V. B. is supported in part by Italian Ministry of Education, University and Research (FIRB project RBAP11T3WB_003), Fondazione Cariverona, project Verona Nanomedicine Initiative, and Italian Association for Cancer Research (AIRC, Grants IG10400, 12182, AGIMM 100005, and 6599). The work of M.J.P. is supported in part by US National Institutes of Health (NIH) grants R01-AI084880, P50-CA086355, and N01-HV08235.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; AMLOT PL, 1985, LANCET, V1, P1008, DOI 10.1016/S0140-6736(85)91613-7; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bonnefoy F, 2011, J IMMUNOL, V186, P5696, DOI 10.4049/jimmunol.1001523; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Buettner M, 2013, SCAND J IMMUNOL, V77, P238, DOI 10.1111/sji.12034; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chotivanich K, 2002, J INFECT DIS, V185, P1538, DOI 10.1086/340213; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Crandall M, 2009, MOL MED, V15, P263, DOI 10.2119/molmed.2009.00029; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Faunce DE, 2002, J IMMUNOL, V169, P31, DOI 10.4049/jimmunol.169.1.31; Fotiadis C, 1999, Int J Surg Investig, V1, P113; FREEDMAN MH, 1981, AM J HEMATOL, V11, P271, DOI 10.1002/ajh.2830110307; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Haverkamp JM, 2011, EUR J IMMUNOL, V41, P749, DOI 10.1002/eji.201041069; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lindmark E, 2013, J AUTOIMMUN, V42, P62, DOI 10.1016/j.jaut.2012.11.004; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; MacNeal WJ, 1929, ARCH PATHOL, V7, P215; Makarenkova VP, 2006, J IMMUNOL, V176, P2085, DOI 10.4049/jimmunol.176.4.2085; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Masli S, 2002, J IMMUNOL, V168, P2264, DOI 10.4049/jimmunol.168.5.2264; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; McAlpine H M, 1988, Am J Med, V84, P61, DOI 10.1016/0002-9343(88)90206-9; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MELLEMKJAER L, 1995, CANCER, V75, P577, DOI 10.1002/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Metchnikoff E, 1884, VIRCHOWS ARCH, V96, P177; MILLER SD, 1979, J IMMUNOL, V123, P2344; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Norris BA, 2013, IMMUNITY, V38, P309, DOI 10.1016/j.immuni.2012.10.022; Oakley OR, 2010, ENDOCRINOLOGY, V151, P4551, DOI 10.1210/en.2009-1444; Ohyagi H, 2013, IMMUNITY, V39, P584, DOI 10.1016/j.immuni.2013.06.019; OKEANE JC, 1989, CANCER, V63, P1539; PELLAS TC, 1990, AM J ANAT, V187, P347, DOI 10.1002/aja.1001870404; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Ravishankar B, 2013, CELL MOL LIFE SCI, V70, P3571, DOI 10.1007/s00018-013-1261-0; Ravishankar B, 2012, P NATL ACAD SCI USA, V109, P3909, DOI 10.1073/pnas.1117736109; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; ROBINETTE CD, 1977, LANCET, V2, P127; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SCHWARZ RE, 1990, J SURG RES, V48, P448, DOI 10.1016/0022-4804(90)90011-P; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; STREILEIN JW, 1981, J EXP MED, V153, P1058, DOI 10.1084/jem.153.5.1058; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wang XL, 2012, J CLIN INVEST, V122, P3888, DOI 10.1172/JCI64397; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; YOUNG MRI, 1988, CANCER RES, V48, P6826; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	118	505	515	27	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					806	818		10.1016/j.immuni.2013.10.010	http://dx.doi.org/10.1016/j.immuni.2013.10.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238338	Bronze, Green Accepted			2022-12-18	WOS:000330950600005
J	Zenewicz, LA; Yancopoulos, GD; Valenzuela, DM; Murphy, AJ; Karow, M; Flavell, RA				Zenewicz, Lauren A.; Yancopoulos, George D.; Valenzuela, David M.; Murphy, Andrew J.; Karow, Margaret; Flavell, Richard A.			Interleukin-22 but not interleukin-17 provides protection to Hepatocytes during acute liver inflammation	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY GENE-EXPRESSION; T-CELLS; RHEUMATOID-ARTHRITIS; CONCANAVALIN-A; HUMAN KERATINOCYTES; INNATE IMMUNITY; POTENTIAL ROLE; IL-22; IL-17	The cytokine interleukin-22 (IL-22) is primarily expressed by T helper 17 (Th17) CD4(+) T cells and is highly upregulated during chronic inflammatory diseases. IL-22 receptor expression is absent on immune cells, but is instead restricted to the tissues, providing signaling directionality from the immune system to the tissues. However, the role of IL-22 in inflammatory responses has been confounded by data suggesting both pro- and anti-inflammatory functions. Herein, we provide evidence that during inflammation, IL-22 played a protective role in preventing tissue injury. Hepatocytes from mice deficient in IL-22 were highly sensitive to the detrimental immune response associated with hepatitis. Additionally, IL-22-expressing Th17 cells provided protection during hepatitis in IL-22-deflcient mice. On the other hand, interleukin-17 (IL-17), which is coexpressed with IL-22 and can induce similar cellular responses, had no observable role in liver inflammation. Our data suggest that IL-22 serves as a protective molecule to counteract the destructive nature of the immune response to limit tissue damage.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Yale University; Howard Hughes Medical Institute; Yale University; Regeneron	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu		Zenewicz, Lauren/0000-0002-8787-5955; Murphy, Andrew/0000-0003-4152-4081	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [T32 AI007019-29, 2-T32-AI07019-29, T32 AI007019] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blum HE, 2005, WORLD J GASTROENTERO, V11, P7391; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chabaud M, 1998, J IMMUNOL, V161, P409; Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kuniyasu Y, 2005, CELL IMMUNOL, V238, P31, DOI 10.1016/j.cellimm.2005.12.006; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Subramaniam SV, 1999, BIOCHEM BIOPH RES CO, V262, P14, DOI 10.1006/bbrc.1999.1156; Tagawa YI, 2000, J LEUKOCYTE BIOL, V67, P90, DOI 10.1002/jlb.67.1.90; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	53	503	558	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	2007	27	4					647	659		10.1016/j.immuni.2007.07.023	http://dx.doi.org/10.1016/j.immuni.2007.07.023			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17919941	Bronze, Green Accepted			2022-12-18	WOS:000250490700015
J	Evavold, CL; Ruan, JB; Tan, YH; Xia, SY; Wu, H; Kagan, JC				Evavold, Charles L.; Ruan, Jianbin; Tan, Yunhao; Xia, Shiyu; Wu, Hao; Kagan, Jonathan C.			The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages	IMMUNITY			English	Article							PYROPTOTIC CELL-DEATH; STAPHYLOCOCCUS-AUREUS; INFLAMMATORY CASPASES; IN-VIVO; PEPTIDOGLYCAN; ACTIVATION; GSDMD; INFLAMMASOMES; IMMUNITY; RECEPTOR	The interleukin-1 (IL-1) family cytokines are cytosolic proteins that exhibit inflammatory activity upon release into the extracellular space. These factors are released following various cell death processes, with pyroptosis being a common mechanism. Recently, it was recognized that phagocytes can achieve a state of hyperactivation, which is defined by their ability to secrete IL-1 while retaining viability, yet it is unclear how IL-1 can be secreted from living cells. Herein, we report that the pyroptosis regulator gasdermin D (GSDMD) was necessary for IL-1b secretion from living macrophages that have been exposed to inflammasome activators, such as bacteria and their products or host-derived oxidized lipids. Cell-and liposome-based assays demonstrated that GSDMD pores were required for IL-1b transport across an intact lipid bilayer. These findings identify a non-pyroptotic function for GSDMD, and raise the possibility that GSDMD pores represent conduits for the secretion of cytosolic cytokines under conditions of cell hyperactivation.	[Evavold, Charles L.; Tan, Yunhao; Kagan, Jonathan C.] Harvard Med Sch, Boston, MA 02115 USA; [Evavold, Charles L.; Tan, Yunhao; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Evavold, Charles L.; Kagan, Jonathan C.] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA; [Ruan, Jianbin; Xia, Shiyu; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Ruan, Jianbin; Xia, Shiyu; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Kagan, JC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Harvard Med Sch, Program Immunol, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu	Xia, Shiyu/P-8621-2019	Xia, Shiyu/0000-0001-9024-0689; Evavold, Charles/0000-0003-3913-5626	NIH [AI093589, AI116550, HD087988, AI124491]; Burroughs Wellcome Fund; Harvard Herchel Smith Fellowship; Landry Cancer Biology Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124491, R01AI116550, R01AI093589] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Herchel Smith Fellowship; Landry Cancer Biology Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Douglas Golenbock, Russell Vance, and David Underhill for providing essential reagents. This work was supported by NIH grants AI093589 and AI116550 to J.C.K., and NIH grants HD087988 and AI124491 to H.W. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. C.L.E. is supported by the Harvard Herchel Smith and Landry Cancer Biology Fellowships. Y.T. is a postdoctoral fellow of the Jane Coffin Childs Fund (the Merck Fellow).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Tzeng TC, 2016, CELL REP, V16, P571, DOI 10.1016/j.celrep.2016.06.011; VANOOSTRUM J, 1991, J STRUCT BIOL, V107, P189; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	29	502	516	15	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					35	+		10.1016/j.immuni.2017.11.013	http://dx.doi.org/10.1016/j.immuni.2017.11.013			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29195811	Bronze, Green Accepted			2022-12-18	WOS:000422751600009
J	Rogers, PR; Song, JX; Gramaglia, I; Killeen, N; Croft, M				Rogers, PR; Song, JX; Gramaglia, I; Killeen, N; Croft, M			OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells	IMMUNITY			English	Article							KAPPA-B ACTIVATION; CHEMOKINE RECEPTOR; FAMILY-MEMBER; UP-REGULATION; OX-40 LIGAND; CD28; PROLIFERATION; DIFFERENTIATION; APOPTOSIS; RESPONSES	It is important to understand which molecules are essential for long-lived immunity. We show that OX40 (CD134) is required with CD28 for the survival of CD4 T cells following antigen-driven expansion. In contrast to CD28(-/-) T cells, which show defects early, OX40(-/-)T cells are relatively unimpaired in IL-2 production, cell division, and expansion. However, OX40(-/-) T cells fall to maintain high levels of Bci-xL and Bcl-2 4-8 days after activation, and undergo apoptosis. Conversely, OX40 stimulation promotes Bcl-xL and Bcl-2 and suppresses apoptosis. Moreover, retroviral transduction of OX40(-/-) T cells with Bcl-xL or Bcl-2 reverses their survival defect. Thus, a temporal relationship exists between CD28 and OX40, with OX40 being a critical regulator of antigen-driven T cell survival.	La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	La Jolla Institute for Immunology; University of California System; University of California San Francisco	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA.	mick_croft@liai.org			NIAID NIH HHS [AI 42944] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042944] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlShamkhani A, 1996, EUR J IMMUNOL, V26, P1695, DOI 10.1002/eji.1830260805; Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Behrens TW, 1997, IMMUNOL RES, V16, P149, DOI 10.1007/BF02786359; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Costa GL, 2000, J IMMUNOL, V164, P3581, DOI 10.4049/jimmunol.164.7.3581; Croft M, 1997, CRIT REV IMMUNOL, V17, P89, DOI 10.1615/CritRevImmunol.v17.i1.40; CROFTON J, 1992, AMORPHOUS CRYSTALLIN, V4, P176; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; DEL PL, 1997, SCIENCE, V278, P687; DENG G, 1993, P NATL ACAD SCI USA, V90, P2189, DOI 10.1073/pnas.90.6.2189; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Gramaglia I, 2000, J IMMUNOL, V165, P3043, DOI 10.4049/jimmunol.165.6.3043; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074/jbc.273.39.25185; Jaiswal AI, 1996, INT IMMUNOL, V8, P275, DOI 10.1093/intimm/8.2.275; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Maxwell JR, 2000, J IMMUNOL, V164, P107, DOI 10.4049/jimmunol.164.1.107; Mueller DL, 1996, J IMMUNOL, V156, P1764; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ozes ON, 1999, NATURE, V401, P82; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Pastorino JG, 1999, J BIOL CHEM, V274, P19411, DOI 10.1074/jbc.274.27.19411; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Pippig SD, 1999, J IMMUNOL, V163, P6520; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Sperling AI, 1996, J IMMUNOL, V157, P3909; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; VASILAKOS JP, 1995, J IMMUNOL, V155, P3433; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; WEINBERG AD, 1994, J IMMUNOL, V152, P4712; Weinberg AD, 2000, J IMMUNOL, V164, P2160, DOI 10.4049/jimmunol.164.4.2160; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5	66	502	534	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		445	455		10.1016/S1074-7613(01)00191-1	http://dx.doi.org/10.1016/S1074-7613(01)00191-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567634	Bronze			2022-12-18	WOS:000171211800011
J	Nimmerjahn, F; Bruhns, P; Horiuchi, K; Ravetch, JV				Nimmerjahn, F; Bruhns, P; Horiuchi, K; Ravetch, JV			Fc gamma RIV: A novel FcR with distinct IgG subclass specificity	IMMUNITY			English	Article							ANTIBODY-MEDIATED PROTECTION; IN-VIVO; IMMUNOGLOBULIN ISOTYPE; DENDRITIC CELLS; ARTHUS REACTION; DEFICIENT MICE; RECEPTOR; RESPONSES; RIII; EXPRESSION	Mouse IgG subclasses display a hierarchy of in vivo activities, with IgG2a and IgG2b showing the greatest protective and pathogenic properties. These enhanced activities result, in part, from their ability to bind to a novel, 7 chain-dependent, activating IgG Fc receptor, Fc gamma RIV. Fc gamma RIV maps in the 75 kb genomic interval between Fc gamma RII and Fc gamma RIII; its expression is restricted to myeloid lineage cells, and it binds to IgG2a and IgG2b with intermediate affinity. No binding to IgG1 or IgG3 was observed. Blocking Fc gamma RIV binding to pathogenic anti-platelet antibodies is sufficient to protect mice from antibody-induced thrombocytopenia. Thus, the Fc gamma R system has evolved distinct activation receptors displaying selectivity for IgG subclasses, with IgG1 antibodies exclusively dependent on Fc gamma RIII, whereas IgG2a and IgG2b show preferential dependence on Fc gamma RIV activation. These distinct binding affinities for the IgG subclasses to Fc gamma Rs account for their differential protective and pathogenic activities in vivo.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Nimmerjahn, Falk/J-4986-2013; Bruhns, Pierre/F-5567-2013; Ravetch, Jeffrey/Z-1596-2019	Bruhns, Pierre/0000-0002-4709-8936; Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X				BALDRIDGE JR, 1992, J VIROL, V66, P4252, DOI 10.1128/JVI.66.7.4252-4257.1992; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnes N, 2002, IMMUNITY, V16, P379, DOI 10.1016/S1074-7613(02)00287-X; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; da Silveira SA, 2002, J EXP MED, V195, P665, DOI 10.1084/jem.20012024; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; KAMINSKI MS, 1986, J IMMUNOL, V136, P1123; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; KUROSAKI T, 1992, J EXP MED, V175, P447, DOI 10.1084/jem.175.2.447; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; Mechetina LV, 2002, IMMUNOGENETICS, V54, P463, DOI 10.1007/s00251-002-0486-0; Meyer D, 1998, BLOOD, V92, P3997, DOI 10.1182/blood.V92.11.3997.423k52_3997_4002; Miller KL, 1996, J EXP MED, V183, P2227, DOI 10.1084/jem.183.5.2227; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Okayama Y, 2000, J IMMUNOL, V164, P4332, DOI 10.4049/jimmunol.164.8.4332; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Ramalingam T, 2003, INFECT IMMUN, V71, P4361, DOI 10.1128/IAI.71.8.4361-4367.2003; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; SCHLAGETER AM, 1990, INFECT IMMUN, V58, P1914, DOI 10.1128/IAI.58.6.1914-1918.1990; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tridandapani S, 2003, J IMMUNOL, V170, P4572, DOI 10.4049/jimmunol.170.9.4572; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wernersson S, 1999, J IMMUNOL, V163, P618; *WHO, 1994, B WORLD HEALTH ORGAN, V72, P809; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313	53	501	578	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					41	51		10.1016/j.immuni.2005.05.010	http://dx.doi.org/10.1016/j.immuni.2005.05.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039578	Bronze			2022-12-18	WOS:000231024800007
J	Siddiqui, I; Schaeuble, K; Chennupati, V; Marraco, SAF; Calderon-Copete, S; Ferreira, DP; Carmona, SJ; Scarpellino, L; Gfeller, D; Pradervand, S; Luther, SA; Speiser, DE; Held, W				Siddiqui, Imran; Schaeuble, Karin; Chennupati, Vijaykumar; Marraco, Silvia A. Fuertes; Calderon-Copete, Sandra; Ferreira, Daniela Pais; Carmona, Santiago J.; Scarpellino, Leonardo; Gfeller, David; Pradervand, Sylvain; Luther, Sanjiv A.; Speiser, Daniel E.; Held, Werner			Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy	IMMUNITY			English	Article							CANCER; EXPRESSION; MELANOMA; TCF1; DYSFUNCTION; PACKAGE; MODULE; MODEL	Checkpoint blockade mediates a proliferative response of tumor-infiltrating CD8(+) T lymphocytes (TILs). The origin of this response has remained elusive because chronic activation promotes terminal differentiation or exhaustion of tumor-specific T cells. Here we identified a subset of tumor-reactive TILs bearing hallmarks of exhausted cells and central memory cells, including expression of the checkpoint protein PD-1 and the transcription factor Tcf1. Tcf1(+)PD-1(+) TILs mediated the proliferative response to immunotherapy, generating both Tcf1(+)PD-1(+) and differentiated Tcf1(-)PD-1(+) cells. Ablation of Tcf1(+)PD-1(+) TILs restricted responses to immunotherapy. Tcf1 was not required for the generation of Tcf1(+)PD-1(+) TILs but was essential for the stem-like functions of these cells. Human TCF1(+)PD-1(+) cells were detected among tumor-reactive CD8(+) T cells in the blood of melanoma patients and among TILs of primary melanomas. Thus, immune checkpoint blockade relies not on reversal of T cell exhaustion programs, but on the proliferation of a stem-like TIL subset.	[Siddiqui, Imran; Schaeuble, Karin; Chennupati, Vijaykumar; Marraco, Silvia A. Fuertes; Ferreira, Daniela Pais; Carmona, Santiago J.; Gfeller, David; Speiser, Daniel E.; Held, Werner] Univ Lausanne, Dept Oncol UNIL CHUV, CH-1066 Epalinges, Switzerland; [Calderon-Copete, Sandra; Pradervand, Sylvain] Univ Lausanne, LGTF, CH-1015 Lausanne, Switzerland; [Carmona, Santiago J.; Gfeller, David] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Carmona, Santiago J.; Gfeller, David] SIB, CH-1015 Lausanne, Switzerland; [Scarpellino, Leonardo; Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Chennupati, Vijaykumar] Syngene Int Ltd, Discovery Biol Div, Bengaluru 560056, India	University of Lausanne; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Syngene International Limited	Held, W (corresponding author), Univ Lausanne, Dept Oncol UNIL CHUV, CH-1066 Epalinges, Switzerland.	werner.held@unil.ch	Carmona, Santiago J/E-9356-2015; Luther, Sanjiv/AAP-6525-2020; Speiser, Daniel E./F-2173-2013; Siddiqui, Imran/K-5000-2012	Carmona, Santiago J/0000-0002-2495-0671; Luther, Sanjiv/0000-0002-8758-957X; Siddiqui, Imran/0000-0002-6792-8730; Schauble, Karin/0000-0003-1826-0129; Pais Ferreira, Daniela/0000-0003-2277-5563	SystemsX grant from the Swiss National Science Foundation (SNSF) [SNSF 31003A_173156, SNSF (31003A-166161)]; SNSF [31003A_173156, 31003A-166161, 320030-152856, 310030-179459, CRSII3-160708, 310030_159598, 310030B_179570]; Swiss Cancer League (SCL) [KFS-3971-08-2016]; SCL [KFS-3601-02-2015, KFS-4407-02-2018]	SystemsX grant from the Swiss National Science Foundation (SNSF); SNSF(Swiss National Science Foundation (SNSF)); Swiss Cancer League (SCL); SCL	S.J.C. was supported by a SystemsX grant from the Swiss National Science Foundation (SNSF) and D.G. is supported by a grant from the SNSF 31003A_173156). S.A.L. is supported in part by a grant from the SNSF (31003A-166161). D.E.S. is supported in part by grants the Swiss Cancer League (SCL) (KFS-3971-08-2016) and the SNSF (320030-152856, 310030-179459, and CRSII3-160708). W.H. is supported in part by grants from the SCL (KFS-3601-02-2015 and KFS-4407-02-2018) and the SNSF (310030_159598 and 310030B_179570).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; DILLON SR, 1994, J IMMUNOL, V152, P1790; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Horton BL, 2018, CANCER IMMUNOL RES, V6, P14, DOI 10.1158/2326-6066.CIR-17-0249; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Reiser J, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8941260; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schaeuble K, 2017, CELL REP, V21, P2500, DOI 10.1016/j.celrep.2017.10.119; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	52	500	507	12	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					195	+		10.1016/j.immuni.2018.12.021	http://dx.doi.org/10.1016/j.immuni.2018.12.021			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30635237	Bronze, Green Accepted			2022-12-18	WOS:000455661600020
J	Weinberg, SE; Sena, LA; Chandel, NS				Weinberg, Samuel E.; Sena, Laura A.; Chandel, Navdeep S.			Mitochondria in the Regulation of Innate and Adaptive Immunity	IMMUNITY			English	Review							T-CELL-ACTIVATION; NF-KAPPA-B; RIG-I; TRANSCRIPTION FACTOR; MACROPHAGE POLARIZATION; NLRP3 INFLAMMASOME; DENDRITIC CELLS; METABOLISM; PROTEIN; HYPOXIA		[Weinberg, Samuel E.; Sena, Laura A.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60615 USA	Northwestern University; Feinberg School of Medicine	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60615 USA.	nav@northwestern.edu	Weinberg, Sam/ABD-5721-2021	Weinberg, Sam/0000-0002-9532-7051	 [R01CA123067];  [RO1HL12206201];  [5P01HL071643];  [T32HL076139]; NATIONAL CANCER INSTITUTE [T32CA009560, R01CA123067, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122062, P01HL071643, T32HL076139] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by R01CA123067, RO1HL12206201, and 5P01HL071643 to N.S.C. and T32HL076139 to S.E.W.	Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Martin-Cofreces NB, 2014, TRENDS CELL BIOL, V24, P61, DOI 10.1016/j.tcb.2013.09.005; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carroll KC, 2013, J LEUKOCYTE BIOL, V94, P1113, DOI 10.1189/jlb.0313157; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Contento RL, 2010, EMBO J, V29, P4035, DOI 10.1038/emboj.2010.258; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Ferreira GB, 2012, J PROTEOME RES, V11, P941, DOI 10.1021/pr200724e; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Gergely P, 2002, J IMMUNOL, V169, P1092, DOI 10.4049/jimmunol.169.2.1092; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gill T, 2013, J BIOL CHEM, V288, P26246, DOI 10.1074/jbc.M113.476895; Gurung P., 2014, TRENDS MOL MED; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huang S.C.-C., 2014, NAT IMMUNOL; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Klotz L, 2007, J IMMUNOL, V178, P2122, DOI 10.4049/jimmunol.178.4.2122; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lodhi IJ, 2015, CELL METAB, V21, P51, DOI 10.1016/j.cmet.2014.12.002; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Richards SM, 2009, EUR J IMMUNOL, V39, P3395, DOI 10.1002/eji.200939587; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shriver LP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00079; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Singhal A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009885; Subramanian N., 2014, FASEB J, V28, P349; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wahl DR, 2010, LUPUS, V19, P1492, DOI 10.1177/0961203310373109; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wheeler ML, 2012, J IMMUNOL, V189, P4405, DOI 10.4049/jimmunol.1201433; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	118	500	515	14	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					406	417		10.1016/j.immuni.2015.02.002	http://dx.doi.org/10.1016/j.immuni.2015.02.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786173	Green Accepted, Bronze			2022-12-18	WOS:000351301900007
J	Jakubzick, C; Gautier, EL; Gibbings, SL; Sojka, DK; Schlitzer, A; Johnson, TE; Ivanov, S; Duan, QN; Bala, S; Condon, T; van Rooijen, N; Grainger, JR; Belkaid, Y; Ma'ayan, A; Riches, DWH; Yokoyama, WM; Ginhoux, F; Henson, PM; Randolph, GJ				Jakubzick, Claudia; Gautier, Emmanuel L.; Gibbings, Sophie L.; Sojka, Dorothy K.; Schlitzer, Andreas; Johnson, Theodore E.; Ivanov, Stoyan; Duan, Qiaonan; Bala, Shashi; Condon, Tracy; van Rooijen, Nico; Grainger, John R.; Belkaid, Yasmine; Ma'ayan, Avi; Riches, David W. H.; Yokoyama, Wayne M.; Ginhoux, Florent; Henson, Peter M.; Randolph, Gwendalyn J.			Minimal Differentiation of Classical Monocytes as They Survey Steady-State Tissues and Transport Antigen to Lymph Nodes	IMMUNITY			English	Article							GENE-EXPRESSION PROFILES; DENDRITIC CELL-MIGRATION; BLOOD MONOCYTES; CD8(+) T; MACROPHAGES; SUBSETS; REVEALS; PROLIFERATION; INFECTION; RESPONSES	It is thought that monocytes rapidly differentiate to macrophages or dendritic cells (DCs) upon leaving blood. Here we have shown that Ly-6C(+) monocytes constitutively trafficked into skin, lung, and lymph nodes (LNs). Entry was unaffected in gnotobiotic mice. Monocytes in resting lung and LN had similar gene expression profiles to blood monocytes but elevated transcripts of a limited number of genes including cyclo-oxygenase-2 (COX-2) and major histocompatibility complex class II (MHCII), induced by monocyte interaction with endothelium. Parabiosis, bromodoxyuridine (BrdU) pulse-chase analysis, and intranasal instillation of tracers indicated that instead of contributing to resident macrophages in the lung, recruited endogenous monocytes acquired antigen for carriage to draining LNs, a function redundant with DCs though differentiation to DCs did not occur. Thus, monocytes can enter steady-state nonlymphoid organs and recirculate to LNs without differentiation to macrophages or DCs, revising a long-held view that monocytes become tissue-resident macrophages by default.	[Jakubzick, Claudia; Gibbings, Sophie L.; Riches, David W. H.; Henson, Peter M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Jakubzick, Claudia; Johnson, Theodore E.; Condon, Tracy; Riches, David W. H.; Henson, Peter M.] Univ Colorado, Integrated Dept Immunol, Denver, CO 80206 USA; [Jakubzick, Claudia; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Gautier, Emmanuel L.; Ivanov, Stoyan; Bala, Shashi; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Sojka, Dorothy K.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Schlitzer, Andreas; Ginhoux, Florent] ASTAR, Singapore Immunol Network, Singapore SIgN, Singapore 138648, Singapore; [Duan, Qiaonan; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [van Rooijen, Nico] Free Univ Med Ctr, Dept Mol Cell Biol, NL-1007 Amsterdam, Netherlands; [Grainger, John R.; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Jewish Health; University of Colorado System; University of Colorado Denver; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Randolph, GJ (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	grandolph@path.wustl.edu	Van Rooijen, Nico/Z-1578-2019; Schlitzer, Andreas/R-2237-2016; Ma'ayan, Avi/AAG-3131-2019; Gautier, Emmanuel L./E-2259-2017	Schlitzer, Andreas/0000-0001-7662-3712; Ma'ayan, Avi/0000-0002-6904-1017; Gautier, Emmanuel L./0000-0003-2976-7566; Ivanov, Stoyan/0000-0002-0527-2297; Grainger, John/0000-0002-4052-5923; Belkaid, Yasmine/0000-0001-9962-3571	National Institutes of Health [AI049653]; U.S. Department of Defense [DOD W81XWH-07-1-0550-Mason]; AHA [10POST4160140]; Training in Cancer Biology grant [T32CA009547]; Singapore Immunology Network core grant; Washington University Digestive Diseases Research Core Center (DDRCC) [DK052574];  [NHLBI-HL81151];  [NHLBI-HL115334];  [R24 AI072073]; NATIONAL CANCER INSTITUTE [T32CA009547, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, R01HL115334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132, R24AI072073, R01AI049653, R37AI049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098316, P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); AHA(American Heart Association); Training in Cancer Biology grant; Singapore Immunology Network core grant; Washington University Digestive Diseases Research Core Center (DDRCC); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Benoist and the Immunological Genome Consortium (Immgen) for their roles in the gene expression analysis. We thank J. Faith and J. Gordon for gnotobiotic mice, R. Schreiber for anti-IFN-gamma mAb H22, L. Yang for technical assistance and advice with parabiosis, and D. Homann for assistance and reagents used in chemokine staining. This work was supported by National Institutes of Health grant AI049653 to G. J. R. with a Primary Caregiver's Supplement to C. J. C. J. and P. M. H. were supported by NHLBI-HL81151 and NHLBI-HL115334. D. W. H. R. and T. C. were supported by the U.S. Department of Defense grant DOD W81XWH-07-1-0550-Mason. E. L. G. was funded in part by the AHA (10POST4160140). D. K. S. is supported by Training in Cancer Biology grant T32CA009547. A. S. and F. G. were supported by a Singapore Immunology Network core grant. The Immunological Genome project is funded by R24 AI072073 to C. Benoist. Funding related to the use of gnotobiotic mice was through Washington University Digestive Diseases Research Core Center (DDRCC) grant DK052574.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; COGGLE JE, 1984, J LEUKOCYTE BIOL, V35, P317; Drutman SB, 2012, J IMMUNOL, V188, P3603, DOI 10.4049/jimmunol.1102741; Eberlein J, 2010, J CLIN INVEST, V120, P907, DOI 10.1172/JCI40645; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Leiriao P, 2012, EUR J IMMUNOL, V42, P2042, DOI 10.1002/eji.201142166; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Ochando JC, 2012, IMMUNOL RES, V54, P275, DOI 10.1007/s12026-012-8335-1; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; SAWYER RT, 1982, LAB INVEST, V46, P165; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	35	500	505	4	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					599	610		10.1016/j.immuni.2013.08.007	http://dx.doi.org/10.1016/j.immuni.2013.08.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24012416	Green Accepted, Bronze			2022-12-18	WOS:000330949600021
J	Gordon, SM; Chaix, J; Rupp, LJ; Wu, JM; Madera, S; Sun, JC; Lindsten, T; Reiner, SL				Gordon, Scott M.; Chaix, Julie; Rupp, Levi J.; Wu, Junmin; Madera, Sharline; Sun, Joseph C.; Lindsten, Tullia; Reiner, Steven L.			The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation	IMMUNITY			English	Article							MOUSE NK CELLS; FACTOR EOMESODERMIN; GENE-EXPRESSION; CUTTING EDGE; BONE-MARROW; RECEPTOR; MEMORY; CYTOMEGALOVIRUS; IDENTIFICATION; ACTIVATION	Natural killer (NK) cells play critical roles defending against tumors and pathogens. We show that mice lacking both transcription factors Eomesodermin (Eomes) and T-bet failed to develop NK cells. Developmental stability of immature NK cells constitutively expressing the death ligand TRAIL depended on T-bet. Conversely, maturation characterized by loss of constitutive TRAIL expression and induction of Ly49 receptor diversity and integrin CD49b (DX5(+)) required Eomes. Mature NK cells from which Eomes was deleted reverted to phenotypic immaturity if T-bet was present or downregulated NK lineage antigens if T-bet was absent, despite retaining expression of Ly49 receptors. Fetal and adult hepatic hematopoiesis restricted Eomes expression and limited NK development to the T-bet-dependent, immature stage, whereas medullary hematopoiesis permitted Eomes-dependent NK maturation in adult mice. These findings reveal two sequential, genetically separable checkpoints of NK cell maturation, the progression of which is metered largely by the anatomic localization of hematopoiesis.	[Gordon, Scott M.; Chaix, Julie; Rupp, Levi J.; Wu, Junmin; Reiner, Steven L.] Univ Penn, Perelman Sch Med, Inst Immunol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Gordon, Scott M.; Chaix, Julie; Rupp, Levi J.; Wu, Junmin; Reiner, Steven L.] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Madera, Sharline; Sun, Joseph C.; Lindsten, Tullia] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10065 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Reiner, SL (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sreiner@columbia.edu		Madera, Sharline/0000-0003-3658-5488; Gordon, Scott/0000-0003-1028-1953	NIH [AI042370, AI076458, AI061699, NCI T32 CA09140]; Abramson Family; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061699, R01AI100874, R01AI076458, R01AI042370, R56AI076458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Matloubian for providing the CXCL16-Fc reagent and A. Bhandoola, T. Kambayashi, J. Maltzman, J. Orange, J. Wherry, M. Paley, M. Ciocca, and B. Barnett for assistance and discussion. Supported by NIH grants AI042370, AI076458, and AI061699 and the Abramson Family (S.L.R.) and NIH grant NCI T32 CA09140 (S.M.G.).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Anzivino E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-40; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; Brennan J, 1996, J EXP MED, V184, P2085, DOI 10.1084/jem.184.6.2085; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gordon SM, 2011, J IMMUNOL, V186, P4573, DOI 10.4049/jimmunol.1100037; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kinjyo I, 2010, J IMMUNOL, V185, P7151, DOI 10.4049/jimmunol.1003193; Kuboto A, 1999, J IMMUNOL, V163, P212; Kumar V, 1997, CURR OPIN IMMUNOL, V9, P52, DOI 10.1016/S0952-7915(97)80158-6; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Liu JX, 2000, J IMMUNOL, V164, P1793, DOI 10.4049/jimmunol.164.4.1793; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Luther C, 2011, BLOOD, V117, P4012, DOI 10.1182/blood-2010-07-298901; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Rouhi A, 2007, MOL IMMUNOL, V44, P821, DOI 10.1016/j.molimm.2006.04.006; Rouhi A, 2006, J IMMUNOL, V176, P2991, DOI 10.4049/jimmunol.176.5.2991; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	59	500	512	3	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					55	67		10.1016/j.immuni.2011.11.016	http://dx.doi.org/10.1016/j.immuni.2011.11.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22261438	Bronze, Green Accepted			2022-12-18	WOS:000299766000010
J	Thompson, CB; Allison, JP				Thompson, CB; Allison, JP			The emerging role of CTLA-4 as an immune attenuator	IMMUNITY			English	Review							T-CELL ACTIVATION; LYMPHOCYTE-ASSOCIATED MOLECULE-4; NEGATIVE REGULATOR; CD28; RECEPTOR; DISEASE; LOCALIZATION; STIMULATION; EXPRESSION; ENGAGEMENT		UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOL & CELL BIOL,DIV IMMUNOL,CANC RES LAB,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Thompson, CB (corresponding author), UNIV CHICAGO,HOWARD HUGHES MED INST,DEPT MED,GWEN KNAPP CTR LUPUS & IMMUNOL RES,CHICAGO,IL 60637, USA.			Allison, James/0000-0001-8980-5697				Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; Alegre ML, 1996, J IMMUNOL, V157, P4762; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; CHAMBERS CA, 1997, IN PRESS P NATL ACAD; Chuang E, 1997, J IMMUNOL, V159, P144; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; Hurwitz AA, 1997, J NEUROIMMUNOL, V73, P57, DOI 10.1016/S0165-5728(96)00168-3; Hutchcroft JE, 1996, J IMMUNOL, V156, P4071; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; KEARNEY ER, 1995, J IMMUNOL, V155, P1033; Krummel MF, 1996, INT IMMUNOL, V8, P519, DOI 10.1093/intimm/8.4.519; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1995, J EXP MED, V182, P289, DOI 10.1084/jem.182.2.289; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Perrin PJ, 1996, J IMMUNOL, V157, P1333; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Todd JA, 1996, HUM MOL GENET, V5, P1443, DOI 10.1093/hmg/5.Supplement_1.1443; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Waterhouse P, 1996, IMMUNOL REV, V153, P183, DOI 10.1111/j.1600-065X.1996.tb00925.x; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jcem.80.1.7829637; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	40	500	533	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					445	450		10.1016/S1074-7613(00)80366-0	http://dx.doi.org/10.1016/S1074-7613(00)80366-0			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354465	Bronze			2022-12-18	WOS:A1997YD59300001
J	Kopf, M; Brombacher, F; Hodgkin, PD; Ramsay, AJ; Milbourne, EA; Dai, WJ; Ovington, KS; Behm, CA; Kohler, G; Young, IG; Matthaei, KI				Kopf, M; Brombacher, F; Hodgkin, PD; Ramsay, AJ; Milbourne, EA; Dai, WJ; Ovington, KS; Behm, CA; Kohler, G; Young, IG; Matthaei, KI			IL-5-Deficient mice have a developmental defect in CD5(+) B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; DIFFERENTIATION FACTOR; STEM-CELLS; B-CELLS; REPLACING FACTOR; INTERLEUKIN-5; EXPRESSION; GROWTH; CLONES; MOUSE	Mice deficient in interleukin-5 (IL-5(-/-) mice) were generated by gene targeting in embryonal stem cells. Contrary to previous studies, no obligatory role for IL-5 was demonstrated in the regulation of conventional B (B-2) cells, in normal T cell-dependent antibody responses or in cytotoxic T cell development. However, CD5(+) B cells (B-1 cells) in the peritoneal cavity were reduced by 50%-80% in 2-week-old IL-5(-/-) mice, returning to normal by 6-8 weeks of age. The IL-5(-/-)mice did not develop blood and tissue eosinophilia when infected with the helminth Mesocestoides corti, but basal levels of eosinophils with normal morpholgy were produced in the absence of IL-5. IL-5 deficiency did not affect the worm burden of infected mice, indicating that increased eosinophils do not play a significant role in the host defence in this parasite model.	MAX PLANCK INST IMMUNBIOL,D-79108 FREIBURG,GERMANY; AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV CELL BIOL,CANBERRA,ACT 0200,AUSTRALIA; AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV BIOCHEM & MOLEC BIOL,CANBERRA,ACT 0200,AUSTRALIA	Max Planck Society; Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research			Kopf, Manfred/B-6907-2009; Behm, Carolyn A/A-2102-2008; Klaus, Matthaei/D-8691-2011	Kopf, Manfred/0000-0002-0628-7140; Behm, Carolyn A/0000-0002-0603-221X; Hodgkin, Philip/0000-0002-8604-1940				BEAGLEY KW, 1988, J IMMUNOL, V141, P2035; BOULAY JL, 1992, CURR OPIN IMMUNOL, V4, P294, DOI 10.1016/0952-7915(92)90079-T; CAMPBELL HD, 1987, P NATL ACAD SCI USA, V84, P6629, DOI 10.1073/pnas.84.19.6629; CAMPBELL HD, 1988, EUR J BIOCHEM, V174, P345, DOI 10.1111/j.1432-1033.1988.tb14104.x; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531; CORRIGAN CJ, 1992, IMMUNOL TODAY, V13, P501, DOI 10.1016/0167-5699(92)90026-4; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; FINKELMAN FD, 1991, IMMUNOL TODAY, V12, P62; HARDY RR, 1994, ADV IMMUNOL, V55, P297; ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213; JOHNSON GR, 1979, INT ARCH ALLER A IMM, V59, P315, DOI 10.1159/000232275; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; KARUPIAH G, 1990, J IMMUNOL, V144, P290; Kearney J F, 1992, Int Rev Immunol, V8, P247, DOI 10.3109/08830189209055577; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; MANDLER R, 1993, J EXP MED, V178, P1577, DOI 10.1084/jem.178.5.1577; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MIYAJIMA A, 1993, BLOOD, V82, P1960; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURRAY PD, 1987, J IMMUNOL, V139, P2669; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; NITSCHKE L, 1993, BIOTECHNIQUES, V14, P914; POCKLEY AG, 1991, IMMUNOLOGY, V73, P19; RAMSAY AJ, 1993, EUR J IMMUNOL, V23, P3141, DOI 10.1002/eji.1830231215; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SANDERSON CJ, 1993, EOSINOPHILS IMMUNOLO, P335; Sanderson CL, 1994, CYTOKINE HDB, P127; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; TAKAHASHI T, 1990, MOL IMMUNOL, V27, P911, DOI 10.1016/0161-5890(90)90158-V; TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234; TCHERNITCHIN A, 1974, NATURE, V248, P142, DOI 10.1038/248142a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; VAUX DL, 1990, INT IMMUNOL, V2, P965, DOI 10.1093/intimm/2.10.965; WARREN DJ, 1988, J IMMUNOL, V140, P94; WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926; YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388	44	500	513	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					15	24		10.1016/S1074-7613(00)80294-0	http://dx.doi.org/10.1016/S1074-7613(00)80294-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574848	Bronze			2022-12-18	WOS:A1996TT31900002
J	Venkatesh, M; Mukherjee, S; Wang, HW; Li, H; Sun, K; Benechet, AP; Qiu, ZJ; Maher, L; Redinbo, MR; Phillips, RS; Fleet, JC; Kortagere, S; Mukherjee, P; Fasano, A; Le Ven, J; Nicholson, JK; Dumas, ME; Khanna, KM; Mani, S				Venkatesh, Madhukumar; Mukherjee, Subhajit; Wang, Hongwei; Li, Hao; Sun, Katherine; Benechet, Alexandre P.; Qiu, Zhijuan; Maher, Leigh; Redinbo, Matthew R.; Phillips, Robert S.; Fleet, James C.; Kortagere, Sandhya; Mukherjee, Paromita; Fasano, Alessio; Le Ven, Jessica; Nicholson, Jeremy K.; Dumas, Marc E.; Khanna, Kamal M.; Mani, Sridhar			Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; PREGNANE X RECEPTOR; INTESTINAL EPITHELIUM; MOUSE MODEL; METABOLOMICS; HOMEOSTASIS; MICROBIOTA; EXPRESSION; PROTECTION; REVEALS	Intestinal microbial metabolites are conjectured to affect mucosal integrity through an incompletely characterized mechanism. Here we showed that microbial-specific indoles regulated intestinal barrier function through the xenobiotic sensor, pregnane X receptor (PXR). Indole 3-propionic acid (IPA), in the context of indole, is a ligand for PXR in vivo, and IPA downregulated enterocyte TNF-alpha while it upregulated junctional protein-coding mRNAs. PXR-deficient (Nr1i2(-/-)) mice showed a distinctly "leaky" gut physiology coupled with upregulation of the Toll-like receptor (TLR) signaling pathway. These defects in the epithelial barrier were corrected in Nr1i2(-/-)Tlr4(-/-) mice. Our results demonstrate that a direct chemical communication between the intestinal symbionts and PXR regulates mucosal integrity through a pathway that involves luminal sensing and signaling by TLR4.	[Venkatesh, Madhukumar; Mukherjee, Subhajit; Wang, Hongwei; Li, Hao; Mukherjee, Paromita; Mani, Sridhar] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Venkatesh, Madhukumar; Mukherjee, Subhajit; Wang, Hongwei; Li, Hao; Mukherjee, Paromita; Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Sun, Katherine] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA; [Benechet, Alexandre P.; Qiu, Zhijuan; Maher, Leigh; Khanna, Kamal M.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Phillips, Robert S.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Fleet, James C.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Kortagere, Sandhya] Drexel Univ, Coll Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA; [Fasano, Alessio] Harvard Univ, Sch Med, Dept Pediat, MassGen Hosp Children, Boston, MA 02114 USA; [Le Ven, Jessica; Nicholson, Jeremy K.; Dumas, Marc E.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Div Computat & Syst Med,Sect Biomol Med, London SW7 2AZ, England	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Drexel University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Imperial College London	Khanna, KM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA.	kkhanna@uchc.edu; sridhar.mani@einstein.yu.edu	Dumas, Marc-Emmanuel/C-1736-2008; Nicholson, Jeremy K/B-3395-2012; Fasano, Alessio/K-5486-2016; Fleet, James/D-2628-2017	Dumas, Marc-Emmanuel/0000-0001-9523-7024; Nicholson, Jeremy K/0000-0002-8123-8349; Fasano, Alessio/0000-0002-2134-0261; Benechet, Alexandre/0000-0001-8746-2459; Fleet, James/0000-0002-0142-9517; Phillips, Robert/0000-0001-8710-562X	NIH [CA127231, CA161879, AI097375]; Damon Runyon Foundation [CI 1502, P30CA013330]; University of Connecticut Health Center; European Commission FP7 grant METACARDIS [FP7-HEALTH-2012-INNOVATION-I-305312]; NATIONAL CANCER INSTITUTE [R01CA222469, R01CA161879, P30CA013330, R01CA127231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Foundation; University of Connecticut Health Center; European Commission FP7 grant METACARDIS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Analytical Imaging and Histotechnology and comparative pathology facilities of the Albert Einstein College of Medicine. We thank J. Staudinger (University of Kansas, Lawrence, KS) and W. Xie (University of Pittsburgh, Pittsburgh, PA) for providing Nr1i2<SUP>-/-</SUP> and humanized PXR transgenic mice (hNr1i2), respectively. This work was supported by NIH grants CA127231 (S. Mani), CA161879 (S. Mani), and AI097375 (K.M.K.), by Damon Runyon Foundation Clinical Investigatora Award (CI 1502) P30CA013330 (S. Mani), by institutional support funds from the University of Connecticut Health Center (K.M.K.), and by European Commission FP7 grant METACARDIS (FP7-HEALTH-2012-INNOVATION-I-305312 to J.L.V., J.K.N., and M.E.D.).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203; Chen HQ, 2010, AM J PHYSIOL-GASTR L, V299, pG1287, DOI 10.1152/ajpgi.00196.2010; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dong FC, 2013, J PROTEOME RES, V12, P2958, DOI 10.1021/pr4002383; Ettarh RR, 1996, J ANAT, V189, P51; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Gupta NK, 2012, INFLAMM BOWEL DIS, V18, P1214, DOI 10.1002/ibd.21849; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Leavy Olive, 2011, Nat Rev Immunol, V11, P806, DOI 10.1038/nri3115; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lin HM, 2010, J PROTEOME RES, V9, P1965, DOI 10.1021/pr901130s; Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.40; Matsui H, 2011, J CLIN BIOCHEM NUTR, V48, P107, DOI 10.3164/jcbn.10-79; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Meier C, 2007, NAT CLIN PRACT RHEUM, V3, P667, DOI 10.1038/ncprheum0625; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Rath CM, 2012, CURR OPIN MICROBIOL, V15, P147, DOI 10.1016/j.mib.2011.12.009; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Salzman NH, 2011, CURR OPIN MICROBIOL, V14, P99, DOI 10.1016/j.mib.2010.09.018; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wang HW, 2011, J CLIN INVEST, V121, P3220, DOI 10.1172/JCI41514; Wang K, 2010, LAB INVEST, V90, P257, DOI 10.1038/labinvest.2009.129; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; WEISER MM, 1973, J BIOL CHEM, V248, P2542; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	48	499	522	15	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					296	310		10.1016/j.immuni.2014.06.014	http://dx.doi.org/10.1016/j.immuni.2014.06.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25065623	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000341455300016
J	Stuart, LM; Ezekowitz, RAB				Stuart, LM; Ezekowitz, RAB			Phagocytosis: Elegant complexity	IMMUNITY			English	Review							PROGRAMMED CELL-DEATH; LECTIN-DEFICIENT MICE; APOPTOTIC CELLS; ENDOPLASMIC-RETICULUM; CROSS-PRESENTATION; MEDIATED PHAGOCYTOSIS; SCAVENGER RECEPTORS; IMMUNE-RESPONSES; MANNOSE RECEPTOR; IN-VITRO	Phagocytosis requires receptor-mediated recognition of particles, usually in the guise of infectious agents and apoptotic cells. Phagosomes fuse with lysosomes to generate phagolysosomes, which play a key role in enzymatic digestion of the internalized contents into component parts. Recent findings indicate that a simple paradigm of a single cognate receptor interaction that guides the phagosome to phagolysosome formation belles the complexity of combinatorial receptor recognition and diversity of phagosome function. In fact, phagosomes are comprised of hundreds of proteins that play a key role in deciphering the contents of the phagosome and in defining host response. In this review we discuss how the challenge of recognizing diverse molecular patterns is met by combinatorial interactions between phagocytic receptors. Furthermore, these combinations are dynamic and both sculpt the balance between a proinflammatory or anti-inflammatory response and direct phagosome diversity. We also indicate an important role for genetically tractable model organisms in defining key components of this evolutionarily conserved process.	Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Edinburgh	Ezekowitz, RAB (corresponding author), Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA.	aezekowitz1@partners.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042788] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI 4420, R01 AI 42788] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ADEREM AA, 1985, J EXP MED, V161, P617, DOI 10.1084/jem.161.3.617; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; EZEKOWITZ RAB, 1984, J EXP MED, V159, P244, DOI 10.1084/jem.159.1.244; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fajardo M, 2004, MICROBIOL-SGM, V150, P2825, DOI 10.1099/mic.0.27111-0; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gagnon E, 2005, J LEUKOCYTE BIOL, V77, P843, DOI 10.1189/jlb.0305129; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; GORDON S, 1986, CIBA F SYMP, V118, P54, DOI 10.1002/9780470720998.ch5; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Metchnikoff E., 1905, IMMUNITY INFECT DIS; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Touret N, 2005, J LEUKOCYTE BIOL, V77, P878, DOI 10.1189/jlb.1104630; Triantafilou M, 2002, J CELL SCI, V115, P2603; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	94	497	539	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					539	550		10.1016/j.immuni.2005.05.002	http://dx.doi.org/10.1016/j.immuni.2005.05.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894272	Bronze			2022-12-18	WOS:000229447200004
J	BLUESTONE, JA				BLUESTONE, JA			NEW PERSPECTIVES OF CD28-B7-MEDIATED T-CELL COSTIMULATION	IMMUNITY			English	Article							CTLA-4 COUNTER-RECEPTOR; LYMPHOCYTES-T; ANTIGEN; CD28; MOLECULE; B7; INTERLEUKIN-2; EXPRESSION; ACTIVATION; LIGAND		UNIV CHICAGO, COMM IMMUNOL, CHICAGO, IL 60637 USA	University of Chicago	BLUESTONE, JA (corresponding author), UNIV CHICAGO, BEN MAY INST, DEPT PATHOL, CHICAGO, IL 60637 USA.							AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; CHEN CY, 1994, J IMMUNOL, V152, P2105; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; DEBOER M, 1993, EUR J IMMUNOL, V23, P3120, DOI 10.1002/eji.1830231212; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; GUERDER S, 1994, IMMUNITY, V1, P155; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HARPER K, 1991, J IMMUNOL, V147, P1037; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JENKINS MK, 1991, ADV EXP MED BIOL, V292, P167; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LAFFERTY KJ, 1993, IMMUNOL CELL BIOL, V71, P209, DOI 10.1038/icb.1993.23; LANLER LL, 1995, J IMMUNOL, V154, P97; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LIEW FY, 1974, J EXP MED, V139, P779, DOI 10.1084/jem.139.3.779; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; MILLER JFAP, 1989, COLD SPRING HARB SYM, V54, P807; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; REISER H, 1992, P NATL ACAD SCI USA, V89, P271, DOI 10.1073/pnas.89.1.271; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; SETHNA MP, 1994, IMMUNITY, V1, P415, DOI 10.1016/1074-7613(94)90072-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SPERLING AI, 1995, IN PRESS J EXP MED; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WU Y, 1993, J EXP MED, V178, P1789, DOI 10.1084/jem.178.5.1789; YANG L, 1992, CURR OPIN IMMUNOL, V4, P265, DOI 10.1016/0952-7915(92)90075-P	49	497	518	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1995	2	6					555	559		10.1016/1074-7613(95)90000-4	http://dx.doi.org/10.1016/1074-7613(95)90000-4			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7540940	Bronze			2022-12-18	WOS:A1995RE53800001
J	McNelis, JC; Olefsky, JM				McNelis, Joanne C.; Olefsky, Jerrold M.			Macrophages, Immunity, and Metabolic Disease	IMMUNITY			English	Review							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RECEPTOR SUBSTRATE-1; NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; REGULATORY T-CELLS; ADIPOSE-TISSUE MACROPHAGES; ALTERNATIVELY ACTIVATED MACROPHAGES; INNATE LYMPHOID TYPE-2; HIGH-FAT DIET; SKELETAL-MUSCLE	Chronic, low-grade adipose tissue inflammation is a key etiological mechanism linking the increasing incidence of type 2 diabetes (T2D) and obesity. It is well recognized that the immune system and metabolism are highly integrated, and macrophages, in particular, have been identified as critical effector cells in the initiation of inflammation and insulin resistance. Recent advances have been made in the understanding of macrophage recruitment and retention to adipose tissue and the participation of other immune cell populations in the regulation of this inflammatory process. Here we discuss the pathophysiological link between macrophages, obesity, and insulin resistance, highlighting the dynamic immune cell regulation of adipose tissue inflammation. We also describe the mechanisms by which inflammation causes insulin resistance and the new therapeutic targets that have emerged.	[McNelis, Joanne C.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			NIH [DK-033651, DK-074868, DK-063491, P01-DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, R01DK033651, P01DK074868, R37DK033651, P30DK063491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK-033651, DK-074868, DK-063491, and P01-DK054441.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Chen CY, 2000, GENE DEV, V14, P1236; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042971, 10.1371/journal.pone.0037149]; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Desvergne B, 2008, CELL METAB, V7, P467, DOI 10.1016/j.cmet.2008.05.002; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Feig JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028534; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Goldfine AB, 2013, DIABETES CARE, V36, P4132, DOI 10.2337/dc13-0859; Gutierrez DA, 2011, DIABETES, V60, P2820, DOI 10.2337/db11-0314; Hamaguchi M, 2012, CELL METAB, V16, P4, DOI 10.1016/j.cmet.2012.06.007; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Lanthier N, 2011, FASEB J, V25, P4301, DOI 10.1096/fj.11-189472; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Mothe-Satney I, 2012, DIABETES, V61, P2311, DOI 10.2337/db11-1455; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schmidt AM, 2013, CELL METAB, V18, P461, DOI 10.1016/j.cmet.2013.09.011; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Sullivan TJ, 2013, METABOLISM, V62, P1623, DOI 10.1016/j.metabol.2013.06.008; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tam CS, 2012, OBESITY, V20, P1530, DOI 10.1038/oby.2012.24; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Tang TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081949; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; van Diepen JA, 2011, J LIPID RES, V52, P942, DOI 10.1194/jlr.M010405; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wan WZ, 2013, CARDIOVASC RES, V97, P580, DOI 10.1093/cvr/cvs349; Wanschel A, 2013, ARTERIOSCL THROM VAS, V33, P886, DOI 10.1161/ATVBAHA.112.300941; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zhong JX, 2014, DIABETES, V63, P1289, DOI 10.2337/db13-1094	122	496	521	7	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					36	48		10.1016/j.immuni.2014.05.010	http://dx.doi.org/10.1016/j.immuni.2014.05.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035952	Bronze			2022-12-18	WOS:000341444200009
J	Koni, PA; Sacca, R; Lawton, P; Browning, JL; Ruddle, NH; Flavell, RA				Koni, PA; Sacca, R; Lawton, P; Browning, JL; Ruddle, NH; Flavell, RA			Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELL; NECROSIS FACTOR-BETA; MONOCLONAL-ANTIBODIES; HETEROMERIC COMPLEX; GERMINAL-CENTERS; RECEPTOR; SURFACE; ACTIVATION; GENERATION; MEMORY	Lymphotoxin alpha (LT alpha)-deficient mice revealed critical roles for LT alpha in lymphoid organogenesis, but it is not clear whether LT alpha functions through an LT alpha homotrimer (LT alpha(3)) or LT alpha/beta heterotrimers. We generated LT beta-deficient mice and found them to lack Peyer's patches, peripheral lymph nodes, splenic germinal centers, and follicular dendritic cells. Unlike LT alpha-deficient mice, LT beta-deficient mice had cervical and mesenteric lymph nodes. Furthermore, the mesenteric lymph nodes had germinal center-like regions, although these structures appeared to lack follicular dendritic cells. The absence of cervical and mesenteric lymph nodes in LT alpha-deficient mice, and yet their presence in LT beta-deficient mice and in mice deficient in tumor necrosis factor receptor types I and II, suggest that LT alpha(3) may signal via an as yet unidentified receptor.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06520; BIOGEN INC,CAMBRIDGE,MA 02142; YALE UNIV,DEPT EPIDEMIOL & PUBL HLTH,SCH MED,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520	Howard Hughes Medical Institute; Yale University; Biogen; Yale University; Yale University			Koni, Pandelakis/A-3349-2008	Koni, Pandelakis/0000-0002-0892-4764; Browning, Jeffrey/0000-0001-9168-5233	NCI NIH HHS [R01 CA16885] Funding Source: Medline; NIAID NIH HHS [R01 AI34404] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034404] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ANDROLEWICZ MJ, 1992, J BIOL CHEM, V267, P2542; BANKS TA, 1995, J IMMUNOL, V155, P1685; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; BROWNING JL, 1995, J IMMUNOL, V154, P33; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DEVOS T, 1991, J IMMUNOL METHODS, V141, P285, DOI 10.1016/0022-1759(91)90155-9; ECK MJ, 1992, J BIOL CHEM, V267, P2119; HEBEL R, 1976, ANATOMY LAB RAT, P112; KELLY BS, 1979, IMMUNOLOGY, V37, P45; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KOSCO MH, 1992, J IMMUNOL, V148, P2331; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; KUNKL A, 1981, IMMUNOLOGY, V43, P371; LAWTON P, 1995, J IMMUNOL, V154, P239; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Liu Y.J., 1996, IMMUNOLOGIST, V4, P55; Liu YJ, 1996, J EXP MED, V184, P1207, DOI 10.1084/jem.184.4.1207; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P177; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCKNIGHT SL, 1980, NUCLEIC ACIDS RES, V8, P5949, DOI 10.1093/nar/8.24.5949; MILLET I, 1994, J IMMUNOL, V152, P4336; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; SCHOENFELD HJ, 1991, J BIOL CHEM, V266, P3863; SCHRIEVER F, 1992, ADV IMMUNOL, V51, P243, DOI 10.1016/S0065-2776(08)60489-7; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; YOSHIDA K, 1994, EUR J IMMUNOL, V24, P464, DOI 10.1002/eji.1830240230	44	496	504	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					491	500		10.1016/S1074-7613(00)80292-7	http://dx.doi.org/10.1016/S1074-7613(00)80292-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133428	hybrid			2022-12-18	WOS:A1997XC61900014
J	Malek, TR; Castro, I				Malek, Thomas R.; Castro, Iris			Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity	IMMUNITY			English	Review							REGULATORY T-CELLS; TRANSCRIPTIONAL REPRESSOR BLIMP-1; DE-NOVO INDUCTION; CUTTING EDGE; TGF-BETA; FOXP3 EXPRESSION; IN-VIVO; IL-2 RECEPTOR; AUTOIMMUNE-DISEASE; REG-CELLS	Interleukin-2 receptor (IL-2R) signaling regulates tolerance and immunity. Here, we review recent work concerning the structure, signaling, and function of the IL-2R, emphasizing the contribution of IL-2 for T cell-dependent activity in vivo. IL-2R signaling influences two discrete aspects of immune responses by CD8(+) T cells, terminal differentiation of effector cells in primary responses, and aspects of memory recall responses. IL-2 also delivers essential signals for thymic development of regulatory T (Treg) cells and later to promote their homeostasis and function. Each of these outcomes on T effector and Treg cells requires distinct amounts of IL-2R signaling, with low IL-2R signaling sufficient for many key aspects of Treg cells. Thus, tolerance is readily maintained and favored with limited IL-2.	[Malek, Thomas R.; Castro, Iris] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; [Malek, Thomas R.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA	University of Miami; University of Miami	Malek, TR (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, POB 01960, Miami, FL 33101 USA.	tmalek@med.miami.edu			National Institutes of Health [R01CA45957, RO1A1055815, P01CA109094, 3R56A140114]; NATIONAL CANCER INSTITUTE [R01CA045957, P01CA109094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055815, R56AI040114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank O. Umland for critically reading this manuscript. Our work is supported by National Institutes of Health grants (R01CA45957; RO1A1055815; P01CA109094; 3R56A140114).	Adeegbe D, 2010, J IMMUNOL, V184, P56, DOI 10.4049/jimmunol.0902379; Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brandenburg S, 2008, EUR J IMMUNOL, V38, P1643, DOI 10.1002/eji.200737791; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Carrier Y, 2007, J IMMUNOL, V178, P172, DOI 10.4049/jimmunol.178.1.172; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Hwang KW, 2004, J IMMUNOL, V173, P5415, DOI 10.4049/jimmunol.173.9.5415; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jin HL, 2006, INT IMMUNOL, V18, P565, DOI 10.1093/intimm/dxh398; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Le Bras S, 2009, P NATL ACAD SCI USA, V106, P7519, DOI 10.1073/pnas.0806410106; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; Long SA, 2008, J AUTOIMMUN, V30, P293, DOI 10.1016/j.jaut.2007.12.012; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Phelan JD, 2008, J IMMUNOL, V180, P44, DOI 10.4049/jimmunol.180.1.44; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandau MM, 2010, J IMMUNOL, V184, P35, DOI 10.4049/jimmunol.0803355; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; Zheng L, 2008, INT IMMUNOL, V20, P517, DOI 10.1093/intimm/dxn017; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	132	495	531	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					153	165		10.1016/j.immuni.2010.08.004	http://dx.doi.org/10.1016/j.immuni.2010.08.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732639	Bronze, Green Accepted			2022-12-18	WOS:000281654900006
J	Migone, TS; Zhang, J; Luo, X; Zhuang, L; Chen, C; Hu, BG; Hong, JS; Perry, JW; Chen, SF; Zhou, JXH; Cho, YH; Ullrich, S; Kanakaraj, P; Carrell, J; Boyd, E; Olsen, HS; Hu, G; Pukac, L; Liu, D; Ni, J; Kim, S; Gentz, R; Feng, P; Moore, PA; Ruben, SM; Wei, P				Migone, TS; Zhang, J; Luo, X; Zhuang, L; Chen, C; Hu, BG; Hong, JS; Perry, JW; Chen, SF; Zhou, JXH; Cho, YH; Ullrich, S; Kanakaraj, P; Carrell, J; Boyd, E; Olsen, HS; Hu, G; Pukac, L; Liu, D; Ni, J; Kim, S; Gentz, R; Feng, P; Moore, PA; Ruben, SM; Wei, P			TL1A is a TNF-like ligand and functions as a T cell for DR3 and TR6/DcR3 costimulator	IMMUNITY			English	Article							DOMAIN-CONTAINING RECEPTOR; DEATH-DOMAIN; SIGNAL-TRANSDUCTION; FAS LIGAND; APOPTOSIS; ACTIVATION; CYTOKINE; FAMILY; MEMBER; TWEAK	DR3 is a death domain-containing receptor that is upregulated during T cell activation and whose overexpression induces apoptosis and NF-kappaB activation in cell lines. Here we show that an endothelial cell-derived TNF-like factor, TL1A, is a ligand for DR3 and decoy receptor TR6/DcR3 and that its expression is inducible by TNF and IL-1alpha. TL1A induces NF-kappaB activation and apoptosis in DR3-expressing cell lines, while TR6-Fc protein antagonizes these signaling events. Interestingly, in T cells, TL1A acts as a costimulator that increases IL-2 responsiveness and secretion of proinflammatory cytokines both in vitro and in vivo. Our data suggest that interaction of TL1A with DR3 promotes T cell expansion during an immune response, whereas TR6 has an opposing effect.	Human Genome Sci Inc, Rockville, MD 20850 USA	GlaxoSmithKline; Human Genome Sciences Inc	Wei, P (corresponding author), Human Genome Sci Inc, Rockville, MD 20850 USA.	ping_wei@hgsi.com	Carrell, Jeffrey/AAV-7361-2020	Carrell, Jeffrey/0000-0001-7484-4407				Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Connolly K, 2001, J PHARMACOL EXP THER, V298, P25; ECK MJ, 1992, J BIOL CHEM, V267, P2119; Kaptein A, 2000, FEBS LETT, V485, P135, DOI 10.1016/S0014-5793(00)02219-5; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Newton K, 2001, CURR BIOL, V11, P273, DOI 10.1016/S0960-9822(01)00067-7; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VIA CS, 1991, J IMMUNOL, V146, P2603; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Yue TL, 1999, J BIOL CHEM, V274, P1479, DOI 10.1074/jbc.274.3.1479; Zhai YF, 1999, INT J CANCER, V82, P131, DOI 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3.3.CO;2-F; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang J, 2001, J CLIN INVEST, V107, P1459, DOI 10.1172/JCI12159; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	28	493	556	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					479	492		10.1016/S1074-7613(02)00283-2	http://dx.doi.org/10.1016/S1074-7613(02)00283-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911831	Bronze			2022-12-18	WOS:000174572800015
J	Tamoutounour, S; Guilliams, M; Sanchis, FM; Liu, H; Terhorst, D; Malosse, C; Pollet, E; Ardouin, L; Luche, H; Sanchez, C; Dalod, M; Malissen, B; Henri, S				Tamoutounour, Samira; Guilliams, Martin; Sanchis, Frederic Montanana; Liu, Hong; Terhorst, Dorothea; Malosse, Camille; Pollet, Emeline; Ardouin, Laurence; Luche, Herve; Sanchez, Cindy; Dalod, Marc; Malissen, Bernard; Henri, Sandrine			Origins and Functional Specialization of Macrophages and of Conventional and Monocyte-Derived Dendritic Cells in Mouse Skin	IMMUNITY			English	Article							LANGERHANS CELLS; LYMPHOID ORGANS; REVEALS; MICE; EXPRESSION; PATHWAYS; DISTINCT; LINEAGE	In the skin, the lack of markers permitting the unambiguous identification of macrophages and of conventional and monocyte-derived dendritic cells (DCs) complicates understanding of their contribution to skin integrity and to immune responses. By combining CD64 and CCR2 staining, we successfully identified each of these cell types and studied their origin, transcriptomic signatures, and migratory and T cell stimulatory properties. We also analyzed the impact of microbiota on their development and their contribution to skin inflammation during contact hypersensitivity. Dermal macrophages had a unique scavenging role and were unable to migrate and activate T cells. Conventional dermal DCs excelled both at migrating and activating T cells. In the steady-state dermis, monocyte-derived DCs are continuously generated by extravasated Ly-6C(hi) monocytes. Their T cell stimulatory capacity combined with their poor migratory ability made them particularly suited to activate skin-tropic T cells. Therefore, a high degree of functional specialization occurs among the mononuclear phagocytes of the skin.	[Tamoutounour, Samira; Guilliams, Martin; Sanchis, Frederic Montanana; Terhorst, Dorothea; Malosse, Camille; Pollet, Emeline; Ardouin, Laurence; Luche, Herve; Sanchez, Cindy; Dalod, Marc; Malissen, Bernard; Henri, Sandrine] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; [Tamoutounour, Samira; Guilliams, Martin; Sanchis, Frederic Montanana; Terhorst, Dorothea; Malosse, Camille; Pollet, Emeline; Ardouin, Laurence; Luche, Herve; Sanchez, Cindy; Dalod, Marc; Malissen, Bernard; Henri, Sandrine] INSERM, U1104, F-13288 Marseille, France; [Tamoutounour, Samira; Guilliams, Martin; Sanchis, Frederic Montanana; Terhorst, Dorothea; Malosse, Camille; Pollet, Emeline; Ardouin, Laurence; Luche, Herve; Sanchez, Cindy; Dalod, Marc; Malissen, Bernard; Henri, Sandrine] CNRS, UMR7280, F-13288 Marseille, France; [Guilliams, Martin] VIB, Dept Mol Biomed Res, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Pulm Med, B-9000 Ghent, Belgium; [Liu, Hong] Sanofi, BioInnovat, Cambridge, MA 02139 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Flanders Institute for Biotechnology (VIB); Ghent University; Sanofi-Aventis	Malissen, B (corresponding author), Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr; henri@ciml.univ-mrs.fr	LUCHE, Herve/GLT-1401-2022; Guilliams, Martin/N-7803-2013; Henri, Sandrine/O-3045-2016; Dalod, Marc/AAK-6163-2020; BATAILLE, Laurence/AAA-5535-2021; Malissen, Bernard/AAK-4659-2020	Guilliams, Martin/0000-0003-3525-7570; Dalod, Marc/0000-0002-6436-7966; BATAILLE, Laurence/0000-0001-7770-2041; Malissen, Bernard/0000-0003-1340-9342; Terhorst, Dorothea/0000-0001-9411-8998; LUCHE, Herve/0000-0003-4309-8338; HENRI, Sandrine/0000-0002-8980-9193	CNRS; INSERM; ANR (SkinDC); European Communities Framework Program 7 [HEALTH-F2-2008-223404]; Marie Curie reintegration grant; BELSPO; I2HD CIML-SANOFI project; Ministere de la Recherche; MASTERSWITCH Project; European Communities [237109]; Sanofi; FWO; SYBILLA Project	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR (SkinDC)(French National Research Agency (ANR)); European Communities Framework Program 7; Marie Curie reintegration grant(European Commission); BELSPO(Belgian Federal Science Policy Office); I2HD CIML-SANOFI project; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); MASTERSWITCH Project; European Communities(European Commission); Sanofi; FWO(FWO); SYBILLA Project	We thank M. Malissen, T. Soos, C. Arendt, C. Bain, and M. Bajenoff for discussions; A. Zouine, M. Barad, P. Grenot, and M. L. Thibult for assistance with cell sorting; and V. Alunni and C. Thibault-Carpentier from the Plate-forme Biopuces (Strasbourg). This work was supported by CNRS, INSERM, ANR (SkinDC to S. H.), European Communities Framework Program 7 (MASTERSWITCH Integrating Project [HEALTH-F2-2008-223404] and NANOASIT Euronanomed Project to B. M.), a Marie Curie reintegration grant (to M. G.), a BELSPO return grant (to M. G.), and the I2HD CIML-SANOFI project, by doctoral fellowships from Ministere de la Recherche and the MASTERSWITCH Project (S. T.), a Marie Curie fellowship from the European Communities (M. G., project number 237109), and fellowships from Sanofi (D. T., C. S., E. P. and F. M. S.), FWO (M. G.), and the SYBILLA Project (H. Luche). This work benefited from data assembled by the ImmGen consortium. H. Liu is an employee of Sanofi. Part of this study has been funded by the I2HD CIML-SANOFI project.	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Elpek KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023921; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025	25	490	499	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					925	938		10.1016/j.immuni.2013.10.004	http://dx.doi.org/10.1016/j.immuni.2013.10.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24184057	Bronze			2022-12-18	WOS:000330950600014
J	Heller, F; Fuss, IJ; Nieuwenhuis, EE; Blumberg, RS; Strober, W				Heller, F; Fuss, IJ; Nieuwenhuis, EE; Blumberg, RS; Strober, W			Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells	IMMUNITY			English	Article							CROHNS-DISEASE; TOLERANCE INDUCTION; MURINE MODEL; IFN-GAMMA; B-CELLS; INTERLEUKIN-4; EXPRESSION; MICE; RECEPTOR; CD1D	Oxazolone colitis (OC) is an experimental colitis that has a histologic resemblance to human ulcerative colitis. Here we show that IL-13 production is a significant pathologic factor in OC since its neutralization by IL-13Ralpha2-Fc administration prevents colitis. We further show that OC is mediated by NK-T cells since it can be induced neither in mice depleted of NK-T cells nor in mice that cannot present antigen to NK-T cells and mice lacking an NK-T cell-associated TCR. Finally, we show that NK-T cells are the source of the IL-13, since they produce IL-13 upon stimulation by a-galactosylceramide, an NK-T cell-specific antigen. These data thus describe a cellular mechanism underlying an experimental colitis that may explain the pathogenesis of ulcerative colitis.	NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Div Gastroenterol, Brigham & Womens Hosp, Boston, MA 02115 USA; Royal Netherland Acad Arts & Sci, Ter Meulen Fund, Amsterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK044319, R01DK051362] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44319, DK51362] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALK SP, 1989, P NATL ACAD SCI USA, V86, P252, DOI 10.1073/pnas.86.1.252; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; Chen HJ, 1997, J IMMUNOL, V159, P2240; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; GRUNIG GG, 1998, SCIENCE, V282, P2160; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hameg A, 1999, J IMMUNOL, V162, P7067; HAYAKAWA K, 1992, J EXP MED, V176, P269, DOI 10.1084/jem.176.1.269; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KOYASU S, 1994, J EXP MED, V179, P1957, DOI 10.1084/jem.179.6.1957; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Minty A, 1997, EUR CYTOKINE NETW, V8, P203; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Park SH, 1998, J IMMUNOL, V160, P3128; Parronchi P, 1997, AM J PATHOL, V150, P823; Roark JH, 1998, J IMMUNOL, V160, P3121; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; SCHEIFFELE F, 2002, CURRENT PROTOCOLS IM, V4; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Strober S, 1996, IMMUNOL REV, V149, P217, DOI 10.1111/j.1600-065X.1996.tb00906.x; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; [No title captured]	49	490	555	1	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					629	638		10.1016/S1074-7613(02)00453-3	http://dx.doi.org/10.1016/S1074-7613(02)00453-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433369	Bronze			2022-12-18	WOS:000179335100009
J	Oliphant, CJ; Hwang, YY; Walker, JA; Salimi, M; Wong, SH; Brewer, JM; Englezakis, A; Barlow, JL; Hams, E; Scanlon, ST; Ogg, GS; Fallon, PG; McKenzie, ANJ				Oliphant, Christopher J.; Hwang, You Yi; Walker, Jennifer A.; Salimi, Maryam; Wong, See Heng; Brewer, James M.; Englezakis, Alexandros; Barlow, Jillian L.; Hams, Emily; Scanlon, Seth T.; Ogg, Graham S.; Fallon, Padraic G.; McKenzie, Andrew N. J.			MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4(+) T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion	IMMUNITY			English	Article							CYSTEINE PROTEASE; TH2 IMMUNITY; IN-VIVO; IL-4; EXPRESSION; RESPONSES; INFLAMMATION; CONTRIBUTE; INDUCTION; CYTOKINES	Group 2 innate lymphoid cells (ILC2s) release interleukin-13 (IL-13) during protective immunity to helminth infection and detrimentally during allergy and asthma. Using two mouse models to deplete ILC2s in vivo, we demonstrate that T helper 2 (Th2) cell responses are impaired in the absence of ILC2s. We show that MHCII-expressing ILC2s interact with antigen-specific T cells to instigate a dialog in which IL-2 production from T cells promotes ILC2 proliferation and IL-13 production. Deletion of MHCII renders IL-13-expressing ILC2s incapable of efficiently inducing Nippostrongylus brasiliensis expulsion. Thus, during transition to adaptive T cell-mediated immunity, the ILC2 and T cell crosstalk contributes to their mutual maintenance, expansion and cytokine production. This interaction appears to augment dendritic-cell-induced T cell activation and identifies a previously unappreciated pathway in the regulation of type-2 immunity.	[Oliphant, Christopher J.; Hwang, You Yi; Walker, Jennifer A.; Wong, See Heng; Englezakis, Alexandros; Barlow, Jillian L.; Scanlon, Seth T.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Salimi, Maryam; Ogg, Graham S.] Univ Oxford, John Radcliffe Hosp, NIHR Biomed Res Ctr, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Hams, Emily; Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin 12, Ireland; [Fallon, Padraic G.] Trinity Coll Dublin, Inst Mol Med, Dublin 2, Ireland; [Brewer, James M.] Univ Pl, GRBC, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	MRC Laboratory Molecular Biology; University of Oxford; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	anm@mrc-lmb.cam.ac.uk	Fallon, Padraic/Y-2711-2019; Brewer, James/A-7186-2010	Fallon, Padraic/0000-0002-8401-7293; Brewer, James/0000-0001-7933-0915; Hams, Emily/0000-0002-9745-3246; Ogg, Graham/0000-0002-3097-045X; Barlow, Jillian Lynne/0000-0002-8680-3589; Englezakis, Alexandros/0000-0003-0727-5579; Scanlon, Seth Thomas/0000-0002-1792-6382	American Asthma Foundation; UK-MRC; Wellcome Trust [100963/Z/13/Z]; A-STAR; Science Foundation Ireland; National Children's Research Centre; NIHR Biomedical Research Centre Programme; Janssen Research and Development; MRC [MC_U105178805, MC_UU_12010/5, MC_U137881017, G0701693] Funding Source: UKRI; Medical Research Council [G1000800h, MC_UU_12010/5, G0701693, MC_U137881017, MC_U105178805] Funding Source: researchfish	American Asthma Foundation; UK-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); A-STAR(Agency for Science Technology & Research (A*STAR)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Children's Research Centre; NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Janssen Research and Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Ares staff for their technical assistance. We also thank A. Betz for providing MHCII-deficient mice. This work was supported by the American Asthma Foundation (A.N.J.M.), UK-MRC (A.N.J.M., G.S.O.), Wellcome Trust (grant number 100963/Z/13/Z) (A.N.J.M.), A-STAR (Y.Y.H.), Science Foundation Ireland and National Children's Research Centre (P.G.F.), and NIHR Biomedical Research Centre Programme (G.S.O.). A.N.J.M. and G.S.O. have research grant funding from Janssen Research and Development.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Forbes E, 2010, IMMUNOL CELL BIOL, V88, P240, DOI 10.1038/icb.2009.101; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Jenkins SJ, 2008, J IMMUNOL, V180, P8083, DOI 10.4049/jimmunol.180.12.8083; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KAMATA I, 1995, CLIN EXP IMMUNOL, V102, P71; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; RONCAROLO MG, 1991, J IMMUNOL, V147, P781; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	44	489	502	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					283	295		10.1016/j.immuni.2014.06.016	http://dx.doi.org/10.1016/j.immuni.2014.06.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25088770	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000341455300015
J	Silvestri, G; Sodora, DL; Koup, RA; Paiardini, M; O'Neil, SP; McClure, HM; Staprans, SI; Feinberg, MB				Silvestri, G; Sodora, DL; Koup, RA; Paiardini, M; O'Neil, SP; McClure, HM; Staprans, SI; Feinberg, MB			Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia	IMMUNITY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL DEPLETION; RECENT THYMIC EMIGRANTS; HIV-1 INFECTION; PERIPHERAL-BLOOD; ANTIRETROVIRAL THERAPY; LYMPHOCYTE-ACTIVATION; IMMUNE ACTIVATION; VIRAL DYNAMICS; CD4(+)	HIV-infected humans and SIV-infected rhesus macaques who remain healthy despite long-term infection exhibit exceptionally low levels of virus replication and active antiviral cellular immune responses. In contrast, sooty mangabey monkeys that represent natural hosts for SIV infection do not develop AIDS despite high levels of virus replication and limited antiviral CD8(+) T cell responses. We report here that SIV-infected mangabeys; maintain preserved T lymphocyte populations and regenerative capacity and manifest far lower levels of aberrant immune activation and apoptosis than are seen in pathogenic SIV and HIV infections. These data suggest that direct consequences of virus replication alone cannot account for progressive CD4(+) T cell depletion leading to AIDS. Rather, attenuated immune activation enables SIV-infected mangabeys to avoid the bystander damage seen in pathogenic infections and protects them from developing AIDS.	Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA USA; Emory Univ, Sch Med, Emory Vaccine Res Ctr, Atlanta, GA USA; Univ Texas, SW Med Ctr, Dallas, TX USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA USA	Emory University; Emory University; Emory University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; Emory University	Feinberg, MB (corresponding author), Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA.	mbf@sph.emory.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005014, ZIAAI005014] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; CHOREMIPAPADOPOULOU H, 1994, J ACQ IMMUN DEF SYND, V7, P245; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fleury S, 1998, NAT MED, V4, P794, DOI 10.1038/nm0798-794; FULTZ PN, 1990, AIDS, V4, P619, DOI 10.1097/00002030-199007000-00002; Gehri R, 1996, AIDS, V10, P9, DOI 10.1097/00002030-199601000-00002; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gougeon ML, 1996, J IMMUNOL, V156, P3509; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang SS, 2000, CLIN INFECT DIS, V30, P504, DOI 10.1086/313714; Kaur A, 2000, J IMMUNOL, V164, P934, DOI 10.4049/jimmunol.164.2.934; Kaur A, 2001, EUR J IMMUNOL, V31, P3207, DOI 10.1002/1521-4141(200111)31:11<3207::AID-IMMU3207>3.0.CO;2-H; Koester SK, 1997, CYTOMETRY, V29, P306; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MEYAARD L, 1994, J CLIN INVEST, V94, P1947, DOI 10.1172/JCI117545; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mitra D, 1996, IMMUNOLOGY, V87, P581, DOI 10.1046/j.1365-2567.1996.510589.x; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Orendi JM, 1998, J INFECT DIS, V178, P1279, DOI 10.1086/314451; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rey-Cuille MA, 1998, J VIROL, V72, P3872; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; Sodora DL, 2002, J VIROL, V76, P9981, DOI 10.1128/JVI.76.19.9981-9990.2002; Sodora DL, 2000, EUR J IMMUNOL, V30, P1145, DOI 10.1002/(SICI)1521-4141(200004)30:4<1145::AID-IMMU1145>3.0.CO;2-7; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Staprans SI, 1999, J VIROL, V73, P4829, DOI 10.1128/JVI.73.6.4829-4839.1999; Ullum H, 1997, AIDS, V11, P1479, DOI 10.1097/00002030-199712000-00012; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Watson A, 1997, J VIROL, V71, P284, DOI 10.1128/JVI.71.1.284-290.1997; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Weiss RA, 2001, NATURE, V410, P963, DOI 10.1038/35073632; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1	58	489	502	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					441	452		10.1016/S1074-7613(03)00060-8	http://dx.doi.org/10.1016/S1074-7613(03)00060-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648460	Bronze			2022-12-18	WOS:000181713700013
J	Mildner, A; Jung, S				Mildner, Alexander; Jung, Steffen			Development and Function of Dendritic Cell Subsets	IMMUNITY			English	Review							CD8(+) T-CELLS; STEADY-STATE CONDITIONS; PERIPHERAL LYMPHOID ORGANS; EPIDERMAL LANGERHANS CELLS; TRANSCRIPTION FACTOR E2-2; BLOOD-BORNE ANTIGENS; MOUSE BONE-MARROW; IN-VIVO; CROSS-PRESENTATION; GM-CSF	Classical dendritic cells (cDCs) form a critical interface between innate and adaptive immunity. As myeloid immune cell sentinels, cDCs are specialized in the sensing of pathogen challenges and cancer. They translate the latter for T cells into peptide form. Moreover, cDCs provide additional critical information on the original antigen context to trigger a diverse spectrum of appropriate protective responses. Here we review recent progress in our understanding of cDC subsets in mice. We will discuss cDC subset ontogeny and transcription factor dependencies, as well as emerging functional specializations within the cDC compartment in lymphoid and nonlymphoid tissues.	[Mildner, Alexander; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Jung, Steffen/K-1409-2012; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AFK-2161-2022; mildner, alexander/GQA-3761-2022; mildner, alexander/AAF-9451-2022	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; Arora P, 2014, IMMUNITY, V40, P105, DOI 10.1016/j.immuni.2013.12.004; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Berg JV, 2013, J EXP MED, V210, P2803, DOI 10.1084/jem.20130678; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; COSENZA H, 1971, J IMMUNOL, V107, P414; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Dicken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077490; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dresch C, 2011, EUR J IMMUNOL, V41, P2544, DOI 10.1002/eji.201041374; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Ersland K, 2010, CELL HOST MICROBE, V7, P474, DOI 10.1016/j.chom.2010.05.010; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Haniffa M, 2013, ADV IMMUNOL, V120, P1, DOI 10.1016/B978-0-12-417028-5.00001-6; Hartmann K, 1970, Cell Immunol, V1, P182, DOI 10.1016/0008-8749(70)90005-5; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; HOLT P G, 1990, International Reviews of Immunology, V6, P139, DOI 10.3109/08830189009056625; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kusunoki T, 2003, J ALLERGY CLIN IMMUN, V111, P136, DOI 10.1067/mai.2003.29; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luche H, 2011, EUR J IMMUNOL, V41, P2165, DOI 10.1002/eji.201141728; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; McCloskey ML, 2011, J EXP MED, V208, P135, DOI 10.1084/jem.20100354; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Milo I, 2013, BLOOD, V122, P193, DOI 10.1182/blood-2012-01-401265; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Murphy KM, 2013, ADV IMMUNOL, V120, P239, DOI 10.1016/B978-0-12-417028-5.00009-0; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Romani N, 2012, J INVEST DERMATOL, V132, P872, DOI 10.1038/jid.2011.437; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Saito Y, 2013, EUR J IMMUNOL, V43, P1651, DOI 10.1002/eji.201243163; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Satpathy A. T., 2014, BLOOD; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Seillet C, 2013, BLOOD, V121, P1574, DOI 10.1182/blood-2012-07-445650; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Wumesh KC, 2014, NATURE, V507, P243, DOI 10.1038/nature12967; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	200	488	516	10	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					642	656		10.1016/j.immuni.2014.04.016	http://dx.doi.org/10.1016/j.immuni.2014.04.016			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837101	Bronze			2022-12-18	WOS:000336026100005
J	Mesin, L; Ersching, J; Victora, GD				Mesin, Luka; Ersching, Jonatan; Victora, Gabriel D.			Germinal Center B Cell Dynamics	IMMUNITY			English	Review							FOLLICULAR DENDRITIC CELLS; PRIMARY IMMUNE-RESPONSE; REGULATORY T-CELLS; MEMORY B; PLASMA-CELL; AFFINITY MATURATION; IN-VIVO; DARK ZONE; CLONAL SELECTION; ANTIBODY-RESPONSES	Germinal centers (GCs) are the site of antibody diversification and affinity maturation and as such are vitally important for humoral immunity. The study of GC biology has undergone a renaissance in the past 10 years, with a succession of findings that have transformed our understanding of the cellular dynamics of affinity maturation. In this review, we discuss recent developments in the field, with special emphasis on how GC cellular and clonal dynamics shape antibody affinity and diversity during the immune response.	[Mesin, Luka; Ersching, Jonatan; Victora, Gabriel D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Mesin, Luka; Ersching, Jonatan; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Rockefeller University	Victora, GD (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.; Victora, GD (corresponding author), Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA.	victora@rockefeller.edu		Victora, Gabriel/0000-0001-8807-348X	NIH [DP5OD012146]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank O. Bannard (Oxford University) and D. Dominguez-Sola (Mount Sinai School of Medicine) for helpful comments and suggestions. This work is supported by NIH grant DP5OD012146 to G.D.V.	Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Barnett BE, 2012, SCIENCE, V335, P342, DOI 10.1126/science.1213495; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Goenka R, 2014, J EXP MED, V211, P45, DOI 10.1084/jem.20130505; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Good-Jacobson KL, 2014, P NATL ACAD SCI USA, V111, P9585, DOI 10.1073/pnas.1402485111; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; He JS, 2015, CURR TOP MICROBIOL, V388, P1, DOI 10.1007/978-3-319-13725-4_1; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Muppidi JR, 2015, J EXP MED, V212, P2213, DOI 10.1084/jem.20151250; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Radmacher MD, 1998, IMMUNOL CELL BIOL, V76, P373, DOI 10.1046/j.1440-1711.1998.00753.x; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Robbiani DF, 2015, CELL, V162, P727, DOI 10.1016/j.cell.2015.07.019; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Sutherland DB, 2016, IMMUNOL REV, V270, P20, DOI 10.1111/imr.12384; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; TEW JG, 1979, IMMUNOLOGY, V37, P69; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tiller T, 2010, J EXP MED, V207, P2767, DOI 10.1084/jem.20100171; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Xu YS, 2014, CELL RES, V24, P651, DOI 10.1038/cr.2014.65; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; ZIEGNER M, 1994, EUR J IMMUNOL, V24, P2393, DOI 10.1002/eji.1830241020; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	143	487	493	9	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					471	482		10.1016/j.immuni.2016.09.001	http://dx.doi.org/10.1016/j.immuni.2016.09.001			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653600	Green Accepted, Bronze			2022-12-18	WOS:000388454300007
J	Joller, N; Lozano, E; Burkett, PR; Patel, B; Xiao, S; Zhu, C; Xia, JR; Tan, TG; Sefik, E; Yajnik, V; Sharpe, AH; Quintana, FJ; Mathis, D; Benoist, C; Hafler, DA; Kuchroo, VK				Joller, Nicole; Lozano, Ester; Burkett, Patrick R.; Patel, Bonny; Xiao, Sheng; Zhu, Chen; Xia, Junrong; Tan, Tze G.; Sefik, Esen; Yajnik, Vijay; Sharpe, Arlene H.; Quintana, Francisco J.; Mathis, Diane; Benoist, Christophe; Hafler, David A.; Kuchroo, Vijay K.			Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses	IMMUNITY			English	Article							REGULATORY T-CELLS; AIRWAY INFLAMMATION; FOXP3; DIFFERENTIATION; INTERLEUKIN-23; RESOLUTION; RECEPTOR; PROMOTE; PROTEIN; T(H)17	Foxp3(+) T regulatory (Treg) cells regulate immune responses and maintain self-tolerance. Recent work shows that Treg cells are comprised of many subpopulations with specialized regulatory functions. Here we identified Foxp3(+) T cells expressing the coinhibitory molecule TIGIT as a distinct Treg cell subset that specifically suppresses proinflammatory T helper 1 (Th1) and Th17 cell, but not Th2 cell responses. Transcriptional profiling characterized TIGIT(+) Treg cells as an activated Treg cell subset with high expression of Treg signature genes. Ligation of TIGIT on Treg cells induced expression of the effector molecule fibrinogen-like protein 2 (Fgl2), which promoted Treg-cell-mediated suppression of T effector cell proliferation. In addition, Fgl2 was necessary to prevent suppression of Th2 cytokine production in a model of allergic airway inflammation. TIGIT expression therefore identifies a Treg cell subset that demonstrates selectivity for suppression of Th1 and Th17 cell but not Th2 cell responses.	[Joller, Nicole; Burkett, Patrick R.; Patel, Bonny; Xiao, Sheng; Zhu, Chen; Xia, Junrong; Quintana, Francisco J.; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Lozano, Ester; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol & Immunobiol, New Haven, CT 06520 USA; [Burkett, Patrick R.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; [Sefik, Esen; Sharpe, Arlene H.; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Yajnik, Vijay] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sharpe, Arlene H.; Kuchroo, Vijay K.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kuchroo, Vijay K.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kuchroo, VK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Joller, Nicole/G-7897-2015; Quintana, Francisco Javier/AAB-6915-2020; Lozano, Ester/H-2215-2014	Joller, Nicole/0000-0003-1996-1672; Lozano, Ester/0000-0002-6307-9807; Sefik, Esen/0000-0002-6807-3498	NIH [P01AI056299, P01AI039671, P01AI073748, R01NS045937, 5T32HL007633, K01DK090105, AI075285, AI09390]; National Multiple Sclerosis Society [RG4111A1, RG2751]; Swiss Multiple Sclerosis Society; Arthritis National Research Foundation; AGAUR-Government of Catalonia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, R56AI093903, U01AI102011, R00AI075285, K99AI075285, P01AI039671, P01AI056299, R01AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030843, R01NS045937, R01NS035685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Swiss Multiple Sclerosis Society; Arthritis National Research Foundation(National Research Foundation of Korea); AGAUR-Government of Catalonia(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank G. Levi for the Fgl2 reagents and KO mice, Zymogenetics for mice and reagents, D. Kozoriz for cell sorting, J. Sullivan for technical assistance, and members of the V. K. K. group, especially A. Peters, for discussions. This work was supported by grants P01AI056299 (to V. K. K., A. H. S., and C. B.), P01AI039671 (to V. K. K., D. A. H., and A. H. S.), P01AI073748, R01NS045937 (to V. K. K.), 5T32HL007633 (to P. R. B.), K01DK090105 (to S. X.), and AI075285 and AI093903 (to F. J. Q.) from NIH and by RG4111A1 (to F. J. Q.) and RG2751 (to V. K. K.) from the National Multiple Sclerosis Society. N.J. is supported by the Swiss Multiple Sclerosis Society and the Arthritis National Research Foundation. E. L. is recipient of a Postdoctoral Scholarship in the Beatriu de Pinos Programme (2011-2013) (AGAUR-Government of Catalonia). V. K. K. is a founder of, and has a financial interest in, Tempero Pharmaceuticals. V.K.K.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict-of-interest policies.	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	33	487	519	8	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					569	581		10.1016/j.immuni.2014.02.012	http://dx.doi.org/10.1016/j.immuni.2014.02.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745333	Bronze, Green Accepted			2022-12-18	WOS:000334849400014
J	Ohkura, N; Hamaguchi, M; Morikawa, H; Sugimura, K; Tanaka, A; Ito, Y; Osaki, M; Tanaka, Y; Yamashita, R; Nakano, N; Huehn, J; Fehling, HJ; Sparwasser, T; Nakai, K; Sakaguchi, S				Ohkura, Naganari; Hamaguchi, Masahide; Morikawa, Hiromasa; Sugimura, Kyoko; Tanaka, Atsushi; Ito, Yoshinaga; Osaki, Motonao; Tanaka, Yoshiaki; Yamashita, Riu; Nakano, Naoko; Huehn, Jochen; Fehling, Hans Joerg; Sparwasser, Tim; Nakai, Kenta; Sakaguchi, Shimon			T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; GENE-EXPRESSION; DNA METHYLATION; GENERATION; PLASTICITY; TOLERANCE; INFLAMMATION; MUTATIONS; PROGRAMS; PEPTIDE	The transcription factor Foxp3 is essential for the development of regulatory T (Treg) cells, yet its expression is insufficient for establishing the Treg cell lineage. Here we showed that Treg cell development was achieved by the combination of two independent processes, i.e., the expression of Foxp3 and the establishment of Treg cell-specific CpG hypomethylation pattern. Both events were induced by T cell receptor stimulation. The Treg cell-type CpG hypomethylation began in the thymus and continued to proceed in the periphery and could be fully established without Foxp3. The hypomethylation was required for Foxp3(+) T cells to acquire Treg cell-type gene expression, lineage stability, and full suppressive activity. Thus, those T cells in which the two events have concurrently occurred are developmentally set into the Treg cell lineage. This model explains how Treg cell fate and plasticity is controlled and can be exploited to generate functionally stable Treg cells.	[Ohkura, Naganari; Hamaguchi, Masahide; Morikawa, Hiromasa; Osaki, Motonao; Sakaguchi, Shimon] Osaka Univ, Dept Expt Immunol, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Ohkura, Naganari; Hamaguchi, Masahide; Morikawa, Hiromasa; Sugimura, Kyoko; Tanaka, Atsushi; Ito, Yoshinaga; Osaki, Motonao; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Tanaka, Yoshiaki; Nakai, Kenta] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Tanaka, Yoshiaki; Yamashita, Riu; Nakai, Kenta] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo 1088639, Japan; [Yamashita, Riu] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Tokyo 1088639, Japan; [Nakano, Naoko] Tokyo Univ Sci, Res Inst Biol Sci, Chiba 2780022, Japan; [Huehn, Jochen] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany; [Sparwasser, Tim] TWINCORE Ctr Expt & Clin Infect Res, Inst Infect Immunol, D-30625 Hannover, Germany; [Nakai, Kenta] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev BIRD, Tokyo 1020081, Japan	Osaka University; Kyoto University; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo University of Science; Helmholtz Association; Helmholtz-Center for Infection Research; Ulm University; Helmholtz Association; Helmholtz-Center for Infection Research; Japan Science & Technology Agency (JST)	Sakaguchi, S (corresponding author), Osaka Univ, Dept Expt Immunol, World Premier Int Immunol Frontier Res Ctr, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shimon@ifrec.osaka-u.ac.jp	Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019; Sakaguchi, Shimon/C-9535-2009; Tanaka, Yoshiaki/AAE-2425-2022; Morikawa, Hiromasa/AAU-9261-2020; Morikawa, Hiromasa/H-5958-2013; Tanaka, Atsushi/U-6761-2019; Nakai, Kenta/B-7293-2009	Sparwasser, Tim/0000-0001-5645-902X; Tanaka, Yoshiaki/0000-0002-2078-9374; Morikawa, Hiromasa/0000-0002-6793-5885; Morikawa, Hiromasa/0000-0002-6793-5885; Tanaka, Atsushi/0000-0003-1660-9892; Nakai, Kenta/0000-0002-8721-8883; Hamaguchi, Masahide/0000-0002-8651-4445; Ito, Yoshinaga/0000-0002-5567-7014; xing zhi, shi zhi/0000-0003-3289-5681	Japan Society for the Promotion of Science [20002007, 21590533, 23790791]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank N.E. Crabb, J.B. Wing, and O.A. Hehinde for critical reading of the manuscript; A. Kawasaki, M. Yoshida, and R. Ishii for technical assistance; and T. Kitamura for gifts of the packaging cell line Plat-E and retrovirus vector pMCs-Ig. Computation time was provided by the Super Computer System, Human Genome Center, Institute of Medical Science, The University of Tokyo. This study was supported by Grant-in-Aid for Specially Promoted Research 20002007 to S.S., for Scientific Research (C) 21590533 to N.O, and for Young Scientists (B) 23790791 to M.H. from Japan Society for the Promotion of Science.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2009, J IMMUNOL, V183, P5662, DOI 10.4049/jimmunol.0803762; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Musri MM, 2012, CURR OPIN CLIN NUTR, V15, P342, DOI 10.1097/MCO.0b013e3283546fba; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Prokhortchouk E, 2008, BBA-MOL CELL RES, V1783, P2167, DOI 10.1016/j.bbamcr.2008.07.015; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yamashiro H, 2002, INT IMMUNOL, V14, P857, DOI 10.1093/intimm/dxf061; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	41	487	505	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					785	799		10.1016/j.immuni.2012.09.010	http://dx.doi.org/10.1016/j.immuni.2012.09.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23123060	Bronze, Green Submitted			2022-12-18	WOS:000311460000007
J	Jamieson, AM; Diefenbach, A; McMahon, CW; Xiong, N; Carlyle, JR; Raulet, DH				Jamieson, AM; Diefenbach, A; McMahon, CW; Xiong, N; Carlyle, JR; Raulet, DH			The role of the NKG2D immunoreceptor in immune cell activation and natural killing	IMMUNITY			English	Article							CLASS-I MOLECULES; KILLER NK CELLS; T-CELLS; MONOCLONAL-ANTIBODY; SURFACE PROTEINS; RECEPTOR; EXPRESSION; FAMILY; CYTOTOXICITY; ANTIGEN	Little is known concerning the stimulatory receptors responsible for tumor cell lysis by NK cells. We generated a monoclonal antibody specific for murine NKG2D in order to investigate its function. Blocking of NKG2D inhibited natural cytotoxicity of all tumor cells tested that express ligands for the receptor. Staining analysis showed that NKG2D is also expressed by activated CD8(+) T cells and macrophages, and subsets of TCRgammadelta(+) and NK1.1(+) T cells. Contradicting reports that NKG2D is solely a costimulatory receptor, we observed that cross-linking of NKG2D directly stimulates NK cells and activated macrophages. In contrast, NKG2D costimulates activated CD8(+) T cells. Thus, NKG2D engagement directly stimulates NK cells and macrophages, costimulates CD8(+) T cells, and plays a substantial role in natural killing.	Univ Calif Berkeley, Dept Mol & Cell Biol, Life Sci Addit 489, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Life Sci Addit 489, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Life Sci Addit 489, Berkeley, CA 94720 USA.		Carlyle, James R/A-1224-2008; Jamieson, Amanda/U-7169-2019; Diefenbach, Andreas/T-2589-2018	Jamieson, Amanda/0000-0002-5781-9231; Diefenbach, Andreas/0000-0002-9176-9530; Raulet, David/0000-0002-1257-8649; Carlyle, James/0000-0002-3579-0300				Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Chu CL, 1999, J IMMUNOL, V162, P1896; Coligan JKA, 1991, CURRENT PROTOCOLS IM; CORREA I, 1994, EUR J IMMUNOL, V24, P1323, DOI 10.1002/eji.1830240613; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; DENNERT G, 1988, J IMMUNOL, V140, P2472; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; KUBO RT, 1989, J IMMUNOL, V142, P2736; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Maniatis T., 1989, MOL CLONING LAB MANU; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; RYAN JC, 1995, J EXP MED, V181, P1911, DOI 10.1084/jem.181.5.1911; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; Tsuchihashi N, 2000, EUR J IMMUNOL, V30, P1785, DOI 10.1002/1521-4141(200006)30:6<1785::AID-IMMU1785>3.0.CO;2-T; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	41	487	538	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					19	29		10.1016/S1074-7613(02)00333-3	http://dx.doi.org/10.1016/S1074-7613(02)00333-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150888	Bronze			2022-12-18	WOS:000177187500003
J	Durant, L; Watford, WT; Ramos, HL; Laurence, A; Vahedi, G; Wei, L; Takahashi, H; Sun, HW; Kanno, Y; Powrie, F; O'Shea, JJ				Durant, Lydia; Watford, Wendy T.; Ramos, Haydee L.; Laurence, Arian; Vahedi, Golnez; Wei, Lai; Takahashi, Hayato; Sun, Hong-Wei; Kanno, Yuka; Powrie, Fiona; O'Shea, John J.			Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; HYPER-IGE SYNDROME; GENOME-WIDE ASSOCIATION; IN-VIVO; INTESTINAL INFLAMMATION; HELPER-CELLS; T-H-17 CELLS; TH17 CELLS; ROR-GAMMA; DIFFERENTIATION	STAT3, an essential transcription factor with pleiotropic functions, plays critical roles in the pathogenesis of autoimmunity. Despite recent data linking STAT3 with inflammatory bowel disease, exactly how it contributes to chronic intestinal inflammation is not known. Using a T cell transfer model of colitis, we found that STAT3 expression in T cells was essential for the induction of both colitis and systemic inflammation. STAT3 was critical in modulating the balance of T helper 17 (Th17) and regulatory T (Treg) cells, as well as in promoting CD4(+) T cell proliferation. We used chromatin immunoprecipitation and massive parallel sequencing (ChIP-Seq) to define the genome-wide targets of STAT3 in CD4(+) T cells. We found that STAT3 bound to multiple genes involved in Th17 cell differentiation, cell activation, proliferation, and survival, regulating both expression and epigenetic modifications. Thus, STAT3 orchestrates multiple critical aspects of T cell function in inflammation and homeostasis.	[Durant, Lydia; Watford, Wendy T.; Ramos, Haydee L.; Laurence, Arian; Vahedi, Golnez; Wei, Lai; Takahashi, Hayato; Kanno, Yuka; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Durant, Lydia; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Durant, Lydia; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Durant, L (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	durantl@mail.nih.gov	Kanno, Yuka/B-5802-2013; Laurence, Arian/A-8770-2009; Wei, Lai/D-1088-2014	Kanno, Yuka/0000-0001-5668-9319; Laurence, Arian/0000-0003-0942-8292; Watford, Wendy/0000-0003-4261-5399; Durant, Lydia/0000-0002-5068-1479	Intramural Research Program at NIAMS; National Institutes of Health [1 K22 AR53953-01]; Wellcome Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041167, ZIAAR041159, ZICAR041181, Z01AR041132, ZIHAR041173, K22AR053953, ZIAAR041106] Funding Source: NIH RePORTER	Intramural Research Program at NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Simone, J.Lay, K. Zaal, and the NIAMS LACU Staff for their assistance. We thank P. Ahern, M. Asquith, and A. Izcue for advice and critical reading of the manuscript. This research was funded by the Intramural Research Program at NIAMS. W.T.W. is supported by National Institutes of Health grant #1 K22 AR53953-01. F.P. is supported by funding from the Wellcome Trust.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756	52	486	513	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 28	2010	32	5					605	615		10.1016/j.immuni.2010.05.003	http://dx.doi.org/10.1016/j.immuni.2010.05.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20493732	Green Accepted, Bronze			2022-12-18	WOS:000278280500007
J	Leon, B; Lopez-Bravo, M; Ardavin, C				Leon, Beatriz; Lopez-Bravo, Maria; Ardavin, Carlos			Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania	IMMUNITY			English	Article							LYMPH-NODE; LANGERHANS CELLS; IN-VIVO; STEADY-STATE; MAJOR INFECTION; T-CELLS; ANTIGEN; SKIN; PRECURSORS; DIFFERENTIATION	Infection-induced inflammatory reactions involve a strong increase in dendritic cells (DCs) at the infection site and draining lymph nodes (dLNs). Whether inflammatory DCs are recruited to these locations or differentiate locally, and what their functional relevance is, remain unclear. Here we showed that during Leishmania infection, monocytes were recruited to the dermis and differentiated into "dermal monocyte-derived DCs," which subsequently migrated into the dLNs. In addition, monocyte recruitment to the dLNs resulted in the differentiation into "LN monocyte-derived DCs." Analysis of the kinetics of monocyte differentiation into DCs, susceptibility to infection, IL-12 production, and L. major-specific T cell stimulation potential suggest that dermal monocyte-derived DCs controlled the induction of protective T helper 1 responses against Leishmania. Thus, the demonstration of monocyte differentiation potential into DCs during in vivo infection and of local DC differentiation in inflammatory foci suggests that de novo formed monocyte-derived DCs are essential in T cell immunity against pathogens.	Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Ardavin, C (corresponding author), Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain.	ardavin@cnb.uam.es		Lopez-Bravo, Maria/0000-0002-1898-9465				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Baldwin T, 2004, INFECT IMMUN, V72, P1991, DOI 10.1128/IAI.72.4.1991-2001.2004; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Bendriss-Vermare N, 2004, LEUKEMIA, V18, P1491, DOI 10.1038/sj.leu.2403452; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Martin P, 2002, BLOOD, V99, P1282, DOI 10.1182/blood.V99.4.1282; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MOLL H, 1993, EUR J IMMUNOL, V23, P1595, DOI 10.1002/eji.1830230730; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Palucka K, 1999, NAT MED, V5, P868, DOI 10.1038/11303; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rotta G, 2003, J EXP MED, V198, P1253, DOI 10.1084/jem.20030335; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	28	485	498	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					519	531		10.1016/j.immuni.2007.01.017	http://dx.doi.org/10.1016/j.immuni.2007.01.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17412618	Bronze			2022-12-18	WOS:000246126400015
J	Wang, JH; Nichogiannopoulou, A; Wu, L; Sun, L; Sharpe, AH; Bigby, M; Georgopoulos, K				Wang, JH; Nichogiannopoulou, A; Wu, L; Sun, L; Sharpe, AH; Bigby, M; Georgopoulos, K			Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation	IMMUNITY			English	Article							DENDRITIC EPIDERMAL-CELLS; HEMATOPOIETIC STEM-CELLS; NATURAL-KILLER-CELLS; DELTA-T-CELLS; MOUSE THYMUS; TRANSCRIPTION FACTOR; PRECURSOR CELLS; GENE; DIFFERENTIATION; THYMOCYTES	Mice homozygous for an Ikaros null mutation display distinct defects in the development of fetal and adult lymphocytes. Fetal T lymphocytes, and fetal and adult B lymphocytes and their earliest progenitors are absent. Postnatally, hematopoietic stem cells give rise to thymocyte precursors that undergo aberrant differentiation into the CD4 lineage and clonal expansion. The lack of NK cells and some gamma delta T cell subsets and a large reduction in thymic dendritic APCs suggest that Ikaros is essential for establishing early branch points in the postnatal T cell pathway. The lymphoid defects detected in Ikaros null mice reveal critical molecular differences between fetal and postnatal hematopoietic progenitors that dictate their ability to give rise to T cells, These studies also establish Ikaros as a tumor suppressor gene acting during thymocyte differentiation, Phenotypic comparison of this null mutation with a severe dominant-negative Ikaros mutation identifies molecular redundancy in the postnatal hemo-lymphoid system.	WALTER & ELIZA HALL INST MED RES, MELBOURNE, VIC 3050, AUSTRALIA; HARVARD UNIV, SCH MED, BRIGHAM & WOMENS HOSP, DIV IMMUNOL RES, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02114 USA	Walter & Eliza Hall Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wang, JH (corresponding author), HARVARD UNIV, SCH MED, MASSACHUSETTS GEN HOSP, CUTANEOUS BIOL RES CTR, CHARLESTOWN, MA 02129 USA.				NCI NIH HHS [CA-06927] Funding Source: Medline; PHS HHS [A1-26782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLISON JP, 1993, CURR OPIN IMMUNOL, V5, P241, DOI 10.1016/0952-7915(93)90011-G; ANDERSON SJ, 1992, EMBO J, V11, P4866; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; ASNARNOW DM, 1988, CELL, V55, P837; BIGBY M, 1993, J IMMUNOL, V151, P4465; BIGBY M, 1987, J INVEST DERMATOL, V89, P495, DOI 10.1111/1523-1747.ep12460983; Clevers HC, 1996, IMMUNOL TODAY, V17, P336, DOI 10.1016/0167-5699(96)10019-0; DIETERLENLIEVRE F, 1994, ANN NY ACAD SCI, V718, P140; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; GARNIWAGNER BA, 1990, J IMMUNOL, V144, P796; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; GUY GD, 1991, J EXP MED, V173, P471; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HARDY RR, 1994, IMMUNOL REV, V137, P92; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; IKUTA K, 1991, J EXP MED, V174, P1279, DOI 10.1084/jem.174.5.1279; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; JUHLIN L, 1977, ACTA DERM-VENEREOL, V57, P289; KANTOR AB, 1992, ANN NY ACAD SCI, V651, P168; KONING F, 1987, SCIENCE, V236, P834, DOI 10.1126/science.2883729; LEFRANCOIS L, 1991, IMMUNOL TODAY, V12, P436, DOI 10.1016/0167-5699(91)90015-L; LEFRANCOIS L, 1990, CELL, V63, P333, DOI 10.1016/0092-8674(90)90166-C; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LYNCH F, 1992, J IMMUNOL, V149, P2307; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; MOLNAR A, 1994, MOL CELL BIOL, V83, P785; MORGAN B, 1996, IN PRESS EMBO J; OKADA S, 1992, BLOOD, V80, P3044; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217	45	484	491	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					537	549		10.1016/S1074-7613(00)80269-1	http://dx.doi.org/10.1016/S1074-7613(00)80269-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986714	Bronze			2022-12-18	WOS:A1996WA65100005
J	Guilliams, M; Dutertre, CA; Scott, CL; McGovern, N; Sichien, D; Chakarov, S; Van Gassen, S; Chen, JM; Poidinger, M; De Prijck, S; Tavernier, SJ; Low, I; Irac, SE; Mattar, CN; Sumatoh, HR; Low, GHL; Chung, TJK; Chan, DKH; Tan, KK; Hon, TLK; Fossum, E; Bogen, B; Choolani, M; Chan, JKY; Larbi, A; Luche, H; Henri, S; Saeys, Y; Newell, EW; Lambrecht, BN; Malissen, B; Ginhoux, F				Guilliams, Martin; Dutertre, Charles-Antoine; Scott, Charlotte L.; McGovern, Naomi; Sichien, Dorine; Chakarov, Svetoslav; Van Gassen, Sofie; Chen, Jinmiao; Poidinger, Michael; De Prijck, Sofie; Tavernier, Simon J.; Low, Ivy; Irac, Sergio Erdal; Mattar, Citra Nurfarah; Sumatoh, Hermi Rizal; Low, Gillian Hui Ling; Chung, Tam John Kit; Chan, Dedrick Kok Hong; Tan, Ker Kan; Hon, Tony Lim Kiat; Fossum, Even; Bogen, Bjame; Choolani, Mahesh; Chan, Jerry Kok Yen; Larbi, Anis; Luche, Herve; Henri, Sandrine; Saeys, Yvan; Newell, Evan William; Lambrecht, Bart N.; Malissen, Bernard; Ginhoux, Florent			Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species	IMMUNITY			English	Article							CLONOGENIC PROGENITOR; SIGNALING CONTROLS; STEADY-STATE; LYMPH-NODES; BONE-MARROW; MACROPHAGES; EXPRESSION; RESPONSES; BLOOD; HOMEOSTASIS	Dendritic cells (DCs) are professional antigen-presenting cells that hold great therapeutic potential. Multiple DC subsets have been described, and it remains challenging to align them across tissues and species to analyze their function in the absence of macrophage contamination. Here, we provide and validate a universal toolbox for the automated identification of DCs through unsupervised analysis of conventional flow cytometry and mass cytometry data obtained from multiple mouse, macaque, and human tissues. The use of a minimal set of lineage-imprinted markers was sufficient to subdivide DCs into conventional type 1 (cDC1s), conventional type 2 (cDC2s), and plasmacytoid DCs (pDCs) across tissues and species. This way, a large number of additional markers can still be used to further characterize the heterogeneity of DCs across tissues and during inflammation. This framework represents the way forward to a universal, high-throughput, and standardized analysis of DC populations from mutant mice and human patients.	[Guilliams, Martin; Scott, Charlotte L.; Sichien, Dorine; De Prijck, Sofie; Tavernier, Simon J.; Lambrecht, Bart N.] VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium; [Guilliams, Martin; Scott, Charlotte L.; Sichien, Dorine] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Guilliams, Martin; Luche, Herve; Henri, Sandrine; Malissen, Bernard] Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Dutertre, Charles-Antoine; McGovern, Naomi; Chakarov, Svetoslav; Chen, Jinmiao; Poidinger, Michael; Low, Ivy; Sumatoh, Hermi Rizal; Low, Gillian Hui Ling; Chan, Jerry Kok Yen; Larbi, Anis; Newell, Evan William; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, BIOPOLIS, 8A Biomed Grove,IMMUNOS Bldg 3-4, Singapore 138648, Singapore; [Dutertre, Charles-Antoine; Irac, Sergio Erdal] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore; [Van Gassen, Sofie] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Van Gassen, Sofie; Saeys, Yvan] VIB Inflammat Res Ctr, Data Min & Modeling Biomed, B-9052 Ghent, Belgium; [De Prijck, Sofie; Tavernier, Simon J.; Saeys, Yvan; Lambrecht, Bart N.] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Mattar, Citra Nurfarah; Choolani, Mahesh; Chan, Jerry Kok Yen] Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Singapore 119077, Singapore; [Chung, Tam John Kit; Chan, Dedrick Kok Hong; Tan, Ker Kan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119077, Singapore; [Hon, Tony Lim Kiat] Natl Univ Singapore, Dept Pathol, Singapore 119077, Singapore; [Fossum, Even; Bogen, Bjame] Univ Oslo, Oslo Univ Hosp, KG Jebsen Ctr Influenza Vaccine Res, N-0027 Oslo, Norway; [Bogen, Bjame] Univ Oslo, Oslo Univ Hosp, Rikshosp, Inst Immunol,Ctr Immune Regulat, N-0424 Oslo, Norway; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Div Obstet & Gynaecol, Singapore 229899, Singapore; [Chan, Jerry Kok Yen] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 119077, Singapore; [Luche, Herve; Malissen, Bernard] Aix Marseille Univ, CNRS, Ctr Immunophenom, INSERM, F-13288 Marseille, France; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Ghent University; IMEC; Flanders Institute for Biotechnology (VIB); Ghent University; National University of Singapore; National University of Singapore; National University of Singapore; University of Oslo; University of Oslo; National Hospital Norway; KK Women's & Children's Hospital; National University of Singapore; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC	Guilliams, M; Lambrecht, BN (corresponding author), VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.; Guilliams, M; Malissen, B (corresponding author), Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France.; Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, BIOPOLIS, 8A Biomed Grove,IMMUNOS Bldg 3-4, Singapore 138648, Singapore.; Lambrecht, BN (corresponding author), Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium.; Malissen, B (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunophenom, INSERM, F-13288 Marseille, France.; Lambrecht, BN (corresponding author), Erasmus MC, Dept Pulm Med, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	martin.guilliams@irc.vib-ugent.be; bart.lambrecht@irc.vib-ugent.be; bernardm@ciml.univ-mrs.fr; florent_ginhoux@immunol.a-star.edu.sg	Irac, Sergio Erdal/G-6690-2014; Tam, John/B-6048-2012; Newell, Evan W/F-9711-2012; Chen, Jinmiao/ABE-5601-2021; Tavernier, Simon/L-9949-2019; Tan, Ker Kan/K-2506-2017; Lambrecht, Bart N/K-2484-2014; Henri, Sandrine/O-3045-2016; Larbi, Anis/ABE-5868-2020; Chan, Dedrick/AAK-1440-2021; Chan, Dedrick/AAI-8469-2021; Saeys, Yvan/C-1311-2009; Fossum, Even/W-9136-2019; Guilliams, Martin/N-7803-2013; Chakarov, Svetoslav/AAC-9283-2019; LUCHE, Herve/GLT-1401-2022; Scott, Charlotte/K-3563-2014; Malissen, Bernard/AAK-4659-2020	Irac, Sergio Erdal/0000-0001-5622-1409; Newell, Evan W/0000-0002-2889-243X; Tavernier, Simon/0000-0003-2514-5655; Tan, Ker Kan/0000-0002-0410-0450; Lambrecht, Bart N/0000-0003-4376-6834; Chan, Dedrick/0000-0002-4237-8648; Saeys, Yvan/0000-0002-0415-1506; Fossum, Even/0000-0001-7064-0327; Guilliams, Martin/0000-0003-3525-7570; Chakarov, Svetoslav/0000-0002-0665-5417; Poidinger, Michael/0000-0002-1047-2277; McGovern, Naomi/0000-0001-5200-2698; Van Gassen, Sofie/0000-0002-7119-5330; Sichien, Dorine/0000-0002-7298-3005; Scott, Charlotte/0000-0003-4914-6580; HENRI, Sandrine/0000-0002-8980-9193; Dutertre, Charles-Antoine/0000-0001-7950-3652; Malissen, Bernard/0000-0003-1340-9342; Mattar, Citra Nurfarah/0000-0003-0068-6957	Singapore Immunology Network; National Research Foundation Singapore under its cooperative basic research grant new investigator grant [NMRC/BNIG/2026/2014]; Marie Curie Intra-European Fellowship (IEF) as part of Horizon; Marie Curie Reintegration grant; Odysseus grant; FWO grants of the Flemish Government; CNRS; INSERM; PHENOMIN; European Research Council (FP7) [322465]; Flanders Agency for Innovation by Science and Technology (IWT)	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); National Research Foundation Singapore under its cooperative basic research grant new investigator grant; Marie Curie Intra-European Fellowship (IEF) as part of Horizon; Marie Curie Reintegration grant(European Commission); Odysseus grant; FWO grants of the Flemish Government(FWO); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PHENOMIN; European Research Council (FP7); Flanders Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank Gert Van Isterdael and Charlene Foong Shu Fen from the Flow Cytometry Core Platform of the IRC and SingHealth, respectively. This work was supported by core grants of the Singapore Immunology Network to F.G. and E.W.N. and by the National Research Foundation Singapore under its cooperative basic research grant new investigator grant (NMRC/BNIG/2026/2014) and administered by the Singapore Ministry of Health's National Medical Research Council to C.-A.D. C.L.S. is supported by a Marie Curie Intra-European Fellowship (IEF) as part of Horizon 2020. M.G. is supported by a Marie Curie Reintegration grant, an Odysseus grant, and FWO grants of the Flemish Government. B.M. is supported by the CNRS, INSERM, PHENOMIN, and European Research Council (FP7/2007-2013 grant no 322465). S.V.G. is funded by the Flanders Agency for Innovation by Science and Technology (IWT).	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheng YQ, 2015, J IMMUNOL, V195, P3922, DOI 10.4049/jimmunol.1500638; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dutertre CA, 2014, J IMMUNOL, V192, P4697, DOI 10.4049/jimmunol.1302448; Fossum E, 2015, EUR J IMMUNOL, V45, P624, DOI 10.1002/eji.201445080; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00406; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gurka S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00035; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Maisonnasse P, 2016, MUCOSAL IMMUNOL, V9, P835, DOI 10.1038/mi.2015.105; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; McGovern N, 2015, INT IMMUNOL, V27, P65, DOI 10.1093/intimm/dxu091; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022	47	482	490	6	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					669	684		10.1016/j.immuni.2016.08.015	http://dx.doi.org/10.1016/j.immuni.2016.08.015			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27637149	Green Published, hybrid			2022-12-18	WOS:000388454300021
J	Helft, J; Bottcher, J; Chakravarty, P; Zelenay, S; Huotari, J; Schraml, BU; Goubau, D; Sousa, CRE				Helft, Julie; Boettcher, Jan; Chakravarty, Probir; Zelenay, Santiago; Huotari, Jatta; Schraml, Barbara U.; Goubau, Delphine; Reis e Sousa, Caetano			GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells	IMMUNITY			English	Article							GENE-EXPRESSION; STEADY-STATE; FLT3 LIGAND; IN-VITRO; MONOCYTES; PROGENITORS; GENERATION; REVEALS; DISTINCT; LINEAGE	Dendritic cells (DCs) are key players in the immune system. Much of their biology has been elucidated via culture systems in which hematopoietic precursors differentiate into DCs under the aegis of cytokines. A widely used protocol involves the culture of murine bone marrow (BM) cells with granulocyte-macrophage colony-stimulating factor (GM-CSF) to generate BM-derived DCs (BMDCs). BMDCs express CD11c and MHC class II (MHCII) molecules and share with DCs isolated from tissues the ability to present exogenous antigens to T cells and to respond to microbial stimuli by undergoing maturation. We demonstrate that CD11c(+)MHCII(+) BMDCs are in fact a heterogeneous group of cells that comprises conventional DCs and monocyte-derived macrophages. DCs and macrophages in GM-CSF cultures both undergo maturation upon stimulation with lipopolysaccharide but respond differentially to the stimulus and remain separable entities. These results have important implications for the interpretation of a vast array of data obtained with DC culture systems.	[Helft, Julie; Boettcher, Jan; Zelenay, Santiago; Huotari, Jatta; Schraml, Barbara U.; Goubau, Delphine; Reis e Sousa, Caetano] Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, London WC2A 3LY, England; [Chakravarty, Probir] Lincolns Inn Fields Lab, Francis Crick Inst, Bioinformat Lab, London WC2A 3LY, England	Francis Crick Institute; Francis Crick Institute	Sousa, CRE (corresponding author), Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@crick.ac.uk	Helft, Julie/ABE-6179-2020; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Helft, Julie/0000-0002-2733-1972; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; chakravarty, probir/0000-0003-1146-8824; Schraml, Barbara/0000-0002-5801-0151; Bottcher, Jan/0000-0002-8163-8107; Zelenay, Santiago/0000-0002-6865-3978	ERC; Cancer Research UK; Cancer Research UK [15689] Funding Source: researchfish; The Francis Crick Institute [10138, 10136, 10334, 10002] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank the LRI FACS laboratory for technical help. We are grateful to all members of the Immunobiology laboratory for helpful discussions and comments. This work was supported by the ERC and core funding from Cancer Research UK.	Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Balan S, 2014, J IMMUNOL, V193, P1622, DOI 10.4049/jimmunol.1401243; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lu L, 1995, TRANSPLANTATION, V60, P1539, DOI 10.1097/00007890-199560120-00028; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Palucka KA, 1998, J IMMUNOL, V160, P4587; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Son YI, 2002, J IMMUNOL METHODS, V262, P145, DOI 10.1016/S0022-1759(02)00013-3; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	47	481	488	7	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1197	1211		10.1016/j.immuni.2015.05.018	http://dx.doi.org/10.1016/j.immuni.2015.05.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084029	Bronze			2022-12-18	WOS:000356362800022
J	Tanaka, M; Fuentes, ME; Yamaguchi, K; Durnin, MH; Dalrymple, SA; Hardy, KL; Goeddel, DV				Tanaka, M; Fuentes, ME; Yamaguchi, K; Durnin, MH; Dalrymple, SA; Hardy, KL; Goeddel, DV			Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice	IMMUNITY			English	Article							RECEPTOR-1 SIGNALING COMPLEX; ALPHA-INDUCED APOPTOSIS; INDUCED CELL-DEATH; KINASE COMPLEX; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; IMMUNE-RESPONSES; CONTAINS 2; TNF; PHOSPHORYLATION	I kappa B kinase-alpha and -beta (IKK-alpha and IKK-beta), the catalytic subunits of the IKK complex, phosphorylate I kappa B proteins on specific serine residues, thus targeting I kappa B for degradation and activating the transcription factor NF-kappa B. To elucidate the in vivo function of IKK-beta, we generated IKK-beta-deficient mice. The homozygous mouse embryo dies at similar to 14.5 days of gestation due to liver degeneration and apoptosis. IKK-beta-deficient embryonic fibroblasts have both reduced basal NF-kappa B activity and impaired cytokine-induced NF-kappa B activation. Similarly, basal and cytokine-inducible kinase activities of the IKK complex are greatly reduced in IKK-beta-deficient cells. These results indicate that IKK-beta is crucial for liver development and regulation of NF-kappa B activity and that IKK-alpha can only partially compensate for the loss of IKK-beta.	Tularik Inc, S San Francisco, CA 94080 USA; Roche Biosci, Inflammatory Dis Unit, Palo Alto, CA 94304 USA	Roche Holding	Goeddel, DV (corresponding author), Tularik Inc, 2 Corp Dr, S San Francisco, CA 94080 USA.		Fuentes, Maria/HGA-8617-2022					AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BankersFulbright JL, 1996, LIFE SCI, V59, P61, DOI 10.1016/0024-3205(96)00135-X; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu MCT, 1998, GENE, V222, P31, DOI 10.1016/S0378-1119(98)00462-4; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li J, 1998, J BIOL CHEM, V273, P30736, DOI 10.1074/jbc.273.46.30736; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Tanaka M, 1997, J IMMUNOL, V158, P2303; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wurst W., 1993, Gene targeting: a practical approach., P33; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	47	481	503	3	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					421	429		10.1016/S1074-7613(00)80042-4	http://dx.doi.org/10.1016/S1074-7613(00)80042-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229185	Bronze			2022-12-18	WOS:000079989600003
J	Deeks, SG; Tracy, R; Douek, DC				Deeks, Steven G.; Tracy, Russell; Douek, Daniel C.			Systemic Effects of Inflammation on Health during Chronic HIV Infection	IMMUNITY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; RECEIVING ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE EVENTS; MUCOSAL IMMUNE RECONSTITUTION; INTESTINAL EPITHELIAL BARRIER; RANDOMIZED CONTROLLED-TRIAL; MICROBIAL TRANSLOCATION; D-DIMER; MONOCYTE ACTIVATION	Combination antiretroviral therapy for HIV infection improves immune function and eliminates the risk of AIDS-related complications but does not restore full health. HIV-infected adults have excess risk of cardiovascular, liver, kidney, bone, and neurologic diseases. Many markers of inflammation are elevated in HIV disease and strongly predictive of the risk of morbidity and mortality. A conceptual model has emerged to explain this syndrome of diseases where HIV-mediated destruction of gut mucosa leads to local and systemic inflammation. Translocated microbial products then pass through the liver, contributing to hepatic damage, impaired microbial clearance, and impaired protein synthesis. Chronic activation of monocytes and altered liver protein synthesis subsequently contribute to a hypercoagulable state. The combined effect of systemic inflammation and excess clotting on tissue function leads to end-organ disease. Multiple therapeutic interventions designed to reverse these pathways are now being tested in the clinic. It is likely that knowledge gained on how inflammation affects health in HIV disease could have implications for our understanding of other chronic inflammatory diseases and the biology of aging.	[Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94114 USA; [Tracy, Russell] Univ Vermont, Colchester, VT 05405 USA; [Douek, Daniel C.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of Vermont; National Institutes of Health (NIH) - USA	Deeks, SG (corresponding author), Univ Calif San Francisco, San Francisco, CA 94114 USA.	sdeeks@php.ucsf.edu			National Institute of Allergy and Infectious Diseases [K24 AI069994]; DARE: Delaney AIDS Research Enterprise (DARE) [U19AI096109]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, P30AI027763, K24AI069994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARE: Delaney AIDS Research Enterprise (DARE); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (K24 AI069994), the DARE: Delaney AIDS Research Enterprise (DARE; U19AI096109), and the Intramural Program of the National Institute of Allergy and Infectious Diseases.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker J, 2010, HIV MED, V11, P608, DOI 10.1111/j.1468-1293.2010.00835.x; Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Balagopal A, 2009, AIDS, V23, P2397, DOI 10.1097/QAD.0b013e3283324344; BISSUEL F, 1992, J ACQ IMMUN DEF SYND, V5, P484; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brummel-Ziedins K, 2013, J THROMB HAEMOST, V11, P212, DOI 10.1111/jth.12256; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Byakwaga H, 2011, J INFECT DIS, V204, P1532, DOI 10.1093/infdis/jir559; Cahn P, 2013, CLIN INFECT DIS, V57, P139, DOI 10.1093/cid/cit171; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Ellis CL, 2011, JAIDS-J ACQ IMM DEF, V57, P363, DOI 10.1097/QAI.0b013e31821a603c; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Finch C.E., 2007, BIOL HIMAN LONGETIVI; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Fultz SL, 2004, AM J MED, V116, P420, DOI 10.1016/j.amjmed.2003.10.011; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Gori A, 2008, J CLIN MICROBIOL, V46, P757, DOI 10.1128/JCM.01729-07; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hasegawa A, 2009, BLOOD, V114, P2917, DOI 10.1182/blood-2009-02-204263; Hatano H, 2013, J INFECT DIS; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Hileman CO, 2012, ANTIVIR THER, V17, P1345, DOI 10.3851/IMP2297; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jong E, 2010, THROMB HAEMOSTASIS, V104, P1228, DOI 10.1160/TH10-04-0233; Jong E, 2009, AIDS PATIENT CARE ST, V23, P1001, DOI 10.1089/apc.2009.0173; Justice A, 2010, ALCOHOL RES HEALTH, V33, P258; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Klatt NR, 2013, J CLIN INVEST, V123, P903, DOI 10.1172/JCI66227; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Ledwaba L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024243; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lijfering WM, 2008, CLIN CHEM, V54, P1226, DOI 10.1373/clinchem.2008.103614; Lok JJ, 2013, AIDS, V27, P2101, DOI 10.1097/QAD.0b013e32836191b1; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Monte SV, 2012, SURGERY, V151, P587, DOI 10.1016/j.surg.2011.09.038; Moore RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021843; Musselwhite LW, 2011, AIDS, V25, P787, DOI 10.1097/QAD.0b013e3283453fcb; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nalle SC, 2013, ADV EXP MED BIOL, V763, P105; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; O'Brien M, 2013, JAIDS-J ACQ IMM DEF, V63, P280, DOI 10.1097/QAI.0b013e31828a292c; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Pandrea I, 2012, BLOOD, V120, P1357, DOI 10.1182/blood-2012-03-414706; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Paton NI, 2012, JAMA-J AM MED ASSOC, V308, P353, DOI 10.1001/jama.2012.6936; Peters L, 2011, ANTIVIR THER, V16, P667, DOI 10.3851/IMP1815; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Piconi S, 2011, BLOOD, V118, P3263, DOI 10.1182/blood-2011-01-329060; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shen YMP, 2004, CLIN APPL THROMB-HEM, V10, P277, DOI 10.1177/107602960401000311; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Smith MZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-100; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	125	480	493	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					633	645		10.1016/j.immuni.2013.10.001	http://dx.doi.org/10.1016/j.immuni.2013.10.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138880	Green Accepted, Bronze			2022-12-18	WOS:000330950000006
J	Balazs, M; Martin, F; Zhou, T; Kearney, JF				Balazs, M; Martin, F; Zhou, T; Kearney, JF			Blood dendritic cells interact with splenic marginal zone B cells to initiate T-Independent immune responses	IMMUNITY			English	Article							IN-VIVO; LYMPHOCYTE STIMULATOR; GERMINAL-CENTERS; B1B CELLS; ANTIBODIES; ACTIVATION; ANTIGENS; SUBSETS; CD8-ALPHA(+); MACROPHAGES	Marginal zone (MZ) and B1 B lymphocytes participate jointly in the early immune response against T-independent (TI) particulate antigens. Here we show that blood-derived neutrophil granulocytes and CD11c(lo) immature dendritic cells (DC) are the primary cells that efficiently capture and transport particulate bacteria to the spleen. In a systemic infection, CD11c(lo) DC, but not neutrophils, provide critical survival signals, which can be inhibited by TACl-Fc, to antigen-specific MZ B cells and promote their differentiation into IgM-secreting plasmablasts. In a local TI response, peritoneal cavity macrophages provide similar support to B1 B-derived Ag-specific blasts. In the absence of soluble TACl ligands, Ag-activated MZ- and B1-derived blasts lack survival signals and undergo apoptosis, resulting in severely impaired antibody responses.	Univ Alabama, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kearney, JF (corresponding author), Univ Alabama, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.		Kearney, John/GOV-3123-2022		NCI NIH HHS [CA13148] Funding Source: Medline; NIAID NIH HHS [AI4782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Balazs M, 1999, HYBRIDOMA, V18, P177, DOI 10.1089/hyb.1999.18.177; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Carey GB, 2000, IMMUNOL REV, V176, P105; CLAFLIN JL, 1974, J IMMUNOL, V112, P1747; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; OGHISO Y, 1992, J LEUKOCYTE BIOL, V52, P421, DOI 10.1002/jlb.52.4.421; OReilly LA, 1997, J IMMUNOL, V159, P2301; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Segundo C, 2001, THYROID, V11, P525, DOI 10.1089/105072501750302813; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wykes M, 1998, J IMMUNOL, V161, P1313; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	36	479	496	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					341	352		10.1016/S1074-7613(02)00389-8	http://dx.doi.org/10.1016/S1074-7613(02)00389-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354386	Bronze			2022-12-18	WOS:000178163100010
J	Martin, C; Burdon, PCE; Bridger, G; Gutierrez-Ramos, JC; Williams, TJ; Rankin, SM				Martin, C; Burdon, PCE; Bridger, G; Gutierrez-Ramos, JC; Williams, TJ; Rankin, SM			Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence	IMMUNITY			English	Article							FACTOR-I; SURFACE EXPRESSION; LEUKOCYTE SUBSETS; RECEPTOR; MOBILIZATION; ANTAGONIST; HIV-1; CHEMOATTRACTANT; INTERNALIZATION; GRANULOCYTES	In this study we provide evidence that the SDF-1alpha/ CXCR4 chemokine axis is involved in both the retention of neutrophils within the bone marrow and the homing of senescent neutrophils back to the bone marrow. We show that the functional responses of freshly isolated human and murine neutrophils to CXCR2 chemokines are significantly attenuated by SDF-1alpha, acting via CXCR4. As a consequence, the mobilization of neutrophils from the bone marrow in vivo by the CXCR2-chemokine, KC, was dramatically enhanced by blocking the effects of endogenous SDF-1alpha using a specific CXCR4 antagonist. As neutrophils age, they upregulate expression of CXCR4 and acquire the ability to migrate toward SDF-1alpha. We show here that these senescent CXCR4(high) neutrophils preferentially home to the bone marrow in vivo in a CXCR4-dependent manner, suggesting a previously undefined mechanism for the clearance of senescent neutrophils from the circulation.	Imperial Coll Sch Sci Technol & Med, Fac Med, Div Biomed Sci, Leukocyte Biol Sect, London SW7 2AZ, England; Anormed Inc, Langley, BC V2Y 1N5, Canada; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Imperial College London; AnorMED Inc; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Rankin, SM (corresponding author), Imperial Coll Sch Sci Technol & Med, Fac Med, Div Biomed Sci, Leukocyte Biol Sect, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	s.rankin@imperial.ac.uk	martin, coralie/O-3983-2019; Martin, Coralie/N-6293-2018	martin, coralie/0000-0003-3801-2595; 				Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bruhl H, 2001, CLIN EXP IMMUNOL, V126, P551, DOI 10.1046/j.1365-2249.2001.01679.x; Forster R, 1998, J IMMUNOL, V160, P1522; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Haribabu B, 2000, IMMUNOL RES, V22, P271, DOI 10.1385/IR:22:2-3:271; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; HASLETT C, 1985, AM J PATHOL, V119, P101; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Honczarenko M, 2002, BLOOD, V100, P2321, DOI 10.1182/blood-2002-01-0248; Hori T, 1998, J IMMUNOL, V160, P180; JAGELS MA, 1992, J IMMUNOL, V148, P1119; Kowalska MA, 1999, BRIT J HAEMATOL, V104, P220, DOI 10.1046/j.1365-2141.1999.01169.x; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lovas K, 1996, EUR J HAEMATOL, V56, P221; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Nagase H, 2002, J LEUKOCYTE BIOL, V71, P711; Palframan RT, 1998, J EXP MED, V188, P1621, DOI 10.1084/jem.188.9.1621; Patel L, 2001, CYTOKINE, V14, P27, DOI 10.1006/cyto.2000.0851; Richardson RM, 2003, J BIOL CHEM, V278, P15867, DOI 10.1074/jbc.M211745200; Sabroe I, 1999, J IMMUNOL, V162, P2946; SAVERYMUTTU SH, 1985, BRIT J HAEMATOL, V61, P675, DOI 10.1111/j.1365-2141.1985.tb02882.x; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Terashima T, 1998, BLOOD, V92, P1062; THAKUR ML, 1977, J NUCL MED, V18, P1014; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095	33	478	495	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					583	593		10.1016/S1074-7613(03)00263-2	http://dx.doi.org/10.1016/S1074-7613(03)00263-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563322	Bronze			2022-12-18	WOS:000186051900014
J	Vonderheide, RH; Hahn, WC; Schultze, JL; Nadler, LM				Vonderheide, RH; Hahn, WC; Schultze, JL; Nadler, LM			The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes	IMMUNITY			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; POLYVALENT MELANOMA VACCINE; HUMAN EPITHELIAL-CELLS; IMMORTAL CELLS; LIFE-SPAN; IN-VITRO; GENE; LENGTH; CANCER; MAGE-3	The discovery of tumor-associated antigens (TAA) in certain human malignancies has prompted renewed efforts to develop antigen-specific immunotherapy of cancer. However, most TAA described thus far are expressed in one or a few tumor types, and, among patients with these types of tumors, TAA expression is not universal. Here, we characterize the telomerase catalytic subunit (hTERT) as a widely expressed TAA capable of triggering antitumor cytotoxic T lymphocyte (CTL) responses. More than 85% of human cancers exhibit strong telomerase activity, but normal adult tissues, with few exceptions, do not. In a human system, CD8(+) CTL specific for an hTERT peptide and restricted to MHC HLA-A2 lysed hTERT(+) tumors from multiple histologies. These findings identify hTERT as a potentially important and widely applicable target for anticancer immunotherapeutic strategies.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Vonderheide, RH (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.		Schultze, Joachim L./ABA-8176-2020; Schultze, Joachim L/D-7794-2011	Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853	NCI NIH HHS [P01-CA-66996] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; BYSTRYN JC, 1992, CANCER RES, V52, P5948; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; Fujie T, 1997, CLIN CANCER RES, V3, P2425; GREIDER CW, 1995, TELOMERES, P35; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; KLINGELHUTZ AJ, 1994, MOL CELL BIOL, V14, P961, DOI 10.1128/MCB.14.2.961; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Norrback KF, 1997, EUR J CANCER, V33, P774, DOI 10.1016/S0959-8049(97)00059-2; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Ramakrishnan S, 1998, CANCER RES, V58, P622; Reynolds SR, 1997, INT J CANCER, V72, P972; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Stoppler H, 1997, J BIOL CHEM, V272, P13332, DOI 10.1074/jbc.272.20.13332; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P3038, DOI 10.1002/eji.1830241218; VANPEL A, 1995, IMMUNOL REV, V145, P229, DOI 10.1111/j.1600-065X.1995.tb00084.x; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; WEYNANTS P, 1994, INT J CANCER, V56, P826, DOI 10.1002/ijc.2910560612; Yasumoto S, 1996, ONCOGENE, V13, P433	34	478	527	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					673	679		10.1016/S1074-7613(00)80066-7	http://dx.doi.org/10.1016/S1074-7613(00)80066-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403642	Bronze			2022-12-18	WOS:000081209600005
J	Zilionis, R; Engblom, C; Pfirschke, C; Savova, V; Zemmour, D; Saatcioglu, HD; Krishnan, I; Maroni, G; Meyerovitz, CV; Kerwin, CM; Choi, S; Richards, WG; De Rienzo, A; Tenen, DG; Bueno, R; Levantini, E; Pittet, MJ; Klein, AM				Zilionis, Rapolas; Engblom, Camilla; Pfirschke, Christina; Savova, Virginia; Zemmour, David; Saatcioglu, Hatice D.; Krishnan, Indira; Maroni, Giorgia; Meyerovitz, Claire V.; Kerwin, Clara M.; Choi, Sun; Richards, William G.; De Rienzo, Assunta; Tenen, Daniel G.; Bueno, Raphael; Levantini, Elena; Pittet, Mikael J.; Klein, Allon M.			Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species	IMMUNITY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; GENE-EXPRESSION PROFILES; DENDRITIC CELLS; MACROPHAGES; NEUTROPHILS; PATHWAYS; TISSUES	Tumor-infiltrating myeloid cells (TIMs) comprise monocytes, macrophages, dendritic cells, and neutrophils, and have emerged as key regulators of cancer growth. These cells can diversify into a spectrum of states, which might promote or limit tumor outgrowth but remain poorly understood. Here, we used single-cell RNA sequencing (scRNA-seq) to map TIMs in non-small-cell lung cancer patients. We uncovered 25 TIM states, most of which were reproducibly found across patients. To facilitate translational research of these populations, we also profiled TIMs in mice. In comparing TIMs across species, we identified a near-complete congruence of population structures among dendritic cells and monocytes; conserved neutrophil subsets; and species differences among macrophages. By contrast, myeloid cell population structures in patients' blood showed limited overlap with those of TIMs. This study determines the lung TIM landscape and sets the stage for future investigations into the potential of TIMs as immunotherapy targets.	[Zilionis, Rapolas; Savova, Virginia; Klein, Allon M.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Zilionis, Rapolas] Vilnius Univ, Inst Biotechnol, Life Sci Ctr, Vilnius, Lithuania; [Engblom, Camilla; Pfirschke, Christina; Pittet, Mikael J.] Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA; [Engblom, Camilla; Pfirschke, Christina; Meyerovitz, Claire V.; Kerwin, Clara M.; Choi, Sun; Richards, William G.; De Rienzo, Assunta; Bueno, Raphael; Pittet, Mikael J.] Harvard Med Sch, Boston, MA 02115 USA; [Engblom, Camilla; Zemmour, David] Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA; [Savova, Virginia] Sanofi, Precis Immunol Immunol & Inflammat Therapeut Area, Bridgewater, NJ USA; [Zemmour, David] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Saatcioglu, Hatice D.] Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA; [Saatcioglu, Hatice D.] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Krishnan, Indira; Maroni, Giorgia; Tenen, Daniel G.; Levantini, Elena] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Krishnan, Indira; Maroni, Giorgia; Levantini, Elena] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Maroni, Giorgia; Levantini, Elena] Natl Res Council CNR, Inst Biomed Technol, Pisa, Italy; [Meyerovitz, Claire V.; Kerwin, Clara M.; Choi, Sun; Richards, William G.; De Rienzo, Assunta; Bueno, Raphael] Brigham & Womens Hosp, Lung Ctr, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA; [Meyerovitz, Claire V.; Kerwin, Clara M.; Choi, Sun; Richards, William G.; De Rienzo, Assunta; Bueno, Raphael] Brigham & Womens Hosp, Int Mesothelioma Program, 75 Francis St, Boston, MA 02115 USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore	Harvard University; Harvard Medical School; Vilnius University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Sanofi-Aventis; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; National University of Singapore	Savova, V; Klein, AM (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA.; Savova, V (corresponding author), Sanofi, Precis Immunol Immunol & Inflammat Therapeut Area, Bridgewater, NJ USA.	virginia.savova@sanofi.com; mpittet@mgh.harvard.edu; allon_klein@hms.harvard.edu	levantini, elena/AAK-7201-2021; Pittet, Mikael/ABD-6300-2021; Levantini, Elena/AGY-0242-2022	levantini, elena/0000-0003-4612-3105; Maroni, Giorgia/0000-0003-1866-5898; Zemmour, David/0000-0002-0990-217X	Samana Cay Massachusetts General Hospital (MGH) Research Scholar Fund; Robert Wenner Award from the Swiss Cancer League; NIH [R01-AI084880, R01-CA206890, P50-CA86355, R33-CA212697, R01-CA218579, R35CA197697, P01 HL131477-01A1]; Edward J. Mallinckrodt Jr. Fellowship; Boehringer Ingelheim Fonds PhD fellowships; Deutsche Forschungsgemeinschaft [PF809/1-1]; MGH Executive Committee on Research (ECOR) Tosteson Postdoctoral Fellowship; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NCIS Yong Siew Yoon Research Grant; NATIONAL CANCER INSTITUTE [R33CA212697, R01CA218579, R01CA206890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER	Samana Cay Massachusetts General Hospital (MGH) Research Scholar Fund; Robert Wenner Award from the Swiss Cancer League; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward J. Mallinckrodt Jr. Fellowship; Boehringer Ingelheim Fonds PhD fellowships(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MGH Executive Committee on Research (ECOR) Tosteson Postdoctoral Fellowship; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NCIS Yong Siew Yoon Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Harvard Stem Cell Institute for help with FACS sorting; the Single Cell Core Facility at Harvard Medical School for in Drop reagents; the Bauer Core Facility for sequencing; Lucian Chirieac, M.D. for reviewing the H&E slides for the patient tumor samples; Klein and Pittet lab members for helpful discussions; David Pepin for expertise and support with ISH/IHC. This work was supported in part by the Samana Cay Massachusetts General Hospital (MGH) Research Scholar Fund, the Robert Wenner Award from the Swiss Cancer League, and NIH grants R01-AI084880, R01-CA206890, and P50-CA86355 to M.J.P.; NIH grant R33-CA212697 and an Edward J. Mallinckrodt Jr. Fellowship to A.M.K.; NIH grant R01-CA218579 to A.M.K and M.J.P.; Boehringer Ingelheim Fonds PhD fellowships to C.E. and D.Z.; Deutsche Forschungsgemeinschaft PF809/1-1 and MGH Executive Committee on Research (ECOR) Tosteson Postdoctoral Fellowship to C.P.; the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award, NCIS Yong Siew Yoon Research Grant through donations from the Yong Loo Lin Trust, and NIH grants R35CA197697 and P01 HL131477-01A1 to D.G.T.; A.M.K. is a founder of 1CellBio. V.S. is an employee of Sanofi US.	Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bogaert DJA, 2016, J MED GENET, V53, P575, DOI 10.1136/jmedgenet-2015-103690; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Dutertre CA, 2014, CELL IMMUNOL, V291, P3, DOI 10.1016/j.cellimm.2014.08.006; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Guffroy A, 2017, J CLIN IMMUNOL, V37, P715, DOI 10.1007/s10875-017-0434-2; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hou YZ, 2018, PROTEIN CELL, V9, P1027, DOI 10.1007/s13238-018-0505-z; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weinreb C, 2018, BIOINFORMATICS, V34, P1246, DOI 10.1093/bioinformatics/btx792; Wolock S. L., 2018, BIORXIV, DOI [10.1101/357368, DOI 10.1101/357368]; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; 2018, J ALLERGY CLIN IMMUN, V141, P2276, DOI DOI 10.1016/J.JACI.2017.12.988; 2017, IMMUNITY, V46, P849, DOI DOI 10.1016/J.IMMUNI.2017.04.018	46	477	485	13	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1317	+		10.1016/j.immuni.2019.03.009	http://dx.doi.org/10.1016/j.immuni.2019.03.009			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	30979687	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000468429500020
J	Randolph, HE; Barreiro, LB				Randolph, Haley E.; Barreiro, Luis B.			Herd Immunity: Understanding COVID-19	IMMUNITY			English	Editorial Material							CORONAVIRUS	The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has demonstrated the devastating impact of a novel, infectious pathogen on a susceptible population. Here, we explain the basic concepts of herd immunity and discuss its implications in the context of COVID-19.	[Randolph, Haley E.; Barreiro, Luis B.] Univ Chicago, Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Barreiro, Luis B.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Barreiro, Luis B.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Barreiro, LB (corresponding author), Univ Chicago, Genet Genom & Syst Biol, Chicago, IL 60637 USA.; Barreiro, LB (corresponding author), Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA.; Barreiro, LB (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	lbarreiro@uchicago.edu	Barreiro, Luis/I-7772-2015	Randolph, Haley/0000-0003-2044-1180; Barreiro, Luis/0000-0001-9456-367X	National Institute of General Medical Sciences [R01-GM134376]; National Science Foundation [DGE-1746045]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF))	We thank members of the Barreiro lab, Valerie Abadie, Sarah Cobey, Maziar Divangahi, Bana Jabri, William Koval, Joaquin Sanz, and Patrick Wilson for the constructive comments and feedback. This work was supported by grant R01-GM134376 from the National Institute of General Medical Sciences to L.B.B. H.E.R is supported by a National Science Foundation Graduate Research Fellowship (DGE-1746045).	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bao L., 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226, DOI 10.1101/2020.03.13.990226V1, https://doi.org/10.1101/2020.03.13.990226]; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; CEBM: The Centre for Evidence-Based Medicine, 2020, GLOB COV 19 CAS; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mo HY, 2006, RESPIROLOGY, V11, P49, DOI 10.1111/j.1440-1843.2006.00783.x; Nasiri MJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00459; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]	16	476	508	5	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					737	741		10.1016/j.immuni.2020.04.012	http://dx.doi.org/10.1016/j.immuni.2020.04.012			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433946	Green Published, Bronze			2022-12-18	WOS:000535371100008
J	Zigmond, E; Varol, C; Farache, J; Elmaliah, E; Satpathy, AT; Friedlander, G; Mack, M; Shpigel, N; Boneca, IG; Murphy, KM; Shakhar, G; Halpern, Z; Jung, S				Zigmond, Ehud; Varol, Chen; Farache, Julia; Elmaliah, Elinor; Satpathy, Ansuman T.; Friedlander, Gilgi; Mack, Matthias; Shpigel, Nahum; Boneca, Ivo G.; Murphy, Kenneth M.; Shakhar, Guy; Halpern, Zamir; Jung, Steffen			Ly6C(hi) Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells	IMMUNITY			English	Article							CD103(+) DENDRITIC CELLS; REGULATORY T-CELLS; INTESTINAL HOMEOSTASIS; EXPERIMENTAL COLITIS; BACTERIAL-INFECTION; LAMINA-PROPRIA; MACROPHAGES; INFLAMMATION; MICE; RECOGNITION	Ly6C(hi) monocytes seed the healthy intestinal lamina propria to give rise to resident CX(3)CR1(+) macrophages that contribute to the maintenance of gut homeostasis. Here we report on two alternative monocyte fates in the inflamed colon. We showed that CCR2 expression is essential to the recruitment of Ly6C(hi) monocytes to the inflamed gut to become the dominant mononuclear cell type in the lamina propria during settings of acute colitis. In the inflammatory microenvironment, monocytes upregulated TLR2 and NOD2, rendering them responsive to bacterial products to become proinflammatory effector cells. Ablation of Ly6C(hi) monocytes ameliorated acute gut inflammation. With time, monocytes differentiated into migratory antigen-presenting cells capable of priming naive T cells, thus acquiring hallmarks reminiscent of dendritic cells. Collectively, our results highlight cellular dynamics in the inflamed colon and the plasticity of Ly6C(hi) monocytes, marking them as potential targets for inflammatory bowel disease (IBD) therapy.	[Zigmond, Ehud; Farache, Julia; Shakhar, Guy; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Friedlander, Gilgi] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Zigmond, Ehud; Varol, Chen; Elmaliah, Elinor; Halpern, Zamir] Tel Aviv Univ, Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-64239 Tel Aviv, Israel; [Zigmond, Ehud; Varol, Chen; Elmaliah, Elinor; Halpern, Zamir] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Satpathy, Ansuman T.; Murphy, Kenneth M.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Mack, Matthias] Univ Regensburg, Dept Internal Med, D-93042 Regensburg, Germany; [Shpigel, Nahum] Hebrew Univ Jerusalem, Koret Sch Vet Med, Fac Agr, IL-76100 Rehovot, Israel; [Boneca, Ivo G.] Inst Pasteur, Grp Biol & Genet Bacterial Cell Wall, F-75015 Paris, France; [Boneca, Ivo G.] INSERM, Grp Avenir, F-75015 Paris, France	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Washington University (WUSTL); University of Regensburg; Hebrew University of Jerusalem; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Jung, Steffen/K-1409-2012; Boneca, Ivo G/H-1677-2014; Varol, Chen/AAW-4202-2021; Varol, Chen/ABH-6487-2020	Jung, Steffen/0000-0003-4290-5716; Boneca, Ivo G/0000-0001-8122-509X; Satpathy, Ansuman/0000-0002-5167-537X	Leir Charitable Foundation; NanoII project of the EU-FP7 program; Helmsley Foundation; European Research Council [202283]	Leir Charitable Foundation; NanoII project of the EU-FP7 program; Helmsley Foundation; European Research Council(European Research Council (ERC)European Commission)	We would like to thank the staff of the Weizmann Animal facility for excellent animal care. We are grateful to E. Ariel and A. Sharp for help with flow cytometry and sorting and to S. Horn-Saban, A. Weisman, and the staff of the Biological Services unit for the help with the microarray. This work was supported by the Leir Charitable Foundation, the NanoII project of the EU-FP7 program, and the Helmsley Foundation and the European Research Council (ERC starting Grant PGNfromSHAPEtoVIR no202283 to I.G.B.). S.J. is a Helmsley Scholar at the Crohn's & Colitis Foundation.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Cerovic V, 2012, MUCOSAL IMMUNOL; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mukhopadhyay S, 2009, ADV EXP MED BIOL, V653, P1, DOI 10.1109/TENCON.2009.5396176; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Saunders D, 1996, J EXP MED, V184, P2185, DOI 10.1084/jem.184.6.2185; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Zigmond E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028858	55	476	482	2	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					1076	1090		10.1016/j.immuni.2012.08.026	http://dx.doi.org/10.1016/j.immuni.2012.08.026			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23219392	Bronze			2022-12-18	WOS:000312575000015
J	Ghisletti, S; Barozzi, I; Mietton, F; Polletti, S; De Santa, F; Venturini, E; Gregory, L; Lonie, L; Chew, A; Wei, CL; Ragoussis, J; Natoli, G				Ghisletti, Serena; Barozzi, Iros; Mietton, Fiore; Polletti, Sara; De Santa, Francesca; Venturini, Elisa; Gregory, Lorna; Lonie, Lorne; Chew, Adeline; Wei, Chia-Lin; Ragoussis, Jiannis; Natoli, Gioacchino			Identification and Characterization of Enhancers Controlling the Inflammatory Gene Expression Program in Macrophages	IMMUNITY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ETS FAMILY-MEMBERS; HUMAN GENOME; TRANSCRIPTION FACTORS; ULTRACONSERVED ELEMENTS; REGULATORY ELEMENTS; IN-VIVO; ACTIVATION; CBP/P300	Enhancers determine tissue-specific gene expression programs. Enhancers are marked by high histone H3 lysine 4 mono-methylation (H3K4me1) and by the acetyl-transferase p300, which has allowed genome-wide enhancer identification. However, the regulatory principles by which subsets of enhancers become active in specific developmental and/or environmental contexts are unknown. We exploited inducible p300 binding to chromatin to identify, and then mechanistically dissect, enhancers controlling endotoxin-stimulated gene expression in macrophages. In these enhancers, binding sites for the lineage-restricted and constitutive Ets protein PU.1 coexisted with those for ubiquitous stress-inducible transcription factors such as NF-kappa B, IRF, and AP-1. PU.1 was required for maintaining H3K4me1 at macrophage-specific enhancers. Reciprocally, ectopic expression of PU.1 reactivated these enhancers in fibroblasts. Thus, the combinatorial assembly of tissue- and signal-specific transcription factors determines the activity of a distinct group of enhancers. We suggest that this may represent a general paradigm in tissue-restricted and stimulus-responsive gene regulation.	[Ghisletti, Serena; Barozzi, Iros; Mietton, Fiore; Polletti, Sara; De Santa, Francesca; Natoli, Gioacchino] IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Venturini, Elisa] Consortium Genom Technol, I-20135 Milan, Italy; [Gregory, Lorna; Lonie, Lorne; Ragoussis, Jiannis] Univ Oxford, WTCHG, Genom Lab, Oxford OX3 7BN, England; [Chew, Adeline; Wei, Chia-Lin] Genome Inst Singapore, Genome Technol & Biol Grp, Singapore 138672, Singapore	IRCCS European Institute of Oncology (IEO); University of Oxford; Wellcome Centre for Human Genetics; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Natoli, G (corresponding author), IEO, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	gioacchino.natoli@ifom-ieo-campus.it	Natoli, gioacchino/J-2100-2018; De Santa, Francesca/A-2954-2014; Polletti, Sara/K-3948-2018; Barozzi, Iros/GLQ-8907-2022; Natoli, gioacchino/ABB-8679-2020; DE SANTA, FRANCESCA/AAX-5810-2020; Ghisletti, Serena/AAO-6437-2021; Polletti, Sara/AAA-9543-2021; Ragoussis, Ioannis/AAD-9790-2022	De Santa, Francesca/0000-0002-0034-5450; Polletti, Sara/0000-0002-5433-0502; Barozzi, Iros/0000-0003-0690-3473; DE SANTA, FRANCESCA/0000-0002-0034-5450; Polletti, Sara/0000-0002-5433-0502; Ghisletti, Serena/0000-0002-7087-5553; Natoli, Gioacchino/0000-0003-0711-2411; Ragoussis, Ioannis/0000-0002-8515-0934	European Community; Italian Association for Research on Cancer, AIRC; Manetti & Roberts and the Fondazione Umberto Veronesi; NIH ENCODE [1R01HG003521-01]; Agency for Science, Technology and Research (A.STAR) of Singapore; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003521] Funding Source: NIH RePORTER	European Community(European Commission); Italian Association for Research on Cancer, AIRC(Fondazione AIRC per la ricerca sul cancro); Manetti & Roberts and the Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NIH ENCODE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research (A.STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the FP6 and FP7 programs of the European Community (Marie Curie Excellence Grant Trans-Tar to GN; Model-In consortium to G.N. and J.R.); the Italian Association for Research on Cancer, AIRC (G.N.); a donation from Manetti & Roberts and the Fondazione Umberto Veronesi (to G.N.); the NIH ENCODE grant 1R01HG003521-01 (C.L.W.) and the Agency for Science, Technology and Research (A.STAR) of Singapore. We thank B. Amati and F. Ciccarelli (IEO) for comments on the manuscript; T. Graf (CRG, Barcelona) for the PU.1 retroviral expression vectors; the Next Generation Sequencing Team at the Cogentech Consortium (IFOM-IEO Campus) and the sequencing team at GIS for the generation of the ChIPSeq data; M. Cesaroni, L. Fornasari, and G. Gargiulo (IEO) for useful discussions on data analysis. S.G. carried out the H3K4me1 and p300 ChIP-Seq experiments, their validation and the functional assays with the help of S.P. I.B. carried out all computational analyses. F.M. carried out the PU.1 ChIPSeq and its validation and the PU.1 over-expression experiment in 3T3. F.D.S. generated the H3K4me3 data set in collaboration with A.C. and the C.L.W. group. E.V., L.L. and L.G. prepared and ran the ChIP-Seq samples. J.R. supervised the generation of the H3K4me1 data set. GN designed the study and wrote the paper.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 1999, MOL CELL BIOL, V19, P959; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nguyen VT, 2000, J BIOL CHEM, V275, P23674, DOI 10.1074/jbc.M002482200; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	44	476	486	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					317	328		10.1016/j.immuni.2010.02.008	http://dx.doi.org/10.1016/j.immuni.2010.02.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20206554	Bronze			2022-12-18	WOS:000276125400006
J	Brown, GD; Gordon, S				Brown, GD; Gordon, S			Fungal beta-glucans and mammalian immunity	IMMUNITY			English	Review							KAPPA-B ACTIVATION; PATTERN-RECOGNITION; INNATE IMMUNITY; PGG-GLUCAN; RECEPTOR; DECTIN-1; CELLS; (1->3)-BETA-D-GLUCANS; MACROPHAGES; BINDING		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 RE, England	University of Oxford	Brown, GD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Pk Rd, Oxford OX1 RE, England.		brown, gordon/B-4249-2012	brown, gordon/0000-0002-0287-5383				Adams DS, 1997, J LEUKOCYTE BIOL, V62, P865, DOI 10.1002/jlb.62.6.865; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Battle J, 1998, BIOCHEM BIOPH RES CO, V249, P499, DOI 10.1006/bbrc.1998.9175; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; CZOP JK, 1991, J EXP MED, V173, P1511, DOI 10.1084/jem.173.6.1511; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; DiCarlo, 1964, ANN NY ACAD SCI, V118, P233; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; HERRING AC, 2002, IMMUNOLOGY INFECT DI; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; KOZEL TR, 1995, TRENDS MICROBIOL, V3, P295, DOI 10.1016/S0966-842X(00)88957-X; Muller A, 1996, J IMMUNOL, V156, P3418; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Nakagawa Y, 2003, J INFECT DIS, V187, P710, DOI 10.1086/368334; NONO I, 1991, J PHARMACOBIO-DYNAM, V14, P9, DOI 10.1248/bpb1978.14.9; OBAYASHI T, 1995, LANCET, V345, P17, DOI 10.1016/S0140-6736(95)91152-9; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Rylander R, 2000, TOXICOLOGY, V152, P47, DOI 10.1016/S0300-483X(00)00291-2; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Suda M, 1996, FEMS IMMUNOL MED MIC, V15, P93, DOI 10.1111/j.1574-695X.1996.tb00058.x; Takahashi H, 2001, FEMS IMMUNOL MED MIC, V31, P1; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van Burik JAH, 2001, ANNU REV MICROBIOL, V55, P743, DOI 10.1146/annurev.micro.55.1.743; VANSTRIJP JAG, 1993, J IMMUNOL, V151, P3324; Williams DL, 1996, CLIN IMMUNOTHER, V5, P392, DOI 10.1007/BF03259335; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	37	476	512	2	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					311	315		10.1016/S1074-7613(03)00233-4	http://dx.doi.org/10.1016/S1074-7613(03)00233-4			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499107	Bronze			2022-12-18	WOS:000185499800003
J	O'Sullivan, D; van der Windt, GJW; Huang, SCC; Curtis, JD; Chang, CH; Buck, MD; Qiu, J; Smith, AM; Lam, WY; DiPlato, LM; Hsu, FF; Birnbaum, MJ; Pearce, EJ; Pearce, EL				O'Sullivan, David; van der Windt, Gerritje J. W.; Huang, Stanley Ching-Cheng; Curtis, Jonathan D.; Chang, Chih-Hao; Buck, Michael D.; Qiu, Jing; Smith, Amber M.; Lam, Wing Y.; DiPlato, Lisa M.; Hsu, Fong-Fu; Birnbaum, Morris J.; Pearce, Edward J.; Pearce, Erika L.			Memory CD8(+) T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development	IMMUNITY			English	Article							FATTY-ACID-METABOLISM; LIPID-METABOLISM; ADIPOSE-TISSUE; LIFE-SPAN; ACTIVATION; OXIDATION; PROTEINS; PROLIFERATION; BIOGENESIS; CATABOLISM	Generation of CD8(+) memory T cells requires metabolic reprogramming that is characterized by enhanced mitochondrial fatty-acid oxidation (FAO). However, where the fatty acids (FA) that fuel this process come from remains unclear. While CD8(+) memory T cells engage FAO to a greater extent, we found that they acquired substantially fewer long-chain FA from their external environment than CD8(+) effector T (Teff) cells. Rather than using extracellular FA directly, memory T cells used extracellular glucose to support FAO and oxidative phosphorylation (OX-PHOS), suggesting that lipids must be synthesized to generate the substrates needed for FAO. We have demonstrated that memory T cells rely on cell intrinsic expression of the lysosomal hydrolase LAL (lysosomal acid lipase) to mobilize FA for FAO and memory T cell development. Our observations link LAL to metabolic reprogramming in lymphocytes and show that cell intrinsic lipolysis is deterministic for memory T cell fate.	[O'Sullivan, David; van der Windt, Gerritje J. W.; Huang, Stanley Ching-Cheng; Curtis, Jonathan D.; Chang, Chih-Hao; Buck, Michael D.; Qiu, Jing; Smith, Amber M.; Lam, Wing Y.; Pearce, Edward J.; Pearce, Erika L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [DiPlato, Lisa M.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Hsu, Fong-Fu] Washington Univ, Dept Internal Med, Div Endocrinol Diabet Metab & Lipid Res, Mass Spectrometry Resource,Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); University of Pennsylvania; Washington University (WUSTL)	Pearce, EL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	erikapearce@path.wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Hsu, Fong-Fu/0000-0001-5368-0183; Birnbaum, Morris/0000-0001-9972-8680; CHANG, CHIH-HAO/0000-0002-0139-7439; Buck, Michael/0000-0002-9611-1199	NIH [AI091965, CA158823, CA164062]; NATIONAL CANCER INSTITUTE [R01CA164062, R21CA158823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Guenther Haemmerle and Rudolf Zechner for the Pnpla2<SUP>-/-</SUP> mice, Nathan Wolins for reagents and advice, Babak Razani for helpful discussion, Wandy Beatty (Molecular Microbiology Imaging Facility), Erica Lantelme, Dorjan Brinja, Hui Jiang, Dave Scherrer, and the Endocrinology, Metabolism and Lipid Research Mass Spectrometry Resource for technical support. The work was supported by NIH grants AI091965, CA158823 (to E.L.P), and CA164062 (to E.J.P.).	Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bowden KL, 2011, J BIOL CHEM, V286, P30624, DOI 10.1074/jbc.M111.274381; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Camus G, 2013, METHOD CELL BIOL, V116, P167, DOI 10.1016/B978-0-12-408051-5.00009-7; Caro-Maldonado A, 2012, SEMIN IMMUNOL, V24, P405, DOI 10.1016/j.smim.2012.12.002; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; DHALLA NS, 1992, MOL CELL BIOCHEM, V116, P3, DOI 10.1007/BF01270562; Dulloo AG, 2004, INT J OBESITY, V28, pS29, DOI 10.1038/sj.ijo.0802861; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Flis V.V., 2013, COLD SPRING HARB PER, V5; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; O'Rourke EJ, 2013, GENE DEV, V27, P429, DOI 10.1101/gad.205294.112; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Qu P, 2009, AM J PATHOL, V174, P944, DOI 10.2353/ajpath.2009.080562; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; TOMODA H, 1995, J ANTIBIOT, V48, P937, DOI 10.7164/antibiotics.48.937; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg JM, 2011, J AM SOC NEPHROL, V22, P431, DOI 10.1681/ASN.2010060643; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014	64	472	473	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					75	88		10.1016/j.immuni.2014.06.005	http://dx.doi.org/10.1016/j.immuni.2014.06.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25001241	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000341444200012
J	Nakaya, M; Xiao, YC; Zhou, XF; Chang, JH; Chang, M; Cheng, XH; Blonska, M; Lin, X; Sun, SC				Nakaya, Mako; Xiao, Yichuan; Zhou, Xiaofei; Chang, Jae-Hoon; Chang, Mikyoung; Cheng, Xuhong; Blonska, Marzenna; Lin, Xin; Sun, Shao-Cong			Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation	IMMUNITY			English	Article							NF-KAPPA-B; MAMMALIAN TARGET; TRANSLATIONAL CONTROL; GLUCOSE-UPTAKE; C-MYC; DIFFERENTIATION; RAPAMYCIN; METABOLISM; EFFECTOR; GLUT1	Glutamine has been implicated as an immunomodulatory nutrient, but how glutamine uptake is mediated during T cell activation is poorly understood. We have shown that naive T cell activation is coupled with rapid glutamine uptake, which depended on the amino acid transporter ASCT2. ASCT2 deficiency impaired the induction of T helper 1 (Th1) and Th17 cells and attenuated inflammatory T cell responses in mouse models of immunity and autoimmunity. Mechanistically, ASCT2 was required for T cell receptor (TCR)-stimulated activation of the metabolic kinase mTORC1. We have further shown that TCR-stimulated glutamine uptake and mTORC1 activation also required a TCR signaling complex composed of the scaffold protein CARMA1, the adaptor molecule BCL10, and the paracaspase MALT1. This function was independent of IKK kinase, a major downstream target of the CARMA1 complex. These findings highlight a mechanism of T cell activation involving ASCT2-dependent integration of the TCR signal and a metabolic signaling pathway.	[Nakaya, Mako; Xiao, Yichuan; Zhou, Xiaofei; Chang, Jae-Hoon; Chang, Mikyoung; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Blonska, Marzenna; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lin, Xin; Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Chang, Jae-Hoon] Yeungnam Univ, Coll Pharm, Kyongsan 712749, South Korea	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Yeungnam University	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin St,Box 902, Houston, TX 77030 USA.	ssun@mdanderson.org	Blonska, Marzenna/U-7751-2019; zhou, xiaofei/A-9844-2013	Blonska, Marzenna/0000-0001-5237-8732	NIH/NCI [P30CA016672]; National Institutes of Health [AI057555, AI064639, GM84459, AI104519]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R37AI064639, R01AI104519, R01AI057555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899, R01GM084459] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Pasparakis, J. Penninger, S. Morris, V. Dixit, and Genentech for genetically ablated mouse strains. We also thank the personnel from the NIH/NCI-supported resources (flow cytometry, DNA analysis, histology, and animal facilities) under award number P30CA016672 at The MD Anderson Cancer Center. This study was supported by grants from the National Institutes of Health (AI057555, AI064639, GM84459, and AI104519).	Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kaadige MR, 2010, TRANSCR-AUSTIN, V1, P36, DOI 10.4161/trns.1.1.12142; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Karinch AM, 2001, J NUTR, V131, p2535S, DOI 10.1093/jn/131.9.2535S; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; LUND P, 1985, BRIT MED BULL, V41, P251, DOI 10.1093/oxfordjournals.bmb.a072059; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Miller S. D., 2010, CURR PROTOC IMMUNOL; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; TAHA C, 1995, J BIOL CHEM, V270, P24678, DOI 10.1074/jbc.270.42.24678; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	42	471	485	7	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					692	705		10.1016/j.immuni.2014.04.007	http://dx.doi.org/10.1016/j.immuni.2014.04.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24792914	Green Accepted, Bronze			2022-12-18	WOS:000336026100009
J	Srivastava, PK; Menoret, A; Basu, S; Binder, RJ; McQuade, KL				Srivastava, PK; Menoret, A; Basu, S; Binder, RJ; McQuade, KL			Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world	IMMUNITY			English	Review							CLASS-I MOLECULES; CYTOLYTIC T-LYMPHOCYTES; STRESS-INDUCED PROTEINS; TRANSPLANTATION ANTIGEN; PEPTIDE-BINDING; TUMOR REJECTION; RESTRICTED ANTIGEN; IMMUNE-RESPONSE; HUMAN-MELANOMA; CELLS		Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA	University of Connecticut	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA.	srivastava@nso2.uchc.edu						Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Arnold D, 1997, J EXP MED, V186, P461, DOI 10.1084/jem.186.3.461; ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; BARRIOS C, 1992, EUR J IMMUNOL, V22, P1365, DOI 10.1002/eji.1830220606; BASOMBRIO MA, 1970, CANCER RES, V30, P2458; Beck G, 1996, SCI AM, V275, P60, DOI 10.1038/scientificamerican1196-60; Bellone M, 1997, J IMMUNOL, V159, P5391; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BLACHERE NE, 1993, J IMMUNOTHER, V14, P352, DOI 10.1097/00002371-199311000-00016; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; Coggin J H Jr, 1974, Adv Cancer Res, V19, P105, DOI 10.1016/S0065-230X(08)60053-6; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; DONAWHO C, 1990, CANCER COMMUN, V2, P101, DOI 10.3727/095535490820874597; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FREY AB, 1995, J IMMUNOL, V155, P4783; GLOBERSON A, 1964, J NATL CANCER I, V32, P1229, DOI 10.1093/jnci/32.6.1229; Gross L, 1943, CANCER RES, V3, P326; Heikema A, 1997, IMMUNOL LETT, V57, P69, DOI 10.1016/S0165-2478(97)00048-5; Hickey RJ, 1997, CRIT REV EUKAR GENE, V7, P125, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.80; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; HUGHES EA, 1998, IN PRESS CURR BIOL; JANETZKI S, 1998, IN PRESS J IMMUNOTHE; KLEIN G, 1960, CANCER RES, V20, P1561; Lammert E, 1997, EUR J IMMUNOL, V27, P1685, DOI 10.1002/eji.1830270714; Lammert E, 1997, EUR J IMMUNOL, V27, P923, DOI 10.1002/eji.1830270418; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MANDELBOIM O, 1995, NAT MED, V1, P1179, DOI 10.1038/nm1195-1179; Marusina K, 1997, BIOCHEMISTRY-US, V36, P856, DOI 10.1021/bi9619738; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; MENORET A, 1995, J IMMUNOL, V155, P740; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; Neisig A, 1996, J IMMUNOL, V156, P3196; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; NOSSNER E, 1995, J EXP MED, V181, P327, DOI 10.1084/jem.181.1.327; OLD LJ, 1981, CANCER RES, V41, P361; OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Ottaviani E, 1997, IMMUNOL TODAY, V18, P169, DOI 10.1016/S0167-5699(97)84663-4; PALLADINO MA, 1987, CANCER RES, V47, P5074; Peng P, 1997, J IMMUNOL METHODS, V204, P13, DOI 10.1016/S0022-1759(97)00017-3; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; PREHN RT, 1957, J NATL CANCER I, V18, P769; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; ROHRER JW, 1994, J IMMUNOL, V152, P754; Roman E, 1997, IMMUNOLOGY, V90, P52, DOI 10.1046/j.1365-2567.1997.00136.x; Roman RC, 1996, DANCE MAG, V70, P88; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; Srivastava P K, 1991, Semin Immunol, V3, P57; SRIVASTAVA PK, 1984, INT J CANCER, V33, P417, DOI 10.1002/ijc.2910330321; SRIVASTAVA PK, 1991, CURR TOP MICROBIOL, V167, P109; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; SRIVASTAVA PK, 1988, IMMUNOL TODAY, V9, P78, DOI 10.1016/0167-5699(88)91269-8; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; UDONO H, 1994, J IMMUNOL, V152, P5398; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Wearsch PA, 1998, BIOCHEMISTRY-US, V37, P5709, DOI 10.1021/bi9801006; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Wells AD, 1997, SCAND J IMMUNOL, V45, P605, DOI 10.1046/j.1365-3083.1997.d01-436.x; WILLIAMS DB, 1995, CURR OPIN IMMUNOL, V7, P77, DOI 10.1016/0952-7915(95)80032-8; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	87	471	520	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1998	8	6					657	665		10.1016/S1074-7613(00)80570-1	http://dx.doi.org/10.1016/S1074-7613(00)80570-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655479	Bronze			2022-12-18	WOS:000074396300001
J	Chaussabel, D; Quinn, C; Shen, J; Patel, P; Glaser, C; Baldwin, N; Stichweh, D; Blankenship, D; Li, L; Munagala, I; Bennett, L; Allantaz, F; Mejias, A; Ardura, M; Kaizer, E; Monnet, L; Allman, W; Randall, H; Johnson, D; Lanier, A; Punaro, M; Wittkowski, KM; White, P; Fay, J; Klintmalm, G; Ramilo, O; Palucka, AK; Banchereau, J; Pascual, V				Chaussabel, Damien; Quinn, Charles; Shen, Jing; Patel, Pinakeen; Glaser, Casey; Baldwin, Nicole; Stichweh, Dorothee; Blankenship, Derek; Li, Lei; Munagala, Indira; Bennett, Lynda; Allantaz, Florence; Mejias, Asuncion; Ardura, Monica; Kaizer, Ellen; Monnet, Laurence; Allman, Windy; Randall, Henry; Johnson, Diane; Lanier, Aimee; Punaro, Marilynn; Wittkowski, Knut M.; White, Perrin; Fay, Joseph; Klintmalm, Goran; Ramilo, Octavio; Palucka, A. Karolina; Banchereau, Jacques; Pascual, Virginia			A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus	IMMUNITY			English	Article							CLINICAL-DISEASE ACTIVITY; GENE-EXPRESSION; MOLECULAR CLASSIFICATION; TRANSCRIPTIONAL PROFILES; MICROARRAY ANALYSIS; MONONUCLEAR-CELLS; INTERFERON; CANCER; SIGNATURES; REPRODUCIBILITY	The analysis of patient blood transcriptional profiles offers a means to investigate the immunological mechanisms relevant to human diseases on a genome-wide scale. In addition, such studies provide a basis for the discovery of clinically relevant biomarker signatures. We designed a strategy for microarray analysis that is based on the identification of transcriptional modules formed by genes coordinately expressed in multiple disease data sets. Mapping changes in gene expression at the module level generated disease-specific transcriptional fingerprints that provide a stable framework for the visualization and functional interpretation of microarray data. These transcriptional modules were used as a basis for the selection of biomarkers and the development of a multivariate transcriptional indicator of disease progression in patients with systemic lupus erythematosus. Thus, this work describes the implementation and application of a methodology designed to support systems-scale analysis of the human immune system in translational research settings.	[Chaussabel, Damien; Quinn, Charles; Shen, Jing; Patel, Pinakeen; Glaser, Casey; Baldwin, Nicole; Stichweh, Dorothee; Li, Lei; Munagala, Indira; Bennett, Lynda; Allantaz, Florence; Monnet, Laurence; Allman, Windy; Fay, Joseph; Palucka, A. Karolina; Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Baylor NIAID Cooperat Ctr Translat Res Human Immu, Dallas, TX 75204 USA; [Chaussabel, Damien; Quinn, Charles; Shen, Jing; Patel, Pinakeen; Glaser, Casey; Baldwin, Nicole; Stichweh, Dorothee; Li, Lei; Munagala, Indira; Bennett, Lynda; Allantaz, Florence; Monnet, Laurence; Allman, Windy; Fay, Joseph; Palucka, A. Karolina; Banchereau, Jacques; Pascual, Virginia] Baylor Res Inst, Dallas, TX 75204 USA; [Patel, Pinakeen] Baylor Univ, Inst Biomed Studies, Waco, TX 75798 USA; [Blankenship, Derek] Baylor Hlth Care System, Inst Hlth Care Res & Improvement, Dallas, TX 75204 USA; [Mejias, Asuncion; Ardura, Monica; Kaizer, Ellen; Punaro, Marilynn; White, Perrin; Ramilo, Octavio] UT SW Med Ctr, Dallas, TX 75235 USA; [Mejias, Asuncion; Ardura, Monica; Kaizer, Ellen; Punaro, Marilynn; White, Perrin; Ramilo, Octavio] Childrens Med Ctr, Dallas, TX 75235 USA; [Randall, Henry; Johnson, Diane; Lanier, Aimee; Klintmalm, Goran] Baylor Reg Transplant Inst, Dallas, TX 75219 USA; [Punaro, Marilynn; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Wittkowski, Knut M.] Rockefeller Univ, New York, NY 10021 USA; [Fay, Joseph] Charles A Sammons Canc Ctr, Dallas, TX 75204 USA	Baylor Scott & White Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor Scott & White Health; Baylor University Medical Center; Baylor University; Baylor Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University Medical Center; Texas Scottish Rite Hospital for Children; Rockefeller University; Baylor University Medical Center	Chaussabel, D (corresponding author), Baylor Inst Immunol Res, Baylor NIAID Cooperat Ctr Translat Res Human Immu, Dallas, TX 75204 USA.	damienc@baylorhealth.edu; jacquesb@baylorhealth.edu	Ardura, Monica/AHA-7339-2022; Randall, Henry/Q-2985-2019; Chaussabel, Damien/AAX-1909-2020; Mejias, Maria Asuncion/E-3659-2011; Mejias, Asuncion/AAC-5998-2019; Pascual, Virginia/ABD-3099-2020	Ardura, Monica/0000-0002-2853-2581; Mejias, Asuncion/0000-0002-5983-8006; Chaussabel, Damien/0000-0002-6131-7242; Bennett, Lynda/0000-0001-7491-5797	NATIONAL CANCER INSTITUTE [P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, R01AI068842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050770, P50AR054083, P50AR055503] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA084512-01A10003, P01 CA084512-070005, R01 CA078846-01A1, R01 CA078846-06, P01 CA084512-06, R01 CA078846-10, P01 CA084512, P01 CA084512-05A29004, P01 CA084512-079004, R01 CA078846-08, R01 CA078846-05, P01 CA084512-05A2, P01 CA084512-079002, P01 CA084512-069002, R01 CA078846-09, P01 CA084512-07, P01 CA084512-040003, P01 CA084512-020003, P01 CA084512-05A29002, P01 CA084512-05A20005, R01 CA078846, R01 CA078846-04, P01 CA084512-060005, R01 CA078846-03, R01 CA078846-02, R01 CA078846-07, P01 CA084512-030003, P01 CA084512-069004] Funding Source: Medline; NIAID NIH HHS [R01 AI068842-02, R01 AI068842-01, U19 AI057234-010004, U19 AI057234-05S10013, U19 AI057234-05S19003, U19 AI057234-06, U19 AI057234-02, U19 AI057234-05S10012, U19 AI057234-010006, U19 AI057234-04, U19 AI057234-05S1, R01 AI068842-03, U19 AI057234-05, U19 AI057234-010005, R01 AI068842, R01 AI068842-04, U19 AI057234, U19 AI057234-03, U19 AI057234-01] Funding Source: Medline; NIAMS NIH HHS [R01 AR050770-06, R01 AR050770-03, P50 AR054083-019001, R01 AR050770-04, P50 AR054083-020001, P50 AR055503-020004, R01 AR050770, R01 AR050770-01, R01 AR050770-02, P50 AR054083-01, R01 AR050770-05A1, P50 AR054083-03, P50 AR054083-029001, P50 AR055503-010004, P50 AR054083, P50 AR054083-02, P50 AR055503, P50 AR054083-030001, P50 AR054083-010001] Funding Source: Medline; PHS HHS [U19 AIO57234-02, R01 I068842] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Bae SC, 2001, LUPUS, V10, P405, DOI 10.1191/096120301678646146; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Balding DJ, 2004, APPL LONGITUDINAL AN; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; BIGGS NL, 1986, NATURE, V406, P536; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bosotti R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S5; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Chaussabel D, 2002, GENOME BIOL, V3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Frantz S, 2005, NAT REV DRUG DISCOV, V4, P362, DOI 10.1038/nrd1746; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HAY EM, 1993, Q J MED, V86, P447; Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Petri M, 1999, LUPUS, V8, P685, DOI 10.1191/096120399680411281; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Steinman RM, 2004, SCIENCE, V305, P197, DOI 10.1126/science.1099688; THACH DC, 2005, SURVEILLANCE TRANSCR; Verbeke G, 2000, LINEAR MIXED MODELS; Wittkowski KM, 2004, STAT MED, V23, P1579, DOI 10.1002/sim.1778	42	470	485	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					150	164		10.1016/j.immuni.2008.05.012	http://dx.doi.org/10.1016/j.immuni.2008.05.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631455	Green Accepted, Bronze			2022-12-18	WOS:000257905400018
J	Hammad, H; Lambrecht, BN				Hammad, Hamida; Lambrecht, Bart N.			Barrier Epithelial Cells and the Control of Type 2 Immunity	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; HOUSE-DUST MITE; THYMIC STROMAL LYMPHOPOIETIN; ALLERGIC AIRWAY INFLAMMATION; MUCIN GENE-EXPRESSION; NATURAL HELPER-CELLS; DENDRITIC CELLS; ATOPIC-DERMATITIS; SKIN BARRIER; URIC-ACID	Type-2-cell-mediated immunity, rich in eosinophils, basophils, mast cells, CD4(+) T helper 2 (Th2) cells, and type 2 innate lymphoid cells (ILC2s), protects the host from helminth infection but also drives chronic allergic diseases like asthma and atopic dermatitis. Barrier epithelial cells (ECs) represent the very first line of defense and express pattern recognition receptors to recognize type-2-cell-mediated immune insults like proteolytic allergens or helminths. These ECs mount a prototypical response made up of chemokines, innate cytokines such as interleukin-1 (IL-1), IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), as well as the alarmins uric acid, ATP, HMGB1, and S100 proteins. These signals program dendritic cells (DCs) to mount Th2-cell-mediated immunity and in so doing boost ILC2, basophil, and mast cell function. Here we review the general mechanisms of how different stimuli trigger type-2-cell-mediated immunity at mucosal barriers and how this leads to protection or disease.	[Hammad, Hamida; Lambrecht, Bart N.] VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Dept Resp Med, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, NL-3015 GE Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Erasmus University Rotterdam; Erasmus MC	Hammad, H (corresponding author), VIB Inflammat Res Ctr, Technol Pk 927, B-9052 Ghent, Belgium.	hamida.hammad@irc.vib-ugent.be; bart.lambrecht@irc.vib-ugent.be	Hammad, Hamida/J-9391-2015; Lambrecht, Bart N/K-2484-2014	Hammad, Hamida/0000-0003-3762-8603; Lambrecht, Bart N/0000-0003-4376-6834				Aich J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1880; Akbari M, 2014, J IMMUNOL, V192, P2271, DOI 10.4049/jimmunol.1301914; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Ather JL, 2011, AM J RESP CELL MOL, V44, P631, DOI 10.1165/rcmb.2010-0106OC; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bleck B., 2015, J ALLERGY CLIN IMMUN; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bleck B, 2010, J IMMUNOL, V185, P6636, DOI 10.4049/jimmunol.1000719; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bousquet J, 2014, J ALLERGY CLIN IMMUN, V133, P1535, DOI 10.1016/j.jaci.2014.01.018; Brandelius A, 2011, PULM PHARMACOL THER, V24, P59, DOI 10.1016/j.pupt.2010.10.004; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Cheng D, 2014, AM J RESP CRIT CARE, V190, P639, DOI 10.1164/rccm.201403-0505OC; Chiu LL, 2007, J IMMUNOL, V178, P5237, DOI 10.4049/jimmunol.178.8.5237; Chu DK, 2014, J EXP MED, V211, P1657, DOI 10.1084/jem.20131800; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Dai XJ, 2011, J ALLERGY CLIN IMMUN, V127, P806, DOI 10.1016/j.jaci.2010.12.006; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Di WL, 2009, BRIT J DERMATOL, V161, P404, DOI 10.1111/j.1365-2133.2009.09231.x; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Duong K.M., 2015, AM J RESP CELL MOL B; El Bakkouri K, 2005, J BIOL CHEM, V280, P17938, DOI 10.1074/jbc.M413588200; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fang CL, 2015, CLIN EXP ALLERGY, V45, P940, DOI 10.1111/cea.12481; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hara K, 2014, J IMMUNOL, V192, P4032, DOI 10.4049/jimmunol.1400110; Harada C, 2011, AM J RESP CRIT CARE, V183, P743, DOI 10.1164/rccm.201002-0188OC; Hasnain SZ, 2011, PARASITE IMMUNOL, V33, P45, DOI 10.1111/j.1365-3024.2010.01258.x; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herre J, 2013, J IMMUNOL, V191, P1529, DOI 10.4049/jimmunol.1300284; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Jin S, 2014, EXP DERMATOL, V23, P938, DOI 10.1111/exd.12563; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Kelly C, 2011, AM J RESP CELL MOL, V44, P743, DOI 10.1165/rcmb.2010-0339TR; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Krimi RB, 2008, INFLAMM BOWEL DIS, V14, P931, DOI 10.1002/ibd.20420; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kumar RK, 2014, J LEUKOCYTE BIOL, V96, P391, DOI [10.1189/jlb.3RI0314-129R, 10.118]; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2014, IMMUNITY, V40, P313, DOI 10.1016/j.immuni.2014.02.010; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Lee SE, 2010, YONSEI MED J, V51, P808, DOI 10.3349/ymj.2010.51.6.808; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Llop-Guevara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088714; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mocsai G, 2014, BRIT J DERMATOL, V170, P617, DOI 10.1111/bjd.12743; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nikolaidis NM, 2003, AM J RESP CELL MOL, V29, P458, DOI 10.1165/rcmb.2002-0309OC; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Grady SM, 2013, J PHYSIOL-LONDON, V591, P4595, DOI 10.1113/jphysiol.2013.254649; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Patel DA, 2014, J ALLERGY CLIN IMMUN, V134, P1402, DOI 10.1016/j.jaci.2014.07.013; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Richard AC, 2015, J IMMUNOL, V194, P3567, DOI 10.4049/jimmunol.1401220; Ring J, 2012, CHEM IMMUNOL ALLERGY, V96, P24, DOI 10.1159/000331807; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sekiya T, 2000, J IMMUNOL, V165, P2205, DOI 10.4049/jimmunol.165.4.2205; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Simon D, 2015, ALLERGY, V70, P443, DOI 10.1111/all.12570; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Spann KM, 2014, THORAX, V69, P918, DOI 10.1136/thoraxjnl-2013-204908; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Stremnitzer C, 2015, J INVEST DERMATOL, V135, P1790, DOI 10.1038/jid.2015.58; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018; Takai T, 2014, METHOD ENZYMOL, V535, P371, DOI 10.1016/B978-0-12-397925-4.00021-3; Tamagawa-Mineoka R, 2014, J AM ACAD DERMATOL, V70, P882, DOI 10.1016/j.jaad.2014.01.867; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tully JE, 2013, J IMMUNOL, V191, P5811, DOI 10.4049/jimmunol.1301329; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Ullah MA, 2014, J ALLERGY CLIN IMMUN, V134, P440, DOI 10.1016/j.jaci.2013.12.1035; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yockey LJ, 2013, J INVEST DERMATOL, V133, P2714, DOI 10.1038/jid.2013.228; Yu X, 2014, MUCOSAL IMMUNOL, V7, P730, DOI 10.1038/mi.2013.92; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	135	469	486	10	135	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					29	40		10.1016/j.immuni.2015.07.007	http://dx.doi.org/10.1016/j.immuni.2015.07.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200011	Bronze			2022-12-18	WOS:000360101100008
J	Rao, RR; Li, QS; Odunsi, K; Shrikant, PA				Rao, Rajesh R.; Li, Qingsheng; Odunsi, Kunle; Shrikant, Protul A.			The mTOR Kinase Determines Effector versus Memory CD8(+) T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin	IMMUNITY			English	Article							CUTTING EDGE; IN-VIVO; LINEAGE COMMITMENT; DIFFERENTIATION; IL-12; ACTIVATION; IMMUNITY; GROWTH; IFN; TOR	The mechanisms underpinning integration of instructions that program naive CD8(+) T cells for effector and/or memory differentiation are not well understood. Herein, we demonstrate that interieukin-12 (IL-12) enhanced and sustained antigen and costimulatory molecule (B7.1)-induced mTOR kinase activity in naive CD8(+) (OT-I) T cells via phosphoinositide 3-kinase and STAT4 transcription factor pathways. Blocking mTOR activity by rapamycin reversed IL-12-induced effector functions because of loss of persistent expression of the transcription factor T-bet. Rapamycin treatment of IL-12-conditioned OT-I cells promoted persistent Eomesodermin expression and produced memory cell precursors that demonstrated enhanced sustenance and antigen-recall responses upon adoptive transfer. The memory cell precursors showed greater tumor efficacy than IL-12-conditioned effector OT-I cells. These results identify mTOR as the central regulator of transcriptional programs that determine effector and/or memory cell fates in CD8(+) T cells. Targeting mTOR activity offers new opportunities to regulate CD8(+) T cell-mediated immunity.	[Rao, Rajesh R.; Li, Qingsheng; Shrikant, Protul A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Shrikant, PA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	protul.shrikant@roswellpark.org			NIH-NCI [RO1 CA104645]; Alliance Foundation of Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA104645, P30CA016056, R01CA158318] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alliance Foundation of Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to entire Shrikant laboratory and Drs. Y. Liu, J. Kesterson, N. Yu, and C. Eppolito for their assistance. The advice from Drs. J. Powell (JHU) and N. Bangia (RPCI) on these studies is appreciated. Our special thanks to Dr. Laurent Gapin, National Jewish Health, University of Colorado, for providing us with T-bet-ER retroviral vector. This work was supported by the grants from NIH-NCI (RO1 CA104645) and Alliance Foundation of Roswell Park Cancer Institute (P.A.S.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Goldberg J, 2003, J IMMUNOL, V170, P228, DOI 10.4049/jimmunol.170.1.228; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li QS, 2006, J IMMUNOL, V177, P7618, DOI 10.4049/jimmunol.177.11.7618; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Welsh RM, 2009, IMMUNITY, V31, P178, DOI 10.1016/j.immuni.2009.08.005; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Yoo JK, 2002, J IMMUNOL, V169, P3637, DOI 10.4049/jimmunol.169.7.3637; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	40	469	476	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					67	78		10.1016/j.immuni.2009.10.010	http://dx.doi.org/10.1016/j.immuni.2009.10.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20060330	Green Accepted, Bronze			2022-12-18	WOS:000274119900012
J	Urban, JF; Noben-Trauth, N; Donaldson, DD; Madden, KB; Morris, SC; Collins, M; Finkelman, FD				Urban, JF; Noben-Trauth, N; Donaldson, DD; Madden, KB; Morris, SC; Collins, M; Finkelman, FD			IL-13, IL-4R alpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis	IMMUNITY			English	Article							RECEPTOR-ALPHA CHAIN; COMMON GAMMA-CHAIN; INTERLEUKIN-4 RECEPTOR; MONOCLONAL-ANTIBODIES; SIGNAL-TRANSDUCTION; TRICHINELLA-SPIRALIS; PROTECTIVE IMMUNITY; RAPID EXPULSION; BINDING SUBUNIT; IGE RESPONSE	Although IL-4 induces expulsion of the gastrointestinal nematode parasite, Nippostrongylus brasiliensis, from immunodeficient mice, this parasite is expelled normally by IL-4-deficient mice. This apparent paradox is explained by observations that IL-4 receptor alpha chain (IL-4R alpha)-deficient mice and Stat6-deficient mice fail to expel N. brasiliensis, and a specific antagonist for IL-13, another activator of Stat6 through IL-4R alpha, prevents worm expulsion. Thus, N. brasiliensis expulsion requires signaling via IL-4R alpha and State, and IL-13 may be more important than IL-4 as an inducer of the State signaling that leads to worm expulsion. Additional observations made in the course of these experiments demonstrate that State signaling is not required for IL-4 enhancement of IgG1 production and actually inhibits IL-4-induction of mucosal mastocytosis.	Univ Cincinnati, Coll Med, Div Immunol, Cincinnati, OH 45267 USA; USDA, Beltsville, MD 20705 USA; NIH, Immunol Lab, Rockville, MD 20852 USA; Genet Inst, Cambridge, MA 02140 USA; Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; Vet Adm Med Ctr, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; Uniformed Services University of the Health Sciences - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Finkelman, FD (corresponding author), Univ Cincinnati, Coll Med, Div Immunol, Cincinnati, OH 45267 USA.	ffinkelman@mem.po.com		Urban, Joseph/0000-0002-1590-8869	NIAID NIH HHS [R01 AI37180, R01 AI35987] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035987, R01AI037180] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMAD A, 1991, J IMMUNOL, V146, P3563; APPLETON JA, 1987, IMMUNOLOGY, V62, P477; BANCROFT AJ, 1997, BIRT SOC PAR SPRING, P57; BANIYASH M, 1984, EUR J IMMUNOL, V14, P797; BECKMANN MP, 1990, J IMMUNOL, V144, P4212; Berton M. T., 1997, Journal of Allergy and Clinical Immunology, V99, pS259; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; ESHHAR Z, 1980, J IMMUNOL, V124, P775; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; FINKELMAN FD, 1994, J EXP MED, V179, P1563, DOI 10.1084/jem.179.5.1563; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; FINKELMAN FD, 1982, J IMMUNOL, V129, P638; HE YW, 1995, J IMMUNOL, V154, P1596; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HIRAYAMA N, 1982, P NATL ACAD SCI-BIOL, V79, P613, DOI 10.1073/pnas.79.2.613; INAGAKI N, 1988, J PHARMACOBIO-DYNAM, V11, P31, DOI 10.1248/bpb1978.11.31; JONES RE, 1994, EXP PARASITOL, V78, P64, DOI 10.1006/expr.1994.1006; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KATONA IM, 1988, J IMMUNOL, V140, P3206; KATONA IM, 1983, J IMMUNOL, V130, P350; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KEEGAN AD, 1995, P NATL ACAD SCI USA, V92, P7681, DOI 10.1073/pnas.92.17.7681; KEHRY MR, 1989, P NATL ACAD SCI USA, V86, P7556, DOI 10.1073/pnas.86.19.7556; KOHLER I, 1994, FEBS LETT, V345, P187, DOI 10.1016/0014-5793(94)00438-2; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lee J, 1996, J CARDIAC SURG, V11, P111, DOI 10.1111/j.1540-8191.1996.tb00023.x; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; OGILVIE BM, 1968, J PARASITOL, V54, P1073, DOI 10.2307/3276966; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SMERZBERTLING C, 1995, J BIOL CHEM, V270, P966, DOI 10.1074/jbc.270.2.966; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; URBAN JF, 1993, J IMMUNOL, V151, P7086; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; URBAN JF, 1995, J IMMUNOL, V154, P4675; VITETTA ES, 1985, J EXP MED, V162, P726; Wang HY, 1996, IMMUNITY, V4, P113, DOI 10.1016/S1074-7613(00)80676-7; WANG LM, 1995, BLOOD, V86, P4218, DOI 10.1182/blood.V86.11.4218.bloodjournal86114218; WILDE DB, 1983, J IMMUNOL, V131, P2178; Zund G, 1996, J BIOL CHEM, V271, P7460; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI G, 1994, STEM CELLS, V12, P169, DOI 10.1002/stem.5530120204; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	56	469	477	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					255	264		10.1016/S1074-7613(00)80477-X	http://dx.doi.org/10.1016/S1074-7613(00)80477-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492006	Bronze			2022-12-18	WOS:000072201800012
J	Mjosberg, J; Bernink, J; Golebski, K; Karrich, JJ; Peters, CP; Blom, B; te Velde, AA; Fokkens, WJ; van Drunen, CM; Spits, H				Mjosberg, Jenny; Bernink, Jochem; Golebski, Korneliusz; Karrich, Julien J.; Peters, Charlotte P.; Blom, Bianca; te Velde, Anje A.; Fokkens, Wytske J.; van Drunen, Cornelis M.; Spits, Hergen			The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells	IMMUNITY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; AIRWAY INFLAMMATION; LUNG INFLAMMATION; ADAPTIVE IMMUNITY; FAMILY-MEMBERS; TH2; HYPERREACTIVITY; EXPRESSION; DIFFERENTIATION; CYTOKINES	Type 2 innate lymphoid cells (ILC2s) are part of a large family of ILCs that are important effectors in innate immunity, lymphoid organogenesis, and tissue remodeling. ILC2s mediate parasite expulsion but also contribute to airway inflammation, emphasizing the functional similarity between these cells and Th2 cells. Consistent with this, we report that the transcription factor GATA3 was highly expressed by human ILC2s. CRTH2(+) ILC2s were enriched in nasal polyps of patients with chronic rhinosinusitis, a typical type 2-mediated disease. Nasal polyp epithelial cells expressed TSLP, which enhanced STAT5 activation, GATA3 expression, and type 2 cytokine production in ILC2s. Ectopic expression of GATA3 in Lin(-)CD127(+)CRTH2(-) cells resulted in induction of CRTH2 and the capacity to produce high amounts of type 2 cytokines in response to TSLP plus IL-33. Hence, we identify GATA3, potently regulated by TSLP, as an essential transcription factor for the function of human ILC2s.	[Mjosberg, Jenny; Bernink, Jochem; Peters, Charlotte P.; te Velde, Anje A.; Spits, Hergen] Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Golebski, Korneliusz; Fokkens, Wytske J.; van Drunen, Cornelis M.] Univ Amsterdam, Dept Otorhinolaryngol, NL-1105 BK Amsterdam, Netherlands; [Karrich, Julien J.; Blom, Bianca] Univ Amsterdam, Dept Cell Biol, NL-1105 BK Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	Spits, H (corresponding author), Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019; Fokkens, Wytske WJ/ABF-2185-2020	Spits, Hergen/0000-0003-3269-8338; Karrich, Julien J./0000-0001-5911-8925; van Drunen, Cornelis M/0000-0001-5503-066X				Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; van Drunen CM, 2012, CURR ALLERGY ASTHM R, V12, P120, DOI 10.1007/s11882-012-0249-4; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	38	468	494	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					649	659		10.1016/j.immuni.2012.08.015	http://dx.doi.org/10.1016/j.immuni.2012.08.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23063330	Bronze			2022-12-18	WOS:000310185400010
J	De Rosa, V; Procaccini, C; Cali, G; Pirozzi, G; Fontana, S; Zappacosta, S; La Cava, A; Matarese, G				De Rosa, Veronica; Procaccini, Claudio; Cali, Gaetano; Pirozzi, Giusepe; Fontana, Silvia; Zappacosta, Serafino; La Cava, Antonio; Matarese, Giuseppe			A key role of leptin in the control of regulatory T cell proliferation	IMMUNITY			English	Article							IN-VITRO; SUPPRESSOR; INDUCTION; MICE; INTERLEUKIN-2; ACTIVATION; SUSCEPTIBILITY; INFLAMMATION; PROGRESSION; EXPRESSION	We report here that leptin can act as a negative signal for the proliferation of human naturally occurring Foxp3(+)CD4(+)CD25(+) regulatory T (T-reg) cells. Freshly isolated Treg cells produced leptin and expressed high amounts of leptin receptor (ObR). In vitro neutralization with leptin monoclonal antibody (mAb), during anti-CD3 and anti-CD28 stimulation, resulted in T-reg cell proliferation, which was interleukin-2 (IL-2) dependent. Treg cells that proliferated in the presence of leptin mAb had increased expression of Foxp3 and remained suppressive. The phenomena appeared secondary to leptin signaling via ObR and, importantly, leptin neutralization reversed the anergic state of the Treg cells, as indicated by downmodulation of the cyclin-dependent kinase inhibitor p27 (p27(kip1)) and the phosphorylation of the extracellular-related kinases 1 (ERK1) and ERK2. Together with the finding of enhanced proliferation of T-reg cells observed in leptin- and ObR-deficient mice, these results suggest a potential for therapeutic interventions in immune and autoimmune diseases.	CNR, IEOS, I-80131 Naples, Italy; Univ Naples Federico II, Cattedra Immunol, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Fdn G Pascale, Sez Immunol, I-80131 Naples, Italy; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; IRCCS Fondazione Pascale; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Matarese, G (corresponding author), CNR, IEOS, I-80131 Naples, Italy.	gmatarese@napoli.com	/AAG-9576-2020; Matarese, Giuseppe/AAO-4077-2021; De Rosa, Veronica/K-6534-2016; Procaccini, Claudio/AAB-3696-2019	/0000-0002-8839-0933; Matarese, Giuseppe/0000-0001-9429-0616; De Rosa, Veronica/0000-0002-9477-0991; PROCACCINI, CLAUDIO/0000-0002-2184-0442	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053239] Funding Source: NIH RePORTER; NIAID NIH HHS [AI63515] Funding Source: Medline; NIAMS NIH HHS [AR53239] Funding Source: Medline; Telethon [GJT04008] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Telethon(Fondazione Telethon)		Barboza JA, 2004, MOL BIOL REP, V31, P13, DOI 10.1023/B:MOLE.0000013503.16301.82; Chen D, 1999, J IMMUNOL, V163, P5796; De Rosa V, 2006, J CLIN INVEST, V116, P447, DOI 10.1172/JCI26523; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Faggioni R, 2000, P NATL ACAD SCI USA, V97, P2367, DOI 10.1073/pnas.040561297; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Jiang SP, 2003, BLOOD, V102, P2180, DOI 10.1182/blood-2003-04-1164; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kuchroo VK, 2003, NATURE, V422, P27, DOI 10.1038/422027a; La Cava A, 2004, J IMMUNOL, V173, P3542, DOI 10.4049/jimmunol.173.5.3542; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lee CH, 2005, DIABETES, V54, P2525, DOI 10.2337/diabetes.54.9.2525; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2002, TRENDS IMMUNOL, V23, P182, DOI 10.1016/S1471-4906(02)02188-9; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Matsumoto A, 2003, J EXP MED, V197, P425, DOI 10.1084/jem.20020939; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Nishibori T, 2004, J EXP MED, V199, P25, DOI 10.1084/jem.20020509; Payne A, 2001, J HUM NUTR DIET, V14, P349, DOI 10.1046/j.1365-277X.2001.00308.x; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Siegmund B, 2004, GUT, V53, P965, DOI 10.1136/gut.2003.027136; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Waiczies S, 2005, J IMMUNOL, V174, P5630, DOI 10.4049/jimmunol.174.9.5630; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	44	467	485	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					241	255		10.1016/j.immuni.2007.01.011	http://dx.doi.org/10.1016/j.immuni.2007.01.011			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307705	Bronze			2022-12-18	WOS:000244628600014
J	ENGEL, P; ZHOU, LJ; ORD, DC; SATO, S; KOLLER, B; TEDDER, TF				ENGEL, P; ZHOU, LJ; ORD, DC; SATO, S; KOLLER, B; TEDDER, TF			ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE	IMMUNITY			English	Article							KINASE-DEPENDENT PATHWAY; TRANSGENIC MICE; MONOCLONAL-ANTIBODIES; CYTOPLASMIC DOMAIN; ANTIGEN RECEPTOR; CLONAL DELETION; CELL PRECURSORS; B-1 CELLS; COMPLEX; IMMUNOGLOBULIN	CD19-deficient mice were generated to examine the role of CD19 in B cell growth regulation in vivo. Deletion of CD19 had no deleterious effects on the generation of B cells in the bone marrow, but there was a significant reduction in the number of B cells in peripheral lymphoid tissues. B cells from CD19-deficient mice exhibited markedly decreased proliferative responses to mitogens, and serum immunoglobulin levels were also significantly decreased. In contrast, mice that overexpressed CD19 had significant defects in early B cell development in the bone marrow, augmented mitogenic responses, and increased serum immunoglobulin levels. These experiments indicate that CD19 functions to define signaling thresholds for cell surface receptors that regulate B lymphocyte selection, activation, and differentiation.	UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27510 USA		ENGEL, P (corresponding author), DUKE UNIV, MED CTR, DEPT IMMUNOL, DURHAM, NC 27710 USA.		Engel, Pablo/R-5907-2019	Engel, Pablo/0000-0001-8410-252X	NCI NIH HHS [CA-34183] Funding Source: Medline; NHLBI NIH HHS [HL-50985] Funding Source: Medline; NIAID NIH HHS [AI-26872] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034183] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL050985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026872] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; BARRETT TB, 1990, EUR J IMMUNOL, V20, P1053, DOI 10.1002/eji.1830200516; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; BRADBURY LE, 1993, J IMMUNOL, V151, P2915; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1991, J IMMUNOL, V147, P3663; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; FEARON DT, 1993, CURR OPIN IMMUNOL, V5, P341, DOI 10.1016/0952-7915(93)90051-S; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOSGROVE D, 1991, CELL, V66, P1051; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1994, INT IMMUNOL, V6, P1417, DOI 10.1093/intimm/6.9.1417; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; KANSAS GS, 1991, J IMMUNOL, V147, P4094; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kearney J F, 1992, Int Rev Immunol, V8, P247, DOI 10.3109/08830189209055577; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LOH DY, 1991, NEW BIOL, V3, P924; MATSUMOTO AK, 1991, J EXP MED, V173, P55, DOI 10.1084/jem.173.1.55; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; NADLER LM, 1983, J IMMUNOL, V131, P244; NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; OI VT, 1979, MOL IMMUNOL, V16, P1005, DOI 10.1016/0161-5890(79)90034-8; PESANDO JM, 1989, J EXP MED, V170, P2159, DOI 10.1084/jem.170.6.2159; PEZZUTTO A, 1987, J IMMUNOL, V138, P2793; PFEFFER K, 1994, ANNU REV IMMUNOL, V12, P367, DOI 10.1146/annurev.immunol.12.1.367; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; RIGLEY KP, 1991, EUR J IMMUNOL, V21, P535, DOI 10.1002/eji.1830210302; RIJKERS GT, 1990, P NATL ACAD SCI USA, V87, P8766, DOI 10.1073/pnas.87.22.8766; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; STRIEBICH CC, 1990, J IMMUNOL, V144, P1857; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; TEDDER TF, 1989, J IMMUNOL, V143, P712; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; UCKUN FM, 1988, P NATL ACAD SCI USA, V85, P8603, DOI 10.1073/pnas.85.22.8603; UCKUN FM, 1993, J BIOL CHEM, V268, P21172; VANNOESEL CJM, 1993, IMMUNOL TODAY, V14, P8, DOI 10.1016/0167-5699(93)90316-D; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WOLF ML, 1993, J IMMUNOL, V151, P138; ZHOU LJ, 1992, IMMUNOGENETICS, V35, P102, DOI 10.1007/BF00189519; ZHOU LJ, 1991, J IMMUNOL, V147, P1424; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	57	467	486	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1995	3	1					39	50		10.1016/1074-7613(95)90157-4	http://dx.doi.org/10.1016/1074-7613(95)90157-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7542548	Bronze			2022-12-18	WOS:A1995RK86800006
J	MACKAREHTSCHIAN, K; HARDIN, JD; MOORE, KA; BOAST, S; GOFF, SP; LEMISCHKA, IR				MACKAREHTSCHIAN, K; HARDIN, JD; MOORE, KA; BOAST, S; GOFF, SP; LEMISCHKA, IR			TARGETED DISRUPTION OF THE FLK2/FLT3 GENE LEADS TO DEFICIENCIES IN PRIMITIVE HEMATOPOIETIC PROGENITORS	IMMUNITY			English	Article							COLONY STIMULATING FACTOR; TYROSINE KINASE RECEPTOR; BONE-MARROW TRANSPLANTATION; C-KIT RECEPTOR; STEM-CELLS; PROTO-ONCOGENE; STROMAL CELLS; LYMPHOCYTES-B; W-LOCUS; MOUSE	The flk2 receptor tyrosine kinase has been implicated in hematopoietic development. Mice deficient in flk2 were generated. Mutants developed into healthy adults with normal mature hematopoietic populations. However, they possessed specific deficiencies in primitive B lymphoid progenitors, Bone marrow transplantation experiments revealed a further deficiency in T cell and myeloid reconstitution by mutant stem cells. Mice deficient for both c-kit and flk2 exhibited a more severe phenotype characterized by large overall decreases in hematopoietic cell numbers, further reductions in the relative frequencies of lymphoid progenitors, and a postnatal lethality. Taken together, the data suggest that flk2 plays a role both in multipotent stem cells and in lymphoid differentiation.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032	Columbia University	MACKAREHTSCHIAN, K (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544, USA.		Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA4533-07, P01CA23767] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BILLIPS LG, 1992, BLOOD, V79, P1185; BIRG F, 1992, BLOOD, V80, P2584; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; DAS SK, 1982, J BIOL CHEM, V257, P13679; DERYUGINA EI, 1994, EXP HEMATOL, V22, P910; DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423; DEXTER TM, 1976, J CELL PHYSL, V91, P335; DORSHKIND K, 1983, J IMMUNOL, V131, P2240; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARRISON DE, 1976, TRANSPLANTATION, V22, P42, DOI 10.1097/00007890-197607000-00007; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1979, BLOOD, V54, P1152; JONESVILLENEUVE E, 1980, EXP HEMATOL, V8, P65; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KITAMURA Y, 1979, NATURE, V281, P154, DOI 10.1038/281154a0; KODAMA H, 1992, J EXP MED, V176, P351, DOI 10.1084/jem.176.2.351; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEMISCHKA IR, 1992, CANCER SURV, V15, P3; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; MAGLI MC, 1982, NATURE, V295, P527, DOI 10.1038/295527a0; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; MCABE PC, 1990, PCR PROTOCOLS GUIDE, P76; MURPHY ED, 1973, TRANSPLANTATION, V15, P526; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OGAWA M, 1993, BLOOD, V81, P2844; OKADA S, 1991, BLOOD, V78, P1706; OKADA S, 1992, BLOOD, V80, P3044; PALACIOS R, 1992, DEVELOPMENT, V115, P1133; PALACIOS R, 1992, MOL CELL BIOL, V12, P518, DOI 10.1128/MCB.12.2.518; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROLINK A, 1991, EUR J IMMUNOL, V21, P2609, DOI 10.1002/eji.1830211044; ROSNET O, 1991, ONCOGENE, V6, P1641; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SCHRADER JW, 1978, J EXP MED, V148, P823, DOI 10.1084/jem.148.3.823; SMALL D, 1994, P NATL ACAD SCI USA, V91, P459, DOI 10.1073/pnas.91.2.459; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; VISSER JWM, 1984, J EXP MED, V59, P1576; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WULF GM, 1993, EMBO J, V12, P5065, DOI 10.1002/j.1460-2075.1993.tb06200.x; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422; ZHANG R, 1994, P NATL ACAD SCI USA, V91, P12755, DOI 10.1073/pnas.91.26.12755	59	467	478	0	10	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					147	161		10.1016/1074-7613(95)90167-1	http://dx.doi.org/10.1016/1074-7613(95)90167-1			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621074	hybrid			2022-12-18	WOS:A1995RK86800016
J	Kim, J; Sif, S; Jones, B; Jackson, A; Koipally, J; Heller, E; Winandy, S; Viel, A; Sawyer, A; Ikeda, T; Kingston, R; Georgopoulos, K				Kim, J; Sif, S; Jones, B; Jackson, A; Koipally, J; Heller, E; Winandy, S; Viel, A; Sawyer, A; Ikeda, T; Kingston, R; Georgopoulos, K			Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes	IMMUNITY			English	Article							MI-2 AUTOANTIGEN; NUCLEOSOMAL DNA; FINGER; GENE; MUTATION; FAMILY	The Ikaros gene family encodes zinc finger DNA-binding proteins essential for lineage determination and control of proliferation in the lymphoid system. Here, we report that, in the nucleus of a T cell, a major fraction of Ikaros and Aiolos proteins associate with the DNA-dependent ATPase Mi-2 and histone deacetylases, in a 2 MD complex. This Ikaros-NURD complex is active in chromatin remodeling and histone deacetylation. Upon T cell activation, Ikaros recruits Mi-2/HDAC to regions of heterochromatin. These studies reveal that Ikaros proteins are capable of targeting chromatin remodeling and deacetylation complexes in vivo. We propose that the restructuring of chromatin is a key aspect of Ikaros function in lymphocyte differentiation.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr Prot Core, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02125 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Georgopoulos, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	georgopoulos@cbrc.mgh.harvard.edu	Sif, Said/AAE-5554-2019	Sawyer, Alan/0000-0001-5942-4498; Sif, Said/0000-0001-6268-1145	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038342] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI38342-04] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; BRENT R, 1996, GENE PROBES PRACTICA; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; FATTAEY AR, 1993, ONCOGENE, V8, P3149; GABIG TG, 1994, J BIOL CHEM, V269, P29515; GE Q, 1995, J CLIN INVEST, V96, P1730, DOI 10.1172/JCI118218; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Kolle D, 1998, METHODS, V15, P323, DOI 10.1006/meth.1998.0636; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; RHODES D, 1989, METHOD ENZYMOL, V170, P575; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Seelig HP, 1996, ARTHRITIS RHEUM, V39, P1769, DOI 10.1002/art.1780391029; SEELIG HP, 1995, ARTHRITIS RHEUM-US, V38, P1389, DOI 10.1002/art.1780381006; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	45	465	480	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1999	10	3					345	355		10.1016/S1074-7613(00)80034-5	http://dx.doi.org/10.1016/S1074-7613(00)80034-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204490	Bronze			2022-12-18	WOS:000079455700007
J	Rosenberg, SA				Rosenberg, SA			A new era for cancer immunotherapy based on the genes that encode cancer antigens	IMMUNITY			English	Review							CYTOLYTIC T-LYMPHOCYTES; TUMOR-INFILTRATING LYMPHOCYTES; HUMAN-MELANOMA; IN-VIVO; HLA-A2 MELANOMAS; BETA-CATENIN; REGRESSION ANTIGENS; IMMUNE-RESPONSES; TYROSINASE GENE; CELL-LINES		NCI, Surg Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, Div Clin Sci, NIH, Bldg 10, Bethesda, MD 20892 USA.	sar@nih.gov						BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; BOON T, 1993, INT J CANCER, V54, P177, DOI 10.1002/ijc.2910540202; Brandle D, 1996, J EXP MED, V183, P2501, DOI 10.1084/jem.183.6.2501; BRASSEUR F, 1992, INT J CANCER, V52, P839, DOI 10.1002/ijc.2910520528; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; Bullock TNJ, 1997, J EXP MED, V186, P1051, DOI 10.1084/jem.186.7.1051; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; Elliott T, 1996, EUR J IMMUNOL, V26, P1175, DOI 10.1002/eji.1830260532; Fleischhauer K, 1996, INT J CANCER, V68, P622; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Gueguen M, 1998, J IMMUNOL, V160, P6188; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C; Jager E, 1996, INT J CANCER, V67, P54, DOI 10.1002/(SICI)1097-0215(19960703)67:1<54::AID-IJC11>3.0.CO;2-C; JAGER E, 1996, INT J CANCER, V66, P162; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kawakami Y, 1998, J IMMUNOL, V161, P6985; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3461; Kittlesen DJ, 1998, J IMMUNOL, V160, P2099; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; Lethe B, 1997, MELANOMA RES, V7, pS83; Loftus DJ, 1996, J EXP MED, V184, P647, DOI 10.1084/jem.184.2.647; MALARKANNAN S, 1995, J EXP MED, V182, P1739, DOI 10.1084/jem.182.6.1739; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Marchand M, 1995, INT J CANCER, V63, P883, DOI 10.1002/ijc.2910630622; Marincola FM, 1996, J IMMUNOTHER, V19, P266, DOI 10.1097/00002371-199607000-00003; Marshall JL, 1999, J CLIN ONCOL, V17, P332, DOI 10.1200/JCO.1999.17.1.332; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Parkhurst MR, 1998, CANCER RES, V58, P4895; QUELLE DE, 1995, CELL, V83, P993; ROBBINS PF, 1995, J IMMUNOL, V154, P5944; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; ROBBINS PF, 1994, CANCER RES, V54, P3124; Robbins PF, 1997, J IMMUNOL, V159, P303; Rosenberg SA, 1998, ANN SURG, V228, P307, DOI 10.1097/00000658-199809000-00004; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rosenberg SA, 1998, J NATL CANCER I, V90, P1894, DOI 10.1093/jnci/90.24.1894; Rosenberg SA, 1996, J IMMUNOTHER, V19, P81, DOI 10.1097/00002371-199601000-00009; Rosenberg SA, 1996, J NATL CANCER I, V88, P1635, DOI 10.1093/jnci/88.22.1635; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schneider J, 1998, INT J CANCER, V75, P451, DOI 10.1002/(SICI)1097-0215(19980130)75:3<451::AID-IJC20>3.0.CO;2-A; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shichijo S, 1998, J EXP MED, V187, P277, DOI 10.1084/jem.187.3.277; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Skipper JCA, 1996, J IMMUNOL, V157, P5027; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tanaka F, 1997, CANCER RES, V57, P4465; TOPALIAN SL, 1994, P NATL ACAD SCI USA, V91, P9461, DOI 10.1073/pnas.91.20.9461; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; Tsai V, 1997, J IMMUNOL, V158, P1796; TSANG KY, 1995, J NATL CANCER I, V87, P982, DOI 10.1093/jnci/87.13.982; Tureci O, 1996, CANCER RES, V56, P4766; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P2134; VANDERBRUGGEN P, 1994, EUR J IMMUNOL, V24, P3038, DOI 10.1002/eji.1830241218; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANPEL A, 1995, IMMUNOL REV, V145, P229, DOI 10.1111/j.1600-065X.1995.tb00084.x; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; Wang RF, 1998, J IMMUNOL, V160, P890; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wang RF, 1998, J IMMUNOL, V161, P3596; WEYNANTS P, 1994, INT J CANCER, V56, P826, DOI 10.1002/ijc.2910560612; WOGLOM WILLIAM H., 1929, CANCER REV, V4, P129; Wolf SS, 1995, MOL BIOTECHNOL, V4, P269, DOI 10.1007/BF02779020; WOLFEL T, 1994, EUR J IMMUNOL, V24, P759, DOI 10.1002/eji.1830240340	79	464	572	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					281	287		10.1016/S1074-7613(00)80028-X	http://dx.doi.org/10.1016/S1074-7613(00)80028-X			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204484	Bronze			2022-12-18	WOS:000079455700001
J	Libby, P; Lichtman, AH; Hansson, GK				Libby, Peter; Lichtman, Andrew H.; Hansson, Goran K.			Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans	IMMUNITY			English	Review							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; ACUTE CORONARY SYNDROME; REGULATORY T-CELLS; HEAT-SHOCK PROTEIN-65; C-REACTIVE PROTEIN; PROMOTES EARLY ATHEROSCLEROSIS; RECEPTOR-DEFICIENT MICE; REDUCES ATHEROSCLEROSIS; INTERFERON-GAMMA	According to the traditional view, atherosclerosis results from a passive buildup of cholesterol in the artery wall. Yet, burgeoning evidence implicates inflammation and immune effector mechanisms in the pathogenesis of this disease. Both innate and adaptive immunity operate during atherogenesis and link many traditional risk factors to altered arterial functions. Inflammatory pathways have become targets in the quest for novel preventive and therapeutic strategies against cardiovascular disease, a growing contributor to morbidity and mortality worldwide. Here we review current experimental and clinical knowledge of the pathogenesis of atherosclerosis through an immunological lens and how host defense mechanisms essential for survival of the species actually contribute to this chronic disease but also present new opportunities for its mitigation.	[Libby, Peter; Lichtman, Andrew H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hansson, Goran K.] Karolinska Univ Hosp, Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden; [Hansson, Goran K.] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Libby, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, 77 Ave Louis Pasteur,NRB7, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X; Hansson, Goran/0000-0003-4148-5190	National Heart, Lung, and Blood Institute [HL80472, HL48743, HL80731]; National Institutes of Health [HL87282]; Swedish Research Council [6816, 8703]; Swedish Heart-Lung Foundation; Foundation for Strategic Research (SSF); Stockholm County Council; European Commission; Fondation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080472, U01HL080731, P01HL048743, R01HL087282] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Stockholm County Council(Stockholm County Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	P.L. was supported by grants from the National Heart, Lung, and Blood Institute (HL80472; HL48743; HL80731). A.H.L. was supported by a grant from the National Institutes of Health (HL87282). G.K.H. was supported by grants from the Swedish Research Council (grants 6816 and 8703), the Swedish Heart-Lung Foundation, the Foundation for Strategic Research (SSF), the Stockholm County Council, and the European Commission. P.L. and G.K.H. were both supported by a grant from Fondation Leducq. P.L. is an unpaid consultant and involved in clinical trials for Novartis.	Afek A, 2000, J AUTOIMMUN, V14, P115, DOI 10.1006/jaut.1999.0351; Afek A, 2005, ATHEROSCLEROSIS, V183, P57, DOI 10.1016/j.atherosclerosis.2005.03.040; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; Amir S, 2012, J LIPID RES, V53, P1316, DOI 10.1194/jlr.M025445; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Binder CJ, 2008, CURR DRUG TARGETS, V9, P190; Binder CJ, 2007, J AM COLL CARDIOL, V50, P547, DOI 10.1016/j.jacc.2007.04.054; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bobryshev YV, 2010, LAB INVEST, V90, P970, DOI 10.1038/labinvest.2010.94; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Buono C, 2004, CIRCULATION, V109, P2009, DOI 10.1161/01.CIR.0000127121.16815.F1; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Cheng XA, 2011, ATHEROSCLEROSIS, V215, P471, DOI 10.1016/j.atherosclerosis.2010.12.034; CLINTON SK, 1992, AM J PATHOL, V140, P301; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Cuffy MC, 2007, J IMMUNOL, V179, P5246, DOI 10.4049/jimmunol.179.8.5246; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Dal Canto AJ, 2001, J CLIN INVEST, V107, pR15, DOI 10.1172/JCI11540; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dumitriu IE, 2012, CIRC RES, V110, P857, DOI 10.1161/CIRCRESAHA.111.261933; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gerdes N, 2011, THROMB HAEMOSTASIS, V106, P353, DOI 10.1160/TH11-01-0020; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2009, ARTERIOSCL THROM VAS, V29, P1714, DOI 10.1161/ATVBAHA.108.179713; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Hermansson A, 2010, J EXP MED, V207, P1081, DOI 10.1084/jem.20092243; Jeon HJ, 2010, CIRCULATION, V121, P1124, DOI 10.1161/CIRCULATIONAHA.109.882704; JONASSON L, 1985, J CLIN INVEST, V76, P125, DOI 10.1172/JCI111934; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Klingenberg R, 2012, IMMUNOBIOLOGY, V217, P540, DOI 10.1016/j.imbio.2011.06.006; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Kruth HS, 1997, CURR OPIN LIPIDOL, V8, P246, DOI 10.1097/00041433-199710000-00002; Kruth HS, 2002, CURR OPIN LIPIDOL, V13, P483, DOI 10.1097/00041433-200210000-00003; Kyaw T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060430; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Lewis RD, 2010, MOL IMMUNOL, V47, P1098, DOI 10.1016/j.molimm.2009.10.035; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Lievens D, 2011, THROMB HAEMOSTASIS, V106, P827, DOI 10.1160/TH11-08-0592; Liuzzo G, 2007, J AM COLL CARDIOL, V50, P1450, DOI 10.1016/j.jacc.2007.06.040; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 2009, J LIPID RES, V50, pS364, DOI 10.1194/jlr.R800092-JLR200; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Megens RTA, 2012, THROMB HAEMOSTASIS, V107, P597, DOI 10.1160/TH11-09-0650; Melian A, 1999, AM J PATHOL, V155, P775, DOI 10.1016/S0002-9440(10)65176-0; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; MURRAY AG, 1995, J IMMUNOL, V154, P151; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nagano H, 1997, J CLIN INVEST, V100, P550, DOI 10.1172/JCI119564; Nakano M, 2010, CARDIOVASC RES, V88, P539, DOI 10.1093/cvr/cvq211; Nicholls SJ, 2012, CARDIOVASC DRUG THER, V26, P71, DOI 10.1007/s10557-011-6358-9; Nilsson J, 2013, EXPERT REV VACCINES, V12, P311, DOI [10.1586/erv.13.4, 10.1586/ERV.13.4]; Nussenblatt RB, 2010, ANN NY ACAD SCI, V1200, pE1, DOI 10.1111/j.1749-6632.2010.05682.x; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Packard RRS, 2008, CIRC RES, V103, P965, DOI 10.1161/CIRCRESAHA.108.185793; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Pierides C, 2013, IMMUNOL RES, V56, P96, DOI 10.1007/s12026-013-8383-1; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Pober JS, 2011, ARTERIOSCL THROM VAS, V31, P1465, DOI 10.1161/ATVBAHA.111.228338; Prescott SM, 2002, ARTERIOSCL THROM VAS, V22, P727, DOI 10.1161/01.ATV.0000016153.47693.B2; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quillard T, 2012, CIRC RES, V111, P231, DOI 10.1161/CIRCRESAHA.112.268144; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Randolph GJ, 2010, CIRC RES, V106, P227, DOI 10.1161/CIRCRESAHA.109.212191; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; ROBINETTE CD, 1977, LANCET, V2, P127; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rook GAW, 2010, CLIN EXP IMMUNOL, V160, P70, DOI 10.1111/j.1365-2249.2010.04133.x; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sakash JB, 2002, INFECT IMMUN, V70, P3959, DOI 10.1128/IAI.70.7.3959-3961.2002; Salagianni M, 2012, CIRCULATION, V126, P952, DOI 10.1161/CIRCULATIONAHA.111.067678; SALOMON RN, 1991, AM J PATHOL, V138, P791; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; SEIFERT PS, 1989, LAB INVEST, V60, P747; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Swirski FK, 2012, CELL METAB, V15, P135, DOI 10.1016/j.cmet.2012.01.012; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Taleb S, 2008, J INTERN MED, V263, P489, DOI 10.1111/j.1365-2796.2008.01944.x; Tardif JC, 2008, LANCET, V371, P1761, DOI 10.1016/S0140-6736(08)60763-1; Torzewski M, 2013, CLIN BIOCHEM, V46, P20, DOI 10.1016/j.clinbiochem.2012.09.012; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; VanderLaan PA, 2007, AM J PATHOL, V170, P1100, DOI 10.2353/ajpath.2007.060188; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wennberg P, 2012, THROMB RES, V129, P68, DOI 10.1016/j.thromres.2011.05.015; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Wigren M, 2009, CIRC RES, V104, pE62, DOI 10.1161/CIRCRESAHA.109.196667; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; XU QB, 1992, ARTERIOSCLER THROMB, V12, P789, DOI 10.1161/01.ATV.12.7.789; Zhang K, 2012, THROMB RES, V130, pE203, DOI 10.1016/j.thromres.2012.07.008; Zhang P, 2010, ARTERIOSCL THROM VAS, V30, P1795, DOI 10.1161/ATVBAHA.109.200758	133	463	482	3	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1092	1104		10.1016/j.immuni.2013.06.009	http://dx.doi.org/10.1016/j.immuni.2013.06.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809160	Green Accepted, Bronze			2022-12-18	WOS:000330947500006
J	Collins, AV; Brodie, DW; Gilbert, RJC; Iaboni, A; Manso-Sancho, R; Walse, B; Stuart, DI; van der Merwe, PA; Davis, SJ				Collins, AV; Brodie, DW; Gilbert, RJC; Iaboni, A; Manso-Sancho, R; Walse, B; Stuart, DI; van der Merwe, PA; Davis, SJ			The interaction properties of costimulatory molecules revisited	IMMUNITY			English	Article							LYMPHOCYTE-ASSOCIATED ANTIGEN-4; T-CELL COSTIMULATION; CD28 COSTIMULATION; LOW-AFFINITY; IN-VIVO; CTLA-4; B7-1; BINDS; CD80; RECOGNITION	B7-1 and B7-2 are generally thought to have comparable structures and affinities for their receptors, CD28 and CTLA-4, each of which is assumed to be bivalent. We show instead (1) that B7-2 binds the two receptors more weakly than B7-1, (2) that, relative to its CTLA-4 binding affinity, B7-2 binds CD28 2- to 3-fold more effectively than B7-11, (3) that, unlike B7-1, B7-2 does not self-associate, and (4) that, in contrast to CTLA-4 homodimers, which are bivalent, CD28 homodimers; are monovalent. Our results indicate that B7-1 markedly favors CTLA-4 over CD28 engagement, whereas B7-2 exhibits much less bias. We propose that the distinct structures and binding properties of B7-1 and B7-2 account for their overlapping but distinct effects on T cell responses.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QT, England; Act Biotech Res AB, S-22363 Lund, Sweden	University of Oxford; University of Oxford; University of Oxford; University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.		Iaboni, Andrea/I-7876-2016; van der Merwe, P. Anton/F-8539-2011	Iaboni, Andrea/0000-0003-4268-6832; Gilbert, Robert/0000-0001-9336-5604; Walse, Bjorn/0000-0003-1513-9040; Stuart, David/0000-0002-3426-4210				Bachmann MF, 1999, J IMMUNOL, V163, P1128; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Fukai T, 1999, GRAEF ARCH CLIN EXP, V237, P928, DOI 10.1007/s004170050388; Greene JAL, 1996, J BIOL CHEM, V271, P26762, DOI 10.1074/jbc.271.43.26762; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Judge TA, 1999, J IMMUNOL, V162, P1947; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KLUG A, 1969, NOB S 11 SYMM FUNCT, P425; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Li S, 2000, EUR J IMMUNOL, V30, P1394, DOI 10.1002/(SICI)1521-4141(200005)30:5<1394::AID-IMMU1394>3.0.CO;2-O; Liang BL, 1999, J IMMUNOL, V163, P2322; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1995, J BIOL CHEM, V270, P15417, DOI 10.1074/jbc.270.25.15417; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Mueller DL, 2000, CURR BIOL, V10, pR227, DOI 10.1016/S0960-9822(00)00400-0; O'Regan MN, 1999, IMMUNOGENETICS, V49, P68, DOI 10.1007/s002510050464; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	45	463	495	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2002	17	2					201	210		10.1016/S1074-7613(02)00362-X	http://dx.doi.org/10.1016/S1074-7613(02)00362-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196291	Bronze			2022-12-18	WOS:000177669400008
J	Kim, SH; Han, SY; Azam, T; Yoon, DY; Dinarello, CA				Kim, SH; Han, SY; Azam, T; Yoon, DY; Dinarello, CA			Interleukin-32: A cytokine and inducer of TNF alpha	IMMUNITY			English	Article							IFN-GAMMA PRODUCTION; NF-KAPPA-B; IL-18 BINDING-PROTEIN; CONVERTING-ENZYME; T-CELLS; RHEUMATOID-ARTHRITIS; BIOLOGICAL-ACTIVITY; RECEPTOR COMPLEX; LIGAND-BINDING; NATURAL-KILLER	We describe the gene structure, regulation, signal transduction. and functions of a cytokine, interleukin (IL)-32. An IL-18 unresponsive cell was converted to a responsive cell by transfection of the IL-18 receptor beta chain, and IL-18-induced microarray revealed high expression of a cytokine-like gene. Although IL-32 does not share sequence homology with known cytokine families, IL-32 induces various cytokines, human TNFalpha, and IL-8 in THP-1 monocytic cells as well as mouse TNFalpha and MIP-2 in Raw macrophage cells. IL-32 activates typical cytokine signal pathways of nuclear factor-kappa B (NF-kappaB) and p38 mitogen-activated protein kinase. IL-32 mRNA is highly expressed in immune tissue rather than other tissues. Human IL-32 exists as four splice variants, and IL-32 from other species were found as expressed sequence tag clones in the databank. Induced in human peripheral lymphocyte cells after mitogen stimulation, in human epithelial cells by IFNgamma, and in NK cells after exposure to the combination of IL-12 plus IL-18, IL-32 may play a role in inflammatory/autoimmune diseases.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Korea Res Inst Biosci & Biotechnol, Yuseong Daejon 305600, South Korea	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SH (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA.	soohyun.kim@uchsc.edu	Dinarello, Charles/C-8524-2013		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R37AI015614, R56AI015614] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-68743] Funding Source: Medline; NIAID NIH HHS [AI-15614] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn HJ, 1997, J IMMUNOL, V159, P2125; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Azam T, 2003, J IMMUNOL, V171, P6574, DOI 10.4049/jimmunol.171.12.6574; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; Banda NK, 2003, J IMMUNOL, V170, P2100, DOI 10.4049/jimmunol.170.4.2100; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2; Brod SA, 1996, NEUROLOGY, V46, P1633, DOI 10.1212/WNL.46.6.1633; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chandrasekar B, 2003, BIOCHEM BIOPH RES CO, V303, P1152, DOI 10.1016/S0006-291X(03)00496-0; CHANG FY, 1995, DIABETES RES CLIN PR, V28, P137, DOI 10.1016/0168-8227(95)00168-8; Choi HJ, 2001, J INFECT DIS, V184, P560, DOI 10.1086/322805; DAHL CA, 1992, J IMMUNOL, V148, P597; Debets R, 2000, J IMMUNOL, V165, P4950, DOI 10.4049/jimmunol.165.9.4950; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Esteban DJ, 2004, VIROLOGY, V323, P197, DOI 10.1016/j.virol.2004.02.027; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Haibel H, 2005, ANN RHEUM DIS, V64, P124, DOI 10.1136/ard.2003.019174; Han SY, 2002, J BIOL CHEM, V277, P47167, DOI 10.1074/jbc.M204270200; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoshino T, 1999, J IMMUNOL, V162, P5070; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Kim SH, 2001, J IMMUNOL, V166, P148; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Lauwerys BR, 2000, J IMMUNOL, V165, P1847, DOI 10.4049/jimmunol.165.4.1847; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Martin TA, 2002, J CELL PHYSIOL, V192, P268, DOI 10.1002/jcp.10133; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Meazza R, 1996, ONCOGENE, V12, P2187; Min CK, 2004, BLOOD, V104, P3393, DOI 10.1182/blood-2004-02-0763; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nishimura H, 1998, J IMMUNOL, V160, P936; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Ohtsuki T, 1997, ANTICANCER RES, V17, P3253; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Panelli MC, 2002, GENOME BIOL, V3; Plater-Zyberk C, 2001, J CLIN INVEST, V108, P1825, DOI 10.1172/JCI200112097; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Pufe T, 2001, ARTHRITIS RHEUM, V44, P1082, DOI 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Siegmund B, 2004, EUR J IMMUNOL, V34, P2356, DOI 10.1002/eji.200425124; Stevenson FT, 1997, P NATL ACAD SCI USA, V94, P508, DOI 10.1073/pnas.94.2.508; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Xiang Y, 1999, VIROLOGY, V257, P297, DOI 10.1006/viro.1999.9676; Yamamoto Y, 2004, BIOCHEM BIOPH RES CO, V317, P181, DOI 10.1016/j.bbrc.2004.03.024	65	462	510	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					131	142		10.1016/j.immuni.2004.12.003	http://dx.doi.org/10.1016/j.immuni.2004.12.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664165	Bronze			2022-12-18	WOS:000226682900013
J	Androulidaki, A; Iliopoulos, D; Arranz, A; Doxaki, C; Schworer, S; Zacharioudaki, V; Margioris, AN; Tsichlis, PN; Tsatsanis, C				Androulidaki, Ariadne; Iliopoulos, Dimitrios; Arranz, Alicia; Doxaki, Christina; Schworer, Steffen; Zacharioudaki, Vassiliki; Margioris, Andrew N.; Tsichlis, Philip N.; Tsatsanis, Christos			The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs	IMMUNITY			English	Article							SIGNALING PATHWAY; GENE-EXPRESSION; TOLL-LIKE-RECEPTOR-4 EXPRESSION; TRANSCRIPTION FACTORS; NEGATIVE REGULATION; CYTOKINE PRODUCTION; CELLS; ALPHA; MICE; LPS	MicroRNAs regulated by lipopolysaccharide (LPS) target genes that contribute to the inflammatory phenotype. Here, we showed that the protein kinase Akt1, which is activated by LIPS, positively regulated miRNAs let-7e and miR-181c but negatively regulated miR-155 and miR-125b. In silico analyses and transfection studies revealed that let-7e repressed Toll-like receptor 4 (TLR4), whereas miR-155 repressed SOCS1, two proteins critical for LPS-driven TLR signaling, which regulate endotoxin sensitivity and tolerance. As a result, Akt1(-/-) macrophages exhibited increased responsiveness to LPS in culture and Akt1(-/-) mice did not develop endotoxin tolerance in vivo. Overexpression of let-7e and suppression of miR-155 in Akt1(-/-) macrophages restored sensitivity and tolerance to LIPS in culture and in animals. These results indicate that Akt1 regulates the response of macrophages to LPS by controlling miRNA expression.	[Androulidaki, Ariadne; Arranz, Alicia; Doxaki, Christina; Zacharioudaki, Vassiliki; Margioris, Andrew N.; Tsatsanis, Christos] Univ Crete, Dept Clin Chem, Sch Med, Iraklion 71003, Crete, Greece; [Zacharioudaki, Vassiliki] Univ Crete, Grad Program Mol Basis Human Dis, Sch Med, Iraklion 71003, Crete, Greece; [Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Schworer, Steffen; Tsichlis, Philip N.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	University of Crete; University of Crete; Harvard University; Harvard Medical School; Tufts Medical Center	Tsatsanis, C (corresponding author), Univ Crete, Dept Clin Chem, Sch Med, Iraklion 71003, Crete, Greece.	tsatsani@med.uoc.gr	Huang, H/E-9490-2010; Arranz, Alicia/F-7477-2010; Iliopoulos, Dimitrios/AAE-9106-2019; Tsatsanis, Christos/AAM-9362-2020	Arranz, Alicia/0000-0002-5212-3024; Tsatsanis, Christos/0000-0003-1214-4151; Schworer, Stephen/0000-0001-7741-8972	Association for International Cancer Research [AICR07-0072]; EU-PIAP-GA-2008-230725-TACIT; UICC ICRETT [ICR-08-054]; National Cancer Institute, National Institutes of Health (NIH) [2-CO-41101]; Hellenic Secretariat for Research and Technology [17ENE0 03EA372]; NIH [R01-CA057436]; NATIONAL CANCER INSTITUTE [R01CA041101, R01CA057436] Funding Source: NIH RePORTER	Association for International Cancer Research; EU-PIAP-GA-2008-230725-TACIT; UICC ICRETT; National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hellenic Secretariat for Research and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly supported from the Association for International Cancer Research (AICR07-0072), from the EU-PIAP-GA-2008-230725-TACIT and UICC ICRETT (ICR-08-054) with Federal funds from the National Cancer Institute, National Institutes of Health (NIH) under Contract #2-CO-41101 to C.T., from the Hellenic Secretariat for Research and Technology (17ENE0 03EA372) to A.N.M. and from the NIH (R01-CA057436) to P.N.T.	Arranz A, 2008, MOL IMMUNOL, V45, P2970, DOI 10.1016/j.molimm.2008.01.023; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; FLEGEL WA, 1993, INFECT IMMUN, V61, P5140, DOI 10.1128/IAI.61.12.5140-5146.1993; FREUDENBERG MA, 1980, INFECT IMMUN, V28, P373; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsatsanis C, 2006, J IMMUNOL, V176, P1869, DOI 10.4049/jimmunol.176.3.1869; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	45	459	487	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					220	231		10.1016/j.immuni.2009.06.024	http://dx.doi.org/10.1016/j.immuni.2009.06.024			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699171	Bronze, Green Accepted			2022-12-18	WOS:000269338600009
J	Minegishi, Y; Saito, M; Morio, T; Watanabe, K; Agematsu, K; Tsuchiya, S; Takada, H; Hara, T; Kawamura, N; Ariga, T; Kaneko, H; Kondo, N; Tsuge, I; Yachie, A; Sakiyama, Y; Iwata, T; Bessho, F; Ohishi, T; Joh, K; Imai, K; Kogawa, K; Shinohara, M; Fujieda, M; Wakiguchi, H; Pasic, S; Abinun, M; Ochs, HD; Renner, ED; Jansson, A; Belohradsky, BH; Ayse, M; Shimizu, N; Mizutani, S; Miyawaki, T; Nonoyama, S; Karasuyama, H				Minegishi, Yoshiyuki; Saito, Masako; Morio, Tomohiro; Watanabe, Ken; Agematsu, Kazunaga; Tsuchiya, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Kaneko, Hideo; Kondo, Naomi; Tsuge, Ikuya; Yachie, Akihiro; Sakiyama, Yukio; Iwata, Tsutomu; Bessho, Fumio; Ohishi, Tsutomu; Joh, Kosuke; Imai, Kohsuke; Kogawa, Kazuhiro; Shinohara, Miwa; Fujieda, Mikiya; Wakiguchi, Hiroshi; Pasic, Srdjan; Abinun, Mario; Ochs, Hans D.; Renner, Eleonore D.; Jansson, Annette; Belohradsky, Bernd H.; Ayse, Metin; Shimizu, Norio; Mizutani, Shuki; Miyawaki, Toshio; Nonoyama, Shigeaki; Karasuyama, Hajime			Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; HYPER-IGE SYNDROME; INTERFERON-ALPHA/BETA; RECEPTOR; TYK2; DEFECTS; IL-12; GAMMA; MUTATIONS; INFECTION	Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family. Here we identified a homozygous Tyk2 mutation in a patient who had been clinically diagnosed with hyper-IgE syndrome. This patient showed unusual susceptibility to various microorganisms including virus, fungi, and mycobacteria and suffered from atopic dermatitis with elevated serum IgE. The patient's cells displayed defects in multiple cytokine signaling pathways including those for type 1 interferon (IFN), interleukin (IL)-6, IL-10, IL-12, and IL-23. The cytokine signals were successfully restored by transducing the intact Tyk2 gene. Thus, the Tyk2 deficiency is likely to account for the patient's complex clinical manifestations, including the phenotype of impaired T helper 1 (Th1) differentiation and accelerated Th2 differentiation. This study identifies human Tyk2 deficiency and demonstrates that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially from Tyk2 function in mice.	Tokyo Med & Dent Univ, Dept Immune Regulat, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Virus Res Unit, Med Res Inst, Tokyo 1138519, Japan; Shinshu Univ, Dept Infect Immunol, Matsumoto, Nagano 3908621, Japan; Tohoku Univ, Grad Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808575, Japan; Kyushu Univ, Dept Pediat, Higashi Ku, Fukuoka 8128582, Japan; Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan; Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi 4701192, Japan; Kanazawa Univ, Fac Med, Sch Hlth Sci, Dept Lab Sci, Kanazawa, Ishikawa 9200942, Japan; Teine Keijinkai Hosp, Ctr Pediat, Sapporo, Hokkaido 0068555, Japan; Tokyo Kasei Univ, Dept Child Hlth & Dev, Tokyo 1738602, Japan; Kyorin Univ, Sch Med, Dept Pediat, Mitaka, Tokyo 1818611, Japan; Saitama Childrens Med Ctr, Iwatsuki, Saitama 3398551, Japan; Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3598516, Japan; Kochi Univ, Kochi Med Sch, Dept Pediat, Nankoku, Kochi 7830043, Japan; Pediat Immunol Mother & Child Hlth Inst, Belgrade 11070, Serbia; Newcastle Gen Hosp, Dept Pediat, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Washington, Dept Pediat, Seattle, WA 98105 USA; Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; SB Ankara Diskapi Childrens Hosp, Dept Pediat Immunol, TR-06110 Ankara, Turkey; Toyama Univ, Fac Med, Dept Pediat, Toyama 9300194, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Shinshu University; Tohoku University; Kyushu University; Hokkaido University; Gifu University; Fujita Health University; Kanazawa University; Teine Keijinkai Hospital; Kyorin University; Saitama Children's Medical Center; National Defense Medical College - Japan; Kochi University; Newcastle General Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Munich; Ankara Children's Hematology Oncology Training & Research Hospital; University of Toyama	Minegishi, Y (corresponding author), Tokyo Med & Dent Univ, Dept Immune Regulat, Bunkyo Ku, Tokyo 1138519, Japan.	yminegishi.mbch@tmd.ac.jp	Ariga, Tadashi/A-4252-2012; Imai, Kohsuke/Q-2602-2015; Karasuyama, Hajime/A-7966-2011; Yachie, Akihiro/C-4660-2015; Renner, Ellen/R-7168-2016; Shinohara, Miwa/AGZ-7981-2022; METIN, AYSE/AAS-2382-2020	Imai, Kohsuke/0000-0003-2132-8403; Karasuyama, Hajime/0000-0003-0689-0836; Renner, Ellen/0000-0001-9816-8538; Shinohara, Miwa/0000-0002-6965-2061; METIN, AYSE/0000-0002-0731-5799; Morio, Tomohiro/0000-0002-9259-1025				Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; de Jong R, 1998, SCIENCE, V280, P1435; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Fieschi C, 2004, BLOOD, V104, P2095, DOI 10.1182/blood-2004-02-0584; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; HART PH, 1995, J LEUKOCYTE BIOL, V57, P909, DOI 10.1002/jlb.57.6.909; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Metin A, 2004, PEDIATR INT, V46, P97, DOI 10.1111/j.1328-0867.2004.01845.x; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Minegishi Y, 2001, IMMUNITY, V14, P631, DOI 10.1016/S1074-7613(01)00131-5; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Pasic S, 1998, ACTA PAEDIATR, V87, P702, DOI 10.1080/080352598750014166; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Seto Y, 2003, J IMMUNOL, V170, P1077, DOI 10.4049/jimmunol.170.2.1077; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wood PMD, 2005, EUR J PEDIATR, V164, P741, DOI 10.1007/s00431-005-1745-5; Wu CY, 1997, J IMMUNOL, V159, P1658	48	458	541	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					745	755		10.1016/j.immuni.2006.09.009	http://dx.doi.org/10.1016/j.immuni.2006.09.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17088085	Bronze			2022-12-18	WOS:000242063100008
J	Suzuki, A; Yamaguchi, MT; Ohteki, T; Sasaki, T; Kaisho, T; Kimura, Y; Yoshida, R; Wakeham, A; Higuchi, T; Fukumoto, M; Tsubata, T; Ohashi, PS; Koyasu, S; Penninger, JM; Nakano, T; Mak, TW				Suzuki, A; Yamaguchi, MT; Ohteki, T; Sasaki, T; Kaisho, T; Kimura, Y; Yoshida, R; Wakeham, A; Higuchi, T; Fukumoto, M; Tsubata, T; Ohashi, PS; Koyasu, S; Penninger, JM; Nakano, T; Mak, TW			T cell-specific loss of Pten leads to defects in central and peripheral tolerance	IMMUNITY			English	Article							TUMOR-SUPPRESSOR PTEN; KAPPA-B ACTIVATION; PHOSPHOINOSITIDE 3-KINASE; PROTEIN-KINASE; GLIOBLASTOMA CELLS; CLONAL ELIMINATION; GERMLINE MUTATIONS; SWITCH REGIONS; IN-VIVO; MICE	PTEN, a tumor suppressor gene, is essential for embryogenesis. We used the Cre-IoxP system to generate a T cell-specific deletion of the Pten gene (Pten(floxl-) mice). All Pten(floxl-) mice develop CD4(+) T cell lymphomas by 17 weeks. Pten(floxl-) mice show increased thymic cellularity due in part to a defect in thymic negative selection. Pten(floxl-) mice exhibit elevated levels of B cells and CD4(+) T cells in the periphery, spontaneous activation of CD4(+) T cells, autoantibody production, and hypergammaglobulinemia. Pten(floxl-) T cells hyperproliferate, are autoreactive, secrete increased levels of Th1/Th2 cytokines, resist apoptosis, and show increased phosphorylation of PKB/Akt and ERK. Peripheral tolerance to SEE is also impaired in Pten(floxl-) mice. PTEN is thus an important regulator of T cell homeostasis and self-tolerance.	Osaka Univ, Res Inst Microbial Dis, Dept Mol & Cellular Biol, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Keio Univ, Dept Microbiol & Immunol, Tokyo 1608582, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Pathol, Sendai, Miyagi 9800801, Japan; Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Osaka University; Osaka University; Keio University; Tokyo Medical & Dental University (TMDU); Tohoku University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Nakano, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Mol & Cellular Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tnakano@biken.osaka-u.ac.jp	Tsubata, Takeshi/AAI-7489-2021; NAKANO, Takayoshi/F-8140-2011; Penninger, Josef M/I-6860-2013; Kaisho, Tsuneyasu/B-4130-2012; Suzuki, Akira/GYD-6697-2022; Koyasu, Shigeo/J-5583-2015; Fukumoto, Manabu/L-1444-2019	Tsubata, Takeshi/0000-0003-0760-1258; Penninger, Josef M/0000-0002-8194-3777; Suzuki, Akira/0000-0002-5950-8808; Koyasu, Shigeo/0000-0001-9585-3038; Ohashi, Pamela S./0000-0003-2915-9317; Sasaki, Takehiko/0000-0003-1837-3748				Borlado LR, 2000, FASEB J, V14, P895; BREIER A, 1994, NEUROPSYCHOPHARMACOL, V10, P1, DOI 10.1038/npp.1994.1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; ESSER C, 1989, EMBO J, V8, P483, DOI 10.1002/j.1460-2075.1989.tb03401.x; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Ghosh AK, 1999, GENE, V235, P85, DOI 10.1016/S0378-1119(99)00206-1; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KIM C, 1991, J EXP MED, V174, P1431, DOI 10.1084/jem.174.6.1431; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Ozes ON, 1999, NATURE, V401, P82; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Sharp LL, 1999, J IMMUNOL, V163, P6598; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; STASZAK C, 1985, AM J PATHOL, V120, P99; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Volkers N, 1999, J NATL CANCER I, V91, P1992, DOI 10.1093/jnci/91.23.1992; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; YAMAMOTO K, 2000, NATURE, V404, P506	47	458	483	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					523	534		10.1016/S1074-7613(01)00134-0	http://dx.doi.org/10.1016/S1074-7613(01)00134-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371355	Bronze			2022-12-18	WOS:000168880900005
J	Schlums, H; Cichocki, F; Tesi, B; Theorell, J; Beziat, V; Holmes, TD; Han, HY; Chiang, SCC; Foley, B; Mattsson, K; Larsson, S; Schaffer, M; Malmberg, KJ; Ljunggren, HG; Miller, JS; Bryceson, YT				Schlums, Heinrich; Cichocki, Frank; Tesi, Bianca; Theorell, Jakob; Beziat, Vivien; Holmes, Tim D.; Han, Hongya; Chiang, Samuel C. C.; Foley, Bree; Mattsson, Kristin; Larsson, Stella; Schaffer, Marie; Malmberg, Karl-Johan; Ljunggren, Hans-Gustaf; Miller, Jeffrey S.; Bryceson, Yenan T.			Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; T-CELLS; CMV REACTIVATION; PLZF CONTROLS; FCR-GAMMA; EXPRESSION; RECEPTOR; ACTIVATION; DIFFERENTIATION; INNATE	The mechanisms underlying human natural killer (NK) cell phenotypic and functional heterogeneity are unknown. Here, we describe the emergence of diverse subsets of human NK cells selectively lacking expression of signaling proteins after human cytomegalovirus (HCMV) infection. The absence of Band myeloid cell-related signaling protein expression in these NK cell subsets correlated with promoter DNA hypermethylation. Genome-wide DNA methylation patterns were strikingly similar between HCMV-associated adaptive NK cells and cytotoxic effector T cells but differed from those of canonical NK cells. Functional interrogation demonstrated altered cytokine responsiveness in adaptive NK cells that was linked to reduced expression of the transcription factor PLZF. Furthermore, subsets of adaptive NK cells demonstrated significantly reduced functional responses to activated autologous T cells. The present results uncover a spectrum of epigenetically unique adaptive NK cell subsets that diversify in response to viral infection and have distinct functional capabilities compared to canonical NK cell subsets.	[Schlums, Heinrich; Cichocki, Frank; Theorell, Jakob; Beziat, Vivien; Holmes, Tim D.; Han, Hongya; Chiang, Samuel C. C.; Mattsson, Kristin; Malmberg, Karl-Johan; Ljunggren, Hans-Gustaf; Bryceson, Yenan T.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden; [Cichocki, Frank; Foley, Bree; Miller, Jeffrey S.] Univ Minnesota, Ctr Canc, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Tesi, Bianca] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, S-17164 Stockholm, Sweden; [Tesi, Bianca] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Mol Med & Surg, Clin Genet Unit, S-14186 Stockholm, Sweden; [Tesi, Bianca] Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, S-14186 Stockholm, Sweden; [Larsson, Stella] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Immunol & Transfus Med, S-14186 Stockholm, Sweden; [Schaffer, Marie] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden; [Malmberg, Karl-Johan] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, N-0310 Oslo, Norway; [Malmberg, Karl-Johan] Oslo Univ Hosp, Inst Canc Res, Dept Immunol, N-0310 Oslo, Norway; [Bryceson, Yenan T.] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, N-5021 Bergen, Norway	Karolinska Institutet; Karolinska University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Oslo; University of Oslo; University of Bergen	Bryceson, YT (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden.	yenan.bryceson@ki.se	Tesi, Bianca/AAH-6304-2021; Béziat, Vivien/G-2971-2011; Bryceson, Yenan T/D-2121-2018; chiang, samuel/M-9267-2016; Chiang, Samuel CC/O-5960-2019; Béziat, Vivien/AAT-4097-2021	Tesi, Bianca/0000-0002-8253-2507; Béziat, Vivien/0000-0002-4020-824X; Bryceson, Yenan T/0000-0002-7783-9934; Chiang, Samuel CC/0000-0001-6597-6117; Béziat, Vivien/0000-0002-4020-824X; Schlums, Heinrich/0000-0002-2895-7766; Miller, Jeffrey S/0000-0002-0339-4944; Malmberg, Karl-Johan/0000-0002-8718-9373	European Research Council under the European Union [311335]; Swedish Research Council; Swedish Foundation for Strategic Research; Swedish Cancer Foundation; Swedish Children's Cancer Foundation; Knut and Alice Wallenberg Foundation; Karolinska Institute Research Foundation; Frontiers in Biomedical Research Fellowship; University of Minnesota; NATIONAL CANCER INSTITUTE [P01CA111412, R35CA197292, P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122216] Funding Source: NIH RePORTER	European Research Council under the European Union(European Research Council (ERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Foundation; Swedish Children's Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institute Research Foundation(Karolinska Institutet); Frontiers in Biomedical Research Fellowship; University of Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 311335, Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Cancer Foundation, Swedish Children's Cancer Foundation, Knut and Alice Wallenberg Foundation, the Karolinska Institute Research Foundation, the Frontiers in Biomedical Research Fellowship, and University of Minnesota T32 Haematology Training Grant. We thank Marcus Holm, Uppsala Multidisciplinary Center for Advanced Computational Science, for writing data pre- and post-processing code enabling usage of Barnes-Hut t-SNE, the Karolinska Institutet Bioinformatics and Expression Analysis core facility, supported by the Karolinska Institiutet Board of Research and the Karolinska Hospital Research Committee, for assistance with arrays, and Iyadh Douagi for assistance with cell sorting.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Cichocki F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00055; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Eidson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024441; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gleimer M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00374; Green ML, 2013, BLOOD, V122, P1316, DOI 10.1182/blood-2013-02-487074; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hesslein DGT, 2011, BLOOD, V117, P3087, DOI 10.1182/blood-2010-06-292219; Hwang I, 2012, INT IMMUNOL, V24, P793, DOI 10.1093/intimm/dxs080; Ito S, 2013, BONE MARROW TRANSPL, V48, P1313, DOI 10.1038/bmt.2013.49; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Puszyk W, 2013, EMBO J, V32, P1941, DOI 10.1038/emboj.2013.118; ROOK AH, 1988, REV INFECT DIS, V10, pS460; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013; Xu HC, 2014, IMMUNITY, V40, P949, DOI 10.1016/j.immuni.2014.05.004; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	49	457	466	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					443	456		10.1016/j.immuni.2015.02.008	http://dx.doi.org/10.1016/j.immuni.2015.02.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786176	Green Accepted, Bronze			2022-12-18	WOS:000351301900010
J	Hildeman, DA; Zhu, YN; Mitchell, TC; Bouillet, P; Strasser, A; Kappler, J; Marrack, P				Hildeman, DA; Zhu, YN; Mitchell, TC; Bouillet, P; Strasser, A; Kappler, J; Marrack, P			Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim	IMMUNITY			English	Article							IN-VIVO; FAS-LIGAND; BACTERIAL SUPERANTIGEN; APOPTOTIC BCL-2; TRANSGENIC MICE; VIRUS-INFECTION; DOWN-REGULATION; HUMAN TISSUES; SURVIVAL; EXPRESSION	At the end of the T cell response, the majority of the activated T cells die. We activated Vbeta8(+) T cells with staphylococcal enterotoxin B (SEB) in vivo and monitored the expansion and deletion of Vbeta8(+) T cells. We found that, in response to SEB, activated T cells died in vivo in the absence of Fas or TNF-R signaling but not when they overexpressed human Bcl-2. We also found that Vbeta8(+) T cells from Bim-deficient mice are resistant to SEB-induced deletion. While Bim levels did not change, endogenous Bcl-2 levels within Vbeta8(+) T cells decrease following SEB injection., Thus, the death of superantigen-stimulated T cells in vivo is mediated by Bim and may be modulated by a decrease in Bcl-2.	Univ Colorado, Hlth Sci Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80206 USA; Univ Louisville, Hlth Sci Ctr, Sch Med, Inst Cellular Therapeut, Louisville, KY 40202 USA; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Colorado, Hlth Sci Ctr, Dept Integrat Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Louisville; Walter & Eliza Hall Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hildeman, DA (corresponding author), Childrens Hosp, Med Ctr, Div Immunobiol, Natl Jewish Med & Res Ctr, NRB1563,3333 Burnet Ave, Cincinnati, OH 45229 USA.		Hildeman, David/AAA-1757-2020; Marrack, Philippa/AHE-6316-2022; Strasser, Andreas/C-7581-2013; Mitchell, Thomas C/B-4193-2013; Hildeman, David/I-4884-2015; Bouillet, Philippe/E-1241-2013	Hildeman, David/0000-0002-0421-8483; Strasser, Andreas/0000-0002-5020-4891; Hildeman, David/0000-0002-0421-8483; Bouillet, Philippe/0000-0002-9012-6058; Marrack, Philippa/0000-0003-1883-3687				Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Blank C, 1997, EUR J IMMUNOL, V27, P825, DOI 10.1002/eji.1830270405; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Desbarats J, 1998, NAT MED, V4, P1377, DOI 10.1038/3965; DHELN J, 1995, NATURE, V373, P438; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FENTON RG, 1988, SCIENCE, V241, P1089, DOI 10.1126/science.2970670; GILLETTEFERGUSON I, 1994, EUR J IMMUNOL, V24, P1181, DOI 10.1002/eji.1830240526; GONZALO JA, 1994, CLIN IMMUNOL IMMUNOP, V71, P176, DOI 10.1006/clin.1994.1069; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hsu SY, 2000, PHYSIOL REV, V80, P593, DOI 10.1152/physrev.2000.80.2.593; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; Kitada S, 1998, AM J PATHOL, V152, P51; Kuroda K, 1996, J IMMUNOL, V157, P1422; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Miethke T, 1996, EUR J IMMUNOL, V26, P1459, DOI 10.1002/eji.1830260709; Mitchell T, 1999, J IMMUNOL, V162, P4527; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Newton K, 1998, CURR OPIN GENET DEV, V8, P68, DOI 10.1016/S0959-437X(98)80064-6; Nguyen LT, 2000, EUR J IMMUNOL, V30, P683, DOI 10.1002/1521-4141(200002)30:2<683::AID-IMMU683>3.3.CO;2-X; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Penault-Llorca F, 1998, PATHOL RES PRACT, V194, P457, DOI 10.1016/S0344-0338(98)80114-3; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; SCOTT DE, 1993, J IMMUNOL, V150, P664; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Vabulas R, 1996, INFECT IMMUN, V64, P4567, DOI 10.1128/IAI.64.11.4567-4573.1996; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Van Parijs L, 1998, J IMMUNOL, V160, P2065; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	51	457	479	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					759	767		10.1016/S1074-7613(02)00322-9	http://dx.doi.org/10.1016/S1074-7613(02)00322-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121658	Bronze			2022-12-18	WOS:000176534000002
J	Moriggl, R; Topham, DJ; Teglund, S; Sexl, V; McKay, C; Wang, D; Hoffmeyer, A; van Deursen, J; Sangster, MY; Bunting, KD; Grosveld, GC; Ihle, JN				Moriggl, R; Topham, DJ; Teglund, S; Sexl, V; McKay, C; Wang, D; Hoffmeyer, A; van Deursen, J; Sangster, MY; Bunting, KD; Grosveld, GC; Ihle, JN			Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells	IMMUNITY			English	Article							INTERLEUKIN-2 RECEPTOR-BETA; GENE-EXPRESSION; PROTEIN GENE; MICE LACKING; LYMPHOCYTES; CHAIN; ACTIVATION; PROLACTIN; SELECTION; PATHWAYS	Many cytokines activate two highly homologous Stat proteins, 5a and 5b. Mice deficient in both genes lack all growth hormone and prolactin functions but retain functions associated with cytokines such as erythropoietin. Here, we demonstrate that, while lymphoid development is normal, Stat5a/b mutant peripheral T cells are profoundly deficient in proliferation and fail to undergo cell cycle progression or to express genes controlling cell cycle progression. In addition, the mice lack NK cells, develop splenomegaly, and have T cells with an activated phenotype, phenotypes seen in IL-2 receptor beta chain-deficient mice. These phenotypes are not seen in mice lacking Stat5a or Stat5b alone. The results demonstrate that the State proteins, redundantly, are essential mediators of IL-2 signaling in T cells.	St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Univ Tennessee, Sch Med, Dept Biochem, Memphis, TN 38063 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.		Wang, Demin/AAX-4449-2020; Moriggl, Richard/H-8118-2019; Sexl, Veronika/B-8657-2016	Wang, Demin/0000-0001-5549-3795; Moriggl, Richard/0000-0003-0918-9463; Sexl, Veronika/0000-0001-9363-0412; Sangster, Mark/0000-0002-1599-5894	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749] Funding Source: Medline; NIDDK NIH HHS [R01 DK42932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; Angerer L.M., 1992, IN SITU HYBRIDIZATIO, P15; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fujii H, 1998, EMBO J, V17, P6551, DOI 10.1093/emboj/17.22.6551; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; GAFFEN SL, 1995, P NATL ACAD SCI USA, V92, P7192, DOI 10.1073/pnas.92.16.7192; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; HOSOKAWA Y, 1994, GENE, V147, P249, DOI 10.1016/0378-1119(94)90075-2; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Kanegane H, 1996, IMMUNOLOGY, V87, P186, DOI 10.1046/j.1365-2567.1996.446530.x; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LUCAS JJ, 1995, J IMMUNOL, V154, P6275; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Nakamura S, 1997, MRS INTERNET J N S R, V2; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Takeda K, 1998, J IMMUNOL, V161, P4652; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; VALLANCE SJ, 1994, HYBRIDOMA, V13, P37, DOI 10.1089/hyb.1994.13.37; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zamorano J, 1998, J IMMUNOL, V160, P3502; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; [No title captured]	34	456	463	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					249	259		10.1016/S1074-7613(00)80025-4	http://dx.doi.org/10.1016/S1074-7613(00)80025-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072077	Bronze			2022-12-18	WOS:000078972200012
J	Hill, JA; Feuerer, M; Tash, K; Haxhinasto, S; Perez, J; Melamed, R; Mathis, D; Benoist, C				Hill, Jonathan A.; Feuerer, Markus; Tash, Kaley; Haxhinasto, Sokol; Perez, Jasmine; Melamed, Rachel; Mathis, Diane; Benoist, Christophe			Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature	IMMUNITY			English	Article							DOWN-REGULATION; SELF-TOLERANCE; CUTTING EDGE; TARGET GENES; LINEAGE; INDUCTION; DIFFERENTIATION; RECOGNITION; COMMITMENT; ACTIVATION	The CD4(+)CD25(+) lineage of regulatory T (Treg) cells plays a key role in controlling immune and autoimmune responses and is characterized by a unique transcriptional signature. The transcription factor Foxp3 had been thought to determine the Treg cell lineage, a hypothesis challenged by recent observations. We have performed a cross-sectional analysis of the Treg cell signature in Treg-like cells generated under a number of conditions, with or without Foxp3, to delineate the elements that can be ascribed to T cell activation, interleukin-2, transforming growth factor-beta (TGF-beta) signaling, or Foxp3 itself. These influences synergized to determine many of the signature's components. Much of the Treg cell signature was not ascribable to Foxp3 because it contained gene clusters that are coregulated with, but not transactivated by, Foxp3. Thus, a higher level of regulation upstream of Foxp3 determines the lineage, distinct from elements downstream of Foxp3 that are essential for its regulatory properties.	Brigham & Womens Hosp, Harvard Med Sch, Joslin Diabet Ctr, Dept Med,Sect Immunol & Immunogenet, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Benoist, C (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, Joslin Diabet Ctr, Dept Med,Sect Immunol & Immunogenet, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu		Melamed, Rachel/0000-0003-3089-9806	NIAID NIH HHS [1R01AI51530-5] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliahmad P, 2006, IMMUNOL REV, V209, P253, DOI 10.1111/j.0105-2896.2006.00345.x; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill CS, 2006, ACS CHEM BIOL, V1, P346, DOI 10.1021/cb6002702; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Kapp JA, 2006, INT IMMUNOL, V18, P1549, DOI 10.1093/intimm/dxl088; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Obst R, 2007, P NATL ACAD SCI USA, V104, P15460, DOI 10.1073/pnas.0707331104; Randall RA, 2004, MOL CELL BIOL, V24, P1106, DOI 10.1128/MCB.24.3.1106-1121.2004; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rothenberg EV, 2002, IMMUNOL REV, V187, P96, DOI 10.1034/j.1600-065X.2002.18709.x; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	51	455	471	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					786	800		10.1016/j.immuni.2007.09.010	http://dx.doi.org/10.1016/j.immuni.2007.09.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18024188	Bronze			2022-12-18	WOS:000251269000012
J	Sun, QM; Sun, LJ; Liu, HH; Chen, X; Seth, RB; Forman, J; Chen, ZJJ				Sun, Qinmiao; Sun, Lijun; Liu, Hong-Hsing; Chen, Xiang; Seth, Rashu B.; Forman, James; Chen, Zhijian J.			The specific and essential role of MAVS in antiviral innate immune responses	IMMUNITY			English	Article							HEPATITIS-C-VIRUS; NF-KAPPA-B; RIG-I; LISTERIA-MONOCYTOGENES; SIGNALING PROTEIN; ADAPTER PROTEIN; VIRAL-INFECTION; RNA VIRUSES; INTERFERON; INDUCTION	The mitochondrial antiviral signaling protein (MAVS) mediates the activation of NF kappa B and IRFs and the induction of interferons in response to viral infection. In vitro studies have also suggested that MAVS is required for interferon induction by cytosolic DNA, but the in vivo evidence is lacking. By generating MAVS-deficient mice, here we show that loss of MAVS abolished viral induction of interferons and prevented the activation of NF kappa B and IRF3 in multiple cell types, except plasmacytoid dendritic cells (pDCs). However, MAVS was not required for interferon induction by cytosolic DNA or by Listeria monocytogenes. Mice lacking MAVS were viable and fertile, but they failed to induce interferons in response to poly(I:C) stimulation and were severely compromised in immune defense against viral infection. These results provide the in vivo evidence that the cytosolic viral signaling pathway through MAVS is specifically required for innate immune responses against viral infection.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Liu, Hong-Hsing/0000-0002-3745-7202				Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Dalton KP, 2001, VIROLOGY, V279, P414, DOI 10.1006/viro.2000.0736; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Freundt EC, 2005, P NATL ACAD SCI USA, V102, P17539, DOI 10.1073/pnas.0509221102; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Machida K, 2006, J VIROL, V80, P866, DOI 10.1128/JVI.80.2.866-874.2006; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Neill LAJ, 2004, SCIENCE, V303, P1481, DOI 10.1126/science.1096113; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	39	455	483	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					633	642		10.1016/j.immuni.2006.04.004	http://dx.doi.org/10.1016/j.immuni.2006.04.004			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713980	Bronze			2022-12-18	WOS:000237970100019
J	Lesley, R; Xu, Y; Kalled, SL; Hess, DM; Schwab, SR; Shu, HB; Cyster, JG				Lesley, R; Xu, Y; Kalled, SL; Hess, DM; Schwab, SR; Shu, HB; Cyster, JG			Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; FAMILY-MEMBER BIM; NF-KAPPA-B; LYMPHOCYTE STIMULATOR; TRANSGENIC MICE; TNF FAMILY; FOLLICULAR EXCLUSION; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; DEFICIENT MICE	Peripheral autoantigen binding B cells are poorly competitive with naive B cells for survival and undergo rapid cell death. However, in monoclonal Ig-transgenic mice lacking competitor B cells, autoantigen binding B cells can survive for extended periods. The basis for competitive elimination of autoantigen binding B cells has been unknown. Here we demonstrate that autoantigen binding B cells have increased dependence on BAFF for survival. In monoclonal Ig-transgenic mice, each autoantigen binding B cell receives elevated amounts of BAFF, exhibiting increased levels of NFkappaB p52 and of the prosurvival kinase Pim2. When placed in a diverse B cell compartment, BAFF receptor engagement and signaling are reduced and the autoantigen binding cells are unable to protect themselves from Bim and possibly other death-promoting factors induced by chronic BCR signaling. These findings indicate that under conditions where BAFF levels are elevated, autoantigen-engaged cells will be rescued from rapid competitive elimination, predisposing to the development of autoimmune disease.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Biogen Inc, Dept Immunol & Inflammat, Cambridge, MA 02142 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Biogen; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu		Schwab, Susan/0000-0002-0834-0822	NIAID NIH HHS [AI-40098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI040098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; AUGUST CS, 1989, IMMUNOLOGICAL DISORD, P634; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cook MC, 1997, J EXP MED, V186, P631, DOI 10.1084/jem.186.5.631; Cyster JG, 1997, IMMUNOL REV, V156, P87, DOI 10.1111/j.1600-065X.1997.tb00961.x; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Ekland EH, 2004, J IMMUNOL, V172, P4700, DOI 10.4049/jimmunol.172.8.4700; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; KARAGOGEOS D, 1986, EUR J IMMUNOL, V16, P1125, DOI 10.1002/eji.1830160916; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; Lang J, 2000, EUR J IMMUNOL, V30, P689, DOI 10.1002/1521-4141(200002)30:2<689::AID-IMMU689>3.0.CO;2-I; Lentz VM, 1998, J IMMUNOL, V160, P3743; Lentz VM, 1996, J IMMUNOL, V157, P598; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay IR, 2002, AUTOIMMUNITY, V35, P551, DOI 10.1080/0891693021000066333; Mandik-Nayak L, 2000, J IMMUNOL, V164, P1161, DOI 10.4049/jimmunol.164.3.1161; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Miosge LA, 2002, J EXP MED, V196, P1113, DOI 10.1084/jem.20020959; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schmidt KN, 1999, J IMMUNOL, V162, P284; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tribouley C, 1999, BIOL CHEM, V380, P1443, DOI 10.1515/BC.1999.186; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xu LG, 2002, J LEUKOCYTE BIOL, V72, P410; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	80	455	464	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					441	453		10.1016/S1074-7613(04)00079-2	http://dx.doi.org/10.1016/S1074-7613(04)00079-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084273	Bronze			2022-12-18	WOS:000221442800010
J	Lio, CWJQ; Hsieh, CS				Lio, Chan-Wang Joaquim; Hsieh, Chyi-Song			A two-step process for thymic regulatory T cell development	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; IMMUNOLOGICAL SELF-TOLERANCE; AUTOIMMUNITY; RECEPTOR; INTERLEUKIN-2; HOMEOSTASIS; EXPRESSION; THYMOCYTES; SELECTION; ANTIGEN	Recognition of self-antigens is required for regulatory T (Treg) cells to exert dominant tolerance. However, the mechanism by which self-reactive thymocytes are diverted into the Treg cell subset is unclear. To address this question, we looked for the immediate precursors to Treg cells within Foxp3(-)CD4(+)CD8(-) thymocytes. By using intrathymic transfer, we found that the CD25(hi) subset is highly enriched in Treg cell precursors. This was supported by tracking of thymocyte development via analysis of T cell receptor (TCR) repertoires in a TCR-beta transgenic model. These Treg cell precursors exist at a developmental stage where they are poised to express Foxp3 without further TCR engagement, requiring only stimulation by interleukin-2 (IL-2) or IL-15. Thus, we propose that the selection of self-reactive thymocytes into the Treg cell subset occurs via an instructive rather than stochastic-selective model whereby TCR signals result in the expression of proximal IL-2 signaling components facilitating cytokine-mediated induction of Foxp3.	[Lio, Chan-Wang Joaquim; Hsieh, Chyi-Song] Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA.	chsieh@im.wustl.edu		Lio, Jerry/0000-0003-3876-6741	NIAID NIH HHS [R01 AI061478-04, R01 AI061478-03, R01 AI061478] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061478] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Itoh M, 1999, J IMMUNOL, V162, P5317; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; KISHIMOTO H, 1995, J EXP MED, V181, P649, DOI 10.1084/jem.181.2.649; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Samy ET, 2006, IMMUNOL REV, V212, P170, DOI 10.1111/j.0105-2896.2006.00404.x; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; TAGUCHI O, 1994, IMMUNOLOGY, V82, P365; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756	44	454	467	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					100	111		10.1016/j.immuni.2007.11.021	http://dx.doi.org/10.1016/j.immuni.2007.11.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199417	Green Accepted, Bronze			2022-12-18	WOS:000252627300014
J	DIGHE, AS; RICHARDS, E; OLD, LJ; SCHREIBER, RD				DIGHE, AS; RICHARDS, E; OLD, LJ; SCHREIBER, RD			ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS	IMMUNITY			English	Article							NECROSIS FACTOR TNF; SIGNAL-TRANSDUCTION; ANTITUMOR FUNCTION; INTERFERON; PROTEIN; ACTIVATION; IDENTIFICATION; INHIBITION; ANTIBODIES; CACHEXIA	Using a neutralizing monoclonal antibody specific for murine IFN gamma we show that endogenously produced IFN gamma plays an obligate role in mediating LPS-induced rejection of the Meth A fibrosarcoma tumor in syngeneic BALB/c mice. To examine the cellular targets of IFN gamma action, we generated IFN gamma-insensitive tumor cells by stably overexpressing in Meth A a truncated dominant negative form of the murine IFN gamma receptor alpha chain. When implanted in BALB/c mice, IFN gamma-insensitive Meth A cells displayed enhanced tumorigenicity compared with control Meth A cells and were not rejected when tumor-bearing mice were treated with concentrations of LPS that eliminated control tumors. In Meth A immune mice, IFN gamma-sensitive Meth A did not establish tumors while IFN gamma-insensitive tumors grew in a progressive manner. In addition, the IFN gamma-insensitive tumor cells were unable to elicit strong protective immunity to subsequent wild-type tumor challenge. These results show that IFN gamma has direct effects on tumor cell immunogenicity and thus plays an important role in promoting tumor cell recognition and elimination.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; LUDWIG INST CANC RES,NEW YORK,NY 10105	Washington University (WUSTL); Ludwig Institute for Cancer Research	DIGHE, AS (corresponding author), WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63110, USA.		Schreiber, Robert/Q-7550-2019; Dighe, Anand/AAP-9640-2020; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Dighe, Anand/0000-0003-4130-0758; Schreiber, Robert/0000-0003-1590-2341	NCI NIH HHS [CA43059] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA043059, R01CA043059] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; BURNHAM DK, 1989, TRANSPLANTATION, V47, P533, DOI 10.1097/00007890-198903000-00027; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; COLOMBO MP, 1994, IMMUNOL TODAY, V15, P48, DOI 10.1016/0167-5699(94)90131-7; DEVITA VT, 1991, BIOL THERAPY CANCER, P1; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; FARRAR MA, 1991, J BIOL CHEM, V266, P19626; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; FUYAMA S, 1991, CELL IMMUNOL, V137, P200, DOI 10.1016/0008-8749(91)90069-N; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HAVELL EA, 1988, J EXP MED, V167, P1067, DOI 10.1084/jem.167.3.1067; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; LECLAIRE RD, 1992, J LEUKOCYTE BIOL, V51, P507, DOI 10.1002/jlb.51.5.507; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NASTALA CL, 1994, J IMMUNOL, V153, P1697; NORTH RJ, 1988, J EXP MED, V167, P1086, DOI 10.1084/jem.167.3.1086; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; PARDOLL D, 1992, CURR OPIN IMMUNOL, V4, P619, DOI 10.1016/0952-7915(92)90037-F; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; TENG MN, 1991, P NATL ACAD SCI USA, V88, P3535, DOI 10.1073/pnas.88.9.3535; TENG MN, 1993, CLIN IMMUNOL IMMUNOP, V69, P215, DOI 10.1006/clin.1993.1172; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0	30	454	477	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1994	1	6					447	456		10.1016/1074-7613(94)90087-6	http://dx.doi.org/10.1016/1074-7613(94)90087-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7895156				2022-12-18	WOS:A1994PK17100002
J	Wakeland, EK; Liu, K; Graham, RR; Behrens, TW				Wakeland, EK; Liu, K; Graham, RR; Behrens, TW			Delineating the genetic basis of systemic lupus erythematosus	IMMUNITY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; SINGLE-NUCLEOTIDE POLYMORPHISMS; CONGENIC MOUSE STRAINS; ZEALAND WHITE MICE; SIB-PAIR FAMILIES; AUTOIMMUNE-DISEASE; AUTOANTIBODY PRODUCTION; SUSCEPTIBILITY GENES; REVISED CRITERIA; SLE PATHOGENESIS	Genetic predisposition plays a crucial role in susceptibility to systemic lupus erythematosus (SLE) in both human patients and animal models. Recent progress in experimental systems and human linkage analysis is providing key insights into the genetic basis for susceptibility and elucidating the manner in which genetic interactions mediate severe disease pathogenesis. Genes in multiple pathways appear to participate in specific elements of the disease, and epistatic interactions among these genes play an important role in both aggravating and suppressing disease development.	Univ Minnesota, Sch Med, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75235 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wakeland, EK (corresponding author), Univ Minnesota, Sch Med, Dept Med, Ctr Immunol, 312 Church St,SE, Minneapolis, MN 55455 USA.							Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Applequist SE, 2000, J IMMUNOL, V165, P2398, DOI 10.4049/jimmunol.165.5.2398; ARNETT FC, 1992, RHEUM DIS CLIN N AM, V18, P865; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; BOWNESS P, 1994, Q J MED, V87, P455; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carroll M C, 2000, Adv Immunol, V74, P61; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Carroll MC, 1998, NAT GENET, V19, P3, DOI 10.1038/ng0598-3; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; DRAKE CG, 1994, P NATL ACAD SCI USA, V91, P4062, DOI 10.1073/pnas.91.9.4062; DRAKE CG, 1995, J IMMUNOL, V154, P2441; FOSSATI L, 1993, INT IMMUNOL, V5, P525, DOI 10.1093/intimm/5.5.525; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; GAFFNEY PM, 2001, IN PRESS RHEUM DIS C; Graham RR, 2001, ARTHRITIS RES, V3, P299, DOI 10.1186/ar319; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; Haywood MEK, 2000, ARTHRITIS RHEUM, V43, P349, DOI 10.1002/1529-0131(200002)43:2<349::AID-ANR14>3.0.CO;2-M; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hochberg MC, 1997, DUBOIS LUPUS ERYTHEM; HOCHBERG MC, 1985, ARTHRIT RHEUMAT, V28, P523; Hogarth MB, 1998, J IMMUNOL, V161, P2753; HOWARD PF, 1986, AM J MED, V81, P187, DOI 10.1016/0002-9343(86)90250-0; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; KELLEY VE, 1980, CLIN IMMUNOL IMMUNOP, V16, P142, DOI 10.1016/0090-1229(80)90198-1; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Mandik-Nayak L, 2000, INT IMMUNOL, V12, P353, DOI 10.1093/intimm/12.3.353; Mohan C, 1999, J IMMUNOL, V162, P6492; Mohan C, 1997, J IMMUNOL, V159, P454; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Mohan C, 1998, J CLIN INVEST, V101, P1362; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; Morel L, 1997, J IMMUNOL, V158, P6019; Morel L, 1999, MAMM GENOME, V10, P176; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Rozzo SJ, 1996, P NATL ACAD SCI USA, V93, P15164, DOI 10.1073/pnas.93.26.15164; Rozzo SJ, 2000, J IMMUNOL, V164, P5515, DOI 10.4049/jimmunol.164.10.5515; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; SANTIAGORABER ML, IN PRESS J IMMUNOL; SCHUR PH, 1990, ARTHRITIS RHEUM, V33, P985, DOI 10.1002/art.1780330710; Schur PH, 1995, LUPUS, V4, P425, DOI 10.1177/096120339500400603; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Suzuki D.T., 1989, INTRO GENETIC ANAL; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P90, DOI 10.1016/0167-5699(95)80095-6; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; Tsao BP, 1999, J CLIN INVEST, V103, P1135, DOI 10.1172/JCI5967; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Vyse TJ, 1997, J IMMUNOL, V158, P5566; Vyse TJ, 1996, J IMMUNOL, V157, P2719; Vyse TJ, 1996, J CLIN INVEST, V98, P1762, DOI 10.1172/JCI118975; WAKELAND EK, 1997, IMMUNOL TODAY, V18, P473; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WARREN RW, 1984, CLIN IMMUNOL IMMUNOP, V31, P65, DOI 10.1016/0090-1229(84)90190-9; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; YAMADA H, 1990, J RHEUMATOL, V17, P1054; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	84	453	473	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		397	408		10.1016/S1074-7613(01)00201-1	http://dx.doi.org/10.1016/S1074-7613(01)00201-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567630	Bronze			2022-12-18	WOS:000171211800007
J	Goldrath, AW; Bevan, MJ				Goldrath, AW; Bevan, MJ			Low-affinity ligands for the TCR drive proliferation of mature CD8(+) T cells in lymphopenic hosts	IMMUNITY			English	Article							MHC CLASS-I; ATHYMIC NUDE RATS; POSITIVE SELECTION; RECEPTOR ANTAGONISTS; LYMPHOCYTES-T; LIFE-SPAN; SURVIVAL; PEPTIDE; EXPANSION; MOLECULES	In the absence of thymic emigration, the peripheral T cell pool is maintained by division of mature lymphocytes. We have examined the molecular interactions required for peripheral CD8(+) T cell expansion in lymphopenic mice without conventional antigenic stimulation. Expansion of CD8+ T cells in lymphopenic hosts was found to be peptide specific. An antagonist peptide known to serve as a ligand for positive selection of these T cells promoted expansion; however, a control peptide that binds the same class I molecule did not. Surprisingly, the cells undergoing proliferation in lymphopenic hosts did not mature to cytotoxic effecters and displayed a partially activated surface phenotype. These data suggest that division of T cells in the periphery of lymphopenic hosts requires specific recognition of self-peptide/MHC complexes, similar to the signal for thymocyte maturation.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.				NATIONAL CANCER INSTITUTE [S15CA053732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029802] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P32CA5373209] Funding Source: Medline; NIAID NIH HHS [AI29802, R01 AI029802-11, R01 AI029802] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; ALAM SM, 1996, NATURE, V381, P558; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; BACIK I, 1994, J IMMUNOL, V152, P381; BARNDEN MJ, 1994, EUR J IMMUNOL, V24, P2452, DOI 10.1002/eji.1830241029; Basu D, 1998, P NATL ACAD SCI USA, V95, P14332, DOI 10.1073/pnas.95.24.14332; Bell E B, 1997, Semin Immunol, V9, P347, DOI 10.1006/smim.1997.0092; BELL EB, 1989, IMMUNOLOGY, V68, P547; BELL EB, 1987, J IMMUNOL, V139, P1379; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Bruno L, 1996, EUR J IMMUNOL, V26, P3179, DOI 10.1002/eji.1830261251; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Freitas AA, 1999, CURR OPIN IMMUNOL, V11, P152, DOI 10.1016/S0952-7915(99)80026-0; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mackall CL, 1996, J IMMUNOL, V156, P4609; MCDONAGH M, 1995, IMMUNOLOGY, V84, P514; Nesic D, 1998, J IMMUNOL, V160, P3705; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; PEREIRA P, 1991, INT IMMUNOL, V3, P1077, DOI 10.1093/intimm/3.11.1077; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891	39	453	469	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					183	190		10.1016/S1074-7613(00)80093-X	http://dx.doi.org/10.1016/S1074-7613(00)80093-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485653	Green Accepted, Bronze			2022-12-18	WOS:000082383400007
J	Zhang, WG; Sommers, CL; Burshtyn, DN; Stebbins, CC; DeJarnette, JB; Trible, RP; Grinberg, A; Tsay, HC; Jacobs, HM; Kessler, CM; Long, EO; Love, PE; Samelson, LE				Zhang, WG; Sommers, CL; Burshtyn, DN; Stebbins, CC; DeJarnette, JB; Trible, RP; Grinberg, A; Tsay, HC; Jacobs, HM; Kessler, CM; Long, EO; Love, PE; Samelson, LE			Essential role of LAT in T cell development	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; KILLER NK CELLS; MICE LACKING; ANTIGEN RECEPTORS; MUTANT MICE; INHIBITORY RECEPTOR; SIGNAL-TRANSDUCTION; THYMOCYTES; CHAIN; SYK	The linker molecule LAT is a substrate of the tyrosine kinases activated following TCR engagement. Phosphorylated LAT binds many critical signaling molecules. The central role of this molecule in TCR-mediated signaling has been demonstrated by experiments in a LAT-deficient cell line. To probe the role of LAT in T cell development, the LAT gene was disrupted by targeting. LAT-deficient mice appeared healthy. Flow cytometric analysis revealed normal B cell populations but the absence of any mature peripheral T cells. Intra; thymic development was blocked within the CD4(-)CD8(-) stage. No gross abnormality of NK or platelet function was observed. LAT is thus critical to both T cell activation and development.	NICHHD, Sect Lymphocyte Signaling, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; NIAID, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Div Hematol Oncol, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Georgetown University	Samelson, LE (corresponding author), NICHHD, Sect Lymphocyte Signaling, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.		Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728; Burshtyn, Deborah/0000-0003-4829-3351	NATIONAL CANCER INSTITUTE [Z01BC010304, ZIABC010304] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bolen JB, 1997, ANNU REV IMMUNOL, V15, P371, DOI 10.1146/annurev.immunol.15.1.371; Buhl AM, 1997, IMMUNOL REV, V160, P127, DOI 10.1111/j.1600-065X.1997.tb01033.x; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; FACCHETTI F, 1999, IN PRESS AM J PATH; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Galandrini R, 1996, J EXP MED, V183, P179, DOI 10.1084/jem.183.1.179; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; GUYGRAND D, 1993, CURR OPIN IMMUNOL, V5, P247, DOI 10.1016/0952-7915(93)90012-H; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Jevremovic D, 1999, J IMMUNOL, V162, P2453; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; Killeen N, 1998, CURR OPIN IMMUNOL, V10, P360, DOI 10.1016/S0952-7915(98)80176-3; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MallickWood CA, 1996, P NATL ACAD SCI USA, V93, P9704, DOI 10.1073/pnas.93.18.9704; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Peterson EJ, 1998, CURR OPIN IMMUNOL, V10, P337, DOI 10.1016/S0952-7915(98)80173-8; PFEFFER K, 1994, ANNU REV IMMUNOL, V12, P367, DOI 10.1146/annurev.immunol.12.1.367; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Rojo S, 1997, J IMMUNOL, V158, P9; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; SAMELSON LE, 1999, IN PRESS PROG BIOPHY; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shores E, 1997, J IMMUNOL, V159, P222; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TURNER H, 1995, J BIOL CHEM, V270, P9500, DOI 10.1074/jbc.270.16.9500; Valiante NM, 1996, J EXP MED, V184, P2243, DOI 10.1084/jem.184.6.2243; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	55	453	472	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					323	332		10.1016/S1074-7613(00)80032-1	http://dx.doi.org/10.1016/S1074-7613(00)80032-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204488	Bronze			2022-12-18	WOS:000079455700005
J	Shibuya, A; Campbell, D; Hannum, C; Yssel, H; FranzBacon, K; McClanahan, T; Kitamura, T; Nicholl, J; Sutherland, GR; Lanier, LL; Phillips, JH				Shibuya, A; Campbell, D; Hannum, C; Yssel, H; FranzBacon, K; McClanahan, T; Kitamura, T; Nicholl, J; Sutherland, GR; Lanier, LL; Phillips, JH			DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes	IMMUNITY			English	Article							NATURAL-KILLER-CELL; MONOCLONAL-ANTIBODIES; ACTIVATION ANTIGEN; IMMUNE-SYSTEM; LFA-1; EXPRESSION; CLONES; CD2; RECEPTORS; CLONING	Intercellular adhesion molecules play an important role in the generation of T lymphocyte-mediated immune responses. Here, we describe a novel accessory molecule, DNAX accessory molecule-1 (DNAM-1), that is constitutively expressed on the majority of peripheral blood T lymphocytes. DNAM-1 is a 65 kDa transmembrane glycoprotein consisting of 318 aa including two immunoglobulin-like domains. Anti-DNAM-1 monoclonal antibody (MAb) inhibits T and NK cell-mediated cytotoxicity against a variety of tumor cell targets and blocks cytokine production by alloantigen-specific T cells. In addition, DNAM-1 is a tyrosine-phosphorylated signal-transducing molecule that participates in primary adhesion during cytotoxic T lymphocyte (CTL)-mediated cytotoxicity.	DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT BIOL MOLEC, PALO ALTO, CA 94304 USA; DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT CELL SIGNALING, PALO ALTO, CA 94304 USA; ADELAIDE CHILDRENS HOSP INC, DEPT CYTOGENET & MOLEC GENET, ADELAIDE, SA 5006, AUSTRALIA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Shibuya, A (corresponding author), DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT HUMAN IMMUNOL, 901 CALIF AVE, PALO ALTO, CA 94304 USA.		Yssel, Hans/C-6406-2009; Yssel, Hans/AFV-2907-2022; Lanier, Lewis L/E-2139-2014; Sutherland, Grant Robert/D-2606-2012	Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836; Lanier, Lewis L/0000-0003-1308-3952; 				APASOV S, 1993, CURR OPIN IMMUNOL, V5, P404, DOI 10.1016/0952-7915(93)90060-6; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.immunol.7.1.579; BIERER BE, 1991, ADV CANCER RES, V56, P49; CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; CANTLEY LC, 1994, J CELL SCI, P121; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; CHRETIEN I, 1989, J IMMUNOL METHODS, V117, P67, DOI 10.1016/0022-1759(89)90120-8; DUSTIN ML, 1987, J EXP MED, V165, P677, DOI 10.1084/jem.165.3.677; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; GUNJI Y, 1992, BLOOD, V80, P429; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; HOGG N, 1993, CURR OPIN IMMUNOL, V5, P383, DOI 10.1016/0952-7915(93)90057-Y; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; JANEWAY CA, 1988, NATURE, V335, P208, DOI 10.1038/335208a0; KILLEEN N, 1992, EMBO J, V11, P4329, DOI 10.1002/j.1460-2075.1992.tb05532.x; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KRENSKY AM, 1983, J IMMUNOL, V131, P611; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1; LANIER LL, 1988, J EXP MED, V167, P1572, DOI 10.1084/jem.167.5.1572; LANIER LL, 1983, J IMMUNOL, V131, P1789; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MCMICHAEL AJ, 1980, HUM IMMUNOL, V1, P121, DOI 10.1016/0198-8859(80)90099-3; MENTZER SJ, 1985, J IMMUNOL, V135, P34; OROURKE AM, 1992, NATURE, V358, P253, DOI 10.1038/358253a0; PHILLIPS JH, 1991, J EXP MED, V174, P1571, DOI 10.1084/jem.174.6.1571; RODRIGUES M, 1992, J EXP MED, V175, P895, DOI 10.1084/jem.175.4.895; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; SCOTT CF, 1989, J IMMUNOL, V142, P4105; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; SPITS H, 1985, EUR J IMMUNOL, V15, P88, DOI 10.1002/eji.1830150117; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; VANDEWIELVANKEMENADE E, 1992, EUR J IMMUNOL, V22, P1467; VIVES J, 1994, IMMUNOLOGIST, V2, P93; WANG PL, 1992, J IMMUNOL, V148, P2600; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	41	453	483	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1996	4	6					573	581		10.1016/S1074-7613(00)70060-4	http://dx.doi.org/10.1016/S1074-7613(00)70060-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673704	Green Submitted, Bronze			2022-12-18	WOS:A1996UU44300006
J	McGeachy, MJ; Cua, DJ; Gaffen, SL				McGeachy, Mandy J.; Cua, Daniel J.; Gaffen, Sarah L.			The IL-17 Family of Cytokines in Health and Disease	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA STABILITY; DELTA-T-CELLS; KAPPA-B-ZETA; TH17 CELLS; RHEUMATOID-ARTHRITIS; KERATINOCYTE PROLIFERATION; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; PSORIATIC-ARTHRITIS	The interleukin 17 (IL-17) family of cytokines contains 6 structurally related cytokines, IL-17A through IL-17F. IL-17A, the prototypical member of this family, just passed the 25th anniversary of its discovery. Although less is known about IL-17B-F, IL-17A (commonly known as IL-17) has received much attention for its pro-inflammatory role in autoimmune disease. Over the past decade, however, it has become clear that the functions of IL-17 are far more nuanced than simply turning on inflammation. Accumulating evidence indicates that IL-17 has important context- and tissue-dependent roles in maintaining health during response to injury, physiological stress, and infection. Here, we discuss the funcions of the IL-17 family, with a focus on the balance between the pathogenic and protective roles of IL-17 in cancer and autoimmune disease, including results of therapeutic blockade and novel aspects of IL-7 signal transduction regulation.	[McGeachy, Mandy J.; Gaffen, Sarah L.] Univ Pittsburgh, Dept Med, Div Rheumatol, Pittsburgh, PA 15260 USA; [Cua, Daniel J.] Merck & Co Inc, Palo Alto, CA 94304 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Merck & Company	McGeachy, MJ; Gaffen, SL (corresponding author), Univ Pittsburgh, Dept Med, Div Rheumatol, Pittsburgh, PA 15260 USA.; Cua, DJ (corresponding author), Merck & Co Inc, Palo Alto, CA 94304 USA.	mandymcgeachy@pitt.edu; daniel.cua@merck.com; sarah.gaffen@pitt.edu	Gaffen, Sarah L/B-1560-2009	Gaffen, Sarah L/0000-0001-8511-2041	NIH [AI110822, DE0225500, AI107825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107825, R01AI110822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE022550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding from NIH to M.J.M. (AI110822) and S.L.G. (DE0225500 and AI107825).	Ahmed M, 2013, CYTOKINE, V61, P898, DOI 10.1016/j.cyto.2012.12.007; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Akira S, 2013, COLD SH Q B, V78, P51, DOI 10.1101/sqb.2013.78.019877; Albanesi C, 1999, J IMMUNOL, V162, P494; Amatya N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat4617; Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Amicarella F, 2017, GUT, V66, P692, DOI 10.1136/gutjnl-2015-310016; Amir M, 2018, CELL REP, V25, P3733, DOI 10.1016/j.celrep.2018.11.101; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bar E, 2012, J IMMUNOL, V188, P5636, DOI 10.4049/jimmunol.1200594; Baeten D, 2018, ANN RHEUM DIS, V77, P1295, DOI 10.1136/annrheumdis-2018-213328; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Bagheri N, 2015, MICROB PATHOGENESIS, V81, P33, DOI 10.1016/j.micpath.2015.03.010; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Beurel E, 2018, BRAIN BEHAV IMMUN, V69, P28, DOI 10.1016/j.bbi.2017.08.001; Beurel E, 2013, BIOL PSYCHIAT, V73, P622, DOI 10.1016/j.biopsych.2012.09.021; Bie QL, 2017, MOL IMMUNOL, V90, P50, DOI 10.1016/j.molimm.2017.07.004; Bie QL, 2017, ONCOTARGET, V8, P18914, DOI 10.18632/oncotarget.14835; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; Buckley KM, 2017, ELIFE, V6, DOI 10.7554/eLife.23481; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen FD, 2016, J IMMUNOL, V196, P4390, DOI 10.4049/jimmunol.1501541; Chen X, 2019, J EXP MED, V216, P195, DOI 10.1084/jem.20171849; Chiricozzi A, 2013, EXPERT OPIN INV DRUG, V22, P993, DOI 10.1517/13543784.2013.806483; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Conti HR, 2016, CELL HOST MICROBE, V20, P606, DOI 10.1016/j.chom.2016.10.001; Conti HR, 2015, J IMMUNOL, V195, P780, DOI 10.4049/jimmunol.1500909; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cruz J Agustin, 2017, Immunohorizons, V1, P133, DOI 10.4049/immunohorizons.1700035; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Diaz LA, 2015, NEW ENGL J MED, V373, P1979, DOI 10.1056/NEJMc1510353; Drummond RA, 2019, SEMIN CELL DEV BIOL, V89, P78, DOI 10.1016/j.semcdb.2018.01.008; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Esfahani K, 2017, NEW ENGL J MED, V376, P1989, DOI 10.1056/NEJMc1703047; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Faraco G, 2018, NAT NEUROSCI, V21, P240, DOI 10.1038/s41593-017-0059-z; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Fleischmann RM, 2017, ARTHRITIS RHEUMATOL, V69, P2283, DOI 10.1002/art.40319; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fu MG, 2017, NAT REV IMMUNOL, V17, P130, DOI 10.1038/nri.2016.129; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2011, J IMMUNOL, V187, P4389, DOI 10.4049/jimmunol.1102576; Garg AV, 2015, IMMUNITY, V43, P475, DOI 10.1016/j.immuni.2015.07.021; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Genovese MC, 2014, ARTHRITIS RHEUMATOL, V66, P1693, DOI 10.1002/art.38617; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Goswami J, 2009, EUR J IMMUNOL, V39, P2831, DOI 10.1002/eji.200939670; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Hamilton T, 2012, J LEUKOCYTE BIOL, V91, P377, DOI 10.1189/jlb.0811404; Han QF, 2015, J IMMUNOL, V195, P5440, DOI 10.4049/jimmunol.1500892; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Herjan T, 2018, NAT IMMUNOL, V19, P354, DOI 10.1038/s41590-018-0071-9; Herjan T, 2013, J IMMUNOL, V191, P640, DOI 10.4049/jimmunol.1203315; Housseau F, 2016, CANCER RES, V76, P2115, DOI 10.1158/0008-5472.CAN-15-0749; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Israel L, 2018, J INVEST DERMATOL, V138, P2075, DOI 10.1016/j.jid.2018.03.1503; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; June CH, 2017, NAT MED, V23, P540, DOI 10.1038/nm.4321; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Klunder B, 2018, CLIN PHARMACOKINET, V57, P977, DOI 10.1007/s40262-017-0605-6; Kohanski MA, 2018, J ALLERGY CLIN IMMUN, V142, P460, DOI 10.1016/j.jaci.2018.03.019; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laprevotte E, 2017, ONCOTARGET, V8, P113360, DOI 10.18632/oncotarget.23008; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Li J, 2018, MUCOSAL IMMUNOL, V11, P581, DOI 10.1038/mi.2017.97; Li J, 2017, CURR OPIN MICROBIOL, V40, P46, DOI 10.1016/j.mib.2017.10.016; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McInnes IB, 2017, RHEUMATOLOGY, V56, P1993, DOI 10.1093/rheumatology/kex301; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Mease P, 2016, RHEUMATOL THER, V3, P5, DOI 10.1007/s40744-016-0031-5; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Monin L, 2017, J IMMUNOL, V198, P767, DOI 10.4049/jimmunol.1601551; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Pavelka K, 2015, J RHEUMATOL, V42, P912, DOI 10.3899/jrheum.141271; Peng T, 2017, J EXP MED, V214, P2315, DOI 10.1084/jem.20160581; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Puel A, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau8876; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qu FF, 2012, MOL CELL BIOL, V32, P3925, DOI 10.1128/MCB.00268-12; Ramani K, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/5103672; Ramani K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98241; Ramani K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005952; Ramani K, 2014, J LEUKOCYTE BIOL, V96, P463, DOI 10.1189/jlb.3A0414-184R; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Robert R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184278; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Saddawi-Konefka R, 2016, CELL REP, V16, P2348, DOI 10.1016/j.celrep.2016.07.075; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Seelige R, 2017, CYTOKINE, V91, P10, DOI 10.1016/j.cyto.2016.11.017; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shin HCK, 1999, CYTOKINE, V11, P257, DOI 10.1006/cyto.1998.0433; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Somma D, 2015, J IMMUNOL, V194, P3286, DOI 10.4049/jimmunol.1401589; Sonder SU, 2012, J IMMUNOL, V188, P5906, DOI 10.4049/jimmunol.1103233; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Tamassia N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00795; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Taylor PR, 2014, J IMMUNOL, V192, P3319, DOI 10.4049/jimmunol.1302235; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Tohyama M, 2018, EUR J IMMUNOL, V48, P168, DOI 10.1002/eji.201747017; Torres T, 2016, EXPERT OPIN INV DRUG, V25, P751, DOI 10.1080/13543784.2016.1187130; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Mens LJJ, 2018, ARTHRITIS RHEUMATOL, V70, P1994, DOI 10.1002/art.40581; Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742; Verma AH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8834; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang MC, 2018, IMMUNITY, V49, P66, DOI 10.1016/j.immuni.2018.05.012; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Whibley N, 2015, IMMUNITY, V43, P620, DOI 10.1016/j.immuni.2015.10.001; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.20141702; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu L, 2015, J EXP MED, V212, P1571, DOI 10.1084/jem.20150204; Wu NL, 2015, J INVEST DERMATOL, V135, P490, DOI 10.1038/jid.2014.383; Xu D, 2018, J EXP MED, V215, P1169, DOI 10.1084/jem.20171285; Yang YF, 2018, CANCER LETT, V422, P44, DOI 10.1016/j.canlet.2018.02.037; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; YOO ZB, 1995, J IMMUNOL, V155, P5483; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	195	452	472	30	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					892	906		10.1016/j.immuni.2019.03.021	http://dx.doi.org/10.1016/j.immuni.2019.03.021			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995505	Green Accepted, Bronze			2022-12-18	WOS:000464660800009
J	Klechevsky, E; Morita, R; Liu, MC; Cao, YY; Coquery, S; Thompson-Snipes, L; Briere, F; Chaussabel, D; Zurawski, G; Palucka, AK; Reiter, Y; Banchereau, J; Ueno, H				Klechevsky, Eynav; Morita, Rimpei; Liu, Maochang; Cao, Yanying; Coquery, Sebastien; Thompson-Snipes, LuAnn; Briere, Francine; Chaussabel, Damien; Zurawski, Gerard; Palucka, A. Karolina; Reiter, Yoram; Banchereau, Jacques; Ueno, Hideki			Functional specializations of human epidermal langerhans cells and CD14(+) dermal dendritic cells	IMMUNITY			English	Article							ANTIGEN-SPECIFIC CTL; REGULATORY T-CELLS; IN-VIVO; HEMATOPOIETIC PROGENITORS; CONTACT HYPERSENSITIVITY; IMMUNITY; SKIN; RESPONSES; IMMUNOLOGY; DISTINCT	Little is known about the functional differences between the human skin myeloid dendritic cell (DC) subsets, epidermal CD207(+) Langerhans cells (LCs) and dermal CD14(+) DCs. We showed that CD14(+) DCs primed CD4(+) T cells into cells that induce naive B cells to switch isotype and become plasma cells. In contrast, LCs preferentially induced the differentiation of CD4(+) T cells secreting T helper 2 (Th2) cell cytokines and were efficient at priming and cross-priming naive CD8(+) T cells. A third DC population, CD14(-)CD207(-)CD1a(+) DC, which resides in the dermis, could activate CD8(+) T cells better than CD14(+) DCs but less efficiently than LCs. Thus, the human skin displays three DC subsets, two of which, i.e., CD14(+) DCs and LCs, display functional specializations, the preferential activation of humoral and cellular immunity, respectively.	[Klechevsky, Eynav; Morita, Rimpei; Liu, Maochang; Cao, Yanying; Coquery, Sebastien; Thompson-Snipes, LuAnn; Briere, Francine; Chaussabel, Damien; Zurawski, Gerard; Palucka, A. Karolina; Banchereau, Jacques; Ueno, Hideki] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Klechevsky, Eynav; Morita, Rimpei; Liu, Maochang; Cao, Yanying; Coquery, Sebastien; Thompson-Snipes, LuAnn; Briere, Francine; Chaussabel, Damien; Zurawski, Gerard; Palucka, A. Karolina; Banchereau, Jacques; Ueno, Hideki] Baylor Res Inst, Dallas, TX 75204 USA; [Reiter, Yoram] Technion Israel Inst Technol, IL-32000 Technion, Haifa, Israel	Baylor Scott & White Health; Baylor Scott & White Health; Baylor University Medical Center; Technion Israel Institute of Technology	Banchereau, J (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	jacquesb@baylorhealth.edu	Liu, Maochang/C-6955-2012; Ueno, Hideki/L-1237-2016; Chaussabel, Damien/AAX-1909-2020	Ueno, Hideki/0000-0001-7747-0738; Klechevsky, Eynav/0000-0001-6121-1571; Chaussabel, Damien/0000-0002-6131-7242	Baylor Health Care System Foundation; National Institutes of Health [RO-1 CA78846, RO-1 CA85540, PO-1 CA84512, U-19 Al-57234]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA085540, P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Baylor Health Care System Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Kowalski, J. Shay, Q. Nguyen, C. Glaser, and S.S. Clayton for their help. We thank J. Duncan and surgeons and nurses from the Plastic Surgery Department for skin samples. We thank R. Germain, I. Mellman, and C. Harrod for critical reading and discussion and M. Ramsay, W. Duncan, and C. Samuelsen for continuous support. This work was supported by grants from Baylor Health Care System Foundation and the National Institutes of Health (RO-1 CA78846, RO-1 CA85540, PO-1 CA84512, and U-19 Al-57234 to J.B.) and a scholarship from Uehara Memorial Foundation (to H.U.). J.B. holds the W.W. Caruth, Jr. Chair for Transplantation Immunology Research. A.K.P. holds the Ramsay Chair for Cancer Immunology. J.B. holds stock options in Argos Therapeutics, a private company that is testing the potential therapeutic applications of dendritic cells.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Alvarez D, 2005, J IMMUNOL, V174, P1664, DOI 10.4049/jimmunol.174.3.1664; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cao T, 2007, EUR J IMMUNOL, V37, P2657, DOI 10.1002/eji.200636499; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Celluzzi CM, 1997, J INVEST DERMATOL, V108, P716, DOI 10.1111/1523-1747.ep12292095; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Frey SE, 2002, NEW ENGL J MED, V346, P1275, DOI 10.1056/NEJMoa013431; Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Morelli AE, 2005, J IMMUNOL, V175, P7905, DOI 10.4049/jimmunol.175.12.7905; Nestle FO, 1998, J INVEST DERMATOL, V110, P762, DOI 10.1046/j.1523-1747.1998.00189.x; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Noy R, 2005, EXPERT REV ANTICANC, V5, P523, DOI 10.1586/14737140.5.3.523; Oh S, 2004, P NATL ACAD SCI USA, V101, P15154, DOI 10.1073/pnas.0406649101; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Ratzinger G, 2004, J IMMUNOL, V173, P2780, DOI 10.4049/jimmunol.173.4.2780; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Silverstein AM, 2003, NAT IMMUNOL, V4, P425, DOI 10.1038/ni0503-425; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Steinbrink K, 1999, BLOOD, V93, P1634, DOI 10.1182/blood.V93.5.1634.405k11_1634_1642; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	48	452	463	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					497	510		10.1016/j.immuni.2008.07.013	http://dx.doi.org/10.1016/j.immuni.2008.07.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18789730	Green Accepted, Bronze			2022-12-18	WOS:000259708900019
J	Trede, NS; Langenau, DM; Traver, D; Look, AT; Zon, LI				Trede, NS; Langenau, DM; Traver, D; Look, AT; Zon, LI			The use of zebrafish to understand immunity	IMMUNITY			English	Review							TOLL-LIKE RECEPTOR; RECOMBINATION ACTIVATING GENE-1; GENETIC DISSECTION; GENOMIC ANALYSIS; EXPRESSION; MYC; MODEL; INFECTION; FAMILY; THYMUS	For decades immunologists have relied heavily on the mouse model for their experimental designs. With the realization of the important role innate immunity plays in orchestrating immune responses, invertebrates such as worms and flies have been added to the repertoire. Here, we discuss the advent of the zebrafish as a powerful vertebrate model organism that promises to positively impact immunologic research.	Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Trede, NS (corresponding author), Childrens Hosp, Dept Med, Div Hematol Oncol, 1 Blackfan Circle, Boston, MA 02115 USA.	trede@enders.tch.harvard.edu	Langenau, David/GXI-0197-2022	Langenau, David/0000-0001-6664-8318	NCI NIH HHS [CA-68484] Funding Source: Medline; NHLBI NIH HHS [K08HL04233] Funding Source: Medline; NIDDK NIH HHS [R21DK63660] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA068484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063660] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Altmann SM, 2004, DEV COMP IMMUNOL, V28, P295, DOI 10.1016/j.dci.2003.09.001; Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Appleby MW, 2003, NAT REV IMMUNOL, V3, P463, DOI 10.1038/nri1109; ARDAVIN CF, 1988, THYMUS, V11, P59; Beattie CE, 1999, METHODS CELL BIOL, V60, P71; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Blyth K, 2001, ONCOGENE, V20, P295, DOI 10.1038/sj.onc.1204090; Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; Braun A, 1997, GENETICS, V147, P623; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; BRUTON OC, 1952, PEDIATRICS, V9, P722; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Danilova N, 2000, IMMUNOGENETICS, V52, P81, DOI 10.1007/s002510000255; Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Donovan A, 2002, BLOOD, V100, P4655, DOI 10.1182/blood-2002-04-1169; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Fischer A, 2002, SCAND J IMMUNOL, V55, P238, DOI 10.1046/j.1365-3083.2002.01056.x; Fischer C, 2002, GENOMICS, V79, P241, DOI 10.1006/geno.2002.6688; Garner JN, 2003, DEV COMP IMMUNOL, V27, P217, DOI 10.1016/S0145-305X(02)00096-4; Guyon JR, 2003, HUM MOL GENET, V12, P601, DOI 10.1093/hmg/ddg071; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Haffter P, 1996, DEVELOPMENT, V123, P1; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Jessen JR, 1999, NAT GENET, V23, P15, DOI 10.1038/12609; Jessen JR, 2001, GENESIS, V29, P156, DOI 10.1002/gene.1019; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Lam SH, 2002, DEV DYNAM, V225, P87, DOI 10.1002/dvdy.10127; LANGENAU D, 2004, IN PRESS P NATL ACAD; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Litman GW, 2001, IMMUNOL REV, V181, P250, DOI 10.1034/j.1600-065X.2001.1810121.x; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Long QM, 1997, DEVELOPMENT, V124, P4105; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Ma CG, 2001, P NATL ACAD SCI USA, V98, P2461, DOI 10.1073/pnas.041449398; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; MEDAWAR PB, 1958, IMMUNOLOGY, V1, P27; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Menudier A, 1996, PATHOL BIOL, V44, P783; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Pack M, 1996, DEVELOPMENT, V123, P321; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Popperl H, 2000, MOL CELL, V6, P255, DOI 10.1016/S1097-2765(00)00027-7; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; Ramakrishnan L, 1997, INFECT IMMUN, V65, P767, DOI 10.1128/IAI.65.2.767-773.1997; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; Reiter JF, 2001, DEVELOPMENT, V128, P125; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scheltema M, 1997, PUB LAW E SE ASIA, V1, P1; Schorpp M, 2000, CURR TOP MICROBIOL, V251, P119; Secombes C. J., 1992, Annual Review of Fish Diseases, V2, P53, DOI 10.1016/0959-8030(92)90056-4; Shen LL, 2004, DEV COMP IMMUNOL, V28, P139, DOI 10.1016/S0145-305X(03)00119-8; Shen LL, 2002, DEV COMP IMMUNOL, V26, P141, DOI 10.1016/S0145-305X(01)00056-8; SHINTO Y, 1995, ONCOGENE, V11, P1729; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 1998, DEV COMP IMMUNOL, V22, P253, DOI 10.1016/S0145-305X(98)00009-3; Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Willett CE, 1999, DEV DYNAM, V214, P323, DOI 10.1002/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.0.CO;2-3; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Willett CE, 1997, IMMUNOGENETICS, V45, P394, DOI 10.1007/s002510050221; Willett CE, 2001, DEV DYNAM, V222, P694, DOI 10.1002/dvdy.1223; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; Yin XY, 2001, ONCOGENE, V20, P4650, DOI 10.1038/sj.onc.1204606; Yoder JA, 2001, P NATL ACAD SCI USA, V98, P6771, DOI 10.1073/pnas.121101598	91	452	476	6	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					367	379		10.1016/S1074-7613(04)00084-6	http://dx.doi.org/10.1016/S1074-7613(04)00084-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084267	Bronze			2022-12-18	WOS:000221442800004
J	He, J; Tsai, LM; Leong, YA; Hu, X; Ma, CS; Chevalier, N; Sun, XL; Vandenberg, K; Rockman, S; Ding, Y; Zhu, L; Wei, W; Wang, CQ; Karnowski, A; Belz, GT; Ghali, JR; Cook, MC; Riminton, DS; Veillette, A; Schwartzberg, PL; Mackay, F; Brink, R; Tangye, SG; Vinuesa, CG; Mackay, CR; Li, ZG; Yu, D				He, Jing; Tsai, Louis M.; Leong, Yew Ann; Hu, Xin; Ma, Cindy S.; Chevalier, Nina; Sun, Xiaolin; Vandenberg, Kirsten; Rockman, Steve; Ding, Yan; Zhu, Lei; Wei, Wei; Wang, Changqi; Karnowski, Alexander; Belz, Gabrielle T.; Ghali, Joanna R.; Cook, Matthew C.; Riminton, D. Sean; Veillette, Andre; Schwartzberg, Pamela L.; Mackay, Fabienne; Brink, Robert; Tangye, Stuart G.; Vinuesa, Carola G.; Mackay, Charles R.; Li, Zhanguo; Yu, Di			Circulating Precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure	IMMUNITY			English	Article							FOLLICULAR HELPER-CELL; CENTER B-CELL; CXC CHEMOKINE RECEPTOR-5; BCL6 EXPRESSION; CENTRAL MEMORY; EFFECTOR; GENERATION; DIFFERENTIATION; INTERLEUKIN-21; EXPANSION	Follicular B helper T (Tfh) cells support high affinity and long-term antibody responses. Here we found that within circulating CXCR5(+) CD4(+) T cells in humans and mice, the CCR7(lo)PD-1(hi) subset has a partial Tfh effector phenotype, whereas CCR7(hi) PD-1(lo) cells have a resting phenotype. The circulating CCR7(lo)PD-1(hi) subset was indicative of active Tfh differentiation in lymphoid organs and correlated with clinical indices in autoimmune diseases. Thus the CCR7(lo)PD-1(hi) subset provides a biomarker to monitor protective antibody responses during infection or vaccination and pathogenic antibody responses in autoimmune diseases. Differentiation of both CCR7(hi)PD-1(lo) and CCR7(lo)PD-1(hi) subsets required ICOS and BCL6, but not SAP, suggesting that circulating CXCR5(+) helper T cells are primarily generated before germinal centers. Upon antigen reencounter, CCR7(lo)PD-1(hi) CXCR5(+) precursors rapidly differentiate into mature Tfh cells to promote anti-body responses. Therefore, circulating CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells are generated during active Tfh differentiation and represent a new mechanism of immunological early memory.	[He, Jing; Sun, Xiaolin; Ding, Yan; Zhu, Lei; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China; [Tsai, Louis M.; Leong, Yew Ann; Hu, Xin; Mackay, Charles R.; Yu, Di] Monash Univ, Sch Biomed Sci, Mol Immunomodulat Lab, Clayton, Vic 3800, Australia; [Hu, Xin; Cook, Matthew C.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Ma, Cindy S.; Chevalier, Nina; Brink, Robert; Tangye, Stuart G.] Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Ma, Cindy S.; Chevalier, Nina; Brink, Robert; Tangye, Stuart G.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Chevalier, Nina] Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, D-79106 Freiburg, Germany; [Vandenberg, Kirsten; Rockman, Steve] BioCSL, Influenza Res & Dev, Parkville, Vic 3052, Australia; [Wei, Wei] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China; [Wang, Changqi] Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan 250014, Shandong, Peoples R China; [Karnowski, Alexander; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Div Mol Immunol, Parkville, Vic 3052, Australia; [Ghali, Joanna R.] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic 3800, Australia; [Cook, Matthew C.] Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia; [Riminton, D. Sean] Concord Hosp, Dept Immunol, Concord, NSW 2139, Australia; [Veillette, Andre] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [Schwartzberg, Pamela L.] NHGRI, Bethesda, MD 20892 USA; [Mackay, Fabienne] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Peking University; Monash University; Australian National University; John Curtin School of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Freiburg; Chinese Academy of Sciences; Institute of Process Engineering, CAS; Qilu University of Technology; Walter & Eliza Hall Institute; Monash University; Australian National University; Concord Repatriation General Hospital; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Monash University	Li, ZG (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China.	li99@bjmu.edu.cn; di.yu@monash.edu	Sun, Xiaolin/AAD-8492-2022; Cook, matthew/F-4151-2019; Vinuesa, Carola G/B-1108-2010; Brink, Robert/B-7910-2010; Mackay, Fabienne/B-7440-2008; Mackay, Charles R/A-9673-2008; Belz, Gabrielle T/C-9350-2013; Yu, Di/C-2163-2009; S, Cindy/B-2340-2012; rockman, steve/AAT-5105-2021; Tangye, Stuart G/H-4023-2014	Sun, Xiaolin/0000-0001-9709-1532; Cook, matthew/0000-0002-3331-9363; Vinuesa, Carola G/0000-0001-9799-0298; Brink, Robert/0000-0002-9586-3655; Mackay, Fabienne/0000-0002-6074-2693; Mackay, Charles R/0000-0002-6338-7340; Belz, Gabrielle T/0000-0002-9660-9587; Yu, Di/0000-0003-1721-8922; S, Cindy/0000-0001-5387-8413; Tangye, Stuart G/0000-0002-5360-5180; Wei, Wei/0000-0002-6244-3187; Riminton, Sean/0000-0002-9953-9959; Leong, Yew Ann/0000-0002-0999-7084	National Basic Research Program of China (973 Program) [2010CB529100]; National Health and Medical Research Council (NHMRC) [1010761]; Australian Research Council [DP110105024]; Ramaciotti Foundation; National Natural Science Foundation of China (NSFC) [81128012]; Beijing Natural Science Foundation [7131015]; NSFC [3107088]; NHMRC program; NHMRC Fellowship [GNT1011947]; Monash Fellowship; Viertel Senior Medical Research Fellowship; NHMRC Australian Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Ramaciotti Foundation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NSFC(National Natural Science Foundation of China (NSFC)); NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Monash Fellowship(Monash University); Viertel Senior Medical Research Fellowship; NHMRC Australian Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank FlowCore, Monash University, and Garvan MLC Flow Cytometry Facility for cell sorting and providing analytical instruments, Monash and Garvan animal facilities for animal husbandry and technical services, Karen Laurie and Anne Kelso for suggestion on influenza vaccination, Andrew Wei for suggestion on immune response after hematopoietic stem cell transplantation, and Zdenka Prodanovic (the Tissue Bank Southern Health) for collecting human tissue samples. This work was funded by National Basic Research Program of China (973 Program, 2010CB529100) To Z.L. and D.Y. National Health and Medical Research Council (NHMRC, 1010761), Australian Research Council (DP110105024), Ramaciotti Foundation and National Natural Science Foundation of China (NSFC, 81128012) to D.Y., Beijing Natural Science Foundation (7131015) to Z.L. NSFC (3107088) to J.H., and NHMRC program to C. R. M., C. G. V., S. G. T., R. B., and F. M. D.Y. is supported by a NHMRC Fellowship (GNT1011947) and a Monash Fellowship. C. S. M. is supported by a NHMRC Fellowship. C. G. V. is supported by a Viertel Senior Medical Research Fellowship. C. R. M. is supported by a NHMRC Australian Fellowship.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2010, CELL MOL IMMUNOL, V7, P198, DOI 10.1038/cmi.2010.18; Yu D, 2009, CURR OPIN IMMUNOL, V21, P619, DOI 10.1016/j.coi.2009.09.013; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	49	451	468	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					770	781		10.1016/j.immuni.2013.09.007	http://dx.doi.org/10.1016/j.immuni.2013.09.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138884	Bronze			2022-12-18	WOS:000330950000017
J	Riese, RJ; Wolf, PR; Bromme, D; Natkin, LR; Villadangos, JA; Ploegh, HL; Chapman, HA				Riese, RJ; Wolf, PR; Bromme, D; Natkin, LR; Villadangos, JA; Ploegh, HL; Chapman, HA			Essential role for cathepsin S in MHC class II - Associated invariant chain processing and peptide loading	IMMUNITY			English	Article							HLA-DR MOLECULES; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS; CYSTEINE PROTEINASES; T-CELLS; EXPRESSION; INHIBITOR; PROTEASES; TRANSPORT; COMPLEX	Destruction of ii by proteolysis is required for MHC class II molecules to bind antigenic peptides, and for transport of the resulting complexes to the cell surface. The cysteine protease cathepsin S is highly expressed in spleen, lymphocytes, monocytes, and other class Ii-positive cells, and is inducible with interferon-gamma. Specific inhibition of cathepsin S in B lymphoblastoid cells prevented complete proteolysis of ii, resulting in accumulation of a class II-associated 13 kDa ii fragment in vivo. Consequently, the formation of SDS-stable complexes was markedly reduced. Purified cathepsin S, but not cathepsin B, H, or D, specifically digested Ii from alpha beta li trimers, generating alpha beta-CLIP complexes capable of binding exogenously added peptide in vitro. Thus, cathepsin S is essential in B cells for effective ii proteolysis necessary to render class II molecules competent for binding peptides.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139; ARRIS PHARMACEUT INC,S SAN FRANCISCO,CA 94080	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Riese, RJ (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,75 FRANCIS ST,BOSTON,MA 02115, USA.		Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL07633] Funding Source: Medline; PHS HHS [5-RO1-A134893, T32-A107463] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTERI E, 1993, ANTIMICROB AGENTS CH, V37, P2087, DOI 10.1128/AAC.37.10.2087; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BELL JI, 1985, P NATL ACAD SCI USA, V82, P3405, DOI 10.1073/pnas.82.10.3405; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; BENNETT K, 1992, EUR J IMMUNOL, V22, P1519, DOI 10.1002/eji.1830220626; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BROMME D, 1993, J BIOL CHEM, V268, P4832; BROMME D, 1989, BIOCHEM J, V264, P475; BROMME D, 1996, IN PRESS PROTEIN SCI; BUUS S, 1986, J IMMUNOL, V136, P452; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CLAESSON L, 1983, P NATL ACAD SCI-BIOL, V80, P7395, DOI 10.1073/pnas.80.24.7395; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DIMENT S, 1990, J IMMUNOL, V145, P417; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HUMBERT M, 1993, EUR J IMMUNOL, V23, P3167, DOI 10.1002/eji.1830231219; LAFUSE WP, 1995, J LEUKOCYTE BIOL, V57, P663, DOI 10.1002/jlb.57.4.663; LAMB CA, 1992, J IMMUNOL, V148, P3478; LARHAMMAR D, 1982, CELL, V30, P153, DOI 10.1016/0092-8674(82)90021-6; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MASON RW, 1984, BIOCHEM J, V217, P209, DOI 10.1042/bj2170209; MASON RW, 1985, BIOCHEM J, V226, P233, DOI 10.1042/bj2260233; MASON RW, 1989, BIOCHEM J, V257, P125, DOI 10.1042/bj2570125; MATSUNAGA Y, 1993, FEBS LETT, V324, P325, DOI 10.1016/0014-5793(93)80144-J; MORTON PA, 1995, J IMMUNOL, V154, P137; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NEWCOMB JR, 1993, J IMMUNOL, V151, P4153; NGUYEN QV, 1989, HUM IMMUNOL, V24, P153, DOI 10.1016/0198-8859(89)90056-6; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; RODRIGUEZ GM, 1992, J IMMUNOL, V149, P2894; ROTHBARD JB, 1988, CELL, V52, P515, DOI 10.1016/0092-8674(88)90464-3; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHAW S, 1985, HUM IMMUNOL, V12, P191, DOI 10.1016/0198-8859(85)90336-2; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SHI GP, 1992, J BIOL CHEM, V267, P7258; SHI GP, 1994, J BIOL CHEM, V269, P11530; SIEGRIST CA, 1995, J EXP MED, V182, P1793, DOI 10.1084/jem.182.6.1793; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VANNOORT JM, 1989, J BIOL CHEM, V264, P14159; VANNOORT JM, 1991, EUR J IMMUNOL, V21, P1989, DOI 10.1002/eji.1830210904; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	55	451	472	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					357	366		10.1016/S1074-7613(00)80249-6	http://dx.doi.org/10.1016/S1074-7613(00)80249-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612130	Bronze			2022-12-18	WOS:A1996UH52200004
J	Utzschneider, DT; Charmoy, M; Chennupati, V; Pousse, L; Ferreira, DP; Calderon-Copete, S; Danilo, M; Alfei, F; Hofmann, M; Wieland, D; Pradervand, S; Thimme, R; Zehn, D; Held, W				Utzschneider, Daniel T.; Charmoy, Melanie; Chennupati, Vijaykumar; Pousse, Laurene; Ferreira, Daniela Pais; Calderon-Copete, Sandra; Danilo, Maxime; Alfei, Francesca; Hofmann, Maike; Wieland, Dominik; Pradervand, Sylvain; Thimme, Robert; Zehn, Dietmar; Held, Werner			T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections	IMMUNITY			English	Article							EXHAUSTION; EFFECTOR; ANTIGEN; PERSISTENCE; EXPRESSION; RECEPTORS; PATHWAYS; MAINTAIN; VIREMIA; RISE	Chronic infections promote the terminal differentiation (or "exhaustion'') of T cells and are thought to preclude the formation of memory T cells. In contrast, we discovered a small subpopulation of virus-specific CD8(+) T cells that sustained the T cell response during chronic infections. These cells were defined by, and depended on, the expression of the transcription factor Tcf1. Transcriptome analysis revealed that this population shared key characteristics of central memory cells but lacked an effector signature. Unlike conventionalmemory cells, Tcf1-expressing T cells displayed hallmarks of an "exhausted'' phenotype, including the expression of inhibitory receptors such as PD-1 and Lag-3. This population was crucial for the T cell expansion that occurred in response to inhibitory receptor blockade during chronic infection. These findings identify a memory-like T cell population that sustains T cell responses and is a prime target for therapeutic interventions to improve the immune response in chronic infections.	[Utzschneider, Daniel T.; Alfei, Francesca; Zehn, Dietmar] Lausanne Univ Hosp CHUV, Dept Med, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Charmoy, Melanie; Chennupati, Vijaykumar; Pousse, Laurene; Ferreira, Daniela Pais; Danilo, Maxime; Held, Werner] Univ Lausanne, Dept Fundamental Oncol, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Calderon-Copete, Sandra; Pradervand, Sylvain] Univ Lausanne, LGTF, CH-1015 Lausanne, Switzerland; [Hofmann, Maike; Wieland, Dominik; Thimme, Robert] Univ Freiburg, Univ Klinikum Freiburg, Klin Innere Med Gastroenterol Hepatol Endokrinol, D-79106 Freiburg, Germany; [Wieland, Dominik] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Wieland, Dominik] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Utzschneider, Daniel T.] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Alfei, Francesca] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, D-85354 Freising Weihenstephan, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Freiburg; University of Freiburg; University of Freiburg; University of California System; University of California San Diego; Technical University of Munich	Zehn, D (corresponding author), Lausanne Univ Hosp CHUV, Dept Med, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland.; Held, W (corresponding author), Univ Lausanne, Dept Fundamental Oncol, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland.	dietmar.zehn@tum.de; werner.held@unil.ch	Utzschneider, Daniel/D-5855-2016; Hofmann, Maike/ABH-7388-2020	Utzschneider, Daniel/0000-0003-2205-9057; DANILO, Maxime/0000-0002-6355-2932; Pais Ferreira, Daniela/0000-0003-2277-5563; Pousse, Laurene/0000-0003-0111-1418	Swiss National Science Foundation (SNSF) [310030B_141178, 310030_159598, CRSII3_141879, PP00P3_144883]; European Research Council (ERC) [337043-ProtecTC]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC))	We are grateful to L. Carrie and C. Fumey for mouse management, the UNIL Flow Cytometry Facility for assistance, the UNIL Genomic Technology Facility for RNA-seq, D. Moradpour (CHUV) for providing initial HCV samples, and M. Prlic (Fred Hutchinson) and A. Wilson (University of Lausanne) for feedback and comments. This work was supported in part by grants from the Swiss National Science Foundation (SNSF) (310030B_141178 and 310030_159598) to W.H. and CRSII3_141879 and PP00P3_144883 to D.Z. and from the European Research Council (ERC) 337043-ProtecTC to D.Z.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boudousquie C, 2014, J IMMUNOL, V193, P2784, DOI 10.4049/jimmunol.1400465; DILLON SR, 1994, J IMMUNOL, V152, P1790; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walker B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007054; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	31	450	450	4	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					415	427		10.1016/j.immuni.2016.07.021	http://dx.doi.org/10.1016/j.immuni.2016.07.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533016	Bronze, Green Accepted			2022-12-18	WOS:000382267300021
J	Shi, XR; Leng, L; Wang, T; Wang, WK; Du, X; Li, J; McDonald, C; Chen, Z; Murphy, JW; Lolis, E; Noble, P; Knudson, W; Bucala, R				Shi, Xuerong; Leng, Lin; Wang, Tian; Wang, Wenkui; Du, Xin; Li, Ji; McDonald, Courtney; Chen, Zun; Murphy, James W.; Lolis, Elias; Noble, Paul; Knudson, Warren; Bucala, Richard			CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; T-CELL-ACTIVATION; INVARIANT CHAIN; FACTOR MIF; REGULATORY ROLE; TYROSINE PHOSPHORYLATION; INDUCED APOPTOSIS; IMMUNE-RESPONSE; CANCER CELLS; KAPPA-B	The macrophage migration inhibitory factor (MIF) receptor (CD74) was cloned recently, but the signaling mechanism is not evident. We hypothesized that signaling requires an additional molecule such as CD44, which activates nonreceptor tyrosine kinases. We utilized the CD74- and CD44-deficient CCS-7/M6 cell to create stable transfectants expressing CD74, CD44, and a truncated CD44 lacking its intracytoplasmic signaling domain. CD74 alone mediated MIF binding; however, MIF-induced ERK1 and ERK2 kinase phosphorylation required the coexpression of full-length CD44. MIF binding was associated with the serine phosphorylation of CD74 and CD44. Investigations that used siRNA or kinase inhibitors indicate that MIF-induced ERK1 and ERK2 activation through CD44 required the Src tyrosine kinase. Studies of CD74, CD44, and CD74-CD44 transformants and corresponding mutant cells showed that CD74 and CD44 were necessary for MIF protection from apoptosis. These data establish CD44 as an integral member of the CD74 receptor complex leading to MIF signal transduction.	Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Shanxi Agr Univ, Taigu, Peoples R China; E Carolina Sch Med, Greenville, NC 27834 USA	Yale University; Yale University; Shanxi Agricultural University; University of North Carolina; East Carolina University	Bucala, R (corresponding author), Yale Univ, Sch Med, Dept Med, 333 Cedar St, New Haven, CT 06520 USA.	richard.bucala@yale.edu		Leng, Lin/0000-0002-0605-358X; Lolis, Elias/0000-0002-7902-7868	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042310, R01AI042310, R01AI065029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610, R01AR050498, R01AR043384] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL060539, R01 HL060539] Funding Source: Medline; NIAID NIH HHS [R56 AI042310, R01 AI065029-02, R01 AI042310, R01 AI065029, AI42310] Funding Source: Medline; NIAMS NIH HHS [AR050498, AR049610, R01 AR043384, R01 AR043384-13, R01 AR050498, AR43384, R01 AR049610] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allouche M, 2000, BLOOD, V96, P1187, DOI 10.1182/blood.V96.3.1187.015k01_1187_1190; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Anderson HA, 1999, J IMMUNOL, V163, P5435; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bouchard MJ, 1997, J VIROL, V71, P2793, DOI 10.1128/JVI.71.4.2793-2798.1997; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Bradbury J, 2002, LANCET, V359, P2008, DOI 10.1016/S0140-6736(02)08854-2; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; FALTYNEK CR, 1995, BIOCHEMISTRY-US, V34, P12404, DOI 10.1021/bi00038a038; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gregersen PK, 2003, ARTHRITIS RHEUM-US, V48, P1171, DOI 10.1002/art.10880; HIBI M, 2001, CYTOKINE REFERENCE, V2, P1761; Hill KJ, 2003, BRIT J PHARMACOL, V139, P721, DOI 10.1038/sj.bjp.0705294; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Ishida M, 1998, CIRC RES, V82, P7; Iversen TM, 2004, FASEB J, V18, pC258; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Lacey D, 2003, ARTHRITIS RHEUM, V48, P103, DOI 10.1002/art.10733; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Liao H, 2003, J BIOL CHEM, V278, P76, DOI 10.1074/jbc.M208820200; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P52598, DOI 10.1074/jbc.M308941200; Matza D, 2002, IMMUNITY, V17, P549, DOI 10.1016/S1074-7613(02)00455-7; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; NAUJOKAS MF, 1995, IMMUNITY, V3, P359, DOI 10.1016/1074-7613(95)90120-5; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Padfield PJ, 1998, BIOCHEM J, V330, P329; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Salazar EP, 1999, J BIOL CHEM, V274, P28371, DOI 10.1074/jbc.274.40.28371; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Sun LK, 2001, INFLAMM RES, V50, P496, DOI 10.1007/PL00000224; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Taher TEI, 1996, J BIOL CHEM, V271, P2863, DOI 10.1074/jbc.271.5.2863; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Topilski I, 2002, J IMMUNOL, V168, P1610, DOI 10.4049/jimmunol.168.4.1610; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984	64	450	468	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					595	606		10.1016/j.immuni.2006.08.020	http://dx.doi.org/10.1016/j.immuni.2006.08.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045821	Bronze, Green Accepted			2022-12-18	WOS:000241481500011
J	Linsley, PS; Bradshaw, J; Greene, J; Peach, R; Bennett, KL; Mittler, RS				Linsley, PS; Bradshaw, J; Greene, J; Peach, R; Bennett, KL; Mittler, RS			Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement	IMMUNITY			English	Article							HELPER T-CELLS; LYMPHOCYTES-T; CD28; RECEPTOR; EXPRESSION; ANTIGEN	T lymphocyte receptor CTLA-4 binds costimulatory molecules CD80 (B7-1) and CD86 (B7-2) with high avidity and negatively regulates T cell activation. CTLA-4 functions at the cell surface, yet is primarily localized in intracellular vesicles. Here, we demonstrate cycling of CTLA-4 between intracellular stores and the cell surface. Intracellular vesicles containing CTLA-4 over-lapped with endocytic compartment(s) and with perforin-containing secretory granules. Cell surface expression of CTLA-4 was rapidly increased by raising intracellular calcium levels. During T cell activation, intracellular and cell surface CTLA-4 became focused towards sites of TCR activation. Cycling and directional control of CTLA-4 expression may regulate its functional interaction with APCs bearing peptide-MHC complexes of appropriate specificity and avidity.			Linsley, PS (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, 3005 1ST AVE, SEATTLE, WA 98121 USA.							ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; AZUMA M, 1992, J IMMUNOL, V149, P1115; BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; DAMLE NK, 1994, J IMMUNOL, V152, P2686; GUINAN EC, 1994, BLOOD, V84, P3261; HARPER K, 1991, J IMMUNOL, V147, P1037; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; LEDBETTER JA, 1990, UCLA SYM BI, V113, P113; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	28	450	479	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	1996	4	6					535	543		10.1016/S1074-7613(00)80480-X	http://dx.doi.org/10.1016/S1074-7613(00)80480-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673700	Bronze			2022-12-18	WOS:A1996UU44300002
J	Fazilleau, N; Mark, L; McHeyzer-Williams, LJ; McHeyzer-Williams, MG				Fazilleau, Nicolas; Mark, Linda; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.			Follicular Helper T Cells: Lineage and Location	IMMUNITY			English	Review							TRANSCRIPTIONAL REPRESSOR BLIMP-1; INDEPENDENT GERMINAL-CENTERS; ANTIGEN-DRIVEN SELECTION; CXC CHEMOKINE RECEPTOR-5; PRIMARY IMMUNE-RESPONSE; IN-VIVO REVEALS; B-CELLS; TGF-BETA; LYMPHOCYTE INTERACTIONS; COSTIMULATORY RECEPTOR	Follicular helper T (Tfh) cells are the class of effector T helper cells that regulates the step-wise development of antigen-specific B cell immunity in vivo. Deployment of CXCR5(+) Tfh cells to B cell zones of lymphoid tissues and stable cognate interactions with B cells are central to the delivery of antigen-specific Tfh cell function. Here, we review recent advances that have helped to unravel distinctive elements of developmental programming for Tfh cells and unique effector Tfh cell functions focused on antigen-primed B cells. Understanding the regulatory functions of Tfh cells in the germinal center and the subsequent regulation of memory B cell responses to antigen recall represent the frontiers of this research area with the potential to alter fundamentally the design of future vaccines.	[Fazilleau, Nicolas; Mark, Linda; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Fazilleau, Nicolas/J-9883-2014	Fazilleau, Nicolas/0000-0002-3574-5614	National Institutes of Health [A1047231, A1040215, A1059475]; Wenner-Grenn Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047231, R01AI040215, R01AI059475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Grenn Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	In honor of Joanne Fanelli-Panus (1967-2009) and her important contributions to our understanding of antigen-specific T helper cell function in vivo. This review is supported by the National Institutes of Health (A1047231, A1040215, and A1059475 to M.G.M.-W.), and L.M. is a recipient of a Wenner-Grenn Fellowship.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; BOWEN MB, 1991, HUM IMMUNOL, V31, P67, DOI 10.1016/0198-8859(91)90050-J; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; FORSTER R, 1994, BLOOD, V84, P830; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gaspal FMC, 2006, EUR J IMMUNOL, V36, P1665, DOI 10.1002/eji.200535339; GulbransonJudge A, 1996, EUR J IMMUNOL, V26, P1830, DOI 10.1002/eji.1830260825; HAN SH, 1995, J IMMUNOL, V155, P556; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Mikszta JA, 1999, J IMMUNOL, V163, P5978; MILLER JFA, 1967, NATURE, V216, P659, DOI 10.1038/216659a0; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MITCHISON N A, 1971, European Journal of Immunology, V1, P10, DOI 10.1002/eji.1830010103; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NOSSAL GJV, 1959, BRIT J EXP PATHOL, V40, P301; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; PAUL WE, 1966, J EXP MED, V123, P689, DOI 10.1084/jem.123.4.689; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zheng B, 1996, J EXP MED, V184, P1083, DOI 10.1084/jem.184.3.1083; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	121	449	482	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					324	335		10.1016/j.immuni.2009.03.003	http://dx.doi.org/10.1016/j.immuni.2009.03.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303387	Green Accepted, Bronze			2022-12-18	WOS:000264405500006
J	Anderson, MS; Venanzi, ES; Chen, ZB; Berzins, SP; Benoist, C; Mathis, D				Anderson, MS; Venanzi, ES; Chen, ZB; Berzins, SP; Benoist, C; Mathis, D			The cellular mechanism of Aire control of T cell tolerance	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; PROMISCUOUS GENE-EXPRESSION; NEGATIVE SELECTION; POSITIVE SELECTION; ANTIGEN; TRANSCRIPTION; THYMUS; THYMOCYTES; DELETION; PROTEIN	Aire promotes the tolerization of thymocytes by inducing the expression of a battery of peripheral-tissue antigens in thymic medullary epithelial cells. We demonstrate that the cellular mechanism by which Aire exerts its tolerance-promoting function is not primarily positive selection of regulatory T cells, but rather negative selection of T effector cells. Surprisingly, supplementing its influence on the transcription of genes encoding peripheral-tissue antigens, Aire somehow enhances the antigen-presentation capability of medullary epithelial cells. Thus, this transcriptional control element promotes central tolerance both by furnishing a specific thymic stromal cell type with a repertoire of self antigens and by better arming such cells to present these antigens to differentiating thymocytes. In Aire's absence, autoimmunity and ultimately overt autoimmune disease develops.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr,Sect Immunol & Immunog, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Benoist, C (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr,Sect Immunol & Immunog, Boston, MA 02215 USA.	cb@joslin.harvard.edu; dm@joslin.harvard.edu		Venanzi, Emily/0000-0002-4185-0381	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK059958, R01DK060027] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK059958, 1 R01 DK60027] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BARNDEN MJ, 1994, EUR J IMMUNOL, V24, P2452, DOI 10.1002/eji.1830241029; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Brocke P, 2002, CURR OPIN IMMUNOL, V14, P22, DOI 10.1016/S0952-7915(01)00294-1; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeYoung AL, 2000, J IMMUNOL, V165, P6170, DOI 10.4049/jimmunol.165.11.6170; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Paulsson KM, 2004, CELL MOL LIFE SCI, V61, P2446, DOI 10.1007/s00018-004-4113-0; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	43	448	469	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					227	239		10.1016/j.immuni.2005.07.005	http://dx.doi.org/10.1016/j.immuni.2005.07.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111640	Bronze			2022-12-18	WOS:000231721700012
J	Oldenhove, G; Bouladoux, N; Wohlfert, EA; Hall, JA; Chou, D; Dos Santos, L; O'Brien, S; Blank, R; Lamb, E; Natarajan, S; Kastenmayer, R; Hunter, C; Grigg, ME; Belkaid, Y				Oldenhove, Guillaume; Bouladoux, Nicolas; Wohlfert, Elizabeth A.; Hall, Jason A.; Chou, David; Dos Santos, Liliane; O'Brien, Shaun; Blank, Rebecca; Lamb, Erika; Natarajan, Sundar; Kastenmayer, Robin; Hunter, Christopher; Grigg, Michael E.; Belkaid, Yasmine			Decrease of Foxp3(+) Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection	IMMUNITY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; IFN-GAMMA; TOXOPLASMA-GONDII; PERORAL INFECTION; SMALL-INTESTINE; C57BL/6 MICE; TGF-BETA; RESISTANCE; TOLERANCE	Using a model of lethal oral infection with Toxoplasma gondii, we examined the fate of both induced and natural regulatory T (Treg) cells in the face of strong inflammatory responses occurring in a tolerogenicprone environment. We found that during highly T helper 1 (Th1) cell-polarized mucosal immune responses, Treg cell numbers collapsed via multiple pathways, including blockade of Treg cell induction and disruption of endogenous Treg cell homeostasis. In particular, shutdown of interleukin 2 (IL-2) in the highly Th1 cell-polarized environment triggered by infection directly contributes to Treg cell incapacity to suppress effector responses and eventually leads to immunopathogenesis. Furthermore, we found that environmental cues provided by both local dendritic cells and effector T cells can induce the expression of T-bet transcription factor and IFN-gamma by Treg cells. These data reveal a mechanism for Th1 cell pathogenicity that extends beyond their proinflammatory program to limit Treg cell survival.	[Oldenhove, Guillaume; Bouladoux, Nicolas; Wohlfert, Elizabeth A.; Hall, Jason A.; Chou, David; Dos Santos, Liliane; Blank, Rebecca; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Kastenmayer, Robin] NIAID, Comparat Med Branch, Bill Young Ctr Biodefense & Emerging Infect Dis, NIH, Bethesda, MD 20892 USA; [Lamb, Erika; Natarajan, Sundar; Grigg, Michael E.] NIAID, Mol Parasitol Unit, NIH, Bethesda, MD 20892 USA; [Hunter, Christopher] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Hall, Jason A.; O'Brien, Shaun] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; University of Pennsylvania	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Hunter, Christopher/H-1970-2011; wohlfert, beth/ABA-2255-2020; Santos, Liliane Martins dos/AAR-9220-2020; dos Santos, Liliane/D-1551-2010	Santos, Liliane Martins dos/0000-0002-4466-8868; Natarajan, Sundar/0000-0002-6737-1995; Chou, David/0000-0002-1659-9308; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X	Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042334, P01AI043620, ZIAAI001017, ZIAAI000955] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. We would like to thank the students of the Biology of Parasitism Course (Woods hole MBL 2008-2009) for contributing to some of the experiments. We thank Dr. F. Torres for help with pathological evaluation of samples. We thank Dr. K. Holmes and the MAID sorting facility and K. Beacht for technical assistance. We thank A. O'Hara (University of Pennsylvania, Immunology Graduate Program) for help with the parasite and Dr. G. Yap for helpful suggestions. We thank Drs. F.A. Sher and D. Jankovic for critical reading of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gaddi PJ, 2007, IMMUNOL CELL BIOL, V85, P155, DOI 10.1038/sj.icb.7100038; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jacobson NG, 1996, ADV EXP MED BIOL, V409, P61; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; O'Malley JT, 2009, IMMUNOLOGY, V127, P587, DOI 10.1111/j.1365-2567.2008.03037.x; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Sher A, 1998, ADV EXP MED BIOL, V452, P103; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	59	446	470	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					772	786		10.1016/j.immuni.2009.10.001	http://dx.doi.org/10.1016/j.immuni.2009.10.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19896394	Bronze, Green Accepted			2022-12-18	WOS:000272097900012
J	Yan, YQ; Jiang, W; Spinetti, T; Tardivel, A; Castillo, R; Bourquin, C; Guarda, G; Tian, ZG; Tschopp, J; Zhou, RB				Yan, Yiqing; Jiang, Wei; Spinetti, Thibaud; Tardivel, Aubry; Castillo, Rosa; Bourquin, Carole; Guarda, Greta; Tian, Zhigang; Tschopp, Jurg; Zhou, Rongbin			Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation	IMMUNITY			English	Article							POLYUNSATURATED FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; INSULIN-SECRETION; OXIDATIVE STRESS; TRANSGENIC MICE; INTERLEUKIN-1; DYSFUNCTION; RESOLVINS; MEDIATORS; INTERACTS	Omega-3 fatty acids (omega-3 FAs) have potential antiinflammatory activity in a variety of inflammatory human diseases, but the mechanisms remain poorly understood. Here we show that stimulation of macrophages with omega-3 FAs, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and other family members, abolished NLRP3 inflammasome activation and inhibited subsequent caspase-1 activation and IL-1 beta secretion. In addition, G protein-coupled receptor 120 (GPR120) and GPR40 and their downstream scaffold protein beta-arrestin-2 were shown to be involved in inflammasome inhibition induced by omega-3 FAs. Importantly, u-3 FAs also prevented NLRP3 inflammasomedependent inflammation and metabolic disorder in a high-fat-diet-induced type 2 diabetes model. Our results reveal a mechanism through which u-3 FAs repress inflammation and prevent inflammation- driven diseases and suggest the potential clinical use of omega-3 FAs in gout, autoinflammatory syndromes, or other NLRP3 inflammasome-driven inflammatory diseases.	[Yan, Yiqing; Jiang, Wei; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Yan, Yiqing; Jiang, Wei; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Spinetti, Thibaud; Tardivel, Aubry; Castillo, Rosa; Guarda, Greta; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Spinetti, Thibaud; Bourquin, Carole] Univ Fribourg, Dept Med, Chair Pharmacol, CH-1700 Fribourg, Switzerland	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Lausanne; University of Fribourg	Tian, ZG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	tzg@ustc.edu.cn; zrb1980@ustc.edu.cn	Jiang, Wei/C-7986-2018; Bourquin, Carole/AAU-1418-2020; Zhou, Rongbin/B-1430-2013; Tian, Zhigang/J-3512-2013	Jiang, Wei/0000-0001-8327-3079; Bourquin, Carole/0000-0003-3862-4583; Guarda, Greta/0000-0001-9243-6116; Spinetti, Thibaud/0000-0001-8057-3746	NSFC [81222040, 81273318, 31200659, 91029303]; National Basic Research Program of China [2013CB944904]; Chinese Academy of Sciences, the Doctoral Fund of Ministry of Education of China [20123402120001, 20123402110010]; Program for New Century Excellent Talents in University; Fundamental Research Funds for the Central Universities; University of Science and Technology of China; Swiss National Science Foundation; NCCR Molecular Oncology; Foundation Louis-Jeantet; EU-FP7 program APO-SYS; Institute for Arthritis Research; Swiss National Science Foundation [PP00P3_ 139094]	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences, the Doctoral Fund of Ministry of Education of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); University of Science and Technology of China; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Foundation Louis-Jeantet; EU-FP7 program APO-SYS; Institute for Arthritis Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Gang Pei for providing the Arrb2<SUP>-/-</SUP> mice. This work was supported by NSFC (81222040, 81273318, 31200659, 91029303), National Basic Research Program of China (2013CB944904), One Hundred Person Project (R.Z.), and CAS President's fund (R.Z.) from The Chinese Academy of Sciences, the Doctoral Fund of Ministry of Education of China (20123402120001, 20123402110010), the Program for New Century Excellent Talents in University, the Fundamental Research Funds for the Central Universities (R.Z. and W.J.), and the start-up funds (R.Z. and W.J.) from University of Science and Technology of China. J.T. was supported by grants from the Swiss National Science Foundation, the NCCR Molecular Oncology, the Foundation Louis-Jeantet and the EU-FP7 program APO-SYS, and the Institute for Arthritis Research. G.G. was supported by the Swiss National Science Foundation (PP00P3_ 139094).	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Lo J, 2007, AM J PHYSIOL-ENDOC M, V293, pE102, DOI 10.1152/ajpendo.00089.2007; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robinson DR, 1996, LIPIDS, V31, pS23, DOI 10.1007/BF02637046; Rosenvinge A, 2007, SCAND J RHEUMATOL, V36, P91, DOI 10.1080/03009740601179605; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	48	445	468	9	174	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1154	1163		10.1016/j.immuni.2013.05.015	http://dx.doi.org/10.1016/j.immuni.2013.05.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809162	Bronze			2022-12-18	WOS:000330947500011
J	Ma, Y; Adjemian, S; Mattarollo, SR; Yamazaki, T; Aymeric, L; Yang, H; Catani, JPP; Hannani, D; Duret, H; Steegh, K; Martins, I; Schlemmer, F; Michaud, M; Kepp, O; Sukkurwala, AQ; Menger, L; Vacchelli, E; Droin, N; Galluzzi, L; Krzysiek, R; Gordon, S; Taylor, PR; Van Endert, P; Solary, E; Smyth, MJ; Zitvogel, L; Kroemer, G				Ma, Yuting; Adjemian, Sandy; Mattarollo, Stephen R.; Yamazaki, Takahiro; Aymeric, Laetitia; Yang, Heng; Portela Catani, Joao Paulo; Hannani, Dalil; Duret, Helene; Steegh, Kim; Martins, Isabelle; Schlemmer, Frederic; Michaud, Mickael; Kepp, Oliver; Sukkurwala, Abdul Qader; Menger, Laurie; Vacchelli, Erika; Droin, Nathalie; Galluzzi, Lorenzo; Krzysiek, Roman; Gordon, Siamon; Taylor, Philip R.; Van Endert, Peter; Solary, Eric; Smyth, Mark J.; Zitvogel, Laurence; Kroemer, Guido			Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells	IMMUNITY			English	Article							FIND-ME SIGNAL; APOPTOTIC CELLS; DENDRITIC CELLS; CALRETICULIN EXPOSURE; CANCER-IMMUNOTHERAPY; EXTRACELLULAR ATP; RELEASE; IMMUNOGENICITY; MONOCYTES; SYSTEM	The therapeutic efficacy of anthracyclines relies on antitumor immune responses elicited by dying cancer cells. How chemotherapy-induced cell death leads to efficient antigen presentation to T cells, however, remains a conundrum. We found that intra-tumoral CD11c(+)CD11b(+)Ly6C(hi) cells, which displayed some characteristics of inflammatory dendritic cells and included granulomonocytic precursors, were crucial for anthracycline-induced anticancer immune responses. ATP released by dying cancer cells recruited myeloid cells into tumors and stimulated the local differentiation of CD11c(+)CD11b(+)Ly6C(hi) cells. Such cells efficiently engulfed tumor antigens in situ and presented them to T lymphocytes, thus vaccinating mice, upon adoptive transfer, against a challenge with cancer cells. Manipulations preventing tumor infiltration by CD11c(+)CD11b(+)Ly6C(hi) cells, such as the local overexpression of ectonucleotidases, the blockade of purinergic receptors, or the neutralization of CD11b, abolished the immune system-dependent antitumor activity of anthracyclines. Our results identify a subset of tumor-infiltrating leukocytes as therapy-relevant antigen-presenting cells.	[Ma, Yuting; Adjemian, Sandy; Yang, Heng; Portela Catani, Joao Paulo; Martins, Isabelle; Schlemmer, Frederic; Michaud, Mickael; Kepp, Oliver; Sukkurwala, Abdul Qader; Menger, Laurie; Vacchelli, Erika; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Ma, Yuting; Adjemian, Sandy; Yamazaki, Takahiro; Aymeric, Laetitia; Yang, Heng; Portela Catani, Joao Paulo; Hannani, Dalil; Martins, Isabelle; Schlemmer, Frederic; Michaud, Mickael; Kepp, Oliver; Sukkurwala, Abdul Qader; Menger, Laurie; Vacchelli, Erika; Droin, Nathalie; Galluzzi, Lorenzo; Solary, Eric; Zitvogel, Laurence] Inst Gustave Roussy, F-94805 Villejuif, France; [Ma, Yuting; Adjemian, Sandy; Yamazaki, Takahiro; Aymeric, Laetitia; Yang, Heng; Portela Catani, Joao Paulo; Hannani, Dalil; Martins, Isabelle; Schlemmer, Frederic; Michaud, Mickael; Kepp, Oliver; Sukkurwala, Abdul Qader; Menger, Laurie; Vacchelli, Erika; Solary, Eric; Zitvogel, Laurence] Univ Paris 11, F-94270 Le Kremlin Bicetre, France; [Mattarollo, Stephen R.; Duret, Helene; Steegh, Kim; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, East Melbourne, Vic 3002, Australia; [Mattarollo, Stephen R.; Duret, Helene; Steegh, Kim; Smyth, Mark J.] Univ Queensland, Diamantina Inst, Woolloongabba, Qld 4102, Australia; [Mattarollo, Stephen R.; Duret, Helene; Steegh, Kim; Smyth, Mark J.] Queensland Inst Med Res, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia; [Mattarollo, Stephen R.; Duret, Helene; Steegh, Kim; Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia; [Yamazaki, Takahiro; Aymeric, Laetitia; Hannani, Dalil; Zitvogel, Laurence] INSERM, U1015, CBT1017, F-94805 Villejuif, France; [Yang, Heng; Krzysiek, Roman] INSERM, UMR 996, LabEx LERMIT, F-92140 Clamart, France; [Portela Catani, Joao Paulo] FM USP, Inst Coracao, Lab Vetores Virais, BR-05403000 Sao Paulo, Brazil; [Droin, Nathalie; Solary, Eric] INSERM, U1009, F-94805 Villejuif, France; [Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, F-75006 Paris, France; [Krzysiek, Roman] Univ Paris 11, Fac Pharm, Inst Paris Sud Innovat Therapeut, F-92290 Chatenay Malabry, France; [Krzysiek, Roman] CHU Bicetre, AP HP, Serv Immunol Biol, F-94270 Le Kremlin Bicetre, France; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Taylor, Philip R.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF14 4YU, S Glam, Wales; [Van Endert, Peter] INSERM, U1013, F-75015 Paris, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol Platform, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Peter Maccallum Cancer Center; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; University of Oxford; Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Zitvogel, L (corresponding author), Inst Gustave Roussy, Rue Camille Desmoulins, F-94805 Villejuif, France.	zitvogel@igr.fr; kroemer@orange.fr	Galluzzi, Lorenzo/AAG-6432-2019; Vacchelli, Erika/E-5212-2018; Smyth, Mark J/H-8709-2014; KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAH-3286-2021; Hannani, Dalil/AAH-4598-2019; Kepp, Oliver/N-2763-2017; ADJEMIAN, Sandy/K-7632-2012; Yang, Heng/GWV-0038-2022; Galluzzi, Lorenzo/AAG-6294-2019; Kepp, Oliver/GPX-8627-2022; van Endert, Peter/R-4606-2017; Droin, Nathalie M/Y-5506-2018; Kroemer, Guido/AAY-9859-2020; Mattarollo, Stephen/B-3671-2011	Vacchelli, Erika/0000-0001-8010-0594; Smyth, Mark J/0000-0001-7098-7240; KROEMER, Guido/0000-0002-9334-4405; Hannani, Dalil/0000-0001-5097-1401; Kepp, Oliver/0000-0002-6081-9558; ADJEMIAN, Sandy/0000-0001-5594-5499; van Endert, Peter/0000-0003-3782-0750; Droin, Nathalie M/0000-0002-6099-5324; Mattarollo, Stephen/0000-0003-3659-6507; Solary, Eric/0000-0002-8629-1341; ZITVOGEL, laurence/0000-0003-1596-0998; Menger, Laurie/0000-0003-0949-6607; Taylor, Philip/0000-0003-0163-1421; Aymeric, Laetitia/0000-0001-7459-7231; Schlemmer, Frederic/0000-0003-2113-7113	European Commission (ArtForce); Agence National de la Recherche (ANR); Ligue contre le Cancer (Equipe labellisee); Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Association pour la Recherche sur le Cancer (ARC) LabEx Immuno-Oncologie; Fondation de France; Fondation Bettencourt-Schueller; AXA Chair for Longevity Research; Canceropole Ile-de-France; Paris Alliance of Cancer Research Institutes (PACRI); China Scholarship Council (CSC); Ligue Nationale contre le Cancer; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES/Brazil); ARC; National Health and Medical Research Council (NHMRC); Victorian Cancer Agency; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Ligue contre le Cancer (Equipe labellisee); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC) LabEx Immuno-Oncologie; Fondation de France(Fondation de France); Fondation Bettencourt-Schueller; AXA Chair for Longevity Research(AXA Research Fund); Canceropole Ile-de-France(Region Ile-de-France); Paris Alliance of Cancer Research Institutes (PACRI); China Scholarship Council (CSC)(China Scholarship Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ARC(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Rameau and Y. Lecluse for assistance with flow cytometry, T. Tordjmann and J.-L. Villeval for discussion, and colleagues from the IGR animal facility. We acknowledge R. Schreiber for providing F244 tumor cells, A. D. Weinberg for OVA-expressing MCA205 cells, and K. Murphy for Batf3<SUP>-/-</SUP> mice. G. K. and L. Z. are supported by the European Commission (ArtForce), Agence National de la Recherche (ANR), Ligue contre le Cancer (Equipe labellisee), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Association pour la Recherche sur le Cancer (ARC) LabEx Immuno-Oncologie, Fondation de France, Fondation Bettencourt-Schueller, AXA Chair for Longevity Research, Canceropole Ile-de-France, and Paris Alliance of Cancer Research Institutes (PACRI). Y. M. and H. Y. were supported by China Scholarship Council (CSC), S. A. and I. M. by Ligue Nationale contre le Cancer, J. P. P. C. by Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES/Brazil), D. H. by ARC, and M. J. S. by a National Health and Medical Research Council (NH&MRC) Australia Fellowship and Program Grant and by a grant from the Victorian Cancer Agency. Y. M., S. A., S. R. M., T. Y., L. A., H. Y., J. P. P. C., D. H., H. D., K. S., I. M., F. S., M. M., O. K., A. Q. S., L. M., E. V., and N. D. performed experiments. Y. M., M. J. S., R. K., E. S., S. G., P. R. T., L. Z., and G. K. conceived the study. Y. M., S. A., L. G., L. Z., and G. K. wrote the paper.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barbosa CMV, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.49; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Duffy D, 2012, IMMUNITY, V37, P917, DOI 10.1016/j.immuni.2012.07.015; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Han JY, 2008, DIABETES, V57, P2118, DOI 10.2337/db07-1499; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zappasodi R, 2010, CANCER RES, V70, P9062, DOI 10.1158/0008-5472.CAN-10-1825	43	445	457	4	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					729	741		10.1016/j.immuni.2013.03.003	http://dx.doi.org/10.1016/j.immuni.2013.03.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23562161	Bronze			2022-12-18	WOS:000330942100015
J	Miller, JD; van der Most, RG; Akondy, RS; Glidewell, JT; Albott, S; Masopust, D; Murali-Krishna, K; Mahar, PL; Edupuganti, S; Lalor, S; Germon, S; Del Rio, C; Mulligan, MJ; Staprans, SI; Altman, JD; Feinberg, MB; Ahmed, R				Miller, Joseph D.; van der Most, Robbert G.; Akondy, Rama S.; Glidewell, John T.; Albott, Sophia; Masopust, David; Murali-Krishna, Kaja; Mahar, Patryce L.; Edupuganti, Srilatha; Lalor, Susan; Germon, Stephanie; Del Rio, Carlos; Mulligan, Mark J.; Staprans, Silvija I.; Altman, John D.; Feinberg, Mark B.; Ahmed, Rafi			Human effector and memory CD8(+) T cell responses to smallpox and yellow fever vaccines	IMMUNITY			English	Article							HEPATITIS-C VIRUS; CHRONIC VIRAL-INFECTION; IN-VIVO; BYSTANDER ACTIVATION; IMMUNE-RESPONSES; HOMEOSTATIC PROLIFERATION; ANTIGENIC-STIMULATION; LYMPHOCYTE RESPONSES; CUTTING EDGE; EPSTEIN-BARR	To explore the human T cell response to acute viral infection, we performed a longitudinal analysis of CD8(+) T cells responding to the live yellow fever virus and smallpox vaccines-two highly successful human vaccines. Our results show that both vaccines generated a brisk primary effector CD8(+) T cell response of substantial magnitude that could be readily quantitated with a simple set of four phenotypic markers. Secondly, the vaccine-induced T cell response was highly specific with minimal bystander effects. Thirdly, virus-specific CD8(+) T cells passed through an obligate effector phase, contracted more than 90% and gradually differentiated into long-lived memory cells. Finally, these memory cells were highly functional and underwent a memory differentiation program distinct from that described for human CD8(+) T cells specific for persistent viruses. These results provide a benchmark for CD8(+) T cell responses induced by two of the most effective vaccines ever developed.	[Miller, Joseph D.; van der Most, Robbert G.; Akondy, Rama S.; Glidewell, John T.; Albott, Sophia; Masopust, David; Murali-Krishna, Kaja; Mahar, Patryce L.; Edupuganti, Srilatha; Lalor, Susan; Germon, Stephanie; Del Rio, Carlos; Mulligan, Mark J.; Staprans, Silvija I.; Altman, John D.; Feinberg, Mark B.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Miller, Joseph D.; van der Most, Robbert G.; Akondy, Rama S.; Glidewell, John T.; Albott, Sophia; Masopust, David; Murali-Krishna, Kaja; Mahar, Patryce L.; Edupuganti, Srilatha; Lalor, Susan; Germon, Stephanie; Del Rio, Carlos; Mulligan, Mark J.; Staprans, Silvija I.; Altman, John D.; Feinberg, Mark B.; Ahmed, Rafi] Emory Univ, Sch Med, Hope Clin, Atlanta, GA 30322 USA	Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ra@microbio.emory.edu	masopust, david/B-5027-2008; del Rio, Carlos/B-3763-2012; Mulligan, Mark/V-9275-2019; Akondy, Rama/AAC-4656-2020	del Rio, Carlos/0000-0002-0153-3517; Kaja, Murali Krishna/0000-0002-6275-1710; Akondy, Rama/0000-0003-4737-5240				Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barouch DH, 2001, CURR OPIN IMMUNOL, V13, P479, DOI 10.1016/S0952-7915(00)00244-2; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Carrasco J, 2006, BLOOD, V108, P2897, DOI 10.1182/blood-2005-11-007237; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; DEMKOWICZ WE, 1993, J VIROL, V67, P1538, DOI 10.1128/JVI.67.3.1538-1544.1993; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; GERDES J, 1984, J IMMUNOL, V133, P1710; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hoffmeister B, 2003, METHODS, V29, P270, DOI 10.1016/S1046-2023(02)00349-3; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; LITTAURA RA, 1992, J VIROL, V66, P2274, DOI 10.1128/JVI.66.4.2274-2280.1992; Lukacher AE, 1999, J IMMUNOL, V163, P3369; MCCARTHY K., 1958, JOUR HYGIENE, V56, P466; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; McNally JM, 2002, CURR TOP MICROBIOL, V263, P29; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; MOSS B, 1999, VACCINES; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; RICE C M, 1989, New Biologist, V1, P285; Rock MT, 2006, J INFECT DIS, V194, P435, DOI 10.1086/505506; Rock MT, 2005, J IMMUNOL, V174, P3757, DOI 10.4049/jimmunol.174.6.3757; Roos MTL, 2000, J INFECT DIS, V182, P451, DOI 10.1086/315737; Sakai A, 2007, J VIROL, V81, P7208, DOI 10.1128/JVI.01774-06; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tan LC, 1999, J IMMUNOL, V162, P1827; Terajima M, 2003, J EXP MED, V197, P927, DOI 10.1084/jem.20022222; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; Urbani S, 2002, J VIROL, V76, P12423, DOI 10.1128/JVI.76.24.12423-12434.2002; van der Most RG, 2003, VIROLOGY, V315, P93, DOI 10.1016/j.virol.2003.07.001; van Leeuwen EM, 2002, J IMMUNOL, V169, P5838, DOI 10.4049/jimmunol.169.10.5838; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2002, ADV EXP MED BIOL, V512, P165; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; *WYETH, 2002, PACK INS DRYV SMALLP, P1; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629	72	445	457	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					710	722		10.1016/j.immuni.2008.02.020	http://dx.doi.org/10.1016/j.immuni.2008.02.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18468462	Bronze			2022-12-18	WOS:000256003900017
J	Gringhuis, SI; den Dunnen, J; Litjens, M; Hof, BV; van Kooyk, Y; Geijtenbeek, TBH				Gringhuis, Sonja I.; den Dunnen, Jeroen; Litjens, Manja; Hof, Bert van het; van Kooyk, Yvette; Geijtenbeek, Teunis B. H.			C-type lectin DC-SIGN modulates toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappa B	IMMUNITY			English	Article							DENDRITIC CELLS; ACTIVATION; PHOSPHORYLATION; LIPOPOLYSACCHARIDE; RECOGNITION; EXPRESSION; PROTEIN; DECTIN-1; PATHWAY; STRESS	Adaptive immune responses by dendritic cells (DCs) are critically controlled by Toll-like receptor (TLR) function. Little is known about modulation of TLR-specific signaling by other pathogen receptors. Here, we have identified a molecular signaling pathway induced by the C-type lectin DC-SIGN that modulates TLR signaling at the level of the transcription factor NF-kappa B. We demonstrated that pathogens trigger DC-SIGN on human DCs to activate the serine and threonine kinase Raf-1, which subsequently leads to acetylation of the NF-kappa B subunit p65, but only after TLR-induced activation of NF-kappa B. Acetylation of p65 both prolonged and increased IL10 transcription to enhance anti-inflammatory cytokine responses. We demonstrated that different pathogens such as Mycobacterium tuberculosis, M. leprae, Candida albicans, measles virus, and human immunodeficiency virus-1 interacted with DC-SIGN to activate the Raf-1-acetylation-dependent signaling pathway to modulate signaling by different TLRs. Thus, this pathway is involved in regulation of adaptive immunity by DCs to bacterial, fungal, and viral pathogens.	Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Geijtenbeek, TBH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands.	t.geijtenbeek@vumc.nl	Geijtenbeek, Teunis/C-2229-2009; Dunnen, Jeroen den/O-9760-2019; den Dunnen, Jeroen/K-4252-2012	Dunnen, Jeroen den/0000-0002-7199-8619; den Dunnen, Jeroen/0000-0002-7199-8619; Gringhuis, Sonja/0000-0003-0383-4978	NIAID NIH HHS [N01 AI-25469] Funding Source: Medline; PHS HHS [HHSN266200400091C] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025469] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumann B, 2000, P NATL ACAD SCI USA, V97, P4615, DOI 10.1073/pnas.080583397; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horiuchi KY, 2006, J BIOMOL SCREEN, V11, P48, DOI 10.1177/1087057105282097; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; King AJ, 2001, FEBS LETT, V497, P6, DOI 10.1016/S0014-5793(01)02425-5; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Remans PHJ, 2004, J IMMUNOL, V173, P920, DOI 10.4049/jimmunol.173.2.920; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	47	445	478	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					605	616		10.1016/j.immuni.2007.03.012	http://dx.doi.org/10.1016/j.immuni.2007.03.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17462920	Bronze			2022-12-18	WOS:000246895900013
J	Roberts, AW; Kim, C; Zhen, L; Lowe, JB; Kapur, R; Petryniak, B; Spaetti, A; Pollock, JD; Borneo, JB; Bradford, GB; Atkinson, SJ; Dinauer, MC; Williams, DA				Roberts, AW; Kim, C; Zhen, L; Lowe, JB; Kapur, R; Petryniak, B; Spaetti, A; Pollock, JD; Borneo, JB; Bradford, GB; Atkinson, SJ; Dinauer, MC; Williams, DA			Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense	IMMUNITY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; HIGH ENDOTHELIAL VENULES; IL-8 RECEPTOR HOMOLOG; L-SELECTIN; BINDING PROTEIN; P-SELECTIN; ACTIN POLYMERIZATION; ADP-RIBOSYLATION; NADPH OXIDASE	In mammals, the Rho family GTPase Rac2 is restricted in expression to hematopoietic cells, where it is coexpressed with Rac1. Rac2-deficient mice were created to define the physiological requirement for two near-identical Pac proteins in hematopoietic cells, rac2(-/-) neutrophils displayed significant defects in chemotaxis, in shear-dependent L-selectin-mediated capture on the endothelial substrate Glycam-1, and in both F-actin generation and p38 and, unexpectedly, p42/ p44 MAP kinase activation induced by chemoattractants. Superoxide production by rac2(-/-) bone marrow neutrophils was significantly reduced compared to wild type, but it was normal in activated peritoneal exudate neutrophils. These defects were reflected in vivo by baseline neutrophilia, reduced inflammatory peritoneal exudate formation, and increased mortality when challenged with Aspergillus fumigatus. Rac2 is an essential regulator of multiple specialized neutrophil functions.	Indiana Univ, Sch Med, Howard Hughes Med Inst, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Pediat,Herman B Wells Ctr Pediat Res, Sect Pediat Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Williams, DA (corresponding author), Indiana Univ, Sch Med, Howard Hughes Med Inst, Indianapolis, IN 46202 USA.		Roberts, Andrew W./C-6736-2012; Pollock, Jonathan D/B-1554-2009	Roberts, Andrew W./0000-0002-7341-5720; 	NCI NIH HHS [1P01CA71932] Funding Source: Medline; NHLBI NIH HHS [R01 HL52565] Funding Source: Medline; PHS HHS [R01 45635] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052565] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BENGTSSON T, 1990, P NATL ACAD SCI USA, V87, P2921, DOI 10.1073/pnas.87.8.2921; Bjorgvinsdottir H, 1997, BLOOD, V89, P41, DOI 10.1182/blood.V89.1.41.41_41_48; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Brenner B, 1997, IMMUNOLOGY, V92, P214, DOI 10.1046/j.1365-2567.1997.00336.x; Broxmeyer HE, 1996, J EXP MED, V184, P1825, DOI 10.1084/jem.184.5.1825; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CASSIMERIS L, 1992, J CELL BIOL, V119, P1261, DOI 10.1083/jcb.119.5.1261; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; Dorseuil O, 1996, J BIOL CHEM, V271, P83, DOI 10.1074/jbc.271.1.83; EHRENGRUBER MU, 1995, FEBS LETT, V372, P161, DOI 10.1016/0014-5793(95)00880-I; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Gao RX, 1997, IEEE-ASME T MECH, V2, P1, DOI 10.1109/3516.558852; Gringhuis SI, 1998, MOL CELL BIOL, V18, P1725, DOI 10.1128/MCB.18.3.1725; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KOCH G, 1994, BIOCHEM J, V299, P775, DOI 10.1042/bj2990775; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 1997, J CLIN INVEST, V100, pS97; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MOLL J, 1991, ONCOGENE, V6, P863; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PROSSNITZ ER, 1993, J IMMUNOL, V151, P5704; SHIRSAT NV, 1990, ONCOGENE, V5, P769; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; STASIA MJ, 1991, BIOCHEM BIOPH RES CO, V180, P615, DOI 10.1016/S0006-291X(05)81110-6; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; WILSON RW, 1993, J IMMUNOL, V151, P1571; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832; Zu YL, 1998, J IMMUNOL, V160, P1982	56	444	455	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					183	196		10.1016/S1074-7613(00)80019-9	http://dx.doi.org/10.1016/S1074-7613(00)80019-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072071	Bronze			2022-12-18	WOS:000078972200006
J	Kobayashi, N; Karisola, P; Pena-Cruz, V; Dorfman, DM; Jinushi, M; Umetsu, SE; Butte, MJ; Nagumo, H; Chernova, I; Zhu, BG; Sharpe, AH; Ito, S; Dranoff, G; Kaplan, GG; Casasnovas, JM; Umetsu, DT; Dekruyff, RH; Freeman, GJ				Kobayashi, Norimoto; Karisola, Piia; Pena-Cruz, Victor; Dorfman, David M.; Jinushi, Masahisa; Umetsu, Sarah E.; Butte, Manish J.; Nagumo, Haruo; Chernova, Irene; Zhu, Baogong; Sharpe, Arlene H.; Ito, Susumu; Dranoff, Glenn; Kaplan, Gerardo G.; Casasnovas, Jose M.; Umetsu, Dale T.; Dekruyff, Rosemarie H.; Freeman, Gordon J.			TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells	IMMUNITY			English	Article							MACROPHAGE RECOGNITION; MOLECULE-1 KIM-1; KIDNEY INJURY; GENE FAMILY; T-CELLS; CLEARANCE; RECEPTOR; PHAGOCYTOSIS; ACTIVATION; SURFACE	The T cell immunoglobulin mucin (TIM) proteins regulate T cell activation and tolerance. Here we showed that TIM-4 is expressed on human and mouse macrophages and dendritic cells, and both TIM-4 and TIM-1 specifically bound phosphatidylserine (PS) on the surface of apoptotic cells but not any other phospholipid tested. TIM-4(+) peritoneal macrophages, TIM-1(+) kidney cells, and TIM-4- or TIM-1-transfected cells efficiently phagocytosed apoptotic cells, and phagocytosis could be blocked by TIM-4 or TIM-1 monoclonal antibodies. Mutations in the unique cavity of TIM-4 eliminated PS binding and phagocytosis. TIM-4 mAbs that blocked PS binding and phagocytosis mapped to epitopes in this binding cavity. These results show that TIM-4 and TIM-1 are immunologically restricted members of the group of receptors whose recognition of PS is critical for the efficient clearance of apoptotic cells and prevention of autoimmunity.	[Kobayashi, Norimoto; Pena-Cruz, Victor; Jinushi, Masahisa; Nagumo, Haruo; Chernova, Irene; Zhu, Baogong; Dranoff, Glenn; Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kobayashi, Norimoto; Pena-Cruz, Victor; Jinushi, Masahisa; Nagumo, Haruo; Chernova, Irene; Zhu, Baogong; Dranoff, Glenn; Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Karisola, Piia; Umetsu, Dale T.; Dekruyff, Rosemarie H.] Harvard Univ, Sch Med, Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Dorfman, David M.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Umetsu, Sarah E.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Butte, Manish J.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ito, Susumu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kaplan, Gerardo G.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Casasnovas, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; US Food & Drug Administration (FDA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Freeman, GJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	gordon_freeman@dfci.harvard.edu	Casasnovas, Jose M/L-6299-2014; Freeman, Gordon/AAC-5380-2019; Jinushi, Masahisa/A-4311-2012; Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019	Casasnovas, Jose M/0000-0002-2873-6410; Freeman, Gordon/0000-0002-7210-5616; Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; Karisola, Piia/0000-0003-0635-2704; Chernova, Irene/0000-0003-3346-0559; kaplan, gerardo/0000-0003-3303-7259	NIAID NIH HHS [P01 AI054456, P01 AI054456-010002, P01 AI054456-019001] Funding Source: Medline; NINDS NIH HHS [R01 NS045937-01, R01 NS045937-03, R01 NS045937-05, R01 NS045937-04, R01 NS045937-02, R01 NS045937] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Beletskii A, 2005, BIOTECHNIQUES, V39, P894, DOI 10.2144/000112001; Binne LL, 2007, J IMMUNOL, V178, P4342, DOI 10.4049/jimmunol.178.7.4342; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; D Sizing I, 2007, J IMMUNOL, V178, P2249, DOI 10.4049/jimmunol.178.4.2249; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Dorfman DM, 2003, AM J PATHOL, V162, P1539, DOI 10.1016/S0002-9440(10)64287-3; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kuchroo VK, 2006, ADV IMMUNOL, V91, P227, DOI 10.1016/S0065-2776(06)91006-2; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; ROBERTSON MJ, 1995, LEUKEMIA LYMPHOMA, V17, P51, DOI 10.3109/10428199509051703; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shakhov AN, 2004, EUR J IMMUNOL, V34, P494, DOI 10.1002/eji.200324590; SMITH JP, 1991, ANAT REC, V229, P511, DOI 10.1002/ar.1092290412; Tami C, 2007, J VIROL, V81, P3437, DOI 10.1128/JVI.01585-06; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vila MR, 2004, KIDNEY INT, V65, P1761, DOI 10.1111/j.1523-1755.2004.00601.x; Wilker PR, 2007, INT IMMUNOL, V19, P763, DOI 10.1093/intimm/dxm044; Williamson Patrick, 2004, J Biol, V3, P14, DOI 10.1186/jbiol14; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	40	443	474	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					927	940		10.1016/j.immuni.2007.11.011	http://dx.doi.org/10.1016/j.immuni.2007.11.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18082433	Green Accepted, Bronze			2022-12-18	WOS:000251907300012
J	Carrasco, YR; Batista, FD				Carrasco, Yolanda R.; Batista, Facundo D.			B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node	IMMUNITY			English	Article							MARGINAL-ZONE MACROPHAGES; DENDRITIC CELLS; IN-VIVO; IMMUNOLOGICAL SYNAPSE; ANTIBODY-RESPONSES; IMMUNE-COMPLEXES; ACTIVATION; RECOGNITION; PROTEIN; POLYSACCHARIDE	Adaptive B cell responses are initiated by B cell receptor-antigen engagement. Despite its importance, the early stages of B cell interaction with antigen in vivo remain elusive. Using fluorescent particulate antigen in combination with multiphoton microscopy and immune staining, we identified the follicle-subcapsular sinus (SCS) boundary of the lymph node as a site for B cell-antigen acquisition. In this macrophagerich region, antigen accumulated shortly after administration, where specific follicular B cells were retained for long periods of time. These B cells acquired antigen cumulatively and became the main antigen carriers inside the follicle before polarizing to the B cell-T cell border. These observations not only provide evidence of a B cell role as antigen transporters into the follicle, but also highlight the boundary between the follicle and the SCS as a site for initiation of B cell responses.	Canc Res United Kingdom London Res Inst, Lymphocyte Interact Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Carrasco, YR (corresponding author), Univ Autonoma Madrid, Dept Immunol & Oncol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain.	ycarrasco@cnb.uam.es; facundo.batista@cancer.org.uk	Carrasco, Yolanda/X-2629-2019	Carrasco, Yolanda R./0000-0003-2148-1926				Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; BROWN JC, 1970, NATURE, V228, P367, DOI 10.1038/228367a0; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRAY D, 1984, IMMUNOLOGY, V52, P659; GRAY D, 1985, ADV EXP MED BIOL, V186, P437; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; HUMPHREY JH, 1981, EUR J IMMUNOL, V11, P221, DOI 10.1002/eji.1830110311; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MOLLER G, 1987, IMMUNOL REV, V96, P1; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Taylor PR, 2004, P NATL ACAD SCI USA, V101, P1963, DOI 10.1073/pnas.0308490100; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; WHITE RG, 1970, J MED MICROBIOL, V3, P65, DOI 10.1099/00222615-3-1-65; Wykes M, 1998, J IMMUNOL, V161, P1313	45	442	450	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					160	171		10.1016/j.immuni.2007.06.007	http://dx.doi.org/10.1016/j.immuni.2007.06.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17658276	Bronze			2022-12-18	WOS:000248398100017
J	Schulz, O; Edwards, AD; Schito, M; Aliberti, J; Manickasingham, S; Sher, A; Sousa, CRE				Schulz, O; Edwards, AD; Schito, M; Aliberti, J; Manickasingham, S; Sher, A; Sousa, CRE			CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal	IMMUNITY			English	Article							IN-VIVO; DIFFERENTIAL EXPRESSION; MOUSE CD40; INTERLEUKIN-12; IMMUNITY; ACTIVATION; INDUCTION; INFECTION; CYTOKINE; ANTIGEN	CD40 ligation triggers IL-12 production by dendritic cells (DC) in vitro. Here, we demonstrate that CD40 cross-linking alone is not sufficient to induce IL-12 production by DC in vivo. Indeed, resting DC make neither the IL-12 p35 nor IL-12 p40 subunits and express only low levels of CD40. Nevertheless, after DC activation by microbial stimuli that primarily upregulate IL-12 p40 and augment CD40 expression, CD40 ligation induces a significant increase in IL-12 p35 and IL-12 p70 heterodimer production. Similarly, IL-12 p70 is produced during T cell activation in the presence but not in the absence of microbial stimuli. Thus, production of bioactive IL-12 by DC can be amplified by T cell-derived signals but must be initiated by innate signals.	Imperial Canc Res Fund, Immunobiol Lab, London WC2A 3PX, England; NIAID, Parasit Dis Lab, Immunobiol Sect, NIH, Bethesda, MD 20892 USA	Cancer Research UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sousa, CRE (corresponding author), Imperial Canc Res Fund, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Edwards, Alexander Daniel/AAX-8524-2021; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Aliberti, Julio/I-7354-2013; Edwards, Alexander D/F-7440-2010; Aliberti, Julio/G-4565-2012	Edwards, Alexander Daniel/0000-0003-2369-989X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Aliberti, Julio/0000-0003-3420-8478; Edwards, Alexander D/0000-0003-2369-989X; Schulz, Oliver/0000-0002-1493-3341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, Z01AI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 1999, J EXP MED, V189, P169, DOI 10.1084/jem.189.1.169; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BETTE M, 1994, EUR J IMMUNOL, V24, P2435, DOI 10.1002/eji.1830241026; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Josien R, 1999, J IMMUNOL, V162, P2562; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kato T, 1996, J IMMUNOL, V156, P3932; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MANICKASINGHAM S, 2000, IN PRESS J IMMUNOL; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Ruedl C, 1999, EUR J IMMUNOL, V29, P3762, DOI 10.1002/(SICI)1521-4141(199911)29:11<3762::AID-IMMU3762>3.0.CO;2-F; Sher A, 1998, EUR CYTOKINE NETW, V9, P65; Snijders A, 1996, J IMMUNOL, V156, P1207; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; VandenBerg TK, 1996, IMMUNOLOGY, V88, P294; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307; Yamane H, 1999, J IMMUNOL, V162, P6433	42	442	451	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					453	462		10.1016/S1074-7613(00)00045-5	http://dx.doi.org/10.1016/S1074-7613(00)00045-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070164	Bronze			2022-12-18	WOS:000090079100005
J	Sonnenberg, GF; Monticelli, LA; Elloso, MM; Fouser, LA; Artis, D				Sonnenberg, Gregory F.; Monticelli, Laurel A.; Elloso, M. Merle; Fouser, Lynette A.; Artis, David			CD4(+) Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut	IMMUNITY			English	Article							ROR-GAMMA-T; NKP46(+) CELLS; HELPER-CELLS; DIFFERENTIATION; INFLAMMATION; INFECTION; RECEPTOR; MUCOSAL; ADULT; INTERLEUKIN-22	Fetal CD4(+) lymphoid tissue inducer (LTi) cells play a critical role in the development of lymphoid tissues. Recent studies identified that LTi cells persist in adults and are related to a heterogeneous population of innate lymphoid cells that have been implicated in inflammatory responses. However, whether LTi cells contribute to protective immunity remains poorly defined. We demonstrate that after infection with Citrobacter rodentium, CD4(+) LTi cells were a dominant source of interleukin-22 (IL-22) early during infection. Infection-induced CD4(+) LTi cell responses were IL-23 dependent, and ablation of IL-23 impaired innate immunity. Further, depletion of CD4(+) LTi cells abrogated infection-induced expression of IL-22 and antimicrobial peptides, resulting in exacerbated host mortality. LTi cells were also found to be essential for host protective immunity in lymphocyte-replete hosts. Collectively these data demonstrate that adult CD4(+) LTi cells are a critical source of IL-22 and identify a previously unrecognized function for CD4(+) LTi cells in promoting innate immunity in the intestine.	[Sonnenberg, Gregory F.; Monticelli, Laurel A.; Artis, David] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.; Monticelli, Laurel A.; Artis, David] Univ Penn, Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.; Monticelli, Laurel A.; Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Elloso, M. Merle] Centocor Res & Dev Inc, Discovery Res Immunol, Radnor, PA 19087 USA; [Fouser, Lynette A.] Pfizer Biotherapeut Res & Dev, Inflammat & Immunol, Cambridge, MA 02140 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Johnson & Johnson; Johnson & Johnson USA; Pfizer	Artis, D (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu		Artis, David/0000-0002-1753-4100	National Institute of Health [AI61570, AI74878, AI087990, AI083480, T32AI007532-08]; Burroughs Wellcome Fund; University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074878, R21AI083480, T32AI007532, R01AI061570, R21AI087990, R01AI095466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge members of the D.A. laboratory for helpful discussions and critical reading of the manuscript. We thank the Morphology Core and Pilot Feasibility Program of the National Institute of Diabetes and Digestive and Kidney Disease Center (DK50306) and Vet School Pathology Service for technical expertise, K. Lam and A. Root (Pfizer) for purification of IL-22 diagnostic antibodies, and R. Askew (Pfizer) for discussion regarding the design of the IL-22-deficient mice. Research in the D.A. lab is supported by National Institute of Health (AI61570, AI74878, AI087990, and AI083480 to D.A.; T32AI007532-08 to G.F.S), the Burroughs Wellcome Fund (Investigator in Pathogenesis of Infectious Disease Award to D.A.), and pilot grants from the University of Pennsylvania (PGFI, VCID, and University Research Fund to D.A.). M.M.E. is employed by Centocor. L.A.F. is employed by Pfizer.	Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; BURNET FM, 1968, NATURE, V218, P426, DOI 10.1038/218426a0; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim MY, 2009, CLIN EXP IMMUNOL, V157, P20, DOI 10.1111/j.1365-2249.2009.03932.x; Kim MY, 2008, IMMUNOLOGY, V124, P166, DOI 10.1111/j.1365-2567.2007.02750.x; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; Lane P, 2008, SEMIN IMMUNOL, V20, P159, DOI 10.1016/j.smim.2008.02.002; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Segel MJ, 2003, AM J PHYSIOL-LUNG C, V285, pL1255, DOI 10.1152/ajplung.00303.2002; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Storek J, 1997, AM J HEMATOL, V54, P131, DOI 10.1002/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veiga-Fernandes H, 2010, J EXP MED, V207, P269, DOI 10.1084/jem.20100105; WALLACE JM, 1993, AM REV RESPIR DIS, V148, P1523, DOI 10.1164/ajrccm/148.6_Pt_1.1523; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	43	441	456	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 28	2011	34	1					122	134		10.1016/j.immuni.2010.12.009	http://dx.doi.org/10.1016/j.immuni.2010.12.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21194981	Green Accepted, Bronze			2022-12-18	WOS:000287336600015
J	BARGATZE, RF; JUTILA, MA; BUTCHER, EC				BARGATZE, RF; JUTILA, MA; BUTCHER, EC			DISTINCT ROLES OF L-SELECTIN AND INTEGRINS ALPHA-4-BETA-7 AND LFA-1 IN LYMPHOCYTE HOMING TO PEYERS PATCH-HEV IN-SITU - THE MULTISTEP MODEL CONFIRMED AND REFINED	IMMUNITY			English	Article							HIGH ENDOTHELIAL VENULES; VASCULAR ADDRESSIN; MOLECULAR MECHANISMS; EXPRESSION; ADHESION; RECEPTOR; MADCAM-1; LECAM-1; SPECIFICITY; RELEVANCE	Circulating lymphocytes home to the mucosal lymphoid organs, Peyer's patches (PP), through high endothelial venules (HEV). In situ analyses revealed that transfused lymph node cells (LNCs) interact with PP-HEV in a series of overlapping adhesion events: L-selectin (CD62L) >alpha 4 beta 7 initiates interaction, L-selectin and alpha 4 beta 7 both participate in rolling, and Gal-linked activation triggers arrest that requires both alpha 4 beta 7 and LFA-1. alpha 4 beta 7 dramatically reduces rolling velocity, and appears to be required for engagement of LFA-1. In contrast with resting LNC, preactivated LNC or alpha 4 beta 7(hi) lymphoma cells require only alpha 4 beta 7 for arrest in PP-HEV. The predominant PP-HEV ligand for alpha 4 beta 7 but also apparently for L-selectin is the mucosal addressin MAd-CAM-1. These results validate the concept of multimolecular adhesion/decision cascades in physiologic lymphocyte-endothelial recognition, define a novel role for alpha 4 integrins as a ''bridge'' between selectin and beta 2 integrin-dependent events, and reemphasize the potential for direct adhesion through preactivated alpha 4 integrins alone.	STANFORD UNIV,SCH MED,CTR DIGEST DIS,STANFORD,CA 94305; VET ADM MED CTR,CTR MOLEC BIOL MED,PALO ALTO,CA 94304; MONTANA STATE UNIV,VET MOLEC BIOL LAB,BOZEMAN,MT 59717	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Montana State University System; Montana State University Bozeman	BARGATZE, RF (corresponding author), STANFORD UNIV,SCH MED,DEPT PATHOL,IMMUNOL & VASC BIOL LAB,STANFORD,CA 94305, USA.				NIAID NIH HHS [AI37832, AI19957] Funding Source: Medline; NIGMS NIH HHS [GM37734] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037832, R01AI019957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734, R01GM037734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREW DP, 1994, J IMMUNOL, V153, P3847; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BARGATZE RF, 1990, J CELL BIOCHEM, V42, P219, DOI 10.1002/jcb.240420405; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; ERLE DJ, 1994, J IMMUNOL, V153, P517; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; HAMANN A, 1994, J IMMUNOL, V52, P282; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; ISSEKUTZ TB, 1991, J IMMUNOL, V147, P4178; JONES DA, 1994, J CLIN INVEST, V94, P2443, DOI 10.1172/JCI117612; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; LAWRENCE MB, 1995, IN PRESS EUR J IMMUN; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; NAKACHE M, 1988, NATURE, V304, P32; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; SHIMIZU Y, 1992, IMMUNOL TODAY, V13, P106, DOI 10.1016/0167-5699(92)90151-V; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; STRAUCH UG, 1994, INT IMMUNOL, V6, P263, DOI 10.1093/intimm/6.2.263; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; TAMATANI T, 1993, J IMMUNOL, V150, P1735; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; VONANDRIAN UH, 1993, INFLAMMATORY DIS THE, V41, P153	35	440	449	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					99	108		10.1016/1074-7613(95)90162-0	http://dx.doi.org/10.1016/1074-7613(95)90162-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7542550	Bronze			2022-12-18	WOS:A1995RK86800011
J	Ebert, PJR; Cheung, J; Yang, YG; McNamara, E; Hong, R; Moskalenko, M; Gould, SE; Maecker, H; Irving, BA; Kim, JM; Belvin, M; Mellman, I				Ebert, Peter J. R.; Cheung, Jeanne; Yang, Yagai; McNamara, Erin; Hong, Rebecca; Moskalenko, Marina; Gould, Stephen E.; Maecker, Heather; Irving, Bryan A.; Kim, Jeong M.; Belvin, Marcia; Mellman, Ira			MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; MEK INHIBITORS; ADVANCED MELANOMA; TUMOR-GROWTH; MUTANT KRAS; BRAF; CANCER; IPILIMUMAB; APOPTOSIS; EFFICACY	Targeted inhibition of mitogen-activated protein kinase (MAPK) kinase (MEK) can induce regression of tumors bearing activating mutations in the Ras pathway but rarely leads to tumor eradication. Although combining MEK inhibition with T-cell-directed immunotherapy might lead to more durable efficacy, T cell responses are themselves at least partially dependent on MEK activity. We show here that MEK inhibition did profoundly block naive CD8(+) T cell priming in tumor-bearing mice, but actually increased the number of effector-phenotype antigen-specific CD8(+) T cells within the tumor. MEK inhibition protected tumor-infiltrating CD8(+) T cells from death driven by chronic TCR stimulation while sparing cytotoxic activity. Combining MEK inhibition with anti-programmed death-ligand 1 (PD-L1) resulted in synergistic and durable tumor regression even where either agent alone was only modestly effective. Thus, despite the central importance of the MAP kinase pathway in some aspects of T cell function, MEK-targeted agents can be compatible with T-cell-dependent immunotherapy.	[Ebert, Peter J. R.; Cheung, Jeanne; Yang, Yagai; McNamara, Erin; Hong, Rebecca; Moskalenko, Marina; Gould, Stephen E.; Maecker, Heather; Irving, Bryan A.; Kim, Jeong M.; Belvin, Marcia; Mellman, Ira] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Maecker, Heather] Gilead Sci Inc, Foster City, CA 94404 USA; [Irving, Bryan A.] Cyt Therapeut, San Francisco, CA 94080 USA	Roche Holding; Genentech; Gilead Sciences	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020	Maecker, Heather/0000-0002-5378-1141				Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Anichini A, 2010, CANCER RES, V70, P8378, DOI 10.1158/0008-5472.CAN-10-2028; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Burgess MR, 2014, BLOOD, V124, P3947, DOI 10.1182/blood-2014-05-574582; Chen D, 1999, J IMMUNOL, V163, P5796; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Djeu JY, 2002, CLIN CANCER RES, V8, P636; Dooley AJ, 2014, THER ADV MED ONCOL, V6, P262, DOI 10.1177/1758834014548187; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Ferris RL, 2014, J IMMUNOL, V193, P1525, DOI 10.4049/jimmunol.1400557; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fujii Y, 2008, GENES CELLS, V13, P411, DOI 10.1111/j.1365-2443.2008.01177.x; Grimaldi AM, 2014, CURR OPIN ONCOL, V26, P196, DOI 10.1097/CCO.0000000000000050; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; GUPTA S, 1994, J BIOL CHEM, V269, P17349; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Jordan KR, 2010, P NATL ACAD SCI USA, V107, P4652, DOI 10.1073/pnas.0914879107; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lebbe C, 2014, ANN ONCOL, V25, P2277, DOI 10.1093/annonc/mdu441; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067401; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Liu X, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23972; McArthur GA, 2013, J CLIN ONCOL, V31, P499, DOI 10.1200/JCO.2012.45.5568; Tan N, 2013, MOL CANCER THER, V12, P853, DOI 10.1158/1535-7163.MCT-12-0949; Ott PA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00346; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Rahman A, 2014, LANCET ONCOL, V15, pE535, DOI 10.1016/S1470-2045(14)71023-X; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rosen L.S., 2011, P 102 ANN M AACR, P71; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Shindo T, 2013, BLOOD, V121, P4617, DOI 10.1182/blood-2012-12-476218; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Terheyden P, 2003, SCAND J IMMUNOL, V58, P566, DOI 10.1046/j.1365-3083.2003.01324.x; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	56	439	452	6	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					609	621		10.1016/j.immuni.2016.01.024	http://dx.doi.org/10.1016/j.immuni.2016.01.024			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26944201	Bronze			2022-12-18	WOS:000372784200018
J	Huber, S; Gagliani, N; Esplugues, E; O'Connor, W; Huber, FJ; Chaudhry, A; Kamanaka, M; Kobayashi, Y; Booth, CJ; Rudensky, AY; Roncarolo, MG; Battaglia, M; Flavell, RA				Huber, Samuel; Gagliani, Nicola; Esplugues, Enric; O'Connor, William, Jr.; Huber, Francis J.; Chaudhry, Ashutosh; Kamanaka, Masahito; Kobayashi, Yasushi; Booth, Carmen J.; Rudensky, Alexander Y.; Roncarolo, Maria Grazia; Battaglia, Manuela; Flavell, Richard A.			Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3(-) and Foxp3(+) Regulatory CD4(+) T Cells in an Interleukin-10-Dependent Manner	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; CRUCIAL ROLE; TGF-BETA; MICE; IL-10; RESPONSES; COLITIS; T(H)17; DIFFERENTIATION	T helper 17 (Th17) cells are important for host defense against extracellular microorganisms. However, they are also implicated in autoimmune and chronic inflammatory diseases, and as such need to be tightly regulated. The mechanisms that directly control committed pathogenic Th17 cells in vivo remain unclear. We showed here that IL-17A-producing CD4(+) T cells expressed interleukin-10 receptor alpha (IL-10R alpha) in vivo. Importantly, T cell-specific blockade of IL-10 signaling led to a selective increase of IL-17A(+)IFN-gamma(-) (Th17) and IL-17A(+)IFN-gamma(+) (Th17+Th1) CD4(+) T cells during intestinal inflammation in the small intestine. CD4(+)Foxp3(-) IL-10-producing (Tr1) cells and CD4(+)Foxp3(+) regulatory (Treg) cells were able to control Th17 and Th17+Th1 cells in an IL-10-dependent manner in vivo. Lastly, IL-10 treatment of mice with established colitis decreased Th17 and Th17+Th1 cell frequencies via direct signaling in T cells. Thus, IL-10 signaling directly suppresses Th17 and Th17+Th1 cells.	[Huber, Samuel; Esplugues, Enric; O'Connor, William, Jr.; Huber, Francis J.; Kamanaka, Masahito; Kobayashi, Yasushi; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20246 Hamburg, Germany; [Gagliani, Nicola; Battaglia, Manuela] San Raffaele Diabet Res Inst HSR DRI, I-20132 Milan, Italy; [Gagliani, Nicola; Roncarolo, Maria Grazia] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Esplugues, Enric] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Esplugues, Enric] Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany; [Chaudhry, Ashutosh; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Roncarolo, Maria Grazia] Dept Regenerat Med Stem Cells & Gene Therapy HSR, I-20132 Milan, Italy; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vita-Salute San Raffaele University; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Esplugues, Enric/AAD-4245-2020	Gagliani, Nicola/0000-0001-8514-1395; Esplugues, Enric/0000-0002-8130-0413; Battaglia, Manuela/0000-0003-4535-3152; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Esplugues, Enric/0000-0002-9733-8707; Huber, Samuel/0000-0001-9325-8227; Chaudhry, Ashutosh/0000-0003-3379-5236	DFG [HU 1714/1-1]; James Hudson Brown-Alexander B. Coxe Fellowship;  [P30 DK45735]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); James Hudson Brown-Alexander B. Coxe Fellowship; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank F. Manzo for expert assistance with manuscript preparation and E. Eynon and J. Alderman for managing the mouse program. We also thank T. Taylor for expert help with the FACS sorting and A. Paoletti for the, graphical abstract design. This work was supported in part by P30 DK45735 (R.A.F.). R.A.F. is an Investigator of the Howard Hughes Medical Institute. S.H. was supported by the DFG (HU 1714/1-1) and by a James Hudson Brown-Alexander B. Coxe Fellowship.	Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Darrah PA, 2010, J EXP MED, V207, P1421, DOI 10.1084/jem.20092532; DING L, 1992, J IMMUNOL, V148, P3133; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gagliani N, 2010, DIABETES, V59, P433, DOI 10.2337/db09-1168; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Naundorf S, 2009, EUR J IMMUNOL, V39, P1066, DOI 10.1002/eji.200838773; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou PF, 2004, AM J PHYSIOL-GASTR L, V287, pG599, DOI 10.1152/ajpgi.00063.2004	42	439	453	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					554	565		10.1016/j.immuni.2011.01.020	http://dx.doi.org/10.1016/j.immuni.2011.01.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511184	Bronze, Green Accepted			2022-12-18	WOS:000290367300014
J	Caldwell, RG; Wilson, JB; Anderson, SJ; Longnecker, R				Caldwell, RG; Wilson, JB; Anderson, SJ; Longnecker, R			Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals	IMMUNITY			English	Article							LATENT MEMBRANE PROTEIN-2A; HEALTHY SEROPOSITIVE INDIVIDUALS; GROWTH TRANSFORMATION INVITRO; REED-STERNBERG CELLS; SURFACE-IMMUNOGLOBULIN; TYROSINE KINASE; IN-VIVO; SPONTANEOUS OUTGROWTH; LYMPHOCYTE INFECTION; RAG-1-DEFICIENT MICE	Epstein-Barr virus (EBV) establishes a persistent latent infection in peripheral B lymphocytes in humans and is associated with a variety of malignancies and proliferative disorders. Latent membrane protein 2A (LMP2A) is one of only two viral proteins expressed in latently infected B lymphocytes in vivo. LMP2A blocks B cell receptor (BCR) signal transduction in vitro by binding the Syk and Lyn protein tyrosine kinases. To analyze the significance of LMP2A expression in vivo, transgenic mice with B cell lineage expression of LMP2A were generated. LMP2A expression results in the bypass of normal B lymphocyte developmental checkpoints allowing immunoglobulin-negative cells to colonize peripheral lymphoid organs, indicating that LMP2A possesses a constitutive signaling activity in nontransformed cells.	Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Mol Genet, Glasgow G11 6NU, Lanark, Scotland	Northwestern University; University of Glasgow	Longnecker, R (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	r-longnecker@nwu.edu	Wilson, Joanna B/B-4466-2009		NCI NIH HHS [CA62234, 5T32CA09560] Funding Source: Medline; NIGMS NIH HHS [GM55626] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009560, R01CA062234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055626] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Braeuninger A, 1997, P NATL ACAD SCI USA, V94, P9337, DOI 10.1073/pnas.94.17.9337; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; DUSH MK, 1985, P NATL ACAD SCI USA, V82, P2731, DOI 10.1073/pnas.82.9.2731; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; Fruehling S, 1996, J VIROL, V70, P6216, DOI 10.1128/JVI.70.9.6216-6226.1996; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; GRATAMA JW, 1988, P NATL ACAD SCI USA, V85, P8693, DOI 10.1073/pnas.85.22.8693; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; Hogan BLM, 1994, MANIPULATING MOUSE E; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0; Kieff Elliott, 1996, P1109; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LEWIN N, 1987, INT J CANCER, V39, P472, DOI 10.1002/ijc.2910390411; LONGNECKER R, 1991, J VIROL, V65, P3681, DOI 10.1128/JVI.65.7.3681-3692.1991; LONGNECKER R, 1990, J VIROL, V64, P2319, DOI 10.1128/JVI.64.5.2319-2326.1990; LONGNECKER R, 1992, J VIROL, V66, P6461, DOI 10.1128/JVI.66.11.6461-6469.1992; LONGNECKER R, 1993, J VIROL, V67, P2006, DOI 10.1128/JVI.67.4.2006-2013.1993; Longnecker R, 1996, TRENDS MICROBIOL, V4, P38; LONGNECKER R, 1993, J VIROL, V67, P5068, DOI 10.1128/JVI.67.8.5068-5074.1993; MARCHINI A, 1993, J VIROL, V67, P606, DOI 10.1128/JVI.67.1.606-609.1993; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKAHAMA Y, 1995, J IMMUNOL, V154, P5862; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; YAO QY, 1989, INT J CANCER, V43, P67, DOI 10.1002/ijc.2910430115; YAO QY, 1991, INT J CANCER, V48, P253, DOI 10.1002/ijc.2910480217; YAO QY, 1985, INT J CANCER, V35, P35, DOI 10.1002/ijc.2910350107	45	439	451	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					405	411		10.1016/S1074-7613(00)80623-8	http://dx.doi.org/10.1016/S1074-7613(00)80623-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768760	Bronze			2022-12-18	WOS:000076202300013
J	Wange, RL; Samelson, LE				Wange, RL; Samelson, LE			Complex complexes: Signaling at the TCR	IMMUNITY			English	Review							CELL ANTIGEN-RECEPTOR; PROTEIN-TYROSINE KINASE; SEVERE COMBINED IMMUNODEFICIENCY; C-CBL PROTOONCOGENE; TANDEM SH2 DOMAINS; JURKAT T-CELLS; ZETA-CHAIN; PHOSPHATIDYLINOSITOL 3'-KINASE; ACTIVATION MOTIFS; ADAPTER PROTEIN				Wange, RL (corresponding author), NICHHD,CELL BIOL & METAB BRANCH,NIH,BETHESDA,MD 20892, USA.		Wange, Ronald/AAI-2505-2021	Wange, Ronald/0000-0001-9593-3572				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BOLEN JB, 1993, ONCOGENE, V8, P2025; BUDAY L, 1994, J BIOL CHEM, V269, P9019; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CAMBIER JC, 1995, IMMUNOL LETT, V44, P77, DOI 10.1016/0165-2478(94)00196-X; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CAPLAN S, 1995, P NATL ACAD SCI USA, V92, P4768, DOI 10.1073/pnas.92.11.4768; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; DESIDERIO S, 1994, CHEM IMMUNOL, V59, P191; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; EXLEY M, 1994, J BIOL CHEM, V269, P15140; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; Fusaki N, 1996, J IMMUNOL, V156, P1369; Gibson S, 1996, J IMMUNOL, V156, P2716; GUANGHUI K, 1996, IN PRESS MOL CELL BI; HARRISON ML, 1994, J BIOL CHEM, V269, P955; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Huby RDJ, 1995, J BIOL CHEM, V270, P30241, DOI 10.1074/jbc.270.51.30241; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; KATZAV S, 1994, J BIOL CHEM, V269, P32579; KonKozlowski M, 1996, J BIOL CHEM, V271, P3856; LEY SC, 1994, EUR J IMMUNOL, V24, P99, DOI 10.1002/eji.1830240116; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MCFARLAND EC, 1994, CHEM IMMUNOL, V59, P40; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; MOTTO DG, 1994, J BIOL CHEM, V269, P21608; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PERI KG, 1994, CHEM IMMUNOL, V59, P19; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; Peters JD, 1996, J BIOL CHEM, V271, P4755; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; REIF K, 1994, J BIOL CHEM, V269, P14081; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VOGEL LB, 1993, MOL CELL BIOL, V13, P7408, DOI 10.1128/MCB.13.12.7408; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WANGE RL, 1995, J BIOL CHEM, V270, P944, DOI 10.1074/jbc.270.2.944; WARDENBURG JB, 1996, IN PRESS J BIOL CHEM; WATTS JD, 1994, J BIOL CHEM, V269, P29520; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN AM, 1994, CHEM IMMUNOL, V59, P1; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9	80	439	446	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1996	5	3					197	205		10.1016/S1074-7613(00)80315-5	http://dx.doi.org/10.1016/S1074-7613(00)80315-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808675	Bronze			2022-12-18	WOS:A1996VJ79700002
J	Pilli, M; Arko-Mensah, J; Ponpuak, M; Roberts, E; Master, S; Mandell, MA; Dupont, N; Ornatowski, W; Jiang, SY; Bradfute, SB; Bruun, JA; Hansen, TE; Johansen, T; Deretic, V				Pilli, Manohar; Arko-Mensah, John; Ponpuak, Marisa; Roberts, Esteban; Master, Sharon; Mandell, Michael A.; Dupont, Nicolas; Ornatowski, Wojciech; Jiang, Shanya; Bradfute, Steven B.; Bruun, Jack-Ansgar; Hansen, Tom Egil; Johansen, Terje; Deretic, Vojo			TBK-1 Promotes Autophagy-Mediated Antimicrobial Defense by Controlling Autophagosome Maturation	IMMUNITY			English	Article							MUTANT HUNTINGTIN; KAPPA-B; PROTEINS; INNATE; CELL; IMMUNITY; ADAPTER; BINDING; PHOSPHORYLATION; RESTRICTS	Autophagy is a fundamental biological process of the eukaryotic cell contributing to diverse cellular and physiological functions including cell-autonomous defense against intracellular pathogens. Here, we screened the Rab family of membrane trafficking regulators for effects on autophagic elimination of Mycobacterium tuberculosis var. bovis BCG and found that Rab8b and its downstream interacting partner, innate immunity regulator TBK-1, are required for autophagic elimination of mycobacteria in macrophages. TBK-1 was necessary for autophagic maturation. TBK-1 coordinated assembly and function of the autophagic machinery and phosphorylated the autophagic adaptor p62 (sequestosome 1) on Ser-403, a residue essential for its role in autophagic clearance. A key proinflammatory cytokine, IL-1 beta 13, induced autophagy leading to autophagic killing of mycobacteria in macrophages, and this IL-1 beta activity was dependent on TBK-1. Thus, TBK-1 is a key regulator of immunological autophagy and is responsible for the maturation of autophagosomes into lytic bactericidal organelles.	[Pilli, Manohar; Arko-Mensah, John; Ponpuak, Marisa; Roberts, Esteban; Master, Sharon; Mandell, Michael A.; Dupont, Nicolas; Ornatowski, Wojciech; Jiang, Shanya; Bradfute, Steven B.; Deretic, Vojo] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Ponpuak, Marisa] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Bruun, Jack-Ansgar; Hansen, Tom Egil; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway	University of New Mexico; University of New Mexico's Health Sciences Center; Mahidol University; UiT The Arctic University of Tromso	Deretic, V (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, 915 Camino Salud NE, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu	Pilli, Manohar/G-6568-2015; Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021; Dupont, Nicolas/AAJ-7192-2021; Mandell, Michael/AAP-3462-2021	Pilli, Manohar/0000-0002-3084-8788; Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Dupont, Nicolas/0000-0002-3056-9906; Mandell, Michael/0000-0002-5773-2806; Bruun, Jack-Ansgar/0000-0003-0614-2790; Ponpuak, Marisa/0000-0002-2889-1314; Deretic, Vojo/0000-0002-3624-5208	UNM Cancer Center; National Institutes of Health [R01 AI069345, RC1AI086845, R01 AI042999]; Bill and Melinda Gates Grand Challenge Explorations grant; Norwegian Research Council; Norwegian Cancer Society;  [T32A007538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538, RC1AI086845, R01AI042999, R01AI069345] Funding Source: NIH RePORTER	UNM Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Grand Challenge Explorations grant; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Vergne, R. Elmaoued, J. Naylor, and M. Mudd for assistance. We are grateful to N. Nukina for anti-phospho-S403 antibody, to H. Virgin for Atg7<SUP>fl/fl</SUP> LysM-Cre<SUP>+</SUP> mice, and to D. Robinsztein for mRFP-GFP-LC3 HeLa cells. M.A.M. was supported by training grant T32A007538. S.B.B. was supported in part by a fellowship from UNM Cancer Center. This work was supported by grants R01 AI069345, RC1AI086845, and R01 AI042999 from National Institutes of Health, a Bill and Melinda Gates Grand Challenge Explorations grant to V.D., and grants from the Norwegian Research Council and the Norwegian Cancer Society to T.J.	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Criollo A, 2011, EMBO J, V30, P4908, DOI 10.1038/emboj.2011.413; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hirota Y., 2009, CELL MOL LIFE SCI; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lam KKY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002691; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Roberts Esteban A., 2008, V445, P111, DOI 10.1007/978-1-59745-157-4_6; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	49	438	446	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					223	234		10.1016/j.immuni.2012.04.015	http://dx.doi.org/10.1016/j.immuni.2012.04.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921120	Green Accepted, Bronze			2022-12-18	WOS:000308261800008
J	Luber, CA; Cox, J; Lauterbach, H; Fancke, B; Selbach, M; Tschopp, J; Akira, S; Wiegand, M; Hochrein, H; O'Keeffe, M; Mann, M				Luber, Christian A.; Cox, Juergen; Lauterbach, Henning; Fancke, Ben; Selbach, Matthias; Tschopp, Jurg; Akira, Shizuo; Wiegand, Marian; Hochrein, Hubertus; O'Keeffe, Meredith; Mann, Matthias			Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; SPECTROMETRY-BASED PROTEOMICS; IFN-ALPHA PRODUCTION; INDUCIBLE GENE-I; RIG-I; MASS-SPECTROMETRY; CROSS-PRESENTATION; CUTTING EDGE; ANTIVIRAL IMMUNITY	Dendritic cell (DC) populations consist of multiple subsets that are essential orchestrators of the immune system. Technological limitations have so far prevented systems-wide accurate proteome comparison of rare cell populations in vivo. Here, we used high-resolution mass spectrometry-based proteomics, combined with label-free quantitation algorithms, to determine the proteome of mouse splenic conventional and plasmacytoid DC subsets to a depth of 5,780 and 6,664 proteins, respectively. We found mutually exclusive expression of pattern recognition pathways not previously known to be different among conventional DC subsets. Our experiments assigned key viral recognition functions to be exclusively expressed in CD4(+) and double-negative DCs. The CD8 alpha(+) DCs largely lack the receptors required to sense certain viruses in the cytoplasm. By avoiding activation via cytoplasmic receptors, including retinoic acid-inducible gene I, CD8 alpha(+) DCs likely gain a window of opportunity to process and present viral antigens before activation-induced shutdown of antigen presentation pathways occurs.	[Wiegand, Marian] Max Planck Inst Biochem, Dept Mol Virol, D-82152 Martinsried, Germany; [Lauterbach, Henning; Fancke, Ben; Hochrein, Hubertus; O'Keeffe, Meredith] Bavarian Nord GmbH, Res Immunol, D-82152 Martinsried, Germany; [Selbach, Matthias] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Akira, Shizuo] ERATO, Osaka 5650871, Japan	Max Planck Society; Bavarian Nordic; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Lausanne; Osaka University; Japan Science & Technology Agency (JST)	O'Keeffe, M (corresponding author), Burnet Inst, Ctr Immunol, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	meredith@burnet.edu.au; mmann@biochem.mpg.de	Akira, Shizuo/C-3134-2009; Mann, Matthias/A-3454-2013; O'Keeffe, Meredith/U-9347-2017; Selbach, Matthias/C-5988-2008; Cox, Jurgen/B-9481-2008; Hochrein, Hubertus/L-3697-2013	Mann, Matthias/0000-0003-1292-4799; O'Keeffe, Meredith/0000-0002-0779-4654; Cox, Jurgen/0000-0001-8597-205X; Lauterbach, Henning/0000-0002-6062-5163; Hochrein, Hubertus/0000-0001-9904-1934	Max-Planck Society; European Union	Max-Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	We thank K. Shortman (WEHI, Melbourne, Australia) and M. Suter (University of Zurich) for providing critical reagents; J. Hamann (University of Amsterdam) for CD97 antibody; A. Egorov (AVIR Green Hills Biotechnology) for deINS1 influenza virus; B. Bathke, M. Dodel, and J. Paetzold for excellent technic I assistance; the animal services facilities at the Max Planck Institute of Biochemistry and Bavarian Nordic for animal husbandry; C. Kumar for gene ontology (GO) support; and M. Schmidt-Supprian, M. Sixt, and M. Vermeulen for critical reading of the manuscript. The Max-Planck Society and the DC Thera 6th framework project of the European Union provided funding. C.A.L. performed most experiments. C.A.L, M.O., H.H, M.S., and M.M. conceived and designed the study and analyzed data. H.L., B.F., M.O., and H.H. performed some experiments. J.C. provided early access to label-free software. J.T. and S.A. provided mice. M.W provided Sendai-GFP virus. C.A.L., M.O., H.H., and M.M. wrote the paper. B.F., H.L., H.H., and M.O. were employees of Bavarian Nordic GrnbH. M.O. and M.M. share senior authorship.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bonaldi T, 2008, MOL CELL, V31, P762, DOI 10.1016/j.molcel.2008.07.018; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fuchsberger M, 2005, IMMUNOL CELL BIOL, V83, P571, DOI 10.1111/j.1440-1711.2005.01392.x; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Imaizumi T, 2006, MICROBIOL IMMUNOL, V50, P811, DOI 10.1111/j.1348-0421.2006.tb03857.x; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2007, CELL, V129, P1024, DOI 10.1016/j.cell.2007.05.017; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kenworthy R, 2009, NUCLEIC ACIDS RES, V37, P6587, DOI 10.1093/nar/gkp714; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; O'Keeffe M, 2005, BLOOD, V106, P3457, DOI 10.1182/blood-2004-12-4965; O'Keeffe M, 2002, BLOOD, V99, P2122, DOI 10.1182/blood.V99.6.2122; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Panchaud A, 2008, J PROTEOMICS, V71, P19, DOI 10.1016/j.jprot.2007.12.001; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saitoh SI, 2009, IMMUNOL REV, V227, P32, DOI 10.1111/j.1600-065X.2008.00729.x; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun QH, 2009, P NATL ACAD SCI USA, V106, P17927, DOI 10.1073/pnas.0907552106; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	75	438	451	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					279	289		10.1016/j.immuni.2010.01.013	http://dx.doi.org/10.1016/j.immuni.2010.01.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20171123	Bronze			2022-12-18	WOS:000275346000016
J	A-Gonzalez, N; Bensinger, SJ; Hong, C; Beceiro, S; Bradley, MN; Zelcer, N; Deniz, J; Ramirez, C; Diaz, M; Gallardo, G; de Galarreta, CR; Salazar, J; Lopez, F; Edwards, P; Parks, J; Andujar, M; Tontonoz, P; Castrillo, A				A-Gonzalez, Noelia; Bensinger, Steven J.; Hong, Cynthia; Beceiro, Susana; Bradley, Michelle N.; Zelcer, Noam; Deniz, Jose; Ramirez, Cristina; Diaz, Mercedes; Gallardo, German; Ruiz de Galarreta, Carlos; Salazar, Jon; Lopez, Felix; Edwards, Peter; Parks, John; Andujar, Miguel; Tontonoz, Peter; Castrillo, Antonio			Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR	IMMUNITY			English	Article							MICE LACKING; SIGNALING PATHWAYS; CHOLESTEROL EFFLUX; LIPID-METABOLISM; TYROSINE KINASE; IN-VITRO; PHAGOCYTOSIS; MACROPHAGES; GENE; IDENTIFICATION	Effective clearance of apoptotic cells by macrophages is essential for immune homeostasis. The transcriptional pathways that allow macrophages to sense and respond to apoptotic cells are poorly defined. We found that liver X receptor (LXR) signaling was important for both apoptotic cell clearance and the maintenance of immune tolerance. Apoptotic cell engulfment activated LXR and thereby induced the expression of Mer, a receptor tyrosine kinase critical for phagocytosis. LXR-deficient macrophages exhibited a selective defect in phagocytosis of apoptotic cells and an aberrant proinflammatory response to them. As a consequence of these defects, mice lacking LXRs manifested a breakdown in self-tolerance and developed autoantibodies and autoimmune glomerulonephritis. Treatment with an LXR agonist ameliorated disease progression in a mouse model of lupus-like autoimmunity. Thus, activation of LXR by apoptotic cells engages a virtuous cycle that promotes their own clearance and couples engulfment to the suppression of inflammatory pathways.	[Bensinger, Steven J.; Hong, Cynthia; Bradley, Michelle N.; Zelcer, Noam; Salazar, Jon; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [A-Gonzalez, Noelia; Beceiro, Susana; Deniz, Jose; Ramirez, Cristina; Diaz, Mercedes; Gallardo, German; Ruiz de Galarreta, Carlos; Lopez, Felix; Castrillo, Antonio] Univ Las Palmas, Immune Signaling Lab, Dept Biochem & Mol Biol, Sch Med,ULPGC, Las Palmas Gran Canaria 35016, Spain; [Bensinger, Steven J.; Hong, Cynthia; Bradley, Michelle N.; Zelcer, Noam; Salazar, Jon; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Edwards, Peter] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Parks, John] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; [Andujar, Miguel] Hosp Univ Materno Infantil, Dept Pathol, Las Palmas Gran Canaria 35016, Spain; [Castrillo, Antonio] CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Universidad de Las Palmas de Gran Canaria; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Wake Forest University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu; acastrillo@iib.uam.es	campos, german gallardo/Z-5267-2019; Gonzalez, Noelia Alonso/ABC-7381-2021; Ramírez, Cristina/ABI-1568-2020; Gonzalez, Noelia Alonso/H-4488-2015; Andújar, Miguel/AAB-7690-2020; Ramírez, Cristina/A-6975-2016; Zelcer, Noam/C-6393-2009	campos, german gallardo/0000-0002-1516-1750; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Ramírez, Cristina/0000-0003-2589-0786; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Ramírez, Cristina/0000-0003-2589-0786; Lopez Blanco, Felix/0000-0003-1167-9787; Zelcer, Noam/0000-0001-6935-7532; ANDUJAR, MIGUEL/0000-0002-4858-6915	Spanish CSIC; MICINN; Ramon y Cajal Program; La Caixa [BM05-228]; NIH [HL066088, HL030568, HL049373]; NATIONAL CANCER INSTITUTE [P30CA016042, R24CA092865, U24CA092865] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL049373, R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001943] Funding Source: NIH RePORTER	Spanish CSIC; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Ramon y Cajal Program(Spanish Government); La Caixa(La Caixa Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank D. Mangelsdorf for the LXR-deficient mice; J. Collins and T. Willson for GW3965; and D.K. Graham, P.M. Henson, S. Gordon, G. Cheng, M.L. Fitzgerald, J.M. Salvador, L. Fernandez-Perez, A. Corbi, A. Tugores, F. DiazGonzalez, L. Bosca, D. Barber, and M.L. Toribio for key reagents and comments. We thank C. Radu and R. Laing for their assistance with the PET imaging studies and Servicio Microscopia Electronica ULPGC for TEM studies. This work was supported by grants from the Spanish CSIC, MICINN of I+D SAF2005-03270 and 2008-00057, Ramon y Cajal Program, BM05-228 from "La Caixa," 67/05 form FUNCIS and Ramon Areces Foundations to A.C. and from the NIH to P.T. (HL066088), P.E. (HL030568), and J.P. (HL049373). Flow cytometry was performed at the UCLA Core Facility supported by CA16042 and AI28697. Imaging was performed at the In Vivo Cellular and Molecular Imaging Center supported by EB001943 and CA92865. P.T. is an Investigator of the Howard Hughes Medical Institute at the University of California, Los Angeles.	Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, J IMMUNOL, V161, P6250; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kalden JR, 1997, LUPUS, V6, P326, DOI 10.1177/096120339700600326; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Qian Y, 2006, BLOOD, V108, P974, DOI 10.1182/blood-2005-12-006858; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; SMITH JP, 1991, ANAT REC, V229, P511, DOI 10.1002/ar.1092290412; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Vaux DL, 2000, CURR OPIN IMMUNOL, V12, P719, DOI 10.1016/S0952-7915(00)00168-0; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	64	438	446	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					245	258		10.1016/j.immuni.2009.06.018	http://dx.doi.org/10.1016/j.immuni.2009.06.018			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19646905	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000269338600011
J	Haghikia, A; Jorg, S; Duscha, A; Berg, J; Manzel, A; Waschbisch, A; Hammer, A; Lee, DH; May, C; Wilck, N; Balogh, A; Ostermann, AI; Schebb, NH; Akkad, DA; Grohme, DA; Kleinewietfeld, M; Kempa, S; Thone, J; Demir, S; Muller, DN; Gold, R; Linker, RA				Haghikia, Aiden; Joerg, Stefanie; Duscha, Alexander; Berg, Johannes; Manzel, Arndt; Waschbisch, Anne; Hammer, Anna; Lee, De-Hyung; May, Caroline; Wilck, Nicola; Balogh, Andras; Ostermann, Annika I.; Schebb, Nils Helge; Akkad, Denis A.; Grohme, Diana A.; Kleinewietfeld, Markus; Kempa, Stefan; Thoene, Jan; Demir, Seray; Mueller, Dominik N.; Gold, Ralf; Linker, Ralf A.			Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine	IMMUNITY			English	Article							REGULATORY T-CELLS; PATHOGENIC T(H)17 CELLS; MULTIPLE-SCLEROSIS; GUT MICROBIOTA; P38; DIFFERENTIATION; INDUCTION; ENCEPHALOMYELITIS; MACROPHAGES; METABOLITES	Growing empirical evidence suggests that nutrition and bacterial metabolites might impact the systemic immune response in the context of disease and autoimmunity. We report that long-chain fatty acids (LCFAs) enhanced differentiation and proliferation of T helper 1 (Th1) and/or Th17 cells and impaired their intestinal sequestration via p38-MAPK pathway. Alternatively, dietary short-chain FAs (SCFAs) expanded gut T regulatory (Treg) cells by suppression of the JNK1 and p38 pathway. We used experimental autoimmune encephalomyelitis (EAE) as a model of T cell-mediated autoimmunity to show that LCFAs consistently decreased SCFAs in the gut and exacerbated disease by expanding pathogenic Th1 and/or Th17 cell populations in the small intestine. Treatment with SCFAs ameliorated EAE and reduced axonal damage via long-lasting imprinting on lamina-propria-derived Treg cells. These data demonstrate a direct dietary impact on intestinal-specific, and subsequently central nervous system-specific, Th cell responses in autoimmunity, and thus might have therapeutic implications for autoimmune diseases such as multiple sclerosis.	[Haghikia, Aiden; Duscha, Alexander; Berg, Johannes; Thoene, Jan; Demir, Seray; Gold, Ralf] Ruhr Univ Bochum, Dept Neurol, D-44801 Bochum, Germany; [Joerg, Stefanie; Manzel, Arndt; Waschbisch, Anne; Hammer, Anna; Lee, De-Hyung; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [May, Caroline] Ruhr Univ Bochum, Med Proteom Ctr, D-44801 Bochum, Germany; [Wilck, Nicola; Balogh, Andras; Mueller, Dominik N.] Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Wilck, Nicola; Balogh, Andras; Mueller, Dominik N.] Max Delbruck Ctr Berlin, D-13125 Berlin, Germany; [Ostermann, Annika I.; Schebb, Nils Helge] Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, D-30559 Hannover, Germany; [Schebb, Nils Helge] Univ Wuppertal, Dept Food Chem, D-42097 Wuppertal, Germany; [Akkad, Denis A.] Ruhr Univ Bochum, Dept Human Genet, D-44801 Bochum, Germany; [Grohme, Diana A.; Kleinewietfeld, Markus] Tech Univ Dresden, Med Fac Carl Gustav Carus, Translat Immunol, D-01307 Dresden, Germany; [Kempa, Stefan] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Integrat Metabol & Prote, D-13125 Berlin, Germany	Ruhr University Bochum; University of Erlangen Nuremberg; Ruhr University Bochum; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Veterinary Medicine Hannover, Foundation; University of Wuppertal; Ruhr University Bochum; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Haghikia, A (corresponding author), Ruhr Univ Bochum, Dept Neurol, D-44801 Bochum, Germany.	aiden.haghikia@rub.de; ralf.linker@uk-erlangen.de	kempa, stefan/C-5213-2008; Kleinewietfeld, Markus/AAI-4497-2021; Linker, Ralf/AAD-8884-2020	kempa, stefan/0000-0002-0696-9299; Schebb, Nils Helge/0000-0003-1299-6629; Haase, Stefanie/0000-0002-9371-4314; Hammer, Anna/0000-0002-0422-8569; Wilck, Nicola/0000-0003-3189-5364; Muller, Dominik N/0000-0003-3650-5644; /0000-0001-8756-747X; Kleinewietfeld, Markus/0000-0002-2832-3149	FACS Core Unit, Nikolaus-Fiebiger-Center, Friedrich-Alexander-University Erlangen, Germany; Novartis Foundation; Deutsche Forschungsgesellschaft (DFG) [CRC128/Z2]	FACS Core Unit, Nikolaus-Fiebiger-Center, Friedrich-Alexander-University Erlangen, Germany; Novartis Foundation(Novartis); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	We wish to thank S. Seubert, K. Bitterer, and X. Pedreiturria for expert technical assistance. The authors also thank Megan Massa (B.A. Neuroscience) for editing the language of the manuscript. Cell sorting was supported by the FACS Core Unit, Nikolaus-Fiebiger-Center, Friedrich-Alexander-University Erlangen, Germany. R.A.L. holds an endowed professorship supported by the Novartis Foundation. This study was supported by the Deutsche Forschungsgesellschaft (DFG) grant CRC128/Z2 (to R.G.).	Alam MS, 2014, J EXP MED, V211, P1257, DOI 10.1084/jem.20131917; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bhargava P, 2012, BIOCHEM J, V442, P253, DOI 10.1042/BJ20111708; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Flavell RA, 1999, COLD SPRING HARB SYM, V64, P563, DOI 10.1101/sqb.1999.64.563; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Haghikia A, 2013, TRENDS MOL MED, V19, P309, DOI 10.1016/j.molmed.2013.03.004; Hedstrom AK, 2014, NEUROLOGY, V82, P865, DOI 10.1212/WNL.0000000000000203; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kleinewietfeld M, 2014, IMMUNOL REV, V259, P231, DOI 10.1111/imr.12169; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Krementsov DN, 2014, ANN NEUROL, V75, P50, DOI 10.1002/ana.24020; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Ostermann AI, 2014, PROSTAG LEUKOTR ESS, V91, P235, DOI 10.1016/j.plefa.2014.10.002; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tanaka S, 2014, J EXP MED, V211, P1857, DOI 10.1084/jem.20130791; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Valdearcos M, 2012, J BIOL CHEM, V287, P10894, DOI 10.1074/jbc.M112.342915; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984	34	435	444	2	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					817	829		10.1016/j.immuni.2015.09.007	http://dx.doi.org/10.1016/j.immuni.2015.09.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488817	Bronze			2022-12-18	WOS:000363478700022
J	Segura, E; Touzot, M; Bohineust, A; Cappuccio, A; Chiocchia, G; Hosmalin, A; Dalod, M; Soumelis, V; Amigorena, S				Segura, Elodie; Touzot, Maxime; Bohineust, Armelle; Cappuccio, Antonio; Chiocchia, Gilles; Hosmalin, Anne; Dalod, Marc; Soumelis, Vassili; Amigorena, Sebastian			Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation	IMMUNITY			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; GROWTH-FACTOR-BETA; STEADY-STATE; GM-CSF; LANGERHANS CELLS; 6-SULFO LACNAC; T(H)17 CELLS; EXPRESSION; IMMUNITY; SUBSETS	Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses.	[Segura, Elodie; Touzot, Maxime; Bohineust, Armelle; Cappuccio, Antonio; Soumelis, Vassili; Amigorena, Sebastian] INSERM, U932, F-75005 Paris, France; [Segura, Elodie; Bohineust, Armelle; Amigorena, Sebastian] Inst Curie, Sect Rech, F-75005 Paris, France; [Segura, Elodie; Touzot, Maxime; Bohineust, Armelle; Cappuccio, Antonio; Soumelis, Vassili; Amigorena, Sebastian] INSERM Ctr Clin Invest CBT507 IGR Curie, F-75005 Paris, France; [Touzot, Maxime; Cappuccio, Antonio; Soumelis, Vassili] Inst Curie, Clin Immunol Lab, F-75005 Paris, France; [Chiocchia, Gilles; Hosmalin, Anne] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Chiocchia, Gilles; Hosmalin, Anne] CNRS, Unite Mixte Rech 8104, F-75014 Paris, France; [Chiocchia, Gilles] Hop Ambroise Pare, Serv Rhumatol, AP HP, F-92100 Boulogne, France; [Hosmalin, Anne] Hop Cochin, AP HP, F-75014 Paris, France; [Hosmalin, Anne] Univ Paris 05, F-75014 Paris, France; [Dalod, Marc] Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Soumelis, Vassili] INSERM, U631, F-13288 Marseille, France; [Soumelis, Vassili] CNRS, Unite Mixte Rech 6102, F-13288 Marseille, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Amigorena, S (corresponding author), INSERM, U932, 26 Rue Ulm, F-75005 Paris, France.	sebastian.amigorena@curie.fr	Dalod, Marc/AAK-6163-2020; CHIOCCHIA, Gilles R/F-6287-2013; Segura, Elodie/K-7614-2017; Hosmalin, Anne/AAF-8561-2019	Dalod, Marc/0000-0002-6436-7966; CHIOCCHIA, Gilles R/0000-0001-9973-0940; Segura, Elodie/0000-0003-1795-1921; Hosmalin, Anne/0000-0001-9021-3488; Amigorena, Sebastian/0000-0001-8583-8416; Cappuccio, Antonio/0000-0002-8266-2344; touzot, Maxime/0000-0002-0510-2431; Bohineust, Armelle/0000-0002-9734-0049	European Research Council (AdG) [233062 PhagoDC]; Ligue contre le Cancer	European Research Council (AdG)(European Research Council (ERC)); Ligue contre le Cancer(Ligue nationale contre le cancer)	The authors wish to thank the Institut Curie Flow Cytometry facility and Affymetrix facility, M. Milder (Institut Curie), and L. Garderet (AP-HP, Hematologie, Hopital Saint Antoine, Paris, France) for sample collection and C. Hivroz for helpful discussions. E. S. is a fellow of Association pour la Recherche sur le Cancer. M. T. is a fellow of Fondation pour la Recherche Medicale. A. B is a fellow of Ligue contre le Cancer. This work was supported by the European Research Council (2008-AdG no233062 PhagoDC) and Ligue contre le Cancer.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Campbell IK, 2011, J IMMUNOL, V186, P5468, DOI 10.4049/jimmunol.1002923; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Ersland K, 2010, CELL HOST MICROBE, V7, P474, DOI 10.1016/j.chom.2010.05.010; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guilliams M, 2009, J IMMUNOL, V182, P1107, DOI 10.4049/jimmunol.182.2.1107; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wollenberg A, 2002, J INVEST DERMATOL, V118, P327, DOI 10.1046/j.0022-202x.2001.01665.x; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	51	434	448	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					336	348		10.1016/j.immuni.2012.10.018	http://dx.doi.org/10.1016/j.immuni.2012.10.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23352235	Bronze			2022-12-18	WOS:000330940800015
J	North, TE; de Bruijin, MFTR; Stacy, T; Talebian, L; Lind, E; Robin, C; Binder, M; Dzierzak, E; Speck, NA				North, TE; de Bruijin, MFTR; Stacy, T; Talebian, L; Lind, E; Robin, C; Binder, M; Dzierzak, E; Speck, NA			Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo	IMMUNITY			English	Article							FETAL LIVER HEMATOPOIESIS; RECEPTOR TYROSINE KINASE; DEFINITIVE HEMATOPOIESIS; ENDOTHELIAL-CELLS; MONOCLONAL-ANTIBODIES; IN-VIVO; AML1; BETA; GENERATION; PRECURSOR	Hematopoietic stem cells (HSCs) are first found in the aorta-gonad-mesonephros region and vitelline and umbilical arteries of the midgestation mouse embryo. Runx1 (AML1), the DNA binding subunit of a core binding factor, is required for the emergence and/or subsequent function of HSCs. We show that all HSCs in the embryo express Runx1. Furthermore, HSCs in Runx1(+/-) embryos are heterogeneous and include CD45(+) cells, endothelial cells, and mesenchymal cells. Comparison with wild-type embryos showed that the distribution of HSCs among these various cell populations is sensitive to Runx1 dosage. These data provide the first morphological description of embryonic HSCs and contribute new insight into their cellular origin.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Dartmouth College; Erasmus University Rotterdam	Speck, NA (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.	nancy.speck@dartmouth.edu	North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X; Lind, Evan/0000-0001-7026-2012	NATIONAL CANCER INSTITUTE [P30CA023108, R01CA058343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058343, R01CA58343, CA 23108] Funding Source: Medline; NIDDK NIH HHS [R01DK054077] Funding Source: Medline; NIGMS NIH HHS [T32GM08704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Choi K, 1998, DEVELOPMENT, V125, P725; CORMIER F, 1988, DEVELOPMENT, V102, P279; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jaffredo T, 2000, DEV BIOL, V224, P204, DOI 10.1006/dbio.2000.9799; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Liu SCH, 1999, J BIOL CHEM, V274, P18093, DOI 10.1074/jbc.274.25.18093; Marshall CJ, 2001, BRIT J HAEMATOL, V112, P838, DOI 10.1046/j.1365-2141.2001.02537.x; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; North T, 1999, DEVELOPMENT, V126, P2563; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; TURPEN JB, 1982, DEV BIOL, V89, P138, DOI 10.1016/0012-1606(82)90302-5; VANDERLOO JCM, 1995, BLOOD, V85, P952, DOI 10.1182/blood.V85.4.952.bloodjournal854952; VANEWIJK W, 1981, J IMMUNOL, V127, P2594; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x	45	434	448	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2002	16	5					661	672		10.1016/S1074-7613(02)00296-0	http://dx.doi.org/10.1016/S1074-7613(02)00296-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049718	Bronze			2022-12-18	WOS:000175820400005
J	Tzou, P; Ohresser, S; Ferrandon, D; Capovilla, M; Reichhart, JM; Lemaitre, B; Hoffmann, JA; Imler, JL				Tzou, P; Ohresser, S; Ferrandon, D; Capovilla, M; Reichhart, JM; Lemaitre, B; Hoffmann, JA; Imler, JL			Tissue-specific inducible expression of antimicrobial peptide genes in Drosophila surface epithelia	IMMUNITY			English	Article							INSECT IMMUNITY; HOST-DEFENSE; HUMAN BETA-DEFENSIN-1; BETA-DEFENSINS; REL PROTEINS; FAT-BODY; INDUCTION; ACTIVATION; INFECTION; INNATE	The production of antimicrobial peptides is an important aspect of host defense in multicellular organisms. In Drosophila, seven antimicrobial peptides with different spectra of activities are synthesized by the fat body during the immune response and secreted into the hemolymph. Using GFP reporter transgenes, we show here that all seven Drosophila antimicrobial peptides can be induced in surface epithelia in a tissue-specific manner. The imd gene plays a critical role in the activation of this local response to infection. In particular, drosomycin expression, which is regulated by the Toll pathway during the systemic response, is regulated by imd in the respiratory tract, thus demonstrating the existence of distinct regulatory mechanisms for local and systemic induction of antimicrobial peptide genes in Drosophila.	CNRS, UPR 9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Imler, JL (corresponding author), CNRS, UPR 9022, Inst Biol Mol & Cellulaire, 15 Rue Descartes, F-67084 Strasbourg, France.	jl.imler@ibmc.u-strasbg.fr	Imler, Jean-Luc/GXH-4323-2022; Lemaitre, Bruno/T-8146-2019; Capovilla, Maria/O-8483-2016	Lemaitre, Bruno/0000-0001-7970-1667; Capovilla, Maria/0000-0002-1308-7964; FERRANDON, Dominique/0000-0001-7680-7773	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [1PO1 AI44220-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Charlet M, 1996, EUR J BIOCHEM, V241, P699, DOI 10.1111/j.1432-1033.1996.00699.x; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Edgerton M, 1998, J BIOL CHEM, V273, P20438, DOI 10.1074/jbc.273.32.20438; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Engstrom Y, 1999, DEV COMP IMMUNOL, V23, P345, DOI 10.1016/S0145-305X(99)00016-6; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; GEORGEL P, 1993, BIOCHEM BIOPH RES CO, V197, P508, DOI 10.1006/bbrc.1993.2508; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lehane MJ, 1997, P NATL ACAD SCI USA, V94, P11502, DOI 10.1073/pnas.94.21.11502; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; MEISTER M, 1994, EMBO J, V13, P5958, DOI 10.1002/j.1460-2075.1994.tb06941.x; MEISTER M, 2000, CURRENT TOPICS MICRO; MURAKAMI R, 1994, ROUX ARCH DEV BIOL, V203, P243, DOI 10.1007/BF00360519; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Quayle AJ, 1998, AM J PATHOL, V152, P1247; REICHHART JM, 1992, EMBO J, V11, P1469, DOI 10.1002/j.1460-2075.1992.tb05191.x; Roos E, 1998, INSECT MOL BIOL, V7, P51, DOI 10.1046/j.1365-2583.1998.71050.x; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Thomma BPHJ, 1998, PLANT PHYSIOL BIOCH, V36, P533, DOI 10.1016/S0981-9428(98)80179-4; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; van den Berg RH, 1998, BLOOD, V92, P3898, DOI 10.1182/blood.V92.10.3898.422k03_3898_3903; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	56	431	449	4	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					737	748		10.1016/S1074-7613(00)00072-8	http://dx.doi.org/10.1016/S1074-7613(00)00072-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114385	Bronze, Green Published			2022-12-18	WOS:000165598500015
J	Hartlova, A; Erttmann, SF; Raffi, FAM; Schmalz, AM; Resch, U; Anugula, S; Lienenklaus, S; Nilsson, LM; Kroger, A; Nilsson, JA; Ek, T; Weiss, S; Gekara, NO				Hartlova, Anetta; Erttmann, Saskia F.; Raffi, Faizal A. M.; Schmalz, Anja M.; Resch, Ulrike; Anugula, Sharath; Lienenklaus, Stefan; Nilsson, Lisa M.; Kroeger, Andrea; Nilsson, Jonas A.; Ek, Torben; Weiss, Siegfried; Gekara, Nelson O.			DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity	IMMUNITY			English	Article							ATAXIA-TELANGIECTASIA; REPLICATION; RESPONSES; IMMUNODEFICIENCY; EXPRESSION; LISTERIA; SAMHD1; SIGNAL; IFI16; AMP	Dysfunction in Ataxia-telangiectasia mutated (ATM), a central component of the DNA repair machinery, results in Ataxia Telangiectasia (AT), a cancer-prone disease with a variety of inflammatory manifestations. By analyzing AT patient samples and Atm(-/-) mice, we found that unrepaired DNA lesions induce type I interferons (IFNs), resulting in enhanced anti-viral and anti-bacterial responses in Atm(-/-) mice. Priming of the type I interferon system by DNA damage involved release of DNA into the cytoplasm where it activated the cytosolic DNA sensing STING-mediated pathway, which in turn enhanced responses to innate stimuli by activating the expression of Toll-like receptors, RIG-I-like receptors, cytoplasmic DNA sensors, and their downstream signaling partners. This study provides a potential explanation for the inflammatory phenotype of AT patients and establishes damaged DNA as a cell intrinsic danger signal that primes the innate immune system for a rapid and amplified response to microbial and environmental threats.	[Hartlova, Anetta; Erttmann, Saskia F.; Raffi, Faizal A. M.; Schmalz, Anja M.; Resch, Ulrike; Anugula, Sharath; Gekara, Nelson O.] Umea Univ, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Hartlova, Anetta; Erttmann, Saskia F.; Raffi, Faizal A. M.; Schmalz, Anja M.; Resch, Ulrike; Anugula, Sharath; Gekara, Nelson O.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Hartlova, Anetta; Erttmann, Saskia F.; Raffi, Faizal A. M.; Schmalz, Anja M.; Resch, Ulrike; Anugula, Sharath; Gekara, Nelson O.] Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden; [Lienenklaus, Stefan; Kroeger, Andrea; Weiss, Siegfried] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Nilsson, Lisa M.; Nilsson, Jonas A.] Univ Gothenburg, Sahlgrenska Canc Ctr, S-41390 Gothenburg, Sweden; [Ek, Torben] Hosp Halland, Dept Paediat, S-30185 Halmstad, Sweden	Umea University; Umea University; Umea University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Gothenburg	Gekara, NO (corresponding author), Umea Univ, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden.	nelson.gekara@mims.umu.se	Ek, Torben/GWN-2839-2022; Gekara, Nelson/AAG-7944-2020; Gekara, Nelson/P-9208-2019; ANUGULA, SHARATH/N-8362-2015; Anugula, Sharath/AAI-2443-2019	Hartlova, Anetta/0000-0002-8152-4361; Ek, Torben/0000-0002-0518-983X; Gekara, Nelson O./0000-0002-1269-8288; Erttmann, Saskia Friederike/0000-0003-2398-8405; Resch, Ulrike/0000-0002-8380-9555; Nilsson, Jonas/0000-0003-0346-6837; Lienenklaus, Stefan/0000-0003-4790-3445	Laboratory for Molecular Infection Medicine Sweden (MIMS); Umea University; Kempe Foundation; Swedish Research Council [2011-2793]	Laboratory for Molecular Infection Medicine Sweden (MIMS); Umea University; Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We are grateful to Dr. S. Akira, Osaka University, Japan, for Myd88<SUP>-/-</SUP>, Ips- 1<SUP>-/-</SUP> mice, and Dr. DA Leib, Geisel School of Medicine at Dartmouth, USA, for HSV1 KOS KOS/Dlux/OriL strain (HSV1-luc). We thank Johanna Heine for technical assistance. This work was supported by funding from Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea University, Kempe Foundation, and Swedish Research Council grant 2011-2793 to N.O.G.	Abdullah Z, 2012, EMBO J, V31, P4153, DOI 10.1038/emboj.2012.274; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; AMMANN AJ, 1971, J PEDIATR-US, V78, P821, DOI 10.1016/S0022-3476(71)80353-0; Arakura F, 2007, J IMMUNOL, V179, P3249, DOI 10.4049/jimmunol.179.5.3249; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; BODER E, 1958, PEDIATRICS, V21, P526; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Deng XQ, 2005, ANN NEUROL, V58, P577, DOI 10.1002/ana.20600; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Giardino G, 2013, EUR J NEUROL, V20, P740, DOI 10.1111/ene.12024; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hata N, 2001, BIOCHEM BIOPH RES CO, V285, P518, DOI 10.1006/bbrc.2001.5159; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Kulinski JM, 2012, J VIROL, V86, P12826, DOI 10.1128/JVI.00917-12; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kutukculer N, 2000, AUTOIMMUNITY, V32, P145, DOI 10.3109/08916930008994084; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; MASUCCI G, 1984, J CLIN IMMUNOL, V4, P369, DOI 10.1007/BF00917140; McGrath-Morrow SA, 2010, J PEDIATR-US, V156, P682, DOI 10.1016/j.jpeds.2009.12.007; Meyts I, 2003, PEDIATR ALLERGY IMMU, V14, P330, DOI 10.1034/j.1399-3038.2003.00037.x; Nowak-Wegrzyn A, 2004, J PEDIATR-US, V144, P505, DOI 10.1016/j.jpeds.2003.12.046; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Schroeder SA, 2014, PEDIATR PULM, V49, P389, DOI 10.1002/ppul.22817; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Summers BC, 2002, J VIROL, V76, P7020, DOI 10.1128/JVI.76.14.7020-7029.2002; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tungler V, 2013, J MOL MED, V91, P759, DOI 10.1007/s00109-013-0995-3; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Westbrook AM, 2010, CANCER RES, V70, P1875, DOI 10.1158/0008-5472.CAN-09-2584; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	42	430	440	4	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					332	343		10.1016/j.immuni.2015.01.012	http://dx.doi.org/10.1016/j.immuni.2015.01.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692705	Bronze			2022-12-18	WOS:000349916400016
J	Caruso, R; Warner, N; Inohara, N; Nunez, G				Caruso, Roberta; Warner, Neil; Inohara, Naohiro; Nunez, Gabriel			NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease	IMMUNITY			English	Review							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; OLIGOMERIZATION DOMAIN 1; HUMAN DENDRITIC CELLS; IMMUNE RECEPTOR NOD1; ILEAL CROHNS-DISEASE; BACTERIAL PEPTIDOGLYCAN; MURAMYL DIPEPTIDE; NEUTROPHIL RECRUITMENT; DIAMINOPIMELIC ACID	The nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2, the founding members of the intracellular NOD-like receptor family, sense conserved motifs in bacterial peptidoglycan and induce proinflammatory and antimicrobial responses. Here, we discuss recent developments about the mechanisms by which NOD1 and NOD2 are activated by bacterial ligands, the regulation of their signaling pathways, and their role in host defense and inflammatory disease. Several routes for the entry of peptidoglycan ligands to the host cytosol to trigger activation of NOD1 and NOD2 have been elucidated. Furthermore, genetic screens and biochemical analyses have revealed mechanisms that regulate NOD1 and NOD2 signaling. Finally, recent studies have suggested several mechanisms to account for the link between NOD2 variants and susceptibility to Crohn's disease. Further understanding of NOD1 and NOD2 should provide new insight into the pathogenesis of disease and the development of new strategies to treat inflammatory and infectious disorders.	[Caruso, Roberta; Warner, Neil; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Caruso, Roberta; Warner, Neil; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014; Caruso, Roberta/AAA-7661-2020; Warner, Neil/ABE-7329-2020	Warner, Neil/0000-0002-9207-5979	NIH; Crohn's & Colitis Foundation of America; Broad Foundation; EMBO Fellowship Programme; Italian Group for Inflammatory Bowel Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Broad Foundation; EMBO Fellowship Programme; Italian Group for Inflammatory Bowel Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Grace Chen for critically reviewing the manuscript. We acknowledge funding from the NIH, the Crohn's & Colitis Foundation of America, the Broad Foundation, the EMBO Fellowship Programme, and the Italian Group for Inflammatory Bowel Diseases.	Agnihotri G, 2011, J MED CHEM, V54, P1490, DOI 10.1021/jm101535e; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bielig H, 2010, CHEMMEDCHEM, V5, P2065, DOI 10.1002/cmdc.201000320; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Burberry A, 2014, CELL HOST MICROBE, V15, P779, DOI 10.1016/j.chom.2014.05.004; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caso F, 2014, AUTOIMMUN REV, V13, P1220, DOI 10.1016/j.autrev.2014.08.010; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Correa RG, 2012, BIOSCIENCE REP, V32, P597, DOI 10.1042/BSR20120055; Correa RG, 2011, CHEM BIOL, V18, P825, DOI 10.1016/j.chembiol.2011.06.009; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; DASILVA CJ, 2006, P NATL ACAD SCI USA, V103, P1840, DOI DOI 10.1073/PNAS.0509228103; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Gasche C, 2005, GUT, V54, P162, DOI 10.1136/gut.2003.035600; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Heul AMV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104017; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Irving AT, 2014, CELL HOST MICROBE, V15, P623, DOI 10.1016/j.chom.2014.04.001; Jakopin Z, 2014, J MED CHEM, V57, P6897, DOI 10.1021/jm401841p; Jakopin Z, 2013, EUR J MED CHEM, V69, P232, DOI 10.1016/j.ejmech.2013.08.022; Jakopin Z, 2012, J MED CHEM, V55, P6478, DOI 10.1021/jm300503b; Jiao YZ, 2014, TRENDS MICROBIOL, V22, P157, DOI 10.1016/j.tim.2013.12.005; Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jun JC, 2013, J LEUKOCYTE BIOL, V94, P927, DOI 10.1189/jlb.0213109; Khan PM, 2011, ACS MED CHEM LETT, V2, P780, DOI 10.1021/ml200158b; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kim ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015371; Kim YG, 2008, J IMMUNOL, V181, P4340, DOI 10.4049/jimmunol.181.6.4340; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kim YG, 2011, J IMMUNOL, V187, P2849, DOI 10.4049/jimmunol.1001854; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Lipinski S, 2012, P NATL ACAD SCI USA, V109, P21426, DOI 10.1073/pnas.1209673109; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Marinis JM, 2011, J BIOL CHEM, V286, P1938, DOI 10.1074/jbc.M110.189308; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rickard DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069619; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Rubino SJ, 2013, INNATE IMMUN-LONDON, V19, P493, DOI 10.1177/1753425912471691; Salucci V, 2008, INFLAMM BOWEL DIS, V14, P812, DOI 10.1002/ibd.20390; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Shanahan MT, 2014, GUT, V63, P903, DOI 10.1136/gutjnl-2012-304190; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Thay B, 2014, INFECT IMMUN, V82, P4034, DOI 10.1128/IAI.01980-14; Theivanthiran B, 2012, INFECT IMMUN, V80, P2558, DOI 10.1128/IAI.06230-11; Tigno-Aranjuez JT, 2014, J BIOL CHEM, V289, P29651, DOI 10.1074/jbc.M114.591388; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Warner N, 2014, J BIOL CHEM, V289, P28213, DOI 10.1074/jbc.M114.574756; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Yang S, 2013, NAT IMMUNOL, V14, P927, DOI 10.1038/ni.2669; Zeissig Y, 2014, GUT; Zhang R, 2014, CELL PHYSIOL BIOCHEM, V33, P1954, DOI 10.1159/000362972; Zilbauer M, 2007, CELL MICROBIOL, V9, P2404, DOI 10.1111/j.1462-5822.2007.00969.x; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	131	430	445	11	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					898	908		10.1016/j.immuni.2014.12.010	http://dx.doi.org/10.1016/j.immuni.2014.12.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526305	Bronze, Green Accepted			2022-12-18	WOS:000346654100009
J	Finco, TS; Kadlecek, T; Zhang, WG; Samelson, LE; Weiss, A				Finco, TS; Kadlecek, T; Zhang, WG; Samelson, LE; Weiss, A			LAT is required for TCR-mediated activation of PLC gamma 1 and the Ras pathway	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; C-CBL PROTOONCOGENE; SIGNAL-TRANSDUCTION; T-CELLS; TYROSINE PHOSPHORYLATION; ZETA-CHAIN; PHOSPHOLIPASE C-GAMMA-1; GENE-EXPRESSION; PROTEIN; GRB2	In this study, we present the further characterization of a mutant Jurkat T cell line, J.CaM2, that is defective in TCR-mediated signal transduction. Although initial TOP-mediated signaling events such as the inducible tyrosine phosphorylation of the TCR-E, chain and ZAP-70 are intact in J.CaM2, subsequent events, including increases in intracellular calcium, Pas activation, and IL-2 gene expression are defective. Subsequent analysis of J.CaM2 demonstrated a severe deficiency in pp36/LAT expression, a recently cloned adaptor protein implicated in TCR signaling. Importantly, reexpression of LAT in J.CaM2 restored all aspects of TCR signaling. These results demonstrate a necessary and exclusive role for LAT in T cell activation.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; NICHHD, Sect Lymphocyte Signaling, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	aweiss@itsa.ucsf.edu		Kadlecek, Theresa/0000-0002-1020-8169				Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; FRASER JD, 1993, IMMUNOL TODAY, V14, P357, DOI 10.1016/0167-5699(93)90236-E; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; Gibson S, 1996, J IMMUNOL, V156, P2716; GILLILAND LK, 1992, J BIOL CHEM, V267, P13610; GOLDSMITH MA, 1988, P NATL ACAD SCI USA, V85, P8613, DOI 10.1073/pnas.85.22.8613; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; JUNE CH, 1990, J IMMUNOL, V144, P1591; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEH M, 1994, MOL CELL BIOL, V14, P4435, DOI 10.1128/MCB.14.7.4435; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; VANOERS NSC, 1994, J IMMUNOL METHODS, V170, P261, DOI 10.1016/0022-1759(94)90401-4; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, J IMMUNOL, V133, P123; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; ZHANG W, 1998, IMMUNITY, V9, P1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	51	430	437	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					617	626		10.1016/S1074-7613(00)80659-7	http://dx.doi.org/10.1016/S1074-7613(00)80659-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846483	Bronze			2022-12-18	WOS:000077298300004
J	Kanneganti, TD; Lamkanfi, M; Kim, YG; Chen, G; Park, JH; Franchi, L; Vandenabeele, P; Nunez, G				Kanneganti, Thirumala-Devi; Lamkanfi, Mohamed; Kim, Yun-Gi; Chen, Grace; Park, Jong-Hwan; Franchi, Luigi; Vandenabeele, Peter; Nunez, Gabriel			Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling	IMMUNITY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; P2X(7) RECEPTOR; MICE DEFICIENT; CASPASE-1; SECRETION; FLAGELLIN; DISEASE; CELLS; IPAF; ATP	Cryopyrin is essential for caspase-1 activation triggered by Toll-like receptor (TLR) ligands in the presence of adenosine triphosphate (ATP). However, the events linking bacterial products and ATP to cryopyrin remain unclear. Here we demonstrate that cryopyrin-mediated caspase-1 activation proceeds independently of TLR signaling, thus dissociating caspase-1 activation and IL-1 beta secretion. Instead, caspase-1 activation required pannexin-1, a hemichannel protein that interacts with the P2X(7) receptor. Direct cytosolic delivery of multiple bacterial products including lipopolysaccharide, but not flagellin, induced caspase-1 activation via cryopyrin in the absence of pannexin-1 activity or ATP stimulation. However, unlike lpaf-dependent caspase-1 activation, stimulation of the pannexin-1-cryopyrin pathway by several intracellular bacteria was independent of a functional bacterial type III secretion system. These results provide evidence for cytosolic delivery and sensing of bacterial molecules as a unifying model for caspase-1 activation and position pannexin-1 as a mechanistic link between bacterial stimuli and the cryopyrin inflammasome.	Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Internal Med, Ann Arbor, MI 48109 USA; Flanders Interuniv, Inst Biotechnol, Dept Mol Biomed Res, Mol Signalling & Cell Death Unit, B-9052 Zwijnaarde, Belgium; Univ Guelph, B-9052 Zwijnaarde, Belgium	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Vandenabeele, Peter/AAD-5793-2022; Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Vandenabeele, Peter/C-8597-2009; Nuñez, Gabriel/A-7160-2014	Vandenabeele, Peter/0000-0002-6669-8822; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063331, R01AI063331, R37AI063331, R01AI064748] Funding Source: NIH RePORTER; NHLBI NIH HHS [5/T32/HL007517] Funding Source: Medline; NIAID NIH HHS [AI063331, AI064748] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Ru LB, 2005, JOINT BONE SPINE, V72, P295, DOI 10.1016/j.jbspin.2004.12.010; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Simberg D, 2004, CRIT REV THER DRUG, V21, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6; Zhou H, 2004, CELL MOL IMMUNOL, V1, P373	48	429	451	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					433	443		10.1016/j.immuni.2007.03.008	http://dx.doi.org/10.1016/j.immuni.2007.03.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17433728	Bronze			2022-12-18	WOS:000246126400009
J	Busch, DH; Pilip, IM; Vijh, S; Pamer, EG				Busch, DH; Pilip, IM; Vijh, S; Pamer, EG			Coordinate regulation of complex T cell populations responding to bacterial infection	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; CLASS-I MOLECULES; LISTERIA-MONOCYTOGENES; ALPHA-BETA; ANTIGEN; PEPTIDE; EPITOPE; MEMORY; VIVO; IMMUNITY	Bacterial infections activate complex T cell populations that differ in size and antigen specificity. We used tetramerized MHC class I molecules complexed with Listeria monocytogenes-derived epitopes to characterize four distinct CD8(+) T lymphocyte populations during bacterial infection. Surprisingly, T cell populations differing in antigen specificity expand, contract, and enter the T cell memory compartment synchronously. Because the four L. monocytogenes epitopes are presented with different efficiencies and have distinct stabilities in infected cells, our findings suggest that these factors do not determine in vivo T cell dynamics. While T cell activation requires antigen presentation, the timing and extent of T cell expansion appear to be regulated in a coordinated fashion independent of antigen quantity and stability.	Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Yale University; Yale University	Pamer, EG (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA.	eric.pamer@yale.edu			NIAID NIH HHS [AI-39031, AI-33143] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039031, R29AI033143] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Busch DH, 1997, INFECT IMMUN, V65, P5326, DOI 10.1128/IAI.65.12.5326-5329.1997; BUSCH DH, 1998, IN PRESS J IMMUNOL; Cao WX, 1996, J IMMUNOL, V157, P505; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; COLE GA, 1994, INT IMMUNOL, V6, P1767, DOI 10.1093/intimm/6.11.1767; COSE SC, 1995, J VIROL, V69, P5849, DOI 10.1128/JVI.69.9.5849-5852.1995; Deng YP, 1997, J IMMUNOL, V158, P1507; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GESSNER A, 1989, J IMMUNOL, V142, P1293; GOURNIER H, 1995, EUR J IMMUNOL, V25, P2019, DOI 10.1002/eji.1830250733; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KAUFMANN SHE, 1995, IMMUNOL TODAY, V16, P338, DOI 10.1016/0167-5699(95)80151-0; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Lehner PJ, 1996, CURR OPIN IMMUNOL, V8, P59, DOI 10.1016/S0952-7915(96)80106-3; Levitsky V, 1996, J EXP MED, V183, P915, DOI 10.1084/jem.183.3.915; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Moudgil KD, 1997, J IMMUNOL, V159, P2574; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Pamer EG, 1997, IMMUNOL REV, V158, P129, DOI 10.1111/j.1600-065X.1997.tb00999.x; Pape KA, 1997, J IMMUNOL, V159, P591; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P7229; SETTE A, 1994, J IMMUNOL, V153, P5586; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; Sijts AJAM, 1996, J IMMUNOL, V156, P685; Sprent J, 1997, CURR OPIN IMMUNOL, V9, P371, DOI 10.1016/S0952-7915(97)80084-2; Steven NM, 1996, J EXP MED, V184, P1801, DOI 10.1084/jem.184.5.1801; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Vijh S, 1997, J IMMUNOL, V158, P3366; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; VINER NJ, 1995, P NATL ACAD SCI USA, V92, P2214, DOI 10.1073/pnas.92.6.2214; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Vitiello A, 1996, J IMMUNOL, V157, P5555; WALKER PR, 1995, J IMMUNOL, V155, P3443; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; YellenShaw AJ, 1997, J IMMUNOL, V158, P3227; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	54	429	436	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					353	362		10.1016/S1074-7613(00)80540-3	http://dx.doi.org/10.1016/S1074-7613(00)80540-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529152	Bronze			2022-12-18	WOS:000072705300008
J	Miyao, T; Floess, S; Setoguchi, R; Luche, H; Fehling, HJ; Waldmann, H; Huehn, J; Hori, S				Miyao, Takahisa; Floess, Stefan; Setoguchi, Ruka; Luche, Herve; Fehling, Hans Joerg; Waldmann, Herman; Huehn, Jochen; Hori, Shohei			Plasticity of Foxp3(+) T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T Cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO; DNA METHYLATION; GENE-EXPRESSION; TGF-BETA; LINEAGE; MICE; INDUCTION; ANTIGEN	The emerging notion of environment-induced reprogramming of Foxp3(+) regulatory T (Treg) cells into helper T (Th) cells remains controversial. By genetic fate mapping or adoptive transfers, we have identified a minor population of nonregulatory Foxp3(+) T cells exhibiting promiscuous and transient Foxp3 expression, which gave rise to Foxp3(-) ("exFoxp3") Th cells and selectively accumulated in inflammatory cytokine milieus or in lymphopenic environments including those in early ontogeny. In contrast, Treg cells did not undergo reprogramming under those conditions irrespective of their thymic or peripheral origins. Moreover, although a few Treg cells transiently lose Foxp3 expression, such "latent" Treg cells retained their memory and robustly reexpressed Foxp3 and suppressive function upon activation. This study establishes that Treg cells constitute a stable cell lineage, whose committed state in a changing environment is ensured by DNA demethylation of the Foxp3 locus irrespectively of ongoing Foxp3 expression.	[Miyao, Takahisa; Setoguchi, Ruka; Hori, Shohei] RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Yokohama, Kanagawa 2300045, Japan; [Floess, Stefan; Huehn, Jochen] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Luche, Herve; Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany; [Waldmann, Herman] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	RIKEN; Helmholtz Association; Helmholtz-Center for Infection Research; Ulm University; University of Oxford	Hori, S (corresponding author), RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Yokohama, Kanagawa 2300045, Japan.	shohei@rcai.riken.jp	waldmann, herman/F-7412-2011; waldmann, herman/W-8051-2019; LUCHE, Herve/GLT-1401-2022; Hori, Shohei/O-6163-2019	Hori, Shohei/0000-0001-8770-4593; LUCHE, Herve/0000-0003-4309-8338; Waldmann, Herman/0000-0001-7519-6720	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [19059014, 20689012]; Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; German Research Foundation [SFB621, SFB738, KFO250, HU 1300/3-1, FE-578/3-1]; UK Medical Research Council; MRC [G1000215] Funding Source: UKRI; Medical Research Council [G1000215] Funding Source: researchfish	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; German Research Foundation(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the PRESTO program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19059014 and 20689012); the Takeda Science Foundation; and the Kanae Foundation for the Promotion of Medical Science (S.H.); the German Research Foundation (SFB621, SFB738, KFO250, and HU 1300/3-1) (J.H.); the UK Medical Research Council (H.W.); and DFG FE-578/3-1 (H.J.F.).	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Hori S, 2010, CURR OPIN IMMUNOL, V22, P575, DOI 10.1016/j.coi.2010.08.004; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Klein L, 2011, SEMIN IMMUNOL, V23, P401, DOI 10.1016/j.smim.2011.06.003; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	48	428	440	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					262	275		10.1016/j.immuni.2011.12.012	http://dx.doi.org/10.1016/j.immuni.2011.12.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22326580	Bronze			2022-12-18	WOS:000300812400014
J	Kazama, H; Ricci, JE; Herndon, JM; Hoppe, G; Green, DR; Ferguson, TA				Kazama, Hirotaka; Ricci, Jean-Ehrland; Herndon, John M.; Hoppe, George; Green, Douglas R.; Ferguson, Thomas A.			Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein	IMMUNITY			English	Article							CD8(+) T-CELLS; DENDRITIC CELLS; IN-VIVO; PERIPHERAL DELETION; MITOCHONDRIAL-FUNCTION; CALRETICULIN EXPOSURE; CROSS-PRESENTATION; TGF-BETA; DEATH; HMGB1	The mammalian immune system discriminates between modes of cell death; necrosis often results in inflammation and adaptive immunity, whereas apoptosis tends to be anti-inflammatory and promote immune tolerance. We have examined apoptosis for the features responsible for tolerance; specifically, we looked at the roles of caspases and mitochondria. Our results show that caspase activation targeted the mitochondria to produce reactive oxygen species (ROS), which were critical to tolerance induction by apoptotic cells. ROS oxidized the potential danger signal high-mobility group box-1 protein (HMGB1) released from dying cells and thereby neutralized its stimulatory activity. Apoptotic cells failed to induce tolerance and instead stimulated immune responses by scavenging or by mutating a mitochondrial caspase target protein when ROS activity was prohibited. Similarly, blocking sites of oxidation in HMGB1 prevented tolerance induction by apoptotic cells. These results suggest that caspase-orchestrated mitochondrial events determine the impact of apoptotic cells on the immune response.	[Kazama, Hirotaka; Herndon, John M.; Ferguson, Thomas A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Ricci, Jean-Ehrland] Univ Nice, F-06107 Nice 02, France; [Hoppe, George] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Washington University (WUSTL); UDICE-French Research Universities; Universite Cote d'Azur; Cleveland Clinic Foundation; St Jude Children's Research Hospital	Ferguson, TA (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	ferguson@vision.wustl.edu	Green, Douglas R/N-8083-2018; RICCI, Jean Ehrland/AAS-4379-2020; Ricci, Jean Ehrland/I-7117-2016	Green, Douglas R/0000-0002-7332-1417; RICCI, Jean Ehrland/0000-0003-1585-8117; Ricci, Jean Ehrland/0000-0003-1585-8117; Herndon, John/0000-0002-8378-9654	NATIONAL EYE INSTITUTE [R01EY015570, F32EY006765, P30EY002687, R01EY006765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R01AI044828] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY002687-319004, R01 EY015570-04, EY02687, EY015570, EY06765, R01 EY006765-22, F32 EY006765, R01 EY006765, P30 EY002687, R01 EY015570] Funding Source: Medline; NIAID NIH HHS [R01 AI044828-11, R01 AI040646, R01 AI044828, AI44848, R01 AI040646-13] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; BATTISTO JR, 2006, AM J PHYSIOL-CELL PH, V291, pC1318; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; Czura CJ, 2003, CRIT CARE MED, V31, pS46, DOI 10.1097/00003246-200301001-00007; Dintilhac A, 2002, J BIOL CHEM, V277, P7021, DOI 10.1074/jbc.M108417200; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferguson TA, 1997, IMMUNOL REV, V156, P167, DOI 10.1111/j.1600-065X.1997.tb00967.x; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Ferguson TA, 2003, IMMUNOL REV, V193, P111, DOI 10.1034/j.1600-065X.2003.00042.x; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gao YK, 1998, J EXP MED, V188, P887, DOI 10.1084/jem.188.5.887; Griffith TS, 2007, J IMMUNOL, V178, P2679, DOI 10.4049/jimmunol.178.5.2679; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Herndon JM, 2005, J IMMUNOL, V174, P4098, DOI 10.4049/jimmunol.174.7.4098; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pape KA, 1998, J IMMUNOL, V160, P4719; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Ronchetti A, 1999, J IMMUNOL, V163, P130; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tomimori Y, 2000, IMMUNOL LETT, V71, P49, DOI 10.1016/S0165-2478(99)00163-7; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260	58	428	450	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					21	32		10.1016/j.immuni.2008.05.013	http://dx.doi.org/10.1016/j.immuni.2008.05.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631454	Green Accepted, Bronze			2022-12-18	WOS:000257905400007
J	Shevach, EM				Shevach, Ethan M.			From vanilla to 28 flavors: Multiple varieties of T regulatory cells	IMMUNITY			English	Editorial Material							CUTTING EDGE; TGF-BETA; ACTIVATION; FOXP3; GENERATION; INDUCTION; PHENOTYPE; MICE; EXPRESSION; TOLERANCE	Numerous T cell subpopulations have now been claimed to exhibit regulatory activity. Shevach discusses the current understanding of the different subsets of T regulatory cells and provides a perspective on the current areas of uncertainly and controversy in the field.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shevach, EM (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000224, Z01AI000224] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Chen WH, 2005, J IMMUNOL, V175, P3409, DOI 10.4049/jimmunol.175.5.3409; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GERSHON RK, 1976, COLD SPRING HARB SYM, V41, P85, DOI 10.1101/SQB.1977.041.01.012; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Hahn BH, 2005, J IMMUNOL, V175, P7728, DOI 10.4049/jimmunol.175.11.7728; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jarvis LB, 2005, EUR J IMMUNOL, V35, P2896, DOI 10.1002/eji.200526162; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Knoechel B, 2006, J IMMUNOL, V176, P6473, DOI 10.4049/jimmunol.176.11.6473; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Vlad G, 2005, J IMMUNOL, V174, P5907, DOI 10.4049/jimmunol.174.10.5907; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	41	428	461	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					195	201		10.1016/j.immuni.2006.08.003	http://dx.doi.org/10.1016/j.immuni.2006.08.003			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16920638	Bronze			2022-12-18	WOS:000240047500006
J	Shibata, Y; Berclaz, PY; Chroneos, ZC; Yoshida, M; Whitsett, JA; Trapnell, BC				Shibata, Y; Berclaz, PY; Chroneos, ZC; Yoshida, M; Whitsett, JA; Trapnell, BC			GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR PU.1; FACTOR-DEFICIENT MICE; COMMON BETA-SUBUNIT; MYELOID DEVELOPMENT; GENE-EXPRESSION; GRANULOCYTE; PROLIFERATION; RECEPTOR; HEMATOPOIESIS	GM-CSF gene targeted (GM(-/-)) mice are susceptible to respiratory infections and develop alveolar proteinosis due to defects in innate immune function and surfactant catabolism in alveolar macrophages (AMs), respectively. Reduced cell adhesion, phagocytosis, pathogen killing, mannose- and Toll-like receptor expression, and LPS- or peptidoglycan-stimulated TNF alpha, release were observed in AMs from GM(-/-) mice. The transcription factor PU.1 was markedly reduced in AMs of GM(-/-) mice in vivo and was restored by selective expression of GM-CSF in the lungs of SPC-GM/GM(-/-) transgenic mice. Retrovirus-mediated expression of PU.1 in AMs from GM(-/-) mice rescued host defense functions and surfactant catabolism by AMs. We conclude that PU.1 mediates GM-CSF-dependent effects on terminal differentiation of AMs regulating innate immune functions and surfactant catabolism by AMs.	Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Trapnell, BC (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA.			, Zissis/0000-0002-9841-7917	NHLBI NIH HHS [R01 HL69549-01, HL56387] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056387, R01HL069549, P01HL056387] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; AKAGAWA KS, 1988, J IMMUNOL, V141, P3383; AMAOUT MA, 1986, J CLIN INVEST, V78, P597; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Anderson KL, 1999, BLOOD, V94, P2310, DOI 10.1182/blood.V94.7.2310.419k34_2310_2318; Basu S, 1997, J IMMUNOL, V159, P1412; BATES CR, 1996, AM J PHYSIOL, V271, pL258; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; CHEN BD, 1988, J IMMUNOL, V141, P139; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Chiaradonna F, 1999, EMBO J, V18, P3013, DOI 10.1093/emboj/18.11.3013; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; COLEMAN DL, 1988, BLOOD, V72, P573; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; DONAHUE RE, 1986, NATURE, V321, P872, DOI 10.1038/321872a0; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; Feng X, 1999, J BIOL CHEM, V274, P1366, DOI 10.1074/jbc.274.3.1366; Gjomarkaj M, 1999, AM J RESP CELL MOL, V20, P135, DOI 10.1165/ajrcmb.20.1.3221; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Henkel GW, 1999, BLOOD, V93, P2849; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Kennedy DW, 1998, P NATL ACAD SCI USA, V95, P14944, DOI 10.1073/pnas.95.25.14944; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; McKercher SR, 1999, J LEUKOCYTE BIOL, V66, P727, DOI 10.1002/jlb.66.5.727; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nishinakamura R, 1996, BLOOD, V88, P2458, DOI 10.1182/blood.V88.7.2458.bloodjournal8872458; Nishinakamura R, 1996, J EXP MED, V183, P2657, DOI 10.1084/jem.183.6.2657; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Otake K, 1998, HUM GENE THER, V9, P2207, DOI 10.1089/hum.1998.9.15-2207; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; RASKO JE, 1994, CYTOKINE HDB, P343; REED JA, 1999, AM J PHYSIOL, V276, pL656; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; SANDRON D, 1986, EUR J RESPIR DIS, V69, P226; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIBATA Y, 2001, IN PRESS BLOOD; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; THOMAS ED, 1976, SCIENCE, V192, P1016, DOI 10.1126/science.775638; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; VOSO MT, 1994, P NATL ACAD SCI USA, V91, P7932, DOI 10.1073/pnas.91.17.7932; Wang MJ, 2000, CELL IMMUNOL, V204, P88, DOI 10.1006/cimm.2000.1697; WEISER WY, 1987, J EXP MED, V166, P1436, DOI 10.1084/jem.166.5.1436; Yoshida M, 2001, AM J PHYSIOL-LUNG C, V280, pL379, DOI 10.1152/ajplung.2001.280.3.L379; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000; Zsengeller ZK, 1998, HUM GENE THER, V9, P2101, DOI 10.1089/hum.1998.9.14-2101	58	428	440	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					557	567		10.1016/S1074-7613(01)00218-7	http://dx.doi.org/10.1016/S1074-7613(01)00218-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672538	Bronze			2022-12-18	WOS:000171757800007
J	Josefowicz, SZ; Rudensky, A				Josefowicz, Steven Z.; Rudensky, Alexander			Control of Regulatory T Cell Lineage Commitment and Maintenance	IMMUNITY			English	Review							BETA-MEDIATED INDUCTION; TRANS-RETINOIC ACID; TGF-BETA; FOXP3 EXPRESSION; DIFFERENTIAL REQUIREMENT; STAT5 ACTIVATION; CUTTING EDGE; REG-CELLS; RECEPTOR; CD4(+)	Foxp3-expressing regulatory T (Treg) cells suppress pathology mediated by immune responses against self and foreign antigens and commensal microorganisms. Sustained expression of the transcription factor Foxp3, a key distinguishing feature of Treg cells, is required for their differentiation and suppressor function. In addition, Foxp3 expression prevents deviation of Treg cells into effector T cell lineages and confers dependence of Treg cell survival and expansion on growth factors, foremost interleukin-2, provided by activated effector T cells. In this review we discuss Treg cell differentiation and maintenance with a particular emphasis on molecular regulation of Foxp3 expression, arguably a key to mechanistic understanding of biology of regulatory T cells.	[Josefowicz, Steven Z.; Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Josefowicz, Steven Z.; Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Josefowicz, Steven Z.; Rudensky, Alexander] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Josefowicz, SZ (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	josefows@mskcc.org; rudenska@mskcc.org	Josefowicz, Steven Z/B-8716-2011	josefowicz, steven/0000-0001-7453-779X	National Institutes of Health [A1061816]; Howard Hughes Medical Insitute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Insitute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of our laboratory for stimulating discussions and M. Busslinger for sharing unpublished data. This work was supported by A1061816 grant from the National Institutes of Health (A.Y.R.). A.Y.R. is an investigator of the Howard Hughes Medical Insitute.	Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; BONOMO A, 1995, J IMMUNOL, V154, P6602; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Carter JD, 2005, J IMMUNOL, V174, P6627, DOI 10.4049/jimmunol.174.11.6627; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Ehrlich P., 1906, COLLECTED STUDIES IM; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; JOSEFOWICZ SZ, 2009, J IMMUNOL IN PRESS, V182; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kretschmer K, 2006, NAT PROTOC, V1, P653, DOI 10.1038/nprot.2006.105; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; MOLINERO LL, 2009, J IMMUNOL IN PRESS, V182; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; OHKI H, 1987, SCIENCE, V237, P1032, DOI 10.1126/science.3616623; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pacholczyk R, 2008, IMMUNOLOGY, V125, P450, DOI 10.1111/j.1365-2567.2008.02992.x; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; SAKAGUCHI S, 1982, J EXP MED, V156, P1565, DOI 10.1084/jem.156.6.1565; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Shevach EM, 2008, EUR J IMMUNOL, V38, P915, DOI 10.1002/eji.200738111; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; So T, 2007, J IMMUNOL, V179, P1427, DOI 10.4049/jimmunol.179.3.1427; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	107	427	449	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					616	625		10.1016/j.immuni.2009.04.009	http://dx.doi.org/10.1016/j.immuni.2009.04.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464984	Green Accepted, Bronze			2022-12-18	WOS:000266356900002
J	Fu, C; Turck, CW; Kurosaki, T; Chan, AC				Fu, C; Turck, CW; Kurosaki, T; Chan, AC			BLNK: a central linker protein in B cell activation	IMMUNITY			English	Article							ANTIGEN RECEPTOR; TYROSINE KINASE; SIGNAL TRANSDUCTION; T-CELLS; SYK; PHOSPHORYLATION; SLP-76; VAV; SHC; RECONSTITUTION	Linker or adapter proteins provide mechanisms by which receptors can amplify and regulate downstream effector proteins. We describe here the identification of a novel (B) under bar cell (l) under bar i<(nk)under bar>r protein, termed BLNK, that interfaces the B cell receptor-associated Syk tyrosine kinase with PLC gamma, the Vav guanine nucleotide exchange factor, and the Grb2 and Nck adapter proteins. Tyrosine phosphorylation of BLNK by Syk provides docking sites for these SH2-containing effector molecules that, in turn, permits the phosphorylation and/or activation of their respective signaling pathways. Hence, BLNK represents a central linker protein that bridges the B cell receptor-associated kinases with a multitude of signaling pathways and may regulate the biologic outcomes of B cell function and development.	Washington Univ, Sch Med, Dept Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Program Mol Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94121 USA; Kansai Med Sch, Inst Hepat Res, Dept Mol Genet, Moriguchi, Osaka 570, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Francisco; Kansai Medical University	Chan, AC (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Immunol, St Louis, MO 63110 USA.	chan@im.wustl.edu	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X	NCI NIH HHS [R01 CA71516] Funding Source: Medline; NIAID NIH HHS [R01 AI42787] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042787] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DAmbrosio D, 1996, EUR J IMMUNOL, V26, P1960, DOI 10.1002/eji.1830260842; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Fang N, 1996, J IMMUNOL, V157, P3769; Fu C, 1997, J BIOL CHEM, V272, P27362, DOI 10.1074/jbc.272.43.27362; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Harmer SL, 1997, MOL CELL BIOL, V17, P4087, DOI 10.1128/MCB.17.7.4087; HARWOOD AE, 1993, J IMMUNOL, V151, P4513; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KONG GH, 1995, IMMUNITY, V2, P485, DOI 10.1016/1074-7613(95)90029-2; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Law CL, 1996, MOL CELL BIOL, V16, P1305; McFarland EDC, 1997, BIOCHEMISTRY-US, V36, P7169, DOI 10.1021/bi970013y; Musci MA, 1997, J IMMUNOL, V159, P1639; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; NAGAI K, 1995, J BIOL CHEM, V270, P6824, DOI 10.1074/jbc.270.12.6824; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; SAXTON TM, 1994, J IMMUNOL, V153, P623; Schlessinger J, 1997, CELL, V91, P869, DOI 10.1016/S0092-8674(00)80477-8; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; SMIT L, 1994, J BIOL CHEM, V269, P20209; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Teramoto H, 1997, J BIOL CHEM, V272, P10751; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	427	436	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					93	103		10.1016/S1074-7613(00)80591-9	http://dx.doi.org/10.1016/S1074-7613(00)80591-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697839	Bronze			2022-12-18	WOS:000075066600009
J	Migueles, SA; Osborne, CM; Royce, C; Compton, AA; Joshi, RP; Weeks, KA; Rood, JE; Berkley, AM; Sacha, JB; Cogliano-Shutta, NA; Lloyd, M; Roby, G; Kwan, R; McLaughlin, M; Stallings, S; Rehm, C; O'Shea, MA; Mican, J; Packard, BZ; Komoriya, A; Palmer, S; Wiegand, AP; Maldarelli, F; Coffin, JM; Mellors, JW; Hallahan, CW; Follman, DA; Connors, M				Migueles, Stephen A.; Osborne, Christine M.; Royce, Cassandra; Compton, Alex A.; Joshi, Rohan P.; Weeks, Kristin A.; Rood, Julia E.; Berkley, Amy M.; Sacha, Jonah B.; Cogliano-Shutta, Nancy A.; Lloyd, Margaret; Roby, Gregg; Kwan, Richard; McLaughlin, Mary; Stallings, Sara; Rehm, Catherine; O'Shea, Marie A.; Mican, JoAnn; Packard, Beverly Z.; Komoriya, Akira; Palmer, Sarah; Wiegand, Ann P.; Maldarelli, Frank; Coffin, John M.; Mellors, John W.; Hallahan, Claire W.; Follman, Dean A.; Connors, Mark			Lytic Granule Loading of CD8(+) T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control	IMMUNITY			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS REPLICATION; LONG-TERM NONPROGRESSORS; VIRAL SUPPRESSION; ELITE SUPPRESSORS; ANTIGEN LOAD; MEMORY; EXPRESSION; INDIVIDUALS; EFFECTOR	Virus-specific CD8(+) T cells probably mediate control over HIV replication in rare individuals, termed long-term nonprogressors; (LTNPs) or elite controllers. Despite extensive investigation, the mechanisms responsible for this control remain incompletely understood. We observed that HIV-specific CD8(+) T cells of LTNPs persisted at higher frequencies than those of treated progressors with equally low amounts of HIV. Measured on a per-cell basis, HIV-specific CDB+ T cells of LTNPs efficiently eliminated primary autologous HIV-infected CD4(+) T cells. This function required lytic granule loading of effectors and delivery of granzyme B to target cells. Defective cytotoxicity of progressor effectors could be restored after treatment with phorbol ester and calcium ionophore. These results establish an effector function and mechanism that clearly segregate with immunologic control of HIV. They also demonstrate that lytic granule contents of memory cells are a critical determinant of cytotoxicity that must be induced for maximal per-cell killing capacity.	[Migueles, Stephen A.; Osborne, Christine M.; Royce, Cassandra; Compton, Alex A.; Joshi, Rohan P.; Weeks, Kristin A.; Rood, Julia E.; Berkley, Amy M.; Cogliano-Shutta, Nancy A.; Lloyd, Margaret; Roby, Gregg; Kwan, Richard; McLaughlin, Mary; Stallings, Sara; Rehm, Catherine; O'Shea, Marie A.; Mican, JoAnn; Hallahan, Claire W.; Follman, Dean A.; Connors, Mark] NIAID, NIH, Bethesda, MD 20892 USA; [Sacha, Jonah B.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53719 USA; [Packard, Beverly Z.; Komoriya, Akira] Oncolmmunin, Gaithersburg, MD 20877 USA; [Palmer, Sarah; Wiegand, Ann P.; Maldarelli, Frank; Coffin, John M.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Mellors, John W.] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15261 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Connors, M (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mconnors@nih.gov	Maldarelli, Frank/O-2428-2016; Compton, Alex/AAZ-6022-2020	Compton, Alex/0000-0002-7508-4953; Rood, Julia/0000-0002-0755-8897	Intramural NIH HHS [Z01 AI000855-09] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000855] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Arrode G, 2005, EUR J IMMUNOL, V35, P159, DOI 10.1002/eji.200425744; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Quiros JCLB, 2000, J VIROL, V74, P2023, DOI 10.1128/JVI.74.4.2023-2028.2000; Dinoso JB, 2008, CLIN INFECT DIS, V47, P102, DOI 10.1086/588791; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Gray CM, 1999, J IMMUNOL, V162, P1780; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Meng YR, 2006, J IMMUNOL, V177, P1981, DOI 10.4049/jimmunol.177.3.1981; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles Stephen A, 2004, Curr HIV/AIDS Rep, V1, P12, DOI 10.1007/s11904-004-0002-2; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Ortiz GM, 2001, P NATL ACAD SCI USA, V98, P13288, DOI 10.1073/pnas.221452198; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tilton JC, 2007, J VIROL, V81, P2713, DOI 10.1128/JVI.01830-06; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	45	426	434	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 19	2008	29	6					1009	1021		10.1016/j.immuni.2008.10.010	http://dx.doi.org/10.1016/j.immuni.2008.10.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19062316	Bronze, Green Accepted			2022-12-18	WOS:000262012400019
J	Haas, KM; Poe, JC; Steeber, DA; Tedder, TF				Haas, KM; Poe, JC; Steeber, DA; Tedder, TF			B-1a and b-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S-pneumoniae	IMMUNITY			English	Article							B-LYMPHOCYTE DEVELOPMENT; MARGINAL ZONE; HUMAN CD19; B1B CELLS; MICE; GENE; EXPRESSION; ANTIBODIES; INFECTION; RESPONSES	B-1a and B-1b lymphocytes were found to exhibit specialized roles in providing immunity to Streptococcus pneumoniae and differ dramatically in their developmental requirements. Transgenic mice over-expressing CD19 (hCD19Tg) generated B-1a cells and natural antibodies that provided protection during infection, while CD19-deficient (CD19(-/-)) mice lacked B-1a cells, lacked natural antibodies, and were more susceptible to infection. By contrast, pneumococcal polysaccharide (PPS) immunization protected CD19(-/-) mice during lethal challenge, whereas hCD19Tg mice remained unprotected. This resulted from differences in the B-1b subset: the key population found to produce protective PPS-specific antibody in both wildtype and CD19(-/-) mice. Thus, CD19(-/-) mice generated B-1b cells and protective adaptive PPS-specific antibody responses, whereas hCD19Tg mice lacked B-1b cells and adaptive PPS-specific antibody responses. This reciprocal contribution of B-1a and B-1b subsets to innate and acquired immunity reveals an unexpected division of labor within the B-1 compartment that is normally balanced by their coordinated development.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27705 USA	Duke University	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Box 3010, Durham, NC 27705 USA.	thomas.tedder@duke.edu		Poe, Jonathan/0000-0002-7789-1564	NATIONAL CANCER INSTITUTE [R01CA105001, R01CA096547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363] Funding Source: NIH RePORTER; NCI NIH HHS [CA96547, CA105001] Funding Source: Medline; NIAID NIH HHS [AI56363] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; AMSBAUGH DF, 1972, J EXP MED, V136, P931, DOI 10.1084/jem.136.4.931; Antall PM, 1999, J ALLERGY CLIN IMMUN, V103, P637, DOI 10.1016/S0091-6749(99)70236-8; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; KENNY JJ, 1983, J IMMUNOL, V130, P2574; Krop I, 1996, J IMMUNOL, V157, P48; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; Mi QS, 2000, P NATL ACAD SCI USA, V97, P6031, DOI 10.1073/pnas.110039497; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Ohdan H, 2000, J IMMUNOL, V165, P5518, DOI 10.4049/jimmunol.165.10.5518; Ortqvist A, 2001, EUR RESPIR J, V18, P184, DOI 10.1183/09031936.01.00084401; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; Sen G, 2002, MOL IMMUNOL, V39, P57, DOI 10.1016/S0161-5890(02)00047-0; Wang YC, 2002, FOOD MICROBIOL, V19, P501, DOI 10.1006/fmic.2002.0506; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Wuorimaa T, 2002, SCAND J IMMUNOL, V56, P111, DOI 10.1046/j.1365-3083.2002.01124.x; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	31	425	434	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					7	18		10.1016/j.immuni.2005.04.011	http://dx.doi.org/10.1016/j.immuni.2005.04.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039575	Bronze			2022-12-18	WOS:000231024800004
J	Lanier, LL; Corliss, B; Wu, J; Phillips, JH				Lanier, LL; Corliss, B; Wu, J; Phillips, JH			Association of DAP12 with activating CD94/NKG2C NK cell receptors	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; TYROSINE-PHOSPHATASE 1C; DI-LEUCINE MOTIF; HLA-B; INHIBITORY RECEPTOR; LECTIN SUPERFAMILY; DIRECT BINDING; PROTEIN; CD94; RECOGNITION	While the inhibitory NK cell receptors for MHC class I express immunoreceptor tyrosine-based inhibitory motifs that recruit intracellular tyrosine phosphatases and prevent NK cell effector function, the activating NK cell receptors lack intrinsic sequences required for cellular stimulation. CD94/NKG2C, an activating NK cell receptor of the C-type lectin superfamily that binds to HLA-E, noncovalently associates with DAP12, a membrane receptor containing an immunoreceptor tyrosine-based activating motif. Efficient expression of CD94/NKG2C on the cell surface requires the presence of DAP12, and charged residues in the transmembrane domains of DAP12 and NKG2C are necessary for this interaction. These results provide a molecular basis for the assembly of NK cell receptors for MHC class I involved in cellular activation and inhibition.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Lanier, LL (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, 901 Calif Ave, Palo Alto, CA 94304 USA.	lanier@dnax.org	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952				BAKER E, 1995, CHROMOSOME RES, V3, P511; Berg SF, 1998, EUR J IMMUNOL, V28, P444, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;444::AID-IMMU444&gt;3.0.CO;2-M; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Blery M, 1997, J BIOL CHEM, V272, P8989; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Borges L, 1997, J IMMUNOL, V159, P5192; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Brumbaugh KM, 1996, J IMMUNOL, V157, P2804; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; Campbell KS, 1998, EUR J IMMUNOL, V28, P599, DOI 10.1002/(SICI)1521-4141(199802)28:02<599::AID-IMMU599>3.3.CO;2-6; Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO;2-O; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; DANDREA A, 1995, J IMMUNOL, V155, P2306; Dietrich J, 1996, J CELL BIOL, V132, P299, DOI 10.1083/jcb.132.3.299; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; Dissen E, 1997, EUR J IMMUNOL, V27, P2080, DOI 10.1002/eji.1830270836; Dohring C, 1996, EUR J IMMUNOL, V26, P365, DOI 10.1002/eji.1830260215; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lanier LL, 1998, CELL, V92, P705, DOI 10.1016/S0092-8674(00)81398-7; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; Lazetic S, 1996, J IMMUNOL, V157, P4741; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LOPEZBOTET M, 1995, LEUCOCYTE TYPING, V5, P1437; MORLEY BJ, 1988, J EXP MED, V168, P1971, DOI 10.1084/jem.168.6.1971; Olcese L, 1996, J IMMUNOL, V156, P4531; Olcese L, 1997, J IMMUNOL, V158, P5083; Onishi M, 1996, EXP HEMATOL, V24, P324; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; PerezVillar JJ, 1996, J IMMUNOL, V157, P5367; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Plougastel B, 1997, EUR J IMMUNOL, V27, P2835, DOI 10.1002/eji.1830271114; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Renedo M, 1997, IMMUNOGENETICS, V46, P307, DOI 10.1007/s002510050276; Rojo S, 1997, EUR J IMMUNOL, V27, P568, DOI 10.1002/eji.1830270231; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; SMITH HRC, 1994, J IMMUNOL, V153, P1068; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; ULBRECHT M, 1992, J IMMUNOL, V149, P2945; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	68	425	435	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1998	8	6					693	701		10.1016/S1074-7613(00)80574-9	http://dx.doi.org/10.1016/S1074-7613(00)80574-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655483	Bronze			2022-12-18	WOS:000074396300005
J	Newell, EW; Sigal, N; Bendall, SC; Nolan, GP; Davis, MM				Newell, Evan W.; Sigal, Natalia; Bendall, Sean C.; Nolan, Garry P.; Davis, Mark M.			Cytometry by Time-of-Flight Shows Combinatorial Cytokine Expression and Virus-Specific Cell Niches within a Continuum of CD8(+) T Cell Phenotypes	IMMUNITY			English	Article							CLASS-I LIGANDS; EFFECTOR FUNCTIONS; PEPTIDE COMPLEXES; MHC TETRAMERS; MEMORY; ANTIGEN; LYMPHOCYTES; SUBSETS; RESPONSES; IMMUNE	Cytotoxic CD8(+) T lymphocytes directly kill infected or aberrant cells and secrete proinflammatory cytokines. By using metal-labeled probes and mass spectrometric analysis (cytometry by time-of-flight, or CyTOF) of human CD8(+) T cells, we analyzed the expression of many more proteins than previously possible with fluorescent labels, including surface markers, cytokines, and antigen specificity with modified peptide-MHC tetramers. With 3-dimensional principal component analysis (3D-PCA) to display phenotypic diversity, we observed a relatively uniform pattern of variation in all subjects tested, highlighting the interrelatedness of previously described subsets and the continuous nature of CD8(+) T cell differentiation. These data also showed much greater complexity in the CD8(+) T cell compartment than previously appreciated, including a nearly combinatorial pattern of cytokine expression, with distinct niches occupied by virus-specific cells. This large degree of functional diversity even between cells with the same specificity gives CD8(+) T cells a remarkable degree of flexibility in responding to pathogens.	[Newell, Evan W.; Bendall, Sean C.; Nolan, Garry P.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Sigal, Natalia; Nolan, Garry P.; Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Bendall, Sean/AGG-0126-2022; Newell, Evan W/F-9711-2012; Nolan, Garry/AAE-7903-2019	Newell, Evan W/0000-0002-2889-243X; Bendall, Sean/0000-0003-1341-2453; Davis, Mark/0000-0001-6868-657X; Nolan, Garry/0000-0002-8862-9043	NIH [U19-AI057229, U19-AI090019]; Bill and Melinda Gates Foundation; Howard Hughes Medical Institute; American Cancer Society; Damon Runyon Postdoctoral Fellowship [DRG-2017-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI090019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); Damon Runyon Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank D. Parks and W. Moore for helpful discussions and help with FlowJo and FCS files, P. Lund for helpful discussions and a T cell stimulation protocol, M. Leipold for help with CyTOF machine maintenance, E. Zunder, B. Bodenmiller, and E. Simonds for general help with CyTOF usage, and A. Han, B. Kidd, W. O'Gorman, O. Goldberger, and Y.-h. Chien for helpful discussions. This work was supported by NIH grants U19-AI057229 and U19-AI090019, Bill and Melinda Gates Foundation Grand Challenges Exploration phase land II grants, and The Howard Hughes Medical Institute. E.W.N. is supported by The American Cancer Society's Steven Stanley and Edward Albert Bielfelt Post-Doctoral Fellowship. S.C.B. is supported by a Damon Runyon Postdoctoral Fellowship (DRG-2017-09). G.P.N. is supported by an endowed chair from Rachtford and Carlota A. Harris. G.P.N. is a paid consultant for Becton Dickinson Biosciences, a member of the Board of Directors and consultant for DVS Sciences, and has equity holdings in DVS Biosciences.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; DeLano WL, 2002, PYMOL USERS MANUAL; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gerlach C, 2011, ANN NY ACAD SCI, V1217, P139, DOI 10.1111/j.1749-6632.2010.05830.x; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Jabbari A, 2006, J IMMUNOL METHODS, V313, P161, DOI 10.1016/j.jim.2006.04.005; Jackson J.E., 1991, USERS GUIDE PRINCIPA, P26, DOI 10.1002/0471725331.ch2; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Qin OY, 2003, J CLIN IMMUNOL, V23, P247, DOI 10.1023/A:1024580531705; Ramachandiran V, 2007, J IMMUNOL METHODS, V319, P13, DOI 10.1016/j.jim.2006.08.014; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Turner JD, 2003, J INFECT DIS, V188, P1768, DOI 10.1086/379370; VERSTEEGEN JMT, 1988, J IMMUNOL METHODS, V111, P25, DOI 10.1016/0022-1759(88)90055-5; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	48	424	464	5	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					142	152		10.1016/j.immuni.2012.01.002	http://dx.doi.org/10.1016/j.immuni.2012.01.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22265676	Green Accepted, Bronze			2022-12-18	WOS:000299766000017
J	Kaplan, DH; Jenison, MC; Saeland, S; Shlomchik, WD; Shlomchik, MJ				Kaplan, DH; Jenison, MC; Saeland, S; Shlomchik, WD; Shlomchik, MJ			Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity	IMMUNITY			English	Article							REGIONAL LYMPH-NODES; DENDRITIC CELLS; T-CELLS; TRANSGENIC MICE; MOUSE; TOLERANCE; ANTIGEN; EXPRESSION; POPULATIONS; RADIATION	Epidermal Langerhans cells (LCs), a distinct skin-resident dendritic cell population, acquire antigen in the skin and migrate to draining lymph nodes where they are thought to initiate adaptive immune responses. To examine the functional requirement of LCs in skin immunity, we generated BAC transgenic mice in which the regulatory elements from human Langerin were used to drive expression of diphtheria toxin. The resulting mice have a constitutive and durable absence of epidermal LCs but are otherwise intact. Unexpectedly, we found that contact hypersensitivity (CHS) was amplified rather than abrogated in the absence of LCs. Moreover, we showed that LCs act during the priming and not the effector phase. Thus, LCs not only were dispensable for CHS, but they served to regulate the response, a previously unappreciated function.	Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; INSERM, U503, IFR 128, F-69369 Lyon 7, France; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Med Oncol Sect, New Haven, CT 06520 USA	Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University; Yale University; Yale University	Kaplan, DH (corresponding author), Yale Univ, Sch Med, Dept Dermatol, 333 Cedar St, New Haven, CT 06520 USA.	dan.kaplan@yale.edu	Kaplan, Daniel H/N-2779-2013; Shlomchik, Mark J./AAN-6189-2020	Kaplan, Daniel H/0000-0002-7851-7320; Shlomchik, Mark J./0000-0002-2152-0959	NHLBI NIH HHS [R01-HL66279] Funding Source: Medline; NIAMS NIH HHS [K08-AR651092, R01-AR44077, K08-AR51092] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR051092, R01AR044077] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Attie AD, 2001, J LIPID RES, V42, P1717; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Duthie MS, 2000, J PHOTOCH PHOTOBIO B, V57, P123, DOI 10.1016/S1011-1344(00)00087-7; Feng DX, 2001, P NATL ACAD SCI USA, V98, P15073, DOI 10.1073/pnas.251550598; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; MAXWELL IH, 1986, CANCER RES, V46, P4660; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Miano JM, 2002, AM J PHYSIOL-HEART C, V282, pH1793, DOI 10.1152/ajpheart.00875.2001; Misulovin Z, 2001, J IMMUNOL METHODS, V257, P99, DOI 10.1016/S0022-1759(01)00452-5; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Schwarz T, 1999, ALLERGY, V54, P1252, DOI 10.1034/j.1398-9995.1999.00105.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SILBERBERGSINAKIN I, 1980, J INVEST DERMATOL, V75, P61, DOI 10.1111/1523-1747.ep12521144; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; TOEWS GB, 1980, J IMMUNOL, V124, P445; Tsuruta D, 1999, BRIT J DERMATOL, V140, P392; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	45	423	434	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					611	620		10.1016/j.immuni.2005.10.008	http://dx.doi.org/10.1016/j.immuni.2005.10.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356859	Bronze			2022-12-18	WOS:000234316900008
J	Saito, T; Chiba, S; Ichikawa, M; Kunisato, A; Asai, T; Shimizu, K; Yamaguchi, T; Yamamoto, G; Seo, S; Kumano, K; Nakagami-Yamaguchi, E; Hamada, Y; Aizawa, S; Hirai, H				Saito, T; Chiba, S; Ichikawa, M; Kunisato, A; Asai, T; Shimizu, K; Yamaguchi, T; Yamamoto, G; Seo, S; Kumano, K; Nakagami-Yamaguchi, E; Hamada, Y; Aizawa, S; Hirai, H			Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development	IMMUNITY			English	Article							FACTOR-KAPPA-B; POSITIVE SELECTION; GENE-EXPRESSION; FATE; MICE; TRANSLOCATION; ACTIVATION; RESPONSES; DEFINES; JAGGED1	The Notch genes play a key role in cellular differentiation. The significance of Notch1 during thymocyte development is well characterized, but the function of Notch2 is poorly understood. Here we demonstrate that Notch2 but no other Notch family member is preferentially expressed in mature B cells and that conditionally targeted deletion of Notch2 results in the defect of marginal zone B (MZB) cells and their presumed precursors, CD1d(hi) fraction of type 2 transitional B cells. Among Notch target genes, the expression level of Deltex1 is prominent in MZB cells and strictly dependent on that of Notch2, suggesting that Deltex1 may play a role in MZB cell differentiation.	Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Cell Therapy & Transplantat Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Blood Transfus Med, Bunkyo Ku, Tokyo 1138655, Japan; Natl Inst Basic Biol, Tissue & Cell Culture Lab, Okazaki, Aichi 4448585, Japan; RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Tokyo; University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); RIKEN	Hirai, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hhirai-tky@umin.ac.jp	Nakagami-Yamacuchi, Etsuko/ABB-9053-2020; Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Ichikawa, Motoshi/0000-0001-6497-0848; Nakagami-Yamaguchi, Etsuko/0000-0001-6718-4658; Yamaguchi, Tomoyuki/0000-0002-4159-5448				Amano M, 1998, J IMMUNOL, V161, P1710; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Bertrand FE, 2000, LEUKEMIA, V14, P2095, DOI 10.1038/sj.leu.2401942; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Makar KW, 2001, INT IMMUNOL, V13, P657, DOI 10.1093/intimm/13.5.657; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roark JH, 1998, J IMMUNOL, V160, P3121; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sato S, 1997, J IMMUNOL, V158, P4662; Seo SJ, 2001, J IMMUNOL, V166, P3710, DOI 10.4049/jimmunol.166.6.3710; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Strobl LJ, 2000, J VIROL, V74, P1727, DOI 10.1128/JVI.74.4.1727-1735.2000; Tan-Pertel HT, 2000, J IMMUNOL, V165, P4428, DOI 10.4049/jimmunol.165.8.4428; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605	47	423	430	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2003	18	5					675	685		10.1016/S1074-7613(03)00111-0	http://dx.doi.org/10.1016/S1074-7613(03)00111-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753744	Bronze			2022-12-18	WOS:000182962200012
J	Savage, PA; Boniface, JJ; Davis, MM				Savage, PA; Boniface, JJ; Davis, MM			A kinetic basis for T cell receptor repertoire selection during an immune response	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; AMINO-ACID; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; ANTIGEN; ACTIVATION; RECOGNITION; LIGAND; AFFINITY; CHAIN	The basis for T cell antigen receptor (TCR) repertoire selection upon repeated antigenic challenge is unclear. We evaluated the avidity and dissociation kinetics of peptide/major histocompatibility complex (MHC) tetramer binding to antigen-specific T lymphocytes isolated following primary or secondary immunization. The data reveal a narrowing of the secondary repertoire relative to the primary repertoire, largely resulting from the loss of cells expressing TCRs with the fastest dissociation rates for peptide/MHC binding. In addition, T cells in the secondary response express TCRs of higher average affinity for peptide/MHC than cells in the primary response. These results provide a link between the kinetics and affinity of TCR-peptide/MHC interactions and TCR sequence selection during the course of an immune response.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Davis, Mark/0000-0001-6868-657X				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; FAZEKASDESTGROTH B, 1992, MOL MECH IMMUNOLOGIC, P123; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; HEDRICK SM, 1988, SCIENCE, V239, P1541, DOI 10.1126/science.2832942; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Khandekar SS, 1997, MOL IMMUNOL, V34, P493, DOI 10.1016/S0161-5890(97)00044-8; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; REAY PA, 1994, J IMMUNOL, V152, P3946; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; Seibel JL, 1997, J EXP MED, V185, P1919, DOI 10.1084/jem.185.11.1919; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815	33	422	434	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					485	492		10.1016/S1074-7613(00)80048-5	http://dx.doi.org/10.1016/S1074-7613(00)80048-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229191	Bronze			2022-12-18	WOS:000079989600009
J	ALEXANDER, J; SIDNEY, J; SOUTHWOOD, S; RUPPERT, J; OSEROFF, C; MAEWAL, A; SNOKE, K; SERRA, HM; KUBO, RT; SETTE, A; GREY, HM				ALEXANDER, J; SIDNEY, J; SOUTHWOOD, S; RUPPERT, J; OSEROFF, C; MAEWAL, A; SNOKE, K; SERRA, HM; KUBO, RT; SETTE, A; GREY, HM			DEVELOPMENT OF HIGH POTENCY UNIVERSAL DR-RESTRICTED HELPER EPITOPES BY MODIFICATION OF HIGH-AFFINITY DR-BLOCKING PEPTIDES	IMMUNITY			English	Article							CLASS-II MOLECULES; MHC CLASS-II; T-CELL RECOGNITION; ANTIGEN-PROCESSING MUTANT; INVARIANT CHAIN PEPTIDES; HISTOCOMPATIBILITY ANTIGEN; STRUCTURAL CHARACTERISTICS; IMMUNOGENIC PEPTIDES; BINDING; HLA	Pan DR-binding peptides engineered by introducing anchor residues for different DR motifs within a polyalanine backbone bound 10 of 10 DR molecules tested, with affinities, in most cases, in the nanomolar range. Because of the small methyl group exposed far T cell recognition, these peptides were poor immunogens but effective blockers of DR-restricted antigen presentation. Introduction of bulky and charged residues at positions accessible for T cell recognition yielded extremely powerful Pan DR epitope peptides (PADRE). These peptides elicited powerful responses in vitro from human peripheral blood mononuclear cells (PBMC). Because these cells also cross-react on certain mouse class II alleles, we could also demonstrate that PADRE peptides are active in vivo. In one example of their capacity to elicit T help, they were approximately 1000 times more powerful than natural T cell epitopes. We propose that PADRE peptides may be useful in the development of subunit vaccines.			ALEXANDER, J (corresponding author), CYTEL CORP,3525 JOHN HOPKINS COURT,SAN DIEGO,CA 92121, USA.		Sette, Alessandro/AFO-8916-2022	SERRA, HORACIO/0000-0003-4979-8642				ALEXANDER J, 1993, J IMMUNOL, V150, P1; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BOEHNCKE WH, 1993, J IMMUNOL, V150, P331; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUSCH R, 1990, INT IMMUNOL, V2, P443, DOI 10.1093/intimm/2.5.443; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; CEPPELLINI R, 1989, NATURE, V339, P392, DOI 10.1038/339392a0; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; DEMAGISTRIS MT, 1992, CELL, V68, P525; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; DICK W E JR, 1989, P48; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FRANCO A, 1994, EUR J IMMUNOL, V24, P940, DOI 10.1002/eji.1830240424; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GELUK A, 1992, EUR J IMMUNOL, V22, P107, DOI 10.1002/eji.1830220117; GORGA JC, 1987, J BIOL CHEM, V262, P16087; HILL CM, 1991, J IMMUNOL, V147, P189; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; IMANISHI T, 1992, 11TH P INT HIST WORK, V1, P1065; ISHIOKA GY, 1994, J IMMUNOL, V152, P4310; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KRIEGER JI, 1991, J IMMUNOL, V146, P2331; LAMONT AG, 1990, J IMMUNOL, V144, P2493; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MANCA F, 1991, J IMMUNOL, V146, P1964; MILICH DR, 1988, P NATL ACAD SCI USA, V85, P1610, DOI 10.1073/pnas.85.5.1610; OSULLIVAN D, 1990, J IMMUNOL, V145, P1799; OSULLIVAN D, 1991, J IMMUNOL, V146, P1240; OSULLIVAN D, 1991, J IMMUNOL, V147, P2663; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; PARKER KC, 1994, J IMMUNOL, V152, P163; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROBBINS JB, 1990, J INFECT DIS, V161, P821, DOI 10.1093/infdis/161.5.821; ROCHE PA, 1991, J IMMUNOL, V144, P1849; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCHILD H, 1991, EUR J IMMUNOL, V21, P2649, DOI 10.1002/eji.1830211102; SETTE A, 1989, J IMMUNOL, V142, P35; SETTE A, 1993, J IMMUNOL, V151, P3163; SETTE A, 1992, J IMMUNOL, V148, P844; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; SIDNEY J, 1992, J IMMUNOL, V149, P2634; SIDNEY J, 1994, J IMMUNOL, V152, P4516; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; SNOKE K, 1993, J IMMUNOL, V151, P1; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; VALLI A, 1993, J CLIN INVEST, V91, P616, DOI 10.1172/JCI116242; VANBLEEK GM, 1990, NATURE, V348, P213; VITIELLO A, 1994, IN PRESS J CLIN INVE; WALL KA, 1994, J IMMUNOL, V152, P4526; WALL M, 1992, INT IMMUNOL, V4, P773, DOI 10.1093/intimm/4.7.773; WEINBERG GA, 1988, J PEDIATR-US, V113, P621, DOI 10.1016/S0022-3476(88)80369-X	63	422	546	1	42	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					751	761		10.1016/S1074-7613(94)80017-0	http://dx.doi.org/10.1016/S1074-7613(94)80017-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895164				2022-12-18	WOS:A1994PX64800005
J	Constantin, G; Majeed, M; Giagulli, C; Piccio, L; Kim, JY; Butcher, EC; Laudanna, C				Constantin, G; Majeed, M; Giagulli, C; Piccio, L; Kim, JY; Butcher, EC; Laudanna, C			Chemokines trigger immediate beta 2 integrin affinity and mobility changes: Differential regulation and roles in lymphocyte arrest under flow	IMMUNITY			English	Article							T-LYMPHOCYTES; ADHESION; ACTIVATION; INHIBITOR; 3-KINASE; BINDING; CALPAIN; LFA-1	Chemokines trigger rapid integrin-dependent lymphocyte arrest to Vascular endothelium. We show that the chemokines SLC, ELC, and SDF-1 alpha rapidly induce lateral mobility and transient increase of affinity of the beta2 integrin LFA-I. Inhibition of phosphatidylinositol 3-OH kinase (PI(3)K) activity blocks mobility but not affinity changes and prevents lymphocyte adhesion to ICAM-1 immobilized at low but not high densities, suggesting that mobility enhances the frequency of encounters between high-affinity integrin and ligand but that at higher ligand density affinity changes are sufficient for arrest. Thus, chemokines trigger, through distinct signaling pathways, both a high-affinity state and lateral mobility of LFA-1 that can coordinately determine the vascular arrest of circulating lymphocytes under physiologic conditions.	Univ Verona, Fac Med, Dept Pathol, Sect Gen Pathol, I-37134 Verona, Italy; IRCCS, Osped Maggiore, Inst Neurol, I-20122 Milan, Italy; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Vet Affairs Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA	University of Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Laudanna, C (corresponding author), Univ Verona, Fac Med, Dept Pathol, Sect Gen Pathol, I-37134 Verona, Italy.			Constantin, Gabriela/0000-0001-8978-3539; Piccio, Laura/0000-0002-8760-109X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734, R01GM037734, R01GM056527] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57492] Funding Source: Medline; NIGMS NIH HHS [GM37734, GM56527] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Ganpule G, 1997, J IMMUNOL, V159, P2685; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Milligan G, 1995, Adv Pharmacol, V32, P1, DOI 10.1016/S1054-3589(08)61010-8; POBER JS, 1986, J IMMUNOL, V137, P1893; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Stewart MP, 1996, J IMMUNOL, V156, P1810; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tangemann K, 1998, J IMMUNOL, V161, P6330; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; TURNER L, 1995, J IMMUNOL, V155, P2437; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Weber C, 1996, P NATL ACAD SCI USA, V93, P10939, DOI 10.1073/pnas.93.20.10939	25	421	443	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6					759	769		10.1016/S1074-7613(00)00074-1	http://dx.doi.org/10.1016/S1074-7613(00)00074-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163192	Bronze			2022-12-18	WOS:000166142300002
J	Shi, GP; Villadangos, JA; Dranoff, G; Small, C; Gu, LJ; Haley, KJ; Riese, R; Ploegh, HL; Chapman, HA				Shi, GP; Villadangos, JA; Dranoff, G; Small, C; Gu, LJ; Haley, KJ; Riese, R; Ploegh, HL; Chapman, HA			Cathepsin S required for normal MHC class II peptide loading and germinal center development	IMMUNITY			English	Article							INVARIANT CHAIN; ANTIGEN PRESENTATION; THYMIC SELECTION; DENDRITIC CELLS; IN-VIVO; T-CELLS; MOLECULES; MICE; EXPRESSION; DIVERSITY	Major histocompatibility complex (MHC) class II molecules acquire antigenic peptides after degradation of the invariant chain (Ii), an MHC class Ii-associated protein that otherwise blocks peptide binding. Antigen-presenting cells of mice that lack the protease cathepsin S fail to process Ii beyond a 10 kDa fragment, resulting in delayed peptide loading and accumulation of cell surface MHC class II/10 kDa Ii complexes. Although cathepsin S-deficient mice have normal numbers of B and T cells and normal IgE responses, they show markedly impaired antibody class switching to IgG2a and IgG3. These results indicate cathepsin S is a major Ii-processing enzyme in splenocytes and dendritic cells. Its role in humoral immunity critically depends on how antigens access the immune system.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Chapman, HA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891	NATIONAL CANCER INSTITUTE [R01CA074886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034893] Funding Source: NIH RePORTER; NCI NIH HHS [CA74886] Funding Source: Medline; NHLBI NIH HHS [HL48716] Funding Source: Medline; NIAID NIH HHS [AI34893] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arps V, 1998, EUR J IMMUNOL, V28, P681, DOI 10.1002/(SICI)1521-4141(199802)28:02<681::AID-IMMU681>3.3.CO;2-1; Bevan MJ, 1997, IMMUNITY, V7, P175, DOI 10.1016/S1074-7613(00)80520-8; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; Brewer JM, 1998, IMMUNOLOGY, V93, P41; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DiMolfetto L, 1998, CELL IMMUNOL, V183, P70, DOI 10.1006/cimm.1997.1231; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MOMBURG F, 1993, J EXP MED, V178, P1453, DOI 10.1084/jem.178.4.1453; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Schountz T, 1996, J IMMUNOL, V157, P3893; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SHI GP, 1992, J BIOL CHEM, V267, P7258; SHI GP, 1994, J BIOL CHEM, V269, P11530; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Shurin MR, 1997, CELL IMMUNOL, V179, P174, DOI 10.1006/cimm.1997.1152; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; SWIGGARD WJ, 1992, CURR PROT IMMUNOL; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	38	421	441	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					197	206		10.1016/S1074-7613(00)80020-5	http://dx.doi.org/10.1016/S1074-7613(00)80020-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072072	Bronze			2022-12-18	WOS:000078972200007
J	Garris, CS; Arlauckas, SP; Kohler, RH; Trefny, MP; Garren, S; Piot, C; Engblom, C; Pfirschke, C; Siwicki, M; Gungabeesoon, J; Freeman, GJ; Warren, SE; Ong, S; Browning, E; Twitty, CG; Pierce, RH; Le, MH; Algazi, AP; Daud, AI; Pai, SI; Zippelius, A; Weissleder, R; Pittet, MJ				Garris, Christopher S.; Arlauckas, Sean P.; Kohler, Rainer H.; Trefny, Marcel P.; Garren, Seth; Piot, Cecile; Engblom, Camilla; Pfirschke, Christina; Siwicki, Marie; Gungabeesoon, Jeremy; Freeman, Gordon J.; Warren, Sarah E.; Ong, Sufey; Browning, Erica; Twitty, Christopher G.; Pierce, Robert H.; Le, Mai H.; Algazi, Alain P.; Daud, Adil I.; Pai, Sara I.; Zippelius, Alfred; Weissleder, Ralph; Pittet, Mikael J.			Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-gamma and IL-12	IMMUNITY			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; PD-1; RESPONSES; CD40; BET; INTERLEUKIN-12; MACROPHAGES; REVEALS; ACTIVATION	Anti-PD-1 immune checkpoint blockers can induce sustained clinical responses in cancer but how they function in vivo remains incompletely understood. Here, we combined intravital real-time imaging with single-cell RNA sequencing analysis and mouse models to uncover anti-PD-1 pharmacodynamics directly within tumors. We showed that effective anti-tumor responses required a subset of tumor-infiltrating dendritic cells (DCs), which produced interleukin 12 (IL-12). These DCs did not bind anti-PD-1 but produced IL-12 upon sensing interferon gamma (IFN-gamma) that was released from neighboring T cells. In turn, DC-derived IL-12 stimulated antitumor T cell immunity. These findings suggest that full-fledged activation of antitumor T cells by anti-PD-1 is not direct, but rather involves T cell: DC crosstalk and is licensed by IFN-gamma and IL-12. Furthermore, we found that activating the non-canonical NF-kappa B transcription factor pathway amplified IL-12-producing DCs and sensitized tumors to anti-PD-1 treatment, suggesting a therapeutic strategy to improve responses to check-point blockade.	[Garris, Christopher S.; Arlauckas, Sean P.; Kohler, Rainer H.; Garren, Seth; Piot, Cecile; Engblom, Camilla; Pfirschke, Christina; Siwicki, Marie; Gungabeesoon, Jeremy; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA; [Garris, Christopher S.; Siwicki, Marie] Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA; [Arlauckas, Sean P.; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Dept Radiol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA; [Trefny, Marcel P.; Zippelius, Alfred] Univ Spital Basel, Med Oncol, Basel, Switzerland; [Trefny, Marcel P.] Univ Basel Hosp, Dept Biomed & Med Oncol, Canc Immunol, Basel, Switzerland; [Freeman, Gordon J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Warren, Sarah E.; Ong, Sufey] NanoString Technol, 500 Fairview Ave N, Seattle, WA 98109 USA; [Browning, Erica; Twitty, Christopher G.; Pierce, Robert H.; Le, Mai H.] Oncosec Inc, 5820 Nancy Ridge Dr, San Diego, CA 92121 USA; [Algazi, Alain P.; Daud, Adil I.] Univ Calif San Francisco, Med Ctr Mt Zion, 1600 Div St, San Francisco, CA 94115 USA; [Pai, Sara I.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Basel; University of Basel; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA.; Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Dept Radiol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Trefny, Marcel/AAH-3956-2019; Daud, Adil/T-3079-2019; Pittet, Mikael/ABD-6300-2021; Freeman, Gordon/AAC-5380-2019	Trefny, Marcel/0000-0001-6755-7899; Daud, Adil/0000-0002-6617-8421; Freeman, Gordon/0000-0002-7210-5616; Pai, Sara/0000-0002-6341-9971; Gungabeesoon, Jeremy/0000-0002-4505-3160; Twitty, Chris/0000-0002-0391-9659	Samana Cay MGH Research Scholar Fund; Robert Wenner Award from the Swiss Cancer League; NIH [R01-AI084880, R01-CA218579, R01-AI123349, R01-CA206890, R33CA202064, U01CA206997, P01 AI056299, P50CA101942, F31-CA196035, T32-CA79443]; Swiss National Cancer Foundation [320030_162575]; MGH ECOR Tosteson Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA079443, R01CA206890, U01CA224348, P50CA101942, R01CA218579, U01CA206997, F31CA196035, R33CA202064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123349, P01AI056299, R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Samana Cay MGH Research Scholar Fund; Robert Wenner Award from the Swiss Cancer League; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Cancer Foundation; MGH ECOR Tosteson Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	'We thank S. Agarwala, K. Lewis, and S. Bhatia for contributing to the ImmunoPulse IL-12 studies; K. King, A. Klein, and C. Weinreb for assistance with single-cell analysis; S. He and C. Chan for help with bone marrow chimera experiments; and the Harvard Biopolymers Core for help with single cell library generation. This work was supported in part by the Samana Cay MGH Research Scholar Fund, the Robert Wenner Award from the Swiss Cancer League, and NIH grants R01-AI084880, R01-CA218579, and R01-AI123349 (to M.J.P.), NIH grant R01-CA206890 (to M.J.P. and R.W.), NIH grants R33CA202064 and U01CA206997 (to R.W.), NIH grants P01 AI056299 and P50CA101942 (to G.J.F.), and Swiss National Cancer Foundation grant 320030_162575 (to A.Z.). C.S.G. was supported by NIH grant F31-CA196035; S.P.A. and S.G. were supported by NIH grant T32-CA79443; and C. Pfirschke was supported by the MGH ECOR Tosteson Postdoctoral Fellowship.	Alloatti A, 2017, J EXP MED, V214, P2231, DOI 10.1084/jem.20170229; Arlauskas S, 2017, SOC TEOR EMP POLIT P, P9; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Byrne KT, 2016, CELL REP, V15, P2719, DOI 10.1016/j.celrep.2016.05.058; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Hennessy EJ, 2013, J MED CHEM, V56, P9897, DOI 10.1021/jm401075x; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoves S, 2018, J EXP MED, V215, P859, DOI 10.1084/jem.20171440; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Katakam AK, 2015, P NATL ACAD SCI USA, V112, P14664, DOI 10.1073/pnas.1520627112; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lee SH, 2013, J IMMUNOL, V191, P4223, DOI 10.4049/jimmunol.1300910; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Ngiow SF, 2016, CANCER RES, V76, P6266, DOI 10.1158/0008-5472.CAN-16-2141; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pittet MJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aaq0491; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Reinhardt RL, 2015, J IMMUNOL, V194, P2358, DOI 10.4049/jimmunol.1401992; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Thurber GM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2506; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Weinreb C, 2018, BIOINFORMATICS, V34, P1246, DOI 10.1093/bioinformatics/btx792; Weissleder R, 2014, NAT MATER, V13, P125, DOI [10.1038/NMAT3780, 10.1038/nmat3780]; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yan J., 2018, COLD SPRING HARB PER, V10, P10	59	420	429	7	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1148	+		10.1016/j.immuni.2018.09.024	http://dx.doi.org/10.1016/j.immuni.2018.09.024			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30552023	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000453556500018
J	Shechter, R; Miller, O; Yovel, G; Rosenzweig, N; London, A; Ruckh, J; Kim, KW; Klein, E; Kalchenko, V; Bendel, P; Lira, SA; Jung, S; Schwartz, M				Shechter, Ravid; Miller, Omer; Yovel, Gili; Rosenzweig, Neta; London, Anat; Ruckh, Julia; Kim, Ki-Wook; Klein, Eugenia; Kalchenko, Vyacheslav; Bendel, Peter; Lira, Sergio A.; Jung, Steffen; Schwartz, Michal			Recruitment of Beneficial M2 Macrophages to Injured Spinal Cord Is Orchestrated by Remote Brain Choroid Plexus	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ECTO-5'-NUCLEOTIDASE CD73; DENDRITIC CELLS; MONOCYTES; CNS; REGENERATION; EXPRESSION; MICROGLIA; DIVERGENT	Monocyte-derived macrophages are essential for recovery after spinal cord injury, but their homing mechanism is poorly understood. Here, we show that although of common origin, the homing of proinflammatory (M1) and the "alternatively activated'' anti-inflammatory (M2) macrophages to traumatized spinal cord (SC) was distinctly regulated, neither being through breached blood-brain barrier. The M1 macrophages (Ly6c(hi)CX3CR1(lo)) derived from monocytes homed in a CCL2 chemokine-dependent manner through the adjacent SC leptomeninges. The resolving M2 macrophages (Ly6c(lo)CX3CR1(hi)) derived from monocytes trafficked through a remote blood-cerebrospinal-fluid (CSF) barrier, the brain-ventricular choroid plexus (CP), via VCAM-1-VLA-4 adhesion molecules and epithelial CD73 enzyme for extravasation and epithelial transmigration. Blockage of these determinants, or mechanical CSF flow obstruction, inhibited M2 macrophage recruitment and impaired motor-function recovery. The CP, along with the CSF and the central canal, provided an anti-inflammatory supporting milieu, potentially priming the trafficking monocytes. Overall, our finding demonstrates that the route of monocyte entry to central nervous system provides an instructional environment to shape their function.	[Shechter, Ravid; Miller, Omer; Yovel, Gili; Rosenzweig, Neta; London, Anat; Ruckh, Julia; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Kim, Ki-Wook; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Klein, Eugenia] Weizmann Inst Sci, Irving & Cherna Moskowitz Ctr Nano & Bio Nano Ima, IL-76100 Rehovot, Israel; [Kalchenko, Vyacheslav] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Bendel, Peter] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Icahn School of Medicine at Mount Sinai	Shechter, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ravid.shechter@weizmann.ac.il; michal.schwartz@weizmann.ac.il	Jung, Steffen/K-1409-2012; Kalchenko, Vyacheslav/F-2924-2012; Shechter, Ravid/GYA-5446-2022	Jung, Steffen/0000-0003-4290-5716; Shechter, Ravid/0000-0002-5956-413X; /0000-0002-7207-4389; Kalchenko, Vyacheslav/0000-0002-3166-7049	ISF-Legacy-Bio-Med program; ERC Advanced grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	ISF-Legacy-Bio-Med program; ERC Advanced grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Thompson for her generous gift of CD73 genetically ablated mice, S. Schwarzbaum for proofreading, and C. Raposo, G. Kunis, and M. Azulai for technical assistance. The work was supported in part by ISF-Legacy-Bio-Med program and the ERC Advanced grant. R. S., under the supervision of M. S., conceived the general ideas for this study and wrote the manuscript. R. S. in collaboration with O.M., G.Y., and N.R. or A. L. designed and performed experiments as well as conducted data analysis, with the assistance of J.R., E. K., V. K., and P. B. S.J. advised regarding monocytes.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bonner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034730; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Fieschi A, 1967, Minerva Med, V58, P4684; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalderon N, 2005, CURR PHARM DESIGN, V11, P1237, DOI 10.2174/1381612053507477; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Mills JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-193; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Radojicic M, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-30; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Slobodian Ili, 2007, Cerebrospinal Fluid Res, V4, P9, DOI 10.1186/1743-8454-4-9; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Takigawa T, 2010, J NEUROTRAUM, V27, P739, DOI 10.1089/neu.2009.1111; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P1031, DOI 10.1002/eji.1830220423; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701	40	420	432	3	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					555	569		10.1016/j.immuni.2013.02.012	http://dx.doi.org/10.1016/j.immuni.2013.02.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23477737	Bronze, Green Accepted			2022-12-18	WOS:000330941500019
J	Strainic, MG; Liu, JB; Huang, DP; An, F; Lalli, PN; Muqim, N; Shapiro, VS; Dubyak, GR; Heeger, PS; Medof, ME				Strainic, Michael G.; Liu, Jinbo; Huang, Danping; An, Fengqi; Lalli, Peter N.; Muqim, Nasima; Shapiro, Virginia S.; Dubyak, George R.; Heeger, Peter S.; Medof, M. Edward			Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4(+) T cells	IMMUNITY			English	Article							ACCELERATING FACTOR DAF; ACTIVATION; PATHWAY; INHIBITION; INFECTION; MIGRATION; IMMUNITY; MICE; CD28	Costimulatory signals are critical to T cell activation, but how their effects are mediated remains incompletely characterized. Here, we demonstrate that locally produced C5a and C3a. anaphylatoxins interacting with their G protein-coupled receptors (GPCRs), C5aR and C3aR, on APCs and T cells both upstream and downstream of CD28 and CD40L signaling are integrally involved in T cell proliferation and differentiation. Disabling these interactions reduced MHC class 11 and costimulatory-molecule expression and dramatically diminished T cell responses. Importantly, impaired T cell activation by Cd80(-/-)Cd86(-/-) and Cd40(-/-) APCs was reconstituted by added C5a. or C3a. C5aR and C3aR mediated their effects via PI-3 kinase-gamma-dependent AKT phosphorylation, providing a link between GPCR signaling, CD28 costimulation, and T cell survival. These local paracrine and autocrine interactions thus operate constitutively in naive T cells to maintain viability, and their amplification by cognate APC partners thus is critical to T cell costimulation.	[Strainic, Michael G.; Liu, Jinbo; Huang, Danping; An, Fengqi; Muqim, Nasima; Medof, M. Edward] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Lalli, Peter N.] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Shapiro, Virginia S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Dubyak, George R.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Heeger, Peter S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Case Western Reserve University; Cleveland Clinic Foundation; University of Pennsylvania; Case Western Reserve University; Icahn School of Medicine at Mount Sinai	Medof, ME (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	mxml6@case.edu		Strainic, Michael/0000-0003-2438-8540; Dubyak, George/0000-0001-9720-4226	NEI NIH HHS [EY11288, R01 EY011288] Funding Source: Medline; NIAID NIH HHS [R01 AI023598, R01 AI043578, R01 AI071185, AI23598, R01 AI071185-02, AI43578] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043578, R01AI071185, R01AI023598] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Diehl L, 2000, J MOL MED, V78, P363, DOI 10.1007/s001090000126; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Janeway C., 2005, IMMUNOBIOLOGY; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kung C, 2006, CHEM BIOL, V13, P399, DOI 10.1016/j.chembiol.2006.02.004; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; Lin F, 2001, IMMUNOLOGY, V104, P215, DOI 10.1046/j.1365-2567.2001.01287.x; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026; Peng Q, 2006, J IMMUNOL, V176, P3330, DOI 10.4049/jimmunol.176.6.3330; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Soruri A, 2003, IMMUNOL LETT, V88, P47, DOI 10.1016/S0165-2478(03)00052-X; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Wenderfer SE, 2005, J AM SOC NEPHROL, V16, P3572, DOI 10.1681/ASN.2005040373	22	420	438	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					425	435		10.1016/j.immuni.2008.02.001	http://dx.doi.org/10.1016/j.immuni.2008.02.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18328742	Bronze, Green Accepted			2022-12-18	WOS:000254142500019
J	NISHIZUMI, H; TANIUCHI, I; YAMANASHI, Y; KITAMURA, D; ILIC, D; MORI, S; WATANABE, T; YAMAMOTO, T				NISHIZUMI, H; TANIUCHI, I; YAMANASHI, Y; KITAMURA, D; ILIC, D; MORI, S; WATANABE, T; YAMAMOTO, T			IMPAIRED PROLIFERATION OF PERIPHERAL B-CELLS AND INDICATION OF AUTOIMMUNE-DISEASE IN LYN-DEFICIENT MICE	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR; LYMPHOCYTES-B; HEMATOPOIETIC-CELLS; MOTH-EATEN; ASSOCIATION; ACTIVATION; IMMUNOGLOBULIN; CHAIN; EXPRESSION	The Src family protein-tyrosine kinase Lyn associates physically with the BCR and has been suggested to play an important role in BCR-mediated signaling. Studies with lyn(-/-) mice showed that the number of B cells decreased by half in their peripheral tissues. In addition, these B cells do not respond normally to a number of stimuli, including BCR cross-linking and CD40 ligand. Induction of tyrosine phosphorylation on a variety of cellular proteins, such as Vav, Cbl, and HS1, upon BCR cross-linking was also abolished in these B cells, Despite the impaired BCR-mediated signaling, concentrations of IgM and IgA in sera were remarkably elevated, and production of autoantibodies was detected in lyn(-/-) mice. Histological study showed splenomegaly and enlargement of lymph nodes that became evident with age in the mutant mice. The spleen contained significant number of plasma cells as well as unusual iymphoblast-like cells carrying Mac1 antigen and cytoplasmic IgM. These cells spontaneously secreted a large amount of IgM in vitro. Finally, significant number of lyn(-/-) mice show glomerulonephritis, an indication of autoimmune disease. From these data, we conclude that Lyn plays a role in signal transduction for not only clonal expansion and terminal differentiation of peripheral B cells but also elimination of autoreactive B cells.	UNIV TOKYO,INST MED SCI,DEPT PATHOL,MINATO KU,TOKYO 108,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,DEPT MOLEC IMMUNOL,HIGASHI KU,FUKUOKA 812,JAPAN	University of Tokyo; Kyushu University	NISHIZUMI, H (corresponding author), UNIV TOKYO,INST MED SCI,DEPT ONCOL,MINATO KU,SHIROKANEDAI 4-6-1,TOKYO 108,JAPAN.		Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; ILIC, DUSKO/0000-0003-1647-0026				APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BELMONT JW, 1995, TRENDS GENET, V11, P112, DOI 10.1016/S0168-9525(00)89012-5; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; CUMANO A, 1994, IMMUNOL REV, V137, P3; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; DEFRANCO AL, 1982, J EXP MED, V155, P1523, DOI 10.1084/jem.155.5.1523; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; EISEMAN E, 1992, NATURE, V355, P78; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FUKUDA T, 1995, P NATL ACAD SCI USA, V92, P7302, DOI 10.1073/pnas.92.16.7302; GOLD MR, 1992, J IMMUNOL, V150, P377; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HIBBS ML, 1995, GENE, V156, P175, DOI 10.1016/0378-1119(95)00022-X; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KIM KM, 1993, IMMUNOL REV, V132, P125, DOI 10.1111/j.1600-065X.1993.tb00840.x; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLAUS GGB, 1987, IMMUNOL REV, V99, P19, DOI 10.1111/j.1600-065X.1987.tb01170.x; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; KOIKE M, 1995, INT IMMUNOL, V7, P21, DOI 10.1093/intimm/7.1.21; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; MORRIS DL, 1994, INT IMMUNOL, V6, P1011, DOI 10.1093/intimm/6.7.1011; MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAGAI K, 1995, J BIOL CHEM, V270, P6824, DOI 10.1074/jbc.270.12.6824; NATHANSON SD, 1977, J IMMUNOL METHODS, V18, P225, DOI 10.1016/0022-1759(77)90176-4; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SAXTON TM, 1994, J IMMUNOL, V153, P623; SCHEUERMANN RH, 1994, P NATL ACAD SCI USA, V91, P4048, DOI 10.1073/pnas.91.9.4048; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SIDORENKO SP, 1996, P NATL ACAD SCI USA, V92, P359; STANLEY E, 1991, MOL CELL BIOL, V11, P3399, DOI 10.1128/MCB.11.7.3399; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TEZUKA T, 1995, IN PRESS J EXP MED; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; YAMADA T, 1993, EUR J BIOCHEM, V213, P455, DOI 10.1111/j.1432-1033.1993.tb17781.x; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; YAMANASHI Y, 1991, CELL REGUL, V2, P979, DOI 10.1091/mbc.2.12.979; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; YI TL, 1991, MOL CELL BIOL, V11, P2391, DOI 10.1128/MCB.11.5.2391; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	73	420	426	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					549	560		10.1016/1074-7613(95)90126-4	http://dx.doi.org/10.1016/1074-7613(95)90126-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584145	Bronze			2022-12-18	WOS:A1995TG28100003
J	XIANG, ZQ; ERTL, HCJ				XIANG, ZQ; ERTL, HCJ			MANIPULATION OF THE IMMUNE-RESPONSE TO A PLASMID-ENCODED VIRAL-ANTIGEN BY COINOCULATION WITH PLASMIDS EXPRESSING CYTOKINES	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; DIRECT GENE-TRANSFER; RABIES VIRUS; MUSCLE INVIVO; MOUSE MUSCLE; MACROPHAGE; ANTIBODIES; INDUCTION; PROTEIN; CELLS	Inoculation of plasm id vectors encoding a viral protein into muscle tissue was shown to result in expression of the transantigen and, consequently, an antiviral immune response. Here, we show that coinoculation of a plasmid expressing the glycoprotein of rabies virus with plasmids encoding mouse cytokines modulated the immune response to the viral protein. Coinoculation with a vector expressing mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) enhanced the B and T helper cell activity to rabies virus, while coinoculation with a plasmid expressing interferon-gamma (IFN gamma) resulted in a decrease of the immune response to the viral antigen.			XIANG, ZQ (corresponding author), WISTAR INST ANAT & BIOL, 3601 SPRUCE ST, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027435, R01AI033683] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-27435, AI-33683] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABAI AM, 1994, VACCINES 94 - MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P77; ACSADI G, 1991, NATURE, V352, P815, DOI 10.1038/352815a0; ALTMANN SW, 1991, J BIOL CHEM, V266, P5333; BRETSCHER P, 1992, IMMUNOL TODAY, V13, P74, DOI 10.1016/0167-5699(92)90138-W; BURGER SR, 1991, J GEN VIROL, V72, P359, DOI 10.1099/0022-1317-72-2-359; COHEN J, 1993, SCIENCE, V259, P1690, DOI 10.1126/science.8456293; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; DAVIS HL, 1993, HUM GENE THER, V4, P151, DOI 10.1089/hum.1993.4.2-151; DONNELLY JJ, 1994, VACCINES 94 - MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P55; ERTL HC, 1990, J VIROL, V64, P3804; FABRY Z, 1994, IMMUNOL TODAY, V15, P218, DOI 10.1016/0167-5699(94)90247-X; FISCHER HG, 1988, J IMMUNOL, V141, P3882; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842; HEUFLER C, 1988, J EXP MED, V167, P700, DOI 10.1084/jem.167.2.700; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KREIDER BL, 1990, MOL CELL BIOL, V10, P4846, DOI 10.1128/MCB.10.9.4846; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; MONTGOMERY DL, 1994, VACCINES 94 - MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P61; MORRISSEY PJ, 1987, J IMMUNOL, V139, P1113; MOSMANN T, 1991, IMMUNOL TODAY, V12, P257, DOI 10.1016/0167-5699(91)90121-9; SCHUMACHER CL, 1989, J CLIN INVEST, V84, P971, DOI 10.1172/JCI114260; SHANKAR V, 1991, J VIROL, V65, P2736, DOI 10.1128/JVI.65.5.2736-2738.1991; STEEG PS, 1982, J EXP MED, V156, P1780, DOI 10.1084/jem.156.6.1780; TAO MH, 1993, NATURE, V362, P755, DOI 10.1038/362755a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WATANABE A, 1993, J IMMUNOL, V151, P2871; WIKTOR TJ, 1977, J VIROL, V21, P626, DOI 10.1128/JVI.21.2.626-635.1977; WIKTOR TJ, 1973, LABORATORY TECHNIQUE, V23, P101; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; XIANG ZQ, 1992, VIRUS RES, V24, P297, DOI 10.1016/0168-1702(92)90125-S; XIANG ZQ, 1994, VIROLOGY, V199, P132, DOI 10.1006/viro.1994.1105; XIANG ZQ, 1994, J VIROL METHODS, V47, P103, DOI 10.1016/0166-0934(94)90070-1; YANKAUCKAS MA, 1993, DNA CELL BIOL, V12, P771, DOI 10.1089/dna.1993.12.771; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0	38	420	488	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1995	2	2					129	135		10.1016/S1074-7613(95)80001-8	http://dx.doi.org/10.1016/S1074-7613(95)80001-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895169	Bronze			2022-12-18	WOS:A1995QH13200001
J	MOREL, L; RUDOFSKY, UH; LONGMATE, JA; SCHIFFENBAUER, J; WAKELAND, EK				MOREL, L; RUDOFSKY, UH; LONGMATE, JA; SCHIFFENBAUER, J; WAKELAND, EK			POLYGENIC CONTROL OF SUSCEPTIBILITY TO MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS	IMMUNITY			English	Article							NEW-ZEALAND MICE; GENETIC-ANALYSIS; AUTOIMMUNE-DISEASE; RENAL-DISEASE; NZW MICE; NEPHRITIS; LYMPHOPROLIFERATION; EXPRESSION; APOPTOSIS; TRAITS	Susceptibility to glomerulonephritis (GN) and anti-dsDNA autoantibody production was analyzed in crosses with a newly developed systemic lupus erythematosus-susceptible inbred strain, NZM/Aeg2410. The mode of inheritance and the number and location of systemic lupus erythematosus-associated susceptibility loci were analyzed by interval mapping in a backcross with C57BL/6. Three chromosomal intervals containing strong recessive GN susceptibility alleles were identified on chromosomes 1, 4, and 7, each containing several potentially interesting candidate genes. Heterozygosity at H-2 was also found to correlate strongly with GN susceptibility, consistent with previous findings in the NZB/NZW parental strain model. Logistic regression analysis indicated that each of these susceptibility alleles independently accounted for a component of GN susceptibility, and that susceptibility was inherited as a threshold genetic liability in this model system.	UNIV FLORIDA,COLL MED,DEPT PATHOL & LAB MED,GAINESVILLE,FL 32610; NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201; UNIV FLORIDA,DEPT STAT,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT MED,GAINESVILLE,FL 32610	State University System of Florida; University of Florida; State University of New York (SUNY) System; Wadsworth Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida	MOREL, L (corresponding author), UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,GAINESVILLE,FL 32610, USA.			Longmate, Jeffrey/0000-0002-0869-7928	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017966] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47138] Funding Source: Medline; NIAID NIH HHS [AI17966] Funding Source: Medline; NIGMS NIH HHS [GM39578] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ATKINSON JP, 1992, SYSTEMIC LUPUS ERYTH, P87; BABCOCK SK, 1989, P NATL ACAD SCI USA, V86, P7552, DOI 10.1073/pnas.86.19.7552; BRAVERMAN IM, 1968, J INVEST DERMATOL, V50, P483, DOI 10.1038/jid.1968.79; Cook L., 1992, SYSTEMIC LUPUS ERYTH, P569; DIETRICH W, 1992, GENETICS, V131, P423; ERLICH HA, 1993, MOL PATHOLOGY AUTOIM, P101; GELEHRTER TD, 1990, PRINCIPLES MED GENET; HIROSE S, 1984, CLIN EXP IMMUNOL, V58, P694; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; KNIGHT JG, 1978, J EXP MED, V147, P1653, DOI 10.1084/jem.147.6.1653; KNIGHT JG, 1981, J CLIN LAB IMMUNOL, V5, P165; KOTZIN BL, 1988, AM J MED, V85, P29, DOI 10.1016/0002-9343(88)90378-6; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Lu C C., 1990, THESIS U FLORIDA; MARUYAMA N, 1983, IMMUNOGENETICS, V18, P365, DOI 10.1007/BF00372469; NELSEN B, 1992, INT REV CYTOL, V133, P121, DOI 10.1016/S0074-7696(08)61859-8; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Osaki S., 1983, IMMUNOGENETICS, V18, P241; Prudliormme G, 1993, MOL PATHOLOGY AUTOIM, P149; RACKE MK, 1991, J IMMUNOL, V146, P3012; RAVECHE ES, 1981, J EXP MED, V153, P1187, DOI 10.1084/jem.153.5.1187; Roderick T. H., 1992, GBASE LINKAGE MAP EN; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; RUDOFSKY UH, 1978, LAB INVEST, V39, P441; RUDOFSKY UH, 1993, LAB INVEST, V68, P419; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Theofilopoulos AN, 1992, SYSTEMIC LUPUS ERYTH, P121; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; WATSON ML, 1990, J EXP MED, V172, P263, DOI 10.1084/jem.172.1.263; Winchester R., 1992, SYSTEMIC LUPUS ERYTH, P65; YOSHIDA H, 1981, J IMMUNOL, V127, P433	38	420	426	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1994	1	3					219	229		10.1016/1074-7613(94)90100-7	http://dx.doi.org/10.1016/1074-7613(94)90100-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7889410				2022-12-18	WOS:A1994PK16500006
J	Bernink, JH; Krabbendam, L; Germar, K; de Jong, E; Gronke, K; Kofoed-Nielsen, M; Munneke, JM; Hazenberg, MD; Villaudy, J; Buskens, CJ; Bemelman, WA; Diefenbach, A; Blom, B; Spits, H				Bernink, Jochem H.; Krabbendam, Lisette; Germar, Kristine; de Jong, Esther; Gronke, Konrad; Kofoed-Nielsen, Michael; Munneke, J. Marius; Hazenberg, Mette D.; Villaudy, Julien; Buskens, Christianne J.; Bemelman, Willem A.; Diefenbach, Andreas; Blom, Bianca; Spits, Hergen			Interleukin-12 and-23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria	IMMUNITY			English	Article							T-BET; RETINOIC-ACID; T(H)17 DIFFERENTIATION; DENDRITIC CELLS; INFLAMMATION; EXPRESSION; INSIGHTS	Human group 1 ILCs consist of at least three phenotypically distinct subsets, including NK cells, CD127(+) ILC1, and intraepithelial CD103(+) ILC1. In inflamed intestinal tissues from Crohn's disease patients, numbers of CD127(+) ILC1 increased at the cost of ILC3. Here we found that differentiation of ILC3 to CD127(+) ILC1 is reversible in vitro and in vivo. CD127(+) ILC1 differentiated to ILC3 in the presence of interleukin-2 (IL-2), IL-23, and IL-1 beta dependent on the transcription factor ROR gamma t, and this process was enhanced in the presence of retinoic acid. Furthermore, we observed in resection specimen from Crohn's disease patients a higher proportion of CD14(+) dendritic cells (DC), which in vitro promoted polarization from ILC3 to CD127(+) ILC1. In contrast, CD14(-) DCs promoted differentiation from CD127(+) ILC1 toward ILC3. These observations suggest that environmental cues determine the composition, function, and phenotype of CD127(+) ILC1 and ILC3 in the gut.	[Bernink, Jochem H.; Krabbendam, Lisette; Germar, Kristine; de Jong, Esther; Blom, Bianca; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Munneke, J. Marius; Hazenberg, Mette D.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; [Villaudy, Julien] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Buskens, Christianne J.; Bemelman, Willem A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Gronke, Konrad; Kofoed-Nielsen, Michael; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Immunol Res Ctr, D-55131 Mainz, Germany; [Gronke, Konrad; Kofoed-Nielsen, Michael; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Diefenbach, Andreas/T-2589-2018; Bemelman, Wilhelmus Adrianus/AAA-1635-2021	Diefenbach, Andreas/0000-0002-9176-9530; Bemelman, Wilhelmus Adrianus/0000-0002-1037-9945; Hazenberg, Mette/0000-0002-5113-0249; Villaudy, Julien/0000-0001-7939-9461	European Research Council	European Research Council(European Research Council (ERC)European Commission)	We thank B. Hooibrink for help with flow cytometry; staff of the Bloemenhove clinic in Heemstede, the Netherlands, for fetal tissues; and K. Weijer for processing fetal material. H.S. is supported by an advanced grant of the European Research Council.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bakdash G, 2015, MUCOSAL IMMUNOL, V8, P265, DOI 10.1038/mi.2014.64; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Sanders TJ, 2014, GASTROENTEROLOGY, V146, P1278, DOI 10.1053/j.gastro.2014.01.057; Sanos SL, 2010, METHODS MOL BIOL, V612, P505, DOI 10.1007/978-1-60761-362-6_32; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017	38	418	432	7	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					146	160		10.1016/j.immuni.2015.06.019	http://dx.doi.org/10.1016/j.immuni.2015.06.019			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26187413	Bronze			2022-12-18	WOS:000360101100017
J	Ahearn, JM; Fischer, MB; Croix, D; Goerg, S; Ma, MH; Xia, JR; Zhou, XN; Howard, RG; Rothstein, TL; Carroll, MC				Ahearn, JM; Fischer, MB; Croix, D; Goerg, S; Ma, MH; Xia, JR; Zhou, XN; Howard, RG; Rothstein, TL; Carroll, MC			Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen	IMMUNITY			English	Article							COMPLEMENT RECEPTOR TYPE-2; FOLLICULAR DENDRITIC CELLS; LYMPHOCYTES-B; IMMUNE-RESPONSE; ANTIBODY-RESPONSE; GERMINAL-CENTERS; LYMPHOID-TISSUE; MEMBRANE IGM; CLASS-II; MOUSE	Covalent attachment of activated products of the third component of complement to antigen enhances its immunogenicity, but the mechanism is not clear. This effect is mediated by specific receptors, mCR1 (CD35) and mCR2 (CD21), expressed primarily on B cells and follicular dendritic cells in mice. To dissect the role of mCR1 and mCR2 in the humoral response, we have disrupted the Cr2 locus to generate mice deficient in both receptors. The deficient mice (Cr2(-/-)) were found to have a reduction in the CD5(+) population of peritoneal B-1 cells, although their serum IgM levels were within the range of normal mice. Moreover, Cr2(-/-) mice had a severe defect in their humoral response to T-dependent antigens that was characterized by a reduction in serum antibody titers and in the number and size of germinal centers within splenic follicles. Reconstitution of the deficient mice with bone marrow from MHC-matched Cr2(+/+) donors corrected the defect, demonstrating that the defect was due to B cells themselves. These results indicate an obligatory role of B cell complement receptors in responses of the B cells to protein antigens.	HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV RHEUMATOL, BALTIMORE, MD 21205 USA; BOSTON UNIV, SCH MED, DEPT MED, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, DEPT MICROBIOL, BOSTON, MA 02118 USA	Harvard University; Harvard Medical School; Johns Hopkins University; Boston University; Boston University			Fischer, Michael/AAU-5579-2020	Fischer, Michael/0000-0002-5876-0243	NIAID NIH HHS [AI-32544, R01 AI029690] Funding Source: Medline; NICHD NIH HHS [HD-1746] Funding Source: Medline; NIGMS NIH HHS [GM-43803] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029690, R01AI032544] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; BITTERSUERMANN D, 1990, CURR TOP MICROBIOL, V153, P222; BOTTGER EC, 1986, EUR J IMMUNOL, V16, P1231, DOI 10.1002/eji.1830161008; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; CARROLL MC, 1988, J EXP MED, V167, P1271, DOI 10.1084/jem.167.4.1271; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1988, J IMMUNOL, V141, P457; CARTER RH, 1991, J IMMUNOL, V147, P3663; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; CROIX D, 1996, IN PRESS J EXP MED, V183; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; FINCO O, 1992, J EXP MED, V175, P537, DOI 10.1084/jem.175.2.537; FINGEROTH JD, 1989, P NATL ACAD SCI USA, V86, P242, DOI 10.1073/pnas.86.1.242; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; HAN SH, 1995, J IMMUNOL, V155, P556; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; HUMPHREY JH, 1984, EUR J IMMUNOL, V14, P859, DOI 10.1002/eji.1830140916; IMAZEKI N, 1992, IMMUNOLOGY, V76, P508; JACKSON CG, 1979, NEW ENGL J MED, V300, P1124, DOI 10.1056/NEJM197905173002002; KALLI KR, 1994, J IMMUNOL, V152, P2899; KANSAS GS, 1991, J IMMUNOL, V147, P4094; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; KELSOE G, 1995, IMMUNOL TODAY, V16, P324, DOI 10.1016/0167-5699(95)80146-4; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; KINOSHITA T, 1985, J IMMUNOL, V134, P2564; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KOLLER BH, 1992, ANNU REV IMMUNOL, V10, P705, DOI 10.1146/annurev.iy.10.040192.003421; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; KURTZ CB, 1990, J IMMUNOL, V144, P3581; LAW SK, 1980, P NATL ACAD SCI-BIOL, V77, P7194, DOI 10.1073/pnas.77.12.7194; LIU Y, 1992, P NATL ACAD SCI USA, V89, P3845, DOI 10.1073/pnas.89.9.3845; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MATSUMOTO AK, 1991, J EXP MED, V173, P55, DOI 10.1084/jem.173.1.55; MOLINA H, 1990, J IMMUNOL, V145, P2974; MOLINA H, 1994, J IMMUNOL, V153, P789; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; OCHS HD, 1983, CLIN EXP IMMUNOL, V53, P208; ONEIL KM, 1988, J IMMUNOL, V140, P1939; PAPAMICHAIL M, 1975, SCAND J IMMUNOL, V4, P343, DOI 10.1111/j.1365-3083.1975.tb02635.x; PEPYS MB, 1972, NATURE-NEW BIOL, V237, P157, DOI 10.1038/newbio237157a0; PRAMOONJAGO P, 1993, INT IMMUNOL, V5, P337, DOI 10.1093/intimm/5.4.337; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; REYCAMPOS J, 1988, J EXP MED, V167, P664, DOI 10.1084/jem.167.2.664; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; TEW JG, 1979, IMMUNOLOGY, V37, P69; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	62	418	436	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1996	4	3					251	262		10.1016/S1074-7613(00)80433-1	http://dx.doi.org/10.1016/S1074-7613(00)80433-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624815	hybrid			2022-12-18	WOS:A1996UC01800006
J	GULBINS, E; BISSONNETTE, R; MAHBOUBI, A; MARTIN, S; NISHIOKA, W; BRUNNER, T; BAIER, G; BAIERBITTERLICH, G; BYRD, C; LANG, F; KOLESNICK, R; ALTMAN, A; GREEN, D				GULBINS, E; BISSONNETTE, R; MAHBOUBI, A; MARTIN, S; NISHIOKA, W; BRUNNER, T; BAIER, G; BAIERBITTERLICH, G; BYRD, C; LANG, F; KOLESNICK, R; ALTMAN, A; GREEN, D			FAS-INDUCED APOPTOSIS IS MEDIATED VIA A CERAMIDE-INITIATED RAS SIGNALING PATHWAY	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; CELL ANTIGEN RECEPTOR; HL-60 CELLS; C-MYC; TYROSINE PHOSPHORYLATION; TRANSDUCTION PATHWAY; ONCOGENE EXPRESSION; DNA FRAGMENTATION; SURFACE ANTIGEN	Fas receptor-induced apoptosis plays critical roles in immune homeostasis. However, most of the signal transduction events distal to Fas ligation have not been elucidated. Here, we show that Res is activated following ligation of Fas on lymphoid lines. The activation of Ras is a critical component of this apoptotic pathway, since inhibition of Res by neutralizing antibody or a dominant-negative Res mutant interfered with Fas-induced apoptosis. Furthermore, ligation of Fas also resulted in stimulation of the sphingomyelin signaling pathway to produce ceramides, which, in turn, are capable of inducing both Res activation and apoptosis. This suggests that ceramides acts as second messengers in Fas signaling via Ras. Thus, ligation of the Fas molecule on lymphocyte lines induces activation of Ras via the action of ceramide, and this activation is necessary, but not sufficient, for subsequent apoptosis.	LA JOLLA INST ALLERGY & IMMUNOL,DIV CELL BIOL,LA JOLLA,CA 92037; LA JOLLA INST ALLERGY & IMMUNOL,DIV CELLULAR IMMUNOL,LA JOLLA,CA 92037; MEM SLOAN KETTERING CANC CTR,DEPT MED,NEW YORK,NY 10021	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Memorial Sloan Kettering Cancer Center	GULBINS, E (corresponding author), UNIV TUBINGEN,INST PHYSIOL,D-72076 TUBINGEN,GERMANY.		Baier, Gottfried/E-8755-2012; Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342; Baier, Gottfried/0000-0002-2085-8325; Martin, Seamus/0000-0002-8539-3143	NCI NIH HHS [CA35299] Funding Source: Medline; NIGMS NIH HHS [GM50819, GM52735] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM052735, R01GM050819] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; ASKEW DS, 1991, ONCOGENE, V6, P1915; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BERGLUND DL, 1991, CYTOMETRY, V12, P64, DOI 10.1002/cyto.990120109; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; BISSONNETTE RP, 1994, APOPTOSIS, V2, P327; CHESA PG, 1987, P NATL ACAD SCI USA, V84, P3234, DOI 10.1073/pnas.84.10.3234; CIFONE MG, 1994, J EXP MED, V177, P1547; CLEMENT MV, 1994, J EXP MED, V180, P557, DOI 10.1084/jem.180.2.557; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; DUKE RC, 1991, CURRENT PROTOCOLS IM; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; GILL BM, 1994, IMMUNOL REV, V142, P113, DOI 10.1111/j.1600-065X.1994.tb00885.x; GREEN DR, 1994, CURR OPIN IMMUNOL, V6, P476, DOI 10.1016/0952-7915(94)90130-9; GULBINS E, 1994, MOL CELL BIOL, V14, P906, DOI 10.1128/MCB.14.2.906; HAGEMEIER E, 1982, J CHROMATOGR, V237, P174, DOI 10.1016/S0021-9673(00)88288-6; HAIMOVITZFRIEDM.A, 1994, J EXP MED, V180, P525; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JOSEPH CK, 1993, J BIOL CHEM, V268, P20002; JUNE CH, 1990, J IMMUNOL, V144, P1591; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIM MY, 1991, J BIOL CHEM, V266, P484; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; MAPARA MY, 1993, EUR J IMMUNOL, V23, P702, DOI 10.1002/eji.1830230320; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1993, NATURE, V264, P806; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; OWENSCHAUB LB, 1992, CELL IMMUNOL, V140, P197, DOI 10.1016/0008-8749(92)90187-T; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAINES MA, 1993, J BIOL CHEM, V268, P14572; REBECCHI MJ, 1983, J BIOL CHEM, V258, P227; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SATOH T, 1992, J BIOL CHEM, V267, P24149; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; Williams Lewis T., 1992, Current Biology, V2, P601, DOI 10.1016/0960-9822(92)90169-B; WONG GHW, 1994, J IMMUNOL, V152, P1751; WU JG, 1994, P NATL ACAD SCI USA, V91, P2344, DOI 10.1073/pnas.91.6.2344; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1987, BRIT J CANCER, V56, P251, DOI 10.1038/bjc.1987.186; YANAGA F, 1992, FEBS LETT, V314, P297, DOI 10.1016/0014-5793(92)81493-6; YANG ZH, 1993, J BIOL CHEM, V268, P20520; YOUNES A, 1992, J BIOL CHEM, V267, P842	67	418	422	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					341	351		10.1016/1074-7613(95)90142-6	http://dx.doi.org/10.1016/1074-7613(95)90142-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7536620	Bronze			2022-12-18	WOS:A1995QU61600004
J	Viglianti, GA; Lau, CM; Hanley, TM; Miko, BA; Shlomchik, MJ; Rothstein, AM				Viglianti, GA; Lau, CM; Hanley, TM; Miko, BA; Shlomchik, MJ; Rothstein, AM			Activation of autoreactive B cells by CpG dsDNA	IMMUNITY			English	Article							BACTERIAL-DNA; ANTIGEN RECEPTOR; IMMUNE-COMPLEXES; MOUSE; AUTOANTIBODY; ISLANDS; MOTIFS; PROLIFERATION; HYPERMUTATION; AUTOIMMUNITY	The proliferative response of autoreactive rheumatoid factor (RF) B cells to mammalian chromatin-containing immune complexes (ICs) results from the sequential engagement of the B cell receptor (BCR) and Toll-like receptor 9 (TLR9). We have used ICs constructed from anti-hapten antibodies and defined haptenated dsDNA fragments to determine the form of mammalian DNA that mediates this process. Despite their relatively low abundance in mammalian DNA, we found that inclusion of hypomethylated CpG motifs in these ICs was necessary for effective activation. In the absence of antibody, the same fragments could efficiently stimulate low-affinity hapten-specific and DNA-reactive 3H9 B cells, but not RF B cells. These results extend the BCR/TLR9 coengagement paradigm to a second major class of autoreactive B cells, further confirm the critical role of the BCR in chromatin ligand delivery to TLR9, and implicate hypomethylated CpG motifs as ligand elements necessary for the initiation of systemic autoimmune disease.	Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Boston University; Yale University; Yale University	Viglianti, GA (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.	gviglian@bu.edu	Shlomchik, Mark J./AAN-6189-2020; Hanley, Timothy/AAG-7547-2020	Shlomchik, Mark J./0000-0002-2152-0959; Hanley, Timothy/0000-0002-6253-6850; Viglianti, Gregory/0000-0002-0244-8293	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI043603, R01AI043603, P01AI036529] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43603, P01-AI36529] Funding Source: Medline; NIAMS NIH HHS [AR35320] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Cross SH, 1997, GENOMICS, V40, P454, DOI 10.1006/geno.1996.4598; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; DONGWORTH DW, 1982, EUR J IMMUNOL, V12, P1018, DOI 10.1002/eji.1830121207; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goeckeritz BE, 1999, INT IMMUNOL, V11, P1693, DOI 10.1093/intimm/11.10.1693; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Heit A, 2003, J IMMUNOL, V170, P2802, DOI 10.4049/jimmunol.170.6.2802; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; JACOBSON BA, 1994, J IMMUNOL, V152, P4489; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Krystosek A, 1999, HISTOCHEM CELL BIOL, V111, P265, DOI 10.1007/s004180050357; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LENART P, 2001, ANTISENSE NUCLEIC A, V4, P247; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; MESSINA JP, 1991, J IMMUNOL, V147, P1759; Monestier M, 1996, MOL IMMUNOL, V33, P89, DOI 10.1016/0161-5890(95)00115-8; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; RADIC MZ, 1991, J IMMUNOL, V146, P176; ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; SANO H, 1982, J IMMUNOL, V128, P1341; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; SONG WX, 1995, J IMMUNOL, V155, P4255; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; Wang HW, 1997, J IMMUNOL, V159, P1125; Wang YQ, 2003, INT IMMUNOL, V15, P223, DOI 10.1093/intimm/dxg020; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; WOLFOWICZ CB, 1988, CLIN IMMUNOL IMMUNOP, V46, P382, DOI 10.1016/0090-1229(88)90057-8; YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983, DOI 10.1111/j.1348-0421.1992.tb02102.x; Zhu FG, 2003, IMMUNOLOGY, V109, P255, DOI 10.1046/j.1365-2567.2003.01653.x	41	417	437	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					837	847		10.1016/S1074-7613(03)00323-6	http://dx.doi.org/10.1016/S1074-7613(03)00323-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670301	Bronze			2022-12-18	WOS:000187230700009
J	Lee, JS; Tato, CM; Joyce-Shaikh, B; Gulan, F; Cayatte, C; Chen, Y; Blumenschein, WM; Judo, M; Ayanoglu, G; McClanahan, TK; Li, XX; Cua, DJ				Lee, Jacob S.; Tato, Cristina M.; Joyce-Shaikh, Barbara; Gulan, Fatih; Cayatte, Corinne; Chen, Yi; Blumenschein, Wendy M.; Judo, Michael; Ayanoglu, Gulesi; McClanahan, Terrill K.; Li, Xiaoxia; Cua, Daniel J.			Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; T-CELLS; PROINFLAMMATORY IL-17(+); BARRIER FUNCTION; TH17 CELLS; INFLAMMATION; RECEPTOR; ACT1; EXPRESSION; IL-23	Whether interleukin-17A (IL-17A) has pathogenic and/or protective roles in the gut mucosa is controversial and few studies have analyzed specific cell populations for protective functions within the inflamed colonic tissue. Here we have provided evidence for IL-17A-dependent regulation of the tight junction protein occludin during epithelial injury that limits excessive permeability and maintains barrier integrity. Analysis of epithelial cells showed that in the absence of signaling via the IL-17 receptor adaptor protein Act-1, the protective effect of IL-17A was abrogated and inflammation was enhanced. We have demonstrated that after acute intestinal injury, IL-23R(+) gamma delta T cells in the colonic lamina propria were the primary producers of early, gut-protective IL-17A, and this production of IL-17A was IL-23 independent, leaving protective IL-17 intact in the absence of IL-23. These results suggest that IL-17-producing gamma delta T cells are important for the maintenance and protection of epithelial barriers in the intestinal mucosa.	[Lee, Jacob S.; Tato, Cristina M.; Joyce-Shaikh, Barbara; Cayatte, Corinne; Chen, Yi; Blumenschein, Wendy M.; Judo, Michael; Ayanoglu, Gulesi; McClanahan, Terrill K.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA; [Gulan, Fatih; Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Merck & Company; Cleveland Clinic Foundation	Cua, DJ (corresponding author), Merck Res Labs, Palo Alto, CA 94304 USA.	daniel.cua@merck.com		Tato, Cristina M./0000-0002-0614-756X	NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA062220] Funding Source: Medline; NHLBI NIH HHS [U10 HL109250, P01 HL103453] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; DSouza CD, 1997, J IMMUNOL, V158, P1217; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakasone C, 2007, MICROBES INFECT, V9, P251, DOI 10.1016/j.micinf.2006.11.015; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Shen W, 2010, NEUROCHEM RES, V35, P940, DOI 10.1007/s11064-009-0091-9; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	47	415	426	5	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					727	738		10.1016/j.immuni.2015.09.003	http://dx.doi.org/10.1016/j.immuni.2015.09.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26431948	Bronze, Green Accepted			2022-12-18	WOS:000363478700015
J	Kaech, SM; Wherry, EJ				Kaech, Susan M.; Wherry, E. John			Heterogeneity and cell-fate decisions in effector and memory CD8(+) T cell differentiation during viral infection	IMMUNITY			English	Review							IL-7 RECEPTOR-ALPHA; CUTTING EDGE; PRECURSOR FREQUENCY; CLONAL EXPANSION; LINEAGE RELATIONSHIP; SECONDARY EXPANSION; PROTECTIVE IMMUNITY; T(H)1 CELLS; CD4(+); EXPRESSION	Heterogeneity is a hallmark of the adaptive immune system. This is most evident in the enormous diversity of B and T cell antigen receptors. There is also heterogeneity within antiviral T cell populations, and subsets of effector and memory T cells now permeate our thinking about specialization of T cell responses to pathogens. It has been less clear, however, how heterogeneity in developing virus-specific effector and memory T cells is related to cell-fate decisions in the immune response, such as the generation long-lived memory T cells. Here we discuss recent findings that might help redefine how heterogeneity in antiviral T cell populations gives rise to T cell subsets with short- and long-lived cell fates.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06437 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA	Yale University; The Wistar Institute	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06437 USA.	susan.kaech@yale.edu; jwherry@wistar.org	Wherry, John/ABI-1280-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309, R01AI066232, R21AI077075, R37AI066232] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI066232, R01 AI071309, R01 AI066232-03, AI066232, AI077075, AI071309, R21 AI077075, R01 AI066232] Funding Source: Medline; Wellcome Trust [1004313] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Bachmann MF, 2004, EUR J IMMUNOL, V34, P317, DOI 10.1002/eji.200324717; Badovinac VP, 2007, J IMMUNOL, V179, P53, DOI 10.4049/jimmunol.179.1.53; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, J IMMUNOL, V177, P999, DOI 10.4049/jimmunol.177.2.999; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Bullock TNJ, 2000, J IMMUNOL, V164, P2354, DOI 10.4049/jimmunol.164.5.2354; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Farber DL, 1998, J IMMUNOL, V160, P535; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Hervas-Stubbs S, 2007, BLOOD, V109, P5318, DOI 10.1182/blood-2006-10-053256; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; LIANG SH, 1994, J IMMUNOL, V152, P1653; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Northrop JK, 2004, CURR OPIN IMMUNOL, V16, P451, DOI 10.1016/j.coi.2004.05.004; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Roberts AD, 2004, J IMMUNOL, V172, P6533, DOI 10.4049/jimmunol.172.11.6533; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; Sabbaj S, 2007, J INFECT DIS, V195, P108, DOI 10.1086/509510; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2001, J CLIN INVEST, V108, P805, DOI 10.1172/JCI14005; Seaman MS, 2004, J VIROL, V78, P206, DOI 10.1128/JVI.78.1.206-215.2004; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Sun JC, 2006, J IMMUNOL, V177, P4458, DOI 10.4049/jimmunol.177.7.4458; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tripathi P, 2007, J IMMUNOL, V178, P4027, DOI 10.4049/jimmunol.178.7.4027; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; van Leeuwen EMM, 2005, BLOOD, V106, P2091, DOI 10.1182/blood-2005-02-0449; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Wherry EJ, 1998, 10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, P393; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Whitmire JK, 2005, J IMMUNOL, V175, P5624, DOI 10.4049/jimmunol.175.9.5624; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	123	415	429	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					393	405		10.1016/j.immuni.2007.08.007	http://dx.doi.org/10.1016/j.immuni.2007.08.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892848	Green Accepted, Bronze			2022-12-18	WOS:000249843400005
J	Chen, YH; Chiu, NM; Mandal, M; Wang, N; Wang, CR				Chen, YH; Chiu, NM; Mandal, M; Wang, N; Wang, CR			Impaired NK1(+) T cell development and early IL-4 production in CD1-deficient mice	IMMUNITY			English	Article							RECEPTOR-ALPHA-CHAIN; ANTIGEN RECEPTOR; LYMPHOCYTES-T; MOUSE CD1; EXPRESSION; SUBSET; THYMOCYTES; FAMILY; CD4(+); RECOGNITION	The MHC class Ib molecule, CD1, has been conserved throughout mammalian evolution. To assess the function of CD1 in lymphocyte development, we generated mice with targeted disruption of the CD1.1 and CD1.2 genes. CD1-deficient mice have normal numbers of CD4(+) and CD8(+) T cells but marked reduction in NK1.1-bearing T cells, particularly those with a canonical gene rearrangement of V alpha 14-J alpha 281. CD1-deficient mice are unable to generate a rapid IL-4 response following systemic T cell activation but can generate effective antigen-specific Th2 responses. Thus, CD1 is required for the development of a specialized subset of T lymphocytes with a monomorphic antigen receptor. The rapid effector cytokine secretion of these T cells suggests that CD1 educates adaptive immune cells to subserve functions of innate immunity.			Chen, YH (corresponding author), UNIV CHICAGO,DEPT PATHOL,COMM IMMUNOL,GWEN KNAPP CTR LUPUS & IMMUNOL RES,5841 S MARYLAND AVE,CHICAGO,IL 60637, USA.				NIMH NIH HHS [K08 MH090397] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090397] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADACHI Y, 1995, P NATL ACAD SCI USA, V92, P1200, DOI 10.1073/pnas.92.4.1200; ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BIX M, 1995, J IMMUNOL, V155, P1020; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; BRADBURY A, 1990, EUR J IMMUNOL, V20, P1831, DOI 10.1002/eji.1830200830; BRADBURY A, 1988, EMBO J, V7, P3081, DOI 10.1002/j.1460-2075.1988.tb03173.x; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Brown DR, 1996, J EXP MED, V184, P803, DOI 10.1084/jem.184.3.803; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; CATTORETTI G, 1987, LEUCOCYTE TYPING, V3, P89; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; DELLABONA P, 1993, J EXP MED, V177, P1763, DOI 10.1084/jem.177.6.1763; Denkers EY, 1996, J EXP MED, V184, P131, DOI 10.1084/jem.184.1.131; EMOTO M, 1995, INT IMMUNOL, V7, P1729, DOI 10.1093/intimm/7.11.1729; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; GOOSSENS PL, 1990, J IMMUNOL METHODS, V132, P137, DOI 10.1016/0022-1759(90)90407-M; HANAU D, 1994, HUM IMMUNOL, V41, P61, DOI 10.1016/0198-8859(94)90086-8; HASHIMOTO W, 1995, J IMMUNOL, V154, P4333; HAYAKAWA K, 1992, J EXP MED, V176, P269, DOI 10.1084/jem.176.1.269; HOWE RC, 1989, EUR J IMMUNOL, V19, P25, DOI 10.1002/eji.1830190105; Joyce S, 1996, J EXP MED, V184, P1579, DOI 10.1084/jem.184.4.1579; Jullien D, 1996, RES IMMUNOL, V147, P321, DOI 10.1016/0923-2494(96)89645-3; KASINRERK W, 1993, J IMMUNOL, V150, P579; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LEITEDEMORAES MD, 1995, J IMMUNOL, V155, P4544; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; MEISLER MH, 1992, GENOME, V3, pS44; Mieza MA, 1996, J IMMUNOL, V156, P4035; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; vonderWeid T, 1996, J IMMUNOL, V157, P4421; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; YU CY, 1989, EMBO J, V8, P3727, DOI 10.1002/j.1460-2075.1989.tb08548.x; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; ZLOTNIK A, 1992, J IMMUNOL, V149, P1211	58	415	418	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					459	467		10.1016/S1074-7613(00)80289-7	http://dx.doi.org/10.1016/S1074-7613(00)80289-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133425	Bronze			2022-12-18	WOS:A1997XC61900011
J	Coyle, AJ; Lehar, S; Lloyd, C; Tian, J; Delaney, T; Manning, S; Nguyen, T; Burwell, T; Schneider, H; Gonzalo, JA; Gosselin, M; Owen, LR; Rudd, CE; Gutierrez-Ramos, JC				Coyle, AJ; Lehar, S; Lloyd, C; Tian, J; Delaney, T; Manning, S; Nguyen, T; Burwell, T; Schneider, H; Gonzalo, JA; Gosselin, M; Owen, LR; Rudd, CE; Gutierrez-Ramos, JC			The CD28-related molecule ICOS is required for effective T cell-dependent immune responses	IMMUNITY			English	Article							IN-VIVO; CUTTING EDGE; TNF-ALPHA; CTLA-4; ACTIVATION; INDUCTION; CD28; RECEPTORS; BLOCKADE; ANTIGEN	While CD28 is critical for expansion of naive T cells, recent evidence suggests that the activation of effector T cells is largely independent of CD28/B7. We suggest that ICOS, the third member of the CD28/CTLA-4 family, plays an important role in production of IL-2, IL-4, IL-5, and lFN gamma from recently activated T cells and contributes to T cell-dependent B help in vivo. Inhibition of ICOS attenuates lung mucosal inflammation induced by Th2 but not Th1 effector populations. Our data indicate a critical function for the third member of the CD28 family in T cell-dependent immune responses.	Millennium Pharmaceut Inc, Dept Biol, Inflammat Div, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Coyle, AJ (corresponding author), Millennium Pharmaceut Inc, Dept Biol, Inflammat Div, Cambridge, MA 02139 USA.	coyle@mpi.com; gutierrez@mpi.com	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019; Lloyd, Clare/0000-0001-8977-6726	Wellcome Trust [087618] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Brown DR, 1996, J EXP MED, V184, P803, DOI 10.1084/jem.184.3.803; Chapman NR, 1999, J COMPUT ACOUST, V7, P1, DOI 10.1142/S0218396X99000023; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; CORRY DB, 1994, J IMMUNOL, V153, P4142; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; CROSS AH, 1995, J CLIN INVEST, V95, P2783, DOI 10.1172/JCI117982; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Gause WC, 1996, EXP PARASITOL, V84, P264, DOI 10.1006/expr.1996.0112; Gause WC, 1997, J IMMUNOL, V158, P4082; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Harris NL, 1999, EUR J IMMUNOL, V29, P311, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;311::AID-IMMU311&gt;3.0.CO;2-B; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JENKINS MK, 1991, J IMMUNOL, V147, P2461; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lefort J, 1998, J IMMUNOL, V161, P474; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; LU P, 1995, J IMMUNOL, V154, P1078; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Rulifson IC, 1997, J IMMUNOL, V158, P658; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tang AM, 1996, J IMMUNOL, V157, P117; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; Tsuyuki S, 1997, J EXP MED, V185, P1671, DOI 10.1084/jem.185.9.1671; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu Y, 1998, J EXP MED, V187, P1151, DOI 10.1084/jem.187.7.1151; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	50	414	466	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					95	105		10.1016/S1074-7613(00)00011-X	http://dx.doi.org/10.1016/S1074-7613(00)00011-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933398	Bronze			2022-12-18	WOS:000088463600010
J	Kumar, BV; Connors, TJ; Farber, DL				Kumar, Brahma V.; Connors, Thomas J.; Farber, Donna L.			Human T Cell Development, Localization, and Function throughout Life	IMMUNITY			English	Review							RECENT THYMIC EMIGRANTS; EFFECTOR MEMORY CELLS; IMMUNE RECONSTITUTION; NEONATAL THYMECTOMY; DIGEORGE-SYNDROME; LYMPHOID ORGANS; DENDRITIC CELLS; BONE-MARROW; RESIDENT; TISSUE	Throughout life, T cells coordinate multiple aspects of adaptive immunity, including responses to pathogens, allergens, and tumors. In mouse models, the role of T cells is studied in the context of a specific type of pathogen, antigen, or disease condition over a limited time frame, whereas in humans, T cells control multiple insults simultaneously throughout the body and maintain immune homeostasis over decades. In this review, we discuss how human T cells develop and provide essential immune protection at different life stages and highlight tissue localization and subset delineation as key determinants of the T cell functional role in immune responses. We also discuss how anatomic compartments undergo distinct age-associated changes in T cell subset composition and function over a lifetime. It is important to consider age and tissue influences on human T cells when developing targeted strategies to modulate T cell-mediated immunity in vaccines and immunotherapies.	[Kumar, Brahma V.; Connors, Thomas J.; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Connors, Thomas J.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Farber, DL (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA.; Farber, DL (corresponding author), Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA.; Farber, DL (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	df2396@cumc.columbia.edu		Connors, Thomas/0000-0002-0199-7733; Farber, Donna/0000-0001-8236-9183	NIH [AI106697, AI128949]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100119, P01AI106697, U19AI128949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI106697 and AI128949 awarded to D.L.F. We wish to thank Michelle Miron for critical reading of this manuscript and Dr. Tomer Granot, Ms. Elana Bell, and Joseph Bell for help with the figures.	Abdelsamed HA, 2017, J EXP MED, V214, P1593, DOI 10.1084/jem.20161760; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bingaman AW, 2005, EUR J IMMUNOL, V35, P3173, DOI 10.1002/eji.200526004; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Booth JS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00294; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Carpenter DJ, 2018, AM J TRANSPLANT, V18, P74, DOI 10.1111/ajt.14434; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Chinn IK, 2013, CLIN EXP IMMUNOL, V173, P140, DOI 10.1111/cei.12088; Cibrian D, 2017, EUR J IMMUNOL, V47, P946, DOI 10.1002/eji.201646837; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cohen IR, 2014, J AUTOIMMUN, V54, P112, DOI 10.1016/j.jaut.2014.05.002; Cupedo T, 2005, EUR J IMMUNOL, V35, P383, DOI 10.1002/eji.200425763; DALMASSO AP, 1963, J EXP MED, V118, P1089, DOI 10.1084/jem.118.6.1089; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; DeWitt WS, 2015, J VIROL, V89, P4517, DOI 10.1128/JVI.03474-14; Di Benedetto S, 2015, BIOGERONTOLOGY, V16, P631, DOI 10.1007/s10522-015-9563-2; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Evans CJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001653; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Golding A, 2017, CLIN EXP IMMUNOL, V188, P12, DOI 10.1111/cei.12904; Gordon CL, 2017, J EXP MED, V214, P651, DOI 10.1084/jem.20160758; Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Gurkan S, 2010, AM J TRANSPLANT, V10, P2132, DOI 10.1111/j.1600-6143.2010.03210.x; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; Hazenberg MD, 2002, BLOOD, V99, P3449, DOI 10.1182/blood.V99.9.3449; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hudson LL, 2007, SEMIN IMMUNOL, V19, P297, DOI 10.1016/j.smim.2007.10.002; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Larbi A, 2014, CYTOM PART A, V85A, P25, DOI 10.1002/cyto.a.22351; Li B, 2011, CLIN IMMUNOL, V140, P244, DOI 10.1016/j.clim.2011.04.004; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Markert ML, 2003, BLOOD, V102, P1121, DOI 10.1182/blood-2002-08-2545; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Morawski PA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40838; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Peters JH, 2013, BLOOD, V122, P2213, DOI 10.1182/blood-2013-03-489443; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Radenkovic M, 2017, CLIN EXP IMMUNOL, V187, P418, DOI 10.1111/cei.12892; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Rosenberg SA, 2014, NAT REV CLIN ONCOL, V11, P630, DOI 10.1038/nrclinonc.2014.174; SAKAGUCHI S, 1982, J EXP MED, V156, P1565, DOI 10.1084/jem.156.6.1565; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Silva SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180385; Silva SL, 2016, ONCOTARGET, V7, P12163, DOI 10.18632/oncotarget.7512; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Soares LRB, 1998, J IMMUNOL, V161, P209; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Swaims-Kohlmeier A, 2016, J IMMUNOL, V197, P368, DOI 10.4049/jimmunol.1502628; Tanaskovic S, 2010, IMMUNOL CELL BIOL, V88, P321, DOI 10.1038/icb.2009.108; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Thiault N, 2015, NAT IMMUNOL, V16, P628, DOI 10.1038/ni.3150; Thom JT, 2015, CELL REP, V13, P1125, DOI 10.1016/j.celrep.2015.09.082; Thome JJC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6506; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Trimble CL, 2010, J IMMUNOL, V185, P7107, DOI 10.4049/jimmunol.1002756; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Ugur M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5821; van den Broek T, 2016, J CLIN INVEST, V126, P1126, DOI 10.1172/JCI84997; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Wells WJ, 1998, J THORAC CARDIOV SUR, V115, P1041, DOI 10.1016/S0022-5223(98)70403-9; Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017; Wieten RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149871; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007; Woon HG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005799; Zens KD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85832; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	130	413	428	10	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					202	213		10.1016/j.immuni.2018.01.007	http://dx.doi.org/10.1016/j.immuni.2018.01.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466753	Bronze, Green Accepted			2022-12-18	WOS:000425507800008
J	Zhou, XY; Yu, SY; Zhao, DM; Harty, JT; Badovinac, VP; Xue, HH				Zhou, Xinyuan; Yu, Shuyang; Zhao, Dong-Mei; Harty, John T.; Badovinac, Vladimir P.; Xue, Hai-Hui			Differentiation and Persistence of Memory CD8(+) T Cells Depend on T Cell Factor 1	IMMUNITY			English	Article							BETA-CATENIN; GENE-EXPRESSION; CUTTING EDGE; C-MYC; WNT; EFFECTOR; NAIVE; TRANSCRIPTION; REQUIREMENT; GENERATION	T cell factor 1 (TCF-1) is a transcription factor known to act downstream of the canonical Wnt pathway and is essential for normal T cell development. However, its physiological roles in mature CD8(+) T cell responses are unknown. Here we showed that TCF-1 deficiency limited proliferation of CD8(+) effector T cells and impaired their differentiation toward a central memory phenotype. Moreover, TCF-1-deficient memory CD8(+) T cells were progressively lost over time, exhibiting reduced expression of the antiapoptotic molecule BcI-2 and interleukin-2 receptor beta chain and diminished IL-15-driven proliferation. TCF-1 was directly associated with the Eomes allele and the Wnt-TCF-1 pathway was necessary and sufficient for optimal Eomes expression in naive and memory CD8(+) T cells. Importantly, forced expression of Eomes partly protected TCF-1-deficient memory CD8(+) T cells from time-dependent attrition. Our studies thus identify TCF-1 as a critical player in a transcriptional program that regulates memory CD8 differentiation and longevity.	[Zhou, Xinyuan; Yu, Shuyang; Zhao, Dong-Mei; Harty, John T.; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Zhao, Dong-Mei] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Harty, John T.; Badovinac, Vladimir P.; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA; [Badovinac, Vladimir P.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Zhao, DM (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.	dong-mei-zhao@uiowa.edu; hai-hui-xue@uiowa.edu	Zhou, Xinyuan/AFS-9817-2022; badovinac, Vladimir/O-7760-2015	Xue, Hai-Hui/0000-0002-9163-7669; Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439; Zhou, Xinyuan/0000-0002-1374-8240	NIH [AI077504, AI080966, HL095540, AI083286, AI046653, AI042767, AI050073, AI059752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077504, R01AI083286, R01AI050073, R01AI042767, R37AI042767, R01AI059752, R01AI046653, R21AI042767, R21AI080966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Clevers (Hubrecht Institute, the Netherlands), W. Held (Ludwig Institute for Cancer Research, Switzerland), and Z. Sun (University of Illinois) for providing Tcf7<SUP>-/-</SUP>, p45 Tg, and beta-catenin Tg mice, respectively. We thank S. Reiner (University of Pennsylvania) for providing Eomes cDNA, J. Fishbaugh and G. Rasmussen (Flow Cytometry Core) for advice and assistance with cell sorting, G. Hauser and T. Bair (DNA Facility) for microarray and data analysis, S. Kaech (Yale University) for sharing the protocol for retroviral infection of effector T cells, and K. Legge and J. McGill (University of Iowa) for advice on IL-15R alpha staining. This study is supported in part by NIH grants to H.-H.X. (AI077504, AI080966, and HL095540), to V.P.B. (AI083286), and to J.T.H. (AI046653, AI042767, AI050073, and AI059752).	Badovinac VP, 2007, J IMMUNOL, V179, P53, DOI 10.4049/jimmunol.179.1.53; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jabbari A, 2005, J IMMUNOL, V175, P4829, DOI 10.4049/jimmunol.175.8.4829; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu SY, 2010, J BIOL CHEM, V285, P10179, DOI 10.1074/jbc.M109.088740; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199	48	413	421	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					229	240		10.1016/j.immuni.2010.08.002	http://dx.doi.org/10.1016/j.immuni.2010.08.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20727791	Green Accepted, Bronze			2022-12-18	WOS:000281654900012
J	Qin, ZH; Blankenstein, T				Qin, ZH; Blankenstein, T			CD4(+) T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells	IMMUNITY			English	Article							DISSEMINATED MURINE LEUKEMIA; NECROSIS IN-VIVO; INTERFERON-GAMMA; GENE-TRANSFER; IMMUNE-RESPONSE; LYMPHOCYTES; THERAPY; HELPER; CYCLOPHOSPHAMIDE; INTERLEUKIN-7	Immunity against MHC class II- tumors can be mediated by CD4(+) T cells in the effector phase through an unknown mechanism. We show that this is IFN gamma dependent but does not require IFN gamma receptor (IFN gamma R) expression on tumor cells, T cells, or other hematopoietic cells and that IFN gamma R expression is not necessary in the priming phase. However, tumor immunity requires IFN gamma R expression on nonhematopoietic cells in the effector phase and involves inhibition of tumor-induced angiogenesis. This shows that an effective anti-tumor response involves communication between CD4(+) T cells and nonhematopoietic cells, most likely within the tumor stroma, and that tumor immunity must not entirely rely on direct tumor cell killing.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Qin, ZH (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	zhihai@mdc-berlin.de						Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BARTH RJ, 1991, J EXP MED, V173, P647, DOI 10.1084/jem.173.3.647; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BLANKENSTEIN T, 1991, J EXP MED, V173, P1047, DOI 10.1084/jem.173.5.1047; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Cayeux S, 1997, J IMMUNOL, V158, P2834; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Folkman J, 1998, P NATL ACAD SCI USA, V95, P9064, DOI 10.1073/pnas.95.16.9064; FRANSEN L, 1986, EUR J CANCER CLIN ON, V22, P419, DOI 10.1016/0277-5379(86)90107-0; FUJIWARA H, 1984, J IMMUNOL, V133, P1671; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; GREENBERG PD, 1981, J EXP MED, V154, P952, DOI 10.1084/jem.154.3.952; GREENBERG PD, 1985, J EXP MED, V161, P1122, DOI 10.1084/jem.161.5.1122; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HEMMI S, 1989, P NATL ACAD SCI USA, V86, P9901, DOI 10.1073/pnas.86.24.9901; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; HOCK H, 1993, P NATL ACAD SCI USA, V90, P2774, DOI 10.1073/pnas.90.7.2774; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Lollini PL, 1999, IMMUNOL TODAY, V20, P347, DOI 10.1016/S0167-5699(99)01450-4; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; MURRAY HW, 1985, J IMMUNOL, V134, P1619; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; PREHN RT, 1957, J NATL CANCER I, V18, P769; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHREIBER H, 1999, FUNDAMENTAL IMMUNOLO, P1237; Sgadari C, 1996, P NATL ACAD SCI USA, V93, P13791, DOI 10.1073/pnas.93.24.13791; Sgadari C, 1997, BLOOD, V89, P2635, DOI 10.1182/blood.V89.8.2635; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397	44	413	438	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					677	686		10.1016/S1074-7613(00)80218-6	http://dx.doi.org/10.1016/S1074-7613(00)80218-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894167	Bronze			2022-12-18	WOS:000087937300009
J	Gaidt, MM; Ebert, TS; Chauhan, D; Schmidt, T; Schmid-Burgk, JL; Rapino, F; Robertson, AAB; Cooper, MA; Graf, T; Hornung, V				Gaidt, Moritz M.; Ebert, Thomas S.; Chauhan, Dhruv; Schmidt, Tobias; Schmid-Burgk, Jonathan L.; Rapino, Francesca; Robertson, Avril A. B.; Cooper, Matthew A.; Graf, Thomas; Hornung, Veit			Human Monocytes Engage an Alternative Inflammasome Pathway	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NLRP3 INFLAMMASOME; CELL-DEATH; ACTIVATION; IL-1-BETA; INTERLEUKIN-1; RECOGNITION; MECHANISM; RECEPTOR; INHIBITION	Interleukin-1 beta (IL-1 beta) is a cytokine whose bioactivity is controlled by activation of the inflammasome. However, in response to lipopolysaccharide, human monocytes secrete IL-1 beta independently of classical inflammasome stimuli. Here, we report that this constituted a species-specific response that is not observed in the murine system. Indeed, in human monocytes, lipopolysaccharide triggered an "alternative inflammasome" that relied on NLRP3-ASC-caspase-1 signaling, yet was devoid of any classical inflammasome characteristics including pyroptosome formation, pyroptosis induction, and K+ efflux dependency. Genetic dissection of the underlying signaling pathway in a monocyte transdifferentiation system revealed that alternative inflammasome activation was propagated by TLR4-TRIF-RIPK1-FADD-CASP8 signaling upstream of NLRP3. Importantly, involvement of this signaling cascade was limited to alternative inflammasome activation and did not extend to classical NLRP3 activation. Because alternative inflammasome activation embraces both sensitivity and promiscuity of TLR4, we propose a pivotal role for this signaling cascade in TLR4-driven, IL-1 beta-mediated immune responses and immunopathology in humans.	[Gaidt, Moritz M.; Ebert, Thomas S.; Chauhan, Dhruv; Schmidt, Tobias; Schmid-Burgk, Jonathan L.; Hornung, Veit] Univ Hosp Bonn, Inst Mol Med, D-53127 Bonn, Germany; [Rapino, Francesca; Graf, Thomas] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Rapino, Francesca; Graf, Thomas] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain; [Robertson, Avril A. B.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Hornung, Veit] Univ Munich, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany; [Hornung, Veit] Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany	University of Bonn; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; University of Queensland; University of Munich; University of Munich	Hornung, V (corresponding author), Univ Hosp Bonn, Inst Mol Med, D-53127 Bonn, Germany.; Hornung, V (corresponding author), Univ Munich, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany.; Hornung, V (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.	hornung@genzentrum.lmu.de	Hornung, Veit/C-3565-2012; Schmid-Burgk, Jonathan/GSN-3512-2022; Cooper, Matthew A./C-7988-2009; Robertson, Avril/A-4043-2012	Hornung, Veit/0000-0002-4150-194X; Cooper, Matthew A./0000-0003-3147-3460; Schmidt, Tobias/0000-0003-3102-3515; Schmid-Burgk, Jonathan/0000-0003-0988-2487; Gaidt, Moritz/0000-0002-8009-294X; Robertson, Avril/0000-0002-9652-8357	German Research Foundation [SFB704, SFB670]; ICREA Funding Source: Custom	German Research Foundation(German Research Foundation (DFG)); ICREA(ICREA)	We kindly thank Karin Pelka for providing pHrodo(R) beads, Gabor Horvath for imaging support, Bernardo Franklin for the ASC-staining protocol (all Institute of Innate Immunity, University of Bonn), Michael Zwick for porcine blood (Haus fur Experimentelle Therapie, University of Bonn), and Andreas Jaensch and Harald Farber for support with K<SUP>+</SUP> measurements (Institute for Hygiene and Public Health, University of Bonn). We kindly thank Elmar Endl and his team for FACSorting, Sarah Zuber for great technical support, Grethe Brugmann for obtaining blood samples, and Christopher Jakobs and Bjorn Hiller for help with murine PBMC isolation (all Institute of Molecular Medicine, University of Bonn). We furthermore kindly thank Vishva Dixit (Genentech) and Egil Lien (UMass Medical School) for providing Nlrp3 or Ripk3-deficient animals. This work was supported by grants from the German Research Foundation (SFB704 and SFB670) to V.H. V.H. is a member of the Excellence cluster ImmunoSensation.	Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; DANIS VA, 1990, CLIN EXP IMMUNOL, V80, P435; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; LONNEMANN G, 1989, EUR J IMMUNOL, V19, P1531, DOI 10.1002/eji.1830190903; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McGettrick AF, 2013, DIABETES OBES METAB, V15, P19, DOI 10.1111/dom.12169; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Munford RS, 2010, J INFECT DIS, V201, P175, DOI 10.1086/649558; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Sha WW, 2014, P NATL ACAD SCI USA, V111, P16059, DOI 10.1073/pnas.1412487111; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Storek KM, 2015, IMMUNOL REV, V265, P112, DOI 10.1111/imr.12289; Thorgersen EB, 2009, INFECT IMMUN, V77, P725, DOI 10.1128/IAI.01305-08; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang HB, 2013, PROTEIN CELL, V4, P565, DOI 10.1007/s13238-013-3905-0; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Zhang M., 2015, TRANSLOCATION INTERL	53	412	421	6	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					833	846		10.1016/j.immuni.2016.01.012	http://dx.doi.org/10.1016/j.immuni.2016.01.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27037191	Bronze, Green Published			2022-12-18	WOS:000374444300015
J	SZABO, SJ; JACOBSON, NG; DIGHE, AS; GUBLER, U; MURPHY, KM				SZABO, SJ; JACOBSON, NG; DIGHE, AS; GUBLER, U; MURPHY, KM			DEVELOPMENTAL COMMITMENT TO THE TH2 LINEAGE BY EXTINCTION OF IL-12 SIGNALING	IMMUNITY			English	Article							CD4+ T-CELLS; INTERFERON-GAMMA PRODUCTION; PROTEIN-TYROSINE KINASE; STIMULATORY FACTOR-I; RECEPTOR EXPRESSION; PHENOTYPE DEVELOPMENT; HIGH-AFFINITY; INTERLEUKIN-4; ALPHA; CYTOKINES	Developmental commitment to Th1 or Th2 responses critically influences host susceptibility to particular pathogens. We describe a novel mechanism governing stable commitment to Th2 differentiation. Naive T cells develop strongly polarized Th1 and Th2 profiles by 7 days after activation. However, commitment of these developing cells differs substantially. Although IL-4 reverses early Th1 differentiation, IL-12 cannot reverse early Th2 differentiation. Th1 reversibility results from maintenance of IL-4 signal transduction, whereas Th2 commitment results from rapid loss of IL-12 signaling. The IL-12 signaling defect in Th2 cells results in failure to phosphorylate Jak2, Stat3, and Stat4. Since Th2 cells express the mRNA for the cloned murine IL-12 receptor beta subunit, the signaling defect may involve expression or function of unidentified receptor components. The rapid extinction of IL-12 signaling in Th2 cells provides a demonstration of a mechanism for the stable commitment to a T helper phenotype.	HOFFMANN LA ROCHE INC,DEPT INFLAMMAT AUTOIMMUNE DIS,NUTLEY,NJ 07110	Roche Holding	SZABO, SJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110, USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758	NIAID NIH HHS [AI34580, AI31238] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031238, U01AI034580, U19AI034580] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BOTTOMLY K, 1988, IMMUNOL TODAY, V9, P268, DOI 10.1016/0167-5699(88)91308-4; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; CHIZZONITE R, 1992, J IMMUNOL, V148, P3117; CHUA AO, 1994, J IMMUNOL, V153, P128; DESAI BB, 1992, J IMMUNOL, V148, P3125; DOKTER WHA, 1992, BLOOD, V80, P2721; FOXWELL BMJ, 1989, EUR J IMMUNOL, V19, P1637, DOI 10.1002/eji.1830190918; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1993, INT IMMUNOL, V5, P371; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LOWENTHAL JW, 1988, J IMMUNOL, V140, P456; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OHARA J, 1988, P NATL ACAD SCI USA, V85, P8221, DOI 10.1073/pnas.85.21.8221; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; PEREZ VC, 1995, IN PRESS INT IMMUNOL; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; SCHMITT E, 1994, EUR J IMMUNOL, V24, P343, DOI 10.1002/eji.1830240211; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; SCOTT P, 1991, IMMUNOL TODAY, V12, P346, DOI 10.1016/0167-5699(91)90063-Y; SCOTT P, 1989, IMMUNOL REV, V112, P161, DOI 10.1111/j.1600-065X.1989.tb00557.x; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; TRIPP CS, 1994, J IMMUNOL, V152, P1883; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	46	412	416	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					665	675		10.1016/1074-7613(95)90011-X	http://dx.doi.org/10.1016/1074-7613(95)90011-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796298	Bronze			2022-12-18	WOS:A1995RE53800012
J	Borriello, F; Sethna, MP; Boyd, SD; Schweitzer, AN; Tivol, EA; Jacoby, D; Strom, TB; Simpson, EM; Freeman, GJ; Sharpe, AH				Borriello, F; Sethna, MP; Boyd, SD; Schweitzer, AN; Tivol, EA; Jacoby, D; Strom, TB; Simpson, EM; Freeman, GJ; Sharpe, AH			B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation	IMMUNITY			English	Article							T-CELL ACTIVATION; CTLA-4 COUNTER-RECEPTOR; B-CELLS; CD40 LIGAND; COSTIMULATORY ACTIVITY; CYTOKINE PRODUCTION; INTERFERON-GAMMA; IMMUNE-RESPONSES; TRANSGENIC MICE; DENDRITIC CELLS	Humoral immune responses were characterized in mouse strains lacking either or both B7 molecules. Mice deficient in both B7-1 and B7-2 failed to generate antigen-specific IgG1 and IgG2a responses and lacked germinal centers when immunized by a number of routes and even in the presence of complete Freund's adjuvant. These results demonstrate that B7-mediated signaling plays a critical role in germinal center formation and immunoglobulin class switching in vivo. Mice lacking only B7-1 or B7-2 mounted high-titer antigen-specific IgG responses when immunized in complete Freund's adjuvant, indicating that B7-1 and B7-2 can have overlapping, compensatory functions for IgG responses. When immunized intravenously without adjuvant, B7-2-deficient mice failed to switch antibody isotypes or form germinal centers, whereas B7-1-deficient mice gave antibody responses comparable with wild-type mice. Thus, B7-2 has an important role in initiating antibody responses in the absence of adjuvant, but the induction of B7-1 by adjuvant in B7-P-deficient mice can compensate for the absence of B7-2.	BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV IMMUNOL RES,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV RHEUMATOL IMMUNOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; BETH ISRAEL HOSP,DEPT MED,DIV IMMUNOL,BOSTON,MA 02115; JACKSON LAB,BAR HARBOR,ME 04609; DANA FARBER CANC INST,DEPT MED,DIV HEMATOL MALIGNANCIES,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Jackson Laboratory; Harvard University; Dana-Farber Cancer Institute			Freeman, Gordon/AAC-5380-2019; Simpson, Elizabeth/H-1183-2012	Freeman, Gordon/0000-0002-7210-5616; Sharpe, Arlene/0000-0002-9736-2109; Simpson, Elizabeth/0000-0002-0654-4303; Borriello, Frank/0000-0003-3957-3685	NHLBI NIH HHS [T32 HLO7627] Funding Source: Medline; NIAID NIH HHS [P01 AI35225] Funding Source: Medline; NIAMS NIH HHS [1P30AR42689] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BOOM WH, 1988, J EXP MED, V167, P1350, DOI 10.1084/jem.167.4.1350; BORRIELLO F, 1995, J IMMUNOL, V155, P5490; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; BRETT SJ, 1993, IMMUNOLOGY, V80, P306; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; CLAASSEN E, 1984, J IMMUNOL METHODS, V75, P181, DOI 10.1016/0022-1759(84)90237-0; CROSS AH, 1995, J CLIN INVEST, V95, P2783, DOI 10.1172/JCI117982; DEBOER M, 1993, EUR J IMMUNOL, V23, P3120, DOI 10.1002/eji.1830231212; Ferguson SE, 1996, J IMMUNOL, V156, P4576; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; FREEDMAN AS, 1987, J IMMUNOL, V139, P3260; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; Gajewski TF, 1996, J IMMUNOL, V156, P465; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HAN SH, 1995, J IMMUNOL, V155, P556; HARPER K, 1991, J IMMUNOL, V147, P1037; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; JOHNSON KA, 1995, NUCLEIC ACIDS RES, V23, P1273, DOI 10.1093/nar/23.7.1273; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KASTER KR, 1993, NUCLEIC ACIDS RES, V11, P6895; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; LANIER LL, 1995, J IMMUNOL, V154, P97; LARSEN CP, 1994, J IMMUNOL, V152, P5208; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LIU Y, 1991, INT IMMUNOL, V3, P323, DOI 10.1093/intimm/3.4.323; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; MILLER SD, 1994, IMMUNOL TODAY, V15, P356, DOI 10.1016/0167-5699(94)90173-2; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; RANHEIM EA, 1995, CELL IMMUNOL, V161, P226, DOI 10.1006/cimm.1995.1031; REISER H, 1992, P NATL ACAD SCI USA, V89, P271, DOI 10.1073/pnas.89.1.271; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; STEURER W, 1995, J IMMUNOL, V155, P1165; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wetzler LW, 1996, J EXP MED, V183, P1151, DOI 10.1084/jem.183.3.1151; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YOKOCHI T, 1982, J IMMUNOL, V128, P823	59	411	425	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					303	313		10.1016/S1074-7613(00)80333-7	http://dx.doi.org/10.1016/S1074-7613(00)80333-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075931	Bronze			2022-12-18	WOS:A1997XC61800010
J	Rutishauser, RL; Martins, GA; Kalachikov, S; Chandele, A; Parish, IA; Meffre, E; Jacob, J; Calame, K; Kaech, SM				Rutishauser, Rachel L.; Martins, Gislaine A.; Kalachikov, Sergey; Chandele, Anmol; Parish, Ian A.; Meffre, Eric; Jacob, Joshy; Calame, Kathryn; Kaech, Susan M.			Transcriptional Repressor Blimp-1 Promotes CD8(+) T Cell Terminal Differentiation and Represses the Acquisition of Central Memory T Cell Properties	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; IL-7 RECEPTOR-ALPHA; IN-VIVO; B-CELLS; SELECTIVE EXPRESSION; LINEAGE RELATIONSHIP; GENE-EXPRESSION; EFFECTOR; HOMEOSTASIS; GENERATION	During acute infections, a small population of effector CD8(+) T cells evades terminal differentiation and survives as long-lived memory T cells. We demonstrate that the transcriptional repressor Blimp-1 enhanced the formation of terminally differentiated CD8(+) T cells during lymphocytic choriomeningitis virus (LCMV) infection, and Blimp-1 deficiency promoted the acquisition of memory cell properties by effector cells. Blimp-1 expression was preferentially increased in terminally differentiated effector and "effector memory" (Tem) CD8(+) T cells, and gradually decayed after infection as central memory (Tcm) cells developed. Blimp-1-deficient effector CD8(+) T cells showed some reduction in effector molecule expression, but primarily developed into memory precursor cells that survived better and more rapidly acquired several Tcm cell attributes, including CD62L and IL-2 expression and enhanced proliferative responses. These results reveal a critical role for Blimp-1 in controlling terminal differentiation and suppressing memory cell developmental potential in effector CD8(+) T cells during viral infection.	[Rutishauser, Rachel L.; Chandele, Anmol; Parish, Ian A.; Meffre, Eric; Kaech, Susan M.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Kalachikov, Sergey] Columbia Univ, Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; [Martins, Gislaine A.; Calame, Kathryn] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Jacob, Joshy] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr,Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA	Yale University; Columbia University; Columbia University; Emory University	Kaech, SM (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.	susan.kaech@yale.edu		Rutishauser, Rachel/0000-0003-3596-059X; Parish, Ian/0000-0003-3528-478X	Burroughs Wellcome Fund; NIH [RO1-AI066232, R21-AI077075, R01-AI50659, R01-AI43576, MSTP TG 5T32GM07205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077075, R01AI050659, R01AI043576, R01AI066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Kaech laboratory, Drs. J. Craft, R. Medzhitov, A. Poholek and T. Bondar for helpful comments and suggestions. We also thank Dr. Frank Constantini for the kind gift of ROSA26:EYFP mice. This work was supported by grants from the Burroughs Wellcome Fund and the NIH RO1-AI066232 and R21-AI077075 (S.M.K.), R01-AI50659 and R01-AI43576 (K.C.), and MSTP TG 5T32GM07205 (R.L.R.).	Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Badovinac VP, 2007, J IMMUNOL, V179, P53, DOI 10.4049/jimmunol.179.1.53; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chappell C, 2006, J IMMUNOL, V176, P4562, DOI 10.4049/jimmunol.176.8.4562; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gaspal FMC, 2005, J IMMUNOL, V174, P3891, DOI 10.4049/jimmunol.174.7.3891; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Heffner M, 2007, P NATL ACAD SCI USA, V104, P13414, DOI 10.1073/pnas.0706040104; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; HUANG S, 1994, CELL, V78, P9, DOI 10.1016/0092-8674(94)90565-7; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Manders PM, 2005, P NATL ACAD SCI USA, V102, P7418, DOI 10.1073/pnas.0501585102; Maris CH, 2003, J IMMUNOL, V171, P2393, DOI 10.4049/jimmunol.171.5.2393; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Ruby CE, 2007, EUR J IMMUNOL, V37, P157, DOI 10.1002/eji.200636428; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; TRIPP RA, 1995, J IMMUNOL, V154, P5870; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wilson DC, 2008, J IMMUNOL, V180, P5935, DOI 10.4049/jimmunol.180.9.5935; Zhang ML, 2007, J IMMUNOL, V178, P3483, DOI 10.4049/jimmunol.178.6.3483; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	61	410	427	4	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 21	2009	31	2					296	308		10.1016/j.immuni.2009.05.014	http://dx.doi.org/10.1016/j.immuni.2009.05.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19664941	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000269338600015
J	Ito, T; Hanabuchi, S; Wang, YH; Park, WR; Arima, K; Bover, L; Qin, FXF; Gilliet, M; Liu, YJ				Ito, Tomoki; Hanabuchi, Shino; Wang, Yi-Hong; Park, Woong Ryeon; Arima, Kazuhiko; Bover, Laura; Qin, F. Xiao-Feng; Gilliet, Michel; Liu, Yong-Jun			Two functional subsets of FOXP3(+) regulatory T cells in human thymus and periphery	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; PLASMACYTOID DENDRITIC CELLS; INTERLEUKIN-10 PRODUCTION; SUPPRESSIVE FUNCTION; EPITHELIAL-CELLS; HUMAN THYMOCYTES; RETINOIC-ACID; REG-CELLS; IN-VITRO; EXPRESSION	Previous studies suggest that thymus produces a homogenous population of natural regulatory T (Treg) cells that express a transcriptional factor FOXP3 and control autoimmunity through a cell-contact-dependent mechanism. We found two subsets of FOXP3(+) natural Treg cells defined by the expression of the costimulatory molecule ICOS in the human thym us and periphery. Whereas the ICOS(+)FOXP3(+) Treg cells used interleukin-10 to suppress dendritic cell function and transforming growth factor (TGF)-beta to suppress T cell function, the ICOS(-)FOXP3(+) Treg cells used TGF-beta only. The survival and proliferation of the two subsets of Treg cells were differentially regulated by signaling through ICOS or CD28, respectively. We suggest that the selection of natural Treg cells in thymus is coupled with Treg cell differentiation into two subsets imprinted with different cytokine expression potentials and use both cell-contact-dependent and independent mechanisms for immunosuppression in periphery.	[Ito, Tomoki; Hanabuchi, Shino; Wang, Yi-Hong; Park, Woong Ryeon; Arima, Kazuhiko; Bover, Laura; Qin, F. Xiao-Feng; Gilliet, Michel; Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Ito, Tomoki; Hanabuchi, Shino; Wang, Yi-Hong; Park, Woong Ryeon; Arima, Kazuhiko; Bover, Laura; Qin, F. Xiao-Feng; Gilliet, Michel; Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, YJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	yjliu@mdanderson.org	Arima, Kazuhiko/I-8962-2014; Hanabuchi, Shino/AAI-8676-2021	Arima, Kazuhiko/0000-0002-0607-8787; QIN, FRANK XIAOFENG/0000-0002-5395-0304	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130, R01AI062888] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI071130, U19 AI071130-01, R01 AI062888-05, R01 AI062888] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238; Annunziato F, 2002, J EXP MED, V196, P379, DOI 10.1084/jem.20020110; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Asseman C, 1998, GUT, V42, P157, DOI 10.1136/gut.42.2.157; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Goldschneider I, 2003, TRENDS IMMUNOL, V24, P77, DOI 10.1016/S1471-4906(02)00038-8; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Janke M, 2006, IMMUNOLOGY, V118, P353, DOI 10.1111/j.1365-2567.2006.02379.x; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kadowaki N, 2002, HUM IMMUNOL, V63, P1126, DOI 10.1016/S0198-8859(02)00751-6; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Tarbell KV, 2006, SEMIN IMMUNOL, V18, P93, DOI 10.1016/j.smim.2006.01.009; Thompson C, 2004, CURR OPIN PHARMACOL, V4, P408, DOI 10.1016/j.coph.2004.05.001; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x	54	410	427	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					870	880		10.1016/j.immuni.2008.03.018	http://dx.doi.org/10.1016/j.immuni.2008.03.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18513999	Green Accepted, Bronze			2022-12-18	WOS:000256760200017
J	Park, SY; Saijo, K; Takahashi, T; Osawa, M; Arase, H; Hirayama, N; Miyake, K; Nakauchi, H; Shirasawa, T; Saito, T				Park, SY; Saijo, K; Takahashi, T; Osawa, M; Arase, H; Hirayama, N; Miyake, K; Nakauchi, H; Shirasawa, T; Saito, T			Developmental defects of lymphoid cells in Jak3 kinase-deficient mice	IMMUNITY			English	Article							RECEPTOR GAMMA-CHAIN; IL-2 RECEPTOR; FUNCTIONAL COMPONENT; T-CELLS; INTERLEUKIN-2; ASSOCIATION; GENE	Jak3 is a tyrosine kinase mediating cytokine receptor signaling through the association with the common gamma chain of the cytokine receptors such as IL-2, IL-4, IL-7, IL-9, and IL-15. Unlike other members of the Jak family, the expression of Jak3 is highly restricted in hematopoietic cells. To elucidate in vivo function of Jak3, Jak3-deficient mice were generated by homologous recombination. Mice homozygous for Jak3 null mutation showed severe defects, specifically in lymphoid cells. B cell precursors in bone marrow, thymocytes, and both T and B cells in the spleen drastically decreased, although these defects were significantly recovered as aging occurred. Peripheral lymph nodes, NK cells, dendritic epidermal T cells, and intestinal intraepithelial gamma delta T cells were absent. Normal number of hematopoietic stem cells in bone marrow from Jak3-deficient mice and the similar capability to generate myeloid and erythroid colonies as wild-type mice indicated specific defects in lymphoid stem cells. Furthermore, the abnormal architecture of lymphoid organs suggested the involvement of Jak3 in the function of epithelial cells. T cells developed in the mutant mice did not respond to either IL-2, IL-4, or IL-7. These findings establish the crucial role of Jak3 in the development of lymphoid cells.	TOKYO METROPOLITAN INST GERONTOL,DEPT MOLEC PATHOL,ITABASHI KU,TOKYO 173,JAPAN; UNIV TSUKUBA,SCH MED,DEPT IMMUNOL,TSUKUBA,IBARAKI 305,JAPAN; NATL INST HLTH & NUTR,DEPT IMMUNOL,SHINJUKU KU,TOKYO 162,JAPAN	Tokyo Metropolitan Institute of Gerontology; University of Tsukuba; National Institute of Health & Nutrition - Japan	Park, SY (corresponding author), CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOLEC GENET,CHUO KU,1-8-1 INOHANA,CHIBA 260,JAPAN.		Arase, Hisashi/C-8442-2009; Saito, Takashi/C-9684-2009	Arase, Hisashi/0000-0002-1153-3166; Saito, Takashi/0000-0001-9495-3547; Takahashi, Takamune/0000-0002-4841-2499; Osawa, Masatake/0000-0002-5318-9826				BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUWATA T, 1995, BIOCHEM BIOPH RES CO, V213, P768, DOI 10.1006/bbrc.1995.2196; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; MINAMI Y, 1993, EMBO J, V12, P759, DOI 10.1002/j.1460-2075.1993.tb05710.x; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; TAKAHASHI T, 1995, BIOCHEM BIOPH RES CO, V209, P218, DOI 10.1006/bbrc.1995.1492; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANAKA N, 1994, P NATL ACAD SCI USA, V91, P7271, DOI 10.1073/pnas.91.15.7271; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	37	410	424	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					771	782		10.1016/1074-7613(95)90066-7	http://dx.doi.org/10.1016/1074-7613(95)90066-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777722	Bronze			2022-12-18	WOS:A1995TM02300011
J	Henkart, PA				Henkart, PA			ICE family proteases: Mediators of all apoptotic cell death?	IMMUNITY			English	Review							GENE CED-3; ENZYME; ENCODES				Henkart, PA (corresponding author), NCI,EXPTL IMMUNOL BRANCH,NIH,BETHESDA,MD 20892, USA.							ALNEMRI ES, 1995, J BIOL CHEM, V270, P4312, DOI 10.1074/jbc.270.9.4312; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; ENARI M, 1995, EMBO J, V14, P5201, DOI 10.1002/j.1460-2075.1995.tb00204.x; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GETTINS P, 1993, BIOESSAYS, V15, P461, DOI 10.1002/bies.950150705; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; HAY BA, 1994, DEVELOPMENT, V120, P2121; HORVITZ HR, 1994, COLD SPRING HARB SYM, V59, P377, DOI 10.1101/SQB.1994.059.01.042; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; KUMAR S, 1995, FEBS LETT, V368, P69, DOI 10.1016/0014-5793(95)00602-6; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEE MR, 1993, J IMMUNOL, V151, P5208; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; MASHIMA T, 1995, BIOCHEM BIOPH RES CO, V209, P907, DOI 10.1006/bbrc.1995.1584; MEMON SA, 1995, J IMMUNOL, V155, P4644; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; NAKAJIMA H, 1995, J EXP MED, V181, P1905, DOI 10.1084/jem.181.5.1905; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; RABIZADEH S, 1993, J NEUROCHEM, V61, P2318, DOI 10.1111/j.1471-4159.1993.tb07477.x; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; SMITH ML, 1994, EXP CELL RES, V215, P386, DOI 10.1006/excr.1994.1356; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; VASILAKOS JP, 1995, J IMMUNOL, V155, P3433; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; WILLIAMS MS, 1994, J IMMUNOL, V153, P4247; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wyllie A H, 1980, Int Rev Cytol, V68, P251; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; ZHU HJ, 1995, FEBS LETT, V374, P303, DOI 10.1016/0014-5793(95)01116-V	52	409	429	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					195	201		10.1016/S1074-7613(00)80428-8	http://dx.doi.org/10.1016/S1074-7613(00)80428-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624810	Bronze			2022-12-18	WOS:A1996UC01800001
J	Yang, DD; Conze, D; Whitmarsh, AJ; Barrett, T; Davis, RJ; Rincon, M; Flavell, RA				Yang, DD; Conze, D; Whitmarsh, AJ; Barrett, T; Davis, RJ; Rincon, M; Flavell, RA			Differentiation of CD4(+) T cells to Th1 cells requires MAP kinase JNK2	IMMUNITY			English	Article							AP-1 TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION PATHWAY; JUN NH2-TERMINAL KINASE; IFN-GAMMA; IL-4-PRODUCING CELLS; SELECTIVE EXPRESSION; INTERLEUKIN-12; ACTIVATION; RECEPTOR; LYMPHOCYTES	Precursor CD4(+) T cells develop into effector Th1 and Th2 cells that play a central role in the immune response. We show that the JNK MAP kinase pathway is induced in Th1 but not in Th2 effector cells upon antigen stimulation. Further, the differentiation of precursor CD4(+) T cells into effector Th1 but not Th2 cells is impaired in JNK2-deficient mice. The inability of IL-12 to differentiate JNK2-deficient CD4(+) T cells fully into effector Th1 cells is caused by a defect in IFN gamma production during the early stages of differentiation. The addition of exogenous IFN gamma during differentiation restores IL-12-mediated Th1 polarization in the JNK2-deficient mice. The JNK MAP kinase signaling pathway, therefore, plays an important role in the balance of Th1 and Th2 immune responses.	Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Vermont; Yale University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Rincon, M (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA.			Whitmarsh, Alan/0000-0003-1184-6610	NCI NIH HHS [P01 CA72009, R01 CA65861] Funding Source: Medline; NIAID NIH HHS [P01 AI36529] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072009, R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036529] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Bradley LM, 1996, J IMMUNOL, V157, P1350; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; GILLIS S, 1978, J IMMUNOL, V120, P1109; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rincon Mercedes, 1997, Genes and Function, V1, P51; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SWAIN SL, 1995, CURR BIOL, V5, P849, DOI 10.1016/S0960-9822(95)00170-9; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Wenner CA, 1996, J IMMUNOL, V156, P1442; Whitmarsh A. J., 1996, J MOL MED, V17, P2360; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	40	408	431	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					575	585		10.1016/S1074-7613(00)80640-8	http://dx.doi.org/10.1016/S1074-7613(00)80640-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806643	Bronze			2022-12-18	WOS:000076680700015
J	Kwon, DS; Gregorio, G; Bitton, N; Hendrickson, WA; Littman, DR				Kwon, DS; Gregorio, G; Bitton, N; Hendrickson, WA; Littman, DR			DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection	IMMUNITY			English	Article							DENDRITIC CELLS; CARCINOMA A431-CELLS; DISEASE PROGRESSION; MEMBRANE-FUSION; LEUKEMIA-VIRUS; CORECEPTOR USE; G-PROTEIN; LOW PH; RECEPTOR; TRANSMISSION	Fusion of the human immunodeficiency virus (HIV) to the plasma membrane of target cells is mediated by interaction of its envelope glycoprotein, gp120, with CD4 and appropriate chemokine receptors. gp120 additionally binds to DC-SIGN, a C-type lectin expressed on immature dendritic cells. This interaction does not result in viral fusion, but instead contributes to enhanced infection in trans of target cells that express CD4 and chemokine receptors. Here we show that DC-SIGN mediates rapid internalization of intact HIV into a low pH nonlysosomal compartment. Internalized virus retains competence to infect target cells. Removal of the DC-SIGN cytoplasmic tail reduced viral uptake and abrogated the trans-enhancement of T cell infection. We propose that HIV binds to DC-SIGN to gain access to an intracellular compartment that contributes to augmentation or retention of viral infectivity.	NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Howard Hughes Medical Institute; New York University; New York University; Columbia University; Howard Hughes Medical Institute	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA.			Gregorio, Gabriel Glenn/0000-0001-8677-133X				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; CHEN JW, 1988, J BIOL CHEM, V263, P8754; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CORNELISSEN M, 1995, J VIROL, V69, P1810, DOI 10.1128/JVI.69.3.1810-1818.1995; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; GEISOW MJ, 1984, EXP CELL RES, V150, P29, DOI 10.1016/0014-4827(84)90698-0; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; KEMPF C, 1991, J ACQ IMMUN DEF SYND, V4, P828; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Rowland-Jones SL, 1999, CURR BIOL, V9, pR248, DOI 10.1016/S0960-9822(99)80155-9; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; STEINMAN RM, 1999, DENDRITIC CELLS BIOL; Tacchetti C, 1997, AM J PATHOL, V150, P533; TEW JG, 1980, IMMUNOL REV, V53, P175; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	46	405	424	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					135	144		10.1016/S1074-7613(02)00259-5	http://dx.doi.org/10.1016/S1074-7613(02)00259-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825572	Bronze			2022-12-18	WOS:000173575700013
J	Gumperz, JE; Roy, C; Makowska, A; Lum, D; Sugita, M; Podrebarac, T; Koezuka, Y; Porcelli, SA; Cardell, S; Brenner, MB; Behar, SM				Gumperz, JE; Roy, C; Makowska, A; Lum, D; Sugita, M; Podrebarac, T; Koezuka, Y; Porcelli, SA; Cardell, S; Brenner, MB; Behar, SM			Murine CD1d-restricted T cell recognition of cellular lipids	IMMUNITY			English	Article							MOUSE CD1; ANTIGEN PRESENTATION; MOLECULES; LYMPHOCYTES; REACTIVITY; EXPRESSION; PATTERNS; SUBSET; MICE; TCR	NKT cells are associated with immunological control of autoimmune disease and cancer and can recognize cell surface mCD1d without addition of exogenous antigens. Cellular antigens presented by mCD1d have not been identified, although NKT cells can recognize a synthetic glycolipid, alpha-GalCer. Here we show that after addition of a lipid extract from a tumor cell line, plate-bound mCD1d molecules stimulated an NKT cell hybridoma. This hybridoma also responded strongly to three purified phospholipids, but failed to recognize alpha-GalCer. Seven of sixteen other mCD1d restricted hybridomas also showed a response to certain purified phospholipids. These findings suggest NKT cells can recognize cellular antigens distinct from alpha-GalCer and identify phospholipids as potential self-antigens presented by mCD1d.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Lund, Dept Cell & Mol Biol, Immunol Sect, S-22362 Lund, Sweden; Kirin Brewery Co Ltd, Pharmaceut Res Lab, Takasaki, Gumma 37012, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lund University; Kirin Brewery Company Limited	Behar, SM (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.		Cardell, Susanna/ABC-4944-2021; Behar, Samuel M/C-3541-2009	Sugita, Masahiko/0000-0001-5511-1304; Behar, Samuel/0000-0002-3374-6699	NIAID NIH HHS [AI28973] Funding Source: Medline; NIAMS NIH HHS [AR01978] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028973, R37AI028973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001978] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		[Anonymous], [No title captured]; Apostolou I, 1999, P NATL ACAD SCI USA, V96, P5141, DOI 10.1073/pnas.96.9.5141; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Behar SM, 1999, J IMMUNOL, V162, P161; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Brossay L, 1998, J IMMUNOL, V160, P3681; Brossay L, 1997, J IMMUNOL, V159, P1216; Burdin N, 1998, J IMMUNOL, V161, P3271; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Couedel C, 1998, EUR J IMMUNOL, V28, P4391, DOI 10.1002/(SICI)1521-4141(199812)28:12<4391::AID-IMMU4391>3.0.CO;2-2; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; FOLCH J, 1957, J BIOL CHEM, V226, P497; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kawano T, 1999, INT IMMUNOL, V11, P881, DOI 10.1093/intimm/11.6.881; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; Mandal M, 1998, MOL IMMUNOL, V35, P525, DOI 10.1016/S0161-5890(98)00055-8; Park SH, 1998, J IMMUNOL, V160, P3128; Porcelli SA, 1997, CURR BIOL, V7, pR508, DOI 10.1016/S0960-9822(06)00250-8; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Taniguchi M, 1996, P NATL ACAD SCI USA, V93, P11025, DOI 10.1073/pnas.93.20.11025; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	30	405	433	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					211	221		10.1016/S1074-7613(00)80174-0	http://dx.doi.org/10.1016/S1074-7613(00)80174-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714687	Bronze			2022-12-18	WOS:000085621400011
